PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	BENSON, JA				BENSON, JA			CERTIFICATION AND RECERTIFICATION - ONE APPROACH TO PROFESSIONAL ACCOUNTABILITY	ANNALS OF INTERNAL MEDICINE			English	Article								Professional accountability requires a self-regulating profession to set and maintain credible, useful standards for its members. Voluntary certification and recertification-evaluation by peers-serves the responsibility of the profession to establish and enforce its own standards. The goal of certification by the American Board of Internal Medicine is to improve the quality of medical care by ensuring that the certified internist and subspecialist possess the knowledge, skills, and attitudes essential to the provision of excellent care. Without a true constituency and with a valid certification process, the Board provides a credential sought by nearly every graduate resident and acceptable both to the profession and patients. Recertification now presents the opportunity to foster continuing scholarship and self-improvement throughout the career of an internist.			BENSON, JA (corresponding author), AMER BOARD INTERNAL MED, 200 SW MARKET ST, SUITE 1770, PORTLAND, OR 97201 USA.							GLASSOCK RJ, 1991, ANN INTERN MED, V114, P59, DOI 10.7326/0003-4819-114-1-59; KELLEY WN, 1989, TXB INTERNAL MED; MOORE FD, 1981, NEW ENGL J MED, V304, P1078, DOI 10.1056/NEJM198104303041805; RAMSEY PG, 1989, ANN INTERN MED, V110, P719, DOI 10.7326/0003-4819-110-9-719; RELMAN AS, 1988, NEW ENGL J MED, V319, P1220, DOI 10.1056/NEJM198811033191810; STEIN JH, 1990, INTERNAL MED; THIER SO, 1987, HEALTH AFFAIR, V6, P70, DOI 10.1377/hlthaff.6.4.70	7	33	33	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 1	1991	114	3					238	242		10.7326/0003-4819-114-3-238	http://dx.doi.org/10.7326/0003-4819-114-3-238			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EV339	1984748				2022-12-28	WOS:A1991EV33900012
J	MUDER, RR; BRENNEN, C; WAGENER, MM; VICKERS, RM; RIHS, JD; HANCOCK, GA; YEE, YC; MILLER, JM; YU, VL				MUDER, RR; BRENNEN, C; WAGENER, MM; VICKERS, RM; RIHS, JD; HANCOCK, GA; YEE, YC; MILLER, JM; YU, VL			METHICILLIN-RESISTANT STAPHYLOCOCCAL COLONIZATION AND INFECTION IN A LONG-TERM CARE FACILITY	ANNALS OF INTERNAL MEDICINE			English	Article							AUREUS NASAL CARRIAGE; NOSOCOMIAL INFECTIONS; NURSING-HOMES; STRAIN; CIPROFLOXACIN; HEMODIALYSIS; PROPHYLAXIS; OUTBREAK	Objective: To determine the natural history of colonization by methicillin-resistant Staphylococcus aureus (MRSA) among patients in a long-term care facility. We specifically sought to determine if MRSA colonization was predictive of subsequent infection. Design: Cohort study. Setting: Long-term Veterans Affairs Medical Center. Patients: A total of 197 patients residing on two units were followed with regular surveillance cultures of the anterior nares. Main Outcome Measurement: The development of staphylococcal infection. Results: Thirty-two patients were persistent carriers of MRSA and 44 were persistent carriers of methicillin-susceptible strains (MSSA). Twenty-five percent of MRSA carriers had an episode of staphylococcal infection compared with 4% of MSSA carriers and 4.5% of non-carriers (P < 0.01; relative risk 3.8%; 95% CI, 2.0 to 6.4). The rate of development of infection among MRSA carriers was 15% for every 100 days of carriage. Using logistic regression analysis, persistent MRSA carriage was the most significant predictor of infection (P < 0.001; odds ratio, 3.7). Seventy-three percent of all MRSA infections occurred among MRSA carriers. Isolates of MRSA from 7 patients were typed. Colonizing and infecting strains had the same phage type in all 7 patients and the same pattern of plasmid EcoRI restriction endonuclease fragments in 5 patients. Conclusions: Colonization of the anterior nares by MRSA predicts the development of staphylococcal infection in long-term care patients; most infections arise from endogenously carried strains. Colonization by MRSA indicates a significantly greater risk for infection than does colonization by MSSA. The results offer a theoretic rationale for reduction in MRSA infections by interventions aimed at eliminating the carrier state.	UNIV PITTSBURGH, SCH MED, PITTSBURGH, PA 15261 USA; CTR DIS CONTROL, ATLANTA, GA 30333 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Centers for Disease Control & Prevention - USA	MUDER, RR (corresponding author), PITTSBURGH VET AFFAIRS MED CTR, INFECT DIS SECT, UNIV DR C, PITTSBURGH, PA 15240 USA.							AEILTS GD, 1982, J CLIN MICROBIOL, V16, P218, DOI 10.1128/JCM.16.2.218-223.1982; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; BOYCE JM, 1981, INFECT CONT HOSP EP, V2, P110, DOI 10.1017/S0195941700053881; BRENNEN C, 1990, AM J MED, V88, pN14; BRUMFITT W, 1989, NEW ENGL J MED, V320, P1188, DOI 10.1056/NEJM198905043201806; CEDERNA JE, 1990, INFECT CONT HOSP EP, V11, P13, DOI 10.1086/646072; CHOW JW, 1989, ARCH INTERN MED, V149, P1258, DOI 10.1001/archinte.149.6.1258; COLEMAN DC, 1986, J HOSP INFECT, V7, P29, DOI 10.1016/0195-6701(86)90005-8; CRAVEN DE, 1981, AM J MED, V71, P53, DOI 10.1016/0002-9343(81)90258-8; CROSSLEY KB, 1985, JAMA-J AM MED ASSOC, V254, P2918, DOI 10.1001/jama.254.20.2918; GARIBALDI RA, 1981, NEW ENGL J MED, V305, P731, DOI 10.1056/NEJM198109243051304; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; HALEY RW, 1982, ANN INTERN MED, V97, P297, DOI 10.7326/0003-4819-97-3-297; HSU CCS, 1988, ARCH INTERN MED, V148, P569, DOI 10.1001/archinte.148.3.569; ISCHHOROWICZ D, 1984, NUCLEIC ACIDS RES, V9, P2989; Kloos W, 1985, MANUAL CLIN MICROBIO, P143; LACEY RW, 1987, J HOSP INFECT, V9, P103, DOI 10.1016/0195-6701(87)90046-6; LINNEMANN CC, 1982, AM J EPIDEMIOL, V115, P941, DOI 10.1093/oxfordjournals.aje.a113381; LUZAR MA, 1990, NEW ENGL J MED, V322, P505, DOI 10.1056/NEJM199002223220804; MACRINA FL, 1978, PLASMID, V1, P417, DOI 10.1016/0147-619X(78)90056-2; MULLIGAN ME, 1987, AM J MED, V82, P215; PEACOCK JE, 1981, J INFECT DIS, V144, P575, DOI 10.1093/infdis/144.6.575; PRICE LE, 1985, INFECT CONT HOSP EP, V6, P437, DOI 10.1017/S0195941700064778; ROCCAFORTE JS, 1988, AM J INFECT CONTROL, V16, P141, DOI 10.1016/0196-6553(88)90024-7; SMITH PB, 1972, STAPHYLOCOCCI, P431; SMITH SM, 1989, ANTIMICROB AGENTS CH, V33, P181, DOI 10.1128/AAC.33.2.181; STORCH GA, 1987, INFECT CONT HOSP EP, V8, P24, DOI 10.1017/S0195941700066947; THOMAS JC, 1989, INFECT CONT HOSP EP, V10, P106, DOI 10.1086/645976; THOMPSON RL, 1982, ANN INTERN MED, V97, P309, DOI 10.7326/0003-4819-97-3-309; THORNSBERRY C, 1983, J CLIN MICROBIOL, V18, P1084, DOI 10.1128/JCM.18.5.1084-1091.1983; TUAZON CU, 1975, ANN INTERN MED, V82, P788, DOI 10.7326/0003-4819-82-6-788; WRIGHT CE, 1989, 29TH INT C ANT AG CH; YU VL, 1986, NEW ENGL J MED, V315, P91, DOI 10.1056/NEJM198607103150204	33	304	305	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 15	1991	114	2					107	112		10.7326/0003-4819-114-2-1-107	http://dx.doi.org/10.7326/0003-4819-114-2-1-107			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ER534	1984384				2022-12-28	WOS:A1991ER53400002
J	ZARCHY, TM; ERSHOFF, D				ZARCHY, TM; ERSHOFF, D			WHICH CLINICAL-VARIABLES PREDICT AN ABNORMAL DOUBLE-CONTRAST BARIUM ENEMA RESULT	ANNALS OF INTERNAL MEDICINE			English	Article							CANCER	Objective: To determine the relations among patient history, symptoms, objective indicators, and abnormal double-contrast barium enema results in outpatients. Patients and Setting: Seven hundred and ninety-four patients receiving care in a large multispecialty medical group. Design: Physicians completed a form before ordering a double-contrast barium enema, listing information about patient history, symptoms, and objective findings, including the results of a complete blood count, stool hemoccult, and sigmoidoscopy. Measurements and Main Results: Outcome measures were colon cancer and any abnormal finding. The results of 18.6% of the barium enemas were abnormal. The most frequent positive findings were of polyps (8.8%) and colon cancer (2.9%). Over 50% of the barium enemas were ordered solely on the basis of symptoms, yet there was no statistical correlation between symptoms and colon cancer or any positive finding. Using logistic regression, four variables were shown to be significant predictors of colon cancer (P < 0.05): abnormal sigmoidoscopy, iron deficiency anemia, positive stool hemoccult results, and relevant history. The respective odds ratios of these variables were 3.76 (95% CI, 2.89 to 4.90); 2.86 (CI, 2.13 to 3.74); 1.87 (CI, 1.46 to 2.39); and 1.91 (CI, 1.44 to 2.52), respectively. In a patient without any of these indicators, the predicted probability of having colon cancer was only 0.7%. In a patient with at least two objective indicators, the probability of having colon cancer was greater than 15%. Conclusions: Symptoms without objective indicators or pertinent risk factors do not correlate with an abnormal double-contrast barium enema result. Objective indicators are useful predictors of an abnormal barium enema result, particularly when looking for colon cancer.	HAWTHORNE COMMUNITY MED GRP, LOS ANGELES, CA USA; SO CALIF PERMANENTE MED GRP, PASADENA, CA USA	Kaiser Permanente; Southern California Permanente Medical Group (SCPMG); Permanente Medical Groups								BARRY MJ, 1987, GASTROENTEROLOGY, V93, P301, DOI 10.1016/0016-5085(87)91019-5; DEVROEDE G, 1989, GASTROINTESTINAL DIS, P331; DROSSMAN DA, 1988, HOSP PRACT, V23, P119; DROSSMAN DA, 1989, ANN INTERN MED, V111, P627, DOI 10.7326/0003-4819-111-8-627; EDDY DM, 1990, ANN INTERN MED, V113, P373, DOI 10.7326/0003-4819-113-5-373; FLEISCHER DE, 1989, JAMA-J AM MED ASSOC, V261, P580, DOI 10.1001/jama.261.4.580; GERSON DE, 1979, RADIOLOGY, V130, P297, DOI 10.1148/130.2.297; GROSSMAN S, 1988, GASTROENTEROLOGY, V94, P395, DOI 10.1016/0016-5085(88)90427-1; HARVEY RF, 1987, LANCET, V1, P963; LODD DD, 1985, CARCINOMA LARGE BOWE, P133; MACEWAN DW, 1978, RADIOLOGY, V126, P39, DOI 10.1148/126.1.39; OTT DJ, 1985, SOUTHERN MED J, V78, P1033, DOI 10.1097/00007611-198509000-00002; TEDESCO FJ, 1978, ANN INTERN MED, V89, P907, DOI 10.7326/0003-4819-89-6-907; ZARCHY TM, 1984, GASTROENTEROLOGY, V86, P1307; 1987, MEDICARE BARIUM ENEM	15	13	13	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 15	1991	114	2					137	141		10.7326/0003-4819-114-2-137	http://dx.doi.org/10.7326/0003-4819-114-2-137			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ER534	1984389				2022-12-28	WOS:A1991ER53400007
J	CHUN, JJM; SCHATZ, DG; OETTINGER, MA; JAENISCH, R; BALTIMORE, D				CHUN, JJM; SCHATZ, DG; OETTINGER, MA; JAENISCH, R; BALTIMORE, D			THE RECOMBINATION ACTIVATING GENE-1 (RAG-1) TRANSCRIPT IS PRESENT IN THE MURINE CENTRAL-NERVOUS-SYSTEM	CELL			English	Article							DENTATE GYRUS; ORIGIN; TIME; SUPERFAMILY; NEURONS; SUBSETS; CORTEX; BRAIN; MICE; RAT	The recombination activating genes, RAG-1 and RAG-2, are likely to encode components of the V(D)J site-specific recombination machinery. We report here the detection of low levels of the RAG-1 transcript in the murine central nervous system by polymerase chain reaction, in situ hybridization, and Northern blot analyses. In contrast, an authentic RAG-2 transcript could not be detected reproducibly in the central nervous system. The RAG-1 transcript was found to be widespread in embryonic and postnatal neurons, with transcription being most apparent in regions of the postnatal brain with a high neuronal cell density (the cerebellum and the hippocampal formation). The results suggest that RAG-1 functions in neurons, where its role might be to recombine elements of the neuronal genome site-specifically, or to prevent detrimental alterations of the genome in these long-lived cells.	MIT, DEPT BIOL, CAMBRIDGE, MA 02139 USA; ROCKEFELLER UNIV, NEW YORK, NY 10021 USA	Massachusetts Institute of Technology (MIT); Rockefeller University	CHUN, JJM (corresponding author), WHITEHEAD INST BIOMED RES, 9 CAMBRIDGE CTR, CAMBRIDGE, MA 02142 USA.		Schatz, David/A-6748-2013	Schatz, David/0000-0002-5669-1176	NATIONAL CANCER INSTITUTE [R35CA044339] Funding Source: NIH RePORTER; NCI NIH HHS [5R35-CA 44339, CA51466] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AGUILERA A, 1990, MOL CELL BIOL, V10, P1439, DOI 10.1128/MCB.10.4.1439; ALT FW, 1984, EMBO J, V3, P1209, DOI 10.1002/j.1460-2075.1984.tb01955.x; ALTMAN J, 1972, J COMP NEUROL, V145, P353, DOI 10.1002/cne.901450305; ANGEVINE JAY B., 1965, EXP NEUROL SUPPL, V2, P1; ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; Ausubel FM, 1988, MOL REPROD DEV; BOSMA GC, 1983, NATURE, V301, P527, DOI 10.1038/301527a0; BRAITENBERG V, 1958, J COMP NEUROL, V109, P1, DOI 10.1002/cne.901090102; CARLSON LM, 1991, CELL, V64, P201, DOI 10.1016/0092-8674(91)90221-J; CAVINESS VS, 1982, DEV BRAIN RES, V4, P293, DOI 10.1016/0165-3806(82)90141-9; CAVINESS VS, 1973, J COMP NEUROL, V151, P113, DOI 10.1002/cne.901510203; CHUN JJM, 1989, J NEUROSCI, V9, P1648; CLAYTON DF, 1988, NEURON, V1, P249, DOI 10.1016/0896-6273(88)90146-8; DREYER WJ, 1967, COLD SPRING HARB SYM, V32, P353, DOI 10.1101/SQB.1967.032.01.048; EDWARDS MKS, 1983, DEV BIOL, V98, P187, DOI 10.1016/0012-1606(83)90348-2; ENOCH T, 1986, MOL CELL BIOL, V6, P801, DOI 10.1128/MCB.6.3.801; FARRAR WL, 1987, IMMUNOL REV, V100, P361, DOI 10.1111/j.1600-065X.1987.tb00539.x; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FULOP GM, 1990, NATURE, V347, P479, DOI 10.1038/347479a0; Goetzl E J, 1990, Adv Immunol, V48, P161, DOI 10.1016/S0065-2776(08)60754-3; HUNKAPILLER T, 1989, ADV IMMUNOL, V44, P1; JONESVILLENEUVE EMV, 1983, MOL CELL BIOL, V3, P2271, DOI 10.1128/MCB.3.12.2271; JONESVILLENEUVE EMV, 1982, J CELL BIOL, V94, P253, DOI 10.1083/jcb.94.2.253; LIEBER MR, 1987, GENE DEV, V1, P751, DOI 10.1101/gad.1.8.751; Maniatis T., 1982, MOL CLONING; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; PARNES JR, 1987, IMMUNOL REV, V100, P109, DOI 10.1111/j.1600-065X.1987.tb00529.x; RAKIC P, 1977, PHILOS T R SOC B, V278, P245, DOI 10.1098/rstb.1977.0040; RALPH P, 1979, IMMUNOL REV, V48, P107, DOI 10.1111/j.1600-065X.1979.tb00300.x; Runnicki M.A., 1987, TERATOCARCINOMAS EMB, P19; SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5; SCHATZ DG, 1988, CELL, V53, P107, DOI 10.1016/0092-8674(88)90492-8; SCHLESSINGER AR, 1978, ANAT EMBRYOL, V154, P153, DOI 10.1007/BF00304660; SCHLESSINGER AR, 1975, J COMP NEUROL, V159, P149, DOI 10.1002/cne.901590202; SCHULER W, 1990, MOL BASIS B CELL DEV, V3, P132; SEED B, 1987, NATURE, V329, P840, DOI 10.1038/329840a0; WANG JC, 1990, CELL, V62, P403, DOI 10.1016/0092-8674(90)90002-V	37	252	259	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 11	1991	64	1					189	200		10.1016/0092-8674(91)90220-S	http://dx.doi.org/10.1016/0092-8674(91)90220-S			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ET175	1986864				2022-12-28	WOS:A1991ET17500020
J	BEARD, KC; KRISHTALKA, L; STUCKY, RK				BEARD, KC; KRISHTALKA, L; STUCKY, RK			1ST SKULLS OF THE EARLY EOCENE PRIMATE SHOSHONIUS-COOPERI AND THE ANTHROPOID-TARSIER DICHOTOMY	NATURE			English	Article							ORIGINS; OMOMYIDAE; EVOLUTION; TARSIIDAE; AFRICA	THE phylogenetic relationships of living tarsiers and extinct omomyid primates are critical for deciphering the origin and relationships of primate higher taxa, particularly anthropoids1-6. Three competing phylogenetic hypotheses are: (1) tarsiers are most closely related to early Cenozoic Omomyidae5-8, particularly genera such as Necrolemur from the late Eocene of Europe9-11; (2) tarsiers share a more recent common ancestry with anthropoids than they do with any known omoyid2-4,12,13; (3) tarsiers and/or omoyids are most closely related to strepsirhines14. The anatomy of four skulls of the early Eocene omomyid Shoshonius cooperi-the first cranial material recovered for this genus-strongly suggests that Schoshonius shares a more recent common ancestry with Tarsius than do either anthropoids or other Eocene omomyids for which cranial anatomy is known. If the primate suborder Haplorhini (anthropoids, omomyids, tarsiids) is monophyletic, the phylogenetic position of Shoshonius requires that anthropoids and Tarsius diverged by at least the early Eocene, some 15 million years before the first appearance of anthropoids in the fossil record15-17.	DENVER MUSEUM NAT HIST,DEPT EARTH SCI,DENVER,CO 80205		BEARD, KC (corresponding author), CARNEGIE MUSEUM NAT HIST,VERTEBRATE PALEONTOL SECT,4400 FORBES AVE,PITTSBURGH,PA 15213, USA.		Beard, K. Christopher/AAQ-4438-2021	Beard, K. Christopher/0000-0002-6279-9837				Cartmill M., 1980, P243; CARTMILL M, 1981, AM J PHYS ANTHROPOL, V56, P3; Cartmill M., 1978, RECENT ADV PRIMATOL, P205; CONROY GC, 1980, AM J PHYS ANTHROPOL, V52, P443, DOI 10.1002/ajpa.1330520316; DEBONIS L, 1988, CR ACAD SCI II, V306, P929; DEJONG WW, 1988, J HUM EVOL, V17, P575, DOI 10.1016/0047-2484(88)90085-1; DZELUSNIAK J, 1990, CURRENT MAMMALOGY, V2, P545; FLEAGLE JG, 1987, J HUM EVOL, V16, P483, DOI 10.1016/0047-2484(87)90036-4; GEBO DL, 1986, J HUM EVOL, V15, P421, DOI 10.1016/S0047-2484(86)80025-2; GINGERICH PD, 1981, J HUM EVOL, V10, P345, DOI 10.1016/S0047-2484(81)80057-7; GINSBURG L, 1987, CR ACAD SCI II, V304, P1213; KOOP BF, 1989, J BIOL CHEM, V264, P68; Krishtalka L., 1987, P77; Luckett WP., 1975, PHYLOGENY PRIMATES, P157, DOI [10.1007/978-1-4684-2166-8, DOI 10.1007/978-1-4684-2166-8]; MacPhee R.D.E., 1981, Contributions to Primatology, V18, P1; MacPhee R. D. E., 1986, COMP PRIM B, V1, P219; Martin R.D., 1990, PRIMATE ORIGINS EVOL; POCOCK RI, 1918, P ZOOL SOC LOND, P19; POLLOCK JI, 1987, AM J PHYS ANTHROPOL, V73, P65, DOI 10.1002/ajpa.1330730106; RASMUSSEN DT, 1986, J HUM EVOL, V15, P1, DOI 10.1016/S0047-2484(86)80060-4; Rosenberger A.L., 1980, P139; ROSENBERGER AL, 1985, FOLIA PRIMATOL, V45, P179, DOI 10.1159/000156227; SCHMID P, 1981, PRIMATE EVOLUTIONARY, P6; SCHWARTZ JH, 1987, J HUM EVOL, V16, P23, DOI 10.1016/0047-2484(87)90059-5; SIMONS EL, 1990, SCIENCE, V247, P1567, DOI 10.1126/science.2108499; SIMONS EL, 1985, NATURE, V313, P475, DOI 10.1038/313475a0; SIMONS EL, 1989, AM J PHYS ANTHROPOL, V79, P1, DOI 10.1002/ajpa.1330790103; SIMONS EL, 1989, P NATL ACAD SCI USA, V86, P9956, DOI 10.1073/pnas.86.24.9956; SIMONS ELWYN L., 1961, BULL BRIT MUS [NAT HIST] GEOL, V5, P43; STUCKY RK, 1990, GEOL SOC AM SPEC PAP, V243, P169; SZALAY F S, 1976, Bulletin of the American Museum of Natural History, V156, P157; SZALAY FS, 1976, FOLIA PRIMATOL, V25, P288, DOI 10.1159/000155721	32	59	65	0	14	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JAN 3	1991	349	6304					64	67		10.1038/349064a0	http://dx.doi.org/10.1038/349064a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EQ601	1985267				2022-12-28	WOS:A1991EQ60100051
J	CLAESSON, M; SHORT, R				CLAESSON, M; SHORT, R			LANCET WITH LESS PAIN	LANCET			English	Article									MONASH UNIV,DEPT ANAT,CLAYTON,VIC 3168,AUSTRALIA; MONASH UNIV,DEPT PHYSIOL,CLAYTON,VIC 3168,AUSTRALIA; DUKE UNIV,DEPT ZOOL,DURHAM,NC 27706	Monash University; Monash University; Duke University								Penfield W, 1937, BRAIN, V60, P389, DOI 10.1093/brain/60.4.389	1	2	2	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	DEC 22	1990	336	8730					1566	1567						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP037	1979381				2022-12-28	WOS:A1990EP03700019
J	GARDINER, HM; DUNN, PM				GARDINER, HM; DUNN, PM			CONTROLLED TRIAL OF IMMEDIATE SPLINTING VERSUS ULTRASONOGRAPHIC SURVEILLANCE IN CONGENITALLY DISLOCATABLE HIPS	LANCET			English	Article							ULTRASOUND; DIAGNOSIS; CLASSIFICATION; DYSPLASIA	79 infants with congenitally dislocatable hips diagnosed clinically soon after birth were examined sonographically and randomised in a controlled trial to immediate splinting (n = 41) or sonographic surveillance for 2 weeks (38). Infants from this second group were splinted at age 2 weeks if instability persisted (11 of 38) or if sonographic abnormality had shown no improvement (4 of 38). Sonographic findings or clinical outcome did not differ between the two groups at bitch or at 6 and 12 months' follow-up. We conclude that dislocatable hips may be safely watched for 2 weeks after birth to allow spontaneous resolution, but that this approach requires considerable resources and attention to detail. Our experience confirms the importance of the dynamic sonographic scan. The low specificity(70%) of sonographic examination in the first week of life makes it an unsatisfactory primary method of screening at birth, but is a most useful adjunct to the clinical screening and management of congenital dislocation of the hip.	UNIV BRISTOL,SOUTHMEAD HOSP,INST CHILD HLTH,BRISTOL BS10 5NB,AVON,ENGLAND	Southmead Hospital; University of Bristol								[Anonymous], 1986, ARCH DIS CHILD, V61, P921; BARLOW TG, 1962, J BONE JOINT SURG BR, V44, P292, DOI 10.1302/0301-620X.44B2.292; BERMAN L, 1986, BRIT MED J, V293, P719, DOI 10.1136/bmj.293.6549.719; CLARKE NMP, 1986, J PEDIATR ORTHOPED, V6, P527, DOI 10.1097/01241398-198609000-00002; CLARKE NMP, 1985, J BONE JOINT SURG BR, V67, P406, DOI 10.1302/0301-620X.67B3.3889008; CLARKE NMP, 1989, J BONE JOINT SURG BR, V71, P9, DOI 10.1302/0301-620X.71B1.2644290; DIAZ JJ, 1990, MAY P EUR SOC PAED R, P175; DUNN PM, 1976, BRIT MED BULL, V32, P71, DOI 10.1093/oxfordjournals.bmb.a071327; DUNN PM, 1985, ARCH DIS CHILD, V60, P407, DOI 10.1136/adc.60.5.407; DUNN PM, 1987, PROGR CHILD HLTH, V3, P1; DUNN PM, 1976, CLIN ORTHOP RELAT R, V119, P11; DUNN PM, 1969, THESIS CAMBRIDGE U C; ENGESAETER LB, 1990, J BONE JOINT SURG BR, V72, P197, DOI 10.1302/0301-620X.72B2.2179221; FENDEL H, 1987, 1985 P COMM EUR COMM, P51; GARDINER HM, 1990, J PEDIATR ORTHOPED, V10, P633, DOI 10.1097/01241398-199009000-00012; GRAF R, 1984, ARCH ORTHOP TRAUM SU, V102, P248, DOI 10.1007/BF00436138; GRAF R, 1988, DEC P BRIT MED ULTR, P48; KALAMCHI A, 1980, J BONE JOINT SURG AM, V62, P876, DOI 10.2106/00004623-198062060-00002; LANGER R, 1987, SKELETAL RADIOL, V16, P275, DOI 10.1007/BF00361468; MACFARLANE A, 1987, BRIT MED J, V294, P1047, DOI 10.1136/bmj.294.6579.1047; ZIEGER M, 1987, PEDIATR RADIOL, V17, P226, DOI 10.1007/BF02388165	21	70	70	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	DEC 22	1990	336	8730					1553	1556		10.1016/0140-6736(90)93318-J	http://dx.doi.org/10.1016/0140-6736(90)93318-J			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP037	1979376				2022-12-28	WOS:A1990EP03700014
J	MALONE, PS; RANSLEY, PG; KIELY, EM				MALONE, PS; RANSLEY, PG; KIELY, EM			PRELIMINARY-REPORT - THE ANTEGRADE CONTINENCE ENEMA	LANCET			English	Article									HOSP SICK CHILDREN,DEPT UROL,LONDON WC1N 3JH,ENGLAND; HOSP SICK CHILDREN,DEPT PAEDIAT SURG,LONDON WC1N 3JH,ENGLAND	University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	MALONE, PS (corresponding author), SOUTHAMPTON GEN HOSP,WESSEX REG CTR PAEDIAT SURG,TREMONA RD,SOUTHAMPTON SO9 4XY,HANTS,ENGLAND.							DUDLEY HAF, 1980, BRIT J SURG, V67, P80, DOI 10.1002/bjs.1800670203; HEWITT J, 1973, LANCET, V2, P337; MITROFANOFF P, 1980, CHIR PEDIATR, V21, P297; MUIR EG, 1968, J ROYAL SOC MED, V61, P401; RADCLIFFE AG, 1983, SURG GYNECOL OBSTET, V156, P721; SHANDLING B, 1987, J PEDIATR SURG, V22, P271, DOI 10.1016/S0022-3468(87)80345-7	6	564	582	0	3	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 17	1990	336	8725					1217	1218		10.1016/0140-6736(90)92834-5	http://dx.doi.org/10.1016/0140-6736(90)92834-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ064	1978072				2022-12-28	WOS:A1990EJ06400005
J	BRAHAMS, D				BRAHAMS, D			DETENTION WITHOUT TRIAL	LANCET			English	Editorial Material																		BACON GP, 1989, LAW SOC GAZ, P19	1	1	1	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 27	1990	336	8722					1061	1062		10.1016/0140-6736(90)92519-N	http://dx.doi.org/10.1016/0140-6736(90)92519-N			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF076	1977033				2022-12-28	WOS:A1990EF07600020
J	LEVINE, MM; FERRECCIO, C; CRYZ, S; ORTIZ, E				LEVINE, MM; FERRECCIO, C; CRYZ, S; ORTIZ, E			COMPARISON OF ENTERIC-COATED CAPSULES AND LIQUID FORMULATION OF TY21A TYPHOID VACCINE IN RANDOMIZED CONTROLLED FIELD TRIAL	LANCET			English	Article									MINIST SALUD, TYPHOID FEVER & ENTER INFECT CONTROL PROGRAM, SANTIAGO, CHILE; UNIV MARYLAND, SCH MED, DEPT MED, DIV GEOG MED, BALTIMORE, MD 21201 USA; SWISS SERUM & VACCINE INST, BERN, SWITZERLAND	University System of Maryland; University of Maryland Baltimore	LEVINE, MM (corresponding author), UNIV MARYLAND, SCH MED, CTR VACCINE DEV, 10 S PINE ST, BALTIMORE, MD 21201 USA.							ASHCROFT M. T., 1962, W INDIAN MED JOUR, V11, P62; ASHCROFT MT, 1964, AM J HYG, V79, P196, DOI 10.1093/oxfordjournals.aje.a120376; AVENDANO A, 1986, J INFECT DIS, V53, P359; BLACK RE, 1990, VACCINE, V8, P81, DOI 10.1016/0264-410X(90)90183-M; BLASER MJ, 1980, J INFECT DIS, V142, P934, DOI 10.1093/infdis/142.6.934; BORGONO MJ, 1978, DEV BIOL STAND, V41, P301; EDELMAN R, 1986, REV INFECT DIS, V8, P329; FERRECCIO C, 1989, J INFECT DIS, V159, P766, DOI 10.1093/infdis/159.4.766; GERMANIER R, 1975, J INFECT DIS, V131, P553, DOI 10.1093/infdis/131.5.553; GILMAN RH, 1977, J INFECT DIS, V136, P717, DOI 10.1093/infdis/136.6.717; HEJFEC LB, 1966, B WORLD HEALTH ORGAN, V34, P321; LEVINE M, 1989, VACCINES, P333; LEVINE MM, 1987, LANCET, V1, P1049; LEVINE MM, 1989, PEDIATR INFECT DIS J, V8, P374, DOI 10.1097/00006454-198906000-00010; LEVINE MM, 1989, REV INFECT DIS, V11, pS552; LEVINE MM, 1978, AM J TROP MED HYG, V27, P795, DOI 10.4269/ajtmh.1978.27.795; Levine MM, 1985, PAN AM HLTH ORG COPU, V1, P37; SERIE CW, 1980, B WORLD HEALTH ORGAN, V58, P469; SIMANJANTUK C, 1988, 28TH INT C ANT AG CH; TAYLOR DN, 1983, J INFECT DIS, V148, P599, DOI 10.1093/infdis/148.3.599; WAHDAN MH, 1982, J INFECT DIS, V145, P292, DOI 10.1093/infdis/145.3.292; 1964, B WORLD HEALTH ORGAN, V30, P623; 1986, NEW VACCINE DEV ESTA, V2, P1	23	143	153	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 13	1990	336	8720					891	894						4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EC456	1976928				2022-12-28	WOS:A1990EC45600001
J	[Anonymous]				[Anonymous]			LOADING THE LODS	LANCET			English	Editorial Material																		BARON M, 1990, NATURE, V346, P618, DOI 10.1038/346618a0; DETERAWADLEIGH SD, 1989, NATURE, V340, P391, DOI 10.1038/340391a0; EDWARDS JH, 1989, NATURE, V339, P584; EGELAND JA, 1987, NATURE, V325, P783, DOI 10.1038/325783a0; GURLING H, 1990, NATURE, V344, P298, DOI 10.1038/344298a0; KELSOE JR, 1989, NATURE, V342, P238, DOI 10.1038/342238a0; KENNEDY JL, 1988, NATURE, V336, P167, DOI 10.1038/336167a0; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; MORTON NE, 1955, AM J HUM GENET, V7, P277; ROBERTSON M, 1989, NATURE, V342, P222, DOI 10.1038/342222a0; SHERRINGTON R, 1988, NATURE, V336, P164, DOI 10.1038/336164a0; STCLAIR D, 1989, NATURE, V339, P305; YATES JRW, 1986, BRIT J HOSP MED, V36, P133	13	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 29	1990	336	8718					778	779						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB077	1976149				2022-12-28	WOS:A1990EB07700007
J	BRAHAMS, D				BRAHAMS, D			SECRECY AND PRODUCT LIABILITY LITIGATION	LANCET			English	Editorial Material																		BRAHAMS D, 1987, LANCET, V1, P874; BRAHAMS D, 1990, LANCET, P619; DOGGETT L, 1990, TRIAL            JUL; OSWALD I, 1989, LANCET, V2, P451; RUSHFORD G, 1990, LEGAL TIMES     0226, pR12; Sigelman D. W., 1989, TRIAL            NOV, P38; VANDERKROEF C, 1979, LANCET, V2, P526; 1989, PRODUCT SAFETY LIABI, P340; 1990, BJORKSHILEY HEART VA; 1988, SCRIP           0429; 1987, SCRIP           0320	11	0	0	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	SEP 22	1990	336	8717					737	738		10.1016/0140-6736(90)92220-C	http://dx.doi.org/10.1016/0140-6736(90)92220-C			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DZ624	1975905				2022-12-28	WOS:A1990DZ62400016
J	BARRETTCONNOR, EL; COHN, BA; WINGARD, DL; EDELSTEIN, SL				BARRETTCONNOR, EL; COHN, BA; WINGARD, DL; EDELSTEIN, SL			WHY IS DIABETES-MELLITUS A STRONGER RISK FACTOR FOR FATAL ISCHEMIC-HEART-DISEASE IN WOMEN THAN IN MEN - THE RANCHO-BERNARDO STUDY	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Note							POLYCYSTIC OVARIAN DISEASE; ADULT COMMUNITY; CARDIOVASCULAR-DISEASE; FASTING HYPERGLYCEMIA; PREMENOPAUSAL WOMEN; INSULIN RESISTANCE; PLASMA-GLUCOSE; ADIPOSE-TISSUE; MORTALITY; OBESITY	We report here the 14-year sex-specific effect of non-insulin-dependent diabetes mellitus on the risk of fatal ischemic heart disease in a geographically defined population of men and women aged 40 through 79 years. There were 207 men and 127 women who had diabetes at baseline based on medical history or fasting hyperglycemia. They were compared with 2137 adults who had fasting euglycemia and a negative personal and family history of diabetes. The relative hazard of ischemic heart disease death in diabetics vs nondiabetics was 1.8 in men and 3.3 in women, after adjusting for age, and 1.9 and 3.3, respectively, after adjusting for age, systolic blood pressure, cholesterol, body mass index, and cigarette smoking using the Cox regression model. The sex difference in the independent contribution of diabetes to fatal heart disease was largely explained by the persistently more favorable survival rate of women (than men) without diabetes.	CALIF PUBL HLTH FDN,BERKELEY,CA		BARRETTCONNOR, EL (corresponding author), UNIV CALIF SAN DIEGO,DEPT COMMUNITY & FAMILY MED,M-007,LA JOLLA,CA 92093, USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK031801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R29AG008387] Funding Source: NIH RePORTER; NIA NIH HHS [AG08387] Funding Source: Medline; NIDDK NIH HHS [DK31801] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		[Anonymous], 1985, DIABETOLOGIA, V28, P615, DOI [10.1007/BF00290267, DOI 10.1007/BF00290267]; AUSTIN MA, 1981, AM J EPIDEMIOL, V114, P137, DOI 10.1093/oxfordjournals.aje.a113160; BARRETTCONNOR E, 1982, AM J EPIDEMIOL, V115, P657, DOI 10.1093/oxfordjournals.aje.a113348; BARRETTCONNOR E, 1983, AM J EPIDEMIOL, V118, P489, DOI 10.1093/oxfordjournals.aje.a113654; BARRETTCONNOR E, 1981, AM J EPIDEMIOL, V113, P276, DOI 10.1093/oxfordjournals.aje.a113097; BARRETTCONNOR E, 1980, AM J EPIDEMIOL, V112, P518, DOI 10.1093/oxfordjournals.aje.a113021; BARRETTCONNOR E, 1980, AM J EPIDEMIOL, V111, P705, DOI 10.1093/oxfordjournals.aje.a112948; BARRETTCONNOR E, 1983, AM J EPIDEMIOL, V117, P186, DOI 10.1093/oxfordjournals.aje.a113529; BARRETTCONNOR E, 1984, J CHRON DIS, V37, P773, DOI 10.1016/0021-9681(84)90046-8; BARRETTCONNOR E, 1985, NIH851468 PUBL; BLUNT BA, 1990, 50TH SCI SESS M AM D; CHANG RJ, 1983, J CLIN ENDOCR METAB, V57, P356, DOI 10.1210/jcem-57-2-356; COX DR, 1972, J R STAT SOC B, V34, P187; CRIQUI MH, 1978, AM J EPIDEMIOL, V108, P367, DOI 10.1093/oxfordjournals.aje.a112633; CROUSE JR, 1989, LANCET, V1, P318, DOI 10.1016/S0140-6736(89)91320-2; EAKER ED, 1987, CORONARY HEART DISEA, P122; EVANS DJ, 1983, J CLIN ENDOCR METAB, V57, P304, DOI 10.1210/jcem-57-2-304; GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8; HARRIS MI, 1987, DIABETES, V36, P523, DOI 10.2337/diabetes.36.4.523; JIALAL I, 1987, J CLIN ENDOCR METAB, V64, P1066, DOI 10.1210/jcem-64-5-1066; KALBFLEISCH JD, 1980, STATISTICAL ANAL FAI; KISSEBAH AH, 1982, J CLIN ENDOCR METAB, V54, P254, DOI 10.1210/jcem-54-2-254; Kissebah AHK, 1985, METABOLIC COMPLICATI, P115; KLEINMAN JC, 1988, AM J EPIDEMIOL, V128, P389, DOI 10.1093/oxfordjournals.aje.a114979; KROTKIEWSKI M, 1986, INT J OBESITY, V10, P331; KROTKIEWSKI M, 1983, J CLIN INVEST, V72, P1150, DOI 10.1172/JCI111040; LAPIDUS L, 1985, ACTA MED SCAND S, V705, P2; Mann J, 1983, DIABETES EPIDEMIOLOG, P183; NELSON RG, 1990, CIRCULATION, V81, P987, DOI 10.1161/01.CIR.81.3.987; OSTLUND RE, 1990, NEW ENGL J MED, V322, P229, DOI 10.1056/NEJM199001253220404; PAN WH, 1986, AM J EPIDEMIOL, V123, P504, DOI 10.1093/oxfordjournals.aje.a114266; PEIRIS AN, 1989, AM J CLIN NUTR, V49, P758, DOI 10.1093/ajcn/49.5.758; PORETSKY L, 1987, ENDOCR REV, V8, P132, DOI 10.1210/edrv-8-2-132; ROBERTSON WB, 1968, LAB INVEST, V18, P538; SEIDELL JC, 1989, AM J CLIN NUTR, V50, P269, DOI 10.1093/ajcn/50.2.269; WALDEN CE, 1984, NEW ENGL J MED, V311, P953, DOI 10.1056/NEJM198410113111505; WILD RA, 1985, J CLIN ENDOCR METAB, V61, P946, DOI 10.1210/jcem-61-5-946; WILD RA, 1988, AM J OBSTET GYNECOL, V159, P423, DOI 10.1016/S0002-9378(88)80099-1; WINGARD D L, 1990, Diabetes Care, V13, P3; WINGARD DL, 1984, ANNU REV PUBL HEALTH, V5, P433, DOI 10.1146/annurev.pu.05.050184.002245; 1980, INT CLASSIFICATION D	41	548	564	0	13	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	1991	265	5					627	631		10.1001/jama.265.5.627	http://dx.doi.org/10.1001/jama.265.5.627			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EV718	1987413				2022-12-28	WOS:A1991EV71800021
J	GATES, G				GATES, G			SUBMANDIBULAR CALCULI	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter											GATES, G (corresponding author), WASHINGTON UNIV,SCH MED,ST LOUIS,MO 63110, USA.								0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	1991	265	5					650	650						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EV718	1987419				2022-12-28	WOS:A1991EV71800027
J	WEINSTEIN, IB				WEINSTEIN, IB			MITOGENESIS IS ONLY ONE FACTOR IN CARCINOGENESIS	SCIENCE			English	Editorial Material							HUMAN CANCER; LECTURE		COLUMBIA UNIV,DEPT GENET & DEV,NEW YORK,NY 10032; COLUMBIA UNIV,SCH PUBL HLTH,NEW YORK,NY 10032	Columbia University; Columbia University	WEINSTEIN, IB (corresponding author), COLUMBIA UNIV,DEPT MED,CTR COMPREHENS CANC,NEW YORK,NY 10032, USA.							ABELSON PH, 1990, SCIENCE, V249, P1357, DOI 10.1126/science.2402628; AMES BN, 1990, SCIENCE, V249, P970, DOI 10.1126/science.2136249; AMES BN, 1979, SCIENCE, V204, P587, DOI 10.1126/science.373122; AMES BN, 1990, P NATL ACAD SCI USA, V87, P7772, DOI 10.1073/pnas.87.19.7772; AMES BN, 1990, P NATL ACAD SCI USA, V87, P7782, DOI 10.1073/pnas.87.19.7782; AMES BN, 1990, P NATL ACAD SCI USA, V87, P7777, DOI 10.1073/pnas.87.19.7777; BLUM A, 1978, SCIENCE, V201, P1020, DOI 10.1126/science.684422; BOYD JA, 1990, GENETIC PHARM THER, V46, P469; COHEN SM, 1990, SCIENCE, V249, P1007, DOI 10.1126/science.2204108; COLBURN NH, 1989, GENES SIGNAL TRANSDU; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; HENDERSON BE, 1988, CANCER RES, V48, P246; HERRLICH P, 1986, ADV ENZYME REGUL, V25, P485, DOI 10.1016/0065-2571(86)90030-0; HOEL DG, 1988, CARCINOGENESIS, V9, P2045, DOI 10.1093/carcin/9.11.2045; HUFF J, IN PRESS MAXCYROSENA; IVANOVIC V, 1981, NATURE, V293, P404, DOI 10.1038/293404a0; MELNICK R, COMMUNICATION; RAO GN, 1987, FUND APPL TOXICOL, V9, P329, DOI 10.1016/0272-0590(87)90055-8; RONAI ZA, 1990, CELL BIOL TOXICOL, V6, P105, DOI 10.1007/BF00135030; TOMATIS L, 1989, JPN J CANCER RES, V80, P795, DOI 10.1111/j.1349-7006.1989.tb01717.x; WEINSTEIN IB, 1988, CANCER RES, V48, P4135; WEINSTEIN IB, 1990, ADV 2ND MESSENGERS P; 1988, MONOGRAPHS EVALUA S7, V1	23	123	126	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JAN 25	1991	251	4992					387	388		10.1126/science.1989073	http://dx.doi.org/10.1126/science.1989073			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU504	1989073				2022-12-28	WOS:A1991EU50400031
J	YEH, HJ; RUIT, KG; WANG, YX; PARKS, WC; SNIDER, WD; DEUEL, TF				YEH, HJ; RUIT, KG; WANG, YX; PARKS, WC; SNIDER, WD; DEUEL, TF			PDGF A-CHAIN GENE IS EXPRESSED BY MAMMALIAN NEURONS DURING DEVELOPMENT AND IN MATURITY	CELL			English	Article							CENTRAL NERVOUS-SYSTEM; RAT OPTIC-NERVE; GROWTH-FACTOR; PROGENITOR-CELL; PLATELET; ASTROCYTE; DIFFERENTIATION; CULTURE; TRANSFORMATION; FIBROBLASTS	Platelet-derived growth factor (PDGF) may be a critical factor in the temporal differentiation of glial elements in the mammalian central nervous system. We have used in situ hybridization and immunoperoxidase staining to investigate the localization of PDGF A and have observed high levels of PDGF A-chain mRNA and immunoreactive PDGF A in neurons of embryonic and adult mice. PDGF A-chain expression was shown to be developmentally regulated and tissue specific. Every neuronal population examined in the central and peripheral nervous systems expresses PDGF A transcripts. Variable, significantly weaker signals are observed in glial cells. In contrast to known neurotrophic factors, the PDGF A transcripts are widely distributed among neurons. This generalized distribution of PDGF A transcripts, together with the known effects of PDGF on glial cells in vitro, suggests a unique role of neurons in regulating the proliferation and differentiation of glial cells in vivo.	WASHINGTON UNIV,MED CTR,DEPT NEUROL,ST LOUIS,MO 63110; WASHINGTON UNIV,MED CTR,DEPT BIOCHEM & MOLEC BIOPHYS,ST LOUIS,MO 63110; JEWISH HOSP ST LOUIS,ST LOUIS,MO 63110; CHINESE ACAD SCI,SHANGHAI INST CELL BIOL,SHANGHAI,PEOPLES R CHINA	Washington University (WUSTL); Washington University (WUSTL); Barnes-Jewish Hospital; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	YEH, HJ (corresponding author), WASHINGTON UNIV,MED CTR,DEPT MED,ST LOUIS,MO 63110, USA.		Parks, William C./AAH-6786-2021		NCI NIH HHS [CA49712] Funding Source: Medline; NHLBI NIH HHS [HL14147, HL31102] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA049712] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL031102, R01HL031102, P50HL014147] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BEJCEK BE, 1989, SCIENCE, V245, P1496, DOI 10.1126/science.2551043; BOWENPOPE DF, 1984, P NATL ACAD SCI-BIOL, V81, P2396, DOI 10.1073/pnas.81.8.2396; BRESSLER JP, 1985, BRAIN RES, V344, P249, DOI 10.1016/0006-8993(85)90802-9; DEUEL TF, 1987, ANNU REV CELL BIOL, V3, P443, DOI 10.1146/annurev.cb.03.110187.002303; DEUEL TF, 1982, J CLIN INVEST, V69, P1046, DOI 10.1172/JCI110509; ERNFORS P, 1990, P NATL ACAD SCI USA, V87, P5454, DOI 10.1073/pnas.87.14.5454; GROTENDORST GR, 1981, P NATL ACAD SCI-BIOL, V78, P3669, DOI 10.1073/pnas.78.6.3669; HELDIN CH, 1986, NATURE, V319, P511, DOI 10.1038/319511a0; HUANG JS, 1984, CELL, V39, P79, DOI 10.1016/0092-8674(84)90193-4; HUGHES SM, 1988, NATURE, V335, P70, DOI 10.1038/335070a0; LILLIEN LE, 1988, NEURON, V1, P485, DOI 10.1016/0896-6273(88)90179-1; LILLIEN LE, 1990, NEURON, V5, P111, DOI 10.1016/0896-6273(90)90301-U; LILLIEN LE, 1990, NEURON, V4, P525, DOI 10.1016/0896-6273(90)90110-2; MILLER RH, 1985, DEV BIOL, V111, P35, DOI 10.1016/0012-1606(85)90432-4; Nauta W.J.H., 1986, FUNDAMENTAL NEUROANA, P33; NOBLE M, 1988, NATURE, V333, P560, DOI 10.1038/333560a0; POMEROY SL, 1988, J CELL BIOL, V107, P1167, DOI 10.1083/jcb.107.3.1167; PRINGLE N, 1988, EMBO J, V18, P1049; PROSSER IW, 1989, AM J PATHOL, V135, P1073; RAFF MC, 1985, CELL, V42, P61, DOI 10.1016/S0092-8674(85)80101-X; RAFF MC, 1988, NATURE, V333, P562, DOI 10.1038/333562a0; RAFF MC, 1983, NATURE, V303, P390, DOI 10.1038/303390a0; RAFF MC, 1989, SCIENCE, V243, P1450, DOI 10.1126/science.2648568; RICHARDSON WD, 1988, CELL, V53, P309, DOI 10.1016/0092-8674(88)90392-3; SENIOR RM, 1983, J CELL BIOL, V96, P382, DOI 10.1083/jcb.96.2.382; SEPPA H, 1982, J CELL BIOL, V92, P584, DOI 10.1083/jcb.92.2.584; SNIDER WD, 1989, ANN NEUROL, V26, P489, DOI 10.1002/ana.410260402; TONG BD, 1987, NATURE, V328, P619, DOI 10.1038/328619a0; WALICKE PA, 1988, J NEUROSCI, V8, P2618; WANAKA A, 1990, NEURON, V5, P267, DOI 10.1016/0896-6273(90)90164-B; WHITTEMORE SR, 1987, BRAIN RES REV, V12, P439, DOI 10.1016/0165-0173(87)90008-7	31	335	338	0	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	JAN 11	1991	64	1					209	216		10.1016/0092-8674(91)90222-K	http://dx.doi.org/10.1016/0092-8674(91)90222-K			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ET175	1986867				2022-12-28	WOS:A1991ET17500022
J	WATSON, SR; FENNIE, C; LASKY, LA				WATSON, SR; FENNIE, C; LASKY, LA			NEUTROPHIL INFLUX INTO AN INFLAMMATORY SITE INHIBITED BY A SOLUBLE HOMING RECEPTOR-IGG CHIMERA	NATURE			English	Article							MONOCLONAL-ANTIBODY; GLYCOPROTEIN; INVIVO; LYMPHOCYTES; PREVENTION; PLATELETS; ADHESION; PROTEINS; CLONING	Neutrophil-mediated inflammation is involved in a number of human clinical manifestations, including the adult respiratory distress syndrome, multi-organ failure and reperfusion injury 1. One way of inhibiting this type of inflammatory response would be to block competitively the adhesive interactions between neutrophils and the endothelium adjacent to the inflamed region 2. The lectin-containing 3,4 murine adhesion molecule gp90MET, the homing receptor, is found on all leukocytic cells, including neutrophils. 5 MEL 14, a monoclonal antibody directed against this adhesion molecule, blocks lymphocyte traffic to lymph nodes 6 and extravasation of neutrophils from blood to inflammatory sites 7. Here we show that administration to mice of a soluble immunoglobulin chimaera containing the murine homing receptor extracellular domain significantly decreases the number of neutrophils that migrate to the peritoneum in response to the inflammatory irritant thioglycollate. These results indicate that soluble forms of a single type of adhesion molecule, the homing receptor, could be clinically effective compounds for the inhibition of neutrophil-mediated inflammation.			WATSON, SR (corresponding author), GENENTECH INC,DEPT IMMUNOBIOL,460 POINT SAN BRUNO BLVD,S SAN FRANCISCO,CA 94080, USA.							ARFORS KE, 1987, BLOOD, V69, P338; BEVILACQUA MP, 1989, SCIENCE, V243, P1160, DOI 10.1126/science.2466335; BOWEN B, 1990, J CELL BIOL, V110, P421; CAPON DJ, 1989, NATURE, V337, P525, DOI 10.1038/337525a0; COSIMI AB, 1990, J IMMUNOL, V144, P4604; FANSLOW WC, 1990, SCIENCE, V248, P739, DOI 10.1126/science.2139736; FISCHER A, 1986, LANCET, V2, P1058; GALLATIN M, 1986, CELL, V44, P673, DOI 10.1016/0092-8674(86)90832-9; GALLATIN WM, 1983, NATURE, V304, P30, DOI 10.1038/304030a0; Goldstein I., 1988, INFLAMMATION BASIC P; IMAI Y, UNPUB J CELL BIOL; JOHNSTON GI, 1989, CELL, V56, P1033, DOI 10.1016/0092-8674(89)90636-3; JUTILA MA, 1989, J IMMUNOL, V143, P3318; LARSEN E, 1989, CELL, V59, P305, DOI 10.1016/0092-8674(89)90292-4; LASKY LA, 1989, CELL, V56, P1045, DOI 10.1016/0092-8674(89)90637-5; LASKY LA, 1986, SCIENCE, V233, P209, DOI 10.1126/science.3014647; LEWINSOHN DM, 1987, J IMMUNOL, V138, P4313; MARLIN SD, 1990, NATURE, V344, P70, DOI 10.1038/344070a0; MOUNTZ JD, 1988, J IMMUNOL, V140, P2943; SIEGELMAN MH, 1989, SCIENCE, V243, P1165, DOI 10.1126/science.2646713; SPRINGER T, 1990, NATURE, V436, P425; STREETER PR, 1988, J CELL BIOL, V107, P1853, DOI 10.1083/jcb.107.5.1853; WATSON SR, 1990, J CELL BIOL, V110, P2221, DOI 10.1083/jcb.110.6.2221	23	297	351	0	0	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JAN 10	1991	349	6305					164	166		10.1038/349164a0	http://dx.doi.org/10.1038/349164a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER418	1986307				2022-12-28	WOS:A1991ER41800061
J	ZELLER, K; WHITTAKER, E; SULLIVAN, L; RASKIN, P; JACOBSON, HR				ZELLER, K; WHITTAKER, E; SULLIVAN, L; RASKIN, P; JACOBSON, HR			EFFECT OF RESTRICTING DIETARY-PROTEIN ON THE PROGRESSION OF RENAL-FAILURE IN PATIENTS WITH INSULIN-DEPENDENT DIABETES-MELLITUS	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EXPERIMENTAL GLOMERULONEPHRITIS; UREMIC RATS; NEPHROPATHY; PRESERVATION; FILTRATION; PHOSPHATE; SURVIVAL	Background. Restriction of dietary protein may slow the progression of renal failure in diverse renal diseases, but the extent to which such a diet is beneficial in patients with diabetic nephropathy is uncertain. Methods. We studied the effect of reduced intake of protein and phosphorus on the progression of renal disease in 35 patients with insulin-dependent (Type I) diabetes mellitus and clinically evident nephropathy. The low-protein, low-phosphorus diet contained 0.6 g of protein per kilogram of ideal body weight per day, 500 to 100 mg of phosphorus, and 2000 mg of sodium. The control diet consisted of the patient's prestudy diet with the stipulation that it contain 2000 mg of sodium and at least 1 g of protein per kilogram per day and 1000 mg of phosphorus. Renal function was assessed by measurement of iothalamate and creatinine clearances at intervals of 3 to 6 months, and the patients were followed for a minimum of 12 months (mean, 34.7). The declines in mean glomerular filtration rates were compared between groups by linear-regression analysis of the glomerular filtration rate as a function of time. Results. The patients who followed the study diet for a mean of 37.1 months had declines in iothalamate clearance of 0.0043 ml per second per month and in creatinine clearance of 0.0055 ml per second per month. The comparable values in the control group were 0.0168 and 0.0135, respectively (P < 0.05). Blood pressure was well controlled, and the degree of glycemic control was comparable in both groups. Conclusions. Dietary restriction of protein and phosphorus can retard the progression of renal failure in patients with Type I diabetes mellitus who have nephropathy. We believe that wider use of this treatment is indicated.	UNIV TEXAS, SW MED CTR, CTR HUMAN NUTR, DALLAS, TX 75235 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	ZELLER, K (corresponding author), UNIV TEXAS, SW MED CTR, DEPT INTERNAL MED, 5323 HARRY HINES BLVD, DALLAS, TX 75235 USA.				NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000633] Funding Source: NIH RePORTER; NCRR NIH HHS [MO1-RR00633] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ANDERSEN AR, 1983, DIABETOLOGIA, V25, P496; Barsotti G., 1983, Kidney International, V24, pS278; BERGSTROM J, 1986, CLIN NEPHROL, V25, P1; BJORCK S, 1986, BMJ-BRIT MED J, V293, P471, DOI 10.1136/bmj.293.6545.471; DECKERT T, 1978, DIABETOLOGIA, V14, P363, DOI 10.1007/BF01228130; DORMAN JS, 1984, DIABETES, V33, P271, DOI 10.2337/diabetes.33.3.271; DWORKIN LD, 1986, J CLIN INVEST, V77, P797, DOI 10.1172/JCI112377; ELNAHAS AM, 1983, CLIN SCI, V65, P399, DOI 10.1042/cs0650399; ELNAHAS AM, 1986, LANCET, V1, P597; EVANOFF GV, 1987, ARCH INTERN MED, V147, P492, DOI 10.1001/archinte.147.3.492; Farr LE, 1939, J EXP MED, V70, P615, DOI 10.1084/jem.70.6.615; HOSTETTER TH, 1981, AM J PHYSIOL, V241, pF85, DOI 10.1681/ASN.V1261315; IBELS LS, 1978, NEW ENGL J MED, V298, P122, DOI 10.1056/NEJM197801192980302; ISRAELIT AH, 1973, KIDNEY INT, V4, P346, DOI 10.1038/ki.1973.127; KARLINSKY ML, 1980, KIDNEY INT, V17, P293, DOI 10.1038/ki.1980.35; KENNER CH, 1985, KIDNEY INT, V27, P739, DOI 10.1038/ki.1985.74; Kikuchi H, 1983, Kidney Int Suppl, V16, pS254; KLEINKNECHT C, 1979, KIDNEY INT, V15, P534, DOI 10.1038/ki.1979.68; KNOWLES HC, 1974, KIDNEY INT S, V1, pS2; Laouari D, 1983, Kidney Int Suppl, V16, pS248; LAOUARI D, 1982, CLIN SCI, V63, P539, DOI 10.1042/cs0630539; LUMLERTGUL D, 1986, KIDNEY INT, V29, P658, DOI 10.1038/ki.1986.49; MARONI BJ, 1985, KIDNEY INT, V27, P58, DOI 10.1038/ki.1985.10; MASCHIO G, 1982, KIDNEY INT, V22, P371, DOI 10.1038/ki.1982.184; MITCH WE, 1984, NEW ENGL J MED, V311, P623, DOI 10.1056/NEJM198409063111002; MITCH WE, 1984, ANNU REV MED, V35, P249, DOI 10.1146/annurev.med.35.1.249; MOGENSEN CE, 1982, BRIT MED J, V285, P685, DOI 10.1136/bmj.285.6343.685; NATHAN DM, 1984, CLIN CHEM, V30, P813; NEUGARTEN J, 1983, KIDNEY INT, V24, P595, DOI 10.1038/ki.1983.199; PARVING HH, 1983, LANCET, V1, P1175; PIETRI A, 1980, DIABETES, V29, P1001, DOI 10.2337/diabetes.29.12.1001; RENNKE HG, 1986, KIDNEY INT, V29, P289; ROSMAN JB, 1984, LANCET, V2, P1291; SCHUSTER VL, 1985, KIDNEY PHYSL PATHOPH, V1, P365; WALSER M, 1988, KIDNEY INT, V34, P412, DOI 10.1038/ki.1988.196; WEN SF, 1985, J LAB CLIN MED, V106, P589; ZELLER KR, 1989, AM J KIDNEY DIS, V13, P17, DOI 10.1016/S0272-6386(89)80108-8; 1981, INVEST OPHTHALMOL VI, V21, P149	38	381	386	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 10	1991	324	2					78	84		10.1056/NEJM199101103240202	http://dx.doi.org/10.1056/NEJM199101103240202			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EQ977	1984187				2022-12-28	WOS:A1991EQ97700002
J	SMITH, JM; DOWSON, CG; SPRATT, BG				SMITH, JM; DOWSON, CG; SPRATT, BG			LOCALIZED SEX IN BACTERIA	NATURE			English	Review							PENICILLIN-BINDING PROTEINS; ESCHERICHIA-COLI; NEISSERIA-MENINGITIDIS; HEMOPHILUS-INFLUENZAE; GENETIC DIVERSITY; STRAINS; DNA; TRANSFORMATION; RECOMBINATION; GONORRHOEAE	Electrophoretic studies suggest that bacterial populations consist of a number of independent clones and that genetic recombination is rare in nature. But DNA sequencing reveals that individual bacterial genes have a mosaic structure that could have arisen only by recombination. How can these observations be reconciled and what is their relevance to prokaryotic evolution?			SMITH, JM (corresponding author), UNIV SUSSEX,SCH BIOL SCI,BRIGHTON BN1 9QG,E SUSSEX,ENGLAND.		Spratt, Brian G/A-1676-2009; Dowson, Christopher/ABG-5083-2021; Dowson, Chris/N-6195-2014	Dowson, Christopher/0000-0002-8294-8836; Dowson, Chris/0000-0002-8294-8836				ARTHUR M, 1990, INFECT IMMUN, V58, P471, DOI 10.1128/IAI.58.2.471-479.1990; BELTRAN P, 1988, P NATL ACAD SCI USA, V85, P7753, DOI 10.1073/pnas.85.20.7753; CAUGANT DA, 1987, J BACTERIOL, V169, P2781, DOI 10.1128/jb.169.6.2781-2792.1987; CAUGANT DA, 1986, P NATL ACAD SCI USA, V83, P4927, DOI 10.1073/pnas.83.13.4927; CERRITELLI S, 1989, P NATL ACAD SCI USA, V86, P9223, DOI 10.1073/pnas.86.23.9223; DOWSON CG, 1989, P NATL ACAD SCI USA, V86, P8842, DOI 10.1073/pnas.86.22.8842; DOWSON CG, 1990, P NATL ACAD SCI USA, V87, P5858, DOI 10.1073/pnas.87.15.5858; DUBOSE RF, 1988, P NATL ACAD SCI USA, V85, P7036, DOI 10.1073/pnas.85.18.7036; DYKHUIZEN DE, 1986, GENETICS, V113, P871; GIBBS CP, 1989, NATURE, V338, P651, DOI 10.1038/338651a0; Griffith F, 1928, J HYG-CAMBRIDGE, V27, P113, DOI 10.1017/S0022172400031879; KROLL JS, 1990, J BACTERIOL, V172, P1374, DOI 10.1128/jb.172.3.1374-1379.1990; LACKS SA, 1986, CELL, V46, P993, DOI 10.1016/0092-8674(86)90698-7; Levin B. R., 1988, EVOLUTION SEX, P194; MARCA RL, IN PRESS ANTIMICROB; MICHOD RE, 1988, GENETICS, V118, P31; MILKMAN R, 1983, SCIENCE, V221, P378, DOI 10.1126/science.6346486; MUSSER JM, 1988, P NATL ACAD SCI USA, V85, P7758, DOI 10.1073/pnas.85.20.7758; MUSSER JM, 1985, P NATL ACAD SCI USA, V82, P5078, DOI 10.1073/pnas.82.15.5078; OLYHOEK T, 1987, REV INFECT DIS, V9, P665; ORSKOV F, 1983, J INFECT DIS, V148, P346, DOI 10.1093/infdis/148.2.346; PLOS K, 1989, INFECT IMMUN, V57, P1604, DOI 10.1128/IAI.57.5.1604-1611.1989; RAYSSIGUIER C, 1989, NATURE, V342, P396, DOI 10.1038/342396a0; SAWYER S, 1989, MOL BIOL EVOL, V6, P526; SEIFERT HS, 1988, NATURE, V336, P392, DOI 10.1038/336392a0; SELANDER RK, 1980, SCIENCE, V210, P545, DOI 10.1126/science.6999623; SELANDER RK, 1987, ESCHERICHIA COLI SAL, P1625; SHARP PM, 1987, MOL BIOL EVOL, V4, P222; SMITH NH, 1990, J BACTERIOL, V172, P2209, DOI 10.1128/jb.172.5.2209-2216.1990; SPRATT BG, 1988, REV INFECT DIS, V10, P699; SPRATT BG, 1988, NATURE, V332, P173, DOI 10.1038/332173a0; SPRATT BG, 1989, P NATL ACAD SCI USA, V86, P8988, DOI 10.1073/pnas.86.22.8988; SPRATT BG, 1989, HDB EXPT PHARM, V91, P77; STEPHENS JC, 1985, MOL BIOL EVOL, V2, P539; STEWART GJ, 1986, ANNU REV MICROBIOL, V40, P211, DOI 10.1146/annurev.micro.40.1.211; STOLTZFUS A, 1988, GENETICS, V120, P345; WHITTAM TS, 1983, P NATL ACAD SCI-BIOL, V80, P1751, DOI 10.1073/pnas.80.6.1751; WOJCIECHOWSKI MF, 1989, GENETICS, V121, P411	38	288	299	0	9	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JAN 3	1991	349	6304					29	31		10.1038/349029a0	http://dx.doi.org/10.1038/349029a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EQ601	1985260				2022-12-28	WOS:A1991EQ60100040
J	STAFFORD, RS				STAFFORD, RS			THE IMPACT OF NONCLINICAL FACTORS ON REPEAT CESAREAN-SECTION	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEALTH-MAINTENANCE ORGANIZATION; UNITED-STATES; VAGINAL BIRTH; RATES; DELIVERY; CARE	Nonclinical factors, including the setting in which health care takes place, influence clinical decisions. This research measures the independent effects of organizational and socioeconomic factors on repeat cesarean section use in California. Of 45 425 births to women with previous cesarean sections in 1986, vaginal birth after cesarean section occurred in 10.9%. Sizable nonclinical variations were notes. By hospital ownership, rates ranged from 4.9% (for-profit hospitals) to 29.2% (University of California). Variations also existed by hospital teaching level (nonteaching hospitals, 7.0%, vs formalized teaching hospitals, 23.3%); payment source (private insurance, 8.1%, vs indigent services, 25.2%); and obstetric volume (low-volume hospitals, 5.4%, vs high-volume hospitals, 16.6%). Multiple logistic regression demonstrated that these variables had independent effects after accounting for the overlapping influences and the effects of patient characteristics. The observed variations demonstrate the prominence of nonclinical factors in decision making and question the clinical appropriateness of current practice patterns.			STAFFORD, RS (corresponding author), UNIV CALIF BERKELEY,SCH PUBL HLTH,EPIDEMIOL PROGRAM,140 WARREN HALL,BERKELEY,CA 94720, USA.		Stafford, Randall/F-3974-2017	Stafford, Randall/0000-0003-1805-1271	AHRQ HHS [HS-06116] Funding Source: Medline	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		ANDERSON GM, 1985, CAN MED ASSOC J, V132, P253; EISENBERG JM, 1986, DOCTROS DECISIONS CO; FLAMM BL, 1988, AM J OBSTET GYNECOL, V158, P1079, DOI 10.1016/0002-9378(88)90224-4; FRASER W, 1987, AM J OBSTET GYNECOL, V156, P300, DOI 10.1016/0002-9378(87)90272-9; GOLDFARB MG, 1987, INQUIRY-J HEALTH CAR, V24, P68; GOLDFARB MG, 1984, PHS843345 NAT CTR HL; GOULD JB, 1988, J PERINAT MED, V16, P305, DOI 10.1515/jpme.1988.16.4.305; GOULD JB, 1989, NEW ENGL J MED, V321, P233, DOI 10.1056/NEJM198907273210406; MARTIN JN, 1988, OBSTET GYN CLIN N AM, V15, P719; MOLLOY BG, 1987, BRIT MED J, V294, P1645, DOI 10.1136/bmj.294.6588.1645; MYERS SA, 1988, NEW ENGL J MED, V319, P1511, DOI 10.1056/NEJM198812083192304; ODRISCOLL K, 1983, OBSTET GYNECOL, V61, P1; PLACEK PJ, 1988, OBSTET GYN CLIN N AM, V15, P607; PLACEK PJ, 1988, AM J PUBLIC HEALTH, V78, P512, DOI 10.2105/AJPH.78.5.512; RUTKOW IM, 1986, OBSTET GYNECOL, V67, P755, DOI 10.1097/00006250-198606000-00001; SHIONO PH, 1987, JAMA-J AM MED ASSOC, V257, P494, DOI 10.1001/jama.257.4.494; STAFFORD RS, 1990, JAMA-J AM MED ASSOC, V263, P683, DOI 10.1001/jama.263.5.683; STAFFORD RS, 1990, AM J PUBLIC HEALTH, V80, P313, DOI 10.2105/AJPH.80.3.313; TAFFEL SM, 1990, NEW ENGL J MED, V323, P199; WILLIAMS RL, 1983, AM J PUBLIC HEALTH, V73, P863, DOI 10.2105/AJPH.73.8.863; WILNER S, 1981, NEW ENGL J MED, V304, P784, DOI 10.1056/NEJM198103263041313; Woolson R. F, 1987, STATISTICAL METHODS; WRIGHT CH, 1984, AM J OBSTET GYNECOL, V149, P848, DOI 10.1016/0002-9378(84)90603-3; 1986, 1986 DISCHARGE DATA; 1988, NEW GUIDELINES VBAC; 1987, 1986 STAT HLTH PLANN; 1988, STAT B, V69, P25; 1988, STAT B, V69, P18; 1987, AHA GUIDE HLTH CARE; 1981, NIH822067 US DEP HLT	30	131	131	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	1991	265	1					59	63		10.1001/jama.265.1.59	http://dx.doi.org/10.1001/jama.265.1.59			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EP555	1984126				2022-12-28	WOS:A1991EP55500028
J	BOLOS, AM; DEAN, M; LUCASDERSE, S; RAMSBURG, M; BROWN, GL; GOLDMAN, D				BOLOS, AM; DEAN, M; LUCASDERSE, S; RAMSBURG, M; BROWN, GL; GOLDMAN, D			POPULATION AND PEDIGREE STUDIES REVEAL A LACK OF ASSOCIATION BETWEEN THE DOPAMINE-D2 RECEPTOR GENE AND ALCOHOLISM	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									NIAAA,CLIN STUDIES LAB,GENET STUDIES LAB,9000 ROCKVILLE PIKE,BLDG 10,ROOM 3C-102,ROCKVILLE,MD 20852; PROGRAM RESOURCES INC,FREDERICK,MD; NIAAA,CLIN STUDIES LAB,FAMILY STUDIES UNIT,ROCKVILLE,MD 20852	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)			Dean, Michael/R-7501-2019; Goldman, David/F-9772-2010; Dean, Michael/G-8172-2012	Goldman, David/0000-0002-1724-5405; Dean, Michael/0000-0003-2234-0631	OFFICE OF THE DIRECTOR, NCI [N01CO074102] Funding Source: NIH RePORTER; NCI NIH HHS [N01-CO-74102] Funding Source: Medline	OFFICE OF THE DIRECTOR, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ASTON CE, 1990, AM J HUM GENET, V46, P879; BLUM K, 1990, JAMA-J AM MED ASSOC, V263, P2055, DOI 10.1001/jama.263.15.2055; BOHMAN M, 1981, ARCH GEN PSYCHIAT, V38, P965; CLONINGER CR, 1981, ARCH GEN PSYCHIAT, V38, P861; DAUSSET J, 1990, GENOMICS, V6, P676; DEAN M, 1990, CELL, V61, P863, DOI 10.1016/0092-8674(90)90196-L; DEVOR EJ, 1989, ANNU REV GENET, V23, P19, DOI 10.1146/annurev.ge.23.120189.000315; ENDICOTT J, 1978, ARCH GEN PSYCHIAT, V35, P837; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GILLIGAN SB, 1987, GENET EPIDEMIOL, V4, P395, DOI 10.1002/gepi.1370040602; GOODWIN DW, 1973, ARCH GEN PSYCHIAT, V28, P238; GOODWIN DW, 1974, ARCH GEN PSYCHIAT, V31, P164; GRANDY DK, 1989, P NATL ACAD SCI USA, V86, P9762, DOI 10.1073/pnas.86.24.9762; GRANDY DK, 1989, AM J HUM GENET, V45, P778; KAIJ L, 1960, ALCOHOLISM TWINS; MAINIATIS T, 1982, MOL CLONING LABORATO, P280; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; SCHUCKIT MA, 1986, AM J PSYCHIAT, V143, P140; SCHUCKIT MA, 1972, AM J PSYCHIAT, V128, P1132, DOI 10.1176/ajp.128.9.1132; SELZER ML, 1971, AM J PSYCHIAT, V127, P1653, DOI 10.1176/ajp.127.12.1653; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SPITZER RL, 1978, ARCH GEN PSYCHIAT, V35, P773, DOI 10.1001/archpsyc.1978.01770300115013; STABENAU JR, 1984, AM J PSYCHIAT, V141, P1178; VONKNORRING AL, 1985, ACTA PSYCHIAT SCAND, V72, P51; WHITE MB, 1990, NATURE, V344, P665, DOI 10.1038/344665a0; WINOKUR G, 1971, BRIT J PSYCHIAT, V118, P525, DOI 10.1192/bjp.118.546.525; 1987, DIAGNOSTIC STATISTIC; 1990, ADM901656 US DEP HLT	28	225	233	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 26	1990	264	24					3156	3160						5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EN614	1979357				2022-12-28	WOS:A1990EN61400035
J	CARLSON, J; HELMBY, H; HILL, AVS; BREWSTER, D; GREENWOOD, BM; WAHLGREN, M				CARLSON, J; HELMBY, H; HILL, AVS; BREWSTER, D; GREENWOOD, BM; WAHLGREN, M			HUMAN CEREBRAL MALARIA - ASSOCIATION WITH ERYTHROCYTE ROSETTING AND LACK OF ANTI-ROSETTING ANTIBODIES	LANCET			English	Article									UNIV STOCKHOLM, DEPT IMMUNOL, S-10691 STOCKHOLM, SWEDEN; MRC LABS, FAJARA, SENEGAMBIA; UNIV UPPSALA, AKAD SJUKHUSET, DEPT INFECT DIS, S-75105 UPPSALA, SWEDEN; ROYAL VICTORIA HOSP BANJUL, DEPT PEDIAT, BANJUL, NSW, AUSTRALIA; KAROLINSKA INST, ROSLAGSTULLS SJUKHUS, DEPT INFECT DIS, S-10401 STOCKHOLM 60, SWEDEN; INST MOLEC MED, MOLEC IMMUNOL GRP, OXFORD, ENGLAND	Stockholm University; Uppsala University; Uppsala University Hospital; Karolinska Institutet; University of Oxford			HILL, Adrian V>S>/C-1306-2008; Helmby, Helena/ABE-1649-2020	Helmby, Helena/0000-0003-0761-7348; Carlson, Johan/0000-0002-6216-6132				BARNWELL JW, 1989, J CLIN INVEST, V84, P1; BERENDT AR, 1989, NATURE, V341, P57, DOI 10.1038/341057a0; CARLSON J, 1990, P NATL ACAD SCI USA, V87, P2511, DOI 10.1073/pnas.87.7.2511; DAVID PH, 1988, AM J TROP MED HYG, V38, P289, DOI 10.4269/ajtmh.1988.38.289; HANDUNNETTI SM, 1989, AM J TROP MED HYG, V40, P115, DOI 10.4269/ajtmh.1989.40.115; HOWARD RJ, 1988, PROG ALLERGY, V41, P98; Knisely M. H., 1941, Anatomical Record Philadelphia, V79, P90; MACPHERSON GG, 1985, AM J PATHOL, V119, P385; MARSH K, 1988, EXP PARASITOL, V65, P202, DOI 10.1016/0014-4894(88)90123-3; OCKENHOUSE CF, 1989, SCIENCE, V243, P1469, DOI 10.1126/science.2467377; ROBERTS DD, 1985, NATURE, V318, P64, DOI 10.1038/318064a0; TAYLOR DW, 1987, MOL BIOCHEM PARASIT, V25, P165, DOI 10.1016/0166-6851(87)90005-3; TAYLOR TE, 1988, NEW ENGL J MED, V319, P1040, DOI 10.1056/NEJM198810203191602; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; UDOMSANGPETCH R, 1989, J EXP MED, V169, P1835, DOI 10.1084/jem.169.5.1835; WAHLGREN M, 1990, VACCINES 90, P467; WAHLGREN M, 1990, AM J TROP MED HYG, V43, P333, DOI 10.4269/ajtmh.1990.43.333; WAHLGREN M, 1989, PARASITOL TODAY, V5, P183, DOI 10.1016/0169-4758(89)90141-5; WAHLGREN M, 1986, ANTIGENS ANTIBODIES, P1	19	380	385	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 15	1990	336	8729					1457	1460		10.1016/0140-6736(90)93174-N	http://dx.doi.org/10.1016/0140-6736(90)93174-N			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EN157	1979090				2022-12-28	WOS:A1990EN15700001
J	SOUTHERN, JP; SMITH, RMM; PALMER, SR				SOUTHERN, JP; SMITH, RMM; PALMER, SR			BIRD ATTACK ON MILK BOTTLES - POSSIBLE MODE OF TRANSMISSION OF CAMPYLOBACTER-JEJUNI TO MAN	LANCET			English	Article									CARDIFF ROYAL INFIRM, CTR COMMUNICABLE DIS SURVEILLANCE, PUBL HLTH LAB SERV, WELSH UNIT, CARDIFF CF2 1SZ, S GLAM, WALES	Cardiff Royal Infirmary								BLASER MJ, 1987, JAMA-J AM MED ASSOC, V257, P43, DOI 10.1001/jama.257.1.43; DEMING MS, 1987, AM J EPIDEMIOL, V126, P526, DOI 10.1093/oxfordjournals.aje.a114685; HARRIS NV, 1986, AM J PUBLIC HEALTH, V76, P407, DOI 10.2105/AJPH.76.4.407; HOPKINS RS, 1983, J INFECT DIS, V148, P770, DOI 10.1093/infdis/148.4.770; HUDSON SJ, 1990, LANCET, V335, P1160, DOI 10.1016/0140-6736(90)91162-4; KAPPERUD G, 1983, APPL ENVIRON MICROB, V45, P375, DOI 10.1128/AEM.45.2.375-380.1983; KORNBLATT AN, 1985, AM J EPIDEMIOL, V122, P884, DOI 10.1093/oxfordjournals.aje.a114171; OOSTEROM J, 1984, J HYG-CAMBRIDGE, V93, P325, DOI 10.1017/S002217240006486X; PALMER SR, 1989, J EPIDEMIOL COMMUN H, V43, P311, DOI 10.1136/jech.43.4.311; PALMER SR, 1983, LANCET, V1, P287, DOI 10.1016/S0140-6736(83)91698-7; PALMER SR, 1990, BRIT MED J, V300, P774, DOI 10.1136/bmj.300.6727.774; ROBINSON DA, 1981, BRIT MED J, V282, P1374, DOI 10.1136/bmj.282.6273.1374; SALFIELD NJ, 1987, BRIT MED J, V294, P21, DOI 10.1136/bmj.294.6563.21; Schlesselman JJ, 1982, CASE CONTROL STUDIES; 1990, MICROBIOLOGICAL SA 1, P126	15	40	41	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 8	1990	336	8728					1425	1427		10.1016/0140-6736(90)93114-5	http://dx.doi.org/10.1016/0140-6736(90)93114-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL851	1978882				2022-12-28	WOS:A1990EL85100016
J	PRUSINER, SB; SCOTT, M; FOSTER, D; PAN, KM; GROTH, D; MIRENDA, C; TORCHIA, M; YANG, SL; SERBAN, D; CARLSON, GA; HOPPE, PC; WESTAWAY, D; DEARMOND, SJ				PRUSINER, SB; SCOTT, M; FOSTER, D; PAN, KM; GROTH, D; MIRENDA, C; TORCHIA, M; YANG, SL; SERBAN, D; CARLSON, GA; HOPPE, PC; WESTAWAY, D; DEARMOND, SJ			TRANSGENETIC STUDIES IMPLICATE INTERACTIONS BETWEEN HOMOLOGOUS PRP ISOFORMS IN SCRAPIE PRION REPLICATION	CELL			English	Article									UNIV CALIF SAN FRANCISCO,DEPT BIOCHEM & BIOPHYS,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT PATHOL,SAN FRANCISCO,CA 94143; MCLAUGHLIN RES INST,GREAT FALLS,MT 59401; JACKSON LAB,BAR HARBOR,ME 04609	University of California System; University of California San Francisco; University of California System; University of California San Francisco; McLaughlin Research Institute for Biomedical Sciences, Inc.; Jackson Laboratory	PRUSINER, SB (corresponding author), UNIV CALIF SAN FRANCISCO,DEPT NEUROL,SAN FRANCISCO,CA 94143, USA.				NIA NIH HHS [AG02132] Funding Source: Medline; NINDS NIH HHS [NS22786, NS14069] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS014069, P01NS014069, P01NS022786] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG002132] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		AIKEN JM, 1989, J VIROL, V63, P1686, DOI 10.1128/JVI.63.4.1686-1694.1989; AMBLER L, 1984, ANAL BIOCHEM, V137, P66, DOI 10.1016/0003-2697(84)90347-6; BARRY R A, 1987, P239; BARRY RA, 1986, J INFECT DIS, V154, P518, DOI 10.1093/infdis/154.3.518; BARRY RA, 1985, J IMMUNOL, V135, P603; BASLER K, 1986, CELL, V46, P417, DOI 10.1016/0092-8674(86)90662-8; BELLINGERKAWAHARA C, 1987, VIROLOGY, V160, P271, DOI 10.1016/0042-6822(87)90072-9; BELLINGERKAWAHARA C, 1987, J VIROL, V61, P159, DOI 10.1128/JVI.61.1.159-166.1987; BELLINGERKAWAHARA CG, 1988, VIROLOGY, V164, P537, DOI 10.1016/0042-6822(88)90569-7; BOCKMAN JM, 1987, ANN NEUROL, V21, P589, DOI 10.1002/ana.410210611; BORCHELT DR, 1990, J CELL BIOL, V110, P743, DOI 10.1083/jcb.110.3.743; BRAIG HR, 1985, EMBO J, V4, P2309, DOI 10.1002/j.1460-2075.1985.tb03931.x; BRUCE ME, 1985, J NEUROPATH EXP NEUR, V44, P285, DOI 10.1097/00005072-198505000-00006; BRUCE ME, 1976, NEUROPATH APPL NEURO, V2, P471, DOI 10.1111/j.1365-2990.1976.tb00521.x; BRUCE ME, 1987, J GEN VIROL, V68, P79, DOI 10.1099/0022-1317-68-1-79; BUTLER DA, 1988, J VIROL, V62, P1558, DOI 10.1128/JVI.62.5.1558-1564.1988; CARLSON GA, 1989, P NATL ACAD SCI USA, V86, P7475, DOI 10.1073/pnas.86.19.7475; CARLSON GA, 1986, CELL, V46, P503, DOI 10.1016/0092-8674(86)90875-5; CARLSON GA, 1988, MOL CELL BIOL, V8, P5528, DOI 10.1128/MCB.8.12.5528; CAUGHEY B, 1990, J VIROL, V64, P1093, DOI 10.1128/JVI.64.3.1093-1101.1990; CAUGHEY B, 1989, J VIROL, V63, P175, DOI 10.1128/JVI.63.1.175-181.1989; CHANDLER RL, 1961, LANCET, V1, P1378; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CREIGHTON TE, 1980, J MOL BIOL, V142, P43, DOI 10.1016/0022-2836(80)90205-3; CZUB M, 1988, J GEN VIROL, V69, P1753, DOI 10.1099/0022-1317-69-7-1753; DEARMOND S J, 1987, P387; DEARMOND SJ, 1985, CELL, V41, P221, DOI 10.1016/0092-8674(85)90076-5; DEARMOND SJ, 1987, NEUROLOGY, V37, P1271, DOI 10.1212/WNL.37.8.1271; DICKINSON AG, 1968, J COMP PATHOL, V78, P293, DOI 10.1016/0021-9975(68)90005-4; Dickinson AG., 1979, SLOW TRANSMISSIBLE D, P13; DUGUID JR, 1988, P NATL ACAD SCI USA, V85, P5738, DOI 10.1073/pnas.85.15.5738; EKLUND CM, 1967, J INFECT DIS, V117, P15, DOI 10.1093/infdis/117.1.15; ENDO T, 1989, BIOCHEMISTRY-US, V28, P8380, DOI 10.1021/bi00447a017; EVANS PA, 1987, NATURE, V329, P266, DOI 10.1038/329266a0; FOX RO, 1986, NATURE, V320, P192, DOI 10.1038/320192a0; FRASER H, 1989, ALZHEIMERS DISEASE R, P637; GABIZON R, 1990, BIOCHEM J, V266, P1; GABIZON R, 1988, P NATL ACAD SCI USA, V85, P6617, DOI 10.1073/pnas.85.18.6617; GABIZON R, 1987, P NATL ACAD SCI USA, V84, P4017, DOI 10.1073/pnas.84.12.4017; HAY B, 1987, BIOCHEMISTRY-US, V26, P8110, DOI 10.1021/bi00399a014; HAY B, 1987, MOL CELL BIOL, V7, P914, DOI 10.1128/MCB.7.2.914; HSIAO K, 1989, NATURE, V338, P342, DOI 10.1038/338342a0; HUNTER N, 1987, J GEN VIROL, V68, P2711, DOI 10.1099/0022-1317-68-10-2711; IJSSELMUIDEN OE, 1987, EUR J CLIN MICROBIOL, V6, P281, DOI 10.1007/BF02017613; IJSSELMUIDEN OE, 1989, J IMMUNOL METHODS, V119, P35, DOI 10.1016/0022-1759(89)90378-5; KIMBERLIN RH, 1977, J GEN VIROL, V34, P295, DOI 10.1099/0022-1317-34-2-295; KIMBERLIN RH, 1978, J COMP PATHOL, V88, P39, DOI 10.1016/0021-9975(78)90059-2; KIMBERLIN RH, 1989, J GEN VIROL, V70, P2017, DOI 10.1099/0022-1317-70-8-2017; KRIEG PA, 1984, NUCLEIC ACIDS RES, V12, P7057, DOI 10.1093/nar/12.18.7057; LANG K, 1987, NATURE, V329, P268, DOI 10.1038/329268a0; LEINIKKI PO, 1978, J CLIN MICROBIOL, V8, P419; LOPEZ CD, 1990, SCIENCE, V248, P226, DOI 10.1126/science.1970195; MANUELIDIS L, 1987, EMBO J, V6, P341, DOI 10.1002/j.1460-2075.1987.tb04760.x; MARSH RF, 1975, J INFECT DIS, V131, P104, DOI 10.1093/infdis/131.2.104; MCBRIDE PA, 1988, NEUROPATH APPL NEURO, V14, P325, DOI 10.1111/j.1365-2990.1988.tb00892.x; MCKINLEY MP, 1983, CELL, V35, P57, DOI 10.1016/0092-8674(83)90207-6; MEYER N, 1990, IN PRESS J GEN VIROL; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; MURDOCH GH, 1990, J VIROL, V64, P1477, DOI 10.1128/JVI.64.4.1477-1486.1990; OESCH B, 1990, BIOCHEMISTRY-US, V29, P5848, DOI 10.1021/bi00476a029; OESCH B, 1985, CELL, V40, P735, DOI 10.1016/0092-8674(85)90333-2; OSTERMANN J, 1989, NATURE, V341, P125, DOI 10.1038/341125a0; Pattison I. H., 1965, NINDB MONOGRAPH, V2, P249; PATTISON IH, 1968, RES VET SCI, V9, P408; PRUISNER SB, 1989, ANNU REV MICROBIOL, V43, P345; PRUSINER S B, 1987, P83; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PRUSINER SB, 1982, BIOCHEMISTRY-US, V21, P6942, DOI 10.1021/bi00269a050; PRUSINER SB, 1982, ANN NEUROL, V11, P353, DOI 10.1002/ana.410110406; PRUSINER SB, 1977, P NATL ACAD SCI USA, V74, P4656, DOI 10.1073/pnas.74.10.4656; PUISSANT C, 1990, BIOTECHNIQUES, V8, P148; RACE RE, 1988, J VIROL, V62, P2845, DOI 10.1128/JVI.62.8.2845-2849.1988; RACE RE, 1990, J GEN VIROL, V71, P493, DOI 10.1099/0022-1317-71-2-493; ROBERTS GW, 1986, NEW ENGL J MED, V315, P1231; Rosen K., 1990, FOCUS, V12, P23; SCOTT M, 1989, CELL, V59, P847, DOI 10.1016/0092-8674(89)90608-9; SERBAN D, 1990, NEUROLOGY, V40, P110, DOI 10.1212/WNL.40.1.110; SINGH L, 1984, NUCLEIC ACIDS RES, V12, P5627, DOI 10.1093/nar/12.14.5627; SKLAVIADIS TK, 1989, J VIROL, V63, P1212, DOI 10.1128/JVI.63.3.1212-1222.1989; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4; TARABOULOS A, 1990, IN PRESS P NATL ACAD; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; UHL J, 1988, J IMMUNOL METHODS, V110, P79, DOI 10.1016/0022-1759(88)90085-3; WEISSMANN C, 1989, NATURE, V338, P298, DOI 10.1038/338298a0; WEITGREFE S, 1985, SCIENCE, V230, P1177; WESTAWAY D, 1987, CELL, V51, P651, DOI 10.1016/0092-8674(87)90134-6; WOOD GS, 1981, J HISTOCHEM CYTOCHEM, V29, P1196, DOI 10.1177/29.10.7028859; YOST CS, 1990, NATURE, V343, P669, DOI 10.1038/343669a0	88	755	777	0	30	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	NOV 16	1990	63	4					673	686		10.1016/0092-8674(90)90134-Z	http://dx.doi.org/10.1016/0092-8674(90)90134-Z			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EJ590	1977523				2022-12-28	WOS:A1990EJ59000004
J	STACEY, C; MUNDAY, P; THOMAS, B; GILCHRIST, C; TAYLORROBINSON, D; BEARD, R				STACEY, C; MUNDAY, P; THOMAS, B; GILCHRIST, C; TAYLORROBINSON, D; BEARD, R			CHLAMYDIA-TRACHOMATIS IN THE FALLOPIAN-TUBES OF WOMEN WITHOUT LAPAROSCOPIC EVIDENCE OF SALPINGITIS	LANCET			English	Article									CLIN RES CTR,DIV SEXUALLY TRANSMITTED DIS,HARROW HA1 3UJ,MIDDX,ENGLAND; ST MARYS HOSP,DEPT GENITOURINARY MED,LONDON,ENGLAND; ST MARYS HOSP,DEPT OBSTET & GYNAECOL,LONDON W2 1PG,ENGLAND	Imperial College London; Imperial College London				Phillips, Richard/0000-0003-0277-5435				BEARD RW, 1988, BRIT J OBSTET GYNAEC, V95, P153, DOI 10.1111/j.1471-0528.1988.tb06845.x; BRUNHAM RC, 1985, J INFECT DIS, V152, P1275, DOI 10.1093/infdis/152.6.1275; BRUNHAM RC, 1988, J INFECT DIS, V158, P510, DOI 10.1093/infdis/158.3.510; HAGER WD, 1983, OBSTET GYNECOL, V61, P113; KELVER ME, 1989, INT J FERTIL, V34, P42; KIVIAT NB, 1986, AM J OBSTET GYNECOL, V154, P865, DOI 10.1016/0002-9378(86)90473-4; KRISEMAN MM, 1982, S AFR MED J, V61, P107; MOLLER BR, 1986, LANCET, V2, P390; NORDVALL S, 1970, ACTA OBSTET GYN SCAN, V49, P111, DOI 10.3109/00016347009157524; PAAVONEN J, 1985, AM J OBSTET GYNECOL, V151, P645, DOI 10.1016/0002-9378(85)90156-5; ROBERTSON JN, 1988, BR J OBSTET GYNAECOL, V151, P645; THOMAS BJ, 1976, J CLIN MICROBIOL, V4, P6; THOMAS BJ, 1984, J CLIN PATHOL, V37, P812, DOI 10.1136/jcp.37.7.812; THOMAS BJ, 1977, J CLIN MICROBIOL, V6, P285; TUFFREY M, 1990, J EXP PATHOL, V71, P403; WESTROM L, 1989, SEXUALLY TRANSMITTED; WOLNERHANSSEN P, 1983, OBSTET GYNECOL, V61, P299	17	39	39	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 20	1990	336	8721					960	963		10.1016/0140-6736(90)92418-H	http://dx.doi.org/10.1016/0140-6736(90)92418-H			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ED601	1977003				2022-12-28	WOS:A1990ED60100002
J	SKIRROW, MB				SKIRROW, MB			CAMPYLOBACTER	LANCET			English	Article											SKIRROW, MB (corresponding author), WORCESTER ROYAL INFIRM,DEPT MICROBIOL,CASTLE ST,WORCESTER WR1 3AS,ENGLAND.							BLASER MJ, 1983, EPIDEMIOL REV, V5, P157, DOI 10.1093/oxfordjournals.epirev.a036256; BOLTON FJ, 1985, J HYG-CAMBRIDGE, V95, P1, DOI 10.1017/S0022172400062215; CALVA JJ, 1988, LANCET, V1, P503; FRICKER CR, 1989, J APPL BACTERIOL, V66, P477, DOI 10.1111/j.1365-2672.1989.tb04568.x; GOOSSENS H, 1990, LANCET, V335, P584, DOI 10.1016/0140-6736(90)90359-D; HARRIS NV, 1986, AM J PUBLIC HEALTH, V76, P407, DOI 10.2105/AJPH.76.4.407; HOOD AM, 1988, EPIDEMIOL INFECT, V100, P17, DOI 10.1017/S0950268800065511; HUDSON SJ, 1990, LANCET, V335, P1160, DOI 10.1016/0140-6736(90)91162-4; KALDOR J, 1984, BRIT MED J, V288, P1867, DOI 10.1136/bmj.288.6434.1867; KENDALL EJC, 1982, J HYG-CAMBRIDGE, V88, P155, DOI 10.1017/S0022172400070030; PEARSON AD, 1988, CAMPYLOBACTER, V4, P304; ROBINSON DA, 1981, BRIT MED J, V282, P1374, DOI 10.1136/bmj.282.6273.1374; SKIRROW MB, 1987, EPIDEMIOL INFECT, V99, P647, DOI 10.1017/S0950268800066504; SKIRROW MB, 1984, MED MICROBIOLOGY, V4, P105; SOCKETT PN, 1988, CAMPYLOBACTER, V4, P261; WALKER RI, 1986, MICROBIOL REV, V50, P81, DOI 10.1128/MMBR.50.1.81-94.1986; WINER JB, 1988, J NEUROL NEUROSUR PS, V51, P613, DOI 10.1136/jnnp.51.5.613	17	110	110	0	12	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 13	1990	336	8720					921	923		10.1016/0140-6736(90)92282-M	http://dx.doi.org/10.1016/0140-6736(90)92282-M			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EC456	1976939	Bronze			2022-12-28	WOS:A1990EC45600013
J	ROBERTS, D				ROBERTS, D			SOURCES OF INFECTION - FOOD	LANCET			English	Article											ROBERTS, D (corresponding author), CENT PUBL HLTH LAB,PUBL HLTH LAB SERV,FOOD HYG LAB,61 COLINDALE AVE,LONDON NW9 5HT,ENGLAND.							BARRETT NJ, 1989, J SOC DAIRY TECHNOL, V42, P4; BOLTON FJ, 1985, CAMPYLOBACTER, V3, P106; CRUICKSHANK JG, 1987, EPIDEMIOL INFECT, V98, P223, DOI 10.1017/S0950268800061975; D'Aoust J. Y., 1989, Foodborne bacterial pathogens., P327; GELDREICH EE, 1971, J MILK FOOD TECHNOL, V34, P184, DOI 10.4315/0022-2747-34.4.184; Gilbert R. J., 1989, PHLS (Public Health Laboratory Service) Microbiology Digest, V6, P33; GREENWOOD M, IN PRESS INT J FOOD; HOOD AM, 1988, EPIDEMIOL INFECT, V100, P17, DOI 10.1017/S0950268800065511; HUMPHREY TJ, 1989, EPIDEMIOL INFECT, V103, P415, DOI 10.1017/S0950268800030818; JONES PH, 1981, J HYG-CAMBRIDGE, V87, P155, DOI 10.1017/S0022172400069357; LAMMERDING AM, 1988, J FOOD PROTECT, V51, P47, DOI 10.4315/0362-028X-51.1.47; MARTH EH, 1990, FOODBORNE LISTERIOSI, P151; MORRIS IJ, 1989, LANCET, V2, P1285; PINI PN, 1988, INT J FOOD MICROBIOL, V6, P317, DOI 10.1016/0168-1605(88)90025-6; RAMPLING A, 1987, LANCET, V2, P1209; RAMPLING A, 1990, TOPLEY WILSONS PRINC, V1, P265; ROBERTS D, 1986, 2ND P WORLD C FOODB, P157; ROBERTS D, 1982, SOC APPL BACTERIOLOG, V10, P169; ROWE B, 1987, LANCET, V2, P900; SHARP JCM, 1987, B WORLD HEALTH ORGAN, V65, P397; 1988, PHLS MICROBIOL DIG, V5, P69; 1989, PHLS MICROBIOL DIG, V6, P1	22	49	52	0	5	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 6	1990	336	8719					859	861		10.1016/0140-6736(90)92352-I	http://dx.doi.org/10.1016/0140-6736(90)92352-I			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB901	1976886				2022-12-28	WOS:A1990EB90100014
J	BIRCH, LL; JOHNSON, SL; ANDRESEN, G; PETERS, JC; SCHULTE, MC				BIRCH, LL; JOHNSON, SL; ANDRESEN, G; PETERS, JC; SCHULTE, MC			THE VARIABILITY OF YOUNG CHILDRENS ENERGY-INTAKE	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FOOD-INTAKE; CALORIC COMPENSATION; SELF-REGULATION	Background. Research conducted in the 1930s showed that, given nutritious choices, children can select an adequate diet without adult supervision. Paradoxically, children grew well and were healthy despite patterns of intake at individual meals that were unpredictable and highly variable. Methods. To investigate in more detail the energy intake of young children, we measured 24-hour food intake for 15 children, from two to five years of age, on six days. For each of the six days of the study, coefficients of variation were calculated for each child for each of the six meals and snacks (breakfast, lunch, dinner, and morning, afternoon, and evening snacks) and for total daily energy intake. Results. The children's intake at individual meals was highly variable, but total daily energy intake was relatively constant for each child. The mean coefficient of variation for each child's energy intake at individual meals was 33.6 percent; in contrast, the mean coefficient of variation for each child's total daily energy intake was 10.4 percent. In most cases, high energy intake at one meal was followed by low energy intake at the next meal, or vice versa. Conclusions. Although children's food consumption is highly variable from meal to meal, daily energy intake is relatively constant, because children adjust their energy intake at successive meals.	PROCTER & GAMBLE CO,MIAMI VALLEY LABS,CINCINNATI,OH 45247	Procter & Gamble	BIRCH, LL (corresponding author), UNIV ILLINOIS,SCH HUMAN RESOURCES & FAMILY STUDIES,CHILD DEV LAB,URBANA,IL 61801, USA.							BIRCH LL, 1980, CHILD DEV, V51, P856, DOI 10.2307/1129474; BIRCH LL, 1986, APPETITE, V7, P323, DOI 10.1016/S0195-6663(86)80001-0; BIRCH LL, 1985, LEARN MOTIV, V16, P341, DOI 10.1016/0023-9690(85)90020-7; BIRCH LL, 1989, PHYSIOL BEHAV, V45, P387, DOI 10.1016/0031-9384(89)90145-5; BIRCH LL, 1984, CHILD DEV, V55, P431, DOI 10.2307/1129954; Costanzo P. R., 1984, J SOC CLIN PSYCHOL, V2, P305; Davis CM, 1928, AM J DIS CHILD, V36, P651; Davis CM, 1939, CAN MED ASSOC J, V41, P257; FOLTIN RW, 1990, AM J CLIN NUTR, V52, P969, DOI 10.1093/ajcn/52.6.969; FOMON SJ, 1974, INFANT NUTRITION; HARRIES JM, 1962, P NUTR SOC, V21, P157, DOI 10.1079/PNS19620027; PELLETT PL, 1990, AM J CLIN NUTR, V51, P711, DOI 10.1093/ajcn/51.5.711	12	253	257	0	13	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 24	1991	324	4					232	235		10.1056/NEJM199101243240405	http://dx.doi.org/10.1056/NEJM199101243240405			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EU022	1985244				2022-12-28	WOS:A1991EU02200005
J	SACHS, GA; MILES, SH; LEVIN, RA				SACHS, GA; MILES, SH; LEVIN, RA			LIMITING RESUSCITATION - EMERGING POLICY IN THE EMERGENCY MEDICAL SYSTEM	ANNALS OF INTERNAL MEDICINE			English	Article							PROSPECTIVE PAYMENT SYSTEM	Patients, families, and physicians frequently decide that a hospitalized patient will forgo cardiopulmonary resuscitation and document this decision with a do-not-resuscitate (DNR) order. In community settings (home, nursing home, hospice), these orders may conflict with paramedics' standing orders to provide cardiopulmonary resuscitation whenever it is medically indicated. We did a nationwide telephone survey of state offices for coordination of emergency medical services (EMS) to see how the states deal with this potential conflict. We identified eight states that have specific policies enabling EMS personnel to accept DNR orders for patients being transported by ambulance. State officials identified administrative complexities and legal concerns as the primary barriers to enacting prehospitalization DNR policies. We also identified 21 local EMS systems that have developed policies for accepting orders to withhold life-sustaining treatment. Four types of policy models, characterized according to procedure for validating DNR orders and telephone accessing the EMS system, show that regulatory reform can address policy barriers in the absence of enabling legislation.	UNIV CHICAGO, PRITZKER SCH MED, CHICAGO, IL 60637 USA; UNIV MINNESOTA, HENNEPIN CTY MED CTR, MINNEAPOLIS, MN 55415 USA	University of Chicago; Hennepin County Medical Center; University of Minnesota System; University of Minnesota Twin Cities								CRIMMINS TJ, 1988, MINN MED, V71, P708; CRIMMINS TJ, 1990, PREHOSP DISASTER MED, V5, P47; FITZGERALD JF, 1988, NEW ENGL J MED, V319, P1392, DOI 10.1056/NEJM198811243192106; LEWIS MA, 1985, GERONTOLOGIST, V25, P382, DOI 10.1093/geront/25.4.382; MARSHALL L, 1985, J EMERG MED SERV, P24; MILES SH, 1985, JAMA-J AM MED ASSOC, V254, P525, DOI 10.1001/jama.254.4.525; MILES SH, 1987, J AM GERIATR SOC, V35, P74, DOI 10.1111/j.1532-5415.1987.tb01323.x; MILES SH, 1989, PROTOCOLS ELECTIVE U; President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research, 1983, DECIDING FOREGO LIFE; SAGER MA, 1989, NEW ENGL J MED, V320, P433, DOI 10.1056/NEJM198902163200705; WAGNER A, 1984, NEW ENGL J MED, V310, P1129, DOI 10.1056/NEJM198404263101732; 1986, JAMA-J AM MED ASSOC, V255, P2979; 1988, ANN EMERG MED, V17, P1106; 1988, LONG TERM CARE STAND, P27; 1987, ACEP NEWS, V6, P11; 1987, GUIDELINES TERMINATI; 1985, PHYSICIAN HOPELESSLY; 1988, ACCREDITATION MANUAL, P90	18	29	29	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 15	1991	114	2					151	154		10.7326/0003-4819-114-2-151	http://dx.doi.org/10.7326/0003-4819-114-2-151			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ER534	1984394				2022-12-28	WOS:A1991ER53400012
J	SELBY, R; STARZL, TE; YUNIS, E; BROWN, BI; KENDALL, RS; TZAKIS, A				SELBY, R; STARZL, TE; YUNIS, E; BROWN, BI; KENDALL, RS; TZAKIS, A			LIVER-TRANSPLANTATION FOR TYPE-IV GLYCOGEN-STORAGE-DISEASE	NEW ENGLAND JOURNAL OF MEDICINE			English	Note							BRANCHING ENZYME-ACTIVITY; PEPTIDYL-PROLYL ISOMERASE; IMMUNOSUPPRESSANT FK506; DEFICIENCY; VARIANT; LIGHT		UNIV PITTSBURGH,UNIV HLTH CTR PITTSBURGH,CHILDRENS HOSP,DEPT SURG,3601 5TH AVE,PITTSBURGH,PA 15213; UNIV PITTSBURGH,UNIV HLTH CTR PITTSBURGH,CHILDRENS HOSP,DEPT PATHOL,PITTSBURGH,PA 15213; MARY BRIDGE CHILDRENS HOSP,TACOMA,WA; WASHINGTON UNIV,SCH MED,DEPT BIOCHEM,ST LOUIS,MO 63110	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Washington University (WUSTL)					NIDDK NIH HHS [DK 29961, R01 DK029961-19] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK029961, R37DK029961] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSEN DH, 1952, CARBOHYD METABOL, P28; BANNAYAN GA, 1976, AM J CLIN PATHOL, V66, P702; BROWN BI, 1989, AM J HUM GENET, V44, P378; BROWN BI, 1966, P NATL ACAD SCI USA, V56, P725, DOI 10.1073/pnas.56.2.725; BROWN BI, 1986, MYOLOGY, P1653; BROWN DH, 1983, BIOCHEM BIOPH RES CO, V111, P636, DOI 10.1016/0006-291X(83)90354-6; FERGUSON IT, 1983, J NEUROL SCI, V60, P337, DOI 10.1016/0022-510X(83)90144-2; GREENE GM, 1987, ARCH PATHOL LAB MED, V111, P977; GREENE HL, 1988, HEPATOLOGY, V8, P302, DOI 10.1002/hep.1840080219; GUERRA AS, 1986, EUR J PEDIATR, V145, P179, DOI 10.1007/BF00446059; HARDING MW, 1989, NATURE, V341, P758, DOI 10.1038/341758a0; HERS HG, 1989, METABOLIC BASIS INHE, V1, P425; ILLINGWORTH B, 1952, J BIOL CHEM, V199, P653; ISHIHARA T, 1975, ACTA PATHOL JAPON, V25, P613; ISHIHARA T, 1987, ACTA PATHOL JAPON, V37, P1591; MAZZAFERRO V, 1990, SURGERY, V107, P533; MCMASTER KR, 1979, ARCH PATHOL LAB MED, V103, P105; REED GB, 1968, LAB INVEST, V19, P546; SCHOCHET SS, 1970, ARCH PATHOL, V90, P354; SERVIDEI S, 1987, J PEDIATR-US, V111, P51, DOI 10.1016/S0022-3476(87)80341-4; SIEKIERKA JJ, 1989, NATURE, V341, P755, DOI 10.1038/341755a0; STARZL TE, 1976, LANCET, V1, P821; STARZL TE, 1989, NEW ENGL J MED, V321, P1014, DOI 10.1056/NEJM198910123211505; STARZL TE, 1979, GASTROENTEROLOGY, V77, P375; STARZL TE, IN PRESS TRANSPLANTA; ZELLWEGE.H, 1972, J PEDIATR-US, V80, P842	26	49	49	0	0	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 3	1991	324	1					39	42		10.1056/NEJM199101033240107	http://dx.doi.org/10.1056/NEJM199101033240107			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EQ503	1984162	Green Accepted			2022-12-28	WOS:A1991EQ50300007
J	SERRUYS, PW; STRAUSS, BH; BEATT, KJ; BERTRAND, ME; PUEL, J; RICKARDS, AF; MEIER, B; GOY, JJ; VOGT, P; KAPPENBERGER, L; SIGWART, U				SERRUYS, PW; STRAUSS, BH; BEATT, KJ; BERTRAND, ME; PUEL, J; RICKARDS, AF; MEIER, B; GOY, JJ; VOGT, P; KAPPENBERGER, L; SIGWART, U			ANGIOGRAPHIC FOLLOW-UP AFTER PLACEMENT OF A SELF-EXPANDING CORONARY-ARTERY STENT	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							STENOSIS GEOMETRY; ANGIOPLASTY; RESTENOSIS; OCCLUSION	Background. The placement of stents in coronary arteries after coronary angioplasty has been investigated as a way of treating abrupt coronary-artery occlusion related to the angioplasty and of reducing the late intimal hyperplasia responsible for gradual restenosis of the dilated lesion. Methods. From March 1986 to January 1988, we implanted 117 self-expanding, stainless-steel endovascular stents (Wallstent) in the native coronary arteries (94 stents) or saphenous-vein bypass grafts (23 stents) of 105 patients. Angiograms were obtained immediately before and after placement of the stent and at follow-up at least one month later (unless symptoms required angiography sooner). The mortality after one year was 7.6 percent (8 patients). Follow-up angiograms (after a mean [+/- SD] of 5.7 +/- 4.4 months) were obtained in 95 patients with 105 stents and were analyzed quantitatively by a computer-assisted system of cardiovascular angiographic analysis. The 10 patients without follow-up angiograms included 4 who died. Results. Complete occlusion occurred in 27 stents in 25 patients (24 percent); 21 occlusions were documented within the first 14 days after implantation. Overall, immediately after placement of the stent there was a significant increase in the minimal luminal diameter and a significant decrease in the percentage of the diameter with stenosis (changing from a mean [+/- SD] of 1.88 +/- 0.43 to 2.48 +/- 0.51 mm from 37 +/- 12 to 21 +/- 10 percent, respectively; P < 0.0001). Later, however, there was a significant decrease in the minimal luminal diameter and a significant increase in the stenosis of the segment with the stent (1.68 +/- 1.78 mm and 48 +/- 34 percent at follow up). Significant restenosis, as indicated by a reduction of 0.72 mm in the minimal luminal diameter or by an increase in the percentage of stenosis to greater-than-or-equal-to 50 percent, occurred in 32 percent and 14 percent of patent stents, respectively. Conclusions. Early occlusion remains an important limitation of this coronary-artery stent. Even when the early effects are beneficial, there are frequently late occlusions or restenosis. The place of this form of treatment for coronary artery disease remains to be determined.	CTR HOSP REG UNIV RANGUEIL,DEPT CLIN & EXPTL CARDIOL,TOULOUSE,FRANCE; HOP CARDIOL,DEPT CARDIOL,LILLE,FRANCE; CHU VAUDOIS,DEPT MED,DIV CARDIOL,CH-1011 LAUSANNE,SWITZERLAND; UNIV GENEVA,HOP CANTONAL,CTR CARDIOL,CH-1211 GENEVA 4,SWITZERLAND; NATL HEART INST,DEPT CLIN MEASUREMENT,LONDON,ENGLAND	CHU de Toulouse; Universite de Lille - ISITE; CHU Lille; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Geneva; Imperial College London	SERRUYS, PW (corresponding author), ERASMUS UNIV,CATHETERIZAT LAB,POB 1738,3000 DR ROTTERDAM,NETHERLANDS.							BEATT KJ, 1988, J AM COLL CARDIOL, V12, P315, DOI 10.1016/0735-1097(88)90400-7; DOTTER CT, 1964, CIRCULATION, V30, P654, DOI 10.1161/01.CIR.30.5.654; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KONING R, 1989, ARCH MAL COEUR VAISS, V82, P177; PUEL J, 1988, AM J CARDIOL, V61, P546, DOI 10.1016/0002-9149(88)90762-X; REIBER JHC, 1985, CIRCULATION, V71, P280, DOI 10.1161/01.CIR.71.2.280; ROUSSEAU H, 1987, RADIOLOGY, V164, P709, DOI 10.1148/radiology.164.3.3303120; SCHWARTZ L, 1988, NEW ENGL J MED, V318, P1714, DOI 10.1056/NEJM198806303182603; SERRUYS PW, 1989, EUR HEART J, V10, P774, DOI 10.1093/oxfordjournals.eurheartj.a059570; SERRUYS PW, 1988, AM J CARDIOL, V61, pG71, DOI 10.1016/S0002-9149(88)80036-5; SERRUYS PW, 1988, CIRCULATION, V77, P361, DOI 10.1161/01.CIR.77.2.361; SIGWART U, 1988, CIRCULATION, V78, P1121, DOI 10.1161/01.CIR.78.5.1121; SIGWART U, 1987, NEW ENGL J MED, V316, P701, DOI 10.1056/NEJM198703193161201; URBAN P, 1989, J AM COLL CARDIOL, V13, P1085, DOI 10.1016/0735-1097(89)90265-9; Van Der Giessen WJ, 1988, J INTERV CARDIOL, V1, P109, DOI DOI 10.1111/J.1540-8183.1988.TB00395.X	15	574	583	1	19	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 3	1991	324	1					13	17		10.1056/NEJM199101033240103	http://dx.doi.org/10.1056/NEJM199101033240103			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EQ503	1984159	Green Submitted, Bronze			2022-12-28	WOS:A1991EQ50300003
J	WHALEN, GF				WHALEN, GF			SOLID TUMORS AND WOUNDS - TRANSFORMED-CELLS MISUNDERSTOOD AS INJURED TISSUE	LANCET			English	Review											WHALEN, GF (corresponding author), CORNELL UNIV, MED CTR,COLL MED,NEW YORK HOSP F1906,DEPT SURG, SURG ONCOL LAB, NEW YORK, NY 10021 USA.							BERRIDGE MJ, 1989, JAMA-J AM MED ASSOC, V262, P1834; BLAY J, 1985, J CELL PHYSIOL, V124, P107, DOI 10.1002/jcp.1041240117; CHAUDRY IH, 1983, AM J PHYSIOL, V245, pR117, DOI 10.1152/ajpregu.1983.245.2.R117; CRUM R, 1985, SCIENCE, V230, P1375, DOI 10.1126/science.2416056; DOWNWARD J, 1984, NATURE, V307, P521, DOI 10.1038/307521a0; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; FISHEL RS, 1987, ANN SURG, V206, P25, DOI 10.1097/00000658-198707000-00004; FOLKMAN J, 1989, NATURE, V339, P58, DOI 10.1038/339058a0; FOLKMAN J, 1988, AM J PATHOL, V130, P393; FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0; FRATERSCHRODER M, 1987, P NATL ACAD SCI USA, V84, P5277, DOI 10.1073/pnas.84.15.5277; GAMBLE JR, 1988, SCIENCE, V242, P97; GRAVES DT, 1989, SCIENCE, V245, P1490, DOI 10.1126/science.2781291; INGBER DE, 1987, IN VITRO CELL DEV B, V23, P387; KALEBIC T, 1983, SCIENCE, V221, P281, DOI 10.1126/science.6190230; KIMCHI A, 1988, SCIENCE, V240, P196, DOI 10.1126/science.2895499; KNUDSON W, 1984, J CELL BIOCHEM, V25, P183, DOI 10.1002/jcb.240250402; KRUMMEL TM, 1988, J PEDIATR SURG, V23, P647, DOI 10.1016/S0022-3468(88)80638-9; LEIBOVICH SJ, 1987, NATURE, V329, P630, DOI 10.1038/329630a0; Liotta L A, 1988, Adv Exp Med Biol, V233, P161; MADTES DK, 1988, CELL, V53, P285, DOI 10.1016/0092-8674(88)90390-X; MOSCATELLI D, 1986, P NATL ACAD SCI USA, V83, P2091, DOI 10.1073/pnas.83.7.2091; MURPHY JG, 1987, CIRCULATION, V75, P15; NICKOLOFF BJ, 1988, AM J PATHOL, V132, P543; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; POSTLETHWAITE AE, 1987, J EXP MED, V165, P251, DOI 10.1084/jem.165.1.251; PURO DG, 1989, INVEST OPHTH VIS SCI, V30, P521; ROBERTS AB, 1988, RECENT PROG HORM RES, V44, P157; ROSS R, 1986, CELL, V46, P155, DOI 10.1016/0092-8674(86)90733-6; SAGER R, 1989, SCIENCE, V246, P1406, DOI 10.1126/science.2574499; SHIPLEY GD, 1986, CANCER RES, V46, P2068; SMITH R, 1988, EMBO J, V7, P1013, DOI 10.1002/j.1460-2075.1988.tb02908.x; SPINUCCI C, 1988, JNCI-J NATL CANCER I, V80, P1416, DOI 10.1093/jnci/80.17.1416; SPORN MB, 1988, NATURE, V332, P217, DOI 10.1038/332217a0; TANG A, 1988, SCIENCE, V242, P263, DOI 10.1126/science.3175651; VANZOELEN EJJ, 1989, ENDOCRINOLOGY, V124, P2029, DOI 10.1210/endo-124-4-2029; VERRIER B, 1986, EMBO J, V5, P913, DOI 10.1002/j.1460-2075.1986.tb04303.x; WAHL SM, 1987, P NATL ACAD SCI USA, V84, P5788, DOI 10.1073/pnas.84.16.5788; WATERFIELD MD, 1983, NATURE, V304, P35, DOI 10.1038/304035a0	39	52	56	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 15	1990	336	8729					1489	1492		10.1016/0140-6736(90)93188-U	http://dx.doi.org/10.1016/0140-6736(90)93188-U			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EN157	1979101				2022-12-28	WOS:A1990EN15700012
J	VANDENPOL, AN; WUARIN, JP; DUDEK, FE				VANDENPOL, AN; WUARIN, JP; DUDEK, FE			GLUTAMATE, THE DOMINANT EXCITATORY TRANSMITTER IN NEUROENDOCRINE REGULATION	SCIENCE			English	Article									UNIV CALIF LOS ANGELES,SCH MED,MENTAL RETARDAT RES CTR,LOS ANGELES,CA 90024	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	VANDENPOL, AN (corresponding author), YALE UNIV,SCH MED,NEUROSURG SECT,NEW HAVEN,CT 06510, USA.				NIDA NIH HHS [DA05711] Funding Source: Medline; NINDS NIH HHS [NS10174, NS16296] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS016296, P50NS010174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA005711, F30DA005711] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		ANDREW RD, 1981, SCIENCE, V211, P1187, DOI 10.1126/science.7466393; BROADWELL RD, 1976, J COMP NEUROL, V166, P257, DOI 10.1002/cne.901660302; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; COBBETT P, 1986, BRAIN RES, V362, P7, DOI 10.1016/0006-8993(86)91392-2; CONNOR JA, 1988, SCIENCE, V240, P649, DOI 10.1126/science.2452481; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; COTMAN CW, 1987, TRENDS NEUROSCI, V10, P273, DOI 10.1016/0166-2236(87)90172-X; DECAVEL C, 1989, Society for Neuroscience Abstracts, V15, P1086; DECAVEL C, UNPUB; DECAVEL C, IN PRESS J COMP NEUR; EVERITT BJ, 1984, NEUROENDOCRINOLOGY, V39, P189, DOI 10.1159/000123977; GANONG WF, 1990, FRONT NEUROENDOCRIN, V11, P1; GRIBKOFF VK, 1990, J NEUROPHYSIOL, V63, P60, DOI 10.1152/jn.1990.63.1.60; GRIBKOFF VK, 1988, BRAIN RES, V442, P152, DOI 10.1016/0006-8993(88)91443-6; HERMAN JP, 1986, BRAIN RES, V383, P367, DOI 10.1016/0006-8993(86)90042-9; HOFFMAN N W, 1989, Society for Neuroscience Abstracts, V15, P1088; HOKFELT T, 1989, ACTA PHYSL SCAND S, V583, P105; HONORE T, 1989, BIOCHEM PHARMACOL, V38, P3207, DOI 10.1016/0006-2952(89)90615-1; MEEKER RB, 1989, NEUROSCIENCE, V33, P157, DOI 10.1016/0306-4522(89)90318-7; MEISTER B, 1988, NEUROENDOCRINOLOGY, V48, P516, DOI 10.1159/000125058; MONAGHAN DT, 1982, BRAIN RES, V252, P91, DOI 10.1016/0006-8993(82)90981-7; OTTERSEN OP, 1989, J CHEM NEUROANAT, V2, P57; PETERSON GM, 1980, BRAIN RES, V202, P165, DOI 10.1016/0006-8993(80)90651-4; POULAIN DA, 1982, NEUROSCIENCE, V7, P773, DOI 10.1016/0306-4522(82)90044-6; POULAIN P, 1987, BRAIN RES BULL, V19, P453, DOI 10.1016/0361-9230(87)90149-3; RAINBOW TC, 1984, BRAIN RES, V309, P173, DOI 10.1016/0006-8993(84)91025-4; RANDLE JCR, 1987, J PHYSIOL-LONDON, V387, P629, DOI 10.1113/jphysiol.1987.sp016592; RENAUD LP, 1985, ELECTROPHYSIOLOGY SE, P165; Silverman A.J., 1983, CHEM NEUROANATOMY, P295; Sladek CD, 1987, VASOPRESSIN PRINCIPL, P275; SOMOGYI P, 1984, J NEUROSCI, V4, P2590; SOMOGYI P, 1986, NEUROSCIENCE, V19, P1045, DOI 10.1016/0306-4522(86)90121-1; STORMMATHISEN J, 1983, NATURE, V301, P517, DOI 10.1038/301517a0; SWANSON LW, 1983, ANNU REV NEUROSCI, V6, P269, DOI 10.1146/annurev.ne.06.030183.001413; SWANSON LW, 1987, HDB CHEM NEUROANATOM, P1; TAPPAZ ML, 1984, PSYCHONEUROENDOCRINO, V9, P85, DOI 10.1016/0306-4530(84)90028-3; TASKER JG, IN PRESS J PHYSL LON; VANDENPOL AN, 1986, J CELL BIOL, V102, P2281, DOI 10.1083/jcb.102.6.2281; VANDENPOL AN, 1982, J COMP NEUROL, V206, P317, DOI 10.1002/cne.902060402; VANDENPOL AN, 1982, J COMP NEUROL, V204, P65, DOI 10.1002/cne.902040108; VANDENPOL AN, 1985, SCIENCE, V228, P332, DOI 10.1126/science.2858916; VANDENPOL AN, 1989, J MICROSC-OXFORD, V155, P27, DOI 10.1111/j.1365-2818.1989.tb04297.x; VANDENPOL AN, 1985, J NEUROSCI, V5, P2940	43	527	539	1	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 30	1990	250	4985					1276	1278		10.1126/science.1978759	http://dx.doi.org/10.1126/science.1978759			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK723	1978759				2022-12-28	WOS:A1990EK72300043
J	THOMPSON, C; STINSON, D; SMITH, A				THOMPSON, C; STINSON, D; SMITH, A			SEASONAL AFFECTIVE-DISORDER AND SEASON-DEPENDENT ABNORMALITIES OF MELATONIN SUPPRESSION BY LIGHT	LANCET			English	Article									ST GEORGE HOSP, LONDON, ENGLAND; CHARING CROSS HOSP, LONDON W6 8RP, ENGLAND; UNIV SOUTHAMPTON, ROYAL S HANTS HOSP, DEPT PSYCHIAT, SOUTHAMPTON SO9 5NH, HANTS, ENGLAND	St Georges University London; Imperial College London; University of Southampton; University Hospital Southampton NHS Foundation Trust; Royal South Hants Hospital								ARENDT J, 1989, SEASONAL AFFECTIVE D, P133; BOJKOWSKI CJ, 1987, HORM METAB RES, V19, P437, DOI 10.1055/s-2007-1011846; CARLSSON A, 1980, ACTA PSYCHIAT SCAND, V61, P75, DOI 10.1111/acps.1980.61.s280.75; CUMMINGS MA, 1989, PSYCHIAT RES, V27, P351, DOI 10.1016/0165-1781(89)90149-2; ECONOMOU SG, 1979, ACTA PSYCHIAT SCAND, V60, P155, DOI 10.1111/j.1600-0447.1979.tb03583.x; EMRICH HM, 1984, PSYCHIAT RES, V13, P355, DOI 10.1016/0165-1781(84)90084-2; FRASER S, 1983, CLIN CHEM, V29, P396; JACOBSEN FM, 1987, ARCH GEN PSYCHIAT, V44, P1086; KROPF D, 1986, NEUROPSYCHOBIOLOGY, V15, P34, DOI 10.1159/000118239; LEWY AJ, 1985, AM J PSYCHIAT, V142, P725; LEWY AJ, 1980, SCIENCE, V210, P1267, DOI 10.1126/science.7434030; LEWY AJ, 1981, LANCET, V1, P383; LEWY AJ, 1983, PSYCHOPHARMACOL BULL, V19, P523; MCINTYRE IM, 1990, LANCET, V335, P488, DOI 10.1016/0140-6736(90)90732-K; MCINTYRE IM, 1989, LIFE SCI, V45, P327, DOI 10.1016/0024-3205(89)90142-2; MCINTYRE IM, 1989, PSYCHONEUROENDOCRINO, V14, P187, DOI 10.1016/0306-4530(89)90016-4; Minors D, 1981, CIRCADIAN RHYTHMS HU, DOI 10.1016/C2013-0-06453-5; MURPHY DGM, 1989, SEASONAL AFFECTIVE D, P233; OROURKE D, 1989, J CLIN PSYCHIAT, V50, P343; OROURKE DA, 1987, PSYCHOPHARMACOL BULL, V23, P358; REME C, IN PRESS ARCH GEN PS; ROSENTHAL NE, 1984, ARCH GEN PSYCHIAT, V41, P72; TERMAN M, 1985, ANN NY ACAD SCI, V453, P147, DOI 10.1111/j.1749-6632.1985.tb11807.x; TERMAN M, 1989, NEUROPSYCHOPHARMACOL, V2, P1, DOI 10.1016/0893-133X(89)90002-X; THOMPSON C, 1985, BRIT J PSYCHIAT, V147, P389, DOI 10.1192/bjp.147.4.389; THOMPSON C, 1988, J AFFECT DISORDERS, V14, P1, DOI 10.1016/0165-0327(88)90065-1; THOMPSON C, 1990, J AFFECT DISORDERS, V18, P129; ULLRICH A, 1985, ACTA PSYCHIAT SCAND, V72, P113, DOI 10.1111/j.1600-0447.1985.tb02581.x; YEREVANIAN BI, 1986, PSYCHIAT RES, V18, P355, DOI 10.1016/0165-1781(86)90020-X; 1987, DIAGNOSTIC STATISTIC	30	91	92	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 22	1990	336	8717					703	706		10.1016/0140-6736(90)92202-S	http://dx.doi.org/10.1016/0140-6736(90)92202-S			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DZ624	1975891				2022-12-28	WOS:A1990DZ62400002
J	LONGAKER, MT; GOLBUS, MS; FILLY, RA; ROSEN, MA; CHANG, SW; HARRISON, MR				LONGAKER, MT; GOLBUS, MS; FILLY, RA; ROSEN, MA; CHANG, SW; HARRISON, MR			MATERNAL OUTCOME AFTER OPEN FETAL SURGERY - A REVIEW OF THE 1ST 17 HUMAN CASES	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CONGENITAL DIAPHRAGMATIC-HERNIA; EXPERIMENTAL PULMONARY HYPOPLASIA; HYDRONEPHROSIS INUTERO; NATURAL-HISTORY; SACROCOCCYGEAL TERATOMA; HYDROCEPHALUS INUTERO; PRENATAL-DIAGNOSIS; RENAL DYSPLASIA; URINARY-TRACT; MANAGEMENT	A few fetal diseases may benefit from surgical treatment before birth, but hysterotomy and subsequent delivery by cesarean section pose a risk to the otherwise unaffected mother. To assess maternal risk of mortality, morbidity, and reproductive potential after fetal surgery, we reviewed our experience with 17 highly selected women who underwent fetal surgery. Fifteen of these procedures were performed for one of two congenital anomalies: severe bilateral hydronephrosis and congenital diaphragmatic hernia. There were no deaths or serious maternal injuries. In the 14 women who continued pregnancy after hysterotomy, uterine irritability and preterm labor were frequent complications, requiring early confinement in most cases. There has been no detectable effect on future fertility, as indicated by eight subsequent normal pregnancies. We conclude that hysterotomy for fetal surgery can be accomplished without unduly endangering the mother's life or her future reproductive potential. However, morbidity related to premature labor remains a serious problem, and our ability to control uterine contractions after hysterotomy remains the limiting factor in human fetal surgery.	UNIV CALIF SAN FRANCISCO, DEPT SURG,FETAL TREATMENT PROGRAM, 3RD & PARNASSUS AVE,ROOM 585 HSE, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, DEPT OBSTET GYNECOL & REPROD SCI, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, DEPT ANESTHESIOL, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, INST HLTH POLICY STUDIES, SAN FRANCISCO, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco			Harrison, Michael/GYD-8608-2022					ADZICK NS, 1985, J PEDIATR SURG, V20, P673, DOI 10.1016/S0022-3468(85)80022-1; ADZICK NS, 1985, J PEDIATR SURG, V20, P315; ADZICK NS, 1984, J PEDIATR SURG, V19, P658, DOI 10.1016/S0022-3468(84)80349-8; ADZICK NS, 1986, J PEDIATR SURG, V21, P477, DOI 10.1016/S0022-3468(86)80215-9; ADZICK NS, 1985, J PEDIATR SURG, V20, P483; BOND SJ, 1989, OBSTET GYNECOL, V74, P25; CHINN DH, 1983, RADIOLOGY, V148, P119, DOI 10.1148/radiology.148.1.6856820; CROMBLEHOLME TM, 1988, J PEDIATR SURG, V23, P1114, DOI 10.1016/S0022-3468(88)80325-7; DUMESIC DA, 1982, NEW ENGL J MED, V307, P1128, DOI 10.1056/NEJM198210283071806; FLAKE AW, 1986, J PEDIATR SURG, V21, P563, DOI 10.1016/S0022-3468(86)80404-3; GLICK PL, 1984, J PEDIATR-US, V105, P97, DOI 10.1016/S0022-3476(84)80371-6; GLICK PL, 1983, J PEDIATR SURG, V18, P681, DOI 10.1016/S0022-3468(83)80003-7; GLICK PL, 1984, J PEDIATR SURG, V19, P870, DOI 10.1016/S0022-3468(84)80387-5; GLICK PL, 1984, J PEDIATR SURG, V19, P649, DOI 10.1016/S0022-3468(84)80348-6; GRANNUM PA, 1986, NEW ENGL J MED, V314, P1431, DOI 10.1056/NEJM198605293142207; HARRIGAN JT, 1981, NEW ENGL J MED, V304, P1527, DOI 10.1056/NEJM198106183042506; Harrison M.R., 1990, UNBORN PATIENT PRENA; HARRISON MR, 1990, J PEDIATR SURG, V25, P47, DOI 10.1016/S0022-3468(05)80163-0; HARRISON MR, 1982, J PEDIATR SURG, V17, P115, DOI 10.1016/S0022-3468(82)80193-0; HARRISON MR, 1981, J PEDIATR SURG, V16, P934, DOI 10.1016/S0022-3468(81)80849-4; HARRISON MR, 1980, SURGERY, V88, P174; HARRISON MR, 1980, SURGERY, V88, P260; HARRISON MR, 1982, J PEDIATR SURG, V17, P728, DOI 10.1016/S0022-3468(82)80437-5; HARRISON MR, 1981, JAMA-J AM MED ASSOC, V246, P774, DOI 10.1001/jama.246.7.774; HARRISON MR, 1987, J PEDIATR SURG, V22, P556, DOI 10.1016/S0022-3468(87)80221-X; HARRISON MR, 1982, J PEDIATR SURG, V17, P965, DOI 10.1016/S0022-3468(82)80476-4; HARRISON MR, 1982, NEW ENGL J MED, V306, P591, DOI 10.1056/NEJM198203113061006; HARRISON MR, 1982, NEW ENGL J MED, V307, P1651, DOI 10.1056/NEJM198212233072623; HARRISON MR, 1983, J PEDIATR SURG, V18, P247, DOI 10.1016/S0022-3468(83)80094-3; HARRISON MR, 1986, CLIN OBSTET GYNECOL, V29, P490, DOI 10.1097/00003081-198609000-00005; HARRISON MR, 1981, JAMA-J AM MED ASSOC, V246, P635, DOI 10.1001/jama.246.6.635; HOLZGREVE W, 1985, PRENATAL DIAG, V5, P245, DOI 10.1002/pd.1970050402; JEFFCOATE TNA, 1959, AM J OBSTET GYNECOL, V77, P475, DOI 10.1016/S0002-9378(16)36717-5; KUHLMANN R S, 1987, Fetal Therapy, V2, P95; LANGER JC, 1989, AM J OBSTET GYNECOL, V160, P1145, DOI 10.1016/0002-9378(89)90177-4; LONGAKER MT, 1989, J PEDIATR SURG, V24, P573, DOI 10.1016/S0022-3468(89)80509-3; NAKAYAMA DK, 1985, J PEDIATR SURG, V20, P118, DOI 10.1016/S0022-3468(85)80282-7; NAKAYAMA DK, 1983, J PEDIATR SURG, V18, P331, DOI 10.1016/S0022-3468(83)80177-8; NAKAYAMA DK, 1983, J PEDIATR SURG, V18, P347, DOI 10.1016/S0022-3468(83)80179-1; NAKAYAMA DK, 1984, J PEDIATR SURG, V19, P333, DOI 10.1016/S0022-3468(84)80248-1; NICOLAIDES K H, 1986, Fetal Therapy, V1, P185; NISULA BC, 1980, AM J OBSTET GYNECOL, V138, P77, DOI 10.1016/0002-9378(80)90014-9; RODECK CH, 1988, NEW ENGL J MED, V319, P1135, DOI 10.1056/NEJM198810273191706; RODECK CH, 1984, AM J OBSTET GYNECOL, V150, P769, DOI 10.1016/0002-9378(84)90683-5	44	115	120	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 13	1991	265	6					737	741		10.1001/jama.265.6.737	http://dx.doi.org/10.1001/jama.265.6.737			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EW479	1990189				2022-12-28	WOS:A1991EW47900025
J	KLAG, MJ; WHELTON, PK; CORESH, J; GRIM, CE; KULLER, LH				KLAG, MJ; WHELTON, PK; CORESH, J; GRIM, CE; KULLER, LH			THE ASSOCIATION OF SKIN COLOR WITH BLOOD-PRESSURE IN UNITED-STATES BLACKS WITH LOW SOCIOECONOMIC-STATUS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GEOGRAPHIC DIFFERENCES; STROKE MORTALITY; PUERTO-RICO; HYPERTENSION; POPULATION; WHITES; LIGHT; MEN	To determine the association of skin color, measured by a reflectometer, with blood pressure in US blacks, we studied a community sample of 457 blacks from three US cities. Persons taking antihypertensive medications were excluded. Both systolic and diastolic blood pressure were higher in darker persons and increased by 2 mm Hg for every 1-SD increase in skin darkness. However, the association was dependent on socioeconomic status, whether measured by education or an index consisting of education, occupation, and ethnicity, being present only in persons with lower levels of either indicator. Using multiple linear regression, both systolic and diastolic blood pressure remained significantly associated with darker skin color in the lower levels of socioeconomic status, independent of age, body mass index, and concentrations of blood glucose, serum urea nitrogen, serum uric acid, and urinary sodium and potassium. The association of skin color with blood pressure only in low socioeconomic strata may be due to the lesser ability of such groups to deal with the psychosocial stress associated with darker skin color. However, these findings also are consistent with an interaction between an environmental factor associated with low socioeconomic status and a susceptible gene that has a higher prevalence in persons with darker skin color.	JOHNS HOPKINS UNIV, SCH MED, DEPT MED, BALTIMORE, MD 21205 USA; JOHNS HOPKINS UNIV, SCH MED, DEPT EPIDEMIOL, BALTIMORE, MD 21205 USA; JOHNS HOPKINS UNIV, SCH MED, DEPT HLTH POLICY & MANAGEMENT, BALTIMORE, MD 21205 USA; JOHNS HOPKINS UNIV, SCH HYG & PUBL HLTH, DEPT EPIDEMIOL, BALTIMORE, MD 21218 USA; CHARLES R DREW UNIV, SCH MED, DEPT MED, LOS ANGELES, CA USA; UNIV PITTSBURGH, SCH PUBL HLTH, DEPT EPIDEMIOL, PITTSBURGH, PA 15260 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Charles R. Drew University of Medicine & Science; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh					NCRR NIH HHS [5M01RR00722] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000722] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		BOYLE E, 1970, J AMER MED ASSOC, V213, P1637, DOI 10.1001/jama.213.10.1637; Cavalli-Sforza L.L., 1971, GENETICS HUMAN POPUL; COMSTOCK GW, 1957, AM J HYG, V65, P271, DOI 10.1093/oxfordjournals.aje.a119870; COSTAS R, 1981, AM J PUBLIC HEALTH, V71, P614, DOI 10.2105/AJPH.71.6.614; DRIZD R, 1986, VITAL HLTH STAT, V11, P31; GILLUM RF, 1979, HYPERTENSION, V1, P468, DOI 10.1161/01.HYP.1.5.468; GREEN LW, 1970, PUBLIC HEALTH REP, V85, P815, DOI 10.2307/4593972; GRIM CE, 1984, AUST NZ J MED, V14, P453, DOI 10.1111/j.1445-5994.1984.tb03614.x; HARBURG E, 1978, AM J PUBLIC HEALTH, V68, P1177, DOI 10.2105/AJPH.68.12.1177; HARBURG E, 1982, HUM BIOL, V54, P283; HYPERTENSION DETECTION FOLLOW-UP, 1977, AM J EPIDEMIOL, V106, P351; JAMES SA, 1987, AM J EPIDEMIOL, V126, P664, DOI 10.1093/oxfordjournals.aje.a114706; KEIL JE, 1981, AM J PUBLIC HEALTH, V71, P532, DOI 10.2105/AJPH.71.5.532; KEIL JE, 1977, AM J PUBLIC HEALTH, V67, P634, DOI 10.2105/AJPH.67.7.634; LUFT FC, 1977, J LAB CLIN MED, V90, P555; MACLEAN CJ, 1974, AM J HUM GENET, V26, P614; MILLER JM, 1985, AM J PUBLIC HEALTH, V75, P558, DOI 10.2105/AJPH.75.5.558; NEFZGER MD, 1977, STROKE, V8, P546, DOI 10.1161/01.STR.8.5.546; SORLIE PD, 1988, AM HEART J, V116, P777, DOI 10.1016/0002-8703(88)90337-7; STOLLEY PD, 1977, STROKE, V8, P551, DOI 10.1161/01.STR.8.5.551; TYROLER HA, 1978, AM J PUBLIC HEALTH, V68, P1170, DOI 10.2105/AJPH.68.12.1170; 1985, SAS USERS GUIDE BASI	22	131	133	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	1991	265	5					599	602		10.1001/jama.265.5.599	http://dx.doi.org/10.1001/jama.265.5.599			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EV718	1987409				2022-12-28	WOS:A1991EV71800015
J	SATO, K				SATO, K			HYPERHIDROSIS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter											SATO, K (corresponding author), UNIV IOWA,SCH MED,IOWA CITY,IA 52242, USA.							FEALEY RD, 1989, MAYO CLIN PROC, V64, P617, DOI 10.1016/S0025-6196(12)65338-5; GOBBI PG, 1990, CANCER, V65, P2074, DOI 10.1002/1097-0142(19900501)65:9<2074::AID-CNCR2820650931>3.0.CO;2-O; KENNEY MJ, 1986, CLIN EXP DERMATOL, V11, P543, DOI 10.1111/j.1365-2230.1986.tb00506.x; SANDEL ME, 1986, ARCH PHYS MED REHAB, V67, P469; SATO K, 1989, J AM ACAD DERMATOL, V20, P713, DOI 10.1016/S0190-9622(89)70081-5; SATO KT, 1988, AM J MED SCI, V295, P528, DOI 10.1097/00000441-198806000-00006	6	9	13	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	1991	265	5					651	651		10.1001/jama.265.5.651	http://dx.doi.org/10.1001/jama.265.5.651			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EV718	1987421				2022-12-28	WOS:A1991EV71800029
J	SARTORI, S; NIELSEN, I; INDELLI, M; TREVISANI, L; PAZZI, P; GRANDI, E				SARTORI, S; NIELSEN, I; INDELLI, M; TREVISANI, L; PAZZI, P; GRANDI, E			BARRETT-ESOPHAGUS AFTER CHEMOTHERAPY WITH CYCLOPHOSPHAMIDE, METHOTREXATE, AND 5-FLUOROURACIL (CMF) - AN IATROGENIC INJURY	ANNALS OF INTERNAL MEDICINE			English	Note							COLUMNAR-LINED ESOPHAGUS; AGENTS	Methotrexate and 5-fluorouracil can provoke oral mucosal erosions and ulceration that may extend throughout the esophagus. This study was conducted to determine whether prolonged chemotherapy-induced esophageal damage may cause the development of Barrett esophagus. Sixteen women who had breast cancer and had been selected to receive at least six breast cancer and had been selected to receive at least six courses of chemotherapy with cyclophosphamide, methotrexate, and 5-flourouracil were included in the study. They had esophagoscopy, and several biopsy specimens were taken from the lower esophagus (3, 6, and 9 cm above the lower esophageal sphincter) before chemotherapy was begun and 1 month after the sixth course of chemotherapy. All patients had a normal esophagus at the first examination. After finishing chemotherapy, 10 (63%) had developed Barrett esophagus. One patient had the junctional type, 2 patients had the fundic type, 4 patients had a combination of the junctional and fundic types, and 3 patients had the intestinal type. These results suggest that chemotherapy-induced esophageal injury may have been responsible for the development of Barrett esophagus in our patients.	UNIV FERRARA, SCH MED, I-44100 FERRARA, ITALY	University of Ferrara	SARTORI, S (corresponding author), ST ANNA GEN HOSP, CORSO GIOVECCA 230, I-44100 FERRARA, ITALY.		sartori, samantha/AAL-8884-2020					ADRIAN RM, 1980, CA-CANCER J CLIN, V30, P143, DOI 10.3322/canjclin.30.3.143; DAHMS BB, 1987, CANCER, V60, P2896, DOI 10.1002/1097-0142(19871215)60:12<2896::AID-CNCR2820601208>3.0.CO;2-P; LEWIS JH, 1986, AM J GASTROENTEROL, V81, P819; MCCLAVE SA, 1987, GASTROINTEST ENDOSC, V33, P413, DOI 10.1016/S0016-5107(87)71676-9; ROTHERY GA, 1986, GUT, V27, P1062, DOI 10.1136/gut.27.9.1062; SARTORI S, 1989, HEPATO-GASTROENTEROL, V36, P304; SAVARY M, 1985, ESOPHAGEAL DISORDERS, P101; SPECHLER SJ, 1986, NEW ENGL J MED, V315, P362, DOI 10.1056/NEJM198608073150605; TYTGAT GNJ, 1989, ENDOSCOPY, V21, P177, DOI 10.1055/s-2007-1012937	9	53	54	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 1	1991	114	3					210	211		10.7326/0003-4819-114-3-210	http://dx.doi.org/10.7326/0003-4819-114-3-210			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EV339	1984745				2022-12-28	WOS:A1991EV33900007
J	BEUTLER, E				BEUTLER, E			GLUCOSE-6-PHOSPHATE-DEHYDROGENASE DEFICIENCY	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							SICKLE-CELL ANEMIA; DOSE VITAMIN-E; HEMOLYTIC-ANEMIA; INTERNATIONAL COMMITTEE; NEUTROPHIL DYSFUNCTION; MEDITERRANEAN-TYPE; POINT MUTATIONS; VARIANT; ENZYME; SEQUENCE				BEUTLER, E (corresponding author), SCRIPPS RES INST, DEPT MOLEC & EXPTL MED, 10666 N TORREY PINES RD, LA JOLLA, CA 92037 USA.				NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000833] Funding Source: NIH RePORTER; NCRR NIH HHS [RR00833] Funding Source: Medline; NHLBI NIH HHS [HL2552] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ARESE P, 1990, SEMIN HEMATOL, V27, P1; ARNOLD H, 1981, HUM GENET, V57, P226; BARTSOCAS CS, 1982, ACTA HAEMATOL-BASEL, V67, P228, DOI 10.1159/000207064; BASHAN N, 1988, ISRAEL J MED SCI, V24, P61; BERNINI L, 1964, BRIT J HAEMATOL, V10, P171, DOI 10.1111/j.1365-2141.1964.tb00692.x; BERRY E, 1977, ISRAEL J MED SCI, V13, P600; BEUTLER E, 1989, BLOOD, V73, P1397; BEUTLER E, 1967, NEW ENGL J MED, V276, P389, DOI 10.1056/NEJM196702162760706; BEUTLER E, 1983, P NATL ACAD SCI-BIOL, V80, P3767, DOI 10.1073/pnas.80.12.3767; BEUTLER E, 1989, BLOOD, V74, P2550; BEUTLER E, 1990, CELL, V62, P7, DOI 10.1016/0092-8674(90)90231-3; BEUTLER E, 1979, BRIT J HAEMATOL, V43, P465, DOI 10.1111/j.1365-2141.1979.tb03774.x; BEUTLER E, 1977, BRIT J HAEMATOL, V35, P331, DOI 10.1111/j.1365-2141.1977.tb00589.x; BEUTLER E, 1962, P NATL ACAD SCI USA, V48, P9, DOI 10.1073/pnas.48.1.9; BEUTLER E, 1974, NEW ENGL J MED, V290, P826, DOI 10.1056/NEJM197404112901504; BEUTLER E, 1990, AM J HUM GENET, V47, P1008; BEUTLER E, 1990, SEMIN HEMATOL, V27, P137; BEUTLER E, 1959, BLOOD, V14, P103, DOI 10.1182/blood.V14.2.103.103; BEUTLER E, 1978, HEMOLYTIC ANEMIA DIS, P75; BEUTLER E, 1990, HEMATOLOGY, P591; BEUTLER E, IN PRESS J BIOL CHEM; BEUTLER E, IN PRESS HUM GENET; BROWN C B, 1972, British Journal of Urology, V44, P155, DOI 10.1111/j.1464-410X.1972.tb10059.x; BROWNE EA, 1957, J HOPKINS MED J, V101, P115; BURKA ER, 1966, ANN INTERN MED, V64, P817, DOI 10.7326/0003-4819-64-4-817; CAYANIS E, 1975, BRIT J HAEMATOL, V30, P343, DOI 10.1111/j.1365-2141.1975.tb00550.x; Chan TK, 1974, B HONG KONG MED ASS, V26, P41; CLEARFIELD HR, 1969, ARCH INTERN MED, V123, P689, DOI 10.1001/archinte.1969.00300160079012; COLONNA P, 1981, BRIT MED J, V283, P1189, DOI 10.1136/bmj.283.6300.1189-c; CORASH L, 1980, NEW ENGL J MED, V303, P416, DOI 10.1056/NEJM198008213030802; DERN RJ, 1955, J LAB CLIN MED, V45, P30; DEVITA G, 1989, AM J HUM GENET, V44, P233; DURSO M, 1988, AM J HUM GENET, V42, P735; ELDAMHOUGY S, 1988, INT J VITAM NUTR RES, V58, P184; FEY MF, 1990, HUM GENET, V84, P471; FIALKOW PJ, 1976, BIOCHIM BIOPHYS ACTA, V458, P283, DOI 10.1016/0304-419X(76)90003-2; GAETANI GD, 1976, BRIT J HAEMATOL, V32, P183, DOI 10.1111/j.1365-2141.1976.tb00921.x; GELPI AP, 1965, BLOOD-J HEMATOL, V25, P486, DOI 10.1182/blood.V25.4.486.486; GLADER BE, 1976, J PEDIATR-US, V89, P1027, DOI 10.1016/S0022-3476(76)80626-9; GRAY GR, 1973, LANCET, V2, P530; HAFEZ M, 1986, J PEDIATR-US, V108, P558, DOI 10.1016/S0022-3476(86)80833-2; HEINTZ B, 1989, KLIN WOCHENSCHR, V67, P1068, DOI 10.1007/BF01727011; HELLER P, 1979, NEW ENGL J MED, V300, P1001, DOI 10.1056/NEJM197905033001801; HERMAN J, 1975, ISRAEL J MED SCI, V11, P340; HERZ F, 1970, BLOOD-J HEMATOL, V35, P90, DOI 10.1182/blood.V35.1.90.90; HIRONO A, 1988, P NATL ACAD SCI USA, V85, P3951, DOI 10.1073/pnas.85.11.3951; HIRONO A, 1989, P NATL ACAD SCI USA, V86, P10015, DOI 10.1073/pnas.86.24.10015; HORTON HM, 1986, DRUG METAB REV, V17, P261, DOI 10.3109/03602538608998292; JOHNSON GJ, 1983, NEW ENGL J MED, V308, P1014, DOI 10.1056/NEJM198304283081708; KANNO H, 1989, CELL, V58, P595, DOI 10.1016/0092-8674(89)90440-6; KELLERMEYER RW, 1962, JAMA-J AM MED ASSOC, V180, P388, DOI 10.1001/jama.1962.03050180034008a; KHALIFA AS, 1989, ACTA HAEMATOL-BASEL, V82, P113; LINDER D, 1965, SCIENCE, V150, P67, DOI 10.1126/science.150.3692.67; MAGON AM, 1981, J LAB CLIN MED, V397, P764; MAMLOK RJ, 1987, J PEDIATR-US, V111, P852, DOI 10.1016/S0022-3476(87)80203-2; MARTINI G, 1986, EMBO J, V5, P1849, DOI 10.1002/j.1460-2075.1986.tb04436.x; MASON PJ, 1990, CELL, V62, P9, DOI 10.1016/0092-8674(90)90232-4; MCCURDY PR, 1975, VOX SANG, V28, P230, DOI 10.1111/j.1423-0410.1975.tb02761.x; MELONI T, 1989, ACTA HAEMATOL-BASEL, V81, P208; MIMOUNI F, 1986, ISRAEL J MED SCI, V22, P120; MORELLI A, 1981, BLOOD, V58, P642; MOSKOWIZ RM, 1970, JOHNS HOPKINS MED J, V126, P139; OLUBOYEDE OA, 1979, J LAB CLIN MED, V93, P783; PERSICO MG, 1986, NUCLEIC ACIDS RES, V14, P2511, DOI 10.1093/nar/14.6.2511; PERSICO MG, 1986, NUCLEIC ACIDS RES, V14, P7822; PIOMELLI S, 1972, NEW ENGL J MED, V287, P213, DOI 10.1056/NEJM197208032870502; PIOMELLI S, 1986, GLUCOSE 6 PHOSPHATE, P95; POOTRAKUL P, 1983, ACTA HAEMATOL-BASEL, V69, P358, DOI 10.1159/000206920; RUBINS J, 1977, JAMA-J AM MED ASSOC, V237, P797; SANPITAK N, 1973, HUM HERED, V23, P83, DOI 10.1159/000152558; SINGH H, 1986, BRIT MED J, V292, P397, DOI 10.1136/bmj.292.6517.397; SINISCALCO M, 1961, NATURE, V190, P1179, DOI 10.1038/1901179a0; STAMATOYANNOPOULOS G, 1966, AM J HUM GENET, V18, P253; STEINBERG MH, 1988, BLOOD, V71, P748; SZEINBERG A, 1973, ISRAEL J MED SCI, V9, P1171; TAKIZAWA T, 1987, Genomics, V1, P228, DOI 10.1016/0888-7543(87)90048-6; TAKIZAWA T, 1986, P NATL ACAD SCI USA, V83, P4157, DOI 10.1073/pnas.83.12.4157; USANGA EA, 1985, NATURE, V313, P793, DOI 10.1038/313793a0; VIGLIETTO G, 1990, ANN HUM GENET, V54, P1, DOI 10.1111/j.1469-1809.1990.tb00355.x; VIVESCORRONS JL, 1990, AM J HUM GENET, V47, P575; VULLIAMY TJ, 1988, P NATL ACAD SCI USA, V85, P5171, DOI 10.1073/pnas.85.14.5171; VULLIAMY TJ, 1989, NUCLEIC ACIDS RES, V17, P5868, DOI 10.1093/nar/17.14.5868; WESTRING DW, 1966, ARCH INTERN MED, V118, P385, DOI 10.1001/archinte.118.4.385; YOSHIDA A, 1990, CELL, V62, P11, DOI 10.1016/0092-8674(90)90233-5; ZUO L, 1990, BLOOD S, V76, pA51; 1967, WHO TECH REP SER, V366	86	263	268	0	8	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 17	1991	324	3					169	174						6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ER471	1984194				2022-12-28	WOS:A1991ER47100006
J	LACKRITZ, EM; LOBEL, HO; HOWELL, BJ; BLOLAND, P; CAMPBELL, CC				LACKRITZ, EM; LOBEL, HO; HOWELL, BJ; BLOLAND, P; CAMPBELL, CC			IMPORTED PLASMODIUM-FALCIPARUM MALARIA IN AMERICAN TRAVELERS TO AFRICA - IMPLICATIONS FOR PREVENTION STRATEGIES	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Note								Data from the US National Malaria Surveillance System were analyzed to assess characteristics of travelers who acquired Plasmodium falciparum infections in Africa and evaluate the impact of chloroquine resistance on the incidence of imported malaria. Although the number of cases acquired in East Africa has stabilized, the number of imported P falciparum infections acquired in West Africa increased threefold from 1985 to 1988, and the proportion of travelers who reported failure of chloroquine prophylaxis increased from 10% to 48%. Fifty-eight percent of patients who acquired malaria in West Africa had not used chemoprophylaxis. To curb the rising incidence of P falciparum infections in American travelers, the Centers for Disease Control revised malaria prophylaxis recommendations to include the use of mefloquine in areas of chloroquine resistance. Use of malaria protection measures by travelers to West Africa must also be improved.			LACKRITZ, EM (corresponding author), CTR DIS CONTROL,CTR INFECT DIS,DIV PARASIT DIS,MALARIA BRANCH,MAILSTOP F-12,1600 CLIFTON RD,ATLANTA,GA 30333, USA.			Lackritz, Eve/0000-0002-5397-7291				KEAN BH, 1979, JAMA-J AM MED ASSOC, V241, P395, DOI 10.1001/jama.241.4.395; LOBEL HO, 1990, B WORLD HEALTH ORGAN, V68, P209; LOBEL HO, 1991, JAMA-J AM MED ASSOC, V265, P361, DOI 10.1001/jama.265.3.361; LOBEL HO, 1985, J INFECT DIS, V152, P613, DOI 10.1093/infdis/152.3.613; LOBEL HO, 1988, TRAVEL MED, P81; MORAN JS, 1989, JAMA-J AM MED ASSOC, V262, P245, DOI 10.1001/jama.262.2.245; MORAN JS, 1987, AMA, V257, P2376; PHILLIPSHOWARD PA, 1990, LANCET, V335, P119, DOI 10.1016/0140-6736(90)90596-W; SANSONETTI PJ, 1985, LANCET, V1, P1154; 1988, MALARIA SURVEILLANCE; 1990, MMWR, V39, P630; 1988, EC SURVEY; 1990, CDC908280 US DEP HLT; 1990, MMWR, V39, P1	14	42	44	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 16	1991	265	3					383	385		10.1001/jama.265.3.383	http://dx.doi.org/10.1001/jama.265.3.383			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ER256	1984539				2022-12-28	WOS:A1991ER25600030
J	DJABALI, K; PORTIER, MM; GROS, F; BLOBEL, G; GEORGATOS, SD				DJABALI, K; PORTIER, MM; GROS, F; BLOBEL, G; GEORGATOS, SD			NETWORK ANTIBODIES IDENTIFY NUCLEAR LAMIN-B AS A PHYSIOLOGICAL ATTACHMENT SITE FOR PERIPHERIN INTERMEDIATE FILAMENTS	CELL			English	Article							ANTI-IDIOTYPIC ANTIBODIES; AMINO-ACID-SEQUENCE; PLASMA-MEMBRANE; AVIAN ERYTHROCYTES; MESSENGER-RNA; DESMIN DERIVATIVES; SIZED FILAMENTS; DYNAMIC ASPECTS; PROTEIN FAMILY; KERATIN CDNAS	We studied the molecular associations between peripherin (a neuronal, type III intermediate filament subunit) and nuclear lamins. We show here that isolated peripherin binds selectively to mammalian lamin B under in vitro conditions. We further demonstrate that a synthetic peptide, representing the proximal part of peripherin's tall domain (P(I)), also associates with mammalian lamin B in a saturable, cooperative, and specific fashion. Laboratory animals immunized with P(I) spontaneously develop idiotypic and antiidiotypic antibodies recognizing peripherin and lamin B, respectively. These data provide essentially in vivo evidence that lamin B represents a constitutive nuclear "receptor" site for the tail domains of peripherin intermediate filaments.	ROCKEFELLER UNIV,HOWARD HUGHES MED INST,CELL BIOL LAB,NEW YORK,NY 10021; EUROPEAN MOLEC BIOL LAB,PROGRAMME CELL BIOL,W-6900 HEIDELBERG,GERMANY	Howard Hughes Medical Institute; Rockefeller University; European Molecular Biology Laboratory (EMBL)	DJABALI, K (corresponding author), COLL FRANCE,11 PL MARCELIN BERTHELOT,F-75231 PARIS 05,FRANCE.			Georgatos, Spyros/0000-0002-2078-7467				AARONSON RP, 1975, P NATL ACAD SCI USA, V72, P1007, DOI 10.1073/pnas.72.3.1007; AEBI U, 1983, J CELL BIOL, V97, P1131, DOI 10.1083/jcb.97.4.1131; AEBI U, 1986, NATURE, V323, P560, DOI 10.1038/323560a0; ALBERS K, 1987, J CELL BIOL, V105, P791, DOI 10.1083/jcb.105.2.791; ALBERS K, 1989, J CELL BIOL, V108, P1477, DOI 10.1083/jcb.108.4.1477; ALETTA JM, 1989, J BIOL CHEM, V264, P4619; BLALOCK JE, 1984, BIOCHEM BIOPH RES CO, V121, P203, DOI 10.1016/0006-291X(84)90707-1; BOST KL, 1985, P NATL ACAD SCI USA, V82, P1372, DOI 10.1073/pnas.82.5.1372; BOST KL, 1989, METHOD ENZYMOL, V168, P16; CAPCO DG, 1982, CELL, V29, P847, DOI 10.1016/0092-8674(82)90446-9; CARMO-FONSECA M, 1987, European Journal of Cell Biology, V45, P282; CARMOFONSECA M, 1990, ELECTRON MICROSC REV, V3, P115, DOI 10.1016/0892-0354(90)90017-M; CARTAUD A, 1989, J CELL BIOL, V109, P1745, DOI 10.1083/jcb.109.4.1745; CARTAUD A, 1990, J CELL BIOL, V111, P581, DOI 10.1083/jcb.111.2.581; CHIN SSM, 1989, EUR J CELL BIOL, V50, P475; COULOMBE PA, 1990, J CELL BIOL, V111, P153, DOI 10.1083/jcb.111.1.153; CROIZAT B, 1979, CR ACAD SCI D NAT, V289, P1283; ESCURAT M, 1990, J NEUROSCI, V10, P764; FISHER DZ, 1986, P NATL ACAD SCI USA, V83, P6450, DOI 10.1073/pnas.83.17.6450; FRANKE WW, 1971, PROTOPLASMA, V73, P263, DOI 10.1007/BF01275600; FRANKE WW, 1987, CELL, V48, P3, DOI 10.1016/0092-8674(87)90345-X; GEISLER N, 1982, EMBO J, V1, P1649, DOI 10.1002/j.1460-2075.1982.tb01368.x; GEISLER N, 1982, CELL, V30, P277, DOI 10.1016/0092-8674(82)90033-2; GEISLER N, 1986, STRUCTURAL ASPECTS I; GEORGATOS SD, 1985, J CELL BIOL, V100, P1955, DOI 10.1083/jcb.100.6.1955; GEORGATOS SD, 1987, J CELL BIOL, V105, P117, DOI 10.1083/jcb.105.1.117; GEORGATOS SD, 1987, P NATL ACAD SCI USA, V84, P6780, DOI 10.1073/pnas.84.19.6780; GEORGATOS SD, 1985, J CELL BIOL, V100, P1962, DOI 10.1083/jcb.100.6.1962; GEORGATOS SD, 1987, J CELL BIOL, V105, P105, DOI 10.1083/jcb.105.1.105; GOLDMAN R, 1985, ANN NY ACAD SCI, V455, P1, DOI 10.1111/j.1749-6632.1985.tb50400.x; GRANGER BL, 1982, CELL, V30, P263, DOI 10.1016/0092-8674(82)90032-0; GUILLY MN, 1987, EUR J CELL BIOL, V43, P266; HANUKOGLU I, 1983, CELL, V33, P915, DOI 10.1016/0092-8674(83)90034-X; HARLOW E, 1968, ANTIBODIES LABORATOR; HOGER TH, 1990, CHROMOSOMA, V99, P379, DOI 10.1007/BF01726689; HOGER TH, 1988, EUR J CELL BIOL, V47, P283; JERNE NK, 1974, ANN INST PASTEUR IMM, VC125, P373; JERNE NK, 1985, EMBO J, V4, P847, DOI 10.1002/j.1460-2075.1985.tb03709.x; JONES JCR, 1982, CELL MOTIL CYTOSKEL, V2, P197, DOI 10.1002/cm.970020302; KAUFMANN E, 1985, J MOL BIOL, V185, P733, DOI 10.1016/0022-2836(85)90058-0; KAUFMANN S, 1989, J BIOL CHEM, V267, P13946; KROHNE G, 1987, EMBO J, V6, P3801, DOI 10.1002/j.1460-2075.1987.tb02716.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANDON F, 1989, EMBO J, V8, P1719, DOI 10.1002/j.1460-2075.1989.tb03564.x; LANGLEY RC, 1985, J CELL BIOCHEM, V30, P101; LAZARIDES E, 1982, ANNU REV BIOCHEM, V51, P219, DOI 10.1146/annurev.bi.51.070182.001251; LAZARIDES E, 1980, NATURE, V283, P249, DOI 10.1038/283249a0; LEHNER CF, 1987, J CELL BIOL, V105, P577, DOI 10.1083/jcb.105.1.577; LEHNER CF, 1986, J BIOL CHEM, V261, P3293; LEHTO VP, 1978, NATURE, V272, P175, DOI 10.1038/272175a0; LEONARD DGB, 1988, J CELL BIOL, V106, P181, DOI 10.1083/jcb.106.1.181; LISCHWE MA, 1982, ANAL BIOCHEM, V127, P453, DOI 10.1016/0003-2697(82)90203-2; LU X, 1990, CELL, V62, P681, DOI 10.1016/0092-8674(90)90114-T; MCKEON FD, 1986, NATURE, V319, P463, DOI 10.1038/319463a0; MULCHAHEY JJ, 1986, P NATL ACAD SCI USA, V83, P9714, DOI 10.1073/pnas.83.24.9714; NGAI J, 1990, CELL, V60, P415, DOI 10.1016/0092-8674(90)90593-4; OAS TG, 1988, NATURE, V336, P42, DOI 10.1038/336042a0; PARYSEK LM, 1988, NEURON, V1, P395, DOI 10.1016/0896-6273(88)90189-4; PASCUAL DW, 1989, J IMMUNOL, V143, P3697; PETER M, 1989, J MOL BIOL, V208, P393, DOI 10.1016/0022-2836(89)90504-4; PORTIER MM, 1984, DEV NEUROSCI-BASEL, V6, P335, DOI 10.1159/000112360; QUAX W, 1985, CELL, V43, P327, DOI 10.1016/0092-8674(85)90038-8; QUAX W, 1983, CELL, V35, P215, DOI 10.1016/0092-8674(83)90224-6; QUINLAN RA, 1984, J MOL BIOL, V178, P365, DOI 10.1016/0022-2836(84)90149-9; RAMAEKERS FCS, 1982, P NATL ACAD SCI-BIOL, V79, P3208, DOI 10.1073/pnas.79.10.3208; RENNER W, 1981, J MOL BIOL, V149, P285, DOI 10.1016/0022-2836(81)90303-X; RIVAS CI, 1988, P NATL ACAD SCI USA, V85, P6092, DOI 10.1073/pnas.85.16.6092; SARRIA AJ, 1990, J CELL BIOL, V111, P553, DOI 10.1083/jcb.111.2.553; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SHECHTER Y, 1984, J BIOL CHEM, V259, P6411; SHECHTER Y, 1982, SCIENCE, V216, P542, DOI 10.1126/science.7041258; SMITH LR, 1987, J IMMUNOL, V138, P7; STEINERT PM, 1990, CELL, V60, P521, DOI 10.1016/0092-8674(90)90651-T; STEINERT PM, 1988, ANNU REV BIOCHEM, V57, P593, DOI 10.1146/annurev.bi.57.070188.003113; Stewart M, 1990, CURR OPIN CELL BIOL, V2, P91, DOI 10.1016/S0955-0674(05)80037-7; TOOZE J, 1989, EUR J CELL BIOL, V49, P259; VIKSTROM KL, 1989, P NATL ACAD SCI USA, V86, P549, DOI 10.1073/pnas.86.2.549; VORBURGER K, 1989, J MOL BIOL, V208, P405, DOI 10.1016/0022-2836(89)90505-6; WANG E, 1985, ANN NY ACAD SCI, V455, P32, DOI 10.1111/j.1749-6632.1985.tb50402.x; WELLING GW, 1985, FEBS LETT, V188, P215, DOI 10.1016/0014-5793(85)80374-4; WRIGHT PE, 1988, BIOCHEMISTRY-US, V27, P7167, DOI 10.1021/bi00419a001; ZACKROFF RV, 1979, P NATL ACAD SCI USA, V76, P6226, DOI 10.1073/pnas.76.12.6226; ZEHNER ZE, 1987, J BIOL CHEM, V262, P8112	83	107	107	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	JAN 11	1991	64	1					109	121		10.1016/0092-8674(91)90213-I	http://dx.doi.org/10.1016/0092-8674(91)90213-I			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ET175	1986862				2022-12-28	WOS:A1991ET17500013
J	BERGSAGEL, DE; FITZGERALD, B; QUIRT, I; MEHARCHAND, J; HASSELBACK, R				BERGSAGEL, DE; FITZGERALD, B; QUIRT, I; MEHARCHAND, J; HASSELBACK, R			TREATMENT OF ANEMIA ASSOCIATED WITH MULTIPLE-MYELOMA	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter											BERGSAGEL, DE (corresponding author), PRINCESS MARGARET HOSP, TORONTO M4X 1K9, ONTARIO, CANADA.							BERGSAGEL DE, 1989, HEMATOLOGY, P1114; LUDWIG H, 1990, NEW ENGL J MED, V322, P1693, DOI 10.1056/NEJM199006143222402	2	4	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 3	1991	324	1					59	59						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EQ503	1984168				2022-12-28	WOS:A1991EQ50300016
J	GLASSOCK, RJ; BENSON, JA; COPELAND, RB; GODWIN, HA; JOHANSON, WG; POINT, W; POPP, RL; SCHERR, L; STEIN, JH; TAUNTON, OD				GLASSOCK, RJ; BENSON, JA; COPELAND, RB; GODWIN, HA; JOHANSON, WG; POINT, W; POPP, RL; SCHERR, L; STEIN, JH; TAUNTON, OD			TIME-LIMITED CERTIFICATION AND RECERTIFICATION - THE PROGRAM OF THE AMERICAN-BOARD-OF-INTERNAL-MEDICINE - THE TASK-FORCE-ON-RECERTIFICATION	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									AMER BOARD INTERNAL MED, 200 SW MARKET ST 1770, PORTLAND, OR 97201 USA									LANGDON LO, 1989, J GEN INTERN MED, V4, P557, DOI 10.1007/BF02599561	1	38	38	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 1	1991	114	1					59	62		10.7326/0003-4819-114-1-59	http://dx.doi.org/10.7326/0003-4819-114-1-59			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EQ040	1983934				2022-12-28	WOS:A1991EQ04000010
J	MCGUIRE, LB				MCGUIRE, LB			JUST BEYOND THE NEXT BEND IN THE RIVER - REFLECTIONS ON A MEDICAL CAREER	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									UNIV VIRGINIA, HLTH SCI CTR, CHARLOTTESVILLE, VA 22908 USA	University of Virginia									0	2	2	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 1	1991	114	1					83	87		10.7326/0003-4819-114-1-83	http://dx.doi.org/10.7326/0003-4819-114-1-83			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EQ040	1983940				2022-12-28	WOS:A1991EQ04000015
J	BURGER, BJ; BURGER, JD; BOS, CFA; OBERMANN, WR; ROZING, PM; VANDENBROUCKE, JP				BURGER, BJ; BURGER, JD; BOS, CFA; OBERMANN, WR; ROZING, PM; VANDENBROUCKE, JP			NEONATAL SCREENING AND STAGGERED EARLY TREATMENT FOR CONGENITAL DISLOCATION OR DYSPLASIA OF THE HIP	LANCET			English	Article							AVASCULAR NECROSIS; NEWBORN	In 14 264 consecutive newborn babies the results of screening and early treatment for congenital dislocation and/or dysplasia of the hip (CDH) were evaluated in a prospective follow-up study. Barlow's test was done and the family history was recorded. Babies who were positive (n = 140) were immediately given abduction treatment. If the screening result was doubtful (133) or if the test was negative but the family history positive (685) the child was radiographed at 5 months and abduction treatment was started if any form of CDH was seen. Among Barlow-negative children with no family history (13 306), two reference groups were selected - at age 5 months (596) and at age 2 years (4365). Dislocation was missed at screening in 0.02%. Dysplasia was seen at 5 months in 15% of Barlow-negative children with a positive family history and in 2-3% of the reference group children. Crude estimates of the lower limits of validity indices for the screening test showed that the test is efficient in the identification of dislocation but probably has not value for dysplasia. Of the babies in whom treatment was started immediately 17% had relapse dysplasia after withdrawal of therapy, 3% had avascular necrosis, and 78% were normal at 2 years. When treatment was started at 5 months were found no relapse dysplasia, only 1% avascular necrosis, and 53-63% success at 2 years. In children with dislocatable hips were propose a wait-and-see treatment strategy, with early ultrasonography or radiography at 5 months.	UNIV HOSP LEIDEN, DEPT RADIOL, 2300 RC LEIDEN, NETHERLANDS; UNIV HOSP LEIDEN, DEPT CLIN EPIDEMIOL, 2300 RC LEIDEN, NETHERLANDS; ELIZABETH GASTHUIS, HAARLEM, NETHERLANDS	Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC)	BURGER, BJ (corresponding author), UNIV HOSP LEIDEN, DEPT ORTHOPAED SURG, 2300 RC LEIDEN, NETHERLANDS.		Vandenbroucke, Jan/AAM-3928-2020	Vandenbroucke, Jan/0000-0001-5668-6716				ANDREN L, 1961, ACTA ORTHOP SCAND, V30, P169; BARLOW TG, 1962, J BONE JOINT SURG BR, V44, P292, DOI 10.1302/0301-620X.44B2.292; BECKER F, 1979, Z ORTHOP, V106, P173; BJERKREIM I, 1987, ACTA ORTHOP SCAND, V58, P504, DOI 10.3109/17453678709146388; BRADLEY J, 1987, J BONE JOINT SURG BR, V69, P257, DOI 10.1302/0301-620X.69B2.3818757; CARDOSO AC, 1987, MONTHLY B HLTH STATI, V4, P22; DAVIES RW, 1970, J BONE JOINT SURG BR, V53, P704; DAVIES SJM, 1984, J BONE JOINT SURG BR, V66, P479, DOI 10.1302/0301-620X.66B4.6746677; DUNN PM, 1984, LANCET, V1, P846; DUNN PM, 1985, ARCH DIS CHILD, V60, P407, DOI 10.1136/adc.60.5.407; DUNN PM, 1976, CLIN ORTHOP RELAT R, V119, P11; HADLOW V, 1988, J BONE JOINT SURG BR, V70, P740, DOI 10.1302/0301-620X.70B5.3192572; JONES D, 1977, J BONE JOINT SURG BR, V59, P318, DOI 10.1302/0301-620X.59B3.893510; KALAMCHI A, 1980, J BONE JOINT SURG AM, V62, P876, DOI 10.2106/00004623-198062060-00002; KELLER MS, 1988, RADIOLOGY, V169, P733, DOI 10.1148/radiology.169.3.3055037; KLISIC PJ, 1989, J BONE JOINT SURG BR, V71, P136, DOI 10.1302/0301-620X.71B1.2914985; MacKenzie I G, 1972, J Bone Joint Surg Br, V54, P18; MITCHELL G P, 1972, Journal of Bone and Joint Surgery British Volume, V54, P4; ROBERTON NRC, 1984, LANCET, V1, P909; SAIES AD, 1988, J PEDIATR ORTHOPED, V8, P436, DOI 10.1097/01241398-198807000-00010; SERINGE R, 1982, REV CHIR ORTHOP, V68, P145; TONNIS D, 1976, CLIN ORTHOP RELAT R, P39; TONNIS D, 1984, CONGENITAL HIP DISLO; VONROSEN S, 1962, J BONE JOINT SURG BR, V44, P284, DOI 10.1302/0301-620X.44B2.284; WEINER DS, 1977, J BONE JOINT SURG AM, V59, P306, DOI 10.2106/00004623-197759030-00002; WILLIAMSON J, 1972, Journal of Bone and Joint Surgery British Volume, V54, P13	26	46	48	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 22	1990	336	8730					1549	1553		10.1016/0140-6736(90)93317-I	http://dx.doi.org/10.1016/0140-6736(90)93317-I			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP037	1979375				2022-12-28	WOS:A1990EP03700013
J	MONAHAN, BP; FERGUSON, CL; KILLEAVY, ES; LLOYD, BK; TROY, J; CANTILENA, LR				MONAHAN, BP; FERGUSON, CL; KILLEAVY, ES; LLOYD, BK; TROY, J; CANTILENA, LR			TORSADES-DE-POINTES OCCURRING IN ASSOCIATION WITH TERFENADINE USE	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Note									UNIFORMED SERV UNIV HLTH SCI, DEPT MED, DIV CLIN PHARMACOL, 4301 JONES BRIDGE RD, BETHESDA, MD 20814 USA; NATL NAVAL MED CTR, DEPT MED, DIV INTERNAL MED, BETHESDA, MD 20814 USA; NATL NAVAL MED CTR, DIV CARDIOL, BETHESDA, MD 20814 USA; UNIFORMED SERV UNIV HLTH SCI, DEPT PHARMACOL, BETHESDA, MD 20814 USA	Uniformed Services University of the Health Sciences - USA; Walter Reed National Military Medical Center; Walter Reed National Military Medical Center; Uniformed Services University of the Health Sciences - USA								BAST A, 1984, XENOBIOTICA, V14, P399, DOI 10.3109/00498258409151428; BROWN MW, 1985, CLIN PHARMACOL THER, V37, P290, DOI 10.1038/clpt.1985.42; DAAVIES AJ, 1989, BRIT MED J, V298, P325; Dansette P M, 1986, Adv Exp Med Biol, V197, P155; EICHELBAUM M, 1983, CURRENT REV BIOMEDIC, V3, P115; JACKMAN WM, 1988, PROG CARDIOVASC DIS, V31, P115, DOI 10.1016/0033-0620(88)90014-X; JORI A, 1981, CONCEPTS DRUG META B, P265; LOOSE DS, 1983, J CLIN INVEST, V71, P1495, DOI 10.1172/JCI110903; MEREDITH CG, 1985, DRUG METAB DISPOS, V13, P156; RITTER JK, 1987, DRUG METAB DISPOS, V15, P335; RUMACK BH, 1989, POISINDEX SYSTEMS, P63; SORKIN EM, 1985, DRUGS, V29, P34, DOI 10.2165/00003495-198529010-00002; SPEEG KV, 1982, GASTROENTEROLOGY, V82, P89; TOMIKA DK, 1989, DRUG UTILIZATION US	14	512	529	1	10	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 5	1990	264	21					2788	2790		10.1001/jama.264.21.2788	http://dx.doi.org/10.1001/jama.264.21.2788			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EK537	1977935				2022-12-28	WOS:A1990EK53700035
J	MCMURDO, MET; HUTCHISON, GL; LINDSAY, G				MCMURDO, MET; HUTCHISON, GL; LINDSAY, G			TASTE DISTURBANCE WITH ACETAZOLAMIDE	LANCET			English	Letter									UNIV DUNDEE,NINEWELLS HOSP & MED SCH,DEPT ANAESTHET,DUNDEE DD1 9SY,SCOTLAND; UNIV DUNDEE,NINEWELLS HOSP & MED SCH,DEPT PHARM,DUNDEE DD1 9SY,SCOTLAND	University of Dundee; University of Dundee	MCMURDO, MET (corresponding author), UNIV DUNDEE,NINEWELLS HOSP & MED SCH,DEPT MED,DUNDEE DD1 9SY,SCOTLAND.							GRABER M, 1988, AM J MED, V84, P979, DOI 10.1016/0002-9343(88)90091-5; Hansson HPJ, 1961, NORD MED, V65, P566	2	14	14	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 10	1990	336	8724					1190	1191		10.1016/0140-6736(90)92803-P	http://dx.doi.org/10.1016/0140-6736(90)92803-P			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG701	1978045				2022-12-28	WOS:A1990EG70100038
J	THOMSON, A; CONTRERAS, M; GORICK, B; KUMPEL, B; CHAPMAN, GE; LANE, RS; TEESDALE, P; HUGHESJONES, NC; MOLLISON, PL				THOMSON, A; CONTRERAS, M; GORICK, B; KUMPEL, B; CHAPMAN, GE; LANE, RS; TEESDALE, P; HUGHESJONES, NC; MOLLISON, PL			CLEARANCE OF RH D-POSITIVE RED-CELLS WITH MONOCLONAL ANTI-D	LANCET			English	Article									N LONDON BLOOD TRANSFUS CTR,COLINDALE AVE,LONDON NW9 5BG,ENGLAND; AFRC,INST ANIM PHYSIOL & GENET RES,MRC,MOLEC IMMUNOPATHOL UNIT,BABRAHAM,ENGLAND; BIO PROD LAB,ELSTREE,ENGLAND; UK TRANSPLANT SERV,BRISTOL,ENGLAND	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute								ENGLELFRIET CP, 1981, SEMINAR IMMUNE MEDIA, P93; GOOSSENS D, 1987, J IMMUNOL METHODS, V101, P193, DOI 10.1016/0022-1759(87)90150-5; HADLEY AG, 1989, IMMUNOLOGY, V67, P550; KUMPEL BM, 1989, BRIT J HAEMATOL, V71, P415; KUMPEL BM, 1989, BRIT J HAEMATOL, V71, P125, DOI 10.1111/j.1365-2141.1989.tb06285.x; MELAMED MD, 1987, J IMMUNOL METHODS, V104, P245, DOI 10.1016/0022-1759(87)90511-4; MOLLISON PL, 1965, BRIT J HAEMATOL, V11, P461, DOI 10.1111/j.1365-2141.1965.tb06609.x; Mollison PL, 1984, HEMOLYTIC DIS NEWBOR, P1; MOLLISON PL, 1987, BLOOD TRANSFUSION CL, P430; MOLLISON PL, 1967, IMMUNOLOGY, V12, P23; THOMPSON KM, 1986, IMMUNOLOGY, V58, P157; WIENER E, 1987, IMMUNOLOGY, V62, P401; WIENER E, 1988, IMMUNOLOGY, V65, P159; ZUPANSKA B, 1986, VOX SANG, V50, P97, DOI 10.1111/j.1423-0410.1986.tb04854.x; ZUPANSKA B, 1989, VOX SANG, V56, P247; 1980, BRIT J HAEMATOL, V45, P659	16	60	63	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 10	1990	336	8724					1147	1150		10.1016/0140-6736(90)92767-C	http://dx.doi.org/10.1016/0140-6736(90)92767-C			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG701	1978026				2022-12-28	WOS:A1990EG70100003
J	LIPUMA, JJ; DASEN, SE; NIELSON, DW; STERN, RC; STULL, TL				LIPUMA, JJ; DASEN, SE; NIELSON, DW; STERN, RC; STULL, TL			PERSON-TO-PERSON TRANSMISSION OF PSEUDOMONAS-CEPACIA BETWEEN PATIENTS WITH CYSTIC-FIBROSIS	LANCET			English	Article									MED COLL PENN,DEPT MICROBIOL IMMUNOL,PHILADELPHIA,PA 19129; UNIV UTAH,DEPT PEDIAT,SALT LAKE CITY,UT 84112; CASE WESTERN RESERVE UNIV,SCH MED,DEPT PEDIAT,CLEVELAND,OH 44106	Drexel University; Utah System of Higher Education; University of Utah; Case Western Reserve University	LIPUMA, JJ (corresponding author), MED COLL PENN,DEPT PEDIAT,3300 HENRY AVE,PHILADELPHIA,PA 19129, USA.							GILLIGAN PH, 1985, J CLIN MICROBIOL, V22, P5, DOI 10.1128/JCM.22.1.5-8.1985; GOLD R, 1983, J ANTIMICROB CHEMOTH, V12, P331, DOI 10.1093/jac/12.suppl_A.331; GOVAN JRW, 1985, J CLIN MICROBIOL, V22, P490, DOI 10.1128/JCM.22.4.490-494.1985; HARDY KA, 1986, J PEDIATR-US, V109, P51, DOI 10.1016/S0022-3476(86)80571-6; HEIDT A, 1983, J CLIN MICROBIOL, V18, P738, DOI 10.1128/JCM.18.3.738-740.1983; ISLES A, 1984, J PEDIATR-US, V104, P206, DOI 10.1016/S0022-3476(84)80993-2; KUIJPER EJ, 1989, J CLIN MICROBIOL, V27, P1280, DOI 10.1128/JCM.27.6.1280-1285.1989; LIPUMA JJ, 1988, J PEDIATR-US, V113, P859, DOI 10.1016/S0022-3476(88)80018-0; LIPUMA JJ, 1989, J INFECT DIS, V159, P526, DOI 10.1093/infdis/159.3.526; NAKAMURA Y, 1986, J CLIN MICROBIOL, V24, P152, DOI 10.1128/JCM.24.1.152-154.1986; PRINCE A, 1986, AM REV RESPIR DIS, V134, P644; PRINCE A, 1986, J PEDIATR-US, V108, P830, DOI 10.1016/S0022-3476(86)80753-3; RABKIN CS, 1989, REV INFECT DIS, V11, P600; RICHARD C, 1981, ANN BIOL CLIN-PARIS, V39, P9; ROSENSTEIN BJ, 1980, JOHNS HOPKINS MED J, V147, P188; SNIPES KP, 1989, J CLIN MICROBIOL, V27, P1847, DOI 10.1128/JCM.27.8.1847-1853.1989; STERN RC, 1989, J PEDIATR-US, V114, P31, DOI 10.1016/S0022-3476(89)80597-9; STULL TL, 1988, J INFECT DIS, V157, P280, DOI 10.1093/infdis/157.2.280; TABLAN OC, 1987, J CLIN MICROBIOL, V25, P485, DOI 10.1128/JCM.25.3.485-487.1987; TABLAN OC, 1987, CHEST, V91, P527, DOI 10.1378/chest.91.4.527; TABLAN OC, 1985, J PEDIATR-US, V107, P382, DOI 10.1016/S0022-3476(85)80511-4; TABLAN OC, 1989, PEDIATR PULM S, V4, P138; THOMASSEN MJ, 1985, AM REV RESPIR DIS, V131, P791; THOMASSEN MJ, 1986, AM REV RESPIR DIS, V134, P669	24	250	251	0	11	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 3	1990	336	8723					1094	1096		10.1016/0140-6736(90)92571-X	http://dx.doi.org/10.1016/0140-6736(90)92571-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF992	1977981				2022-12-28	WOS:A1990EF99200005
J	TREASURE, T				TREASURE, T			WHICH HEART-VALVES SHOULD WE USE	LANCET			English	Editorial Material											TREASURE, T (corresponding author), ST GEORGE HOSP,DEPT CARDIOTHORAC SURG,LONDON SW17 0QT,ENGLAND.							BLOOMFIELD P, 1989, BRIT HEART J, V61, P452; BRAHAMS D, 1990, LANCET, V336, P619, DOI 10.1016/0140-6736(90)93411-H; Butchart E G, 1988, Eur J Cardiothorac Surg, V2, P72, DOI 10.1016/S1010-7940(88)80002-2; BUTCHART EG, 1988, CIRCULATION, V78, P66; EDMUNDS LH, 1988, ANN THORAC SURG, V46, P257, DOI 10.1016/S0003-4975(10)65920-6; EDMUNDS LH, 1988, J THORAC CARDIOV SUR, V96, P351; GERSH BJ, 1986, J THORAC CARDIOV SUR, V91, P460; HIRATZKA LF, 1988, J AM COLL CARDIOL, V11, P1130, DOI 10.1016/S0735-1097(98)90075-4; KUNTZE CEE, 1989, LANCET, V1, P514; LYTLE BW, 1989, J THORAC CARDIOV SUR, V97, P675; MACMANUS Q, 1980, J THORAC CARDIOV SUR, V80, P834; SAOUR JN, 1990, NEW ENGL J MED, V322, P428, DOI 10.1056/NEJM199002153220703; SETHIA B, 1986, J THORAC CARDIOV SUR, V91, P350; 1990, LANCET, V336, P152	14	13	13	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 3	1990	336	8723					1115	1117		10.1016/0140-6736(90)92583-4	http://dx.doi.org/10.1016/0140-6736(90)92583-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF992	1977992				2022-12-28	WOS:A1990EF99200016
J	BREWSTER, DR; KWIATKOWSKI, D; WHITE, NJ				BREWSTER, DR; KWIATKOWSKI, D; WHITE, NJ			NEUROLOGICAL SEQUELAE OF CEREBRAL MALARIA IN CHILDREN	LANCET			English	Review									ROYAL VICTORIA HOSP,BANJUL,SENEGAMBIA; MRC LABS,FAJARA,SENEGAMBIA; MAHIDOL UNIV,FAC TROP MED,BANGKOK 10700,THAILAND; UNIV OXFORD,NUFFIELD DEPT CLIN MED,OXFORD,ENGLAND	Mahidol University; University of Oxford			White, Nicholas J/I-4629-2012; White, Nick/AAC-6527-2019	White, Nick/0000-0002-1897-1978; Kwiatkowski, Dominic/0000-0002-5023-0176	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AHMAD S H, 1986, Indian Journal of Pediatrics, V53, P409, DOI 10.1007/BF02760427; ARMENGAUD M., 1962, Bulletin de la Societe Medicale d'Afrique Noire de Langue Francaise, V7, P167; BRUCECHWATT LJ, 1952, ANN TROP MED PARASIT, V40, P173; Collomb H, 1967, Bull Soc Med Afr Noire Lang Fr, V12, P791; Commey J. O. O., 1980, Ghana Medical Journal, V19, P68; GRAU GE, 1987, SCIENCE, V237, P1210, DOI 10.1126/science.3306918; GRAU GE, 1987, IMMUNOLOGY, V61, P521; GREENWOOD BM, 1988, LANCET, V1, P1121; GREENWOOD BM, 1987, T ROY SOC TROP MED H, V81, P478, DOI 10.1016/0035-9203(87)90170-2; GREENWOOD BM, 1987, ANN TROP PAEDIATR, V7, P91, DOI 10.1080/02724936.1987.11748482; GUIGNARD J, 1963, ANN PEDIATR, V43, P646; Harinasuta T, 1988, MALARIA PRINCIPLES P, V1, P721; KWIATKOWSKI D, IN PRESS LANCET; LEMERCIER G, 1969, PATHOL BIOL, V17, P459; MCGREGOR IA, 1987, PARASITOLOGY, V94, pS159, DOI 10.1017/S0031182000085875; MENON A, IN PRESS T R SOC TRO; MOLYNEUX ME, 1989, Q J MED, V71, P441; Musoke L. K., 1966, East African Medical Journal, V43, P561; NOUHOUAYI A, 1967, THESIS U DAKAR SENEG; OMANGA U, 1983, ANN PEDIATR-PARIS, V30, P294; OMANGA V, 1977, AFRIQUE MED, V16, P507; PUKRITTAYAKAMEE S, 1989, T ROY SOC TROP MED H, V83, P762, DOI 10.1016/0035-9203(89)90321-0; REY M, 1966, Bulletin de la Societe de Pathologie Exotique, V59, P683; ROTHE H, 1956, East Afr Med J, V33, P405; SANOHKO A, 1968, Bulletin de la Societe Medicale d'Afrique Noire de Langue Francaise, V13, P662; SCHMUTZHARD E, 1984, T ROY SOC TROP MED H, V78, P351, DOI 10.1016/0035-9203(84)90118-4; SNOW RW, 1988, T ROY SOC TROP MED H, V82, P838, DOI 10.1016/0035-9203(88)90011-9; STACE J, 1982, PAPUA NEW GUINEA MED, V25, P230; TAYLOR TE, 1988, NEW ENGL J MED, V319, P1040, DOI 10.1056/NEJM198810203191602; TEASDALE G, 1974, LANCET, V2, P81; THAPA B R, 1988, Indian Pediatrics, V25, P61; TRAPE JF, 1987, T ROY SOC TROP MED H, V81, P34; WARRELL DA, 1988, LANCET, V2, P534; WHITE NJ, 1989, T ROY SOC TROP MED H, V83, P767, DOI 10.1016/0035-9203(89)90322-2; WHITE NJ, 1989, LANCET, V2, P1313, DOI 10.1016/S0140-6736(89)91918-1; WHITE NJ, 1987, LANCET, V1, P708; WHITE NJ, 1986, CLIN TROPICAL MED CO; 1987, POPULATION HOUSING C, V1; BENCH AIDS DIAGNOSIS	39	317	321	0	10	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 27	1990	336	8722					1039	1043		10.1016/0140-6736(90)92498-7	http://dx.doi.org/10.1016/0140-6736(90)92498-7			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF076	1977027				2022-12-28	WOS:A1990EF07600012
J	POHANKA, E; COHEN, N; COLOMBE, BW; LOU, C; SALVATIERRA, O; GAROVOY, MR				POHANKA, E; COHEN, N; COLOMBE, BW; LOU, C; SALVATIERRA, O; GAROVOY, MR			NONINHERITED MATERNAL HLA ANTIGENS AND PROTECTION AGAINST SENSITIZATION	LANCET			English	Article									UNIV CALIF SAN FRANCISCO,IMMUNOGENET & TRANSPLANTAT LAB,ROOM HSE 520,BOX 0508,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,TRANSPLANT SERV,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; University of California System; University of California San Francisco					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL036589] Funding Source: NIH RePORTER; NHLBI NIH HHS [IP01 HL 36589-02] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AMOS DB, 1979, NIH80545 PUBL, P42; BILLINGHAM RE, 1953, NATURE, V172, P603, DOI 10.1038/172603a0; BURLINGHAM WJ, 1988, TRANSPLANTATION, V45, P1066, DOI 10.1097/00007890-198806000-00013; CHARDONNENS X, 1980, TISSUE ANTIGENS, V15, P401; CLAAS FHJ, 1988, SCIENCE, V241, P1815, DOI 10.1126/science.3051377; CLAAS FHJ, 1988, TRANSPLANT INT, V1, P53, DOI 10.1007/BF00353819; COLOMBE BW, 1987, TRANSPLANTATION, V44, P509, DOI 10.1097/00007890-198710000-00010; DEJELO CL, 1981, AACHT LABORATORY MAN; FOTINO M, 1981, AACHT LABORATORY MAN; FULLER TC, 1982, TRANSPLANTATION, V34, P24, DOI 10.1097/00007890-198207000-00005; GAROVOY MR, 1983, TRANSPLANT P, V15, P1939; HOPKINS K, 1981, AACHT LABORATORY MAN; JACOBY DR, 1984, ADV IMMUNOL, V35, P157, DOI 10.1016/S0065-2776(08)60576-3; KALIA A, 1988, TRANSPLANTATION, V46, P70, DOI 10.1097/00007890-198807000-00012; KENNEALY P, CLIN TRANSPLANT  198, P147; NAGARKATTI PS, 1983, TRANSPLANTATION, V36, P695, DOI 10.1097/00007890-198336060-00022; PANAJOTOPOULOS N, 1990, TRANSPLANTATION, V50, P443, DOI 10.1097/00007890-199009000-00016; PHELAN DL, 1989, TRANSPLANTATION, V48, P57, DOI 10.1097/00007890-198907000-00013; POHANKA E, 1989, HUM IMMUNOL, V26, P17, DOI 10.1016/0198-8859(89)90029-3; REED E, 1987, NEW ENGL J MED, V316, P1450, DOI 10.1056/NEJM198706043162305; REED E, 1983, J IMMUNOL, V131, P2890; SALVATIERRA O, 1980, ANN SURG, V192, P543, DOI 10.1097/00000658-198010000-00012; STREILEIN JW, 1977, J IMMUNOL, V119, P2147; SUCIUFOCA N, 1983, P NATL ACAD SCI-BIOL, V80, P830, DOI 10.1073/pnas.80.3.830; WALKNOWSKA J, 1969, LANCET, V1, P1119	25	12	12	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 27	1990	336	8722					1025	1028		10.1016/0140-6736(90)92488-4	http://dx.doi.org/10.1016/0140-6736(90)92488-4			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF076	1977018				2022-12-28	WOS:A1990EF07600003
J	TRANTER, HS				TRANTER, HS			FOODBORNE STAPHYLOCOCCAL ILLNESS	LANCET			English	Article											TRANTER, HS (corresponding author), PUBL HLTH LAB SERV, CTR APPL MICROBIOL & RES, DIV BIOL, PORTON DOWN, SALISBURY SP4 0JG, WILTS, ENGLAND.							Bean N H, 1990, MMWR CDC Surveill Summ, V39, P15; BEERY JT, 1984, INFECT IMMUN, V44, P234, DOI 10.1128/IAI.44.2.234-240.1984; BERGDOLL MS, 1989, BACTERIAL FOODBORNE, P464; BERRY PR, 1987, SOC APPLIED BACTERIO, V24, P245; DESAXE M, 1982, SOC APPLIED BACTERIO, V17, P173; DOSSANTOS EC, 1981, J FOOD PROTECT, V44, P172, DOI 10.4315/0362-028X-44.3.172; FEY H, 1986, ANTIGEN DETECTION DI, V2, P211; HALPINDOHNALEK MI, 1989, J FOOD PROTECT, V52, P267, DOI 10.4315/0362-028X-52.4.267; MARRACK P, 1990, SCIENCE, V248, P705, DOI 10.1126/science.2185544; MODI NK, IN PRESS INT J FOOD; SCHEUBER PH, 1985, INFECT IMMUN, V50, P869, DOI 10.1128/IAI.50.3.869-876.1985; SCHWABE M, 1990, INT J FOOD MICROBIOL, V10, P33, DOI 10.1016/0168-1605(90)90005-P; SPERO L, 1978, J BIOL CHEM, V253, P8787; STELMA GN, 1982, BIOCHEM BIOPH RES CO, V105, P121, DOI 10.1016/S0006-291X(82)80019-3; TATINI SR, 1976, J MILK FOOD TECHNOL, V39, P432, DOI 10.4315/0022-2747-39.6.432; Tranter H S, 1990, Soc Appl Bacteriol Symp Ser, V19, p109S; YAQOOB M, 1990, J INFECTION, V20, P176, DOI 10.1016/0163-4453(90)93678-L	17	89	92	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 27	1990	336	8722					1044	1046						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF076	1977028				2022-12-28	WOS:A1990EF07600013
J	YOKOKAWA, K; TAHARA, H; KOHNO, M; MURAKAWA, K; YASUNARI, K; NAKAGAWA, K; HAMADA, T; OTANI, S; YANAGISAWA, M; TAKEDA, T				YOKOKAWA, K; TAHARA, H; KOHNO, M; MURAKAWA, K; YASUNARI, K; NAKAGAWA, K; HAMADA, T; OTANI, S; YANAGISAWA, M; TAKEDA, T			HYPERTENSION ASSOCIATED WITH ENDOTHELIN-SECRETING MALIGNANT HEMANGIOENDOTHELIOMA	ANNALS OF INTERNAL MEDICINE			English	Note								Two patients with malignant hemangioendothelioma presented with hypertension and elevated plasma endothelin-1 levels. In both patients, changes in plasma endothelin-1 levels corresponded with changes in blood pressure, which returned to normal after surgical excision of the tumor. In one patient, recurrence of the tumor was associated with rising endothelin-1 and blood pressure levels. The endothelin-1 content and its messenger RNA level in this patient's tumor extract were higher than those from normal parts of the patient's skin. We conclude that the tumor secreted excessive amounts of endothelin-1.	UNIV TSUKUBA, INST BASIC MED SCI, SAKURA, IBARAKI 30031, JAPAN	University of Tsukuba	YOKOKAWA, K (corresponding author), OSAKA CITY UNIV, SCH MED, DEPT INTERNAL MED 1, 1-5-7 ASAHI MACHI, ABENO KU, OSAKA 545, JAPAN.							CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; KOHNO M, 1989, METABOLISM, V38, P712, DOI 10.1016/0026-0495(89)90054-1; KOHNO M, 1990, AM J MED, V88, P614, DOI 10.1016/0002-9343(90)90527-K; MIYAUCHI T, 1989, LANCET, V2, P53, DOI 10.1016/S0140-6736(89)90303-6; NAKAO K, 1984, BIOCHEM BIOPH RES CO, V124, P815, DOI 10.1016/0006-291X(84)91030-1; PETITO CK, 1978, ANN NEUROL, V3, P393, DOI 10.1002/ana.410030505; VIERHAPPER H, 1990, CIRCULATION, V81, P1415, DOI 10.1161/01.CIR.81.4.1415; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0	8	158	159	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 1	1991	114	3					213	215		10.7326/0003-4819-114-3-213	http://dx.doi.org/10.7326/0003-4819-114-3-213			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EV339	1984746				2022-12-28	WOS:A1991EV33900009
J	FINGERHUT, MA; HALPERIN, WE; MARLOW, DA; PIACITELLI, LA; HONCHAR, PA; SWEENEY, MH; GREIFE, AL; DILL, PA; STEENLAND, K; SURUDA, AJ				FINGERHUT, MA; HALPERIN, WE; MARLOW, DA; PIACITELLI, LA; HONCHAR, PA; SWEENEY, MH; GREIFE, AL; DILL, PA; STEENLAND, K; SURUDA, AJ			CANCER MORTALITY IN WORKERS EXPOSED TO 2,3,7,8-TETRACHLORODIBENZO-PARA-DIOXIN	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SOFT-TISSUE SARCOMA; NON-HODGKINS LYMPHOMA; PHENOXYACETIC ACIDS; MALIGNANT-LYMPHOMA; ORGANIC-SOLVENTS; CHEMICAL WORKERS; COHORT MORTALITY; CASE-REFERENT; CHLOROPHENOLS; PROMOTION	Background. In both animal and epidemiologic studies, exposure to dioxin (2,3,7,8-tetrachlorodibenzo-p-dioxin, or TCDD) has been associated with an increased risk of cancer. Methods. We conducted a retrospective cohort study of mortality among the 5172 workers at 12 plants in the United States that produced chemicals contaminated with TCDD. Occupational exposure was documented by reviewing job descriptions and by measuring TCDD in serum from a sample of 253 workers. Causes of death were taken from death certificates. Results. Mortality from several cancers previously associated with TCDD (stomach, liver, and nasal cancers, Hodgkin's disease, and non-Hodgkin's lymphoma) was not significantly elevated in this cohort. Mortality from soft-tissue sarcoma was increased, but not significantly (4 deaths; standardized mortality ratio [SMR], 338; 95 percent confidence interval, 92 to 865). In the subcohort of 1520 workers with greater-than-or-equal-to 1 year of exposure and greater-than-or-equal-to 20 years of latency, however, mortality was significantly increased for soft-tissue sarcoma (3 deaths; SMR, 922;95 percent confidence interval, 190 to 2695) and for cancers of the respiratory system (SMR, 142; 95 percent confidence interval, 103 to 192). Mortality from all cancers combined was slightly but significantly elevated in the overall cohort (SMR, 115; 95 percent confidence interval, 102 to 130) and was higher in the subcohort with greater-than-or-equal-to 1 year of exposure and greater-than-or-equal-to 20 years of latency (SMR, 146; 95 percent confidence interval, 121 to 176). Conclusions. This study of mortality among workers with occupational exposure to TCDD does not confirm the high relative risks reported for many cancers in previous studies. Conclusions about an increase in the risk of soft-tissue sarcoma are limited by small numbers and misclassification on death certificates. Excess mortality from all cancers combined, cancers of the respiratory tract, and soft-tissue sarcoma may result from exposure to TCDD, although we cannot exclude the possible contribution of factors such as smoking and occupational exposure to other chemicals.			FINGERHUT, MA (corresponding author), CTR DIS CONTROL, DIV SURVEILLANCE HAZARD EVALUAT & FIELD STUDIES, IND WIDE STUDIES BRANCH, CINCINNATI, OH 45226 USA.							AXELSON O, 1978, SCAND J WORK ENV HEA, V4, P98, DOI 10.5271/sjweh.2720; AXELSON O, 1980, SCAND J WORK ENV HEA, V6, P73, DOI 10.5271/sjweh.2631; ERIKSSON M, 1981, BRIT J IND MED, V38, P27; ERIKSSON M, 1990, J NATL CANCER I, V82, P486, DOI 10.1093/jnci/82.6.486; ESPOSITO M, 1980, EPA600280197 PUBL; FINGERHUT M, 1990, PB91125971; FINGERHUT MA, 1984, SCAND J WORK ENV HEA, V10, P299, DOI 10.5271/sjweh.2325; FOX AJ, 1976, BRIT J PREV SOC MED, V30, P225; HARDELL L, 1979, BRIT J CANCER, V39, P711, DOI 10.1038/bjc.1979.125; HARDELL L, 1984, BRIT J CANCER, V50, P389, DOI 10.1038/bjc.1984.188; HARDELL L, 1981, BRIT J CANCER, V43, P169, DOI 10.1038/bjc.1981.25; HARDELL L, 1988, CANCER, V62, P652, DOI 10.1002/1097-0142(19880801)62:3<652::AID-CNCR2820620334>3.0.CO;2-4; HARDELL L, 1983, BRIT J CANCER, V48, P217, DOI 10.1038/bjc.1983.177; HARDELL L, 1982, American Journal of Industrial Medicine, V3, P247, DOI 10.1002/ajim.4700030304; KOCIBA RJ, 1978, TOXICOL APPL PHARM, V46, P279, DOI 10.1016/0041-008X(78)90075-3; MONSON RR, 1990, OCCUPATIONAL EPIDEMI, P100; OLSEN JH, 1984, LANCET, V2, P47; OTT MG, 1987, J OCCUP ENVIRON MED, V29, P422; PATTERSON DG, 1989, AM J IND MED, V16, P135, DOI 10.1002/ajim.4700160205; PEARCE NE, 1987, INT J CANCER, V39, P155, DOI 10.1002/ijc.2910390206; PERCY C, 1981, AM J PUBLIC HEALTH, V71, P242, DOI 10.2105/AJPH.71.3.242; PERSSON B, 1989, BRIT J IND MED, V46, P516; PITOT HC, 1980, CANCER RES, V40, P3616; POLAND A, 1982, NATURE, V300, P271, DOI 10.1038/300271a0; RAO MS, 1988, CARCINOGENESIS, V9, P1677, DOI 10.1093/carcin/9.9.1677; ROTHMAN KJ, 1979, DHEW NIH791649 PUBL, P30; ROTHMAN KJ, 1986, MODERN EPIDEMIOLOGY, P229; SIEMIATYCKI J, 1988, J OCCUP ENVIRON MED, V30, P617, DOI 10.1097/00043764-198808000-00004; SMITH AH, 1984, J NATL CANCER I, V73, P1111; STEENLAND K, 1990, J OCCUP ENVIRON MED, V32, P1091, DOI 10.1097/00043764-199011000-00008; STEENLAND K, 1984, SCAND J WORK ENV HEA, V10, P143, DOI 10.5271/sjweh.2349; SUIT HD, 1978, CA-CANCER J CLIN, V28, P284, DOI 10.3322/canjclin.28.5.284; SUSKIND RR, 1984, JAMA-J AM MED ASSOC, V251, P2372, DOI 10.1001/jama.251.18.2372; SWEENEY MH, 1989, CHEMOSPHERE, V19, P973, DOI 10.1016/0045-6535(89)90443-8; THIESS A M, 1982, American Journal of Industrial Medicine, V3, P179, DOI 10.1002/ajim.4700030209; WIKLUND K, 1987, BRIT J CANCER, V56, P505, DOI 10.1038/bjc.1987.234; WIKLUND K, 1986, J NATL CANCER I, V76, P229; WIKLUND K, 1984, BRIT J CANCER, V2, P47; WOODS JS, 1987, J NATL CANCER I, V78, P899; ZACK JA, 1980, J OCCUP ENVIRON MED, V22, P11, DOI 10.1097/00043764-198001000-00005; Zack Judith A., 1983, HUMAN ENV RISKS CHLO, P575; ZOBER A, 1990, INT ARCH OCC ENV HEA, V62, P139, DOI 10.1007/BF00383591; 1977, INT CLASSIFICATION D; 1982, DHHS NIH821765 PUBL	44	467	476	0	32	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 24	1991	324	4					212	218		10.1056/NEJM199101243240402	http://dx.doi.org/10.1056/NEJM199101243240402			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU022	1985242				2022-12-28	WOS:A1991EU02200002
J	MOSER, M; BLAUFOX, MD; FREIS, E; GIFFORD, RW; KIRKENDALL, W; LANGFORD, H; SHAPIRO, A; SHEPS, S				MOSER, M; BLAUFOX, MD; FREIS, E; GIFFORD, RW; KIRKENDALL, W; LANGFORD, H; SHAPIRO, A; SHEPS, S			WHO REALLY DETERMINES YOUR PATIENTS PRESCRIPTIONS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							FOLLOW-UP; HYPERTENSION; DIURETICS; GLUCOSE; LIPIDS; TRIAL		YALE UNIV,SCH MED,DEPT MED,NEW HAVEN,CT 06510; YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT MED,BRONX,NY 10461; VET ADM,WASHINGTON,DC 20420; CLEVELAND CLIN EDUC FDN,CLEVELAND,OH 44106; UNIV TEXAS,HLTH SCI CTR,HOUSTON,TX 77225; UNIV MISSISSIPPI,MED CTR,SCH MED,JACKSON,MS 39216; UNIV PITTSBURGH,SCH MED,PITTSBURGH,PA 15261; MAYO CLIN & MAYO FDN,ROCHESTER,MN 55905	Yale University; Yeshiva University; Albert Einstein College of Medicine; Cleveland Clinic Foundation; University of Texas System; University of Texas Health Science Center Houston; University of Mississippi; University of Mississippi Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Mayo Clinic			Blaufox, MDonald/AAF-6965-2020	Blaufox, MDonald/0000-0002-4148-6866				AMES RP, 1986, DRUGS, V32, P260, DOI 10.2165/00003495-198632030-00003; [Anonymous], 1981, LANCET, V2, P539; COLLINS R, 1990, LANCET, V335, P827, DOI 10.1016/0140-6736(90)90944-Z; CURB JD, 1986, PROG CARDIOVASC DIS, V29, P73; EDELSON JT, 1990, JAMA-J AM MED ASSOC, V263, P407, DOI 10.1001/jama.263.3.407; FREIS ED, 1989, ARCH INTERN MED, V149, P2649; GREENBERG G, 1984, AM J MED, V76, P45, DOI 10.1016/0002-9343(84)90956-2; MACMAHON S, 1989, HYPERTENSION S1, V13, P145; MOSER M, 1989, CARDIOVASC DRUG THER, V3, P743, DOI 10.1007/BF01857624; MOSER M, 1989, AM HEART J, V118, P1362, DOI 10.1016/0002-8703(89)90059-8; MOSER M, 1985, J HYPERTENS, V3, P437; MOSER M, 1989, AM FAM PHYSICIAN, V40, P213; MURPHY MB, 1982, LANCET, V2, P1293; PARVING HH, 1987, BRIT MED J, V294, P1443, DOI 10.1136/bmj.294.6585.1443; POLLARE T, 1989, NEW ENGL J MED, V321, P868, DOI 10.1056/NEJM198909283211305; SHAPIRO AP, 1961, NEW ENGL J MED, V265, P1028, DOI 10.1056/NEJM196111232652102; SHEKELLE RB, 1984, ATHER REV, V12, P113; 1980, LANCET, V1, P1261; 1985, AM J CARDIOL, V56, P913; 1979, JAMA-J AM MED ASSOC, V242, P2562; 1980, AM J MED, V69, P725; 1988, JAMA-J AM MED ASSOC, V259, P2113; 1990, CIRCULATION, V82, P1616; 1985, JAMA-J AM MED ASSOC, V291, P97; 1985, LANCET, V1, P1349; 1982, JAMA-J AM MED ASSOC, V248, P1996	26	30	30	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	1991	265	4					498	500		10.1001/jama.265.4.498	http://dx.doi.org/10.1001/jama.265.4.498			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ET377	1985236				2022-12-28	WOS:A1991ET37700031
J	WILENSKY, GR				WILENSKY, GR			NURSING-HOME REFORM	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									HLTH CARE FINANCING ADM,HLTH STAND & QUAL BUR,BALTIMORE,MD 21207										0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	1991	265	4					444	444						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ET377	1985225				2022-12-28	WOS:A1991ET37700005
J	GOODALE, MA; MILNER, AD; JAKOBSON, LS; CAREY, DP				GOODALE, MA; MILNER, AD; JAKOBSON, LS; CAREY, DP			A NEUROLOGICAL DISSOCIATION BETWEEN PERCEIVING OBJECTS AND GRASPING THEM	NATURE			English	Article								Studies of the visual capacity of neurological patients have provided evidence for a dissociation between the perceptual report of a visual stimulus and the ability to direct spatially accurate movements toward that stimulus. Some patients with damage to the parietal lobe, for example, are unable to reach accurately towards visual targets that they unequivocally report seeing 1,2. Conversely, some patients with extensive damage to primary visual cortex can make accurate pointing movements or saccades toward a stimulus presented in their 'blind' scotoma 3-5. But in investigations of visuomotor control in patients with visual disorders, little consideration has ben given to complex acts such as manual prehension. Grasping a three-dimensional object requires knowledge not only of the object's spatial location, but also of its form, orientation and size. We have examined a patient with a profound disorder in the perception of such object qualities. Our quantitative analyses demonstrate strikingly accurate guidance of hand and finger movements directed at the very objects whose qualities she fails to perceive. These data suggest that the neural substrates for the visual perception of object qualities such as shape, orientation and size are distinct from those underlying the use of those qualities in the control of manual skills.	UNIV ST ANDREWS,PSYCHOL LAB,ST ANDREWS KY16 9JU,FIFE,SCOTLAND; UNIV WESTERN ONTARIO,DEPT PSYCHOL,LONDON N6A 5C2,ONTARIO,CANADA	University of St Andrews; Western University (University of Western Ontario)			Carey, David P/C-5238-2008; Goodale, Melvyn A/M-5907-2013	Carey, David P/0000-0001-8860-9731; Goodale, Melvyn A/0000-0001-6748-0561				DAMASIO AR, 1979, NEUROLOGY, V29, P170, DOI 10.1212/WNL.29.2.170; Damasio H, 1989, ANAL NEUROPSYCHOLOGY; EFRON R, 1969, BOSTON STUDIES PHILO, V4, P137; Jeannerod M., 1981, ATTENTION PERFORM, P153; MAUNSELL JHR, 1987, ANNU REV NEUROSCI, V10, P363, DOI 10.1146/annurev.ne.10.030187.002051; MILNER AD, 1989, CORTEX, V25, P489, DOI 10.1016/S0010-9452(89)80062-0; MILNER AD, IN PRESS BRAIN; PERENIN MT, 1988, BRAIN, V111, P643, DOI 10.1093/brain/111.3.643; PERENIN MT, 1975, NEUROPSYCHOOGIA, V4, P1; POEPPEL E, 1973, Nature (London), V243, P295; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; WEISKRANTZ L, 1974, BRAIN, V97, P709, DOI 10.1093/brain/97.1.709	12	903	915	3	88	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JAN 10	1991	349	6305					154	156		10.1038/349154a0	http://dx.doi.org/10.1038/349154a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER418	1986306				2022-12-28	WOS:A1991ER41800057
J	TREVINO, FM; MOYER, ME; VALDEZ, RB; STROUPBENHAM, CA				TREVINO, FM; MOYER, ME; VALDEZ, RB; STROUPBENHAM, CA			HEALTH-INSURANCE COVERAGE AND UTILIZATION OF HEALTH-SERVICES BY MEXICAN-AMERICANS, MAINLAND PUERTO-RICANS, AND CUBAN AMERICANS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								This investigation examines data on 13 000 Mexican Americans, Puerto Ricans, and Cuban Americans between 6 months and 74 years of age who were interviewed from 1982 through 1984 in the Hispanic Health and Nutrition Examination Survey. In addition, data from the 1989 Current Population Survey (N = 145 000) conducted by the US Bureau of the Census are presented for the white and black non-Hispanic populations as well as the three Hispanic national origin groups. The study revealed that over one third of the Mexican-American population, one fifth of the Puerto Rican population, and one fourth of the Cuban-American population is uninsured for medical expenditures compared with one fifth of the black, non-Hispanic population and one tenth of the white, non-Hispanic population. Furthermore, compared with Hispanics with private health insurance, uninsured Hispanics are less likely to have a regular source of health care, less likely to have visited a physician in the past year, less likely to have had a routine physical examination, and less likely to rate their health status as excellent or very good.	US DEPT HHS,OFF ASSISTANT SECRETARY PLANNING & EVALUAT,WASHINGTON,DC 20201; RAND CORP,LOS ANGELES,CA; UNIV TEXAS,MED BRANCH,DEPT PREVENT MED & COMMUNITY HLTH,GALVESTON,TX 77550; UNIV CALIF LOS ANGELES,SCH PUBL HLTH,LOS ANGELES,CA 90024	RAND Corporation; University of Texas System; University of Texas Medical Branch Galveston; University of California System; University of California Los Angeles	TREVINO, FM (corresponding author), UNIV TEXAS,MED BRANCH,CTR CROSS CULTURAL RES,202 GAIL BORDEN BLDG F-24,GALVESTON,TX 77550, USA.				NIMH NIH HHS [R01 MH44212-01] Funding Source: Medline	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ANDERSEN R, 1981, J HEALTH SOC BEHAV, V22, P78, DOI 10.2307/2136370; ANDERSEN RM, 1986, PUBLIC HEALTH REP, V101, P238; [Anonymous], 1989, GUIDE CLIN PREVENTIV; MOYER ME, 1989, HEALTH AFFAIR, V8, P102, DOI 10.1377/hlthaff.8.2.102; SWARTZ K, 1989, HEALTH AFFAIR, V8, P193, DOI 10.1377/hlthaff.8.4.193; TREVINO FM, 1985, VITAL HLTH STAT 1, V19, P4; TREVINO FM, 1983, PHS841232 DEP HLTH H; TREVINO FM, 1984, VITAL HLTH STAT, V148, P1; WEISFELD VD, 1987, 21987 RW JOHNS F SPE; 1979, CURRENT POPULATI P20, V354; 1982, ACCESS HLTH CARE SER	11	167	169	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 9	1991	265	2					233	237		10.1001/jama.265.2.233	http://dx.doi.org/10.1001/jama.265.2.233			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EQ602	1984153				2022-12-28	WOS:A1991EQ60200031
J	LUCAS, A; COLE, TJ				LUCAS, A; COLE, TJ			BREAST-MILK AND NEONATAL NECROTIZING ENTEROCOLITIS	LANCET			English	Article							BIRTH-WEIGHT INFANTS; INTENSIVE-CARE UNIT; NECROTIZING ENTEROCOLITIS; RISK-FACTORS; EPIDEMIOLOGY; EXPERIENCE; PREVENTION; INFECTION; GROWTH	In a prospective multicentre study on 926 preterm infants formally assigned to their early diet, necrotising enterocolitis developed in 51 (5.5%). Mortality was 26% in stringently confirmed cases. In exclusively formula-fed babies confirmed disease was 6-10 times more common than in those fed breast milk along and 3 times more common than in those who received formula plus breast milk. Pasteurised donor milk seemed to be as protective as raw maternal milk. Among babies born at more than 30 weeks' gestation confirmed necrotising enterocolitis was rare in those whose diet included breast milk; it was 20 times more common in those fed formula only. Other risk factors included very low gestational age, respiratory disease, umbilical artery catheterisation, and polycythaemia. In formula-fed but not breast-milk-fed infants, delayed enteral feeding was associated with a lower frequency of necrotising enterocolitis. With the fall in the use of breast milk in British neonatal units, exclusive formula feeding could account for an estimated 500 extra cases of necrotising enterocolitis each year. About 100 of these infants would die.	UNIV CAMBRIDGE,DEPT PAEDIAT,CAMBRIDGE,ENGLAND	University of Cambridge	LUCAS, A (corresponding author), MRC,DUNN NUTR UNIT,DOWNHAMS LANE,MILTON RD,CAMBRIDGE CB4 1XJ,ENGLAND.		Cole, Tim J/B-7883-2008	Cole, Tim J/0000-0001-5711-8200				ANDERSON CL, 1984, AM J DIS CHILD, V138, P979, DOI 10.1001/archpedi.1984.02140480081025; BARLOW B, 1974, J PEDIATR SURG, V9, P587, DOI 10.1016/0022-3468(74)90093-1; BELL MJ, 1978, ANN SURG, V187, P1, DOI 10.1097/00000658-197801000-00001; BLACK TL, 1989, SOUTHERN MED J, V82, P1103, DOI 10.1097/00007611-198909000-00011; BOOK LS, 1977, NEW ENGL J MED, V297, P984, DOI 10.1056/NEJM197711032971805; BOOK LS, 1975, J PEDIATR-US, V87, P602, DOI 10.1016/S0022-3476(75)80835-3; BUNTON GL, 1977, ARCH DIS CHILD, V52, P772, DOI 10.1136/adc.52.10.772; DECURTIS M, 1987, EUR J PEDIATR, V146, P398, DOI 10.1007/BF00444947; EGLIN RP, 1987, LANCET, V1, P1093; EIBL MM, 1988, NEW ENGL J MED, V319, P1, DOI 10.1056/NEJM198807073190101; EVANS TJ, 1978, ARCH DIS CHILD, V53, P239, DOI [10.1136/adc.53.3.239, 10.1136/adc.53.10.827-a]; EYAL F, 1982, ARCH DIS CHILD, V57, P274, DOI 10.1136/adc.57.4.274; GOLDMAN HI, 1980, AM J DIS CHILD, V134, P553, DOI 10.1001/archpedi.1980.02130180011004; KLEIGMAN RM, 1979, PEDIATR CLIN N AM, V26, P327; KLIEGMAN RM, 1979, J PEDIATR-US, V95, P450, DOI 10.1016/S0022-3476(79)80534-X; KLIEGMAN RM, 1981, AM J DIS CHILD, V135, P603, DOI 10.1001/archpedi.1981.02130310009005; KLIEGMAN RM, 1982, J PEDIATR-US, V100, P440, DOI 10.1016/S0022-3476(82)80456-3; KOSLOSKE AM, 1984, PEDIATRICS, V74, P1086; LAGAMMA EF, 1985, AM J DIS CHILD, V139, P385, DOI 10.1001/archpedi.1985.02140060067031; LUCAS A, 1989, ARCH DIS CHILD-FETAL, V64, P902, DOI 10.1136/adc.64.7_Spec_No.902; LUCAS A, 1984, ARCH DIS CHILD, V59, P722, DOI 10.1136/adc.59.8.722; LUCAS A, 1990, LANCET, V335, P1477, DOI 10.1016/0140-6736(90)93026-L; MORIARTEY RR, 1979, J PEDIATR-US, V94, P295, DOI 10.1016/S0022-3476(79)80848-3; PALMER SR, 1987, J EPIDEMIOL COMMUN H, V41, P210, DOI 10.1136/jech.41.3.210; PITT J, 1977, PEDIATR RES, V11, P906, DOI 10.1203/00006450-197708000-00011; SANTULLI TV, 1975, PEDIATRICS, V55, P376; SMITH MF, 1980, J INFECTION, V2, P23, DOI 10.1016/S0163-4453(80)91727-2; STOLL BJ, 1980, J PEDIATR-US, V96, P447; WILLIS DM, 1977, PEDIATRICS, V60, P535; YU VYH, 1984, ARCH DIS CHILD, V59, P430, DOI 10.1136/adc.59.5.430; 1983, BRIT MED J, V287, P824	31	1053	1093	3	61	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	DEC 22	1990	336	8730					1519	1523		10.1016/0140-6736(90)93304-8	http://dx.doi.org/10.1016/0140-6736(90)93304-8			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP037	1979363				2022-12-28	WOS:A1990EP03700001
J	REGAN, L; OWEN, EJ; JACOBS, HS				REGAN, L; OWEN, EJ; JACOBS, HS			HYPERSECRETION OF LUTEINIZING-HORMONE, INFERTILITY, AND MISCARRIAGE	LANCET			English	Article									ROSIE MATERN HOSP, DEPT OBSTET & GYNAECOL, CAMBRIDGE, ENGLAND; UNIV COLL & MIDDLESEX SCH MED, MIDDLESEX HOSP, COBBOLD LABS, LONDON W1, ENGLAND; ADDENBROOKES HOSP, DEPT OBSTET & GYNAECOL, CAMBRIDGE CB2 2QQ, ENGLAND	University of London; University College London; Addenbrooke's Hospital; University of Cambridge			Jacobs, Howard/A-9845-2009					ARMAR NA, 1990, FERTIL STERIL, V53, P45; Austin C.R., 1982, P46; BAKKER TG, REPRODUCTION MAMMA 1, P17; CONWAY GS, 1989, CLIN ENDOCRINOL, V30, P459, DOI 10.1111/j.1365-2265.1989.tb00446.x; EDEN JA, 1989, CLIN ENDOCRINOL, V30, P77, DOI 10.1111/j.1365-2265.1989.tb03729.x; EDEN JA, 1989, BRIT J OBSTET GYNAEC, V96, P809, DOI 10.1111/j.1471-0528.1989.tb03320.x; GUERREROV R, 1975, NEW ENGL J MED, V293, P573; HOMBURG R, 1990, HUM REPROD, V5, P32, DOI 10.1093/oxfordjournals.humrep.a137035; HOMBURG R, 1988, BRIT MED J, V297, P1024, DOI 10.1136/bmj.297.6655.1024; HOMBURG R, 1989, FERTIL STERIL, V51, P196; HOMBURG R, 1989, BRIT MED J, V298, P809, DOI 10.1136/bmj.298.6676.809; HOWLES CM, 1986, LANCET, V2, P521; HUNTER RHF, 1976, NATURE, V260, P156, DOI 10.1038/260156a0; JACOBS HS, 1990, CLIN ENDOCRINOLOGY M, V4, P195; POLSON DW, 1988, LANCET, V1, P870; PUNNONEN R, 1988, FERTIL STERIL, V49, P479; REGAN L, 1989, BRIT MED J, V299, P541, DOI 10.1136/bmj.299.6698.541; REIJNDERS FJL, 1988, BRIT J OBSTET GYNAEC, V95, P462, DOI 10.1111/j.1471-0528.1988.tb12797.x; SAGLE M, 1988, BMJ-BRIT MED J, V297, P1027, DOI 10.1136/bmj.297.6655.1027; SETH J, 1989, LANCET, V1, P671; SETH J, 1989, CLIN CHIM ACTA, V186, P67, DOI 10.1016/0009-8981(89)90205-2; SHEARMAN RP, 1963, BRIT MED J, P292; STANGER JD, 1985, BRIT J OBSTET GYNAEC, V92, P385, DOI 10.1111/j.1471-0528.1985.tb01113.x; THOMAS A, 1989, BRIT J OBSTET GYNAEC, V96, P1328, DOI 10.1111/j.1471-0528.1989.tb03232.x; Tsafriri A., 1988, P527; WALKER EM, 1988, BRIT J OBSTET GYNAEC, V95, P659, DOI 10.1111/j.1471-0528.1988.tb06526.x; WHITTAKER PG, 1989, BRIT J OBSTET GYNAEC, V96, P1207, DOI 10.1111/j.1471-0528.1989.tb03198.x; WILCOX AJ, 1988, NEW ENGL J MED, V319, P189, DOI 10.1056/NEJM198807283190401; 1977, ACTA OBSTEG GYNAECOL, V56, P247	29	370	383	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 10	1990	336	8724					1141	1144		10.1016/0140-6736(90)92765-A	http://dx.doi.org/10.1016/0140-6736(90)92765-A			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG701	1978024				2022-12-28	WOS:A1990EG70100001
J	SULLIVAN, SN				SULLIVAN, SN			HYPOTHESIS REVISITED - TOOTHPASTE AND THE CAUSE OF CROHNS-DISEASE	LANCET			English	Article											SULLIVAN, SN (corresponding author), VICTORIA HOSP,GASTROINTESTINAL UNIT,LONDON N6A 4G5,ONTARIO,CANADA.							BAXTER PM, 1980, BRIT DENT J, V148, P125, DOI 10.1038/sj.bdj.4804398; CALKINS BM, 1989, DIGEST DIS SCI, V34, P1841, DOI 10.1007/BF01536701; CHESS S, 1950, SURGERY, V27, P221; COFFEY RJ, 1938, MAYO CLIN P, V13, P541; KIRSNER JB, 1982, NEW ENGL J MED, V306, P837, DOI 10.1056/NEJM198204083061404; KIRSNER JB, 1988, J CLIN GASTROENTEROL, V10, P286, DOI 10.1097/00004836-198806000-00012; KORELITZ BI, 1982, AM J GASTROENTEROL, V77, P929; KOWITZ G, 1973, Journal of Oral Medicine, V28, P105; LASHNER BA, 1986, GASTROENTEROLOGY, V91, P1396, DOI 10.1016/0016-5085(86)90193-9; MAYBERRY JF, 1989, INT J COLORECTAL DIS, V4, P59, DOI 10.1007/BF01648555; MAYBERRY JF, 1984, GUT, V25, P886, DOI 10.1136/gut.25.8.886; MILLARD LG, 1973, BRIT MED J, V1, P676, DOI 10.1136/bmj.1.5854.676; MILLER WA, 1976, J PERIODONTOL, V47, P101, DOI 10.1902/jop.1976.47.2.101; PINCHBECK BR, 1988, J CLIN GASTROENTEROL, V10, P505, DOI 10.1097/00004836-198810000-00007; REICHERT FL, 1936, ANN SURG, V104, P606; REIMANN HA, 1964, JAMA-J AM MED ASSOC, V189, P195; REIMANN HA, 1966, AM J CARDIOL, V17, P269, DOI 10.1016/0002-9149(66)90362-6; ROTH MP, 1989, GASTROENTEROLOGY, V97, P900, DOI 10.1016/0016-5085(89)91495-9; VANDERWOERD LA, 1962, ACTA PHYSIOL PHARM N, V11, P133; 1982, ACCEPTED DENTAL THER, P369	20	42	43	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 3	1990	336	8723					1096	1097		10.1016/0140-6736(90)92572-Y	http://dx.doi.org/10.1016/0140-6736(90)92572-Y			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF992	1977982				2022-12-28	WOS:A1990EF99200006
J	CHANT, A				CHANT, A			TISSUE PRESSURE, POSTURE, AND VENOUS ULCERATION	LANCET			English	Editorial Material											CHANT, A (corresponding author), ROYAL S HANS HOSP,DEPT VASC SURG,GRAHAM RD,SOUTHAMPTON SO9 4PE,HANTS,ENGLAND.							Allen AJ, 1988, PHLEBOLOGY, V3, P163; BROWSE NL, 1982, LANCET, V2, P243; CHANT ADB, 1970, BMJ-BRIT MED J, V2, P235, DOI 10.1136/bmj.2.5703.235-c; CHANT ADB, 1972, BRIT J SURG, V59, P552, DOI 10.1002/bjs.1800590713; CHANT ADB, 1970, THESIS U LONDON; CHRISTENSON JT, 1986, SCAND J CLIN LAB INV, V46, P137, DOI 10.3109/00365518609083649; HARGENS AR, 1987, NATURE, V329, P59, DOI 10.1038/329059a0; HENDRIKSEN O, 1977, ACTA PHYSL SCAND S, V450, P7; HENDRIKSEN O, 1983, ACTA PHYSL SCAND, V118, P271; LANSMAN JB, 1987, NATURE, V325, P811, DOI 10.1038/325811a0; LEVICK JR, 1978, J PHYSIOL-LONDON, V274, P97, DOI 10.1113/jphysiol.1978.sp012136; MELLANDER S, 1964, ACTA PHYSIOL SCAND, V61, P34, DOI 10.1111/j.1748-1716.1964.tb02940.x; RAYMAN G, 1986, BRIT MED J, V292, P87, DOI 10.1136/bmj.292.6513.87; SCOTT HJ, 1989, PHLEBOLOGY, V4, P217; SKAGEN S, 1982, CLIN SCI, V62, P605; Wilson E., 1989, HLTH THENDS, V21, P97	16	20	20	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 27	1990	336	8722					1050	1051		10.1016/0140-6736(90)92503-A	http://dx.doi.org/10.1016/0140-6736(90)92503-A			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF076	1977031				2022-12-28	WOS:A1990EF07600016
J	GERACI, E				GERACI, E			ENROLLMENT IN TRIALS OF THROMBOLYSIS	LANCET			English	Letter											GERACI, E (corresponding author), V CEVELLO HOSP,DIV CARDIOL,I-90146 PALERMO,ITALY.							ARMSTRONG PW, 1989, J AM COLL CARDIOL, V13, P1469, DOI 10.1016/0735-1097(89)90334-3; GUERCI AD, 1987, NEW ENGL J MED, V317, P1613, DOI 10.1056/NEJM198712243172601; HINE LK, 1988, LANCET, V2, P1318; KENNEDY JW, 1988, CIRCULATION, V77, P345, DOI 10.1161/01.CIR.77.2.345; OROURKE M, 1988, CIRCULATION, V77, P1311, DOI 10.1161/01.CIR.77.6.1311; VANDEWERF F, 1988, BMJ-BRIT MED J, V297, P1374, DOI 10.1136/bmj.297.6660.1374; Wang-Gillam A., 2016, LANCET, V387, P545; WILCOX, 1990, LANCET, V335, P1175; 1988, LANCET, V1, P213; 1990, AM J CARDIOL, V65, P401	10	3	3	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 27	1990	336	8722					1069	1070		10.1016/0140-6736(90)92540-X	http://dx.doi.org/10.1016/0140-6736(90)92540-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF076	1977042				2022-12-28	WOS:A1990EF07600038
J	[Anonymous]				[Anonymous]			ALL ABOARD FOR OCTREOTIDE	LANCET			English	Editorial Material																		AARSEN RSR, 1987, ACTA ENDOCRINOL-COP, V116, P45; BAUER W, 1982, LIFE SCI, V31, P1133, DOI 10.1016/0024-3205(82)90087-X; BRAZEAU P, 1973, SCIENCE, V179, P77, DOI 10.1126/science.179.4068.77; CAMISA C, 1989, CLIN RES, V37, pA968; CELLO J P, 1990, Gastroenterology, V98, pA163; CHANSON P, 1989, LANCET, V1, P1263; CHRISTIANSEN J, 1989, GASTROENTEROLOGY, V97, P568, DOI 10.1016/0016-5085(89)90626-4; CREUTZFELDT W, 1987, AM J MED, V82, P49, DOI 10.1016/0002-9343(87)90426-8; EDWARDS CA, 1986, SCAND J GASTROENTERO, V21, P259, DOI 10.3109/00365528609087465; GESUNDHEIT N, 1989, ANN INTERN MED, V111, P827, DOI 10.7326/0003-4819-111-10-827; GORDEN P, 1989, ANN INTERN MED, V110, P33; HARRIS AG, 1990, NEW ANTIDIABETIC DRU, P279; HARRIS AG, 1988, SANDOSTATIN TREATMEN, P117; JAROS W, 1988, GASTROENTEROLOGY, V94, P189, DOI 10.1016/0016-5085(88)90629-4; KRAENZLIN ME, 1985, EXPERIENTIA, V41, P738, DOI 10.1007/BF02012573; KRENNING EP, 1989, LANCET, V1, P242; LAMBERTS SWJ, 1990, J CLIN ENDOCR METAB, V71, P566, DOI 10.1210/jcem-71-3-566; LAMBERTS SWJ, 1989, ACTA ENDOCRINOL-COP, V120, P760, DOI 10.1530/acta.0.1200760; LAMBERTS SWJ, 1990, CLIN ENDOCRINOL META, V4, P29; LIGHTMAN SL, 1986, SCAND J GASTROENTERO, V21, P84, DOI 10.3109/00365528609087435; MCKEE R, 1990, DIGESTION, V45, P60, DOI 10.1159/000200264; MORGAN JS, 1989, DIGEST DIS SCI, V34, pS40, DOI 10.1007/BF01536044; NUBIOLA P, 1989, ANN SURG, V210, P56, DOI 10.1097/00000658-198907000-00009; PENN RD, 1990, LANCET, V1, P738; PRINZ RA, 1988, AM J SURG, V155, P36, DOI 10.1016/S0002-9610(88)80255-1; REICHLIN S, 1983, NEW ENGL J MED, V309, P1495, DOI 10.1056/NEJM198312153092406; REICHLIN S, 1983, NEW ENGL J MED, V309, P1556, DOI 10.1056/NEJM198312223092506; RITTS RE, 1989, P AM ASS CANCER RES, V30; SERRI O, 1990, Diabetologia, V33, pA76; VINIK AI, 1986, AM J MED, V81, P23, DOI 10.1016/0002-9343(86)90582-6; WARNET A, 1989, J NEUROSURG, V71, P687, DOI 10.3171/jns.1989.71.5.0687; WILLIAMS G, 1987, BMJ-BRIT MED J, V295, P247, DOI 10.1136/bmj.295.6592.247; WILLIAMS ST, 1989, AM J SURG, V157, P459, DOI 10.1016/0002-9610(89)90634-X	33	0	0	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 13	1990	336	8720					909	911						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EC456	1976932				2022-12-28	WOS:A1990EC45600006
J	TEWARI, A; BUHLES, WC; STARNES, HF				TEWARI, A; BUHLES, WC; STARNES, HF			PRELIMINARY-REPORT - EFFECTS OF INTERLEUKIN-1 ON PLATELET COUNTS	LANCET			English	Article									STANFORD UNIV,MED CTR,DEPT SURG,SURG METAB LAB,ROOM S-067,STANFORD,CA 94305; SYNTEX INC,PALO ALTO,CA 94304	Stanford University; Syntex Corporation					NATIONAL CANCER INSTITUTE [R29CA047963] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000070] Funding Source: NIH RePORTER; NCI NIH HHS [CA-47963] Funding Source: Medline; NCRR NIH HHS [RR00070] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ANTMAN KS, 1988, NEW ENGL J MED, V319, P593, DOI 10.1056/NEJM198809083191001; BAGBY GC, 1986, J CLIN INVEST, V78, P1316, DOI 10.1172/JCI112717; BENJAMIN WR, 1989, J IMMUNOL, V142, P792; BRANDT SJ, 1988, NEW ENGL J MED, V318, P869, DOI 10.1056/NEJM198804073181401; BULL BS, 1965, AM J CLIN PATHOL, V44, P678; CHAPMAN PB, 1987, J CLIN ONCOL, V5, P1942, DOI 10.1200/JCO.1987.5.12.1942; FIBBE WE, 1988, BLOOD, V72, P860; FIBBE WE, 1988, BLOOD, V71, P430; FIBBE WE, 1986, BLOOD, V68, P1316; GASER A, 1989, BLOOD S, V74, P50; HERRMANN F, 1988, J CLIN INVEST, V81, P1415, DOI 10.1172/JCI113471; HERRMANN F, 1989, J CLIN ONCOL, V7, P159, DOI 10.1200/JCO.1989.7.2.159; HILL RJ, 1990, J CLIN INVEST, V85, P1242, DOI 10.1172/JCI114559; ISHIBASHI T, 1989, BLOOD, V74, P1241; JAKUBOWSKI AA, 1989, NEW ENGL J MED, V320, P38, DOI 10.1056/NEJM198901053200107; JOHNSON CS, 1989, BLOOD, V73, P678; KRONHEIM SR, 1985, J EXP MED, V161, P490, DOI 10.1084/jem.161.3.490; LINDEMANN A, 1989, BLOOD, V74, P2644; MARCH CJ, 1985, NATURE, V315, P641, DOI 10.1038/315641a0; SCHAAFSMA MR, 1989, BLOOD, V74, P2619; SHRESTHA K, 1985, CELL IMMUNOL, V90, P24, DOI 10.1016/0008-8749(85)90165-0; TAYLOR KM, 1989, J CLIN ONCOL, V7, P1791, DOI 10.1200/JCO.1989.7.12.1791; VADHANRAJ S, 1988, BLOOD, V72, P134; WARREN MK, 1989, EXP HEMATOL, V17, P1095; WILLIAMS DE, 1989, J IMMUNOL, V142, P4361; ZHOU YQ, 1988, BLOOD, V72, P1870	26	160	164	0	10	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	SEP 22	1990	336	8717					712	714		10.1016/0140-6736(90)92206-W	http://dx.doi.org/10.1016/0140-6736(90)92206-W			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DZ624	1975894				2022-12-28	WOS:A1990DZ62400005
J	BROSIUS, J				BROSIUS, J			RETROPOSONS - SEEDS OF EVOLUTION	SCIENCE			English	Editorial Material							GENES; DNA				BROSIUS, J (corresponding author), CUNY MT SINAI SCH MED,FISHBERG RES CTR NEUROBIOL,NEW YORK,NY 10029, USA.		Brosius, Jürgen/F-5029-2016	Brosius, Jürgen/0000-0003-1650-2059				ASHWORTH A, 1990, EMBO J, V9, P1529, DOI 10.1002/j.1460-2075.1990.tb08271.x; BOER PH, 1987, MOL CELL BIOL, V7, P3107, DOI 10.1128/MCB.7.9.3107; DAHL HHM, 1990, GENOMICS, V8, P225, DOI 10.1016/0888-7543(90)90275-Y; Deininger PL, 1989, MOBILE DNA, P619; DOOLITTLE WF, 1980, NATURE, V284, P601, DOI 10.1038/284601a0; FINK GR, 1988, CELL, V49, P5; FOUREL G, 1990, NATURE, V347, P294, DOI 10.1038/347294a0; GOULD SJ, 1982, PALEOBIOLOGY, V8, P4, DOI 10.1017/S0094837300004310; MARTIGNETTI JA, UNPUB; MCCARREY JR, 1987, NATURE, V326, P501, DOI 10.1038/326501a0; NELSON DL, 1989, P NATL ACAD SCI USA, V86, P6686, DOI 10.1073/pnas.86.17.6686; Ohno S., 1970, EVOLUTION GENE DUPLI; ORGEL LE, 1980, NATURE, V284, P604, DOI 10.1038/284604a0; REYNAUD CA, 1987, CELL, V48, P379, DOI 10.1016/0092-8674(87)90189-9; ROGERS JH, 1985, INT REV CYTOL, V93, P187, DOI 10.1016/S0074-7696(08)61375-3; ROTH CW, 1986, EMBO J, V5, P1065, DOI 10.1002/j.1460-2075.1986.tb04323.x; SAMUELSON LC, 1990, MOL CELL BIOL, V10, P2513, DOI 10.1128/MCB.10.6.2513; TEMIN HM, 1989, NATURE, V339, P254, DOI 10.1038/339254a0; WATSON JB, 1987, MOL CELL BIOL, V7, P3324, DOI 10.1128/MCB.7.9.3324; WEINER AM, 1986, ANNU REV BIOCHEM, V55, P631, DOI 10.1146/annurev.bi.55.070186.003215	20	287	296	2	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	FEB 15	1991	251	4995					753	753		10.1126/science.1990437	http://dx.doi.org/10.1126/science.1990437			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX575	1990437				2022-12-28	WOS:A1991EX57500033
J	LALONDE, RG; DESCHENES, JG; SEAMONE, C				LALONDE, RG; DESCHENES, JG; SEAMONE, C			ZIDOVUDINE-INDUCED MACULAR EDEMA	ANNALS OF INTERNAL MEDICINE			English	Note									MCGILL UNIV, MONTREAL H3A 2T5, QUEBEC, CANADA	McGill University	LALONDE, RG (corresponding author), ROYAL VICTORIA HOSP, INFECT DIS CLIN, 687 PINE AVE, MONTREAL H3A 1A1, QUEBEC, CANADA.							FISCHL MA, 1989, AIDS, V3, pS137, DOI 10.1097/00002030-198901001-00021; FISCHL MA, 1987, NEW ENGL J MED, V317, P185, DOI 10.1056/NEJM198707233170401; HOLLAND GN, 1988, AIDS NERVOUS SYSTEM, P103; POMERANTZ RJ, 1987, NEW ENGL J MED, V317, P1643, DOI 10.1056/NEJM198712243172607; VOLBERDING PA, 1990, NEW ENGL J MED, V322, P941, DOI 10.1056/NEJM199004053221401	5	18	19	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 15	1991	114	4					297	298		10.7326/0003-4819-114-4-297	http://dx.doi.org/10.7326/0003-4819-114-4-297			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EX521	1987876				2022-12-28	WOS:A1991EX52100008
J	BRENNAN, TA; LEAPE, LL; LAIRD, NM; HEBERT, L; LOCALIO, AR; LAWTHERS, AG; NEWHOUSE, JP; WEILER, PC; HIATT, HH				BRENNAN, TA; LEAPE, LL; LAIRD, NM; HEBERT, L; LOCALIO, AR; LAWTHERS, AG; NEWHOUSE, JP; WEILER, PC; HIATT, HH			INCIDENCE OF ADVERSE EVENTS AND NEGLIGENCE IN HOSPITALIZED-PATIENTS - RESULTS OF THE HARVARD MEDICAL-PRACTICE STUDY-I	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MALPRACTICE	Background. As part of an interdisciplinary study of medical injury and malpractice litigation, we estimated the incidence of adverse events, defined as injuries caused by medical management, and of the subgroup of such injuries that resulted from negligent or substandard care. Methods. We reviewed 30, 121 randomly selected records from 51 randomly selected acute care, nonpsychiatric hospitals in New York State in 1984. We then developed population estimates of injuries and computed rates according to the age and sex of the patients as well as the specialties of the physicians. Results. Adverse events occurred in 3.7 percent of the hospitalizations (95 percent confidence interval, 3.2 to 4.2), and 27.6 percent of the adverse events were due to negligence (95 percent confidence interval, 22.5 to 32.6). Although 70.5 percent of the adverse events gave rise to disability lasting less than six months, 2.6 percent caused permanently disabling injuries and 13.6 percent led to death. The percentage of adverse events attributable to negligence increased in the categories of more severe injuries (Wald test chi-2 = 21.04, P < 0.0001). Using weighted totals, we estimated that among the 2,671,863 patients discharged from New York hospitals in 1984 there were 98,609 adverse events and 27,179 adverse events involving negligence. Rates of adverse events rose with age (P < 0.0001). The percentage of adverse events due to negligence was markedly higher among the elderly (P < 0.01). There were significant differences in rates of adverse events among categories of clinical specialties (P < 0.0001), but no differences in the percentage due to negligence. Conclusions. There is a substantial amount of injury to patients from medical management, and many injuries are the result of substandard care.	HARVARD UNIV,SCH PUBL HLTH,DEPT HLTH POLICY & MANAGEMENT,BOSTON,MA 02115; HARVARD UNIV,SCH PUBL HLTH,DEPT BIOSTAT,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT HLTH CARE POLICY,BOSTON,MA 02115; HARVARD UNIV,JOHN F KENNEDY SCH GOVT,CAMBRIDGE,MA 02138; HARVARD UNIV,SCH LAW,CAMBRIDGE,MA 02138	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Harvard University	BRENNAN, TA (corresponding author), BRIGHAM & WOMENS HOSP,DIV GEN MED,75 FRANCIS ST,BOSTON,MA 02115, USA.		Newhouse, Joseph/AGJ-5632-2022					BRENNAN TA, 1990, ANN INTERN MED, V112, P221, DOI 10.7326/0003-4819-112-3-221; BRENNAN TA, 1989, MED CARE, V27, P1148, DOI 10.1097/00005650-198912000-00006; BRENNAN TA, IN PRESS JUST DOCTOR; COUCH NP, 1981, NEW ENGL J MED, V304, P634, DOI 10.1056/NEJM198103123041103; HIATT HH, 1989, NEW ENGL J MED, V321, P480, DOI 10.1056/NEJM198908173210725; NADER R, 1987, GONZAGA LAW REV, V22, P15; PEAR T, 1990, NY TIMES        0923, P1; PRIEST, 1987, VAL UL REV, V22, P1; ROBINSON GO, 1986, LAW CONTEMP PROBL, V49, P5, DOI 10.2307/1191413; SHAH BV, 1981, SESUDAAN STANDARD ER; SIEGEL DR, 1986, NEW YORK STATE J MED, V86, P377; STEEL K, 1981, NEW ENGL J MED, V304, P638, DOI 10.1056/NEJM198103123041104; 1986, GAO HRD86112 GEN ACC; 1985, STATEWIDE PLANNING R; 1987, DHHS19041270133 DEP; 1977, REPORT MED INSURANCE; 1986, GAO HRD8755 GEN ACC; 1987, PRELIMINARY FACT FIN; 1986, GAO HRD8721 GEN ACC; 1990, PATIENTS DOCTORS LAW	20	2979	3075	1	68	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 7	1991	324	6					370	376		10.1056/NEJM199102073240604	http://dx.doi.org/10.1056/NEJM199102073240604			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EW296	1987460				2022-12-28	WOS:A1991EW29600004
J	JOHNSON, ID				JOHNSON, ID			REPORTS TO THE NATIONAL-PRACTITIONER-DATA-BANK	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material											JOHNSON, ID (corresponding author), AMER MED ASSOC,CHICAGO,IL 60610, USA.							1990, GUIDEBOOK REFERENCE; 1989, FED REGISTER, V54, P42731; 1989, FED REGISTER, V54, P42725; 1989, FED REGISTER, V54, P42734; 1989, FED REGISTER, V54, P42732; 1990, FED REGISTER, V55, P31239	6	13	13	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 16	1991	265	3					407	&		10.1001/jama.265.3.407	http://dx.doi.org/10.1001/jama.265.3.407			0	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ER256	1984543				2022-12-28	WOS:A1991ER25600037
J	RICHET, HM; CRAVEN, PC; BROWN, JM; LASKER, BA; COX, CD; MCNEIL, MM; TICE, AD; JARVIS, WR; TABLAN, OC				RICHET, HM; CRAVEN, PC; BROWN, JM; LASKER, BA; COX, CD; MCNEIL, MM; TICE, AD; JARVIS, WR; TABLAN, OC			A CLUSTER OF RHODOCOCCUS (GORDONA) BRONCHIALIS-STERNAL WOUND INFECTIONS AFTER CORONARY-ARTERY BYPASS-SURGERY	NEW ENGLAND JOURNAL OF MEDICINE			English	Note							CORYNEBACTERIUM EQUI; IDENTIFICATION; ENDOPHTHALMITIS; AURANTIACUS; GENUS; AIDS		CTR DIS CONTROL,CTR INFECT DIS,DIV MYCOT DIS,ATLANTA,GA 30333; INFECT LTD,TACOMA,WA	Centers for Disease Control & Prevention - USA	RICHET, HM (corresponding author), CTR DIS CONTROL,CTR INFECT DIS,HOSP INFECT PROGRAM,MAILSTOP C10,ATLANTA,GA 30333, USA.			McNeil, Michael/0000-0003-0713-8312				BARTON MD, 1984, VET MICROBIOL, V9, P65, DOI 10.1016/0378-1135(84)90079-8; BERD D, 1973, APPL MICROBIOL, V25, P665, DOI 10.1128/AEM.25.4.665-681.1973; BROUGHTON RA, 1981, J CLIN MICROBIOL, V13, P209, DOI 10.1128/JCM.13.1.209-213.1981; BUTLER WR, 1988, J CLIN MICROBIOL, V26, P50, DOI 10.1128/JCM.26.1.50-53.1988; CARRIGAN MJ, 1988, AUST VET J, V65, P331, DOI 10.1111/j.1751-0813.1988.tb14522.x; DEBEY MC, 1987, VET MICROBIOL, V14, P251, DOI 10.1016/0378-1135(87)90112-X; EBERSOLE LL, 1988, J CLIN MICROBIOL, V26, P1221, DOI 10.1128/JCM.26.6.1221-1222.1988; ELLISPEGLER RB, 1983, J INFECTION, V6, P39, DOI 10.1016/S0163-4453(83)95531-7; FIERER J, 1987, J CLIN PATHOL, V40, P556, DOI 10.1136/jcp.40.5.556; Goodfellow M, 1989, BERGEYS MANUAL SYSTE, V4, P2362; HILLIDGE CJ, 1987, VET MICROBIOL, V14, P337, DOI 10.1016/0378-1135(87)90121-0; HILLMAN D, 1989, ARCH OPHTHALMOL-CHIC, V107, P20, DOI 10.1001/archopht.1989.01070010022012; ISHHOROWICZ D, 1981, NUCLEIC ACIDS RES, V9, P2989, DOI 10.1093/nar/9.13.2989; KASWECK KL, 1981, ACTINOMYCETES, V16, P57; LEBAR WD, 1986, J INFECT DIS, V154, P919, DOI 10.1093/infdis/154.5.919; MACGREGOR JH, 1986, RADIOLOGY, V160, P83, DOI 10.1148/radiology.160.1.3715049; MANIATIS T, 1982, MOL CLONING LABORATO, P368; MARA DD, 1981, APPL ENVIRON MICROB, V42, P1037, DOI 10.1128/AEM.42.6.1037-1042.1981; MARTENS JG, 1988, AM J VET RES, V49, P295; MCNEIL MM, 1990, REV INFECT DIS, V12, P778; MISHRA SK, 1980, J CLIN MICROBIOL, V11, P728, DOI 10.1128/JCM.11.6.728-736.1980; MULLER F, 1988, J CLIN MICROBIOL, V26, P618; MUTIMER MD, 1982, AUST VET J, V58, P67, DOI 10.1111/j.1751-0813.1982.tb02691.x; NOVAK RM, 1988, INFECTION, V16, P186, DOI 10.1007/BF01644100; PRINZ G, 1985, J CLIN MICROBIOL, V22, P472, DOI 10.1128/JCM.22.3.472-474.1985; RIGGSBY WS, 1982, MOL CELL BIOL, V2, P853, DOI 10.1128/MCB.2.7.853; SANE DC, 1986, NEW ENGL J MED, V314, P56; SEVERO LC, 1987, MYCOPATHOLOGIA, V98, P129, DOI 10.1007/BF00437647; STULL TL, 1988, J INFECT DIS, V157, P280, DOI 10.1093/infdis/157.2.280; TSUKAMUR.M, 1971, J GEN MICROBIOL, V68, P15, DOI 10.1099/00221287-68-1-15; TSUKAMURA M, 1988, J CLIN MICROBIOL, V26, P155, DOI 10.1128/JCM.26.1.155-157.1988; TSUKAMURA M, 1988, J CLIN MICROBIOL, V26, P201, DOI 10.1128/JCM.26.2.201-205.1988; WEINGARTEN JS, 1988, CHEST, V94, P156; 1988, M7T2 NAT COMM CLIN L	34	76	76	0	2	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 10	1991	324	2					104	109		10.1056/NEJM199101103240206	http://dx.doi.org/10.1056/NEJM199101103240206			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EQ977	1984175	Bronze			2022-12-28	WOS:A1991EQ97700006
J	YAMASHIRO, S; YAMAKITA, Y; HOSOYA, H; MATSUMURA, F				YAMASHIRO, S; YAMAKITA, Y; HOSOYA, H; MATSUMURA, F			PHOSPHORYLATION OF NONMUSCLE CALDESMON BY P34CDC2 KINASE DURING MITOSIS	NATURE			English	Article							MATURATION-PROMOTING FACTOR; CONTROL GENE CDC2+; CELL-CYCLE; SMOOTH-MUSCLE; PROTEIN-KINASE; M-PHASE; ACTIVATION; COMPONENT; REGULATOR; HOMOLOGS	One of the profound changes in cellular morphology which occurs during mitosis is a massive alteration in the organization of the microfilament cytoskeleton 1,2. This change, together with other mitotic events including nuclear membrane breakdown, chromosome condensation and formation of mitotic spindles, is induced by a molecular complex called maturation promoting factor 3-5. This consists of at least two subunits, a polypeptide for relative molecular mass 45,000-62,000 (M(r) 45-62K) known as cyclin, and a 34K catalytic subunit which as series/threonine kinase activity and is known as cdc2 kinase 6-9. Non-muscle caldesmon, an 83K actin- and calmodulin-binding protein, is dissociated from microfilaments during mitosis, apparently as a consequence of mitosis-specific phosphorylation 10. We now report that cdc2 kinase phosphorylates caldesmon in vitro principally at the same sites as those phosphorylated in vivo during mitosis, and that phosphorylation reduces the binding affinity of caldesmon for both actin and calmodulin. Because caldesmon inhibits actomyosin ATPase, our results suggest that cdc2 kinase directly causes microfilament reorganization during mitosis.	TOKYO METROPOLITAN INST MED SCI,TOKYO 113,JAPAN	Tokyo Metropolitan Institute of Medical Science	YAMASHIRO, S (corresponding author), RUTGERS STATE UNIV,DEPT MOLEC BIOL & BIOCHEM,NELSON HALL,BUSCH CAMPUS,PISCATAWAY,NJ 08855, USA.		Yamakita, Yoshihiko/A-3003-2016	Yamashiro, Shigeko/0000-0001-7207-9406; Matsumura, Fumio/0000-0002-8204-153X				ARION D, 1988, CELL, V55, P371, DOI 10.1016/0092-8674(88)90060-8; BRETSCHER A, 1986, NATURE, V321, P726, DOI 10.1038/321726b0; BRYAN J, 1989, J BIOL CHEM, V264, P13873; DRAETTA G, 1987, CELL, V50, P319, DOI 10.1016/0092-8674(87)90227-3; DRAETTA G, 1988, CELL, V54, P17, DOI 10.1016/0092-8674(88)90175-4; DUNPHY WG, 1988, CELL, V54, P423, DOI 10.1016/0092-8674(88)90205-X; ELDER JH, 1977, J BIOL CHEM, V252, P6510; GAUTIER J, 1988, CELL, V54, P433, DOI 10.1016/0092-8674(88)90206-1; Hunt T, 1989, CURR OPIN CELL BIOL, V1, P268, DOI 10.1016/0955-0674(89)90099-9; HUNTER T, 1980, P NATL ACAD SCI-BIOL, V77, P1311, DOI 10.1073/pnas.77.3.1311; KAWAMOTO S, 1987, J BIOL CHEM, V262, P7282; LABBE JC, 1988, NATURE, V335, P251, DOI 10.1038/335251a0; LOHKA MJ, 1989, J CELL SCI, V92, P131; LOHKA MJ, 1988, P NATL ACAD SCI USA, V85, P3009, DOI 10.1073/pnas.85.9.3009; MORENO S, 1990, CELL, V61, P549, DOI 10.1016/0092-8674(90)90463-O; NORBURY CJ, 1989, BIOCHIM BIOPHYS ACTA, V989, P85, DOI 10.1016/0304-419X(89)90036-X; RISEMAN VM, 1989, J BIOL CHEM, V264, P2869; SANGER JW, 1976, CELL MOTILITY, P1295; SCHROEDER TE, 1976, CELL MOTILITY, P265; YAMASHIRO S, 1990, NATURE, V344, P675, DOI 10.1038/344675a0	20	166	169	0	3	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JAN 10	1991	349	6305					169	172		10.1038/349169a0	http://dx.doi.org/10.1038/349169a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER418	1986309				2022-12-28	WOS:A1991ER41800063
J	RAUB, W				RAUB, W			TAMOXIFEN AND CHEMOTHERAPY MORE EFFECTIVE THAN TAMOXIFEN ALONE IN TREATING BREAST-CANCER	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material											RAUB, W (corresponding author), NIH, BLDG 31, ROOM 2B23, BETHESDA, MD 20892 USA.							1990, J CLIN ONCOL, V8, P1005	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	1991	265	1					19	19						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP555	1984118				2022-12-28	WOS:A1991EP55500007
J	BRAHAMS, D				BRAHAMS, D			DUTY OF CARE TO UNBORN CHILD	LANCET			English	Editorial Material																			0	2	2	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	DEC 22	1990	336	8730					1572	1572		10.1016/0140-6736(90)93335-M	http://dx.doi.org/10.1016/0140-6736(90)93335-M			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP037	1979383				2022-12-28	WOS:A1990EP03700021
J	TROTTER, WR				TROTTER, WR			IS BRACKEN A HEALTH-HAZARD	LANCET			English	Article							SHIKIMIC ACID; CARCINOGENICITY											COOKMOZAFFARI P, 1990, LANCET, V335, P736, DOI 10.1016/0140-6736(90)90858-3; Evans I A, 1987, Rev Environ Health, V7, P161; EVANS IA, 1990, LANCET, V335, P231, DOI 10.1016/0140-6736(90)90329-4; EVANS IA, 1965, NATURE, V208, P913, DOI 10.1038/208913a0; EVANS IA, 1974, NATURE, V250, P348, DOI 10.1038/250348a0; EVANS IA, 1984, ACS MONOGR SER, V182, P1171; GALPIN OP, 1990, BRIT J CANCER, V61, P737, DOI 10.1038/bjc.1990.165; Hirayama T., 1979, NUTR CANCER, V1, P67; HIRONO I, 1977, TOXICOL LETT, V1, P9; HIRONO I, 1984, JPN J CANCER RES, V75, P833; Hudson P. J., 1986, Bracken. Ecology, land use and control technology., P161; MUHLEMANN MF, 1987, LANCET, V1, P260, DOI 10.1016/S0140-6736(87)90074-2; SMITH BL, 1990, AUSTR I AGR SCI OCCA, V40, P227; TAYLOR JA, 1989, U COLLEGE WALES PUBL, V44; VILLALOBOSSALAZ.J, 1989, U COLLEGES WALES PUB, V40, P40; VILLALOBOSSALAZ.J, 1990, AUSTR I AGR SCI OCCA, V40, P247; WILLIAMS D, 1986, BRIT MED J, V292, P156; WILSON ML, 1986, J ECON ENTOMOL, V79, P693, DOI 10.1093/jee/79.3.693; 1990, BRACKEN PROBLEMS CON; 1989, LANCET, V1, P198	20	9	10	0	3	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	DEC 22	1990	336	8730					1563	1565		10.1016/0140-6736(90)93325-J	http://dx.doi.org/10.1016/0140-6736(90)93325-J			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP037	1979379				2022-12-28	WOS:A1990EP03700017
J	MARSDEN, PD				MARSDEN, PD			LETTER FROM BRASILIA - YELLOW-FEVER	BRITISH MEDICAL JOURNAL			English	Editorial Material											MARSDEN, PD (corresponding author), UNIV BRASILIA,CP 153127,BR-70010 BRASILIA,DF,BRAZIL.							PORTERFIELD J, 1989, BR MED J, V299	1	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	DEC 15	1990	301	6765					1382	1383		10.1136/bmj.301.6765.1382	http://dx.doi.org/10.1136/bmj.301.6765.1382			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EN919	1980221	Bronze, Green Published			2022-12-28	WOS:A1990EN91900030
J	POWLES, R; SMITH, C; MILAN, S; TRELEAVEN, J; MILLAR, J; MCELWAIN, T; GORDONSMITH, E; MILLIKEN, S; TILEY, C				POWLES, R; SMITH, C; MILAN, S; TRELEAVEN, J; MILLAR, J; MCELWAIN, T; GORDONSMITH, E; MILLIKEN, S; TILEY, C			HUMAN RECOMBINANT GM-CSF IN ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR LEUKEMIA - DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL	LANCET			English	Article									ROYAL MARSDEN HOSP,DEPT MED,SUTTON SM2 5PT,SURREY,ENGLAND; ROYAL MARSDEN HOSP,DEPT COMP,SUTTON SM2 5PT,SURREY,ENGLAND; INST CANC RES,SUTTON SM2 5PX,SURREY,ENGLAND; ST GEORGE HOSP,SCH MED,LONDON,ENGLAND	Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; St Georges University London	POWLES, R (corresponding author), ROYAL MARSDEN HOSP,LEUKAEMIA UNIT,DOWNS RD,SUTTON SM2 5PT,SURREY,ENGLAND.			Tiley, Campbell/0000-0002-4314-0877				ANTMAN KS, 1988, NEW ENGL J MED, V319, P593, DOI 10.1056/NEJM198809083191001; BRANDT SJ, 1988, NEW ENGL J MED, V318, P869, DOI 10.1056/NEJM198804073181401; BRONCHUD MH, 1987, BRIT J CANCER, V56, P809, DOI 10.1038/bjc.1987.295; BROWN Z, 1987, TRANSPLANT P, V19, P1178; CLUTTERBUCK R, 1989, BONE MARROW TRANSPL, V4, P40; GABRILOVE JL, 1988, J CLIN INVEST, V82, P1454, DOI 10.1172/JCI113751; GANSER A, 1989, BLOOD, V73, P31; GELLER RB, 1989, BLOOD, V73, P2209; GLUCKSBERG H, 1974, TRANSPLANTATION, V18, P295, DOI 10.1097/00007890-197410000-00001; HELENGLASS G, 1988, BONE MARROW TRANSPL, V3, P21; HELENGLASS G, 1988, J CELL BIOL S12C, V117, P89; KAPLAN EL, 1987, J AM STAT ASSOC, V54, P457; METCALF D, 1989, TRANSPLANT P, V21, P2932; MORSTYN G, 1988, LANCET, V1, P667, DOI 10.1016/S0140-6736(88)91475-4; PETERS WP, 1989, SEMIN HEMATOL, V26, P18; PETO R, 1977, BRIT J CANCER, V35, P1, DOI 10.1038/bjc.1977.1; POLLARD CM, 1986, LANCET, V2, P1404; THOMAS ED, 1975, NEW ENGL J MED, V292, P832, DOI 10.1056/NEJM197504172921605; THOMAS ED, 1975, NEW ENGL J MED, V292, P895, DOI 10.1056/NEJM197504242921706; THOMPSON JA, 1989, J CLIN ONCOL, V7, P629, DOI 10.1200/JCO.1989.7.5.629; VADHANRAJ S, 1988, BLOOD, V72, P134; VADHANRAJ S, 1987, NEW ENGL J MED, V317, P1545, DOI 10.1056/NEJM198712173172501	22	134	134	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	DEC 8	1990	336	8728					1417	1420		10.1016/0140-6736(90)93111-2	http://dx.doi.org/10.1016/0140-6736(90)93111-2			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL851	1978880				2022-12-28	WOS:A1990EL85100013
J	RES, PCM; TELGT, D; VANLAAR, JM; POOL, MO; BREEDVELD, FC; DEVRIES, RRP				RES, PCM; TELGT, D; VANLAAR, JM; POOL, MO; BREEDVELD, FC; DEVRIES, RRP			HIGH ANTIGEN REACTIVITY IN MONONUCLEAR-CELLS FROM SITES OF CHRONIC INFLAMMATION	LANCET			English	Article									STATE UNIV LEIDEN HOSP, DEPT RHEUMATOL, 2333 AA LEIDEN, NETHERLANDS; FREE UNIV AMSTERDAM HOSP, DEPT INTERNAL MED, AMSTERDAM, NETHERLANDS	Leiden University; Leiden University Medical Center (LUMC); Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	RES, PCM (corresponding author), UNIV HOSP LEIDEN, DEPT IMMUNOHAEMATOL & BLOOD BANK, BLDG 1 E3-Q, POSTBUS 9600, 2300 RC LEIDEN, NETHERLANDS.							DAUPHINEE MJ, 1989, J AUTOIMMUN, V2, P813, DOI 10.1016/0896-8411(89)90007-3; GASTON JSH, 1989, J IMMUNOL, V143, P2494; HARDING B, 1986, CLIN EXP IMMUNOL, V63, P594; HOLOSHITZ J, 1983, SCIENCE, V219, P56, DOI 10.1126/science.6336851; HOLOSHITZ J, 1986, LANCET, V2, P305; KLUINNELEMANS HC, 1984, J RHEUMATOL, V11, P272; KOSTER FT, 1971, J EXP MED, V133, P400, DOI 10.1084/jem.133.2.400; KOSTER FT, 1971, J EXP MED, V133, P864, DOI 10.1084/jem.133.4.864; LIFE PF, 1990, CLIN EXP IMMUNOL, V79, P189; PITZALIS C, 1988, EUR J IMMUNOL, V18, P1397, DOI 10.1002/eji.1830180915; RES PCM, 1988, LANCET, V2, P478, DOI 10.1016/S0140-6736(88)90123-7; ROSENSTREICH DL, 1971, J EXP MED, V134, P1170, DOI 10.1084/jem.134.5.1170; SANDERS ME, 1988, IMMUNOL TODAY, V9, P195, DOI 10.1016/0167-5699(88)91212-1; THOLE JER, 1987, INFECT IMMUN, V55, P1466, DOI 10.1128/IAI.55.6.1466-1475.1987; VANDEPUTTE LBA, 1976, ANN RHEUM DIS, V35, P451, DOI 10.1136/ard.35.5.451; VANEDEN W, 1985, P NATL ACAD SCI USA, V82, P5117; VANEDEN W, 1988, NATURE, V331, P171, DOI 10.1038/331171a0; WAALEN K, 1987, CLIN EXP IMMUNOL, V70, P1; WERNET D, 1975, J EXP MED, V141, P573, DOI 10.1084/jem.141.3.573	19	55	55	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 8	1990	336	8728					1406	1408		10.1016/0140-6736(90)93104-W	http://dx.doi.org/10.1016/0140-6736(90)93104-W			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL851	1978874				2022-12-28	WOS:A1990EL85100007
J	HAYASHI, S; SCOTT, MP				HAYASHI, S; SCOTT, MP			WHAT DETERMINES THE SPECIFICITY OF ACTION OF DROSOPHILA HOMEODOMAIN PROTEINS	CELL			English	Review									STANFORD UNIV,MED CTR,SCH MED,DEPT DEV BIOL,STANFORD,CA 94305	Stanford University	HAYASHI, S (corresponding author), NATL INST GENET,MISHIMA,SHIZUOKA 411,JAPAN.		Hayashi, Shigeo/J-9628-2019; Hayashi, Shigeo/N-5128-2015	Hayashi, Shigeo/0000-0001-7785-1290; Hayashi, Shigeo/0000-0001-7785-1290				AFFOLTER M, 1990, P NATL ACAD SCI USA, V87, P4093, DOI 10.1073/pnas.87.11.4093; AGGARWAL AK, 1988, SCIENCE, V242, P899, DOI 10.1126/science.3187531; AKAM M, 1989, CELL, V57, P347, DOI 10.1016/0092-8674(89)90909-4; ALTSCHMIED L, 1988, EMBO J, V7, P4011, DOI 10.1002/j.1460-2075.1988.tb03290.x; BEACHY PA, 1988, CELL, V55, P1069, DOI 10.1016/0092-8674(88)90251-6; BIENZ M, 1988, NATURE, V333, P576, DOI 10.1038/333576a0; BIGGIN MD, 1989, CELL, V58, P433, DOI 10.1016/0092-8674(89)90424-8; BILLETER M, 1990, J MOL BIOL, V214, P183, DOI 10.1016/0022-2836(90)90155-F; CARROLL SB, 1986, CELL, V47, P113, DOI 10.1016/0092-8674(86)90372-7; CASANOVA J, 1988, EMBO J, V7, P1097, DOI 10.1002/j.1460-2075.1988.tb02918.x; CHADWICK R, 1990, DEV BIOL, V141, P130, DOI 10.1016/0012-1606(90)90108-U; DEAROLF CR, 1989, NATURE, V341, P340, DOI 10.1038/341340a0; DESPLAN C, 1988, CELL, V54, P1081, DOI 10.1016/0092-8674(88)90123-7; DESPLAN C, 1985, NATURE, V318, P630, DOI 10.1038/318630a0; DRIEVER W, 1989, NATURE, V340, P363, DOI 10.1038/340363a0; DRIEVER W, 1989, NATURE, V342, P149, DOI 10.1038/342149a0; DRIEVER W, 1988, CELL, V54, P83, DOI 10.1016/0092-8674(88)90182-1; DRIEVER W, 1989, NATURE, V337, P138, DOI 10.1038/337138a0; DRIEVER W, 1988, CELL, V54, P95, DOI 10.1016/0092-8674(88)90183-3; DUBOULE D, 1989, EMBO J, V8, P1497, DOI 10.1002/j.1460-2075.1989.tb03534.x; DUNCAN I, 1987, ANNU REV GENET, V21, P285, DOI 10.1146/annurev.ge.21.120187.001441; EBRIGHT RH, 1984, NATURE, V311, P232, DOI 10.1038/311232a0; FITZPATRICK VD, 1989, NATURE, V337, P666, DOI 10.1038/337666a0; GARCIABELLIDO A, 1977, AM ZOOL, V17, P613; GAY NJ, 1988, EMBO J, V7, P4291, DOI 10.1002/j.1460-2075.1988.tb03327.x; GEHRING WJ, 1987, SCIENCE, V236, P1245, DOI 10.1126/science.2884726; GIBSON G, 1990, CELL, V62, P1087, DOI 10.1016/0092-8674(90)90386-S; GONZALEZREYES A, 1990, NATURE, V344, P78, DOI 10.1038/344078a0; GONZALEZREYES A, 1990, CELL, V61, P515, DOI 10.1016/0092-8674(90)90533-K; GRAHAM A, 1988, GENE DEV, V2, P1424, DOI 10.1101/gad.2.11.1424; GRAHAM A, 1989, CELL, V57, P367, DOI 10.1016/0092-8674(89)90912-4; HAFEN E, 1984, NATURE, V307, P287, DOI 10.1038/307287a0; HAN KH, 1989, CELL, V56, P573, DOI 10.1016/0092-8674(89)90580-1; HANES SD, 1989, CELL, V57, P1275, DOI 10.1016/0092-8674(89)90063-9; HOEY T, 1988, MOL CELL BIOL, V8, P4598, DOI 10.1128/MCB.8.11.4598; HOEY T, 1988, NATURE, V332, P858, DOI 10.1038/332858a0; IMMERGLUCK K, 1990, CELL, V62, P261, DOI 10.1016/0092-8674(90)90364-K; ISHHOROWICZ D, 1989, CELL, V57, P223, DOI 10.1016/0092-8674(89)90960-4; JARVIS EE, 1989, GENE DEV, V3, P936, DOI 10.1101/gad.3.7.936; JAYNES JB, 1988, NATURE, V336, P744, DOI 10.1038/336744a0; JOHNSON FB, 1990, GENE DEV, V4, P1044, DOI 10.1101/gad.4.6.1044; JORDAN SR, 1988, SCIENCE, V242, P893, DOI 10.1126/science.3187530; KAUFMAN TC, 1978, GENETICS, V90, P579; KAUFMAN TC, 1980, GENETICS, V94, P115; KELEHER CA, 1988, CELL, V53, P927, DOI 10.1016/S0092-8674(88)90449-7; KENNISON JA, 1988, P NATL ACAD SCI USA, V85, P8136, DOI 10.1073/pnas.85.21.8136; KISSINGER CR, 1990, CELL, V63, P579, DOI 10.1016/0092-8674(90)90453-L; KRASNOW MA, 1989, CELL, V57, P1031, DOI 10.1016/0092-8674(89)90341-3; KRAUSE HM, 1988, GENE DEV, V2, P1021, DOI 10.1101/gad.2.8.1021; KUZIORA MA, 1988, CELL, V55, P477, DOI 10.1016/0092-8674(88)90034-7; KUZIORA MA, 1989, CELL, V59, P563, DOI 10.1016/0092-8674(89)90039-1; LAUGHON A, 1984, NATURE, V310, P25, DOI 10.1038/310025a0; LAUGHON A, 1988, DEVELOPMENT S, V104, P85; LEHMING N, 1987, EMBO J, V6, P3145, DOI 10.1002/j.1460-2075.1987.tb02625.x; LEVINE M, 1988, CELL, V55, P537, DOI 10.1016/0092-8674(88)90209-7; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; LEWIS EB, 1963, AM ZOOL, V3, P33; MACDONALD PM, 1986, NATURE, V324, P537, DOI 10.1038/324537a0; MAHAFFEY JW, 1988, DEV GENETICS HIGHER, P329; MALICKI J, 1990, CELL, V63, P961, DOI 10.1016/0092-8674(90)90499-5; MANN RS, 1990, CELL, V60, P597, DOI 10.1016/0092-8674(90)90663-Y; MARTINEZARIAS A, 1985, NATURE, V313, P639, DOI 10.1038/313639a0; MCGINNIS N, 1990, CELL, V63, P969, DOI 10.1016/0092-8674(90)90500-E; MCGINNIS W, 1984, NATURE, V308, P428, DOI 10.1038/308428a0; MCGINNIS W, 1984, CELL, V37, P403, DOI 10.1016/0092-8674(84)90370-2; MLODZIK M, 1990, DEVELOPMENT, V109, P271; MULLER J, 1989, EMBO J, V8, P4143, DOI 10.1002/j.1460-2075.1989.tb08599.x; MULLER M, 1988, EMBO J, V7, P4299, DOI 10.1002/j.1460-2075.1988.tb03328.x; NELSON H B, 1990, New Biologist, V2, P171; NORMAN C, 1988, CELL, V55, P989, DOI 10.1016/0092-8674(88)90244-9; OHKUMA Y, 1990, P NATL ACAD SCI USA, V87, P2289, DOI 10.1073/pnas.87.6.2289; OHKUMA Y, 1990, CELL, V61, P475, DOI 10.1016/0092-8674(90)90529-N; OTTING G, 1990, EMBO J, V9, P3085, DOI 10.1002/j.1460-2075.1990.tb07505.x; OTTING G, 1988, EMBO J, V7, P4305, DOI 10.1002/j.1460-2075.1988.tb03329.x; PABO CO, 1984, ANNU REV BIOCHEM, V53, P293, DOI 10.1146/annurev.bi.53.070184.001453; PANGANIBAN GEF, 1990, CELL, V110; PASSMORE S, 1989, GENE DEV, V3, P921, DOI 10.1101/gad.3.7.921; PERCIVALSMITH A, 1990, IN PRESS EMBO J; QIAN YQ, 1989, CELL, V59, P573, DOI 10.1016/0092-8674(89)90040-8; REGULSKI M, 1987, EMBO J, V6, P767, DOI 10.1002/j.1460-2075.1987.tb04819.x; REUTER R, 1990, CELL, V110; ROWE A, 1988, EMBO J, V7, P1107, DOI 10.1002/j.1460-2075.1988.tb02919.x; SAINT R, 1988, NATURE, V334, P151, DOI 10.1038/334151a0; SAMSON ML, 1989, CELL, V57, P1045, DOI 10.1016/0092-8674(89)90342-5; SCHRODER C, 1988, EMBO J, V7, P2881, DOI 10.1002/j.1460-2075.1988.tb03145.x; SCHULZ B, 1990, CELL, V60, P295, DOI 10.1016/0092-8674(90)90744-Y; SCOTT MP, 1984, P NATL ACAD SCI-BIOL, V81, P4115, DOI 10.1073/pnas.81.13.4115; SCOTT MP, 1989, BIOCHIM BIOPHYS ACTA, V989, P25, DOI 10.1016/0304-419X(89)90033-4; SEEGER MA, 1990, EMBO J, V9, P2977, DOI 10.1002/j.1460-2075.1990.tb07490.x; SHEPHERD JCW, 1984, NATURE, V310, P70, DOI 10.1038/310070a0; STERN S, 1989, NATURE, V341, P624, DOI 10.1038/341624a0; STRUHL G, 1989, CELL, V57, P1259, DOI 10.1016/0092-8674(89)90062-7; STRUHL G, 1985, NATURE, V318, P677, DOI 10.1038/318677a0; TANG S, 1990, CELL, V62, P367; TAUTZ D, 1987, NATURE, V327, P383, DOI 10.1038/327383a0; TAUTZ D, 1988, NATURE, V332, P281, DOI 10.1038/332281a0; THALI M, 1988, NATURE, V336, P598, DOI 10.1038/336598a0; TOMLINSON A, 1988, CELL, V55, P771, DOI 10.1016/0092-8674(88)90133-X; TREISMAN J, 1989, CELL, V59, P553; WHARTON RP, 1984, CELL, V38, P361, DOI 10.1016/0092-8674(84)90491-4; WINSLOW GM, 1989, CELL, V57, P1017, DOI 10.1016/0092-8674(89)90340-1; WRIGHT CVE, 1989, TRENDS BIOCHEM SCI, V14, P52, DOI 10.1016/0968-0004(89)90043-1	102	340	345	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	NOV 30	1990	63	5					883	894		10.1016/0092-8674(90)90492-W	http://dx.doi.org/10.1016/0092-8674(90)90492-W			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EL759	1979524				2022-12-28	WOS:A1990EL75900004
J	BOWES, C; LI, TS; DANCIGER, M; BAXTER, LC; APPLEBURY, ML; FARBER, DB				BOWES, C; LI, TS; DANCIGER, M; BAXTER, LC; APPLEBURY, ML; FARBER, DB			RETINAL DEGENERATION IN THE RD MOUSE IS CAUSED BY A DEFECT IN THE BETA-SUBUNIT OF ROD CGMP-PHOSPHODIESTERASE	NATURE			English	Article									UNIV CALIF LOS ANGELES,SCH MED,JULES STEIN EYE INST,LOS ANGELES,CA 90024; UNIV CHICAGO,EYE RES LABS,CHICAGO,IL 60637; LOYOLA MARYMOUNT UNIV,LOS ANGELES,CA 90045	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Chicago; Loyola Marymount University				Bowes Rickman, Catherine/0000-0002-8555-9596; Farber, Debora/0000-0002-3207-697X				BAEHR W, 1979, J BIOL CHEM, V254, P1669; BOWES C, 1987, EXP EYE RES, V45, P467, DOI 10.1016/S0014-4835(87)80058-1; BOWES C, 1989, P NATL ACAD SCI USA, V86, P9722, DOI 10.1073/pnas.86.24.9722; BOWES C, 1988, EXP EYE RES, V47, P369, DOI 10.1016/0014-4835(88)90049-8; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5924; DANCIGER M, 1989, EXP EYE RES, V48, P303, DOI 10.1016/S0014-4835(89)80079-X; DANCIGER M, 1990, INVEST OPHTH VIS SCI, V31, P1427; DANCIGER M, 1990, EXP EYE RES, V351, P185; DAVIS RC, 1987, DEV BIOL, V119, P164, DOI 10.1016/0012-1606(87)90218-1; DETERRE P, 1988, P NATL ACAD SCI USA, V85, P2424, DOI 10.1073/pnas.85.8.2424; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DRAGER UC, 1978, J COMP NEUROL, V180, P85, DOI 10.1002/cne.901800107; FARBER DB, 1976, J CYCLIC NUCL PROT, V2, P139; FARBER DB, 1974, SCIENCE, V186, P449, DOI 10.1126/science.186.4162.449; FARBER DB, 1988, EXPL EYE RES, V46, P3363; LAVAIL MM, 1974, ARCH OPHTHALMOL-CHIC, V91, P394; LI T, 1990, P NATL ACAD SCI USA, V87, P293, DOI 10.1073/pnas.87.1.293; LIPKIN VM, 1990, J BIOL CHEM, V265, P12955; Maniatis T., 1982, MOL CLONING; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SIDMAN RL, 1965, J HERED, V56, P23, DOI 10.1093/oxfordjournals.jhered.a107364; YAU KW, 1989, ANNU REV NEUROSCI, V12, P289, DOI 10.1146/annurev.ne.12.030189.001445	22	691	710	0	12	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	OCT 18	1990	347	6294					677	680		10.1038/347677a0	http://dx.doi.org/10.1038/347677a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED620	1977087				2022-12-28	WOS:A1990ED62000057
J	NIGHTINGALE, JMD; LENNARDJONES, JE; WALKER, ER; FARTHING, MJG				NIGHTINGALE, JMD; LENNARDJONES, JE; WALKER, ER; FARTHING, MJG			JEJUNAL EFFLUX IN SHORT BOWEL SYNDROME	LANCET			English	Article									ST MARKS HOSP,CITY RD,LONDON EC1V 2PS,ENGLAND	Imperial College London								BORGSTROM B, 1957, J CLIN INVEST, V36, P1521, DOI 10.1172/JCI103549; BUXTON B, 1974, GUT, V15, P229, DOI 10.1136/gut.15.3.229; DAVIS GR, 1982, GASTROENTEROLOGY, V83, P844; FORDTRAN JS, 1966, AM J DIG DIS, V11, P503, DOI 10.1007/BF02233563; LADEFOGED K, 1989, GUT, V30, P943, DOI 10.1136/gut.30.7.943; MILLER DS, 1959, BRIT J NUTR, V13, P501, DOI 10.1079/BJN19590064; MUGHAL M, 1986, LANCET, V2, P383; NEWTON CR, 1985, J ROY SOC MED, V78, P27; NIGHTINGALE JMD, 1989, GUT, V30, pA718; NIGHTINGALE JMD, 1989, ALIMENT PHARM THERAP, V3, P367; RODRIGUES CA, 1989, GUT, V30, pA719; RODRIGUES CA, 1989, ALIMENT PHARM THERAP, V3, P159; SHAFFER JL, 1988, GUT, V29, pA1432; SPILLER RC, 1984, GUT, V25, P365, DOI 10.1136/gut.25.4.365	14	138	142	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	SEP 29	1990	336	8718					765	768		10.1016/0140-6736(90)93238-K	http://dx.doi.org/10.1016/0140-6736(90)93238-K			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB077	1976145				2022-12-28	WOS:A1990EB07700003
J	TODD, E				TODD, E			EPIDEMIOLOGY OF FOODBORNE ILLNESS - NORTH-AMERICA	LANCET			English	Article											TODD, E (corresponding author), HLTH PROTECT BRANCH, BUR MICROBIAL HAZARDS, OTTAWA K1A OL2, ONTARIO, CANADA.			Todd, Ewen/0000-0001-7266-279X				ARCHER DL, 1985, J FOOD PROTECT, V48, P887, DOI 10.4315/0362-028X-48.10.887; BARTLESON CA, 1987, FOOD PROTECTION TECH, P141; Bean N H, 1990, MMWR CDC Surveill Summ, V39, P15; Bennett J. V., 1987, CLOSING GAP BURDEN U, P102; Centers for Disease Control (CDC), 1990, MMWR Morb Mortal Wkly Rep, V38, P877; CHALKER RB, 1988, REV INFECT DIS, V10, P111; COLLINS RK, 1989, MMWR-MORBID MORTAL W, V38, P417; EASTAUGH J, 1989, ARCH INTERN MED, V149, P1735, DOI 10.1001/archinte.149.8.1735; GARTHRIGHT WE, 1988, PUBLIC HEALTH REP, V103, P107; Hargrett-Bean N T, 1988, MMWR CDC Surveill Summ, V37, P25; Hauschild A. H. W., 1989, Foodborne bacterial pathogens., P111; KVENBERG JE, 1987, FOOD TECHNOL-CHICAGO, V41, P77; Lovett J., 1989, Foodborne bacterial pathogens., P283; MACDONALD KL, 1988, JAMA-J AM MED ASSOC, V259, P3567, DOI 10.1001/jama.259.24.3567; MCLEAN HE, 1987, CAN DIS WKLY REP, V13, P35; ROBERTS T, 1989, AM J AGR ECON, V71, P468, DOI 10.2307/1241614; RYAN CA, 1987, JAMA-J AM MED ASSOC, V258, P3269, DOI 10.1001/jama.258.22.3269; STLOUIS ME, 1988, JAMA-J AM MED ASSOC, V259, P2103, DOI 10.1001/jama.259.14.2103; TODD ECD, 1985, J FOOD PROTECT, V48, P621, DOI 10.4315/0362-028X-48.7.621; TODD ECD, 1989, J FOOD PROTECT, V52, P595, DOI 10.4315/0362-028X-52.8.595; TODD ECD, 1989, J FOOD PROTECT, V52, P503, DOI 10.4315/0362-028X-52.7.503; TODD ECD, 1989, J FOOD PROTECT, V52, P586, DOI 10.4315/0362-028X-52.8.586; TODD ECD, 1990, TOXIC MARINE PHYTOPLANKTON, P504; 1988, FED REGISTER, V53, P44949; 1988, MMWR, V37, P1	25	43	43	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 29	1990	336	8718					788	790		10.1016/0140-6736(90)93250-S	http://dx.doi.org/10.1016/0140-6736(90)93250-S			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB077	1976155				2022-12-28	WOS:A1990EB07700013
J	GIBSON, G; SCHIER, A; LEMOTTE, P; GEHRING, WJ				GIBSON, G; SCHIER, A; LEMOTTE, P; GEHRING, WJ			THE SPECIFICITIES OF SEX COMBS REDUCED AND ANTENNAPEDIA ARE DEFINED BY A DISTINCT PORTION OF EACH PROTEIN THAT INCLUDES THE HOMEODOMAIN	CELL			English	Article											GIBSON, G (corresponding author), BIOZENTRUM,DEPT CELL BIOL,KLINGELBERGSTR 70,CH-4056 BASEL,SWITZERLAND.			Schier, Alexander Franz/0000-0001-7645-5325				ABBOTT MK, 1986, GENETICS, V114, P919; Affolter M, 1990, CURR OPIN CELL BIOL, V2, P485, DOI 10.1016/0955-0674(90)90132-X; AKAM M, 1987, DEVELOPMENT, V101, P1; BENDER A, 1987, CELL, V50, P681, DOI 10.1016/0092-8674(87)90326-6; BERMINGHAM JR, 1988, EMBO J, V7, P3211, DOI 10.1002/j.1460-2075.1988.tb03188.x; CARBONARE BD, 1989, THESIS U BASEL BASEL; COOLEY L, 1988, SCIENCE, V239, P1121, DOI 10.1126/science.2830671; COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4; DENELL RE, 1981, DEV BIOL, V81, P43, DOI 10.1016/0012-1606(81)90346-8; DESPLAN C, 1988, CELL, V54, P1081, DOI 10.1016/0092-8674(88)90123-7; DRIEVER W, 1989, NATURE, V340, P363, DOI 10.1038/340363a0; DRIEVER W, 1989, NATURE, V337, P138, DOI 10.1038/337138a0; FRISCHER LE, 1986, CELL, V47, P1017, DOI 10.1016/0092-8674(86)90816-0; GEHRING WJ, 1987, SCIENCE, V236, P1245, DOI 10.1126/science.2884726; GIBSON G, 1988, DEVELOPMENT, V102, P657; GIBSON G, 1989, THESIS U BASEL BASEL; GOUTTE C, 1988, CELL, V52, P875, DOI 10.1016/0092-8674(88)90429-1; GRAHAM A, 1989, CELL, V57, P367, DOI 10.1016/0092-8674(89)90912-4; HAFEN E, 1984, NATURE, V307, P287, DOI 10.1038/307287a0; HALL MN, 1987, SCIENCE, V237, P1007, DOI 10.1126/science.2887035; HAN KH, 1989, CELL, V56, P573, DOI 10.1016/0092-8674(89)90580-1; HANES SD, 1989, CELL, V57, P1275, DOI 10.1016/0092-8674(89)90063-9; HERR W, 1988, GENE DEV, V2, P1513, DOI 10.1101/gad.2.12a.1513; HERSKOWITZ I, 1989, NATURE, V342, P747; HOEY T, 1988, NATURE, V332, P858, DOI 10.1038/332858a0; ISHHOROWICZ D, 1988, DEVELOPMENT, V104, P67; JARVIS EE, 1989, GENE DEV, V3, P936, DOI 10.1101/gad.3.7.936; JAYNES JB, 1988, NATURE, V336, P744, DOI 10.1038/336744a0; JORGENSEN EM, 1987, GENE DEV, V1, P544, DOI 10.1101/gad.1.6.544; KARESS RE, 1984, CELL, V38, P135, DOI 10.1016/0092-8674(84)90534-8; KELEHER CA, 1988, CELL, V53, P927, DOI 10.1016/S0092-8674(88)90449-7; KRASNOW MA, 1989, CELL, V57, P1031, DOI 10.1016/0092-8674(89)90341-3; KRUSKAL WH, 1953, J AM STAT ASSOC, V48, P907, DOI 10.2307/2281082; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; KUZIORA MA, 1988, CELL, V55, P477, DOI 10.1016/0092-8674(88)90034-7; KUZIORA MA, 1989, CELL, V59, P563, DOI 10.1016/0092-8674(89)90039-1; LAUGHON A, 1988, DEVELOPMENT, V104, P75; LEMOTTE PK, 1989, EMBO J, V8, P219, DOI 10.1002/j.1460-2075.1989.tb03367.x; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; MANGALAM HJ, 1989, GENE DEV, V3, P946, DOI 10.1101/gad.3.7.946; Maniatis T., 1982, MOL CLONING; MANN RS, 1990, CELL, V60, P597, DOI 10.1016/0092-8674(90)90663-Y; MCGINNIS W, 1984, NATURE, V308, P428, DOI 10.1038/308428a0; MIHARA H, 1988, SCIENCE, V242, P925, DOI 10.1126/science.2903553; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; MLODZIK M, 1990, DEVELOPMENT, V109, P271; MULLER M, 1988, EMBO J, V7, P4299, DOI 10.1002/j.1460-2075.1988.tb03328.x; OTTING G, 1988, EMBO J, V7, P4305, DOI 10.1002/j.1460-2075.1988.tb03329.x; PASSMORE S, 1989, GENE DEV, V3, P921, DOI 10.1101/gad.3.7.921; POOLE SJ, 1988, DEVELOPMENT, V104, P85; PORTER SD, 1986, NATURE, V320, P766, DOI 10.1038/320766a0; POSTLETHWAIT JH, 1971, DEV BIOL, V25, P606, DOI 10.1016/0012-1606(71)90008-X; PTASHNE M, 1988, NATURE, V335, P683, DOI 10.1038/335683a0; QIAN YQ, 1989, CELL, V59, P573, DOI 10.1016/0092-8674(89)90040-8; RILEY PD, 1987, GENE DEV, V1, P716, DOI 10.1101/gad.1.7.716; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; SAINT R, 1988, NATURE, V334, P151, DOI 10.1038/334151a0; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SAUER RT, 1988, GENE DEV, V2, P807, DOI 10.1101/gad.2.7.807; SCHIER A, 1987, THESIS U BASEL BASEL; SCHNEUWLY S, 1987, EMBO J, V6, P201, DOI 10.1002/j.1460-2075.1987.tb04739.x; SCHNEUWLY S, 1986, EMBO J, V5, P733, DOI 10.1002/j.1460-2075.1986.tb04275.x; SCHNEUWLY S, 1987, NATURE, V325, P816, DOI 10.1038/325816a0; SCOTT MP, 1984, P NATL ACAD SCI-BIOL, V81, P4115, DOI 10.1073/pnas.81.13.4115; SCOTT MP, 1989, BIOCHIM BIOPHYS ACTA, V989, P25, DOI 10.1016/0304-419X(89)90033-4; SEIFERT HS, 1986, P NATL ACAD SCI USA, V83, P735, DOI 10.1073/pnas.83.3.735; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; STERN S, 1989, NATURE, V341, P624, DOI 10.1038/341624a0; STROEHER VL, 1988, MOL CELL BIOL, V8, P4143, DOI 10.1128/MCB.8.10.4143; STRUHL G, 1981, NATURE, V292, P635, DOI 10.1038/292635a0; STRUHL G, 1989, CELL, V57, P1259, DOI 10.1016/0092-8674(89)90062-7; STRUHL G, 1985, NATURE, V318, P677, DOI 10.1038/318677a0; TABOR S, 1987, P NATL ACAD SCI USA, V84, P4767, DOI 10.1073/pnas.84.14.4767; THALI M, 1988, NATURE, V336, P598, DOI 10.1038/336598a0; TOMLINSON A, 1988, CELL, V55, P771, DOI 10.1016/0092-8674(88)90133-X; TREISMAN J, 1989, CELL, V59, P553; WALLDORF U, 1989, P NATL ACAD SCI USA, V86, P9971, DOI 10.1073/pnas.86.24.9971; WHARTON KA, 1985, CELL, V43, P567, DOI 10.1016/0092-8674(85)90229-6; WINSLOW GM, 1989, CELL, V57, P1017, DOI 10.1016/0092-8674(89)90340-1	79	178	180	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	SEP 21	1990	62	6					1087	1103		10.1016/0092-8674(90)90386-S	http://dx.doi.org/10.1016/0092-8674(90)90386-S			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EA117	1976044				2022-12-28	WOS:A1990EA11700007
J	GRIFFIN, MR; PIPER, JM; DAUGHERTY, JR; SNOWDEN, M; RAY, WA				GRIFFIN, MR; PIPER, JM; DAUGHERTY, JR; SNOWDEN, M; RAY, WA			NONSTEROIDAL ANTIINFLAMMATORY DRUG-USE AND INCREASED RISK FOR PEPTIC-ULCER DISEASE IN ELDERLY PERSONS	ANNALS OF INTERNAL MEDICINE			English	Article							GASTRIC-ULCER; ASPIRIN; PERFORATION; INGESTION	Objective: To evaluate the relative risk for peptic ulcer disease that is associated with the use of nonaspirin nonsteroidal anti-inflammatory drugs. Design: Nested case-control study. Setting: Tennessee Medicaid program. Participants: Medicaid enrollees 65 years of age or older were included in the study. The 1415 case patients had been hospitalized for confirmed peptic ulcer disease at some point from 1984 through 1986. The 7063 control persons represented a stratified random sample of other Medicaid enrollees. Measurements and Main Results: The estimated relative risk for the development of peptic ulcer disease among current users of nonaspirin nonsteroidal anti-inflammatory drugs, compared with that among nonusers, was 4.1 (95% CI, 3.5 to 4.7). For current users, the risk increased with increasing dose, from a relative risk of 2.8 (CI, 1.8 to 4.3) for the lowest to a relative risk of 8.0 (CI, 4.4 to 14.8) for the highest dose category. The risk was greatest in the first month of use (relative risk, 7.2; CI, 4.9 to 10.5). If the association is fully causal, 29% of peptic ulcers in the study sample resulted from the use of these drugs, and the excess risk associated with such use was 17.4 hospitalizations for ulcer disease per 1000 person-years of exposure. Conclusions: These data support other findings indicating that a clinically significant risk for serious ulcer disease is associated with the use of nonaspirin nonsteroidal anti-inflammatory drugs. The data show that this risk increases with dose and recency of use and that use of these drugs may be responsible for a large proportion of peptic ulcer disease among elderly persons.			GRIFFIN, MR (corresponding author), VANDERBILT UNIV, MED CTR, SCH MED, DEPT PREVENT MED, NASHVILLE, TN 37232 USA.				FDA HHS [FD-U-000073] Funding Source: Medline	FDA HHS		ARMSTRONG CP, 1987, GUT, V28, P527, DOI 10.1136/gut.28.5.527; BARTLE WR, 1986, ARCH INTERN MED, V146, P2365, DOI 10.1001/archinte.146.12.2365; BEARDON PHG, 1989, Q J MED, V71, P497; BUSSON M, 1986, J INT MED RES, V14, P53, DOI 10.1177/030006058601400201; CARSON JL, 1987, ARCH INTERN MED, V147, P85, DOI 10.1001/archinte.147.1.85; CLINCH D, 1987, J ROY COLL PHYS LOND, V21, P183; COGGON D, 1982, GUT, V23, P340, DOI 10.1136/gut.23.4.340; COLLIER DS, 1985, GUT, V26, P359, DOI 10.1136/gut.26.4.359; DAVIS W, 1980, STATISTICAL METHODS, V1, P74; DEAN AG, 1988, AM J EPIDEMIOL, V127, P654, DOI 10.1093/oxfordjournals.aje.a114840; DUGGAN JM, 1986, GUT, V27, P929, DOI 10.1136/gut.27.8.929; DUGGAN JM, 1972, GUT, V13, P631, DOI 10.1136/gut.13.8.631; FRIEDMAN GD, 1974, NEW ENGL J MED, V290, P469, DOI 10.1056/NEJM197402282900901; GRAHAM DY, 1988, GASTROENTEROLOGY, V95, P327, DOI 10.1016/0016-5085(88)90487-8; GRIFFIN MR, 1988, ANN INTERN MED, V109, P359, DOI 10.7326/0003-4819-109-5-359; GUESS HA, 1988, J CLIN EPIDEMIOL, V41, P35, DOI 10.1016/0895-4356(88)90007-8; KELSEY JL, 1989, AM J EPIDEMIOL, V130, P857, DOI 10.1093/oxfordjournals.aje.a115418; Kleinbaum D.G, 1982, EPIDEMIOLOGIC RES PR, P220; LANZA FL, 1989, SCAND J GASTROENTERO, V24, P24, DOI 10.3109/00365528909091171; LEVY M, 1988, ARCH INTERN MED, V148, P281, DOI 10.1001/archinte.148.2.281; LEVY M, 1974, NEW ENGL J MED, V290, P1158, DOI 10.1056/NEJM197405232902102; MCINTOSH JH, 1988, AM J EPIDEMIOL, V128, P761, DOI 10.1093/oxfordjournals.aje.a115029; MCINTOSH JH, 1985, GUT, V26, P789, DOI 10.1136/gut.26.8.789; PAYNE CD, 1986, GENERALIZED LINEAR I; PIPER DW, 1981, GASTROENTEROLOGY, V80, P427; RAY WA, 1989, AM J EPIDEMIOL, V129, P837, DOI 10.1093/oxfordjournals.aje.a115198; SOMERVILLE K, 1986, LANCET, V1, P462; Steel R.G.D., 1980, PRINCIPLES PROCEDURE, P186; STRUM WB, 1986, ANN INTERN MED, V105, P757, DOI 10.7326/0003-4819-105-5-757; WILCOSKY TC, 1985, J CHRON DIS, V38, P849, DOI 10.1016/0021-9681(85)90109-2; 1986, MED LETT DRUGS THER, V28, P61; 1985, CLIN MODIFICATION, V2; 1989, NATIONAL HOSPITAL 13	33	643	649	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 15	1991	114	4					257	263		10.7326/0003-4819-114-4-257	http://dx.doi.org/10.7326/0003-4819-114-4-257			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EX521	1987872				2022-12-28	WOS:A1991EX52100001
J	PHILLIPS, MJ; BLENDIS, LM; POUCELL, S; PATTERSON, J; PETRIC, M; ROBERTS, E; LEVY, GA; SUPERINA, RA; GREIG, PD; CAMERON, R; LANGER, B; PURCELL, RH				PHILLIPS, MJ; BLENDIS, LM; POUCELL, S; PATTERSON, J; PETRIC, M; ROBERTS, E; LEVY, GA; SUPERINA, RA; GREIG, PD; CAMERON, R; LANGER, B; PURCELL, RH			SYNCYTIAL GIANT-CELL HEPATITIS - SPORADIC HEPATITIS WITH DISTINCTIVE PATHOLOGICAL FEATURES, A SEVERE CLINICAL COURSE, AND PARAMYXOVIRAL FEATURES	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHRONIC ACTIVE HEPATITIS; SUBACUTE SCLEROSING PANENCEPHALITIS; FATAL MEASLES INFECTION; CANINE-DISTEMPER VIRUS; ANTIBODY TITERS; MULTIPLE-SCLEROSIS; RUBELLA-VIRUS; YOUNG-ADULTS; MORBILLIVIRUSES; PHOSPHOPROTEIN	Background and Methods. We describe a new form of hepatitis, occurring in 10 patients over a period of six years, characterized clinically by manifestations of severe hepatitis, histologically by large syncytial giant hepatocytes, and ultrastructurally by intracytoplasmic structures consistent with paramyxoviral nucleocapsids. Results. The patients ranged in age from 5 months to 41 years. The tentative clinical diagnosis before biopsy was non-A, non-B hepatitis in five patients and autoimmune chronic active hepatitis in the others. Five patients underwent liver transplantation; the others died. The diagnosis of syncytial giant-cell hepatitis was established pathologically. The liver cords were replaced in all 10 patients by syncytial giant cells with up to 30 nuclei. In 8 of the 10 the cytoplasm contained pleomorphic particles of 150 to 250 mu-m, filamentous strands, and particles of 14 t o 17 nm with peripherally disposed spikes resembling paramyxoviral nucleocapsids. Structures resembling degenerated forms were found in the other two patients. One of two chimpanzees injected with a liver homogenate from the index patient had an increase in the titer of paramyxoviral antibodies, probably an anamnestic reaction to previous paramyxoviral infection, suggesting that a paramyxoviral antigen but not viable virus was present in the liver homogenate. Conclusions. Although further virologic studies will be required for precise classification, we believe that paramyxoviruses should be considered in patients with severe sporadic hepatitis.	HOSP SICK CHILDREN, DEPT MICROBIOL, TORONTO M5G 1X8, ONTARIO, CANADA; HOSP SICK CHILDREN, DEPT PEDIAT, TORONTO M5G 1X8, ONTARIO, CANADA; HOSP SICK CHILDREN, DEPT SURG, TORONTO M5G 1X8, ONTARIO, CANADA; UNIV TORONTO, TORONTO M5S 1A1, ONTARIO, CANADA; TORONTO GEN HOSP, DEPT MED, TORONTO M5G 1L7, ONTARIO, CANADA; TORONTO GEN HOSP, DEPT PATHOL, TORONTO M5G 1L7, ONTARIO, CANADA; TORONTO GEN HOSP, DEPT SURG, TORONTO M5G 1L7, ONTARIO, CANADA; NIAID, INFECT DIS LAB, BETHESDA, MD 20892 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	PHILLIPS, MJ (corresponding author), HOSP SICK CHILDREN, DEPT PATHOL, 555 UNIV AVE, TORONTO M5G 1X8, ONTARIO, CANADA.							ARCHIBALD RW, 1971, J PATHOL, V103, P27, DOI 10.1002/path.1711030104; BECROFT DMO, 1980, HISTOPATHOLOGY, V4, P401, DOI 10.1111/j.1365-2559.1980.tb02935.x; BELLINI WJ, 1984, J VIROL, V50, P939, DOI 10.1128/JVI.50.3.939-942.1984; BERNARD O, 1981, J PEDIATR-US, V99, P704, DOI 10.1016/S0022-3476(81)80388-5; BOHN W, 1986, VIROLOGY, V149, P91, DOI 10.1016/0042-6822(86)90090-5; BREITFELD V, 1973, LAB INVEST, V28, P279; BRODY JA, 1971, J AMER MED ASSOC, V216, P1441, DOI 10.1001/jama.216.9.1441; COOK MK, 1959, AM J HYG, V69, P250, DOI 10.1093/oxfordjournals.aje.a119998; COSBY SL, 1989, J GEN VIROL, V70, P2027, DOI 10.1099/0022-1317-70-8-2027; CRAIG JM, 1952, AMA ARCH PATHOL, V54, P321; FOURNIER JG, 1985, NEW ENGL J MED, V313, P910, DOI 10.1056/NEJM198510103131502; FOURNIER JG, 1986, BRIT MED J, V293, P523, DOI 10.1136/bmj.293.6546.523; FUJINAMI RS, 1983, P NATL ACAD SCI-BIOL, V80, P2346, DOI 10.1073/pnas.80.8.2346; GAVISH D, 1983, ARCH INTERN MED, V143, P674, DOI 10.1001/archinte.143.4.674; HALL WW, 1980, VIROLOGY, V100, P433, DOI 10.1016/0042-6822(80)90534-6; ISHAK KG, 1987, IAP MONOGRAPH, V28, P223; LAITINEN O, 1974, LANCET, V1, P194; LENNETTE EH, 1988, LABORATORY DIAGNOSIS, V2, P484; LONDON WT, 1975, J INFECT DIS, V125, P382; LOTAN C, 1986, EUR J PEDIATR, V145, P160, DOI 10.1007/BF00441888; LUCAS CJ, 1972, LANCET, V1, P115; MCLELLAN RK, 1977, JAMA-J AM MED ASSOC, V247, P2000; MODAI D, 1986, DIGEST DIS SCI, V31, P333, DOI 10.1007/BF01318127; NICKELL MD, 1979, ANN INTERN MED, V90, P354, DOI 10.7326/0003-4819-90-3-354; PHILLIPS PE, 1970, SCIENCE, V168, P982, DOI 10.1126/science.168.3934.982; PINKERTON H, 1945, AM J PATHOL, V21, P1; PURCELL RH, 1971, J INFECT DIS, V123, P406, DOI 10.1093/infdis/123.4.406; RICHEY J, 1977, GASTROENTEROLOGY, V73, P570; ROBERTS GBS, 1958, J PATHOL BACTERIOL, V76, P111, DOI 10.1002/path.1700760112; ROBERTSON DAF, 1987, LANCET, V2, P9; ROZENBLATT S, 1985, J VIROL, V53, P684, DOI 10.1128/JVI.53.2.684-690.1985; SATA T, 1986, VIRCHOWS ARCH A, V410, P133; SCHAFFNER F, 1963, ANN NY ACAD SCI, V111, P358, DOI 10.1111/j.1749-6632.1963.tb36977.x; SHALEVZIMELS H, 1988, HEPATOLOGY, V8, P1138, DOI 10.1002/hep.1840080529; SHESHBERADARAN H, 1984, J VIROL, V52, P995, DOI 10.1128/JVI.52.3.995-999.1984; SIEGEL D, 1977, ARCH INTERN MED, V137, P1178, DOI 10.1001/archinte.137.9.1178; SPICHTIN HP, 1982, LIVER, V2, P355; STOKES J, 1951, AMA AM J DIS CHILD, V82, P213; THALER H, 1982, LIVER, V2, P393; Thaler M M, 1976, Prog Liver Dis, V5, P476; THIJS JC, 1985, AM J GASTROENTEROL, V80, P294; TRIGER DR, 1972, LANCET, V1, P665; WITZLEBEN CL, 1988, HUM PATHOL, V19, P603, DOI 10.1016/S0046-8177(88)80213-2; 1988, NEW ENGL J MED, V319, P495	44	145	146	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 14	1991	324	7					455	460		10.1056/NEJM199102143240705	http://dx.doi.org/10.1056/NEJM199102143240705			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EX363	1988831				2022-12-28	WOS:A1991EX36300005
J	HOOPER, DC; WOLFSON, JS				HOOPER, DC; WOLFSON, JS			FLUOROQUINOLONE ANTIMICROBIAL AGENTS	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							URINARY-TRACT INFECTIONS; INTRAVENOUS ORAL CIPROFLOXACIN; FEBRILE NEUTROPENIC PATIENTS; PELVIC INFLAMMATORY DISEASE; SINGLE-DOSE CIPROFLOXACIN; SOFT-TISSUE INFECTIONS; TRAVELERS DIARRHEA; CLINICAL EFFICACY; TRIMETHOPRIM-SULFAMETHOXAZOLE; RANDOMIZED TRIAL		HARVARD UNIV, SCH MED, BOSTON, MA 02115 USA	Harvard University; Harvard Medical School	HOOPER, DC (corresponding author), MASSACHUSETTS GEN HOSP, MED SERV, INFECT DIS UNIT, 32 FRUIT ST, BOSTON, MA 02114 USA.							ALLAIS JM, 1988, ANTIMICROB AGENTS CH, V32, P1327, DOI 10.1128/AAC.32.9.1327; BALL P, 1986, J ANTIMICROB CHEMOTH, V18, P187, DOI 10.1093/jac/18.SD.187; BARRETT JF, 1989, ANTIMICROB AGENTS CH, V33, P1697, DOI 10.1128/AAC.33.10.1697; Batteiger B E, 1989, Am J Med, V87, p75S; BERGAN T, 1988, INFECTION, V16, pS3, DOI 10.1007/BF01650500; BLACK JR, 1989, ANTIMICROB AGENTS CH, V33, P167, DOI 10.1128/AAC.33.2.167; BLOCK JM, 1987, DRUGS, V34, P100, DOI 10.2165/00003495-198700341-00022; BOSLEGO JW, 1988, SEX TRANSM DIS, V15, P186, DOI 10.1097/00007435-198810000-00002; BOWIE WR, 1986, ANTIMICROB AGENTS CH, V30, P594, DOI 10.1128/AAC.30.4.594; BOWIE WR, 1989, ANTIMICROB AGENTS CH, V33, P1774, DOI 10.1128/AAC.33.10.1774; BOWIE WR, 1989, ANTIMICROB AGENTS CH, V33, P1778, DOI 10.1128/AAC.33.10.1778; CHAN CC, 1989, ANTIMICROB AGENTS CH, V33, P87, DOI 10.1128/AAC.33.1.87; CHAN MK, 1988, J ANTIMICROB CHEMOTH, V22, P371, DOI 10.1093/jac/22.3.371; CHODOSH S, 1989, AM J MED, V87, pS107, DOI 10.1016/0002-9343(89)90035-1; Christ W, 1988, Rev Infect Dis, V10 Suppl 1, pS141; CHRYSANTHOPOULOS CJ, 1988, INFECTION, V16, P249, DOI 10.1007/BF01650766; CHU DTW, 1989, ANTIMICROB AGENTS CH, V33, P131, DOI 10.1128/AAC.33.2.131; COOPER B, 1989, AM J MED, V87, P475; COVINO JM, 1990, ANTIMICROB AGENTS CH, V34, P148, DOI 10.1128/AAC.34.1.148; CROMBLEHOLME WR, 1989, AM J MED, V87, pS142, DOI 10.1016/0002-9343(89)90045-4; CRUCIANI M, 1989, INFECTION, V17, P65, DOI 10.1007/BF01646878; DAN M, 1989, AM J MED, V87, P479; DAVIES BI, 1986, EUR J CLIN MICROBIOL, V5, P226, DOI 10.1007/BF02013995; DAVIES BI, 1989, REV INFECT DIS, V11, pS1083; DAVIS H, 1989, ANN INTERN MED, V111, P1041, DOI 10.7326/0003-4819-111-12-1041; DRLICA K, 1984, MICROBIOL REV, V48, P273, DOI 10.1128/MMBR.48.4.273-289.1984; DRUSANO GL, 1989, QUINOLONE ANTIMICROB, P71; DUPONT HL, 1989, QUINOLONE ANTMICROBI, P167; DWORKIN RJ, 1989, LANCET, V2, P1071; DWORZACK DL, 1988, ANTIMICROB AGENTS CH, V32, P1740, DOI 10.1128/AAC.32.11.1740; EDLUND C, 1988, INFECTION, V16, P8, DOI 10.1007/BF01646921; Eliopoulos G M, 1988, Rev Infect Dis, V10 Suppl 1, pS102; ELIOPOULOS GM, 1989, QUINOLONE ANTIMICROB, P35; ERICSSON CD, 1987, ANN INTERN MED, V106, P216, DOI 10.7326/0003-4819-106-2-216; FALCK G, 1988, SCAND J INFECT DIS, V20, P619, DOI 10.3109/00365548809035662; FASS RJ, 1987, AM J MED, V82, P202; FASS RJ, 1986, J ANTIMICROB CHEMOTH, V18, P153, DOI 10.1093/jac/18.Supplement_D.153; FLAHERTY JP, 1989, AM J MED, V87, pS278, DOI 10.1016/0002-9343(89)90080-6; FLEMING LW, 1990, J ANTIMICROB CHEMOTH, V25, P441, DOI 10.1093/jac/25.3.441; FOLLATH F, 1986, EUR J CLIN MICROBIOL, V5, P236, DOI 10.1007/BF02013997; FONG IW, 1987, AM J MED, V82, P311; GAUNT PN, 1988, J ANTIMICROB CHEMOTH, V21, P489, DOI 10.1093/jac/21.4.489; GELLERT M, 1981, ANNU REV BIOCHEM, V50, P879, DOI 10.1146/annurev.bi.50.070181.004311; Gentry L O, 1989, Am J Med, V87, p57S; GENTRY LO, 1989, AM J MED, V87, pS132, DOI 10.1016/0002-9343(89)90042-9; GENTRY LO, 1989, ARCH INTERN MED, V149, P2579, DOI 10.1001/archinte.149.11.2579; GENTRY LO, 1990, ANTIMICROB AGENTS CH, V34, P40, DOI 10.1128/AAC.34.1.40; GOODMAN LJ, 1990, ARCH INTERN MED, V150, P541, DOI 10.1001/archinte.150.3.541; GOTUZZO E, 1989, ANTIMICROB AGENTS CH, V33, P1101, DOI 10.1128/AAC.33.7.1101; GOTUZZO E, 1988, J INFECT DIS, V157, P1221, DOI 10.1093/infdis/157.6.1221; GREENBERG RN, 1987, ANTIMICROB AGENTS CH, V31, P151, DOI 10.1128/AAC.31.2.151; Halkin H, 1988, Rev Infect Dis, V10 Suppl 1, pS258; HEINONEN PK, 1989, AM J MED, V87, pS152, DOI 10.1016/0002-9343(89)90047-8; HENRY NK, 1986, J ANTIMICROB CHEMOTH, V18, P103, DOI 10.1093/jac/18.Supplement_D.103; HODSON ME, 1987, LANCET, V1, P235; HOOGKAMPKORSTANJE JAA, 1989, J ANTIMICROB CHEMOTH, V23, P427, DOI 10.1093/jac/23.3.427; HOOPER DC, 1989, REV INFECT DIS, V11, pS902; HOOPER DC, 1989, ANTIMICROB AGENTS CH, V33, P1662, DOI 10.1128/AAC.33.10.1662; HOOPER DC, 1989, QUINOLONE ANTIMICROB, P233; HUSSY P, 1986, ANTIMICROB AGENTS CH, V29, P1073, DOI 10.1128/AAC.29.6.1073; JACOBSON MA, 1989, ANN INTERN MED, V110, P1027, DOI 10.7326/0003-4819-110-12-1027; JENSEN T, 1987, EUR J CLIN MICROBIOL, V6, P618, DOI 10.1007/BF02013055; JOHNSON PC, 1986, ANTIMICROB AGENTS CH, V30, P671, DOI 10.1128/AAC.30.5.671; KELSEY SM, 1989, AM J MED, V87, pS274, DOI 10.1016/0002-9343(89)90079-X; KHAN FA, 1989, CHEST, V96, P528, DOI 10.1378/chest.96.3.528; KRESKEN M, 1988, ANTIMICROB AGENTS CH, V32, P1285, DOI 10.1128/AAC.32.8.1285; LANG J, 1989, AM J MED, V87, pS82, DOI 10.1016/0002-9343(89)90029-6; LANG R, 1990, J INFECT DIS, V161, P537, DOI 10.1093/infdis/161.3.537; LEBEL M, 1990, ANTIMICROB AGENTS CH, V34, P1254, DOI 10.1128/AAC.34.6.1254; LEWIN CS, 1990, 4 QUINOLONES ANTIBAC, P37; LIANG RHS, 1990, ANTIMICROB AGENTS CH, V34, P215, DOI 10.1128/AAC.34.2.215; LICITRA CM, 1987, ANTIMICROB AGENTS CH, V31, P805, DOI 10.1128/AAC.31.5.805; LOLEKHA S, 1988, SCAND J INFECT DIS, P35; MACDONALD KS, 1989, ANTIMICROB AGENTS CH, V33, P612, DOI 10.1128/AAC.33.5.612; Malinverni R, 1988, Rev Infect Dis, V10 Suppl 1, pS153; MITSCHER LA, 1990, 4 QUINOLONES, P115; MOORHOUSE EC, 1988, J ANTIMICROB CHEMOTH, V22, P135, DOI 10.1093/jac/22.Supplement_C.135; MULLIGAN ME, 1987, AM J MED, V82, P215; MURRAY BE, 1989, REV INFECT DIS, V11, pS1372; MURRAY BE, 1989, EUR J CLIN MICROBIOL, V8, P1093, DOI 10.1007/BF01975176; NAAMARA W, 1988, GENITOURIN MED, V64, P189; NAAMARA W, 1987, AM J MED, V82, P317; NABER KG, 1989, REV INFECT DIS, V11, pS1321; NEU HC, 1989, AM J MED, V87, pS209, DOI 10.1016/0002-9343(89)90061-2; NICOLLE LE, 1989, ANTIMICROB AGENTS CH, V33, P1032, DOI 10.1128/AAC.33.7.1032; NIX DE, 1990, ANTIMICROB AGENTS CH, V34, P432, DOI 10.1128/AAC.34.3.432; NORRBY SR, 1987, J INFECT DIS, V155, P170, DOI 10.1093/infdis/155.2.170; ODE B, 1987, SCAND J INFECT DIS, V19, P677, DOI 10.3109/00365548709117203; PANIKABUTRA K, 1988, GENITOURIN MED, V64, P235; PARENT M, 1990, ANTIMICROB AGENTS CH, V34, P1249, DOI 10.1128/AAC.34.6.1249; PETERSON LR, 1989, AM J MED, V86, P801, DOI 10.1016/0002-9343(89)90476-2; PICHLER HET, 1987, AM J MED, V82, P329; POLK RE, 1989, ANTIMICROB AGENTS CH, V33, P1841, DOI 10.1128/AAC.33.11.1841; PRIGOGINE T, 1988, J ANTIMICROB CHEMOTH, V21, P131, DOI 10.1093/jac/21.suppl_B.131; PUST RA, 1988, J ANTIMICROB CHEMOTH, V22, P227, DOI 10.1093/jac/22.Supplement_D.227; RADEMAKER CMA, 1989, EUR J CLIN MICROBIOL, V8, P690, DOI 10.1007/BF01963753; RAEBURN JA, 1987, J ANTIMICROB CHEMOTH, V20, P295, DOI 10.1093/jac/20.3.295; RUBIN J, 1989, ARCH OTOLARYNGOL, V115, P1063; RUBINSTEIN E, 1987, AM J MED, V82, P119; RUBINSTEIN E, 1989, REV INFECT DIS S5, V11; RUBINSTEIN E, 1988, REV INFECT DIS S1, V10; SABBAJ J, 1986, SCAND J INFECT DIS, P48; SANDERS WE, 1988, REV INFECT DIS, V10, P528; SCHAEFLER S, 1989, J CLIN MICROBIOL, V27, P335, DOI 10.1128/JCM.27.2.335-336.1989; SCHONWALD S, 1989, AM J MED, V87, pS248, DOI 10.1016/0002-9343(89)90071-5; SCOTT DA, 1990, AM J TROP MED HYG, V42, P160, DOI 10.4269/ajtmh.1990.42.160; SEGEV S, 1989, ARCH INTERN MED, V149, P1314, DOI 10.1001/archinte.149.6.1314; SHALIT I, 1989, ANTIMICROB AGENTS CH, V33, P593, DOI 10.1128/AAC.33.4.593; SHEN LL, 1989, J BIOL CHEM, V264, P2973; SMITH SM, 1989, ANTIMICROB AGENTS CH, V33, P181, DOI 10.1128/AAC.33.2.181; SUZUKI K, 1989, REV INFECT DIS, V11, pS969; TAKAYAMA S, 1986, ARZNEIMITTEL-FORSCH, V36-2, P1244; THORSTEINSSON SB, 1987, CHEMOTHERAPY, V33, P448, DOI 10.1159/000238534; TSUKAMURA M, 1985, AM REV RESPIR DIS, V131, P352; UNE T, 1987, ARZNEIMITTEL-FORSCH, V37-2, P1048; VANDERWILLIGEN AH, 1987, ANTIMICROB AGENTS CH, V31, P535, DOI 10.1128/AAC.31.4.535; WALLACE RJ, 1990, ANTIMICROB AGENTS CH, V34, P65, DOI 10.1128/AAC.34.1.65; WEIDNER W, 1987, AM J MED, V82, P280; WINSTON DJ, 1990, AM J MED, V88, P36, DOI 10.1016/0002-9343(90)90125-W; Wise R, 1988, Rev Infect Dis, V10 Suppl 1, pS83; WISTROM J, 1989, J ANTIMICROB CHEMOTH, V23, P905, DOI 10.1093/jac/23.6.905; WISTROM J, 1987, J ANTIMICROB CHEMOTH, V20, P563, DOI 10.1093/jac/20.4.563; WOLFSON JS, 1989, REV INFECT DIS, V11, pS960; WOLFSON JS, 1989, CLIN MICROBIOL REV, V2, P378, DOI 10.1128/CMR.2.4.378-424.1989; WOLFSON JS, 1989, ANTIMICROB AGENTS CH, V33, P1655, DOI 10.1128/AAC.33.10.1655	125	486	495	1	33	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 7	1991	324	6					384	394						11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EW296	1987461				2022-12-28	WOS:A1991EW29600006
J	NELSON, DE				NELSON, DE			A NEW METHOD FOR CARBON ISOTOPIC ANALYSIS OF PROTEIN	SCIENCE			English	Article							ACCELERATOR MASS-SPECTROMETRY; BONE-COLLAGEN; RADIOCARBON; RATIOS; MARINE; C-13	The reaction of ninhydrin with amino acids can be used in carbon isotopic studies of protein. The reaction can be applied to extract as carbon dioxide only peptide-bonded carbon in proteinaceous material, thus avoiding most, if not all, contaminants. Test radiocarbon dates on ancient bone indicate that the method provides reliable ages, and stable carbon isotopic data suggest that our understanding of isotopic dietary reconstruction needs detailed examination. The technique should also be useful in biochemical tracing experiments and in global carbon budget studies, and the underlying principle may be applicable to other isotopes and molecules.	UNIV CALIF LAWRENCE LIVERMORE NATL LAB,CTR ACCELERATOR MASS SPECT,LIVERMORE,CA 94550	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of California System								BROWN TA, 1988, RADIOCARBON, V30, P171, DOI 10.1017/S0033822200044118; CHISHOLM BS, 1982, SCIENCE, V216, P1131, DOI 10.1126/science.216.4550.1131; DENIRO MJ, 1985, NATURE, V317, P806, DOI 10.1038/317806a0; GILLESPIE R, 1984, J ARCHAEOL SCI, V11, P165, DOI 10.1016/0305-4403(84)90051-7; HARE PE, 1983, CARNEGIE I WASHINGTO, V82, P410; Hedges R.E.M., 1980, P35; HOWE EE, 1951, AMINO ACIDS PROTEINS, P30; LEHNINGER AL, 1978, BIOCHEMISTRY-US, P85; LOGIN R, 1971, NATURE, V320, P241; LOVELL NC, 1986, ARCHAEOMETRY, V28, P51, DOI 10.1111/j.1475-4754.1986.tb00373.x; LOY TH, 1990, ANTIQUITY, V64, P110, DOI 10.1017/S0003598X00077346; Morlan R.E., 1990, CANADIAN J ARCHAEOLO, V14, P75; NELSON DE, 1986, RADIOCARBON, V28, P170, DOI 10.1017/S0033822200060082; NELSON DL, COMMUNICATION; NELSON DR, UNPUB; SCHOENINGER MJ, 1984, GEOCHIM COSMOCHIM AC, V48, P625, DOI 10.1016/0016-7037(84)90091-7; SOUTHON JR, IN PRESS NUCL INSTRU; STAFFORD TW, 1988, GEOCHIM COSMOCHIM AC, V52, P2257, DOI 10.1016/0016-7037(88)90128-7; STAFFORD TW, 1987, RADIOCARBON, V29, P24; STUIVER M, 1977, RADIOCARBON, V19, P355, DOI 10.1017/S0033822200003672; Van SLYKE DONALD D., 1941, JOUR BIOL CHEM, V141, P627; Van SLYKE DONALD D., 1941, JOUR BIOL CHEM, V141, P671; VANDERMERWE NJ, 1978, NATURE, V276, P815, DOI 10.1038/276815a0; VANKLINKEN GJ, 1990, RADIOCARBON, V32, P155, DOI 10.1017/S0033822200040157; VOGEL JS, 1987, RADIOCARBON, V29, P323; VOGEL JS, IN PRESS NUCL INSTRU; WILLIAMS PM, 1987, NATURE, V330, P246, DOI 10.1038/330246a0	27	54	54	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	FEB 1	1991	251	4993					552	554		10.1126/science.1990430	http://dx.doi.org/10.1126/science.1990430			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV459	1990430				2022-12-28	WOS:A1991EV45900048
J	PEVNY, L; SIMON, MC; ROBERTSON, E; KLEIN, WH; TSAI, SF; DAGATI, V; ORKIN, SH; COSTANTINI, F				PEVNY, L; SIMON, MC; ROBERTSON, E; KLEIN, WH; TSAI, SF; DAGATI, V; ORKIN, SH; COSTANTINI, F			ERYTHROID-DIFFERENTIATION IN CHIMERIC MICE BLOCKED BY A TARGETED MUTATION IN THE GENE FOR TRANSCRIPTION FACTOR GATA-1	NATURE			English	Article							DNA-BINDING FACTOR; STEM-CELLS; EXPRESSION; PROTEIN	THE zinc-finger transcription factor GATA-1 (previously known as GF-1, NF-E1 or Eryf 1 (refs 1-5)) binds to GATA consensus elements in regulatory regions of the alpha- and beta-globin gene clusters 2-6 and other erythroid cell-specific genes 7-9. Analysis of the effects of mutations in GATA-bindig sites in cell culture and in binding assays in vitro 2,5,10,11, as well as transactivation studies with GATA-1 expression vectors in heterologous cells 12, have provided indirect evidence that this factor is involved in the activation of globin and other genes during erythroid cell maturation. GATA-1 is also expressed in megakaryocyte 13,14 and mast cells, but not in other blood cell lineages or in non-haemopoietic cells. To investigate the role of this factor in haematopoiesis in vivo, we disrupted the X-linked GATA-1 gene by homologous recombination in a male (XY) murine embryonic stem cell line and tested the GATA-1-deficient cells for their ability to contribute to different tissues in chimaeric mice. The mutant embryonic stem cells contributed to all non-haemopoietic tissues tested and to a white blood cell fraction, but failed to give rise to mature red blood cells. This demonstrates that GATA-1 is required for the normal differentiation of erythroid cells, and that other GATA-binding proteins 15,16 cannot compensate for its absence.	COLUMBIA UNIV COLL PHYS & SURG,DEPT GENET & DEV,701 W 168TH ST,NEW YORK,NY 10032; COLUMBIA UNIV COLL PHYS & SURG,DEPT PATHOL,NEW YORK,NY 10032; HARVARD UNIV,CHILDRENS HOSP,SCH MED,DEPT PEDIAT,DIV HEMATOL ONCOL,BOSTON,MA 02115; HOWARD HUGHES MED INST,BOSTON,MA 02115	Columbia University; Columbia University; Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute			Simon, Celeste/AAG-3941-2021; Tsai, Shih-Feng/E-3997-2010					BRADY HJM, 1989, FEBS LETT, V257, P451, DOI 10.1016/0014-5793(89)81594-7; DICHIARA TM, 1990, NATURE, V344, P78; EVANS T, 1988, P NATL ACAD SCI USA, V85, P5976, DOI 10.1073/pnas.85.16.5976; EVANS T, 1989, CELL, V58, P877, DOI 10.1016/0092-8674(89)90940-9; FLEISCHMAN RA, 1982, CELL, V30, P351, DOI 10.1016/0092-8674(82)90233-1; FRAMPTON J, 1990, MOL CELL BIOL, V10, P3838, DOI 10.1128/MCB.10.7.3838; KOLLER BH, 1990, SCIENCE, V248, P1227, DOI 10.1126/science.2112266; MANSOUR SL, 1988, NATURE, V236, P438; MARTIN DIK, 1990, GENE DEV, V4, P1886, DOI 10.1101/gad.4.11.1886; MARTIN DIK, 1989, NATURE, V338, P435, DOI 10.1038/338435a0; MARTIN DIK, 1990, NATURE, V344, P444, DOI 10.1038/344444a0; MCCULLOCH EA, 1964, SCIENCE, V144, P844, DOI 10.1126/science.144.3620.844; MCLAREN A, 1981, GENET RES CAMB, V37, P305; MIGNOTTE V, 1989, NUCLEIC ACIDS RES, V17, P37, DOI 10.1093/nar/17.1.37; ORKIN SH, 1990, CELL, V63, P665, DOI 10.1016/0092-8674(90)90133-Y; REITMAN M, 1988, P NATL ACAD SCI USA, V85, P6267, DOI 10.1073/pnas.85.17.6267; ROBERTSON E, 1986, NATURE, V323, P445, DOI 10.1038/323445a0; Robertson EJ, 1987, TERATOCARCINOMAS EMB, P71; ROMEO PH, 1990, NATURE, V344, P447, DOI 10.1038/344447a0; RUSSELL ES, 1974, ANN NY ACAD SCI, V241, P25, DOI 10.1111/j.1749-6632.1974.tb21864.x; SCHOLER HR, 1989, EMBO J, V8, P2543, DOI 10.1002/j.1460-2075.1989.tb08392.x; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; TSAI SF, 1989, NATURE, V339, P446, DOI 10.1038/339446a0; WALL L, 1988, GENE DEV, V2, P1089, DOI 10.1101/gad.2.9.1089; WHITNEY JB, 1978, BIOCHEM GENET, V16, P667, DOI 10.1007/BF00484723; WILSON DB, 1990, MOL CELL BIOL, V10, P4854, DOI 10.1128/MCB.10.9.4854; YAMAMOTO M, IN PRESS GENES DEV; YOUSSOUFIAN H, 1990, MOL CELL BIOL, V10, P3675, DOI 10.1128/MCB.10.7.3675; ZIJLSTRA M, 1990, NATURE, V344, P742, DOI 10.1038/344742a0; ZON LI, 1990, P NATL ACAD SCI USA, V87, P668, DOI 10.1073/pnas.87.2.668	30	1112	1139	0	20	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JAN 17	1991	349	6306					257	260		10.1038/349257a0	http://dx.doi.org/10.1038/349257a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET519	1987478				2022-12-28	WOS:A1991ET51900062
J	GOODWIN, JS				GOODWIN, JS			MERCY KILLING - MERCY FOR WHOM	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	13	13	1	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 16	1991	265	3					326	326		10.1001/jama.265.3.326	http://dx.doi.org/10.1001/jama.265.3.326			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ER256	1984530				2022-12-28	WOS:A1991ER25600009
J	LIN, HF; WOLFNER, MF				LIN, HF; WOLFNER, MF			THE DROSOPHILA MATERNAL-EFFECT GENE FS(1)YA ENCODES A CELL-CYCLE DEPENDENT NUCLEAR-ENVELOPE COMPONENT REQUIRED FOR EMBRYONIC MITOSIS	CELL			English	Article							FEMALE-STERILE MUTANTS; DNA-BINDING PROTEINS; MONOCLONAL-ANTIBODIES; DEVELOPMENTAL REGULATION; MITOTIC CONTROL; POLE CELLS; HEAT-SHOCK; MELANOGASTER; EMBRYOGENESIS; DIVISION	The maternal-effect gene fs(1)Ya is specifically required for embryonic mitosis in Drosophila. fs(1)Ya is involved in the initiation of the first embryonic mitosis and may also be necessary for subsequent embryonic mitotic divisions. fs(1)Ya encodes a 91.3 kd hydrophilic protein containing two putative MPF phosphorylation target sites and two potential nuclear localization signals. This protein is synthesized during postoogenic maturation from its maternal RNA and persists throughout embryogenesis. In early embryos, the fs(1)Ya protein is localized to the nuclear envelope from interphase to metaphase. During anaphase and telophase, it is dispersed in the nucleoplasm and cytoplasm, a behavior that is different from that of both the nuclear envelope and lamins. These results suggest that the fs(1)Ya protein is a cell cycle-dependent component of the nuclear envelope that specifically functions in embryonic mitosis.	CORNELL UNIV, GENET & DEV SECT, ITHACA, NY 14853 USA	Cornell University								ALLIS CD, 1977, DEV BIOL, V56, P372, DOI 10.1016/0012-1606(77)90277-9; BAKER BS, 1975, GENETICS, V80, P267; BERLETH T, 1988, EMBO J, V7, P1749, DOI 10.1002/j.1460-2075.1988.tb03004.x; BLOW J, 1989, TRENDS GENET, V5, P166, DOI 10.1016/0168-9525(89)90067-X; Blumenthal AB, 1974, COLD SPRING HARB SYM, V38, P205, DOI 10.1101/sqb.1974.038.01.024; BREEDEN L, 1987, CELL, V48, P389, DOI 10.1016/0092-8674(87)90190-5; BREEUWER JAJ, 1990, NATURE, V346, P558, DOI 10.1038/346558a0; BROWN NH, 1988, J MOL BIOL, V203, P425, DOI 10.1016/0022-2836(88)90010-1; CAVENER DR, 1987, NUCLEIC ACIDS RES, V15, P1353, DOI 10.1093/nar/15.4.1353; CHURCHILL MEA, 1989, EMBO J, V8, P4189, DOI 10.1002/j.1460-2075.1989.tb08604.x; COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4; CYERT MS, 1989, CELL, V57, P891, DOI 10.1016/0092-8674(89)90325-5; DIBENEDETTO AJ, 1990, DEV BIOL, V139, P134, DOI 10.1016/0012-1606(90)90284-P; DINGWALL C, 1986, ANNU REV CELL BIOL, V2, P367, DOI 10.1146/annurev.cellbio.2.1.367; DOOLITTLE FR, 1986, URFS ORFS PRIMER ANA; DRIEVER W, 1988, CELL, V54, P83, DOI 10.1016/0092-8674(88)90182-1; DUNPHY WG, 1988, CELL, V55, P925, DOI 10.1016/0092-8674(88)90234-6; EDGAR BA, 1986, CELL, V44, P871, DOI 10.1016/0092-8674(86)90009-7; EDGAR BA, 1986, CELL, V44, P365, DOI 10.1016/0092-8674(86)90771-3; EDGAR BA, 1989, CELL, V57, P177, DOI 10.1016/0092-8674(89)90183-9; ELKINS T, 1990, CELL, V60, P565, DOI 10.1016/0092-8674(90)90660-7; EVANS RM, 1988, CELL, V52, P1, DOI 10.1016/0092-8674(88)90522-3; FINNEY M, 1988, CELL, V55, P757, DOI 10.1016/0092-8674(88)90132-8; FOE VE, 1983, J CELL SCI, V61, P31; FOE VE, 1989, DEVELOPMENT, V107, P1; FOX CA, 1989, GENE DEV, V3, P2151, DOI 10.1101/gad.3.12b.2151; FOX VE, 1983, J CELL SCI, V61, P31; FRASCH M, 1988, J CELL SCI, V90, P247; FREEMAN M, 1986, CELL, V46, P457, DOI 10.1016/0092-8674(86)90666-5; FREEMAN M, 1987, GENE DEV, V1, P924, DOI 10.1101/gad.1.9.924; FUCHS JP, 1983, J CELL SCI, V64, P331; FUYAMA Y, 1984, JPN J GENET, V59, P91, DOI 10.1266/jjg.59.91; FUYAMA Y, 1986, GENETICS, V112, P237; GANS M, 1975, GENETICS, V81, P683; GERACE L, 1986, TRENDS BIOCHEM SCI, V11, P443, DOI 10.1016/0968-0004(86)90243-4; GILBERT SF, 1988, DEV BIOL, P785; GLOVER DM, 1989, J CELL SCI, V92, P137; GLOVER DM, 1990, NATURE, V348, P117, DOI 10.1038/348117a0; GOEBL M, 1988, CELL, V54, P739; GUO LH, 1984, GENE, V29, P251, DOI 10.1016/0378-1119(84)90186-0; HARLOW E, 1988, ANTIBODIES LABORATOR; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; HEALD R, 1990, CELL, V61, P579, DOI 10.1016/0092-8674(90)90470-Y; HENIKOFF S, 1984, GENE, V28, P351, DOI 10.1016/0378-1119(84)90153-7; JUDD BH, 1972, GENETICS, V71, P139; JUDD BH, 1973, COLD SPRING HARB SYM, V38, P573, DOI 10.1101/SQB.1974.038.01.061; KARR TL, 1986, J CELL BIOL, V102, P1494, DOI 10.1083/jcb.102.4.1494; KLEMENZ R, 1987, NUCLEIC ACIDS RES, V15, P3947, DOI 10.1093/nar/15.10.3947; KOMALSKI D, 1976, BIOCHEMISTRY-US, V15, P4463; KROHNE G, 1986, EXP CELL RES, V162, P1, DOI 10.1016/0014-4827(86)90421-0; KROHNE G, 1989, J CELL BIOL, V109, P2003, DOI 10.1083/jcb.109.5.2003; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; LASKO PF, 1988, NATURE, V335, P611, DOI 10.1038/335611a0; LAUGHON A, 1984, NATURE, V310, P25, DOI 10.1038/310025a0; LEHNER CF, 1989, CELL, V56, P957, DOI 10.1016/0092-8674(89)90629-6; LEHNER CF, 1990, CELL, V61, P535, DOI 10.1016/0092-8674(90)90535-M; LEWIN B, 1990, CELL, V61, P743, DOI 10.1016/0092-8674(90)90181-D; LIN H, 1989, MOL GEN GENET, V215, P257, DOI 10.1007/BF00339726; LOHKA MJ, 1989, J CELL SCI, V92, P131; Mahowald A.P., 1980, Genetics and Biology of Drosophila, V2d, P141; Maniatis T., 1982, MOL CLONING; MASUI Y, 1971, J EXP ZOOL, V177, P129, DOI 10.1002/jez.1401770202; MCGINNIS W, 1984, NATURE, V308, P428, DOI 10.1038/308428a0; MERRILL PT, 1988, DEVELOPMENT, V104, P495; MOHLER JD, 1977, GENETICS, V85, P259; MONSMA SA, 1988, GENE DEV, V2, P1063, DOI 10.1101/gad.2.9.1063; MURRAY AW, 1989, NATURE, V339, P275, DOI 10.1038/339275a0; NEWPORT J, 1987, CELL, V48, P205, DOI 10.1016/0092-8674(87)90424-7; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; OFARRELL PH, 1989, SCIENCE, V246, P635, DOI 10.1126/science.2683080; PERRIMON N, 1986, GENETICS, V113, P695; PETER M, 1990, CELL, V61, P591, DOI 10.1016/0092-8674(90)90471-P; PETER M, 1990, CELL, V60, P791, DOI 10.1016/0092-8674(90)90093-T; POOLE SJ, 1985, CELL, V40, P37, DOI 10.1016/0092-8674(85)90306-X; PTASHNE M, 1988, NATURE, V335, P683, DOI 10.1038/335683a0; QUERY CC, 1989, CELL, V57, P89, DOI 10.1016/0092-8674(89)90175-X; RAFF JW, 1989, CELL, V57, P611, DOI 10.1016/0092-8674(89)90130-X; RESTIFO LL, 1986, DEV BIOL, V115, P507, DOI 10.1016/0012-1606(86)90271-X; RISAU W, 1981, EXP CELL RES, V133, P47, DOI 10.1016/0014-4827(81)90355-4; ROBERTSON HM, 1988, GENETICS, V118, P461; SANTAMARIA P, 1980, NATURE, V287, P143, DOI 10.1038/287143a0; SAUMWEBER H, 1980, CHROMOSOMA, V80, P253, DOI 10.1007/BF00292684; SCHUPBACH T, 1989, GENETICS, V121, P101; SMITH DE, 1984, J CELL BIOL, V99, P20, DOI 10.1083/jcb.99.1.20; SMITH LD, 1971, DEV BIOL, V25, P232, DOI 10.1016/0012-1606(71)90029-7; SOLOMON M, 1988, CELL, V54, P738, DOI 10.1016/S0092-8674(88)90933-6; Sonnenblick B., 1950, BIOL DROSOPHILA, P62; STAFSTROM JP, 1984, EUR J CELL BIOL, V34, P179; STRUHL G, 1989, CELL, V57, P1259, DOI 10.1016/0092-8674(89)90062-7; SUZUKI M, 1989, EMBO J, V8, P797, DOI 10.1002/j.1460-2075.1989.tb03440.x; THEILL LE, 1989, NATURE, V342, P945, DOI 10.1038/342945a0; VASSALLI JD, 1989, GENE DEV, V3, P2163, DOI 10.1101/gad.3.12b.2163; WARD GE, 1990, CELL, V61, P561, DOI 10.1016/0092-8674(90)90469-U; WHARTON KA, 1985, CELL, V40, P55, DOI 10.1016/0092-8674(85)90308-3; WHITFIELD WGF, 1988, J CELL SCI, V89, P467; WHITFIELD WGF, 1989, NATURE, V338, P337, DOI 10.1038/338337a0; WIESCHAUS E, 1988, DEVELOPMENT, V104, P483; WOLSTENHOLME DR, 1965, GENETICS, V52, P949; XIAO H, 1989, MOL CELL BIOL, V9, P1746, DOI 10.1128/MCB.9.4.1746; YOUNG MW, 1978, GENETICS, V88, P723; ZALOKAR M, 1976, DEV BIOL, V49, P425, DOI 10.1016/0012-1606(76)90185-8; ZALOKAR M, 1976, J MICROSC BIOL CELL, V25, P97; ZALOKAR M, 1975, DEV BIOL, V47, P419, DOI 10.1016/0012-1606(75)90295-X	103	67	68	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 11	1991	64	1					49	62		10.1016/0092-8674(91)90208-G	http://dx.doi.org/10.1016/0092-8674(91)90208-G			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ET175	1986869	hybrid			2022-12-28	WOS:A1991ET17500008
J	BECERRA, JE; HOGUE, CJR; ATRASH, HK; PEREZ, N				BECERRA, JE; HOGUE, CJR; ATRASH, HK; PEREZ, N			INFANT-MORTALITY AMONG HISPANICS - A PORTRAIT OF HETEROGENEITY	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UNITED-STATES; STANDARDIZED TERMINOLOGY; MEXICAN-AMERICAN; WOMEN; POPULATIONS; LATINO; HEALTH; BIRTH	In the United States, infant mortality risks among Hispanics have not been previously evaluated at the nation level. We used the 1983 and 1984 national Linked Birth and Infant Death data sets to compare infant mortality risks among single-delivery infants of Hispanic descent with those among single-delivery infants of non-Hispanic whites (the reference group). We also included the 1983 and 1984 linked birth cohort for single-delivery infants in Puerto Rico. Among all Hispanic groups, the neonatal (< 28 days) mortality risk was higher among Puerto Rican islanders (relative risk ]RR[ = 2.3) and continental Puerto Ricans (RR = 1.5) and lower among Cuban-Americans (RR = 1.0) and Mexican-Americans (RR = 1.0). The postneonatal mortality risk (28 to 364 days) was highest among continental Puerto Ricans (RR = 1.2) and lowest among Cuban-Americans (RR = 0.6). Our study underscores the heterogeneity of the Hispanic population in the United States and suggests that interventions to prevent infant mortality be tailored to ethnic-specific risk factors and outcomes.	COMMONWEALTH PUERTO RICO DEPT HLTH,OFF HLTH STAT,SAN JUAN,PR		BECERRA, JE (corresponding author), CTR DIS CONTROL,CTR CHRON DIS PREVENT & HLTH PROMOT,DIV REPROD HLTH,ATLANTA,GA 30333, USA.		Becerra, Jose E/C-4071-2014	Becerra, Jose E/0000-0002-7425-8501				Becerra J E, 1989, P R Health Sci J, V8, P253; BUEHLER JW, 1987, PUBLIC HEALTH REP, V102, P151; FROST F, 1980, AM J PUBLIC HEALTH, V70, P974, DOI 10.2105/AJPH.70.9.974; HAYESBAUTISTA DE, 1983, AM J PUBLIC HEALTH, V73, P274, DOI 10.2105/AJPH.73.3.274; HOLCK SE, 1984, J STUD ALCOHOL, V45, P149, DOI 10.15288/jsa.1984.45.149; HOLCK SE, 1982, AM J PUBLIC HEALTH, V72, P38, DOI 10.2105/AJPH.72.1.38; HUGHES D, 1988, HLTH AM CHILDREN MAT; KLEINBAUM DG, 1982, EPIDEMIOLOGIC RES; MARKIDES KS, 1986, PUBLIC HEALTH REP, V101, P253; MCCARTHY BJ, 1980, AM J PUBLIC HEALTH, V70, P977, DOI 10.2105/AJPH.70.9.977; PEREZ N, 1981, MORTALIDAD INFANTIL; POWELLGRINER E, 1982, AM J PUBLIC HEALTH, V72, P993, DOI 10.2105/AJPH.72.9.993; PRAGER K, IN PRESS P LINKED BI; SCHUR CL, 1987, MED CARE, V25, P627, DOI 10.1097/00005650-198707000-00006; TAFFEL SM, 1987, PHS871120 US DEP HLT; TREVINO FM, 1987, AM J PUBLIC HEALTH, V77, P69, DOI 10.2105/AJPH.77.1.69; TREVINO FM, 1982, AM J PUBLIC HEALTH, V72, P979, DOI 10.2105/AJPH.72.9.979; VALDEVIESO R, 1988, US HISPANICS CHALLEN; VENTURA SJ, 1985, PUBLIC HEALTH REP, V100, P647; VENTURA SJ, 1985, PHS851120 US DEP HLT; WILLIAMS RL, 1986, AM J PUBLIC HEALTH, V76, P387, DOI 10.2105/AJPH.76.4.387; YANKAUER A, 1987, AM J PUBLIC HEALTH, V77, P15, DOI 10.2105/AJPH.77.1.15; 1988, OTAH345 OFF TECHN AS; 1987, PHS881122 US DEP HLT; 1988, PHS891232; 1989, LINKED BIRTH INFANT; 1984, PAHO EPIDEMIOL B, V5, P1; 1985, REPORT SECRETARYS TA; 1988, PHS881120 US DEP HLT, V37; 1988, PHS881101 US DEP HLT; 1989, PHS891120 US DEP HLT; [No title captured]; 1985, HRSPDV851 US DEP HLT; 1982, RES ISSUES ASSESSMEN	35	124	124	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 9	1991	265	2					217	221		10.1001/jama.265.2.217	http://dx.doi.org/10.1001/jama.265.2.217			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EQ602	1984150				2022-12-28	WOS:A1991EQ60200028
J	GOLDEN, MHN; BROOKS, SEH; RAMDATH, DD; TAYLOR, E				GOLDEN, MHN; BROOKS, SEH; RAMDATH, DD; TAYLOR, E			EFFACEMENT OF GLOMERULAR FOOT PROCESSES IN KWASHIORKOR	LANCET			English	Article									UNIV W INDIES, DEPT PATHOL, KINGSTON 7, JAMAICA	University West Indies Mona Jamaica	GOLDEN, MHN (corresponding author), UNIV W INDIES, TROP MED RES UNIT, KINGSTON 7, JAMAICA.		Golden, Michael/AAB-8989-2020	Golden, Michael/0000-0002-4039-7538				BRAVO ME, 1982, EUR J CLIN PHARMACOL, V21, P499, DOI 10.1007/BF00542045; COTRAN RS, 1983, NEW ENGL J MED, V309, P1050, DOI 10.1056/NEJM198310273091709; FISHER ER, 1967, LAB INVEST, V17, P99; FORRESTER T, 1990, EUR J CLIN NUTR, V44, P363; GOLDEN M, 1988, T ROY SOC TROP MED H, V82, P3, DOI 10.1016/0035-9203(88)90245-3; HALLCRAGGS M, 1980, HUM PATHOL, V11, P23, DOI 10.1016/S0046-8177(80)80102-X; JACKSON AA, 1987, OXFORD TXB MED, P823; KANWAR YS, 1979, P NATL ACAD SCI USA, V76, P1303, DOI 10.1073/pnas.76.3.1303; KLAHR S, 1973, KIDNEY INT, V3, P129, DOI 10.1038/ki.1973.21; KLAHR S, 1988, NUTRITION KIDNEY, P59; LATTA H, 1975, J ULTRA MOL STRUCT R, V51, P354, DOI 10.1016/S0022-5320(75)80100-6; LATTA H, 1976, J ULTRA MOL STRUCT R, V57, P65, DOI 10.1016/S0022-5320(76)80055-X; MARTINEZHERNANDEZ A, 1983, LAB INVEST, V48, P656; MICHAEL AF, 1970, LAB INVEST, V23, P649; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; SEILER MW, 1977, LAB INVEST, V36, P48; SEILER MW, 1975, SCIENCE, V189, P390, DOI 10.1126/science.1145209; VERNIER RL, 1983, NEW ENGL J MED, V309, P1001, DOI 10.1056/NEJM198310273091701	18	16	16	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 15	1990	336	8729					1472	1474		10.1016/0140-6736(90)93180-W	http://dx.doi.org/10.1016/0140-6736(90)93180-W			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EN157	1979094				2022-12-28	WOS:A1990EN15700005
J	OBRIEN, E; MEE, F; ATKINS, N; OMALLEY, K				OBRIEN, E; MEE, F; ATKINS, N; OMALLEY, K			INACCURACY OF THE HAWKSLEY RANDOM ZERO SPHYGMOMANOMETER	LANCET			English	Article							BLOOD-PRESSURE; DEVICES; PERFORMANCE		ROYAL COLL SURG IRELAND, DEPT CLIN PHARMACOL, DUBLIN 2, IRELAND	Royal College of Surgeons - Ireland	OBRIEN, E (corresponding author), BEAUMONT HOSP, BLOOD PRESSURE UNIT, DUBLIN 9, IRELAND.			Atkins, Neil/0000-0002-9575-4686				[Anonymous], 1980, LANCET, V1, P1261; DEGAUDEMARIS R, 1985, AM J EPIDEMIOL, V121, P282, DOI 10.1093/oxfordjournals.aje.a113998; EVANS JG, 1970, BRIT J PREV SOC MED, V24, P10; FITZGERALD DJ, 1982, BRIT MED J, V284, P18, DOI 10.1136/bmj.284.6308.18; GARROW JS, 1963, LANCET, V2, P1205; HAYLER CR, 1985, BRIT MED J, V291, P137, DOI 10.1136/bmj.291.6488.137-c; HENSE HW, 1990, LANCET, V336, P254; HOSIE GAC, 1985, BRIT MED J, V291, P137, DOI 10.1136/bmj.291.6488.137-d; HUNYOR SN, 1978, BRIT MED J, V2, P159, DOI 10.1136/bmj.2.6131.159; Hypertension Detection Follow-up Program Cooperative Group, 1979, JAMA-J AM MED ASSOC, V242, P2562, DOI DOI 10.1001/JAMA.1979.03300230018021; JAMIESON M, 1989, BLOOD PRESSURE MEASU; KRONMAL RA, 1990, LANCET, V336, P255; KRONMAL RA, 1990, LANCET, V335, P360, DOI 10.1016/0140-6736(90)90652-L; LABARTHE DR, 1973, AM J CARDIOL, V32, P546, DOI 10.1016/S0002-9149(73)80046-3; OBRIEN E, 1990, J HYPERTENS, V8, P607, DOI 10.1097/00004872-199007000-00004; OBRIEN ET, 1979, BRIT MED J, V2, P775, DOI 10.1136/bmj.2.6193.775; PARKER D, 1988, HYPERTENSION, V11, P269, DOI 10.1161/01.HYP.11.3.269; POOLE PH, 1990, LANCET, V336, P254, DOI 10.1016/0140-6736(90)91787-B; PRINEAS RJ, 1980, HYPERTENSION, V2, pI18, DOI 10.1161/01.HYP.2.4_Pt_2.I18; ROSE GA, 1964, LANCET, V1, P296; SILMAN AJ, 1985, BRIT MED J, V290, P1781, DOI 10.1136/bmj.290.6484.1781; Sloan P J, 1984, J Hypertens, V2, P547, DOI 10.1097/00004872-198410000-00016; STEINER R, 1985, J HYPERTENS, V3, P23; WILHELMSEN L, 1987, J HYPERTENS, V5, P561, DOI 10.1097/00004872-198710000-00009; WRIGHT BM, 1970, LANCET, V1, P337; 1977, BRIT MED J, V1, P1437; 1987, AM NATIONAL STANDARD	27	110	110	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 15	1990	336	8729					1465	1468		10.1016/0140-6736(90)93177-Q	http://dx.doi.org/10.1016/0140-6736(90)93177-Q			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EN157	1979092				2022-12-28	WOS:A1990EN15700003
J	CAMPBELL, S; SOOTHILL, PW				CAMPBELL, S; SOOTHILL, PW			ROLE OF FETAL BLOOD-GAS ANALYSIS IN INTRAUTERINE GROWTH-RETARDATION	LANCET			English	Letter											CAMPBELL, S (corresponding author), UNIV LONDON KINGS COLL HOSP,DEPT OBSTET & GYNAECOL,LONDON SE5 8RX,ENGLAND.		Soothill, Peter/D-2814-2009					BILARDO CM, 1990, AM J OBSTET GYNECOL, V162, P115, DOI 10.1016/0002-9378(90)90833-S; NICOLAIDES KH, 1988, BRIT MED J, V297, P1026, DOI 10.1136/bmj.297.6655.1026; NICOLINI, 1990, LANCET, V336, P768; STANLEY FJ, 1988, AM J OBSTET GYNECOL, V158, P89, DOI 10.1016/0002-9378(88)90784-3; VYAS S, 1990, BRIT J OBSTET GYNAEC, V97, P797, DOI 10.1111/j.1471-0528.1990.tb02573.x	5	1	1	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 24	1990	336	8726					1316	1317		10.1016/0140-6736(90)92999-X	http://dx.doi.org/10.1016/0140-6736(90)92999-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ943	1978137				2022-12-28	WOS:A1990EJ94300034
J	TAMIMI, TM; WOSORNU, L; ALKHOZAIM, A; ABDULGHANI, A				TAMIMI, TM; WOSORNU, L; ALKHOZAIM, A; ABDULGHANI, A			INCREASED CHOLECYSTECTOMY RATES IN SAUDI-ARABIA	LANCET			English	Article									KING FAISAL UNIV,KING FAHD HOSP,DEPT SURG,AL KHOBAR,SAUDI ARABIA; KING FAISAL UNIV,KING FAHD HOSP,DEPT HAEMATOL,AL KHOBAR,SAUDI ARABIA	Imam Abdulrahman Bin Faisal University; King Faisal University; Imam Abdulrahman Bin Faisal University; King Faisal University								ACALOVSCHI M, 1987, DIGEST DIS SCI, V32, P354, DOI 10.1007/BF01296287; BATES T, 1990, J ROY SOC MED, V83, P176, DOI 10.1177/014107689008300316; BENNION LJ, 1978, NEW ENGL J MED, V299, P1221, DOI 10.1056/NEJM197811302992205; BENNION LJ, 1978, NEW ENGL J MED, V299, P1161, DOI 10.1056/NEJM197811232992104; BIANTON D, 1976, NEW ENGL J MED, V294, P1147; BOUCHIER IA, 1969, GUT, V10, P705, DOI 10.1136/gut.10.9.705; BRETT M, 1976, INT J EPIDEMIOL, V5, P335, DOI 10.1093/ije/5.4.335; BURKITT DP, 1973, BMJ-BRIT MED J, V1, P274, DOI 10.1136/bmj.1.5848.274; BURKITT DP, 1975, J TROP MED HYG, V78, P140; CRANSTON D, 1988, BRIT J SURG, V75, P508, DOI 10.1002/bjs.1800750604; DIEHL AK, 1987, LANCET, V2, P683; HEATON KW, 1975, REFINED CARBOHYDRATE, P173; KALSER MH, 1985, GASTROENTEROLOGY, V6, P3619; LOEFLER IJP, 1988, LANCET, V2, P683; LOWENFELS AB, 1988, LANCET, V1, P1385; MOFTI AB, 1987, ANN SAUDI MED, V7, P107, DOI 10.5144/0256-4947.1987.107; NASSR HAR, 1987, SAUDI MED J, V8, P396; NORRBY S, 1986, SCAND J GASTROENTERO, V21, P158, DOI 10.3109/00365528609034641; PHILIPP R, 1987, LANCET, V1, P170; PIXLEY F, 1985, BRIT MED J, V291, P11, DOI 10.1136/bmj.291.6487.11; SAMPLINER RE, 1970, NEW ENGL J MED, V283, P1358, DOI 10.1056/NEJM197012172832502; SCRAGG RKR, 1984, BRIT MED J, V288, P1113, DOI 10.1136/bmj.288.6424.1113; 1988, FOOD BALANCE SHEETS; 1984, AM J EPIDEMIOL, V119, P796	24	24	24	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 17	1990	336	8725					1235	1237		10.1016/0140-6736(90)92845-9	http://dx.doi.org/10.1016/0140-6736(90)92845-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ064	1978082				2022-12-28	WOS:A1990EJ06400015
J	GRIMM, G; ODER, W; PRAYER, L; FERENCI, P; MADL, C				GRIMM, G; ODER, W; PRAYER, L; FERENCI, P; MADL, C			EVOKED-POTENTIALS IN ASSESSMENT AND FOLLOW-UP OF PATIENTS WITH WILSONS-DISEASE	LANCET			English	Article									UNIV VIENNA,DEPT MED,A-1090 VIENNA,AUSTRIA; UNIV VIENNA,DEPT NEUROL,A-1090 VIENNA,AUSTRIA; UNIV VIENNA,DEPT RADIOL,A-1090 VIENNA,AUSTRIA; UNIV VIENNA,DEPT GASTROENTEROL & HEPATOL,A-1090 VIENNA,AUSTRIA	University of Vienna; University of Vienna; University of Vienna; University of Vienna								ANDERSON DC, 1984, ARCH NEUROL-CHICAGO, V41, P369, DOI 10.1001/archneur.1984.04050160031011; CANT BR, 1986, EVOKED POTENTIAL, P58; CHIAPPA KH, 1988, NEUROL CLIN, V6, P161; CHU NS, 1986, BRAIN, V109, P491, DOI 10.1093/brain/109.3.491; FUJITA M, 1981, ANN NEUROL, V9, P42, DOI 10.1002/ana.410090108; GRIMM G, IN PRESS NEUROLOGY; HOROUPIAN DS, 1988, CLIN NEUROPATHOL, V7, P62; ROACH ES, 1985, J NEUROL, V232, P20, DOI 10.1007/BF00314035; STAROSTARUBINSTEIN S, 1987, ARCH NEUROL-CHICAGO, V44, P365, DOI 10.1001/archneur.1987.00520160007005; STOCKARD JJ, 1977, MAYO CLIN PROC, V52, P761; WALSHE JM, 1988, LANCET, V2, P435; [No title captured]	12	48	49	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 20	1990	336	8721					963	964		10.1016/0140-6736(90)92419-I	http://dx.doi.org/10.1016/0140-6736(90)92419-I			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ED601	1977004				2022-12-28	WOS:A1990ED60100003
J	[Anonymous]				[Anonymous]			TREATMENT OF ORAL LICHEN-PLANUS	LANCET			English	Editorial Material																		BAGAN JV, 1985, ORAL SURG ORAL MED O, V60, P608, DOI 10.1016/0030-4220(85)90362-7; BOLLAG W, 1989, LANCET, V2, P974; CAMISA C, 1986, ORAL SURG ORAL MED O, V62, P393, DOI 10.1016/0030-4220(86)90288-4; CAWSON RA, 1968, BRIT MED J, V1, P86, DOI 10.1136/bmj.1.5584.86; CONKLIN RJ, 1987, DERMATOL CLIN, V5, P663, DOI 10.1016/S0733-8635(18)30709-5; EISEN D, 1990, NEW ENGL J MED, V323, P290, DOI 10.1056/NEJM199008023230502; FRANCES C, 1988, DERMATOLOGICA, V177, P194, DOI 10.1159/000248548; GIUSTINA TA, 1986, ARCH DERMATOL, V122, P534, DOI 10.1001/archderm.122.5.534; LOZADA F, 1980, ARCH DERMATOL, V116, P898, DOI 10.1001/archderm.116.8.898; LOZADA F, 1981, ORAL SURG ORAL MED O, V52, P257, DOI 10.1016/0030-4220(81)90258-9; Matthews R W, 1989, Ann Dent, V48, P41; PLEMONS JM, 1990, ORAL SURG ORAL MED O, V69, P688, DOI 10.1016/0030-4220(90)90349-W; RONBECK BA, 1990, ORAL SURG ORAL MED O, V69, P694, DOI 10.1016/0030-4220(90)90350-2; SCHULLY C, 1985, J ORAL PATHOL MED, V14, P431, DOI 10.1111/j.1600-0714.1985.tb00516.x; SILVERMAN S, 1985, ORAL SURG ORAL MED O, V59, P360, DOI 10.1016/0030-4220(85)90060-X; SLEEPER HR, 1967, YALE J BIOL MED, V40, P164; SLOBERG K, 1979, ARCH DERMATOL, V115, P716, DOI 10.1001/archderm.115.6.716; THORN JJ, 1988, J ORAL PATHOL MED, V17, P213, DOI 10.1111/j.1600-0714.1988.tb01527.x; TYLDESLEY WR, 1977, BRIT J DERMATOL, V96, P659, DOI 10.1111/j.1365-2133.1977.tb05211.x; ZEGARELLI E V, 1960, Oral Surg Oral Med Oral Pathol, V13, P170, DOI 10.1016/0030-4220(60)90426-6	20	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 13	1990	336	8720					913	914						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EC456	1976935				2022-12-28	WOS:A1990EC45600009
J	BRAHAMS, D				BRAHAMS, D			CONFIDENTIAL DOCUMENTS IN HIV HEMOPHILIA LITIGATION	LANCET			English	Editorial Material																		BRAHAMS D, 1990, LANCET, V336, P238, DOI 10.1016/0140-6736(90)91753-W; BRAHAMS D, 1990, LANCET, V335, P528, DOI 10.1016/0140-6736(90)90751-P; BRAHAMS D, 1984, LANCET, V2, P1224	3	0	0	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	SEP 29	1990	336	8718					805	805		10.1016/0140-6736(90)93260-V	http://dx.doi.org/10.1016/0140-6736(90)93260-V			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB077	1976159				2022-12-28	WOS:A1990EB07700021
J	BERTORELLO, AM; HOPFIELD, JF; APERIA, A; GREENGARD, P				BERTORELLO, AM; HOPFIELD, JF; APERIA, A; GREENGARD, P			INHIBITION BY DOPAMINE OF (NA++K+)ATPASE ACTIVITY IN NEOSTRIATAL NEURONS THROUGH D1 AND D2 DOPAMINE RECEPTOR SYNERGISM	NATURE			English	Article									ROCKEFELLER UNIV,MOLEC & CELLULAR NEUROSCI LAB,NEW YORK,NY 10021; KAROLINSKA INST,ST GORANS CHILDRENS HOSP,DEPT PEDIAT,S-11281 STOCKHOLM,SWEDEN	Rockefeller University; Karolinska Institutet								APERIA A, 1987, AM J PHYSIOL, V252, pF39, DOI 10.1152/ajprenal.1987.252.1.F39; BERTORELLO A, 1987, ACTA PHYSIOL SCAND, V130, P571, DOI 10.1111/j.1748-1716.1987.tb08178.x; BERTORELLO A, 1989, AM J PHYSIOL, V256, pF57, DOI 10.1152/ajprenal.1989.256.1.F57; BERTORELLO A, 1988, ACTA PHYSIOL SCAND, V132, P441, DOI 10.1111/j.1748-1716.1988.tb08350.x; BERTORELLO A, 1989, AM J PHYSIOL, V256, pG370; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CARLSSON A, 1988, NEUROPSYCHOPHARMACOL, V1, P179, DOI 10.1016/0893-133X(88)90012-7; CLARK D, 1987, SYNAPSE, V1, P347, DOI 10.1002/syn.890010408; DAPRADA M, 1984, EXPERIENTIA, V40, P1165; FREEDMAN JE, 1988, P NATL ACAD SCI USA, V85, P3618, DOI 10.1073/pnas.85.10.3618; GADSBY DC, 1983, NATURE, V306, P691, DOI 10.1038/306691a0; GERFEN CR, 1988, J ELECTRON MICR TECH, V10, P265, DOI 10.1002/jemt.1060100305; Glynn I. M., 1985, ENZYMES BIOL MEMBR, P35; HEMMINGS HC, 1987, RECEPTOR BIOCH METHO, V9, P115; KAY AR, 1986, J NEUROSCI METH, V16, P227, DOI 10.1016/0165-0270(86)90040-3; KEBABIAN JW, 1972, P NATL ACAD SCI USA, V69, P2145, DOI 10.1073/pnas.69.8.2145; LAFFERTY P, 1985, BIOCHEM PHARMACOL, V34, P3591, DOI 10.1016/0006-2952(85)90738-5; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MERCURI N, 1985, BRAIN RES, V358, P110, DOI 10.1016/0006-8993(85)90954-0; PHILLIS JW, 1981, PROG NEUROBIOL, V17, P141, DOI 10.1016/0301-0082(81)90012-5; RICHFIELD EK, 1989, NEUROSCIENCE, V30, P767, DOI 10.1016/0306-4522(89)90168-1; SHARP T, 1986, J NEUROCHEM, V47, P113; SKOU JC, 1965, PHYSIOL REV, V45, P596, DOI 10.1152/physrev.1965.45.3.596; SMITH PA, 1986, NEUROSCI LETT, V71, P72, DOI 10.1016/0304-3940(86)90259-4; SMITH PA, 1984, TRENDS PHARMACOL SCI, P422; STOOF JC, 1984, LIFE SCI, V35, P2281, DOI 10.1016/0024-3205(84)90519-8; VANDERKROGT JA, 1980, BIOCHEM PHARMACOL, V29, P857, DOI 10.1016/0006-2952(80)90215-4; WANG RY, 1987, DOPAMINE RECEPTORS, P153	28	280	282	1	10	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	SEP 27	1990	347	6291					386	388		10.1038/347386a0	http://dx.doi.org/10.1038/347386a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA564	1977083				2022-12-28	WOS:A1990EA56400064
J	DUPUY, JM; FREIDEL, L				DUPUY, JM; FREIDEL, L			LAG BETWEEN DISCOVERY AND PRODUCTION OF NEW VACCINES FOR THE DEVELOPING-WORLD	LANCET			English	Editorial Material											DUPUY, JM (corresponding author), PASTEUR MERIEUX SERUMS & VACCINS,58 AVE LECLERC,F-69007 LYONS,FRANCE.							GIBBONS A, 1990, SCIENCE, V249, P678; HINMAN AR, 1990, LANCET, P707; HINMAN AR, 1989, REV INFECT DIS S3, V11, P663; ROBBINS A, 1988, SCI AM, V259, P126, DOI 10.1038/scientificamerican1188-126; ROBBINS A, 1990, LANCET, P1436	5	7	8	0	2	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	SEP 22	1990	336	8717					733	734		10.1016/0140-6736(90)92216-5	http://dx.doi.org/10.1016/0140-6736(90)92216-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DZ624	1975902				2022-12-28	WOS:A1990DZ62400014
J	WINKLER, J; NEUMANLEVIN, M; BONER, G				WINKLER, J; NEUMANLEVIN, M; BONER, G			A SUCCESSFUL TREATMENT OF AN INTRARENAL ARTERIOVENOUS-FISTULA BY PERCUTANEOUS EMBOLIZATION	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Note								A 37-year-old woman patient, known to have poorly controlled arterial hypertension that was diagnosed following a cerebrovascular accident at the age of 15 years, was referred to our outpatient clinic for investigation in 1987. An intrarenal arteriovenous fistula was diagnosed by selective renal angiography. Embolization of the fistula was performed using four 15-mm/5-cm coils, which induced thrombosis and obstructed the fistula. The vascularization of the affected kidney improved immediately. During the following 4 months, the antihypertensive treatment was stopped gradually, and the patient remained normotensive. This is an unusual case of a large intrarenal arteriovenous fistula, whose etiology was not clear, that was successfully treated by percutaneous embolization.	BEILINSON MED CTR,NEPHROL UNIT,IL-49100 PETAH TIQWA,ISRAEL; BEILINSON MED CTR,DEPT RADIOL,IL-49100 PETAH TIQWA,ISRAEL; TEL AVIV UNIV,SACKLER SCH MED,TEL AVIV,ISRAEL	Rabin Medical Center; Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine								BECKER GJ, 1984, SEMIN INTERVENT RAD, V1, P118; CHO KJ, 1984, SEM INTERVENT RADIOL, V1, P130; INGRAM CW, 1987, CHEST, V92, P1117, DOI 10.1378/chest.92.6.1117; JAHNKE RW, 1976, J UROLOGY, V115, P646; KIRKPATRICK JR, 1984, J TRAUMA, V15, P363; MALDONADO JE, 1964, AM J MED, V37, P499, DOI 10.1016/0002-9343(64)90064-6; MAZER MJ, 1984, SEMINARS INTERVENT R, V1, P95; MCALHANY JC, 1971, AM J SURG, V122, P117, DOI 10.1016/0002-9610(71)90363-1; OBRIEN DP, 1974, SURG GYNECOL OBSTET, V139, P739; RIBA LW, 1967, J UROLOGY, V98, P293, DOI 10.1016/S0022-5347(17)62873-8; TADAVARTHY SM, 1984, SEMIN INTERVENT RAD, V1, P101; THOMAS RG, 1962, BRIT J RADIOL, V35, P128, DOI 10.1259/0007-1285-35-410-128; TYNES WV, 1970, J UROLOGY, V103, P692, DOI 10.1016/S0022-5347(17)62029-9	13	7	7	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	1991	265	5					631	632		10.1001/jama.265.5.631	http://dx.doi.org/10.1001/jama.265.5.631			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EV718	1987414				2022-12-28	WOS:A1991EV71800022
J	HEIJERMAN, HG; LAMERS, CB; BAKKER, W				HEIJERMAN, HG; LAMERS, CB; BAKKER, W			OMEPRAZOLE ENHANCES THE EFFICACY OF PANCREATIN (PANCREASE) IN CYSTIC-FIBROSIS	ANNALS OF INTERNAL MEDICINE			English	Article							ENTERIC-COATED PREPARATION; STEATORRHEA; ACIDITY	We studied the effect of the addition of omeprazole (20 mg once a day) to treatment with pancreatin (Pancrease, Cilag, Herentals, Belgium), two or four capsules three times a day, on fecal fat excretion in a double-blind, crossover fashion in nine patients with cystic fibrosis having persistent steatorrhea while taking Pancrease, two capsules three times a day (mean fecal fat excretion, 22.3%; range, 12% to 44%). Neither doubling of the dose of Pancrease nor addition of omeprazole to the lower dose of Pancrease significantly reduced fecal fat excretion (mean, 19.6% [range, 10% to 34%]; mean, 16.4% [range, 6% to 32%], respectively). However, addition of omeprazole to the higher dose of Pancrease (four capsules three times a day) significantly reduced fecal fat excretion when compared with the two doses of Pancrease alone (mean, 10.7%; range, 4% to 25%; P < 0.01). We conclude that adjunct therapy with omeprazole reduces fecal fat excretion in cystic fibrosis provided that a high dose of Pancrease is supplied.	STATE UNIV LEIDEN HOSP, 2333 AA LEIDEN, NETHERLANDS	Leiden University; Leiden University Medical Center (LUMC)	HEIJERMAN, HG (corresponding author), LEYENBURG HOSP, CTR ADULT CYST FIBROSIS, DEPT PULM, THE HAGUE, NETHERLANDS.							BOUQUET J, 1988, J PEDIATR GASTR NUTR, V7, pS30, DOI 10.1097/00005176-198811001-00007; COREY M, 1988, J CLIN EPIDEMIOL, V41, P583, DOI 10.1016/0895-4356(88)90063-7; GOW R, 1981, LANCET, V2, P1071; HEIJERMAN HG, 1987, LANCET, V2, P1187; LLOYDSTILL JD, 1983, TXB CYSTIC FIBROSIS; STEAD RJ, 1987, THORAX, V42, P533, DOI 10.1136/thx.42.7.533; van de Kamer JH, 1958, STAND METH CLIN CHEM, V2, P34; WALT RP, 1983, BRIT MED J, V287, P12, DOI 10.1136/bmj.287.6384.12; ZENTLERMUNRO PL, 1984, GUT, V25, P500, DOI 10.1136/gut.25.5.500	9	64	98	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 1	1991	114	3					200	201		10.7326/0003-4819-114-3-200	http://dx.doi.org/10.7326/0003-4819-114-3-200			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EV339	1984743				2022-12-28	WOS:A1991EV33900005
J	LEHRER, RI; GANZ, T; SELSTED, ME				LEHRER, RI; GANZ, T; SELSTED, ME			DEFENSINS - ENDOGENOUS ANTIBIOTIC PEPTIDES OF ANIMAL-CELLS	CELL			English	Review							EXPRESSION; MECHANISM		UNIV CALIF LOS ANGELES,SCH MED,WILL ROGERS INST,PULM RES LABS,LOS ANGELES,CA 90024; UNIV CALIF IRVINE,SCH MED,DEPT PATHOL,IRVINE,CA 92717; UNIV CALIF IRVINE,SCH MED,DEPT MICROBIOL & MOLEC GENET,IRVINE,CA 92717	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Irvine; University of California System; University of California Irvine	LEHRER, RI (corresponding author), UNIV CALIF LOS ANGELES,SCH MED,DEPT MED,LOS ANGELES,CA 90024, USA.		Ganz, Tomas/AAN-3308-2020; Ganz, Tomas/D-4567-2009	Ganz, Tomas/0000-0002-2830-5469				DAHER KA, 1988, P NATL ACAD SCI USA, V85, P7327, DOI 10.1073/pnas.85.19.7327; DIMARCQ JL, 1990, EMBO J, V9, P2507, DOI 10.1002/j.1460-2075.1990.tb07430.x; FIELDS PI, 1989, SCIENCE, V243, P1059, DOI 10.1126/science.2646710; GANZ T, 1989, J IMMUNOL, V143, P1358; GANZ T, 1990, EUR J HAEMATOL, V44, P1; KAGAN BL, 1990, P NATL ACAD SCI USA, V87, P210, DOI 10.1073/pnas.87.1.210; LAMBERT J, 1989, P NATL ACAD SCI USA, V86, P262, DOI 10.1073/pnas.86.1.262; LEHRER RI, 1990, BLOOD, V76, P2169; LEHRER RI, 1989, J CLIN INVEST, V84, P553, DOI 10.1172/JCI114198; LICHTENSTEIN AK, 1988, J IMMUNOL, V140, P2686; MILLER SI, 1989, P NATL ACAD SCI USA, V86, P5054, DOI 10.1073/pnas.86.13.5054; OUELLETTE AJ, 1989, J CELL BIOL, V108, P1687, DOI 10.1083/jcb.108.5.1687; SELSTED ME, 1989, J BIOL CHEM, V264, P4003; SPARKES RS, 1989, GENOMICS, V5, P240, DOI 10.1016/0888-7543(89)90052-9; TERRITO MC, 1989, J CLIN INVEST, V84, P2017, DOI 10.1172/JCI114394; TOMINAGA T, 1990, J ENDOCRINOL, V125, P287, DOI 10.1677/joe.0.1250287; ZHU QH, 1988, P NATL ACAD SCI USA, V85, P592, DOI 10.1073/pnas.85.2.592	17	331	359	1	13	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	JAN 25	1991	64	2					229	230		10.1016/0092-8674(91)90632-9	http://dx.doi.org/10.1016/0092-8674(91)90632-9			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EV336	1988144				2022-12-28	WOS:A1991EV33600001
J	BIX, M; LIAO, NS; ZIJLSTRA, M; LORING, J; JAENISCH, R; RAULET, D				BIX, M; LIAO, NS; ZIJLSTRA, M; LORING, J; JAENISCH, R; RAULET, D			REJECTION OF CLASS-I MHC-DEFICIENT HEMATOPOIETIC-CELLS BY IRRADIATED MHC-MATCHED MICE	NATURE			English	Article							BONE-MARROW ALLOGRAFTS; NATURAL-KILLER CELLS; EMBRYONIC STEM-CELLS; GRAFT-REJECTION; T-CELLS; HISTOCOMPATIBILITY ANTIGENS; HOMOLOGOUS RECOMBINATION; EXPRESSION; SUSCEPTIBILITY; DIFFERENTIATION	IRRADIATED MHC-heterozygous mice often reject bone marrow cells transplanted from one of the homozygous parental strains, a phenomenon ('hybrid resistance') that appears to violate the laws of transplantation 1,2. Rejection of parental and allogeneic marrow cells also differs from conventional T cell-mediated rejection mechanisms as it is effected by NK1.1+ cells 3-5. To account for the unusual specificity of bone marrow rejection, it has been proposed that NK1.1+ cells destroy marrow cells that fail to express the full complement of self MHC class I (MHC-I) molecules 5. We show here that NK1.1+ cells in normal mice reject haemopoietic transplants from mice that are deficient for normal cell-surface MHC-I expression because of a targeted mutation in the beta-2-microglobulin gene 6-9. These findings demonstrate that deficient expression of MHC-I molecules renders marrow cells susceptible to rejection.	MIT,CTR CANC RES,CAMBRIDGE,MA 02139; MIT,DEPT BIOL,CAMBRIDGE,MA 02139; MIT,DEPT BIOL,CAMBRIDGE,MA 02142; WHITEHEAD INST BIOMED RES,CAMBRIDGE,MA 02142	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute			Liao, Nan-Shih/ABE-7580-2020; Loring, Jeanne F/A-1620-2011	Liao, Nan-Shih/0000-0003-3707-4145; Loring, Jeanne F/0000-0001-6226-9767; Bix, Mark/0000-0003-4617-0497; Raulet, David/0000-0002-1257-8649				CUDKOWICZ G, 1964, NATURE, V204, P450, DOI 10.1038/204450a0; CUDKOWICZ G, 1971, J EXP MED, V134, P1513, DOI 10.1084/jem.134.6.1513; CUDKOWICZ G, 1973, TRANSPLANT P, V4, P1399; DENNERT G, 1990, IMMUNOGENETICS, V31, P161; FOWLKES BJ, 1985, J EXP MED, V162, P802, DOI 10.1084/jem.162.3.802; HARELBELLAN A, 1986, P NATL ACAD SCI USA, V83, P5688, DOI 10.1073/pnas.83.15.5688; HERBERMAN RB, 1981, SCIENCE, V214, P24, DOI 10.1126/science.7025208; HOGLUND P, 1988, J EXP MED, V168, P1469, DOI 10.1084/jem.168.4.1469; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; KIESSLING R, 1977, EUR J IMMUNOL, V7, P655, DOI 10.1002/eji.1830070915; KLEIN J, 1978, IMMUNOGENETICS, V6, P489, DOI 10.1007/BF01563941; KOLLER BH, 1989, P NATL ACAD SCI USA, V86, P8932, DOI 10.1073/pnas.86.22.8932; KOLLER BH, 1990, SCIENCE, V248, P1227, DOI 10.1126/science.2112266; KOO GC, 1986, J IMMUNOL, V137, P3742; LIAO NS, 1989, J EXP MED, V170, P135, DOI 10.1084/jem.170.1.135; MURPHY WJ, 1987, J EXP MED, V166, P1499, DOI 10.1084/jem.166.5.1499; MURPHY WJ, 1987, J EXP MED, V165, P1212, DOI 10.1084/jem.165.4.1212; OHLEN C, 1989, SCIENCE, V246, P666, DOI 10.1126/science.2814488; REMBECKI RM, 1987, J IMMUNOL, V138, P2734; SCHRIER PI, 1983, NATURE, V305, P771, DOI 10.1038/305771a0; SHIMIZU Y, 1989, EUR J IMMUNOL, V19, P447, DOI 10.1002/eji.1830190306; STALLCUP KC, 1981, J IMMUNOL, V127, P923; STORKUS WJ, 1987, J IMMUNOL, V138, P1657; STUMHOFEL K, 1990, EUR J IMMUNOL, V20, P171; YANKELEVICH B, 1989, J IMMUNOL, V142, P3423; ZIJLSTRA M, 1989, NATURE, V342, P435, DOI 10.1038/342435a0; ZIJLSTRA M, 1990, NATURE, V344, P742, DOI 10.1038/344742a0	27	359	384	0	3	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JAN 24	1991	349	6307					329	331		10.1038/349329a0	http://dx.doi.org/10.1038/349329a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU501	1987491				2022-12-28	WOS:A1991EU50100052
J	BATES, DW; GOLDMAN, L; LEE, TH				BATES, DW; GOLDMAN, L; LEE, TH			CONTAMINANT BLOOD CULTURES AND RESOURCE UTILIZATION - THE TRUE CONSEQUENCES OF FALSE-POSITIVE RESULTS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COSTS	To determine whether contaminant blood cultures increase resource utilization, we studied charge and length of stay data for episodes in which blood cultures were obtained from hospitalized adults. Compared with 1097 negative episodes, 94 false-positive episodes were associated with increased subsequent length of stay (median, 12.5 vs 8 days) and subsequent total charges (median, $13 116 vs $8731), pharmacy charges (median, $1456 vs $798), and laboratory charges (median, $2057 vs $1426). In multivariate analyses, contaminants were independently correlated with 20% and 39% increases in total subsequent laboratory charges and intravenous antibiotic charges, respectively. Thus, the true costs of contaminants may greatly exceed those of the test itself. Identifying patients at very low risk of bacteremia and attention to sterile technique may reduce costs by decreasing the frequency of contaminants.	BRIGHAM & WOMENS HOSP,DEPT MED,DIV CLIN EPIDEMIOL,75 FRANCIS ST,BOSTON,MA 02115; BRIGHAM & WOMENS HOSP,DEPT MED,DIV GEN MED,BOSTON,MA 02115; HARVARD UNIV,SCH MED,BOSTON,MA 02115	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School					AHRQ HHS [1 F32 HS00040-01] Funding Source: Medline	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		ARONSON MD, 1987, ANN INTERN MED, V106, P246, DOI 10.7326/0003-4819-106-2-246; BATES DW, 1990, ANN INTERN MED, V113, P495, DOI 10.7326/0003-4819-113-7-495; BOR DH, 1988, J GEN INTERN MED, V3, P119, DOI 10.1007/BF02596115; BRANNEN AL, 1989, ARCH INTERN MED, V149, P1083, DOI 10.1001/archinte.149.5.1083; BUSHICK JB, 1989, J GEN INTERN MED, V4, P493, DOI 10.1007/BF02599547; DUNAGAN WC, 1989, AM J MED, V87, P253; EISENBERG JM, 1987, ANN INTERN MED, V107, P900, DOI 10.7326/0003-4819-107-6-900; FINKLER SA, 1982, ANN INTERN MED, V96, P102, DOI 10.7326/0003-4819-96-1-102; MACGREGOR RR, 1972, ARCH INTERN MED, V130, P84, DOI 10.1001/archinte.130.1.84; MCCABE WR, 1962, ARCH INTERN MED, V110, P845; RATNER HB, 1985, J CLIN MICROBIOL, V21, P995, DOI 10.1128/JCM.21.6.995-996.1985; WAKEFIELD DS, 1987, MED CARE, V25, P481, DOI 10.1097/00005650-198706000-00003; WEINSTEIN MP, 1983, REV INFECT DIS, V5, P35, DOI 10.1093/clinids/5.1.35	13	402	406	0	12	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 16	1991	265	3					365	369		10.1001/jama.265.3.365	http://dx.doi.org/10.1001/jama.265.3.365			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ER256	1984535				2022-12-28	WOS:A1991ER25600026
J	CONN, PM; CROWLEY, WF				CONN, PM; CROWLEY, WF			GONADOTROPIN-RELEASING-HORMONE AND ITS ANALOGS	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							CENTRAL PRECOCIOUS PUBERTY; FOLLICLE-STIMULATING-HORMONE; POLYCYSTIC OVARIAN DISEASE; IDIOPATHIC HYPOGONADOTROPIC HYPOGONADISM; HUMAN MENSTRUAL-CYCLE; HUMAN-BREAST CANCER; PROTEIN KINASE-C; SEX STEROID-SECRETION; BONE-MINERAL DENSITY; ACTING GNRH AGONIST		MASSACHUSETTS GEN HOSP,DEPT MED,BOSTON,MA 02114	Harvard University; Massachusetts General Hospital	CONN, PM (corresponding author), UNIV IOWA,COLL MED,DEPT PHARMACOL,IOWA CITY,IA 52242, USA.				NICHD NIH HHS [HD24697, HD19899, U54 HD028138, HD15080, R01 HD015788, U54 HD029164] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD015788, U54HD028138] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD024697, R01HD015080, U54HD029164, R01HD019899, R37HD019899] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ANDREWS WV, 1988, J BIOL CHEM, V263, P13755; ANDREWS WV, 1986, ENDOCRINOLOGY, V119, P2537, DOI 10.1210/endo-119-6-2537; ANIK ST, 1984, J PHARM SCI, V73, P684, DOI 10.1002/jps.2600730523; BACKSTROM CT, 1982, CLIN ENDOCRINOL, V17, P29, DOI 10.1111/j.1365-2265.1982.tb02631.x; BARBIERI RL, 1988, NEW ENGL J MED, V318, P512, DOI 10.1056/NEJM198802253180810; BELCHETZ PE, 1978, SCIENCE, V202, P631, DOI 10.1126/science.100883; BENNETT HPJ, 1978, PHARMACOL REV, V30, P247; BERGH T, 1985, ACTA ENDOCRINOL-COP, V110, P440, DOI 10.1530/acta.0.1100440; BINDER C, 1984, DIABETES CARE, V7, P188, DOI 10.2337/diacare.7.2.188; Binder C, 1983, ARTIFICIAL SYSTEMS I, P53; BOEPPLE PA, 1986, ENDOCR REV, V7, P24, DOI 10.1210/edrv-7-1-24; BOEPPLE PA, 1988, AM J PHYSIOL, V255, pE559, DOI 10.1152/ajpendo.1988.255.4.E559; BOEPPLE PA, 1989, GROWTH GENETICS HORM, V5, P1; BOYAR R, 1972, NEW ENGL J MED, V287, P582, DOI 10.1056/NEJM197209212871203; BRADEN TD, 1990, ENDOCRINOLOGY, V126, P2577, DOI 10.1210/endo-126-5-2577; BRADEN TD, 1990, ENDOCRINOLOGY, V127, P2387, DOI 10.1210/endo-127-5-2387; CARATY A, 1982, CR ACAD SCI III-VIE, V295, P103; CEDARS MI, 1990, OBSTET GYNECOL, V75, P641; CHAN RL, 1985, BIOCHEM BIOPH RES CO, V127, P673, DOI 10.1016/S0006-291X(85)80214-X; CHANG RJ, 1983, J CLIN ENDOCR METAB, V56, P897, DOI 10.1210/jcem-56-5-897; CLARKE IJ, 1987, NEUROENDOCRINOLOGY, V46, P82, DOI 10.1159/000124800; CLARKE IJ, 1982, ENDOCRINOLOGY, V111, P1737, DOI 10.1210/endo-111-5-1737; COMITE F, 1981, NEW ENGL J MED, V305, P1546, DOI 10.1056/NEJM198112243052602; CONN PM, 1987, RECENT PROG HORM RES, V43, P29; CONN PM, 1987, BIOL REPROD, V36, P17, DOI 10.1095/biolreprod36.1.17; CONN PM, 1984, MOL PHARMACOL, V25, P51; CONN PM, IN PRESS NEUROENDOCR; CONTE FA, 1980, J CLIN ENDOCR METAB, V50, P163, DOI 10.1210/jcem-50-1-163; CORLEY KP, 1981, PEDIATR RES, V15, P157, DOI 10.1203/00006450-198102000-00015; CORTESPRIETO J, 1987, INT J FERTIL, V32, P290; Crowley W F Jr, 1985, Recent Prog Horm Res, V41, P473; CROWLEY WF, 1980, J CLIN ENDOCR METAB, V51, P173, DOI 10.1210/jcem-51-1-173; CROWLEY WF, 1981, J CLIN ENDOCR METAB, V52, P370, DOI 10.1210/jcem-52-2-370; CROWLEY WF, 1982, GONADOTROPINS BASIC, P457; DAHL KD, 1986, J CLIN ENDOCR METAB, V63, P792; DAMEWOOD MD, 1989, FERTIL STERIL, V52, P596; DANFORTH DR, 1990, J CLIN ENDOCR METAB, V70, P554, DOI 10.1210/jcem-70-2-554; DEFAZIO J, 1983, J CLIN ENDOCR METAB, V56, P445, DOI 10.1210/jcem-56-3-445; DEZIEGLER D, 1987, FERTIL STERIL, V48, P807; DEZIEGLER D, 1989, J CLIN ENDOCR METAB, V68, P1111, DOI 10.1210/jcem-68-6-1111; DUPONT A, 1988, EUR J CANCER CLIN ON, V24, P659, DOI 10.1016/0277-5379(88)90296-9; EIDNE KA, 1985, SCIENCE, V229, P989, DOI 10.1126/science.2992093; FEKETE M, 1989, J CLIN LAB ANAL, V3, P137, DOI 10.1002/jcla.1860030302; FEKETE M, 1989, PANCREAS, V4, P521, DOI 10.1097/00006676-198910000-00001; FILICORI M, 1983, AM J OBSTET GYNECOL, V147, P726, DOI 10.1016/0002-9378(83)90463-5; FILICORI M, 1989, J CLIN ENDOCR METAB, V69, P825, DOI 10.1210/jcem-69-4-825; FILICORI M, 1986, J CLIN ENDOCR METAB, V62, P1136, DOI 10.1210/jcem-62-6-1136; FILICORI M, 1988, J CLIN ENDOCR METAB, V66, P327, DOI 10.1210/jcem-66-2-327; FOSTER CM, 1984, J CLIN ENDOCR METAB, V59, P801, DOI 10.1210/jcem-59-4-801; GEORGE M, 1989, INT J FERTIL, V34, P19; GIBSON MJ, 1988, NEUROENDOCRINOLOGY, V48, P112, DOI 10.1159/000124998; GIBSON MJ, 1984, ENDOCRINOLOGY, V114, P1938, DOI 10.1210/endo-114-5-1938; GIBSON MJ, 1984, SCIENCE, V225, P949, DOI 10.1126/science.6382608; GONZALEZBARCENA D, 1989, BIOMED PHARMACOTHER, V43, P313, DOI 10.1016/0753-3322(89)90014-0; GONZALEZBARCENA D, 1986, PROSTATE, V9, P207, DOI 10.1002/pros.2990090211; GOULDING A, 1990, CALCIFIED TISSUE INT, V46, P14, DOI 10.1007/BF02555819; GRIFFITHS EC, 1983, MOL CELL ENDOCRINOL, V33, P1, DOI 10.1016/0303-7207(83)90053-9; GUDMUNDSSON JA, 1987, J CLIN ENDOCR METAB, V65, P159, DOI 10.1210/jcem-65-1-159; HALL JE, 1988, J CLIN ENDOCR METAB, V67, P524, DOI 10.1210/jcem-67-3-524; HANDELSMAN DJ, 1986, ENDOCR REV, V7, P95, DOI 10.1210/edrv-7-1-95; HAZUM E, 1989, ENDOCR REV, V10, P229; HAZUM E, 1988, ENDOCR REV, V9, P379, DOI 10.1210/edrv-9-4-379; HENZL MR, 1988, CLIN OBSTET GYNECOL, V31, P840, DOI 10.1097/00003081-198812000-00010; HOFFMAN AR, 1982, NEW ENGL J MED, V307, P1237, DOI 10.1056/NEJM198211113072003; HOLLAND FJ, 1986, J CLIN ENDOCR METAB, V63, P1065, DOI 10.1210/jcem-63-5-1065; Huckle W. R., 1988, Neural control of reproductive function. Proceedings of the Fifth Galveston Neuroscience Symposium held in Galveston, Texas, May 10-13, 1988., P441; HUCKLE WR, 1987, METHOD ENZYMOL, V141, P149; HUCKLE WR, 1988, J BIOL CHEM, V263, P3296; HUCKLE WR, 1987, ENDOCRINOLOGY, V120, P160, DOI 10.1210/endo-120-1-160; HUCKLE WR, 1988, ENDOCR REV, V9, P387, DOI 10.1210/edrv-9-4-387; JAKACKI RI, 1982, J CLIN ENDOCR METAB, V55, P453, DOI 10.1210/jcem-55-3-453; JOHANSEN JS, 1988, J CLIN ENDOCR METAB, V67, P701, DOI 10.1210/jcem-67-4-701; KAPEN S, 1974, J CLIN ENDOCR METAB, V39, P293, DOI 10.1210/jcem-39-2-293; KAPPY M, 1989, J CLIN ENDOCR METAB, V69, P1087, DOI 10.1210/jcem-69-5-1087; KARTEN MJ, 1986, ENDOCR REV, V7, P44, DOI 10.1210/edrv-7-1-44; KAULI R, 1984, CLIN ENDOCRINOL, V20, P377, DOI 10.1111/j.1365-2265.1984.tb03433.x; KESSEL B, 1988, FERTIL STERIL, V49, P538; KHOURY SA, 1987, J CLIN ENDOCR METAB, V64, P755, DOI 10.1210/jcem-64-4-755; KLIBANSKI A, 1989, J CLIN ENDOCR METAB, V68, P81, DOI 10.1210/jcem-68-1-81; KLIJN JG, 1989, J STEROID BIOCHEM, V4, P521; KLIJN JGM, 1985, J STEROID BIOCHEM, V23, P867, DOI 10.1016/S0022-4731(85)80029-7; KNOBIL E, 1980, SCIENCE, V207, P1371, DOI 10.1126/science.6766566; KUHN JM, 1989, NEW ENGL J MED, V321, P413, DOI 10.1056/NEJM198908173210701; LABRIE F, 1986, ENDOCR REV, V7, P67, DOI 10.1210/edrv-7-1-67; LABRIE F, 1987, J UROLOGY, V138, P804, DOI 10.1016/S0022-5347(17)43380-5; LABRIE F, 1984, P NATL ACAD SCI-BIOL, V81, P3861, DOI 10.1073/pnas.81.12.3861; LACOSTE D, 1988, J STEROID BIOCHEM, V31, P963, DOI 10.1016/0022-4731(88)90339-1; LAHLOU N, 1987, J CLIN ENDOCR METAB, V65, P946, DOI 10.1210/jcem-65-5-946; LEMAY A, 1989, HORM RES, V32, P93, DOI 10.1159/000181319; LEVINE JE, 1982, ENDOCRINOLOGY, V111, P1449, DOI 10.1210/endo-111-5-1449; LEVINE JE, 1988, ENDOCRINOLOGY, V122, P2211, DOI 10.1210/endo-122-5-2211; LEYENDECKER G, 1983, J REPROD FERTIL, V69, P397; LUMSDEN MA, 1989, J ENDOCRINOL, V12, P389; MAHEUX R, 1989, HORM RES, V32, P125, DOI 10.1159/000181327; MANSFIELD MJ, 1983, NEW ENGL J MED, V309, P1286, DOI 10.1056/NEJM198311243092104; MANSFIELD MJ, 1988, J CLIN ENDOCR METAB, V66, P3, DOI 10.1210/jcem-66-1-3; MARSHALL JC, 1986, NEW ENGL J MED, V315, P1459; MARSHALL JC, 1983, J CLIN INVEST, V71, P248, DOI 10.1172/JCI110765; MASON AJ, 1986, SCIENCE, V234, P1366, DOI 10.1126/science.3024317; MATHE G, 1986, PROSTATE, V9, P327, DOI 10.1002/pros.2990090404; MATTA WH, 1987, BRIT MED J, V294, P1523, DOI 10.1136/bmj.294.6586.1523; MATTA WHM, 1989, BRIT J OBSTET GYNAEC, V96, P200, DOI 10.1111/j.1471-0528.1989.tb01663.x; MELDRUM DR, 1982, J CLIN ENDOCR METAB, V54, P1081, DOI 10.1210/jcem-54-5-1081; MEYER B R, 1989, Skin Pharmacology, V2, P120; MILLER WL, 1989, ENDOCRINOLOGY, V124, P667; MILLER WR, 1985, NATURE, V313, P231, DOI 10.1038/313231a0; MOORJANI S, 1988, J CLIN ENDOCR METAB, V66, P314, DOI 10.1210/jcem-66-2-314; NAKAYAMA Y, 1990, J CLIN ENDOCR METAB, V70, P1233, DOI 10.1210/jcem-70-5-1233; NETT TM, 1974, ENDOCRINOLOGY, V94, P713, DOI 10.1210/endo-94-3-713; OKADA H, 1983, J PHARM SCI, V72, P75, DOI 10.1002/jps.2600720118; OKADA H, 1982, J PHARM SCI, V71, P1367, DOI 10.1002/jps.2600711214; PARMAR H, 1985, LANCET, V2, P1201; PERL V, 1987, FERTIL STERIL, V48, P383; PESCOVITZ OH, 1985, ANN NY ACAD SCI, V458, P174, DOI 10.1111/j.1749-6632.1985.tb14602.x; PESCOVITZ OH, 1986, J PEDIATR-US, V108, P47, DOI 10.1016/S0022-3476(86)80767-3; RAPPAPORT R, 1987, HORM RES, V28, P149, DOI 10.1159/000180938; REAME N, 1984, J CLIN ENDOCR METAB, V59, P328, DOI 10.1210/jcem-59-2-328; REAME NE, 1985, J CLIN ENDOCR METAB, V61, P851, DOI 10.1210/jcem-61-5-851; REDDING TW, 1984, P NATL ACAD SCI-BIOL, V81, P248, DOI 10.1073/pnas.81.1.248; REID RL, 1981, FERTIL STERIL, V36, P553; ROSS JL, 1983, J CLIN ENDOCR METAB, V57, P288, DOI 10.1210/jcem-57-2-288; SANDOW J, 1981, P SERONO CLIN C REPR, V2, P221; SANTEN RJ, 1986, BREAST CANCER RES TR, V7, P129, DOI 10.1007/BF01806244; SANTORO N, 1986, ENDOCR REV, V7, P11, DOI 10.1210/edrv-7-1-11; SANTORO N, 1986, J CLIN ENDOCR METAB, V62, P109, DOI 10.1210/jcem-62-1-109; SCHOU J, 1971, CONCEPTS BIOCH PHA 1, V1, P47; SCHWANZELFUKUDA M, 1989, MOL BRAIN RES, V6, P311, DOI 10.1016/0169-328X(89)90076-4; SHAW RW, 1989, HORM RES, V32, P150, DOI 10.1159/000181332; SHAW RW, 1988, BAILLIERE CLIN OB GY, V2, P659, DOI 10.1016/S0950-3552(88)80051-8; SHECKTER CB, 1988, J CLIN ENDOCR METAB, V67, P1221, DOI 10.1210/jcem-67-6-1221; SKARIN G, 1982, J CLIN ENDOCR METAB, V55, P723, DOI 10.1210/jcem-55-4-723; SOGANI PC, 1987, UROL CLIN N AM, V14, P353; SPRATT DI, 1985, J CLIN ENDOCR METAB, V61, P890, DOI 10.1210/jcem-61-5-890; SPRATT DI, 1988, AM J PHYSIOL, V254, pE658, DOI 10.1152/ajpendo.1988.254.5.E658; SPRATT DI, 1986, ANN INTERN MED, V105, P848, DOI 10.7326/0003-4819-105-6-848; STANHOPE R, 1988, ACTA PAEDIATR SCAND, V77, P525, DOI 10.1111/j.1651-2227.1988.tb10694.x; STARNAUD R, 1986, CLIN INVEST MED, V9, P215; STARNAUD R, 1986, J CLIN ENDOCR METAB, V63, P297; STEINGOLD K, 1987, J CLIN ENDOCR METAB, V65, P773, DOI 10.1210/jcem-65-4-773; SURREY ES, 1989, FERTIL STERIL, V54, P547; THARANDT L, 1979, HORM METAB RES, V11, P391, DOI 10.1055/s-0028-1092746; TUMMON IS, 1988, FERTIL STERIL, V49, P792; VALK TW, 1980, J CLIN ENDOCR METAB, V51, P730, DOI 10.1210/jcem-51-4-730; WAIBELTREBER S, 1989, HUM REPROD, V4, P384, DOI 10.1093/oxfordjournals.humrep.a136912; WALDHAUSER F, 1981, EUR J PEDIATR, V137, P71, DOI 10.1007/BF00441173; WARNER B, 1983, J CLIN INVEST, V71, P1842, DOI 10.1172/JCI110940; WATERS SB, 1990, ENDOCRINOLOGY, V126, P2583, DOI 10.1210/endo-126-5-2583; WEISS J, 1989, J CLIN ENDOCR METAB, V69, P299, DOI 10.1210/jcem-69-2-299; WHITCOMB RW, 1990, J CLIN ENDOCR METAB, V70, P3, DOI 10.1210/jcem-70-1-3; WILDT L, 1980, SCIENCE, V207, P1373, DOI 10.1126/science.6986658; WILDT L, 1981, ENDOCRINOLOGY, V109, P376, DOI 10.1210/endo-109-2-376; WILLIAMS IA, 1990, EUR J OBSTET GYN R B, V34, P111, DOI 10.1016/0028-2243(90)90014-R; WINTERS SJ, 1983, J CLIN ENDOCR METAB, V57, P432, DOI 10.1210/jcem-57-2-432; YAMAZAKI I, 1982, ENDOCRINOL JAPON, V29, P415; YAMAZAKI I, 1984, J REPROD FERTIL, V72, P129; YAMAZAKI I, 1980, ENDOCRINOL JAPON, V27, P593; YEN SSC, 1972, J CLIN ENDOCR METAB, V34, P671, DOI 10.1210/jcem-34-4-671; ZORN JR, 1990, FERTIL STERIL, V53, P401	158	394	413	0	24	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 10	1991	324	2					93	103						11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EQ977	1984190				2022-12-28	WOS:A1991EQ97700005
J	MENDOZA, FS; VENTURA, SJ; VALDEZ, RB; CASTILLO, RO; SALDIVAR, LE; BAISDEN, K; MARTORELL, R				MENDOZA, FS; VENTURA, SJ; VALDEZ, RB; CASTILLO, RO; SALDIVAR, LE; BAISDEN, K; MARTORELL, R			SELECTED MEASURES OF HEALTH-STATUS FOR MEXICAN-AMERICAN, MAINLAND PUERTO-RICAN, AND CUBAN-AMERICAN CHILDREN	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UNITED-STATES	The 1987 National Vital Statistics System and the Hispanic Health and Nutrition Examination Survey (1982 through 1984) were used to assess the health status of Mexican-American, mainland Puerto Rican, and Cuban-American children by examining the prevalences of pregnancy outcomes and chronic medical conditions. The low-birth-weight rate among Hispanics (7.0%) compared favorably with that of non-Hispanic whites (7.1%) despite the greater poverty and lower levels of education among Hispanics. When examined by Hispanic subgroup, however, significant differences were present, with mainland Puerto Ricans having the highest prevalences of low-birth-weight infants. Premature births were more common among all three Hispanic subgroups than among non-Hispanic whites. Mexican-American and Cuban-American children had a similar prevalence of (3.9% and 2.5%, respectively) chronic medical conditions compared with non-Hispanic white children; Puerto Rican children had a higher prevalence of chronic medical conditions (6.2%). When assessed by these health status indicators, Hispanic children seem to have a health status similar to non-Hispanic white children. However, mainland Puerto Rican children seem at greater risk for poor health, reflecting the US Hispanic population's heterogeneity. Health programs targeted at US Hispanics should appropriately consider these groups differences.	STANFORD UNIV,MED CTR,SCH MED,STANFORD,CA 94305; STANFORD UNIV,FOOD RES INST,STANFORD,CA 94305; UNIV CALIF LOS ANGELES,SCH PUBL HLTH,LOS ANGELES,CA 90024; NATL CTR HLTH STAT,HYATTSVILLE,MD 20782	Stanford University; Stanford University; University of California System; University of California Los Angeles; Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS)	MENDOZA, FS (corresponding author), STANFORD UNIV,STANFORD CTR CHICANO RES,CYPRESS HALL,E WING,STANFORD,CA 94305, USA.		Martorell, Reynaldo/I-2539-2012	Mendoza, Fernando/0000-0001-5516-4588	PHS HHS [MCJ-060518] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		DELGADO JL, 1990, AM J PUBLIC HEALTH, V80, P6, DOI 10.2105/AJPH.80.Suppl.6; FELICE ME, 1986, J ADOLESCENT HEALTH, V7, P305, DOI 10.1016/S0197-0070(86)80158-9; GERGEN PJ, 1988, PEDIATRICS, V81, P1; Kovar MG, 1986, P SECTION SURVEY RES, P396; NEWACHECK PW, 1986, AM J PUBLIC HEALTH, V76, P178, DOI 10.2105/AJPH.76.2.178; SCHOENBORN CA, 1988, VITAL HLTH STATIS 10, V163; SCHUR CL, 1987, MED CARE, V25, P627, DOI 10.1097/00005650-198707000-00006; SHAH BV, 1981, SESUDAAN STANDARD ER; SHAH BV, 1982, RITFREQS PROGRAM COM; TRAFFEL S, 1978, VITAL HLTH STATIS 21, V33; TREVINO FM, 1984, VITAL HLTH STAT, V10, P50; VENTURA SJ, 1985, PUBLIC HEALTH REP, V100, P647; VENTURA SJ, 1984, MONTHLY VITAL STAT S, P33; VENTURA SJ, 1987, MONTHLY VITAL STA S2, P36; VENTURA SJ, 1988, MONTHLY VITAL STATIS, P36; VENTURA SJ, 1981, MONTHLY VITAL STAT S, P29; VENTURA SJ, 1982, MONTHLY VITAL STAT S, P31; VENTURA SJ, 1983, MONTHLY VITAL STAT S, P32; VENTURA SJ, 1985, MONTH VITAL STA 0723, P34; 1985, VITAL HLTH STATIST 1, V19; 1989, VITAL STATISTICS US, P1; 1977, INT CLASSIFICATION D, P1; 1987, BUREAU CENSUS P20, V416; 1987, CALIFORNIANS HLTH IN; 1989, MONTHLY VITAL STAT S, P38; 1990, VITAM STATISTICS US, P2	26	76	76	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 9	1991	265	2					227	232		10.1001/jama.265.2.227	http://dx.doi.org/10.1001/jama.265.2.227			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EQ602	1984152				2022-12-28	WOS:A1991EQ60200030
J	SULLIVAN, TJ				SULLIVAN, TJ			CROSS-REACTIONS AMONG FUROSEMIDE, HYDROCHLOROTHIAZIDE, AND SULFONAMIDES	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							SUSCEPTIBILITY; SENSITIVITY				SULLIVAN, TJ (corresponding author), UNIV TEXAS,HLTH SCI CTR,DALLAS,TX 75235, USA.							ANDREWS AW, 1984, MUTAT RES, V135, P105, DOI 10.1016/0165-1218(84)90162-9; BARNHART ER, 1990, PHYSICIANS DESK REFE, P1046; BARNHART ER, 1989, PHYSICIANS DESK REFE, P1024; CARRINGTON DM, 1987, J ALLERGY CLIN IMMUN, V79, P442, DOI 10.1016/0091-6749(87)90361-7; GRUCHALLA R S, 1990, Journal of Allergy and Clinical Immunology, V85, P157; HANSBROUGH JR, 1987, J ALLERGY CLIN IMMUN, V80, P538, DOI 10.1016/0091-6749(87)90004-2; MITCHELL JR, 1976, J PHARMACOL EXP THER, V199, P41; MOSS C, 1985, CLIN EXP IMMUNOL, V61, P232; RIEDER MJ, 1988, J PHARMACOL EXP THER, V244, P724; ROUJEAU JC, 1987, ARCH DERMATOL, V123, P1171, DOI 10.1001/archderm.123.9.1171; SCHNEIWEISS F, 1983, CLIN PHARMACY, V2, P510; SULLIVAN TJ, 1989, J ALLERGY CLIN IMMUN, V83, P270; SULLIVAN TJ, 1988, ALLERGY PRINCIPLES P, P1523	13	17	18	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	1991	265	1					120	121		10.1001/jama.265.1.120	http://dx.doi.org/10.1001/jama.265.1.120			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP555	1984112				2022-12-28	WOS:A1991EP55500045
J	REITEMEIER, RJ				REITEMEIER, RJ			THE LEADERSHIP CRISIS IN INTERNAL-MEDICINE - WHAT CAN BE DONE	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							EDUCATION; HEALTH; CARE; TIME	During the 1990s, internal medicine will change. Whether that change will be in directions desired by internists will depend on whether effective leadership of the discipline is accepted by the academic department chairs. Individually, and as a group, they are the only ones with sufficient authority to take control and initiate and sustain needed change. The time frame for action is short and diminishing. Opportunities still exist for effective leadership to present the discipline as more attractive to students by demonstrating that they can play an important role in helping to solve problems in health care. Unmet societal needs underlie much of the public's disaffection with the profession, and the chairpersons must begin to solve those needs. Today's practice environment is ever less appealing with increasing regulation and intrusive third-party actions. These stresses will increase until internists understand from research the value of what they do in practice and learn to choose what is effective in outcome and cost. Practice models integrating the skills and talents of internists, as these are focused on the needs of patients, are experiments that can be started in academic departments. Initiatives for such changes depend on active leadership-now sorely lacking in internal medicine.			REITEMEIER, RJ (corresponding author), MAYO CLIN & MAYO FDN, EMERITUS STAFF, 200 SW 1ST ST, ROCHESTER, MN 55905 USA.							ANGELL M, 1988, HEALTH AFFAIR, V7, P58, DOI 10.1377/hlthaff.7.2.58; BEATY HN, 1989, MAYO CLIN PROC, V64, P1307, DOI 10.1016/S0025-6196(12)61296-8; BULGER RJ, 1988, HEALTH AFFAIR, V7, P185, DOI 10.1377/hlthaff.7.4.185; BULGER RJ, 1988, TECHNOLOGY BUREAUCRA, P27; CLUFF LE, 1988, RW JOHNSON ANN REPOR; EISENBERG L, 1988, TASK MED DIALOGUE WI, P190; FEDERMAN DD, 1990, ACAD MED, V65, P221, DOI 10.1097/00001888-199004000-00001; Friedman E, 1989, Health Prog, V70, P34; FRIEDMAN RH, 1985, ANN INTERN MED, V103, P439, DOI 10.7326/0003-4819-103-3-439; GINZBERG E, 1987, HEALTH AFFAIR, V6, P128, DOI 10.1377/hlthaff.6.4.128; MCDERMOTT W, 1982, ANN INTERN MED, V96, P512, DOI 10.7326/0003-4819-96-4-512; ODEGAARD CE, 1986, DEAR DOCTOR PERSONAL; PETERSDORF RG, 1989, J GEN INTERN MED, V4, P527, DOI 10.1007/BF02599554; PETERSDORF RG, 1983, NEW ENGL J MED, V309, P1053, DOI 10.1056/NEJM198310273091711; Reitemeier R J, 1988, Indiana Med, V81, P160; REUBEN DB, 1988, ARCH INTERN MED, V148, P914, DOI 10.1001/archinte.148.4.914; SCHMID R, 1989, MAYO CLIN PROC, V64, P1180, DOI 10.1016/S0025-6196(12)64989-1; Schroeder S A, 1985, Health Aff (Millwood), V4, P22, DOI 10.1377/hlthaff.4.2.22; SCHROEDER SA, 1986, ANN INTERN MED, V104, P554, DOI 10.7326/0003-4819-104-4-554; Shivdasani R A, 1989, Pharos Alpha Omega Alpha Honor Med Soc, V52, P21; SPITZER WO, 1989, ANN INTERN MED, V111, P939, DOI 10.7326/0003-4819-111-11-939; TOSTESON DC, 1990, NEW ENGL J MED, V322, P234, DOI 10.1056/NEJM199001253220405; WHITE KL, 1988, TASK MED DIALOGUE WI, P67	23	15	15	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 1	1991	114	1					69	75		10.7326/0003-4819-114-1-69	http://dx.doi.org/10.7326/0003-4819-114-1-69			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EQ040	1983937				2022-12-28	WOS:A1991EQ04000012
J	STOTT, EJ; CHAN, WL; MILLS, KHG; PAGE, M; TAFFS, F; CRANAGE, M; GREENAWAY, P; KITCHIN, P				STOTT, EJ; CHAN, WL; MILLS, KHG; PAGE, M; TAFFS, F; CRANAGE, M; GREENAWAY, P; KITCHIN, P			PRELIMINARY-REPORT - PROTECTION OF CYNOMOLGUS MACAQUES AGAINST SIMIAN IMMUNODEFICIENCY VIRUS BY FIXED INFECTED-CELL VACCINE	LANCET			English	Article							ANIMAL-MODELS; AIDS	Cynomolgus macaques were vaccinated with inactivated simian immunodeficiency virus-infected cells and 'Quil-A' as adjuvant at 0,4,8, and 36 weeks or at 0,4,8, and 16 weeks. 2 weeks later these animals, together with a similar unvaccinated group, were challenged with 10 MID50 (50% monkey infectious doses) of a pool of SIVmac251 previously titrated in vivo. Virus was repeatedly isolated from unvaccinated animals on at least five separate occasions and proviral DNA was detected in circulating lymphocytes by polymerase chain reaction amplification. By contrast, virus and proviral DNA were not found in any of the vaccinated animals. However, the same vaccination regimen used after live virus challenge did not eliminate virus from previously infected macaques.	NATL INST BIOL STAND & CONTROLS,DIV IMMUNOBIOL,POTTERS BAR EN6 3QG,HERTS,ENGLAND; CTR APPL MICROBIOL & RES,SALISBURY,WILTS,ENGLAND	National Institute for Biological Standards & Control	STOTT, EJ (corresponding author), NATL INST BIOL STAND & CONTROLS,CTR AIDS COLLABORATING,BLANCHE LANE,ROTTERS BAR EN6 3QG,HERTS,ENGLAND.		Mills, Kingston H/F-5684-2013	Mills, Kingston H/0000-0003-3646-8222				ALMOND N, 1990, J VIROL METHODS, V28, P305, DOI 10.1016/0166-0934(90)90124-X; BERMAN PW, 1990, NATURE, V345, P622, DOI 10.1038/345622a0; CARLSON JR, IN PRESS AIDS RES HU; CRANAGE MP, IN PRESS P INT M ANI; DANIEL MD, 1989, AIDS, V3, pS31; DESROSIERS RC, 1987, REV INFECT DIS, V9, P438; DESROSIERS RC, 1989, AIDS RES HUM RETROV, V5, P465, DOI 10.1089/aid.1989.5.465; DESROSIERS RC, 1989, P NATL ACAD SCI USA, V86, P6353, DOI 10.1073/pnas.86.16.6353; GARDNER MB, 1989, J MED PRIMATOL, V18, P321; GARDNER MB, 1989, FASEB J, V3, P2593, DOI 10.1096/fasebj.3.14.2556312; GNANN JW, 1987, SCIENCE, V237, P1346, DOI 10.1126/science.2888192; KITCHIN PA, 1990, J VIROL METHODS, V28, P85, DOI 10.1016/0166-0934(90)90090-3; KITCHIN PA, IN PRESS P INT M ANI; LEVINE A, 1990, JUN SAN FRANC AIDS M; MILLS KHG, 1990, J IMMUNOL, V144, P1677; MONTEFIORI DC, 1990, J VIROL, V64, P113, DOI 10.1128/JVI.64.1.113-119.1990; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; MURPHEYCORB M, 1989, SCIENCE, V246, P1293, DOI 10.1126/science.2555923; PICARD O, 1990, LANCET, V336, P179, DOI 10.1016/0140-6736(90)91699-B; ROBINSON WE, 1990, JUN SAN FRANC AIDS M; SALK J, 1987, NATURE, V327, P473, DOI 10.1038/327473a0; SODROSKI JG, 1984, SCIENCE, V225, P381, DOI 10.1126/science.6330891; STOTT EJ, 1984, J HYG-CAMBRIDGE, V93, P251, DOI 10.1017/S0022172400064779; SUTJIPTO S, 1990, J VIROL, V64, P2290, DOI 10.1128/JVI.64.5.2290-2297.1990	24	159	166	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	DEC 22	1990	336	8730					1538	1541		10.1016/0140-6736(90)93310-L	http://dx.doi.org/10.1016/0140-6736(90)93310-L			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP037	1979369				2022-12-28	WOS:A1990EP03700007
J	CASEMORE, DP				CASEMORE, DP			FOODBORNE PROTOZOAL INFECTION	LANCET			English	Article											CASEMORE, DP (corresponding author), GLAN GLWYD GEN HOSP, PUBL HLTH LAB, RHYL LL18 5UJ, CLWYD, WALES.							Barnard R. J., 1984, Giardiaand giardiasis - biology, pathogenesis, and epidemiology., P365; Bean N H, 1990, MMWR CDC Surveill Summ, V39, P15; BRODSKY RE, 1974, J INFECT DIS, V130, P319, DOI 10.1093/infdis/130.3.319; Casemore D., 1987, PHLS Microbiology Digest, V4, P1; CASEMORE DP, 1990, EPIDEMIOL INFECT, V104, P1, DOI 10.1017/S0950268800054480; CHIODINI PL, 1989, RECENT ADV INFECTION, V3, P237; CLIVER DO, 1987, INT J FOOD MICROBIOL, V4, P269, DOI 10.1016/0168-1605(87)90001-8; CURRENT WL, 1986, CRIT REV ENV CONTR, V17, P21, DOI 10.1080/10643388609388328; DESILVA L, 1984, J INFECTION, V8, P163, DOI 10.1016/S0163-4453(84)92617-3; FAYER R, 1985, FOOD TECHNOL-CHICAGO, V39, P57; FAYER R, 1986, MICROBIOL REV, V50, P458, DOI 10.1128/MMBR.50.4.458-483.1986; FAYER R, IN PRESS AM PUBLIC H; Fleck D. G., 1989, PHLS Microbiology Digest, V6, P69; GALBRAITH NS, 1987, PUBLIC HEALTH, V101, P319, DOI 10.1016/S0033-3506(87)80090-2; GALBRAITH NS, 1987, J INST WATER ENV MAN, V1, P7; JEPHCOTT AE, 1986, LANCET, V1, P730; JOKIPII AMM, 1985, LANCET, V2, P487; MATA L, 1986, PEDIATR INFECT DIS J, V5, pS117; MILLER RA, 1988, REV INFECT DIS, V10, P930; MURRELL KD, 1989, IN PRESS BIOTECHNOLO; OSTERHOLM MT, 1981, NEW ENGL J MED, V304, P24, DOI 10.1056/NEJM198101013040106; PETERSEN LR, 1988, J INFECT DIS, V157, P846, DOI 10.1093/infdis/157.4.846; PORTER JDH, 1990, AM J PUBLIC HEALTH, V80, P1259, DOI 10.2105/AJPH.80.10.1259; RAVDIN JI, 1988, CLIN TROPICAL MED CO, P503; ROSE JB, IN PRESS ENV SCI TEC; SHADDUCK JA, 1989, REV INFECT DIS, V11, P203; SMITH HV, 1990, PARASITOL TODAY, V6, P8, DOI 10.1016/0169-4758(90)90378-H; SOAVE R, 1988, J INFECT DIS, V157, P225, DOI 10.1093/infdis/157.2.225; Warhurst D. C., 1988, PHLS Microbiology Digest, V5, P31; WARHUST DC, 1983, SANITATION DISEASES, P337; WHITE KE, 1989, J INFECT DIS, V160, P298, DOI 10.1093/infdis/160.2.298; 1990, COMMUNICABLE DISEA S, V1; 1990, CRYPTOSPORIDIUM WATE	33	39	42	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 8	1990	336	8728					1427	1432		10.1016/0140-6736(90)93115-6	http://dx.doi.org/10.1016/0140-6736(90)93115-6			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL851	1978883				2022-12-28	WOS:A1990EL85100017
J	MYBURGH, KH; HUTCHINS, J; FATAAR, AB; HOUGH, SF; NOAKES, TD				MYBURGH, KH; HUTCHINS, J; FATAAR, AB; HOUGH, SF; NOAKES, TD			LOW BONE-DENSITY IS AN ETIOLOGIC FACTOR FOR STRESS-FRACTURES IN ATHLETES	ANNALS OF INTERNAL MEDICINE			English	Article									UNIV CAPE TOWN, SCH MED, DEPT PHYSIOL, MRC, BIOENERGET RES UNIT, CAPE TOWN 7925, SOUTH AFRICA; GROOTE SCHUUR HOSP, DEPT NUCL MED, CAPE TOWN 7925, SOUTH AFRICA; TYGERBERG HOSP, ENDOCRINE UNIT, TYGERBERG 7505, SOUTH AFRICA	University of Cape Town; University of Cape Town; Tygerberg Hospital			Noakes, Tim/AAD-3162-2020	Noakes, Tim/0000-0001-7244-2375; Myburgh, Kathryn/0000-0003-4501-2120				BARROW GW, 1988, AM J SPORT MED, V16, P209, DOI 10.1177/036354658801600302; BERNING J, 1985, MED SCI SPORT EXER, V17, P242, DOI 10.1249/00005768-198504000-00270; BILANIN JE, 1989, MED SCI SPORT EXER, V21, P66, DOI 10.1249/00005768-198902000-00012; CUMMINGS SR, 1985, EPIDEMIOL REV, V7, P178, DOI 10.1093/oxfordjournals.epirev.a036281; DESMET AA, 1985, AM J ROENTGENOL, V145, P601, DOI 10.2214/ajr.145.3.601; DRINKWATER BL, 1984, NEW ENGL J MED, V311, P277, DOI 10.1056/NEJM198408023110501; DRINKWATER BL, 1986, JAMA-J AM MED ASSOC, V256, P380, DOI 10.1001/jama.256.3.380; HOUGH FS, 1988, S AFRICAN J CONTINUI, V6, P39; JONES HH, 1977, J BONE JOINT SURG AM, V59, P204, DOI 10.2106/00004623-197759020-00012; LANGENHOVEN L, 1986, NRIND FOOD QUANTITIE; LINDBERG JS, 1984, ANN INTERN MED, V101, P647, DOI 10.7326/0003-4819-101-5-647; LINDBERG JS, 1987, WESTERN J MED, V146, P39; LLOYD T, 1986, MED SCI SPORT EXER, V18, P374; MARCUS R, 1985, ANN INTERN MED, V102, P158, DOI 10.7326/0003-4819-102-2-158; MATKOVIC V, 1979, AM J CLIN NUTR, V32, P540, DOI 10.1093/ajcn/32.3.540; MAZESS RB, 1983, OSTEOPOROTIC SYNDROM, P85; MESSIER SP, 1988, MED SCI SPORT EXER, V20, P501; MORRIS JM, 1967, FATIGUE FRACTURES CL; MYBURGH KH, 1988, PHYSICIAN SPORTSMED, V16, P129, DOI 10.1080/00913847.1988.11709486; NOAKES TD, 1985, LORE RUNNING, P354; ORAVA S, 1978, ACTA ORTHOP SCAND, V49, P19, DOI 10.3109/17453677809005718; POUILLES JM, 1989, BONE, V10, P105, DOI 10.1016/8756-3282(89)90006-9; RIGGS BL, 1967, J BONE JOINT SURG AM, VA 49, P915, DOI 10.2106/00004623-196749050-00008; RIGOTTI NA, 1984, NEW ENGL J MED, V311, P1601, DOI 10.1056/NEJM198412203112503; SIEGEL S, 1956, NONPARAMETRIC STAT, P63; SMITH EL, 1986, ACTA MED SCAND, P149; SNEDECOR GW, 1946, STATISTICAL METHODS, P85; STEVENSON JC, 1982, BRIT MED J, V285, P585, DOI 10.1136/bmj.285.6342.585; WAHNER HH, 1982, NONINVASIVE BONE MEA, P191; 1979, J AM DIET ASSOC, P623	30	283	286	2	43	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 15	1990	113	10					754	759		10.7326/0003-4819-113-10-754	http://dx.doi.org/10.7326/0003-4819-113-10-754			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EH363	1978620				2022-12-28	WOS:A1990EH36300006
J	SANTIS, G; OSBORNE, L; KNIGHT, RA; HODSON, ME				SANTIS, G; OSBORNE, L; KNIGHT, RA; HODSON, ME			INDEPENDENT GENETIC-DETERMINANTS OF PANCREATIC AND PULMONARY STATUS IN CYSTIC-FIBROSIS	LANCET			English	Article											SANTIS, G (corresponding author), ROYAL BROMPTON & NATL HEART HOSP,NATL HEART & LUNG INST,DEPT CYST FIBROSIS,MANRESA RD,LONDON SW3 6LR,ENGLAND.							BORGO G, 1990, LANCET, V1, P1601; COREY M, 1989, J PEDIATR-US, V115, P274, DOI 10.1016/S0022-3476(89)80082-4; CUTTING GR, 1990, NATURE, V346, P366, DOI 10.1038/346366a0; DEAN M, 1990, CELL, V61, P863, DOI 10.1016/0092-8674(90)90196-L; DEVOTO M, 1989, GENOMICS, V5, P894, DOI 10.1016/0888-7543(89)90131-6; GASKIN K, 1982, J PEDIATR-US, V100, P857, DOI 10.1016/S0022-3476(82)80501-5; HODSON ME, 1983, BMJ-BRIT MED J, V286, P1381, DOI 10.1136/bmj.286.6375.1381; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KEREM BS, 1989, AM J HUM GENET, V44, P827; KEREM E, 1990, J PEDIATR-US, V116, P714, DOI 10.1016/S0022-3476(05)82653-8; KNOWLES M, 1981, NEW ENGL J MED, V305, P1489, DOI 10.1056/NEJM198112173052502; KOPELMAN H, 1990, LANCET, V1, P1601; PENKETH ARL, 1987, THORAX, V42, P526, DOI 10.1136/thx.42.7.526; ROMMENS J, 1990, AM J HUM GENET, V46, P395; SANTIS G, 1990, LANCET, V1, P1426; SHWACHMAN H, 1975, PEDIATR CLIN N AM, V22, P787; SHWACHMAN H, 1965, AM J DIS CHILD, V92, P347; STUHRMANN M, 1990, LANCET, V1, P738; WATERS DL, 1990, NEW ENGL J MED, V322, P303, DOI 10.1056/NEJM199002013220505	19	129	131	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 3	1990	336	8723					1081	1084		10.1016/0140-6736(90)92566-Z	http://dx.doi.org/10.1016/0140-6736(90)92566-Z			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF992	1977977				2022-12-28	WOS:A1990EF99200001
J	TERVAERT, JWC; HUITEMA, MG; HENE, RJ; SLUITER, WJ; THE, TH; VANDERHEM, GK; KALLENBERG, CGM				TERVAERT, JWC; HUITEMA, MG; HENE, RJ; SLUITER, WJ; THE, TH; VANDERHEM, GK; KALLENBERG, CGM			PREVENTION OF RELAPSES IN WEGENERS GRANULOMATOSIS BY TREATMENT BASED ON ANTINEUTROPHIL CYTOPLASMIC ANTIBODY TITER	LANCET			English	Article									STATE UNIV UTRECHT HOSP,DEPT NEPHROL,3511 GV UTRECHT,NETHERLANDS	Utrecht University; Utrecht University Medical Center	TERVAERT, JWC (corresponding author), STATE UNIV GRONINGEN HOSP,DEPT INTERNAL MED,9713 EZ GRONINGEN,NETHERLANDS.		tervaert, jan willem cohen/AAB-1111-2019					BRADLEY JD, 1989, ARTHRITIS RHEUM, V32, P45, DOI 10.1002/anr.1780320108; DEREMEE RA, 1985, MAYO CLIN PROC, V60, P27, DOI 10.1016/S0025-6196(12)65279-3; DEREMEE RA, 1988, ARTHRITIS RHEUM, V31, P1068, DOI 10.1002/art.1780310821; FALK RJ, 1988, NEW ENGL J MED, V318, P1651, DOI 10.1056/NEJM198806233182504; FAUCI AS, 1978, ANN INTERN MED, V89, P660, DOI 10.7326/0003-4819-89-5-660; FAUCI AS, 1983, ANN INTERN MED, V98, P76, DOI 10.7326/0003-4819-98-1-76; GOLDSCHMEDING R, 1989, J CLIN INVEST, V84, P1577, DOI 10.1172/JCI114335; HIND CRK, 1984, CLIN NEPHROL, V21, P341; ISRAEL HL, 1988, ARCH INTERN MED, V148, P2293, DOI 10.1001/archinte.148.10.2293; JAYNE D, 1990, NEPHROL DIAL TRANSPL, V5, P309; JENNETTE JC, 1989, AM J PATHOL, V135, P921; KALLENBERG CGM, 1990, NETH J MED, V36, P163; LUDEMANN J, 1990, J EXP MED, V171, P357, DOI 10.1084/jem.171.1.357; NILES JL, 1989, BLOOD, V74, P1888; NOLLE B, 1989, ANN INTERN MED, V111, P28, DOI 10.7326/0003-4819-111-1-28; PINCHING AJ, 1980, BRIT MED J, V281, P836, DOI 10.1136/bmj.281.6244.836; PINCHING AJ, 1983, Q J MED, V52, P435; RASMUSSEN N, 1988, LANCET, V1, P706; REZA MJ, 1975, ARTHRITIS RHEUM, V18, P501, DOI 10.1002/art.1780180513; SAVAGE COS, 1987, LANCET, V1, P1389; Steppat D, 1989, Arthritis Rheum, V32, P1050, DOI 10.1002/anr.1780320817; STILLWELL TJ, 1988, ARTHRITIS RHEUM, V31, P465, DOI 10.1002/art.1780310402; TERBORG EJ, 1990, ARTHRITIS RHEUM-US, V33, P634, DOI 10.1002/art.1780330505; TERVAERT JWC, 1989, ARCH INTERN MED, V149, P2461, DOI 10.1001/archinte.149.11.2461; TERVAERT JWC, 1990, KIDNEY INT, V37, P799, DOI 10.1038/ki.1990.48; VANDERWOUDE FJ, 1985, LANCET, V1, P425; VANDERWOUDE FJ, 1990, NETH J MED, V36, P169; Wiik A, 1989, APMIS Suppl, V6, P12	28	369	375	0	3	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	SEP 22	1990	336	8717					709	711						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DZ624	1975893				2022-12-28	WOS:A1990DZ62400004
J	CREUZET, F; MCDERMOTT, A; GEBHARD, R; VANDERHOEF, K; SPIJKERASSINK, MB; HERZFELD, J; LUGTENBURG, J; LEVITT, MH; GRIFFIN, RG				CREUZET, F; MCDERMOTT, A; GEBHARD, R; VANDERHOEF, K; SPIJKERASSINK, MB; HERZFELD, J; LUGTENBURG, J; LEVITT, MH; GRIFFIN, RG			DETERMINATION OF MEMBRANE-PROTEIN STRUCTURE BY ROTATIONAL RESONANCE NMR - BACTERIORHODOPSIN	SCIENCE			English	Article							MAGIC-ANGLE; POLYCRYSTALLINE SOLIDS; SPIN DIFFUSION; SPECTRA	Rotationally resonant magnetization exchange, a new nuclear magnetic resonance (NMR) technique for measuring internuclear distances between like spins in solids, was used to determine the distance between the C-8 and C-18 carbons of retinal in two model compounds and in the membrane protein bacteriorhodopsin. Magnetization transfer between inequivalent spins with an isotropic shift separation, delta, is driven by magic angle spinning at a speed omega-r that matches the rotational resonance condition delta = n-omega-r, where n is a small integer. The distances measured in this way for both the 6-s-cis- and 6-s-trans-retinoic acid model compounds agreed well with crystallographically known distances. In bacteriorhodopsin the exchange trajectory between C-8 and C-18 was in good agreement with the internuclear distance for a 6-s-trans configuration [4.2 angstroms (angstrom)] and inconsistent with that for a 6-s-cis configuration (3.1 angstrom). The results illustrate that rotational resonance can be used for structural studies in membrane proteins and in other situations where diffraction and solution NMR techniques yield limited information.	MIT,FRANCIS BITTER NATL MAGNET LAB,CAMBRIDGE,MA 02139; LEIDEN STATE UNIV,GORLAEUS LABS,2300 RA LEIDEN,NETHERLANDS; BRANDEIS UNIV,DEPT CHEM,WALTHAM,MA 02254; MIT,DEPT CHEM,CAMBRIDGE,MA 02139	Massachusetts Institute of Technology (MIT); Leiden University; Leiden University - Excl LUMC; Brandeis University; Massachusetts Institute of Technology (MIT)			Levitt, Malcolm/B-3746-2010	Levitt, Malcolm/0000-0001-9878-1180; McDermott, Ann/0000-0002-9249-1649	NIGMS NIH HHS [GM-36810, GM-23403, GM-36920] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036810, R01GM036920, R01GM023403, R37GM023403] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDREW ER, 1963, PHYS LETT, V4, P99, DOI 10.1016/0031-9163(63)90123-9; ANDREW ER, 1966, PHYS LETT, V21, P505, DOI 10.1016/0031-9163(66)91274-1; ANDREW ER, 1958, NATURE, V182, P1659, DOI 10.1038/1821659a0; COLUMBO MG, 1988, CHEM PHYS LETT, V146, P189; CREUZET F, UNPUB; DEGRIP WJ, 1988, PHOTOCHEM PHOTOBIOL, V48, P799, DOI 10.1111/j.1751-1097.1988.tb02895.x; GAN ZH, 1990, MOL PHYS, V67, P1419; GRIFFIN RG, 1988, PHYSICS NMR SPECTROS, P203; HARBISON G S, 1985, Journal of the American Chemical Society, V107, P4809, DOI 10.1021/ja00303a001; HARBISON GS, 1985, BIOCHEMISTRY-US, V24, P6955, DOI 10.1021/bi00345a031; HERZFELD J, 1980, J CHEM PHYS, V73, P6021, DOI 10.1063/1.440136; HONIG B, 1971, P NATL ACAD SCI USA, V68, P1289, DOI 10.1073/pnas.68.6.1289; HONIG B, 1976, BIOCHEMISTRY-US, V15, P4593, DOI 10.1021/bi00666a008; KUBO A, 1988, J CHEM SOC FARAD T 1, V84, P3713, DOI 10.1039/f19888403713; LEVITT MH, 1990, J CHEM PHYS, V92, P6347, DOI 10.1063/1.458314; LOWE IJ, 1959, PHYS REV LETT, V2, P285, DOI 10.1103/PhysRevLett.2.285; MAAS WEJR, 1988, CHEM PHYS LETT, V149, P170, DOI 10.1016/0009-2614(88)87216-6; Mathies R. A., 1987, BIOL APPLICATIONS RA, P59; MCDERMOTT AE, 1990, BIOCHEMISTRY-US, V29, P5767, DOI 10.1021/bi00476a018; MEHRING M, 1983, PRINCIPLES HIGH RESO, P250; RALEIGH DP, 1989, J AM CHEM SOC, V111, P4502, DOI 10.1021/ja00194a057; RALEIGH DP, 1988, CHEM PHYS LETT, V146, P71, DOI 10.1016/0009-2614(88)85051-6; REDFIELD AG, 1971, COLD SPRING HARB SYM, V36, P405, DOI 10.1101/SQB.1972.036.01.052; RODMANGILSON HS, 1988, J AM CHEM SOC, V110, P1943; SCHAEFER J, 1976, J AM CHEM SOC, V98, P1031, DOI 10.1021/ja00420a036; STAM CH, 1972, ACTA CRYSTALL B-STRU, VB 28, P2936, DOI 10.1107/S0567740872007253; STAM CH, 1963, ACTA CRYSTALLOGR, V16, P62, DOI 10.1107/S0365110X63000104; WOLFF EK, 1977, J CHEM PHYS, V67, P2387, DOI 10.1063/1.435081; Wuthrich K., 1986, NMR PROTEINS NUCL AC; [No title captured]	31	185	187	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	FEB 15	1991	251	4995					783	786		10.1126/science.1990439	http://dx.doi.org/10.1126/science.1990439			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX575	1990439				2022-12-28	WOS:A1991EX57500040
J	KAPLOWITZ, LG; BAKER, D; GELB, L; BLYTHE, J; HALE, R; FROST, P; CRUMPACKER, C; RABINOVICH, S; PEACOCK, JE; HERNDON, J; DAVIS, LG				KAPLOWITZ, LG; BAKER, D; GELB, L; BLYTHE, J; HALE, R; FROST, P; CRUMPACKER, C; RABINOVICH, S; PEACOCK, JE; HERNDON, J; DAVIS, LG			PROLONGED CONTINUOUS ACYCLOVIR TREATMENT OF NORMAL ADULTS WITH FREQUENTLY RECURRING GENITAL HERPES-SIMPLEX VIRUS-INFECTION	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACQUIRED IMMUNODEFICIENCY SYNDROME; DOUBLE-BLIND TRIAL; ORAL ACYCLOVIR; SUPPRESSION; MULTICENTER; THERAPY; FOSCARNET	In this 3-year study of suppressive acyclovir for recurrent genital herpes, patients with more than six recurrences per year were randomized initially to 400 mg of acyclovir or placebo orally two times per day, with recurrences treated with 200 mg of acyclovir five times per day for 5 days. In the second year of the study, all patients received acyclovir as a daily suppressive or intermittent acute therapy; in the third year, all received daily acyclovir. Among 525 patients completing 3 study years, 289 received 3 years of suppressive therapy and 236 received 1 year of acute therapy followed by 2 years of suppressive therapy. Of those who completed the third year, 61% were recurrence free that year; 25% of the suppressive therapy-only group were recurrence free for all 3 years. The annual recurrence rate dropped from more than 12 recurrences per year at baseline to 1.0 (suppressive therapy) and 1.4 (acute and suppressive therapy) recurrences during the third year. No significant toxic effects were detected. Daily suppressive acyclovir therapy was effective and well tolerated.	SUNY STONY BROOK,STONY BROOK,NY 11794; WASHINGTON UNIV,SCH MED,ST LOUIS,MO 63110; ST JOHNS MERCY MED CTR,ST LOUIS,MO 63141; UNIV HAWAII,HONOLULU,HI 96822; SINAI MED CTR,MIAMI,FL; BETH ISRAEL HOSP,BOSTON,MA 02215; SO ILLINOIS UNIV,SCH MED,SPRINGFIELD,IL 62708; WAKE FOREST UNIV,BOWMAN GRAY SCH MED,WINSTON SALEM,NC 27103; BURROUGHS WELLCOME CO,RES TRIANGLE PK,NC 27709	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Washington University (WUSTL); Saint Johns Mercy Medical Center; University of Hawaii System; Harvard University; Beth Israel Deaconess Medical Center; Southern Illinois University System; Southern Illinois University; Wake Forest University; Wake Forest Baptist Medical Center; Burroughs Wellcome Fund	KAPLOWITZ, LG (corresponding author), VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DIV INFECT DIS,BOX 49,MCV STN,RICHMOND,VA 23298, USA.							CHATIS PA, 1989, NEW ENGL J MED, V320, P297, DOI 10.1056/NEJM198902023200507; DOUGLAS JM, 1984, NEW ENGL J MED, V310, P1551, DOI 10.1056/NEJM198406143102402; ERLICH KS, 1989, NEW ENGL J MED, V320, P293, DOI 10.1056/NEJM198902023200506; ERLICH KS, 1989, ANN INTERN MED, V110, P710, DOI 10.7326/0003-4819-110-9-710; KINGHORN GR, 1988, AM J MED, V85, P26; MATTISON HR, 1988, AM J MED, V85, P20; MERTZ GJ, 1988, AM J MED, V85, P14; MERTZ GJ, 1988, JAMA-J AM MED ASSOC, V260, P201, DOI 10.1001/jama.260.2.201; MINDEL A, 1988, LANCET, V1, P926; MINDEL A, 1984, LANCET, V2, P57; MOSTOW SR, 1988, AM J MED, V85, P30; NUSINOFFLEHRMAN S, 1986, ANN INTERN MED, V104, P786; STRAUS SE, 1988, JAMA-J AM MED ASSOC, V260, P2227, DOI 10.1001/jama.260.15.2227; THIN RN, 1985, J ANTIMICROB CHEMOTH, V16, P219, DOI 10.1093/jac/16.2.219	14	89	90	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 13	1991	265	6					747	751		10.1001/jama.265.6.747	http://dx.doi.org/10.1001/jama.265.6.747			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EW479	1990191				2022-12-28	WOS:A1991EW47900027
J	[Anonymous]				[Anonymous]			UNIFORM REQUIREMENTS FOR MANUSCRIPTS SUBMITTED TO BIO-MEDICAL JOURNALS	NEW ENGLAND JOURNAL OF MEDICINE			English	Article								In the 12 years since it was first published, the "Uniform Requirements for Manuscripts Submitted to Biomedical Journals" (the Vancouver style), developed by the International Committee of Medical Journal Editors, has been widely accepted by both authors and editors; over 400 journals have stated that they will consider manuscripts that conform to its requirements. This is the fourth edition of the Uniform Requirements, the first to be published in the Journal, which now serves as coordinator of the ICMJE in North America.											0	40	41	1	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 7	1991	324	6					424	428						5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EW296	1987468				2022-12-28	WOS:A1991EW29600029
J	FANTL, JA; WYMAN, JF; MCCLISH, DK; HARKINS, SW; ELSWICK, RK; TAYLOR, JR; HADLEY, EC				FANTL, JA; WYMAN, JF; MCCLISH, DK; HARKINS, SW; ELSWICK, RK; TAYLOR, JR; HADLEY, EC			EFFICACY OF BLADDER TRAINING IN OLDER WOMEN WITH URINARY-INCONTINENCE	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TEST-RETEST ANALYSIS; DETRUSOR INSTABILITY; TRIAL	The efficacy of bladder training was evaluated in a randomized clinical trial involving 123 noninstitutionalized women 55 years and older with urinary incontinence. Subjects were urodynamically categorized as those with urethral sphincteric incompetence (N = 88) and those with detrusor instability with or without concomitant sphincteric incompetence (N = 35). Bladder training reduced the number of incontinent episodes by 57%; the effect was similar for both urodynamic diagnostic groups. The quantity of fluid loss was reduced by 54%. This was greater for patients with detrusor instability than for those without it. Diurnal and nocturnal voluntary micturitions were also reduced. The effect on nocturnal micturition, however, was not observed in subjects with unstable detrusor function. It is recommended that bladder training be considered as an initial step in treatment of women with urinary incontinence. Provided prior comprehensive clinical evaluation is done, it can be prescribed without the need for urodynamic characterization.	VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT COMMUNITY & PSYCHIAT NURSING,RICHMOND,VA 23298; VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT BIOSTAT,RICHMOND,VA 23298; VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT GERONTOL,RICHMOND,VA 23298; VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT NEUROL,RICHMOND,VA 23298; NIA,GERIATR PROGRAM,BETHESDA,MD 20892	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	FANTL, JA (corresponding author), VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT OBSTET & GYNECOL,CONTINENCE PROGRAM WOMEN,RICHMOND,VA 23298, USA.				NIA NIH HHS [AG05170] Funding Source: Medline	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ANDERSON RS, 1983, J UROLOGY, V130, P727, DOI 10.1016/S0022-5347(17)51425-1; ASMUSSEN M, 1975, ACTA OBSTET GYN SCAN, V54, P385, DOI 10.3109/00016347509156772; AWAD SA, 1983, J UROLOGY, V130, P114, DOI 10.1016/S0022-5347(17)50986-6; BATES C P, 1981, British Journal of Urology, V53, P333, DOI 10.1111/j.1464-410X.1981.tb03191.x; BURNS PA, 1990, J AM GERIATR SOC, V38, P341, DOI 10.1111/j.1532-5415.1990.tb03517.x; CARDOZO L, 1990, BRIT J OBSTET GYNAEC, V97, P463, DOI 10.1111/j.1471-0528.1990.tb02512.x; CONSTANTINOU CE, 1982, J UROLOGY, V127, P964, DOI 10.1016/S0022-5347(17)54148-8; DIOKNO AC, 1986, J UROLOGY, V136, P1022; FANTL JA, 1990, AM J OBSTET GYNECOL, V162, P946, DOI 10.1016/0002-9378(90)91295-N; FANTL JA, 1987, OBSTET GYNECOL, V70, P739; FANTL JA, 1986, AM J OBSTET GYNECOL, V155, P544; Fillenbaum GG, 1988, MULTIDIMENSIONAL FUN; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; HADLEY EC, 1986, JAMA-J AM MED ASSOC, V256, P372, DOI 10.1001/jama.256.3.372; HANDMARSH JR, 1983, BR J UROL, V55, P648; HILTON P, 1981, BRIT MED J, V282, P940, DOI 10.1136/bmj.282.6268.940; HODGKINSON CP, 1963, AM J OBSTET GYNECOL, V87, P717; HU TW, 1990, J AM GERIATR SOC, V38, P292, DOI 10.1111/j.1532-5415.1990.tb03507.x; JARVIS GJ, 1980, BRIT MED J, V281, P1322, DOI 10.1136/bmj.281.6251.1322-a; JEFFCOATE TN, 1966, AM J OBSTET GYNECOL, V94, P604, DOI 10.1016/0002-9378(66)90395-4; Johnson P.O., 1936, STAT RES MEMOIRS, V1, P57; PEATTIE AB, 1988, BRIT J OBSTET GYNAEC, V95, P1049, DOI 10.1111/j.1471-0528.1988.tb06512.x; PENGELLY AW, 1980, BRIT J UROL, V52, P463, DOI 10.1111/j.1464-410X.1980.tb03091.x; RAZ S, 1990, J AM GERIATR SOC, V38, P345, DOI 10.1111/j.1532-5415.1990.tb03518.x; STANTON SL, 1990, J AM GERIATR SOC, V38, P348, DOI 10.1111/j.1532-5415.1990.tb03519.x; WEIN AJ, 1990, J AM GERIATR SOC, V38, P317, DOI 10.1111/j.1532-5415.1990.tb03512.x; WYMAN JF, 1988, OBSTET GYNECOL, V71, P812; WYMAN JF, 1987, OBSTET GYNECOL, V70, P378	28	251	260	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	1991	265	5					609	613		10.1001/jama.265.5.609	http://dx.doi.org/10.1001/jama.265.5.609			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EV718	1987410				2022-12-28	WOS:A1991EV71800017
J	KRUMHOLZ, A; FISHER, RS; LESSER, RP; HAUSER, WA				KRUMHOLZ, A; FISHER, RS; LESSER, RP; HAUSER, WA			DRIVING AND EPILEPSY - A REVIEW AND REAPPRAISAL	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SEIZURES; REMISSION	Driving and epilepsy is a problem that involves physicians as both care providers to patients and consultants to regulatory authorities. Driving restrictions for people with seizure disorders are intended to ensure the public's safety, but such restrictions may unduly harm the welfare of many people with seizures. In the United States, all states now permit some people with epilepsy to drive. In general, only people whose seizures are adequately controlled are licensed to drive. Adequate control has been judged principally by the seizure-free interval, but individual state standards widely vary. There is a trend toward greater liberalization of driving standards for people with seizure disorders, but the appropriateness and application of these standards continue to raise questions, as does the role physicians should have in the licensing process. Our responsibilities to persons with disabilities and advances in our understanding of seizures and the nature of driving risks warrant a reappraisal of the current medical, legal, and social implications of driving and epilepsy.	JOHNS HOPKINS UNIV, SCH MED, DEPT NEUROL, JOHNS HOPKINS EPILEPSY CTR, BALTIMORE, MD 21205 USA; COLUMBIA UNIV, GH SERGIEVSKY CTR, NEW YORK, NY 10027 USA; COLUMBIA UNIV, DEPT NEUROL, NEW YORK, NY 10027 USA	Johns Hopkins University; Johns Hopkins Medicine; Columbia University; Columbia University	KRUMHOLZ, A (corresponding author), UNIV MARYLAND, MED SYST,SCH MED,DEPT NEUROL, MARYLAND EPILEPSY CTR, 22 S GREENE ST, BALTIMORE, MD 21201 USA.		Hauser, W Allen/AAB-5277-2020	Fisher, Robert/0000-0003-0287-613X				ANDERMANN F, 1988, CAN J NEUROL SCI, V15, P371, DOI 10.1017/S0317167100028079; ANNEGERS JF, 1979, EPILEPSIA, V20, P729, DOI 10.1111/j.1528-1157.1979.tb04857.x; [Anonymous], 1981, Epilepsia, V22, P489; BAKER SP, 1970, NEW ENGL J MED, V283, P405, DOI 10.1056/NEJM197008202830806; CALLAGHAN N, 1988, NEW ENGL J MED, V318, P942, DOI 10.1056/NEJM198804143181502; CRANCER A, 1968, JAMA-J AM MED ASSOC, V205, P74; DOEGE TC, 1986, MED CONDITIONS AFFEC; EDEH J, 1985, LANCET, V2, P1014; FISHER R S, 1988, MMJ (Maryland Medical Journal), V37, P795; FOUNTAIN AJ, 1983, SOUTHERN MED J, V76, P481, DOI 10.1097/00007611-198304000-00017; GASTAUT H, 1987, NEUROLOGY, V37, P1613, DOI 10.1212/WNL.37.10.1613; Gregory D R, 1982, Leg Med, P257; HANSOTIA P, 1991, NEW ENGL J MED, V324, P22, DOI 10.1056/NEJM199101033240105; HARVEY P, 1983, LANCET, V1, P401; HAUSER WA, 1975, EPILEPSIA, V16, P1, DOI 10.1111/j.1528-1157.1975.tb04721.x; HAUSER WA, 1990, NEUROLOGY, V40, P1163, DOI 10.1212/WNL.40.8.1163; HAUSER WA, 1982, NEW ENGL J MED, V307, P522, DOI 10.1056/NEJM198208263070903; HAUSER WA, 1989, GENETICS EPILEPSIES, P7; KUHL V., 1967, EPILEPSIA, V8, P195, DOI 10.1111/j.1528-1157.1967.tb04436.x; LeBlang Theodore R, 1979, Loyola Univ Chic Law J, V10, P203; MASLAND RL, 1978, ANN NEUROL, V4, P485, DOI 10.1002/ana.410040602; MOSHER CG, 1987, SEMIN NEUROL, V7, P372, DOI 10.1055/s-2008-1041439; NAUGHTON TJ, 1980, DOT HS805595 US DEP; OBRIEN SJ, 1986, PUBLIC HEALTH, V100, P21, DOI 10.1016/S0033-3506(86)80082-8; OKUMA T, 1981, EPILEPSIA, V22, P35, DOI 10.1111/j.1528-1157.1981.tb04331.x; PARSONAGE M, 1982, INT SUMMARY DRIVING; Perrine M W, 1975, Clin Plast Surg, V2, P11; PHEMISTER J, 1961, LANCET, V1, P888; SCAMBLER G, 1980, J EPIDEMIOL COMMUN H, V34, P129, DOI 10.1136/jech.34.2.129; SHAFER SQ, 1988, EPILEPSIA, V29, P590, DOI 10.1111/j.1528-1157.1988.tb03767.x; SILLANPAA M, 1983, ACTA NEUROL SCAND, V68, P1; SPUDIS EV, 1986, ARCH NEUROL-CHICAGO, V43, P558, DOI 10.1001/archneur.1986.00520060022011; Steinwall O, 1972, Scand J Rehabil Med, V4, P123; Thalwitzer F, 1906, MUNCHEN MED WOCHEN, V37, P1818; VANDERLUGT PJM, 1975, EPILEPSIA, V16, P747, DOI 10.1111/j.1528-1157.1975.tb04760.x; VANDERLUGT PJM, 1975, EPILEPSIA, V16, P743; WALLER JA, 1965, NEW ENGL J MED, V273, P1413, DOI 10.1056/NEJM196512232732605; 1988, FHWAMC88042 US DEP T; 1966, EPILEPSY LAW, P57; 1985, OVERVIEW LEGAL ISSUE; 1956, EPILEPSY LAW PROPOSA, P55; 1983, FEDERAL HIGHWAY ADM	42	80	80	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	1991	265	5					622	626		10.1001/jama.265.5.622	http://dx.doi.org/10.1001/jama.265.5.622			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EV718	1987412				2022-12-28	WOS:A1991EV71800020
J	FIRLIK, AD				FIRLIK, AD			MARGO LOGO	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	41	41	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 9	1991	265	2					201	201		10.1001/jama.265.2.201	http://dx.doi.org/10.1001/jama.265.2.201			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EQ602	1984141				2022-12-28	WOS:A1991EQ60200013
J	LEWIS, CE; PROUT, DM; CHALMERS, EP; LEAKE, B				LEWIS, CE; PROUT, DM; CHALMERS, EP; LEAKE, B			HOW SATISFYING IS THE PRACTICE OF INTERNAL-MEDICINE - A NATIONAL SURVEY	ANNALS OF INTERNAL MEDICINE			English	Article								Objective: To survey members of the American College of Physicians about their level of satisfaction and sources of dissatisfaction with practice, the extent to which their satisfaction is reflected in their counseling of students about careers in internal medicine, the prevalence of their concerns about patients' access to care, and their attitudes toward changes in the health care system. Design: A questionnaire survey of a random sample of members of the College. Participants: Members (2254) of the College were surveyed; 1446 (64%) responded and 1290 (57%) of the responses were usable. Measurements and Main Results: More than 80% of respondents were satisfied with their relationships with patients, professional challenges, and opportunities to interact with colleagues. Only about half were satisfied with their potential income, and most were dissatisfied with their autonomy or loss of control over clinical decision making. Major sources of concern were administrative burdens, the threat of malpractice litigation, loss of income, and loss of clinical autonomy. Forty percent of internists say that they discourage students from careers in internal medicine, and only 39% would once again pursue such a career. "Pain in the practice" seems generalized among internists; logistic regression analysis failed to show any specific groups who were most dissatisfied or concerned. With regard to access, 18% of internists had many patients without health care insurance; 69% had some patients without coverage; and the majority (61%) had some patients who lost their insurance because of changing jobs or location. Assuring universal access to care received the highest priority rating of a set of criteria for health care reform. Conclusions: There is growing dissatisfaction with the practice of internal medicine, primarily related to concerns over loss of clinical autonomy, the increase in administrative burdens, the potential loss of income, and the threat of malpractice litigation. Although physicians are concerned about patients' access to care, proposals to improve access should be examined for their effects on the major sources of physicians' dissatisfaction with practice.	AMER COLL PHYSICIANS, WASHINGTON, DC 20005 USA	American College of Physicians	LEWIS, CE (corresponding author), UNIV CALIF LOS ANGELES, SCH MED, DEPT MED, DIV GEN INTERNAL MED, B-558 FACTOR BLDG, LOS ANGELES, CA 90024 USA.							ASTRACHAN JH, 1989, ARCH INTERN MED, V149, P1509, DOI 10.1001/archinte.149.7.1509; CLARK DS, 1990, ACAD MED, V65, P219, DOI 10.1097/00001888-199003000-00019; GREENBERGER NJ, 1990, OBSERVER         JUL, P2; PATRICELLI RE, 1989, PROVIDING UNIVERSAL; REAMES HR, 1989, ARCH INTERN MED, V149, P1951, DOI 10.1001/archinte.149.9.1951; 1990, NATIONAL MED EXPENDI	6	100	101	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 1	1991	114	1					1	5		10.7326/0003-4819-114-1-1	http://dx.doi.org/10.7326/0003-4819-114-1-1			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EQ040	1983926				2022-12-28	WOS:A1991EQ04000001
J	BUNKER, CB; TERENGHI, G; SPRINGALL, DR; POLAK, JM; DOWD, PM				BUNKER, CB; TERENGHI, G; SPRINGALL, DR; POLAK, JM; DOWD, PM			DEFICIENCY OF CALCITONIN GENE-RELATED PEPTIDE IN RAYNAUDS-PHENOMENON	LANCET			English	Article							HUMAN-SKIN	Skin biopsy samples from the fingers of nine patients with primary Raynaud's phenomenon, nine with the disorder associated with systemic sclerosis, and eleven healthy controls were examined by immunocytochemistry. There were no differences between the groups in the distribution of PGP 9.5 (a pan-neuronal marker) immunoreactivity, but there was a significant reduction in the number of calcitonin gene-related peptide (CGRP) immunoreactive neurons in the skin of patients with primary Raynaud's phenomenon and those with systemic sclerosis. These finding implicate dysfunction of the CGRP neurovascular axis in the pathophysiology of Raynaud's phenomenon.	UNIV COLL & MIDDLESEX SCH MED,MIDDLESEX HOSP,DEPT DERMATOL,MORTIMER ST,LONDON W1N 8AA,ENGLAND; HAMMERSMITH HOSP,ROYAL POSTGRAD MED SCH,DEPT HISTOCHEM,LONDON W12 0HS,ENGLAND	University of London; University College London; Imperial College London				Bunker, Christopher/0000-0002-6693-7483				Allen EV, 1932, AM J MED SCI, V183, P187, DOI 10.1097/00000441-193202000-00004; BUNKER C B, 1990, British Journal of Rheumatology, V29, P1; BUNKER CB, 1990, LANCET, V335, P239, DOI 10.1016/0140-6736(90)90343-4; BUNKER CB, 1988, BRIT J DERMATOL, V119, P771, DOI 10.1111/j.1365-2133.1988.tb03502.x; BUNKER CB, 1989, BR J DERMATOL S34, V121, P43; BUNKER CB, IN PRESS J INVEST DE; Coffman JD., 1989, RAYNAUDS PHENOMENON; DALSGAARD CJ, 1989, HISTOCHEMISTRY, V91, P35, DOI 10.1007/BF00501907; DALSGAARD CJ, 1989, HISTOCHEMISTRY, V92, P385, DOI 10.1007/BF00492495; DOWD PM, 1990, LANCET, V336, P1014, DOI 10.1016/0140-6736(90)92481-V; GIBBINS IL, 1987, BRAIN RES, V414, P143, DOI 10.1016/0006-8993(87)91335-7; HOWDEN CW, 1988, CLIN SCI, V74, P413, DOI 10.1042/cs0740413; Lewis T, 1929, HEART-J STUD CIRC, V15, P7; Lewis T., 1927, BLOOD VESSELS HUMAN; LEWIS T, 1933, CLIN SCI, V1, P327; MARSHALL I, 1986, NEUROENDOCRINE MOL B, P1; PIOTROWSKI W, 1986, BRIT J DERMATOL, V114, P37, DOI 10.1111/j.1365-2133.1986.tb02777.x; RAYNAUD M, 1888, SELECTED MONOGRAPHS, V121; SHAWKET S, 1989, LANCET, V2, P1354; STRUTHERS AD, 1986, CLIN SCI, V70, P389, DOI 10.1042/cs0700389; WALLENGREN J, 1987, ACTA DERM-VENEREOL, V67, P185; ZAMORA MR, 1990, LANCET, V336, P1144, DOI 10.1016/0140-6736(90)92766-B; 1980, ARCH RHEUM, V23, P581	23	96	98	1	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	DEC 22	1990	336	8730					1530	1533		10.1016/0140-6736(90)93307-B	http://dx.doi.org/10.1016/0140-6736(90)93307-B			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP037	1979366				2022-12-28	WOS:A1990EP03700004
J	KARPATI, S; BURGINWOLFF, A; KRIEG, T; MEURER, M; STOLZ, W; BRAUNFALCO, O				KARPATI, S; BURGINWOLFF, A; KRIEG, T; MEURER, M; STOLZ, W; BRAUNFALCO, O			BINDING TO HUMAN JEJUNUM OF SERUM IGA ANTIBODY FROM CHILDREN WITH CELIAC-DISEASE	LANCET			English	Article									HEIM PAL CHILDRENS HOSP, DEPT DERMATOL, H-1089 BUDAPEST, HUNGARY; UNIV BASEL, CHILDRENS HOSP, DEPT MICROBIOL & IMMUNOL, BASEL, SWITZERLAND	University of Basel	KARPATI, S (corresponding author), UNIV MUNICH, DEPT DERMATOL, FRAUENLOBSTR 9-11, W-8000 MUNICH 2, GERMANY.		Stolz, Wilhelm/M-5074-2019					BRANDTZAEG P, 1985, SCAND J GASTROENTERO, V20, P17, DOI 10.3109/00365528509093765; BUGAWAN TL, 1989, NATURE, V339, P470, DOI 10.1038/339470a0; BURGINWOLFF A, 1990, INFLAMMATORY BOWEL DISEASE AND COELIAC DISEASE IN CHILDREN, P177; BURGINWOLFF A, 1989, EUR J PEDIATR, V148, P496, DOI 10.1007/BF00441541; BURGINWOLFF A, 1983, J PEDIATR-US, V102, P655, DOI 10.1016/S0022-3476(83)80229-7; CHORZELSKI TP, 1983, ANN NY ACAD SCI, V420, P325, DOI 10.1111/j.1749-6632.1983.tb22220.x; DICK HM, 1969, BRIT J DERMATOL, V81, P692, DOI 10.1111/j.1365-2133.1969.tb16210.x; EADE OE, 1977, GUT, V18, P991, DOI 10.1136/gut.18.12.991; ETERMAN KP, 1978, CLIN EXP IMMUNOL, V31, P92; HALLSTROM O, 1989, GUT, V30, P1225, DOI 10.1136/gut.30.9.1225; KARPATI S, 1986, J INVEST DERMATOL, V87, P703, DOI 10.1111/1523-1747.ep12456660; KARPATI S, 1988, J INVEST DERMATOL, V91, P336, DOI 10.1111/1523-1747.ep12475672; KARPATI S, IN PRESS J INVEST DE; KUMAR V, 1989, IMMUNOL INVEST, V18, P533, DOI 10.3109/08820138909112261; Kumar V, 1987, IMMUNOPATHOLOGY SKIN, P483; LANCASTERSMITH M, 1977, GUT, V18, P887, DOI 10.1136/gut.18.11.887; MAKI M, 1984, J PEDIATR-US, V105, P901, DOI 10.1016/S0022-3476(84)80074-8; MALLAS EG, 1977, GUT, V18, P647, DOI 10.1136/gut.18.8.647; MALLSTROM O, 1985, ACTA DERM-VENEREOL, V65, P330; MARTINI A, 1989, AM J DIS CHILD, V143, P493, DOI 10.1001/archpedi.1989.02150160123025; MCNEISH AS, 1979, ARCH DIS CHILD, V54, P783, DOI 10.1136/adc.54.10.783; REUNALA T, 1984, ARCH DIS CHILD, V59, P517, DOI 10.1136/adc.59.6.517; SEAH PP, 1971, LANCET, V1, P834; SEAH PP, 1973, GUT, V14, P311, DOI 10.1136/gut.14.4.311; SHINER M, 1972, LANCET, V1, P1202; TAKAHASHIIWANAGA H, 1985, CELL TISSUE RES, V242, P57; UNSWORTH DJ, 1983, LANCET, V1, P874; UNSWORTH DJ, 1985, INT ARCH ALLER A IMM, V76, P47, DOI 10.1159/000233660; VAINIO E, 1986, J PEDIATR GASTR NUTR, V5, P735, DOI 10.1097/00005176-198609000-00012	29	79	80	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 1	1990	336	8727					1335	1338		10.1016/0140-6736(90)92893-M	http://dx.doi.org/10.1016/0140-6736(90)92893-M			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL365	1978162				2022-12-28	WOS:A1990EL36500002
J	KWIATKOWSKI, D; HILL, AVS; SAMBOU, I; TWUMASI, P; CASTRACANE, J; MANOGUE, KR; CERAMI, A; BREWSTER, DR; GREENWOOD, BM				KWIATKOWSKI, D; HILL, AVS; SAMBOU, I; TWUMASI, P; CASTRACANE, J; MANOGUE, KR; CERAMI, A; BREWSTER, DR; GREENWOOD, BM			TNF CONCENTRATION IN FATAL CEREBRAL, NONFATAL CEREBRAL, AND UNCOMPLICATED PLASMODIUM-FALCIPARUM MALARIA	LANCET			English	Article									MRC LABS,FAJARA,SENEGAMBIA; ENDOGEN CORP,BOSTON,MA; UNIV OXFORD,INST MOLEC MED,OXFORD,ENGLAND; ROCKEFELLER UNIV,NEW YORK,NY 10021; ROYAL VICTORIA HOSP,BANJUL,SENEGAMBIA	University of Oxford; Rockefeller University			HILL, Adrian V>S>/C-1306-2008	Kwiatkowski, Dominic/0000-0002-5023-0176				BERENDT AR, 1989, NATURE, V341, P57, DOI 10.1038/341057a0; BEUTLER BA, 1985, J IMMUNOL, V135, P3972; BREWSTER DR, 1990, LANCET, V336, P1039, DOI 10.1016/0140-6736(90)92498-7; CLARK IA, 1978, LANCET, V2, P75; CLARK IA, 1987, PARASITOL TODAY, V3, P300, DOI 10.1016/0169-4758(87)90187-6; CLARK IA, IN PRESS TUMOR NECRO; ENGELMANN H, 1990, J BIOL CHEM, V265, P1531; GRAU GE, 1989, NEW ENGL J MED, V320, P1586, DOI 10.1056/NEJM198906153202404; GRAU GE, 1987, SCIENCE, V237, P1210, DOI 10.1126/science.3306918; GREENWOOD BM, 1987, T ROY SOC TROP MED H, V81, P478, DOI 10.1016/0035-9203(87)90170-2; KERN P, 1989, AM J MED, V87, P139, DOI 10.1016/S0002-9343(89)80688-6; KWIATKOWSKI D, 1989, PARASITOL TODAY, V5, P264, DOI 10.1016/0169-4758(89)90261-5; KWIATKOWSKI D, 1989, CLIN EXP IMMUNOL, V77, P361; KWIATKOWSKI D, 1989, J EXP MED, V169, P357, DOI 10.1084/jem.169.1.357; LE JM, 1987, LAB INVEST, V56, P234; MOLYNEUX ME, 1989, Q J MED, V71, P441; PHILLIPS R E, 1986, Parasitology Today, V2, P271, DOI 10.1016/0169-4758(86)90136-5; SCHALL TJ, 1990, CELL, V61, P361, DOI 10.1016/0092-8674(90)90816-W; SHENTON FC, 1988, T ROY SOC TROP MED H, V82, P216, DOI 10.1016/0035-9203(88)90415-4; TAVERNE J, 1989, CLIN EXP IMMUNOL, V67, P1; TRACEY KJ, 1989, LANCET, V1, P1122; WHITE NJ, 1985, LANCET, V1, P776	22	762	773	0	19	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 17	1990	336	8725					1201	1204		10.1016/0140-6736(90)92827-5	http://dx.doi.org/10.1016/0140-6736(90)92827-5			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ064	1978068				2022-12-28	WOS:A1990EJ06400001
J	MAYANS, MV; HALL, AJ; INSKIP, HM; CHOTARD, J; LINDSAY, SW; COROMINA, E; MENDY, M; ALONSO, PL; WHITTLE, H				MAYANS, MV; HALL, AJ; INSKIP, HM; CHOTARD, J; LINDSAY, SW; COROMINA, E; MENDY, M; ALONSO, PL; WHITTLE, H			RISK-FACTORS FOR TRANSMISSION OF HEPATITIS-B VIRUS TO GAMBIAN CHILDREN	LANCET			English	Article									WHO,INT AGCY RES CANC,BANJUL,GAMBIA; MRC LABS,FAJARA,SENEGAMBIA	World Health Organization; International Agency for Research on Cancer (IARC)			Alonso, Pedro L/AAZ-3645-2020; Mendy, Maimuna/ABD-5038-2021; Inskip, Hazel/L-5467-2018	Alonso, Pedro L/0000-0003-3292-3443; Inskip, Hazel/0000-0001-8897-1749				BERNIER RH, 1982, AM J EPIDEMIOL, V116, P199, DOI 10.1093/oxfordjournals.aje.a113406; FOSTER O, 1984, LANCET, V1, P576; FOX E, 1988, T ROY SOC TROP MED H, V82, P750, DOI 10.1016/0035-9203(88)90225-8; JOUBERT JJ, 1985, S AFR J SCI, V81, P167; JUPP PG, 1979, S AFR MED J, V56, P54; OGSTON CW, 1981, J MED ENTOMOL, V18, P107, DOI 10.1093/jmedent/18.2.107; OGSTON CW, 1979, J INFECT DIS, V140, P411, DOI 10.1093/infdis/140.3.411; OGSTON CW, 1980, T ROY SOC TROP MED H, V74, P823, DOI 10.1016/0035-9203(80)90216-3; PRINCE AM, 1972, LANCET, V2, P247; SMITH PG, 1976, BIOMETRICS, V32, P817, DOI 10.2307/2529267; STEVENS CE, 1975, NEW ENGL J MED, V292, P771, DOI 10.1056/NEJM197504102921503; TABOR E, 1985, J MED VIROL, V15, P113, DOI 10.1002/jmv.1890150203; WHITTLE HC, 1983, LANCET, V1, P1203; WHITTLE HC, IN PRESS J INFECT DI; WILLS W, 1977, LANCET, V2, P217	15	59	61	0	2	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 3	1990	336	8723					1107	1109						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF992	1977989				2022-12-28	WOS:A1990EF99200013
J	TAKASU, N; KOMIYA, I; ASAWA, T; NAGASAWA, Y; YAMADA, T				TAKASU, N; KOMIYA, I; ASAWA, T; NAGASAWA, Y; YAMADA, T			TEST FOR RECOVERY FROM HYPOTHYROIDISM DURING THYROXINE THERAPY IN HASHIMOTOS-THYROIDITIS	LANCET			English	Article											TAKASU, N (corresponding author), SHINSHU UNIV,SCH MED,DEPT GERONTOL ENDOCRINOL & METAB,ASAHI 3-1-1,MATSUMOTO,NAGANO 390,JAPAN.							BEIERWAL.WH, 1965, ANN NY ACAD SCI, V124, P586, DOI 10.1111/j.1749-6632.1965.tb18989.x; BUCHANAN WW, 1965, ARCH INTERN MED, V115, P411, DOI 10.1001/archinte.1965.03860160037006; CARLSON HE, 1980, ARCH INTERN MED, V140, P1675, DOI 10.1001/archinte.1980.00330230122034; DEGROOT LJ, 1975, THYROID ITS DISEASES, P405; FIELD JB, 1979, J CLIN INVEST, V64, P265, DOI 10.1172/JCI109447; HOFFENBERG R, 1986, THYROID, P1255; RALLISON ML, 1975, J PEDIATR-US, V86, P675, DOI 10.1016/S0022-3476(75)80350-7; TAKASU N, 1978, EUR J BIOCHEM, V90, P131, DOI 10.1111/j.1432-1033.1978.tb12583.x; TAKASU N, 1990, NEW ENGL J MED, V322, P1708, DOI 10.1056/NEJM199006143222404; TAKASU N, 1987, J CLIN ENDOCRINOLOGY, V65, P239; UTIGER RD, 1986, THYROID, P511; YAMAMOTO T, 1978, ANN INTERN MED, V88, P808, DOI 10.7326/0003-4819-88-6-808; YOSHINARI M, 1983, BRIT MED J, V287, P720, DOI 10.1136/bmj.287.6394.720	13	39	39	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 3	1990	336	8723					1084	1086		10.1016/0140-6736(90)92567-2	http://dx.doi.org/10.1016/0140-6736(90)92567-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF992	1977978				2022-12-28	WOS:A1990EF99200002
J	[Anonymous]				[Anonymous]			BOARDING THE TRAIN	LANCET			English	Editorial Material																		AKERLUND M, 1976, BRIT J OBSTET GYNAEC, V83, P673, DOI 10.1111/j.1471-0528.1976.tb00911.x; AKERLUND M, 1979, ACTA OBSTET GYN SCAN, P27; ANDERSCH B, 1982, AM J OBSTET GYNECOL, V144, P655, DOI 10.1016/0002-9378(82)90433-1; ANDERSSON KE, 1978, BRIT J OBSTET GYNAEC, V85, P142, DOI 10.1111/j.1471-0528.1978.tb10469.x; GREER G, 1980, FEMALE EUNUCH, P47; KILLICK S, 1990, Journal of Obstetrics and Gynaecology (Abingdon), V10, P406, DOI 10.3109/01443619009151232; LENNANE KJ, 1973, NEW ENGL J MED, V288, P288, DOI 10.1056/NEJM197302082880605; PICKLES V R, 1965, J Obstet Gynaecol Br Commonw, V72, P185; PLATH S, 1960, FEMALE EUNUCH, P41; ROCKER I, 1990, PELVIC PAIN WOMEN, P63; SCULLY D, 1980, MEN WHO CONTROL WOME, P94; SJOBERG NO, 1979, ACTA OBSTET GYN SCAN, P57; Sturgis SH, 1940, ENDOCRINOLOGY, V26, P68, DOI 10.1210/endo-26-1-68; SUNDELL G, 1990, BRIT J OBSTET GYNAEC, V97, P588, DOI 10.1111/j.1471-0528.1990.tb02545.x; TAYLOR P, 1985, GOODMAN GILMANS PHAR, P215	15	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 22	1990	336	8717					720	721						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DZ624	1975898				2022-12-28	WOS:A1990DZ62400009
J	OLERUP, O; SMITH, CIE; HAMMARSTROM, L				OLERUP, O; SMITH, CIE; HAMMARSTROM, L			DIFFERENT AMINO-ACIDS AT POSITION-57 OF THE HLA-DQ-BETA CHAIN ASSOCIATED WITH SUSCEPTIBILITY AND RESISTANCE TO IGA DEFICIENCY	NATURE			English	Article									KAROLINSKA INST,HUDDINGE HOSP,DEPT CLIN IMMUNOL,S-14186 HUDDINGE,SWEDEN	Karolinska Institutet	OLERUP, O (corresponding author), KAROLINSKA INST,NOVUM,CTR BIOTECHNOL,S-14152 HUDDINGE,SWEDEN.			SMITH, C. I. Edvard/0000-0003-1907-3392				AMBRUS M, 1977, CLIN IMMUNOL IMMUNOP, V7, P311, DOI 10.1016/0090-1229(77)90062-9; BIDWELL J, 1988, IMMUNOL TODAY, V9, P18, DOI 10.1016/0167-5699(88)91351-5; BIDWELL JL, 1987, MOL IMMUNOL, V24, P513, DOI 10.1016/0161-5890(87)90026-5; BOSS JM, 1984, P NATL ACAD SCI USA, V81, P1599; CARLSSON B, 1987, HUM IMMUNOL, V20, P95, DOI 10.1016/0198-8859(87)90025-5; COBAIN TJ, 1983, TISSUE ANTIGENS, V22, P151; CUCCIABELVEDERA M, 1987, TISSUE ANTIGENS, V34, P127; DUPONT B, 1989, IMMUNOBIOLOGY HLA, V1, P1027; HAMMARSTROM L, 1983, TISSUE ANTIGENS, V21, P75; HAMMARSTROM L, 1984, TISSUE ANTIGENS, V24, P35; HORN GT, 1988, P NATL ACAD SCI USA, V85, P6012, DOI 10.1073/pnas.85.16.6012; HYLDIGNIELSEN JJ, 1987, P NATL ACAD SCI USA, V84, P1644, DOI 10.1073/pnas.84.6.1644; KLEMOLA T, 1988, TISSUE ANTIGENS, V32, P218, DOI 10.1111/j.1399-0039.1988.tb01659.x; LEE BSM, 1987, IMMUNOGENETICS, V26, P85; LEE BSM, 1987, P NATL ACAD SCI USA, V84, P4591, DOI 10.1073/pnas.84.13.4591; MOREL PA, 1988, P NATL ACAD SCI USA, V85, P8111, DOI 10.1073/pnas.85.21.8111; OLERUP O, 1989, P NATL ACAD SCI USA, V86, P7113, DOI 10.1073/pnas.86.18.7113; RONNINGEN KS, 1989, HUM IMMUNOL, V26, P215; SCHAFFER FM, 1989, P NATL ACAD SCI USA, V86, P8015, DOI 10.1073/pnas.86.20.8015; SCHARF SJ, 1988, P NATL ACAD SCI USA, V85, P3504, DOI 10.1073/pnas.85.10.3504; SHEEHY MJ, 1989, J CLIN INVEST, V83, P830, DOI 10.1172/JCI113965; SMITH WI, 1978, DIABETES, V27, P1092, DOI 10.2337/diabetes.27.11.1092; TODD JA, 1987, NATURE, V329, P599, DOI 10.1038/329599a0; TODD JA, 1989, NATURE, V338, P587, DOI 10.1038/338587a0; TODD JA, 1990, IMMUNOL TODAY, V11, P122, DOI 10.1016/0167-5699(90)90049-F; TONNELLE C, 1985, EMBO J, V4, P2839, DOI 10.1002/j.1460-2075.1985.tb04012.x	26	100	103	0	2	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	SEP 20	1990	347	6290					289	290		10.1038/347289a0	http://dx.doi.org/10.1038/347289a0			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ452	1976229				2022-12-28	WOS:A1990DZ45200062
J	KITZMILLER, JL; GAVIN, LA; GIN, GD; JOVANOVICPETERSON, L; MAIN, EK; ZIGRANG, WD				KITZMILLER, JL; GAVIN, LA; GIN, GD; JOVANOVICPETERSON, L; MAIN, EK; ZIGRANG, WD			PRECONCEPTION CARE OF DIABETES - GLYCEMIC CONTROL PREVENTS CONGENITAL-ANOMALIES	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RAT-EMBRYO CULTURE; EARLY-PREGNANCY; SPONTANEOUS-ABORTION; EARLY EMBRYOGENESIS; ARACHIDONIC-ACID; INFANTS; MALFORMATIONS; MOTHERS; ORGANOGENESIS; HYPERGLYCEMIA	To test the value of intensive management of diabetes before and during early pregnancy, 84 women recruited prior to conception were compared with 110 women who were already pregnant referred at 6 to 30 weeks' gestation. All underwent daily measurement of fasting and postprandial capillary blood glucose levels. Mean blood glucose levels during embryogenesis and organogenesis were within 3.3 to 7.8 mmol/L in 50% of preconception subjects and exceeded 10 mmol/L in 6.5%. One major congenital anomaly occurred in 84 infants (1.2%) of women treated before conception compared with 12 anomalies in 110 infants (10.9%) of mothers in the postconception group. Transient symptomatic hypoglycemia occurred during embryogenesis in 60% of women in the preconception group, with a median frequency of 2.7 episodes per week, but was not associated with excess malformations. We conclude that education and intensive management for glycemic control of diabetic women before and during early pregnancy will prevent excess rates of congenital anomalies in their infants.	UNIV CALIF SAN FRANCISCO,DEPT MED,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT PEDIAT,SAN FRANCISCO,CA 94143; CHILDRENS HOSP,SAN FRANCISCO,CA 94119	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute	KITZMILLER, JL (corresponding author), UNIV CALIF SAN FRANCISCO,DEPT OBSTET GYNECOL & REPROD SCI,ROOM M-1489,SAN FRANCISCO,CA 94143, USA.							AKAZAWA M, 1989, DIABETES, V38, P1573, DOI 10.2337/diabetes.38.12.1573; BUCHANAN TA, 1986, J CLIN INVEST, V78, P643, DOI 10.1172/JCI112622; BUCHANAN TA, 1989, DIABETES, V38, P1063, DOI 10.2337/diabetes.38.8.1063; COUSINS L, 1983, AM J OBSTET GYNECOL, V147, P333, DOI 10.1016/0002-9378(83)91122-5; CROCKROFT DL, 1977, TERATOLOGY, V16, P141; DAMM P, 1989, AM J OBSTET GYNECOL, V161, P1163, DOI 10.1016/0002-9378(89)90656-X; ERIKSSON UJ, 1988, TERATOLOGY, V37, P365, DOI 10.1002/tera.1420370410; FREINKEL N, 1986, AM J CLIN NUTR, V44, P986, DOI 10.1093/ajcn/44.6.986; FREINKEL N, 1984, NEW ENGL J MED, V310, P223, DOI 10.1056/NEJM198401263100404; FUHRMANN K, 1983, DIABETES CARE, V6, P219, DOI 10.2337/diacare.6.3.219; Gabbe S G, 1977, Obstet Gynecol Surv, V32, P125, DOI 10.1097/00006254-197703000-00001; GOLDMAN AS, 1985, P NATL ACAD SCI USA, V82, P8227, DOI 10.1073/pnas.82.23.8227; GOLDMAN JA, 1986, AM J OBSTET GYNECOL, V155, P293, DOI 10.1016/0002-9378(86)90812-4; GREENE MF, 1989, TERATOLOGY, V39, P225, DOI 10.1002/tera.1420390303; HARE JW, 1980, DIABETES CARE, V3, P294; HOD M, 1986, BIOCHEM BIOPH RES CO, V140, P974, DOI 10.1016/0006-291X(86)90731-X; HORTON WE, 1983, DIABETES, V32, P610, DOI 10.2337/diabetes.32.7.610; HUNTER ES, 1987, AM J PHYSIOL, V253, pE72, DOI 10.1152/ajpendo.1987.253.1.E72; KARLSSON K, 1972, AM J OBSTET GYNECOL, V112, P213, DOI 10.1016/0002-9378(72)90118-4; KEY TC, 1987, AM J OBSTET GYNECOL, V156, P1096, DOI 10.1016/0002-9378(87)90117-7; KITZMILLER JL, 1978, AM J OBSTET GYNECOL, V131, P560, DOI 10.1016/0002-9378(78)90120-5; KITZMILLER JL, 1988, CURR PROBL OBSTET GY, V11, P107; KITZMILLER JL, 1985, OBSTET GYNECOL, V66, P1177; LESLIE RDG, 1978, LANCET, V2, P958; MILLER E, 1981, NEW ENGL J MED, V304, P1331, DOI 10.1056/NEJM198105283042204; MILLS JL, 1979, DIABETES, V28, P292, DOI 10.2337/diabetes.28.4.292; MILLS JL, 1988, NEW ENGL J MED, V319, P1617, DOI 10.1056/NEJM198812223192501; MILLS JL, 1988, NEW ENGL J MED, V318, P671, DOI 10.1056/NEJM198803173181104; MIODOVNIK M, 1988, DIABETES CARE, V11, P713, DOI 10.2337/diacare.11.9.713; PEDERSEN J, 1977, PREGNANT DIABETIC HE; PIAQUADI K, 1990, DIABETES S1, V39, pA123; PINTER E, 1986, AM J OBSTET GYNECOL, V155, P691, DOI 10.1016/S0002-9378(86)80001-1; SADLER TW, 1980, TERATOLOGY, V21, P349, DOI 10.1002/tera.1420210311; SADLER TW, 1989, DIABETES, V38, P70, DOI 10.2337/diabetes.38.1.70; SOSENKO JM, 1982, DIABETES CARE, V5, P566, DOI 10.2337/diacare.5.6.566; STEEL JM, 1990, BRIT MED J, V301, P1070, DOI 10.1136/bmj.301.6760.1070; SUSSMAN I, 1988, DIABETES, V37, P974, DOI 10.2337/diabetes.37.7.974; YLINEN K, 1984, BRIT MED J, V289, P345, DOI 10.1136/bmj.289.6441.345	38	350	359	2	14	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 13	1991	265	6					731	736		10.1001/jama.265.6.731	http://dx.doi.org/10.1001/jama.265.6.731			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EW479	1990188				2022-12-28	WOS:A1991EW47900024
J	KLERMAN, GL; WEISSMAN, MM; OUELLETTE, R; JOHNSON, J; GREENWALD, S				KLERMAN, GL; WEISSMAN, MM; OUELLETTE, R; JOHNSON, J; GREENWALD, S			PANIC ATTACKS IN THE COMMUNITY - SOCIAL MORBIDITY AND HEALTH-CARE UTILIZATION	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DISORDER	This article focuses on social morbidity and health care utilization in persons with panic attacks not meeting full diagnostic criteria for panic disorder. The findings are based on data from a random sample of over 18 000 adults drawn from five US communities. Panic attacks not meeting full criteria for panic disorder have a relatively high lifetime prevalence (3.6% of the adult population). Persons with panic attacks had impairment in perceived physical and emotional health, and in occupational and financial functioning, increased use of health care facilities, emergency departments, and psychoactive drugs. Persons with panic attacks were intermediate in severity between those with panic disorder and those with other psychiatric disorders. The findings could not be explained by comorbidity with other psychiatric disorders. We conclude that panic attacks have clinical significance and are associated with substantial morbidity.	COLUMBIA UNIV COLL PHYS & SURG,NEW YORK,NY 10032; NEW YORK STATE PSYCHIAT INST & HOSP,NEW YORK,NY 10032	Columbia University; New York State Psychiatry Institute	KLERMAN, GL (corresponding author), COLUMBIA UNIV,COLL MED,DEPT PSYCHIAT,PAYNE WHITNEY PSYCHIAT CLIN,525 E 68TH ST,NEW YORK,NY 10021, USA.			Weissman, Myrna/0000-0003-3490-3075	NATIONAL INSTITUTE OF MENTAL HEALTH [P01MH037592, R01MH043525, U01MH043077] Funding Source: NIH RePORTER; NIMH NIH HHS [MH 37592, MH 43525, U01 MH43077] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ANGST J, IN PRESS ACTA PSYCHI; BARLOW DH, 1988, ANXIETY ITS DISORDER, P479; BEITMAN BD, 1987, ARCH INTERN MED, V147, P1548, DOI 10.1001/archinte.147.9.1548; CANINO GJ, 1987, ARCH GEN PSYCHIAT, V44, P727; Eaton W.M., 1985, EPIDEMIOLOGIC FIELD; GELDER MG, 1989, PSYCHOL MED, V19, P277, DOI 10.1017/S0033291700012319; GOLDBERG RJ, 1988, J ANXIETY DISORD, V2, P61; KATON W, 1989, ADM891629 US DEP HLT; KELSEY JL, 1986, METHODS OBSERVATIONA, P293; KLERMAN GL, 1990, J PSYCHIATR RES S, V24, P2; MANNUZZA S, 1990, J ANXIETY DISORD, V4, P41, DOI 10.1016/0887-6185(90)90023-3; MARKOWITZ JS, 1989, ARCH GEN PSYCHIAT, V46, P984; MARKS IM, 1987, FEARS PHOBIAS; MCCAULAY JL, 1989, J ANXIETY DISORD, V3, P221; NAGY LM, 1989, ARCH GEN PSYCHIAT, V46, P993; NOYES R, 1990, HDB ANXIETY, P4; REGIER DA, 1984, ARCH GEN PSYCHIAT, V41, P934; ROBINS LN, 1981, ARCH GEN PSYCHIAT, V38, P381; VANKORFF MR, 1985, AM J EPIDEMIOL, V122, P970; WEISSMAN MM, 1989, NEW ENGL J MED, V321, P1209, DOI 10.1056/NEJM198911023211801; WEISSMAN MM, 1988, REV PSYCHIATRY, V7, P54; 1980, DIAGNOSTIC STATISTIC; [No title captured]	23	237	239	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 13	1991	265	6					742	746		10.1001/jama.265.6.742	http://dx.doi.org/10.1001/jama.265.6.742			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EW479	1990190				2022-12-28	WOS:A1991EW47900026
J	PEREZMESA, C				PEREZMESA, C			PATHOLOGY EVALUATION OF LUMPECTOMY SPECIMEN	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							BREAST-CANCER; MASTECTOMY				PEREZMESA, C (corresponding author), ELLIS FISCHEL STATE CANC CTR,COLUMBIA,MO 65203, USA.							FERGUSON DJ, 1989, NEW ENGL J MED, V321, P689; FISHER B, 1985, WORLD J SURG, V9, P692, DOI 10.1007/BF01655182; FISHER ER, 1986, CANCER-AM CANCER SOC, V57, P1717, DOI 10.1002/1097-0142(19860501)57:9<1717::AID-CNCR2820570902>3.0.CO;2-H; LAGIOS MD, 1983, CANCER, V52, P2173, DOI 10.1002/1097-0142(19831201)52:11<2173::AID-CNCR2820521133>3.0.CO;2-0; ROSEN PP, 1975, CANCER, V35, P739, DOI 10.1002/1097-0142(197503)35:3<739::AID-CNCR2820350329>3.0.CO;2-5	5	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 16	1991	265	3					412	412		10.1001/jama.265.3.412	http://dx.doi.org/10.1001/jama.265.3.412			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ER256	1984544				2022-12-28	WOS:A1991ER25600039
J	Lapuma, J; Schiedermayer, DL				Lapuma, J; Schiedermayer, DL			Ethics Consultation - Skills, Roles, and Training	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CLINICAL ETHICS; MEDICAL-ETHICS; COMMITTEES; PHYSICIANS; RESIDENCY; CARE; QUESTIONS; BEDSIDE	A clinical ethics consultant gathers information firsthand at the patient's bedside. The consultant's special clinical skills include the ability to identify and analyze ethical problems; use reasonable clinical judgment; communicate effectively; negotiate and facilitate negotiations; and teach others how to construct their own ethical frameworks for medical decision making. Appropriate roles for the consultant include those of professional colleague, negotiator, patient and physician advocate, case manager, and educator. The training necessary for an ethics consultant includes substantial patient care experience, instruction in health care law and moral reasoning, and preparation in medical humanism. We favor a clinical model for ethics consultation. When urgent care is needed, other consultants promptly see the patient; the clinical ethics consultant can be expected to do the same.	Lutheran Gen Hosp, Ctr Clin Ethics, 1775 Dempster St, Park Ridge, IL 60068 USA; Med Coll Wisconsin, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Lapuma, J (corresponding author), Lutheran Gen Hosp, Ctr Clin Ethics, 1775 Dempster St, Park Ridge, IL 60068 USA.							American College of Physicians Ethics Manual, 1989, ANN INTERN MED, V111, P245; [Anonymous], 1983, PRESIDENTS COMMISSIO; ANZIA D, 1991, IN PRESS ACAD PSYCH; ARNOLD RM, 1987, ANN INTERN MED, V106, P313, DOI 10.7326/0003-4819-106-2-313; BARNARD D, 1988, ARCH INTERN MED, V148, P1836, DOI 10.1001/archinte.148.8.1836; BENSON JA, 1983, ANN INTERN MED, V99, P720, DOI 10.7326/0003-4819-99-5-720; BERMEL J, 1985, HASTINGS CENT REP, V15, P2; BRENNAN TA, 1988, JAMA-J AM MED ASSOC, V260, P803, DOI 10.1001/jama.260.6.803; Burt, 1979, TAKING CARE STRANGER; CASSEL CK, 1986, J AM GERIATR SOC, V34, P399, DOI 10.1111/j.1532-5415.1986.tb04326.x; CASSELL EJ, 1985, TALKING PATIENTS, V1; CASSELL EJ, 1985, TALKING PATIENTS, V2; COHEN C, 1982, CRIT CARE MED, V10, P41; CRANFORD RE, 1989, NEUROL CLIN, V7, P697, DOI 10.1016/S0733-8619(18)30384-0; CRANFORD RE, 1984, I ETHICS COMMITTEES; CULVER CM, 1985, NEW ENGL J MED, V312, P253, DOI 10.1056/NEJM198501243120430; DERSE A, 1991, IN PRESS ANN EMERG M; DRANE JF, 1989, ETHICS CONSULTATION IN HEALTH CARE, P117; FLEETWOOD JE, 1989, J MED ETHICS, V15, P137, DOI 10.1136/jme.15.3.137; Fletcher, 1989, ETHICS CONSULTATION; FLETCHER J, 1986, BIOLAW, V2, P36; FLETCHER JC, 1989, ETHICS CONSULTATION, P73; FOST N, 1985, JAMA-J AM MED ASSOC, V253, P2687, DOI 10.1001/jama.253.18.2687; Glaser J W, 1989, Theor Med, V10, P275, DOI 10.1007/BF00489649; GLASSER G, 1988, J AM GERIATR SOC, V36, P150, DOI 10.1111/j.1532-5415.1988.tb01786.x; Glover J J, 1986, Theor Med, V7, P13, DOI 10.1007/BF00489419; GOLDMAN L, 1983, ARCH INTERN MED, V143, P1753, DOI 10.1001/archinte.143.9.1753; HOFFMASTR B, 1989, CLIN ETHICS THEORY P; Jonsen A. R., 1980, FRONTIERS MED ETHICS; Jonsen A. R., 1988, ABUSE CASUISTRY HIST; Jonsen Albert R., 1998, CLIN ETHICS, V4th; JONSEN AR, 1978, ANN INTERN MED, V88, P827, DOI 10.7326/0003-4819-88-6-827; JONSEN AR, 1982, CLIN ETHICS; Kemmler S B, 1989, HEC Forum, V1, P275; La Puma J, 1990, J Clin Ethics, V1, P56; LAPUMA J, 1989, ARCH INTERN MED, V149, P1109, DOI 10.1001/archinte.149.5.1109; LAPUMA J, 1988, JAMA-J AM MED ASSOC, V260, P808, DOI 10.1001/jama.260.6.808; LAPUMA J, 1989, J GEN INTERN MED, V4, P413; LAPUMA J, 1988, ARCH INTERN MED, V148, P1809, DOI 10.1001/archinte.148.8.1809; LAPUMA J, 1990, HOSP HEALTH SERV ADM, V35, P321; LAPUMA J, 1987, WESTERN J MED, V146, P633; LAPUMA J, 1989, CLIN RES, V37, P569; LAPUMA J, 1988, ANN INTERN MED, V108, P121, DOI 10.7326/0003-4819-108-1-121; LO B, 1987, NEW ENGL J MED, V317, P46, DOI 10.1056/NEJM198707023170110; MCCARRICK P, 1989, SCOPE NOTE, V3; MERLI GJ, 1987, MED CLIN N AM, V71, P353, DOI 10.1016/S0025-7125(16)30844-6; MILES SH, 1989, ACAD MED, V64, P705, DOI 10.1097/00001888-198912000-00004; Moreno J D, 1990, J Clin Ethics, V1, P38; NIELSEN K, 1987, CLIN MED ETHICS EXPL, P95; PELLEGRINO ED, 1979, J MED PHILOS, V4, P32, DOI 10.1093/jmp/4.1.32; PELLEGRINO ED, 1978, JAMA-J AM MED ASSOC, V239, P960; PELLEGRINO ED, 1988, JAMA-J AM MED ASSOC, V260, P837; PERKINS H, 1989, SGIM NEWSLETTER, V12, P6; PERKINS HS, 1989, ACAD MED, V64, P262, DOI 10.1097/00001888-198905000-00013; PERKINS HS, 1988, AM J MED, V85, P761; PHILLIPS DF, 1988, JAMA-J AM MED ASSOC, V260, P751; President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research, 1982, MAKING HLTH CARE DEC; PURTILO RB, 1984, NEW ENGL J MED, V311, P983, DOI 10.1056/NEJM198410113111511; Reich Warren T., 1978, ENCY BIOETHICS, V1; ROTHENBERG LS, 1989, ETHICS CONSULTATION IN HEALTH CARE, P19; RUDD P, 1988, J GEN INTERN MED, V3, P592, DOI 10.1007/BF02596106; SCHIEDERMAYER DL, 1989, ARCH INTERN MED, V149, P1303, DOI 10.1001/archinte.149.6.1303; SELF DJ, 1983, J FAM PRACTICE, V16, P355; SIEGLER M, 1978, JAMA-J AM MED ASSOC, V239, P951, DOI 10.1001/jama.239.10.951; Siegler M, 1990, J Clin Ethics, V1, P5; SIEGLER M, 1988, AM J MED, V85, P759; SIEGLER M, 1979, ARCH INTERN MED, V139, P914, DOI 10.1001/archinte.139.8.914; SIEGLER M, 1981, HASTINGS CENT REP, V11, P19, DOI 10.2307/3561068; SIEGLER M, 1988, MED ETHICS ANNOTATED; Skeel J D, 1989, Theor Med, V10, P289, DOI 10.1007/BF00489650; TOULMIN S, 1981, HASTINGS CENT REP, V11, P31, DOI 10.2307/3560542; TUMULTY PA, 1970, NEW ENGL J MED, V283, P20, DOI 10.1056/NEJM197007022830105; WAITZKIN H, 1984, JAMA-J AM MED ASSOC, V252, P2441, DOI 10.1001/jama.252.17.2441; Young EWD, 1989, ALPHA OMEGA ETHICS F; 1984, ANN INTERN MED, V101, P129; 1978, DHEW OS780012 PUB; 1978, DHEW OS780013 PUB; 1990, GUIDE AWARENESS EVAL; 1989, CURRENT OPINIONS; 1984, ANN INTERN MED, V101, P263; 1984, CRITERIA DEFINITION; 1990, J CLIN ETHICS, V1, P1	82	56	56	1	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 15	1991	114	2					155	160		10.7326/0003-4819-114-2-155	http://dx.doi.org/10.7326/0003-4819-114-2-155			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	ER534	1984395				2022-12-28	WOS:A1991ER53400013
J	SASAHARA, M; FRIES, JWU; RAINES, EW; GOWN, AM; WESTRUM, LE; FROSCH, MP; BONTHRON, DT; ROSS, R; COLLINS, T				SASAHARA, M; FRIES, JWU; RAINES, EW; GOWN, AM; WESTRUM, LE; FROSCH, MP; BONTHRON, DT; ROSS, R; COLLINS, T			PDGF B-CHAIN IN NEURONS OF THE CENTRAL-NERVOUS-SYSTEM, POSTERIOR PITUITARY, AND IN A TRANSGENIC MODEL	CELL			English	Article							EPIDERMAL GROWTH-FACTOR; FACTOR-A-CHAIN; FACTOR RECEPTORS; MESSENGER-RNA; HUMAN-FIBROBLASTS; CELL-MEMBRANES; FACTOR-BINDING; FACTOR-ALPHA; RAT-BRAIN; C-SIS	Platelet-derived growth factors (PDGFs) are growth-regulatory molecules that stimulate chemotaxis, proliferation, and increased metabolism of primarily connective tissue cells. In a survey of normal tissues, we found specific immunostaining for PDGF B-chain in neurons, principal dendrites, some axons, and probable terminals throughout the brain, in the dorsal horn of the spinal cord, and in the posterior pituitary of the nonhuman primate (Macaca nemestrina). PDGF activity was extracted from brain cortex and posterior pituitary, and ubiquitous expression of transcripts for the two chains of PDGF and both PDGF receptors was detected throughout the brain and posterior pituitary. A transgenic model was also evaluated in which the chloramphenicol acetyltransferase gene was placed under transcriptional control of the PDGF B-chain promoter. The transgene was preferentially expressed within neural cell bodies in the cortex, hippocampus, and cerebellum. PDGF may act as a neuronal regulatory agent. Neuronal release of PDGF could contribute to nerve regeneration and to glial proliferation that leads to gliosis and scarring.	UNIV WASHINGTON,DEPT NEUROL SURG & BIOL STRUCT,SEATTLE,WA 98195; BRIGHAM & WOMENS HOSP,DEPT PATHOL,BOSTON,MA 02115; UNIV EDINBURGH,WESTERN GEN HOSP,HUMAN GENET UNIT,EDINBURGH EH8 9YL,MIDLOTHIAN,SCOTLAND	University of Washington; University of Washington Seattle; Harvard University; Brigham & Women's Hospital; University of Edinburgh	SASAHARA, M (corresponding author), UNIV WASHINGTON,DEPT PATHOL,SEATTLE,WA 98195, USA.		Frosch, Matthew P/ABD-7456-2021; Fries, Jochen/AAM-5999-2020	Frosch, Matthew P/0000-0002-3940-9861; Fries, Jochen/0000-0003-2054-6345; Bonthron, David/0000-0001-8132-8179	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL018645, R01HL029873] Funding Source: NIH RePORTER; NCI NIH HHS [CA-36250] Funding Source: Medline; NHLBI NIH HHS [HL-29873, HL-18645] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BARRETT TB, 1988, P NATL ACAD SCI USA, V85, P2810, DOI 10.1073/pnas.85.8.2810; BETSHOLTZ C, 1986, NATURE, V320, P695, DOI 10.1038/320695a0; BETSHOLTZ C, 1989, MOL CHEM NEUROPATHOL, V10, P27, DOI 10.1007/BF02969484; BONTHRON DT, 1988, P NATL ACAD SCI USA, V85, P1492, DOI 10.1073/pnas.85.5.1492; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRESSLER JP, 1985, BRAIN RES, V344, P249, DOI 10.1016/0006-8993(85)90802-9; BRODAL A, 1981, NEUROLOGICAL RELATIO, P734; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COOPER JA, 1982, CELL, V31, P263, DOI 10.1016/0092-8674(82)90426-3; DAVIS JB, 1990, J CELL BIOL, V110, P1353, DOI 10.1083/jcb.110.4.1353; EK B, 1984, J BIOL CHEM, V259, P1145; Emoto N, 1989, GROWTH FACTORS, V2, P21, DOI 10.3109/08977198909069078; Fallon JH, 1990, GROWTH FACTORS, V2, P241, DOI 10.3109/08977199009071510; FALLON JH, 1984, SCIENCE, V224, P1107, DOI 10.1126/science.6144184; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GARCIA RL, 1989, AM J PATHOL, V134, P733; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GRONWALD RGK, 1988, P NATL ACAD SCI USA, V85, P3435, DOI 10.1073/pnas.85.10.3435; HANAI K, 1987, J CELL BIOL, V104, P1675, DOI 10.1083/jcb.104.6.1675; HARLOW E, 1988, ANTIBODIES LABORATOR, P594; HART CE, 1988, SCIENCE, V240, P1529, DOI 10.1126/science.2836952; HART CE, 1990, BIOCHEMISTRY-US, V29, P166, DOI 10.1021/bi00453a022; HARVEY AK, 1987, INVEST OPHTH VIS SCI, V28, P1092; HELDIN CH, 1988, EMBO J, V7, P1387, DOI 10.1002/j.1460-2075.1988.tb02955.x; HELDIN CH, 1990, CELL REGUL, V1, P555, DOI 10.1091/mbc.1.8.555; HELDIN CH, 1989, J BIOL CHEM, V264, P8905; HEMMINGS HC, 1989, FASEB J, V3, P1583, DOI 10.1096/fasebj.3.5.2493406; HOGAN B, 1986, MANIPULATING MOUSE E; KENNEDY MB, 1989, CELL, V59, P777, DOI 10.1016/0092-8674(89)90601-6; KUDLOW JE, 1989, J BIOL CHEM, V264, P3880; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MALDONADO PE, 1988, J MEMBRANE BIOL, V106, P203, DOI 10.1007/BF01872158; MARCH SC, 1974, ANAL BIOCHEM, V60, P149, DOI 10.1016/0003-2697(74)90139-0; MATSUI T, 1989, SCIENCE, V243, P800, DOI 10.1126/science.2536956; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MERCOLA M, 1990, DEV BIOL, V138, P114, DOI 10.1016/0012-1606(90)90181-H; MERCOLA M, 1985, SCIENCE, V227, P266, DOI 10.1126/science.3917575; MORRISON RS, 1987, SCIENCE, V238, P72, DOI 10.1126/science.3498986; NISHIMURA J, 1982, P NATL ACAD SCI-BIOL, V79, P4303, DOI 10.1073/pnas.79.14.4303; NISTER M, 1988, CANCER RES, V48, P3910; NOBLE M, 1988, NATURE, V333, P560, DOI 10.1038/333560a0; OVERBEEK PA, 1986, SCIENCE, V231, P1574, DOI 10.1126/science.3006249; OWEN AJ, 1982, P NATL ACAD SCI-BIOL, V79, P3203, DOI 10.1073/pnas.79.10.3203; PECH M, 1989, MOL CELL BIOL, V9, P396, DOI 10.1128/MCB.9.2.396; PIKE LJ, 1983, J BIOL CHEM, V258, P9383; PLATASALAMAN CR, 1988, NEUROSCI LETT, V94, P161, DOI 10.1016/0304-3940(88)90288-1; PRENCE EM, 1990, J CELL BIOL, V110, P319, DOI 10.1083/jcb.110.2.319; Raines E. W., 1990, HDB EXPT PHARM PEPTI, V951, P173; RAINES EW, 1987, METHOD ENZYMOL, V147, P48; RAINES EW, 1985, METHOD ENZYMOL, V109, P749; RAINES EW, 1989, SCIENCE, V243, P393, DOI 10.1126/science.2783498; RAIVICH G, 1987, J NEUROCYTOL, V16, P701, DOI 10.1007/BF01637661; RATNER L, 1987, NUCLEIC ACIDS RES, V15, P6017, DOI 10.1093/nar/15.15.6017; RICHARDSON WD, 1988, CELL, V53, P309, DOI 10.1016/0092-8674(88)90392-3; Roberts AB, 1990, HDB EXPT PHARM, V95, P419; RORSMAN F, 1988, MOL CELL BIOL, V8, P571, DOI 10.1128/MCB.8.2.571; ROSS R, 1986, NEW ENGL J MED, V314, P488, DOI 10.1056/NEJM198602203140806; ROSS R, 1990, SCIENCE, V248, P1009, DOI 10.1126/science.2343305; SEIFERT RA, 1989, J BIOL CHEM, V264, P8771; Shaw W V, 1975, Methods Enzymol, V43, P737; SHAW WV, 1991, IN PRESS ANN REV BIO; SHIMOKADO K, 1985, CELL, V43, P277, DOI 10.1016/0092-8674(85)90033-9; SHIRAISHI T, 1989, CLIN CHIM ACTA, V184, P65, DOI 10.1016/0009-8981(89)90257-X; Smits A, 1989, GROWTH FACTORS, V2, P1, DOI 10.3109/08977198909069076; VANZOELEN EJJ, 1985, MOL CELL BIOL, V5, P2289, DOI 10.1128/MCB.5.9.2289; WALICKE P, 1986, P NATL ACAD SCI USA, V83, P3012, DOI 10.1073/pnas.83.9.3012; WALICKE PA, 1988, DEV BRAIN RES, V40, P71, DOI 10.1016/0165-3806(88)90009-0; YOSHIZAWA T, 1990, SCIENCE, V247, P462, DOI 10.1126/science.2405487; YOUNG G, 1990, IN PRESS MOL CELL BI	69	383	405	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	JAN 11	1991	64	1					217	227		10.1016/0092-8674(91)90223-L	http://dx.doi.org/10.1016/0092-8674(91)90223-L			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ET175	1986868				2022-12-28	WOS:A1991ET17500023
J	KOSTREWA, D; GRANZIN, J; KOCH, C; CHOE, HW; RAGHUNATHAN, S; WOLF, W; LABAHN, J; KAHMANN, R; SAENGER, W				KOSTREWA, D; GRANZIN, J; KOCH, C; CHOE, HW; RAGHUNATHAN, S; WOLF, W; LABAHN, J; KAHMANN, R; SAENGER, W			3-DIMENSIONAL STRUCTURE OF THE ESCHERICHIA-COLI DNA-BINDING PROTEIN FIS	NATURE			English	Article							SITE-SPECIFIC RECOMBINATION; HOST FACTOR; RESOLUTION; INVERSION; ENHANCER; LAMBDA; PHASE; REFINEMENT; REPRESSOR; GROWTH	The factor for inversion stimulation, FIS, is involved in several cellular processes, including site-specific recombination and transcriptional activation 1-4. In the reactions catalysed by the DNA invertases Gin, Hin and Cin, FIS stimulates recombination by binding to an enhancer sequence 1. Within the enhancer, two FIS dimers (each 2 x 98 amino acids) 5-7 bind to two 15-base-pair consensus sequences 8,9 (Fig. 1) and induce bending of DNA 10,11. Current models propose that the enhancer-FIS complex organizes a specific synapse, either through direct interactions with Gin, or by modelling the substrate into a configuration suitable for recombination 1,9,12. Using X-ray analysis at 2.0 angstrom resolution, we now show that FIS is composed of four alpha-helices tightly intertwined to form a globular dimer with two protruding helix-turn-helix motifs. The 24 N-terminal amino acids are so poorly defined in the electron density map as to make interpretation doubtful, indicating that they might act as 'feelers' suitable for DNA or protein (invertase) recognition. We infer from model building that DNA has to bend for tight binding to FIS.	INST GENBIOL FORSCH BERLIN GMBH,W-1000 BERLIN 33,GERMANY		KOSTREWA, D (corresponding author), FREE UNIV BERLIN,INST KRISTALLOG,TAKUSTR 6,W-1000 BERLIN 33,GERMANY.		Granzin, Joachim/G-8937-2013; Koch, Christian/W-5731-2019; Labahn, Jörg/G-9593-2013; Koch, Christian/J-5716-2013	Granzin, Joachim/0000-0001-6604-950X; Koch, Christian/0000-0001-8407-4952; Labahn, Jörg/0000-0002-0648-8145; Wolf, Wojciech/0000-0002-9162-9933				ANDERSON WF, 1981, NATURE, V290, P754, DOI 10.1038/290754a0; BETERMIER M, 1989, MOL MICROBIOL, V3, P459, DOI 10.1111/j.1365-2958.1989.tb00192.x; BREG JN, 1990, NATURE, V346, P586, DOI 10.1038/346586a0; BRENNAN RG, 1989, J BIOL CHEM, V264, P1903; BRUIST MF, 1987, GENE DEV, V1, P762, DOI 10.1101/gad.1.8.762; CHOE HW, 1989, J MOL BIOL, V208, P209, DOI 10.1016/0022-2836(89)90098-3; HUBNER P, 1989, J MOL BIOL, V205, P493, DOI 10.1016/0022-2836(89)90220-9; HUNER P, 1989, EMBO J, V8, P577; JOHNSON RC, 1988, P NATL ACAD SCI USA, V85, P3484, DOI 10.1073/pnas.85.10.3484; JOHNSON RC, 1987, TRENDS GENET, V3, P262, DOI 10.1016/0168-9525(87)90261-7; KANAAR R, 1988, P NATL ACAD SCI USA, V85, P752, DOI 10.1073/pnas.85.3.752; KOCH C, 1986, J BIOL CHEM, V261, P5673; KOCH C, 1988, P NATL ACAD SCI USA, V85, P4237, DOI 10.1073/pnas.85.12.4237; KOCH C, 1988, THESIS FREIE U BERLI; NILSSON L, 1990, EMBO J, V9, P727, DOI 10.1002/j.1460-2075.1990.tb08166.x; PABO CO, 1990, SCIENCE, V247, P1210, DOI 10.1126/science.2315694; PABO CO, 1982, NATURE, V298, P443, DOI 10.1038/298443a0; PRAFFERTYJB, 1989, NATURE, V341, P705; RICE DW, 1981, ACTA CRYSTALLOGR A, V37, P491, DOI 10.1107/S0567739481001186; RICHMOND TJ, 1984, NATURE, V311, P532, DOI 10.1038/311532a0; STEITZ TA, 1990, Q REV BIOPHYS, V23, P205, DOI 10.1017/S0033583500005552; TANAKA I, 1984, NATURE, V310, P376, DOI 10.1038/310376a0; THOMPSON JF, 1987, CELL, V50, P901, DOI 10.1016/0092-8674(87)90516-2; THOMPSON JF, 1988, NUCLEIC ACIDS RES, V16, P9687, DOI 10.1093/nar/16.20.9687; TRONRUD DE, 1987, ACTA CRYSTALLOGR A, V43, P489, DOI 10.1107/S0108767387099124; WANG BC, 1985, METHOD ENZYMOL, V115, P90; WILMOT CM, 1988, J MOL BIOL, V203, P221, DOI 10.1016/0022-2836(88)90103-9; 1986, CCP4 COOPERATIVE COM	28	141	143	0	6	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JAN 10	1991	349	6305					178	180		10.1038/349178a0	http://dx.doi.org/10.1038/349178a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER418	1986310				2022-12-28	WOS:A1991ER41800066
J	HAROOTUNIAN, AT; KAO, JPY; PARANJAPE, S; TSIEN, RY				HAROOTUNIAN, AT; KAO, JPY; PARANJAPE, S; TSIEN, RY			GENERATION OF CALCIUM OSCILLATIONS IN FIBROBLASTS BY POSITIVE FEEDBACK BETWEEN CALCIUM AND IP3	SCIENCE			English	Article							DEPENDENT PROTEIN-KINASE; INOSITOL 1,4,5-TRISPHOSPHATE; SARCOPLASMIC-RETICULUM; INTRACELLULAR CA-2+; PHOSPHOLIPASE-C; INDUCED RELEASE; PHOSPHATES; HEPARIN; MUSCLE; POTENT	A wide variety of nonexcitable cells generate repetitive transient increases in cytosolic calcium ion concentration ([Ca2+]i) when stimulated with agonists that engage the phosphoinositide signalling pathway. Current theories regarding the mechanisms of oscillation disagree on whether Ca2+ inhibits or stimulates its own release from internal stores and whether inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DG) also undergo oscillations linked to the Ca2+ spikes. In this study, Ca2+ was found to stimulate its own release in REF52 fibroblasts primed by mitogens plus depolarization. However, unlike Ca2+ release in muscle and nerve cells, this amplification was insensitive to caffeine or ryanodine and required hormone receptor occupancy and functional IP3 receptors. Oscillations in [Ca2+]i were accompanied by oscillations in IP3 concentration but did not require functional protein kinase C. Therefore, the dominant feedback mechanism in this cell type appears to be Ca2+ stimulation of phospholipase C once this enzyme has been activated by hormone receptors.	UNIV CALIF SAN DIEGO,HOWARD HUGHES MED INST M047,LA JOLLA,CA 92093	University of California System; University of California San Diego				Kao, Joseph/0000-0002-8875-2180	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027177, R37NS027177] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 31004] Funding Source: Medline; NINDS NIH HHS [NS 27177] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADAMS SR, 1988, J AM CHEM SOC, V110, P3212, DOI 10.1021/ja00218a034; AMBLER SK, 1987, MOL PHARMACOL, V32, P376; BERRIDGE MJ, 1988, PHILOS T ROY SOC B, V320, P325, DOI 10.1098/rstb.1988.0080; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; BERRIDGE MJ, 1990, J BIOL CHEM, V265, P9583; DEAN NM, 1989, ANAL BIOCHEM, V183, P199, DOI 10.1016/0003-2697(89)90468-5; EBERHARD DA, 1988, TRENDS NEUROSCI, V11, P517, DOI 10.1016/0166-2236(88)90174-9; ENDO M, 1970, NATURE, V228, P34, DOI 10.1038/228034a0; FABIATO A, 1983, AM J PHYSIOL, V245, pC1; GHOSH TK, 1988, J BIOL CHEM, V263, P11075; GOLDBETER A, 1990, P NATL ACAD SCI USA, V87, P1461, DOI 10.1073/pnas.87.4.1461; HANNUN YA, 1989, SCIENCE, V243, P500, DOI 10.1126/science.2643164; HAROOTUNIAN A, UNPUB; HAROOTUNIAN A T, 1989, Journal of Cell Biology, V109, p99A; HAROOTUNIAN AT, 1988, COLD SPRING HARB SYM, V53, P945; JACOB R, 1990, BIOCHIM BIOPHYS ACTA, V1052, P427, DOI 10.1016/0167-4889(90)90152-4; KAO JPY, 1989, J BIOL CHEM, V264, P8179; KAPLAN JH, 1990, ANNU REV PHYSIOL, V52, P897; KIKKAWA U, 1982, J BIOL CHEM, V257, P13341; KOBAYASHI S, 1989, J BIOL CHEM, V264, P17997; KUBA K, 1980, J PHYSL, V298, P547; LIPSCOMBE D, 1988, NEURON, V1, P335; MALGAROLI A, 1990, J BIOL CHEM, V265, P3005; MEYER T, 1988, P NATL ACAD SCI USA, V85, P5051, DOI 10.1073/pnas.85.14.5051; MICHEL MC, 1989, J BIOL CHEM, V264, P4986; MOCHLYROSEN D, 1987, J BIOL CHEM, V262, P2291; PALADE P, 1989, MOL PHARMACOL, V36, P673; PARKER I, 1990, P NATL ACAD SCI USA, V87, P260, DOI 10.1073/pnas.87.1.260; PAYNE R, 1990, NEURON, V4, P547, DOI 10.1016/0896-6273(90)90112-S; RENARD D, 1987, BIOCHEM J, V243, P319; RHEE SG, 1989, SCIENCE, V244, P546, DOI 10.1126/science.2541501; Rink TJ, 1990, CURR OPIN CELL BIOL, V2, P198, DOI 10.1016/0955-0674(90)90007-2; RODRIGUEZPENA A, 1984, BIOCHEM BIOPH RES CO, V120, P1053, DOI 10.1016/S0006-291X(84)80213-2; ROONEY TA, 1989, J BIOL CHEM, V264, P17131; RUEGG UT, 1989, TRENDS PHARMACOL SCI, V10, P218, DOI 10.1016/0165-6147(89)90263-0; SEISHIMA M, 1988, BIOCHEM BIOPH RES CO, V156, P1077, DOI 10.1016/S0006-291X(88)80742-3; TSIEN RW, 1990, ANNU REV CELL BIOL, V6, P715, DOI 10.1146/annurev.cb.06.110190.003435; VALDEOLMILLOS M, 1989, PFLUG ARCH EUR J PHY, V413, P676, DOI 10.1007/BF00581820; WAKUI M, 1989, NATURE, V339, P317, DOI 10.1038/339317a0; WOODS NM, 1987, CELL CALCIUM, V8, P79, DOI 10.1016/0143-4160(87)90038-8	40	302	304	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JAN 4	1991	251	4989					75	78		10.1126/science.1986413	http://dx.doi.org/10.1126/science.1986413			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EQ603	1986413				2022-12-28	WOS:A1991EQ60300030
J	LAZO, RL				LAZO, RL			FAMILY MATTERS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article											LAZO, RL (corresponding author), UNIV VIRGINIA,MED CTR,SCH MED,CHARLOTTESVILLE,VA 22901, USA.								0	4	4	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	1991	265	1					119	119		10.1001/jama.265.1.119	http://dx.doi.org/10.1001/jama.265.1.119			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP555	1984111				2022-12-28	WOS:A1991EP55500044
J	ALEXANDER, FE; RICKETTS, TJ; MCKINNEY, PA; CARTWRIGHT, RA				ALEXANDER, FE; RICKETTS, TJ; MCKINNEY, PA; CARTWRIGHT, RA			COMMUNITY LIFE-STYLE CHARACTERISTICS AND RISK OF ACUTE LYMPHOBLASTIC-LEUKEMIA IN CHILDREN	LANCET			English	Article											ALEXANDER, FE (corresponding author), UNIV LEEDS, DEPT PATHOL, LEUKAEMIA RES FUND, CTR CLIN EPIDEMIOL, 17 SPRINGFIELD MT, LEEDS LS2 9NG, W YORKSHIRE, ENGLAND.							ALEXANDER F, 1990, J EPIDEMIOL COMMUN H, V44, P39, DOI 10.1136/jech.44.1.39; ALEXANDER FE, 1990, LANCET, V335, P1336; ALEXANDER FE, 1990, J PUBLIC HEALTH MED, V12, P109, DOI 10.1093/oxfordjournals.pubmed.a042527; BARCLAY R, 1987, COMMUNITY MED, V9, P279; BLACK D, 1984, INVESTIGATION POSSIB; BLAIR A, 1987, CAN MED ASSOC J, V136, P924; BRESLOW NE, 1975, J CHRON DIS, V28, P289, DOI 10.1016/0021-9681(75)90010-7; CARTWRIGHT RA, 1990, LEUKAEMIA LYMPHOMA A; COOKMOZAFFARI PJ, 1989, BRIT J CANCER, V59, P476, DOI 10.1038/bjc.1989.99; CRAIG J, 1982, URBAN RURAL CATEGORI; DARBY SC, 1987, BMJ-BRIT MED J, V294, P603, DOI 10.1136/bmj.294.6572.603; DAVIS S, 1986, CANCER, V57, P1602, DOI 10.1002/1097-0142(19860415)57:8<1602::AID-CNCR2820570828>3.0.CO;2-A; DOLL R, 1989, J R STAT SOC A STAT, V152, P1; DONHAM KJ, 1980, AM J EPIDEMIOL, V112, P80, DOI 10.1093/oxfordjournals.aje.a112979; GARDNER MJ, 1990, BRIT MED J, V300, P423, DOI 10.1136/bmj.300.6722.423; GERRARD M, 1986, LEUKEMIA RES, V10, P561, DOI 10.1016/0145-2126(86)90091-3; GREAVES MF, 1986, BRIT J HAEMATOL, V64, P1, DOI 10.1111/j.1365-2141.1986.tb07568.x; GREAVES MF, 1988, LEUKEMIA, V2, P120; HEATH CW, 1963, AM J MED, V34, P796, DOI 10.1016/0002-9343(63)90088-3; JANICKI K, 1987, CHEMOSPHERE, V16, P253, DOI 10.1016/0045-6535(87)90129-9; KINLEN L, 1988, LANCET, V2, P1323; KINLEN LJ, 1990, LANCET, V336, P577, DOI 10.1016/0140-6736(90)93389-7; KNOX G, 1964, BR J PREVENT SOC MED, V18, P14; LAGAKOS SW, 1986, J AM STAT ASSOC, V81, P583, DOI 10.2307/2288982; LINET MS, 1985, MONOGRAPHS EPIDEMIOL; PAYNE RW, 1987, REFERENCES MANUAL; PINKEL D, 1959, CANCER, V12, P351, DOI 10.1002/1097-0142(195903/04)12:2<351::AID-CNCR2820120218>3.0.CO;2-7; SHU XO, 1987, LANCET, V2, P934; WHELDON TE, 1989, LANCET, V1, P792; WHELDON TE, 1989, J ROY STAT SOC A STA, V152, P327, DOI 10.2307/2983130; WRIXON AD, 1988, NRPBR190 NATURAL RAD; YORKE JA, 1979, AM J EPIDEMIOL, V109, P103, DOI 10.1093/oxfordjournals.aje.a112666; 1988, INVESTIGATION POSSIB	33	96	97	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 15	1990	336	8729					1461	1465		10.1016/0140-6736(90)93176-P	http://dx.doi.org/10.1016/0140-6736(90)93176-P			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EN157	1979091				2022-12-28	WOS:A1990EN15700002
J	FELDMAN, M; BURTON, ME				FELDMAN, M; BURTON, ME			DRUG-THERAPY - HISTAMINE2-RECEPTOR ANTAGONISTS - STANDARD THERAPY FOR ACID-PEPTIC DISEASE .1.	NEW ENGLAND JOURNAL OF MEDICINE			English	Review									VET AFFAIRS MED CTR,CLIN PHARMACOL SECT,DALLAS,TX; UNIV TEXAS,COLL PHARM,AUSTIN,TX 78712; UNIV TEXAS,SW MED CTR,DEPT INTERNAL MED,DALLAS,TX 75230	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Texas System; University of Texas Austin; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	FELDMAN, M (corresponding author), VET AFFAIRS MED CTR,MED SERV,4500 S LANCASTER RD,DALLAS,TX 75216, USA.				NIDDK NIH HHS [R01 DK16816] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK016816] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABATE M A, 1982, Clinical Pharmacy, V1, P225; ABERNETHY DR, 1984, J PHARMACOL EXP THER, V229, P702; ARONOFF GR, 1988, CLIN PHARMACOL THER, V43, P688, DOI 10.1038/clpt.1988.97; ASGHARNEJAD M, 1988, J CLIN PHARMACOL, V28, P339, DOI 10.1002/j.1552-4604.1988.tb03155.x; AVELLA J, 1978, LANCET, V1, P624; AYMARD JP, 1988, MED TOXICOL ADV DRUG, V3, P430, DOI 10.1007/BF03259895; BACIEWICZ AM, 1990, ANN INTERN MED, V112, P76, DOI 10.7326/0003-4819-112-1-76_2; BACIEWICZ AM, 1986, THER DRUG MONIT, V8, P305, DOI 10.1097/00007691-198609000-00012; BACIEWICZ AM, 1989, AM HEART J, V118, P144, DOI 10.1016/0002-8703(89)90085-9; BALDI F, 1984, HEPATO-GASTROENTEROL, V31, P38; BARTLE WR, 1983, CLIN PHARMACOL THER, V33, P649, DOI 10.1038/clpt.1983.88; BARZAGHI N, 1989, J CLIN PHARMACOL, V29, P670, DOI 10.1002/j.1552-4604.1989.tb03399.x; BAUER LA, 1984, AM HEART J, V108, P413, DOI 10.1016/0002-8703(84)90636-7; BERARDI RR, 1988, CLIN PHARMACY, V7, P271; BERK SI, 1987, INT J CARDIOL, V14, P91, DOI 10.1016/0167-5273(87)90182-3; BERNER B D, 1982, Clinical Pharmacy, V1, P499; BJAELDAGE PAL, 1983, NEPHRON, V34, P159; BLUMER JL, 1986, J PEDIATR-US, V108, P630, DOI 10.1016/S0022-3476(86)80855-1; BLUMER JL, 1985, J PEDIATR-US, V107, P301, DOI 10.1016/S0022-3476(85)80156-6; BODEMAR G, 1981, CLIN PHARMACOKINET, V6, P306, DOI 10.2165/00003088-198106040-00005; BRADBEAR RA, 1982, J PEDIATR-US, V100, P325, DOI 10.1016/S0022-3476(82)80667-7; BRAMHALL D, 1988, DRUG INTEL CLIN PHAR, V22, P979, DOI 10.1177/106002808802201210; BRATER CD, 1982, CLIN PHARMACOL THER, V32, P484; BRITTON ML, 1985, DRUG INTEL CLIN PHAR, V19, P666, DOI 10.1177/106002808501900910; BROGDEN RN, 1982, DRUGS, V24, P267, DOI 10.2165/00003495-198224040-00002; BROGDEN RN, 1978, DRUGS, V15, P93, DOI 10.2165/00003495-197815020-00002; BROUGHTON LJ, 1981, BRIT J CLIN PHARMACO, V12, P155; CABALLERIA J, 1989, GASTROENTEROLOGY, V96, P388, DOI 10.1016/0016-5085(89)91562-X; CALLAGHAN JT, 1987, J CLIN PHARMACOL, V27, P618, DOI 10.1002/j.1552-4604.1987.tb03075.x; CAMPOLIRICHARDS DM, 1986, DRUGS, V32, P197, DOI 10.2165/00003495-198632030-00001; CARTER DC, 1977, CIMETIDINE, P135; CELLO JP, 1983, EUR J CLIN PHARMACOL, V25, P223, DOI 10.1007/BF00543795; CERRA FB, 1982, ANN SURG, V196, P565, DOI 10.1097/00000658-198211000-00009; CHEW CS, 1986, AM J PHYSIOL, V250, pG814, DOI 10.1152/ajpgi.1986.250.6.G814; CHREMOS AN, 1986, AM J MED, V81, P3, DOI 10.1016/0002-9343(86)90593-0; CHRISTIAN CD, 1984, CLIN PHARMACOL THER, V36, P221, DOI 10.1038/clpt.1984.166; COMSTOCK TJ, 1988, J CLIN PHARMACOL, V28, P1081, DOI 10.1002/j.1552-4604.1988.tb05718.x; CREMER KF, 1989, J CLIN PHARMACOL, V29, P451, DOI 10.1002/j.1552-4604.1989.tb03361.x; CUPIT G C, 1988, Advances in Therapy, V5, P168; DALTON MJ, 1985, EPILEPSIA, V26, P127, DOI 10.1111/j.1528-1157.1985.tb05395.x; DALTON MJ, 1985, DRUG INTEL CLIN PHAR, V19, P941, DOI 10.1177/106002808501901217; DANESHMEND TK, 1984, GUT, V25, P125, DOI 10.1136/gut.25.2.125; DELITALA G, 1982, EUR J CLIN PHARMACOL, V22, P207, DOI 10.1007/BF00545216; DESMOND PV, 1984, CLIN PHARMACOL THER, V35, P338, DOI 10.1038/clpt.1984.40; DONN KH, 1984, J CLIN PHARMACOL, V24, P360, DOI 10.1002/j.1552-4604.1984.tb02788.x; DONN KH, 1984, J CLIN PHARMACOL, V24, P500, DOI 10.1002/j.1552-4604.1984.tb02759.x; DUBB JW, 1978, CLIN PHARMACOL THER, V24, P76; DUNK AA, 1983, BRIT J CLIN PHARMACO, V16, P117, DOI 10.1111/j.1365-2125.1983.tb04973.x; EPSTEIN C M, 1988, Advances in Therapy, V5, P245; FARRINGER JA, 1984, CLIN PHARMACY, V3, P81; FEELY J, 1982, ANN INTERN MED, V96, P592, DOI 10.7326/0003-4819-96-5-592; FEELY J, 1981, NEW ENGL J MED, V304, P692, DOI 10.1056/NEJM198103193041202; FEELY J, 1983, SOUTHERN MED J, V76, P753, DOI 10.1097/00007611-198306000-00020; FEELY J, 1983, BRIT J CLIN PHARMACO, V15, P378, DOI 10.1111/j.1365-2125.1983.tb01514.x; FERNANDES E, 1984, ANN INTERN MED, V100, P459, DOI 10.7326/0003-4819-100-3-459_1; FISCHER J, 1985, DRUG INTEL CLIN PHAR, V19, P664; FLODGREN P, 1983, INT J CANCER, V32, P657, DOI 10.1002/ijc.2910320603; FREELAND GR, 1977, GASTROENTEROLOGY, V72, P28; Freston J W, 1987, Am J Med, V83, P58, DOI 10.1016/0002-9343(87)90813-8; FRIEDMAN H, 1988, J CLIN PHARMACOL, V28, P228, DOI 10.1002/j.1552-4604.1988.tb03137.x; FRISLID K, 1986, SCAND J GASTROENTERO, V21, P119, DOI 10.3109/00365528609034634; FUJIMURA A, 1989, J CLIN PHARMACOL, V29, P230, DOI 10.1002/j.1552-4604.1989.tb03318.x; FULLARTON GM, 1988, GUT, V30, P449; GALBRAITH RA, 1989, NEW ENGL J MED, V321, P269, DOI 10.1056/NEJM198908033210501; GARDNER ME, 1985, ANN INTERN MED, V102, P559, DOI 10.7326/0003-4819-102-4-559_1; GARG DC, 1985, PHARMACOLOGY, V31, P189, DOI 10.1159/000138114; GARG DC, 1986, J CLIN PHARMACOL, V26, P286, DOI 10.1002/j.1552-4604.1986.tb03525.x; GIFFORD RRM, 1980, TRANSPLANTATION, V29, P143, DOI 10.1097/00007890-198002000-00011; GONZALEZMARTIN G, 1987, INT J CLIN PHARM TH, V25, P139; GRAHNEN A, 1984, EUR J CLIN PHARMACOL, V26, P347, DOI 10.1007/BF00548766; GRANT SM, 1989, DRUGS, V37, P801, DOI 10.2165/00003495-198937060-00003; GREEN AW, 1984, AM J MED, V77, P1115, DOI 10.1016/0002-9343(84)90199-2; GREENE DS, 1986, CLIN PHARMACOL THER, V39, P300, DOI 10.1038/clpt.1986.43; GRIFFIN JW, 1984, AM J MED, V77, P85; GRYGIEL JJ, 1984, EUR J CLIN PHARMACOL, V26, P335, DOI 10.1007/BF00548764; GUAY DRP, 1985, BRIT J CLIN PHARMACO, V20, P55, DOI 10.1111/j.1365-2125.1985.tb02798.x; GUAY DRP, 1984, BRIT J CLIN PHARMACO, V18, P907, DOI 10.1111/j.1365-2125.1984.tb02563.x; GUGLER R, 1982, BRIT J CLIN PHARMACO, V14, P421, DOI 10.1111/j.1365-2125.1982.tb02002.x; GUGLER R, 1981, EUR J CLIN PHARMACOL, V20, P225, DOI 10.1007/BF00544602; GUGLER R, 1983, NEW ENGL J MED, V309, P1518; GUTFELD MB, 1989, J CLIN PHARMACOL, V29, P665, DOI 10.1002/j.1552-4604.1989.tb03398.x; HANSTEN P D, 1988, Drug Interactions Newsletter, V8, P39; HARDY BG, 1983, AM J CARDIOL, V52, P172, DOI 10.1016/0002-9149(83)90091-7; HEADING RC, 1977, CIMETIDINE, P145; HENANN NE, 1988, DRUG INTEL CLIN PHAR, V22, P976, DOI 10.1177/106002808802201209; HENAUER SA, 1984, CLIN PHARMACOL THER, V35, P183, DOI 10.1038/clpt.1984.24; HIRSCHOWITZ BI, 1984, POSTGRAD MED J, V60, P743, DOI 10.1136/pgmj.60.709.743; HSU K, 1984, AM REV RESPIR DIS, V130, P740; HUGHES DG, 1989, J CLIN PHARMACOL, V29, P472, DOI 10.1002/j.1552-4604.1989.tb03365.x; HUMPHRIES TJ, 1984, AM J GASTROENTEROL, V79, P593; HUSSEY EK, 1989, DICP ANN PHARMAC, V23, P675; ITEOGU MO, 1983, CLIN PHARMACY, V2, P302; JACKSON JE, 1981, NEW ENGL J MED, V305, P99; JENSEN RT, 1983, NEW ENGL J MED, V308, P883, DOI 10.1056/NEJM198304143081508; JONDERKO K, 1988, J CLIN GASTROENTEROL, V10, P143, DOI 10.1097/00004836-198804000-00008; JONES DB, 1988, GUT, V29, P890, DOI 10.1136/gut.29.7.890; JORIZZO JL, 1980, ANN INTERN MED, V92, P192, DOI 10.7326/0003-4819-92-2-192; KAGEVI I, 1985, LANCET, V1, P164; KANTO J, 1981, BRIT J CLIN PHARMACO, V11, P629, DOI 10.1111/j.1365-2125.1981.tb01184.x; KELLY HW, 1986, CLIN PHARMACOL THER, V39, P577, DOI 10.1038/clpt.1986.99; KENYON CJ, 1986, GUT, V27, P1143, DOI 10.1136/gut.27.10.1143; KIMELBLATT BJ, 1980, GASTROENTEROLOGY, V78, P791; KIRCH W, 1983, DEUT MED WOCHENSCHR, V108, P1757, DOI 10.1055/s-2008-1069821; KIRCH W, 1989, GASTROENTEROLOGY, V96, P1388, DOI 10.1016/0016-5085(89)90503-9; KIRCH W, 1982, KLIN WOCHENSCHR, V60, P1401, DOI 10.1007/BF01716245; KIRCH W, 1984, CLIN PHARMACOKINET, V9, P493, DOI 10.2165/00003088-198409060-00002; KLOTZ U, 1987, SCAND J GASTROENTERO, V22, P18, DOI 10.3109/00365528709094481; KNADLER MP, 1987, CLIN PHARMACOL THER, V42, P514, DOI 10.1038/clpt.1987.190; KNAPP AB, 1983, ANN INTERN MED, V98, P174, DOI 10.7326/0003-4819-98-2-174; KNIGGE U, 1983, CLIN ENDOCRINOL, V18, P307, DOI 10.1111/j.1365-2265.1983.tb03216.x; KOGAN FJ, 1983, J CLIN PHARMACOL, V23, P252, DOI 10.1002/j.1552-4604.1983.tb02732.x; KOLB KW, 1984, THER DRUG MONIT, V6, P306, DOI 10.1097/00007691-198409000-00009; KOSOGLOU T, 1989, DICP ANN PHARMAC, V23, P116, DOI 10.1177/106002808902300202; KOWALSKY S F, 1988, Advances in Therapy, V5, P229; KRAUS G, 1990, CLIN PHARMACOKINET, V18, P77, DOI 10.2165/00003088-199018010-00005; KRAVITZ JJ, 1978, GASTROENTEROLOGY, V74, P435; KRISHNA DR, 1988, CLIN PHARMACOKINET, V15, P205, DOI 10.2165/00003088-198815040-00001; KROBOTH PD, 1988, PHARMACOKINETICS PHA, V2, P10; KRUSS DM, 1978, GASTROENTEROLOGY, V74, P478; KURZROCK R, 1987, CLIN EXP DERMATOL, V12, P326, DOI 10.1111/j.1365-2230.1987.tb02501.x; LALONDE RL, 1983, CHEST, V83, P221, DOI 10.1378/chest.83.2.221; LANGTRY HD, 1989, DRUGS, V38, P551, DOI 10.2165/00003495-198938040-00005; LARSSON R, 1981, CLIN PHARMACOKINET, V6, P316, DOI 10.2165/00003088-198106040-00006; LEWIS JH, 1987, AM J GASTROENTEROL, V82, P987; LLOYD CW, 1985, J PEDIATR-US, V107, P295, DOI 10.1016/S0022-3476(85)80155-4; LONGSTRETH GF, 1977, GASTROENTEROLOGY, V72, P9; MA KW, 1978, GASTROENTEROLOGY, V74, P473; MARKS IN, 1989, AM J MED, V86, P145, DOI 10.1016/0002-9343(89)90177-0; MATTHEWS SJ, 1982, CLIN PHARM, V11, P556; MAVLIGIT G M, 1987, Pharmacotherapy, V7, p120S; MAVLIGIT GM, 1981, J IMMUNOL, V126, P2272; MAY DC, 1982, CLIN PHARMACOL THER, V31, P656, DOI 10.1038/clpt.1982.91; MCFADYEN ML, 1983, EUR J CLIN PHARMACOL, V25, P347, DOI 10.1007/BF01037946; MIWA M, 1984, INT J CLIN PHARM TH, V22, P214; MOBERG S, 1977, SCAND J GASTROENTERO, V12, P145, DOI 10.1080/00365521.1977.12031126; MOJAVERIAN P, 1990, CLIN PHARMACOL THER, V47, P382, DOI 10.1038/clpt.1990.43; MORGAN DJ, 1983, EUR J CLIN PHARMACOL, V25, P29, DOI 10.1007/BF00544010; MORGAN MY, 1990, ALIMENT PHARM THERAP, V4, P83; MORTON DM, 1987, SCAND J GASTROENTE S, V136, P1; NAZARIO M, 1986, DRUG INTEL CLIN PHAR, V20, P342, DOI 10.1177/106002808602000502; NELIS GF, 1980, POSTGRAD MED J, V56, P26, DOI 10.1136/pgmj.56.651.26; NELIS GF, 1980, POSTGRAD MED J, V56, P478, DOI 10.1136/pgmj.56.657.478; NWOKOLO C U, 1990, Gastroenterology, V98, pA97; NYREN O, 1986, NEW ENGL J MED, V314, P339, DOI 10.1056/NEJM198602063140603; OHNISHI K, 1985, AM J GASTROENTEROL, V80, P290; OKOLICSANYI L, 1984, INT J CLIN PHARM TH, V22, P329; OKOLICSANYI L, 1982, INT J CLIN PHARM TH, V20, P482; OREILLY RA, 1984, ARCH INTERN MED, V144, P989, DOI 10.1001/archinte.144.5.989; OSBAND M, 1980, CLIN RES, V28, pA356; PEDEN NR, 1981, ACTA ENDOCRINOL-COP, V96, P564, DOI 10.1530/acta.0.0960564; PORTER JB, 1986, ARCH INTERN MED, V146, P2237, DOI 10.1001/archinte.146.11.2237; POWELL JR, 1984, AM J MED, V77, P57; POWELL JR, 1986, CLIN PHARMACY, V5, P993; PRICE AH, 1988, DRUGS, V36, P521, DOI 10.2165/00003495-198836050-00002; REDOLFI A, 1979, EUR J CLIN PHARMACOL, V15, P257, DOI 10.1007/BF00618514; REIMANN IW, 1981, BRIT J CLIN PHARMACO, V12, P785, DOI 10.1111/j.1365-2125.1981.tb01307.x; REIMANN IW, 1982, CLIN PHARMACOL THER, V32, P749, DOI 10.1038/clpt.1982.232; RICHARDSON CT, 1978, GASTROENTEROLOGY, V74, P366; RICHTER JM, 1989, AM J MED, V87, P278; RITSCHEL WA, 1983, METHOD FIND EXP CLIN, V5, P255; ROBSON RA, 1985, BRIT J CLIN PHARMACO, V20, P170, DOI 10.1111/j.1365-2125.1985.tb05053.x; ROY AK, 1988, GASTROENTEROLOGY, V94, pA389; SAIGENJI K, 1987, SCAND J GASTROENTERO, V22, P34, DOI 10.3109/00365528709090138; SANCHO JM, 1984, EUR J CLIN PHARMACOL, V27, P495, DOI 10.1007/BF00549601; SAX M J, 1988, Advances in Therapy, V5, P210; SAX M J, 1988, Advances in Therapy, V5, P153; SAX M J, 1987, Pharmacotherapy, V7, p110S; SAX MJ, 1987, CLIN PHARMACY, V6, P492; SAX MJ, 1988, CLIN PHARM, V7, P269; SCHENTAG JJ, 1981, CLIN PHARMACOL THER, V29, P737, DOI 10.1038/clpt.1981.104; SCHENTAG JJ, 1979, LANCET, V1, P177, DOI 10.1016/S0140-6736(79)90578-6; SCHWARTZ J I, 1982, Clinical Pharmacy, V1, P534; SERLIN MJ, 1981, BRIT J CLIN PHARMACO, V12, P791, DOI 10.1111/j.1365-2125.1981.tb01308.x; SILVER BA, 1979, ANN INTERN MED, V90, P348, DOI 10.7326/0003-4819-90-3-348; SILVERSTONE PH, 1984, LANCET, V1, P1071; SKINNER MH, 1989, AM J MED, V86, P129, DOI 10.1016/0002-9343(89)90246-5; SMITH MS, 1984, CLIN PHARMACOL THER, V36, P551, DOI 10.1038/clpt.1984.218; SMOUT AJPM, 1985, GASTROENTEROLOGY, V88, P557, DOI 10.1016/0016-5085(85)90521-9; SOMOGYI A, 1981, METHOD FIND EXP CLIN, V3, pS83; SOMOGYI A, 1979, EUR J CLIN PHARMACOL, V16, P431, DOI 10.1007/BF00568207; SOMOGYI A, 1983, EUR J CLIN PHARMACOL, V25, P339, DOI 10.1007/BF01037945; SOMOGYI A, 1980, CLIN PHARMACOKINET, V5, P84, DOI 10.2165/00003088-198005010-00003; SOMOGYI A, 1985, EUR J PEDIATR, V144, P72, DOI 10.1007/BF00491931; SOMOGYI A, 1983, CLIN PHARMACOKINET, V8, P463, DOI 10.2165/00003088-198308060-00001; SOMOGYI A, 1981, EUR J CLIN PHARMACOL, V19, P343, DOI 10.1007/BF00544584; SOMOGYI A, 1982, CLIN PHARMACOKINET, V7, P23, DOI 10.2165/00003088-198207010-00002; SOMOGYI A, 1984, BRIT J CLIN PHARMACO, V18, P175, DOI 10.1111/j.1365-2125.1984.tb02450.x; SORKIN EM, 1983, DRUG INTEL CLIN PHAR, V17, P60, DOI 10.1177/106002808301700120; SPAHN H, 1983, BRIT MED J, V286, P1546, DOI 10.1136/bmj.286.6377.1546; STEINBERG WM, 1982, NEW ENGL J MED, V307, P400, DOI 10.1056/NEJM198208123070703; STEINER E, 1987, CLIN PHARMACOL THER, V42, P278, DOI 10.1038/clpt.1987.147; TOON S, 1987, EUR J CLIN PHARMACOL, V32, P165, DOI 10.1007/BF00542190; TOON S, 1986, BRIT J CLIN PHARMACO, V21, P245, DOI 10.1111/j.1365-2125.1986.tb05186.x; VANDERMEER JWM, 1980, J ANTIMICROB CHEMOTH, V6, P552, DOI 10.1093/jac/6.4.552; VESTAL RE, 1987, J PHARMACOL EXP THER, V241, P488; VESTAL RE, 1983, BRIT J CLIN PHARMACO, V15, P411, DOI 10.1111/j.1365-2125.1983.tb01523.x; WALLIN L, 1983, GUT, V24, P154, DOI 10.1136/gut.24.2.154; WHITE WB, 1985, NEW ENGL J MED, V312, P198, DOI 10.1056/NEJM198501243120402; WING LMH, 1984, CLIN PHARMACOL THER, V35, P695, DOI 10.1038/clpt.1984.97; WOLFE MM, 1988, NEW ENGL J MED, V319, P1707; ZIEMNIAK JA, 1983, CLIN PHARMACOL THER, V34, P375, DOI 10.1038/clpt.1983.182; ZIEMNIAK JA, 1984, CLIN PHARMACOL THER, V36, P228, DOI 10.1038/clpt.1984.167; ZIEMNIAK JA, 1986, APPLIED PHARMACOKINE, P782; 1982, JAMA-J AM MED ASSOC, V247, P3174	204	202	207	0	2	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 13	1990	323	24					1672	1680						9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL856	1978250				2022-12-28	WOS:A1990EL85600005
J	HART, YM; SANDER, JWAS; JOHNSON, AL; SHORVON, SD				HART, YM; SANDER, JWAS; JOHNSON, AL; SHORVON, SD			NATIONAL GENERAL-PRACTICE STUDY OF EPILEPSY - RECURRENCE AFTER A 1ST SEIZURE	LANCET			English	Article									INST NEUROL,LONDON WC1N 3BG,ENGLAND; MRC,BIOSTAT UNIT,CAMBRIDGE,ENGLAND	University of London; University College London; MRC Biostatistics Unit	HART, YM (corresponding author), NATL HOSP,CHALFONT CTR EPILEPSY,CHALFONT ST PETER SL9 0RJ,BUCKS,ENGLAND.		Shorvon, Simon D/A-2019-2009; Sander, Josemir W/C-1576-2008	Sander, Josemir W/0000-0001-6041-9661				ANNEGERS JF, 1986, EPILEPSIA, V27, P43, DOI 10.1111/j.1528-1157.1986.tb03499.x; BLOM S, 1978, EPILEPSIA, V19, P342; CAMFIELD PR, 1985, NEUROLOGY, V35, P1657, DOI 10.1212/WNL.35.11.1657; CLELAND PG, 1981, BRIT MED J, V283, P1364, DOI 10.1136/bmj.283.6303.1364; COSTEFF H, 1965, NEW ENGL J MED, V273, P1410, DOI 10.1056/NEJM196512232732604; ELWES RDC, 1985, LANCET, V2, P752; GOODRIDGE DMG, 1983, BRIT MED J, V287, P645, DOI 10.1136/bmj.287.6393.645; HART YM, 1989, NEUROEPIDEMIOLOGY, V8, P221; HAUSER WA, 1975, EPILEPSIA, V16, P1, DOI 10.1111/j.1528-1157.1975.tb04721.x; HAUSER WA, 1982, NEW ENGL J MED, V307, P522, DOI 10.1056/NEJM198208263070903; HOPKINS A, 1988, LANCET, V1, P721; SANDER JWA, 1990, LANCET, P1267; SAUNDERS S, 1975, EPILEPSIA, V16, P731; SHORVON SD, 1982, THESIS U CAMBRIDGE; THOMAS MH, 1959, JAMA-J AM MED ASSOC, V169, P457, DOI 10.1001/jama.1959.03000220037008	15	181	183	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 24	1990	336	8726					1271	1274		10.1016/0140-6736(90)92960-P	http://dx.doi.org/10.1016/0140-6736(90)92960-P			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ943	1978114				2022-12-28	WOS:A1990EJ94300002
J	BAIRDPARKER, AC				BAIRDPARKER, AC			FOODBORNE SALMONELLOSIS	LANCET			English	Article											BAIRDPARKER, AC (corresponding author), UNILEVER RES,COLWORTH LAB,SHARNBROOK MK44 1LQ,ENGLAND.							[Anonymous], 1989, CONSULTATION EPIDEMI; ARCHER DL, 1984, J FOOD PROTECT, V47, P322, DOI 10.4315/0362-028X-47.4.321; BLASER MJ, 1982, REV INFECT DIS, V4, P1096; DAOUST JY, 1985, AM J EPIDEMIOL, V122, P717, DOI 10.1093/oxfordjournals.aje.a114151; DAOUST JY, 1989, FOODBORNE BACTERIAL, P328; HUMPHREY TJ, 1989, LANCET, V1, P281; ISENBERG H D, 1988, Clinical Microbiology Reviews, V1, P40; Mackey B., 1989, Food Science & Technology Today, V3, P246; MAWER SL, 1989, LANCET, V1, P280; RAMPLING A, 1989, LANCET, V2, P436; ROBERTS JA, 1989, BRIT MED J, V298, P1227, DOI 10.1136/bmj.298.6682.1227; ROBERTS T, 1989, AM J AGR ECON, V71, P468, DOI 10.2307/1241614; SIMONSEN B, 1987, INT J FOOD MICROBIOL, V4, P227, DOI 10.1016/0168-1605(87)90040-7; SOCKETT PN, 1986, 22ND P WORLD C FOODB, V2, P1036; TODD ECD, 1987, J FOOD PROTECT, V50, P1048, DOI 10.4315/0362-028X-50.12.1048; TODD ECD, 1989, J FOOD PROTECT, V52, P586, DOI 10.4315/0362-028X-52.8.586; 1989, FOOD SAFETY EXAMPLES; 1988, WHO TECH REP SERIES, V774; 1988, MICROORGANISMS FOODS, V4; 1990, FOOD ENV HLTH GUIDE; 1989, PHLS MICROBIOL DIG, V6, P1; MICROBIOLOGY SAFET 1, P116	22	142	148	4	24	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 17	1990	336	8725					1231	1235		10.1016/0140-6736(90)92844-8	http://dx.doi.org/10.1016/0140-6736(90)92844-8			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ064	1978081				2022-12-28	WOS:A1990EJ06400014
J	LAWRENCE, GW; LEHMANN, D; ANIAN, G; COAKLEY, CA; SALEU, G; BARKER, MJ; DAVIS, MW				LAWRENCE, GW; LEHMANN, D; ANIAN, G; COAKLEY, CA; SALEU, G; BARKER, MJ; DAVIS, MW			IMPACT OF ACTIVE IMMUNIZATION AGAINST ENTERITIS-NECROTICANS IN PAPUA-NEW-GUINEA	LANCET			English	Article									PAPUA NEW GUINEA INST MED RES, GOROKA, PAPUA N GUINEA; WODEN VALLEY HOSP, DEPT GERIATR, WODEN, ACT 2606, AUSTRALIA	PNG Institute Of Medical Research; Australian National University; Canberra Hospital	LAWRENCE, GW (corresponding author), QUEENSLAND INST MED RES, BRAMSTON TERRACE, HERSTON, QLD 4006, AUSTRALIA.							ALTO WA, 1989, PAPUA NEW GUINEA MED, V32, P45; Breslow NE, 1980, STATISTICAL METHODS, V1, P122; DAVIS M, 1984, PNG I MED RES MONOGR, V6; DAVIS PR, 1985, ERGONOMICS, V28, P1, DOI 10.1080/00140138508963103; LAWRENCE G, 1979, LANCET, V1, P227; LEHMANN D, 1984, TARI RES UNIT FINAL; LINNEMANN V, 1984, PNG I MED RES MONOGR, V6, P11; MURRELL TGC, 1966, LANCET, V1, P217; WALKER PD, 1979, J BIOL STAND, V7, P315, DOI 10.1016/S0092-1157(79)80006-2	9	42	42	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 10	1990	336	8724					1165	1167		10.1016/0140-6736(90)92776-E	http://dx.doi.org/10.1016/0140-6736(90)92776-E			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG701	1978034				2022-12-28	WOS:A1990EG70100011
J	BRAHAMS, D				BRAHAMS, D			PRODUCT LIABILITY PROPOSALS, SWEDEN	LANCET			English	Editorial Material																			0	0	0	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 20	1990	336	8721					997	998		10.1016/0140-6736(90)92446-O	http://dx.doi.org/10.1016/0140-6736(90)92446-O			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ED601	1977016				2022-12-28	WOS:A1990ED60100016
J	LI, S; CRENSHAW, EB; RAWSON, EJ; SIMMONS, DM; SWANSON, LW; ROSENFELD, MG				LI, S; CRENSHAW, EB; RAWSON, EJ; SIMMONS, DM; SWANSON, LW; ROSENFELD, MG			DWARF LOCUS MUTANTS LACKING 3 PITUITARY CELL-TYPES RESULT FROM MUTATIONS IN THE POU-DOMAIN GENE PIT-1	NATURE			English	Article									UNIV CALIF SAN DIEGO, DEPT CHEM, LA JOLLA, CA 92093 USA; UNIV CALIF SAN DIEGO, SCH MED, HOWARD HUGHES MED INST, LA JOLLA, CA 92093 USA; SALK INST BIOL STUDIES, NEURAL SYST LAB, LA JOLLA, CA 92037 USA	University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; Salk Institute	LI, S (corresponding author), UNIV CALIF SAN DIEGO, EUKARYOT REGULATORY BIOL PROGRAM, M-013, LA JOLLA, CA 92093 USA.							BALLING R, 1988, CELL, V55, P531, DOI 10.1016/0092-8674(88)90039-6; BEHRINGER RR, 1988, GENE DEV, V2, P453, DOI 10.1101/gad.2.4.453; BODNER M, 1988, CELL, V55, P505, DOI 10.1016/0092-8674(88)90037-2; BORRELLI HR, 1989, NATURE, V339, P267; CAO ZD, 1987, MOL CELL BIOL, V7, P3402, DOI 10.1128/MCB.7.10.3402; CARSNER RL, 1960, SCIENCE, V131, P829, DOI 10.1126/science.131.3403.829-a; CASTRILLO JL, 1989, SCIENCE, V243, P814, DOI 10.1126/science.2563596; CHALFIE M, 1981, CELL, V24, P59, DOI 10.1016/0092-8674(81)90501-8; CHENG TC, 1983, ENDOCRINOLOGY, V113, P1669, DOI 10.1210/endo-113-5-1669; CRENSHAW EB, 1989, GENE DEV, V3, P959, DOI 10.1101/gad.3.7.959; DOLLE P, 1990, CELL, V60, P809, DOI 10.1016/0092-8674(90)90095-V; EICHER EM, 1980, J HERED, V71, P187, DOI 10.1093/oxfordjournals.jhered.a109344; FINNEY M, 1988, CELL, V55, P757, DOI 10.1016/0092-8674(88)90132-8; FOX SR, 1990, MOL ENDOCRINOL, V4, P1069, DOI 10.1210/mend-4-7-1069; GEHRING WJ, 1987, SCIENCE, V236, P1245, DOI 10.1126/science.2884726; HERR W, 1988, GENE DEV, V2, P1513, DOI 10.1101/gad.2.12a.1513; HERSKOWITZ I, 1989, NATURE, V342, P749, DOI 10.1038/342749a0; HOEFFLER JP, 1985, ENDOCRINOLOGY, V117, P187, DOI 10.1210/endo-117-1-187; INGHAM PW, 1988, NATURE, V335, P25, DOI 10.1038/335025a0; INGRAHAM HA, 1988, CELL, V55, P519, DOI 10.1016/0092-8674(88)90038-4; INGRAHAM HA, 1990, REV PHYSL, V52, P773; KEMLER I, 1990, FASEB J, V4, P1444, DOI 10.1096/fasebj.4.5.2407588; LARKIN S, IN PRESS EUR J BIOCH; LUFKIN T, 1987, SCIENCE, V237, P283, DOI 10.1126/science.3474782; MANGALAM HJ, 1989, GENE DEV, V3, P946, DOI 10.1101/gad.3.7.946; NELSON C, 1988, SCIENCE, V239, P1400, DOI 10.1126/science.2831625; NELSON C, 1986, NATURE, V322, P557, DOI 10.1038/322557a0; ROUX M, 1982, CELL TISSUE RES, V223, P415, DOI 10.1007/BF01258498; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schaible R., 1961, Genetics, V46, P896; SCHUSTER WA, 1988, EMBO J, V7, P1721, DOI 10.1002/j.1460-2075.1988.tb03001.x; Schwind JL, 1928, AM J ANAT, V41, P295, DOI 10.1002/aja.1000410206; SCOTT MP, 1989, BIOCHIM BIOPHYS ACTA, V989, P25, DOI 10.1016/0304-419X(89)90033-4; SIMMONS DM, 1990, GENE DEV, V4, P695, DOI 10.1101/gad.4.5.695; Smith PE, 1930, ANAT RECORD, V46, P249, DOI 10.1002/ar.1090460305; Smith PE, 1931, ANAT REC, V50, P85, DOI 10.1002/ar.1090500108; Snell GD, 1929, P NATL ACAD SCI USA, V15, P274, DOI 10.1073/pnas.15.3.274; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STURM RA, 1988, NATURE, V336, P601, DOI 10.1038/336601a0; VANBUULOFFERS S, 1983, ACTA ENDOCR-COP    S, V258, P7; WAHL GM, 1987, P NATL ACAD SCI USA, V84, P2160, DOI 10.1073/pnas.84.8.2160; WATANABE YG, 1979, DEV BIOL, V68, P557, DOI 10.1016/0012-1606(79)90226-4; WEST BL, 1987, MOL CELL BIOL, V7, P1193, DOI 10.1128/MCB.7.3.1193; WILSON DB, 1986, ANAT REC, V215, P282, DOI 10.1002/ar.1092150311; WILSON DB, 1986, ANAT EMBRYOL, V174, P277, DOI 10.1007/BF00824343; XI H, 1989, NATURE, V340, P35, DOI 10.1038/340035a0; YASHIRO T, 1988, CELL TISSUE RES, V251, P249, DOI 10.1007/BF00215832; YE ZS, 1987, J BIOL CHEM, V262, P6313; 1982, MOUSE NEWS LETT, V66, P4	50	1063	1092	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 11	1990	347	6293					528	533		10.1038/347528a0	http://dx.doi.org/10.1038/347528a0			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC454	1977085				2022-12-28	WOS:A1990EC45400043
J	COULTER, DM; EDWARDS, IR				COULTER, DM; EDWARDS, IR			MIANSERIN AND AGRANULOCYTOSIS IN NEW-ZEALAND	LANCET			English	Article											COULTER, DM (corresponding author), UNIV OTAGO,SCH MED,NATL TOXICOL GRP,MED ADVERSE REACT COMM,POB 913,DUNEDIN,NEW ZEALAND.							BEGG EJ, 1989, BRIT J CLIN PHARMACO, V27, P445, DOI 10.1111/j.1365-2125.1989.tb05392.x; CHAPLIN S, 1986, ADV DRUG REACT AC PO, V2, P97; COLTER DM, 1986, MONITORING DRUG SAFE, P119; COULTER DM, 1982, NZ FAM PHYS, V9, P13; Davies D., 1985, TXB ADVERSE DRUG REA, P18; INMAN WHW, 1988, LANCET, V2, P90; INMAN WHW, 1977, BRIT MED J, V1, P1500, DOI 10.1136/bmj.1.6075.1500	7	25	25	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	SEP 29	1990	336	8718					785	787		10.1016/0140-6736(90)93248-N	http://dx.doi.org/10.1016/0140-6736(90)93248-N			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB077	1976154				2022-12-28	WOS:A1990EB07700012
J	RICHARDS, P				RICHARDS, P			AMERICA THROUGH THE LOOKING-GLASS .1. MEDICAL-STUDENT YEARS	LANCET			English	Article											RICHARDS, P (corresponding author), ST MARYS HOSP,SCH MED,LONDON W2 1PG,ENGLAND.								0	2	2	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	SEP 29	1990	336	8718					794	796		10.1016/0140-6736(90)93252-K	http://dx.doi.org/10.1016/0140-6736(90)93252-K			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB077	1976157				2022-12-28	WOS:A1990EB07700015
J	MENZIES, R; CHARBONNEAU, M				MENZIES, R; CHARBONNEAU, M			THORACOSCOPY FOR THE DIAGNOSIS OF PLEURAL DISEASE	ANNALS OF INTERNAL MEDICINE			English	Article							RIGID THORACOSCOPE; EFFUSION; MESOTHELIOMA; FEATURES; VALUES	Objective: To assess the accuracy and safety of thoracoscopy for the evaluation of pleural disease. Design: Prospective evaluation of patients referred for thoracoscopy. Setting: University hospital specializing in chest diseases. Patients: We studied 102 patients with pleural disease, the cause of which had not been determined after initial investigation, including thoracentesis and needle biopsy. Eighty-six patients had pleural effusion, 11 had pleural mass, and 5 had pleural effusion in association with a known primary lung carcinoma. Intervention: All patients had thoracoscopy under local anesthesia with mild sedation. Visually directed biopsies were done of parietal pleura. Measurements: We recorded clinical characteristics, laboratory data, findings and duration of thoracoscopy, and any complications associated with the procedure. Hospital and clinic follow-up records were reviewed, and patients were contacted by telephone 12 and 24 months after thoracoscopy to assess their health status. Main Results: One hundred and four thoracoscopies were done in 102 patients. A definitive diagnosis was established in 95 patients: 42 had malignant pleural disease and 53 had benign pleural disease. A diagnosis of benign pleural disease using thoracoscopy could not be confirmed in the remaining 7 patients because of insufficient follow-up information. Overall, thoracoscopy was 96% accurate wit a sensitivity of 91%, a specificity of 100%, and a negative predictive value of 93% for the diagnosis of pleural malignancy. Thoracoscopy was well tolerated under local anesthesia and entailed hospitalization for less than 24 hours in most cases. No deaths occurred, although 1.9% of patients had major complications, and 5.5% had minor complications. Conclusions: Among patients with pleural disease remaining undiagnosed after usual initial investigation, thoracoscopy done under local anesthesia is a rapid, safe, and well-tolerated procedure with an excellent diagnostic yield that is equivalent to that of thoracotomy.			MENZIES, R (corresponding author), MONTREAL CHEST HOSP, 3650 ST URBAIN ST, MONTREAL H2X 2P4, QUEBEC, CANADA.							BOUTIN C, 1981, AM REV RESPIR DIS, V124, P588; CANTIN R, 1982, AM J SURG PATHOL, V6, P215, DOI 10.1097/00000478-198204000-00003; CANTO A, 1985, CHEST, V87, P649, DOI 10.1378/chest.87.5.649; CANTO A, 1977, THORAX, V32, P550, DOI 10.1136/thx.32.5.550; Colton T., 1974, STAT MED, V1; DAVIDSON AC, 1988, THORAX, V43, P327, DOI 10.1136/thx.43.4.327; De Camp P T, 1973, Ann Thorac Surg, V16, P79; ENK B, 1981, EUR J RESPIR DIS, V62, P344; FAURSCHOU P, 1983, THORAX, V38, P341, DOI 10.1136/thx.38.5.341; FEINSILVER SH, 1986, CHEST, V90, P516, DOI 10.1378/chest.90.4.516; GUNNELS JJ, 1978, CHEST, V74, P390, DOI 10.1378/chest.74.4.390; HALLA JT, 1980, ANN INTERN MED, V92, P748, DOI 10.7326/0003-4819-92-6-748; LEGHA SS, 1977, ANN INTERN MED, V87, P613, DOI 10.7326/0003-4819-87-5-613; LIGHT RW, 1983, PLEURAL DISEASES; MCCAUGHEY WTE, 1986, PATHOL ANNU, V21, P271; MEYER PC, 1966, THORAX, V21, P437, DOI 10.1136/thx.21.5.437; OLDENBURG FA, 1979, CHEST, V75, P45, DOI 10.1378/chest.75.1.45; PAGE RD, 1989, ANN THORAC SURG, V48, P66, DOI 10.1016/0003-4975(89)90179-3; POE RH, 1984, ARCH INTERN MED, V144, P325, DOI 10.1001/archinte.144.2.325; PUGATCH RD, 1978, J COMPUT ASSIST TOMO, V2, P601, DOI 10.1097/00004728-197811000-00016; RYAN CJ, 1981, MAYO CLIN PROC, V56, P145; Viskum K, 1981, Poumon Coeur, V37, P25; WEISSBERG D, 1980, CHEST, V78, P732, DOI 10.1378/chest.78.5.732; WU MH, 1989, JPN J CLIN ONCOL, V19, P116	24	219	225	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 15	1991	114	4					271	276		10.7326/0003-4819-114-4-271	http://dx.doi.org/10.7326/0003-4819-114-4-271			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EX521	1987873				2022-12-28	WOS:A1991EX52100003
J	WHITLEY, R; ARVIN, A; PROBER, C; COREY, L; BURCHETT, S; PLOTKIN, S; STARR, S; JACOBS, R; POWELL, D; NAHMIAS, A; SUMAYA, C; EDWARDS, K; ALFORD, C; CADDELL, G; SOONG, SJ				WHITLEY, R; ARVIN, A; PROBER, C; COREY, L; BURCHETT, S; PLOTKIN, S; STARR, S; JACOBS, R; POWELL, D; NAHMIAS, A; SUMAYA, C; EDWARDS, K; ALFORD, C; CADDELL, G; SOONG, SJ			PREDICTORS OF MORBIDITY AND MORTALITY IN NEONATES WITH HERPES-SIMPLEX VIRUS-INFECTIONS	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RECURRENT GENITAL HERPES; VIDARABINE THERAPY; ENCEPHALITIS; HISTORY; MOTHERS	Background. In a controlled trial comparing acyclovir with vidarabine in the treatment of neonatal herpes simplex virus (HSV) infection, we found no significant difference between the treatments in adjusted mortality and morbidity. Hence, we sought to define for the entire cohort (n = 202) the clinical characteristics that best predicted the eventual outcome in these neonates. Methods. Data were gathered prospectively at 27 centers between 1981 and 1988 in infants less than one months of age who had virologically confirmed HSV infection. We examined the outcomes by multivariate analyses of 24 variables. Disease was classified in one of three categories based on the extent of the involvement at entry into the trial: infection confined to skin, eyes, or mouth; encephalitis; or disseminated infection. Results and Conclusions. There were no deaths among the 85 infants with localized HSV infection. The mortality rate was significantly higher in the 46 neonates with disseminated infection (57 percent) than in the 71 with encephalitis (15 percent). In addition, the risk of death was increased in neonates who were in or near coma at entry (relative risk, 5.2), had disseminated intravascular coagulopathy (relative risk, 3.8), or were premature (relative risk, 3.7). In babies with disseminated disease, HSV pneumonitis was also associated with greater mortality (relative risk, 3.6). In the survivors, morbidity was most frequent in infants with encephalitis (relative risk, 4.4), disseminated infection (relative risk, 2.1), seizures (relative risk, 3.0), or infection with HSV type 2 (relative risk, 4.9). With HSV infection limited to the skin, eyes, or mouth, the presence of three or more recurrences of vesicles was associated with an increased risk of neurologic impairment as compared with two or fewer recurrences.	UNIV ALABAMA,DEPT MICROBIOL,BIRMINGHAM,AL 35294; UNIV ALABAMA,DEPT MED,BIRMINGHAM,AL 35294; UNIV ALABAMA,DEPT BIOSTAT,BIRMINGHAM,AL 35294; STANFORD UNIV,DEPT PEDIAT,STANFORD,CA 94305; UNIV WASHINGTON,DEPT MED,SEATTLE,WA 98195; JOSEPH STOKES JR RES INST,DEPT PEDIAT,PHILADELPHIA,PA; UNIV ARKANSAS,DEPT PEDIAT,LITTLE ROCK,AR 72204; OHIO STATE UNIV,DEPT PEDIAT,COLUMBUS,OH 43210; EMORY UNIV,DEPT PEDIAT,ATLANTA,GA 30322; UNIV TEXAS,DEPT PEDIAT,SAN ANTONIO,TX 78285; VANDERBILT UNIV,DEPT PEDIAT,NASHVILLE,TN 37240	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Stanford University; University of Washington; University of Washington Seattle; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas Little Rock; University System of Ohio; Ohio State University; Emory University; University of Texas System; Vanderbilt University	WHITLEY, R (corresponding author), UNIV ALABAMA,DEPT PEDIAT,BIRMINGHAM,AL 35294, USA.		Corey, Lawrence/AAE-1796-2020	Corey, Lawrence/0000-0002-2179-2436	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI062554] Funding Source: NIH RePORTER; NCRR NIH HHS [RR-032] Funding Source: Medline; NIAID NIH HHS [N01-AI-62554] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		COREY L, 1988, LANCET, V1, P1; JOHNSON RE, 1989, NEW ENGL J MED, V321, P7, DOI 10.1056/NEJM198907063210102; KALBFLEISCH JD, 1980, STATISTICAL ANAL FAI; LEE FK, 1985, J CLIN MICROBIOL, V22, P641, DOI 10.1128/JCM.22.4.641-644.1985; PROBER CG, 1987, NEW ENGL J MED, V316, P240, DOI 10.1056/NEJM198701293160503; STONE KM, 1989, SEX TRANSM DIS, V16, P152, DOI 10.1097/00007435-198907000-00007; STRAUS SE, 1989, SEX TRANSM DIS, V16, P107; SULLIVANBOLYAI J, 1983, JAMA-J AM MED ASSOC, V250, P3059, DOI 10.1001/jama.250.22.3059; SULLIVANBOLYAI JZ, 1986, PEDIATR INFECT DIS J, V5, P309, DOI 10.1097/00006454-198605000-00007; WHITLEY R, 1991, NEW ENGL J MED, V324, P444, DOI 10.1056/NEJM199102143240703; WHITLEY RJ, 1980, PEDIATRICS, V66, P489; WHITLEY RJ, 1977, NEW ENGL J MED, V297, P289, DOI 10.1056/NEJM197708112970601; WHITLEY RJ, 1988, J INFECT DIS, V158, P109, DOI 10.1093/infdis/158.1.109; WHITLEY RJ, 1986, NEW ENGL J MED, V314, P144, DOI 10.1056/NEJM198601163140303; WHITLEY RJ, 1981, NEW ENGL J MED, V304, P313, DOI 10.1056/NEJM198102053040602; WHITLEY RJ, 1983, PEDIATRICS, V72, P778; WHITLEY RJ, 1980, PEDIATRICS, V66, P495; YEAGER AS, 1984, PEDIATRICS, V73, P188; [No title captured]; 1985, NEW VACCINE DEV ESTA, V1, P280	20	270	273	0	2	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 14	1991	324	7					450	454		10.1056/NEJM199102143240704	http://dx.doi.org/10.1056/NEJM199102143240704			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EX363	1988830				2022-12-28	WOS:A1991EX36300004
J	OHOLLAREN, MT; YUNGINGER, JW; OFFORD, KP; SOMERS, MJ; OCONNELL, EJ; BALLARD, DJ; SACHS, MI				OHOLLAREN, MT; YUNGINGER, JW; OFFORD, KP; SOMERS, MJ; OCONNELL, EJ; BALLARD, DJ; SACHS, MI			EXPOSURE TO AN AEROALLERGEN AS A POSSIBLE PRECIPITATING FACTOR IN RESPIRATORY ARREST IN YOUNG-PATIENTS WITH ASTHMA	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NEW-ZEALAND; ALTERNARIA ALLERGENS; FATAL ASTHMA; ALT-I; MORTALITY; DEATHS; IMMUNOTHERAPY; PATHOGENESIS; INCREASES; RESPONSES	Background. Exposure to airborne spores of the common mold Alternaria alternata has been implicated in asthma attacks. Such exposure is particularly frequent in the Midwest during the summer and fall months. To determine the role of A. alternata in triggering severe asthma attacks, we investigated the cases of 11 patients with asthma who had sudden respiratory arrest and determined the frequency of sensitivity to this allergen in these patients. Methods. The 11 patients (age range, 11 to 25 years) with initial episodes of respiratory arrest, which was fatal in 2 patients, were identified in the course of their care in our pediatric and adult clinical allergy practice and by a retrospective review of all Mayo Clinic records of patients with severe asthma cared for between 1980 and 1989. Skin-test reactivity to A. alternata and levels of IgE antibody against this mold in the 11 patients were compared with those in 99 matched controls with asthma who had no history of respiratory arrest. Results. All the patients came from the upper Mid-West, and the episodes of respiratory arrest occurred in the summer or early fall. Ten of the 11 patients with asthma who had respiratory arrest (91 percent) had positive skin-puncture tests for sensitivity to alternaria, as compared with 31 percent of the controls (P < 0.001), and the serum levels of IgE antibodies to alternaria were elevated in all 9 patients tested. Among the covariates we examined (age, sex, and distance from the Mayo Clinic), only age was a significant confounder. After adjustment for age, alternaria skin-test reactivity was found to be associated with an increase of approximately 200-fold in the risk of respiratory arrest (adjusted odd ratio, 189.5; 95 percent confidence interval, 6.5 to 5535.8). Conclusions. Exposure to the aeroallergen A. alternata is a risk factor for respiratory arrest in children and young adults with asthma.	MAYO CLIN & MAYO FDN,DIV ALLERG DIS & INTERNAL MED,200 1ST ST SW,ROCHESTER,MN 55905; MAYO CLIN & MAYO FDN,DEPT HLTH SCI RES,ROCHESTER,MN 55905; MAYO CLIN & MAYO FDN,GEN PEDIAT & PEDIAT ALLERGY & IMMUNOL SECT,ROCHESTER,MN 55905	Mayo Clinic; Mayo Clinic; Mayo Clinic			Ballard, David J/H-1062-2018					AGARWAL MK, 1983, J ALLERGY CLIN IMMUN, V72, P40, DOI 10.1016/0091-6749(83)90050-7; BENATAR SR, 1986, NEW ENGL J MED, V314, P423, DOI 10.1056/NEJM198602133140706; BURNEY PGJ, 1986, LANCET, V2, P323; BURNEY PGJ, 1987, J ALLERGY CLIN IMMUN, V80, P379, DOI 10.1016/0091-6749(87)90054-6; COCKCROFT DW, 1977, CLIN ALLERGY, V7, P503, DOI 10.1111/j.1365-2222.1977.tb01481.x; DRAZEN JM, 1987, J ALLERGY CLIN IMMUN, V80, P428, DOI 10.1016/0091-6749(87)90069-8; EVANS R, 1987, J ALLERGY CLIN IMMUN, V80, P377, DOI 10.1016/0091-6749(87)90053-4; HOGG JC, 1987, J ALLERGY CLIN IMMUN, V80, P417, DOI 10.1016/0091-6749(87)90065-0; JACKSON RT, 1982, BRIT MED J, V285, P771, DOI 10.1136/bmj.285.6344.771; KRAVIS LP, 1985, AM J DIS CHILD, V139, P558, DOI 10.1001/archpedi.1985.02140080028026; LICORISH K, 1985, J ALLERGY CLIN IMMUN, V76, P819, DOI 10.1016/0091-6749(85)90755-9; MARKHAM D, 1986, J ALLERGY CLIN IMMUN, V77, P161; METZGER WJ, 1983, J ALLERGY CLIN IMMUN, V71, P119, DOI 10.1016/0091-6749(83)90245-2; MILES RM, 1983, J ALLERGY CLIN IMMUN, V71, P36, DOI 10.1016/0091-6749(83)90544-4; NYHOLM L, 1983, J ALLERGY CLIN IMMUN, V71, P461, DOI 10.1016/0091-6749(83)90462-1; OBYRNE PM, 1987, AM REV RESPIR DIS, V136, P740, DOI 10.1164/ajrccm/136.3.740; OGDEN EC, 1967, J ALLERGY, V40, P1, DOI 10.1016/0021-8707(67)90053-6; PICCOLO MC, 1988, ANN ALLERGY, V60, P107; PLATTSMILLS TAE, 1982, LANCET, V2, P675; POLLART SM, 1989, J ALLERGY CLIN IMMUN, V83, P875, DOI 10.1016/0091-6749(89)90100-0; REA HH, 1986, THORAX, V41, P833, DOI 10.1136/thx.41.11.833; REID MJ, 1986, J ALLERGY CLIN IMMUN, V78, P590, DOI 10.1016/0091-6749(86)90076-X; Richerson H B, 1986, Iowa Med, V76, P212; RICHERSON HB, 1986, ASTHMA CLIN PHARM TH, P23; RUBINSTEIN S, 1984, ANN ALLERGY, V53, P311; SALVAGGI.J, 1970, J ALLERGY, V45, P257, DOI 10.1016/0021-8707(70)90032-8; SEARS MR, 1987, J ALLERGY CLIN IMMUN, V80, P477, DOI 10.1016/0091-6749(87)90079-0; SEARS MR, 1988, J ALLERGY CLIN IMMUN, V82, P957, DOI 10.1016/0091-6749(88)90130-3; SEARS MR, 1985, NEW ZEAL MED J, V98, P271; SEARS MR, 1987, J ALLERGY CLIN IMMUN, V80, P383, DOI 10.1016/0091-6749(87)90055-8; SIEGEL SC, 1987, J ALLERGY CLIN IMMUN, V80, P458, DOI 10.1016/0091-6749(87)90075-3; SLY RM, 1984, ANN ALLERGY, V53, P20; SLY RM, 1986, ANN ALLERGY, V56, P207; SLY RM, 1988, J ALLERGY CLIN IMMUN, V82, P705, DOI 10.1016/0091-6749(88)90069-3; SOLOMON WR, 1988, ALLERGY PRINCIPLES P, V1, P312; STRUNK RC, 1985, JAMA-J AM MED ASSOC, V254, P1193; STRUNK RC, 1989, J ALLERGY CLIN IMMUN, V83, P477, DOI 10.1016/0091-6749(89)90137-1; WEISS KB, 1990, JAMA-J AM MED ASSOC, V263, P2323; WOOLCOCK AJ, 1986, CHEST, V90, pS40, DOI 10.1378/chest.90.5_Supplement.40S; YAN K, 1983, THORAX, V38, P760, DOI 10.1136/thx.38.10.760; YUNGINGER JW, 1980, J ALLERGY CLIN IMMUN, V66, P138, DOI 10.1016/0091-6749(80)90061-5; CAUSES DEATH AUSTR 1; 1982, BMJ, V285, P1251	43	500	508	0	18	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 7	1991	324	6					359	363		10.1056/NEJM199102073240602	http://dx.doi.org/10.1056/NEJM199102073240602			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EW296	1987459				2022-12-28	WOS:A1991EW29600002
J	SPOOR, TC				SPOOR, TC			SUDDEN VISUAL-LOSS FOLLOWING CATARACT REMOVAL	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter											SPOOR, TC (corresponding author), WAYNE STATE UNIV,SCH MED,KRESGE EYE INST,DETROIT,MI 48201, USA.								0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	1991	265	5					650	651						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EV718	1987420				2022-12-28	WOS:A1991EV71800028
J	MARGOTTIN, F; DUJARDIN, G; GERARD, M; EGLY, JM; HUET, J; SENTENAC, A				MARGOTTIN, F; DUJARDIN, G; GERARD, M; EGLY, JM; HUET, J; SENTENAC, A			PARTICIPATION OF THE TATA FACTOR IN TRANSCRIPTION OF THE YEAST U6 GENE BY RNA POLYMERASE-C	SCIENCE			English	Article							III TRANSCRIPTION; UPSTREAM PROMOTER; BINDING-PROTEIN; SEQUENCES; SNRNA; DNA; BOX; SUBSTITUTE; ELEMENTS; INVITRO	Fractionation of transcription extracts has led to the identification of multiple transcription factors specific for each form of nuclear RNA polymerase. Accurate transcription in vitro of the yeast U6 RNA gene by RNA polymerase C requires at least two factors. One of them was physically and functionally indistinguishable from transcription factor IID (TFIID or BTFI), a pivotal component of polymerase B transcription complexes, which binds to the TATA element. Purified yeast TFIID (yIID) or bacterial extracts that contained recombinant yIID were equally competent to direct specific transcription of the U6 gene by RNA polymerase C. The results suggest the formation of a hybrid transcription machinery, which may imply an evolutionary relation between class B and class C transcription factors.	CNRS,GENET MOLEC EUCARYOTES LAB,INSERM,U184,F-67085 STRASBOURG,FRANCE	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	MARGOTTIN, F (corresponding author), CENS,DEPT BIOL,SERV BIOCHIM,F-91191 GIF SUR YVETTE,FRANCE.		Margottin-Goguet, Florence/F-9272-2013; GERARD, Matthieu/D-2235-2014	Margottin-Goguet, Florence/0000-0002-3124-6690; GERARD, Matthieu/0000-0001-8956-0597				BARK C, 1987, NATURE, V328, P356, DOI 10.1038/328356a0; BROW DA, 1988, NATURE, V334, P213, DOI 10.1038/334213a0; BROW DA, 1990, GENE DEV, V4, P1345, DOI 10.1101/gad.4.8.1345; BURATOWSKI S, 1989, CELL, V56, P549, DOI 10.1016/0092-8674(89)90578-3; CARBON P, 1987, CELL, V51, P71, DOI 10.1016/0092-8674(87)90011-0; CAVALLINI B, 1989, P NATL ACAD SCI USA, V86, P9803, DOI 10.1073/pnas.86.24.9803; CAVALLINI B, 1988, NATURE, V334, P77, DOI 10.1038/334077a0; DAS G, 1988, EMBO J, V7, P503, DOI 10.1002/j.1460-2075.1988.tb02838.x; DAVISON BL, 1983, NATURE, V301, P680, DOI 10.1038/301680a0; GABRIELSEN OS, 1989, J BIOL CHEM, V264, P7505; GEIDUSCHEK EP, 1988, ANNU REV BIOCHEM, V57, P873, DOI 10.1146/annurev.bi.57.070188.004301; HAHN S, 1989, P NATL ACAD SCI USA, V86, P5718, DOI 10.1073/pnas.86.15.5718; KASSAVETIS GA, 1989, MOL CELL BIOL, V9, P2551, DOI 10.1128/MCB.9.6.2551; KASSAVETIS GA, 1990, CELL, V60, P235, DOI 10.1016/0092-8674(90)90739-2; KLEINERT H, 1988, NUCLEIC ACIDS RES, V16, P1319, DOI 10.1093/nar/16.4.1319; KLEKAMP MS, 1986, J BIOL CHEM, V261, P2819; KUNKEL GR, 1989, NUCLEIC ACIDS RES, V17, P7371, DOI 10.1093/nar/17.18.7371; LEE DI, 1989, J BIOCHEM-TOKYO, V105, P526, DOI 10.1093/oxfordjournals.jbchem.a122700; LOBO SM, 1989, CELL, V58, P55, DOI 10.1016/0092-8674(89)90402-9; MANIATIS T, 1983, MOL CLONING; MARGOTTIN F, UNPUB; MATTAJ IW, 1988, CELL, V55, P435, DOI 10.1016/0092-8674(88)90029-3; MEMET S, 1988, J BIOL CHEM, V263, P10048; MOENNE A, 1990, EMBO J, V9, P271, DOI 10.1002/j.1460-2075.1990.tb08105.x; MURPHY S, 1989, CELL, V59, P1071, DOI 10.1016/0092-8674(89)90763-0; MURPHY S, 1989, TRENDS GENET, V5, P122, DOI 10.1016/0168-9525(89)90043-7; MURPHY S, 1987, CELL, V51, P81, DOI 10.1016/0092-8674(87)90012-2; PALMER JM, 1990, TRENDS BIOCHEM SCI, V15, P300, DOI 10.1016/0968-0004(90)90018-7; PTASHNE M, 1990, NATURE, V346, P329, DOI 10.1038/346329a0; SAWADOGO M, 1990, ANNU REV BIOCHEM, V59, P711, DOI 10.1146/annurev.bi.59.070190.003431; SOLLNERWEBB B, 1988, CELL, V52, P153, DOI 10.1016/0092-8674(88)90500-4; WAIBEL G, 1990, NUCLEIC ACIDS RES, V18, P3451; WAIBEL G, 1990, NATURE, V346, P199	33	162	163	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JAN 25	1991	251	4992					424	426		10.1126/science.1989075	http://dx.doi.org/10.1126/science.1989075			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU504	1989075				2022-12-28	WOS:A1991EU50400039
J	WAGNER, DD; SAFFARIPOUR, S; BONFANTI, R; SADLER, JE; CRAMER, EM; CHAPMAN, B; MAYADAS, TN				WAGNER, DD; SAFFARIPOUR, S; BONFANTI, R; SADLER, JE; CRAMER, EM; CHAPMAN, B; MAYADAS, TN			INDUCTION OF SPECIFIC STORAGE ORGANELLES BY VON-WILLEBRAND FACTOR PROPOLYPEPTIDE	CELL			English	Article							HUMAN-ENDOTHELIAL CELLS; VONWILLEBRAND ANTIGEN-II; WEIBEL-PALADE BODIES; VIII-RELATED ANTIGEN; GRANULE MEMBRANE-PROTEIN; INTRACELLULAR-LOCALIZATION; PLASMINOGEN-ACTIVATOR; FUNCTIONAL DOMAINS; MULTIMER FORMATION; SECRETION	Endothelial cells store the multimeric adhesive glycoprotein von Willebrand factor (vWf), which promotes the formation of a platelet plug at the site of vessel injury. To investigate the packaging of vWf into the granules called Weibel-Palade bodies, we expresed pro-vWf cDNA and cDNA lacking the prosequence in a variety of cell lines. Storage granules formed only in cells that contain a regulated pathway of secretion. Furthermore, packaging required the prosequence. Pro-vWf, lacking the C-terminal region involved in interchain disulfide bonding, formed granules. We conclude that the signal for storage is universal in that an adhesive glycoprotein can be stored by a hormone-secreting cell; the storage of vWf is independent of its covalent multimeric structure; the unusual rod shape of Weibel-Palade bodies is due to vWf; and the vWf propolypeptide is necessary for the formation of vWf storage granules.	TUFTS UNIV, DEPT MED, BOSTON, MA 02111 USA; TUFTS UNIV, DEPT ANAT, BOSTON, MA 02111 USA; TUFTS UNIV, DEPT CELLULAR BIOL, BOSTON, MA 02111 USA; WASHINGTON UNIV, SCH MED, HOWARD HUGHES MED INST, ST LOUIS, MO 63110 USA; HOP LARIBOISIERE, INST VAISSEAUX & SANG, F-75475 PARIS 10, FRANCE; HOP LARIBOISIERE, INSERM, U150, F-75475 PARIS 10, FRANCE; CHIRON CORP, EMERYVILLE, CA 94608 USA	Tufts University; Tufts University; Howard Hughes Medical Institute; Washington University (WUSTL); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Novartis	WAGNER, DD (corresponding author), NEW ENGLAND MED CTR HOSP, BOSTON, MA 02111 USA.		Sadler, Evan/D-8556-2011	Cramer Borde, Elisabeth/0000-0001-7595-0885; Sadler, J. Evan/0000-0001-5705-469X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL041002] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL41002] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BONFANTI R, 1989, BLOOD, V73, P1109; BURGESS TL, 1987, ANNU REV CELL BIOL, V3, P243, DOI 10.1146/annurev.cellbio.3.1.243; BURKE RL, 1986, J BIOL CHEM, V261, P2574; CHUNG KN, 1989, SCIENCE, V243, P192, DOI 10.1126/science.2911732; CRAMER EM, 1985, BLOOD, V66, P710; EWENSTEIN BM, 1987, J CELL BIOL, V104, P1423, DOI 10.1083/jcb.104.5.1423; FAY PJ, 1986, SCIENCE, V232, P995, DOI 10.1126/science.3486471; FRETTO LJ, 1986, J BIOL CHEM, V261, P5679; FUMAGALLI G, 1985, J CELL BIOL, V100, P2019, DOI 10.1083/jcb.100.6.2019; GIDDINGS JC, 1982, BRIT J HAEMATOL, V52, P79, DOI 10.1111/j.1365-2141.1982.tb03863.x; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HAIGWOOD NL, 1989, PROTEIN ENG, V2, P611, DOI 10.1093/protein/2.8.611; HAMBURGER SA, 1990, BLOOD, V75, P550; HAMILTON KK, 1987, J CLIN INVEST, V79, P600, DOI 10.1172/JCI112853; HANSS M, 1987, J LAB CLIN MED, V109, P97; HATTORI R, 1989, J BIOL CHEM, V264, P9053; HORMIA M, 1984, EUR J CELL BIOL, V33, P217; IKAUFMAN RJ, 1989, MOL CELL BIOL, V9, P1233; JAFFE EA, 1973, J CLIN INVEST, V52, P2757, DOI 10.1172/JCI107471; KELLY RB, 1985, SCIENCE, V230, P25, DOI 10.1126/science.2994224; KEMMLER W, 1973, J BIOL CHEM, V248, P4544; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LARSEN E, 1989, CELL, V59, P305, DOI 10.1016/0092-8674(89)90292-4; LEVINE JD, 1982, BLOOD, V60, P531; LOESBERG C, 1983, BIOCHIM BIOPHYS ACTA, V763, P160, DOI 10.1016/0167-4889(83)90039-3; LYNCH DC, 1983, P NATL ACAD SCI-BIOL, V80, P2738, DOI 10.1073/pnas.80.9.2738; MARTI T, 1987, BIOCHEMISTRY-US, V26, P8099, DOI 10.1021/bi00399a013; MATSUDA H, 1970, INVEST OPHTH VISUAL, V9, P919; MAYADAS TN, 1989, J BIOL CHEM, V264, P13497; MCCARROLL DR, 1985, J CLIN INVEST, V75, P1089, DOI 10.1172/JCI111802; MCEVER RP, 1989, J CLIN INVEST, V84, P92, DOI 10.1172/JCI114175; NACHMAN R, 1977, J CLIN INVEST, V60, P914, DOI 10.1172/JCI108846; POWELL SK, 1988, J CELL BIOL, V106, P1843, DOI 10.1083/jcb.106.6.1843; REINDERS JH, 1985, BIOCHIM BIOPHYS ACTA, V844, P306, DOI 10.1016/0167-4889(85)90131-4; REINDERS JH, 1988, HAEMOSTASIS, V18, P246; RIBES JA, 1987, J CLIN INVEST, V79, P117, DOI 10.1172/JCI112771; RUGGERI ZM, 1980, J CLIN INVEST, V65, P1318, DOI 10.1172/JCI109795; RUGGERI ZM, 1987, BLOOD, V70, P895; SADLER JE, 1985, P NATL ACAD SCI USA, V82, P6394, DOI 10.1073/pnas.82.19.6394; SENGEL A, 1970, J CELL BIOL, V44, P223, DOI 10.1083/jcb.44.1.223; SEVARINO KA, 1987, J BIOL CHEM, V262, P4987; SEVARINO KA, 1989, CELL, V57, P11, DOI 10.1016/0092-8674(89)90167-0; SHELTONINLOES BB, 1987, BIOCHEM BIOPH RES CO, V144, P657, DOI 10.1016/S0006-291X(87)80016-5; SOSSIN WS, 1990, J CELL BIOL, V110, P1, DOI 10.1083/jcb.110.1.1; SPORN LA, 1986, CELL, V46, P185, DOI 10.1016/0092-8674(86)90735-X; STEINER DF, 1974, FED PROC, V33, P2105; STOLLER TJ, 1989, J CELL BIOL, V108, P1647, DOI 10.1083/jcb.108.5.1647; Tarentino A L, 1978, Methods Enzymol, V50, P574; TOOZE J, 1986, J CELL BIOL, V103, P839, DOI 10.1083/jcb.103.3.839; VERWEIJ CL, 1987, EMBO J, V6, P2885, DOI 10.1002/j.1460-2075.1987.tb02591.x; VERWEIJ CL, 1988, J BIOL CHEM, V263, P7921; VOORBERG J, 1990, EMBO J, V9, P797, DOI 10.1002/j.1460-2075.1990.tb08176.x; WAGNER DD, 1987, P NATL ACAD SCI USA, V84, P1955, DOI 10.1073/pnas.84.7.1955; WAGNER DD, 1986, J CELL BIOL, V102, P1320, DOI 10.1083/jcb.102.4.1320; WAGNER DD, 1987, BLOOD, V69, P27; WAGNER DD, 1982, J CELL BIOL, V95, P355, DOI 10.1083/jcb.95.1.355; WAGNER DD, 1984, J CELL BIOL, V99, P2123, DOI 10.1083/jcb.99.6.2123; WAGNER DD, 1990, ANNU REV CELL BIOL, V6, P217, DOI 10.1146/annurev.cellbio.6.1.217; WAGNER DD, 1983, J BIOL CHEM, V258, P2065; WAGNER DD, 1989, COAGULATION BLEEDING, P161; WEIBEL ER, 1964, J CELL BIOL, V23, P101, DOI 10.1083/jcb.23.1.101; WENCELDRAKE JD, 1984, AM J PATHOL, V115, P156; WHITE JG, 1968, BLOOD, V32, P148, DOI 10.1182/blood.V32.1.148.148; WIGLER M, 1978, CELL, V14, P725, DOI 10.1016/0092-8674(78)90254-4; WISE RJ, 1988, CELL, V52, P229, DOI 10.1016/0092-8674(88)90511-9; ZIMMERMAN TS, 1983, PROG HEMATOL, V13, P279; ZOLLER MJ, 1983, METHOD ENZYMOL, V100, P468	67	233	237	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 25	1991	64	2					403	413		10.1016/0092-8674(91)90648-I	http://dx.doi.org/10.1016/0092-8674(91)90648-I			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EV336	1988154				2022-12-28	WOS:A1991EV33600016
J	WEATHERALL, DJ				WEATHERALL, DJ			GENE-THERAPY IN PERSPECTIVE	NATURE			English	Editorial Material											WEATHERALL, DJ (corresponding author), UNIV OXFORD,JOHN RADCLIFFE HOSP,INST MOLEC MED,OXFORD OX3 9DU,ENGLAND.							ANDERSON WF, 1990, HUM GENE THER, V1, P1, DOI 10.1089/hum.1990.1.1-1; ANDERSON WF, 1990, HUM GENE THER, V1, P227, DOI 10.1089/hum.1990.1.3-227; APPERLEY JF, 1990, BRIT J HAEMATOL, V75, P148, DOI 10.1111/j.1365-2141.1990.tb02641.x; BURNET M, 1971, GENES DREAMS REALITI; FRIEDMANN T, 1989, SCIENCE, V244, P1275, DOI 10.1126/science.2660259; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; HIGGS DR, 1990, GENE DEV, V4, P1588, DOI 10.1101/gad.4.9.1588; Hobbs J R, 1988, Adv Intern Med, V33, P81; LUCARELLI G, 1989, ADV CONTROVERSIES TH; MARTIN FH, 1990, CELL, V63, P203, DOI 10.1016/0092-8674(90)90301-T; MILLER AD, 1990, HUM GENE THER, V1, P5, DOI 10.1089/hum.1990.1.1-5; MORGAN RA, 1990, HUM GENE THER, V1, P135, DOI 10.1089/hum.1990.1.2-135; OLD JM, 1989, MOL BIOL MED, V6, P55; SMITHIES O, 1985, NATURE, V317, P230, DOI 10.1038/317230a0; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; Weatherall David J., 1991, NEW GENETICS CLIN PR; WILLIAMS DA, 1990, HUM GENE THER, V1, P229, DOI 10.1089/hum.1990.1.3-229; ZSEBO KM, 1990, CELL, V63, P195, DOI 10.1016/0092-8674(90)90300-4; 1990, HUM GENE THER, V1, P327	19	29	37	0	1	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JAN 24	1991	349	6307					275	276		10.1038/349275a0	http://dx.doi.org/10.1038/349275a0			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU501	1987488				2022-12-28	WOS:A1991EU50100018
J	TINETTI, ME; LIU, WL; MAROTTOLI, RA; GINTER, SF				TINETTI, ME; LIU, WL; MAROTTOLI, RA; GINTER, SF			MECHANICAL RESTRAINT USE AMONG RESIDENTS OF SKILLED NURSING FACILITIES - PREVALENCE, PATTERNS, AND PREDICTORS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PHYSICAL RESTRAINTS; HOME RESIDENTS	The patterns of and risk factors for mechanical restraint use were determined in 12 skilled nursing facilities. Restraints were being used for 59% of residents at the beginning of the study; 31% of remaining were restrained during the follow-up year. No facility characteristic was associated with restraint use. The resident characteristics independently associated with initiation of restraints were older age, disorientation, dependence in dressing, greater participation in social activities, and nonuse of antidepressants. Unsteadiness (72%), disruptive behavior such as agitation (41%), and wandering (20%) were the most frequently cited reasons for initiation of restraints.	YALE UNIV,SCH MED,DEPT MED,NEW HAVEN,CT 06510; YALE UNIV,SCH MED,DEPT EPIDEMIOL & PUBL HLTH,NEW HAVEN,CT 06510	Yale University; Yale University					NIA NIH HHS [KO 8AG00292] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [K08AG000292] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BLAKESLEE JA, 1988, AM J NURS, V88, P833, DOI 10.2307/3425798; Creighton H, 1982, Nurs Manage, V13, P45; DUBE AH, 1986, JAMA-J AM MED ASSOC, V256, P2725, DOI 10.1001/jama.256.19.2725; EVANS LK, 1989, J AM GERIATR SOC, V37, P65, DOI 10.1111/j.1532-5415.1989.tb01571.x; EVANS LK, 1987, GERONTOLOGIST, V27, P272; FRANCIS J, 1989, NEW ENGL J MED, V320, P870; Halpert A, 1986, Law Med Health Care, V14, P20; HUSSIAN RA, 1987, J GERONTOL, V42, P558, DOI 10.1093/geronj/42.5.558; LOFGREN RP, 1989, AM J PUBLIC HEALTH, V79, P735, DOI 10.2105/AJPH.79.6.735; Masters R, 1990, Rehabil Nurs, V15, P22; MCLARDYSMITH P, 1986, J HAND SURG-BRIT EUR, V11B, P65, DOI 10.1016/0266-7681(86)90016-1; MION LC, 1989, J AM GERIATR SOC, V37, P949, DOI 10.1111/j.1532-5415.1989.tb07280.x; POWELL C, 1989, CAN MED ASSOC J, V141, P561; Rader J, 1985, Geriatr Nurs, V6, P196, DOI 10.1016/S0197-4572(85)80083-5; RADER J, 1987, GERONTOLOGIST, V27, P756, DOI 10.1093/geront/27.6.756; ROBBINS LJ, 1987, J AM GERIATR SOC, V35, P290, DOI 10.1111/j.1532-5415.1987.tb04633.x; STRUMPF NE, 1988, NURS RES, V37, P132; TINETTI ME, 1986, AM J MED, V80, P429, DOI 10.1016/0002-9343(86)90717-5; TINETTI ME, 1987, J AM GERIATR SOC, V35, P644, DOI 10.1111/j.1532-5415.1987.tb04341.x; TINETTI ME, IN PRESS J AM GERIAT; WERNER P, 1989, J AM GERIATR SOC, V37, P1122, DOI 10.1111/j.1532-5415.1989.tb06675.x; 1984, LANCET, P383; 1990, UNTIE ELDERLY QUALIT; 1988, SAS STAT USERS GUIDE, P189; 1989, FED REGISTER, V54, P5317; 1985, CITATION, V50, P81	26	125	126	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	1991	265	4					468	471		10.1001/jama.265.4.468	http://dx.doi.org/10.1001/jama.265.4.468			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ET377	1985233				2022-12-28	WOS:A1991ET37700024
J	SMITH, GR				SMITH, GR			CONJUGATIONAL RECOMBINATION IN ESCHERICHIA-COLI - MYTHS AND MECHANISMS	CELL			English	Review							DOUBLE-STRAND BREAKS; ESCHERICHIA-COLI; HOMOLOGOUS RECOMBINATION; GENETIC-RECOMBINATION; ENTERIC BACTERIA; DNA; REPAIR; TRANSFORMATION; DELETION; RECBC				SMITH, GR (corresponding author), FRED HUTCHINSON CANC RES CTR,SEATTLE,WA 98104, USA.			Smith, Gerald/0000-0002-8747-1352	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032194, R01GM031693, R56GM031693] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM32194, GM31693] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMATI P, 1965, GENETICS, V51, P369; BERNSTEIN H, 1985, SCIENCE, V229, P1277, DOI 10.1126/science.3898363; CAMPBELL A, 1984, COLD SPRING HARB SYM, V49, P839, DOI 10.1101/SQB.1984.049.01.095; CAMPBELL AM, 1962, ADV GENET, V11, P101; CHASE M, 1958, GENETICS, V43, P332; CLARK AJ, 1971, ANNU REV MICROBIOL, V25, P437, DOI 10.1146/annurev.mi.25.100171.002253; CLARK AJ, 1965, P NATL ACAD SCI USA, V53, P451, DOI 10.1073/pnas.53.2.451; COSLOY SD, 1973, P NATL ACAD SCI USA, V70, P84, DOI 10.1073/pnas.70.1.84; CURTISS R, 1969, ANNU REV MICROBIOL, V23, P69, DOI 10.1146/annurev.mi.23.100169.000441; CURTISS R, 1965, J BACTERIOL, V89, P28, DOI 10.1128/JB.89.1.28-40.1965; Davis B., 1990, MICROBIOLOGY; DEHAAN PG, 1972, MUTAT RES, V14, P375, DOI 10.1016/0027-5107(72)90134-0; DOWER NA, 1981, P NATL ACAD SCI-BIOL, V78, P7033, DOI 10.1073/pnas.78.11.7033; FAULDS D, 1979, J MOL BIOL, V131, P681, DOI 10.1016/0022-2836(79)90197-9; GROSS J, 1959, VIROLOGY, V9, P314, DOI 10.1016/0042-6822(59)90125-4; HAEFNER K, 1968, J BACTERIOL, V96, P652, DOI 10.1128/JB.96.3.652-659.1968; Hayes W., 1968, GENETICS BACTERIA TH; HOEKSTRA WPM, 1980, J BACTERIOL, V143, P1031, DOI 10.1128/JB.143.2.1031-1032.1980; IPPENIHLER KA, 1986, ANNU REV GENET, V20, P593, DOI 10.1146/annurev.ge.20.120186.003113; Jacob F., 1961, SEXUALITY GENETICS B; JASIN M, 1984, J BACTERIOL, V159, P783, DOI 10.1128/JB.159.2.783-786.1984; JOHNSON EM, 1964, J BACTERIOL, V87, P54, DOI 10.1128/JB.87.1.54-60.1964; KRASIN F, 1977, J MOL BIOL, V116, P81, DOI 10.1016/0022-2836(77)90120-6; LEDERBERG J, 1946, NATURE, V158, P558, DOI 10.1038/158558a0; LLOYD RG, 1985, J BACTERIOL, V164, P836, DOI 10.1128/JB.164.2.836-844.1985; LLOYD RG, 1984, MOL GEN GENET, V197, P328, DOI 10.1007/BF00330981; LOW B, 1965, GENET RES, V6, P469, DOI 10.1017/S0016672300004341; MACCACARO G, 1961, GENET RES, V2, P406, DOI 10.1017/S0016672300000884; MAHAJAN SK, 1979, MOL GEN GENET, V169, P67, DOI 10.1007/BF00267547; MALONE RE, 1978, J MOL BIOL, V121, P473, DOI 10.1016/0022-2836(78)90395-9; MANDEL M, 1970, J MOL BIOL, V53, P159, DOI 10.1016/0022-2836(70)90051-3; MASTERS M, 1985, GENETICS BACTERIA, P197; MCKITTRICK NH, 1989, J MOL BIOL, V210, P485, DOI 10.1016/0022-2836(89)90125-3; MURIALDO H, 1988, MOL GEN GENET, V213, P42, DOI 10.1007/BF00333396; NEWCOMBE HB, 1950, AM NAT, V84, P457, DOI 10.1086/281642; NEWMAN BJ, 1980, MOL GEN GENET, V180, P585, DOI 10.1007/BF00268064; NORKIN LC, 1970, J MOL BIOL, V51, P633, DOI 10.1016/0022-2836(70)90013-6; OISHI M, 1972, BIOCHEM BIOPH RES CO, V49, P1568, DOI 10.1016/0006-291X(72)90520-7; PITTARD J, 1967, J BACTERIOL, V94, P1656, DOI 10.1128/JB.94.5.1656-1663.1967; RESNICK MA, 1976, J THEOR BIOL, V59, P97, DOI 10.1016/S0022-5193(76)80025-2; ROMAN LJ, 1989, BIOCHEMISTRY-US, V28, P2873, DOI 10.1021/bi00433a019; ROTHFELS KH, 1952, GENETICS, V37, P297; RUSSELL CB, 1989, J BACTERIOL, V171, P2609, DOI 10.1128/jb.171.5.2609-2613.1989; SARGENTINI NJ, 1986, RADIAT RES, V107, P58, DOI 10.2307/3576850; SCHULTZ DW, 1986, J MOL BIOL, V189, P585, DOI 10.1016/0022-2836(86)90489-4; SHEVELL DE, 1988, J BACTERIOL, V170, P3294, DOI 10.1128/jb.170.7.3294-3296.1988; SIDDIQI O, 1973, J MOL BIOL, V77, P101, DOI 10.1016/0022-2836(73)90365-3; SMITH GR, 1986, GENETICS, V112, P429; SMITH GR, 1989, CELL, V58, P807, DOI 10.1016/0092-8674(89)90929-X; SMITH GR, 1988, MICROBIOL REV, V52, P1; SMITH GR, 1987, ANNU REV GENET, V21, P179, DOI 10.1146/annurev.genet.21.1.179; SMITH JV, 1981, SCOT EDUC REV, V13, P25; STAHL FW, 1986, PROG NUCLEIC ACID RE, V33, P169, DOI 10.1016/S0079-6603(08)60023-9; Stent G. S., 1978, MOL GENETICS INTRO N; STRICKBERGER MW, 1986, GENETICS; SUSMAN M, 1970, ANNU REV GENET, V4, P135, DOI 10.1146/annurev.ge.04.120170.001031; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; TAYLOR AL, 1960, GENETICS, V45, P1233; WILLETTS N, 1987, ESCHERICHIA COLI SAL, P1110; WILLETTS NS, 1969, J BACTERIOL, V100, P231, DOI 10.1128/JB.100.1.231-239.1969; WINANS SC, 1985, J BACTERIOL, V161, P1219, DOI 10.1128/JB.161.3.1219-1221.1985; WOLLMAN EL, 1956, COLD SPRING HARB SYM, V21, P141, DOI 10.1101/SQB.1956.021.01.012; WOOD TH, 1968, J BACTERIOL, V96, P2077, DOI 10.1128/JB.96.6.2077-2084.1968	63	153	155	2	13	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	JAN 11	1991	64	1					19	27		10.1016/0092-8674(91)90205-D	http://dx.doi.org/10.1016/0092-8674(91)90205-D			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ET175	1986865				2022-12-28	WOS:A1991ET17500005
J	TUOMANEN, E; LINDQUIST, S; SANDE, S; GALLENI, M; LIGHT, K; GAGE, D; NORMARK, S				TUOMANEN, E; LINDQUIST, S; SANDE, S; GALLENI, M; LIGHT, K; GAGE, D; NORMARK, S			COORDINATE REGULATION OF BETA-LACTAMASE INDUCTION AND PEPTIDOGLYCAN COMPOSITION BY THE AMP OPERON	SCIENCE			English	Article							PENICILLIN-BINDING PROTEINS; ESCHERICHIA-COLI; MUREIN; DELETION; GENE	The amp operon, which is located on the Escherichia coli chromosome, modulates the induction of plasmid-borne beta-lactamase genes by extracellular beta-lactam antibiotics. This suggests that the gene products AmpD and AmpE may function in the transduction of external signals. Beta-Lactam antibiotics are analogs of cell wall components that can be released during cell wall morphogenesis of enterobacteria. The amp operon was studied to determine its importance in signal transduction during cell wall morphogenesis. The peptidoglycan compositions of amp mutants were determined by high-performance liquid chromotography and fast atom bombardment mass spectrometry. When a chromosomal or plasmid-borne copy of ampD was present, the amount of pentapeptide-containing muropeptides in the cell wall increased upon addition of the cell wall constituent diaminopimelic acid to the growth medium. These results suggest that beta-lactamase induction and modulation of the composition of the cell wall share elements of a regulatory circuit that involves AmpD. Escherichia coli requires AmpD to respond to extracellular signaling amino acids, such as diaminopimelic acid, and this signal transduction system may regulate peptidoglycan composition in response to cell wall turnover products.	UMEA UNIV,DEPT MICROBIOL,S-90187 UMEA,SWEDEN; WASHINGTON UNIV,DEPT MOLEC MICROBIOL,ST LOUIS,MO 63110; MICHIGAN STATE UNIV,NIH,MASS SPECT FACIL,DEPT BIOCHEM,E LANSING,MI 48824	Umea University; Washington University (WUSTL); Michigan State University; National Institutes of Health (NIH) - USA	TUOMANEN, E (corresponding author), ROCKEFELLER UNIV,MICROBIOL LAB,NEW YORK,NY 10021, USA.		Tuomanen, Elaine I/N-3081-2018	Tuomanen, Elaine I/0000-0003-0349-8716	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000480] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI023459, R01AI027913] Funding Source: NIH RePORTER; NCRR NIH HHS [DRR00480] Funding Source: Medline; NIAID NIH HHS [AI23459, AI27913] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BROOMESMITH JK, 1982, J BACTERIOL, V152, P904; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; GALLENI M, 1990, 90TH ANN M AM SOC MI, P187; GALLENI M, UNPUB; GLAUNER B, 1988, ANAL BIOCHEM, V172, P451, DOI 10.1016/0003-2697(88)90468-X; GOODELL EW, 1983, J BACTERIOL, V156, P136, DOI 10.1128/JB.156.1.136-140.1983; LANGLEY D, 1977, J GEN MICROBIOL, V99, P263, DOI 10.1099/00221287-99-2-263; LINDBERG F, 1987, J BACTERIOL, V169, P1923, DOI 10.1128/jb.169.5.1923-1928.1987; LINDBERG F, 1985, P NATL ACAD SCI USA, V82, P4620, DOI 10.1073/pnas.82.14.4620; LINDQUIST S, 1989, MOL MICROBIOL, V3, P1091, DOI 10.1111/j.1365-2958.1989.tb00259.x; MARKIEWICZ Z, 1985, ACTA MICROBIOL POL, V34, P121; METT H, 1980, J BACTERIOL, V144, P45, DOI 10.1128/JB.144.1.45-52.1980; SPRATT BG, 1977, EUR J BIOCHEM, V72, P341, DOI 10.1111/j.1432-1033.1977.tb11258.x; TIPPER D, 1956, P NATL ACAD SCI USA, V54, P1133; TOMASZ A, 1975, P NATL ACAD SCI USA, V72, P4162, DOI 10.1073/pnas.72.10.4162; TUOMANEN E, 1987, J BACTERIOL, V169, P5308, DOI 10.1128/jb.169.11.5308-5310.1987; TUOMANEN E, 1989, J BIOL CHEM, V264, P11093	17	41	49	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JAN 11	1991	251	4990					201	204		10.1126/science.1987637	http://dx.doi.org/10.1126/science.1987637			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET173	1987637				2022-12-28	WOS:A1991ET17300042
J	SMALL, DM; OLIVA, C; TERCYAK, A				SMALL, DM; OLIVA, C; TERCYAK, A			CHEMISTRY IN THE KITCHEN - MAKING GROUND MEAT MORE HEALTHFUL	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY	Background. The National Cholesterol Education Program recommends a diet containing less than 30 percent of calories in the form of fat, less than 10 percent in the form of saturated fat, and less than 300 mg of cholesterol per day. Since American's diets generally exceed these recommendations, we wished to find an easy kitchen method to reduce substantially saturated fat and cholesterol in ground meat. Methods. Raw ground meat was hated in vegetable oil and rinsed with boiling water to extract fat and cholesterol. The fat-free broth was recombined with the meat to restore flavor. The amounts of total fat, saturated fat, and cholesterol in the meat after extraction were compared with the amounts in meat cooked as patties and in stir-fried, rinsed meat. Results. When raw ground beef containing 9.6 to 20.8 percent fat was cooked as patties and the fat poured off, 6 to 17 percent of the fat and 1.3 to 4.3 percent of the cholesterol were lost. In stir-fried, rinsed ground beef, 23 to 59 percent of the fat and 9.0 to 18.8 percent of the cholesterol were lost. When vegetable oil was use to extract fat and cholesterol from beef containing 20.7 percent fat, a mean (+/- SD) of 67.7 +/- 1.6 percent of the fat and 39.2 +/- 5.1 percent of the cholesterol were lost. The differences between conventionally cooked meat and meat prepared by the extraction of fat were significant (P < 0.001). An average of 43 percent (range, 38 to 49) of cholesterol was extracted from a wide variety of ground meats. Although conventional cooking produced no change in fatty-acid composition as compared with raw meat, our extraction process greatly increased the ratio of unsaturated to saturated fat, from 1.32 in conventionally cooked meat to 2.92 to 4.56 in meat after extraction. Extraction resulted in the loss of 72 to 87 percent of saturated fat. Conclusions. This method produces a tasty meat product that is much lower in saturated fat and cholesterol than conventionally cooked meat, and that can be used in sauces, soups, and solid meat products.			SMALL, DM (corresponding author), BOSTON UNIV, SCH MED, HOUSMAN MED RES CTR, DEPT BIOPHYS, 80 E CONCORD ST, BOSTON, MA 02118 USA.			Small, Donald/0000-0002-3072-243X				BARTLETT GR, 1959, J BIOL CHEM, V234, P466; BLANKENHORN DH, 1987, JAMA-J AM MED ASSOC, V257, P3233, DOI 10.1001/jama.257.23.3233; DOWNING DT, 1968, J CHROMATOGR, V38, P91, DOI 10.1016/0021-9673(68)85011-3; FOLCH J, 1957, J BIOL CHEM, V226, P497; FRICK MH, 1987, NEW ENGL J MED, V317, P1237, DOI 10.1056/NEJM198711123172001; GURR MI, 1989, FATS FUTURE, P41; KATZ S S, 1976, Journal of Clinical Investigation, V58, P200; Keys A., 1980, SCIENCE, DOI DOI 10.1126/SCIENCE.208.4448.1138; MORRISON WR, 1964, J LIPID RES, V5, P600; RIFKIND BM, 1984, JAMA-J AM MED ASSOC, V251, P351; SMALL DM, 1979, NEW ENGL J MED, V300, P801, DOI 10.1056/NEJM197904053001421; SMALL DM, 1986, HDB LIPID RES, V64; 1980, 17 SUP CHROM SUPPL C, P25; 1988, ARCH INTERN MED, V48, P36	14	16	16	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 10	1991	324	2					73	77		10.1056/NEJM199101103240201	http://dx.doi.org/10.1056/NEJM199101103240201			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EQ977	1984186				2022-12-28	WOS:A1991EQ97700001
J	HANSOTIA, P; BROSTE, SK				HANSOTIA, P; BROSTE, SK			THE EFFECT OF EPILEPSY OR DIABETES-MELLITUS ON THE RISK OF AUTOMOBILE ACCIDENTS	NEW ENGLAND JOURNAL OF MEDICINE			English	Article								Background. Previous studies of possible associations between chronic medical conditions and traffic safety have been inconsistent and subject to bias because of the incomplete identification of affected persons. Recent advances in the diagnosis and management of epilepsy and diabetes mellitus have improved the control of these disorders and suggest a need to reexamine the risk of traffic mishaps among patients with these conditions. Methods. We conducted a population-based retrospective cohort study of 30,420 subjects 16 to 90 years of age, with and without epilepsy or diabetes mellitus. Subjects included all the licensed drivers in seven contiguous ZIP Code areas in which the Marshfield Clinic and St. Joseph's Hospital, Marshfield, Wisconsin, are the primary sources of medical care. Standardized rates of moving violations and accidents over a four-year period (1985 through 1988) were compared in affected and unaffected cohorts. Results. Standardized mishap ratios for subjects with diabetes were 1.14 for all moving violations (P = 0.23) and 1.32 for accidents (P = 0.01); for subjects with epilepsy the ratios were 1.13 for moving violations (P = 0.26) and 1.33 for accidents (P = 0.04). Conclusions. We conclude that drivers with epilepsy or diabetes mellitus have slightly increased risks of traffic accidents as compared with unaffected persons. The increases in risk observed in our study were generally smaller than those in previous studies, and we believe they are not great enough to warrant further restrictions on driving privileges.	MARSHFIELD MED RES FDN, DEPT EPIDEMIOL & BIOSTAT, MARSHFIELD, WI USA		HANSOTIA, P (corresponding author), MARSHFIELD CLIN FDN MED RES & EDUC, DEPT NEUROL, 1000 N OAK AVE, MARSHFIELD, WI 54449 USA.							Checkoway H., 1989, RES METHODS OCCUPATI; CRANCER A, 1968, J AMER MED ASSOC, V205, P272, DOI 10.1001/jama.1968.03140310030006; DCCT Res Grp, 1987, DIABETES CARE, V10, P1; GASTAUT H, 1987, NEUROLOGY, V37, P1613, DOI 10.1212/WNL.37.10.1613; HORMIA A, 1961, ACTA PSYCHIATR SCA S, V150, P210; KLEINBAUM DG, 1987, APPLIED REGRESSION A; ROTHMAN KJ, 1979, NIH791649 DEP HLTH P; SONGER TJ, 1988, DIABETES CARE, V11, P701, DOI 10.2337/diacare.11.9.701; Waller J.A, 1973, MED IMPAIRMENT DRIVI; WALLER JA, 1965, NEW ENGL J MED, V273, P1413, DOI 10.1056/NEJM196512232732605; YSANDER L, 1966, BRIT J IND MED, V23, P28; 1985, DHHS PHS861232 NAT C; 1980, DHHS PHS801260 DEP H	13	200	202	1	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 3	1991	324	1					22	26		10.1056/NEJM199101033240105	http://dx.doi.org/10.1056/NEJM199101033240105			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EQ503	1984160	Bronze			2022-12-28	WOS:A1991EQ50300005
J	RAUB, W				RAUB, W			NEW REPORT ON HYPERTENSION IN PREGNANCY PUBLISHED	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material											RAUB, W (corresponding author), NIH, BLDG 31, ROOM 2B23, BETHESDA, MD 20892 USA.							1990, AM J OBSTET GYNECOL, V63, P1689	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	1991	265	1					19	19						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP555	1984118				2022-12-28	WOS:A1991EP55500009
J	SUNDT, TM				SUNDT, TM			CAROTID BRUIT AUDIBLE TO PATIENT	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter											SUNDT, TM (corresponding author), MAYO CLIN & MAYO FDN,ROCHESTER,MN 55905, USA.								0	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	1991	265	1					121	121		10.1001/jama.265.1.121	http://dx.doi.org/10.1001/jama.265.1.121			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP555	1984113				2022-12-28	WOS:A1991EP55500046
J	LYTTLE, CS; ANDERSEN, RM; NEYMARC, K; SCHMIDT, C; KOHRMAN, CH; LEVEY, GS				LYTTLE, CS; ANDERSEN, RM; NEYMARC, K; SCHMIDT, C; KOHRMAN, CH; LEVEY, GS			NATIONAL STUDY OF INTERNAL-MEDICINE MANPOWER .18. SUBSPECIALTY FELLOWSHIPS WITH A SPECIAL LOOK AT HEMATOLOGY AND ONCOLOGY, 1988-1989	ANNALS OF INTERNAL MEDICINE			English	Article								Objective: To determine the number and distribution of internists in subspecialty training and compare with data collected since 1976; to determine the distribution of activity of subspecialty fellows; and to focus on hematology and oncology. Design: Repeated mail survey with telephone follow-up. Participants: All directors of subspecialty training programs in internal medicine in the United States. Results: The 1988-1989 census identified 7530 fellows in training, 55 more than in 1987-1988. There are 24 more first-year fellows. Reports on the activities of subspecialty fellows show that, overall, 53% of fellows' time is spent in direct patient care, 20% on basic research, 15% on patient-related research, and 12% in teaching. Conclusions: The number of internists entering subspecialty training has risen at a considerably slower rate in the last 5 years compared with the 5 years before that. The length of subspecialty training has increased significantly since 1976. There has been a shift in subspecialty choice from hematology to oncology and toward joint programs offering both subspecialties.	UNIV PITTSBURGH, SCH MED, DEPT MED, PITTSBURGH, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	LYTTLE, CS (corresponding author), UNIV CHICAGO, CTR HLTH ADM STUDIES, 1101 E 58TH ST, CHICAGO, IL 60637 USA.							ANDERSEN RM, 1990, ANN INTERN MED, V113, P243, DOI 10.7326/0003-4819-113-3-243; ANDERSEN RM, 1988, ANN INTERN MED, V109, P62, DOI 10.7326/0003-4819-109-1-62; BARNETT PG, 1989, JAMA-J AM MED ASSOC, V262, P2864, DOI 10.1001/jama.262.20.2864; ETZEL SI, 1989, JAMA-J AM MED ASSOC, V262, P1029, DOI 10.1001/jama.262.8.1029; FRENKEL E, 1988, SUMMARY REPORT HEMAT; LYTTLE C, 1989, ANN INTERN MED, V111, P604, DOI 10.7326/0003-4819-111-7-604; SCHROEDER SA, 1987, ANN INTERN MED, V106, P768, DOI 10.7326/0003-4819-106-5-768; TEICH JL, 1986, COTH SURVEY HOUSESTA, P95; ZIMMERMAN SC, 1988, COTH SURVEY HOUSESTA, P87; 1990, CANCER FACTS FIGURES; 1989, 1989 1990 DIRECTORY; 1987, TRAINING REQUIREMENT; 1980, SUMMARY REPORT GRADU, V1; 1989, STAT ABSTR US 1989	14	20	20	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 1	1991	114	1					36	42		10.7326/0003-4819-114-1-36	http://dx.doi.org/10.7326/0003-4819-114-1-36			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EQ040	1983930				2022-12-28	WOS:A1991EQ04000006
J	ROBERTS, RG; BENTLEY, DR; BARBY, TFM; MANNERS, E; BOBROW, M				ROBERTS, RG; BENTLEY, DR; BARBY, TFM; MANNERS, E; BOBROW, M			DIRECT DIAGNOSIS OF CARRIERS OF DUCHENNE AND BECKER MUSCULAR-DYSTROPHY BY AMPLIFICATION OF LYMPHOCYTE RNA	LANCET			English	Article							PRENATAL-DIAGNOSIS; DNA AMPLIFICATION; DMD CDNA; DELETION; GENE; PROBES	Rapid detection of deletion and duplication mutations that cause Duchenne and Becker muscular dystrophy was achieved in patients and carriers after amplification of small amounts of mRNA from peripheral blood lymphocytes. The entire coding region of the dystrophin mRNA was amplified in 10 sections by reverse transcription and nested polymerase chain reaction, and the products were directly visualised on acrylamide minigels with ethidium staining. Major structural gene mutations were identified by the appearance of a band of different size to that of the wild type. The altered band was readily detected in all patients and heterozygous relatives. This non-radioactive test of venous blood samples can be used for unambiguous and rapid identification of virtually all carriers of deletions or insertions within the dystrophin gene.			ROBERTS, RG (corresponding author), UNITED MED & DENT SCH GUYS & ST THOMAS HOSP, GUYS HOSP, DIV MED & MOLEC GENET, PAEDIAT RES UNIT, LONDON SE1 9RT, ENGLAND.		Roberts, Roland G/C-3596-2009	Roberts, Roland/0000-0001-6636-1579				BAKKER E, 1987, NATURE, V329, P554, DOI 10.1038/329554a0; CHAMBERLAIN JS, 1988, NUCLEIC ACIDS RES, V16, P11141, DOI 10.1093/nar/16.23.11141; CHELLY J, 1988, NATURE, V333, P858, DOI 10.1038/333858a0; CHEN JD, 1988, AM J HUM GENET, V42, P777; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DENDUNNEN JT, 1989, AM J HUM GENET, V45, P835; GILLARD EF, 1989, AM J HUM GENET, V45, P507; GREENPM, 1989, EMBO J, V8, P1067; HODGSON S, 1989, J MED GENET, V26, P682, DOI 10.1136/jmg.26.11.682; HODGSON SV, 1989, BRIT MED BULL, V45, P719, DOI 10.1093/oxfordjournals.bmb.a072354; HOLDING C, 1989, LANCET, V2, P532; KAARIAINEN H, 1990, CLIN GENET, V37, P179; KOENIG M, 1989, AM J HUM GENET, V45, P498; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; MAO YP, 1989, HUM GENET, V81, P193, DOI 10.1007/BF00293903; Monaco AP, 1988, GENOMICS, V2, P90, DOI 10.1016/0888-7543(88)90113-9; NORMAN AM, 1990, J MED GENET, V27, P236, DOI 10.1136/jmg.27.4.236; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SIBERT JR, 1979, ARCH DIS CHILD, V54, P534, DOI 10.1136/adc.54.7.534; SPEER A, 1989, J MED GENET, V26, P1, DOI 10.1136/jmg.26.1.1; VOGELSTEIN B, 1987, CANCER RES, V47, P4806; ZATZ M, 1977, LANCET, V1, P759	23	83	101	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 22	1990	336	8730					1523	1526		10.1016/0140-6736(90)93305-9	http://dx.doi.org/10.1016/0140-6736(90)93305-9			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP037	1979364				2022-12-28	WOS:A1990EP03700002
J	ACHESON, ED				ACHESON, ED			CHADWICK,EDWIN AND THE WORLD WE LIVE IN	LANCET			English	Article																		[Anonymous], 1988, CM289; BARKER DJP, 1990, BRIT MED J, V301, P1111, DOI 10.1136/bmj.301.6761.1111; CHADWICK E, 1832, REPORT INVESTIGATION; Chadwick Edwin, 1842, REPORT INQUIRY SANIT; DAHLGREN G, 1985, JUL WHO M SOC JUST H; Flinn MW, 1965, REPORT SANITARY COND; MARMOT MG, 1986, LANCET, V2, P274; VALKONEN T, 1990, 49 U HELS DEP SOC WO; Whitehead M., 1987, HLTH DIVIDE INEQUALI; 1980 OFF POP CENS SU; MORTALITY STATIS DH3; 1976 OFF POP CENS SU; 1988 OFF POP CENS SU; 1988, DHSS1980 DEP HLTH SO; 1985, WHO TARGETS HLTH ALL; 1974 OFF POP CENS SU; 1955, PUBLIC HLTH REPORT; 1988, ENGLISH HOUSE CONDIT; 1984 OFF POP CENS SU; 1989, MORTALITY STATIS DH1; 1990, UNFPA1990 UN POP FUN	21	15	16	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 15	1990	336	8729					1482	1485						4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EN157	1979099				2022-12-28	WOS:A1990EN15700010
J	WONG, CS; PAVORD, ID; WILLIAMS, J; BRITTON, JR; TATTERSFIELD, AE				WONG, CS; PAVORD, ID; WILLIAMS, J; BRITTON, JR; TATTERSFIELD, AE			BRONCHODILATOR, CARDIOVASCULAR, AND HYPOKALEMIC EFFECTS OF FENOTEROL, SALBUTAMOL, AND TERBUTALINE IN ASTHMA	LANCET			English	Article											WONG, CS (corresponding author), CITY HOSP,RESP MED UNIT,NOTTINGHAM NG5 1PB,ENGLAND.		Britton, John R/G-9705-2011	Pavord, Ian/0000-0002-4288-5973				ALHILLAWI AH, 1984, BRIT MED J, V288, P367, DOI 10.1136/bmj.288.6414.367; [Anonymous], 1990, BMJ, V301, P797; BARNES RB, 1945, IND ENG CHEM, V17, P605, DOI 10.1021/i560146a001; Bazett HC, 1920, HEART-J STUD CIRC, V7, P353; BENSHLOMO I, 1986, LANCET, V2, P917; BIRMINGHAM AT, 1985, J NEUROL NEUROSUR PS, V48, P788, DOI 10.1136/jnnp.48.8.788; BIRMINGHAM AT, 1978, J PHYSL, V276, P20; BROWN JE, 1983, CLIN PHARMACOL THER, V33, P424, DOI 10.1038/clpt.1983.57; BURGESS CD, 1990, AUST NZ J MED S, V20, P525; CRANE J, 1989, THORAX, V44, P136, DOI 10.1136/thx.44.2.136; CRANE J, 1989, LANCET, V1, P917; DAVIS C, 1980, BRIT J CLIN PHARMACO, V10, P425, DOI 10.1111/j.1365-2125.1980.tb01783.x; FLATT A, 1990, POSTGRAD MED J, V66, P98, DOI 10.1136/pgmj.66.772.98; GOLDIE RG, 1986, BRIT J CLIN PHARMACO, V22, P669, DOI 10.1111/j.1365-2125.1986.tb02956.x; GRAY BJ, 1982, BRIT J DIS CHEST, V76, P341, DOI 10.1016/0007-0971(82)90068-7; GREENBERG MJ, 1965, LANCET, V2, P442; HEEL RC, 1978, DRUGS, V15, P3, DOI 10.2165/00003495-197815010-00002; INMAN WHW, 1969, LANCET, V2, P279; KURLAND G, 1979, J ALLERGY CLIN IMMUN, V63, P407, DOI 10.1016/0091-6749(79)90214-8; LAWFORD P, 1981, CURR MED RES OPIN, V7, P349; MORGAN DJ, 1986, BRIT J CLIN PHARMACO, V22, P587, DOI 10.1111/j.1365-2125.1986.tb02939.x; PEARCE N, 1990, THORAX, V45, P170, DOI 10.1136/thx.45.3.170; SCHEININ M, 1987, BRIT J CLIN PHARMACO, V24, P645, DOI 10.1111/j.1365-2125.1987.tb03224.x; SPEIZER FE, 1968, BRIT MED J, V1, P335, DOI 10.1136/bmj.1.5588.335; STOLLEY PD, 1978, PREV MED, V7, P319; SVEDMYR N, 1985, PHARMACOTHERAPY, V5, P109; TANDON MK, 1980, CHEST, V77, P429, DOI 10.1378/chest.77.3.429; TATTERSFIELD AE, 1988, ASTHMA BASIC MECHANI, P563; WHYTE KF, 1988, BRIT J CLIN PHARMACO, V25, P571, DOI 10.1111/j.1365-2125.1988.tb03347.x; YAN K, 1983, THORAX, V38, P760, DOI 10.1136/thx.38.10.760	30	216	221	2	24	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	DEC 8	1990	336	8728					1396	1399		10.1016/0140-6736(90)93099-B	http://dx.doi.org/10.1016/0140-6736(90)93099-B			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL851	1978872				2022-12-28	WOS:A1990EL85100002
J	OLIVIERI, NF; KOREN, G; HERMANN, C; BENTUR, Y; CHUNG, D; KLEIN, J; STLOUIS, P; FREEDMAN, MH; MCCLELLAND, RA; TEMPLETON, DM				OLIVIERI, NF; KOREN, G; HERMANN, C; BENTUR, Y; CHUNG, D; KLEIN, J; STLOUIS, P; FREEDMAN, MH; MCCLELLAND, RA; TEMPLETON, DM			COMPARISON OF ORAL IRON CHELATOR L1 AND DESFERRIOXAMINE IN IRON-LOADED PATIENTS	LANCET			English	Article									UNIV TORONTO,DEPT CHEM,TORONTO M5S 1A1,ONTARIO,CANADA; UNIV TORONTO,DEPT CLIN BIOCHEM,TORONTO M5S 1A1,ONTARIO,CANADA; HOSP SICK CHILDREN,DIV CLIN PHARMACOL,TORONTO M5G 1X8,ONTARIO,CANADA; HOSP SICK CHILDREN,DEPT PAEDIAT,TORONTO M5G 1X8,ONTARIO,CANADA; HOSP SICK CHILDREN,DEPT CLIN BIOCHEM,TORONTO M5G 1X8,ONTARIO,CANADA; HOSP SICK CHILDREN,DEPT BIOCHEM,TORONTO M5G 1X8,ONTARIO,CANADA	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	OLIVIERI, NF (corresponding author), HOSP SICK CHILDREN,DIV HAEMATOL ONCOL,555 UNIV AVE,TORONTO M5G 1X8,ONTARIO,CANADA.		Olivieri, Nancy/AAI-2250-2020	Templeton, Douglas/0000-0003-0693-662X				BORGNAPIGNATTI C, 1985, J PEDIATR-US, V106, P150, DOI 10.1016/S0022-3476(85)80488-1; COHEN A, 1984, BRIT J HAEMATOL, V58, P369, DOI 10.1111/j.1365-2141.1984.tb06096.x; COHEN A, 1987, PEDIATRIC HEMATOLOGY, V1, P521; GRADY RW, 1987, BLOOD, V70, pA47; GRADY RW, 1986, BLOOD, V68, pA46; GYPARAKI M, 1987, ACTA HAEMATOL-BASEL, V78, P217, DOI 10.1159/000205878; HERSHKO C, 1988, CRC CR REV CL LAB SC, V26, P303, DOI 10.3109/10408368809105894; HERSHKO C, 1988, BRIT MED J, V296, P1081, DOI 10.1136/bmj.296.6629.1081; HILLIARD EP, 1979, ANALYST, V104, P312; HOFFBRAND AV, 1989, LANCET, V2, P457; KONTOGHIORGHES GJ, 1987, BRIT MED J, V295, P1509, DOI 10.1136/bmj.295.6612.1509; KONTOGHIORGHES GJ, 1989, LANCET, V2, P1516; KONTOGHIORGHES GJ, 1987, INORG CHIM A-BIOINOR, V136, pL11, DOI 10.1016/S0020-1693(00)85549-8; KONTOGHIORGHES GJ, 1987, LANCET, V1, P1294; KONTOGHIORGHES GJ, 1989, LANCET, V2, P457; KONTOGHIORGHES GJ, 1986, BRIT J HAEMATOL, V62, P607, DOI 10.1111/j.1365-2141.1986.tb04082.x; MARCUS RE, 1984, LANCET, V1, P392; MCGEE A, 1989, BLOOD, V74, pA311; MODELL B, 1982, BRIT MED J, V284, P1081, DOI 10.1136/bmj.284.6322.1081; OLIVIERI NF, 1986, NEW ENGL J MED, V314, P869, DOI 10.1056/NEJM198604033141402; PIPPARD MJ, 1982, BLOOD, V60, P288; PORTER JB, 1986, BIOCHEM SOC T, V14, P1180, DOI 10.1042/bst0141180; PORTER JB, 1989, LANCET, V2, P156; TESARO A, 1989, THER DRUG MONIT, V11, P463; WOLFE L, 1985, NEW ENGL J MED, V312, P1600, DOI 10.1056/NEJM198506203122503; WOLFE LC, 1989, BRIT J HAEMATOL, V72, P456, DOI 10.1111/j.1365-2141.1989.tb07732.x; WOOLF GM, 1983, GASTROENTEROLOGY, V84, P823; 1989, LANCET, V2, P1016	28	168	173	0	5	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 24	1990	336	8726					1275	1279		10.1016/0140-6736(90)92962-H	http://dx.doi.org/10.1016/0140-6736(90)92962-H			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ943	1978115				2022-12-28	WOS:A1990EJ94300003
J	DOYLE, MP				DOYLE, MP			PATHOGENIC ESCHERICHIA-COLI, YERSINIA-ENTEROCOLITICA, AND VIBRIO-PARAHAEMOLYTICUS	LANCET			English	Article											DOYLE, MP (corresponding author), UNIV WISCONSIN,FOOD RES INST,MADISON,WI 53706, USA.							COVER TL, 1989, NEW ENGL J MED, V321, P16, DOI 10.1056/NEJM198907063210104; DOYLE MP, 1985, ANNU REV NUTR, V5, P25, DOI [10.1146/annurev.nu.05.070185.000325, 10.1146/annurev.nutr.5.1.25]; DOYLE MP, 1987, APPL ENVIRON MICROB, V53, P2394, DOI 10.1128/AEM.53.10.2394-2396.1987; DOYLE MP, 1989, FOODBORNE BACTERIAL, P236; FINLAY BB, 1989, MICROBIOL REV, V53, P210, DOI 10.1128/MMBR.53.2.210-230.1989; GROSS RJ, 1985, J HYG-CAMBRIDGE, V95, P531, DOI 10.1017/S0022172400060666; HANNA MO, 1977, J FOOD SCI, V42, P1180, DOI 10.1111/j.1365-2621.1977.tb14455.x; KARMALI MA, 1989, CLIN MICROBIOL REV, V2, P15, DOI 10.1128/CMR.2.1.15-38.1989; LEVINE MM, 1987, J INFECT DIS, V155, P377, DOI 10.1093/infdis/155.3.377; MOON HW, 1983, INFECT IMMUN, V41, P1340, DOI 10.1128/IAI.41.3.1340-1351.1983; ROBINSBROWNE RM, 1987, REV INFECT DIS, V9, P28; SCHEIMANN DA, 1989, FOODBORNE BACTERIAL, P601; TAUXE RV, 1987, LANCET, V1, P1129; Twedt R. M., 1989, FOODBORNE BACTERIAL, P543; WEST PA, 1989, EPIDEMIOL INFECT, V103, P1, DOI 10.1017/S0950268800030326	15	46	46	0	5	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 3	1990	336	8723					1111	1115		10.1016/0140-6736(90)92582-3	http://dx.doi.org/10.1016/0140-6736(90)92582-3			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF992	1977991				2022-12-28	WOS:A1990EF99200015
J	HUGHES, WT; KENNEDY, W; DUGDALE, M; LAND, MA; STEIN, DS; WEEMS, JJ; PALTE, S; LANCASTER, D; GIDANKOVNAR, S; MORRISON, RE				HUGHES, WT; KENNEDY, W; DUGDALE, M; LAND, MA; STEIN, DS; WEEMS, JJ; PALTE, S; LANCASTER, D; GIDANKOVNAR, S; MORRISON, RE			PREVENTION OF PNEUMOCYSTIS-CARINII PNEUMONITIS IN AIDS PATIENTS WITH WEEKLY DAPSONE	LANCET			English	Letter									BAPTIST MEM HOSP, MEMPHIS, TN 38146 USA; UNIV TENNESSEE, KNOXVILLE, TN 37996 USA	Baptist Memorial Hospital Memphis; University of Tennessee System; University of Tennessee Knoxville	HUGHES, WT (corresponding author), ST JUDE CHILDRENS RES HOSP, MEMPHIS, TN 38101 USA.				NCI NIH HHS [P30CA21765] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		HUGHES WT, 1984, ANTIMICROB AGENTS CH, V26, P436, DOI 10.1128/AAC.26.4.436; HUGHES WT, 1988, ANTIMICROB AGENTS CH, V32, P623, DOI 10.1128/AAC.32.5.623; LEOUNG GS, 1986, ANN INTERN MED, V105, P45, DOI 10.7326/0003-4819-105-1-45; LUCAS RC, 1989, MED J AUSTRALIA, P30; METROKA CE, 1987, 3RD INT C AIDS WASH; METROKA CE, 1989, 5TH INT C AIDS MONTR; MILLS J, 1988, ANTIMICROB AGENTS CH, V32, P1057, DOI 10.1128/AAC.32.7.1057; PHAIR J, 1990, NEW ENGL J MED, V322, P161, DOI 10.1056/NEJM199001183220304; 1989, MMWR S15, V38, P1	9	64	64	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 27	1990	336	8722					1066	1066		10.1016/0140-6736(90)92533-N	http://dx.doi.org/10.1016/0140-6736(90)92533-N			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF076	1977035				2022-12-28	WOS:A1990EF07600031
J	IVERSEN, HK; NIELSEN, TH; OLESEN, J; TFELTHANSEN, P				IVERSEN, HK; NIELSEN, TH; OLESEN, J; TFELTHANSEN, P			ARTERIAL RESPONSES DURING MIGRAINE HEADACHE	LANCET			English	Article									UNIV COPENHAGEN,BISPEBJERG HOSP,DK-1168 COPENHAGEN,DENMARK	University of Copenhagen; Bispebjerg Hospital	IVERSEN, HK (corresponding author), GENTOFTE HOSP,DEPT NEUROL,DK-2900 COPENHAGEN,DENMARK.		Iversen, Helle Klingenberg/P-5726-2019; Iversen, Helle Klingenberg/B-9154-2009	Iversen, Helle Klingenberg/0000-0002-5880-6352; Olesen, Jes/0000-0002-6712-2702				ABBOUD FM, 1968, FED PROC, V27, P1391; ABBOUD FM, 1966, CIRC RES, V18, P263, DOI 10.1161/01.RES.18.3.263; ANDERSON EA, 1989, CIRCULATION, V79, P93, DOI 10.1161/01.CIR.79.1.93; ANTHONY M, 1981, CEPHALALGIA, V1, P83, DOI 10.1111/j.1468-2982.1981.tb00014.x; BRAZIL P, 1956, NEUROLOGY, V6, P96, DOI 10.1212/WNL.6.2.96; DRUMMOND PD, 1983, ANN NEUROL, V13, P32, DOI 10.1002/ana.410130108; EDVINSSON L, 1988, BASIC MECHANISMS HEA, P129; FOGMOLLER F, 1978, CURRENT CONCEPTS MIG, P115; GREGA GJ, 1987, FASEB J, V46, P270; MOSKOWITZ MA, 1984, ANN NEUROL, V16, P157, DOI 10.1002/ana.410160202; NIELSEN TH, IN PRESS ULTRASOUND; SICUTERI F, 1961, INT ARCH ALLER A IMM, V19, P55, DOI 10.1159/000229194; TUNIS MM, 1953, AMA ARCH NEUROL PSY, V70, P551, DOI 10.1001/archneurpsyc.1953.02320350003001; 1988, CEPHALALGIA S, V8, P19	14	155	155	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 6	1990	336	8719					837	839		10.1016/0140-6736(90)92339-J	http://dx.doi.org/10.1016/0140-6736(90)92339-J			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB901	1976878				2022-12-28	WOS:A1990EB90100004
J	BOOTHMAN, BR; SPOKES, EGS				BOOTHMAN, BR; SPOKES, EGS			PHARMACOKINETIC DATA FOR ROPINIROLE	LANCET			English	Letter											BOOTHMAN, BR (corresponding author), GEN INFIRM,LEEDS LS1 3EX,W YORKSHIRE,ENGLAND.							MARSDEN CD, 1990, LANCET, V335, P948, DOI 10.1016/0140-6736(90)91006-V; VIDAILHET, 1990, LANCET, V336, P316	2	18	18	0	7	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	SEP 29	1990	336	8718					814	814		10.1016/0140-6736(90)93281-S	http://dx.doi.org/10.1016/0140-6736(90)93281-S			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB077	1976175				2022-12-28	WOS:A1990EB07700040
J	FODOR, SPA; READ, JL; PIRRUNG, MC; STRYER, L; LU, AT; SOLAS, D				FODOR, SPA; READ, JL; PIRRUNG, MC; STRYER, L; LU, AT; SOLAS, D			LIGHT-DIRECTED, SPATIALLY ADDRESSABLE PARALLEL CHEMICAL SYNTHESIS	SCIENCE			English	Article								Solid-phase chemistry, photolabile protecting groups, and photolithography have been combined to achieve light-directed, spatially addressable parallel chemical synthesis to yield a highly diverse set of chemical products. Binary masking, one of many possible combinatorial synthesis strategies, yields 2n compounds in n chemical steps. An array of 1024 peptides was synthesized in ten steps, and its interaction with a monoclonal antibody was assayed by epifluorescence microscopy. High-density arrays formed by light-directed synthesis are potentially rich sources of chemical diversity for discovering new ligands that bind to biological receptors and for elucidating principles governing molecular interactions. The generality of this approach is illustrated by the light-directed synthesis of a dinucleotide. Spatially directed synthesis of complex compounds could also be used for microfabrication of devices.			FODOR, SPA (corresponding author), AFFYMAX RES INST,3180 PORTER DR,PALO ALTO,CA 94304, USA.							CWIRLA SE, 1990, P NATL ACAD SCI USA, V87, P6378, DOI 10.1073/pnas.87.16.6378; DEVLIN JJ, 1990, SCIENCE, V249, P404, DOI 10.1126/science.2143033; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; GELB MH, 1985, BIOCHEMISTRY-US, V24, P1813, DOI 10.1021/bi00329a001; GEYSEN HM, 1987, J IMMUNOL METHODS, V102, P259, DOI 10.1016/0022-1759(87)90085-8; GEYSEN HM, 1986, CIBA F S, V119, P131; KHRAPKO KR, 1989, FEBS LETT, V256, P118, DOI 10.1016/0014-5793(89)81730-2; LATT SA, 1972, ANAL BIOCHEM, V50, P56, DOI 10.1016/0003-2697(72)90485-X; MATAYOSHI ED, 1990, SCIENCE, V247, P954, DOI 10.1126/science.2106161; McGillis D. A., 1983, VLSI technology, P267; MEO T, 1983, P NATL ACAD SCI-BIOL, V80, P4084, DOI 10.1073/pnas.80.13.4084; Merrifield RB, 1976, SCIENCE, V232, P341, DOI DOI 10.1126/SCIENCE.3961484; NESTOR JJ, 1988, J MED CHEM, V31, P65, DOI 10.1021/jm00396a011; NEWMAN TH, 1987, J VAC SCI TECHNOL B, V5, P88, DOI 10.1116/1.583934; OHTSUKA E, 1977, SYNTHESIS-STUTTGART, P453; PATCHORNIK CA, 1970, J AM CHEM SOC, V92, P6333; PILLAI VNR, 1980, SYNTHESIS-STUTTGART, P1; ROGET A, 1989, NUCLEIC ACIDS RES, V17, P7643, DOI 10.1093/nar/17.19.7643; SCOTT JK, 1990, SCIENCE, V249, P386, DOI 10.1126/science.1696028; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121	20	2203	3247	5	275	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	FEB 15	1991	251	4995					767	773		10.1126/science.1990438	http://dx.doi.org/10.1126/science.1990438			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX575	1990438				2022-12-28	WOS:A1991EX57500036
J	TAKE, C; IKEDA, K; KURASAWA, T; KUROKAWA, K				TAKE, C; IKEDA, K; KURASAWA, T; KUROKAWA, K			INCREASED CHLORIDE REABSORPTION AS AN INHERITED RENAL TUBULAR DEFECT IN FAMILIAL TYPE-II PSEUDOHYPOALDOSTERONISM	NEW ENGLAND JOURNAL OF MEDICINE			English	Note							HYPORENINEMIC HYPOALDOSTERONISM; ALDOSTERONE LEVELS; SHORT STATURE; HYPER-POTASSEMIA; HYPERKALEMIA; HYPERTENSION; ACIDOSIS; POTASSIUM; ASSOCIATION; DISORDERS		UNIV TOKYO,FAC MED,DEPT INTERNAL MED 4,3-28-6 MEJIRODAI,BUNKYO KU,TOKYO 113,JAPAN; TOKYO KOHSEI NENKIN HOSP,DEPT INTERNAL MED,TOKYO,JAPAN	University of Tokyo								ARNOLD JE, 1969, AM J MED, V47, P461, DOI 10.1016/0002-9343(69)90230-7; BRAUTBAR N, 1978, ARCH INTERN MED, V138, P607, DOI 10.1001/archinte.138.4.607; BRAVO E, 1980, CLIN RES, V28, pA782; DEFRONZO RA, 1980, KIDNEY INT, V17, P118, DOI 10.1038/ki.1980.14; FARFEL Z, 1978, ARCH INTERN MED, V138, P1837, DOI 10.1001/archinte.138.12.1837; FARFEL Z, 1978, ARCH INTERN MED, V138, P1828, DOI 10.1001/archinte.138.12.1828; GORDON RD, 1986, SCOT MED J, V31, P43, DOI 10.1177/003693308603100114; GORDON RD, 1986, HYPERTENSION, V8, P93, DOI 10.1161/01.HYP.8.2.93; GORDON RD, 1970, AUST ANN MED, V4, P287; GREKIN RJ, 1979, LANCET, V1, P1116; IITAKA K, 1980, INT J PED NEPHROL, V1, P242; LEE MR, 1980, LANCET, V1, P879; LEE MR, 1979, Q J MED, V48, P245; LICHT JH, 1985, Q J MED, V54, P161; NADLER JL, 1986, NEW ENGL J MED, V314, P1015, DOI 10.1056/NEJM198604173141604; PAVER W K, 1964, Med J Aust, V2, P305; SANJAD SA, 1983, ANN INTERN MED, V99, P624, DOI 10.7326/0003-4819-99-5-624; SANJAD SA, 1982, PEDIATRICS, V69, P317; SAUDER S, 1981, J PEDIATR-US, V98, P1022; SCHAMBELAN M, 1981, KIDNEY INT, V19, P716, DOI 10.1038/ki.1981.72; SEBASTIAN A, 1982, AM J MED, V72, P289, DOI 10.1016/0002-9343(82)90822-1; SHIMIZU T, 1988, J CLIN INVEST, V82, P721, DOI 10.1172/JCI113653; SOPPI E, 1986, HYPERTENSION, V8, P174, DOI 10.1161/01.HYP.8.2.174; SPITZER A, 1973, KIDNEY INT, V3, P251, DOI 10.1038/ki.1973.38; Stokes G S, 1968, Med J Aust, V2, P1050; WAYNE VS, 1986, AUST NZ J MED, V16, P221, DOI 10.1111/j.1445-5994.1986.tb01154.x; WEINSTEIN SF, 1974, J PEDIATR-US, V85, P355, DOI 10.1016/S0022-3476(74)80115-0; WILLIAMS GH, 1986, NEW ENGL J MED, V314, P1041, DOI 10.1056/NEJM198604173141609	28	80	82	0	1	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 14	1991	324	7					472	476		10.1056/NEJM199102143240707	http://dx.doi.org/10.1056/NEJM199102143240707			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EX363	1988833				2022-12-28	WOS:A1991EX36300007
J	ZHUKOVSKY, EA; ROBINSON, PR; OPRIAN, DD				ZHUKOVSKY, EA; ROBINSON, PR; OPRIAN, DD			TRANSDUCIN ACTIVATION BY RHODOPSIN WITHOUT A COVALENT BOND TO THE 11-CIS-RETINAL CHROMOPHORE	SCIENCE			English	Article							VISUAL PIGMENTS; BOVINE RHODOPSIN; SCHIFF-BASE; PROTEINS; FAMILY; BACTERIORHODOPSIN; RECEPTORS	Rhodopsin and the visual pigments are a distinct group within the family of G-protein-linked receptors in that they have as covalently bound ligand, the 11-cis-retinal chromophore, whereas all of the other receptors bind their agonists through noncovalent interactions. The retinal chromophore in rhodopsin is bound by means of a protonated Schiff base linkage to the epsilon-amino group of Lys-296. Two rhodopsin mutants have been constructed, K296G and K296A, in which the covalent linkage to the chromophore is removed. Both mutants form a pigment with an absorption spectrum close to that of the wild type when reconstituted with the Schiff base of an n-alkylamine and 11-cis-retinal. In addition, the pigment formed from K296G and the n-propylamine Schiff base of 11-cis-retinal was found to activate transducin in a light-dependent manner, with 30 to 40% of the specific activity measured for the wild-type protein. It appears that the covalent bond is not essential for binding of the chromophore or for catalytic activation of transducin.			ZHUKOVSKY, EA (corresponding author), BRANDEIS UNIV,DEPT BIOCHEM,WALTHAM,MA 02254, USA.		Zhukovsky, Eugene/Q-3218-2019	Zhukovsky, Eugene/0000-0003-1822-8946	NATIONAL CENTER FOR RESEARCH RESOURCES [S07RR007044] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY007965] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007596] Funding Source: NIH RePORTER; NCRR NIH HHS [S07 RR07044] Funding Source: Medline; NEI NIH HHS [R01 EY007965, EY07965] Funding Source: Medline; NIGMS NIH HHS [5T32 GM07596-11] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		APPLEBURY ML, 1986, VISION RES, V26, P1881, DOI 10.1016/0042-6989(86)90115-X; BLATZ PE, 1972, BIOCHEMISTRY-US, V11, P848, DOI 10.1021/bi00755a026; COOPER A, 1979, NATURE, V282, P531, DOI 10.1038/282531a0; DOHLMAN HG, 1987, BIOCHEMISTRY-US, V26, P2657, DOI 10.1021/bi00384a001; DRATZ EA, 1983, TRENDS BIOCHEM SCI, V8, P128, DOI 10.1016/0968-0004(83)90235-9; FERRETTI L, 1986, P NATL ACAD SCI USA, V83, P599, DOI 10.1073/pnas.83.3.599; FINDLAY JBC, 1986, BIOCHEM J, V238, P625, DOI 10.1042/bj2380625; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; HONG K, 1973, BIOCHEMISTRY-US, V12, P4517, DOI 10.1021/bi00746a033; HONIG B, 1979, P NATL ACAD SCI USA, V76, P2503, DOI 10.1073/pnas.76.6.2503; HONIG B, 1976, BIOCHEMISTRY-US, V15, P4593, DOI 10.1021/bi00666a008; JOHNSON GL, 1989, ENDOCR REV, V10, P317, DOI 10.1210/edrv-10-3-317; MORTON RA, 1955, BIOCHEM J, V59, P128, DOI 10.1042/bj0590128; OPRIAN DD, 1987, P NATL ACAD SCI USA, V84, P8874, DOI 10.1073/pnas.84.24.8874; SAKMAR TP, 1989, P NATL ACAD SCI USA, V86, P8309, DOI 10.1073/pnas.86.21.8309; SCHRECKENBACH T, 1977, EUR J BIOCHEM, V76, P499, DOI 10.1111/j.1432-1033.1977.tb11620.x; STRADER CD, 1988, J BIOL CHEM, V263, P10267; WALD G, 1968, SCIENCE, V162, P230, DOI 10.1126/science.162.3850.230; WESSLINGRESNICK M, 1987, J BIOL CHEM, V262, P3697; ZHUKOVSKY EA, 1989, SCIENCE, V246, P928, DOI 10.1126/science.2573154	20	129	130	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	FEB 1	1991	251	4993					558	560		10.1126/science.1990431	http://dx.doi.org/10.1126/science.1990431			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV459	1990431				2022-12-28	WOS:A1991EV45900050
J	COEN, P; KULIN, H; BALLANTINE, T; ZAINO, R; FRAUENHOFFER, E; BOAL, D; INKSTER, S; BRODIE, A; SANTEN, R				COEN, P; KULIN, H; BALLANTINE, T; ZAINO, R; FRAUENHOFFER, E; BOAL, D; INKSTER, S; BRODIE, A; SANTEN, R			AN AROMATASE-PRODUCING SEX-CORD TUMOR RESULTING IN PREPUBERTAL GYNECOMASTIA	NEW ENGLAND JOURNAL OF MEDICINE			English	Note							PEUTZ-JEGHERS SYNDROME; SERTOLI-CELL TUMOR; PLASMA ANDROSTENEDIONE; STEROIDOGENIC RESPONSE; ADRENAL SUPPRESSION; ANNULAR TUBULES; PUBERTAL GROWTH; BOYS; TESTOSTERONE; ANDROGEN		PENN STATE UNIV, MILTON S HERSHEY MED CTR,COLL MED,DEPT MED, DIV ENDOCRINOL, HERSHEY, PA 17033 USA; PENN STATE UNIV, MILTON S HERSHEY MED CTR, COLL MED, DEPT PEDIAT, HERSHEY, PA 17033 USA; PENN STATE UNIV, MILTON S HERSHEY MED CTR, COLL MED, DEPT SURG, HERSHEY, PA 17033 USA; PENN STATE UNIV, MILTON S HERSHEY MED CTR, COLL MED, DEPT RADIOL, HERSHEY, PA 17033 USA; PENN STATE UNIV, MILTON S HERSHEY MED CTR, COLL MED, DEPT PATHOL, HERSHEY, PA 17033 USA; UNIV MARYLAND, SCH MED, DEPT PHARMACOL & EXPTL THERAPEUT, BALTIMORE, MD 21201 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University System of Maryland; University of Maryland Baltimore								ABRAHAM GE, 1975, CLIN BIOCHEM, V8, P374, DOI 10.1016/S0009-9120(75)93886-2; BERKOVITZ GD, 1985, J CLIN INVEST, V75, P1763, DOI 10.1172/JCI111888; BERTAGNA C, 1981, AM J MED, V71, P855, DOI 10.1016/0002-9343(81)90384-3; BOURGUIGNON JP, 1983, ADOLESCENCE FEMALES, P389; BRODIE AMH, 1989, CANCER RES, V49, P6551; CANTU JM, 1980, CANCER, V46, P223, DOI 10.1002/1097-0142(19800701)46:1<223::AID-CNCR2820460137>3.0.CO;2-8; CUTLER GB, 1986, RECENT PROG HORM RES, V42, P443; DUBOIS RS, 1982, J PEDIATR-US, V101, P568, DOI 10.1016/S0022-3476(82)80705-1; DUNKEL L, 1985, PEDIATR RES, V19, P1, DOI 10.1203/00006450-198501000-00001; ERBE RW, 1976, NEW ENGL J MED, V294, P1101, DOI 10.1056/NEJM197605132942007; FOREST MG, 1978, J CLIN ENDOCR METAB, V47, P931, DOI 10.1210/jcem-47-5-931; FORTI G, 1985, J CLIN ENDOCR METAB, V61, P322, DOI 10.1210/jcem-61-2-322; GEORGE FW, 1980, J CLIN INVEST, V66, P57, DOI 10.1172/JCI109835; GLAZER HS, 1982, AM J ROENTGENOL, V138, P673, DOI 10.2214/ajr.138.4.673; Greulich WW., 1959, CALIF MED, V91, P53; HEMSELL DL, 1977, J CLIN INVEST, V60, P455, DOI 10.1172/JCI108796; INKSTER SE, 1989, BIOL REPROD, V41, P889, DOI 10.1095/biolreprod41.5.889; KULIN HE, 1977, J PEDIATR-US, V90, P760, DOI 10.1016/S0022-3476(77)81243-2; KULIN HE, 1988, CURRENT THERAPY ENDO, P6; LEE PA, 1975, J CLIN ENDOCR METAB, V41, P556, DOI 10.1210/jcem-41-3-556; LIPTON A, 1988, BREAST CANCER RES TR, V12, P31, DOI 10.1007/BF01805737; PROPPE KH, 1980, AM J CLIN PATHOL, V74, P607; SAMOJLIK E, 1977, J CLIN ENDOCR METAB, V45, P480, DOI 10.1210/jcem-45-3-480; SAMOJLIK E, 1978, J CLIN ENDOCR METAB, V47, P717, DOI 10.1210/jcem-47-4-717; SANTEN RJ, 1988, EUR J CANCER CLIN ON, V24, P1811, DOI 10.1016/0277-5379(88)90090-9; SANTNER SJ, 1981, CLIN CHEM, V27, P1892; SCULLY RE, 1970, CANCER, V25, P1107, DOI 10.1002/1097-0142(197005)25:5<1107::AID-CNCR2820250516>3.0.CO;2-7; SOLH HM, 1983, J PEDIATR-US, V103, P593, DOI 10.1016/S0022-3476(83)80595-2; Tanner JM, 1962, GROWTH ADOLESCENCE, V2nd; TAPANAINEN J, 1983, CLIN ENDOCRINOL, V18, P355, DOI 10.1111/j.1365-2265.1983.tb00579.x; TILSONMALLETT N, 1983, J CLIN ENDOCR METAB, V57, P1125, DOI 10.1210/jcem-57-6-1125; WARNER B, 1983, J CLIN INVEST, V71, P1842, DOI 10.1172/JCI110940; WILSON DM, 1986, CANCER, V57, P2238, DOI 10.1002/1097-0142(19860601)57:11<2238::AID-CNCR2820571128>3.0.CO;2-C; ZACHMANN M, 1986, J PEDIATR-US, V108, P694, DOI 10.1016/S0022-3476(86)81043-5; ZACHMANN M, 1986, ACTA ENDOCRINOL-COP, V113, P218, DOI 10.1530/acta.0.112S218	35	101	111	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 31	1991	324	5					317	322		10.1056/NEJM199101313240507	http://dx.doi.org/10.1056/NEJM199101313240507			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU922	1986290				2022-12-28	WOS:A1991EU92200007
J	UMEK, RM; FRIEDMAN, AD; MCKNIGHT, SL				UMEK, RM; FRIEDMAN, AD; MCKNIGHT, SL			CCAAT-ENHANCER BINDING-PROTEIN - A COMPONENT OF A DIFFERENTIATION SWITCH	SCIENCE			English	Article							LIVER NUCLEAR-PROTEIN; GLUCOCORTICOID RECEPTOR; MESSENGER-RNA; EXPRESSION; GENE; DOMAIN; C/EBP; IDENTIFICATION; TRANSFORMATION; DNA	The CCAAT-enhancer binding protein (C/EBP) has now been found to promote the terminal differentiation of adipocytes. During the normal course of adipogenesis, C/EBP expression is restricted to a terminal phase where-in proliferative growth is arrested, and specialized cell phenotype is first manifested. A conditional form of C/EBP was developed, making it feasible to test its capacity to regulate the differentiation of cultured adipocytes. Premature expression of C/EBP in adipoblasts caused a direct cessation of mitotic growth. Moreover, when abetted by the effects of three adipogenic hormones, C/EBP promoted terminal cell differentiation. Since C/EBP is expressed in a variety of tissues, it may have a fundamental role in regulating the balance between cell growth and differentiation in higher animals.			UMEK, RM (corresponding author), CARNEGIE INST WASHINGTON,DEPT EMBRYOL,HOWARD HUGHES RES LABS,115 W UNIV PKWY,BALTIMORE,MD 21210, USA.							BERNLOHR DA, 1984, P NATL ACAD SCI-BIOL, V81, P5468, DOI 10.1073/pnas.81.17.5468; BIRKENMEIER EH, 1989, GENE DEV, V3, P1146, DOI 10.1101/gad.3.8.1146; CAO Z, UNPUB; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHRISTY RJ, 1989, GENE DEV, V3, P1323, DOI 10.1101/gad.3.9.1323; COLE MD, 1986, ANNU REV GENET, V20, P361, DOI 10.1146/annurev.ge.20.120186.002045; CRESCENZI M, 1990, P NATL ACAD SCI USA, V87, P8442, DOI 10.1073/pnas.87.21.8442; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; DEFRANCO D, 1986, MOL CELL BIOL, V6, P993, DOI 10.1128/MCB.6.4.993; EILERS M, 1989, NATURE, V340, P66, DOI 10.1038/340066a0; FRIEDMAN AD, 1990, GENE DEV, V4, P1416, DOI 10.1101/gad.4.8.1416; FRIEDMAN AD, 1989, GENE DEV, V3, P1314, DOI 10.1101/gad.3.9.1314; GRAVES BJ, 1986, CELL, V44, P565, DOI 10.1016/0092-8674(86)90266-7; GREEN H, 1979, OBESITY CELLULAR MOL, P15; GREENE GL, 1986, SCIENCE, V231, P1150, DOI 10.1126/science.3753802; HERRERA R, 1989, MOL CELL BIOL, V9, P5331, DOI 10.1128/MCB.9.12.5331; HOLLENGER SM, 1986, NATURE, V318, P635; JOHNSON PF, 1987, GENE DEV, V1, P133, DOI 10.1101/gad.1.2.133; KAESTNER KH, 1990, P NATL ACAD SCI USA, V87, P251, DOI 10.1073/pnas.87.1.251; KUMAR V, 1986, CELL, V46, P1053; LANDSCHULZ WH, 1989, SCIENCE, V243, P1681, DOI 10.1126/science.2494700; LANDSCHULZ WH, 1988, GENE DEV, V2, P786, DOI 10.1101/gad.2.7.786; LEWIS SA, 1985, J CELL BIOL, V101, P852, DOI 10.1083/jcb.101.3.852; LITTLEFIELD JW, 1964, SCIENCE, V145, P709, DOI 10.1126/science.145.3633.709; Maniatis T., 1982, MOL CLONING; MIESFELD R, 1987, SCIENCE, V236, P423, DOI 10.1126/science.3563519; PICARD D, 1988, CELL, V54, P1073, DOI 10.1016/0092-8674(88)90122-5; SORRENTINO V, 1990, NATURE, V345, P813, DOI 10.1038/345813a0; SOUTHERN PJ, 1982, J MOL APPL GENET, V1, P5331; SPIEGELMAN BM, 1983, J BIOL CHEM, V258, P83; TAYLOR SM, 1979, CELL, V17, P813; UMEK R, UNPUB; XU XF, 1990, EXP CELL RES, V189, P247, DOI 10.1016/0014-4827(90)90243-4; ZARET KS, 1988, P NATL ACAD SCI USA, V85, P9076, DOI 10.1073/pnas.85.23.9076	34	664	679	2	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JAN 18	1991	251	4991					288	292		10.1126/science.1987644	http://dx.doi.org/10.1126/science.1987644			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET678	1987644				2022-12-28	WOS:A1991ET67800025
J	BROWN, CJ; BALLABIO, A; RUPERT, JL; LAFRENIERE, RG; GROMPE, M; TONLORENZI, R; WILLARD, HF				BROWN, CJ; BALLABIO, A; RUPERT, JL; LAFRENIERE, RG; GROMPE, M; TONLORENZI, R; WILLARD, HF			A GENE FROM THE REGION OF THE HUMAN X-INACTIVATION CENTER IS EXPRESSED EXCLUSIVELY FROM THE INACTIVE X-CHROMOSOME	NATURE			English	Article							CONTROLLING ELEMENTS; LINKED GENE; MOUSE; DNA; LOCUS; HYPOTHESIS; DELETIONS; MUTATIONS; CELLS; CDNA	X-chromosome inactivation results in the cis-limited dosage compensation of genes on one of the pair of X chromosomes in mammalian females. Although most X-linked genes are believed to be subject to inactivation, several are known to be expressed from both active and inactive X chromosomes. Here we describe an X-linked gene with a novel expression pattern-transcript are detected only from the inactive X chromosome (X(i)) and not from the active X chromosome (X(a)). This gene, called XIST (for X(i)-specific transcripts), is a candidate for a gene either involved in or uniquely influenced by the process of X inactivation.	STANFORD UNIV,MED CTR,SCH MED,DEPT GENET,STANFORD,CA 94305; BAYLOR UNIV,INST MOLEC GENET,HOUSTON,TX 77030	Stanford University; Baylor College of Medicine; Baylor University			Tonlorenzi, Rossana/AAN-2241-2020; BALLABIO, Andrea/AAL-2672-2020; Brown, Carolyn J/A-5159-2014	BALLABIO, Andrea/0000-0003-1381-4604; Brown, Carolyn J/0000-0002-8959-0101; Tonlorenzi, Rossana/0000-0002-6060-8208; Grompe, Markus/0000-0002-6616-4345				BALLABIO A, 1987, P NATL ACAD SCI USA, V84, P4519, DOI 10.1073/pnas.84.13.4519; BROWN CJ, 1991, NATURE, V349, P82, DOI 10.1038/349082a0; BROWN CJ, 1989, AM J HUM GENET, V45, P592; BROWN CJ, 1989, J HUM GENET, V45, pA178; BROWN SW, 1973, P NATL ACAD SCI USA, V70, P195, DOI 10.1073/pnas.70.1.195; BROWNCJ, 1990, NUCLEIC ACIDS RES, V18, P4191; BRWN CJ, 1990, J HUM GENET, V46, P273; CATTANACH BM, 1975, ANNU REV GENET, V9, P1, DOI 10.1146/annurev.ge.09.120175.000245; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DAVIDSON RG, 1963, P NATL ACAD SCI USA, V50, P481, DOI 10.1073/pnas.50.3.481; FICKETT JW, 1982, NUCLEIC ACIDS RES, V10, P5303, DOI 10.1093/nar/10.17.5303; FISHER EMC, 1990, CELL, V63, P1205, DOI 10.1016/0092-8674(90)90416-C; FLEJTER WL, 1984, AM J HUM GENET, V36, P218; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GARTLER SM, 1983, ANNU REV GENET, V17, P155, DOI 10.1146/annurev.ge.17.120183.001103; GIBBS RA, 1989, P NATL ACAD SCI USA, V86, P1919, DOI 10.1073/pnas.86.6.1919; GOODFELLOW P, 1984, AM J HUM GENET, V36, P777; GRAVES JAM, 1986, SOMAT CELL MOLEC GEN, V12, P275, DOI 10.1007/BF01570786; GROMPE M, 1989, P NATL ACAD SCI USA, V86, P5888, DOI 10.1073/pnas.86.15.5888; JOHNSTON PG, 1981, GENET RES, V37, P151, DOI 10.1017/S0016672300020127; KEER JT, 1990, GENOMICS, V7, P566, DOI 10.1016/0888-7543(90)90200-E; KORNELUK RG, 1985, GENE, V40, P317, DOI 10.1016/0378-1119(85)90055-1; LYON MF, 1972, BIOL REV, V47, P1; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; LYON MF, 1986, J EMBRYOL EXP MORPH, V97, P75; MATTEI MG, 1981, HUM GENET, V56, P401, DOI 10.1007/BF00274702; MEYER WJ, 1975, P NATL ACAD SCI USA, V72, P1469, DOI 10.1073/pnas.72.4.1469; MIGEON BR, 1979, CELL, V18, P637, DOI 10.1016/0092-8674(79)90118-1; MIGEON BR, 1968, SCIENCE, V160, P425, DOI 10.1126/science.160.3826.425; NADON N, 1988, SOMAT CELL MOLEC GEN, V14, P541, DOI 10.1007/BF01535309; RASTAN S, 1982, GENET RES, V40, P139, DOI 10.1017/S0016672300019017; RASTAN S, 1983, J EMBRYOL EXP MORPH, V78, P1; RASTAN S, 1985, J EMBRYOL EXP MORPH, V90, P379; RIGGS AD, 1990, AUST J ZOOL, V37, P419, DOI 10.1071/ZO9890419; RUSSELL LB, 1963, SCIENCE, V140, P976, DOI 10.1126/science.140.3570.976; SCHNEIDERGADICKE A, 1989, CELL, V57, P1247, DOI 10.1016/0092-8674(89)90061-5; SHAPIRO LJ, 1979, SCIENCE, V204, P1224, DOI 10.1126/science.156396; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; Summitt R L, 1978, Birth Defects Orig Artic Ser, V14, P219; THERMAN E, 1974, CHROMOSOMA, V44, P361; WILLARD HF, 1980, SOMAT CELL GENET, V6, P187, DOI 10.1007/BF01538795	41	1227	1274	4	96	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JAN 3	1991	349	6304					38	44		10.1038/349038a0	http://dx.doi.org/10.1038/349038a0			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EQ601	1985261				2022-12-28	WOS:A1991EQ60100042
J	MILLS, JL; KLEBANOFF, MA; GRAUBARD, BI; CAREY, JC; BERENDES, HW				MILLS, JL; KLEBANOFF, MA; GRAUBARD, BI; CAREY, JC; BERENDES, HW			BARRIER CONTRACEPTIVE METHODS AND PREECLAMPSIA	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PRE-ECLAMPSIA	Recent investigations have suggested that women who use barrier methods of contraception may be at increased risk for preeclampsia. We used data from two prospective pregnancy studies to examine the relationship between contraceptive use before conception and preeclampsia. The preeclampsia rates among women using barrier contraceptives were not significantly higher than the rates in women using nonbarrier contraceptives or the rates in women using no contraceptives in either study. The odds ratios for preeclampsia in barrier contraceptive users in the two studies were 0.89 (95% confidence interval [Cl], 0.71 to 1.12) and 0.85 (95% Cl, 0.49 to 1.45) compared with nonbarrier contraceptive users and 0.91 (95% Cl, 0.71 to 1.16) and 0.81 (95% Cl, 0.48 to 1.35) compared with women using no contraceptives. After adjusting for other risk factors, we found no association between preeclampsia and barrier contraceptive use. Additional studies are needed to resolve this issues; however, we would recommend that women not be advised to avoid barrier contraceptives unless more data linking their use to preeclampsia appear.	NCI,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	MILLS, JL (corresponding author), NICHHD,PREVENT RES PROGRAM,EPN BLDG,ROOM 640,BETHESDA,MD 20892, USA.			Mills, James/0000-0003-4496-332X				ARMITAGE P, 1955, BIOMETRICS, V11, P375, DOI 10.2307/3001775; BEER AE, 1978, SEMIN PERINATOL, V2, P39; CHESLEY LC, 1984, CLIN OBSTET GYNECOL, V27, P801, DOI 10.1097/00003081-198412000-00004; Feeney JG, 1980, P 1 C INT SOC STUD H, P41; KONOFFCOHEN HS, 1989, JAMA-J AM MED ASSOC, V262, P3143; MARTI JJ, 1977, AM J OBSTET GYNECOL, V128, P489, DOI 10.1016/0002-9378(77)90030-8; Mosher W. D., 1990, ADV DATA, V182, P1; SCOTT JR, 1976, AM J OBSTET GYNECOL, V125, P418, DOI 10.1016/0002-9378(76)90579-2; SERHAL PF, 1987, LANCET, V2, P744; WOOLF B, 1956, ANN HUM GENET, V20, P309; 1983, BMDP BIOMEDICAL CO P; 1985, SAS USERS GUIDE STAT	12	25	25	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	1991	265	1					70	73		10.1001/jama.265.1.70	http://dx.doi.org/10.1001/jama.265.1.70			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP555	1984127				2022-12-28	WOS:A1991EP55500030
J	RAUB, W				RAUB, W			GENETIC MUTATION IN FAMILIAL AORTIC-ANEURYSMS IDENTIFIED	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material											RAUB, W (corresponding author), NIH, BLDG 31, ROOM 2B23, BETHESDA, MD 20892 USA.							1990, J CLIN INVEST, V86, P1465	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	1991	265	1					19	19						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP555	1984118				2022-12-28	WOS:A1991EP55500006
J	NORCINI, JJ; SHEA, JA; BENSON, JA				NORCINI, JJ; SHEA, JA; BENSON, JA			CHANGES IN THE MEDICAL KNOWLEDGE OF CANDIDATES FOR CERTIFICATION	ANNALS OF INTERNAL MEDICINE			English	Article								Purpose: To determine whether the medical knowledge of candidates from different types of medical schools changed between 1983 and 1988. Subjects: Candidates for certification who took the 1983 to 1988 examinations in internal medicine were divided into five groups according to the type and location of the medical school they had attended and, in some instances, their citizenship: graduates of U.S. medical schools, of Canadian medical schools, and of osteopathic medical schools as well as U.S. citizens who graduated from foreign medical schools and non-U.S. citizens who graduated from foreign medical schools. Design: Performance on items that were common to four pairs of the 1983 to 1988 certifying examinations (1983 and 1985, 1984 and 1986, 1985 and 1987, and 1986 and 1988) was analyzed. Results: The scores of graduates of U.S. medical schools decreased, and the scores of non-U.S. citizens who graduated from foreign medical schools increased. Trends in the performance of graduates of Canadian and osteopathic medical schools and of U.S. citizens who graduated from foreign medical schools were not discernible. Conclusions: The cumulative decline in the performance of graduates from U.S. medical schools and the progressive improvement in the performance of non-U.S. citizens who graduated from foreign medical schools may ultimately manifest itself in patient care.			NORCINI, JJ (corresponding author), AMER BOARD INTERNAL MED, 3624 MARKET ST, PHILADELPHIA, PA 19104 USA.			Norcini, John/0000-0002-8464-4115				NORCINI JJ, 1989, JAMA-J AM MED ASSOC, V262, P2402, DOI 10.1001/jama.262.17.2402; SHEA JA, 1990, ACAD MED, V65, P523, DOI 10.1097/00001888-199008000-00008; SHEA JA, 1989, TEACH LEARN MED, V1, P10	3	18	18	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 1	1991	114	1					33	35		10.7326/0003-4819-114-1-33	http://dx.doi.org/10.7326/0003-4819-114-1-33			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EQ040	1983929				2022-12-28	WOS:A1991EQ04000005
J	THOMPSON, P; SALSBURY, PA; ADAMS, C; ARCHER, DL				THOMPSON, P; SALSBURY, PA; ADAMS, C; ARCHER, DL			UNITED-STATES FOOD LEGISLATION	LANCET			English	Article									US FOOD SAFETY & INSPECT SERV,WASHINGTON,DC 20250		THOMPSON, P (corresponding author), US FDA,CTR FOOD SAFETY & APPL NUTR,WASHINGTON,DC 20204, USA.							ARCHER D L, 1988, Clinical Microbiology Reviews, V1, P377; GILCHRIST A, 1981, FOODBORNE DISEASES F, P2; Olsson P. C., 1984, 75TH ANNIVERSARY COM, P220; OREILLY JT, 1979, REGULATORY MANUAL SE; 1985, MEAT POULTRY INSPECT, P1; 1987, BRIEF HIST US FOOD C, P22; 1987, POULTRY INSPECTION B, P1; 1985, EVALUATION ROLE MICR, P48	8	2	2	1	4	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	DEC 22	1990	336	8730					1557	1559		10.1016/0140-6736(90)93320-O	http://dx.doi.org/10.1016/0140-6736(90)93320-O			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EP037	1979377				2022-12-28	WOS:A1990EP03700015
J	DEVERSON, EV; GOW, IR; COADWELL, WJ; MONACO, JJ; BUTCHER, GW; HOWARD, JC				DEVERSON, EV; GOW, IR; COADWELL, WJ; MONACO, JJ; BUTCHER, GW; HOWARD, JC			MHC CLASS-II REGION ENCODING PROTEINS RELATED TO THE MULTIDRUG RESISTANCE FAMILY OF TRANSMEMBRANE TRANSPORTERS	NATURE			English	Article									VIRGINIA COMMONWEALTH UNIV,DEPT MICROBIOL & IMMUNOL,RICHMOND,VA 23298	Virginia Commonwealth University	DEVERSON, EV (corresponding author), INST ANIM PHYSIOL & GENET,DEPT IMMUNOL,CAMBRIDGE RES STN,BABRAHAM HALL,BABRAHAM,CAMBRIDGE CB2 4AT,ENGLAND.			Howard, Jonathan/0000-0003-2756-5143				AMES GFL, 1986, ANNU REV BIOCHEM, V55, P397, DOI 10.1146/annurev.biochem.55.1.397; BLIGHT MA, 1990, MOL MICROBIOL, V4, P873, DOI 10.1111/j.1365-2958.1990.tb00660.x; BUTCHER GW, 1986, HDB EXPT IMMUNOLOGY; CARTER C, IN PRESS IMMUNOGENET; CERUNDOLO V, 1990, NATURE, V345, P449, DOI 10.1038/345449a0; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; DIAMOND AG, 1989, J IMMUNOL, V142, P3268; DOOLITTLE RF, 1986, NATURE, V323, P451, DOI 10.1038/323451a0; EISENBERG D, 1984, ANNU REV BIOCHEM, V53, P595, DOI 10.1146/annurev.bi.53.070184.003115; ENDICOTT JA, 1989, REV BIOCH, V58, P137; FELMLEE T, 1985, J BACTERIOL, V163, P94, DOI 10.1128/JB.163.1.94-105.1985; GERMAIN RN, 1986, NATURE, V322, P687, DOI 10.1038/322687a0; GLASER P, 1988, EMBO J, V7, P3997, DOI 10.1002/j.1460-2075.1988.tb03288.x; GROS P, 1986, CELL, V47, P371, DOI 10.1016/0092-8674(86)90594-5; HIGGINS CF, 1986, NATURE, V323, P448, DOI 10.1038/323448a0; HIGGINS CF, 1990, PHILOS T R SOC B, V326, P353, DOI 10.1098/rstb.1990.0017; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; HYDE SC, 1990, NATURE, V346, P362, DOI 10.1038/346362a0; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; KLEIN J, 1990, IMMUNOGENETICS, V32, P147, DOI 10.1007/BF02114967; LIVINGSTONE AM, 1989, J EXP MED, V170, P777, DOI 10.1084/jem.170.3.777; MCGRATH JP, 1989, NATURE, V340; MONACO JJ, IN PRESS SCIENCE; MOORE MW, 1988, CELL, V54, P777, DOI 10.1016/S0092-8674(88)91043-4; MORRISON LA, 1986, J EXP MED, V163, P903, DOI 10.1084/jem.163.4.903; MUESCH A, 1990, TRENDS BIOCHEM SCI, V15, P86, DOI 10.1016/0968-0004(90)90186-F; NICKERSON CL, 1990, J EXP MED, V172, P1255, DOI 10.1084/jem.172.4.1255; RADA C, 1990, P NATL ACAD SCI USA, V87, P2167, DOI 10.1073/pnas.87.6.2167; RIORDAN JR, 1989, SCIENCE, V245, P1066; SALTER RD, 1985, IMMUNOGENETICS, V21, P235, DOI 10.1007/BF00375376; STEINMETZ M, 1986, CELL, V44, P895, DOI 10.1016/0092-8674(86)90012-7; TOWNSEND A, 1989, NATURE, V340, P443, DOI 10.1038/340443a0; TOWNSEND A, 1989, REV IMMUNOL, V7, P601; TOWNSEND ARM, 1985, CELL, V42, P457, DOI 10.1016/0092-8674(85)90103-5; VANDERBLIEK AM, 1987, EMBO J, V6, P3325, DOI 10.1002/j.1460-2075.1987.tb02653.x; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WANG R, IN PRESS J MOL BIOL; WATSON MEE, 1984, NUCLEIC ACIDS RES, V12, P5145, DOI 10.1093/nar/12.13.5145; WATTERS JWF, 1987, IMMUNOGENETICS, V26, P220, DOI 10.1007/BF00346516; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	40	443	446	0	3	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	DEC 20	1990	348	6303					738	741		10.1038/348738a0	http://dx.doi.org/10.1038/348738a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EP049	1979660				2022-12-28	WOS:A1990EP04900062
J	FITZPATRICK, MF; MACKAY, T; DRIVER, H; DOUGLAS, NJ				FITZPATRICK, MF; MACKAY, T; DRIVER, H; DOUGLAS, NJ			SALMETEROL IN NOCTURNAL ASTHMA - A DOUBLE-BLIND, PLACEBO CONTROLLED TRIAL OF A LONG-ACTING INHALED BETA-2 AGONIST	BRITISH MEDICAL JOURNAL			English	Article							SLOW-RELEASE AMINOPHYLLINE; SLEEP; THEOPHYLLINE; SALBUTAMOL; TERBUTALINE; PERFORMANCE; PATTERNS; CHILDREN; BEHAVIOR; THERAPY	Objective - To determine whether inhaled salmeterol, a new long acting inhaled beta-adrenergic agonist, reduces nocturnal bronchoconstriction and improved sleep quality in patients with nocturnal asthma. Design - Randomised, double blind, placebo controlled crossover study. Setting - Hospital outpatient clinics in Edinburgh. Subjects - Twenty clinically stable patients (13 women, seven men) with nocturnal asthma, median age 39 (range 18-60) years. Interventions - Salmeterol 50-mu-g and 100-mu-g and placebo taken each morning and evening by metered dose inhaler. Rescue salbutamol inhalers were provided throughout the run in and study periods. Main outcome measures - Improvement in nocturnal asthma as measured by peak expiratory flow rates and change in sleep quality as measured by electroencephalography. Results - Salmeterol improved the lowest overnight peak flow rate at both 50-mu-g (difference in median values (95% confidence interval for difference in medians) 69 (18 to 88) 1/min) and 100-mu-g (72(23 to 61) 1/min) doses twice daily. While taking salmeterol 50-mu-g twice daily patients had an objective improvement in sleep quality, spending less time awake or in light sleep (-9(-4 to -44) min) and more time in stage 4 sleep (26 (6-34) min). Conclusions - Salmeterol is an effective long acting inhaled bronchodilator for patients with nocturnal asthma and at a dose of 50-mu-g twice daily improves objective sleep quality.	UNIV WITWATERSRAND,DEPT PHYSIOL,JOHANNESBURG 2001,SOUTH AFRICA	University of Witwatersrand	FITZPATRICK, MF (corresponding author), UNIV EDINBURGH,CITY HOSP,RESP MED UNIT,EDINBURGH EH10 5SB,MIDLOTHIAN,SCOTLAND.		Douglas, Neil/B-1491-2013					BARNES PJ, 1982, LANCET, V1, P299; BRADSHAW J, 1987, British Journal of Pharmacology, V92, p590P; CARPENTIERE G, 1983, CHEST, V83, P211, DOI 10.1378/chest.83.2.211; CATTERALL JR, 1982, LANCET, V1, P301; COE CI, 1986, CHEST, V90, P485, DOI 10.1378/chest.90.4.485; CONNOLLY CK, 1979, BRIT J DIS CHEST, V73, P357, DOI 10.1016/S0007-0971(79)80173-4; DAVIES PDO, 1984, BRIT J CLIN PHARMACO, V17, P335, DOI 10.1111/j.1365-2125.1984.tb02350.x; DOUGLAS NJ, 1989, Q J MED, V71, P279; FAIRFAX AJ, 1980, THORAX, V35, P526, DOI 10.1136/thx.35.7.526; FITZPATRICK MF, 1990, THORAX, V45, pP338; FRIEDMAN RC, 1971, NEW ENGL J MED, V285, P201, DOI 10.1056/NEJM197107222850405; FURUKAWA CT, 1984, PEDIATRICS, V74, P453; GLENVILLE M, 1978, SLEEP, V1, P169, DOI 10.1093/sleep/1.2.169; HEINS M, 1988, EUR RESPIR J, V1, P306; HORN CR, 1984, LANCET, V1, P1143; KALES A, 1968, J ALLERGY, V41, P164, DOI 10.1016/0021-8707(68)90056-7; KALES A, 1970, J ALLERGY, V46, P300, DOI 10.1016/0021-8707(70)90070-5; MILLEDGE JS, 1979, J INT MED RES, V7, P106; MONTPLAISIR J, 1982, AM REV RESPIR DIS, V125, P18; MORRISON JFJ, 1988, BRIT MED J, V296, P1427, DOI 10.1136/bmj.296.6634.1427; RACHELEFSKY GS, 1986, PEDIATRICS, V78, P1133; RALL TW, 1985, PHARMACOL BASIS THER, P589; RAPPAPORT L, 1989, AM J DIS CHILD, V143, P368, DOI 10.1001/archpedi.1989.02150150126032; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; RHIND GB, 1985, BRIT MED J, V291, P1605, DOI 10.1136/bmj.291.6509.1605; SPRINGER C, 1985, J ALLERGY CLIN IMMUN, V76, P64, DOI 10.1016/0091-6749(85)90806-1; STEWART IC, 1987, THORAX, V42, P797, DOI 10.1136/thx.42.10.797; TURNERWARWICK M, 1988, AM J MED, V85, P6, DOI 10.1016/0002-9343(88)90231-8; ULLMAN A, 1988, THORAX, V43, P674, DOI 10.1136/thx.43.9.674; WILLIAMS HL, 1959, PSYCHOL MONOGR, V73, P1	30	150	151	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	DEC 15	1990	301	6765					1365	1368		10.1136/bmj.301.6765.1365	http://dx.doi.org/10.1136/bmj.301.6765.1365			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EN919	1980220	Bronze, Green Published			2022-12-28	WOS:A1990EN91900023
J	HSIAO, KK; SCOTT, M; FOSTER, D; GROTH, DF; DEARMOND, SJ; PRUSINER, SB				HSIAO, KK; SCOTT, M; FOSTER, D; GROTH, DF; DEARMOND, SJ; PRUSINER, SB			SPONTANEOUS NEURODEGENERATION IN TRANSGENIC MICE WITH MUTANT PRION PROTEIN	SCIENCE			English	Article									UNIV CALIF SAN FRANCISCO,DEPT PATHOL,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT BIOCHEM,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; University of California System; University of California San Francisco	HSIAO, KK (corresponding author), UNIV CALIF SAN FRANCISCO,DEPT NEUROL,SAN FRANCISCO,CA 94143, USA.				NIA NIH HHS [AG02132] Funding Source: Medline; NINDS NIH HHS [NS22786, NS14069] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS014069, P01NS014069, P01NS022786] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG002132] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ALLEN ND, 1990, CELL, V61, P853, DOI 10.1016/0092-8674(90)90195-K; BAKER HF, 1985, BRIT MED J, V291, P299, DOI 10.1136/bmj.291.6491.299; BASLER K, 1986, CELL, V46, P417, DOI 10.1016/0092-8674(86)90662-8; BOLTON DC, 1982, SCIENCE, V218, P1309, DOI 10.1126/science.6815801; BORCHELT DR, 1990, J CELL BIOL, V110, P743, DOI 10.1083/jcb.110.3.743; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRINSTER RL, 1988, P NATL ACAD SCI USA, V85, P836, DOI 10.1073/pnas.85.3.836; CARLSON GA, 1986, CELL, V46, P503, DOI 10.1016/0092-8674(86)90875-5; CARLSON GA, 1988, MOL CELL BIOL, V8, P5528, DOI 10.1128/MCB.8.12.5528; CHANDLER RL, 1961, LANCET, V1, P1378; COLLINGE J, 1989, LANCET, V2, P15, DOI 10.1016/S0140-6736(89)90256-0; DICKINSON AG, 1969, GENET RES, V13, P213, DOI 10.1017/S0016672300002895; DOHURA K, 1989, BIOCHEM BIOPH RES CO, V163, P974, DOI 10.1016/0006-291X(89)92317-6; GABIZON R, 1990, BIOCHEM J, V266, P1; GABIZON R, IN PRESS NEUROLOGY; Gerstmann J., 1936, Z NEUROL, V154, P736, DOI [10.1007/BF02865827, DOI 10.1007/BF02865827]; GOLDFARB L, 1990, LANCET, P637; GOLDFARB LG, 1990, LANCET, P514; GOLDGABER D, 1989, EXP NEUROL, V106, P204, DOI 10.1016/0014-4886(89)90095-2; Haldane JBS, 1941, J GENET, V41, P149, DOI 10.1007/BF02983018; HISAO K, 1989, NATURE, V338, P342; HSIAO K, 1989, ANN NEUROL, V26, P137; HSIAO K, UNPUB; HSIAO K K, 1988, American Journal of Human Genetics, V43, pA87; HSIAO KK, IN PRESS NEUROLOGY; HUNTER N, 1987, J GEN VIROL, V68, P2711, DOI 10.1099/0022-1317-68-10-2711; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAIRD CD, 1990, TRENDS GENET, V6, P242, DOI 10.1016/0168-9525(90)90206-L; LIAO YCJ, 1986, SCIENCE, V233, P364, DOI 10.1126/science.3014653; MASTERS CL, 1981, BRAIN, V104, P559, DOI 10.1093/brain/104.3.559; MCKINLEY MP, 1983, CELL, V35, P57, DOI 10.1016/0092-8674(83)90207-6; MEYER RK, 1986, P NATL ACAD SCI USA, V83, P2310, DOI 10.1073/pnas.83.8.2310; OESCH B, 1985, CELL, V40, P735, DOI 10.1016/0092-8674(85)90333-2; OWEN F, 1989, LANCET, V1, P51; Pattison I. H., 1965, NINDB MONOGRAPH, V2, P249; PRUSINER SB, 1989, ANNU REV MICROBIOL, V43, P345, DOI 10.1146/annurev.mi.43.100189.002021; PRUSINER SB, 1982, BIOCHEMISTRY-US, V21, P6942, DOI 10.1021/bi00269a050; PRUSINER SB, 1990, CELL, V63, P673, DOI 10.1016/0092-8674(90)90134-Z; RACE RE, 1990, CELL, V71, P493; RIDLEY RM, 1988, J MED GENET, V25, P589, DOI 10.1136/jmg.25.9.589; ROBAKIS NK, 1986, BIOCHEM BIOPH RES CO, V140, P758, DOI 10.1016/0006-291X(86)90796-5; SCOTT M, 1989, CELL, V59, P847, DOI 10.1016/0092-8674(89)90608-9; SERBAN D, 1990, NEUROLOGY, V40, P110, DOI 10.1212/WNL.40.1.110; SPARKES RS, 1986, P NATL ACAD SCI USA, V83, P7358, DOI 10.1073/pnas.83.19.7358; TATEISHI J, 1979, ANN NEUROL, V5, P581, DOI 10.1002/ana.410050616; WEISSMANN C, 1989, NATURE, V338, P298, DOI 10.1038/338298a0; WESTAWAY D, 1987, CELL, V51, P651, DOI 10.1016/0092-8674(87)90134-6; WESTAWAY D, 1990, 8TH INT C VIR BERL, P59	48	496	501	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	DEC 14	1990	250	4987					1587	1590		10.1126/science.1980379	http://dx.doi.org/10.1126/science.1980379			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM931	1980379				2022-12-28	WOS:A1990EM93100045
J	APPLETON, H				APPLETON, H			FOODBORNE VIRUSES	LANCET			English	Article											APPLETON, H (corresponding author), CENT PUBL HLTH LAB, PUBL HLTH LAB SERV, VIRUS REFERENCE LAB, 61 COLINDALE AVE, LONDON NW9 5HT, ENGLAND.							APPLETON H, 1977, LANCET, V1, P780; APPLETON H, 1987, NOVEL DIARRHOEA VIRU, P108; BLOCH AB, 1990, AM J PUBLIC HEALTH, V80, P428, DOI 10.2105/AJPH.80.4.428; CLIVER D O, 1985, Public Health Reviews, V13, P235; GILL ON, 1983, BRIT MED J, V287, P1532, DOI 10.1136/bmj.287.6404.1532; GRIFFIN MR, 1982, AM J EPIDEMIOL, V115, P178, DOI 10.1093/oxfordjournals.aje.a113289; IVERSEN AM, 1987, LANCET, V2, P556; Katzenelson E., 1984, MONOGR VIROL, V15, P216, DOI [10.1159/000409140, DOI 10.1159/000409140]; KURITSKY JN, 1984, ANN INTERN MED, V100, P519, DOI 10.7326/0003-4819-100-4-519; MILLARD J, 1987, EPIDEMIOL INFECT, V98, P397, DOI 10.1017/S0950268800062166; MURPHY AM, 1979, MED J AUSTRALIA, V2, P329, DOI 10.5694/j.1326-5377.1979.tb104133.x; OMAHONY MC, 1983, LANCET, V1, P518; PETHER JVS, 1983, J HYG-CAMBRIDGE, V91, P343, DOI 10.1017/S0022172400060368; REID TMS, 1987, EPIDEMIOL INFECT, V98, P109, DOI 10.1017/S095026880006177X; TICEHURST JR, 1987, J CLIN MICROBIOL, V25, P1822, DOI 10.1128/JCM.25.10.1822-1829.1987; 1988, PHLS MICROBIOL DIG, V5, P69; 1988, WKLY EPIDEMIOL REC, V63, P91	17	13	15	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 1	1990	336	8727					1362	1364		10.1016/0140-6736(90)92905-W	http://dx.doi.org/10.1016/0140-6736(90)92905-W			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL365	1978173				2022-12-28	WOS:A1990EL36500013
J	HARRISON, MR; ADZICK, NS; JENNINGS, RW; DUNCAN, BW; ROSEN, MA; FILLY, RA; GOLDBERG, JD; DELORIMIER, AA; GOLBUS, MS				HARRISON, MR; ADZICK, NS; JENNINGS, RW; DUNCAN, BW; ROSEN, MA; FILLY, RA; GOLDBERG, JD; DELORIMIER, AA; GOLBUS, MS			ANTENATAL INTERVENTION FOR CONGENITAL CYSTIC ADENOMATOID MALFORMATION	LANCET			English	Article									UNIV CALIF SAN FRANCISCO, FETAL TREATMENT PROGRAM, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, DEPT OBSTET GYNECOL & REPROD SCI, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, DEPT RADIOL, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, DEPT ANESTHESIA, SAN FRANCISCO, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	HARRISON, MR (corresponding author), UNIV CALIF SAN FRANCISCO, DEPT SURG, SAN FRANCISCO, CA 94143 USA.		Harrison, Michael/GYD-8608-2022					ADZICK N S, 1986, Surgical Forum (Chicago), V37, P309; ADZICK NS, 1985, SURG FORUM, V36, P479; ADZICK NS, 1986, J PEDIATR SURG, V21, P477, DOI 10.1016/S0022-3468(86)80215-9; ADZICK NS, 1985, J PEDIATR SURG, V20, P483; CHIN KY, 1949, ARCH PATHOL, V48, P221; CLARK SL, 1987, AM J OBSTET GYNECOL, V157, P294, DOI 10.1016/S0002-9378(87)80154-0; CROMBLEHOLME TM, 1988, J PEDIATR SURG, V23, P1114, DOI 10.1016/S0022-3468(88)80325-7; DONN SM, 1981, PEDIATR RADIOL, V10, P180, DOI 10.1007/BF00975197; GOODLIN RC, 1979, CARE FETUS, P48; HARRISON MR, 1990, J PEDIATR SURG, V25, P47, DOI 10.1016/S0022-3468(05)80163-0; HARRISON MR, 1982, J PEDIATR SURG, V17, P115, DOI 10.1016/S0022-3468(82)80193-0; HARRISON MR, 1990, NEW ENGL J MED, V322, P1582, DOI 10.1056/NEJM199005313222207; HARRISON MR, 1980, SURGERY, V88, P260; LANGER JC, 1989, AM J OBSTET GYNECOL, V160, P1145, DOI 10.1016/0002-9378(89)90177-4; LONGAKER MT, 1989, J PEDIATR SURG, V24, P573, DOI 10.1016/S0022-3468(89)80509-3; NAKAYAMA DK, 1984, J PEDIATR SURG, V19, P333, DOI 10.1016/S0022-3468(84)80248-1; RODECK CH, 1988, NEW ENGL J MED, V319, P1135, DOI 10.1056/NEJM198810273191706	17	119	122	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 20	1990	336	8721					965	967		10.1016/0140-6736(90)92420-M	http://dx.doi.org/10.1016/0140-6736(90)92420-M			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ED601	1977005				2022-12-28	WOS:A1990ED60100004
J	DRUMMOND, DC; THOM, B; BROWN, C; EDWARDS, G; MULLAN, MJ				DRUMMOND, DC; THOM, B; BROWN, C; EDWARDS, G; MULLAN, MJ			SPECIALIST VERSUS GENERAL-PRACTITIONER TREATMENT OF PROBLEM DRINKERS	LANCET			English	Article									MAUDSLEY HOSP & INST PSYCHIAT, LONDON SE5 8AZ, ENGLAND	South London & Maudsley NHS Trust; University of London; King's College London	DRUMMOND, DC (corresponding author), INST PSYCHIAT, NATL ADDICT CTR, ADDICT RES UNIT, 101 DENMARK HILL, LONDON SE5 8AF, ENGLAND.		Drummond, Colin/O-9141-2019	Drummond, Colin/0000-0001-9379-5452; Mullan, Michael/0000-0002-1473-7527				ANDERSON P, 1985, BRIT MED J, V290, P1873, DOI 10.1136/bmj.290.6485.1873; BALDWIN S, 1987, HELPING PROBLEM DRIN; CHICK J, 1988, BRIT J ADDICT, V83, P159; CLEMENT S, 1986, BRIT J ADDICT, V81, P257; CLEMENT S, 1987, HELPING PROBLEM DRIN; DRUMMOND DC, 1990, BRIT J ADDICT, V85, P357; EDWARDS G, 1968, BRIT MED J, V4, P435, DOI 10.1136/bmj.4.5628.435; EDWARDS G, 1976, BRIT MED J, V1, P1058, DOI 10.1136/bmj.1.6017.1058; EDWARDS G, 1967, LANCET, V1, P555; EDWARDS G, 1977, J STUD ALCOHOL, V38, P1004, DOI 10.15288/jsa.1977.38.1004; FINE EW, 1978, J STUD ALCOHOL, V39, P466, DOI 10.15288/jsa.1978.39.466; Goldberg DP., 1972, DETECTION PSYCHIATRI; HESSELBROCK M, 1983, INT J ADDICT, V18, P593, DOI 10.3109/10826088309027359; MAISTO SA, 1979, J CONSULT CLIN PSYCH, V47, P106, DOI 10.1037/0022-006X.47.1.106; ORFORD J, 1976, BEHAV RES THER, V14, P409, DOI 10.1016/0005-7967(76)90087-5; POLLAK B, 1978, BRIT J ALCOHOL ALCOH, V13, P24; Shaw S., 1978, RESPONDING DRINKING; STOCKWELL T, 1979, BRIT J ADDICT, V74, P79; Strong P M, 1980, Sociol Health Illn, V2, P24, DOI 10.1111/1467-9566.ep11340296; THOM B, 1986, BRIT J ADDICT, V81, P405; WALLACE P, 1988, BRIT MED J, V297, P663, DOI 10.1136/bmj.297.6649.663; WILKINS RH, 1974, HIDDEN ALCOHOLIC GEN; 1978, PATTERN RANGE SERVIC; [No title captured]	24	52	52	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 13	1990	336	8720					915	918		10.1016/0140-6736(90)92279-Q	http://dx.doi.org/10.1016/0140-6736(90)92279-Q			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EC456	1976937				2022-12-28	WOS:A1990EC45600011
J	UEYAMA, Y; MATSUZAWA, Y; YAMASHITA, S; FUNAHASHI, T; SAKAI, N; NAKAMURA, T; KUBO, M; TARUI, S				UEYAMA, Y; MATSUZAWA, Y; YAMASHITA, S; FUNAHASHI, T; SAKAI, N; NAKAMURA, T; KUBO, M; TARUI, S			HYPOCHOLESTEROLEMIC FACTOR FROM GALLBLADDER CANCER-CELLS	LANCET			English	Article									OSAKA UNIV,SCH MED,DEPT INTERNAL MED 2,1-1-50 FUKUSHIMA,FUKUSHIMA KU,OSAKA 553,JAPAN	Osaka University								AUWERX JH, 1989, P NATL ACAD SCI USA, V86, P1133, DOI 10.1073/pnas.86.4.1133; BJELKE E, 1974, LANCET, V1, P1116; CAIT A, 1979, J CLIN ENDOCR METAB, V48, P887; ECKARDT H, 1988, BIOCHEM J, V252, P889, DOI 10.1042/bj2520889; FEINLEIB M, 1983, CANCER RES, V43, P2503; FILIPOVIC I, 1985, J CLIN CHEM CLIN BIO, V23, P331; GOLDSTEIN JL, 1977, CELL, V12, P629, DOI 10.1016/0092-8674(77)90263-X; GOLOS TG, 1987, MOL ENDOCRINOL, V1, P321, DOI 10.1210/mend-1-4-321; GORE JM, 1984, AM J CARDIOL, V54, P722, DOI 10.1016/S0002-9149(84)80197-6; HO YK, 1978, BLOOD, V52, P1099; KARK JD, 1980, J CHRON DIS, V33, P311, DOI 10.1016/0021-9681(80)90026-0; LILIENFELD AM, 1981, AM J EPIDEMIOL, V114, P1; MAZZONE T, 1989, J BIOL CHEM, V264, P15529; NISHIGAKI I, 1984, BIOCH INT, V8, P5011; PETERSON C, 1985, MED ONCOL TUMOR PHAR, V2, P143; SEMENKOVICH CF, 1987, BIOCHEMISTRY-US, V26, P4987, DOI 10.1021/bi00390a016; SIROEDA O, 1987, CANCER RES, V47, P4630; STEPHAN ZF, 1987, J BIOL CHEM, V262, P6096; VITOLS S, 1984, BLOOD, V63, P1186; WADE DP, 1989, EUR J BIOCHEM, V181, P727, DOI 10.1111/j.1432-1033.1989.tb14784.x	20	33	34	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	SEP 22	1990	336	8717					707	709		10.1016/0140-6736(90)92204-U	http://dx.doi.org/10.1016/0140-6736(90)92204-U			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DZ624	1975892				2022-12-28	WOS:A1990DZ62400003
J	RAUB, W				RAUB, W			RISK OF OCCUPATIONAL TRANSMISSION OF HUMAN-IMMUNODEFICIENCY-VIRUS EVALUATED	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material											RAUB, W (corresponding author), NIH,BETHESDA,MD 20892, USA.							1990, ANN INTERN MED, V113, P740	1	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 13	1991	265	6					706	706						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EW479	1990184				2022-12-28	WOS:A1991EW47900009
J	NOSSENT, HC; SWAAK, TJG; BERDEN, JHM				NOSSENT, HC; SWAAK, TJG; BERDEN, JHM			SYSTEMIC LUPUS-ERYTHEMATOSUS AFTER RENAL-TRANSPLANTATION - PATIENT AND GRAFT-SURVIVAL AND DISEASE-ACTIVITY	ANNALS OF INTERNAL MEDICINE			English	Article							KIDNEY-TRANSPLANTS; CLINICAL COURSE; EXPERIENCE; RATES	Objective: To determine the outcome of renal transplantation in patients with systemic lupus erythematosus and end-stage renal failure and to compare disease activity after transplantation with disease activity before transplantation. Design: Retrospective case finding using data for an 8-year period from the central registry for renal replacement therapy in The Netherlands. Setting: Tertiary care hospitals with facilities for renal transplantation in The Netherlands. Patients: Twenty-eight patients who fulfilled at least four of the American Rheumatology Association's criteria for the classification of systemic lupus erythematosus and who received a renal transplant. Measurements: Acturial survival rates for grafts and patients after transplantation, maximal nonrenal scores on the Systemic Lupus Erythematosus Disease Activity Index, and time-adjusted disease exacerbation rates in all patients before and after transplantation. Results: The actuarial graft survival rate at 1 year and 5 years was 68% (95% CI, 47% to 82%) and 54% (CI, 25% to 77%), respectively, whereas the acturial patient survival rate was 87% (CI, 69% to 96%) at 1 and 5 years. High disease activity was not found to affect graft survival adversely before the start of renal replacement therapy or during dialysis. After transplantation, disease activity per patient and the overall incidence of disease exacerbations decreased. One case of recurrent lupus nephritis was seen. Conclusions: Patients with systemic lupus erythematosus and end-stage renal failure are excellent candidates for renal transplantation; disease activity after transplantation is sporadic and low, and the recurrence of lupus nephritis is rare.	DR DANIEL DENHOED CLIN, POB 5201, 3008 AE ROTTERDAM, NETHERLANDS; UNIV HOSP NIJMEGEN, NIJMEGEN, NETHERLANDS	Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Radboud University Nijmegen			Berden, J.H.M./H-8009-2014	Nossent, Johannes/0000-0002-2833-7997				AMEND WJC, 1981, ANN INTERN MED, V94, P444, DOI 10.7326/0003-4819-94-4-444; CAMERON JS, 1982, TRANSPLANTATION, V34, P237; CANTAROVICH M, 1988, ANN INTERN MED, V109, P254, DOI 10.7326/0003-4819-109-3-254; CATS S, 1984, TRANSPLANTATION, V37, P575, DOI 10.1097/00007890-198406000-00010; CHANG C, 1986, ARTHRITIS RHEUM, V29, P593; COPLON NS, 1983, NEW ENGL J MED, V308, P186, DOI 10.1056/NEJM198301273080403; DUBOIS EL, 1952, JAMA-J AM MED ASSOC, V149, P995, DOI 10.1001/jama.1952.02930280017006; GOLDBLUM SE, 1980, ANN INTERN MED, V93, P597, DOI 10.7326/0003-4819-93-4-597; HELLERSTEDT WL, 1984, MAYO CLIN PROC, V59, P776, DOI 10.1016/S0025-6196(12)65589-X; JARRETT MP, 1983, ARCH INTERN MED, V143, P1353, DOI 10.1001/archinte.143.7.1353; Klemperer P, 1941, ARCH PATHOL, V32, P569; KUMANO K, 1987, CLIN NEPHROL, V27, P94; LIANG MH, 1989, ARTHRITIS RHEUM, V32, P1107, DOI 10.1002/anr.1780320909; LIANG MH, 1989, 2ND P INT C SYST LUP, P64; MEJIA G, 1983, ARCH INTERN MED, V143, P2089, DOI 10.1001/archinte.143.11.2089; MIETTINEN O, 1985, STAT MED, V4, P213, DOI 10.1002/sim.4780040211; MOARTY AV, 1989, ARTHRITIS RHEUM, V31, P464; OPELZ G, 1973, TRANSPLANT P, V5, P253; POLLAK VE, 1961, J LAB CLIN MED, V57, P495; ROTH D, 1987, AM J NEPHROL, V7, P367, DOI 10.1159/000167615; ROTHFIELD NF, 1963, NEW ENGL J MED, V269, P537, DOI 10.1056/NEJM196309122691101; SINGH YN, 1989, 2ND P INT C SYST LUP, P59; SOHMIYA S, 1986, JPN J TRANSPLANT, V21, P18; SWAAK AJG, 1989, ANN RHEUM DIS, V48, P455, DOI 10.1136/ard.48.6.455; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; YAKUB YN, 1981, NEPHRON, V27, P197; ZWEIMAN B, 1968, ANN INTERN MED, V69, P441, DOI 10.7326/0003-4819-69-3-441; 1975, JAMA-J AM MED ASSOC, V232, P148	28	80	82	1	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 1	1991	114	3					183	188		10.7326/0003-4819-114-3-183	http://dx.doi.org/10.7326/0003-4819-114-3-183			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EV339	1984742				2022-12-28	WOS:A1991EV33900002
J	MCCUNE, JM				MCCUNE, JM			HIV-1 - THE INFECTIVE PROCESS INVIVO	CELL			English	Review							HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE-DEFICIENCY SYNDROME; AIDS-RELATED COMPLEX; SCID-HU MOUSE; III HTLV-III; NF-KAPPA-B; NUCLEOTIDE-SEQUENCE; T-CELLS; PERIPHERAL-BLOOD; GENE-EXPRESSION				MCCUNE, JM (corresponding author), SYSTEMIX INC, PALO ALTO, CA 94303 USA.							ALBERT J, 1990, AIDS, V4, P107, DOI 10.1097/00002030-199002000-00002; ALDOVINI A, 1990, J VIROL, V64, P1920, DOI 10.1128/JVI.64.5.1920-1926.1990; ALIZON M, 1986, CELL, V46, P63, DOI 10.1016/0092-8674(86)90860-3; ARMSTRONG JA, 1984, LANCET, V2, P370; ARTHOS J, 1989, CELL, V57, P469, DOI 10.1016/0092-8674(89)90922-7; AUGER I, 1988, NATURE, V336, P575, DOI 10.1038/336575a0; BAEUERLE PA, 1988, CELL, V53, P211, DOI 10.1016/0092-8674(88)90382-0; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; BARRETT ADT, 1986, CURR TOP MICROBIOL, V128, P55; BIETH E, 1990, NUCLEIC ACIDS RES, V18, P119, DOI 10.1093/nar/18.1.119; BISHOP DK, 1990, J IMMUNOL, V144, P1153; BRAHIC M, 1981, NATURE, V292, P240, DOI 10.1038/292240a0; BUJDOSO R, 1989, EUR J IMMUNOL, V19, P1779, DOI 10.1002/eji.1830191003; CHENGMAYER C, 1989, SCIENCE, V246, P1629, DOI 10.1126/science.2531920; CHENGMAYER C, 1990, J VIROL, V64, P4390, DOI 10.1128/JVI.64.9.4390-4398.1990; CHENGMAYER C, 1988, SCIENCE, V240, P80, DOI 10.1126/science.2832945; CLEMENTS JE, 1988, ANNU REV IMMUNOL, V6, P139, DOI 10.1146/annurev.iy.06.040188.001035; COOMBS RW, 1989, NEW ENGL J MED, V321, P1626, DOI 10.1056/NEJM198912143212402; CULLEN BR, 1989, CELL, V58, P423, DOI 10.1016/0092-8674(89)90420-0; CURRAN JW, 1988, SCIENCE, V239, P610, DOI 10.1126/science.3340847; DIMARIA H, 1986, LANCET, V2, P215; DORNER AJ, 1985, J VIROL, V53, P32, DOI 10.1128/JVI.53.1.32-39.1985; DOUGHERTY JP, 1988, J VIROL, V62, P2817, DOI 10.1128/JVI.62.8.2817-2822.1988; EIGEN M, 1981, SCI AM, V244, P88, DOI 10.1038/scientificamerican0481-88; FARNET CM, 1990, P NATL ACAD SCI USA, V87, P4164, DOI 10.1073/pnas.87.11.4164; FENYO EM, 1988, J VIROL, V62, P4414; FIELDS AP, 1988, NATURE, V333, P278, DOI 10.1038/333278a0; FISHER AG, 1988, NATURE, V334, P444, DOI 10.1038/334444a0; FOLKS TM, 1988, SCIENCE, V242, P919, DOI 10.1126/science.2460922; FREDRICKSON GG, 1989, J EXP MED, V169, P1473, DOI 10.1084/jem.169.4.1473; FULTZ PN, 1986, J INFECT DIS, V154, P896, DOI 10.1093/infdis/154.5.896; GALLATIN M, 1986, CELL, V44, P673, DOI 10.1016/0092-8674(86)90832-9; GALLO RC, 1984, SCIENCE, V224, P500, DOI 10.1126/science.6200936; GENDELMAN HE, 1989, AIDS, V3, P475, DOI 10.1097/00002030-198908000-00001; GOWANS JL, 1964, PROC R SOC SER B-BIO, V159, P257, DOI 10.1098/rspb.1964.0001; GUIDOS CJ, 1990, J EXP MED, V172, P835, DOI 10.1084/jem.172.3.835; HAASE AT, 1986, NATURE, V322, P130, DOI 10.1038/322130a0; HAHN BH, 1986, SCIENCE, V232, P1548, DOI 10.1126/science.3012778; HARPER ME, 1986, P NATL ACAD SCI USA, V83, P772, DOI 10.1073/pnas.83.3.772; HATTORI T, 1989, FEBS LETT, V248, P48, DOI 10.1016/0014-5793(89)80429-6; HICKEY WF, 1988, SCIENCE, V239, P290, DOI 10.1126/science.3276004; HIRSCH MS, 1988, J INFECT DIS, V157, P427, DOI 10.1093/infdis/157.3.427; HIRSCH VM, 1989, NATURE, V341, P573, DOI 10.1038/341573a0; HO DD, 1989, NEW ENGL J MED, V321, P1621, DOI 10.1056/NEJM198912143212401; HOFFENBACH A, 1989, J IMMUNOL, V142, P452; HOSMALIN A, 1990, P NATL ACAD SCI USA, V87, P2344, DOI 10.1073/pnas.87.6.2344; HUMPHRIES EH, 1974, J VIROL, V14, P531, DOI 10.1128/JVI.14.3.531-546.1974; IOACHIM HL, 1990, ARCH PATHOL LAB MED, V114, P284; KANESHIMA H, 1990, 6TH INT C AIDS, V3, P99; KELLER R, 1976, J IMMUNOL, V116, P772; KESTLER H, 1990, SCIENCE, V248, P1109, DOI 10.1126/science.2160735; KIM SY, 1989, J VIROL, V63, P3708, DOI 10.1128/JVI.63.9.3708-3713.1989; KINTER AL, 1990, J VIROL, V64, P4306, DOI 10.1128/JVI.64.9.4306-4312.1990; KLAUS GGB, 1980, IMMUNOL REV, V53, P3, DOI 10.1111/j.1600-065X.1980.tb01038.x; KOENIG S, 1990, J IMMUNOL, V145, P127; KOYANAGI Y, 1987, SCIENCE, V236, P819, DOI 10.1126/science.3646751; KRIPKE ML, 1990, J IMMUNOL, V145, P2833; KROWKA J, 1990, 6TH INT C AIDS, V1, P194; LACOSTE J, 1990, J VIROL, V64, P4726, DOI 10.1128/JVI.64.10.4726-4734.1990; LARDER BA, 1989, SCIENCE, V243, P1731, DOI 10.1126/science.2467383; LASKY LA, 1987, CELL, V50, P975, DOI 10.1016/0092-8674(87)90524-1; LEIDER JM, 1988, J VIROL, V62, P3084, DOI 10.1128/JVI.62.9.3084-3091.1988; LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7; LETOURNEAU A, 1986, HUM PATHOL, V17, P1047, DOI 10.1016/S0046-8177(86)80089-2; LETVIN NL, 1990, IMMUNOL TODAY, V11, P322, DOI 10.1016/0167-5699(90)90127-U; LEVY JA, 1984, SCIENCE, V225, P840, DOI 10.1126/science.6206563; LEWIS SH, 1990, LANCET, V335, P565, DOI 10.1016/0140-6736(90)90349-A; LUCEY DR, 1989, J EXP MED, V169, P327, DOI 10.1084/jem.169.1.327; MADDON PJ, 1986, CELL, V47, P333, DOI 10.1016/0092-8674(86)90590-8; MCCUNE JM, 1990, UCLA SYM BI, V119, P347; MCCUNE JM, 1990, SCIENCE, V250, P1152, DOI 10.1126/science.2174574; MCCUNE JM, 1990, SCIENCE, V247, P564, DOI 10.1126/science.2300816; MCCUNE JM, 1988, SCIENCE, V241, P1632, DOI 10.1126/science.2971269; MCCUNE JM, 1988, CELL, V53, P55, DOI 10.1016/0092-8674(88)90487-4; MCCUNE JM, 1990, SEMIN VIROL, V1, P229; MCCUNE JM, 1990, IN PRESS ANN NY ACAD; MCDOUGAL JS, 1985, J IMMUNOL, V135, P3151; MEYERHANS A, 1989, CELL, V58, P901, DOI 10.1016/0092-8674(89)90942-2; MIEDEMA F, 1990, IMMUNOL TODAY, V11, P293, DOI 10.1016/0167-5699(90)90116-Q; MITSUYA H, 1990, SCIENCE, V249, P1533, DOI 10.1126/science.1699273; MUESING MA, 1985, NATURE, V313, P450, DOI 10.1038/313450a0; NABEL G, 1987, NATURE, V326, P711, DOI 10.1038/326711a0; NAMIKAWA R, 1988, SCIENCE, V242, P1684, DOI 10.1126/science.3201256; NAMIKAWA R, 1990, J EXP MED, V172, P1055, DOI 10.1084/jem.172.4.1055; NAMIKAWA R, 1990, 6TH INT C AIDS, V1, P194; NARA P, 1989, LOS ALAMOS SCI   FAL, P55; NARA PL, 1990, J VIROL, V64, P3779, DOI 10.1128/JVI.64.8.3779-3791.1990; NARAYAN O, 1989, J GEN VIROL, V70, P1617, DOI 10.1099/0022-1317-70-7-1617; NELSON JA, 1988, VIROLOGY, V165, P286, DOI 10.1016/0042-6822(88)90685-X; NELSON JA, 1990, AIDS, V4, P1, DOI 10.1097/00002030-199001000-00001; NIEDERMAN TMJ, 1989, P NATL ACAD SCI USA, V86, P1128, DOI 10.1073/pnas.86.4.1128; NOTKA MA, 1989, ANTIVIR RES, V11, P191; OREAR JJ, 1982, P NATL ACAD SCI-BIOL, V79, P1230, DOI 10.1073/pnas.79.4.1230; OVERBAUGH J, 1988, SCIENCE, V239, P906, DOI 10.1126/science.2893454; OWEN RL, 1977, GASTROENTEROLOGY, V72, P440; PARDEE AB, 1989, SCIENCE, V246, P603, DOI 10.1126/science.2683075; PATARCA R, 1988, P NATL ACAD SCI USA, V85, P2733, DOI 10.1073/pnas.85.8.2733; PEDERSEN C, 1990, AIDS, V4, P523, DOI 10.1097/00002030-199006000-00005; PERRY VH, 1987, J EXP MED, V166, P1138, DOI 10.1084/jem.166.4.1138; PETERLIN BM, 1988, AIDS, V2, pS29, DOI 10.1097/00002030-198800001-00005; PIOT P, 1988, SCIENCE, V239, P573, DOI 10.1126/science.3277271; PIRCHER H, 1990, NATURE, V346, P629, DOI 10.1038/346629a0; PRATS AC, 1990, J VIROL, V64, P774, DOI 10.1128/JVI.64.2.774-783.1990; QUINN TC, 1986, SCIENCE, V234, P955, DOI 10.1126/science.3022379; QUINNAN GV, 1984, JAMA-J AM MED ASSOC, V252, P72, DOI 10.1001/jama.252.1.72; RABIN L, 1990, 6TH INT C AIDS, V3, P113; RATNER L, 1985, NATURE, V313, P277, DOI 10.1038/313277a0; RAZZECA KJ, 1986, EUR J IMMUNOL, V16, P393, DOI 10.1002/eji.1830160414; REDDEHASE MJ, 1989, IMMUNOL TODAY, V10, pS39; ROSENBERG ZF, 1989, ADV IMMUNOL, V47, P377; ROUSE BT, 1986, REV INFECT DIS, V8, P850; ROUSE RV, 1982, J IMMUNOL, V128, P2243; SAAG MS, 1988, NATURE, V334, P440, DOI 10.1038/334440a0; SAKAI K, 1988, J VIROL, V62, P4078, DOI 10.1128/JVI.62.11.4078-4085.1988; SALAHUDDIN SZ, 1985, P NATL ACAD SCI USA, V82, P5530, DOI 10.1073/pnas.82.16.5530; SANCHEZPESCADOR R, 1985, SCIENCE, V227, P484, DOI 10.1126/science.2578227; SATTENTAU QJ, 1989, J EXP MED, V170, P1319, DOI 10.1084/jem.170.4.1319; SATTENTAU QJ, 1988, CELL, V52, P631, DOI 10.1016/0092-8674(88)90397-2; SCADDEN DT, 1989, BLOOD, V74, P1455; SCHNITTMAN SM, 1990, P NATL ACAD SCI USA, V87, P6058, DOI 10.1073/pnas.87.16.6058; SCHNITTMAN SM, 1989, SCIENCE, V245, P305, DOI 10.1126/science.2665081; SHIELDS JW, 1989, LYMPHOLOGY, V22, P62; SHIH CC, 1991, IN PRESS J INFECT DI; SILBERBERGSINAKIN I, 1980, J INVEST DERMATOL, V75, P61, DOI 10.1111/1523-1747.ep12521144; SOMASUNDARAN M, 1988, SCIENCE, V242, P1554, DOI 10.1126/science.3201245; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; SPRECHER S, 1986, LANCET, V2, P288; SRINIVASAN A, 1987, BLOOD, V69, P1766; STEIN BS, 1987, CELL, V49, P659, DOI 10.1016/0092-8674(87)90542-3; SZAKAL AK, 1983, J IMMUNOL, V131, P1714; SZAKAL AK, 1989, ANNU REV IMMUNOL, V7, P91, DOI 10.1146/annurev.immunol.7.1.91; TEMIN HM, 1967, J CELL PHYSIOL, V69, P53, DOI 10.1002/jcp.1040690108; TENNERRACZ K, 1988, AIDS, V2, P299, DOI 10.1097/00002030-198808000-00010; TERSMETTE M, 1988, J VIROL, V62, P2026, DOI 10.1128/JVI.62.6.2026-2032.1988; TERWILLIGER EF, 1990, ANN EMERG MED, V19, P233, DOI 10.1016/S0196-0644(05)82036-0; TEVETHIA MJ, 1989, PROG MED VIROL, V36, P120; TOMASI TB, 1980, TRANSPLANTATION, V29, P353, DOI 10.1097/00007890-198005000-00001; TONGSTARKSEN SE, 1989, J IMMUNOL, V142, P702; TSCHACHLER E, 1987, J INVEST DERMATOL, V88, P233, DOI 10.1111/1523-1747.ep12525402; TSUBOTA H, 1989, J EXP MED, V169, P1421, DOI 10.1084/jem.169.4.1421; VOLBERDING PA, 1990, NEW ENGL J MED, V322, P941, DOI 10.1056/NEJM199004053221401; VONLAER D, 1990, BLOOD, V76, P1281; WAINHOBSON S, 1985, CELL, V40, P9, DOI 10.1016/0092-8674(85)90303-4; WALKER CM, 1986, SCIENCE, V234, P1563, DOI 10.1126/science.2431484; WONGSTAAL F, 1985, SCIENCE, V229, P759, DOI 10.1126/science.2992084; YARCHOAN R, 1989, NEW ENGL J MED, V321, P726, DOI 10.1056/NEJM198909143211106; ZACK JA, 1990, CELL, V61, P213, DOI 10.1016/0092-8674(90)90802-L; ZUCKERFRANKLIN D, 1989, P NATL ACAD SCI USA, V86, P5595, DOI 10.1073/pnas.86.14.5595	148	130	142	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 25	1991	64	2					351	363		10.1016/0092-8674(91)90644-E	http://dx.doi.org/10.1016/0092-8674(91)90644-E			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EV336	1988152				2022-12-28	WOS:A1991EV33600012
J	SAWYERS, CL; DENNY, CT; WITTE, ON				SAWYERS, CL; DENNY, CT; WITTE, ON			LEUKEMIA AND THE DISRUPTION OF NORMAL HEMATOPOIESIS	CELL			English	Review							THYROID-HORMONE RECEPTOR; CHRONIC MYELOGENOUS LEUKEMIA; CHRONIC MYELOCYTIC-LEUKEMIA; PROTO-ONCOGENE PRODUCT; BCR-ABL ONCOGENE; T-CELL LYMPHOMAS; V-FMS ONCOGENE; BONE-MARROW; STEM-CELLS; GROWTH-FACTOR		UNIV CALIF LOS ANGELES, SCH MED, DEPT MICROBIOL & MOLEC GENET, LOS ANGELES, CA 90024 USA; UNIV CALIF LOS ANGELES, SCH MED, DEPT PEDIAT, LOS ANGELES, CA 90024 USA; UNIV CALIF LOS ANGELES, HOWARD HUGHES MED INST, LOS ANGELES, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Howard Hughes Medical Institute; University of California System; University of California Los Angeles	SAWYERS, CL (corresponding author), UNIV CALIF LOS ANGELES, SCH MED, DEPT HEMATOL ONCOL, LOS ANGELES, CA 90024 USA.		Sawyers, Charles/G-5327-2016					AHUJA H, 1989, P NATL ACAD SCI USA, V86, P6783, DOI 10.1073/pnas.86.17.6783; ANDREWS RG, 1990, J EXP MED, V172, P355, DOI 10.1084/jem.172.1.355; BAKHSHI A, 1985, CELL, V41, P899, DOI 10.1016/S0092-8674(85)80070-2; BALLARD DW, 1990, CELL, V63, P803, DOI 10.1016/0092-8674(90)90146-6; BARLOZZARI T, 1987, P NATL ACAD SCI USA, V84, P7691, DOI 10.1073/pnas.84.21.7691; BEGLEY CG, 1989, P NATL ACAD SCI USA, V86, P10128, DOI 10.1073/pnas.86.24.10128; BELONGIA EA, 1990, NEW ENGL J MED, V323, P357, DOI 10.1056/NEJM199008093230601; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; BLATT C, 1988, EMBO J, V7, P4283, DOI 10.1002/j.1460-2075.1988.tb03326.x; BODINE DM, 1989, P NATL ACAD SCI USA, V86, P8897, DOI 10.1073/pnas.86.22.8897; BORROW J, 1990, SCIENCE, V249, P1577, DOI 10.1126/science.2218500; BORZILLO GV, 1990, MOL CELL BIOL, V10, P2703, DOI 10.1128/MCB.10.6.2703; BORZILLO GV, 1989, MOL CELL BIOL, V9, P3973, DOI 10.1128/MCB.9.9.3973; BOS JL, 1989, CANCER RES, V49, P4682; BREITMAN TR, 1981, BLOOD, V57, P1000; CAAN AJ, 1990, VIROLOGY, P1501; CHANG JM, 1989, BLOOD, V73, P1487; CHEN Q, 1990, EMBO J, V9, P415, DOI 10.1002/j.1460-2075.1990.tb08126.x; CHENG J, 1990, MOL CELL BIOL, V10, P5502, DOI 10.1128/MCB.10.10.5502; CLEARY ML, 1985, P NATL ACAD SCI USA, V82, P7439, DOI 10.1073/pnas.82.21.7439; CLINE TW, 1989, CELL, V59, P231, DOI 10.1016/0092-8674(89)90280-8; COOK WD, 1987, MOL CELL BIOL, V7, P2631, DOI 10.1128/MCB.7.7.2631; COOK WD, 1985, CELL, V41, P677, DOI 10.1016/S0092-8674(85)80048-9; DALEY GQ, 1988, P NATL ACAD SCI USA, V85, P9312, DOI 10.1073/pnas.85.23.9312; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; DAMM K, 1989, NATURE, V339, P593, DOI 10.1038/339593a0; DETHE H, 1990, NATURE, V347, P558, DOI 10.1038/347558a0; DEXTER TM, 1977, J CELL PHYSIOL, V91, P335, DOI 10.1002/jcp.1040910303; DUBOIS CM, 1990, J EXP MED, V172, P737, DOI 10.1084/jem.172.3.737; EASTMAN A, 1990, CANCER CELL-MON REV, V2, P275; EAVES AC, 1987, CRIT REV ONCOL HEMAT, V7, P125, DOI 10.1016/S1040-8428(87)80022-7; ELEFANTY AG, 1990, EMBO J, V9, P1069, DOI 10.1002/j.1460-2075.1990.tb08212.x; EPSTEIN J, 1990, NEW ENGL J MED, V322, P664, DOI 10.1056/NEJM199003083221005; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; FINGER LR, 1989, P NATL ACAD SCI USA, V86, P5039, DOI 10.1073/pnas.86.13.5039; FUKUHARA S, 1979, CANCER RES, V39, P3119; GANSER A, 1990, BLOOD, V76, P455; GEARING DP, 1989, EMBO J, V8, P3667, DOI 10.1002/j.1460-2075.1989.tb08541.x; GHOSH S, 1990, CELL, V62, P1019, DOI 10.1016/0092-8674(90)90276-K; GOODWIN RG, 1990, CELL, V60, P941, DOI 10.1016/0092-8674(90)90342-C; GRAF T, 1983, CELL, V34, P7, DOI 10.1016/0092-8674(83)90130-7; GRAHAM GJ, 1990, NATURE, V344, P442, DOI 10.1038/344442a0; GROOPMAN JE, 1989, NEW ENGL J MED, V321, P1449, DOI 10.1056/NEJM198911233212106; HALDAR S, 1989, NATURE, V342, P195, DOI 10.1038/342195a0; HANKINS WD, 1978, NATURE, V276, P506, DOI 10.1038/276506a0; HANTO DW, 1989, TRANSPLANTATION, V47, P458, DOI 10.1097/00007890-198903000-00012; Hariharan I K, 1988, Oncogene Res, V3, P387; HARIHARAN IK, 1989, MOL CELL BIOL, V9, P2798, DOI 10.1128/MCB.9.7.2798; HEARD JM, 1987, CELL, V51, P663, DOI 10.1016/0092-8674(87)90135-8; HEISTERKAMP N, 1990, NATURE, V344, P251, DOI 10.1038/344251a0; HEISTERKAMP N, 1983, NATURE, V306, P239, DOI 10.1038/306239a0; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; HUANG E, 1990, CELL, V63, P225, DOI 10.1016/0092-8674(90)90303-V; HUNTER T, 1991, CELL, V64, P249, DOI 10.1016/0092-8674(91)90637-E; IHLE JN, 1989, INT J CELL CLONING, V7, P68, DOI 10.1002/stem.5530070202; ITOH N, 1990, SCIENCE, V247, P324, DOI 10.1126/science.2404337; JANSSEN JWG, 1989, BLOOD, V73, P248; JOHNSON GR, 1989, EMBO J, V8, P441, DOI 10.1002/j.1460-2075.1989.tb03396.x; JORDAN CT, 1990, GENE DEV, V4, P220, DOI 10.1101/gad.4.2.220; JORDAN CT, 1990, CELL, V61, P953, DOI 10.1016/0092-8674(90)90061-I; KAMELREID S, 1989, SCIENCE, V246, P1597, DOI 10.1126/science.2595371; KAMPS MP, 1990, CELL, V60, P547, DOI 10.1016/0092-8674(90)90658-2; KAPLAN LD, 1989, JAMA-J AM MED ASSOC, V261, P719; KELLER G, 1990, J EXP MED, V171, P1407, DOI 10.1084/jem.171.5.1407; KELLIHER MA, 1990, P NATL ACAD SCI USA, V87, P6649, DOI 10.1073/pnas.87.17.6649; KELMAN Z, 1989, BLOOD, V74, P2318; KIERAN M, 1990, CELL, V62, P1007, DOI 10.1016/0092-8674(90)90275-J; KLEIN G, 1983, CELL, V32, P311, DOI 10.1016/0092-8674(83)90449-X; KLINKEN SP, 1988, CELL, V53, P857, DOI 10.1016/S0092-8674(88)90309-1; KNOWLES DM, 1988, PATHOL ANNU, V23, P33; KOEFFLER HP, 1985, CHRONIC ACUTE LEUKEM, P27; KONOPKA JB, 1984, CELL, V37, P1035, DOI 10.1016/0092-8674(84)90438-0; KURZROCK R, 1988, NEW ENGL J MED, V319, P990; LEDER P, 1983, SCIENCE, V222, P765, DOI 10.1126/science.6356357; LENFANT M, 1989, P NATL ACAD SCI USA, V86, P779, DOI 10.1073/pnas.86.3.779; LEWIN B, 1991, CELL, V64, P303, DOI 10.1016/0092-8674(91)90640-K; LI JP, 1990, NATURE, V343, P762, DOI 10.1038/343762a0; LONGO L, 1990, IN PRESS J EXP MED; LUGO TG, 1990, SCIENCE, V247, P1079, DOI 10.1126/science.2408149; Magrath I, 1990, Adv Cancer Res, V55, P133, DOI 10.1016/S0065-230X(08)60470-4; MCALISTER I, 1990, BLOOD, V75, P1240; MCCUNE JM, 1988, SCIENCE, V241, P1632, DOI 10.1126/science.2971269; MCDONNELL TJ, 1989, CELL, V57, P79, DOI 10.1016/0092-8674(89)90174-8; MCDONNELL TJ, 1991, IN PRESS NATURE; MCLAUGHLIN J, 1987, P NATL ACAD SCI USA, V84, P6558, DOI 10.1073/pnas.84.18.6558; MCLAUGHLIN J, 1989, MOL CELL BIOL, V9, P1866, DOI 10.1128/MCB.9.5.1866; MEEKER TC, 1990, BLOOD, V76, P285; MENGER H, 1988, BLOOD, V72, P567; METCALF D, 1989, NATURE, V339, P27, DOI 10.1038/339027a0; MOSIER DE, 1988, NATURE, V335, P256, DOI 10.1038/335256a0; MULLERSIEBURG CE, 1988, J EXP MED, V167, P1825, DOI 10.1084/jem.167.6.1825; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; NEEL BG, 1981, CELL, V23, P323, DOI 10.1016/0092-8674(81)90128-8; NERENBERG M, 1987, SCIENCE, V237, P1324, DOI 10.1126/science.2888190; NERI A, 1988, P NATL ACAD SCI USA, V85, P2748, DOI 10.1073/pnas.85.8.2748; NOURSE J, 1990, CELL, V60, P535, DOI 10.1016/0092-8674(90)90657-Z; NUNEZ G, 1990, J IMMUNOL, V144, P3602; NUSSE R, 1988, GENES IDENTIFIED P T, P95; OHTA M, 1987, NATURE, V329, P539, DOI 10.1038/329539a0; PELICCI PG, 1986, J EXP MED, V164, P2049, DOI 10.1084/jem.164.6.2049; PERKINS A, 1990, P NATL ACAD SCI USA, V87, P8398, DOI 10.1073/pnas.87.21.8398; PIERCE JH, 1985, CELL, V41, P685, DOI 10.1016/S0092-8674(85)80049-0; PLOEMACHER RE, 1989, EXP HEMATOL, V17, P263; PRINCIPATO M, 1990, MOL CELL BIOL, V10, P3562, DOI 10.1128/MCB.10.7.3562; REED JC, 1990, P NATL ACAD SCI USA, V87, P3660, DOI 10.1073/pnas.87.10.3660; RIDGE SA, 1990, P NATL ACAD SCI USA, V87, P1377, DOI 10.1073/pnas.87.4.1377; ROBERTS R, 1988, NATURE, V332, P376, DOI 10.1038/332376a0; RODRIGUEZTARDUCHY G, 1990, EMBO J, V9, P2997, DOI 10.1002/j.1460-2075.1990.tb07492.x; ROSENBAUM H, 1990, EMBO J, V9, P897, DOI 10.1002/j.1460-2075.1990.tb08187.x; ROSENBLATT JD, 1988, SEMIN HEMATOL, V25, P230; ROUSSEL MF, 1987, NATURE, V325, P549, DOI 10.1038/325549a0; ROUSSEL MF, 1988, CELL, V55, P979, DOI 10.1016/0092-8674(88)90243-7; RUSCETTI SK, 1990, J VIROL, V64, P1057, DOI 10.1128/JVI.64.3.1057-1062.1990; SAP J, 1986, NATURE, V324, P635, DOI 10.1038/324635a0; SAWYERS CL, 1990, P NATL ACAD SCI USA, V87, P563, DOI 10.1073/pnas.87.2.563; SELLERI L, 1990, BLOOD, V75, P1146; SHERR CJ, 1985, CELL, V41, P665, DOI 10.1016/S0092-8674(85)80047-7; SMITH CA, 1989, NATURE, V337, P181, DOI 10.1038/337181a0; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; STRASSER A, 1990, NATURE, V348, P331, DOI 10.1038/348331a0; TEFFERI A, 1990, BLOOD, V75, P1770; TSICHLIS PN, 1989, P NATL ACAD SCI USA, V86, P5487, DOI 10.1073/pnas.86.14.5487; TSUJIMOTO Y, 1985, SCIENCE, V229, P1390, DOI 10.1126/science.3929382; VANLOHUIZEN M, 1989, EMBO J, V8, P133, DOI 10.1002/j.1460-2075.1989.tb03357.x; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; VERMA IM, 1987, CELL, V51, P513, DOI 10.1016/0092-8674(87)90115-2; WEINBERGER C, 1986, NATURE, V324, P641, DOI 10.1038/324641a0; WHITLOCK CA, 1982, P NATL ACAD SCI-BIOL, V79, P3608, DOI 10.1073/pnas.79.11.3608; WILLIAMS DE, 1990, CELL, V63, P167, DOI 10.1016/0092-8674(90)90297-R; WILLIAMS GT, 1990, NATURE, V343, P76, DOI 10.1038/343076a0; WITTE ON, 1990, CELL, V63, P5, DOI 10.1016/0092-8674(90)90280-R; WONG PMC, 1989, MOL CELL BIOL, V9, P798, DOI 10.1128/MCB.9.2.798; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; YIP MT, 1990, MOL BIOL MED, V7, P33; YMER S, 1985, NATURE, V317, P255, DOI 10.1038/317255a0; YOUNG JC, 1991, IN PRESS MOL CELL BI; YUAN JY, 1990, DEV BIOL, V138, P33, DOI 10.1016/0012-1606(90)90174-H; YUNIS JJ, 1983, SCIENCE, V221, P227, DOI 10.1126/science.6336310; ZENKE M, 1990, CELL, V61, P1035, DOI 10.1016/0092-8674(90)90068-P; ZSEBO KM, 1990, CELL, V63, P213, DOI 10.1016/0092-8674(90)90302-U	140	364	383	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 25	1991	64	2					337	350		10.1016/0092-8674(91)90643-D	http://dx.doi.org/10.1016/0092-8674(91)90643-D			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EV336	1988151				2022-12-28	WOS:A1991EV33600011
J	MYERS, MG				MYERS, MG			CAFFEINE AND CARDIAC-ARRHYTHMIAS	ANNALS OF INTERNAL MEDICINE			English	Review							ACUTE MYOCARDIAL-INFARCTION; PURKINJE-FIBERS; COFFEE; MECHANISM; RHYTHM	Purpose: To review the evidence supporting the belief that caffeine causes cardiac arrhythmias. Data Sources: Studies published since 1982 identified through computerized searches of MEDLINE, TOXLINE, and Chemical Abstracts and a review of bibliographies of relevant articles on the subject of caffeine and cardiac arrhythmias. Study Selection: All clinical studies examining caffeine as a cause of cardiac arrhythmias and a selection of basic science experiments to illustrate caffeine's effects in vitro. Data Extraction: Study quality was assessed and all available clinical data pertaining to caffeine as a cause of arrhythmias were summarized. Results of Data Analysis: In one electrophysiologic study, caffeine was associated with an increased susceptibility to provoked cardiac arrhythmias. In five placebo-controlled trials, caffeine in doses up to 500 mg daily (equivalent to 5 to 6 cups of coffee) did not increase the frequency or severity of ventricular arrhythmias. One large epidemiologic study reported an increase in the frequency of ventricular extrasystoles in persons consuming 9 or more cups of coffee daily. Conclusion: Moderate ingestion of caffeine does not increase the frequency or severity of cardiac arrhythmias in normal persons, patients with ischemic heart disease, or those with pre-existing serious ventricular ectopy.	UNIV TORONTO, TORONTO M5S 1A1, ONTARIO, CANADA	University of Toronto	MYERS, MG (corresponding author), SUNNYBROOK MED CTR, DIV CARDIOL, 2075 BAYVIEW AVE, TORONTO M4N 3M5, ONTARIO, CANADA.							BELLET S, 1972, AM HEART J, V84, P215, DOI 10.1016/0002-8703(72)90336-5; BOUTJDIR M, 1990, CIRCULATION, V81, P1393, DOI 10.1161/01.CIR.81.4.1393; CHELSKY LB, 1990, JAMA-J AM MED ASSOC, V264, P2236, DOI 10.1001/jama.264.17.2236; CLUSIN WT, 1983, NATURE, V301, P248, DOI 10.1038/301248a0; CRAWLEY IS, 1986, HEART, P1483; DOBMEYER DJ, 1983, NEW ENGL J MED, V308, P814, DOI 10.1056/NEJM198304073081405; FLYNN JT, 1970, J AMER MED ASSOC, V211, P663, DOI 10.1001/jama.1970.03170040067022; FREDHOLM BB, 1985, ACTA MED SCAND, V217, P149; FUSILLI L, 1989, J APPL CARDIOL, V4, P247; GRABOYS TB, 1989, ARCH INTERN MED, V149, P637, DOI 10.1001/archinte.149.3.637; GRABOYS TB, 1983, NEW ENGL J MED, V308, P835, DOI 10.1056/NEJM198304073081409; HARRIS S L, 1989, Journal of the American College of Cardiology, V13, p32A; HENNEKENS CH, 1976, NEW ENGL J MED, V294, P633, DOI 10.1056/NEJM197603182941203; LIN CI, 1983, INT J CARDIOL, V3, P421, DOI 10.1016/0167-5273(83)90113-4; MYERS MG, 1987, AM J CARDIOL, V59, P1024, DOI 10.1016/0002-9149(87)90842-3; MYERS MG, 1990, CAN J CARDIOL, V6, P95; NEWCOMBE PF, 1988, CHEST, V94, P90, DOI 10.1378/chest.94.1.90; PASPA P, 1984, AM J CARDIOL, V53, P313, DOI 10.1016/0002-9149(84)90445-4; PRINEAS RJ, 1980, J CHRON DIS, V33, P67, DOI 10.1016/0021-9681(80)90029-6; SCHOLZ H, 1984, J AM COLL CARDIOL, V4, P389, DOI 10.1016/S0735-1097(84)80231-4; SUTHERLAND DJ, 1985, CHEST, V87, P319, DOI 10.1378/chest.87.3.319; WILSON PWF, 1989, ARCH INTERN MED, V149, P1169, DOI 10.1001/archinte.149.5.1169; YANO K, 1987, NEW ENGL J MED, V316, P946; 1977, MED LETT, V19, P65	24	56	58	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 15	1991	114	2					147	150		10.7326/0003-4819-114-2-147	http://dx.doi.org/10.7326/0003-4819-114-2-147			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ER534	1984393				2022-12-28	WOS:A1991ER53400011
J	SZTUL, E; KAPLIN, A; SAUCAN, L; PALADE, G				SZTUL, E; KAPLIN, A; SAUCAN, L; PALADE, G			PROTEIN TRAFFIC BETWEEN DISTINCT PLASMA-MEMBRANE DOMAINS - ISOLATION AND CHARACTERIZATION OF VESICULAR CARRIERS INVOLVED IN TRANSCYTOSIS	CELL			English	Article							POLYMERIC IGA RECEPTOR; TRANS-CELLULAR TRANSPORT; INTESTINAL VILLUS CELLS; RAT HEPATOCYTES; COATED VESICLES; GOLGI-COMPLEX; MORPHOLOGICAL CHARACTERIZATION; IMMUNOGLOBULIN RECEPTOR; MONOCLONAL-ANTIBODIES; MICROVILLUS MEMBRANES	We have isolated a population of vesicular carriers involved in the transport (transcytosis) of proteins from the basolateral to the apical plasma membrane of hepatocytes. The obtained fraction was enriched in compartments containing known transcytosed proteins and depleted in elements of the secretory pathway, Golgi elements, basolateral plasma membrane, as well as early endosomal components. The fraction was analyzed by biochemical and immunological procedures. Antibodies raised against the proteins in the fraction recognized a single 108K antigen. Based on its subcellular distribution, the 108K antigen may represent a novel marker for transcytotic vesicular carriers.	JOHNS HOPKINS UNIV,BALTIMORE,MD 21205; UNIV CALIF SAN DIEGO,SCH MED,LA JOLLA,CA 92093	Johns Hopkins University; University of California System; University of California San Diego	SZTUL, E (corresponding author), PRINCETON UNIV,DEPT MOLEC BIOL,PRINCETON,NJ 08544, USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034989] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027303] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 34989] Funding Source: Medline; NIGMS NIH HHS [GM 27303] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRAHAMSON DR, 1981, J CELL BIOL, V91, P270, DOI 10.1083/jcb.91.1.270; BARTLES JR, 1988, TRENDS BIOCHEM SCI, V13, P181, DOI 10.1016/0968-0004(88)90147-8; BARTLES JR, 1987, J CELL BIOL, V105, P1241, DOI 10.1083/jcb.105.3.1241; Boyer J.L., 1986, PHYSL MEMBRANE DISOR, P609; CAMERON RS, 1986, J CELL BIOL, V103, P1299, DOI 10.1083/jcb.103.4.1299; CHAO YS, 1981, P NATL ACAD SCI-BIOL, V78, P597, DOI 10.1073/pnas.78.1.597; DANIELSEN EM, 1985, EUR J BIOCHEM, V152, P493, DOI 10.1111/j.1432-1033.1985.tb09223.x; DECURTIS I, 1989, CELL, V58, P719, DOI 10.1016/0092-8674(89)90106-2; DEVANEY E, 1985, EMBO J, V4, P3123, DOI 10.1002/j.1460-2075.1985.tb04054.x; DUNN WA, 1986, J CELL BIOL, V102, P24, DOI 10.1083/jcb.102.1.24; EHRENREICH JH, 1973, J CELL BIOL, V59, P45, DOI 10.1083/jcb.59.1.45; GEUZE HJ, 1984, CELL, V37, P195, DOI 10.1016/0092-8674(84)90315-5; GRIFFITHS G, 1986, SCIENCE, V234, P438, DOI 10.1126/science.2945253; GRUENBERG J, 1985, EUR J CELL BIOL, V38, P312; HAURI HP, 1985, J CELL BIOL, V101, P838, DOI 10.1083/jcb.101.3.838; HOPPE CA, 1985, J CELL BIOL, V101, P2113, DOI 10.1083/jcb.101.6.2113; HOWELL KE, 1982, J CELL BIOL, V92, P822, DOI 10.1083/jcb.92.3.822; HUBBARD AL, 1985, J CELL BIOL, V100, P1115, DOI 10.1083/jcb.100.4.1115; KORNFELD S, 1986, J CLIN INVEST, V77, P1, DOI 10.1172/JCI112262; KUHN LC, 1983, ANN NY ACAD SCI, V409, P751, DOI 10.1111/j.1749-6632.1983.tb26914.x; LARKIN JM, 1986, P NATL ACAD SCI USA, V83, P4759, DOI 10.1073/pnas.83.13.4759; LEBIVIC A, 1989, P NATL ACAD SCI USA, V86, P9313; LISANTI MP, 1989, J CELL BIOL, V109, P2117, DOI 10.1083/jcb.109.5.2117; MAHAFFEY DT, 1989, J CELL BIOL, V108, P1615, DOI 10.1083/jcb.108.5.1615; MALHOTRA V, 1989, CELL, V58, P329, DOI 10.1016/0092-8674(89)90847-7; MASSEY D, 1987, J MEMBRANE BIOL, V96, P19, DOI 10.1007/BF01869331; MEIER PJ, 1984, J CELL BIOL, V98, P991, DOI 10.1083/jcb.98.3.991; MERISKO EM, 1982, J CELL BIOL, V92, P846, DOI 10.1083/jcb.92.3.846; MOSTOV KE, 1986, CELL, V46, P613, DOI 10.1016/0092-8674(86)90887-1; PEARSE BMF, 1987, ANNU REV BIOPHYS BIO, V16, P49, DOI 10.1146/annurev.bb.16.060187.000405; QUARONI A, 1979, BIOCHEM J, V182, P213, DOI 10.1042/bj1820213; QUARONI A, 1979, BIOCHEM J, V182, P203, DOI 10.1042/bj1820203; RINDLER MJ, 1984, J CELL BIOL, V98, P1301; RODEWALD R, 1984, J CELL BIOL, V99, P595; ROTH J, 1982, J CELL BIOL, V93, P223, DOI 10.1083/jcb.93.1.223; SARASTE J, 1986, P NATL ACAD SCI USA, V83, P6425, DOI 10.1073/pnas.83.17.6425; SCHIFF JM, 1984, J CELL BIOL, V98, P79, DOI 10.1083/jcb.98.1.79; SCHMID SL, 1988, CELL, V52, P73, DOI 10.1016/0092-8674(88)90532-6; SIMONS K, 1985, ANNU REV CELL BIOL, V1, P243, DOI 10.1146/annurev.cb.01.110185.001331; SOLARI R, 1985, J BIOL CHEM, V260, P1141; STOORVOGEL W, 1987, J CELL BIOL, V104, P1261, DOI 10.1083/jcb.104.5.1261; SZTUL ES, 1985, J CELL BIOL, V100, P1248, DOI 10.1083/jcb.100.4.1248; SZTUL ES, 1985, J CELL BIOL, V100, P1255, DOI 10.1083/jcb.100.4.1255; SZTUL ES, 1983, J CELL BIOL, V97, P1582, DOI 10.1083/jcb.97.5.1582; TAKAHASHI I, 1982, J IMMUNOL, V128, P1181; VONFIGURA K, 1986, ANNU REV BIOCHEM, V55, P167, DOI 10.1146/annurev.biochem.55.1.167; WALL DA, 1985, J CELL BIOL, V101, P2104, DOI 10.1083/jcb.101.6.2104	47	85	86	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	JAN 11	1991	64	1					81	89		10.1016/0092-8674(91)90210-P	http://dx.doi.org/10.1016/0092-8674(91)90210-P			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ET175	1986870				2022-12-28	WOS:A1991ET17500010
J	NIGHTINGALE, SL				NIGHTINGALE, SL			GUIDELINE FOR THE STUDY OF DRUGS IN THE ELDERLY	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material											NIGHTINGALE, SL (corresponding author), US FDA,OFF HLTH AFFAIRS,PARKLAWN BLDG,5600 FISHERS LN,ROCKVILLE,MD 20857, USA.								0	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 9	1991	265	2					182	182						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EQ602	1984138				2022-12-28	WOS:A1991EQ60200009
J	PACQUE, M; MUNOZ, B; POETSCHKE, G; FOOSE, J; GREENE, BM; TAYLOR, HR				PACQUE, M; MUNOZ, B; POETSCHKE, G; FOOSE, J; GREENE, BM; TAYLOR, HR			PREGNANCY OUTCOME AFTER INADVERTENT IVERMECTIN TREATMENT DURING COMMUNITY-BASED DISTRIBUTION	LANCET			English	Article									JOHNS HOPKINS UNIV, WILMER INST, DANA CTR PREVENT OPHTHALMOL, BALTIMORE, MD 21218 USA; UNIV ALABAMA, DEPT MED, DIV GEOG MED, BIRMINGHAM, AL 35294 USA	Johns Hopkins University; University of Alabama System; University of Alabama Birmingham				Taylor, Hugh/0000-0002-9437-784X	NCRR NIH HHS [S10-RR04060] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR004060] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		AZIZ MA, 1982, LANCET, V2, P171; Chavez G F, 1988, MMWR CDC Surveill Summ, V37, P17; DESOLE G, 1989, B WORLD HEALTH ORGAN, V67, P707; GUERRERO R, 1969, LANCET, V2, P268; NELSON K, 1989, NEW ENGL J MED, V320, P19, DOI 10.1056/NEJM198901053200104; PACQUE M, 1990, LANCET, V335, P1377, DOI 10.1016/0140-6736(90)91253-7; PACQUE MC, 1989, B WORLD HEALTH ORGAN, V67, P721; SIMPKISS M, 1961, ARCH DIS CHILD, V36, P404, DOI 10.1136/adc.36.188.404; TAYLOR HR, 1990, SCIENCE, V250, P116, DOI 10.1126/science.2218502; WHITE AT, 1987, J INFECT DIS, V156, P463, DOI 10.1093/infdis/156.3.463; 1988, DEMOGRAPHIC HLTH SUR	11	69	72	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 15	1990	336	8729					1486	1489		10.1016/0140-6736(90)93187-T	http://dx.doi.org/10.1016/0140-6736(90)93187-T			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EN157	1979100	hybrid			2022-12-28	WOS:A1990EN15700011
J	LILFORD, RJ				LILFORD, RJ			TRADE-OFF BETWEEN GESTATIONAL-AGE AND MISCARRIAGE RISK OF PRENATAL TESTING - DOES IT VARY ACCORDING TO GENETIC RISK	LANCET			English	Editorial Material											LILFORD, RJ (corresponding author), UNIV LEEDS,ST JAMES UNIV HOSP,DEPT OBSTET & GYNAECOL,LEEDS LS9 7TF,W YORKSHIRE,ENGLAND.							Canadian Collaborative CVS-Amniocentesis Clinical Trial Group, 1989, LANCET, V1, P1; ELSTEIN AS, 1977, PROFESSIONAL JUDGEME, P109; LILFORD RJ, 1986, CLIN OBSTET GYNAECOL, V13, P611; PAUKER SP, 1977, YALE J BIOL MED, V50, P275; Weinstein MC, 1980, CLIN DECISION ANAL	5	9	9	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 24	1990	336	8726					1303	1305		10.1016/0140-6736(90)92977-P	http://dx.doi.org/10.1016/0140-6736(90)92977-P			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ943	1978126				2022-12-28	WOS:A1990EJ94300015
J	GOULD, AP; BROOKMAN, JJ; STRUTT, DI; WHITE, RAH				GOULD, AP; BROOKMAN, JJ; STRUTT, DI; WHITE, RAH			TARGETS OF HOMEOTIC GENE-CONTROL IN DROSOPHILA	NATURE			English	Article											GOULD, AP (corresponding author), UNIV CAMBRIDGE, DEPT ANAT, DOWNING ST, CAMBRIDGE CB2 3DY, ENGLAND.		Gould, Alex/A-7479-2010; White, Rob A H/G-4835-2012; Gould, Alex/M-5353-2019; Strutt, David/E-6196-2010	Gould, Alex/0000-0002-6875-6985; Gould, Alex/0000-0002-6875-6985; Strutt, David/0000-0001-8185-4515	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AKAM ME, 1985, EMBO J, V4, P1689, DOI 10.1002/j.1460-2075.1985.tb03838.x; ALMER A, 1986, EMBO J, V5, P2689, DOI 10.1002/j.1460-2075.1986.tb04552.x; BEACHY PA, 1988, CELL, V55, P1069, DOI 10.1016/0092-8674(88)90251-6; BIEDENKAPP H, 1988, NATURE, V335, P835, DOI 10.1038/335835a0; BIENZ M, 1988, NATURE, V333, P576, DOI 10.1038/333576a0; Campos-Ortega J.A., 2013, EMBRYONIC DEV DROSOP; CARROLL SB, 1986, CELL, V47, P113, DOI 10.1016/0092-8674(86)90372-7; CASANOVA J, 1986, CELL, V47, P627, DOI 10.1016/0092-8674(86)90627-6; CELNIKER SE, 1989, GENE DEV, V3, P1424, DOI 10.1101/gad.3.9.1424; DELORENZI M, 1988, EMBO J, V7, P3223, DOI 10.1002/j.1460-2075.1988.tb03189.x; DESPLAN C, 1988, CELL, V54, P1081, DOI 10.1016/0092-8674(88)90123-7; DESPLAN C, 1985, NATURE, V318, P630, DOI 10.1038/318630a0; Garcia-Bellido A, 1975, Ciba Found Symp, V0, P161; GEHRING WJ, 1987, SCIENCE, V236, P1245, DOI 10.1126/science.2884726; GIBSON G, 1988, DEVELOPMENT, V102, P657; GOULD AP, 1990, THESIS U CAMBRIDGE U; GOUTTE C, 1988, CELL, V52, P875, DOI 10.1016/0092-8674(88)90429-1; GRUSS C, 1988, VIROLOGY, V167, P349, DOI 10.1016/S0042-6822(88)90095-5; HAFEN E, 1984, NATURE, V307, P287, DOI 10.1038/307287a0; HARDING K, 1985, SCIENCE, V229, P1236, DOI 10.1126/science.3898362; HAYES PH, 1984, P NATL ACAD SCI-BIOL, V81, P545, DOI 10.1073/pnas.81.2.545; JOHNSON FB, 1990, GENE DEV, V4, P1044, DOI 10.1101/gad.4.6.1044; KELEHER CA, 1988, CELL, V53, P927, DOI 10.1016/S0092-8674(88)90449-7; KRASNOW MA, 1989, CELL, V57, P1031, DOI 10.1016/0092-8674(89)90341-3; KUZIORA MA, 1988, CELL, V55, P477, DOI 10.1016/0092-8674(88)90034-7; LANE DP, 1985, PROC R SOC SER B-BIO, V226, P25, DOI 10.1098/rspb.1985.0077; LANGERSAFER PR, 1982, P NATL ACAD SCI-BIOL, V79, P4381, DOI 10.1073/pnas.79.14.4381; LAUGHON A, 1988, DEVELOPMENT, V104, P75; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; LEWIS EB, 1963, AM ZOOL, V3, P33; MARTINEZARIAS A, 1985, NATURE, V313, P639, DOI 10.1038/313639a0; MORATA G, 1981, NATURE, V290, P778, DOI 10.1038/290778a0; MULLER M, 1988, EMBO J, V7, P4299, DOI 10.1002/j.1460-2075.1988.tb03328.x; NOLL M, 1975, SCIENCE, V187, P1203, DOI 10.1126/science.187.4182.1203; PINA B, 1990, CELL, V60, P719, DOI 10.1016/0092-8674(90)90087-U; Sambrook J, 1989, MOL CLONING LABORATO; SAMSON ML, 1989, CELL, V57, P1045, DOI 10.1016/0092-8674(89)90342-5; SANCHEZHERRERO E, 1985, NATURE, V313, P108, DOI 10.1038/313108a0; SCOTT MP, 1989, BIOCHIM BIOPHYS ACTA, V989, P25, DOI 10.1016/0304-419X(89)90033-4; SOMPAYRAC L, 1990, P NATL ACAD SCI USA, V87, P3274, DOI 10.1073/pnas.87.9.3274; STADEN R, 1984, NUCLEIC ACIDS RES, V12, P505, DOI 10.1093/nar/12.1Part2.505; STRUHL G, 1984, NATURE, V308, P454, DOI 10.1038/308454a0; STRUHL G, 1985, CELL, V43, P507, DOI 10.1016/0092-8674(85)90180-1; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; THALI M, 1988, NATURE, V336, P598, DOI 10.1038/336598a0; THOMAS GH, 1988, EMBO J, V7, P2191, DOI 10.1002/j.1460-2075.1988.tb03058.x; VINCENT JP, 1990, EMBO J, V9, P2573, DOI 10.1002/j.1460-2075.1990.tb07438.x; WHITE RAH, 1984, CELL, V39, P163, DOI 10.1016/0092-8674(84)90202-2; WHITE RAH, 1985, EMBO J, V4, P2035, DOI 10.1002/j.1460-2075.1985.tb03889.x; WINSLOW GM, 1989, CELL, V57, P1017, DOI 10.1016/0092-8674(89)90340-1; WU C, 1984, NATURE, V309, P229, DOI 10.1038/309229a0	51	152	156	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 22	1990	348	6299					308	312		10.1038/348308a0	http://dx.doi.org/10.1038/348308a0			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EJ955	1979146				2022-12-28	WOS:A1990EJ95500051
J	COSTA, FF; AGRE, P; WATKINS, PC; WINKELMANN, JC; TANG, TK; JOHN, KM; LUX, SE; FORGET, BG				COSTA, FF; AGRE, P; WATKINS, PC; WINKELMANN, JC; TANG, TK; JOHN, KM; LUX, SE; FORGET, BG			LINKAGE OF DOMINANT HEREDITARY SPHEROCYTOSIS TO THE GENE FOR THE ERYTHROCYTE MEMBRANE-SKELETON PROTEIN ANKYRIN	NEW ENGLAND JOURNAL OF MEDICINE			English	Note									YALE UNIV, SCH MED,DEPT INTERNAL MED,HEMATOL SECT,BOX 3333, 333 CEDAR ST, NEW HAVEN, CT 06510 USA; JOHNS HOPKINS UNIV, SCH MED, DEPT INTERNAL MED, DIV HEMATOL, BALTIMORE, MD 21205 USA; JOHNS HOPKINS UNIV, SCH MED, DEPT CELL BIOL & ANAT, DIV DEV THERAPEUT, BALTIMORE, MD 21205 USA; INTEGRATED GENET INC, FRAMINGHAM, MA USA; HARVARD UNIV, CHILDRENS HOSP, SCH MED, DIV HEMATOL ONCOL, BOSTON, MA 02115 USA; HARVARD UNIV, SCH MED, DANA FARBER CANC INST, BOSTON, MA 02115 USA	Yale University; Johns Hopkins University; Johns Hopkins University; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School			Tang, Tang K./S-7012-2018; Costa, Fernando F/D-1566-2012	Tang, Tang K./0000-0002-3660-0695; Costa, Fernando F/0000-0002-4632-572X				AGRE P, 1989, JAMA-J AM MED ASSOC, V262, P2887; AGRE P, 1986, NEW ENGL J MED, V315, P1579, DOI 10.1056/NEJM198612183152504; AGRE P, 1985, NATURE, V314, P380, DOI 10.1038/314380a0; BASS EB, 1983, ANN INTERN MED, V99, P192, DOI 10.7326/0003-4819-99-2-192; BECKER PS, 1987, J CLIN INVEST, V80, P557, DOI 10.1172/JCI113104; BENNETT V, 1985, ANNU REV BIOCHEM, V54, P273, DOI 10.1146/annurev.biochem.54.1.273; BLIN N, 1976, NUCLEIC ACIDS RES, V3, P2303, DOI 10.1093/nar/3.9.2303; BODINE DM, 1984, CELL, V37, P721, DOI 10.1016/0092-8674(84)90408-2; CHILCOTE RR, 1987, BLOOD, V69, P156; COETZER TL, 1988, NEW ENGL J MED, V318, P230, DOI 10.1056/NEJM198801283180407; CONBOY J, 1986, NEW ENGL J MED, V315, P680, DOI 10.1056/NEJM198609113151105; DEJONGH BM, 1983, ANN HUM GENET, V47, P55, DOI 10.1111/j.1469-1809.1983.tb00970.x; Forget B G, 1988, Trans Assoc Am Physicians, V101, P149; FUKUSHIMA Y, 1990, CYTOGENET CELL GENET, V53, P232, DOI 10.1159/000132939; GOODMAN SR, 1982, BLOOD, V60, P772; HOFFMAN N, 1987, NUCLEIC ACIDS RES, V15, P4696, DOI 10.1093/nar/15.11.4696; HUEBNER K, 1985, P NATL ACAD SCI USA, V82, P3790, DOI 10.1073/pnas.82.11.3790; IDEGUCHI H, 1990, BRIT J HAEMATOL, V74, P347, DOI 10.1111/j.1365-2141.1990.tb02594.x; KIMBERLING WJ, 1975, AM J HUM GENET, V27, P586; KITATANI M, 1988, HUM GENET, V78, P94, DOI 10.1007/BF00291244; KLMBERLING WJ, 1978, BLOOD, V52, P859; LAMBERT S, 1990, P NATL ACAD SCI USA, V87, P1730, DOI 10.1073/pnas.87.5.1730; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LINNENBACH AJ, 1986, P NATL ACAD SCI USA, V83, P2397, DOI 10.1073/pnas.83.8.2397; LUX SE, 1990, NATURE, V345, P736, DOI 10.1038/345736a0; LUX SE, 1990, NATURE, V344, P36, DOI 10.1038/344036a0; LUX SE, 1989, METABOLIC BASIS INHE, V2, P2367; MARCHESI SL, 1989, RED BLOOD CELL MEMBR, V11, P77; MARCHESI SL, 1989, BLOOD S, V74, pA182; MARCHESI VT, 1985, ANNU REV CELL BIOL, V1, P531, DOI 10.1146/annurev.cellbio.1.1.531; MORTON NE, 1962, AM J HUM GENET, V14, P170; Palek J, 1990, HEMATOLOGY, P558; RYBICKI AC, 1988, J CLIN INVEST, V81, P893, DOI 10.1172/JCI113400; Sambrook J., 1982, MOL CLONING LAB MANU, V1; TANG TK, 1988, P NATL ACAD SCI USA, V85, P3713, DOI 10.1073/pnas.85.11.3713; WATKINS PC, 1988, BIOTECHNIQUES, V6, P310; WHITE RA, 1990, P NATL ACAD SCI USA, V87, P3117, DOI 10.1073/pnas.87.8.3117; WINKELMANN JC, 1990, J BIOL CHEM, V265, P11827; WINKELMANN JC, 1988, BLOOD, V72, P328; WINKELMANN JC, 1989, RED BLOOD CELL MEMBR, V11, P111; WOLFE LC, 1982, NEW ENGL J MED, V307, P1367, DOI 10.1056/NEJM198211253072203	41	69	69	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 11	1990	323	15					1046	1050		10.1056/NEJM199010113231507	http://dx.doi.org/10.1056/NEJM199010113231507			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB936	1977081				2022-12-28	WOS:A1990EB93600007
J	GRIFFITH, MJ; LINKER, NJ; GARRATT, CJ; WARD, DE; CAMM, AJ				GRIFFITH, MJ; LINKER, NJ; GARRATT, CJ; WARD, DE; CAMM, AJ			RELATIVE EFFICACY AND SAFETY OF INTRAVENOUS DRUGS FOR TERMINATION OF SUSTAINED VENTRICULAR-TACHYCARDIA	LANCET			English	Article									ST GEORGE HOSP,SCH MED,DEPT CARDIOL SCI,LONDON SW17 0RE,ENGLAND	St Georges University London			Linker, Nicholas/AAJ-6450-2021	Linker, Nicholas/0000-0002-2592-0757				ANDERSON JL, 1984, AM J CARDIOL, V53, pB79, DOI 10.1016/0002-9149(84)90507-1; BRUGADA P, 1984, CIRCULATION, V69, P87, DOI 10.1161/01.CIR.69.1.87; FLOWERS D, 1985, AM J CARDIOL, V55, P79, DOI 10.1016/0002-9149(85)90303-0; FRIEDEN J, 1965, AM HEART J, V70, P713, DOI 10.1016/0002-8703(65)90399-6; GARRATT C, 1989, AM J CARDIOL, V64, P1310, DOI 10.1016/0002-9149(89)90573-0; GREEN AGH, 1979, SCOT MED J, V24, P21, DOI 10.1177/003693307902400106; HARRISON DC, 1963, CIRCULATION, V28, P486, DOI 10.1161/01.CIR.28.4.486; HONDEGHEM LM, 1987, CIRCULATION, V75, P514, DOI 10.1161/01.CIR.75.3.514; HULTING J, 1976, J INT MED RES, V4, P90; LERMAN BB, 1983, AM J CARDIOL, V51, P759, DOI 10.1016/S0002-9149(83)80129-5; LERMAN BB, 1986, CIRCULATION, V74, P270, DOI 10.1161/01.CIR.74.2.270; LLEWELLYN MJ, 1987, CLIN CARDIOL, V10, P416, DOI 10.1002/clc.4960100709; MASON JW, 1980, NEW ENGL J MED, V303, P1073, DOI 10.1056/NEJM198011063031901; MORGANROTH J, 1986, J AM COLL CARDIOL, V8, P607, DOI 10.1016/S0735-1097(86)80190-5; MUNOZ A, 1984, EUR HEART J, V5, P735, DOI 10.1093/oxfordjournals.eurheartj.a061734; NATHAN AW, 1986, CLIN CARDIOL, V10, P317; RAMSDALE DR, 1987, POSTGRAD MED J, V63, P579, DOI 10.1136/pgmj.63.741.579; SANTINELLI V, 1982, AM HEART J, V105, P680; SELLERS TD, 1984, CHEST, V84, P647; SENGES J, 1984, CIRCULATION, V69, P577, DOI 10.1161/01.CIR.69.3.577; TEO KK, 1985, CHEST, V87, P113, DOI 10.1378/chest.87.1.113; VANDENBOSCH R, 1975, ACTA CARDIOL, V30, P267; VOGEL M, 1976, ARCH MAL COEUR, V4, P395; WARD DE, 1986, INT J CARDIOL, V10, P251, DOI 10.1016/0167-5273(86)90007-0; WELLENS HJ, 1972, CIRCULATION, V46, P216, DOI 10.1161/01.CIR.46.2.216; 1986, AM J CARDIOL, V57, P1299	26	43	43	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	SEP 15	1990	336	8716					670	673		10.1016/0140-6736(90)92158-E	http://dx.doi.org/10.1016/0140-6736(90)92158-E			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DY737	1975861				2022-12-28	WOS:A1990DY73700012
J	DIEKEMA, DS				DIEKEMA, DS			ACCOMPLICES	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material														Diekema, Douglas/0000-0002-1703-5176					0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 13	1991	265	6					802	802						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EW479	1990197				2022-12-28	WOS:A1991EW47900036
J	CHASE, HP; GARG, SK; MARSHALL, G; BERG, CL; HARRIS, S; JACKSON, WE; HAMMAN, RE				CHASE, HP; GARG, SK; MARSHALL, G; BERG, CL; HARRIS, S; JACKSON, WE; HAMMAN, RE			CIGARETTE-SMOKING INCREASES THE RISK OF ALBUMINURIA AMONG SUBJECTS WITH TYPE-I DIABETES	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RETINOPATHY; NEPHROPATHY; MELLITUS	The effect of cigarette smoking on diabetic renal and retinal complications was evaluated in 359 young subjects with insulin-dependent diabetes mellitus. The prevalence of increased albumin excretion rates was 2.8 times higher in smokers than nonsmokers. Mean glycohemoglobin levels and duration of diabetes were also significant factors in the development of diabetic nephropathy and retinopathy in a logistic regression model. Smoking remained a significant factor in the logistic regression model for albuminuria (but not retinopathy) when controlled for glycohemoglobin level, duration of diabetes, age, gender, and blood pressure. The progression of albuminuria and of retinopathy was also greater in smokers. Albuminuria improved significantly when subjects ceased smoking. It is concluded that cigarette smoking is an independent risk factor and is associated with the development and progression of early diabetic renal damage (albuminuria) and with the worsening of retinal disease in young subjects with diabetes.	UNIV COLORADO,HLTH SCI CTR,DEPT PREVENT MED & BIOMETR,DENVER,CO 80262; UNIV COLORADO,HLTH SCI CTR,DEPT OPHTHALMOL,DENVER,CO 80262	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	CHASE, HP (corresponding author), UNIV COLORADO,HLTH SCI CTR,DEPT PEDIAT,BARBARA DAVIS CTR CHILDHOOD DIABET,4200 E 9TH AVE,DENVER,CO 80262, USA.		Marshall, Guillermo/F-2302-2011		NCRR NIH HHS [RR69] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		AGRESTI A, 1990, CATEGORICAL DATA ANA, P306; BORCHJOHNSEN K, 1985, DIABETOLOGIA, V28, P590, DOI 10.1007/BF00281993; CHASE HP, 1990, OPHTHALMOLOGY, V97, P155; CHASE HP, 1990, ARCH INTERN MED, V150, P639, DOI 10.1001/archinte.150.3.639; CHASE HP, 1989, JAMA-J AM MED ASSOC, V261, P1155, DOI 10.1001/jama.261.8.1155; KLEIN BEK, 1984, OPHTHALMOLOGY, V91, P10; KLEIN R, 1983, AM J EPIDEMIOL, V118, P228, DOI 10.1093/oxfordjournals.aje.a113630; LUNDMAN BM, 1990, J INTERN MED, V227, P101, DOI 10.1111/j.1365-2796.1990.tb00126.x; MCCANCE DR, 1989, LANCET, V2, P824; MOGENSEN CE, 1985, HYPERTENSION, V7, P64; MUHLHAUSER I, 1986, DIABETOLOGIA, V29, P500, DOI 10.1007/BF00453501; NORDEN G, 1984, ACTA MED SCAND, V215, P257; ORCHARD TJ, 1990, DIABETES CARE, V13, P741, DOI 10.2337/diacare.13.7.741; OSBERG I, 1990, CLIN CHEM, V36, P1428; ROSE GA, 1968, CARDIOVASCULAR SURVE, P160; RUDEHILL A, 1989, CLIN PHYSIOL, V9, P243, DOI 10.1111/j.1475-097X.1989.tb00976.x; VIBERTI GC, 1982, LANCET, V1, P1430; VOORS AW, 1976, CIRCULATION, V54, P319, DOI 10.1161/01.CIR.54.2.319; 1987, SAS STAT GUIDE PERSO; 1989, MMWR, V38, P543; 1981, INVEST OPHTHALMOL VI, V21, P210	21	215	222	0	18	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	1991	265	5					614	617		10.1001/jama.265.5.614	http://dx.doi.org/10.1001/jama.265.5.614			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EV718	1987411				2022-12-28	WOS:A1991EV71800018
J	OTTE, AP; KRAMER, IM; DURSTON, AJ				OTTE, AP; KRAMER, IM; DURSTON, AJ			PROTEIN-KINASE-C AND REGULATION OF THE LOCAL COMPETENCE OF XENOPUS ECTODERM	SCIENCE			English	Article							DIFFERENTIAL DOWN-REGULATION; NEURAL INDUCTION; CELLULAR SUBSTRATE; PROSPECTIVE AREAS; LAEVIS; EXPRESSION; GASTRULA; PHOSPHORYLATION; HETEROGENEITY; SPECIFICITY	The limited competence of embryonic tissue to respond to an inductive signal has an essential, regulatory function in embryonic induction. The molecular basis for the competence of Xenopus ectoderm to differentiate into neural tissue was investigated. Dorsal mesoderm or 12-O-tetradecanoyl phorbol-13-acetate (TPA) caused in vivo activation of protein kinase C (PKC) and neural differentiation mainly in dorsal ectoderm and to a lesser extent in ventral ectoderm. These data correlate with the observations that PKC preparations from dorsal and ventral ectoderm differ, the dorsal PKC preparation being more susceptible to activation by TPA and diolein than is the ventral PKC preparation. Monoclonal antibodies against the bovine PKC alpha plus beta or gamma isozymes immunostained dorsal and ventral ectoderm, respectively, which suggests different localizations of PKC isozymes. The results suggest that PKC participates in the establishment of embryonic competence.	NETHERLANDS INST DEV BIOL,HUBRECHT LAB,3584 CT UTRECHT,NETHERLANDS	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW)								ADEREM AA, 1988, NATURE, V332, P362, DOI 10.1038/332362a0; ASE K, 1988, FEBS LETT, V236, P396, DOI 10.1016/0014-5793(88)80064-4; BAZZI MD, 1987, BIOCHEMISTRY-US, V26, P5002, DOI 10.1021/bi00390a018; BAZZI MD, 1987, BIOCHEMISTRY-US, V26, P115, DOI 10.1021/bi00375a017; BROOKS SF, 1990, FEBS LETT, V268, P291, DOI 10.1016/0014-5793(90)81030-R; CAZAUBON S, 1989, EUR J BIOCHEM, V182, P401, DOI 10.1111/j.1432-1033.1989.tb14845.x; COOKE J, 1987, DEVELOPMENT, V99, P197; DAVIDS M, 1987, ROUX ARCH DEV BIOL, V196, P137, DOI 10.1007/BF00402036; DENT JA, 1989, DEVELOPMENT, V105, P61; GIMLICH RL, 1983, NATURE, V306, P471, DOI 10.1038/306471a0; GRAFF JM, 1989, J BIOL CHEM, V264, P11912; GURDON JB, 1987, DEVELOPMENT, V99, P285; HOUSE C, 1987, J BIOL CHEM, V262, P772; HOUSE C, 1987, SCIENCE, V238, P1726, DOI 10.1126/science.3686012; HUANG FL, 1989, J BIOL CHEM, V264, P4238; HUANG KP, 1988, J BIOL CHEM, V263, P14839; KELLER RE, 1976, DEV BIOL, V51, P118, DOI 10.1016/0012-1606(76)90127-5; KELLER RE, 1975, DEV BIOL, V42, P222, DOI 10.1016/0012-1606(75)90331-0; KIKKAWA U, 1989, ANNU REV BIOCHEM, V58, P31, DOI 10.1146/annurev.bi.58.070189.000335; NAOR Z, 1988, MOL ENDOCRINOL, V2, P1043, DOI 10.1210/mend-2-11-1043; NIEDEL J E, 1986, P47; Nieuwkoop P D, 1973, Adv Morphog, V10, P1; NIEUWKOOP PD, 1969, NORMAL TABLE XENOPUS; NIEUWKOOP PD, 1985, EPIGENETIC NATURE EA; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; OTTE AP, 1990, DEVELOPMENT, V110, P461; OTTE AP, 1989, CELL, V58, P641, DOI 10.1016/0092-8674(89)90099-8; OTTE AP, 1988, NATURE, V334, P618, DOI 10.1038/334618a0; OTTE AP, UNPUB; SCHARF SR, 1980, DEV BIOL, V79, P181, DOI 10.1016/0012-1606(80)90082-2; SCHARF SR, 1989, DEV BIOL, V134, P175, DOI 10.1016/0012-1606(89)90087-0; SHARPE CR, 1988, DEVELOPMENT, V103, P269; SHARPE CR, 1987, CELL, V50, P749, DOI 10.1016/0092-8674(87)90333-3; SHEU FS, 1990, BIOCHEM BIOPH RES CO, V171, P1236, DOI 10.1016/0006-291X(90)90818-8; SKENE JHP, 1989, ANNU REV NEUROSCI, V12, P127, DOI 10.1146/annurev.ne.12.030189.001015; SMITH JC, 1983, J EMBRYOL EXP MORPH, V78, P299; Spemann H, 1924, ARCH MIKROSK ANAT EN, V100, P599, DOI 10.1007/BF02108133; STUMPO DJ, 1989, P NATL ACAD SCI USA, V86, P4012, DOI 10.1073/pnas.86.11.4012; WANG JKT, 1989, P NATL ACAD SCI USA, V86, P2253, DOI 10.1073/pnas.86.7.2253; YOUNG S, 1988, EUR J BIOCHEM, V173, P247, DOI 10.1111/j.1432-1033.1988.tb13991.x	41	63	63	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	FEB 1	1991	251	4993					570	573		10.1126/science.1990433	http://dx.doi.org/10.1126/science.1990433			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV459	1990433				2022-12-28	WOS:A1991EV45900055
J	HIRANO, S; FUSE, S; SOHAL, GS				HIRANO, S; FUSE, S; SOHAL, GS			THE EFFECT OF THE FLOOR PLATE ON PATTERN AND POLARITY IN THE DEVELOPING CENTRAL-NERVOUS-SYSTEM	SCIENCE			English	Article							ACID-BINDING-PROTEIN; RETINOIC ACID; CHICK-EMBRYO; NEURAL-TUBE; LOCAL APPLICATION; MOUSE; LIMB; EXPRESSION; ORIGIN; CELLS	The effect of floor plate on cellular differentiation in the neural tube of quail embryos was examined. In the developing neural tube the floor plate, which consists of specialized neuroepithelial cells, is located in the ventral midline of the neural tube. When Hensen's node was extirpated the floor plate and notochord did not develop, and the normal differentiation of the ventral horn motor neurons and dorsal and ventral roots did not occur. When one side of the neural tube was deprived of notochord, the ventro-dorsal differentiation took place on both sides. However, when one side of the neural tube was deprived of the floor plate, the ventral horn motor neurons and dorsal and ventral roots did not develop on that side. These observations suggest that the floor plate influences motor neuron differentiation and acts as an intrinsic organizer to establish pattern and polarity in the developing nervous system.	MED COLL GEORGIA, DEPT ANAT, AUGUSTA, GA 30912 USA; NIIGATA UNIV, SCH MED, DEPT ANAT, NIIGATA 951, JAPAN	University System of Georgia; Augusta University; Niigata University					NICHD NIH HHS [HD 18280, HD 17800] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD017800, R01HD018280] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BARRON DH, 1946, J COMP NEUROL, V85, P149, DOI 10.1002/cne.900850202; BOVOLENTA P, 1990, DEVELOPMENT, V109, P435; CAJAL SRR, 1929, STUDIES VERTEBRATE N; EICHELE G, 1985, J CELL BIOL, V101, P1913, DOI 10.1083/jcb.101.5.1913; FUJITA S, 1964, J COMP NEUROL, V122, P311, DOI 10.1002/cne.901220303; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HOLLYDAY M, 1977, BRAIN RES, V132, P197, DOI 10.1016/0006-8993(77)90416-4; Jacobson M., 2013, DEV NEUROBIOL; JESSELL TM, 1989, CIBA F SYMP, V144, P255; MADEN M, 1990, DEVELOPMENT, V109, P75; MADEN M, 1989, DEV BIOL, V135, P124, DOI 10.1016/0012-1606(89)90163-2; MADEN M, 1989, DEVELOPMENT S, V109; MOMOI M, 1990, DEV BRAIN RES, V54, P161, DOI 10.1016/0165-3806(90)90138-O; NICOLET G, 1970, Journal of Embryology and Experimental Morphology, V23, P79; PEREZCASTRO AV, 1989, P NATL ACAD SCI USA, V86, P8813, DOI 10.1073/pnas.86.22.8813; ROSENQUIST GLENN C., 1966, CARNEGIE INST WASH PUBL, V38, P71; SCHOENWOLF GC, 1989, J EXP ZOOL, V249, P271, DOI 10.1002/jez.1402490305; SMITH JL, 1989, J EXP ZOOL, V250, P49, DOI 10.1002/jez.1402500107; SPRATT NT, 1952, J EXP ZOOL, V120, P109, DOI 10.1002/jez.1401200105; SUMMERBELL D, 1983, J EMBRYOL EXP MORPH, V78, P269; TESSIERLAVIGNE M, 1988, NATURE, V336, P775, DOI 10.1038/336775a0; TICKLE C, 1982, NATURE, V296, P564, DOI 10.1038/296564a0; VAESSEN MJ, 1989, DIFFERENTIATION, V40, P99, DOI 10.1111/j.1432-0436.1989.tb00819.x; VANSTRAATEN HWM, 1988, ANAT EMBRYOL, V177, P317; WAGNER M, 1990, NATURE, V345, P819, DOI 10.1038/345819a0; WENTWORTH LE, 1978, J COMP NEUROL, V177, P611, DOI 10.1002/cne.901770406	26	75	77	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 18	1991	251	4991					310	313		10.1126/science.1987648	http://dx.doi.org/10.1126/science.1987648			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET678	1987648				2022-12-28	WOS:A1991ET67800033
J	DUBACH, UC; ROSNER, B; STURMER, T				DUBACH, UC; ROSNER, B; STURMER, T			AN EPIDEMIOLOGIC-STUDY OF ABUSE OF ANALGESIC DRUGS - EFFECTS OF PHENACETIN AND SALICYLATE ON MORTALITY AND CARDIOVASCULAR MORBIDITY (1968 TO 1987)	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							WORKING FEMALE POPULATION; RENAL-DISEASE; URORENAL DISORDERS; HEART-DISEASE; NEPHROPATHY; PROSTACYCLIN; SWITZERLAND; ASPIRIN	Background. Phenacetin abuse is known to produce kidney disease; salicylate use is supposed to prevent cardiovascular disease. We conducted a prospective, longitudinal epidemiologic study to examine the effects of these drugs on cause-specific mortality and on cardiovascular morbidity. Methods. In 1968 we evaluated a study group of 623 healthy women 30 to 49 years old who had evidence of a regular intake of phenacetin, as measured by urinary excretion of its metabolites, and a matched control group of 621 women. Salicylate excretion was also measured. All subjects were examined over a period of 20 years. Results. Life-table analyses of mortality during the 20 years, with adjustment for the year of birth, cigarette smoking, and length of follow-up, revealed significant differences between the groups in overall mortality (study group vs. control group, 74 vs. 27 deaths; relative risk, 2.2; 95 percent confidence interval, 1.5 to 3.3), deaths due to urologic or renal disease (relative risk, 16.1; 95 percent confidence interval, 3.9 to 66.1), deaths due to cancer (relative risk, 1.9; 95 percent confidence interval, 1.1 to 3.3), and deaths due to cardiovascular disease (relative risk, 2.9; 95 percent confidence interval, 1.5 to 5.5). The relative risk of cardiovascular disease (fatal or nonfatal myocardial infarction, heart failure, or stroke) was 1.8, and the 95 percent confidence interval 1.3 to 2.6. The odds ratio for the incidence of hypertension was 1.6, and the 95 percent confidence interval 1.2 to 2.1. The effects of phenacetin on morbidity and mortality, with adjustment for base-line salicylate excretion, were similar. In contrast, salicylate use had no effect on either mortality or morbidity. Conclusions. Regular use of analgesic drugs containing phenacetin is associated with an increased risk of hypertension and mortality and morbidity due to cardiovascular disease, as well as an increased risk of mortality due to cancer and urologic or renal disease. The use of salicylates carries no such risk.	HARVARD UNIV,SCH MED,CHANNING LAB,BOSTON,MA 02115	Harvard University; Harvard Medical School	DUBACH, UC (corresponding author), UNIV BASEL,KANTONSSPITAL,MED POLIKLIN,DEPT INTERNAL MED,PETERSGRABEN 4,CH-4031 BASEL,SWITZERLAND.		Stürmer, Til/AAB-5459-2022					ARMITAGE P, 1971, STATISTICAL METHODS; Bengtsson U, 2017, SCAND J UROL, V51, P213, DOI 10.3109/00365596809135358; BRODIE BB, 1948, J PHARMACOL EXP THER, V94, P22; BUCKALEW VM, 1986, MEDICINE, V65, P291, DOI 10.1097/00005792-198609000-00002; CIABATTONI G, 1984, NEW ENGL J MED, V310, P279, DOI 10.1056/NEJM198402023100502; CLIVE DM, 1984, NEW ENGL J MED, V310, P563, DOI 10.1056/NEJM198403013100905; COVESMIT.JR, 1973, LANCET, V2, P70; DUBACH UC, 1983, NEW ENGL J MED, V308, P357, DOI 10.1056/NEJM198302173080703; DUBACH UC, 1968, HELV MED ACTA, V34, P297; DUBACH UC, 1971, AM J EPIDEMIOL, V93, P425, DOI 10.1093/oxfordjournals.aje.a121276; DUBACH UC, 1975, LANCET, V1, P539; DUBACH UC, 1967, GER MED MON, V12, P380; FITZGERALD GA, 1983, J CLIN INVEST, V71, P676, DOI 10.1172/JCI110814; GLOOR F, 1982, PATHOLOGE, V3, P132; KALADELFOS G, 1976, NEPHRON, V16, P388, DOI 10.1159/000180624; KINCAIDSMITH P, 1978, KIDNEY INT, V13, P1, DOI 10.1038/ki.1978.1; KLEINBAUM DG, 1982, EPIDEMIOLOGIC RES; KRISHNAS.S, 1974, AUST NZ J MED, V4, P426; MCGIFF JC, 1980, CLIN SCI, V59, pS105, DOI 10.1042/cs059105s; Moncada S., 1980, GOODMAN GILMANS PHAR, V6th., P668; MURRAY TG, 1983, ARCH INTERN MED, V143, P1687, DOI 10.1001/archinte.143.9.1687; NANRA RS, 1978, KIDNEY INT, V13, P79, DOI 10.1038/ki.1978.11; PETO R, 1977, BRIT J CANCER, V35, P1, DOI 10.1038/bjc.1977.1; PRESCOTT LF, 1982, DRUGS, V23, P75, DOI 10.2165/00003495-198223010-00004; SANDLER DP, 1989, NEW ENGL J MED, V320, P1238, DOI 10.1056/NEJM198905113201903; SPUHLER O, 1953, Z KLIN MED, V151, P1; VANE JR, 1978, AGENTS ACTIONS, V8, P430, DOI 10.1007/BF01968671	27	86	86	1	5	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 17	1991	324	3					155	160		10.1056/NEJM199101173240304	http://dx.doi.org/10.1056/NEJM199101173240304			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ER471	1984193				2022-12-28	WOS:A1991ER47100004
J	SCHAPIRA, DV; URBAN, N				SCHAPIRA, DV; URBAN, N			A MINIMALIST POLICY FOR BREAST-CANCER SURVEILLANCE	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ROUTINE FOLLOW-UP; BONE SCANS; CARCINOMA; METASTASES		FRED HUTCHINSON CANC RES CTR,SEATTLE,WA 98104	Fred Hutchinson Cancer Center	SCHAPIRA, DV (corresponding author), UNIV S FLORIDA,COLL MED,H LEE MOFFITT CANC CTR & RES INST,CANC PREVENT SECT,TAMPA,FL 33612, USA.							BAKER RR, 1977, ANN SURG, V186, P363, DOI 10.1097/00000658-197709000-00014; BLUMENSCHEIN GR, 1983, 3RD EUR ONC RES TREA; BROYN T, 1982, ACTA CHIR SCAND, V148, P401; BURKETT FE, 1979, SURG GYNECOL OBSTET, V149, P523; CANTWELL B, 1982, IRISH J MED SCI, V151, P1, DOI 10.1007/BF02940131; CORCORAN RJ, 1976, RADIOLOGY, V121, P663, DOI 10.1148/121.3.663; HARTUNIAN NS, 1980, AM J PUBLIC HEALTH, V70, P1249, DOI 10.2105/AJPH.70.12.1249; HODGSON TA, 1982, MILBANK FUND Q, V60, P429, DOI 10.2307/3349801; HOLLAND JF, 1983, J CLIN ONCOL, V1, P74; KHANDEKAR JD, 1978, P AM ASSOC CANC RES, V19, P379; LEGHA SS, 1979, ANN INTERN MED, V91, P847, DOI 10.7326/0003-4819-91-6-847; LIPPMAN ME, 1988, DIAGNOSIS MANAGEMENT, P375; MCNEIL BJ, 1978, SURG GYNECOL OBSTET, V147, P745; OCONNELL MJ, 1978, MAYO CLIN PROC, V53, P221; PANDYA KJ, 1985, CANCER, V55, P202, DOI 10.1002/1097-0142(19850101)55:1<202::AID-CNCR2820550132>3.0.CO;2-X; PEDRAZZINI A, 1986, J CLIN ONCOL, V4, P389, DOI 10.1200/JCO.1986.4.3.389; PEREZ DJ, 1983, LANCET, V2, P613; ROSSING N, 1982, EUR J CANCER CLIN ON, V18, P629, DOI 10.1016/0277-5379(82)90208-5; RUSSELL L, 1986, IS PREVENTION BETTER, P116; SCANLON EF, 1980, CANCER, V46, P977, DOI 10.1002/1097-0142(19800815)46:4+<977::AID-CNCR2820461320>3.0.CO;2-0; TABAR L, 1989, J EPIDEMIOL COMMUN H, V43, P107, DOI 10.1136/jech.43.2.107; WARNER KE, 1982, COST BENEFIT COST EF, P93; WICKERHAM L, 1983, BREAST CANCER RES TR, V1, P24; WINCHESTER DP, 1979, CANCER, V43, P956, DOI 10.1002/1097-0142(197903)43:3<956::AID-CNCR2820430326>3.0.CO;2-L; ZWAVELING A, 1987, J SURG ONCOL, V34, P194, DOI 10.1002/jso.2930340314; 1989, STATISTICAL ABSTRACT, P17; 1990, CANCER FACTS FIGURES, P6	27	100	102	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 16	1991	265	3					380	382		10.1001/jama.265.3.380	http://dx.doi.org/10.1001/jama.265.3.380			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ER256	1984538				2022-12-28	WOS:A1991ER25600029
J	GEORGE, JN; SHATTIL, SJ				GEORGE, JN; SHATTIL, SJ			THE CLINICAL IMPORTANCE OF ACQUIRED ABNORMALITIES OF PLATELET-FUNCTION	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							PROLONGED BLEEDING-TIME; RECOMBINANT HUMAN ERYTHROPOIETIN; ASPIRIN-INDUCED PROLONGATION; PERIOPERATIVE BLOOD-LOSS; VON-WILLEBRANDS DISEASE; STORAGE POOL DEFICIENCY; ANTI-INFLAMMATORY DRUGS; RED-CELL TRANSFUSIONS; ALPHA-GRANULE RELEASE; BYPASS GRAFT SURGERY		UNIV PENN,SCH MED,DEPT MED,HEMATOL ONCOL SECT,PHILADELPHIA,PA 19104	University of Pennsylvania	GEORGE, JN (corresponding author), UNIV OKLAHOMA,HLTH SCI CTR,DEPT MED,HEMATOL ONCOL SECT,POB 26901,OKLAHOMA CITY,OK 73190, USA.							ABILDGAARD CF, 1980, BLOOD, V56, P712; ABRAMS CS, 1990, BLOOD, V75, P128; AHR DJ, 1978, CANCER, V41, P448, DOI 10.1002/1097-0142(197802)41:2<448::AID-CNCR2820410211>3.0.CO;2-U; ALDORT LM, 1968, P SOC EXP BIOL MED, V128, P658; ALEXANDER DP, 1983, ANTIMICROB AGENTS CH, V23, P59, DOI 10.1128/AAC.23.1.59; AMREIN PC, 1981, JAMA-J AM MED ASSOC, V245, P1825, DOI 10.1001/jama.245.18.1825; ANDRASSY K, 1976, LANCET, V2, P1039; [Anonymous], 1989, LANCET, V1, P938; [Anonymous], 1989, NEW ENGL J MED, V321, P129; ARROWSMITH JB, 1987, PEDIATRICS, V79, P858; BALL WG, 1932, DISEASES KIDNEY, P250; BERNDT MC, 1988, BRIT J HAEMATOL, V68, P97, DOI 10.1111/j.1365-2141.1988.tb04185.x; BICK R L, 1976, Seminars in Thrombosis and Hemostasis, V3, P59; BOLAN CD, 1990, TRANSFUSION, V30, P541, DOI 10.1046/j.1537-2995.1990.30690333487.x; BRACEY AW, 1987, AM J HEMATOL, V24, P247, DOI 10.1002/ajh.2830240304; BRASS LF, 1990, PROG HEMOST THROMB, V10, P127; BROWN CH, 1975, ANTIMICROB AGENTS CH, V7, P652, DOI 10.1128/AAC.7.5.652; BROWN CH, 1974, NEW ENGL J MED, V291, P265, DOI 10.1056/NEJM197408082910601; BROWN CH, 1976, BLOOD, V47, P949; BROWN RB, 1986, ARCH INTERN MED, V146, P2159, DOI 10.1001/archinte.146.11.2159; BUCHANAN GR, 1977, AM J CLIN PATHOL, V68, P355; BUERLINGHARBURY C, 1978, BLOOD, V52, P13; BURROUGHS SF, 1990, BLOOD, V75, P1473; CARVALHO AC, 1987, AM J HEMATOL, V25, P377, DOI 10.1002/ajh.2830250404; CARVALHO AC, 1974, CIRCULATION, V50, P570, DOI 10.1161/01.CIR.50.3.570; CHARO IF, 1977, J CLIN INVEST, V60, P866, DOI 10.1172/JCI108841; CHESEBRO JH, 1983, AM J CARDIOL, V51, P1537, DOI 10.1016/0002-9149(83)90673-2; COLLER BS, 1979, CRC HDB SERIES CLIN, P381; COMFURIUS P, 1990, BIOCHIM BIOPHYS ACTA, V1026, P153, DOI 10.1016/0005-2736(90)90058-V; COWAN DH, 1975, J CLIN INVEST, V56, P188, DOI 10.1172/JCI108067; CREMER KF, 1984, CLIN PHARMACOL THER, V36, P641, DOI 10.1038/clpt.1984.234; CZAPEK EE, 1978, BLOOD, V52, P103; DALE J, 1983, AM HEART J, V105, P103, DOI 10.1016/0002-8703(83)90285-5; DALSGAARDNIELSEN J, 1981, BRIT J ANAESTH, V53, P1039, DOI 10.1093/bja/53.10.1039; DATA JL, 1981, CIRCULATION, V64, P4, DOI 10.1161/01.CIR.64.1.4; DECATERINA R, 1990, AM HEART J, V119, P855, DOI 10.1016/S0002-8703(05)80323-0; DECATERINA R, 1984, AM J CARDIOL, V53, P1683; DECKMYN H, 1990, THROMB HAEMOSTASIS, V64, P74; DEVINE DV, 1987, BLOOD, V70, P428; DEYKIN D, 1982, NEW ENGL J MED, V306, P852, DOI 10.1056/NEJM198204083061406; Diaz-Buxo J A, 1975, Clin Nephrol, V4, P223; DIJKMANS BAC, 1980, J ANTIMICROB CHEMOTH, V6, P554, DOI 10.1093/jac/6.4.554; DIMICHELE DM, 1990, AM J HEMATOL, V33, P39, DOI 10.1002/ajh.2830330108; DIMINNO G, 1986, J CLIN INVEST, V77, P157, DOI 10.1172/JCI112270; DIMINNO G, 1986, J LAB CLIN MED, V108, P246; DIMINNO G, 1985, J CLIN INVEST, V75, P328, DOI 10.1172/JCI111705; DORSCH CA, 1982, ARTHRITIS RHEUM, V25, P966, DOI 10.1002/art.1780250809; DORSO CR, 1980, NEW ENGL J MED, V303, P756; ESCOLAR G, 1990, BLOOD, V76, P1336; EYSTER ME, 1981, BLOOD, V58, P719; FASS RJ, 1987, J INFECT DIS, V155, P1242, DOI 10.1093/infdis/155.6.1242; FERNANDEZ F, 1985, BRIT J HAEMATOL, V59, P139, DOI 10.1111/j.1365-2141.1985.tb02974.x; FERRARIS VA, 1983, SURG GYNECOL OBSTET, V156, P439; FERRARIS VA, 1988, ANN THORAC SURG, V45, P71, DOI 10.1016/S0003-4975(10)62401-0; FILES JC, 1981, BLOOD, V58, P607; FIORE LD, 1990, AM J CLIN PATHOL, V94, P292, DOI 10.1093/ajcp/94.3.292; FISHER CA, 1987, J LAB CLIN MED, V109, P184; FITZGERALD GA, 1987, NEW ENGL J MED, V316, P1247; FLOWER RJ, 1985, GOODMAN GILMANS PHAR, P674; GAFTER U, 1979, RADIOLOGY, V132, P341, DOI 10.1148/132.2.341; GASPARI F, 1987, J CLIN INVEST, V79, P1788, DOI 10.1172/JCI113020; GENTRY LO, 1981, ANTIMICROB AGENTS CH, V19, P532, DOI 10.1128/AAC.19.4.532; GENTRY LO, 1985, ANTIMICROB AGENTS CH, V27, P683, DOI 10.1128/AAC.27.5.683; GEORGE JN, 1984, NEW ENGL J MED, V311, P1084, DOI 10.1056/NEJM198410253111705; GEORGE JN, 1986, J CLIN INVEST, V78, P340, DOI 10.1172/JCI112582; GEORGE JN, 1990, BLOOD, V75, P1383; GEORGE JN, 1990, HEMATOLOGY BASIC PRI, P1528; GILANI AH, 1990, BIOCHEM SOC T, V18, P288, DOI 10.1042/bst0180288; GIMPLE LW, 1989, CIRCULATION, V80, P581, DOI 10.1161/01.CIR.80.3.581; Ginsberg M H, 1988, Prog Clin Biol Res, V283, P171; GINSBERG MH, 1990, BLOOD, V76, P2017; GOLDMAN S, 1988, CIRCULATION, V77, P1324, DOI 10.1161/01.CIR.77.6.1324; GOODNIGHT SH, 1981, BLOOD, V58, P880; GORDGE MP, 1988, THROMB HAEMOSTASIS, V60, P83; GREEN D, 1985, J LAB CLIN MED, V105, P321; GRUBER UF, 1977, LANCET, V1, P207; HABURCHAK DR, 1977, AM J SURG, V134, P630, DOI 10.1016/0002-9610(77)90451-2; HACKMANN T, 1989, NEW ENGL J MED, V321, P1437, DOI 10.1056/NEJM198911233212104; HAKIM RM, 1986, KIDNEY, P1791; HAMBERGER J, 1968, NEPHROLOGY, P347; HAMBURGER SA, 1990, BLOOD, V75, P550; HAMMERSCHMIDT DE, 1980, NEW ENGL J MED, V302, P1191, DOI 10.1056/NEJM198005223022108; HARDISTY RM, 1990, THROMB HAEMOSTASIS, V64, P150; HARKER LA, 1980, BLOOD, V56, P824; HARRIS WH, 1977, NEW ENGL J MED, V297, P1246, DOI 10.1056/NEJM197712082972302; HAUT MJ, 1974, AM J MED, V56, P22, DOI 10.1016/0002-9343(74)90747-5; HEIDEN D, 1977, BRIT J HAEMATOL, V36, P427, DOI 10.1111/j.1365-2141.1977.tb00666.x; HELLEM AJ, 1961, BRIT J HAEMATOL, V7, P42, DOI 10.1111/j.1365-2141.1961.tb00318.x; HEYNS ADP, 1978, J CLIN PATHOL, V31, P1239, DOI 10.1136/jcp.31.12.1239; HOLLOWAY DS, 1988, THROMB HAEMOSTASIS, V59, P62; HORLOCKER TT, 1990, ANESTH ANALG, V70, P631; HUTTON RA, 1968, J CLIN PATHOL, V21, P406, DOI 10.1136/jcp.21.3.406; IKEDA Y, 1978, ANTIMICROB AGENTS CH, V13, P881, DOI 10.1128/AAC.13.5.881; IKEDA Y, 1981, THROMB HAEMOSTASIS, V45, P158; ISRAELS SJ, 1990, BRIT J HAEMATOL, V75, P118, DOI 10.1111/j.1365-2141.1990.tb02626.x; JAIN MK, 1978, THROMB RES, V13, P1067, DOI 10.1016/0049-3848(78)90235-9; JUHL A, 1986, NEPHRON, V43, P305, DOI 10.1159/000183860; JUVELA S, 1990, STROKE, V21, P1283, DOI 10.1161/01.STR.21.9.1283; KALLMAN R, 1987, THROMB RES, V45, P355, DOI 10.1016/0049-3848(87)90224-6; KANESHIRO MM, 1969, NEW ENGL J MED, V281, P1039, DOI 10.1056/NEJM196911062811904; KARWANDE SV, 1987, ANN THORAC SURG, V43, P318, DOI 10.1016/S0003-4975(10)60623-6; KESSLER CM, 1982, BRIT J HAEMATOL, V50, P157, DOI 10.1111/j.1365-2141.1982.tb01900.x; KHAZAN U, 1990, ANN INTERN MED, V112, P472, DOI 10.7326/0003-4819-76-3-112-6-472_2; KIRKMAN RL, 1982, TRANSPLANTATION, V34, P347, DOI 10.1097/00007890-198212000-00007; KITCHEN L, 1982, AM J SURG, V143, P215, DOI 10.1016/0002-9610(82)90071-X; KLEINKNECHT D, 1972, KIDNEY INT, V1, P190, DOI 10.1038/ki.1972.26; KLINE A, 1975, BRIT MED J, V2, P109, DOI 10.1136/bmj.2.5963.109; KROLL MH, 1989, BLOOD, V74, P1181; KUBOTA T, 1989, THROMB RES, V53, P379, DOI 10.1016/0049-3848(89)90316-2; LACKNER H, 1973, SEMIN HEMATOL, V10, P125; LANGDELL RD, 1958, JAMA-J AM MED ASSOC, V166, P346, DOI 10.1001/jama.1958.02990040032007; LAPETINA EG, 1990, FEBS LETT, V268, P400, DOI 10.1016/0014-5793(90)81293-W; LARSEN E, 1989, CELL, V59, P305, DOI 10.1016/0092-8674(89)90292-4; LARSSON PT, 1990, EUR J CLIN INVEST, V20, P398, DOI 10.1111/j.1365-2362.1990.tb01876.x; LAWSON D, 1986, J LAB CLIN MED, V108, P581; LEIST ER, 1974, NEW ENGL J MED, V291, P710, DOI 10.1056/NEJM197410032911406; LIM SH, 1989, J CLIN PATHOL, V42, P950, DOI 10.1136/jcp.42.9.950; LINDBLAD B, 1988, SCAND J THORAC CARD, V22, P55, DOI 10.3109/14017438809106052; LIPSKY JJ, 1988, J ANTIMICROB CHEMOTH, V21, P281, DOI 10.1093/jac/21.3.281; LIVIO M, 1982, LANCET, V2, P1013; MAGUIRE ED, 1981, HAEMOSTASIS, V10, P153; MAKHEJA AN, 1990, AGENTS ACTIONS, V29, P360, DOI 10.1007/BF01966468; MANN KG, 1990, BLOOD, V76, P1; MANNUCCI PM, 1983, NEW ENGL J MED, V308, P8, DOI 10.1056/NEJM198301063080102; MCCLURE PD, 1970, LANCET, V2, P1307; MCINTYRE BA, 1978, CLIN PHARMACOL THER, V24, P616; MCKENNA R, 1983, J LAB CLIN MED, V102, P102; MCQUEEN EG, 1986, NEW ZEAL MED J, V99, P358; MESCHENGIESER S, 1987, THROMB RES, V46, P601, DOI 10.1016/0049-3848(87)90161-7; MICHELSON EL, 1978, J THORAC CARDIOV SUR, V76, P694; MIELKE CH, 1980, J CLIN PHARMACOL, V20, P409; MIELKE CH, 1982, BLOOD, V60, P1139; MIELKE CH, 1983, AM J MED, V74, P72, DOI 10.1016/0002-9343(83)90532-6; MIELKE CH, 1969, BLOOD-J HEMATOL, V34, P204, DOI 10.1182/blood.V34.2.204.204; MIELKE CH, 1976, TOLMETIN NEW NONSTER, P200; MILLER CH, 1979, BLOOD, V54, P117; MILLS DCB, 1967, NATURE, V213, P35, DOI 10.1038/213035a0; MOHRI H, 1987, AM J CLIN PATHOL, V87, P663, DOI 10.1093/ajcp/87.5.663; MOIA M, 1987, LANCET, V2, P1227; MORRISON G, 1985, KIDNEY PHYSL PATHOPH, P1901; MURPHY S, 1978, ARCH INTERN MED, V138, P1251, DOI 10.1001/archinte.138.8.1251; NADELL J, 1974, J CLIN PHARMACOL, V14, P176, DOI 10.1002/j.1552-4604.1974.tb01395.x; NATELSON EA, 1976, ANTIMICROB AGENTS CH, V9, P91, DOI 10.1128/AAC.9.1.91; NENCI GG, 1979, NEPHRON, V23, P287, DOI 10.1159/000181652; NIESSNER H, 1986, BLOOD, V68, P571; NIEUWENHUIS HK, 1987, THROMB HAEMOSTASIS, V58, P527; NIEUWENHUIS HK, 1986, BLOOD, V68, P692; NIEUWENHUIS HK, 1987, BLOOD, V70, P620; NISHIZAWA EE, 1981, THROMB RES, V21, P347, DOI 10.1016/0049-3848(81)90135-3; OBRIEN JR, 1968, LANCET, V1, P894; OLAUGHLIN JC, 1981, GASTROINTEST ENDOSC, V27, P1, DOI 10.1016/S0016-5107(81)73131-6; PANELLA TJ, 1990, CANCER, V65, P1711, DOI 10.1002/1097-0142(19900415)65:8<1711::AID-CNCR2820650808>3.0.CO;2-W; PARETI FI, 1980, AM J MED, V69, P235, DOI 10.1016/0002-9343(80)90383-6; PARVEZ Z, 1984, INVEST RADIOL, V19, P208; POGLIANI EM, 1981, THROMB HAEMOSTASIS, V45, P38; PUSZKIN E, 1972, TRANSFUSION, V12, P9; RAJAH SM, 1985, J THORAC CARDIOV SUR, V90, P373; RAO AK, 1985, RADIOLOGY, V156, P311, DOI 10.1148/radiology.156.2.4011893; RAPAPORT SI, 1983, BLOOD, V61, P229; RELMAN AS, 1963, DISEASES KIDNEY, P320; REMUZZI G, 1983, J CLIN INVEST, V71, P762, DOI 10.1172/JCI110824; RING T, 1983, THROMB RES, V29, P553, DOI 10.1016/0049-3848(83)90210-4; RODEGHIERO F, 1987, BLOOD, V69, P454; RODGERS RPC, 1990, SEMIN THROMB HEMOST, V16, P1, DOI 10.1055/s-2007-1002658; ROSE KD, 1990, NEUROSURGERY, V26, P880, DOI 10.1227/00006123-199005000-00026; ROSING J, 1985, BLOOD, V65, P319; ROSOVE MH, 1980, BLOOD, V55, P903; ROSSI EC, 1973, J CLIN INVEST, V52, P2457, DOI 10.1172/JCI107437; ROTH GJ, 1978, J BIOL CHEM, V253, P3782; ROUSSI JH, 1980, BRIT J HAEMATOL, V46, P503, DOI 10.1111/j.1365-2141.1980.tb06001.x; SALZMAN EW, 1986, NEW ENGL J MED, V314, P1402, DOI 10.1056/NEJM198605293142202; SANTOS MT, IN PRESS J CLIN INVE; SARJI KE, 1979, THROMB RES, V15, P639, DOI 10.1016/0049-3848(79)90174-9; SATTLER FR, 1986, ANN INTERN MED, V105, P924, DOI 10.7326/0003-4819-105-6-924; SAXON A, 1976, BLOOD, V47, P957; SCHAFER AI, 1980, BLOOD, V55, P649; SCHAFER AI, 1984, BLOOD, V64, P1; Schreiner GE., 1963, DISEASES KIDNEY, P335; SHAPIRO RS, 1980, AM J PEDIAT HEMATOL, V2, P207; SHATTIL SJ, 1980, J CLIN INVEST, V65, P329, DOI 10.1172/JCI109676; SHEPHERD LL, 1989, J PEDIATR-US, V114, P470, DOI 10.1016/S0022-3476(89)80575-X; SIESS W, 1989, PHYSIOL REV, V69, P58, DOI 10.1152/physrev.1989.69.1.58; SIMS PJ, 1989, J BIOL CHEM, V264, P17049; SMITH TJ, 1989, AM J HEMATOL, V31, P199, DOI 10.1002/ajh.2830310310; SOMANI P, 1983, J ANTIMICROB CHEMOTH, V11, P33, DOI 10.1093/jac/11.suppl_C.33; SRIVASTAVA KC, 1989, PROSTAG LEUKOTR ESS, V37, P57, DOI 10.1016/0952-3278(89)90187-7; SRIVASTAVA KC, 1989, PROSTAG LEUKOTR ESS, V38, P255, DOI 10.1016/0952-3278(89)90129-4; STEINER RW, 1979, AM J HEMATOL, V7, P107, DOI 10.1002/ajh.2830070203; STEINHERZ PG, 1976, BRIT J HAEMATOL, V32, P439, DOI 10.1111/j.1365-2141.1976.tb00947.x; STEWART JH, 1967, Q J MED, V36, P409; STOFF JS, 1980, AM J MED, V68, P171, DOI 10.1016/0002-9343(80)90351-4; STUART M J, 1979, American Journal of Pediatric Hematology Oncology, V1, P77; STUART MJ, 1981, BLOOD, V58, P326; STUART MJ, 1979, BRIT J HAEMATOL, V43, P649, DOI 10.1111/j.1365-2141.1979.tb03798.x; STUART MJ, 1982, NEW ENGL J MED, V307, P909, DOI 10.1056/NEJM198210073071502; SZCZEKLIK A, 1986, THROMB HAEMOSTASIS, V56, P283; Taggart D P, 1990, Ann Thorac Surg, V50, P424; THOMAS P, 1982, AM J HEMATOL, V12, P131, DOI 10.1002/ajh.2830120205; THOMSON C, 1973, THROMB DIATH HAEMOST, V30, P547, DOI 10.1055/s-0038-1649133; TIFFANY ML, 1983, CRC CR REV CL LAB SC, V19, P27, DOI 10.3109/10408368309165759; TOROSIAN M, 1978, ANN INTERN MED, V89, P325, DOI 10.7326/0003-4819-89-3-325; VANGEET C, 1989, THROMB HAEMOSTASIS, V61, P117; VIGLIANO EM, 1967, BLOOD-J HEMATOL, V29, P823, DOI 10.1182/blood.V29.6.823.823; VONSCHACKY C, 1985, J CLIN INVEST, V76, P2446, DOI 10.1172/JCI112261; WARE JA, 1989, BLOOD, V73, P172; WEINSTEIN RE, 1989, AM J HEMATOL, V32, P258, DOI 10.1002/ajh.2830320405; WEISS HJ, 1967, J LAB CLIN MED, V69, P37; WEISS HJ, 1980, AM J MED, V69, P711, DOI 10.1016/0002-9343(80)90436-2; WEKSLER BB, 1977, BLOOD, V49, P185; WEKSLER BB, 1983, NEW ENGL J MED, V308, P800, DOI 10.1056/NEJM198304073081402; WISLOFF F, 1981, SCAND J HAEMATOL, V27, P45; ZIR LM, 1974, NEW ENGL J MED, V291, P134, DOI 10.1056/NEJM197407182910306; ZUCKERMAN GR, 1985, ANN INTERN MED, V102, P588, DOI 10.7326/0003-4819-102-5-588; 1989, THROMB RES, V55, P13; 1961, CIBA F S, P371	215	239	241	0	4	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 3	1991	324	1					27	39		10.1056/NEJM199101033240106	http://dx.doi.org/10.1056/NEJM199101033240106			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EQ503	1984161				2022-12-28	WOS:A1991EQ50300006
J	SCHWARTZ, JS; LEWIS, CE; CLANCY, C; KINOSIAN, MS; RADANY, MH; KOPLAN, JP				SCHWARTZ, JS; LEWIS, CE; CLANCY, C; KINOSIAN, MS; RADANY, MH; KOPLAN, JP			INTERNISTS PRACTICES IN HEALTH PROMOTION AND DISEASE PREVENTION - A SURVEY	ANNALS OF INTERNAL MEDICINE			English	Review							ADULT CANCER PREVENTION; IMPROVING PHYSICIAN COMPLIANCE; PRIMARY CARE PHYSICIANS; FAMILY PHYSICIANS; SCREENING MAMMOGRAPHY; MEDICINE GUIDELINES; BREAST-CANCER; PERFORMANCE; SMOKING; ATTITUDES	Objective: To estimate internists' use of disease prevention and health promotion activities, and to explore demographic, professional, behavioral, psychological, cognitive, and organizational factors associated with the use of such practices. Design: Mail survey. Setting and Subjects: A sample of 2610 members and fellows of the American College of Physicians (ACP) participated in the study. They engaged in patient care activities more than 20 hours per week and were stratified by gender and region. They lived in four geographic areas of the United States (Northeast, Southeast, Central, and West), comprising 21 ACP regions. Measurements: A questionnaire requesting background information as well as information about personal health; record keeping; use of immunizations (pneumococcal, influenza, tetanus, hepatitis B); use of screening tests and procedures for detecting cancer (breast examination, Papanicolaou smear, stool occult blood test) and other diseases (electrocardiograms, cholesterol level tests, chest radiographs); and behavioral counseling to promote health (in the areas of smoking, exercise, and alcohol and seat belt use). Main results: Internists used effective preventive interventions less frequently and ineffective practices more frequently than experts recommend. Internists' use of health promotion and disease prevention activities is associated with habit, attitude, and a lack of adequate knowledge. Younger physician age, general internal medicine practice, and personal health promotion and disease prevention practices were strongly associated with more appropriate use of recommended practices (P < 0.01). Conclusions: Internists' use of disease prevention and health promotion activities falls short of expert recommendations. Programs to improve the delivery of preventive services might be aimed at improving physicians' personal health practices, might be directed toward patients, and might include the development of effective systems to remind physicians.	CTR DIS CONTROL, ATLANTA, GA 30333 USA; UNIV PENN, PHILADELPHIA, PA 19104 USA; UNIV CALIF LOS ANGELES, SCH MED, DEPT MED, LOS ANGELES, CA 90024 USA; VIRGINIA COMMONWEALTH UNIV, MED COLL VIRGINIA, RICHMOND, VA 23298 USA; AMER COLL PHYSICIANS, PHILADELPHIA, PA USA	Centers for Disease Control & Prevention - USA; University of Pennsylvania; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Virginia Commonwealth University; American College of Physicians								BASSETT LW, 1986, AM J ROENTGENOL, V147, P689, DOI 10.2214/ajr.147.4.689; BATTISTA RN, 1986, MED CARE, V24, P216, DOI 10.1097/00005650-198603000-00004; BATTISTA RN, 1985, CAN MED ASSOC J, V132, P1013; BATTISTA RN, 1983, AM J PUBLIC HEALTH, V73, P1036, DOI 10.2105/AJPH.73.9.1036; BATTISTA RN, 1983, AM J PUBLIC HEALTH, V73, P1040, DOI 10.2105/AJPH.73.9.1040; BRAND DA, 1983, NEW ENGL J MED, V309, P636, DOI 10.1056/NEJM198309153091104; BROWNLEE HJ, 1982, J FAM PRACTICE, V15, P1111; Bruce Dull H., 1987, CLOSING GAP BURDEN U; CATFORD JC, 1984, BMJ-BRIT MED J, V288, P881; CHAO A, 1987, PREV MED, V16, P710, DOI 10.1016/0091-7435(87)90053-3; CLEARIE AF, 1982, J S C MED ASS, V78, P502; COHEN DI, 1982, MED CARE, V20, P1040, DOI 10.1097/00005650-198210000-00006; Conn J M, 1988, MMWR CDC Surveill Summ, V37, P5; CUMMINGS KM, 1983, J FAM PRACTICE, V17, P1029; CUMMINGS SR, 1989, ARCH INTERN MED, V149, P345, DOI 10.1001/archinte.149.2.345; DALY LE, 1980, J IRISH MED ASSOC, V7, P260; DIETRICH AJ, 1984, AM J PUBLIC HEALTH, V74, P223, DOI 10.2105/AJPH.74.3.223; FABER MM, 1985, PEDIATRICS, V75, P248; FEDSON DS, 1984, J INFECT DIS, V149, P817, DOI 10.1093/infdis/149.5.817; Fleming D M, 1981, J R Coll Gen Pract, V31, P615; FOX SA, 1988, RADIOLOGY, V166, P431, DOI 10.1148/radiology.166.2.3336718; Gemson D H, 1988, J Community Health, V13, P53, DOI 10.1007/BF01321480; GEMSON DH, 1986, AM J PREV MED, V2, P226; GLANZ K, 1982, J MED EDUC, V57, P637; HAYWARD RA, 1988, ARCH INTERN MED, V148, P1177, DOI 10.1001/archinte.148.5.1177; HOROWITZ MM, 1987, J MED EDUC, V62, P931; HUGHEY MJ, 1986, JAMA-J AM MED ASSOC, V256, P1775; KLEINMAN JC, 1981, AM J PUBLIC HEALTH, V71, P73, DOI 10.2105/AJPH.71.1.73; KOSECOFF J, 1985, ANN INTERN MED, V102, P250, DOI 10.7326/0003-4819-102-2-250; KOTTKE TE, 1984, PREV MED, V13, P219, DOI 10.1016/0091-7435(84)90053-7; LEWIS CE, 1991, ANN INTERN MED, V114, P54, DOI 10.7326/0003-4819-114-1-54; LEWIS CE, 1986, J GEN INTERN MED, V1, P14, DOI 10.1007/BF02596319; LINN LS, 1986, WESTERN J MED, V144, P484; LURIE N, 1987, AM J PUBLIC HEALTH, V77, P801, DOI 10.2105/AJPH.77.7.801; LYNCH GR, 1986, J MED EDUC, V61, P387; MAKUC DM, 1989, AM J PUBLIC HEALTH, V79, P21, DOI 10.2105/AJPH.79.1.21; MANDEL I, 1985, J FAM PRACTICE, V21, P223; MANDEL IG, 1982, J FAM PRACTICE, V14, P901; MCALISTER A, 1985, TEX MED, V81, P55; MCDONALD CJ, 1984, ANN INTERN MED, V100, P130, DOI 10.7326/0003-4819-100-1-130; MCDOWELL I, 1989, J FAM PRACTICE, V28, P420; MCPHEE SJ, 1986, J GEN INTERN MED, V1, P275, DOI 10.1007/BF02596202; OCKENE JK, 1988, AM J PREV MED, V4, P14, DOI 10.1016/S0749-3797(18)31214-5; OGLE KS, 1988, AM J PREV MED, V4, P11, DOI 10.1016/S0749-3797(18)31213-3; ORLEANS CT, 1985, PREV MED, V14, P636, DOI 10.1016/0091-7435(85)90083-0; PATRIARCA PA, 1982, PUBLIC HEALTH REP, V97, P406; Prislin M D, 1986, Fam Med, V18, P290; RADECKI SE, 1986, PATIENT EDUC COUNS, V8, P165, DOI 10.1016/0738-3991(86)90087-X; RIMER BK, 1986, PREV MED, V15, P92, DOI 10.1016/0091-7435(86)90039-3; RODNEY WM, 1985, J FAM PRACTICE, V20, P265; ROMM FJ, 1981, SOUTHERN MED J, V74, P265, DOI 10.1097/00007611-198103000-00004; ROSEN MA, 1984, PREV MED, V13, P535, DOI 10.1016/0091-7435(84)90022-7; SCHOENBORN CA, 1988, AM J PUBLIC HEALTH, V78, P983, DOI 10.2105/AJPH.78.8.983; Slenker S E, 1988, Ohio Med, V84, P476; SOBAL J, 1985, AM J PUBLIC HEALTH, V75, P1427, DOI 10.2105/AJPH.75.12.1427; TIERNEY WM, 1986, MED CARE, V24, P659, DOI 10.1097/00005650-198608000-00001; VALENTE C M, 1986, American Journal of Preventive Medicine, V2, P82; WELLS KB, 1986, AM J PUBLIC HEALTH, V76, P1009, DOI 10.2105/AJPH.76.8.1009; WELLS KB, 1984, MED CARE, V22, P240, DOI 10.1097/00005650-198403000-00007; WESCHLER H, 1983, NEW ENGL J MED, V308, P97; WILLIAMS WW, 1988, ANN INTERN MED, V108, P616, DOI 10.7326/0003-4819-108-4-616; WOO B, 1985, JAMA-J AM MED ASSOC, V254, P1480, DOI 10.1001/jama.254.11.1480; WOOLHANDLER S, 1988, JAMA-J AM MED ASSOC, V259, P2872; ZIFFER A, 1987, AM J PREV MED, V3, P142; 1978, FAMILY PRACTICE STUD; 1989, MMWR, V38, P117; 1988, PHS NCI NIH882789 DE; 1989, PHS DHHS CDC898411 C; 1977, INTERNAL MED PRACTIC; 1989, MMWR, V38, P157; 1985, CA, V35, P197; 1988, MMWR, V37, P357; 1989, MMWR, V37, P429; 1986, MMWR, V35, P16; 1987, 128 NAT CTR HLTH STA	75	176	177	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 1	1991	114	1					46	53		10.7326/0003-4819-114-1-46	http://dx.doi.org/10.7326/0003-4819-114-1-46			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EQ040	1983932				2022-12-28	WOS:A1991EQ04000008
J	SANDER, JWAS; HART, YM; JOHNSON, AL; SHORVON, SD				SANDER, JWAS; HART, YM; JOHNSON, AL; SHORVON, SD			NATIONAL GENERAL-PRACTICE STUDY OF EPILEPSY - NEWLY DIAGNOSED EPILEPTIC SEIZURES IN A GENERAL-POPULATION	LANCET			English	Article									NATL HOSP,CHALFONT CTR EPILEPSY,CHALFONT ST PETER SL9 0RJ,BUCKS,ENGLAND; INST NEUROL,LONDON WC1N 3BG,ENGLAND; MRC,BIOSTAT UNIT,CAMBRIDGE,ENGLAND	University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; MRC Biostatistics Unit			Shorvon, Simon D/A-2019-2009; Sander, Josemir W/C-1576-2008	Sander, Josemir W/0000-0001-6041-9661; Shorvon, Simon/0000-0003-0313-2001				[Anonymous], 1981, EPILEPSIA, V22, P489; BERAN R G, 1985, Neuroepidemiology, V4, P82, DOI 10.1159/000110218; COSTEFF H, 1965, NEW ENGL J MED, V273, P1410, DOI 10.1056/NEJM196512232732604; GOODRIDGE DMG, 1983, BMJ-BRIT MED J, V287, P641, DOI 10.1136/bmj.287.6393.641; GRANIERI E, 1983, EPILEPSIA, V24, P502, DOI 10.1111/j.1528-1157.1983.tb04921.x; GRIFFIN T, 1989, SOCIAL TRENDS, V19; GUDMUNDSSON G, 1966, ACTA NEUROL SCAND, V43, pS25; HAERER AF, 1986, EPILEPSIA, V27, P66, DOI 10.1111/j.1528-1157.1986.tb03503.x; HART YM, 1989, NEUROEPIDEMIOLOGY, V8, P221; HAUSER WA, 1975, EPILEPSIA, V16, P1, DOI 10.1111/j.1528-1157.1975.tb04721.x; HAUSER WA, 1982, NEW ENGL J MED, V307, P522, DOI 10.1056/NEJM198208263070903; JUULJENSEN P, 1983, EPILEPSIA, V24, P297, DOI 10.1111/j.1528-1157.1983.tb04893.x; LENNOXBUCHTHAL MA, 1973, FEBRILE CONVULSIONS; LI SC, 1985, EPILEPSIA, V26, P391, DOI 10.1111/j.1528-1157.1985.tb05669.x; Millichap JG, 1968, FEBRILE CONVULSIONS; Morrell D C, 1971, J R Coll Gen Pract, V21, P32; SANDER JWAS, 1987, J NEUROL NEUROSUR PS, V50, P829, DOI 10.1136/jnnp.50.7.829; SHORVON SD, 1984, J NEUROL NEUROSUR PS, V47, P1157, DOI 10.1136/jnnp.47.11.1157; SHORVON SD, 1984, J NEUROL NEUROSUR PS, V47, P225, DOI 10.1136/jnnp.47.3.225; SHORVON SD, 1982, THESIS U CAMBRIDGE; TSUBOI T, 1984, NEUROLOGY, V34, P175, DOI 10.1212/WNL.34.2.175; Zielinski J.J., 1974, 19P58325F01 PSYCH I; ZIELINSKI JJ, 1988, TXB EPILEPSY, P21	23	307	311	0	4	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 24	1990	336	8726					1267	1271		10.1016/0140-6736(90)92959-L	http://dx.doi.org/10.1016/0140-6736(90)92959-L			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ943	1978113				2022-12-28	WOS:A1990EJ94300001
J	POTTS, M; ROSENFIELD, A				POTTS, M; ROSENFIELD, A			THE 5TH FREEDOM REVISITED .1. BACKGROUND AND EXISTING PROGRAMS	LANCET			English	Review									COLUMBIA SCH PUBL HLTH,NEW YORK,NY	Columbia University	POTTS, M (corresponding author), FAMILY HLTH INT,POB 13950,RES TRIANGLE PK,NC 27709, USA.							BAIRD D, 1965, BMJ-BRIT MED J, V2, P1141, DOI 10.1136/bmj.2.5471.1141; BLACK T, 1972, NEW CONCEPTS CONTRAC, P43; BONGAARTS J, 1984, POPUL DEV REV, V10, P341, DOI 10.2307/1973086; Bongaarts J, 1983, FERTILITY BIOL BEHAV; CAMP SL, 1989, WORLD BANKS ROLE GLO; Chayovan N., 1988, International Family Planning Perspectives, V14, P86, DOI 10.2307/2947738; CHAYOVAN N, 1988, INT FAM PLANN PERSPE, V14, P102; CUTRIGHT P, 1983, INT FAMILY PLANNING, V9, P101; HUBER SC, 1989, J BIOSOC SCI, V21, P267, DOI 10.1017/S0021932000017971; HUG MN, 1989, PRELIMINARY REPORT B; JANOWITZ BS, 1990, INVESTING FUTURE; MAINE D, 1981, FAMILY PLANNING ITS; MOSHER WD, 1988, FAM PLANN PERSPECT, V20, P207, DOI 10.2307/2135622; MUMFORD SD, 1980, LANCET, V2, P1066; Murphy F X, 1981, Popul Bull, V35, P1; NESS GD, 1989, POPULI, V16, P4; POTTS M, 1977, ABORTION; ROSENFIELD A., 1982, International Family Planning Perspectives, V8, P43, DOI 10.2307/2948087; ROSENFIELD A, 1989, JAMA-J AM MED ASSOC, V262, P376, DOI 10.1001/jama.262.3.376; ROSENFIELD AG, 1972, AM J OBSTET GYNECOL, V114, P942, DOI 10.1016/0002-9378(72)90103-2; ROSENFIELD AG, 1974, AM J OBSTET GYNECOL, V118, P1104, DOI 10.1016/0002-9378(74)90690-5; ROSS JA, 1989, FAM PLANN PERSPECT, V21, P275, DOI 10.2307/2135382; THAPA S, 1988, NATURE, V335, P679, DOI 10.1038/335679a0; Tietze C, 1986, INDUCED ABORTION WOR; ZAVALA AS, 1987, STUD FAMILY PLANN, V18, P284, DOI 10.2307/1966857; 1990, UNFPA1989 ANN REP; 1990, INT FORUM POPULATION	27	13	13	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 17	1990	336	8725					1227	1231		10.1016/0140-6736(90)92843-7	http://dx.doi.org/10.1016/0140-6736(90)92843-7			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EJ064	1978080				2022-12-28	WOS:A1990EJ06400013
J	DEGASPERI, R; THOMAS, LJ; SUGIYAMA, E; CHANG, HM; BECK, PJ; ORLEAN, P; ALBRIGHT, C; WANECK, G; SAMBROOK, JF; WARREN, CD; YEH, ETH				DEGASPERI, R; THOMAS, LJ; SUGIYAMA, E; CHANG, HM; BECK, PJ; ORLEAN, P; ALBRIGHT, C; WANECK, G; SAMBROOK, JF; WARREN, CD; YEH, ETH			CORRECTION OF A DEFECT IN MAMMALIAN GPI ANCHOR BIOSYNTHESIS BY A TRANSFECTED YEAST GENE	SCIENCE			English	Article									HARVARD UNIV,MASSACHUSETTS GEN HOSP,SCH MED,DEPT MED,ARTHRIT UNIT,BOSTON,MA 02114; UNIV TEXAS,SW MED CTR,DEPT BIOCHEM,DALLAS,TX 75235; HARVARD UNIV,MASSACHUSETTS GEN HOSP,SCH MED,DEPT BIOL CHEM & MOLEC PHARMACOL,BOSTON,MA 02114; HARVARD UNIV,MASSACHUSETTS GEN HOSP,SCH MED,DEPT ANESTHESIA,BOSTON,MA 02114; HARVARD UNIV,MASSACHUSETTS GEN HOSP,SCH MED,DEPT SURG,BOSTON,MA 02114; MIT,CTR CANC RES,CAMBRIDGE,MA 02139	Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT)				Chang, Hui-Ming/0000-0002-5856-3397	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD016942, R01HD021087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR003564] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR-03564] Funding Source: Medline; NICHD NIH HHS [HD-21087, HD-16942] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BECK PJ, 1990, MOL CELL BIOL, V10, P4612, DOI 10.1128/MCB.10.9.4612; CARAS IW, 1987, SCIENCE, V238, P1280, DOI 10.1126/science.2446389; CHANG H, UNPUB; CHAPMAN A, 1980, J BIOL CHEM, V255, P4441; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CONZELMANN A, 1986, EMBO J, V5, P3291, DOI 10.1002/j.1460-2075.1986.tb04642.x; DEGASPERI R, UNPUB; DOERING TL, 1990, J BIOL CHEM, V265, P611; FATEMI SH, 1986, CELL, V46, P653, DOI 10.1016/0092-8674(86)90340-5; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FERGUSON MAJ, 1986, J BIOL CHEM, V261, P356; FERGUSON MAJ, 1988, SCIENCE, V239, P753, DOI 10.1126/science.3340856; FERGUSON MAJ, 1988, ANNU REV BIOCHEM, V57, P285; GUPTA D, 1988, SCIENCE, V242, P1446, DOI 10.1126/science.2904699; HOMANS SW, 1988, NATURE, V333, P269, DOI 10.1038/333269a0; HUBBARD SC, 1981, ANNU REV BIOCHEM, V50, P555, DOI 10.1146/annurev.bi.50.070181.003011; LOW MG, 1989, FASEB J, V3, P1600, DOI 10.1096/fasebj.3.5.2522071; MASTERSON WJ, 1989, CELL, V56, P793, DOI 10.1016/0092-8674(89)90684-3; MENON AK, 1988, J BIOL CHEM, V263, P1970; ORLEAN P, 1988, J BIOL CHEM, V263, P17499; ROBERTS WL, 1988, J BIOL CHEM, V263, P18766; SCHWARTZ RT, 1989, J CELL BIOCH SA, V13, P143; THOMAS L, UNPUB; TROWBRIDGE IS, 1979, CELL, V17, P503, DOI 10.1016/0092-8674(79)90258-7; WANECK GL, 1988, SCIENCE, V241, P697, DOI 10.1126/science.3399901; WARREN CD, 1989, SWAINSONINE AND RELATED GLYCOSIDASE INHIBITORS, P304; WARREN CD, 1975, J BIOL CHEM, V250, P8069; WARREN CD, 1983, CARBOHYD RES, V116, P171, DOI 10.1016/0008-6215(83)88107-5; WARREN CD, 1981, CARBOHYD RES, V82, P71; YEH ETH, 1988, CELL, V52, P665, DOI 10.1016/0092-8674(88)90404-7; YEH ETH, 1987, J IMMUNOL, V138, P91	32	90	90	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 16	1990	250	4983					988	991		10.1126/science.1978413	http://dx.doi.org/10.1126/science.1978413			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH793	1978413				2022-12-28	WOS:A1990EH79300043
J	ZAMORA, MR; OBRIEN, RF; RUTHERFORD, RB; WEIL, JV				ZAMORA, MR; OBRIEN, RF; RUTHERFORD, RB; WEIL, JV			SERUM ENDOTHELIN-1 CONCENTRATIONS AND COLD PROVOCATION IN PRIMARY RAYNAUD PHENOMENON	LANCET			English	Article									UNIV COLORADO,HLTH SCI CTR,DIV VASC SURG,DENVER,CO 80262	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	ZAMORA, MR (corresponding author), UNIV COLORADO,HLTH SCI CTR,DEPT MED,CARDIOVASC PULM RES LAB,B-133,4200 E 9TH AVE,DENVER,CO 80262, USA.				NHLBI NIH HHS [HL 14985] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANDO K, 1989, FEBS LETT, V245, P164, DOI 10.1016/0014-5793(89)80213-3; CERNACEK P, 1989, BIOCHEM BIOPH RES CO, V161, P562, DOI 10.1016/0006-291X(89)92636-3; Coffman JD., 1989, RAYNAUDS PHENOMENON; FAGIUS J, 1985, CARDIOVASC RES, V19, P249, DOI 10.1093/cvr/19.5.249; FURCHGOTT RF, 1989, FASEB J, V3, P2007, DOI 10.1096/fasebj.3.9.2545495; FYHRQUIST F, 1990, BIOCHEM BIOPH RES CO, V169, P217, DOI 10.1016/0006-291X(90)91456-3; Lewis T, 1929, HEART-J STUD CIRC, V15, P7; LINDBLAD LE, 1989, J CARDIOVASC PHARM, V14, P881, DOI 10.1097/00005344-198912000-00014; LUSCHER TF, 1988, TRENDS PHARMACOL SCI, V9, P181, DOI 10.1016/0165-6147(88)90035-1; RAYNAUD M, 1988, LOCAL ASPHYXIA SYMME; SEIBOLD JR, 1985, J CARDIOVASC PHARM, V7, pS95; TABUCHI Y, 1989, BIOCHEM BIOPH RES CO, V159, P1304, DOI 10.1016/0006-291X(89)92252-3; TOMITA K, 1989, NEW ENGL J MED, V321, P1127; VANHOUTTE PM, 1980, AM HEART J, V100, P263; WILKINSON D, 1989, BRIT J SURG, V76, P401, DOI 10.1002/bjs.1800760430; WINER N, 1977, LIFE SCI, V20, P887, DOI 10.1016/0024-3205(77)90042-X; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; YANG ZH, 1990, CIRCULATION, V82, P188, DOI 10.1161/01.CIR.82.1.188; ZAMORA M R, 1990, American Review of Respiratory Disease, V141, pA351	19	217	226	0	5	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 10	1990	336	8724					1144	1147		10.1016/0140-6736(90)92766-B	http://dx.doi.org/10.1016/0140-6736(90)92766-B			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG701	1978025				2022-12-28	WOS:A1990EG70100002
J	[Anonymous]				[Anonymous]			WHO ON LOW-DOSE ORAL INTERFERON-ALPHA FOR AIDS	LANCET			English	Editorial Material																		1990, E AFRICAN MED J S2, V67, pSS64	1	0	0	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 13	1990	336	8720					935	935						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EC456	1976944				2022-12-28	WOS:A1990EC45600026
J	ISAKOV, VA; GRIGORIEV, PY; YAKOVENKO, EP				ISAKOV, VA; GRIGORIEV, PY; YAKOVENKO, EP			TREATMENT OF HELICOBACTER-PYLORI POSITIVE DUODENAL-ULCERS	LANCET			English	Letter											ISAKOV, VA (corresponding author), NI PIROGOV MED INST,DEPT GASTROENTEROL,MOSCOW,USSR.		Isakov, Vasily/A-4876-2011	Isakov, Vasily/0000-0002-4417-8076; Yakovenko, Emiliya P./0000-0002-9730-2587				COGHLAN JG, 1987, LANCET, V2, P1109; DOMSHKE S, 1989, THERAPIEWOCHE, V39, P628; GOODWIN CS, 1986, J ANTIMICROB CHEMOTH, V17, P1, DOI 10.1093/jac/17.1.1; MARSHALL BJ, 1987, GASTROENTEROLOGY, V92, P1518; PORRO GB, 1989, GASTROENTEROL CLIN B, V13, P107	5	10	10	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	SEP 22	1990	336	8717					755	756		10.1016/0140-6736(90)92254-F	http://dx.doi.org/10.1016/0140-6736(90)92254-F			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DZ624	1975930				2022-12-28	WOS:A1990DZ62400055
J	ROUSH, MK; MCNUTT, RA; GRAY, TF				ROUSH, MK; MCNUTT, RA; GRAY, TF			THE ADVERSE EFFECT DILEMMA - QUEST FOR ACCESSIBLE INFORMATION	ANNALS OF INTERNAL MEDICINE			English	Note									UNIV N CAROLINA HOSP, DIV GEN MED & CLIN EPIDEMIOL, 101 MANNING DR, 5TH FLOOR OLD CLIN, CHAPEL HILL, NC 27514 USA	University North Carolina Hospital								Jones J K, 1982, Fam Community Health, V5, P58; PEDROBOTET J, 1990, DICP ANN PHARMAC, V24, P438, DOI 10.1177/106002809002400419; TILKEMEIER P, 1988, NEW ENGL J MED, V318, P1275; 1989, AUSTR ADVERSE DRUG R	4	23	23	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 15	1991	114	4					298	299		10.7326/0003-4819-114-4-298	http://dx.doi.org/10.7326/0003-4819-114-4-298			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EX521	1987877				2022-12-28	WOS:A1991EX52100009
J	CRIST, WM; KUN, LE				CRIST, WM; KUN, LE			COMMON SOLID TUMORS OF CHILDHOOD	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							NATIONAL-WILMS-TUMOR; RETINOBLASTOMA SUSCEPTIBILITY GENE; COMBINED-MODALITY TREATMENT; PAEDIATRIC-ONCOLOGY SIOP; LOCALIZED EWINGS-SARCOMA; NEURO-BLASTOMA; RADIATION-THERAPY; INTERGROUP-RHABDOMYOSARCOMA; ADJUVANT CHEMOTHERAPY; HUMAN NEUROBLASTOMAS		ST JUDE CHILDRENS RES HOSP, DEPT RADIAT ONCOL, MEMPHIS, TN 38101 USA; UNIV TENNESSEE, CTR HLTH SCI,COLL MED,DEPT PEDIAT, DIV HYG & PUBL HLTH, MEMPHIS, TN 38163 USA; UNIV TENNESSEE, CTR HLTH SCI, COLL MED, DEPT RADIAT ONCOL, MEMPHIS, TN 38163 USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	CRIST, WM (corresponding author), ST JUDE CHILDRENS RES HOSP, DEPT HEMATOL ONCOL, POB 318, MEMPHIS, TN 38101 USA.				NATIONAL CANCER INSTITUTE [P01CA023099, P30CA021765] Funding Source: NIH RePORTER; NCI NIH HHS [CA-23099, CA-21765] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ABRAMSON D H, 1985, Journal of Pediatric Ophthalmology and Strabismus, V22, P246; ABRAMSON DH, 1984, OPHTHALMOLOGY, V91, P1351; ABRAMSON DH, 1982, ARCH OPHTHALMOL-CHIC, V100, P1253; ALBRIGHT AL, 1985, CANCER, V55, P2789, DOI 10.1002/1097-0142(19850615)55:12<2789::AID-CNCR2820551212>3.0.CO;2-A; ALVORD EC, 1988, J NEUROSURG, V68, P85, DOI 10.3171/jns.1988.68.1.0085; BACCI G, 1989, CANCER-AM CANCER SOC, V63, P1477, DOI 10.1002/1097-0142(19890415)63:8<1477::AID-CNCR2820630805>3.0.CO;2-8; BECKWITH J B, 1990, Pediatric Pathology, V10, P1; BECKWITH JB, 1983, HUM PATHOL, V14, P481, DOI 10.1016/S0046-8177(83)80003-3; BECKWITH JB, 1986, ARCH PATHOL LAB MED, V110, P98; BECKWITH JB, 1978, CANCER-AM CANCER SOC, V41, P1937, DOI 10.1002/1097-0142(197805)41:5<1937::AID-CNCR2820410538>3.0.CO;2-U; BENEDICT WF, 1990, J CLIN INVEST, V85, P988, DOI 10.1172/JCI114575; BIGNER SH, 1988, CANCER RES, V48, P405; BIGNER SH, 1987, CANCER GENET CYTOGEN, V29, P165, DOI 10.1016/0165-4608(87)90045-8; BIGNER SH, 1988, CANCER GENET CYTOGEN, V30, P91, DOI 10.1016/0165-4608(88)90096-9; BIGNER SH, 1990, CANCER RES, V50, P2347; BIRCH JM, 1988, BRIT MED J, V296, P1372, DOI 10.1136/bmj.296.6633.1372; BLOOM HJG, 1990, INT J RADIAT ONCOL, V18, P723, DOI 10.1016/0360-3016(90)90392-W; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; BRODEUR GM, 1977, CANCER-AM CANCER SOC, V40, P2256, DOI 10.1002/1097-0142(197711)40:5<2256::AID-CNCR2820400536>3.0.CO;2-1; BRODEUR GM, 1988, J CLIN ONCOL, V6, P1874, DOI 10.1200/JCO.1988.6.12.1874; BROECKER BH, 1984, UROLOGY, V24, P170, DOI 10.1016/0090-4295(84)90421-7; BURGERT EO, 1990, J CLIN ONCOL, V8, P1514, DOI 10.1200/JCO.1990.8.9.1514; CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; CANGIR A, 1990, CANCER-AM CANCER SOC, V66, P887, DOI 10.1002/1097-0142(19900901)66:5<887::AID-CNCR2820660513>3.0.CO;2-R; CASTLEBERRY RP, IN PRESS J CLIN ONCO; CAVAZZANA AO, 1987, AM J PATHOL, V127, P507; CAVENEE WK, 1985, SCIENCE, V228, P501, DOI 10.1126/science.3983638; CORTES EP, 1974, NEW ENGL J MED, V291, P998, DOI 10.1056/NEJM197411072911903; COWELL JK, 1983, CANCER GENET CYTOGEN, V9, P273, DOI 10.1016/0165-4608(83)90011-0; CRIST WM, 1990, J CLIN ONCOL, V8, P1768; CRIST WM, 1990, J CLIN ONCOL, V8, P443, DOI 10.1200/JCO.1990.8.3.443; DAHLIN DC, 1961, J BONE JOINT SURG AM, V43, P185, DOI 10.2106/00004623-196143020-00004; DANGIO GJ, 1976, CANCER-AM CANCER SOC, V38, P633, DOI 10.1002/1097-0142(197608)38:2<633::AID-CNCR2820380203>3.0.CO;2-S; DANGIO GJ, 1981, CANCER-AM CANCER SOC, V47, P2302, DOI 10.1002/1097-0142(19810501)47:9<2302::AID-CNCR2820470933>3.0.CO;2-K; DANGIO GJ, 1989, CANCER-AM CANCER SOC, V64, P349, DOI 10.1002/1097-0142(19890715)64:2<349::AID-CNCR2820640202>3.0.CO;2-Q; DANGIO GJ, 1983, J CLIN ONCOL, V1, P595, DOI 10.1200/JCO.1983.1.10.595; DANGIO GJ, 1989, PRINCIPLES PRACTICE, P583; DOUGLASS EC, 1990, CYTOGENET CELL GENET, V53, P87, DOI 10.1159/000132901; DOUGLASS EC, 1987, CYTOGENET CELL GENET, V45, P148, DOI 10.1159/000132446; DOUGLASS EC, 1988, CYTOGENET CELL GENET, V47, P233; DRYJA TP, 1984, NEW ENGL J MED, V310, P550, DOI 10.1056/NEJM198403013100902; DUFFNER PK, 1986, NEUROLOGY, V36, P597, DOI 10.1212/WNL.36.5.597; EDWARDS MSB, 1988, J NEUROSURG, V68, P689, DOI 10.3171/jns.1988.68.5.0689; EGBERT PR, 1978, ARCH OPHTHALMOL-CHIC, V96, P1826; EHRLICH RM, 1979, J UROLOGY, V122, P790, DOI 10.1016/S0022-5347(17)56605-7; EILBER F, 1987, J CLIN ONCOL, V5, P21, DOI 10.1200/JCO.1987.5.1.21; EPSTEIN F, 1986, J NEUROSURG, V64, P11, DOI 10.3171/jns.1986.64.1.0011; EVANS AE, 1990, J NEUROSURG, V72, P572, DOI 10.3171/jns.1990.72.4.0572; EVANS RG, IN PRESS J CLIN ONCO; EVANS WE, 1988, BLUT, V56, P241, DOI 10.1007/BF00320282; EWARDS MSB, 1989, J NEUROSURG, V70, P691; FARBER S, 1966, J AMER MED ASSOC, V198, P826; FAREWELL VT, 1981, CANCER CLIN TRIALS, V4, P167; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; FEARON ER, 1984, NATURE, V309, P176, DOI 10.1038/309176a0; FLETCHER BD, IN PRESS PEDIATR CLI; FONG CT, 1989, P NATL ACAD SCI USA, V86, P3753, DOI 10.1073/pnas.86.10.3753; FRANCKE U, 1979, CYTOGENET CELL GENET, V24, P185, DOI 10.1159/000131375; Francois J, 1977, Mod Probl Ophthalmol, V18, P165; FRIEND SH, 1987, P NATL ACAD SCI USA, V84, P9059, DOI 10.1073/pnas.84.24.9059; FRIEND SH, 1988, P NATL ACAD SCI USA, V85, P2234; FURMAN WL, IN PRESS J CLIN ONCO; GAIGER AM, 1981, NATL CANCER I MONOGR, V56, P19; GANSLER T, 1986, CANCER, V58, P2453, DOI 10.1002/1097-0142(19861201)58:11<2453::AID-CNCR2820581117>3.0.CO;2-I; GESSLER M, 1990, NATURE, V343, P774, DOI 10.1038/343774a0; GOORIN AM, 1984, J CLIN ONCOL, V2, P425, DOI 10.1200/JCO.1984.2.5.425; Green DM., 1985, DIAGNOSIS MANAGEMENT; GRUNDY P, 1988, NATURE, V336, P374, DOI 10.1038/336374a0; HABER DA, 1990, CELL, V61, P1257, DOI 10.1016/0092-8674(90)90690-G; HANN HWL, 1985, CANCER RES, V45, P2843; HAYES FA, 1989, J CLIN ONCOL, V7, P208, DOI 10.1200/JCO.1989.7.2.208; HAYES FA, 1983, J CLIN ONCOL, V1, P45, DOI 10.1200/JCO.1983.1.1.45; HAYES FA, 1989, PRINCIPLES PRACTICE, P607; HEIDEMAN RL, 1989, PRINCIPLES PRACTICE, P505; HEIM S, 1987, CANCER CYTOGENETICS, P227; HEYN R, 1989, J CLIN ONCOL, V7, P200, DOI 10.1200/JCO.1989.7.2.200; HEYN RM, 1974, CANCER-AM CANCER SOC, V34, P2128, DOI 10.1002/1097-0142(197412)34:6<2128::AID-CNCR2820340638>3.0.CO;2-M; HIRSCH JF, 1989, J NEUROSURG, V70, P568, DOI 10.3171/jns.1989.70.4.0568; HORN RC, 1958, CANCER, V11, P181, DOI 10.1002/1097-0142(195801/02)11:1<181::AID-CNCR2820110130>3.0.CO;2-I; HOROWITZ ME, 1988, J CLIN ONCOL, V6, P308, DOI 10.1200/JCO.1988.6.2.308; HOROWITZ ME, 1988, CANCER-AM CANCER SOC, V61, P428, DOI 10.1002/1097-0142(19880201)61:3<428::AID-CNCR2820610304>3.0.CO;2-A; HOWARTH C, 1980, CANCER-AM CANCER SOC, V45, P851, DOI 10.1002/1097-0142(19800301)45:5<851::AID-CNCR2820450505>3.0.CO;2-P; HUFF V, 1988, NATURE, V336, P377, DOI 10.1038/336377a0; HUGHES EN, 1988, CANCER, V61, P1992, DOI 10.1002/1097-0142(19880515)61:10<1992::AID-CNCR2820611011>3.0.CO;2-J; ILGREN EB, 1986, ACTA NEUROCHIR, V81, P11, DOI 10.1007/BF01456260; JAFFE N, 1974, NEW ENGL J MED, V291, P994, DOI 10.1056/NEJM197411072911902; JURGENS H, 1988, CANCER, V61, P23, DOI 10.1002/1097-0142(19880101)61:1<23::AID-CNCR2820610106>3.0.CO;2-M; KELLY PJ, 1989, NEUROSURGERY, V25, P185, DOI 10.1227/00006123-198908000-00006; KNUDSON AG, 1972, J NATL CANCER I, V48, P313; KOCK E, 1986, RADIOTHER ONCOL, V7, P19, DOI 10.1016/S0167-8140(86)80121-9; KOUFOS A, 1984, NATURE, V309, P170, DOI 10.1038/309170a0; KOUFOS A, 1989, AM J HUM GENET, V44, P711; KOVNAR EH, 1990, J CLIN ONCOL, V8, P330, DOI 10.1200/JCO.1990.8.2.330; LAWRENCE W, 1987, J CLIN ONCOL, V5, P46, DOI 10.1200/JCO.1987.5.1.46; LAWS ER, 1984, J NEUROSURG, V61, P665, DOI 10.3171/jns.1984.61.4.0665; LEAPE LL, 1978, ANN SURG, V187, P351, DOI 10.1097/00000658-197804000-00001; LEE WH, 1987, SCIENCE, V235, P1394, DOI 10.1126/science.3823889; LEE WH, 1987, NATURE, V329, P642, DOI 10.1038/329642a0; LEMERLE J, 1976, CANCER, V38, P647, DOI 10.1002/1097-0142(197608)38:2<647::AID-CNCR2820380204>3.0.CO;2-C; LEMERLE J, 1983, J CLIN ONCOL, V1, P604, DOI 10.1200/JCO.1983.1.10.604; LENNOX EL, 1975, BRIT MED J, V3, P731, DOI 10.1136/bmj.3.5986.731; LINK MP, 1986, NEW ENGL J MED, V314, P1600, DOI 10.1056/NEJM198606193142502; LINK MP, 1989, PRINCIPLES PRACTICE, V5, P689; LOOK AT, 1988, NEW ENGL J MED, V318, P1567, DOI 10.1056/NEJM198806163182403; LOOK AT, 1984, NEW ENGL J MED, V311, P231, DOI 10.1056/NEJM198407263110405; LOOK AT, IN PRESS J CLIN ONCO; LUDLOW JW, 1990, CELL, V60, P387, DOI 10.1016/0092-8674(90)90590-B; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; MARCUS RB, 1988, INT J RADIAT ONCOL, V15, P53, DOI 10.1016/0360-3016(88)90346-X; MAURER HM, 1977, CANCER-AM CANCER SOC, V40, P2015, DOI 10.1002/1097-0142(197711)40:5<2015::AID-CNCR2820400505>3.0.CO;2-K; MAURER HM, IN PRESS CANCER; MCEWAN AJ, 1986, APPL RADIAT ISOTOPES, V37, P765, DOI 10.1016/0883-2889(86)90271-6; MEADOWS AT, 1980, STATUS CURABILITY CH, P263; MEYER WH, 1987, CANCER-AM CANCER SOC, V59, P374, DOI 10.1002/1097-0142(19870115)59:2<374::AID-CNCR2820590235>3.0.CO;2-6; MEYER WH, 1990, ADJUVANT THERAPY CAN, V6, P580; MISER JS, 1987, J CLIN ONCOL, V5, P1191, DOI 10.1200/JCO.1987.5.8.1191; MISER JS, 1989, PRINCIPLES PRACTICE, P659; Nesbit M E Jr, 1981, Natl Cancer Inst Monogr, P255; NESBIT ME, 1990, J CLIN ONCOL, V8, P1664, DOI 10.1200/JCO.1990.8.10.1664; ORKIN SH, 1984, NATURE, V309, P172, DOI 10.1038/309172a0; PACKER RJ, 1985, ANN NEUROL, V18, P217, DOI 10.1002/ana.410180209; PACKER RJ, 1988, ANN NEUROL, V23, P79, DOI 10.1002/ana.410230113; PACKER RJ, 1990, ANN NEUROL, V27, P167, DOI 10.1002/ana.410270212; PACKER RJ, 1988, ANN NEUROL, V24, P503, DOI 10.1002/ana.410240405; PESIN SR, 1989, AM J OPHTHALMOL, V107, P121, DOI 10.1016/0002-9394(89)90209-2; PILEPICH MV, 1981, CANCER, V47, P1930, DOI 10.1002/1097-0142(19810415)47:8<1930::AID-CNCR2820470803>3.0.CO;2-3; PINTO A, 1989, CANCER-AM CANCER SOC, V64, P1266, DOI 10.1002/1097-0142(19890915)64:6<1266::AID-CNCR2820640617>3.0.CO;2-0; PRATT CB, 1990, CANCER-AM CANCER SOC, V65, P439, DOI 10.1002/1097-0142(19900201)65:3<439::AID-CNCR2820650311>3.0.CO;2-W; PRITCHARDJONES K, 1990, NATURE, V346, P194, DOI 10.1038/346194a0; RANEY RB, 1987, CANCER-AM CANCER SOC, V59, P147, DOI 10.1002/1097-0142(19870101)59:1<147::AID-CNCR2820590129>3.0.CO;2-8; RANEY RB, 1989, PRINCIPLES PRACTICE, P635; ROARTY JD, 1988, OPHTHALMOLOGY, V95, P1583; ROSEN EM, 1984, J CLIN ONCOL, V2, P719, DOI 10.1200/JCO.1984.2.7.719; ROSEN G, 1982, CANCER-AM CANCER SOC, V49, P1221, DOI 10.1002/1097-0142(19820315)49:6<1221::AID-CNCR2820490625>3.0.CO;2-E; RUBIN CM, 1985, J CLIN ONCOL, V3, P680, DOI 10.1200/JCO.1985.3.5.680; SAILER SL, 1988, INT J RADIAT ONCOL, V15, P43, DOI 10.1016/0360-3016(88)90345-8; SCHIPPER J, 1985, RADIOTHER ONCOL, V3, P117, DOI 10.1016/S0167-8140(85)80016-5; SCRABLE H, 1989, GENE CHROMOSOME CANC, V1, P23, DOI 10.1002/gcc.2870010106; SCRABLE HJ, 1987, NATURE, V329, P645, DOI 10.1038/329645a0; SHAFFORD EA, 1984, J CLIN ONCOL, V2, P742, DOI 10.1200/JCO.1984.2.7.742; SHAPIRO DN, 1991, J CLIN ONCOL, V9, P159, DOI 10.1200/JCO.1991.9.1.159; SHAW EG, 1989, INT J RADIAT ONCOL, V16, P663, DOI 10.1016/0360-3016(89)90482-3; SMITH EI, 1980, ANN SURG, V191, P561, DOI 10.1097/00000658-198005000-00007; SMITH LM, 1989, INT J RADIAT ONCOL, V17, P499, DOI 10.1016/0360-3016(89)90100-4; STANNARD C, 1979, BRIT J OPHTHALMOL, V63, P560, DOI 10.1136/bjo.63.8.560; SUTOW WW, 1970, CANCER, V25, P1384, DOI 10.1002/1097-0142(197006)25:6<1384::AID-CNCR2820250617>3.0.CO;2-T; TAIT DM, 1990, EUR J CANCER, V26, P464; TAYLOR WF, 1978, MAYO CLIN PROC, V53, P695; TEFFT M, 1976, CANCER, V37, P1201, DOI 10.1002/1097-0142(197602)37:2+<1201::AID-CNCR2820370831>3.0.CO;2-B; THAMES HD, 1983, INT J RADIAT ONCOL, V9, P127, DOI 10.1016/0360-3016(83)90089-5; TIJSSEN CC, 1982, DEV ONCOLOGY, V9; TOMITA T, 1986, J NEUROSURG, V64, P238, DOI 10.3171/jns.1986.64.2.0238; TURCCAREL C, 1988, CANCER GENET CYTOGEN, V32, P229, DOI 10.1016/0165-4608(88)90285-3; TURCCAREL C, 1986, CANCER GENET CYTOGEN, V19, P361, DOI 10.1016/0165-4608(86)90069-5; TURLEAU C, 1984, HUM GENET, V67, P455, DOI 10.1007/BF00291410; VALENTINE M, 1989, CYTOGENET CELL GENET, V52, P128, DOI 10.1159/000132861; VOGEL F, 1979, HUM GENET, V52, P1; VOUTE PA, 1987, MED PEDIATR ONCOL, V15, P192; WANGWUU S, 1990, CANCER RES, V50, P2786; WEINBERG RA, 1989, CANCER RES, V49, P3713; WHANGPENG J, 1986, CANCER GENET CYTOGEN, V21, P185, DOI 10.1016/0165-4608(86)90001-4; WHANGPENG J, 1984, NEW ENGL J MED, V311, P584, DOI 10.1056/NEJM198408303110907; WHITE L, 1983, RETINA-J RET VIT DIS, V3, P194, DOI 10.1097/00006982-198300330-00009; WILBUR JR, 1974, CANCER CHEMOTH REP 1, V58, P281; WILIMAS JA, 1988, J CLIN ONCOL, V6, P1144, DOI 10.1200/JCO.1988.6.7.1144; YANDELL DW, 1989, NEW ENGL J MED, V321, P1689, DOI 10.1056/NEJM198912213212501; YOUNG J L JR, 1986, Cancer, V58, P598, DOI 10.1002/1097-0142(19860715)58:2+<598::AID-CNCR2820581332>3.0.CO;2-C; YOUNG JL, 1975, J PEDIATR-US, V86, P254, DOI 10.1016/S0022-3476(75)80484-7; 1991, J CLIN ONCOL, V9, P189; 1988, J NEUROONCOL, V6, P9	170	175	179	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 14	1991	324	7					461	471		10.1056/NEJM199102143240706	http://dx.doi.org/10.1056/NEJM199102143240706			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EX363	1988832				2022-12-28	WOS:A1991EX36300006
J	MARTIN, LG				MARTIN, LG			POPULATION AGING POLICIES IN EAST-ASIA AND THE UNITED-STATES	SCIENCE			English	Article								As a result of successful efforts to reduce fertility and mortality, East Asian populations are beginning to age, in some cases rapidly. Policies in response to population aging range from attempts in Singapore to reverse it by encouraging more births to efforts in Japan to accommodate it by increasing employment opportunities for older workers. The populations of the United States, which had a longer postwar baby boom, is aging more slowly than these two countries and may be able to learn from the East Asian experience with aging policies.			MARTIN, LG (corresponding author), NATL ACAD SCI,NATL RES COUNCIL,COMM POPULAT,2101 CONSTITUT AVE NW,WASHINGTON,DC 20418, USA.							BURKHAUSER RV, IN PRESS RES LABOR E; BUTLER RN, 1990, WASHINGTON POST 0605, P6; Chen A.J., 1988, ELDERLY SINGAPORE; CHEUNG PL, 1989, 1989 INT POP C NEW D, P133; CHEUNG PPL, 1989, ASIA PAC POP J, V4, P41; Clark Robert, 1990, RETIREMENT SYSTEMS J; FAWCETT JT, 1980, POPUL DEV REV, V6, P549, DOI 10.2307/1972926; FRIES JF, 1989, MILBANK Q, V67, P208, DOI 10.2307/3350138; GOLDSTEIN C, 1990, FAR E EC REV, V148, P49; HOON SJ, 1990, FAR E EC REV, V148, P19; KOJIMA H, 1990, AUG ANN M AM SOC ASS; KOTKIN J, 1988, 3RD CENTURY AM RESUR; LIANG J, 1989, CARING AGING WORLD, P278; MAEDA N, 1989, CARING AGING WORLD, P253; MANTON KG, 1989, MILBANK Q, V67, P13, DOI 10.2307/3350235; MARTIN LG, 1990, ANN AM ACAD POLIT SS, V510, P102, DOI 10.1177/0002716290510001008; MARTIN LG, 1988, J GERONTOL, V43, pS99, DOI 10.1093/geronj/43.4.S99; MARTIN LG, 1989, POP B, V44; MOORE J, 1990, FAR E EC REV, V148, P19; OGAWA N, 1988, EC SOCIAL IMPLICATIO, P272; OSAKO M, 1988, PROD AGING NEWS, V25, P1; Phua KH, 1987, WORLD HEALTH FORUM, V8, P38; ROBINSON WC, 1989, 1989 INT POP C NEW D, P143; ROGERS RG, 1989, MILBANK Q, V67, P370, DOI 10.2307/3350221; SALEM E, 1988, FAR E EC REV, V141, P141; Sanger David, 1990, NEW YORK TIMES  0707, pA9; SANGER DE, 1990, NY TIMES        0619, pA2; Schulz J., 1989, LIFETIME EMPLOYMENT; SEIKE A, 1989, 2862 RAND NOT; TASKER R, 1990, FAR E EC REV, V148, P18; WATTENBERG BJ, 1990, COMMENTARY, V23; YU YC, 1987, APR ANN M POP ASS AM; 1989, WORLD POPULATION PRO; 1988, EMPLOY EARN, V35, P160; 1987, REPORT INT COMP SURV; 1987, HLTH STATISTICS OLDE, P64; 1989, FAR E EC REV, V145, P14; 1987, EMPLOYMENT MANAGERME; 1988, 1987 JAP STAT BUR AN, P23; 1990, SCOPE CTR IMMIGRATIO, P8	40	24	24	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	FEB 1	1991	251	4993					527	531		10.1126/science.1990428	http://dx.doi.org/10.1126/science.1990428			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV459	1990428				2022-12-28	WOS:A1991EV45900041
J	ROCCELLA, EJ				ROCCELLA, EJ			NATIONAL EDUCATION-PROGRAMS WORKING GROUP-REPORT ON THE MANAGEMENT OF PATIENTS WITH HYPERTENSION AND HIGH BLOOD CHOLESTEROL	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY HEART-DISEASE; PRIMARY-PREVENTION TRIAL; SERUM LIPOPROTEIN LEVELS; RISK-FACTORS; FOLLOW-UP; MYOCARDIAL-INFARCTION; ORAL-CONTRACEPTIVES; CARDIOVASCULAR-DISEASE; TRANSPLANT RECIPIENTS; NEPHROTIC SYNDROME	Cardiovascular diseases are responsible for nearly one of every two deaths in the United States, and have been estimated to cost more than $127 billion annually. Epidemiologic data have shown that persons with fewer or lower levels of the risk factors for cardiovascular disease are less likely to have a cardiovascular event. In addition, the greater the level of any single risk factor, the greater is the chance of incurring disease. Moreover, a combination of risk factors creates a synergistic effect, further increasing risk. Conversely, reducing the number and level of risk factors prevents death and disability from cardiovascular diseases. This report addresses the management of patients with several cardiovascular risk factors, placing a special emphasis on hypertension and high blood cholesterol. Nonpharmacologic therapy, in the form of proper diet, exercise, and smoking cessation, is the foundation for management of both hypertension and high blood cholesterol. Clinicians should use these nondrug measures as definitive or adjunctive therapy. Pharmacologic agents can be very beneficial in managing the risks imposed by elevated levels of blood pressure or blood cholesterol. In selecting medications, it is important to weigh their benefits, costs, and potential untoward effects. Clinicians must consider these issues in managing patients with several risk factors but should not avoid managing any risk factor or quickly dismiss any particular mode of therapy simply because of the potential for adverse effects.			ROCCELLA, EJ (corresponding author), NHLBI, BLDG 31, ROOM 4A05, BETHESDA, MD 20892 USA.							ABBOTT RD, 1988, JAMA-J AM MED ASSOC, V260, P3456, DOI 10.1001/jama.260.23.3456; ALEXANDER JH, 1974, MED J AUSTRALIA, V2, P119, DOI 10.5694/j.1326-5377.1974.tb93641.x; AMES RP, 1976, AM J MED, V61, P748, DOI 10.1016/0002-9343(76)90156-X; [Anonymous], 1988, ARCH INTERN MED, V148, P1023; [Anonymous], 1975, JAMA-J AM MED ASSOC, V231, P360; USA Pooling Project Research Group, 1978, Journal of Chronic Diseases, V31, P201; [Anonymous], 1987, PEDIATRICS, V79, P1; BALLANTYNE CM, 1989, JAMA-J AM MED ASSOC, V262, P53, DOI 10.1001/jama.262.1.53; BENFANTE R, 1990, JAMA-J AM MED ASSOC, V263, P393, DOI 10.1001/jama.263.3.393; BERGKVIST L, 1989, NEW ENGL J MED, V321, P293, DOI 10.1056/NEJM198908033210505; BERGLUND G, 1981, LANCET, V1, P744; BERLYNE GM, 1969, LANCET, V2, P399; BLANKENHORN DH, 1987, JAMA-J AM MED ASSOC, V257, P3233, DOI 10.1001/jama.257.23.3233; BURKMAN RT, 1988, OBSTET GYNECOL, V71, P33; BUSH TL, 1987, CIRCULATION, V75, P1102, DOI 10.1161/01.CIR.75.6.1102; CANNER PL, 1986, J AM COLL CARDIOL, V8, P1245, DOI 10.1016/S0735-1097(86)80293-5; CHOBANIAN AV, 1983, PROG CARDIOVASC DIS, V26, P177, DOI 10.1016/0033-0620(83)90005-1; CHOBANIAN AV, 1989, HYPERTENSION, V14, P203, DOI 10.1161/01.HYP.14.2.203; CLEEMAN JI, 1988, ARCH INTERN MED, V148, P36, DOI 10.1001/archinte.148.1.36; CORPIER CL, 1988, JAMA-J AM MED ASSOC, V260, P239, DOI 10.1001/jama.260.2.239; CRESSMAN MD, 1988, CLIN RES, V36, pA540; CRIQUI MH, 1989, AM J EPIDEMIOL, V129, P1110, DOI 10.1093/oxfordjournals.aje.a115233; FERRANNINI E, 1987, NEW ENGL J MED, V317, P350, DOI 10.1056/NEJM198708063170605; FORD CE, 1988, JAMA-J AM MED ASSOC, V259, P2113; FREEDMAN DS, 1988, CIRCULATION, V77, P856, DOI 10.1161/01.CIR.77.4.856; FRICK MH, 1987, NEW ENGL J MED, V317, P1237, DOI 10.1056/NEJM198711123172001; GASPARD UJ, 1985, CONTRACEPTION, V31, P395, DOI 10.1016/0010-7824(85)90006-X; GILLUM RF, 1987, J CHRON DIS, V40, P421, DOI 10.1016/0021-9681(87)90175-5; GLUECK CJ, 1986, AM J CLIN NUTR, V44, P489, DOI 10.1093/ajcn/44.4.489; GOLDMAN AI, 1980, JAMA-J AM MED ASSOC, V244, P1691, DOI 10.1001/jama.244.15.1691; GREENBERG G, 1985, BMJ-BRIT MED J, V291, P97; GRIMM RH, 1981, ANN INTERN MED, V94, P7, DOI 10.7326/0003-4819-94-1-7; GRUNDY SM, 1990, KIDNEY INT, V37, P847, DOI 10.1038/ki.1990.57; GRUNDY SM, 1989, ARCH INTERN MED, V149, P505, DOI 10.1001/archinte.149.3.505; HARLAN WR, 1989, 7 NIH PHS US DEP HLT; HARRIS T, 1988, J AM GERIATR SOC, V36, P1023, DOI 10.1111/j.1532-5415.1988.tb04370.x; Health. & N.R.C.U.C.o.D.a., 1989, DIET HLTH IMPLICATIO; IBELS LS, 1974, BRIT MED J, V3, P552, DOI 10.1136/bmj.3.5930.552; KANNEL WB, 1986, AM HEART J, V112, P825, DOI 10.1016/0002-8703(86)90481-3; KANNEL WB, 1967, ANN INTERN MED, V67, P48, DOI 10.7326/0003-4819-67-1-48; KASISKE BL, 1988, AM J MED, V84, P985, DOI 10.1016/0002-9343(88)90302-6; KLATSKY AL, 1982, ANNU REV NUTR, V2, P51, DOI 10.1146/annurev.nu.02.070182.000411; LARDINOIS CK, 1988, ARCH INTERN MED, V148, P1280, DOI 10.1001/archinte.148.6.1280; LAZARUS JM, 1975, KIDNEY INT, V7, pS167; LERNER DJ, 1986, AM HEART J, V111, P383, DOI 10.1016/0002-8703(86)90155-9; LIPSON A, 1986, CONTRACEPTION, V34, P121, DOI 10.1016/0010-7824(86)90065-X; LOBO RA, 1987, OBSTET GYN CLIN N AM, V14, P143; MACMAHON SW, 1986, PROG CARDIOVASC DIS, V29, P99, DOI 10.1016/0033-0620(86)90038-1; MALLICK NP, 1981, NEPHRON, V27, P54, DOI 10.1159/000182024; MANDEL FP, 1982, OBSTET GYNECOL, V59, P673; MARGOLIS JR, 1973, AM J CARDIOL, V32, P1, DOI 10.1016/S0002-9149(73)80079-7; NESTEL PJ, 1982, NEW ENGL J MED, V307, P329, DOI 10.1056/NEJM198208053070601; NEWMAN WP, 1986, NEW ENGL J MED, V314, P138, DOI 10.1056/NEJM198601163140302; OLIVER M F, 1978, British Heart Journal, V40, P1069, DOI 10.1136/hrt.40.10.1069; PARVING HH, 1983, LANCET, V1, P1175; POLLARE T, 1989, NEW ENGL J MED, V321, P868, DOI 10.1056/NEJM198909283211305; PORTER GA, 1990, ARCH INTERN MED, V150, P280; REAVEN GM, 1987, LANCET, V2, P435; REISIN E, 1983, ANN INTERN MED, V98, P315, DOI 10.7326/0003-4819-98-3-315; RIFKIND BM, 1984, JAMA-J AM MED ASSOC, V251, P365; RIFKIND BM, 1984, JAMA-J AM MED ASSOC, V251, P351; RIGOTTI NA, 1989, NEW ENGL J MED, V320, P931, DOI 10.1056/NEJM198904063201409; ROBERTSON WB, 1968, LAB INVEST, V18, P538; ROCCELLA EJ, 1985, HYPERTENSION, V7, P457; ROCCELLA EJ, 1986, JAMA-J AM MED ASSOC, V256, P70; ROCCELLA EJ, 1986, HYPERTENSION, V8, P444; SCHONFELD G, 1974, DIABETES, V23, P827, DOI 10.2337/diab.23.10.827; SEMPOS C, 1989, JAMA-J AM MED ASSOC, V262, P45, DOI 10.1001/jama.262.1.45; SLONE D, 1981, NEW ENGL J MED, V305, P420, DOI 10.1056/NEJM198108203050802; STADEL BV, 1981, NEW ENGL J MED, V305, P612, DOI 10.1056/NEJM198109103051104; Stamler J, 1989, Hypertension, V13, pI2; STAMLER J, 1986, JAMA-J AM MED ASSOC, V256, P2823, DOI 10.1001/jama.256.20.2823; SWEDBERG SH, 1989, CIRCULATION, V80, P1726, DOI 10.1161/01.CIR.80.6.1726; TOBERT JA, 1988, AM J CARDIOL, V62, pJ28, DOI 10.1016/0002-9149(88)90004-5; WEIDLE PJ, 1988, DRUG INTEL CLIN PHAR, V22, P443, DOI 10.1177/106002808802200601; WHITEHEAD MI, 1982, J REPROD MED, V27, P539; WILLIAMS RR, 1988, JAMA-J AM MED ASSOC, V259, P3579, DOI 10.1001/jama.259.24.3579; Wing A J, 1978, Proc Eur Dial Transplant Assoc, V15, P2; WOLF PA, 1981, JAMA-J AM MED ASSOC, V245, P1442, DOI 10.1001/jama.245.14.1442; WOOD PD, 1988, NEW ENGL J MED, V319, P1173, DOI 10.1056/NEJM198811033191801; YUSUF S, 1988, JAMA-J AM MED ASSOC, V260, P2259, DOI 10.1001/jama.260.15.2259; 1989, DIAGNOSIS MANAGEMENT; 1986, CLIN OPPORTUNITIES S; 1988, NATIONAL HEART LUNG; 1982, JAMA-J AM MED ASSOC, V248, P2004; 1987, ARCH INTERN MED, V147, P830; 1988, FRAMINGHAM STUDY EPI; 1987, PHYSICIANS GUIDE IMP; 1984, PHYSICIANS GUIDE HEL	89	64	67	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 1	1991	114	3					224	237		10.7326/0003-4819-114-3-224	http://dx.doi.org/10.7326/0003-4819-114-3-224			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EV339	1984747				2022-12-28	WOS:A1991EV33900011
J	MOSS, TJ; REYNOLDS, CP; SATHER, HN; ROMANSKY, SG; HAMMOND, GD; SEEGER, RC				MOSS, TJ; REYNOLDS, CP; SATHER, HN; ROMANSKY, SG; HAMMOND, GD; SEEGER, RC			PROGNOSTIC VALUE OF IMMUNOCYTOLOGIC DETECTION OF BONE-MARROW METASTASES IN NEUROBLASTOMA	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NEURO-BLASTOMA CELLS; MONOCLONAL-ANTIBODY DETECTION; BREAST-CANCER PATIENTS; LUNG-CANCER; CHILDRENS CANCER; MICRO-METASTESES; MODEL SYSTEM; TUMOR-CELLS; TRANSPLANTATION; AGE	Background. Morphologic evaluation of bone marrow for neuroblastoma cells is a routine and important component of clinical staging. Specific immunostaining of malignant cells with monoclonal antibodies should be more sensitive, however, and may improve the detection of metastases and provide additional prognostic information. Methods. We looked for tumor cells in bone marrow from 197 patients with newly diagnosed neuroblastoma, using immunoperoxidase staining with monoclonal antibodies (immunocytologic analysis) and examination of smears and specimens obtained by trephine biopsy (conventional analysis). Results. Routine smears and trephine-biopsy specimens were positive for tumor cells in 46 percent of the patients, whereas 67 percent were positive on immunocytologic analysis (P < 0.0001). Immunocytologic analysis detected bone marrow metastases in 34 percent of patients considered to have only localized or regional disease (Stage l, ll, or lll). It also identified tumor cells that were not detected by conventional analysis in patients with widespread disease (Stage IV or IVS). Tumor content, as determined by immunocytologic analysis, predicted clinical outcome in relation to the age of the patient at diagnosis. Patients with Stage ll or lll disease diagnosed after one year of age who did not have occult marrow etastases did well, whereas those with matastases did poorly (P = 0.006). Patients in whom Stage IV disease was diagnosed before they were one year of age did well if bone marrow metastases were few or absent, but had poor survival if the marrow contained more than 0.02 percent tumor cells (P = 0.03). Conclusions. Immunocytologic analysis of bone marrow aspirates is more sensitive than conventional analysis in detecting tumor cells and provides prognostic information. The relations among marrow metastases, age at diagnosis, and clinical outcome illustrate the biologic heterogeneity of neuroblastoma.	ST JUDE HOSP, FULLERTON, CA USA; UNIV CALIF LOS ANGELES, SCH MED, LOS ANGELES, CA 90024 USA; CHILDRENS CANC STUDY GRP, PASADENA, CA USA; JONSSON COMPREHENS CANC CTR, LOS ANGELES, CA USA; UNIV SO CALIF, SCH MED, LOS ANGELES, CA 90033 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of Southern California				Reynolds, C. Patrick/0000-0002-2827-8536	NATIONAL CANCER INSTITUTE [P30CA016042, U10CA027678, R01CA022794] Funding Source: NIH RePORTER; NCI NIH HHS [CA-22794, CA-27678, CA-16042] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BAYLE C, 1985, EUR PAEDIATR HAEMAT, V2, P123, DOI 10.3109/08880018509141220; BECK D, 1988, EUR J PEDIATR, V147, P609, DOI 10.1007/BF00442474; BERGER U, 1988, AM J CLIN PATHOL, V90, P1; BOSTROM B, 1985, AM J PEDIAT HEMATOL, V7, P303; BRESLOW N, 1971, CANCER RES, V31, P2098; CANON JL, 1988, EUR J CANCER CLIN ON, V24, P147, DOI 10.1016/0277-5379(88)90245-3; CHEUNG NKV, 1986, J CLIN ONCOL, V4, P363, DOI 10.1200/JCO.1986.4.3.363; COMBARET V, 1989, BRIT J CANCER, V59, P844, DOI 10.1038/bjc.1989.180; COX DR, 1972, J R STAT SOC B, V34, P187; EVANS AE, 1987, CANCER, V59, P1853, DOI 10.1002/1097-0142(19870601)59:11<1853::AID-CNCR2820591102>3.0.CO;2-F; EVANS AE, 1981, ARCH DIS CHILD, V56, P271, DOI 10.1136/adc.56.4.271; EVANS AE, 1971, CANCER, V27, P374, DOI 10.1002/1097-0142(197102)27:2<374::AID-CNCR2820270221>3.0.CO;2-G; EVANS AE, 1985, HYBRIDOMA, V4, P289, DOI 10.1089/hyb.1985.4.289; EVANS AE, 1976, CANCER, V38, P661, DOI 10.1002/1097-0142(197608)38:2<661::AID-CNCR2820380206>3.0.CO;2-M; FAVROT MC, 1986, BRIT J CANCER, V54, P637, DOI 10.1038/bjc.1986.220; FLEISS JL, 1973, STATISTICAL METHODS, P72; FRANKLIN IM, 1983, J CLIN PATHOL, V36, P1215, DOI 10.1136/jcp.36.11.1215; FREW AJ, 1986, BRIT J CANCER, V53, P555, DOI 10.1038/bjc.1986.86; GHOSH AK, 1985, BRIT J HAEMATOL, V61, P21, DOI 10.1111/j.1365-2141.1985.tb04056.x; HANN HWL, 1985, CANCER RES, V45, P2843; HARTMANN O, 1986, CANCER CHEMOTH PHARM, V16, P165; HARTMANN O, 1987, J CLIN ONCOL, V5, P1205, DOI 10.1200/JCO.1987.5.8.1205; HARTMANN O, 1986, J CLIN ONCOL, V4, P1804, DOI 10.1200/JCO.1986.4.12.1804; HOLLANDER M, 1973, NONPARAMETRIC STAT M, P67; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; JONAK ZL, 1982, HYBRIDOMA, V1, P349, DOI 10.1089/hyb.1.1982.1.349; JOSHI SS, 1987, BONE MARROW TRANSPL, V1, P303; LOOK AT, 1984, NEW ENGL J MED, V311, P231, DOI 10.1056/NEJM198407263110405; MANSI JL, 1989, J CLIN ONCOL, V7, P445, DOI 10.1200/JCO.1989.7.4.445; MILLIS A E, 1986, Pediatric Pathology, V5, P225; Moss T J, 1985, Prog Clin Biol Res, V175, P367; MOSS TJ, 1988, J NEUROIMMUNOL, V20, P3, DOI 10.1016/0165-5728(88)90108-7; NITSCHKE R, 1988, J CLIN ONCOL, V6, P1271, DOI 10.1200/JCO.1988.6.8.1271; OPPEDAL BR, 1989, HUM PATHOL, V20, P800, DOI 10.1016/0046-8177(89)90076-2; OSBORNE MP, 1989, CANCER RES, V49, P2510; PETO R, 1977, BRIT J CANCER, V35, P1, DOI 10.1038/bjc.1977.1; PHILIP T, 1987, J CLIN ONCOL, V5, P266, DOI 10.1200/JCO.1987.5.2.266; PORRO G, 1988, CANCER, V61, P2407, DOI 10.1002/1097-0142(19880615)61:12<2407::AID-CNCR2820611202>3.0.CO;2-G; REDDING WH, 1983, LANCET, V2, P1271; Reynolds C P, 1985, Prog Clin Biol Res, V175, P425; REYNOLDS CP, 1986, CANCER RES, V46, P5882; REYNOLDS CP, 1986, J NATL CANCER I, V76, P375; REYNOLDS CP, 1990, CANCER TREATMENT, P489; ROGERS DW, 1989, J CLIN PATHOL, V42, P422, DOI 10.1136/jcp.42.4.422; SCHULZ G, 1984, CANCER RES, V44, P5914; SEEGER RC, 1985, NEW ENGL J MED, V313, P1111, DOI 10.1056/NEJM198510313131802; SEEGER RC, 1982, J IMMUNOL, V128, P983; SEEGER RC, 1977, CANCER RES, V37, P1364; SEEGER RC, 1987, AUTOLOGOUS MARROW TR, P375; SHIMADA H, 1984, J NATL CANCER I, V73, P405, DOI 10.1093/jnci/73.2.405; SMITH RG, 1987, DIAGN CLIN IMMUNOL, V5, P209; STAHEL RA, 1985, J CLIN ONCOL, V3, P455, DOI 10.1200/JCO.1985.3.4.455; STEPHENSON SR, 1986, CANCER, V58, P372, DOI 10.1002/1097-0142(19860715)58:2<372::AID-CNCR2820580229>3.0.CO;2-2; TAHA M, 1989, BONE MARROW TRANSPL, V4, P297; YOUNG JL, 1975, J PEDIATR-US, V86, P254, DOI 10.1016/S0022-3476(75)80484-7; ZELTZER PM, 1983, LANCET, V2, P361	56	222	232	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 24	1991	324	4					219	226		10.1056/NEJM199101243240403	http://dx.doi.org/10.1056/NEJM199101243240403			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU022	1985243	Bronze			2022-12-28	WOS:A1991EU02200003
J	SMITH, JS; FISHBEIN, DB; RUPPRECHT, CE; CLARK, K				SMITH, JS; FISHBEIN, DB; RUPPRECHT, CE; CLARK, K			UNEXPLAINED RABIES IN 3 IMMIGRANTS IN THE UNITED-STATES - A VIROLOGICAL INVESTIGATION	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MONOCLONAL-ANTIBODIES; ANTIGENIC SITES; VIRUS; NUCLEOPROTEIN; DIAGNOSIS	Background. Extensive investigation of three patients who died of rabies in the United States failed to reveal any source of exposure to the disease. The three patients had immigrated to the United States from areas in Laos, the Philippines, and Mexico where rabies is endemic. Methods. We studied rabies viruses isolated from the three patients, other patients with a known source of exposure, and animals in the United States, Thailand (as a proxy for Laos), the Philippines, and Mexico. The viruses were characterized by indirect immunofluorescence and neutralization tests according to their reactions to panels of monoclonal antibodies. Transcribed complementary DNA from these isolates was amplified by the polymerase chain reaction; the DNA product was then analyzed by differential digestion with restriction enzymes. Results. The viral isolate from each of the three patients was a rabies variant with distinctive antigenic or genetic characteristics. For each of the three isolates, identical variants were found in specimens from rabid animals obtained from or near the country in which the patient lived before immigrating to the United States. None of these variants were found among the isolates collected from rabid animals in the United States Conclusions. Rabies infection in these three patients did not originate in the United States but resulted from exposures in Laos, the Philippines, and Mexico. Since the three patients had lived in the United States for 4 years, 6 years, and 11 months, our findings suggest that the onset of the clinical manifestations of rabies occurred after long incubation periods.	WISTAR INST, RABIES UNIT, PHILADELPHIA, PA 19104 USA; TEXAS STATE HLTH DEPT, DIV ZOONOSES CONTROL, AUSTIN, TX USA	The Wistar Institute	SMITH, JS (corresponding author), CTR DIS CONTROL, CTR INFECT DIS, DIV VIRAL & RICKETTSIAL DIS, VIRAL & RICKETTSIAL ZOONOSES BRANCH, ATLANTA, GA 30333 USA.		Rupprecht, Charles/AAI-1544-2020					ANDERSON LJ, 1984, ANN INTERN MED, V100, P728, DOI 10.7326/0003-4819-100-5-728; BAER G M, 1990, P883; BERZON DR, 1972, AM J PUBLIC HEALTH N, V62, P422, DOI 10.2105/AJPH.62.3.422; DEAN DJ, 1973, WHO MONOGR SER, V23, P73; DEMPSTER G, 1972, C J PUBLIC HEALTH, V63, P215; FAOAGALI JL, 1988, MED J AUSTRALIA, V149, P702, DOI 10.5694/j.1326-5377.1988.tb120831.x; FARRELL RE, 1989, CLIN BIOTECHNOL, V1, P50; FEKADU M, 1982, J INFECT DIS, V145, P715, DOI 10.1093/infdis/145.2.715; FEKADU M, 1982, AM J EPIDEMIOL, V115, P266, DOI 10.1093/oxfordjournals.aje.a113298; GAVRILA I, 1967, ANN I PASTEUR PARIS, V112, P504; GREENWOOD, 1945, Health Organ Bull, V12, P301; HELD JR, 1967, PUBLIC HEALTH REP, V82, P1009, DOI 10.2307/4593183; HUMPHREY GL, 1960, PUBLIC HEALTH REP, V75, P317, DOI 10.2307/4590791; IWASAKI Y, 1985, J NEUROPATH EXP NEUR, V44, P185, DOI 10.1097/00005072-198503000-00007; Iyengar K R K, 1935, Ind Med Gaz, V70, P562; KAPLAN C, 1986, RABIES FACTS, P18; LAFON M, 1985, J GEN VIROL, V66, P2125, DOI 10.1099/0022-1317-66-10-2125; LAFON M, 1983, J GEN VIROL, V64, P843, DOI 10.1099/0022-1317-64-4-843; LAKHANPAL U, 1985, INT J EPIDEMIOL, V14, P614, DOI 10.1093/ije/14.4.614; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; PARRISH HM, 1959, PUBLIC HEALTH REP, V74, P891, DOI 10.2307/4590605; RUPPRECHT CE, 1989, PROGR RABIES CONTROL, P79; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; Sambrook J, 1989, MOL CLONING LABORATO; SMITH JS, 1989, ADV VIRUS RES, V36, P215; SMITH JS, 1984, J CLIN MICROBIOL, V19, P267, DOI 10.1128/JCM.19.2.267-272.1984; THONGCHAROEN P, 1985, RABIES TROPICS, P55; TORDO N, 1986, NUCLEIC ACIDS RES, V14, P2671, DOI 10.1093/nar/14.6.2671; VAUGHN JB, 1965, J AMER MED ASSOC, V193, P363, DOI 10.1001/jama.1965.03090050039010; WILSON JM, 1975, LANCET, V2, P1139; WINKLER WG, 1973, JAMA-J AM MED ASSOC, V226, P1219, DOI 10.1001/jama.226.10.1219; 1979, MMWR, V28, P297; 1981, MMWR, V30, P343; 1989, MMWR CDC SURVEILL SU, V38, P1; 1984, MMWR, V33, P633; 1979, MMWR, V28, P315; 1979, MMWR, V28, P292; 1989, MMWR, V38, P335; 1984, MMWR, V33, P469; 1985, RABIES SURVEILLANCE; 1979, MMWR, V28, P321; 1977, MMWR, V26, P183; 1961, MMWR, V10, P2; 1985, MMWR, V34, P700; 1988, MMWR, V37, P305; 1981, MMWR, V30, P349	49	161	175	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 24	1991	324	4					205	211		10.1056/NEJM199101243240401	http://dx.doi.org/10.1056/NEJM199101243240401			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU022	1985241				2022-12-28	WOS:A1991EU02200001
J	BRENOWITZ, EA				BRENOWITZ, EA			ALTERED PERCEPTION OF SPECIES-SPECIFIC SONG BY FEMALE BIRDS AFTER LESIONS OF A FOREBRAIN NUCLEUS	SCIENCE			English	Article							WHITE-CROWNED SPARROW; AUDITORY RESPONSES; SEXUAL DIMORPHISM; ZEBRA FINCHES; CANARY; RECOGNITION; NEURONS; SYSTEM; BRAIN	Female birds that do not normally sing possess brain nuclei associated with song production in males. To determine whether one song nucleus, the caudal nucleus of the ventral hyperstriatum (HVc), acts in conspecific song perception, courtship responses of female canaries to canary and white-crowned sparrow songs were compared before and after HVc lesions. Bilateral lesions of a portion of the HVc resulted in copulation solicitations to heterospecific song as well as conspecific song. Control females continued to respond only to conspecific song. This suggests that the HVc is critical for conspecific song perception in females. Because female canaries do not normally sing, neurons in female HVc must develop response selectivity by a mechanism different from that proposed for male birds in the motor theory of song perception.	UNIV WASHINGTON, DEPT ZOOL, SEATTLE, WA 98195 USA	University of Washington; University of Washington Seattle	BRENOWITZ, EA (corresponding author), UNIV WASHINGTON, DEPT PSYCHOL, SEATTLE, WA 98195 USA.		Galantucci, Bruno/E-5770-2010		NIDCD NIH HHS [DC 00487] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R29DC000487] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BAKER MC, 1981, SCIENCE, V214, P819, DOI 10.1126/science.214.4522.819; BAKER MC, 1984, BRAIN RES, V295, P85, DOI 10.1016/0006-8993(84)90818-7; Baptista L. F., 1975, U CALIF PUBL ZOOL, V105; BRENOWITZ E A, 1986, Society for Neuroscience Abstracts, V12, P314; Ingle, 1983, ADV VERTEBRATE NEURO; KATZ LC, 1981, BRAIN RES, V221, P192, DOI 10.1016/0006-8993(81)91073-8; KELLEY DB, 1979, J COMP NEUROL, V183, P455, DOI 10.1002/cne.901830302; KING AP, 1977, SCIENCE, V195, P1002, DOI 10.1126/science.841321; LIBERMAN AM, 1982, AM PSYCHOL, V37, P148, DOI 10.1037/0003-066X.37.2.148; MARGOLIASH D, 1986, J NEUROSCI, V6, P1643; MILLER DB, 1979, NATURE, V280, P389, DOI 10.1038/280389a0; MILLER DB, 1979, ANIM BEHAV, V27, P376, DOI 10.1016/0003-3472(79)90172-6; NOTTEBOHM F, 1978, Z TIERPSYCHOL, V46, P298; NOTTEBOHM F, 1976, SCIENCE, V194, P211, DOI 10.1126/science.959852; NOTTEBOHM F, 1982, J COMP NEUROL, V207, P344, DOI 10.1002/cne.902070406; NOTTEBOHM F, 1987, HDB PHYSL 1, P85; NOTTEBOHM F, 1984, BIOL PERSPECTIVES LA, P65; PESCH A, 1985, J ORNITHOL, V126, P108, DOI 10.1007/BF01640450; SEARCY WA, 1984, Z TIERPSYCHOL, V66, P128; SEARCY WA, 1988, NATURE, V332, P152, DOI 10.1038/332152a0; VOLMAN S F, 1987, Society for Neuroscience Abstracts, V13, P870; WILLIAMS H, 1985, SCIENCE, V229, P279, DOI 10.1126/science.4012321	22	209	212	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 18	1991	251	4991					303	305		10.1126/science.1987645	http://dx.doi.org/10.1126/science.1987645			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET678	1987645				2022-12-28	WOS:A1991ET67800030
J	LOCKSHIN, MD				LOCKSHIN, MD			THERAPY FOR SYSTEMIC LUPUS-ERYTHEMATOSUS	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material											LOCKSHIN, MD (corresponding author), NIAMSD,BETHESDA,MD 20892, USA.							AUSTIN HA, 1986, NEW ENGL J MED, V314, P614, DOI 10.1056/NEJM198603063141004; GINZLER EM, 1988, RHEUM DIS CLIN N AM, V14, P67; GREISMAN SG, IN PRESS ARCH INTERN; LIANG MH, 1989, ARTHRITIS RHEUM, V32, P1107, DOI 10.1002/anr.1780320909; MEENAN RF, 1982, ARTHRITIS RHEUM, V25, P1048, DOI 10.1002/art.1780250903; PETRI M, 1990, Arthritis and Rheumatism, V33, pS83; REVEILLE JD, 1990, ARTHRITIS RHEUM-US, V33, P37, DOI 10.1002/art.1780330105; SWAAK AJG, 1989, ANN RHEUM DIS, V48, P455, DOI 10.1136/ard.48.6.455; UROWITZ MB, 1984, J RHEUMATOL, V11, P783; 1991, NEW ENGL J MED, V324, P150; 1986, ARTHRITIS RHEUM S, V29, pS93	11	18	18	0	0	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 17	1991	324	3					189	191		10.1056/NEJM199101173240309	http://dx.doi.org/10.1056/NEJM199101173240309			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ER471	1984196				2022-12-28	WOS:A1991ER47100009
J	SPEISER, PW; AGDERE, L; UESHIBA, H; WHITE, PC; NEW, MI				SPEISER, PW; AGDERE, L; UESHIBA, H; WHITE, PC; NEW, MI			ALDOSTERONE SYNTHESIS IN SALT-WASTING CONGENITAL ADRENAL-HYPERPLASIA WITH COMPLETE ABSENCE OF ADRENAL 21-HYDROXYLASE	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PLASMA DEOXYCORTICOSTERONE; STEROID 21-HYDROXYLATION; DEFICIENCY; GENE; PROGESTERONE; WOMEN; CYTOCHROME-P-450-1; RADIOIMMUNOASSAY; REARRANGEMENTS; FASCICULATA	Background: Congenital adrenal hyperplasia due to 21-hydroxylase deficiency is a disorder of cortisol and aldosterone biosynthesis that results from mutations in the CYP21 gene encoding the adrenal 21-hydroxylase P-450c21. It can cause severe salt wasting in newborns that requires long-term treatment with glucocorticoids and mineralocorticoids. We describe a spontaneous partial recovery from this disorder in a 19-year-old woman who had discontinued treatment. Methods. We measured plasma and urinary levels of adrenal hormones, plasma renin activity, and sodium balance longitudinally in the patient and four other patients in whom adrenal hyperplasia had been diagnosed in infancy and in whom DNA analysis had predicted a complete absence of functional P-450c21. The ratio of plasma renin activity to urinary aldosterone was used as a measure of the response of the adrenal zona glomerulosa. Two patients underwent intravenous infusion of [H-3]progesterone for the measurement of extraadrenal production of 21-hydroxylated precursors of aldosterone. Results. The patient who had discontinued her medication excreted a normal amount of aldosterone (20.0 nmol per square meter of body-surface area per day) while following a diet low in sodium. Her ratio of plasma renin activity to urinary aldosterone-18-glucuronide excretion was 1.7 after three days of sodium restriction, as compared with a ratio of 4.7 at the age of nine years (normal range, 0.03 to 0.1). The percentage of extraadrenal conversion of progesterone to deoxycorticosterone was low. The four other patients had variable responses to sodium restriction after the neonatal period (range for plasma renin activity:urinary aldosterone-18-glucuronide, 1.9 to 19.4). Conclusions. Although patients with salt-wasting 21-hydroxylase deficiency have functionally equivalent mutations in their CYP21 genes, they may vary from one another and over time in their ability to produce mineralocorticoids. This variation may be attributable to another adrenal enzyme with 21-hydroxylase activity.			SPEISER, PW (corresponding author), CORNELL UNIV,MED CTR,NEW YORK HOSP,DEPT PEDIAT,525 E 68TH ST,NEW YORK,NY 10021, USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD000072, R01HD000072] Funding Source: NIH RePORTER; NCRR NIH HHS [RR-47, RR-06020-01] Funding Source: Medline; NICHD NIH HHS [HD-00072] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AMOR M, 1988, P NATL ACAD SCI USA, V85, P1600, DOI 10.1073/pnas.85.5.1600; ANTONIPILLAI I, 1983, J CLIN ENDOCR METAB, V56, P93, DOI 10.1210/jcem-56-1-93; ANTONIPILLAI I, 1983, J CLIN ENDOCR METAB, V57, P580, DOI 10.1210/jcem-57-3-580; CHAKMAKJIAN ZH, 1974, ANAL LETT, V7, P97; CHIOU SH, 1990, J BIOL CHEM, V265, P3549; DIETER HH, 1982, BIOCHEM BIOPH RES CO, V105, P515, DOI 10.1016/0006-291X(82)91465-6; DUPONT B, 1984, HISTOCOMPATIBILITY T, P660; GLOBERMAN H, 1988, J CLIN INVEST, V82, P139, DOI 10.1172/JCI113562; HIGASHI Y, 1986, P NATL ACAD SCI USA, V83, P2841, DOI 10.1073/pnas.83.9.2841; HORNER JM, 1979, J CLIN ENDOCR METAB, V48, P776, DOI 10.1210/jcem-48-5-776; JOHNSON EF, 1989, ARCH BIOCHEM BIOPHYS, V273, P273, DOI 10.1016/0003-9861(89)90484-0; KORTHSCHUTZ S, 1978, J CLIN ENDOCR METAB, V46, P452, DOI 10.1210/jcem-46-3-452; KUHNLE U, 1981, J CLIN ENDOCR METAB, V52, P534, DOI 10.1210/jcem-52-3-534; LUETSCHER JA, 1962, T ASSOC AM PHYSICIAN, V75, P293; MACDONALD PC, 1982, J CLIN INVEST, V69, P469, DOI 10.1172/JCI110471; MELLON SH, 1989, J CLIN INVEST, V84, P1497, DOI 10.1172/JCI114325; MOREL Y, 1989, J CLIN INVEST, V83, P527, DOI 10.1172/JCI113914; MOREL Y, 1989, J CLIN ENDOCR METAB, V68, P592, DOI 10.1210/jcem-68-3-592; NEW MI, 1970, J CLIN ENDOCR METAB, V30, P361, DOI 10.1210/jcem-30-3-361; NEW MI, 1966, J CLIN INVEST, V45, P412, DOI 10.1172/JCI105356; OKINO ST, 1987, J BIOL CHEM, V262, P16072; OKINO ST, 1988, J BIOL CHEM, V263, P2576; PANG S, 1977, J CLIN ENDOCR METAB, V45, P1003, DOI 10.1210/jcem-45-5-1003; PRADER A, 1958, Helv Paediatr Acta, V13, P5; PREIBISZ JJ, 1982, CARDIOVASC REV REP, V3, P787; RAUH W, 1978, KLIN WOCHENSCHR, V56, P161, DOI 10.1007/BF01477468; ROSENBLOOM AL, 1966, PEDIATRICS, V38, P215; SINNOTT PJ, 1989, J MED GENET, V26, P10, DOI 10.1136/jmg.26.1.10; STONER E, 1986, CLIN ENDOCRINOL, V24, P9, DOI 10.1111/j.1365-2265.1986.tb03249.x; STRACHAN T, 1990, CLIN ENDOCRINOL, V32, P373, DOI 10.1111/j.1365-2265.1990.tb00878.x; TUKEY RH, 1985, J BIOL CHEM, V260, P3347; TUSIELUNA MT, 1990, J BIOL CHEM, V265, P20916; WHITE PC, 1989, ENDOCR RES, V15, P239, DOI 10.1080/07435808909039099; WHITE PC, 1984, P NATL ACAD SCI-BIOL, V81, P7505, DOI 10.1073/pnas.81.23.7505; WHITE PC, 1987, NEW ENGL J MED, V316, P1580, DOI 10.1056/NEJM198706183162506; WHITE PC, 1988, P NATL ACAD SCI USA, V85, P4436, DOI 10.1073/pnas.85.12.4436; WHITE PC, 1986, P NATL ACAD SCI USA, V83, P5111, DOI 10.1073/pnas.83.14.5111; WHITE PC, 1987, NEW ENGL J MED, V316, P1519, DOI 10.1056/NEJM198706113162406; WINKEL CA, 1980, J CLIN INVEST, V66, P803, DOI 10.1172/JCI109918; WINKEL CA, 1983, J CLIN ENDOCR METAB, V56, P104, DOI 10.1210/jcem-56-1-104	40	63	65	0	2	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 17	1991	324	3					145	149		10.1056/NEJM199101173240302	http://dx.doi.org/10.1056/NEJM199101173240302			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ER471	1984191				2022-12-28	WOS:A1991ER47100002
J	PEPINE, CJ				PEPINE, CJ			CIRCADIAN VARIATIONS IN MYOCARDIAL-ISCHEMIA - IMPLICATIONS FOR MANAGEMENT	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-ARTERY DISEASE; SUDDEN CARDIAC DEATH; ANGINA-PECTORIS; HEART-DISEASE; PLASMINOGEN-ACTIVATOR; DIURNAL-VARIATION; STABLE ANGINA; INFARCTION; NITROGLYCERIN; ONSET	Extended ambulatory electrocardiographic monitoring in the patient's customary environment provides clear evidence of circadian patterns in myocardial ischemic episodes. In patients with effort angina, the highest activity occurs between 6 AM and noon. This coincides with peaks in diurnal variation of frequency of acute myocardial infarction, stroke, and sudden death. A number of potential underlying common triggering mechanisms, including catecholamine secretion, sympathetic nervous system activity, blood pressure, heart rate, cortisol secretion, and aggregability of platelets, exhibit similar surges. As a result of these coinciding morning peaks, myocardial oxygen demand is increased and oxygen supply reduced after a person arises in the morning. Attention to this vulnerable period is merited in the timing and choice of medication, both to prevent or reduce ischemia and to modify potential disease-triggering mechanisms.	VET AFFAIRS MED CTR,GAINESVILLE,FL	US Department of Veterans Affairs; Veterans Health Administration (VHA)	PEPINE, CJ (corresponding author), UNIV FLORIDA,DEPT MED,DIV CARDIOL,BOX J-277,GAINESVILLE,FL 32610, USA.							ABRAMS J, 1986, THERAPY ANGINA PECTO, P53; ANDREOTTI F, 1988, AM J CARDIOL, V62, P635, DOI 10.1016/0002-9149(88)90669-8; ANGLETON P, 1989, CIRCULATION, V79, P101, DOI 10.1161/01.CIR.79.1.101; BARRY J, 1987, AM J CARDIOL, V60, P483, DOI 10.1016/0002-9149(87)90290-6; BRAUNWALD E, 1971, AM J CARDIOL, V27, P416, DOI 10.1016/0002-9149(71)90439-5; BROWN BG, 1981, CIRCULATION, V64, P150; CAIRNS JA, 1985, NEW ENGL J MED, V313, P1369, DOI 10.1056/NEJM198511283132201; COHEN MV, 1973, J CLIN INVEST, V52, P2836, DOI 10.1172/JCI107479; DAVIES AB, 1983, BRIT HEART J, V50, P85; DAVIES MJ, 1985, BRIT HEART J, V53, P363; DEANFIELD JE, 1983, LANCET, V2, P753; EHRLY A M, 1973, Biorheology, V10, P577; FAZZINI P F, 1985, Giornale Italiano di Cardiologia, V15, P1085; FELDMAN RL, 1987, AM J CARDIOL, V60, P267, DOI 10.1016/0002-9149(87)90225-6; FLORAS JS, 1978, CLIN SCI MOL MED, V55, P395; FRISHMAN WH, 1983, CIRCULATION, V67, P11; FRISHMAN WH, 1986, THERAPY ANGINA PECTO, P83; FRISHMAN WH, 1980, ADV BETA BLOCKER THE, P165; GOTTLIEB SO, 1988, J CARDIOVASC PHARM, V12, pS18, DOI 10.1097/00005344-198812007-00004; HOEKENGA D, 1984, AM J MED, V76, P309, DOI 10.1016/0002-9343(84)90791-5; HORWITZ LD, 1971, J CLIN INVEST, V50, P1578, DOI 10.1172/JCI106645; IMPERI GA, 1987, AM J CARDIOL, V60, P519, DOI 10.1016/0002-9149(87)90297-9; KIRK ES, 1982, AM HEART J, V103, P756, DOI 10.1016/0002-8703(82)90483-5; KLONER RA, 1976, CARDIOVASC RES, V10, P81, DOI 10.1093/cvr/10.1.81; KRUSKAL JB, 1987, NEW ENGL J MED, V317, P1361, DOI 10.1056/NEJM198711263172201; LAMBERT CR, 1989, AM J CARDIOL, V64, pH8, DOI 10.1016/0002-9149(89)90974-0; LAMBERT CR, 1989, AM J CARDIOL, V64, P835, DOI 10.1016/0002-9149(89)90827-8; LUSCHER TF, 1989, EUR HEART J, V10, P847; MCGREGOR M, 1983, AM J MED, V74, P21, DOI 10.1016/0002-9343(83)90850-1; MILLARCRAIG MW, 1978, LANCET, V1, P795; MOSCHOS CB, 1978, CIRCULATION, V57, P681, DOI 10.1161/01.CIR.57.4.681; MULCAHY D, 1988, LANCET, V2, P755; MULLER JE, 1985, NEW ENGL J MED, V313, P1315, DOI 10.1056/NEJM198511213132103; MULLER JE, 1989, CIRCULATION, V79, P733, DOI 10.1161/01.CIR.79.4.733; NABEL EG, 1989, AM J CARDIOL, V63, P663, DOI 10.1016/0002-9149(89)90248-8; Nademanee K, 1988, CIRCULATION S2, V78, P610; NADEMANEE K, 1987, AM J CARDIOL, V60, P94; Needleman P, 1985, PHARMACOL BASIS THER, P806; Ogawa H, 1988, CIRCULATION S2, V78S, P331; PELC LR, 1987, CIRCULATION, V76, P191, DOI 10.1161/01.CIR.76.1.191; PEPINE CJ, 1989, HEART; PETRALITO A, 1982, CHRONOBIOLOGIA, V9, P195; QUYYUMI AA, 1987, BRIT HEART J, V57, P501; Quyyumi AA, 1988, CIRCULATION S2, V78S, P331; RAEHL CL, 1983, APPL THER, P271; ROCCO MB, 1987, CIRCULATION, V75, P395, DOI 10.1161/01.CIR.75.2.395; ROCCO MB, 1987, AM J CARDIOL, V59, pC13, DOI 10.1016/0002-9149(87)90190-1; ROSING DR, 1970, CIRC RES, V27, P171, DOI 10.1161/01.RES.27.2.171; SCHANG SJ, 1977, AM J CARDIOL, V39, P396, DOI 10.1016/S0002-9149(77)80095-7; STERN S, 1974, BRIT HEART J, V36, P481; TOFLER GH, 1987, NEW ENGL J MED, V316, P1514, DOI 10.1056/NEJM198706113162405; TURTON MB, 1974, CLIN CHIM ACTA, V55, P389, DOI 10.1016/0009-8981(74)90014-X; WEINER DA, 1986, THERAPY ANGINA PECTO, P145; WEITZMAN ED, 1971, J CLIN ENDOCR METAB, V33, P14, DOI 10.1210/jcem-33-1-14; WERTHEIMER L, 1972, Clinical Research, V20, P404; WILLIAMS JK, 1987, CIRCULATION, V76, P294; Willich SN, 1988, J AM COLL CARDIOL, V115, P204; YASUE H, 1979, CIRCULATION, V59, P938, DOI 10.1161/01.CIR.59.5.938; YOUSEFI S, 1987, ANTIMICROB AGENTS CH, V31, P114, DOI 10.1128/AAC.31.1.114; ZAMARRON C, 1984, J BIOL CHEM, V259, P2080	60	77	79	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 16	1991	265	3					386	390		10.1001/jama.265.3.386	http://dx.doi.org/10.1001/jama.265.3.386			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ER256	1984540				2022-12-28	WOS:A1991ER25600031
J	STROUPBENHAM, CA; TREVINO, FM				STROUPBENHAM, CA; TREVINO, FM			REPRODUCTIVE CHARACTERISTICS OF MEXICAN-AMERICAN, MAINLAND PUERTO-RICAN, AND CUBAN-AMERICAN WOMEN - DATA FROM THE HISPANIC HEALTH AND NUTRITION EXAMINATION SURVEY	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LOW-BIRTH-WEIGHT; UNITED-STATES; CONTRACEPTIVE USE; SOCIOECONOMIC-STATUS; DEPRESSIVE SYMPTOMS; NATIONAL SURVEY; FAMILY GROWTH; PREVALENCE; CANCER; FERTILITY	Data from the Hispanic Health and Nutrition Examination Survey were used to investigate reproductive characteristics of Hispanic females aged 15 to 45 years. Mexican-American and Puerto Rican women reported approximately 1.9 and 1.7 live births each, respectively, whereas Cuban-American women reported 1.1. Mexican-American women were more likely to be using oral contraceptives and were more likely to have had a hysterectomy or an oophorectomy than were Cubans and Puerto Ricans. The largest percentage fo tubal ligations were found among Puerto Rican women. Mexican women who had been pregnant in the previous 12 months were more likely than their Puerto Rican and Cuban-American counterparts to be breastfeeding. Further research is needed to investigate the decision processes and/or cultural variations that may be responsible for these differences in reproductive traits across national origin groups.			STROUPBENHAM, CA (corresponding author), UNIV TEXAS, MED BRANCH, CTR CROSS CULTURAL RES, OFF EDUC DEV, 144 GAIL BORDEN BLDG F-64, GALVESTON, TX 77550 USA.							BACHRACH CA, 1984, FAM PLANN PERSPECT, V16, P253, DOI 10.2307/2134914; BACHRACH CA, 1984, PHS851250 US DEP HLT; BLOOM B, 1981, PHS821250 US DEP HLT; BRYANT CA, 1982, SOC SCI MED, V16, P1757, DOI 10.1016/0277-9536(82)90269-6; DELEON CFM, 1988, AM J EPIDEMIOL, V127, P150; Diehl A K, 1989, Adv Intern Med, V34, P73; EHLING MB, 1981, CULTURE CHILDREARING, P192; FOMON SJ, 1971, ACTA PAEDIATR SC   S, V223, P3; FRERICHS RR, 1981, AM J EPIDEMIOL, V113, P691, DOI 10.1093/oxfordjournals.aje.a113149; HAMMAN RF, 1989, AM J EPIDEMIOL, V129, P295, DOI 10.1093/oxfordjournals.aje.a115134; HANIS CL, 1983, AM J EPIDEMIOL, V118, P659, DOI 10.1093/oxfordjournals.aje.a113677; HAZUDA HP, 1988, AM J EPIDEMIOL, V128, P1289, DOI 10.1093/oxfordjournals.aje.a115082; Herold J M, 1986, Fam Plann Perspect, V18, P185, DOI 10.2307/2947984; HIRSCHMAN C, 1979, VITAL HLTH STAT, V23; HOWE HL, 1984, AM J PUBLIC HEALTH, V74, P560, DOI 10.2105/AJPH.74.6.560; HUMBLE CG, 1985, AM J PUBLIC HEALTH, V75, P145, DOI 10.2105/AJPH.75.2.145; HUNT IF, 1984, AM J CLIN NUTR, V40, P508, DOI 10.1093/ajcn/40.3.508; KLEINMAN JC, 1985, AM J EPIDEMIOL, V121, P843, DOI 10.1093/oxfordjournals.aje.a114055; KOVAR MG, 1985, VITAL HLTH STAT, V1, pCH11; LACROIX AZ, 1989, AM J EPIDEMIOL, V129, P669, DOI 10.1093/oxfordjournals.aje.a115183; MOHRER J, 1979, MED ANTHROPOL, V39, P125; MOSHER WD, 1987, STUD FAMILY PLANN, V18, P83, DOI 10.2307/1966699; MOSHER WD, 1988, FAM PLANN PERSPECT, V20, P207, DOI 10.2307/2135622; MOSHER WD, 1981, VITA HLTH STAT, V23; NEWACHECK PW, 1989, PEDIATRICS, V84, P1056; POKRAS R, 1988, AM J PUBLIC HEALTH, V78, P852, DOI 10.2105/AJPH.78.7.852; PRAGER K, 1984, PUBLIC HEALTH REP, V99, P117; PRATT WF, 1984, POPUL BULL, V39, P3; PRESSER HB, 1980, INT FAM PLAN PERSPEC, V6, P20; RASSIN DK, 1984, PEDIATRICS, V73, P132; RICHARDSON JL, 1987, PREV MED, V16, P761, DOI 10.1016/0091-7435(87)90016-8; RUSSELLBRIEFEL R, 1985, AM J PUBLIC HEALTH, V75, P1173, DOI 10.2105/AJPH.75.10.1173; SAMUELS SE, 1985, AM J CLIN NUTR, V42, P504, DOI 10.1093/ajcn/42.3.504; SCRIBNER R, 1989, AM J PUBLIC HEALTH, V79, P1263, DOI 10.2105/AJPH.79.9.1263; SHAI D, 1986, PUBLIC HEALTH REP, V101, P547; SMITH JC, 1982, AM J PUBLIC HEALTH, V72, P59, DOI 10.2105/AJPH.72.1.59; SMITH PB, 1986, J DEV BEHAV PEDIATR, V7, P346; VEGA W, 1984, AM J EPIDEMIOL, V120, P592, DOI 10.1093/oxfordjournals.aje.a113921; VENTURA SJ, 1984, 33 DEP HLGH HUM SERV; WESTOFF CF, 1986, SCIENCE, V234, P554, DOI 10.1126/science.3532324; WRIGHT AL, 1988, PEDIATRICS, V82, P496; 1989, 1987 DEMOGRAPHIC YB, P698; 1989, STATISTIAL ABSTRACT; 1988, CURRENT POPULATI P20, V427; 1988, CURRENT POPULATI P60, V161; 1983, 1980 CENSUS POPULATI, V1	46	29	29	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 9	1991	265	2					222	226		10.1001/jama.265.2.222	http://dx.doi.org/10.1001/jama.265.2.222			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EQ602	1984151				2022-12-28	WOS:A1991EQ60200029
J	SCHWARTZ, MD; LINZER, M; BABBOTT, D; DIVINE, GW; BROADHEAD, E				SCHWARTZ, MD; LINZER, M; BABBOTT, D; DIVINE, GW; BROADHEAD, E			MEDICAL-STUDENT INTEREST IN INTERNAL-MEDICINE - INITIAL REPORT OF THE SOCIETY-OF-GENERAL-INTERNAL-MEDICINE-INTEREST-GROUP SURVEY ON FACTORS INFLUENCING CAREER CHOICE IN INTERNAL-MEDICINE	ANNALS OF INTERNAL MEDICINE			English	Article							SPECIALTY CHOICE; SCHOOL	Objective: To determine the factors that attract students toward and push students away from a career in internal medicine. Design: National survey of senior U.S. medical students using a stratified random cluster sampling of medical schools. Participants: The survey included 1650 U.S. senior students from 16 medical schools, of whom 1244 (76%) responded. Measurements and Main Results: A survey instrument was developed and pilot tested at 17 medical schools. Twenty-four percent of the respondents to the final survey chose a career in general internal medicine (9%) or subspecialty internal medicine (15%). A career in internal medicine had been "seriously considered" by 608 respondents (50%) who finally chose a career other than internal medicine (the "switchers"). Compared with other specialties, internal medicine was perceived as being more stressful to residents, more demanding of time and workload as a career and a residency, and as an easier residency to enter. Internal medicine was also seen as providing less satisfaction for residents, having lower income potential, and allowing less leisure time. For the 608 switchers, the most important influences leading to their decision to switch were the type of patient seen in internal medicine (for example, chronically ill, alcohol and drug abusing patients) as well as dissatisfaction and stress among internal medicine residents. Factor analysis showed that three factors, "intellectual challenge of internal medicine," "primary care interests," and "the medicine clerkship" attracted students toward internal medicine, whereas three others, "taking care of chronically ill patients," "level of satisfaction among internists and medical residents," and "workload and stress" pushed students away from internal medicine. Factors pushing students away from internal medicine were significantly more negative with regard to a career in general as opposed to subspecialty internal medicine (P < 0.001). Conclusion: Medical students have serious reservations about internal medicine as a career choice. Perceptions about the medical residency, the patients they expect to see, and the dissatisfaction among residents and internists are foremost in their thinking. Changes to improve the attractiveness of internal medicine should address these adverse perceptions while building on the positive influences identified by the respondents.	TUFTS UNIV, NEW ENGLAND MED CTR, SCH MED, BOSTON, MA 02111 USA; UNIV VERMONT, COLL MED, BURLINGTON, VT 05405 USA; DUKE UNIV, MED CTR, DIV GEN INTERNAL MED, DURHAM, NC 27710 USA; DUKE UNIV, MED CTR, DEPT COMMUNITY & FAMILY MED, DURHAM, NC 27710 USA	Tufts Medical Center; Tufts University; University of Vermont; Duke University; Duke University								BABBOTT D, 1989, JAMA-J AM MED ASSOC, V261, P2367, DOI 10.1001/jama.261.16.2367; BABBOTT D, 1988, JAMA-J AM MED ASSOC, V259, P1970, DOI 10.1001/jama.259.13.1970; BASHOOK PG, 1981, J MED EDUC, V56, P429; BROOKS WB, 1988, SGIM NEWSLETTER, V11, P6; BROOKS WB, 1988, SGIM NEWSLETTER, V11, P1; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; DUNN WR, 1985, MED TEACH, V7, P15, DOI 10.3109/01421598509036787; FUNKENSTEIN DH, 1961, MED STUDENTS MED SCH; GLICK SM, 1990, AM J MED, V88, P449, DOI 10.1016/0002-9343(90)90421-9; GRAETTINGER JS, 1988, ANN INTERN MED, V108, P101, DOI 10.7326/0003-4819-108-1-101; KEELER EB, 1990, JAMA-J AM MED ASSOC, V264, P1962, DOI 10.1001/jama.264.15.1962; KELLY JV, 1990, P AM PUBLIC HLTH ASS, P3037; KLETKE PR, 1987, ANN INTERN MED, V107, P93, DOI 10.7326/0003-4819-107-1-93; KOSECOFF J, 1990, JAMA-J AM MED ASSOC, V264, P1980, DOI 10.1001/jama.264.15.1980; LIPKIN M, 1990, ANN INTERN MED, V112, P371, DOI 10.7326/0003-4819-112-5-371; MARKERT RJ, 1983, J FAM PRACTICE, V17, P295; MCCARTY DJ, 1987, NEW ENGL J MED, V317, P567, DOI 10.1056/NEJM198708273170909; NESS R, 1989, ACAD MED, V64, P588, DOI 10.1097/00001888-198910000-00009; NOETHER GE, 1987, J AM STAT ASSOC, V82, P645, DOI 10.2307/2289477; Nunnally JC., 1978, PSYCHOMETRIC THEORY, P225; REZLER AG, 1985, INTERPERSONAL DIMENS, P46; SCHROEDER SA, 1986, ANN INTERN MED, V104, P554, DOI 10.7326/0003-4819-104-4-554; SCHWARTZ RW, 1990, ACAD MED, V65, P207, DOI 10.1097/00001888-199003000-00016; SHUMWAY JM, 1988, CLIN RES, V36, pA736	24	97	97	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 1	1991	114	1					6	15		10.7326/0003-4819-114-1-6	http://dx.doi.org/10.7326/0003-4819-114-1-6			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EQ040	1983935				2022-12-28	WOS:A1991EQ04000002
J	SIMMONDS, P; ZHANG, LQ; WATSON, HG; REBUS, S; FERGUSON, ED; BALFE, P; LEADBETTER, GH; YAP, PL; PEUTHERER, JF; LUDLAM, CA				SIMMONDS, P; ZHANG, LQ; WATSON, HG; REBUS, S; FERGUSON, ED; BALFE, P; LEADBETTER, GH; YAP, PL; PEUTHERER, JF; LUDLAM, CA			HEPATITIS-C QUANTIFICATION AND SEQUENCING IN BLOOD PRODUCTS, HEMOPHILIACS, AND DRUG-USERS	LANCET			English	Article									ROYAL INFIRM, DEPT HAEMATOL, LAURISTON PL, EDINBURGH EH3 9YW, MIDLOTHIAN, SCOTLAND; EDINBURGH & SE SCOTLAND REG BLOOD TRANSFUS SERV, EDINBURGH, SCOTLAND; UNIV EDINBURGH, DEPT MED MICROBIOL, EDINBURGH EH8 9YL, MIDLOTHIAN, SCOTLAND; UNIV EDINBURGH, DEPT GENET, EDINBURGH EH8 9YL, MIDLOTHIAN, SCOTLAND	Royal Infirmary of Edinburgh; University of Edinburgh; University of Edinburgh				Balfe, Peter/0000-0002-6246-0876; Simmonds, Peter/0000-0002-7964-4700				ALIZON M, 1986, CELL, V46, P63, DOI 10.1016/0092-8674(86)90860-3; ALSHAWI R, 1988, MOL CELL BIOL, V8, P4821, DOI 10.1128/MCB.8.11.4821; ALTER HJ, 1989, NEW ENGL J MED, V321, P1494, DOI 10.1056/NEJM198911303212202; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; FELSENSTEIN J, 1988, ANNU REV GENET, V22, P521, DOI 10.1146/annurev.ge.22.120188.002513; GARSON JA, 1990, LANCET, V335, P1419, DOI 10.1016/0140-6736(90)91446-H; GARSON JA, 1990, LANCET, P1473; HOUGHTON M, 318216 PUBL; HOUGHTON M, Patent No. 883109925; LI WH, 1985, MOL BIOL EVOL, V2, P150; MACFARLANE IG, 1990, LANCET, P754; MILLER RH, 1990, P NATL ACAD SCI USA, V87, P2057, DOI 10.1073/pnas.87.6.2057; SIMMONDS P, 1990, J VIROL, V64, P864, DOI 10.1128/JVI.64.2.864-872.1990; SIMMONDS P, 1990, J VIROL, V64, P5840, DOI 10.1128/JVI.64.12.5840-5850.1990; SKIDMORE S, 1990, LANCET, P1346; STARCICH BR, 1986, CELL, V45, P637, DOI 10.1016/0092-8674(86)90778-6; WEINER AJ, 1990, LANCET, P1	18	208	217	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 15	1990	336	8729					1469	1472		10.1016/0140-6736(90)93179-S	http://dx.doi.org/10.1016/0140-6736(90)93179-S			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EN157	1979093				2022-12-28	WOS:A1990EN15700004
J	VERRESEN, L; WAER, M; VANRENTERGHEM, Y; MICHIELSEN, P				VERRESEN, L; WAER, M; VANRENTERGHEM, Y; MICHIELSEN, P			ANGIOTENSIN-CONVERTING-ENZYME INHIBITORS AND ANAPHYLACTOID REACTIONS TO HIGH-FLUX MEMBRANE DIALYSIS	LANCET			English	Article											VERRESEN, L (corresponding author), UNIV ZIEKENHUIS GASTHUISBERG,DEPT NEPHROL,HERESTR 49,B-3000 LOUVAIN,BELGIUM.							BIGAZZI R, 1989, 7TH P ANN M INT SOC; BINGEL M, 1986, NEPHRON, V43, P161, DOI 10.1159/000183822; BOUVIER P, 1989, NEPHROLOGIE, V10, P40; GEJYO F, 1986, KIDNEY INT, V30, P385, DOI 10.1038/ki.1986.196; GOLDMAN M, 1989, INT J ARTIF ORGANS, V12, P373, DOI 10.1177/039139888901200605; GOREVIC PD, 1986, P NATL ACAD SCI USA, V83, P7908, DOI 10.1073/pnas.83.20.7908; HAUGLUSTAINE D, 1986, LANCET, V1, P1211; KOZIN F, 1988, INFLAMMATION BASIC P, P101; Lindgren B R, 1988, Acta Physiol Scand Suppl, V573, P1; LONNEMANN G, 1988, KIDNEY INT, V33, P29, DOI 10.1038/ki.1988.5; Man N K, 1988, Contrib Nephrol, V62, P24; MARTINMALO A, 1989, INT J ARTIF ORGANS, V12, P509, DOI 10.1177/039139888901200805; MONTAGNAC R, 1988, NEPHROLOGIE, V9, P29; NORN S, 1985, AGENTS ACTIONS, V16, P273, DOI 10.1007/BF01983158; NORN S, 1986, AGENTS ACTIONS, V18, P149, DOI 10.1007/BF01988007; PORT FK, 1987, AM J KIDNEY DIS, V10, P118, DOI 10.1016/S0272-6386(87)80043-4; WILLIAMS GH, 1977, NEW ENGL J MED, V297, P184, DOI 10.1056/NEJM197707282970404; Yamagami S, 1989, ASAIO Trans, V35, P331, DOI 10.1097/00002480-198907000-00050	18	101	102	0	2	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	DEC 1	1990	336	8727					1360	1362		10.1016/0140-6736(90)92904-V	http://dx.doi.org/10.1016/0140-6736(90)92904-V			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL365	1978172				2022-12-28	WOS:A1990EL36500012
J	CHENG, MY; HARTL, FU; HORWICH, AL				CHENG, MY; HARTL, FU; HORWICH, AL			THE MITOCHONDRIAL CHAPERONIN HSP60 IS REQUIRED FOR ITS OWN ASSEMBLY	NATURE			English	Article									YALE UNIV,SCH MED,DEPT HUMAN GENET,NEW HAVEN,CT 06510; UNIV MUNICH,INST PHYSIOL CHEM,W-8000 MUNICH 2,GERMANY	Yale University; University of Munich	CHENG, MY (corresponding author), YALE UNIV,SCH MED,HOWARD HUGHES MED INST,333 CEDAR ST,NEW HAVEN,CT 06510, USA.		Hartl, F. Ulrich/Y-8206-2019					BAHR GF, 1962, J CELL BIOL, V15, P489, DOI 10.1083/jcb.15.3.489; BARRACLOUGH R, 1980, BIOCHIM BIOPHYS ACTA, V608, P19, DOI 10.1016/0005-2787(80)90129-X; CHENG MY, 1989, NATURE, V337, P620, DOI 10.1038/337620a0; CHENG MY, 1990, THESIS YALE U; ELLIS RJ, 1989, TRENDS BIOCHEM SCI, V14, P339, DOI 10.1016/0968-0004(89)90168-0; GOLOUBINOFF P, 1989, NATURE, V342, P884, DOI 10.1038/342884a0; HARTL FU, 1990, SCIENCE, V247, P930, DOI 10.1126/science.2406905; HEMMINGSEN SM, 1988, NATURE, V333, P330, DOI 10.1038/333330a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKEY RA, 1978, NATURE, V275, P416, DOI 10.1038/275416a0; LISSIN NM, 1990, NATURE, V348, P339, DOI 10.1038/348339a0; LUCK DJL, 1965, J CELL BIOL, V24, P461, DOI 10.1083/jcb.24.3.461; MCMULLIN TW, 1988, MOL CELL BIOL, V8, P371, DOI 10.1128/MCB.8.1.371; MUSGROVE JE, 1987, EUR J BIOCHEM, V163, P529, DOI 10.1111/j.1432-1033.1987.tb10900.x; OSTERMANN J, 1989, NATURE, V341, P125, DOI 10.1038/341125a0; PELHAM HRB, 1976, EUR J BIOCHEM, V67, P247, DOI 10.1111/j.1432-1033.1976.tb10656.x; READING DS, 1989, NATURE, V337, P655, DOI 10.1038/337655a0; ROTHMAN JE, 1989, CELL, V59, P591, DOI 10.1016/0092-8674(89)90005-6; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350	19	164	166	0	10	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 29	1990	348	6300					455	458		10.1038/348455a0	http://dx.doi.org/10.1038/348455a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK697	1978929				2022-12-28	WOS:A1990EK69700067
J	BUCHET, JP; LAUWERYS, R; ROELS, H; BERNARD, A; BRUAUX, P; CLAEYS, F; DUCOFFRE, G; DEPLAEN, P; STAESSEN, J; AMERY, A; LIJNEN, P; THIJS, L; RONDIA, D; SARTOR, F; SAINTREMY, A; NICK, L				BUCHET, JP; LAUWERYS, R; ROELS, H; BERNARD, A; BRUAUX, P; CLAEYS, F; DUCOFFRE, G; DEPLAEN, P; STAESSEN, J; AMERY, A; LIJNEN, P; THIJS, L; RONDIA, D; SARTOR, F; SAINTREMY, A; NICK, L			RENAL EFFECTS OF CADMIUM BODY BURDEN OF THE GENERAL-POPULATION	LANCET			English	Article									CATHOLIC UNIV LOUVAIN,UNITE TOXICOL IND & MED TRAVAIL,B-1200 BRUSSELS,BELGIUM; MINIST HLTH & SOCIAL AFFAIRS,INST HYG & EPIDEMIOL,BRUSSELS,BELGIUM; CATHOLIC UNIV LOUVAIN,DEPT PATHOPHYSIOL,HYPERTENS & CARDIOVASC REHABIL UNIT,B-1200 BRUSSELS,BELGIUM; STATE UNIV LIEGE,ENVIRONM TOXICOL UNIT,B-4000 LIEGE,BELGIUM	Universite Catholique Louvain; Universite Catholique Louvain; University of Liege			BERNARD, Alfred M/A-6511-2010; Staessen, Jan A/A-1065-2011	BERNARD, Alfred M/0000-0003-3171-3743; Staessen, Jan A/0000-0002-3026-1637; Thijs, Lutgarde/0000-0002-8108-2356				Bernard A., 1986, HDB EXPT PHARM, P135, DOI DOI 10.1007/978-3-642-70856-5; BUCHET JP, 1983, FOOD CHEM TOXICOL, V21, P19, DOI 10.1016/0278-6915(83)90263-6; BUCHET JP, 1980, J OCCUP ENVIRON MED, V22, P741; DRASCH GA, 1983, SCI TOTAL ENVIRON, V26, P111, DOI 10.1016/0048-9697(83)90105-5; FLANAGAN PR, 1978, GASTROENTEROLOGY, V74, P841; FRIBERG L, 1985, CADMIUM HLATH TOXICO; LAUWERYS R, 1984, TOXICOL LETT, V23, P287, DOI 10.1016/0378-4274(84)90023-7; LAUWERYS R, 1981, LANCET, V1, P383; LAUWERYS R, IN PRESS ENV HLTH PE; LAUWERYS RR, 1976, INT ARCH OCC ENV HEA, V36, P275, DOI 10.1007/BF00409357; MORGAN H, 1988, SCI TOTAL ENVIRON, V75, P135, DOI 10.1016/0048-9697(88)90162-3; ROELS HA, 1981, ENVIRON RES, V26, P217, DOI 10.1016/0013-9351(81)90199-7; ROELS HA, 1981, ENVIRON RES, V24, P117, DOI 10.1016/0013-9351(81)90138-9; ROELS HA, 1989, BRIT J IND MED, V46, P755; SCOTT R, 1978, Urology, V11, P462, DOI 10.1016/0090-4295(78)90157-7; STAESSEN J, 1988, J HYPERTENS, V6, P965, DOI 10.1097/00004872-198812000-00003; 1987, SAS STAT GUIDE PERSO	17	407	428	0	25	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	SEP 22	1990	336	8717					699	702		10.1016/0140-6736(90)92201-R	http://dx.doi.org/10.1016/0140-6736(90)92201-R			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DZ624	1975890	Green Submitted			2022-12-28	WOS:A1990DZ62400001
J	WHITLEY, R; ARVIN, A; PROBER, C; BURCHETT, S; COREY, L; POWELL, D; PLOTKIN, S; STARR, S; ALFORD, C; CONNOR, J; JACOBS, R; NAHMIAS, A; SOONG, SJ				WHITLEY, R; ARVIN, A; PROBER, C; BURCHETT, S; COREY, L; POWELL, D; PLOTKIN, S; STARR, S; ALFORD, C; CONNOR, J; JACOBS, R; NAHMIAS, A; SOONG, SJ			A CONTROLLED TRIAL COMPARING VIDARABINE WITH ACYCLOVIR IN NEONATAL HERPES-SIMPLEX VIRUS-INFECTION	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							THERAPY; ENCEPHALITIS	Background. Despite the use of vidarabine, herpes simplex virus (HSV) infection in neonates continues to be a disease of high morbidity and mortality. We undertook a controlled trial comparing vidarabine with acyclovir for the treatment of neonatal HSV infection. Methods. Babies less than one month of age with virologically confirmed HSV infection were randomly and blindly assigned to receive either intravenous vidarabine (30 mg per kilogram of body weight per day; n = 95) or acyclovir (30 mg per kilogram per day; n = 107) for 10 days. Actuarial rates of mortality and morbidity among the survivors after one year were compared overall and according to the extent of the disease at entry into the study (infection confined to the skin, eyes, or mouth; encephalitis; or disseminated disease). Results. After adjustment for differences between groups in the extent of disease, there was no difference between vidarabine and acyclovir in either morbidity (P = 0.83) or mortality (P = 0.27). None of the 85 babies with disease confined to the skin, eyes, or mouth died. Of the 31 babies in this group who were treated with vidarabine and followed for a year, 88 percent (22 of 25) were judged to be developing normally after one year, as compared with 98 percent (45 of 46) of the 54 treated with acyclovir (95 percent confidence interval for the difference, -4 to 24). For the 71 babies with encephalitis, mortality was 14 percent with vidarabine (5 of 36) and with acyclovir (5 of 35); of the survivors, 43 percent (13 of 30) and 29 percent (8 of 28), respectively, were developing normally after one year (95 percent confidence interval for the difference, -11 to 39). For the 46 babies with disseminated disease, mortality was 50 percent (14 of 28) with vidarabine and 61 percent (11 of 18) with acyclovir (95 percent confidence interval for the difference, -20 to 40); of the survivors, 58 percent (7 of 12) and 60 percent (3 of 5), respectively, were judged to be developing normally after one year (95 percent confidence interval for the difference, -40 to 50). Both medications were without serious toxic effects. Conclusions. In this multicenter, randomized, blinded study there were no differences in outcome between vidarabine and acyclovir in the treatment of neonatal HSV infection. The study lacked statistical power to determine whether there were sizable differences within the subgroups of those with localized HSV, encephalitis, or disseminated disease.	UNIV ALABAMA,DEPT MICROBIOL,BIRMINGHAM,AL 35294; UNIV ALABAMA,DEPT MED,BIRMINGHAM,AL 35294; UNIV ALABAMA,DEPT BIOSTAT,BIRMINGHAM,AL 35294; STANFORD UNIV,DEPT PEDIAT,STANFORD,CA 94305; UNIV WASHINGTON,DEPT MED,SEATTLE,WA 98195; OHIO STATE UNIV,DEPT PEDIAT,COLUMBUS,OH 43210; UNIV PENN,DEPT PEDIAT,PHILADELPHIA,PA 19104; UNIV CALIF SAN DIEGO,DEPT PEDIAT,SAN DIEGO,CA 92103; UNIV ARKANSAS,DEPT PEDIAT,LITTLE ROCK,AR 72204; EMORY UNIV,DEPT PEDIAT,ATLANTA,GA 30322	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Stanford University; University of Washington; University of Washington Seattle; University System of Ohio; Ohio State University; University of Pennsylvania; University of California System; University of California San Diego; University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas Little Rock; Emory University	WHITLEY, R (corresponding author), UNIV ALABAMA,DEPT PEDIAT,BIRMINGHAM,AL 35294, USA.		Corey, Lawrence/AAE-1796-2020	Corey, Lawrence/0000-0002-2179-2436	NCRR NIH HHS [RR-032] Funding Source: Medline; NIAID NIH HHS [N01-AI-62554] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI062554] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		DORSKY DI, 1987, ANN INTERN MED, V107, P859, DOI 10.7326/0003-4819-107-6-859; ELION GB, 1977, P NATL ACAD SCI USA, V74, P5716, DOI 10.1073/pnas.74.12.5716; GUTMAN LT, 1986, J INFECT DIS, V154, P415, DOI 10.1093/infdis/154.3.415; HUTTO C, 1987, J PEDIATR-US, V110, P97, DOI 10.1016/S0022-3476(87)80298-6; KALBFLEISCH JD, 1980, STATISTICAL ANAL FAI, P152; MCLAREN C, 1985, ANTIMICROB AGENTS CH, V28, P740, DOI 10.1128/AAC.28.6.740; SULLIVANBOLYAI J, 1983, JAMA-J AM MED ASSOC, V250, P3059, DOI 10.1001/jama.250.22.3059; SULLIVANBOLYAI JZ, 1986, PEDIATR INFECT DIS J, V5, P309, DOI 10.1097/00006454-198605000-00007; WHITLEY R, 1991, NEW ENGL J MED, V324, P450, DOI 10.1056/NEJM199102143240704; WHITLEY RJ, 1980, PEDIATRICS, V66, P489; WHITLEY RJ, 1988, J INFECT DIS, V158, P109, DOI 10.1093/infdis/158.1.109; WHITLEY RJ, 1986, NEW ENGL J MED, V314, P144, DOI 10.1056/NEJM198601163140303; WHITLEY RJ, 1983, PEDIATRICS, V72, P778; WHITLEY RJ, 1980, PEDIATRICS, V66, P495; [No title captured]; 1985, NEW VACCINE DEV ESTA, V1	16	266	271	0	6	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 14	1991	324	7					444	449		10.1056/NEJM199102143240703	http://dx.doi.org/10.1056/NEJM199102143240703			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EX363	1988829				2022-12-28	WOS:A1991EX36300003
J	BURNSIDE, JW				BURNSIDE, JW			DESERTED ISLAND	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	1991	265	5					589	589						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EV718	1987405				2022-12-28	WOS:A1991EV71800005
J	FELGNER, PL; RHODES, G				FELGNER, PL; RHODES, G			GENE THERAPEUTICS	NATURE			English	Article							FOREIGN GENE; EXPRESSION; INVIVO; DNA; DELIVERY; TRANSFECTION; VIRUS; LIVER; MICE				FELGNER, PL (corresponding author), VICAL INC,DIV GENE THERAPEUT,9373 TOWNE CTR DR,SAN DIEGO,CA 92121, USA.							BENVENISTY N, 1986, P NATL ACAD SCI USA, V83, P9551, DOI 10.1073/pnas.83.24.9551; BEVIN MJ, 1987, NATURE, V325, P192; BOUCHARD L, 1984, VIROLOGY, V135, P53, DOI 10.1016/0042-6822(84)90116-8; BRIGHAM KL, 1989, AM J MED SCI, V298, P278, DOI 10.1097/00000441-198910000-00013; DUBENSKY TW, 1984, P NATL ACAD SCI-BIOL, V81, P7529, DOI 10.1073/pnas.81.23.7529; FELGNER P L, 1990, Advanced Drug Delivery Reviews, V5, P163, DOI 10.1016/0169-409X(90)90015-K; FUNG YKT, 1983, P NATL ACAD SCI-BIOL, V80, P353, DOI 10.1073/pnas.80.2.353; GERMAIN RN, 1986, NATURE, V322, P687, DOI 10.1038/322687a0; HOLT CE, 1990, NEURON, V4, P203, DOI 10.1016/0896-6273(90)90095-W; ISRAEL MA, 1979, J VIROL, V29, P990, DOI 10.1128/JVI.29.3.990-996.1979; JOHNSTON SA, 1990, NATURE, V346, P776, DOI 10.1038/346776a0; KANEDA Y, 1989, SCIENCE, V243, P375, DOI 10.1126/science.2911748; LIN H, 1990, CIRCULATION, V82, P2217, DOI 10.1161/01.CIR.82.6.2217; MALONE RW, 1989, FOCUS, V11, P4; NABEL EG, 1990, SCIENCE, V249, P1285, DOI 10.1126/science.2119055; NICOLAU C, 1983, P NATL ACAD SCI-BIOL, V80, P1068, DOI 10.1073/pnas.80.4.1068; ONO T, 1990, NEUROSCI LETT, V117, P259, DOI 10.1016/0304-3940(90)90673-W; SEEGER C, 1984, P NATL ACAD SCI-BIOL, V81, P5849, DOI 10.1073/pnas.81.18.5849; TOWNSEND A, 1989, ANNU REV IMMUNOL, V7, P601, DOI 10.1146/annurev.iy.07.040189.003125; WANG CY, 1987, P NATL ACAD SCI USA, V84, P7851, DOI 10.1073/pnas.84.22.7851; WOLFF JA, 1990, SCIENCE, V247, P1465, DOI 10.1126/science.1690918; WU CH, 1989, J BIOL CHEM, V264, P16985; WU GY, 1988, J BIOL CHEM, V263, P14621; YANG NS, 1990, P NATL ACAD SCI USA, V87, P9568, DOI 10.1073/pnas.87.24.9568	24	201	241	2	8	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JAN 24	1991	349	6307					351	352		10.1038/349351a0	http://dx.doi.org/10.1038/349351a0			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU501	1987492				2022-12-28	WOS:A1991EU50100060
J	VANDERLELY, AJ; FOEKEN, K; VANDERMAST, RC; LAMBERTS, SWJ				VANDERLELY, AJ; FOEKEN, K; VANDERMAST, RC; LAMBERTS, SWJ			RAPID REVERSAL OF ACUTE-PSYCHOSIS IN THE CUSHING SYNDROME WITH THE CORTISOL-RECEPTOR ANTAGONIST MIFEPRISTONE (RU-486)	ANNALS OF INTERNAL MEDICINE			English	Note									ERASMUS UNIV,3000 DR ROTTERDAM,NETHERLANDS	Erasmus University Rotterdam								BERTAGNA X, 1986, J CLIN ENDOCR METAB, V63, P639, DOI 10.1210/jcem-63-3-639; BERTAGNA X, 1984, J CLIN ENDOCR METAB, V59, P25, DOI 10.1210/jcem-59-1-25; GAILLARD RC, 1985, J CLIN ENDOCR METAB, V61, P1009, DOI 10.1210/jcem-61-6-1009; HASKETT RF, 1985, AM J PSYCHIAT, V142, P911; LAMBERTS SWJ, 1985, ACTA ENDOCRINOL-COP, V109, P64, DOI 10.1530/acta.0.1090064; LAUE L, 1988, J CLIN ENDOCR METAB, V67, P602, DOI 10.1210/jcem-67-3-602; NIEMAN LK, 1985, J CLIN ENDOCR METAB, V61, P536, DOI 10.1210/jcem-61-3-536; Nieman LK, 1987, RECENT ADV ADRENAL R, P235; PHILIBERT D, 1981, INT C PHARM TOKYO, P1463; RPOUXFERLAND L, 1982, J TEROID BIOCH, V17, pR17	10	91	91	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572	0003-4819			ANN INTERN MED	Ann. Intern. Med.	JAN 15	1991	114	2					143	144		10.7326/0003-4819-114-2-143	http://dx.doi.org/10.7326/0003-4819-114-2-143			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ER534	1984391				2022-12-28	WOS:A1991ER53400009
J	LOWRY, PW; BLANKENSHIP, RJ; GRIDLEY, W; TROUP, NJ; TOMPKINS, LS				LOWRY, PW; BLANKENSHIP, RJ; GRIDLEY, W; TROUP, NJ; TOMPKINS, LS			A CLUSTER OF LEGIONELLA-STERNAL WOUND INFECTIONS DUE TO POSTOPERATIVE TOPICAL EXPOSURE TO CONTAMINATED TAP WATER	NEW ENGLAND JOURNAL OF MEDICINE			English	Note							NOSOCOMIAL LEGIONNAIRES-DISEASE; PNEUMOPHILA; EPIDEMIC; PATIENT; OUTBREAK; SYSTEMS		STANFORD UNIV,MED CTR,SCH MED,DEPT MED,DIV INFECT DIS,RM H1537J,STANFORD,CA 94305; STANFORD UNIV HOSP,DEPT CARE REVIEW RISK MANAGEMENT,INFECT CONTROL PROGRAM,STANFORD,CA 94305; STANFORD UNIV,MED CTR,CLIN MICROBIOL LAB,STANFORD,CA 94305	Stanford University; Stanford University; Stanford University								AMPEL NM, 1985, ANN INTERN MED, V102, P630, DOI 10.7326/0003-4819-102-5-630; ARNOW PM, 1982, J INFECT DIS, V146, P460, DOI 10.1093/infdis/146.4.460; ARNOW PM, 1985, J INFECT DIS, V152, P145, DOI 10.1093/infdis/152.1.145; ARNOW PM, 1983, ANN INTERN MED, V98, P184, DOI 10.7326/0003-4819-98-2-184; BOPP CA, 1981, J CLIN MICROBIOL, V13, P714, DOI 10.1128/JCM.13.4.714-719.1981; BRABENDER W, 1983, JAMA-J AM MED ASSOC, V250, P3091, DOI 10.1001/jama.250.22.3091; BROOME CV, 1979, ANN INTERN MED, V90, P573, DOI 10.7326/0003-4819-90-4-573; CORDES LG, 1981, ANN INTERN MED, V94, P195, DOI 10.7326/0003-4819-94-2-195; DONDERO TJ, 1980, NEW ENGL J MED, V302, P365, DOI 10.1056/NEJM198002143020703; DORMAN SA, 1980, ANN INTERN MED, V93, P835, DOI 10.7326/0003-4819-93-6-835; DOURNON E, 1982, LANCET, V1, P1363; EDELSTEIN PH, 1985, MANUAL CLIN MICROBIO, P373; FISHERHOCH SP, 1981, LANCET, V1, P932; FRASER DW, 1977, NEW ENGL J MED, V297, P1189, DOI 10.1056/NEJM197712012972201; GROSS D, 1981, CHEST, V79, P232, DOI 10.1378/chest.79.2.232; HALEY CE, 1979, ANN INTERN MED, V90, P583, DOI 10.7326/0003-4819-90-4-583; HARRIS LF, 1981, ARCH INTERN MED, V141, P1385, DOI 10.1001/archinte.1981.00340100141031; KALWEIT WH, 1982, ANN INTERN MED, V96, P173, DOI 10.7326/0003-4819-96-2-173; LANDES BW, 1982, ARCH INTERN MED, V142, P1234, DOI 10.1001/archinte.142.6.1234; ROSNER BA, 1982, FUNDAMENTALS BIOSTAT, P417; SCHLANGER G, 1984, AM J MED, V77, P957, DOI 10.1016/0002-9343(84)90551-5; SIEGEL S, 1956, NONPARAMETRIC STAT, P184; STOUT J, 1982, NEW ENGL J MED, V306, P466, DOI 10.1056/NEJM198202253060807; TOBIN JOH, 1980, LANCET, V2, P118; TOMPKINS LS, 1987, J CLIN MICROBIOL, V25, P1875, DOI 10.1128/JCM.25.10.1875-1880.1987; TOMPKINS LS, 1988, NEW ENGL J MED, V318, P530, DOI 10.1056/NEJM198803033180902; WADOWSKY RM, 1982, APPL ENVIRON MICROB, V43, P1104, DOI 10.1128/AEM.43.5.1104-1110.1982	27	87	90	0	3	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 10	1991	324	2					109	113		10.1056/NEJM199101103240207	http://dx.doi.org/10.1056/NEJM199101103240207			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EQ977	1984176				2022-12-28	WOS:A1991EQ97700007
J	BABBOTT, D; LEVEY, GS; WEAVER, SO; KILLIAN, CD				BABBOTT, D; LEVEY, GS; WEAVER, SO; KILLIAN, CD			MEDICAL-STUDENT ATTITUDES ABOUT INTERNAL-MEDICINE - A STUDY OF UNITED-STATES MEDICAL-SCHOOL SENIORS IN 1988	ANNALS OF INTERNAL MEDICINE			English	Article								Objective: To determine the attitudes of medical students toward careers in internal medicine. Design: Cross-sectional national survey of U.S. medical school seniors. Participants: The 10 379 respondents to the 1988 Medical Student Graduation Questionnaire from the Association of American Medical Colleges. Measurements and Main Results: Most men and women selecting internal medicine (n = 1931) as well as those switching from earlier preferences for internal medicine (n = 1606) made their final decisions about specialty during the third and fourth years of medical school. Almost 50% of students planning to be internists cited "intellectual content" as the most important factor in their choice of specialty. "Diagnostic challenge" was next most frequently cited. "Type of patient seen" and "role models" were more frequently cited as the most important factors in specialty choice for all other specialties than for internal medicine. Students who switched away from earlier preferences for general internal medicine cited the following most important factors in descending order of frequency: "too demanding of time and effort," "inconsistent with personality," "negative clerkship experiences," "don't like the type of patient," and "specialty chosen more fulfilling." The same five factors, in a different order of frequency, were given for switching from the subspecialties of internal medicine. Conclusions: Most medical students make their final choices about specialty during or after their clerkship year. Knowledge of these students' attitudes toward internal medicine could form the basis for the development of strategies to enhance the attractiveness of internal medicine among these students while they are making their final decisions about specialty.	UNIV PITTSBURGH, SCH MED, DEPT MED, PITTSBURGH, PA 15261 USA; UNIV VERMONT, COLL MED, DEPT BIOSTAT, BURLINGTON, VT 05405 USA; ASSOC AMER MED COLL, WASHINGTON, DC 20036 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Vermont; Association of American Medical Colleges								BABBOTT D, 1989, JAMA-J AM MED ASSOC, V261, P2367, DOI 10.1001/jama.261.16.2367; BABBOTT D, 1988, JAMA-J AM MED ASSOC, V259, P1970, DOI 10.1001/jama.259.13.1970; BARNETT PG, 1989, JAMA-J AM MED ASSOC, V262, P2864, DOI 10.1001/jama.262.20.2864; DIAL TH, 1987, J MED EDUC, V62, P316; Dixon WJ, 1985, BMDP BIOMEDICAL COMP; FOURLAND M, 1989, ASS PROGRAM DIRECTOR, V5, P4; GRAETTINGER JS, 1988, ANN INTERN MED, V108, P101, DOI 10.7326/0003-4819-108-1-101; GRAETTINGER JS, 1989, ANN INTERN MED, V110, P682, DOI 10.7326/0003-4819-110-9-682; JONAS H S, 1988, Journal of the American Medical Association, V260, P1063, DOI 10.1001/jama.260.8.1063; JONAS HS, 1990, JAMA-J AM MED ASSOC, V264, P801, DOI 10.1001/jama.264.7.801; MCCARTY DJ, 1987, NEW ENGL J MED, V317, P567, DOI 10.1056/NEJM198708273170909; SCHERR L, 1987, ACP OBSERVER     MAY, P21; 1989, NATIONAL RESIDENCY M; 1988, MED STUDENT GRADUATI; 1988, NATIONAL RESIDENCY M; 1990, NATIONAL RESIDENCY M; 1989, STUDENT APPLICANT IN	17	58	58	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 1	1991	114	1					16	22		10.7326/0003-4819-114-1-16	http://dx.doi.org/10.7326/0003-4819-114-1-16			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EQ040	1983927				2022-12-28	WOS:A1991EQ04000003
J	RYDER, CJ				RYDER, CJ			UK FOOD LEGISLATION	LANCET			English	Article											RYDER, CJ (corresponding author), MAFF,DIV MICROBIOL SAFETY FOOD,ERGON HOUSE,NOBEL HOUSE,17 SMITH SQ,LONDON SW1P 3JR,ENGLAND.							1990, MICROBIOLOGICAL SA 1	1	0	0	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	DEC 22	1990	336	8730					1559	1562						4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EP037	1979378				2022-12-28	WOS:A1990EP03700016
J	WALKER, JM; BOND, SA; VOSS, LD; BETTS, PR; WOOTTON, SA; JACKSON, AA				WALKER, JM; BOND, SA; VOSS, LD; BETTS, PR; WOOTTON, SA; JACKSON, AA			TREATMENT OF SHORT NORMAL-CHILDREN WITH GROWTH-HORMONE - A CAUTIONARY TALE	LANCET			English	Article									SOUTHAMPTON GEN HOSP, DEPT PAEDIAT, SOUTHAMPTON SO9 4XY, HANTS, ENGLAND; SOUTHAMPTON GEN HOSP, DEPT HUMAN NUTR, SOUTHAMPTON SO9 4XY, HANTS, ENGLAND; SOUTHAMPTON GEN HOSP, DEPT MED ENDOCRINOL 2, SOUTHAMPTON SO9 4XY, HANTS, ENGLAND; UNIV SOUTHAMPTON, SOUTHAMPTON SO9 5NH, HANTS, ENGLAND	University of Southampton; University of Southampton; University of Southampton; University of Southampton			Wootton, Stephen/I-3712-2012	Wootton, Stephen/0000-0002-9495-9719				ACKLAND FM, 1990, ACTA PAEDIATR SCAND, P32; ALBERTSSONWIKLAND K, 1988, J CLIN ENDOCR METAB, V67, P493, DOI 10.1210/jcem-67-3-493; BENGTSSON BA, 1989, CLIN ENDOCRINOL, V30, P121, DOI 10.1111/j.1365-2265.1989.tb03733.x; BOUGNERES PF, 1990, ACTA PAEDIATR SCAND, P38; BRAY GA, 1977, PROG FOOD NUTR SCI, V2, P395; BROOK CGD, 1971, ARCH DIS CHILD, V46, P182, DOI 10.1136/adc.46.246.182; CHEEK DB, 1974, HDB PHYSIOLOGY END 2, V4, P159; COWELL CT, 1990, ACTA PAEDIATR SCAND, P29; CUNNINGHAM JJ, 1980, AM J CLIN NUTR, V33, P2372, DOI 10.1093/ajcn/33.11.2372; GOODMAN HM, 1974, HDB PHYSIOLOGY     7, V4, P211; HINDMARSH PC, 1990, ACTA PAEDIATR SCAND, P6; HINDMARSH PC, 1987, BRIT MED J, V295, P573, DOI 10.1136/bmj.295.6598.573; ISAKSSON OGP, 1987, ENDOCR REV, V8, P426, DOI 10.1210/edrv-8-4-426; JECQUIER E, 1987, CLIN ENDOCRINOL, V1, P911; SALOMON F, 1989, NEW ENGL J MED, V321, P1797, DOI 10.1056/NEJM198912283212605; Schofield W N, 1985, Hum Nutr Clin Nutr, V39 Suppl 1, P5; SIRI WE, UNPUB BODY COMPOSITI; TANNER JM, 1976, ARCH DIS CHILD, V51, P170, DOI 10.1136/adc.51.3.170; TANNER JM, 1967, J ENDOCRINOL, V39, P263, DOI 10.1677/joe.0.0390263; VOSS L, 1989, ACTA PAEDIATR SCAND, P65; VOSS LD, 1990, IN PRESS ARCH DIS CH	21	41	41	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 1	1990	336	8727					1331	1334		10.1016/0140-6736(90)92891-K	http://dx.doi.org/10.1016/0140-6736(90)92891-K			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL365	1978161				2022-12-28	WOS:A1990EL36500001
J	KHINMAUNGU; BOLIN, TD; DUNCOMBE, VM; PEREIRA, SP; MYOKHIN; NYUNTNYUNTWAI; LINKLATER, JM				KHINMAUNGU; BOLIN, TD; DUNCOMBE, VM; PEREIRA, SP; MYOKHIN; NYUNTNYUNTWAI; LINKLATER, JM			EFFECT OF SHORT-TERM INTERMITTENT ANTIBIOTIC-TREATMENT ON GROWTH OF BURMESE (MYANMAR) VILLAGE CHILDREN	LANCET			English	Article									MINIST HLTH,DEPT MED RES,DIV CLIN RES,RANGOON,MYANMAR; UNIV NEW S WALES,PRINCE WALES HOSP,SCH MED,GASTROINTESTINAL UNIT,SYDNEY,NSW,AUSTRALIA	University of New South Wales Sydney			Pereira, Stephen P/C-5639-2009; Linklater, James/O-8985-2016	Pereira, Stephen P/0000-0003-0821-1809; Linklater, James/0000-0002-5818-2025				BJORNEKLETT A, 1985, SCAND J GASTROENTERO, V20, P123, DOI 10.3109/00365528509103946; BJORNEKLETT A, 1983, SCAND J GASTROENTERO, V18, P289, DOI 10.3109/00365528309181596; DAVIDSON GP, 1985, J PEDIATR GASTR NUTR, V4, P381, DOI 10.1097/00005176-198506000-00010; GORE SM, 1981, BRIT MED J, V283, P600, DOI 10.1136/bmj.283.6291.600; GUPTA MC, 1982, AM J CLIN NUTR, V36, P79, DOI 10.1093/ajcn/36.1.79; HEIKENS GT, 1989, EUR J CLIN NUTR, V43, P145; HIRSCHHORN N, 1975, AM J TROP MED HYG, V24, P320, DOI 10.4269/ajtmh.1975.24.320; KHINMAUNGU, 1990, AM J CLIN NUTR, V52, P342, DOI 10.1093/ajcn/52.2.342; KHINMAUNGU, 1990, AM J CLIN NUTR, V52, P348, DOI 10.1093/ajcn/52.2.348; KHINMAUNGU, 1986, T ROY SOC TROP MED H, V80, P329, DOI 10.1016/0035-9203(86)90050-7; KHINMAUNGU, 1987, THESIS U NEW S WALES; KING CE, 1979, GASTROENTEROLOGY, V76, P1035; LEWIS RA, 1956, AM J TROP MED HYG, V5, P483, DOI 10.4269/ajtmh.1956.5.483; Luckey TD, 1959, ANTIBIOTICS THEIR CH, P174; MACDOUGALL L G, 1957, J Trop Pediatr (Lond), V3, P74; PERMAN JA, 1984, GASTROENTEROLOGY, V87, P1358; ROSENBERG IH, 1978, AM J CLIN NUTR, V31, P2202, DOI 10.1093/ajcn/31.12.2202; ROSENBERG IH, 1974, AM J CLIN NUTR, V27, P304, DOI 10.1093/ajcn/27.3.304; SCRIMSHAW NS, WHO MONOGRAPH SERIES, V57; SIMON GL, 1984, GASTROENTEROLOGY, V86, P174; SUTPHEN JL, 1985, J PEDIATR GASTR NUTR, V4, P169, DOI 10.1097/00005176-198504000-00004; VILLAREJOS VM, 1971, AM J TROP MED HYG, V20, P602, DOI 10.4269/ajtmh.1971.20.602; 1977, B WORLD HEALTH ORGAN, V55, P87	23	8	8	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 3	1990	336	8723					1090	1093		10.1016/0140-6736(90)92569-4	http://dx.doi.org/10.1016/0140-6736(90)92569-4			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF992	1977980				2022-12-28	WOS:A1990EF99200004
J	COLEBATCH, JG; FINDLEY, LJ; FRACKOWIAK, RSJ; MARSDEN, CD; BROOKS, DJ				COLEBATCH, JG; FINDLEY, LJ; FRACKOWIAK, RSJ; MARSDEN, CD; BROOKS, DJ			PRELIMINARY-REPORT - ACTIVATION OF THE CEREBELLUM IN ESSENTIAL TREMOR	LANCET			English	Article									NATL HOSP,INST NEUROL,MRC,HUMAN MOVEMENT & BALANCE UNIT,LONDON WC1N 3BG,ENGLAND	University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust			Frackowiak, Richard/H-4383-2011; Frackowiak, Richard S/I-1809-2013	Frackowiak, Richard/0000-0002-3151-822X; Colebatch, James/0000-0002-2099-4976; Brooks, David/0000-0003-2602-2518	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		DUPUIS MJM, 1989, MOVEMENT DISORD, V4, P183, DOI 10.1002/mds.870040210; FRISTON KJ, 1990, J CEREBR BLOOD F MET, V10, P458, DOI 10.1038/jcbfm.1990.88; FRISTON KJ, 1989, J CEREBR BLOOD F MET, V9, P690, DOI 10.1038/jcbfm.1989.97; HERSKOVI.E, 1969, J NEUROL NEUROSUR PS, V32, P509, DOI 10.1136/jnnp.32.6.509; HIRAI T, 1983, BRAIN, V106, P1001, DOI 10.1093/brain/106.4.1001; LAMARRE Y, 1984, MOVEMENT DISORDERS T, P183; LAMMERTSMA AA, 1990, J CEREBR BLOOD F MET, V10, P675, DOI 10.1038/jcbfm.1990.121; Marsden C. D., 1983, CURRENT CONCEPTS PAR, P31; MARSDEN CD, 1986, TRENDS NEUROSCI, V9, P512, DOI 10.1016/0166-2236(86)90162-1; Raichle M. E., 1987, HDB PHYSL NERVOUS SY, V1, P643; Talairach J., 1988, COPLANAR STEREOTAXIC; YOUNG RR, 1986, HDB CLIN NEUROLOGY, V49, P565	12	158	160	0	4	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 27	1990	336	8722					1028	1030		10.1016/0140-6736(90)92489-5	http://dx.doi.org/10.1016/0140-6736(90)92489-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF076	1977019				2022-12-28	WOS:A1990EF07600004
J	CUTHBERT, RJG; LUDLAM, CA; TUCKER, J; STEEL, CM; BEATSON, D; REBUS, S; PEUTHERER, JF				CUTHBERT, RJG; LUDLAM, CA; TUCKER, J; STEEL, CM; BEATSON, D; REBUS, S; PEUTHERER, JF			5-YEAR PROSPECTIVE-STUDY OF HIV-INFECTION IN THE EDINBURGH HEMOPHILIAC COHORT	BMJ-BRITISH MEDICAL JOURNAL			English	Article									ROYAL INFIRM, DEPT HAEMATOL, EDINBURGH EH3 9YW, MIDLOTHIAN, SCOTLAND; WESTERN GEN HOSP, MRC, HUMAN GENET UNIT, EDINBURGH EH4 2XU, MIDLOTHIAN, SCOTLAND; UNIV EDINBURGH, DEPT BACTERIOL, EDINBURGH EH8 9YL, MIDLOTHIAN, SCOTLAND	Royal Infirmary of Edinburgh; University of Edinburgh; University of Edinburgh								BRETTLER DB, 1986, AM J MED, V81, P607, DOI 10.1016/0002-9343(86)90545-0; CARR R, 1984, LANCET, V1, P1431; CUTHBERT RJG, 1989, BRIT J HAEMATOL, V72, P387, DOI 10.1111/j.1365-2141.1989.tb07720.x; EYSTER ME, 1987, ANN INTERN MED, V107, P1, DOI 10.7326/0003-4819-107-1-1; FUCHS D, 1988, IMMUNOL TODAY, V9, P150, DOI 10.1016/0167-5699(88)91203-0; JIN ZW, 1989, J ALLERGY CLIN IMMUN, V83, P165, DOI 10.1016/0091-6749(89)90492-2; KASLOW RA, 1990, LANCET, V335, P927, DOI 10.1016/0140-6736(90)90995-H; LEE CA, 1989, BRIT J HAEMATOL, V73, P228, DOI 10.1111/j.1365-2141.1989.tb00257.x; LEFRERE JJ, 1989, AIDS, V3, P603, DOI 10.1097/00002030-198909000-00008; LUDLAM CA, 1985, LANCET, V2, P233; MALLAL S, 1990, LANCET, V335, P1591, DOI 10.1016/0140-6736(90)91418-A; MILDVAN D, 1987, CURRENT TOPICS AIDS, V1, P31; MOSS AR, 1988, BRIT MED J, V296, P745, DOI 10.1136/bmj.296.6624.745; MOSS AR, 1988, BRIT MED J, V297, P1067, DOI 10.1136/bmj.297.6656.1067; MUNOZ A, 1988, J ACQ IMMUN DEF SYND, V1, P396; PEDERSEN C, 1989, J INTERN MED, V225, P403, DOI 10.1111/j.1365-2796.1989.tb00103.x; POLK BF, 1987, NEW ENGL J MED, V316, P61, DOI 10.1056/NEJM198701083160201; SEARS SD, 1987, CLIN IMMUNOL IMMUNOP, V45, P177, DOI 10.1016/0090-1229(87)90032-8; SIMMONDS P, 1988, BRIT MED J, V296, P593, DOI 10.1136/bmj.296.6622.593; STEEL CM, 1988, LANCET, V1, P1185; 1989, LANCET, V2, P483	21	37	37	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 27	1990	301	6758					956	961		10.1136/bmj.301.6758.956	http://dx.doi.org/10.1136/bmj.301.6758.956			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF075	1979015	Bronze, Green Published			2022-12-28	WOS:A1990EF07500017
J	WAITES, WM; ARBUTHNOTT, JP				WAITES, WM; ARBUTHNOTT, JP			FOODBORNE ILLNESS - AN OVERVIEW	LANCET			English	Review									UNIV NOTTINGHAM,DEPT APPL BIOCHEM & FOOD SCI,LOUGHBOROUGH LE12 5RD,LEICS,ENGLAND; QUEENS MED CTR,DEPT MED MICROBIOL,NOTTINGHAM NG7 2UH,ENGLAND	University of Nottingham; University of Nottingham								FENLON DR, 1985, J APPL BACTERIOL, V59, P537, DOI 10.1111/j.1365-2672.1985.tb03357.x; INGRAM M, 1972, ROY SOC HEALTH J, V92, P121, DOI 10.1177/146642407209200305; MACDONALD KL, 1988, JAMA-J AM MED ASSOC, V259, P3567, DOI 10.1001/jama.259.24.3567; Munro I.C, 1981, FOOD SAFETY, P141; SILLIKER JH, 1988, MICROORGANISMS FOOD, V4; TODD ECD, 1989, J FOOD PROTECT, V52, P595, DOI 10.4315/0362-028X-52.8.595; WAITES WM, 1990, FOOD SAFETY HUMAN FO, P27; WEST PA, 1989, EPIDEMIOL INFECT, V103, P1, DOI 10.1017/S0950268800030326; WILLARDSEN RR, 1978, J FOOD SCI, V43, P470, DOI 10.1111/j.1365-2621.1978.tb02333.x; 1979, ENV CONTAMINANTS FOO; 1990, LANCET, V336, P215; 1988, GOOD MANUFACTURING P	12	28	28	2	5	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	SEP 22	1990	336	8717					722	725		10.1016/0140-6736(90)92213-2	http://dx.doi.org/10.1016/0140-6736(90)92213-2			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DZ624	1975899				2022-12-28	WOS:A1990DZ62400011
J	SOLL, AH; WEINSTEIN, WM; KURATA, J; MCCARTHY, D				SOLL, AH; WEINSTEIN, WM; KURATA, J; MCCARTHY, D			NONSTEROIDAL ANTIINFLAMMATORY DRUGS AND PEPTIC-ULCER DISEASE	ANNALS OF INTERNAL MEDICINE			English	Discussion							CHRONIC GASTRIC-ULCER; GASTRODUODENAL MUCOSAL DAMAGE; ENTERIC-COATED ASPIRIN; RHEUMATOID-ARTHRITIS; DOUBLE-BLIND; ANTIINFLAMMATORY DRUGS; ENVIRONMENTAL-FACTORS; ANALGESIC INGESTION; CONTROLLED TRIAL; OCCULT BLOOD	Evidence has accumulated that nonsteroidal anti-inflammatory drugs (NSAIDs) cause clinically important gastroduodenal ulcers. The pathogenesis, which involves the impairment of mucosal resistance to injury in an acid-peptic environment, is multi-factorial and controversial. Ulcers caused by NSAIDs can occur either in mucosa inflamed because of infection with Helicobacter pylori or in histologically normal mucosa. The use of these drugs has been linked to an unexpectedly high incidence of ulcer complications, and a history of peptic ulcer disease is common in such cases. Nonsteroidal anti-inflammatory drugs thus appear both to exacerbate an underlying peptic diathesis and to cause de novo ulcers. The association between the use of these drugs and ulcer complications is supported by ulcer prevalence data from cross-sectional studies, and by data from case-controlled and cohort studies, and from randomized, experimental trials. Drug-induced gastric ulcers have been prevented by misoprostol, but not by H-2 blocker therapy. Several therapies have been reported to promote ulcer healing despite continued use of NSAIDs, but adequate controlled trials have not been done. Small gastric and duodenal ulcers readily heal, whereas larger gastric ulcers require vigorous and prolonged therapy. The relative efficacies of various therapies in preventing ulcers, healing ulcers, or preventing complications remain to be established.	UNIV CALIF LOS ANGELES, SCH MED, DEPT MED, DIV GASTROENTEROL, LOS ANGELES, CA 90024 USA; SAN BERNARDINO CTY MED CTR, DEPT FAMILY MED, SAN BERNARDINO, CA USA; UNIV NEW MEXICO, DEPT MED, DIV GASTROENTEROL, ALBUQUERQUE, NM 87131 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of New Mexico	SOLL, AH (corresponding author), WADSWORTH VET AFFAIRS MED CTR, CTR ULCER RES & EDUC, BLDG 115, ROOM 203, LOS ANGELES, CA 90073 USA.				NIDDK NIH HHS [DK 17328] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK017328] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARMSTRONG CP, 1987, GUT, V28, P527, DOI 10.1136/gut.28.5.527; BAHRT KM, 1984, ARCH INTERN MED, V144, P2165, DOI 10.1001/archinte.144.11.2165; BEARD K, 1987, ARCH INTERN MED, V147, P1621, DOI 10.1001/archinte.147.9.1621; BERKOWITZ JM, 1986, J CLIN GASTROENTEROL, V8, P377, DOI 10.1097/00004836-198606002-00009; BIJLSMA JWJ, 1988, ALIMENT PHARM THERAP, V2, P85; BLOOM BS, 1989, ARCH INTERN MED, V149, P1019, DOI 10.1001/archinte.149.5.1019; BUGAT R, 1976, GASTROENTEROLOGY, V71, P754; CALDWELL JR, 1987, AM J MED, V83, P74, DOI 10.1016/0002-9343(87)90832-1; CARSON JL, 1987, ARCH INTERN MED, V147, P1054, DOI 10.1001/archinte.147.6.1054; CARSON JL, 1987, ARCH INTERN MED, V147, P85, DOI 10.1001/archinte.147.1.85; CHEN MCY, 1988, GASTROENTEROLOGY, V94, P1121, DOI 10.1016/0016-5085(88)90002-9; CLINCH D, 1983, J ROY COLL PHYS LOND, V17, P228; COGGON D, 1982, GUT, V23, P340, DOI 10.1136/gut.23.4.340; COLLIER DS, 1985, GUT, V26, P359, DOI 10.1136/gut.26.4.359; CROKER JR, 1980, ANN RHEUM DIS, V39, P275, DOI 10.1136/ard.39.3.275; DAVENPORT HW, 1964, GASTROENTEROLOGY, V47, P142; DUGGAN JM, 1986, GUT, V27, P929, DOI 10.1136/gut.27.8.929; EHSANULLAH RSB, 1988, BRIT MED J, V297, P1017, DOI 10.1136/bmj.297.6655.1017; FARAH D, 1988, ANN RHEUM DIS, V47, P478, DOI 10.1136/ard.47.6.478; FAULKNER G, 1988, BRIT MED J, V297, P1311, DOI 10.1136/bmj.297.6659.1311; GERBER LH, 1981, J CLIN GASTROENTEROL, V3, P7, DOI 10.1097/00004836-198103000-00002; GRAHAM DY, 1988, LANCET, V2, P1277; GRAHAM DY, 1983, DIGEST DIS SCI, V28, P1, DOI 10.1007/BF01393353; GRAHAM DY, 1989, GASTROENTEROLOGY, V96, P615, DOI 10.1016/S0016-5085(89)80057-5; GRAHAM DY, 1985, CLIN PHARMACOL THER, V38, P65, DOI 10.1038/clpt.1985.136; GRIFFIN MR, 1988, ANN INTERN MED, V109, P359, DOI 10.7326/0003-4819-109-5-359; GUESS HA, 1988, J CLIN EPIDEMIOL, V41, P35, DOI 10.1016/0895-4356(88)90007-8; HENNEKENS CH, 1989, NEW ENGL J MED, V321, P129, DOI 10.1056/nejm198907203210301; HOFTIEZER JW, 1980, LANCET, V2, P609; ISENBERG JI, 1985, GASTROENTEROLOGY, V88, P303, DOI 10.1016/S0016-5085(85)80184-0; JASZEWSKI R, 1989, DIGEST DIS SCI, V34, P1361, DOI 10.1007/BF01538069; JICK SS, 1987, LANCET, V2, P380; KURATA JH, 1982, GASTROENTEROLOGY, V82, P373; KURATA JH, 1990, J CLIN GASTROENTEROL, V12, P260, DOI 10.1097/00004836-199006000-00005; LACY ER, 1982, GASTROENTEROLOGY, V83, P619; LAINE L, 1989, Gastroenterology, V96, pA282; LAINE L, 1988, DIGEST DIS SCI, V33, P490, DOI 10.1007/BF01536037; LANZA FL, 1988, GASTROENTEROLOGY, V95, P289, DOI 10.1016/0016-5085(88)90482-9; LANZA FL, 1987, AM J GASTROENTEROL, V82, P939; LARKAI EN, 1987, AM J GASTROENTEROL, V82, P1153; LEVINE RA, 1988, DIGEST DIS SCI, V33, P660, DOI 10.1007/BF01540427; LEVY M, 1988, ARCH INTERN MED, V148, P281, DOI 10.1001/archinte.148.2.281; LEVY M, 1974, NEW ENGL J MED, V290, P1158, DOI 10.1056/NEJM197405232902102; LIGUMSKY M, 1983, GASTROENTEROLOGY, V84, P756; LOIUDICE TA, 1981, AM J GASTROENTEROL, V75, P104; MACDONAL.WC, 1973, GASTROENTEROLOGY, V65, P381; MANNICHE C, 1987, GUT, V28, P226, DOI 10.1136/gut.28.2.226; MCCARTHY DM, 1989, GASTROENTEROLOGY, V96, P662, DOI 10.1016/S0016-5085(89)80063-0; McCarthy DM, 1989, DRUG THER, V19, P59; MCINTOSH JH, 1988, AM J EPIDEMIOL, V128, P761, DOI 10.1093/oxfordjournals.aje.a115029; MCINTOSH JH, 1985, GUT, V26, P789, DOI 10.1136/gut.26.8.789; METZGER WH, 1976, AM J DIG DIS, V21, P963, DOI 10.1007/BF01071908; MORRIS AD, 1981, SCAND J GASTROENTERO, V16, P131; NESLAND AA, 1985, SCAND J GASTROENTERO, V20, P222, DOI 10.3109/00365528509089661; OLAUGHLIN JC, 1981, SCAND J GASTROENTERO, V16, P211; OLAUGHLIN JC, 1981, ARCH INTERN MED, V141, P781, DOI 10.1001/archinte.141.6.781; OLAUGHLIN JC, 1982, DIGEST DIS SCI, V27, P976, DOI 10.1007/BF01391742; PIPER DW, 1981, GASTROENTEROLOGY, V80, P427; PIPER DW, 1982, SCAND J GASTROENTERO, V17, P721, DOI 10.3109/00365528209181085; POUNDER R, 1989, GASTROENTEROLOGY, V96, P626, DOI 10.1016/S0016-5085(89)80058-7; PYE G, 1987, BRIT MED J, V294, P1510, DOI 10.1136/bmj.294.6586.1510; QUIGLEY EMM, 1987, GASTROENTEROLOGY, V92, P1876, DOI 10.1016/0016-5085(87)90619-6; RAINSFORD KD, 1989, SCAND J GASTROENTERO, V24, P9, DOI 10.3109/00365528909091169; REDFERN JS, 1987, GASTROENTEROLOGY, V92, P969, DOI 10.1016/0016-5085(87)90972-3; REDFERN JS, 1989, GASTROENTEROLOGY, V96, P596, DOI 10.1016/S0016-5085(89)80055-1; ROBERT A, 1979, GASTROENTEROLOGY, V77, P433; ROBERT A, 1976, GASTROENTEROLOGY, V70, P359; Robert A, 1984, MECHANISMS MUCOSAL P, P377; ROBINSON MG, 1989, DIGEST DIS SCI, V34, P424, DOI 10.1007/BF01536266; ROTH S, 1989, ARCH INTERN MED, V149, P775, DOI 10.1001/archinte.149.4.775; ROTH SH, 1987, ARCH INTERN MED, V147, P1798, DOI 10.1001/archinte.147.10.1798; SANDERS MJ, 1985, NATURE, V313, P52, DOI 10.1038/313052a0; SILEN W, 1987, PHYSL GASTROINTESTIN, V2, P1055; SILVOSO GR, 1979, ANN INTERN MED, V91, P517, DOI 10.7326/0003-4819-91-4-517; SIMMONS TC, 1981, PROSTAGLANDINS, V21, P165, DOI 10.1016/0090-6980(81)90134-9; SOMERVILLE K, 1986, LANCET, V1, P462; SUN DCH, 1974, AM J DIG DIS, V19, P405, DOI 10.1007/BF01255603; TEMPLE R, 1986, FDAS NSAI GI WARNING; WALAN A, 1989, NEW ENGL J MED, V320, P69, DOI 10.1056/NEJM198901123200201; WALT R, 1986, LANCET, V1, P489	80	368	375	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 15	1991	114	4					307	319		10.7326/0003-4819-114-4-307	http://dx.doi.org/10.7326/0003-4819-114-4-307			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EX521	1987878				2022-12-28	WOS:A1991EX52100011
J	IP, YT; KRAUT, R; LEVINE, M; RUSHLOW, CA				IP, YT; KRAUT, R; LEVINE, M; RUSHLOW, CA			THE DORSAL MORPHOGEN IS A SEQUENCE-SPECIFIC DNA-BINDING PROTEIN THAT INTERACTS WITH A LONG-RANGE REPRESSION ELEMENT IN DROSOPHILA	CELL			English	Article							ANTENNAPEDIA GENE-COMPLEX; NF-KAPPA-B; LEUCINE ZIPPER; RNA-POLYMERASE; V-REL; EXPRESSION; ONCOGENE; EMBRYOS; CELLS; TRANSFORMATION	A gradient of the maternal morphogen dorsal (dl) establishes dorsal-ventral (D-V) polarity in the early Drosophila embryo. The dl concentration gradient is initiated by regulated nuclear transport, and only protein that enters nuclei is active in the D-V patterning process. Here we show that dl is a DNA-binding protein that specifically interacts with distal sequences of the zerknullt (zen) promoter, one of the genetic targets of the morphogen. These zen seqauences have the properties of a silencer element and can act over long distances to repress the expression of a heterologous promoter. The dl protein recognizes a sequence motif similar to that of the mammalian transcriptional activator NF-kappa-B, which was shown to contain extensive homology with dl and the oncoprotein rel. We present evidence that the DNA-binding activity of the dl protein is mediated by the region of homology (the rel domain) conserved in the rel and NF-kappa-B proteins.			IP, YT (corresponding author), COLUMBIA UNIV,FAIRCHILD CTR,DEPT BIOL SCI,NEW YORK,NY 10027, USA.			Levine, Michael/0000-0001-7629-0081	PHS HHS [34431] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ANDERSON KV, 1985, CELL, V42, P779, DOI 10.1016/0092-8674(85)90274-0; ANDERSON KV, 1986, GAMETOGENESIS EARLY, P177; BAEUERLE PA, 1988, CELL, V53, P211, DOI 10.1016/0092-8674(88)90382-0; BAEUERLE PA, 1989, GENE DEV, V3, P1689, DOI 10.1101/gad.3.11.1689; BOULAY JL, 1987, NATURE, V330, P395, DOI 10.1038/330395a0; BRAND AH, 1985, CELL, V41, P41, DOI 10.1016/0092-8674(85)90059-5; DOYLE HJ, 1989, GENE DEV, V3, P1518, DOI 10.1101/gad.3.10.1518; FRIED M, 1981, NUCLEIC ACIDS RES, V9, P6506; GARNER MM, 1981, NUCLEIC ACIDS RES, V9, P3047, DOI 10.1093/nar/9.13.3047; GHOSH S, 1990, CELL, V62, P1019, DOI 10.1016/0092-8674(90)90276-K; GILMORE TD, 1990, CELL, V62, P841, DOI 10.1016/0092-8674(90)90257-F; GILMORE TD, 1986, CELL, V44, P791, DOI 10.1016/0092-8674(86)90845-7; HARRISON SC, 1990, ANNU REV BIOCHEM, V59, P933, DOI 10.1146/annurev.bi.59.070190.004441; HIROMI Y, 1987, CELL, V50, P963, DOI 10.1016/0092-8674(87)90523-X; HOCH M, 1990, EMBO J, V9, P2587, DOI 10.1002/j.1460-2075.1990.tb07440.x; HOEY T, 1988, NATURE, V332, P858, DOI 10.1038/332858a0; IRISH VF, 1987, GENE DEV, V1, P868, DOI 10.1101/gad.1.8.868; KIERAN M, 1990, CELL, V62, P1007, DOI 10.1016/0092-8674(90)90275-J; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7; LEVINE M, 1988, CELL, V55, P537, DOI 10.1016/0092-8674(88)90209-7; Maxam A M, 1980, Methods Enzymol, V65, P499; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; N?sslein-Volhard C., 1979, DETERMINANTS SPATIAL, P185; PADGETT RW, 1987, NATURE, V325, P81, DOI 10.1038/325081a0; RHODES D, 1988, NUCLEIC ACIDS MOL BI, V2; ROTH S, 1989, CELL, V59, P1189, DOI 10.1016/0092-8674(89)90774-5; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; RUSHLOW C, 1987, NATURE, V330, P583, DOI 10.1038/330583a0; RUSHLOW C, 1987, GENE DEV, V1, P1268, DOI 10.1101/gad.1.10.1268; RUSHLOW C, 1990, SEMINARS CELL BIOL, V1, P173; RUSHLOW CA, 1989, CELL, V59, P1165, DOI 10.1016/0092-8674(89)90772-1; SIEBENLIST U, 1980, CELL, V20, P269, DOI 10.1016/0092-8674(80)90613-3; SIMPSON P, 1983, GENETICS, V105, P615; STANOJEVIC D, 1989, NATURE, V341, P331, DOI 10.1038/341331a0; STEPHENS RM, 1983, P NATL ACAD SCI-BIOL, V80, P6229, DOI 10.1073/pnas.80.20.6229; STERN S, 1989, NATURE, V341, P624, DOI 10.1038/341624a0; STEWARD R, 1989, CELL, V59, P1179, DOI 10.1016/0092-8674(89)90773-3; STEWARD R, 1987, SCIENCE, V238, P692, DOI 10.1126/science.3118464; STEWARD R, 1988, CELL, V55, P487, DOI 10.1016/0092-8674(88)90035-9; STJOHNSTON RD, 1987, EMBO J, V6, P2785, DOI 10.1002/j.1460-2075.1987.tb02574.x; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; THISSE B, 1987, GENE DEV, V1, P709, DOI 10.1101/gad.1.7.709; THISSE B, 1988, EMBO J, V7, P2175, DOI 10.1002/j.1460-2075.1988.tb03056.x; TRIEZENBERG SJ, 1988, GENE DEV, V2, P718, DOI 10.1101/gad.2.6.718; VINSON CR, 1989, SCIENCE, V246, P911, DOI 10.1126/science.2683088; WAKIMOTO BT, 1984, DEV BIOL, V102, P147, DOI 10.1016/0012-1606(84)90182-9; ZOLLER MJ, 1984, DNA-J MOLEC CELL BIO, V3, P479, DOI 10.1089/dna.1.1984.3.479	48	211	213	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	JAN 25	1991	64	2					439	446						8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EV336	1988156				2022-12-28	WOS:A1991EV33600019
J	WARNER, DC				WARNER, DC			HEALTH ISSUES AT THE UNITED-STATES-MEXICAN BORDER	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								With a rapidly growing population, increasing manufacturing activity, and increased interdependence, health issues on the US-Mexican border are demanding greater attention. It is unlikely that any other border in the world separates two nations having such variety in health status, entitlements, and utilization. Binational initiatives in the areas of environmental health and sanitation are clearly needed. Further cooperation between the United States and Mexico in provision of health services is warranted and will probably require enhanced federal funding or subsidies to be successful.			WARNER, DC (corresponding author), UNIV TEXAS,LYNDON B JOHNSON SCH PUBL AFFAIRS,DRAWER Y,UNIV STN,AUSTIN,TX 78713, USA.		Potter, Joseph E/A-3122-2008					ALBA F, 1986, POPUL DEV REV, V12, P47, DOI 10.2307/1973351; ALBA F, 1989, MEXICAN CENTRAL AM P, P5; APPELGATE HG, 1989, J BORDERLAND STUD, V4, P1; BOCK K, 1989, MAQUILADORAS HAZADOU; BRADSHAW B, IN PRESS MORTALITY H; CHAN L, 1987, MATERNAL CHILD HLTH; COLLINS H, 1989, AUG TEX MED ASS BORD; Diaz-Briquets S., 1989, MEXICAN CENTRAL AM P, P33; EATON DJ, 1987, STATE RIO GRANDE RIO; FOWKES VK, 1989, ASSESSMENT FACTORS I; GUENDELMAN S, 1988, CROSSING BORDER HLTH; HAFKIN B, 1982, AM J TROP MED HYG, V32, P1222; Hansen N. M., 1981, BORDER EC REGIONAL D; HOLZ R, 1989, 3RD WORLD TEXAS COLO; LANDRIGAN PJ, 1975, NEW ENGL J MED, V292, P123, DOI 10.1056/NEJM197501162920302; LAWRENCE A, 1989, HLTH ISSUES TEXAS ME; LLOYD W, 1984, US MEXICO BORDER REG, P215; MALINA RM, 1987, AM J PUBLIC HEALTH, V77, P573, DOI 10.2105/AJPH.77.5.573; MCDERMOTT C, 1989, FAMILY PLANNING MEXI; MENDOZA FS, 1991, JAMA-J AM MED ASSOC, V265, P227, DOI 10.1001/jama.265.2.227; NICHOLS A, 1989, BORDER HLTH      AUG, P30; NICHOLS A, IN PRESS PUBLIC HLTH; ORTIZ A, 1984, 29 LB JOHN SCH PUBL; Pinheiro F P, 1989, Epidemiol Bull, V10, P1; PORTES A, 1989, UNAUTHORIZED IMMIGRA; POWELLGRINER E, 1983, CHARACTERISTICS BIRT; SOSA FC, 1988, BORDER HLTH, V4, P27; VALDESPINO G, 1989, PAHO B, V23, P20; ZINNECKER AK, 1990, USE US HLTH SERVICES; 1988, HLTH CARE AVAILABILI; 1988, BORDER HLTH INVENTOR; 1989, ARIZONA HLTH STATUS; 1988, EPA ENV NEWS    0503, P1; 1989, VALLEY PRIMARY HLTH; 1987, REPORTED MORBIDITY M, P13; 1989, US MEXICO BORDER HLT, P61; 1988, MEXICO ENCUESTA NACI, P36; 1990, JAMA-J AM MED ASSOC, V263, P3319; 1989, 1988 POPULATION PROJ; 1988, CURRENT POPULATION R, P7; 1986, LIVE BIRTHS STATISTI; 1989, MEXICO ENCUESTA NACI, P92; 1978, REV HLTH SITUATION U	43	40	42	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 9	1991	265	2					242	247		10.1001/jama.265.2.242	http://dx.doi.org/10.1001/jama.265.2.242			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EQ602	1984155				2022-12-28	WOS:A1991EQ60200033
J	HOJER, J; BAEHRENDTZ, S; MATELL, G; GUSTAFSSON, LL				HOJER, J; BAEHRENDTZ, S; MATELL, G; GUSTAFSSON, LL			DIAGNOSTIC UTILITY OF FLUMAZENIL IN COMA WITH SUSPECTED POISONING - A DOUBLE-BLIND, RANDOMIZED CONTROLLED-STUDY	BRITISH MEDICAL JOURNAL			English	Article									KAROLINSKA INST,SO HOSP,DEPT INTERNAL MED,S-10401 STOCKHOLM 60,SWEDEN; KAROLINSKA INST,HUDDINGE HOSP,DEPT CLIN PHARMACOL,S-10401 STOCKHOLM 60,SWEDEN	Karolinska Institutet; Karolinska Institutet			Gustafsson, Lars/G-3902-2010	Gustafsson, Lars Lennart/0000-0002-0063-552X				BODENHAM AR, 1989, BRIT MED J, V299, P457, DOI 10.1136/bmj.299.6696.457; BOEHNERT MT, 1985, NEW ENGL J MED, V313, P474, DOI 10.1056/NEJM198508223130804; BURKHART KK, 1990, ANN EMERG MED, V19, P319, DOI 10.1016/S0196-0644(05)82054-2; BURR W, 1989, BRIT MED J, V298, P1713, DOI 10.1136/bmj.298.6689.1713-a; DESILVA JAF, 1976, ANAL CHEM, V48, P10, DOI 10.1021/ac60365a037; Geller E, 1988, RESUSCITATION S, V16, pS57; Gijsenbergh F P, 1989, Acta Anaesthesiol Belg, V40, P127; HARDWICKE C, 1986, MED J AUSTRALIA, V144, P453, DOI 10.5694/j.1326-5377.1986.tb101046.x; HOJER J, 1989, J INTERN MED, V226, P117; HOJER J, 1988, ACTA MED SCAND, V244, P357; HUNKELER W, 1981, NATURE, V290, P514, DOI 10.1038/290514a0; LEVY DE, 1981, ANN INTERN MED, V94, P293, DOI 10.7326/0003-4819-94-3-293; LEYKIN Y, 1989, ISRAEL J MED SCI, V25, P98; MORA CT, 1989, ANESTH ANALG, V68, P473; PINDER RM, 1977, DRUGS, V13, P321, DOI 10.2165/00003495-197713050-00001; PLUM F, 1980, DIAGNOSIS STUPOR COM, P345; PROUDFOOT AT, 1978, BRIT MED J, V1, P90, DOI 10.1136/bmj.1.6105.90; RUBENSTEIN E, 1989, SCI AM MED, P2; SALZMAN NP, 1956, J PHARMACOL EXP THER, V118, P46; SHANNON M, 1988, AM J EMERG MED, V6, P439, DOI 10.1016/0735-6757(88)90241-0; SHORT TG, 1988, BRIT MED J, V296, P1070, DOI 10.1136/bmj.296.6628.1070-e; TEASDALE G, 1974, LANCET, V2, P81; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P13; VANBRUNT N, 1983, THER DRUG MONIT, V5, P1; VISSER T, 1984, J CHROMATOGR, V309, P81, DOI 10.1016/0378-4347(84)80008-0; WEINFELD RE, 1977, J CHROMATOGR, V143, P581, DOI 10.1016/S0378-4347(00)81313-4; WILLOX DGA, 1985, SCOT MED J, V30, P220, DOI 10.1177/003693308503000406	27	40	41	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	DEC 8	1990	301	6764					1308	1311		10.1136/bmj.301.6764.1308	http://dx.doi.org/10.1136/bmj.301.6764.1308			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM285	1980218	Green Published, Bronze			2022-12-28	WOS:A1990EM28500019
J	MALKIN, D; LI, FP; STRONG, LC; FRAUMENI, JF; NELSON, CE; KIM, DH; KASSEL, J; GRYKA, MA; BISCHOFF, FZ; TAINSKY, MA; FRIEND, SH				MALKIN, D; LI, FP; STRONG, LC; FRAUMENI, JF; NELSON, CE; KIM, DH; KASSEL, J; GRYKA, MA; BISCHOFF, FZ; TAINSKY, MA; FRIEND, SH			GERM LINE P53 MUTATIONS IN A FAMILIAL SYNDROME OF BREAST-CANCER, SARCOMAS, AND OTHER NEOPLASMS	SCIENCE			English	Article									MASSACHUSETTS GEN HOSP,CTR CANC,DIV MOLEC GENET,MGH E,BOSTON,MA 02129; UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT TUMOR BIOL,HOUSTON,TX 77030; HARVARD UNIV,CHILDRENS HOSP,SCH MED,DANA FARBER CANC INST,DEPT PEDIAT,DIV HEMATOL ONCOL,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DANA FARBER CANC INST,DIV BIOSTAT & EPIDEMIOL,BOSTON,MA 02115; UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DIV PEDIAT,HOUSTON,TX 77030; NCI,DIV CANC ETIOL,CLIN EPIDEMIOL BRANCH,BETHESDA,MD 20892; NCI,DIV CANC ETIOL,EPIDEMIOL & BIOSTAT PROGRAM,BETHESDA,MD 20892	Harvard University; Massachusetts General Hospital; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of Texas System; UTMD Anderson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)			Malkin, David/AAW-8715-2021; Pinheiro, Maísa/E-7424-2012	Tainsky, Michael/0000-0002-0261-831X	NCI NIH HHS [5-T32-CA09299] Funding Source: Medline; PHS HHS [34936] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009299] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AHUJA H, 1989, P NATL ACAD SCI USA, V86, P6783, DOI 10.1073/pnas.86.17.6783; BAKER SJ, 1989, SCIENCE, V244, P217, DOI 10.1126/science.2649981; BARTEK J, 1990, ONCOGENE, V5, P893; BIRCH JM, 1990, J CLIN ONCOL, V8, P583, DOI 10.1200/JCO.1990.8.4.583; BIRCH JM, 1984, BRIT J CANCER, V49, P325, DOI 10.1038/bjc.1984.51; BUCHMAN VL, 1988, GENE, V70, P245, DOI 10.1016/0378-1119(88)90196-5; DILLER L, 1990, MOL CELL BIOL, V10, P5772, DOI 10.1128/MCB.10.11.5772; ELIYAHU D, 1989, P NATL ACAD SCI USA, V86, P8763, DOI 10.1073/pnas.86.22.8763; FINLAY CA, 1988, MOL CELL BIOL, V8, P531, DOI 10.1128/MCB.8.2.531; FINLAY CA, 1989, CELL, V57, P1083, DOI 10.1016/0092-8674(89)90045-7; FRANCKE U, 1979, CYTOGENET CELL GENET, V24, P185, DOI 10.1159/000131375; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; FRIEND SH, UNPUB; GARBER JE, 1990, P AM ASSOC CANC RES, V31, P210; HINDS P, 1989, J VIROL, V63, P739, DOI 10.1128/JVI.63.2.739-746.1989; HINDS PW, 1987, MOL CELL BIOL, V7, P2863, DOI 10.1128/MCB.7.8.2863; HINDS PW, IN PRESS CELL GROWTH; IGGO R, 1990, LANCET, V335, P675, DOI 10.1016/0140-6736(90)90801-B; ISOBE M, 1986, NATURE, V320, P84, DOI 10.1038/320084a0; LAVIGUEUR A, 1989, MOL CELL BIOL, V9, P3982, DOI 10.1128/MCB.9.9.3982; LEVINE AJ, UNPUB; LI FP, 1982, JAMA-J AM MED ASSOC, V247, P2692, DOI 10.1001/jama.247.19.2692; LI FP, 1988, CANCER RES, V48, P5358; LI FP, 1969, ANN INTERN MED, V71, P747, DOI 10.7326/0003-4819-71-4-747; MASHARANI U, 1988, NUCLEIC ACIDS RES, V16, P7757, DOI 10.1093/nar/16.15.7757; MENON AG, 1990, P NATL ACAD SCI USA, V87, P5435, DOI 10.1073/pnas.87.14.5435; MULLIGAN LM, 1990, P NATL ACAD SCI USA, P5863; NAKAMURA Y, 1988, NUCLEIC ACIDS RES, V16, P5707, DOI 10.1093/nar/16.12.5707; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; RICARDI VM, 1978, PEDIATRICS, V61, P604; ROMANO JW, 1989, ONCOGENE, V4, P1483; Sambrook J, 1989, MOL CLONING LABORATO; SEIZINGER B, UNPUB; SOUSSI T, 1990, ONCOGENE, V5, P945; STRONG LC, 1987, JNCI-J NATL CANCER I, V79, P1213; STURZBECHER HW, 1987, ONCOGENE, V1, P201; TAKAHASHI T, 1989, SCIENCE, V246, P491, DOI 10.1126/science.2554494; VOGELSTEIN B, UNPUB; WIGGS J, 1988, NEW ENGL J MED, V318, P151, DOI 10.1056/NEJM198801213180305; WILLIAMS WR, 1985, FAM CANCER, P151; YOUNG JL, 1981, NCI MONOGRAPH, V57	41	3043	3149	3	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 30	1990	250	4985					1233	1238		10.1126/science.1978757	http://dx.doi.org/10.1126/science.1978757			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK723	1978757				2022-12-28	WOS:A1990EK72300030
J	POTTS, M; ROSENFIELD, A				POTTS, M; ROSENFIELD, A			THE 5TH FREEDOM REVISITED .2. THE WAY FORWARD	LANCET			English	Review									COLUMBIA UNIV,SCH PUBL HLTH,NEW YORK,NY 10027	Columbia University	POTTS, M (corresponding author), FAMILY HLTH INT,POB 13950,RES TRIANGLE PK,NC 27709, USA.							CLELAND J, 1985, REPRODUCTIVE CHANGE; Donaldson P. J., 1989, International Family Planning Perspectives, V15, P52, DOI 10.2307/2133482; FORREST JD, 1990, FAM PLANN PERSPECT, V22, P6, DOI 10.2307/2135432; JANOWITZ BS, 1990, INVESTING FUTURE; ROWLEY JT, 1990, AIDS, V4, P47, DOI 10.1097/00002030-199001000-00007; THAPA S, 1988, NATURE, V335, P679, DOI 10.1038/335679a0; 1988, LANCET, V2, P1204	7	9	9	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 24	1990	336	8726					1293	1295		10.1016/0140-6736(90)92972-K	http://dx.doi.org/10.1016/0140-6736(90)92972-K			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EJ943	1978122				2022-12-28	WOS:A1990EJ94300011
J	HEMMATIBRIVANLOU, A; STEWART, RM; HARLAND, RM				HEMMATIBRIVANLOU, A; STEWART, RM; HARLAND, RM			REGION-SPECIFIC NEURAL INDUCTION OF AN ENGRAILED PROTEIN BY ANTERIOR NOTOCHORD IN XENOPUS	SCIENCE			English	Article									UNIV CALIF BERKELEY,DEPT MOLEC & CELLULAR BIOL,DIV BIOCHEM & MOLEC BIOL,BERKELEY,CA 94720; UNIV CALIF BERKELEY,DEPT MOLEC & CELLULAR BIOL,DIV CELL & DEV BIOL,BERKELEY,CA 94720	University of California System; University of California Berkeley; University of California System; University of California Berkeley					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042341, R01GM019363, R37GM019363] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 19363, GM 42341] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AKAM M, 1987, DEVELOPMENT, V101, P1; CARROLL SB, 1990, CELL, V60, P9, DOI 10.1016/0092-8674(90)90711-M; DIXON JE, 1989, DEVELOPMENT, V106, P749; GERHART J, 1989, DEVELOPMENT, V107, P37; GIMLICH RL, 1983, NATURE, V306, P471, DOI 10.1038/306471a0; GRANT P, 1972, DEV BIOL, V28, P454, DOI 10.1016/0012-1606(72)90029-2; HEMMATIBRIVANLO.A, 1989, DEVELOPMENT, V106, P611; HEMMATIBRIVANLO.A, UNPUB; JONES EA, 1989, DEVELOPMENT, V107, P785; KELLER RE, 1976, DEV BIOL, V51, P118, DOI 10.1016/0012-1606(76)90127-5; KELLER RE, 1975, DEV BIOL, V42, P222, DOI 10.1016/0012-1606(75)90331-0; KINTNER CR, 1987, DEVELOPMENT, V99, P311; Mangold O, 1933, NATURWISSENSCHAFTEN, V21, P761, DOI 10.1007/BF01503740; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; NIEUWKOOP PD, 1985, J EMBRYOL EXP MORPH, V89, P333; NIEUWKOOP PD, 1952, J EXP ZOOL, V120, P1, DOI 10.1002/jez.1401200102; PATEL NH, 1989, CELL, V58, P955, DOI 10.1016/0092-8674(89)90947-1; RECANZONE G, 1985, Wilhelm Roux's Archives of Developmental Biology, V194, P344, DOI 10.1007/BF00877372; SAVAGE R, 1989, DEV BIOL, V133, P157, DOI 10.1016/0012-1606(89)90307-2; SCHARF SR, 1980, DEV BIOL, V79, P181, DOI 10.1016/0012-1606(80)90082-2; SHARPE CR, 1987, CELL, V50, P749, DOI 10.1016/0092-8674(87)90333-3; SIVE HL, 1989, CELL, V58, P171, DOI 10.1016/0092-8674(89)90413-3; SMITH JC, 1983, J EMBRYOL EXP MORPH, V78, P299; Spemann H., 1924, FDN EXPT EMBRYOLOGY, P144; Spemann H., 1938, EMBRYONIC DEV INDUCT; STEWART RM, 1990, DEVELOPMENT, V109, P363	26	138	140	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 9	1990	250	4982					800	802		10.1126/science.1978411	http://dx.doi.org/10.1126/science.1978411			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG883	1978411				2022-12-28	WOS:A1990EG88300033
J	CROMMEDIJKHUIS, AH; HENKENS, CMA; BIJLEVELD, CMA; HILLEGE, HL; BOM, VJJ; VANDERMEER, J				CROMMEDIJKHUIS, AH; HENKENS, CMA; BIJLEVELD, CMA; HILLEGE, HL; BOM, VJJ; VANDERMEER, J			COAGULATION-FACTOR ABNORMALITIES AS POSSIBLE THROMBOTIC RISK-FACTORS AFTER FONTAN OPERATIONS	LANCET			English	Article									UNIV GRONINGEN HOSP,DEPT INTERNAL MED,POB 30001,9700 RB GRONINGEN,NETHERLANDS; UNIV GRONINGEN HOSP,DIV HAEMATOL,9700 RB GRONINGEN,NETHERLANDS; UNIV GRONINGEN HOSP,DIV PEDIAT CARDIOL,9700 RB GRONINGEN,NETHERLANDS; UNIV GRONINGEN HOSP,DEPT PEDIAT,DIV PEDIAT GASTROENTEROL,9700 RB GRONINGEN,NETHERLANDS	University of Groningen; University of Groningen; University of Groningen; University of Groningen								AMIRAL J, 1984, CLIN CHEM, V30, P1512; BERTINA RM, 1982, THROMB HAEMOSTASIS, V48, P1; BOVILL EG, 1989, BLOOD, V73, P712; DEFOUW NJ, 1988, THROMB HAEMOSTASIS, V60, P328; DEVIVIE ER, 1981, THORAC CARDIOV SURG, V29, P348, DOI 10.1055/s-2007-1023512; DOBELL ARC, 1986, ANN THORAC SURG, V42, P664, DOI 10.1016/S0003-4975(10)64602-4; FONTAN F, 1971, THORAX, V26, P240, DOI 10.1136/thx.26.3.240; GIROD DA, 1987, CIRCULATION, V75, P605, DOI 10.1161/01.CIR.75.3.605; GRIFFIN JH, 1982, BLOOD, V60, P261; GRIFFIN JH, 1981, J CLIN INVEST, V68, P1370, DOI 10.1172/JCI110385; HESS J, 1984, J THORAC CARDIOV SUR, V88, P606; LANGLEY PG, 1988, THROMB HAEMOSTASIS, V59, P316; LAURELL CB, 1966, ANAL BIOCHEM, V15, P45, DOI 10.1016/0003-2697(66)90246-6; LEMMER JH, 1983, J THORAC CARDIOV SUR, V86, P757; MANNUCCI PM, 1982, LANCET, V2, P463; MARLAR RA, 1985, BLOOD, V66, P59; MARLAR RA, 1982, BLOOD, V59, P1067; MARTINOLI JL, 1986, THROMB RES, V43, P253, DOI 10.1016/0049-3848(86)90145-3; STENFLO J, 1976, J BIOL CHEM, V251, P355; VIGANO S, 1984, BRIT J HAEMATOL, V57, P213, DOI 10.1111/j.1365-2141.1984.tb02889.x; VIGANO S, 1985, AM J CLIN PATHOL, V84, P454, DOI 10.1093/ajcp/84.4.454; WALKER FJ, 1984, SEMIN THROMB HEMOST, V10, P131, DOI 10.1055/s-2007-1004415; WILLIAMSON DF, 1989, ANN INTERN MED, V110, P916, DOI 10.7326/0003-4819-110-11-916	23	115	117	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 3	1990	336	8723					1087	1090		10.1016/0140-6736(90)92568-3	http://dx.doi.org/10.1016/0140-6736(90)92568-3			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF992	1977979				2022-12-28	WOS:A1990EF99200003
J	LUND, BM				LUND, BM			FOODBORNE DISEASE DUE TO BACILLUS AND CLOSTRIDIUM SPECIES	LANCET			English	Article											LUND, BM (corresponding author), INST FOOD RES, NORWICH LAB, COLNEY LANE, NORWICH NR4 7AU, ENGLAND.			Lund, Barbara/0000-0001-6177-1878				BERRY PR, 1987, J CLIN PATHOL, V40, P121, DOI 10.1136/jcp.40.1.121-a; BRADSHAW JG, 1975, APPL MICROBIOL, V30, P943, DOI 10.1128/AEM.30.6.943-945.1975; GRANUM PE, 1990, INT J FOOD MICROBIOL, V10, P101, DOI 10.1016/0168-1605(90)90059-E; HATHEWAY CL, 1990, CLIN MICROBIOL REV, V3, P66, DOI 10.1128/CMR.3.1.66-98.1990; Hauschild A. H. W., 1989, Foodborne bacterial pathogens., P111; Kramer J. M., 1989, Foodborne bacterial pathogens., P21; Labbe R., 1989, Foodborne bacterial pathogens., P191; LAMANNA C, 1967, CLIN PHARMACOL THER, V8, P286; MIDURA TF, 1979, J CLIN MICROBIOL, V9, P282; OMAHONY M, 1990, EPIDEMIOL INFECT, V104, P389, DOI 10.1017/S0950268800047403; ROSE SA, 1988, J APPL BACTERIOL, V65, P223, DOI 10.1111/j.1365-2672.1988.tb01889.x; Smith L.D.S., 1977, BOTULISM ORGANISM IT; 1986, REPORT SAFETY WHOLES	13	72	75	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 20	1990	336	8721					982	986		10.1016/0140-6736(90)92431-G	http://dx.doi.org/10.1016/0140-6736(90)92431-G			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ED601	1977014				2022-12-28	WOS:A1990ED60100013
J	CAPSTICK, JB; EDWARDS, PJ				CAPSTICK, JB; EDWARDS, PJ			TRENDS IN OBSTETRIC MALPRACTICE CLAIMS	LANCET			English	Editorial Material																		ENNIS M, 1990, BRIT MED J, V300, P1365, DOI 10.1136/bmj.300.6736.1365	1	11	11	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 13	1990	336	8720					931	932		10.1016/0140-6736(90)92291-O	http://dx.doi.org/10.1016/0140-6736(90)92291-O			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EC456	1976943	Bronze			2022-12-28	WOS:A1990EC45600018
J	SANDERS, TAB; WOOLFE, R; RANTZEN, E				SANDERS, TAB; WOOLFE, R; RANTZEN, E			CONTROLLED EVALUATION OF SLIMMING DIETS - USE OF TELEVISION FOR RECRUITMENT	LANCET			English	Article									BRITISH BROADCASTING CORP,LIME GROVE STUDIOS,LONDON,ENGLAND		SANDERS, TAB (corresponding author), KINGS COLL LONDON,DEPT NUTR DIETET,CAMPDEN HILL RD,LONDON W8 7AH,ENGLAND.			Sanders, Thomas/0000-0001-9529-095X				Evans AS, 1986, MONOGRAPHS EPIDEMIOL, V10; GARROW JS, 1982, OBESITY RELATED DISE; Gregory F., 1990, DIETARY NUTR SURVEY	3	4	5	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 13	1990	336	8720					918	920		10.1016/0140-6736(90)92280-U	http://dx.doi.org/10.1016/0140-6736(90)92280-U			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EC456	1976938				2022-12-28	WOS:A1990EC45600012
J	MARUYAMA, K; TERAKADO, K; USAMI, M; YOSHIKAWA, K				MARUYAMA, K; TERAKADO, K; USAMI, M; YOSHIKAWA, K			FORMATION OF AMYLOID-LIKE FIBRILS IN COS CELLS OVEREXPRESSING PART OF THE ALZHEIMER AMYLOID PROTEIN-PRECURSOR	NATURE			English	Article									PSYCHIAT RES INST TOKYO,DEPT MOLEC BIOL,SETAGAYA KU,TOKYO 156,JAPAN; SAITAMA UNIV,FAC SCI,DEPT REGULAT BIOL,URAWA,SAITAMA 338,JAPAN	Tokyo Institute of Psychiatry; Saitama University								BRANDL CJ, 1987, J BIOL CHEM, V262, P3768; DYRKS T, 1988, EMBO J, V7, P949, DOI 10.1002/j.1460-2075.1988.tb02900.x; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V122, P1131, DOI 10.1016/0006-291X(84)91209-9; ISHII T, 1989, NEUROPATH APPL NEURO, V15, P135, DOI 10.1111/j.1365-2990.1989.tb01216.x; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KIDD M, 1964, BRAIN, V87, P307, DOI 10.1093/brain/87.2.307; KIRSCHNER DA, 1987, P NATL ACAD SCI USA, V84, P6953, DOI 10.1073/pnas.84.19.6953; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MAROTTA CA, 1989, P NATL ACAD SCI USA, V86, P337, DOI 10.1073/pnas.86.1.337; MARUYAMA K, 1988, P NATL ACAD SCI USA, V85, P3314, DOI 10.1073/pnas.85.10.3314; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; MERZ PA, 1983, ACTA NEUROPATHOL, V60, P113, DOI 10.1007/BF00685355; MIYAKAWA T, 1986, VIRCHOWS ARCH B, V52, P99, DOI 10.1007/BF02889954; MIYAKAWA T, 1986, ACTA NEUROPATHOL, V70, P202, DOI 10.1007/BF00686073; ROBAKIS NK, 1987, P NATL ACAD SCI USA, V84, P4190, DOI 10.1073/pnas.84.12.4190; SAITOH T, 1989, CELL, V58, P615, DOI 10.1016/0092-8674(89)90096-2; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SELKOE DJ, 1988, P NATL ACAD SCI USA, V85, P7341, DOI 10.1073/pnas.85.19.7341; SISODIA SS, 1990, SCIENCE, V248, P492, DOI 10.1126/science.1691865; SOMPAYRAC LM, 1981, P NATL ACAD SCI-BIOL, V78, P7575, DOI 10.1073/pnas.78.12.7575; SPRINGER TA, 1981, J BIOL CHEM, V256, P3833; TERRY RD, 1964, AM J PATHOL, V44, P269; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3; WOLF D, 1990, EMBO J, V9, P2079, DOI 10.1002/j.1460-2075.1990.tb07375.x; WONG GG, 1985, SCIENCE, V228, P810, DOI 10.1126/science.3923623; YANKNER BA, 1989, SCIENCE, V245, P417, DOI 10.1126/science.2474201; YOSHIKAWA K, 1984, J BIOL CHEM, V259, P4301	29	121	127	0	4	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	OCT 11	1990	347	6293					566	569		10.1038/347566a0	http://dx.doi.org/10.1038/347566a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC454	1977086				2022-12-28	WOS:A1990EC45400057
J	BRAHAMS, D				BRAHAMS, D			EPILEPSY NO LONGER A DISEASE OF THE MIND	LANCET			English	Editorial Material																		BRAHAMS D, 1989, LANCET, V1, P912; BRAHAMS D, 1983, LANCET, V2, P116; BRAHAMS D, 1990, LANCET, P1333; FENWICK P, 1990, PSYCHOL MED MS, P23; REVILLE NJ, 1989, LAW SOC GAZ     0705, P17	5	0	0	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 6	1990	336	8719					869	869		10.1016/0140-6736(90)92360-T	http://dx.doi.org/10.1016/0140-6736(90)92360-T			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EB901	1976888				2022-12-28	WOS:A1990EB90100016
J	OLD, JM; VARAWALLA, NY; WEATHERALL, DJ				OLD, JM; VARAWALLA, NY; WEATHERALL, DJ			RAPID DETECTION AND PRENATAL-DIAGNOSIS OF BETA-THALASSEMIA - STUDIES IN INDIAN AND CYPRIOT POPULATIONS IN THE UK	LANCET			English	Article									JOHN RADCLIFFE HOSP,INST MOLEC MED,NATL HAEMOGLOBINOPATHY REFERENCE LAB,OXFORD OX3 9DU,ENGLAND	University of Oxford								CHEHAB FF, 1989, P NATL ACAD SCI USA, V86, P9178, DOI 10.1073/pnas.86.23.9178; KRETZ KA, 1989, NUCLEIC ACIDS RES, V17, P5864, DOI 10.1093/nar/17.14.5864; KULOZIK AE, 1988, BRIT J HAEMATOL, V70, P455, DOI 10.1111/j.1365-2141.1988.tb02516.x; NEWTON CR, 1989, LANCET, V2, P1481; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; Old JM., 1983, METHODS HEMATOLOGY T, V6, P74; SAIKI RK, 1986, NATURE, V324, P163, DOI 10.1038/324163a0; SAIKI RK, 1988, NEW ENGL J MED, V319, P537, DOI 10.1056/NEJM198809013190903; SEMENZA GL, 1989, NUCLEIC ACIDS RES, V17, P2376, DOI 10.1093/nar/17.6.2376; THEIN SL, 1989, BLOOD, V73, P924; THEIN SL, 1988, BRIT J HAEMATOL, V70, P225, DOI 10.1111/j.1365-2141.1988.tb02468.x	11	281	287	0	3	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 6	1990	336	8719					834	837		10.1016/0140-6736(90)92338-I	http://dx.doi.org/10.1016/0140-6736(90)92338-I			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB901	1976877				2022-12-28	WOS:A1990EB90100003
J	[Anonymous]				[Anonymous]			ACE INHIBITORS AND TISSUE BINDING	LANCET			English	Editorial Material																		BJORCK S, 1986, BMJ-BRIT MED J, V293, P471, DOI 10.1136/bmj.293.6545.471; BUCKNALL CE, 1988, BRIT MED J, V296, P86, DOI 10.1136/bmj.296.6615.86; CAMPBELL DJ, 1984, NATURE, V308, P206, DOI 10.1038/308206a0; CAMPBELLBOSWELL M, 1981, EXP MOL PATHOL, V35, P265, DOI 10.1016/0014-4800(81)90066-6; DONNELLY R, 1990, HYPERTENSION, V15, P301, DOI 10.1161/01.HYP.15.3.301; DUNN FG, 1984, AM J CARDIOL, V53, P105, DOI 10.1016/0002-9149(84)90692-1; DZAU VJ, 1988, CIRCULATION, V77, P947, DOI 10.1161/01.CIR.77.5.947; DZAU VJ, 1989, J HYPERTENS, V7, P933, DOI 10.1097/00004872-198912000-00001; ERTL G, 1982, CIRCULATION, V65, P40, DOI 10.1161/01.CIR.65.1.40; FRANCIS RJ, 1987, J CARDIOVASC PHARM, V9, P32, DOI 10.1097/00005344-198709010-00006; GANTEN D, 1989, J HUM HYPERTENS, V3, P63; GAVRAS H, 1981, LANCET, V2, P543; JACKSON B, 1989, J HUM HYPERTENS, V3, P107; Johnston C I, 1983, J Hypertens Suppl, V1, P71; KREMER D, 1981, CARDIOVASC RES, V15, P43, DOI 10.1093/cvr/15.1.43; KURIYAMA S, 1988, J CARDIOVASC PHARM, V11, P139; LEES KR, 1989, J PHARMACOKINET BIOP, V17, P529, DOI 10.1007/BF01071348; LEVER AF, 1986, J HYPERTENS, V4, P515, DOI 10.1097/00004872-198610000-00001; LINDPAINTNER K, 1988, CIRCULATION, V77, P18; STAMLER JF, 1980, BRAIN RES, V186, P499, DOI 10.1016/0006-8993(80)90998-1; STEINHAUSEN M, 1986, KIDNEY INT, V30, P56, DOI 10.1038/ki.1986.150; SWEDBERG K, 1989, J HUM HYPERTENS, V3, P79; VELD AJM, 1980, BRIT MED J, V1, P288; WANG DH, 1990, HYPERTENSION, V15, P68, DOI 10.1161/01.HYP.15.1.68; WEBER KT, 1989, BRIT J CLIN PHARMACO, V28, pS141, DOI 10.1111/j.1365-2125.1989.tb03589.x	25	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 22	1990	336	8717					718	720						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DZ624	1975896				2022-12-28	WOS:A1990DZ62400007
J	CYBULSKY, MI; GIMBRONE, MA				CYBULSKY, MI; GIMBRONE, MA			ENDOTHELIAL EXPRESSION OF A MONONUCLEAR LEUKOCYTE ADHESION MOLECULE DURING ATHEROGENESIS	SCIENCE			English	Article							CHEMOTACTIC FACTOR; INTERFERON-GAMMA; ATHEROSCLEROSIS; CELL; ACTIVATION; PROTEINS; LESION; RABBIT; PATHOGENESIS; CHOLESTEROL	An inducible rabbit endothelial adhesion molecule that is selective for mononuclear leukocytes has been identified. This adhesion protein was expressed on the surface of activated cultured endothelium in two forms, 118 and 98 kilodaltons, the amino-terminal sequence of each being highly homologous to human VCAM-1. In dietary hypercholesterolemic and Watanabe heritable hyperlipidemic rabbit models of atherosclerosis, this adhesion molecule was found to be expressed in a localized fashion by aortic endothelium that overlies early foam cell lesions. This lesion-localized expression suggests a potential endothelium-dependent mechanism for mononuclear leukocyte recruitment during atherogenesis and may provide a molecular marker for early atherosclerosis.	BRIGHAM & WOMENS HOSP,DEPT PATHOL,BOSTON,MA 02115	Harvard University; Brigham & Women's Hospital	CYBULSKY, MI (corresponding author), BRIGHAM & WOMENS HOSP,DEPT PATHOL,DIV VASC RES,BOSTON,MA 02115, USA.		Cybulsky, Myron I./AAD-6539-2019	Cybulsky, Myron/0000-0002-1696-2867	NHLBI NIH HHS [P01-HL-36028] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL036028] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BERLINER JA, 1986, ARTERIOSCLEROSIS, V6, P254, DOI 10.1161/01.ATV.6.3.254; BEVILACQUA MP, 1987, P NATL ACAD SCI USA, V84, P9238, DOI 10.1073/pnas.84.24.9238; BEVILACQUA MP, 1989, SCIENCE, V243, P1160, DOI 10.1126/science.2466335; BUJA LM, 1983, ARTERIOSCLEROSIS, V3, P87, DOI 10.1161/01.ATV.3.1.87; COTRAN RS, 1986, J EXP MED, V164, P661, DOI 10.1084/jem.164.2.661; COTRAN RS, 1988, J IMMUNOL, V140, P1883; CYBULSKY MI, UNPUB; CYBULSKY MI, IN PRESS AM J PATHOL; DUSTIN ML, 1986, J IMMUNOL, V137, P245; DUSTIN ML, 1989, NATURE, V341, P619, DOI 10.1038/341619a0; ELICES MJ, 1990, CELL, V60, P577, DOI 10.1016/0092-8674(90)90661-W; FAULL RJ, 1989, TRANSPLANTATION, V48, P226, DOI 10.1097/00007890-198908000-00009; GERRITY RG, 1985, ARTERIOSCLEROSIS, V5, P55, DOI 10.1161/01.ATV.5.1.55; Gimbrone M., 1986, VASCULAR ENDOTHELIUM, P1; GIMBRONE MA, 1980, ATHEROSCLEROSIS, V5, P415; GRYGLEWSKI RJ, 1988, HYPERTENSION, V12, P530, DOI 10.1161/01.HYP.12.6.530; HANSSON GK, 1989, ARTERIOSCLEROSIS, V9, P567, DOI 10.1161/01.ATV.9.5.567; HARRIS P, 1985, J LEUKOCYTE BIOL, V37, P407, DOI 10.1002/jlb.37.4.407; HUBBARD AL, 1975, J CELL BIOL, V64, P438, DOI 10.1083/jcb.64.2.438; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEGENDRE L, 1989, PRODUCTIVITY OCEAN P, P49; LUSCINSKAS FW, 1989, J IMMUNOL, V142, P2257; MUNRO JA, COMMUNICATION; MUNRO JM, 1989, AM J PATHOL, V135, P121; MUNRO JM, 1988, LAB INVEST, V58, P249; OSBORN L, 1989, CELL, V59, P1203, DOI 10.1016/0092-8674(89)90775-7; POLTE T, 1990, NUCLEIC ACIDS RES, V18, P5901, DOI 10.1093/nar/18.19.5901; QUINN MT, 1988, P NATL ACAD SCI USA, V85, P2805, DOI 10.1073/pnas.85.8.2805; RICE GE, 1990, J EXP MED, V171, P1369, DOI 10.1084/jem.171.4.1369; RICE GE, 1989, SCIENCE, V246, P1303, DOI 10.1126/science.2588007; ROSENFELD ME, 1987, ARTERIOSCLEROSIS, V7, P9, DOI 10.1161/01.ATV.7.1.9; ROSS R, 1986, NEW ENGL J MED, V314, P488, DOI 10.1056/NEJM198602203140806; SCHWARTZ BR, 1990, J CLIN INVEST, V85, P2019, DOI 10.1172/JCI114668; SMITH CW, 1988, J CLIN INVEST, V82, P1746, DOI 10.1172/JCI113788; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; VALENTE AJ, 1988, BIOCHEMISTRY-US, V27, P4162, DOI 10.1021/bi00411a039; WALKER LN, 1986, AM J PATHOL, V125, P450; WATANABE T, 1985, LAB INVEST, V53, P80	39	1367	1443	1	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	FEB 15	1991	251	4995					788	791		10.1126/science.1990440	http://dx.doi.org/10.1126/science.1990440			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX575	1990440				2022-12-28	WOS:A1991EX57500042
J	WOODRUFF, BA; PAVIA, AT; BLAKE, PA				WOODRUFF, BA; PAVIA, AT; BLAKE, PA			A NEW LOOK AT TYPHOID VACCINATION - INFORMATION FOR THE PRACTICING PHYSICIAN	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							VI-CAPSULAR POLYSACCHARIDE; CONTROLLED FIELD TRIAL; SALMONELLA-TYPHI; TY21A; FEVER; PREVENTION	Most cases of typhoid fever in the United States occur in international travelers, with the greatest risk associated with travel to Peru, India, Pakistan, and Chile. Laboratory workers and household contacts of long-term carriers are also at greater risk than the general population. Decisions to the use typhoid vaccine involve weighing the risk of illness against the risk of vaccine reactions. Until recently, the only typhoid vaccine commercially available to US civilians was a heat-phenol-inactivated parenteral product that is 51% to 77% effective in preventing typhoid fever but frequently produces local pain and swelling, fever, headache, and malaise. A new orally administered, live-attenuated vaccine, made from the Ty21 a strain of Salmonella typhi, has been recently licensed in the United States. This vaccine provides equivalent protection with a much lower incidence of adverse reactions. It is administered in a four-dose series given over 7 days. Since neither vaccine offers total protection, the most important elements in prevention of typhoid fever remain sound biosafety precautions in laboratory workers and care in selecting food and beverages by those traveling to areas where typhoid fever is endemic.			WOODRUFF, BA (corresponding author), CTR DIS CONTROL,DIV BACTERIAL DIS,1600 CLIFTON RD NE,MAILSTOP C-09,ATLANTA,GA 30333, USA.							ACHARYA IL, 1987, NEW ENGL J MED, V317, P1101, DOI 10.1056/NEJM198710293171801; Ashcroft M T, 1967, Lancet, V2, P1056; ASHCROFT MT, 1964, AM J HYG, V79, P196, DOI 10.1093/oxfordjournals.aje.a120376; BLACK RE, 1990, VACCINE, V8, P81, DOI 10.1016/0264-410X(90)90183-M; BLASER MJ, 1980, J INFECT DIS, V142, P934, DOI 10.1093/infdis/142.6.934; CALIN A, 1987, ARTHRITIS RHEUM, V30, P1197, DOI 10.1002/art.1780301021; EDWARDS EA, 1974, B WORLD HEALTH ORGAN, V51, P501; FERRECCIO C, 1989, J INFECT DIS, V159, P766, DOI 10.1093/infdis/159.4.766; GILMAN RH, 1977, J INFECT DIS, V136, P717, DOI 10.1093/infdis/136.6.717; HEJFEC LB, 1966, B WORLD HEALTH ORGAN, V34, P321; HIRSCHEL B, 1985, EUR J CLIN MICROBIOL, V4, P295, DOI 10.1007/BF02013656; HORNICK RB, 1966, T AM CLIN CLIMAT ASS, V78, P70; KEANE A, 1988, BRIT J RHEUMATOL, V27, P496; KLUGMAN KP, 1987, LANCET, V2, P1165; LEVINE MM, 1987, J CLIN INVEST, V79, P888, DOI 10.1172/JCI112899; LEVINE MM, 1987, LANCET, V1, P1049; LEVINE MM, 1989, REV INFECT DIS, V11, pS552; LEVINE MM, 1986, DEV VACCINES DRUGS D, P90; LEVINE MM, IN PRESS LANCET; RYAN CA, 1989, REV INFECT DIS, V11, P1; SCHWARTZ E, 1990, ARCH INTERN MED, V150, P349, DOI 10.1001/archinte.150.2.349; SIMANJUNTAK CH, 1988, OCT INT C ANT AG CHE; WAHDAN MH, 1980, B WORLD HEALTH ORGAN, V58, P469; WAHDAN MH, 1982, J INFECT DIS, V145, P292, DOI 10.1093/infdis/145.3.292; Wilson GS, 1967, HAZARDS IMMUNIZATION; 1964, B WORLD HEALTH ORGAN, V30, P623; 1989, HLTH INFORMATION INT, P143; 1966, B WORLD HEALTH ORGAN, V34, P211; 1990, MMWR, V39, P1	29	29	29	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 13	1991	265	6					756	759		10.1001/jama.265.6.756	http://dx.doi.org/10.1001/jama.265.6.756			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EW479	1990193				2022-12-28	WOS:A1991EW47900029
J	ELLIS, CN; FRADIN, MS; MESSANA, JM; BROWN, MD; SIEGEL, MT; HARTLEY, AH; ROCHER, LL; WHEELER, S; HAMILTON, TA; PARISH, TG; ELLISMADU, M; DUELL, E; ANNESLEY, TM; COOPER, KD; VOORHEES, JJ				ELLIS, CN; FRADIN, MS; MESSANA, JM; BROWN, MD; SIEGEL, MT; HARTLEY, AH; ROCHER, LL; WHEELER, S; HAMILTON, TA; PARISH, TG; ELLISMADU, M; DUELL, E; ANNESLEY, TM; COOPER, KD; VOORHEES, JJ			CYCLOSPORINE FOR PLAQUE-TYPE PSORIASIS - RESULTS OF A MULTIDOSE, DOUBLE-BLIND TRIAL	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LOW-DOSE CYCLOSPORIN; SERUM CREATININE; CLEARANCE; THERAPY	Background. Severe plaque-type psoriasis has been successfully treated with orally administered cyclosporine, but there has been no comparative, controlled evaluation of various dosages and their efficacy and side effects. Methods. In a 16-week, double-blind trial, we randomly assigned 85 patients with severe psoriasis to receive 3, 5, or 7.5 mg of cyclosporine per kilogram of body weight per day or a placebo consisting of the vehicle for the drug. After eight weeks the dose could be adjusted to improve safety or efficacy while maintaining blinding. Results. The psoriasis improved in a dose-dependent fashion. After eight weeks of fixed-dose therapy, 36, 65, and 80 percent of the patients receiving 3, 5, and 7.5 mg of cyclosporine per kilogram per day, respectively, were rated as being clear or almost clear of psoriasis; each group had significant improvement (P < 0.0001) as compared with the group receiving vehicle, in which none of the patients were rated as clear or almost clear. The patients who received 5 mg per kilogram were the least likely to require dosage adjustments because of side effects or a lack of efficacy. The glomerular filtration rate, measured in a subgroup of 34 patients receiving cyclosporine, decreased by a median of 16 percent. Higher doses of cyclosporine had greater adverse effects on systolic blood pressure, glomerular filtration rate, and serum levels of creatinine, uric acid, bilirubin, and cholesterol. Delayed-type hypersensitivity reactions to skin-test antigens were reduced by cyclosporine administration. Cyclosporine appears to become concentrated in skin. Conclusions. Cyclosporine therapy leads to a rapid and thorough clearing of psoriasis; an initial dose of 5 mg per kilogram per day seems to be appropriate. However, the safety of cyclosporine for the long-term treatment of psoriasis remains to be determined.	UNIV MICHIGAN,MED CTR,DEPT INTERNAL MED,DIV NEPHROL,ANN ARBOR,MI 48109; UNIV MICHIGAN,MED CTR,DEPT PATHOL,ANN ARBOR,MI 48109	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	ELLIS, CN (corresponding author), UNIV MICHIGAN,MED CTR,DEPT DERMATOL,DERMATOPHARMACOL UNIT,1910 TAUBMAN CTR,1500 E MED CTR DR,ANN ARBOR,MI 48109, USA.		Ellis, Charles/ABA-7264-2021	Ellis, Charles/0000-0001-9436-7628	NCRR NIH HHS [M01-RR-00042] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000042] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ANNESLEY T, 1986, CLIN CHEM, V32, P1407; BAKER BS, 1989, BRIT J DERMATOL, V120, P207; BENNETT WM, 1990, J AM ACAD DERMATOL, V23, P1288; BLACK KS, 1990, J INVEST DERMATOL, V94, P644, DOI 10.1111/1523-1747.ep12876218; BROOKES DB, 1986, BRIT MED J, V293, P1098, DOI 10.1136/bmj.293.6554.1098-c; CHAPMAN DG, 1968, BIOMETRICS, V24, P315, DOI 10.2307/2528037; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; COOPER KD, 1990, J INVEST DERMATOL, V94, P649, DOI 10.1111/1523-1747.ep12876222; CURTIS JJ, 1986, LANCET, V2, P447; DEGROEN PC, 1987, NEW ENGL J MED, V317, P861, DOI 10.1056/NEJM198710013171404; ELLIS CN, 1986, JAMA-J AM MED ASSOC, V256, P3110, DOI 10.1001/jama.256.22.3110; FEUTREN G, 1990, BRIT J DERMATOL, V122, P85, DOI 10.1111/j.1365-2133.1990.tb02886.x; FINZI AF, 1989, J AM ACAD DERMATOL, V21, P91, DOI 10.1016/S0190-9622(89)70154-7; FISHER GJ, 1988, J INVEST DERMATOL, V91, P142, DOI 10.1111/1523-1747.ep12464387; FRADIN MS, 1990, J AM ACAD DERMATOL, V23, P1265, DOI 10.1016/0190-9622(90)70353-J; FREDRIKSSON T, 1978, DERMATOLOGICA, V157, P238, DOI 10.1159/000250839; GILBERT SC, 1989, J AM ACAD DERMATOL, V21, P470, DOI 10.1016/S0190-9622(89)70209-7; GRIFFITHS CEM, 1988, TRANSPLANT P, V20, P50; GRIFFITHS CEM, 1986, BRIT MED J, V293, P731, DOI 10.1136/bmj.293.6549.731; HARPER JI, 1984, LANCET, V2, P981; Heule F, 1989, Acta Derm Venereol Suppl (Stockh), V146, P171; HO VC, 1990, J AM ACAD DERMATOL, V22, P94, DOI 10.1016/0190-9622(90)70015-A; KNIKER WT, 1979, ANN ALLERGY, V43, P72; KRUEGER GG, 1978, J INVEST DERMATOL, V71, P189, DOI 10.1111/1523-1747.ep12547129; MARKS J, 1986, BRIT MED J, V293, P509, DOI 10.1136/bmj.293.6545.509-a; MCFADDEN JP, 1990, ACTA DERM-VENEREOL, V70, P262; MEINARDI MMHM, 1988, TRANSPLANT P, V20, P42; MEINARDI MMHM, 1990, BRIT J DERMATOL, V122, P27, DOI 10.1111/j.1365-2133.1990.tb02879.x; MUELLER W, 1979, NEW ENGL J MED, V301, P555; MULLER W, 1981, SCHWEIZ MED WSCHR, V111, P408; OBALEK S, 1977, DERMATOLOGICA, V155, P13; PICASCIA DD, 1987, J AM ACAD DERMATOL, V17, P408, DOI 10.1016/S0190-9622(87)70221-7; POWLES AV, 1990, BRIT J DERMATOL, V122, P665, DOI 10.1111/j.1365-2133.1990.tb07288.x; TIMONEN P, 1990, BRIT J DERMATOL, V122, P33, DOI 10.1111/j.1365-2133.1990.tb02880.x; VANHOOFF JP, 1985, LANCET, V1, P335; VANJOOST T, 1988, BRIT J DERMATOL, V118, P183; VANJOOST T, 1986, BRIT J DERMATOL, V114, P615; WENTZELL JM, 1987, ARCH DERMATOL, V123, P163, DOI 10.1001/archderm.123.2.163; XUE H, 1987, TRANSPLANTATION, V43, P715, DOI 10.1097/00007890-198705000-00022	39	369	372	0	6	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 31	1991	324	5					277	284		10.1056/NEJM199101313240501	http://dx.doi.org/10.1056/NEJM199101313240501			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU922	1986287				2022-12-28	WOS:A1991EU92200001
J	JACOBS, JL; LIBBY, DM; WINTERS, RA; GELMONT, DM; FRIED, ED; HARTMAN, BJ; LAURENCE, J				JACOBS, JL; LIBBY, DM; WINTERS, RA; GELMONT, DM; FRIED, ED; HARTMAN, BJ; LAURENCE, J			A CLUSTER OF PNEUMOCYSTIS-CARINII PNEUMONIA IN ADULTS WITHOUT PREDISPOSING ILLNESSES	NEW ENGLAND JOURNAL OF MEDICINE			English	Note							ACQUIRED IMMUNODEFICIENCY SYNDROME; IMMUNE-DEFICIENCY SYNDROME; BRONCHOALVEOLAR LAVAGE; SYNDROME AIDS; INFECTION; DIAGNOSIS; CHILDREN; ANTIBODY; HIV				JACOBS, JL (corresponding author), CORNELL UNIV,MED CTR,NEW YORK HOSP,525 E 68TH ST,NEW YORK,NY 10021, USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI029119] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-29119] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ANDERSON CD, 1960, AM J CLIN PATHOL, V34, P365; BROADDUS C, 1985, ANN INTERN MED, V102, P747, DOI 10.7326/0003-4819-102-6-747; CHUSID MJ, 1967, PEDIATRICS, V62, P1031; COLEMAN DL, 1986, ARCH INTERN MED, V146, P713, DOI 10.1001/archinte.146.4.713; DAVEY RT, 1990, ANTIMICROB AGENTS CH, V34, P499, DOI 10.1128/AAC.34.4.499; ESTERLY JA, 1968, AM REV RESPIR DIS, V97, P935; FLEIT HB, 1982, P NATL ACAD SCI-BIOL, V79, P3275, DOI 10.1073/pnas.79.10.3275; GIRON JA, 1982, LANCET, V2, P46; HAMLIN WB, 1968, J AMER MED ASSOC, V204, P173, DOI 10.1001/jama.204.2.173; HARON E, 1988, LANCET, V2, P904; JACKSON JB, 1988, J CLIN MICROBIOL, V26, P1416, DOI 10.1128/JCM.26.7.1416-1418.1988; KAFTORI JK, 1962, ARCH INTERN MED, V109, P438, DOI 10.1001/archinte.1962.03620160064009; LAURENCE J, 1983, J CLIN INVEST, V72, P2072, DOI 10.1172/JCI111172; LAURENCE J, 1990, CELL IMMUNOL, V128, P337, DOI 10.1016/0008-8749(90)90031-L; LAURENCE J, 1989, J CLIN INVEST, V83, P1843, DOI 10.1172/JCI114090; LAURENCE J, 1987, SCIENCE, V235, P1501, DOI 10.1126/science.2435004; LECLAIR RA, 1968, AM REV RESPIR DIS, V99, P542; LUNSETH JH, 1955, J PEDIATR-US, V46, P137, DOI 10.1016/S0022-3476(55)80202-8; LYONS HA, 1961, ARCH INTERN MED, V108, P929, DOI 10.1001/archinte.1961.03620120113015; OGNIBENE FP, 1988, ANN INTERN MED, V109, P874, DOI 10.7326/0003-4819-109-11-874; PETERS SG, 1987, AM J MED, V82, P73, DOI 10.1016/0002-9343(87)90380-9; PIFER LL, 1978, PEDIATRICS, V61, P35; REYNOLDS HY, 1974, J LAB CLIN MED, V84, P559; RIFKIND D, 1966, ANN INTERN MED, V65, P943, DOI 10.7326/0003-4819-65-5-943; ROBINSON JJ, 1961, ARCH PATHOL, V71, P156; ROTHENBERG R, 1987, NEW ENGL J MED, V317, P1297, DOI 10.1056/NEJM198711193172101; RUEBUSH TK, 1978, AM J DIS CHILD, V132, P143, DOI 10.1001/archpedi.1978.02120270041009; SINGER C, 1975, ANN INTERN MED, V82, P772, DOI 10.7326/0003-4819-82-6-722; STAGNO S, 1980, PEDIATRICS, V66, P56; STOVER DE, 1984, AM REV RESPIR DIS, V130, P659; VOGEL CL, 1968, ANN INTERN MED, V68, P97, DOI 10.7326/0003-4819-68-1-97; WALZER PD, 1974, ANN INTERN MED, V80, P83, DOI 10.7326/0003-4819-80-1-83; WATANABE JM, 1965, J AMER MED ASSOC, V193, P685, DOI 10.1001/jama.1965.03090080047017; 1987, AIDS WEEKLY SURVEILL	34	137	138	0	2	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 24	1991	324	4					246	250		10.1056/NEJM199101243240407	http://dx.doi.org/10.1056/NEJM199101243240407			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU022	1985246				2022-12-28	WOS:A1991EU02200007
J	BREO, DL				BREO, DL			THE OTHER SUPER BOWL QUESTION - CAN THE NFL POLICE ITS DRUG POLICY	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	1	2	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	1991	265	4					506	508		10.1001/jama.265.4.506	http://dx.doi.org/10.1001/jama.265.4.506			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ET377	1985238				2022-12-28	WOS:A1991ET37700034
J	CEBRATHOMAS, JA; DECKER, CL; SNYDER, LC; PILDER, SH; SILVER, LM				CEBRATHOMAS, JA; DECKER, CL; SNYDER, LC; PILDER, SH; SILVER, LM			ALLELE-SPECIFIC AND HAPLOID-SPECIFIC PRODUCT GENERATED BY ALTERNATIVE SPLICING FROM A MOUSE T-COMPLEX-RESPONDER LOCUS CANDIDATE	NATURE			English	Article							DISTORTER GENES; HAPLOTYPES; FAMILY; DNA	MOUSE t haplotypes represent a variant form of chromosome 17 that has evolved the ability to propagate through natural populations by the phenomenon of 'transmission ratio distortion' (TRD), in which heterozygous +/t males transmit their t-carrying chromosome to 95% or more of their offspring 1,2. Although multiple t-associated loci have a role in expression of this phenotype, only one-the t complex responder (Tcr) locus-is responsible for determining which of the two homologues of chromosome 17 will be transmitted at a high ratio 3. A candiate gene (Tcp-10b) for Tcr that is expressed in both meiotic and post-meiotic male germ cells has been cloned 4. But for this candiate gene to function as the haploid effector of TRD, the t-allele of this gene (Tcp-10b(t)) must express a unique product in a haploid-specific manner. Here we show that a change in the splicing pattern of Tcp-10b(t) transcripts occurs during sperm differentiation. This change results in a unique allele-specific and haploid-specific transcript which could encode a variant polypeptide that would fulfil the conditions required of the Tcr effector of TRD.	PRINCETON UNIV,DEPT MOLEC BIOL,PRINCETON,NJ 08544	Princeton University								Ausubel FM., 1987, CURRENT PROTOCOLS MO, DOI 10.1002/mrd.1080010210; BULLARD DC, 1990, GENETICS, V124, P957; KLEIN J, 1986, NATURAL HIST MAJOR H; LYON MF, 1986, CELL, V44, P357, DOI 10.1016/0092-8674(86)90770-1; LYON MF, 1984, CELL, V37, P621, DOI 10.1016/0092-8674(84)90393-3; ROSEN LL, 1990, GENOMICS, V8, P134, DOI 10.1016/0888-7543(90)90235-M; SCHIMENTI J, 1987, J MOL BIOL, V194, P583, DOI 10.1016/0022-2836(87)90235-X; SCHIMENTI J, 1988, CELL, V55, P71, DOI 10.1016/0092-8674(88)90010-4; SILVER LM, 1985, ANNU REV GENET, V19, P179, DOI 10.1146/annurev.ge.19.120185.001143; WOLGEMUTH DJ, 1985, GAMETE RES, V12, P1, DOI 10.1002/mrd.1120120102	10	45	46	0	1	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JAN 17	1991	349	6306					239	241		10.1038/349239a0	http://dx.doi.org/10.1038/349239a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET519	1987476				2022-12-28	WOS:A1991ET51900055
J	HULL, RD; RASKOB, GE				HULL, RD; RASKOB, GE			LOW-PROBABILITY LUNG-SCAN FINDINGS - A NEED FOR CHANGE	ANNALS OF INTERNAL MEDICINE			English	Note							SUSPECTED PULMONARY-EMBOLISM; VENTILATION-PERFUSION; ANGIOGRAPHY; DIAGNOSIS				HULL, RD (corresponding author), UNIV CALGARY, FOOTHILLS HOSP, DEPT MED, 3330 HOSP DR NW, CALGARY T2N 4N1, ALBERTA, CANADA.							ALDERSON PO, 1976, RADIOLOGY, V120, P633, DOI 10.1148/120.3.633; BIELLO DR, 1979, AM J ROENTGENOL, V133, P1033, DOI 10.2214/ajr.133.6.1033; CHEELY R, 1981, AM J MED, V70, P17, DOI 10.1016/0002-9343(81)90406-X; HULL RD, 1985, CHEST, V88, P819, DOI 10.1378/chest.88.6.819; HULL RD, 1990, CHEST, V97, P23, DOI 10.1378/chest.97.1.23; HULL RD, 1983, ANN INTERN MED, V98, P891, DOI 10.7326/0003-4819-98-6-891; MCNEIL BJ, 1980, J NUCL MED, V21, P319; MOSER KM, 1990, AM REV RESPIR DIS, V141, P235, DOI 10.1164/ajrccm/141.1.235; VREIM CE, 1990, JAMA-J AM MED ASSOC, V263, P2753	9	82	83	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 15	1991	114	2					142	143		10.7326/0003-4819-114-2-142	http://dx.doi.org/10.7326/0003-4819-114-2-142			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ER534	1984390				2022-12-28	WOS:A1991ER53400008
J	GINZBERG, E				GINZBERG, E			ACCESS TO HEALTH-CARE FOR HISPANICS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								The conventional population paradigm in the United States has distinguished between the white majority and the sizable and easily identified black minority. Until recently, much less attention has been paid to Hispanics (or Latinos), currently 20 million in number, who the Census Bureau projects will increase to 31 million persons of a total population of 283 million by the year 2010. In the next two decades Hispanics will account for one of every three net additions to the US population. The analysis that follows considers the critical factors that collectively will determine the access of Hispanics to the health care system and illuminates the changes that, if introduced, will contribute to its improvement. These issues include the homogeneity or heterogeneity of the Hispanic population; the extent to which socioeconomic status adversely affects Hispanics' access to health care; the influence of demographic and epidemiological factors on their needs for care; the role of neighborhood factors in determining their access to the health and medical infrastuctures; the paucity of Hispanic health professionals; and finally, the major reform proposals currently on the nation's health agenda as they relate to the issue of improved access to care of Hispanics.			GINZBERG, E (corresponding author), COLUMBIA UNIV,EISENHOWER CTR CONSERVAT HUMAN RESOURCES,NEW YORK,NY 10027, USA.		Potter, Joseph E/A-3122-2008					Aday LA, 1980, HLTH CARE US EQUITAB; Bunker J, 1989, PATHWAYS HLTH ROLE S; DAWSON DA, 1988, AM J PUBLIC HEALTH, V78, P1326, DOI 10.2105/AJPH.78.10.1326; ESTRADA AL, IN PRESS HISPANIC HL; JONAS HS, 1989, JAMA-J AM MED ASSOC, V262, P1011, DOI 10.1001/jama.262.8.1011; JOSEPH SC, 1988, AIDS PATIENT ACTION; LOE H, 1990, FINAL REPORT MONITOR; STERN MP, 1990, DIABETES METAB REV, V6, P24; STROUPBENHAM CA, 1991, JAMA-J AM MED ASSOC, V265, P222, DOI 10.1001/jama.265.2.222; TREVINO FM, 1991, JAMA-J AM MED ASSOC, V265, P233, DOI 10.1001/jama.265.2.233; WARNER DC, 1991, JAMA-J AM MED ASSOC, V265, P242, DOI 10.1001/jama.265.2.242; 1989, ALLIED HLTH SERIVCES; 1988, CANCER HISPANICS; 1989, NEW YORK CITY HLTH F; 1990, STATISTICAL ABSTRACT; 1989, STATISTIAAL ABSTRACT	16	123	123	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 9	1991	265	2					238	241		10.1001/jama.265.2.238	http://dx.doi.org/10.1001/jama.265.2.238			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EQ602	1984154				2022-12-28	WOS:A1991EQ60200032
J	PARDO, JV; FOX, PT; RAICHLE, ME				PARDO, JV; FOX, PT; RAICHLE, ME			LOCALIZATION OF A HUMAN SYSTEM FOR SUSTAINED ATTENTION BY POSITRON EMISSION TOMOGRAPHY	NATURE			English	Article							INTRAVENOUS (H2O)-O-15; HUMAN-BRAIN; PET IMAGES; CORTEX	POSITRON emission tomographic (PET) studies of human attention have begun to dissect isolable components of this complex higher brain function, including a midline attentional system in a region of the anterior cingulate cortex1-3. The right hemisphere may play a special part in human attention4; neglect, an important phenomenon associated with damage to attentional systems, is more severe, extensive and long-lasting after lesions to the right hemisphere. Here we use PET measurements of brain flood flow in healthy subjects to identify changes in regional brain activity during simple visual and somatosensory tasks of sustained attention or vigilance. We find localized increases in blood flow in the prefrontal and superior parietal cortex primarily in the right hemisphere, regardless of the modality or laterality of sensory input. The anterior cingulate was not activated during either task. These data localize the vigilance aspects of normal human attention to sensory stimuli, thereby clarifying the biology underlying asymmetries of attention to such stimuli that have been reported in clinical lesions.	WASHINGTON UNIV,MED CTR,DEPT NEUROL & NEUROL SURG,ST LOUIS,MO 63110; WASHINGTON UNIV,MED CTR,DEPT PSYCHIAT,ST LOUIS,MO 63110; WASHINGTON UNIV,MED CTR,MALLINCKRODT INST RADIOL,ST LOUIS,MO 63110; WASHINGTON UNIV,MED CTR,MCDONNELL CTR STUDIES HIGHER BRAIN FUNCT,ST LOUIS,MO 63110	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)			Fox, Peter/B-4725-2010	Fox, Peter/0000-0002-0465-2028				CAVADA C, 1989, J COMP NEUROL, V287, P393, DOI 10.1002/cne.902870402; CORBETTA M, 1990, SCIENCE, V248, P1556, DOI 10.1126/science.2360050; FOX PT, 1989, J NUCL MED, V30, P141; FOX PT, 1988, J CEREBR BLOOD F MET, V8, P642, DOI 10.1038/jcbfm.1988.111; FOX PT, 1987, J NEUROSURG, V67, P34, DOI 10.3171/jns.1987.67.1.0034; FOX PT, 1987, J NEUROSCI, V7, P913; Fuster J.M., 1989, PREFRONTAL CORTEX; Goldman-Rakic P.S., 2011, HDB PHYSL, P373, DOI DOI 10.1002/CPHY.CP010509; HEILMAN KM, 1987, HDB PHYSL 1, V5, P461; HERSCOVITCH P, 1983, J NUCL MED, V24, P782; MINTUN MA, 1989, J CEREBR BLOOD F MET, V9, P96, DOI 10.1038/jcbfm.1989.13; PARDO JV, 1990, P NATL ACAD SCI USA, V87, P256, DOI 10.1073/pnas.87.1.256; POSNER MI, 1988, SCIENCE, V240, P1627, DOI 10.1126/science.3289116; RAICHLE ME, 1983, J NUCL MED, V24, P790; Talairach J, 1967, ATLAS ANATOMIE STERE; YAMAMOTO M, 1982, IEEE T NUCL SCI, V29, P529, DOI 10.1109/TNS.1982.4335901	16	1056	1068	0	47	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JAN 3	1991	349	6304					61	64		10.1038/349061a0	http://dx.doi.org/10.1038/349061a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EQ601	1985266				2022-12-28	WOS:A1991EQ60100050
J	PRICE, JA; POLLOCK, I; LITTLE, SA; LONGBOTTOM, JL; WARNER, JO				PRICE, JA; POLLOCK, I; LITTLE, SA; LONGBOTTOM, JL; WARNER, JO			MEASUREMENT OF AIRBORNE MITE ANTIGEN IN HOMES OF ASTHMATIC-CHILDREN	LANCET			English	Article											PRICE, JA (corresponding author), BROMPTON HOSP,NATL HEART & LUNG INST,DEPT PAEDIAT,FULHAM RD,LONDON SW3 6HP,ENGLAND.		Warner, John/AAF-9587-2020					DOWSE GK, 1985, J ALLERGY CLIN IMMUN, V75, P75, DOI 10.1016/0091-6749(85)90016-8; MANSELL K, 1968, LANCET, V1, P1267; PLATTSMILLS TAE, 1989, J ALLERGY CLIN IMMUN, V83, P416, DOI 10.1016/0091-6749(89)90128-0; SARSFIELD JK, 1974, ARCH DIS CHILD, V49, P711, DOI 10.1136/adc.49.9.711; TOVEY ER, 1981, AM REV RESPIR DIS, V124, P630	5	116	117	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 13	1990	336	8720					895	897		10.1016/0140-6736(90)92268-M	http://dx.doi.org/10.1016/0140-6736(90)92268-M			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EC456	1976929				2022-12-28	WOS:A1990EC45600002
J	RICHARDS, P				RICHARDS, P			AMERICA THROUGH THE LOOKING-GLASS .3. TEACHING, RESEARCH, AND SERVICE	LANCET			English	Article											RICHARDS, P (corresponding author), ST MARYS HOSP,SCH MED,LONDON W2 1PG,ENGLAND.								0	2	2	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 13	1990	336	8720					926	927		10.1016/0140-6736(90)92285-P	http://dx.doi.org/10.1016/0140-6736(90)92285-P			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EC456	1976941				2022-12-28	WOS:A1990EC45600015
J	FISCHL, MA; PARKER, CB; PETTINELLI, C; WULFSOHN, M; HIRSCH, MS; COLLIER, AC; ANTONISKIS, D; HO, M; RICHMAN, DD; FUCHS, E; MERIGAN, TC; REICHMAN, RC; GOLD, J; STEIGBIGEL, N; LEOUNG, GS; RASHEED, S; TSIATIS, A				FISCHL, MA; PARKER, CB; PETTINELLI, C; WULFSOHN, M; HIRSCH, MS; COLLIER, AC; ANTONISKIS, D; HO, M; RICHMAN, DD; FUCHS, E; MERIGAN, TC; REICHMAN, RC; GOLD, J; STEIGBIGEL, N; LEOUNG, GS; RASHEED, S; TSIATIS, A			A RANDOMIZED CONTROLLED TRIAL OF A REDUCED DAILY DOSE OF ZIDOVUDINE IN PATIENTS WITH THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									RES TRIANGLE INST,RES TRIANGLE PK,NC 27709; NIAID,DIV AIDS,ROCKVILLE,MD; HARVARD UNIV,SCH PUBL HLTH,BOSTON,MA 02115; HARVARD UNIV,SCH MED,BOSTON,MA 02115; UNIV WASHINGTON,SCH MED,SEATTLE,WA 98195; UNIV SO CALIF,SCH MED,LOS ANGELES,CA 90033; UNIV PITTSBURGH,PITTSBURGH,PA 15260; UNIV CALIF SAN DIEGO,SAN DIEGO,CA 92103; JOHNS HOPKINS UNIV,SCH MED,BALTIMORE,MD 21205; STANFORD UNIV,STANFORD,CA 94305; UNIV ROCHESTER,SCH MED,ROCHESTER,NY 14627; MEM SLOAN KETTERING CANC CTR,NEW YORK,NY 10021; ALBERT EINSTEIN MONTEFIORE MED CTR,BRONX,NY; UNIV CALIF SAN FRANCISCO,SAN FRANCISCO GEN HOSP,SAN FRANCISCO,CA 94110	Research Triangle Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; University of Washington; University of Washington Seattle; University of Southern California; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California San Diego; Johns Hopkins University; Stanford University; University of Rochester; Memorial Sloan Kettering Cancer Center; Montefiore Medical Center; Yeshiva University; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	FISCHL, MA (corresponding author), UNIV MIAMI,SCH MED,DEPT MED R-60A,POB 016960,MIAMI,FL 33101, USA.		Merigan, Thomas/AGQ-7464-2022	Parker, Corette/0000-0002-6822-6845				CHAISSON RE, 1988, ARCH INTERN MED, V148, P2151, DOI 10.1001/archinte.148.10.2151; COOMBS RW, 1989, NEW ENGL J MED, V321, P1626, DOI 10.1056/NEJM198912143212402; FISCHL MA, 1989, JAMA-J AM MED ASSOC, V262, P2405; FISCHL MA, 1987, NEW ENGL J MED, V317, P185, DOI 10.1056/NEJM198707233170401; Fleiss JL, 1981, STAT METHODS RATES P; HO DD, 1989, NEW ENGL J MED, V321, P1621, DOI 10.1056/NEJM198912143212401; JACKSON GG, 1988, ANN INTERN MED, V108, P175, DOI 10.7326/0003-4819-108-2-175; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; LARDER BA, 1989, SCIENCE, V243, P1731, DOI 10.1126/science.2467383; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; MITSUYA H, 1985, P NATL ACAD SCI USA, V82, P7096, DOI 10.1073/pnas.82.20.7096; PETO R, 1977, BRIT J CANCER, V35, P1, DOI 10.1038/bjc.1977.1; PETO R, 1972, J R STAT SOC SER A-G, V135, P185, DOI 10.2307/2344317; PINCHING AJ, 1989, J INFECTION, V18, P33, DOI 10.1016/S0163-4453(89)80078-7; RICHMAN DD, 1990, J ACQ IMMUN DEF SYND, V3, P743; RICHMAN DD, 1987, NEW ENGL J MED, V317, P192, DOI 10.1056/NEJM198707233170402; SPECTOR SA, 1989, J INFECT DIS, V159, P822, DOI 10.1093/infdis/159.5.822; STAMBUK D, 1989, J INFECTION, V18, P41, DOI 10.1016/S0163-4453(89)80079-9; VOLBERDING PA, 1990, NEW ENGL J MED, V322, P941, DOI 10.1056/NEJM199004053221401; YARCHOAN R, 1988, ANN NEUROL, V23, pS82, DOI 10.1002/ana.410230722	20	315	318	0	0	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 11	1990	323	15					1009	1014		10.1056/NEJM199010113231501	http://dx.doi.org/10.1056/NEJM199010113231501			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB936	1977079				2022-12-28	WOS:A1990EB93600001
J	ZOSCHKE, DC; SKEMP, AA; DEFOSSE, DL				ZOSCHKE, DC; SKEMP, AA; DEFOSSE, DL			LYMPHOPROLIFERATIVE RESPONSES TO BORRELIA-BURGDORFERI IN LYME-DISEASE	ANNALS OF INTERNAL MEDICINE			English	Article							FLUID; ANTIGENS; CELLS	Objective: To compare lymphocyte proliferative responses to Borrelia burgdorferi in healthy controls and patients with Lyme disease. Patients: Twelve patients fulfilling case-definition criteria for Lyme disease. Twelve healthy volunteers and two newborns served as controls. Measurements: Antibodies to B. burgdorferi were measured by enzyme-linked immunosorbent assay (ELISA). Proliferation of peripheral blood lymphocytes cultured for 5 days with B. burgdorferi, recall antigens, or pokeweed mitogen was measured by radioactive thymidine uptake. Results: Lymphocytes from 11 patients with Lyme disease, 8 healthy seronegative controls, and two newborns showed elevated responses when stimulated with B. burgdorferi. When a patient and a control were studied on the same day, the patient's lymphocyte response to B. burgdorferi exceeded the control's in only 5 of 12 cases. Lymphocytes from both patients and controls responded to B. burgdorferi isolates from three different sources. Conclusions: Heightened lymphocyte responses to B. burgdorferi are found in patients with Lyme disease but elevated responses also frequently occur in healthy controls. At present, the interpretation of a positive lymphocyte response to B. burgdorferi would be difficult in ambiguous clinical situations.			ZOSCHKE, DC (corresponding author), UNIV MINNESOTA, DEPT MED, RHEUMATOL SECT, 420 DELAWARE ST SE, MINNEAPOLIS, MN 55455 USA.				NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR033492] Funding Source: NIH RePORTER; NIAMS NIH HHS [5R01-AR-33492] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BECK G, 1985, J INFECT DIS, V152, P108, DOI 10.1093/infdis/152.1.108; BENACH JL, 1988, ANN NY ACAD SCI, V539, P115, DOI 10.1111/j.1749-6632.1988.tb31845.x; DATTWYLER R, 1989, ARTHRITIS RHEUM S, V80, P52; DATTWYLER RJ, 1988, NEW ENGL J MED, V319, P1441, DOI 10.1056/NEJM198812013192203; Goebel K M, 1988, Scand J Rheumatol Suppl, V75, P314; HABICHT GS, 1985, J IMMUNOL, V134, P3147; MAGNARELLI LA, 1988, AM J EPIDEMIOL, V127, P818, DOI 10.1093/oxfordjournals.aje.a114864; MARTIN R, 1988, ANN NEUROL, V24, P509, DOI 10.1002/ana.410240406; SCHAIBLE UE, 1989, INFECT IMMUN, V57, P41, DOI 10.1128/IAI.57.1.41-47.1989; SCHWARTZ BS, 1989, JAMA-J AM MED ASSOC, V262, P3431, DOI 10.1001/jama.262.24.3431; SIGAL LH, 1986, ARTHRITIS RHEUM, V29, P761, DOI 10.1002/art.1780290609; SIGAL LH, 1988, J RHEUMATOL, V15, P648; SIGAL LH, 1989, SEMIN ARTHRITIS RHEU, V18, P151, DOI 10.1016/0049-0172(89)90058-9; SIGAL LH, 1987, ARTHRITIS RHEUM, V30, P536; STEERE AC, 1989, NEW ENGL J MED, V321, P586, DOI 10.1056/NEJM198908313210906; STEERE AC, 1983, NEW ENGL J MED, V308, P733, DOI 10.1056/NEJM198303313081301; WEYAND LM, 1980, ARTHRITIS RHEUM, V32, P1057; YOSHINARI NH, 1989, ARTHRITIS RHEUM, V546, P31; ZOSCHKE DC, 1989, J RHEUMATOL, V16, P1233	19	73	73	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 15	1991	114	4					285	289		10.7326/0003-4819-114-4-285	http://dx.doi.org/10.7326/0003-4819-114-4-285			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EX521	1987874				2022-12-28	WOS:A1991EX52100006
J	GREENE, WC				GREENE, WC			MECHANISMS OF DISEASE - THE MOLECULAR-BIOLOGY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							TRANS-ACTIVATOR GENE; HTLV-III/LAV ENVELOPE; AIDS-RELATED COMPLEX; T-CELL; TAT PROTEIN; REV PROTEIN; TRANSCRIPTION FACTOR; GLYCOPROTEIN GP120; REGULATORY GENES; TARGET SEQUENCE		DUKE UNIV,MED CTR,DEPT MICROBIOL & IMMUNOL,DURHAM,NC 27710	Duke University	GREENE, WC (corresponding author), DUKE UNIV,MED CTR,HOWARD HUGHES MED INST,DEPT MED,DURHAM,NC 27710, USA.							ABRAMS DI, 1989, ANN INTERN MED, V110, P183, DOI 10.7326/0003-4819-110-3-183; AHMAD N, 1988, SCIENCE, V241, P1481, DOI 10.1126/science.3262235; ARTHUR LO, 1989, J VIROL, V63, P5046, DOI 10.1128/JVI.63.12.5046-5053.1989; ARYA SK, 1985, SCIENCE, V229, P69, DOI 10.1126/science.2990040; BALTIMORE D, 1988, NATURE, V335, P395, DOI 10.1038/335395a0; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; BEDINGER P, 1988, NATURE, V334, P162, DOI 10.1038/334162a0; BENKO DM, 1990, J VIROL, V64, P2505, DOI 10.1128/JVI.64.6.2505-2518.1990; BERKHOUT B, 1990, CELL, V62, P757, DOI 10.1016/0092-8674(90)90120-4; BERMAN PW, 1988, P NATL ACAD SCI USA, V85, P5200, DOI 10.1073/pnas.85.14.5200; BERMAN PW, 1990, NATURE, V345, P622, DOI 10.1038/345622a0; BOHNLEIN E, 1988, CELL, V53, P827, DOI 10.1016/0092-8674(88)90099-2; BRYANT ML, 1989, P NATL ACAD SCI USA, V86, P8655, DOI 10.1073/pnas.86.22.8655; CASTRO BA, 1988, AIDS, V2, pS17, DOI 10.1097/00002030-198800001-00004; CHANG DD, 1989, CELL, V59, P789, DOI 10.1016/0092-8674(89)90602-8; COHEN EA, 1990, J VIROL, V64, P3097, DOI 10.1128/JVI.64.6.3097-3099.1990; CORDONNIER A, 1989, NATURE, V340, P571, DOI 10.1038/340571a0; CULLEN BR, 1989, CELL, V58, P423, DOI 10.1016/0092-8674(89)90420-0; CULLEN BR, 1986, CELL, V46, P973, DOI 10.1016/0092-8674(86)90696-3; CULLEN BR, 1988, J VIROL, V62, P2489; CURRAN JW, 1988, SCIENCE, V239, P610, DOI 10.1126/science.3340847; DAAR ES, 1990, P NATL ACAD SCI USA, V87, P6574, DOI 10.1073/pnas.87.17.6574; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; DALY TJ, 1989, NATURE, V342, P816, DOI 10.1038/342816a0; DAYTON AI, 1986, CELL, V44, P941, DOI 10.1016/0092-8674(86)90017-6; DAYTON ET, 1989, SCIENCE, V246, P1625, DOI 10.1126/science.2688093; DINGWALL C, 1989, P NATL ACAD SCI USA, V86, P6925, DOI 10.1073/pnas.86.18.6925; FAUCI AS, 1988, SCIENCE, V239, P617, DOI 10.1126/science.3277274; FEINBERG MB, 1986, CELL, V46, P807, DOI 10.1016/0092-8674(86)90062-0; FINBERG RW, 1990, SCIENCE, V249, P287, DOI 10.1126/science.2115689; FISCHL MA, 1987, NEW ENGL J MED, V317, P185, DOI 10.1056/NEJM198707233170401; FISHER AG, 1986, NATURE, V320, P367, DOI 10.1038/320367a0; FISHER AG, 1988, NATURE, V334, P444, DOI 10.1038/334444a0; FISHER RA, 1988, NATURE, V331, P76, DOI 10.1038/331076a0; FRANKEL AD, 1988, SCIENCE, V240, P70, DOI 10.1126/science.2832944; GALLO RC, 1984, SCIENCE, V224, P500, DOI 10.1126/science.6200936; GARDNER MB, 1990, AIDS RES HUM RETROV, V6, P835, DOI 10.1089/aid.1990.6.835; GARTNER S, 1986, SCIENCE, V233, P215, DOI 10.1126/science.3014648; GATIGNOL A, 1989, P NATL ACAD SCI USA, V86, P7828, DOI 10.1073/pnas.86.20.7828; GAYNOR R, 1989, P NATL ACAD SCI USA, V86, P4858, DOI 10.1073/pnas.86.13.4858; GELDERBLOM HR, 1987, VIROLOGY, V156, P171, DOI 10.1016/0042-6822(87)90449-1; GREENE WC, 1989, IMMUNOL TODAY, V10, P272, DOI 10.1016/0167-5699(89)90141-2; GREENE WC, 1990, ANNU REV IMMUNOL, V8, P453, DOI 10.1146/annurev.iy.08.040190.002321; GUPTA S, 1987, J CLIN IMMUNOL, V7, P486, DOI 10.1007/BF00915060; GUY B, 1987, NATURE, V330, P266, DOI 10.1038/330266a0; HAMMES SR, 1989, P NATL ACAD SCI USA, V86, P9549, DOI 10.1073/pnas.86.23.9549; HAUBER J, 1987, P NATL ACAD SCI USA, V84, P6364, DOI 10.1073/pnas.84.18.6364; HEAPHY S, 1990, CELL, V60, P685, DOI 10.1016/0092-8674(90)90671-Z; HO DD, 1986, J CLIN INVEST, V77, P1712, DOI 10.1172/JCI112491; HOYOS B, 1989, SCIENCE, V244, P457, DOI 10.1126/science.2497518; JACKS T, 1988, NATURE, V331, P280, DOI 10.1038/331280a0; JONES KA, 1986, SCIENCE, V232, P755, DOI 10.1126/science.3008338; KAO SY, 1987, NATURE, V330, P489, DOI 10.1038/330489a0; KESHET E, 1979, J VIROL, V31, P376, DOI 10.1128/JVI.31.2.376-388.1979; KIM SY, 1989, P NATL ACAD SCI USA, V86, P9544, DOI 10.1073/pnas.86.23.9544; KIM SY, 1989, J VIROL, V63, P3708, DOI 10.1128/JVI.63.9.3708-3713.1989; KLATZMANN D, 1984, NATURE, V312, P767, DOI 10.1038/312767a0; KLIMKAIT T, 1990, J VIROL, V64, P621, DOI 10.1128/JVI.64.2.621-629.1990; LASPIA MF, 1989, CELL, V59, P283, DOI 10.1016/0092-8674(89)90290-0; LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7; LEONARD R, 1988, P NATL ACAD SCI USA, V85, P3570, DOI 10.1073/pnas.85.10.3570; LETVIN NL, 1990, IMMUNOL TODAY, V11, P322, DOI 10.1016/0167-5699(90)90127-U; LEVY JA, 1985, ANN INTERN MED, V103, P694, DOI 10.7326/0003-4819-103-5-694; LIFSON JD, 1986, SCIENCE, V232, P1123, DOI 10.1126/science.3010463; LOWE DM, 1988, BIOCHEMISTRY-US, V27, P8884, DOI 10.1021/bi00425a002; LUCIW PA, 1987, P NATL ACAD SCI USA, V84, P1434, DOI 10.1073/pnas.84.5.1434; LYERLY HK, 1987, P NATL ACAD SCI USA, V84, P4601, DOI 10.1073/pnas.84.13.4601; LYNN WS, 1988, VIROLOGY, V163, P43, DOI 10.1016/0042-6822(88)90232-2; MADDON PJ, 1986, CELL, V47, P333, DOI 10.1016/0092-8674(86)90590-8; MALIM MH, 1988, NATURE, V335, P181, DOI 10.1038/335181a0; MALIM MH, 1990, CELL, V60, P675, DOI 10.1016/0092-8674(90)90670-A; MALIM MH, 1989, NATURE, V338, P254, DOI 10.1038/338254a0; MALIM MH, 1989, CELL, V58, P205, DOI 10.1016/0092-8674(89)90416-9; MATTHEWS TJ, 1986, P NATL ACAD SCI USA, V83, P9709, DOI 10.1073/pnas.83.24.9709; MCKEEVER BM, 1989, J BIOL CHEM, V264, P1919; MCQUADE TJ, 1990, SCIENCE, V247, P454, DOI 10.1126/science.2405486; MEEK TD, 1990, NATURE, V343, P90, DOI 10.1038/343090a0; MITSUYA H, 1988, SCIENCE, V240, P646, DOI 10.1126/science.2452480; NABEL G, 1987, NATURE, V326, P711, DOI 10.1038/326711a0; NIEDERMAN TMJ, 1989, P NATL ACAD SCI USA, V86, P1128, DOI 10.1073/pnas.86.4.1128; PAVLAKIS G N, 1990, New Biologist, V2, P20; RICHARDSON CD, 1983, VIROLOGY, V131, P518, DOI 10.1016/0042-6822(83)90517-2; ROOK AH, 1987, J IMMUNOL, V138, P1064; ROSENBERG ZF, 1990, J NIH RES, V2, P41; SADAIE MR, 1988, SCIENCE, V239, P910, DOI 10.1126/science.3277284; SALFELD J, 1990, EMBO J, V9, P965, DOI 10.1002/j.1460-2075.1990.tb08195.x; SANDSTROM EG, 1985, LANCET, V1, P1480; SCHNITTMAN SM, 1989, SCIENCE, V245, P305, DOI 10.1126/science.2665081; SHARP PA, 1989, CELL, V59, P229, DOI 10.1016/0092-8674(89)90279-1; SMITH DH, 1987, SCIENCE, V238, P1704, DOI 10.1126/science.3500514; SODROSKI J, 1986, SCIENCE, V231, P1549, DOI 10.1126/science.3006244; SODROSKI J, 1986, NATURE, V321, P412, DOI 10.1038/321412a0; SODROSKI J, 1986, NATURE, V322, P470, DOI 10.1038/322470a0; SODROSKI J, 1985, SCIENCE, V229, P74, DOI 10.1126/science.2990041; STEIN BS, 1987, CELL, V49, P659, DOI 10.1016/0092-8674(87)90542-3; STREBEL K, 1987, NATURE, V328, P728, DOI 10.1038/328728a0; TERWILLIGER E, 1986, J VIROL, V60, P754, DOI 10.1128/JVI.60.2.754-760.1986; TRONO D, 1989, CELL, V59, P113, DOI 10.1016/0092-8674(89)90874-X; VARMUS H, 1988, SCIENCE, V240, P1427, DOI 10.1126/science.3287617; VERONESE FD, 1985, SCIENCE, V229, P1402, DOI 10.1126/science.2994223; VOLBERDING PA, 1990, NEW ENGL J MED, V322, P941, DOI 10.1056/NEJM199004053221401; WALKER BD, 1987, NATURE, V328, P345, DOI 10.1038/328345a0; WLODAWER A, 1989, SCIENCE, V245, P616, DOI 10.1126/science.2548279; YARCHOAN R, 1990, IMMUNOL TODAY, V11, P327, DOI 10.1016/0167-5699(90)90128-V; YORKHIGGINS D, 1990, J VIROL, V64, P4016, DOI 10.1128/JVI.64.8.4016-4020.1990; ZACK JA, 1990, CELL, V61, P213, DOI 10.1016/0092-8674(90)90802-L; ZAPP ML, 1989, NATURE, V342, P714, DOI 10.1038/342714a0; 1990, AIDS UPDATE, V3, P6	108	209	220	0	11	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 31	1991	324	5					308	317						10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU922	1986289				2022-12-28	WOS:A1991EU92200006
J	CELANDER, DW; CECH, TR				CELANDER, DW; CECH, TR			VISUALIZING THE HIGHER-ORDER FOLDING OF A CATALYTIC RNA MOLECULE	SCIENCE			English	Article							SELF-SPLICING RNA; GROUP-I INTRONS; NUCLEAR MAGNETIC-RESONANCE; PHENYLALANINE TRANSFER-RNA; TETRAHYMENA RIBOZYME; ENDORIBONUCLEASE ACTIVITY; INTERVENING SEQUENCE; TERTIARY STRUCTURE; BINDING-SITE; PROTEIN	The higher order folding process of the catalytic RNA derived from the self-splicing intron of Tetrahymena thermophila was monitored with the use of Fe(II)-EDTA-induced free radical chemistry. The overall tertiary structure of the RNA molecule forms cooperatively with the uptake of at least three magnesium ions. Local folding transitions display different metal ion dependencies, suggesting that the RNA tertiary structure assembles through a specific folding intermediate before the catalytic core is formed. Enzymatic activity, assayed with an RNA substrate that is complementary to the catalytic RNA active site, coincides with the cooperative structural transition. The higher order RNA foldings produced by Mg(II), Ca(II), and Sr(II) are similar; however, only the Mg(II)-stabilized RNA is catalytically active. Thus, these results directly demonstrate that divalent metal ions participate in general folding of the ribozyme tertiary structure, and further indicate a more specific involvement of Mg(II) in catalysis.			CELANDER, DW (corresponding author), UNIV COLORADO, DEPT CHEM & BIOCHEM, HOWARD HUGHES MED INST, BOULDER, CO 80309 USA.							ALTMAN S, 1989, ADV ENZYMOL RAMB, V62, P1; [Anonymous], COMMUNICATION; BEAUDRY AA, 1990, BIOCHEMISTRY-US, V29, P6534, DOI 10.1021/bi00479a027; BEEN MD, 1986, CELL, V47, P207, DOI 10.1016/0092-8674(86)90443-5; BEEN MD, 1987, COLD SPRING HARB SYM, V52, P147, DOI 10.1101/SQB.1987.052.01.019; BOGUSKI MS, 1980, J BIOL CHEM, V255, P2160; BOYLE J, 1980, J MOL BIOL, V139, P601, DOI 10.1016/0022-2836(80)90051-0; BURKE JM, 1987, NUCLEIC ACIDS RES, V15, P7217, DOI 10.1093/nar/15.18.7217; BURKE JM, 1988, GENE, V73, P273, DOI 10.1016/0378-1119(88)90493-3; CECH TR, 1988, GENE, V73, P259, DOI 10.1016/0378-1119(88)90492-1; CECH TR, 1990, ANNU REV BIOCHEM, V59, P543, DOI 10.1146/annurev.bi.59.070190.002551; CECH TR, 1987, SCIENCE, V236, P1532, DOI 10.1126/science.2438771; CELANDER DW, 1990, BIOCHEMISTRY-US, V29, P1355, DOI 10.1021/bi00458a001; CELANDER DW, UNPUB; CHANDRY S, COMMUNICATION; Creighton TE, 1983, PROTEINS STRUCTURES; CROTHERS DM, 1979, COLD SPRING HARBOR A, V9, P163; DANCHIN A, 1972, BIOCHIMIE, V54, P333, DOI 10.1016/S0300-9084(72)80212-8; DAVIES RW, 1982, NATURE, V300, P719, DOI 10.1038/300719a0; DONISKELLER H, 1977, NUCLEIC ACIDS RES, V4, P2527, DOI 10.1093/nar/4.8.2527; DOUDNA JA, 1989, MOL CELL BIOL, V9, P5480, DOI 10.1128/MCB.9.12.5480; DOUDNA JA, 1989, NATURE, V339, P519, DOI 10.1038/339519a0; DOWNS WD, 1990, BIOCHEMISTRY-US, V29, P5605, DOI 10.1021/bi00475a027; FLOR PJ, 1989, EMBO J, V8, P3391, DOI 10.1002/j.1460-2075.1989.tb08503.x; FRESCO JR, 1966, COLD SPRING HARB SYM, V31, P527, DOI 10.1101/SQB.1966.031.01.068; GOLDENBERG DP, 1988, ANNU REV BIOPHYS BIO, V17, P481; GROSSHANS CA, 1989, BIOCHEMISTRY-US, V28, P6888, DOI 10.1021/bi00443a017; GUERRIERTAKADA C, 1983, CELL, V35, P849, DOI 10.1016/0092-8674(83)90117-4; HAMPEL A, 1989, BIOCHEMISTRY-US, V28, P4929, DOI 10.1021/bi00438a002; HASELOFF J, 1988, NATURE, V334, P585, DOI 10.1038/334585a0; HERSCHLAG D, 1990, BIOCHEMISTRY-US, V29, P10172, DOI 10.1021/bi00496a004; HERSCHLAG D, 1990, BIOCHEMISTRY-US, V29, P10159, DOI 10.1021/bi00496a003; HERSCHLAG D, 1990, NATURE, V344, P405, DOI 10.1038/344405a0; HERSCHLAG D, COMMUNICATION; HERTZBERG RP, 1984, BIOCHEMISTRY-US, V23, P3934, DOI 10.1021/bi00312a022; HEUER T, UNPUB; HOLBROOK SR, 1977, NUCLEIC ACIDS RES, V4, P2811, DOI 10.1093/nar/4.8.2811; JACK A, 1977, J MOL BIOL, V111, P315, DOI 10.1016/S0022-2836(77)80054-5; JAEGER JA, 1990, BIOCHEMISTRY-US, V29, P10147, DOI 10.1021/bi00496a002; JAENICKE R, 1987, PROG BIOPHYS MOL BIO, V49, P117, DOI 10.1016/0079-6107(87)90011-3; JEZEWSKA MJ, 1990, BIOCHEMISTRY-US, V29, P5220, DOI 10.1021/bi00473a032; JOYCE GF, 1989, NUCLEIC ACIDS RES, V17, P7879, DOI 10.1093/nar/17.19.7879; KAYNE MS, 1972, BIOCHEM BIOPH RES CO, V46, P1285; KIM PS, 1990, ANNU REV BIOCHEM, V59, P631, DOI 10.1146/annurev.biochem.59.1.631; KIM PS, 1982, ANNU REV BIOCHEM, V51, P459, DOI 10.1146/annurev.bi.51.070182.002331; KRUGER K, 1982, CELL, V31, P147, DOI 10.1016/0092-8674(82)90414-7; LATHAM JA, 1989, SCIENCE, V245, P276, DOI 10.1126/science.2501870; MICHEL F, 1989, GENE, V82, P5, DOI 10.1016/0378-1119(89)90026-7; MICHEL F, 1982, BIOCHIMIE, V64, P867, DOI 10.1016/S0300-9084(82)80349-0; MICHEL F, 1989, NATURE, V342, P391, DOI 10.1038/342391a0; MURPHY FL, 1989, P NATL ACAD SCI USA, V86, P9218, DOI 10.1073/pnas.86.23.9218; NAZAR RN, COMMUNICATION; PACE NR, 1990, J BIOL CHEM, V265, P3587; PYLE AM, 1990, P NATL ACAD SCI USA, V87, P8187, DOI 10.1073/pnas.87.21.8187; QUIGLEY GJ, 1978, P NATL ACAD SCI USA, V75, P64, DOI 10.1073/pnas.75.1.64; ROBILLARD GT, 1977, BIOCHEMISTRY-US, V16, P5261, DOI 10.1021/bi00643a016; SYMONS RH, 1989, TRENDS BIOCHEM SCI, V14, P445, DOI 10.1016/0968-0004(89)90103-5; SZOSTAK JW, 1986, NATURE, V322, P83, DOI 10.1038/322083a0; TULLIUS TD, 1987, METHOD ENZYMOL, V155, P537; TULLIUS TD, 1985, SCIENCE, V230, P679, DOI 10.1126/science.2996145; TULLIUS TD, 1986, P NATL ACAD SCI USA, V83, P5469, DOI 10.1073/pnas.83.15.5469; UHLENBECK OC, 1987, NATURE, V328, P596, DOI 10.1038/328596a0; VANDERHORST G, IN PRESS P NATL ACAD; WARING RB, 1986, NATURE, V321, P133, DOI 10.1038/321133a0; WILLIAMS AP, 1989, BIOCHEMISTRY-US, V28, P4283, DOI 10.1021/bi00436a025; WU HN, 1989, P NATL ACAD SCI USA, V86, P1831, DOI 10.1073/pnas.86.6.1831; ZAUG AJ, 1986, NATURE, V324, P429, DOI 10.1038/324429a0; ZAUG AJ, 1986, SCIENCE, V231, P470, DOI 10.1126/science.3941911; ZAUG AJ, 1988, BIOCHEMISTRY-US, V27, P8924, DOI 10.1021/bi00425a008	69	346	355	2	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 25	1991	251	4992					401	407		10.1126/science.1989074	http://dx.doi.org/10.1126/science.1989074			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU504	1989074				2022-12-28	WOS:A1991EU50400034
J	CARLSON, LM; OETTINGER, MA; SCHATZ, DG; MASTELLER, EL; HURLEY, EA; MCCORMACK, WT; BALTIMORE, D; THOMPSON, CB				CARLSON, LM; OETTINGER, MA; SCHATZ, DG; MASTELLER, EL; HURLEY, EA; MCCORMACK, WT; BALTIMORE, D; THOMPSON, CB			SELECTIVE EXPRESSION OF RAG-2 IN CHICKEN B-CELLS UNDERGOING IMMUNOGLOBULIN GENE CONVERSION	CELL			English	Article							LIGHT CHAIN GENE; TRANSGENIC MICE; REARRANGEMENT; FABRICIUS; BURSA; RECOMBINATION; MECHANISM; SEGMENTS; OCCURS; REGION	Chickens create their immunoglobulin (Ig) repertoires during B cell development in the bursa of Fabricius by intrachromasomal gene conversion. Recent evidence has suggested that Ig gene conversion may involve cis-acting DNA elements related to those involved in V(D)J recombination. Therefore, we have examined the potential role of the V(D)J recombination activating genes, RAG-1 and RAG-2, in regulating chicken Ig gene conversion. In contrast to the coexpression of RAG-1 and RAG-2 observed in mammalian B cells that undergo V(D)J recombination, chicken B cells isolated from the bursa of Fabricius express high levels of the RAG-2 mRNA but do not express RAG-1 mRNA. The developmental and phenotypic characteristics of the bursal lymphocytes and chicken B cell lines that express RAG-2 mRNA demonstrate that selective RAG-2 expression occurs specifically in B cells undergoing Ig diversification by gene conversion. These data suggest that RAG-2 plays a fundamental role in Ig-specific gene conversion.	UNIV MICHIGAN, MED CTR, DEPT INTERNAL MED, ANN ARBOR, MI 48109 USA; UNIV MICHIGAN, MED CTR, DEPT MICROBIOL & IMMUNOL, ANN ARBOR, MI 48109 USA; WHITEHEAD INST BIOMED RES, CAMBRIDGE, MA 02142 USA; MIT, DEPT BIOL, CAMBRIDGE, MA 02139 USA; ROCKEFELLER UNIV, NEW YORK, NY 10021 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Rockefeller University	CARLSON, LM (corresponding author), UNIV MICHIGAN, MED CTR, HOWARD HUGHES MED INST, ANN ARBOR, MI 48109 USA.		Schatz, David/A-6748-2013	Schatz, David/0000-0002-5669-1176; McCormack, Wayne/0000-0002-2117-8727	NCI NIH HHS [CA51466, CA48023] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA048023, R01CA048023] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AGUILERA A, 1988, GENETICS, V119, P779; AGUILERA A, 1990, MOL CELL BIOL, V10, P1439, DOI 10.1128/MCB.10.4.1439; ALT FW, 1986, IMMUNOL REV, V89, P5, DOI 10.1111/j.1600-065X.1986.tb01470.x; BECKER RS, 1990, CELL, V63, P987, DOI 10.1016/0092-8674(90)90502-6; BUCCHINI D, 1987, NATURE, V326, P409, DOI 10.1038/326409a0; BUERSTEDDE JM, 1990, EMBO J, V9, P921, DOI 10.1002/j.1460-2075.1990.tb08190.x; CARLSON LM, 1990, GENE DEV, V4, P536, DOI 10.1101/gad.4.4.536; CHAN MM, 1988, J IMMUNOL, V140, P2133; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHUN JJM, 1991, CELL, V64, P189, DOI 10.1016/0092-8674(91)90220-S; CLEVELAND DW, 1980, CELL, V20, P95, DOI 10.1016/0092-8674(80)90238-X; COLTEY M, 1989, J EXP MED, V170, P543, DOI 10.1084/jem.170.2.543; FULOP GM, 1990, NATURE, V347, P479, DOI 10.1038/347479a0; GOODHARDT M, 1987, P NATL ACAD SCI USA, V84, P4229, DOI 10.1073/pnas.84.12.4229; HUNKAPILLER T, 1989, ADV IMMUNOL, V44, P1; KIM S, 1990, MOL CELL BIOL, V10, P3224, DOI 10.1128/MCB.10.6.3224; KLEINFIELD R, 1986, NATURE, V322, P843, DOI 10.1038/322843a0; LEWIS S, 1989, CELL, V59, P585, DOI 10.1016/0092-8674(89)90002-0; LIEBER MR, 1987, GENE DEV, V1, P751, DOI 10.1101/gad.1.8.751; McCormack W T, 1990, Adv Immunol, V48, P41, DOI 10.1016/S0065-2776(08)60751-8; McCormack W T, 1989, Int Immunol, V1, P332, DOI 10.1093/intimm/1.4.332; MCCORMACK WT, 1989, CELL, V56, P785, DOI 10.1016/0092-8674(89)90683-1; MCCORMACK WT, 1989, GENE DEV, V3, P838, DOI 10.1101/gad.3.6.838; MCCORMACK WT, 1990, GENE DEV, V4, P548, DOI 10.1101/gad.4.4.548; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; PINK JRL, 1986, IMMUNOL REV, V91, P115, DOI 10.1111/j.1600-065X.1986.tb01486.x; PRATT LF, 1988, EMBO J, V7, P931, DOI 10.1002/j.1460-2075.1988.tb02898.x; RATCLIFFE MJH, 1985, IMMUNOL TODAY, V6, P223, DOI 10.1016/0167-5699(85)90039-8; RETH M, 1986, NATURE, V322, P840, DOI 10.1038/322840a0; REYNAUD CA, 1989, CELL, V59, P171, DOI 10.1016/0092-8674(89)90879-9; REYNAUD CA, 1987, CELL, V48, P379, DOI 10.1016/0092-8674(87)90189-9; ROUX KH, 1991, IN PRESS J IMMUNOL; SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5; THOMPSON CB, 1987, CELL, V48, P369, DOI 10.1016/0092-8674(87)90188-7; THOMPSON CB, 1985, NATURE, V314, P363, DOI 10.1038/314363a0; THOMPSON CB, 1987, CELL, V51, P371, DOI 10.1016/0092-8674(87)90633-7; THOMPSON CB, 1989, MECHANISMS B CELL NE, P46; TJOELKER LW, 1990, P NATL ACAD SCI USA, V87, P7856, DOI 10.1073/pnas.87.20.7856; TONEGAWA S, 1983, SCIENCE, V241, P577; WANG JC, 1990, CELL, V62, P403, DOI 10.1016/0092-8674(90)90002-V; WEILL JC, 1986, P NATL ACAD SCI USA, V83, P3336, DOI 10.1073/pnas.83.10.3336; YANCOPOULOS GD, 1986, CELL, V44, P251, DOI 10.1016/0092-8674(86)90759-2	42	121	126	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 11	1991	64	1					201	208		10.1016/0092-8674(91)90221-J	http://dx.doi.org/10.1016/0092-8674(91)90221-J			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ET175	1986866	Green Published			2022-12-28	WOS:A1991ET17500021
J	EDDY, DM				EDDY, DM			RATIONING BY PATIENT CHOICE	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARE		DUKE UNIV,DURHAM,NC 27706	Duke University								CALLAHAN D, 1990, WHAT KIND LIFE LIMIT; EDDY DM, 1990, JAMA-J AM MED ASSOC, V264, P1737, DOI 10.1001/jama.264.13.1737; EDDY DM, 1990, JAMA-J AM MED ASSOC, V264, P1161, DOI 10.1001/jama.264.9.1161; EDDY DM, 1990, JAMA-J AM MED ASSOC, V263, P2493, DOI 10.1001/jama.263.18.2493; EDDY DM, 1990, JAMA-J AM MED ASSOC, V263, P2505; EDDY DM, 1990, JAMA-J AM MED ASSOC, V264, P1169; EDDY DM, 1990, JAMA-J AM MED ASSOC, V264, P1165; EDDY DM, 1990, JAMA-J AM MED ASSOC, V264, P1170; EDDY DM, 1990, JAMA-J AM MED ASSOC, V263, P2498; EDDY DM, 1990, JAMA-J AM MED ASSOC, V263, P2501; FUCHS VR, 1984, NEW ENGL J MED, V311, P1572, DOI 10.1056/NEJM198412133112411; RELMAN AS, 1990, NEW ENGL J MED, V323, P991, DOI 10.1056/NEJM199010043231411; RELMAN RS, 1990, NEW ENGL J MED, V323, P911; SCHWARTZ WB, 1984, NEW ENGL J MED, V310, P52, DOI 10.1056/NEJM198401053100120	14	47	47	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	1991	265	1					105	108		10.1001/jama.265.1.105	http://dx.doi.org/10.1001/jama.265.1.105			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP555	1984107				2022-12-28	WOS:A1991EP55500039
J	RAUB, W				RAUB, W			RESEARCH ON EOSINOPHILIA-MYALGIA-SYNDROME	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material											RAUB, W (corresponding author), NIH, BLDG 31, ROOM 2B23, BETHESDA, MD 20892 USA.							1990, P NATL ACAD SCI USA, V87, P8647	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	1991	265	1					19	19						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP555	1984118				2022-12-28	WOS:A1991EP55500008
J	SCHULTZ, PN; SOBOL, WM				SCHULTZ, PN; SOBOL, WM			ANGIOID STREAKS AND PSEUDOXANTHOMA ELASTICUM	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									UNIV IOWA HOSP & CLIN,DEPT OPHTHALMOL,RETINA SERV,IOWA CITY,IA 52242	University of Iowa								CLARKSON JG, 1982, SURV OPHTHALMOL, V26, P235, DOI 10.1016/0039-6257(82)90158-8; CONNOR PJ, 1961, AM J MED, V30, P537, DOI 10.1016/0002-9343(61)90078-X; ESTES JW, 1968, ANN INTERN MED, V68, P1237, DOI 10.7326/0003-4819-68-6-1237; LEBWOHL M, 1987, NEW ENGL J MED, V317, P347, DOI 10.1056/NEJM198708063170604; LEBWOHL MG, 1982, NEW ENGL J MED, V307, P228, DOI 10.1056/NEJM198207223070406; MCDONALD HR, 1988, OPHTHALMOLOGY, V95, P306; POPE FM, 1974, J MED GENET, V11, P152, DOI 10.1136/jmg.11.2.152; Scholz R, 1941, ARCH OPHTHALMOL-CHIC, V26, P677; SHIELDS JA, 1975, BRIT J OPHTHALMOL, V59, P257, DOI 10.1136/bjo.59.5.257; Singerman L J, 1981, Retina, V1, P75	10	4	4	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	1991	265	1					45	45						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP555	1984125				2022-12-28	WOS:A1991EP55500027
J	BURTON, JL				BURTON, JL			HERBAL REMEDIES - AN ALTERNATIVE	LANCET			English	Article											BURTON, JL (corresponding author), BRISTOL ROYAL INFIRM & GEN HOSP,DEPT DERMATOL,BRISTOL BS3 8HW,ENGLAND.							RIIVERIUS L, 1678, 4 BOOKS LEARNED RENO	1	1	1	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	DEC 22	1990	336	8730					1565	1566		10.1016/0140-6736(90)93326-K	http://dx.doi.org/10.1016/0140-6736(90)93326-K			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP037	1979380				2022-12-28	WOS:A1990EP03700018
J	LAGRENADE, L; HANCHARD, B; FLETCHER, V; CRANSTON, B; BLATTNER, W				LAGRENADE, L; HANCHARD, B; FLETCHER, V; CRANSTON, B; BLATTNER, W			INFECTIVE DERMATITIS OF JAMAICAN CHILDREN - A MARKER FOR HTLV-I INFECTION	LANCET			English	Article									NCI,EXECUT PLAZA N,ROOM 434,BETHESDA,MD 20892; UNIV W INDIES,DEPT MED,KINGSTON 7,JAMAICA; UNIV W INDIES,DEPT PATHOL,KINGSTON 7,JAMAICA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University West Indies Mona Jamaica; University West Indies Mona Jamaica					NCI NIH HHS [N01-CP3-1006-00] Funding Source: Medline; DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS [N01CP031006] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics)		BARTHOLOMEW C, 1987, LANCET, V2, P1469; BIGGAR RJ, 1985, INT J CANCER, V35, P763, DOI 10.1002/ijc.2910350611; BLAYNEY DW, 1983, BLOOD, V62, P401; ESSEX M, 1984, HUMAN T CELL LEUKEMI, P355; GIBBS WN, 1987, ANN INTERN MED, V106, P361, DOI 10.7326/0003-4819-106-3-361; KAWANO F, 1985, CANCER-AM CANCER SOC, V55, P851, DOI 10.1002/1097-0142(19850215)55:4<851::AID-CNCR2820550424>3.0.CO;2-J; KINOSHITA K, 1985, BLOOD, V66, P120; KRONKE M, 1985, SCIENCE, V228, P1215, DOI 10.1126/science.2988127; MANNS A, 1988, 4TH P INT C AIDS STO, P255; MERINO F, 1984, INT J CANCER, V34, P501, DOI 10.1002/ijc.2910340412; MORGAN OS, 1989, LANCET, V2, P1184; MURPHY EL, 1988, J ACQ IMMUN DEF SYND, V1, P143; MURPHY EL, 1989, INT J CANCER, V43, P250, DOI 10.1002/ijc.2910430214; NEVA FA, 1989, NEW ENGL J MED, V320, P252, DOI 10.1056/NEJM198901263200416; POPOVIC M, 1984, SCIENCE, V226, P459, DOI 10.1126/science.6093248; RODGERSJOHNSON P, 1985, LANCET, V2, P1247; SATO E, 1982, GANN MONOGR CANCER R, V28, P51; SUGAMURA K, 1984, INT J CANCER, V34, P221, DOI 10.1002/ijc.2910340213; SWEET RD, 1966, BRIT J DERMATOL, V78, P93, DOI 10.1111/j.1365-2133.1966.tb12181.x; TACHIBANA N, 1988, INT J CANCER, V42, P829, DOI 10.1002/ijc.2910420605; TAKATSUKI K, 1982, GANN MONOGRAPH CANCE, V28, P13; TAKATSUKI K, 1977, TOPICS HEMATOLOGY, P76; WALSHE MM, 1967, BRIT J DERMATOL, V79, P229, DOI 10.1111/j.1365-2133.1967.tb11479.x	23	344	353	0	2	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	DEC 1	1990	336	8727					1345	1347						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL365	1978165				2022-12-28	WOS:A1990EL36500005
J	TWENTYMAN, OP; FINNERTY, JP; HARRIS, A; PALMER, J; HOLGATE, ST				TWENTYMAN, OP; FINNERTY, JP; HARRIS, A; PALMER, J; HOLGATE, ST			PROTECTION AGAINST ALLERGEN-INDUCED ASTHMA BY SALMETEROL	LANCET			English	Article									SOUTHAMPTON GEN HOSP,SOUTHAMPTON SO9 4XY,HANTS,ENGLAND; GLAXO GRP RES LTD,DIV MED,GREENFORD UB6 0HE,MIDDX,ENGLAND	University of Southampton; GlaxoSmithKline								AHRENS RC, 1987, J ALLERGY CLIN IMMUN, V79, P876, DOI 10.1016/0091-6749(87)90235-1; ARMITAGE P, 1987, STATISTICAL METHODS; BAKER A J, 1990, American Review of Respiratory Disease, V141, pA394; BARNES PJ, 1989, NEW ENGL J MED, V321, P1517; BEASLEY R, 1989, AM REV RESPIR DIS, V139, P806, DOI 10.1164/ajrccm/139.3.806; BOYD G, 1989, THORAX, V56, pP141; BRITTAIN RT, 1990, LUNG, V168, P111, DOI 10.1007/BF02718122; BRITTON J, 1988, THORAX, V43, P300, DOI 10.1136/thx.43.4.300; BUTCHERS P R, 1987, British Journal of Pharmacology, V92, p745P; CHAI H, 1975, J ALLERGY CLIN IMMUN, V56, P323, DOI 10.1016/0091-6749(75)90107-4; CHURCH MK, 1987, BRIT J PHARMACOL, V90, P421, DOI 10.1111/j.1476-5381.1987.tb08972.x; COCKCROFT DW, 1977, CLIN ALLERGY, V7, P503, DOI 10.1111/j.1365-2222.1977.tb01481.x; COCKCROFT DW, 1987, J ALLERGY CLIN IMMUN, V79, P734, DOI 10.1016/0091-6749(87)90204-1; DAHL R, 1986, EUR J RESPIR DIS, V69, P263; DAHL R, 1990, RHINITIS ASTHMA SIMI, P203; DEMONCHY JGR, 1985, AM REV RESPIR DIS, V131, P373; Fuller R W, 1988, Pulm Pharmacol, V1, P101, DOI 10.1016/S0952-0600(88)80006-1; HOOD SK, 1989, THORAX, V44, pP350; HOWARTH PH, 1985, AM REV RESPIR DIS, V132, P986; JOHNSON M, 1990, LUNG, V168, P115, DOI 10.1007/BF02718123; MACONOCHIE JG, 1988, BRIT J CLIN PHARMACO, V25, pP115; METZGER WJ, 1986, CHEST, V89, P477, DOI 10.1378/chest.89.4.477; MIADONNA A, 1990, J ALLERGY CLIN IMMUN, V50, P906; NIALS AT, 1990, BR J PHARM S, V90, pP120; OBYRNE PM, 1987, AM REV RESPIR DIS, V136, P740, DOI 10.1164/ajrccm/136.3.740; PALMQVIST M, 1989, J ALLERGY CLIN IMMUN, V83, P244; PERSSON CGA, 1986, LANCET, V2, P1126; SPORIK R, 1990, NEW ENGL J MED, V323, P497; TWENTYMAN O P, 1990, Clinical and Experimental Allergy, V20, P94; TWENTYMAN OP, IN PRESS AM REV RESP; ULLMAN A, 1988, THORAX, V43, P674, DOI 10.1136/thx.43.9.674	31	207	208	0	3	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	DEC 1	1990	336	8727					1338	1342		10.1016/0140-6736(90)92894-N	http://dx.doi.org/10.1016/0140-6736(90)92894-N			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL365	1978163				2022-12-28	WOS:A1990EL36500003
J	KAPLAN, C; DAFFOS, F; FORESTIER, F; TERTIAN, G; CATHERINE, N; PONS, JC; TCHERNIA, G				KAPLAN, C; DAFFOS, F; FORESTIER, F; TERTIAN, G; CATHERINE, N; PONS, JC; TCHERNIA, G			FETAL PLATELET COUNTS IN THROMBOCYTOPENIC PREGNANCY	LANCET			English	Article									INST PUERICULTURE,DEPT MED & BIOL FOETALES,F-75014 PARIS,FRANCE; HOP BECLERE,HEMATOL LAB,F-92140 CLAMART,FRANCE; HOP BECLERE,SERV OBSTET,F-92140 CLAMART,FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP	KAPLAN, C (corresponding author), INST NATL TRANSFUS SANGUINE,IMMUNOL LEUCOPLAQUETTAIRE LAB,6 RUE ALEXANDRE CABANEL,F-75015 PARIS,FRANCE.							AYROMLOOI J, 1978, AM J OBSTET GYNECOL, V130, P235, DOI 10.1016/0002-9378(78)90378-2; BURROWS RF, 1990, AM J OBSTET GYNECOL, V162, P731, DOI 10.1016/0002-9378(90)90996-K; CINES DB, 1982, NEW ENGL J MED, V306, P826, DOI 10.1056/NEJM198204083061402; DAFFOS F, 1985, AM J OBSTET GYNECOL, V153, P655, DOI 10.1016/S0002-9378(85)80254-4; DAFFOS F, 1988, AM J OBSTET GYNECOL, V158, P939, DOI 10.1016/0002-9378(88)90098-1; DAN U, 1989, GYNECOL OBSTET INVES, V27, P193, DOI 10.1159/000293654; FAY RA, 1983, OBSTET GYNECOL, V61, P238; KELTON JG, 1982, AM J OBSTET GYNECOL, V144, P449, DOI 10.1016/0002-9378(82)90252-6; KELTON JG, 1983, ANN INTERN MED, V99, P796, DOI 10.7326/0003-4819-99-6-796; MCMILLAN R, 1981, NEW ENGL J MED, V304, P1135, DOI 10.1056/NEJM198105073041904; MOISE KJ, 1988, OBSTET GYNECOL, V72, P346; MULLER JY, 1981, REV FR TRANSFUS IMMU, V24, P169, DOI 10.1016/S0338-4535(81)80040-2; REECE EA, 1990, AM J OBSTET GYNECOL, V162, P1127, DOI 10.1016/0002-9378(90)91340-I; SACHER RA, 1989, BLUT, V59, P128, DOI 10.1007/BF00320264; SCIOSCIA AL, 1988, AM J OBSTET GYNECOL, V159, P1066, DOI 10.1016/0002-9378(88)90414-0; SCOTT JR, 1983, AM J OBSTET GYNECOL, V145, P932, DOI 10.1016/0002-9378(83)90843-8; TERRITO M, 1973, OBSTET GYNECOL, V41, P579	17	87	87	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 20	1990	336	8721					979	982		10.1016/0140-6736(90)92430-P	http://dx.doi.org/10.1016/0140-6736(90)92430-P			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ED601	1977013				2022-12-28	WOS:A1990ED60100012
J	ZIEGLER, EJ; FISHER, CJ; SPRUNG, CL; STRAUBE, RC; SADOFF, JC; FOULKE, GE; WORTEL, CH; FINK, MP; DELLINGER, RP; TENG, NNH; ALLEN, IE; BERGER, HJ; KNATTERUD, GL; LOBUGLIO, AF; SMITH, CR				ZIEGLER, EJ; FISHER, CJ; SPRUNG, CL; STRAUBE, RC; SADOFF, JC; FOULKE, GE; WORTEL, CH; FINK, MP; DELLINGER, RP; TENG, NNH; ALLEN, IE; BERGER, HJ; KNATTERUD, GL; LOBUGLIO, AF; SMITH, CR			TREATMENT OF GRAM-NEGATIVE BACTEREMIA AND SEPTIC SHOCK WITH HA-1A HUMAN MONOCLONAL-ANTIBODY AGAINST ENDOTOXIN - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MUTANT ESCHERICHIA-COLI; IGG ANTIBODY; LIPID-A; PROTECTION; SEPSIS; CORE; J5	Background. HA-1A is a human monoclonal IgM antibody that binds specifically to the lipid A domain of endotoxin and prevents death in laboratory animals with gram-negative bacteremia and endotoxemia. Methods. To evaluate the efficacy and safety of HA-1A, we conducted a randomized, double-blind trial in patients with sepsis and a presumed diagnosis of gram-negative infection. The patients received either a single 100-mg intravenous dose of HA-1A (in 3.5 g of albumin) or placebo (3.5 g of albumin). Other interventions, including the administration of antibiotics and fluids, were not affected by the study protocol. Results. Of 543 patients with sepsis who were treated, 200 (37 percent) had gram-negative bacteremia as proved by blood culture. For the patients with gram-negative bacteremia followed to death or day 28, there were 45 deaths among the 92 recipients of placebo (49 percent) and 32 deaths among the 105 recipients of HA-1A (30 percent; P = 0.014). For the patients with gram-negative bacteremia and shock at entry, there were 27 deaths among the 47 recipients of placebo (57 percent) and 18 deaths among the 54 recipients of HA-1A (33 percent; P = 0.017). Analyses that stratified according to the severity of illness at entry showed improved survival with HA-1A treatment in both severely ill and less severely ill patients. Of the 196 patients with gram-negative bacteremia who were followed to hospital discharge or death, 45 of the 93 given placebo (48 percent) were discharged alive, as compared with 65 of the 103 treated with HA-1A (63 percent; P = 0.038). No benefit of treatment with HA-1A was demonstrated in the 343 patients with sepsis who did not prove to have gram-negative bacteremia. For all 543 patients with sepsis who were treated, the mortality rate was 43 percent among the recipients of placebo and 39 percent among those given HA-1A (P = 0.24). All patients tolerated HA-1A well, and no anti-HA-1A antibodies were detected. Conclusions. HA-1A is safe and effective for the treatment of patients with sepsis and gram-negative bacteremia.	UNIV HOSP CLEVELAND,CTR CRIT CARE RES,DIV PULM & CRIT CARE MED,2074 ABINGTON RD,CLEVELAND,OH 44106; UNIV CALIF SAN DIEGO,DEPT MED,SAN DIEGO,CA 92103; CASE WESTERN RESERVE UNIV,DEPT MED,CLEVELAND,OH 44106; UNIV MIAMI,DEPT MED,MIAMI,FL 33152; CENTOCOR INC,DIV RES & DEV,MALVERN,PA; WALTER REED ARMY MED CTR,DEPT BACTERIAL DIS,WASHINGTON,DC 20307; UNIV CALIF DAVIS,SACRAMENTO MED CTR,DEPT MED,SACRAMENTO,CA 95817; UNIV AMSTERDAM,ACAD MED CTR,CTR HEMOSTASIS THROMBOSIS & ATHEROSCLEROSIS RES,1105 AZ AMSTERDAM,NETHERLANDS; UNIV AMSTERDAM,ACAD MED CTR,DEPT INTENS CARE,1105 AZ AMSTERDAM,NETHERLANDS; UNIV MASSACHUSETTS,DEPT SURG,WORCESTER,MA 01605; BAYLOR UNIV,DEPT MED,HOUSTON,TX 77030; STANFORD UNIV,DEPT OBSTET & GYNECOL,STANFORD,CA 94305; STANFORD UNIV,CANC BIOL RES LAB,STANFORD,CA 94305; MARYLAND MED RES INST,BALTIMORE,MD; UNIV ALABAMA,DEPT MED,BIRMINGHAM,AL 35294	University Hospitals of Cleveland; University of California System; University of California San Diego; Case Western Reserve University; University of Miami; Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc; United States Department of Defense; United States Army; Walter Reed National Military Medical Center; University of California System; University of California Davis; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Massachusetts System; University of Massachusetts Worcester; Baylor University; Stanford University; Stanford University; University of Alabama System; University of Alabama Birmingham								BAUMGARTNER JD, 1990, J EXP MED, V171, P889, DOI 10.1084/jem.171.3.889; BAUMGARTNER JD, 1985, LANCET, V2, P59; BOGARD WC, 1990, OCT INT C ANT AG CHE; BONE RC, 1987, NEW ENGL J MED, V317, P653, DOI 10.1056/NEJM198709103171101; BONE RC, 1989, CRIT CARE MED, V17, P389, DOI 10.1097/00003246-198905000-00002; CALANDRA T, 1988, J INFECT DIS, V158, P312, DOI 10.1093/infdis/158.2.312; FISHER CJ, 1990, CRIT CARE MED, V18, P1311, DOI 10.1097/00003246-199012000-00001; FLEMING TR, 1984, CONTROL CLIN TRIALS, V5, P348, DOI 10.1016/S0197-2456(84)80014-8; KHAZAELI MB, 1990, J BIOL RESP MODIF, V9, P178; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; KREGER BE, 1980, AM J MED, V68, P344, DOI 10.1016/0002-9343(80)90102-3; LOBUGLIO AF, 1989, P NATL ACAD SCI USA, V86, P4220, DOI 10.1073/pnas.86.11.4220; MCCABE WR, 1988, J INFECT DIS, V158, P291, DOI 10.1093/infdis/158.2.291; MURRAY JF, 1988, AM REV RESPIR DIS, V138, P720, DOI 10.1164/ajrccm/138.3.720; MURRAY JF, 1989, AM REV RESPIR DIS, V139, P1065; RIETSCHEL ET, 1984, REV INFECT DIS, V6, P432; SPIER SJ, 1989, CIRC SHOCK, V28, P235; STUMACHER RJ, 1973, NEW ENGL J MED, V288, P1261, DOI 10.1056/NEJM197306142882402; TENG NNH, 1985, P NATL ACAD SCI USA, V82, P1790, DOI 10.1073/pnas.82.6.1790; VANDEVENTER SJH, 1988, LANCET, V1, P605; ZIEGLER EJ, 1987, CLIN RES, V35, pA619; ZIEGLER EJ, 1982, NEW ENGL J MED, V307, P1225, DOI 10.1056/NEJM198211113072001; ZIEGLER EJ, 1988, J INFECT DIS, V158, P286, DOI 10.1093/infdis/158.2.286; 1990, MMWR, V39, P31; 1987, NEW ENGL J MED, V317, P659	25	1302	1344	1	29	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 14	1991	324	7					429	436		10.1056/NEJM199102143240701	http://dx.doi.org/10.1056/NEJM199102143240701			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EX363	1988827				2022-12-28	WOS:A1991EX36300001
J	DESIMONE, G; DEVEREUX, RB; ROMAN, MJ; SCHLUSSEL, Y; ALDERMAN, MH; LARAGH, JH				DESIMONE, G; DEVEREUX, RB; ROMAN, MJ; SCHLUSSEL, Y; ALDERMAN, MH; LARAGH, JH			ECHOCARDIOGRAPHIC LEFT-VENTRICULAR MASS AND ELECTROLYTE INTAKE PREDICT ARTERIAL-HYPERTENSION	ANNALS OF INTERNAL MEDICINE			English	Article							BLOOD-PRESSURE; CARDIAC SIZE; HYPERTROPHY; POTASSIUM; SALT; RECOMMENDATIONS; POPULATION; RESPONSES; STRESS; TWINS	Objective: To identify predictors of arterial hypertension. Patients: One hundred thirty-two normotensive adults from a large employed population. Methods: Echocardiography, standard blood tests, and 24-hour urine collection, at baseline and after an interval of 3 to 6 years (mean, 4.7 +/- 0.8 years). Results: At follow-up, 15 subjects (11%; 7 men, 8 women) had a systolic blood pressure greater than 140 mm Hg or a diastolic blood pressure greater than 90 mm Hg or both (mean, 143 +/- 7 and 87 +/- 6 mm Hg, respectively). At baseline, subjects who developed hypertension had a greater left ventricular mass index than those who did not (92 +/- 25 compared with 77 +/- 19 g/m2 body surface area; P < 0.005) and higher 24-hour urinary sodium/potassium excretion ratio (3.6 +/- 1.7 compared with 2.6 +/- 1.4; P < 0.04); there were no differences in race, initial age, systolic or diastolic blood pressure, coronary risk factors, or plasma renin activity. The likelihood of developing hypertension rose from 3% in the lowest quartile of sex-adjusted left ventricular mass index to 24% in the highest quartile (P < 0.005); a parallel trend was less regular for quartiles of the sodium/potassium excretion ratio (P < 0.04). In multivariate analyses, follow-up systolic pressures in all subjects and in the 117 who remained normotensive were predicted by initial age, systolic blood pressure, black race, and sex-adjusted left ventricular mass index; final diastolic blood pressure was predicted by its initial value, plasma triglyceride levels, urinary sodium/potassium ratio, low renin activity, black race, and plasma glucose level. Conclusions: Echocardiographic left ventricular mass in normotensive adults is directly related to the risk for developing subsequent hypertension. Left ventricular mass improves prediction of future systolic pressure, whereas diastolic pressure is more related to initial metabolic status. Black race is also an independent determinant of higher subsequent blood pressure.	CORNELL UNIV, MED CTR,NEW YORK HOSP,DIV CARDIOL,BOX 222, 525 E 68TH ST, NEW YORK, NY 10021 USA	Cornell University; NewYork-Presbyterian Hospital			de Simone, Giovanni/D-1767-2011	de Simone, Giovanni/0000-0001-8567-9881	NHLBI NIH HHS [HL 18323] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL018323] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABERNATHY JR, 1988, AM J CARDIOL, V61, P1071, DOI 10.1016/0002-9149(88)90128-2; ADAMS TD, 1985, CIRCULATION, V71, P39, DOI 10.1161/01.CIR.71.1.39; BLAUSTEIN MP, 1977, AM J PHYSIOL, V232, pC165, DOI 10.1152/ajpcell.1977.232.5.C165; CASALE PN, 1986, ANN INTERN MED, V105, P173, DOI 10.7326/0003-4819-105-2-173; CELENTANO A, 1988, J HYPERTENS, V6, pS107, DOI 10.1097/00004872-198812040-00030; CHIANG BN, 1969, CIRCULATION, V39, P403, DOI 10.1161/01.CIR.39.3.403; CHIEN S, 1965, P SOC EXP BIOL MED, V119, P1155; DAHL LK, 1972, AM J CLIN NUTR, V25, P231; DELEONARDIS V, 1988, AM J HYPERTENS, V1, P305, DOI 10.1093/ajh/1.3.305; DESIMONE G, 1990, CIRCULATION, V81, P107, DOI 10.1161/01.CIR.81.1.107; DESIMONE G, 1988, AM J NONINVAS CARD, V2, P217; DEVEREUX RB, 1989, AM J HYPERTENS, V2, pS186, DOI 10.1093/ajh/2.6.186S; DEVEREUX RB, 1987, HYPERTENSION, V9, P97; DEVEREUX RB, 1977, CIRCULATION, V55, P613, DOI 10.1161/01.CIR.55.4.613; DEVEREUX RB, 1983, CIRCULATION, V68, P470, DOI 10.1161/01.CIR.68.3.470; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; DEVEREUX RB, 1984, J AM COLL CARDIOL, V4, P1222, DOI 10.1016/S0735-1097(84)80141-2; DEVEREUX RB, 1988, AM HEART J, V116, P1124, DOI 10.1016/0002-8703(88)90176-7; DITTO B, 1989, HYPERTENSION, V13, P181, DOI 10.1161/01.HYP.13.2.181; FAGARD R, 1987, AM J CARDIOL, V60, P1362, DOI 10.1016/0002-9149(87)90620-5; GANAU A, 1989, J AM COLL CARDIOL, V14, P715, DOI 10.1016/0735-1097(89)90116-2; GANAU A, 1990, CIRCULATION, V81, P25, DOI 10.1161/01.CIR.81.1.25; GOSSE P, 1986, J HYPERTENS, V4, pS297; GOTTDIENER JS, 1990, ANN INTERN MED, V112, P161, DOI 10.7326/0003-4819-112-3-161; GUDMUNDSSON O, 1984, ACTA MED SCAND, V688, P31; HAMMOND IW, 1988, J AM COLL CARDIOL, V12, P996, DOI 10.1016/0735-1097(88)90467-6; HAMMOND IW, 1986, J AM COLL CARDIOL, V7, P639, DOI 10.1016/S0735-1097(86)80476-4; HARSHFIELD GA, 1990, AM J HYPERTENS, V3, P538, DOI 10.1093/ajh/3.7.538; KESTELOOT H, 1984, ANN CLIN RES, V16, P72; KOREN MJ, 1991, IN PRESS ANN INTERN; KRISHNA GG, 1987, J LAB CLIN MED, V109, P724; LEVY D, 1989, ANN INTERN MED, V110, P101, DOI 10.7326/0003-4819-110-2-101; LIU K, 1979, AM J EPIDEMIOL, V110, P219, DOI 10.1093/oxfordjournals.aje.a112806; MACGREGOR GA, 1985, HYPERTENSION, V7, P628, DOI 10.1161/01.HYP.7.4.628; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; MAHONEY LT, 1988, HYPERTENSION, V12, P206, DOI 10.1161/01.HYP.12.2.206; NATHWANI D, 1985, AM HEART J, V109, P386, DOI 10.1016/0002-8703(85)90622-2; Nielsen J R, 1985, Acta Med Scand Suppl, V693, P61; Pickering G, 1968, HIGH BLOOD PRESSURE, P236; RADICE M, 1986, AM HEART J, V111, P115, DOI 10.1016/0002-8703(86)90562-4; RAVOGLI A, 1990, IN PRESS HYPERTENSIO; SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072; SEALEY JE, 1977, CARDIOVASC MED, V2, P1079; SEALEY JE, 1970, J CLIN INVEST, V49, P2119, DOI 10.1172/JCI106429; STAESSEN J, 1981, J EPIDEMIOL COMMUN H, V35, P256, DOI 10.1136/jech.35.4.256; TANNEN RL, 1983, ANN INTERN MED, V98, P773, DOI 10.7326/0003-4819-98-5-773; WALLERSON DC, 1987, HYPERTENSION, V9, P6; WEDER AB, 1985, PSYCHOSOM MED, V47, P406, DOI 10.1097/00006842-198509000-00001; WOOD DL, 1984, HYPERTENSION, V6, P301, DOI 10.1161/01.HYP.6.3.301; YOUNG DB, 1976, CIRC RES, V38, P84, DOI 10.1161/01.RES.38.6.84; ZAR JH, 1984, BIOSTAT ANAL, P346	51	105	105	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 1	1991	114	3					202	209		10.7326/0003-4819-114-3-202	http://dx.doi.org/10.7326/0003-4819-114-3-202			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EV339	1984744				2022-12-28	WOS:A1991EV33900006
J	HARDY, SJS; RANDALL, LL				HARDY, SJS; RANDALL, LL			A KINETIC PARTITIONING MODEL OF SELECTIVE BINDING OF NONNATIVE PROTEINS BY THE BACTERIAL CHAPERONE SECB	SCIENCE			English	Article							ESCHERICHIA-COLI SECB; MEMBRANE TRANSLOCATION; TRYPTOPHAN-SYNTHETASE; TRIGGER FACTOR; EXPORT; SEQUENCE; INVITRO; PRECURSOR; GROEL; GENE	An in vitro assay for the interaction of SecB, a molecular chaperone from Escherichia coli, with polypeptide ligands was established based on the ability of SecB to block the refolding of denatured maltose-binding protein. Competition experiments show that SecB binds selectively to nonnative proteins with high affinity and without specificity for a particular sequence of amino acids. It is proposed that selectivity in binding is due to a kinetic partitioning of polypeptides between folding and association with SecB.	WASHINGTON STATE UNIV,DEPT BIOCHEM & BIOPHYS,PULLMAN,WA 99164	Washington State University								ADACHI O, 1974, J BIOL CHEM, V249, P7756; ANDERER FA, 1966, J BIOL CHEM, V241, P1568; BAGSHAW CR, 1987, SPECTROPHOTOMETRY SP, P109; BEASTY AM, 1985, BIOCHEMISTRY-US, V24, P3547, DOI 10.1021/bi00335a024; BOCHKAREVA ES, 1988, NATURE, V336, P254, DOI 10.1038/336254a0; CHANDRASEKHAR GN, 1986, J BIOL CHEM, V261, P2414; CHENG MY, 1989, NATURE, V337, P620, DOI 10.1038/337620a0; CHIRICO WJ, 1988, NATURE, V332, P805, DOI 10.1038/332805a0; COLLIER DN, 1988, CELL, V53, P273, DOI 10.1016/0092-8674(88)90389-3; CREIGHTON TE, 1978, PROG BIOPHYS MOL BIO, V33, P231; CROOKE E, 1988, CELL, V54, P1003, DOI 10.1016/0092-8674(88)90115-8; DESHAIES RJ, 1988, NATURE, V332, P800, DOI 10.1038/332800a0; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DUPLAY P, 1984, J BIOL CHEM, V259, P606; ELLIS RJ, 1988, PHOTOSYNTH RES, V16, P101, DOI 10.1007/BF00039488; ELLIS RJ, 1989, TRENDS BIOCHEM SCI, V14, P339, DOI 10.1016/0968-0004(89)90168-0; Fersht A., 1985, ENZYME STRUCTURE MEC; FLYNN GC, 1989, SCIENCE, V245, P385, DOI 10.1126/science.2756425; FREEDMAN RB, 1989, CELL, V57, P1069, DOI 10.1016/0092-8674(89)90043-3; GANNON PM, 1989, J BACTERIOL, V171, P813, DOI 10.1128/jb.171.2.813-818.1989; GOLOUBINOFF P, 1989, NATURE, V337, P44, DOI 10.1038/337044a0; GROARKE JM, 1983, J BIOL CHEM, V258, P2952; HAGERMAN PJ, 1976, BIOCHEMISTRY-US, V15, P1462, DOI 10.1021/bi00652a017; HARTL FU, IN PRESS CELL; HIRS CHW, 1960, J BIOL CHEM, V235, P633; HURTLEY SM, 1989, J CELL BIOL, V108, P2117, DOI 10.1083/jcb.108.6.2117; KASSENBROCK CK, 1988, NATURE, V333, P90, DOI 10.1038/333090a0; KIM PS, 1982, ANNU REV BIOCHEM, V51, P459, DOI 10.1146/annurev.bi.51.070182.002331; KUMAMOTO CA, 1988, J BIOL CHEM, V263, P11554; KUMAMOTO CA, 1985, J BACTERIOL, V163, P267, DOI 10.1128/JB.163.1.267-274.1985; KUMAMOTO CA, 1989, GENE, V75, P167, DOI 10.1016/0378-1119(89)90393-4; KUMAMOTO CA, 1989, J BIOL CHEM, V264, P2242; KUMAMOTO CA, UNPUB; KUSUKAWA N, 1989, EMBO J, V8, P3517, DOI 10.1002/j.1460-2075.1989.tb08517.x; LAMINET AA, 1989, EMBO J, V8, P1469, DOI 10.1002/j.1460-2075.1989.tb03530.x; LAMINET AA, IN PRESS EMBO J; LANG K, 1987, NATURE, V329, P268, DOI 10.1038/329268a0; LECKER S, 1989, EMBO J, V8, P2703, DOI 10.1002/j.1460-2075.1989.tb08411.x; LI SH, 1972, J BIOL CHEM, V247, P1031; LIU G, 1988, J BIOL CHEM, V263, P14790; LIU GP, 1989, P NATL ACAD SCI USA, V86, P9213, DOI 10.1073/pnas.86.23.9213; LOWRY OH, 1951, J BIOL CHEM, V193, P265; OSTERMANN J, 1989, NATURE, V341, P125, DOI 10.1038/341125a0; PARK SH, 1988, SCIENCE, V239, P1033, DOI 10.1126/science.3278378; Randall L., UNPUB; RANDALL LL, 1989, SCIENCE, V243, P1156, DOI 10.1126/science.2646712; RANDALL LL, 1990, SCIENCE, V248, P860, DOI 10.1126/science.2188362; ROTHMAN JE, 1989, CELL, V59, P591, DOI 10.1016/0092-8674(89)90005-6; Tanford C, 1968, Adv Protein Chem, V23, P121, DOI 10.1016/S0065-3233(08)60401-5; TESCHKE CM, UNPUB; WATANABE M, 1989, P NATL ACAD SCI USA, V86, P2728, DOI 10.1073/pnas.86.8.2728; WATANABE M, 1989, CELL, V58, P695, DOI 10.1016/0092-8674(89)90104-9; WEIS SJB, 1990, J BACTERIOL, V172, P3023; WEISS JB, 1988, P NATL ACAD SCI USA, V85, P8978, DOI 10.1073/pnas.85.23.8978; WICKNER W, 1989, TRENDS BIOCHEM SCI, V14, P280, DOI 10.1016/0968-0004(89)90064-9; ZETTLMEISSL G, 1979, BIOCHEMISTRY-US, V18, P5567, DOI 10.1021/bi00592a007	56	202	205	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JAN 25	1991	251	4992					439	443		10.1126/science.1989077	http://dx.doi.org/10.1126/science.1989077			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU504	1989077				2022-12-28	WOS:A1991EU50400045
J	MARSHALL, CJ				MARSHALL, CJ			TUMOR SUPPRESSOR GENES	CELL			English	Review							HUMAN CELL HYBRIDS; RETINOBLASTOMA SUSCEPTIBILITY GENE; FAMILIAL POLYPOSIS COLI; WILMS-TUMOR; P53 GENE; T-ANTIGEN; COLORECTAL CARCINOMAS; ADENOMATOUS POLYPOSIS; PROTO-ONCOGENE; OSTEO-SARCOMA				MARSHALL, CJ (corresponding author), INST CANC RES,CHESTER BEATTY LABS,LONDON SW3 6JB,ENGLAND.							ASHTONRICKARDT PG, 1989, ONCOGENE, V4, P1169; BAKER SJ, 1990, SCIENCE, V249, P912, DOI 10.1126/science.2144057; BAKER SJ, 1989, SCIENCE, V244, P217, DOI 10.1126/science.2649981; BALABAN G, 1982, CANCER GENET CYTOGEN, V6, P213, DOI 10.1016/0165-4608(82)90058-9; BALLESTER R, 1990, CELL, V63, P851, DOI 10.1016/0092-8674(90)90151-4; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BARKER D, 1987, SCIENCE, V236, P1100, DOI 10.1126/science.3107130; BARTEK J, 1990, ONCOGENE, V5, P893; BISCHOFF JR, 1990, P NATL ACAD SCI USA, V87, P4766, DOI 10.1073/pnas.87.12.4766; BODMER WF, 1987, NATURE, V328, P614, DOI 10.1038/328614a0; BODMER WF, 1991, TUMOR SUPPRESSOR GEN, P49; BOOKSTEIN R, 1990, P NATL ACAD SCI USA, V87, P7762, DOI 10.1073/pnas.87.19.7762; BOOKSTEIN R, 1990, SCIENCE, V247, P712, DOI 10.1126/science.2300823; BRAITHWAITE AW, 1987, NATURE, V329, P458, DOI 10.1038/329458a0; BRESSAC B, 1990, P NATL ACAD SCI USA, V87, P1973, DOI 10.1073/pnas.87.5.1973; BUCHBERG AM, 1990, NATURE, V347, P291, DOI 10.1038/347291a0; BUCHKOVICH K, 1989, CELL, V58, P1097, DOI 10.1016/0092-8674(89)90508-4; CAIRNS J, 1975, NATURE, V255, P197, DOI 10.1038/255197a0; CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; CAVENEE WK, 1983, NATURE, V305, P779, DOI 10.1038/305779a0; CAVENEE WK, 1985, SCIENCE, V228, P501, DOI 10.1126/science.3983638; CAWTHON RM, 1990, CELL, V62, P193, DOI 10.1016/0092-8674(90)90253-B; CHEN PL, 1989, CELL, V58, P1193, DOI 10.1016/0092-8674(89)90517-5; DECAPRIO JA, 1988, CELL, V54, P275, DOI 10.1016/0092-8674(88)90559-4; DEMARS R, 1970, 23RD ANN S FUND CANC, P105; DILLER L, 1990, MOL CELL BIOL, V10, P5772, DOI 10.1128/MCB.10.11.5772; DOWNWARD J, 1990, NATURE, V346, P719, DOI 10.1038/346719a0; DRYJA TP, 1989, NATURE, V339, P556, DOI 10.1038/339556a0; ELIYAHU D, 1984, NATURE, V312, P646, DOI 10.1038/312646a0; ELIYAHU D, 1989, P NATL ACAD SCI USA, V86, P8763, DOI 10.1073/pnas.86.22.8763; ELIYAHU D, 1988, ONCOGENE, V3, P313; FEARON ER, 1990, SCIENCE, V247, P49, DOI 10.1126/science.2294591; FEARON ER, 1987, SCIENCE, V238, P193, DOI 10.1126/science.2889267; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; FIELDS S, 1990, SCIENCE, V249, P1046, DOI 10.1126/science.2144363; FINLAY CA, 1988, MOL CELL BIOL, V8, P531, DOI 10.1128/MCB.8.2.531; FINLAY CA, 1989, CELL, V57, P1083, DOI 10.1016/0092-8674(89)90045-7; FRANCKE U, 1979, CYTOGENET CELL GENET, V24, P185, DOI 10.1159/000131375; FRANCKE U, 1978, BIRTH DEFECTS, V12, P131; Frech M, 1990, SCIENCE, V249, P169, DOI 10.1126/science.2164710; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; FURUKAWA Y, 1990, P NATL ACAD SCI USA, V87, P2770, DOI 10.1073/pnas.87.7.2770; GAGE JR, 1990, J VIROL, V64, P723, DOI 10.1128/JVI.64.2.723-730.1990; GANNON JV, 1987, NATURE, V329, P456, DOI 10.1038/329456a0; GANNON JV, 1990, EMBO J, V9, P1595, DOI 10.1002/j.1460-2075.1990.tb08279.x; GESSLER M, 1990, NATURE, V343, P774, DOI 10.1038/343774a0; GOLDGAR DE, 1989, AM J HUM GENET, V44, P6; GREEN MR, 1989, CELL, V56, P1, DOI 10.1016/0092-8674(89)90975-6; GRUNDY P, 1988, NATURE, V336, P374, DOI 10.1038/336374a0; HABER DA, 1990, CELL, V61, P1257, DOI 10.1016/0092-8674(90)90690-G; HALEVY O, 1990, SCIENCE, V250, P113, DOI 10.1126/science.2218501; HALL A, 1990, CELL, V61, P921, DOI 10.1016/0092-8674(90)90054-I; HARBOUR JW, 1988, SCIENCE, V241, P353, DOI 10.1126/science.2838909; HARRIS H, 1988, CANCER RES, V48, P3302; HEIKKILA R, 1987, NATURE, V328, P445, DOI 10.1038/328445a0; HENRY I, 1989, P NATL ACAD SCI USA, V86, P3247, DOI 10.1073/pnas.86.9.3247; HOROWITZ JM, 1989, SCIENCE, V243, P937, DOI 10.1126/science.2521957; HOROWITZ JM, 1990, P NATL ACAD SCI USA, V87, P2775, DOI 10.1073/pnas.87.7.2775; HUANG HJS, 1988, SCIENCE, V242, P1563, DOI 10.1126/science.3201247; HUFF V, 1988, NATURE, V336, P377, DOI 10.1038/336377a0; HUNTER T, 1991, CELL, V64, P249, DOI 10.1016/0092-8674(91)90637-E; IGGO R, 1990, LANCET, V335, P675, DOI 10.1016/0140-6736(90)90801-B; JADAYEL D, 1990, NATURE, V343, P558, DOI 10.1038/343558a0; JAMES CD, 1989, P NATL ACAD SCI USA, V86, P2858, DOI 10.1073/pnas.86.8.2858; JENKINS JR, 1984, NATURE, V312, P651, DOI 10.1038/312651a0; KAYE FJ, 1990, P NATL ACAD SCI USA, V87, P6922, DOI 10.1073/pnas.87.17.6922; KITAYAMA H, 1989, CELL, V56, P77, DOI 10.1016/0092-8674(89)90985-9; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; KOUFOS A, 1989, AM J HUM GENET, V44, P711; LAIHO M, 1990, CELL, V62, P175, DOI 10.1016/0092-8674(90)90251-9; LANE DP, 1979, NATURE, V278, P261, DOI 10.1038/278261a0; LEE EYHP, 1988, SCIENCE, V241, P218, DOI 10.1126/science.3388033; LEE WH, 1987, SCIENCE, V235, P1394, DOI 10.1126/science.3823889; LEPPERT M, 1987, SCIENCE, V238, P1411, DOI 10.1126/science.3479843; LIOTTA LA, 1991, CELL, V64, P327, DOI 10.1016/0092-8674(91)90642-C; LUDLOW JW, 1990, CELL, V60, P387, DOI 10.1016/0092-8674(90)90590-B; LYONS J, 1990, SCIENCE, V249, P655, DOI 10.1126/science.2116665; MACKAY J, 1988, LANCET, V2, P1384; MANFREDI JJ, 1990, J VIROL, V64, P5250, DOI 10.1128/JVI.64.11.5250-5259.1990; MARKS PA, 1990, TUMOR SUPPRESSOR GEN, P201; MARTIN GA, 1990, CELL, V63, P843, DOI 10.1016/0092-8674(90)90150-D; MATHEW CGP, 1987, NATURE, V328, P524, DOI 10.1038/328524a0; MATSUNAGA E, 1981, HUM GENET, V57, P231; MEEK DW, 1990, EMBO J, V9, P3253, DOI 10.1002/j.1460-2075.1990.tb07524.x; MENON AG, 1990, P NATL ACAD SCI USA, V87, P5435, DOI 10.1073/pnas.87.14.5435; MERCER WE, 1990, P NATL ACAD SCI USA, V87, P6166, DOI 10.1073/pnas.87.16.6166; MIHARA K, 1989, SCIENCE, V246, P1300, DOI 10.1126/science.2588006; MOSES HL, 1990, CELL, V63, P245, DOI 10.1016/0092-8674(90)90155-8; MOWAT M, 1985, NATURE, V314, P633, DOI 10.1038/314633a0; MULLIGAN LM, 1990, P NATL ACAD SCI USA, V87, P5863, DOI 10.1073/pnas.87.15.5863; MUNGER K, 1989, EMBO J, V8, P4099, DOI 10.1002/j.1460-2075.1989.tb08594.x; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; NISHIKURA K, 1987, MOL CELL BIOL, V7, P639, DOI 10.1128/MCB.7.2.639; PARADA LF, 1984, NATURE, V312, P649, DOI 10.1038/312649a0; PARASKEVA C, 1990, BRIT J CANCER, V61, P828, DOI 10.1038/bjc.1990.185; PEEHL DM, 1982, INT J CANCER, V30, P113, DOI 10.1002/ijc.2910300119; PEPPERKOK R, 1988, P NATL ACAD SCI USA, V85, P6748, DOI 10.1073/pnas.85.18.6748; PEREIRASMITH OM, 1983, SCIENCE, V221, P964, DOI 10.1126/science.6879195; PEREIRASMITH OM, 1988, P NATL ACAD SCI USA, V85, P6042, DOI 10.1073/pnas.85.16.6042; PIETENPOL JA, 1990, CELL, V61, P777, DOI 10.1016/0092-8674(90)90188-K; PIETENPOL JA, 1990, P NATL ACAD SCI USA, V87, P3758, DOI 10.1073/pnas.87.10.3758; PIGNATELLI M, 1988, P NATL ACAD SCI USA, V85, P5561, DOI 10.1073/pnas.85.15.5561; PONDER B, 1988, NATURE, V335, P400, DOI 10.1038/335400a0; PONDER BAJ, 1985, NATURE, V313, P689, DOI 10.1038/313689a0; PRITCHARDJONES K, 1990, NATURE, V346, P194, DOI 10.1038/346194a0; RAYCROFT L, 1990, SCIENCE, V249, P1049, DOI 10.1126/science.2144364; REEVE AE, 1989, MOL CELL BIOL, V9, P1799, DOI 10.1128/MCB.9.4.1799; RICCARDI VM, 1980, CANCER GENET CYTOGEN, V2, P131, DOI 10.1016/0165-4608(80)90056-4; ROBBINS PD, 1990, NATURE, V346, P668, DOI 10.1038/346668a0; RODRIGUES NR, 1990, P NATL ACAD SCI USA, V87, P7555, DOI 10.1073/pnas.87.19.7555; ROSE EA, 1990, CELL, V60, P495, DOI 10.1016/0092-8674(90)90600-J; ROSENGARD AM, 1989, NATURE, V342, P177, DOI 10.1038/342177a0; SAGER R, 1985, ADV CANCER RES, V44, P43, DOI 10.1016/S0065-230X(08)60025-1; SAPIENZA C, 1990, MOL CARCINOGEN, V3, P118, DOI 10.1002/mc.2940030303; SARNOW P, 1982, CELL, V28, P387, DOI 10.1016/0092-8674(82)90356-7; SASAKI M, 1989, CANCER RES, V49, P4402; SAXON PJ, 1986, EMBO J, V5, P3461, DOI 10.1002/j.1460-2075.1986.tb04670.x; SCHAEFER R, 1988, P NATL ACAD SCI USA, V85, P1590, DOI 10.1073/pnas.85.5.1590; SCHNEIDER C, 1988, CELL, V54, P787, DOI 10.1016/S0092-8674(88)91065-3; SHENOY S, 1989, CELL, V57, P763, DOI 10.1016/0092-8674(89)90791-5; SHIMIZU M, 1990, ONCOGENE, V5, P185; SOLOMON E, 1987, NATURE, V328, P616, DOI 10.1038/328616a0; STANBRIDGE EJ, 1981, CANCER RES, V41, P573; STANBRIDGE EJ, 1988, CANCER SURV, V7, P317; STANBRIDGE EJ, 1976, NATURE, V260, P17, DOI 10.1038/260017a0; STEIN GH, 1990, SCIENCE, V249, P666, DOI 10.1126/science.2166342; STOLER A, 1985, P NATL ACAD SCI USA, V82, P570, DOI 10.1073/pnas.82.2.570; SUGAWARA O, 1990, SCIENCE, V247, P707, DOI 10.1126/science.2300822; TAKAHASHI T, 1989, SCIENCE, V246, P491, DOI 10.1126/science.2554494; TANG A, 1988, SCIENCE, V242, P263, DOI 10.1126/science.3175651; TEMPLETON DJ, 1991, IN PRESS P NATL ACAD; TOGUCHIDA J, 1989, NATURE, V338, P156, DOI 10.1038/338156a0; TRAHEY M, 1988, SCIENCE, V242, P1697, DOI 10.1126/science.3201259; TRENT JM, 1990, SCIENCE, V247, P568, DOI 10.1126/science.2300817; VANHEYNINGEN V, 1990, P NATL ACAD SCI USA, V87, P5383, DOI 10.1073/pnas.87.14.5383; VARESCO L, 1989, P NATL ACAD SCI USA, V86, P10118, DOI 10.1073/pnas.86.24.10118; VISKOCHIL D, 1990, CELL, V62, P187, DOI 10.1016/0092-8674(90)90252-A; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; WALLACE MR, 1990, SCIENCE, V249, P181, DOI 10.1126/science.2134734; WANG EH, 1989, CELL, V57, P379, DOI 10.1016/0092-8674(89)90913-6; WEISSMAN BE, 1983, JNCI-J NATL CANCER I, V70, P667; WERNESS BA, 1990, SCIENCE, V248, P76, DOI 10.1126/science.2157286; WHYTE P, 1988, NATURE, V334, P124, DOI 10.1038/334124a0; WIGLER MH, 1990, NATURE, V346, P696, DOI 10.1038/346696a0; WOLF D, 1984, CELL, V38, P119, DOI 10.1016/0092-8674(84)90532-4; XU GF, 1990, CELL, V63, P835, DOI 10.1016/0092-8674(90)90149-9; XU GF, 1990, CELL, V62, P599, DOI 10.1016/0092-8674(90)90024-9; YATANI A, 1990, CELL, V61, P769, DOI 10.1016/0092-8674(90)90187-J; YOKOTA J, 1987, P NATL ACAD SCI USA, V84, P9252, DOI 10.1073/pnas.84.24.9252; ZHU XP, 1989, NATURE, V340, P312, DOI 10.1038/340312a0	151	849	877	1	23	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	JAN 25	1991	64	2					313	326		10.1016/0092-8674(91)90641-B	http://dx.doi.org/10.1016/0092-8674(91)90641-B			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EV336	1988150				2022-12-28	WOS:A1991EV33600009
J	OFFNER, H; HASHIM, GA; VANDENBARK, AA				OFFNER, H; HASHIM, GA; VANDENBARK, AA			T-CELL RECEPTOR PEPTIDE THERAPY TRIGGERS AUTOREGULATION OF EXPERIMENTAL ENCEPHALOMYELITIS	SCIENCE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; MYELIN BASIC-PROTEIN; VACCINATION; RAT; SUPPRESSION; DISEASES; GENES	Encephalitogenic T cells specific for myelin basic protein share common V-beta-8 peptide sequences in their T cell receptor (TCR) that can induce autoregulatory T cells and antibodies that prevent clinical signs of experimental autoimmune encephalomyelitis (EAE). It is not known, however, if TCR peptides can treat established disease. To test its therapeutic value, TCR-V-beta-8-39-59 peptide was injected into rats with clinical signs of EAE. This treatment reduced disease severity and speeded recovery, apparently by boosting anti-V-beta-8 T cells and antibodies raised naturally in response to encephalitogenic V-beta-8+ T cells. These results demonstrate that synthetic TCR be used therapeutically, and implicate the TCR-V-beta-8-39-59 sequence as a natural idiotope involved in EAE recovery. Similarly, human TCR peptides may be effective in enhancing natural regulation of autoreactive T cells that share common V genes.	ST LUKES ROOSEVELT HOSP,DEPT MICROBIOL & SURG,NEW YORK,NY 10025; OREGON HLTH SCI UNIV,DEPT NEUROL,PORTLAND,OR 97201; OREGON HLTH SCI UNIV,DEPT MICROBIOL & IMMUNOL AAV,PORTLAND,OR 97201; COLUMBIA UNIV,NEW YORK,NY 10027	Mount Sinai St. Luke's; Mount Sinai West; Oregon Health & Science University; Oregon Health & Science University; Columbia University	OFFNER, H (corresponding author), VET ADM MED CTR,PORTLAND,OR 97201, USA.				NINDS NIH HHS [NS23444, NS21466, NS23221] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021466, R01NS023221, R01NS023444] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ACHAORBEA H, 1989, ANNU REV IMMUNOL, V7, P371, DOI 10.1146/annurev.iy.07.040189.002103; ACHAORBEA H, 1988, CELL, V54, P263, DOI 10.1016/0092-8674(88)90558-2; BENNUN A, 1981, EUR J IMMUNOL, V11, P195, DOI 10.1002/eji.1830110307; BERNARD CCA, 1977, CLIN EXP IMMUNOL, V29, P100; BURNS FR, 1989, J EXP MED, V169, P27, DOI 10.1084/jem.169.1.27; CHLUBA J, 1989, EUR J IMMUNOL, V19, P279, DOI 10.1002/eji.1830190210; CHOU YK, IN PRESS J NEUROSCI; ELLERMAN KE, 1988, NATURE, V331, P265, DOI 10.1038/331265a0; HASHIM GA, 1981, NEUROCHEM RES, V6, P699, DOI 10.1007/BF00963886; HASHIM GA, 1990, J IMMUNOL, V144, P4621; HEBERKATZ E, 1989, IMMUNOL TODAY, V10, P164, DOI 10.1016/0167-5699(89)90174-6; HOWELL MD, 1989, SCIENCE, V246, P668, DOI 10.1126/science.2814489; KUMAR V, 1989, ANNU REV IMMUNOL, V7, P657, DOI 10.1146/annurev.iy.07.040189.003301; LIDER O, 1988, SCIENCE, V239, P181, DOI 10.1126/science.2447648; LOHSE AW, 1989, SCIENCE, V244, P820, DOI 10.1126/science.2471264; LYMAN WD, 1984, CELL IMMUNOL, V85, P542, DOI 10.1016/0008-8749(84)90266-1; OFFNER H, 1989, J NEUROIMMUNOL, V21, P13, DOI 10.1016/0165-5728(89)90154-9; OFFNER H, 1988, J IMMUNOL, V141, P3828; OFFNER H, 1984, J NEUROIMMUNOL, V9, P147; OKSENBERG JR, 1990, NATURE, V345, P344, DOI 10.1038/345344a0; OWHASHI M, 1988, J EXP MED, V168, P2153, DOI 10.1084/jem.168.6.2153; SUN D, 1988, NATURE, V332, P843, DOI 10.1038/332843a0; URBAN JL, 1988, CELL, V54, P577, DOI 10.1016/0092-8674(88)90079-7; VANDENBARK AA, 1989, NATURE, V341, P541, DOI 10.1038/341541a0; VARRIALE S, 1989, J IMMUNOL, V125, P186; WELCH AM, 1980, J IMMUNOL, V125, P186; WHITHAM RH, 1990, CELL IMMUNOL, V126, P290, DOI 10.1016/0008-8749(90)90322-I; WUCHERPFENNIG KW, 1990, SCIENCE, V248, P1016, DOI 10.1126/science.1693015	28	236	271	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JAN 25	1991	251	4992					430	432		10.1126/science.1989076	http://dx.doi.org/10.1126/science.1989076			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU504	1989076				2022-12-28	WOS:A1991EU50400041
J	HILLIS, DM; MORITZ, C; PORTER, CA; BAKER, RJ				HILLIS, DM; MORITZ, C; PORTER, CA; BAKER, RJ			EVIDENCE FOR BIASED GENE CONVERSION IN CONCERTED EVOLUTION OF RIBOSOMAL DNA	SCIENCE			English	Article							HETERONOTIA-BINOEI GEKKONIDAE; NON-HOMOLOGOUS CHROMOSOMES; MULTIGENE FAMILIES; MOLECULAR DRIVE; LINKAGE DISEQUILIBRIUM; IMMUNOGLOBULIN GENES; PARTHENOGENESIS; SEQUENCES; VARIANTS; REGIONS	Concerted evolution is the production and maintenance of homogeneity within repeated families of DNA. Two mechanisms-unequal crossing over and biased gene conversion-have been the principal explanation of concerted evolution. Concerted evolution of ribosomal DNA (rDNA) arrays is thought to be largely the result of unequal crossing over. However, concerted evolution of rDNA in parthenogenetic lizards of hybrid origin is strongly biased toward one of two parental sequences, which is consistent with biased gene conversion as the operative mechanism. The apparent gene conversions are independent of initial genome dosage and result in homogenization of rDNA arrays across all nucleolar organizer regions.	UNIV QUEENSLAND, DEPT ZOOL, ST LUCIA, QLD 4067, AUSTRALIA; TEXAS TECH UNIV, DEPT BIOL SCI, LUBBOCK, TX 79409 USA	University of Queensland; Texas Tech University System; Texas Tech University	HILLIS, DM (corresponding author), UNIV TEXAS, DEPT ZOOL, AUSTIN, TX 78712 USA.		Moritz, Craig/A-7755-2012; Hillis, David/L-5421-2019; Hillis, David M/B-4278-2008	Moritz, Craig/0000-0001-5313-7279; 				ARNHEIM N, 1980, P NATL ACAD SCI-BIOL, V77, P7323, DOI 10.1073/pnas.77.12.7323; Arnheim N., 1983, P38; ARNHEIM N, 1979, GENE, V7, P83, DOI 10.1016/0378-1119(79)90025-8; ARNOLD ML, 1988, CHROMOSOMA, V96, P368, DOI 10.1007/BF00330703; BALTIMORE D, 1981, CELL, V24, P592, DOI 10.1016/0092-8674(81)90082-9; CIMINO MC, 1972, SCIENCE, V175, P1484, DOI 10.1126/science.175.4029.1484; COEN ES, 1982, NATURE, V295, P564, DOI 10.1038/295564a0; COEN ES, 1982, J MOL BIOL, V153, P841; DAWLEY RM, 1989, BIOL UNISEXUAL VERTE, P1; DOVER G, 1982, NATURE, V299, P111, DOI 10.1038/299111a0; DOVER G, 1982, BIOSCIENCE, V32, P526, DOI 10.2307/1308904; DOVER GA, 1986, TRENDS GENET, V2, P159, DOI 10.1016/0168-9525(86)90211-8; DOVER GA, 1989, GENETICS, V122, P249; GOODMAN M, 1987, COLD SPRING HARB SYM, V52, P875, DOI 10.1101/SQB.1987.052.01.096; GOODPASTURE C, 1975, CHROMOSOMA, V53, P37, DOI 10.1007/BF00329389; HILLIS DM, 1989, INT CONGR SER, V824, P355; HILLIS DM, 1986, EVOLUTION, V40, P1275, DOI 10.1111/j.1558-5646.1986.tb05751.x; HILLIS DM, 1987, MOL BIOL EVOL, V4, P117; KRYSTAL M, 1981, P NATL ACAD SCI-BIOL, V78, P5744, DOI 10.1073/pnas.78.9.5744; LONG EO, 1980, ANNU REV BIOCHEM, V49, P727, DOI 10.1146/annurev.bi.49.070180.003455; MORITZ C, 1989, EVOLUTION, V43, P994, DOI 10.1111/j.1558-5646.1989.tb02545.x; MORITZ C, 1984, CHROMOSOMA, V89, P151, DOI 10.1007/BF00292899; MORITZ C, 1983, SCIENCE, V220, P735, DOI 10.1126/science.220.4598.735; MORITZ C, 1990, COPEIA, P333, DOI 10.2307/1446339; Moritz C., 1989, BIOL UNISEXUAL VERTE, P87; MOYZIS RK, 1987, CHROMOSOMA, V95, P375, DOI 10.1007/BF00333988; NAGYLAKI T, 1982, GENETICS, V100, P315; NAGYLAKI T, 1988, GENETICS, V120, P291; OHTA T, 1980, GENET RES, V36, P181, DOI 10.1017/S0016672300019790; OHTA T, 1981, GENETICS, V99, P555; OHTA T, 1983, P NATL ACAD SCI-BIOL, V80, P4079, DOI 10.1073/pnas.80.13.4079; RASCH EM, 1982, HISTOCHEMISTRY, V73, P515, DOI 10.1007/BF00493366; SCHERER S, 1980, SCIENCE, V209, P1380, DOI 10.1126/science.6251545; SEPERACK P, 1988, GENETICS, V119, P943; SLATKIN M, 1986, GENETICS, V112, P681; SMITH GP, 1973, COLD SPRING HARB SYM, V38, P507, DOI 10.1101/SQB.1974.038.01.055; TARTOF KD, 1973, COLD SPRING HARB SYM, V38, P491, DOI 10.1101/SQB.1974.038.01.053; UZZELL T, 1970, AM NAT, V104, P433, DOI 10.1086/282678	38	337	353	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 18	1991	251	4991					308	310		10.1126/science.1987647	http://dx.doi.org/10.1126/science.1987647			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET678	1987647				2022-12-28	WOS:A1991ET67800032
J	MENKE, A; JOCKUSCH, H				MENKE, A; JOCKUSCH, H			DECREASED OSMOTIC STABILITY OF DYSTROPHIN-LESS MUSCLE-CELLS FROM THE MDX MOUSE	NATURE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; GENE	HUMAN X-linked Duchenne and Becker muscular dystrophies are due to defects in dystrophin, the product of an exceptionally large gene1,2. Although dystrophin has been characterized as a spectrin-like3 submembranous4 cytoskeletal protein, there is no experimental evidence for its function in the structural maintenance of muscle5. Current hypotheses attribute necrosis of hystrophin-less fibres in situ to mechanical weakening of the outer membrane6, to an excessive influx of Ca2+ ions7,8, or to a combination of these two mechanisms, possibly mediated by stretch-sensitive ion channels9. Using hypo-osmotic shock to determine stress resistance10 and a mouse model (mdx)11,12 for the human disease, we show that functional dystrophin contributes to the stability of both cultured myotubes and isolated mature muscle fibres.			MENKE, A (corresponding author), UNIV BIELEFELD,DEV BIOL UNIT,W-4800 BIELEFELD 1,GERMANY.							BLAU HM, 1981, P NATL ACAD SCI-BIOL, V78, P5623, DOI 10.1073/pnas.78.9.5623; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; CARNWATH JW, 1987, J NEUROL SCI, V80, P39, DOI 10.1016/0022-510X(87)90219-X; COOPER BJ, 1989, SOC NEUR ABSTR, V15, P412; CULLEN MJ, 1990, PROC R SOC SER B-BIO, V240, P197, DOI 10.1098/rspb.1990.0034; DUNCAN CJ, 1989, EXPERIENTIA, V45, P175, DOI 10.1007/BF01954866; ERVASTI JM, 1990, NATURE, V345, P315, DOI 10.1038/345315a0; FOSTER AH, 1980, ANESTH ANALG, V58, P727; FRANCO A, 1990, NATURE, V344, P670, DOI 10.1038/344670a0; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; JOCKUSCH H, 1990, MUSCLE NERVE, V13, P551, DOI 10.1002/mus.880130613; JOCKUSCH H, 1990, DYNAMIC STATE OF MUSCLE FIBERS, P429; KARPATI G, 1986, AM J MED GENET, V25, P653, DOI 10.1002/ajmg.1320250407; KOELTGEN D, IN PRESS MUSCLE NERV; KOENIG M, 1990, J BIOL CHEM, V265, P4560; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; MENKE A, 1990, J NEUROL SCI S, V98, P124; PARTRIDGE TA, 1989, NATURE, V337, P176, DOI 10.1038/337176a0; SICINSKI P, 1989, SCIENCE, V244, P1578, DOI 10.1126/science.2662404; Slater CR, 1989, CURR OPIN CELL BIOL, V1, P110, DOI 10.1016/S0955-0674(89)80046-8; TURNER PR, 1988, NATURE, V335, P735, DOI 10.1038/335735a0; WATKINS SC, 1989, MUSCLE NERVE, V12, P861, DOI 10.1002/mus.880121013	22	296	300	0	7	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JAN 3	1991	349	6304					69	71		10.1038/349069a0	http://dx.doi.org/10.1038/349069a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EQ601	1985268				2022-12-28	WOS:A1991EQ60100053
J	BELL, W				BELL, W			THROMBOTIC THROMBOCYTOPENIC PURPURA	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PATHOGENESIS		JOHNS HOPKINS UNIV,SCH MED,DEPT MED,DIV HEMATOL,BALTIMORE,MD 21205	Johns Hopkins University								AMOROSI EL, 1966, MEDICINE, V45, P139, DOI 10.1097/00005792-196603000-00003; BARTHOLOMEW JR, 1986, J INTENSIVE CARE MED, V1, P341; BUKOWSKI RM, 1982, PROG HEMOST THROMB, V6, P287; BYRNES JJ, 1986, CLIN HAEMATOL, V15, P413; FELDMAN JD, 1966, LAB INVEST, V15, P927; GASSER C, 1955, Schweiz Med Wochenschr, V85, P905; LIAN ECY, 1987, SEMIN HEMATOL, V24, P82; Moschcowitz E, 1925, ARCH INTERN MED, V36, P89, DOI 10.1001/archinte.1925.00120130092009; Moschcowitz E., 1924, P NY PATHOL SOC, V24, P21; REMUZZI G, 1987, KIDNEY INT, V32, P292, DOI 10.1038/ki.1987.206; RIDOLFI RL, 1979, ANN INTERN MED, V91, P357, DOI 10.7326/0003-4819-91-3-357; RIDOLFI RL, 1981, MEDICINE, V60, P413, DOI 10.1097/00005792-198111000-00003; SINGER K, 1954, ADV INTERNAL MED, V6, P195; UMLOS J, 1900, AM J MED, V49, P723	14	16	16	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	1991	265	1					91	93		10.1001/jama.265.1.91	http://dx.doi.org/10.1001/jama.265.1.91			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP555	1984130				2022-12-28	WOS:A1991EP55500035
J	WESTREICH, L				WESTREICH, L			DOCTORS AND LANGUAGE - HOW WE CONFUSE OUR PATIENTS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article											WESTREICH, L (corresponding author), BETH ISRAEL MED CTR,PSYCHIAT,NEW YORK,NY 10003, USA.								0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	1991	265	1					117	117		10.1001/jama.265.1.117	http://dx.doi.org/10.1001/jama.265.1.117			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP555	1984110				2022-12-28	WOS:A1991EP55500043
J	JONES, D				JONES, D			FOODBORNE LISTERIOSIS	LANCET			English	Article											JONES, D (corresponding author), UNIV LEICESTER,DEPT MICROBIOL,MED SCI BLDG,UNIV RD,LEICESTER LE1 9HN,ENGLAND.							ARUGHESE PV, 1989, CAN DIS WEEKLY REC, V15, P213; BERCHE P, 1990, LANCET, V335, P624, DOI 10.1016/0140-6736(90)90411-W; BIBB WF, 1990, APPL ENVIRON MICROB, V56, P2133, DOI 10.1128/AEM.56.7.2133-2141.1990; BOISIVON A, 1990, EUR J CLIN MICROBIOL, V9, P206, DOI 10.1007/BF01963839; BROOME CV, 1990, FOODBORNE LISTERIOSI, P61; CAMPBELL DM, 1990, J INFECTION, V20, P241, DOI 10.1016/0163-4453(90)91219-4; COSSART P, 1989, INFECT IMMUN, V57, P3629, DOI 10.1128/IAI.57.11.3629-3636.1989; CZUPRYNSKI CJ, 1989, MICROB PATHOGENESIS, V7, P213, DOI 10.1016/0882-4010(89)90057-0; FARBER JM, 1989, LETT APPL MICROBIOL, V9, P181, DOI 10.1111/j.1472-765X.1989.tb00319.x; FENLON DR, 1985, J APPL BACTERIOL, V59, P537, DOI 10.1111/j.1365-2672.1985.tb03357.x; GAILLARD JL, 1987, INFECT IMMUN, V55, P2822, DOI 10.1128/IAI.55.11.2822-2829.1987; GELLIN BG, 1989, JAMA-J AM MED ASSOC, V261, P1313, DOI 10.1001/jama.261.9.1313; GRAY ML, 1966, BACTERIOL REV, V30, P309, DOI 10.1128/MMBR.30.2.309-382.1966; JUNTTILA J, 1989, SCAND J INFECT DIS, V21, P339, DOI 10.3109/00365548909035707; KOHLER S, 1990, INFECT IMMUN, V58, P1943; LAMONT RJ, 1988, J INFECTION, V17, P7, DOI 10.1016/S0163-4453(88)92236-0; Lund B. M., 1990, British Food Journal, V92, P13, DOI 10.1108/EUM0000000002318; MCLAUCHLIN J, 1990, EPIDEMIOL INFECT, V104, P181, DOI 10.1017/S0950268800059343; MCLAUCHLIN J, 1986, J MED MICROBIOL, V22, P357, DOI 10.1099/00222615-22-4-357; MCLAUCHLIN J, 1987, J APPL BACTERIOL, V63, P1, DOI 10.1111/j.1365-2672.1987.tb02411.x; MCLAUCHLIN J, 1990, EUR J CLIN MICROBIOL, V9, P210, DOI 10.1007/BF01963840; MCLAUCHLIN J, 1990, EPIDEMIOL INFECT, V104, P191, DOI 10.1017/S0950268800059355; MORRIS IJ, 1989, LANCET, V2, P1285; MOUNIER J, 1990, INFECT IMMUN, V58, P1048, DOI 10.1128/IAI.58.4.1048-1058.1990; Murray EGD, 1926, J PATHOL BACTERIOL, V29, P407, DOI 10.1002/path.1700290409; PIFFARETTI JC, 1989, P NATL ACAD SCI USA, V86, P3818, DOI 10.1073/pnas.86.10.3818; POYARTSALMERON, 1990, LANCET, V335, P1422; ROCOURT J, 1987, INT J SYST BACTERIOL, V37, P298, DOI 10.1099/00207713-37-3-298; SAMUELSSON S, 1990, J INFECTION, V20, P251, DOI 10.1016/0163-4453(90)91244-8; SAUNDERS NA, 1989, ACTA MICROBIOL HUNG, V36, P205; Seeliger H.P.R., 1986, BERGEYS MANUAL SYSTE, P1235; Seeliger H.P.R., 1979, METHOD MICROBIOL, V13, P31, DOI [10.1016/S0580-9517(08)70372-6, DOI 10.1016/S0580-9517(08)70372-6]	32	66	67	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 10	1990	336	8724					1171	1174		10.1016/0140-6736(90)92778-G	http://dx.doi.org/10.1016/0140-6736(90)92778-G			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG701	1978036				2022-12-28	WOS:A1990EG70100013
J	RIGHARD, L; ALADE, MO				RIGHARD, L; ALADE, MO			EFFECT OF DELIVERY ROOM ROUTINES ON SUCCESS OF 1ST BREAST-FEED	LANCET			English	Article									OBAFEMI AWOLOWO UNIV,FAC HLTH SCI,DEPT NURSING,IFE,NIGERIA	Obafemi Awolowo University	RIGHARD, L (corresponding author), LUND UNIV,MALMO GEN HOSP,DEPT PAEDIAT,S-21401 MALMO,SWEDEN.							BELFRAGE P, 1981, ACTA OBSTET GYN SCAN, V60, P43, DOI 10.3109/00016348109154108; BROCKUTNE JG, 1982, S AFR MED J, V62, P985; CALDWELL J, 1978, LIFE SCI, V22, P589, DOI 10.1016/0024-3205(78)90338-7; CARLSSON SG, 1978, DEV PSYCHOBIOL, V11, P143, DOI 10.1002/dev.420110206; DECHATEAU P, 1977, ACTA PAEDIATR SCAND, V66, P145, DOI 10.1111/j.1651-2227.1977.tb07826.x; KLAUS MH, 1972, NEW ENGL J MED, V286, P460, DOI 10.1056/NEJM197203022860904; KUHNERT BR, 1985, ANESTH ANALG, V64, P335; KUHNERT BR, 1985, AM J OBSTET GYNECOL, V151, P410, DOI 10.1016/0002-9378(85)90314-X; MARX GF, 1961, ANESTHESIOLOGY, V22, P294, DOI 10.1097/00000542-196103000-00021; RICHARDS MPM, 1981, NEUROPHARMACOLOGY, V20, P1259; STECHLER G, 1964, SCIENCE, V144, P315, DOI 10.1126/science.144.3616.315; WIDSTROM AM, 1987, ACTA PAEDIATR SCAND, V76, P566, DOI 10.1111/j.1651-2227.1987.tb10522.x; WIMMERPUCHINGER B, 1982, ADV PSYCHOSOMATIC OB, P782	13	242	251	1	15	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 3	1990	336	8723					1105	1107		10.1016/0140-6736(90)92579-7	http://dx.doi.org/10.1016/0140-6736(90)92579-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF992	1977988				2022-12-28	WOS:A1990EF99200012
J	ELLIS, DH; PFEIFFER, TJ				ELLIS, DH; PFEIFFER, TJ			ECOLOGY, LIFE-CYCLE, AND INFECTIOUS PROPAGULE OF CRYPTOCOCCUS-NEOFORMANS	LANCET			English	Editorial Material											ELLIS, DH (corresponding author), ADELAIDE CHILDRENS HOSP INC,DEPT MICROBIOL,MYCOL UNIT,ADELAIDE,SA 5006,AUSTRALIA.		Ellis, David H/B-3677-2011					ALEXOPOULOS CJ, 1962, INTRO MYCOLOGY, P477; BOLLIGER A, 1962, MED J AUSTRALIA, V1, P545, DOI 10.5694/j.1326-5377.1962.tb26113.x; BOOMSMA CD, 1981, NATIVE TREES S AUSTR, P22; CLANCY MN, 1990, J INFECT DIS, V161, P809, DOI 10.1093/infdis/161.4.809; COHEN J, 1982, J INFECTION, V5, P109, DOI 10.1016/S0163-4453(82)91598-5; COHEN J, 1982, LANCET, V2, P1301; ELLIS DH, 1990, J CLIN MICROBIOL, V28, P1642, DOI 10.1128/JCM.28.7.1642-1644.1990; Kwon-Chung K. J., 1984, The yeasts. A taxonomic study, P472; KWONCHUNG KJ, 1982, A VAN LEEUW J MICROB, V48, P25, DOI 10.1007/BF00399484; KWONCHUNG KJ, 1984, ZBL BAKT-INT J MED M, V257, P213, DOI 10.1016/S0174-3031(84)80074-8; KWONCHUNG KJ, 1989, 3RD S TOP MYC MYC AI, P55; OLIVE LINDSAY S., 1968, J ELISHA MITCHELL SCI SOC, V84, P261; Penfold A, 1961, EUCALYPTS; Rippon JW, 1988, MED MYCOLOGY PATHOGE, P582; SMITH JMB, 1989, OPPORTUNISTIC MYCOSE, P53; Staib F., 1987, AIDS-Forschung, V2, P363; Staib F., 1989, AIDS-Forschung, V4, P649	17	187	196	0	25	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 13	1990	336	8720					923	925		10.1016/0140-6736(90)92283-N	http://dx.doi.org/10.1016/0140-6736(90)92283-N			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EC456	1976940				2022-12-28	WOS:A1990EC45600014
J	VANDERLINDEN, PWG; HACK, CE; KERCKHAERT, JAM; STRUYVENBERG, A; VANDERZWAN, JC				VANDERLINDEN, PWG; HACK, CE; KERCKHAERT, JAM; STRUYVENBERG, A; VANDERZWAN, JC			PRELIMINARY-REPORT - COMPLEMENT ACTIVATION IN WASP-STING ANAPHYLAXIS	LANCET			English	Article									NETHERLANDS RED CROSS, BLOOD TRANSFUS SERV, CENT LAB, AMSTERDAM, NETHERLANDS; STATE UNIV UTRECHT HOSP, DEPT MED, 3511 GV UTRECHT, NETHERLANDS	Utrecht University; Utrecht University Medical Center	VANDERLINDEN, PWG (corresponding author), EEMLAND HOSP, DEPT INTERNAL MED, UTRECHTSWEG 160, 3818 ES AMERSFOORT, NETHERLANDS.		Levi, Marcel/AAZ-8559-2020					BLAAUW PJ, 1985, J ALLERGY CLIN IMMUN, V75, P556, DOI 10.1016/0091-6749(85)90029-6; DELBALZO U, 1988, J PHARMACOL EXP THER, V246, P911; Friedberger E, 1910, Z IMMUNITATSFORSCH, V4, P636; GOLDEN DBK, 1989, JAMA-J AM MED ASSOC, V262, P240, DOI 10.1001/jama.262.2.240; HACK CE, 1989, AM J MED, V86, P20, DOI 10.1016/0002-9343(89)90224-6; HAKIM RM, 1984, NEW ENGL J MED, V311, P878, DOI 10.1056/NEJM198410043111403; HUGLI TE, 1981, INT ARCH ALLER A IMM, V66, P113, DOI 10.1159/000232882; JOHNSON AR, 1975, IMMUNOLOGY, V28, P1067; KAMPELMACHER MJ, 1987, CLIN ALLERGY, V17, P317, DOI 10.1111/j.1365-2222.1987.tb02021.x; LEVI R, 1988, CLIN IMMUNOLOGY, V1, P93; LICHTENSTEIN LM, 1979, J ALLERGY CLIN IMMUN, V64, P5, DOI 10.1016/0091-6749(79)90075-7; LOMNITZER R, 1988, CLIN ALLERGY, V18, P39, DOI 10.1111/j.1365-2222.1988.tb02841.x; Mueller H L, 1966, J Asthma Res, V3, P331; NAGATA S, 1987, J ALLERGY CLIN IMMUN, V80, P24, DOI 10.1016/S0091-6749(87)80186-0; POITIER P, 1902, CR SOC BIOL, V54, P170; REISMAN RE, 1975, J ALLERGY CLIN IMMUN, V56, P443, DOI 10.1016/0091-6749(75)90062-7; REISMAN RE, 1987, ANN ALLERGY, V59, P429; SCHWARTZ LB, 1987, NEW ENGL J MED, V316, P1622, DOI 10.1056/NEJM198706253162603; SCHWARTZ LB, 1983, J IMMUNOL, V130, P1891; SCHWARTZ LB, 1989, J CLIN INVEST, V83, P1551, DOI 10.1172/JCI114051; SERAFIN WE, 1987, NEW ENGL J MED, V317, P30, DOI 10.1056/NEJM198707023170106; SETTIPANE GA, 1979, CLIN ALLERGY, V9, P385, DOI 10.1111/j.1365-2222.1979.tb02497.x; SMITH PL, 1980, J CLIN INVEST, V66, P1072, DOI 10.1172/JCI109936; VOGT W, 1986, Complement, V3, P177; WESTABY S, 1985, CARDIOVASC RES, V19, P85, DOI 10.1093/cvr/19.2.85	25	49	49	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 13	1990	336	8720					904	906		10.1016/0140-6736(90)92272-J	http://dx.doi.org/10.1016/0140-6736(90)92272-J			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EC456	1976931				2022-12-28	WOS:A1990EC45600005
J	BARBOUR, VM; WILLIAMS, PF				BARBOUR, VM; WILLIAMS, PF			NEPHROTIC SYNDROME ASSOCIATED WITH SULFASALAZINE	BRITISH MEDICAL JOURNAL			English	Letter											BARBOUR, VM (corresponding author), IPSWICH HOSP,IPSWICH IP4 5PD,ENGLAND.			Barbour, Virginia/0000-0002-2358-2440				DAS KM, 1976, CLIN PHARMACOKINET, V1, P406, DOI 10.2165/00003088-197601060-00002; KLOTZ U, 1985, CLIN PHARMACOKINET, V10, P285, DOI 10.2165/00003088-198510040-00001; NOVIS BH, 1988, BRIT MED J, V296, P1442, DOI 10.1136/bmj.296.6634.1442	3	50	50	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	OCT 6	1990	301	6755					818	818		10.1136/bmj.301.6755.818-b	http://dx.doi.org/10.1136/bmj.301.6755.818-b			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB584	1977483	Green Published, Bronze			2022-12-28	WOS:A1990EB58400048
J	RICHARDS, P				RICHARDS, P			AMERICA THROUGH THE LOOKING-GLASS .2. POSTGRADUATE EDUCATION	LANCET			English	Editorial Material											RICHARDS, P (corresponding author), ST MARYS HOSP,SCH MED,LONDON W2 1PG,ENGLAND.								0	2	2	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 6	1990	336	8719					862	864		10.1016/0140-6736(90)92353-J	http://dx.doi.org/10.1016/0140-6736(90)92353-J			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB901	1976887				2022-12-28	WOS:A1990EB90100015
J	HUGHES, T; GOLDMAN, JM				HUGHES, T; GOLDMAN, JM			IMPROVED RESULTS WITH PCR FOR CHRONIC MYELOID-LEUKEMIA	LANCET			English	Letter											HUGHES, T (corresponding author), ROYAL POSTGRAD MED SCH,DEPT HAEMATOL,LONDON W12 0NN,ENGLAND.							HUGHES T, 1990, LANCET, V335, P1037, DOI 10.1016/0140-6736(90)91102-G; KWOK S, 1989, NATURE, V339, P237, DOI 10.1038/339237a0	2	18	18	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	SEP 29	1990	336	8718					812	812		10.1016/0140-6736(90)93275-T	http://dx.doi.org/10.1016/0140-6736(90)93275-T			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB077	1976169				2022-12-28	WOS:A1990EB07700034
J	SACKMANN, M; PAULETZKI, J; SAUERBRUCH, T; HOLL, J; SCHELLING, G; PAUMGARTNER, G				SACKMANN, M; PAULETZKI, J; SAUERBRUCH, T; HOLL, J; SCHELLING, G; PAUMGARTNER, G			THE MUNICH GALLBLADDER LITHOTRIPSY STUDY - RESULTS OF THE 1ST 5 YEARS WITH 711 PATIENTS	ANNALS OF INTERNAL MEDICINE			English	Article							SHOCK-WAVE LITHOTRIPSY; BILIARY LITHOTRIPSY; MEDICAL DISSOLUTION; URSODEOXYCHOLIC ACID; GALLSTONE RECURRENCE; STONES; FRAGMENTATION; INVITRO; THERAPY; NUMBER	Objective: To evaluate the long-term results of three types of shock wave treatment in patients with radiolucent gallbladder stones. Design: Cohort study. Setting: Single-center trial. Patients: Of 5824 patients with gallstones, 19% were eligible; 711 patients were treated. Interventions: Patients received extracorporeal shock wave lithotripsy as well as adjuvant therapy with bile acids. Results: Lithotripsy was done in three ways, using a water-tank lithotriptor (group A), a water-cushion lithotriptor at low energy levels (group B), and a water-cushion lithotriptor at high energy levels (group C). The rate of complete fragment clearance 9 to 12 months after lithotripsy was done differed significantly among the three groups: Among patients with single stones of 20 mm or less in diameter, the rate of fragment clearance for group A was 76%; for group B, it was 60%; and for group C, it was 83% (P = 0.03). Among patients with single stones of 21 to 30 mm, the rate of fragment clearance for group A was 63%; for group B, it was 32%; and for group C, it was 58% (P < 0.005). Among patients with two or three stones, the rate of fragment clearance for group A was 38%; for group B, it was 16%; and for group C, it was 46% (P = 0.01). Patients with fragments of 3 mm or less 24 hours after lithotripsy was done showed a higher probability of fragment disappearance than did those with larger fragments (P < 0.001). The clearance rate was higher in patients who were compliant than in those who were noncompliant with bile acid therapy (P < 0.001). Adverse effects included liver hematoma in 1 patient, biliary pain attacks in 253 patients (36%), mild biliary pancreatitis in 13 patients (2%), and cholestasis in 7 patients (1%). Elective cholecystectomy was done in 16 patients (2%), and endoscopic sphincterotomy was done in 4 patients (1%). Conclusions: The rate of complete disappearance of stones after shock wave therapy depends on the size and the number of the initial stones, the diameter of the largest fragment, and the mode of shock wave treatment. Adjuvant therapy with bile acids appears to be important for complete fragment clearance.			SACKMANN, M (corresponding author), UNIV MUNICH, KLINIKUM GROSSHADERN, DEPT MED 2, POB 701260, W-8000 MUNICH 70, GERMANY.							ALBERT M B, 1989, Gastroenterology, V96, pA570; BARON RL, 1988, AM J ROENTGENOL, V151, P1123, DOI 10.2214/ajr.151.6.1123; BEHAR J, 1989, GASTROENTEROLOGY, V97, P1479, DOI 10.1016/0016-5085(89)90392-2; BORY RM, 1990, BILIARY LITHOTRIPSY, V2, P89; BRAKEL K, 1990, RADIOLOGY, V174, P337, DOI 10.1148/radiology.174.2.2296642; BRINK JA, 1989, AM J ROENTGENOL, V153, P503, DOI 10.2214/ajr.153.3.503; BRINK JA, 1988, AM J ROENTGENOL, V151, P927, DOI 10.2214/ajr.151.5.927; BRUNNER H, 1989, Gastroenterology, V96, pA580; BURHENNE HJ, 1989, RADIOLOGY, V171, P363, DOI 10.1148/radiology.171.2.2649916; BURNETT D, 1989, DIGEST DIS SCI, V34, P1011, DOI 10.1007/BF01536365; DARZI A, 1990, Gastroenterology, V98, pA581; DELIUS M, 1987, ULTRASOUND MED BIOL, V13, P61, DOI 10.1016/0301-5629(87)90075-5; ELL C, 1988, DEUT MED WOCHENSCHR, V113, P317; ERLINGER S, 1984, HEPATOLOGY, V4, P308, DOI 10.1002/hep.1840040222; FORGACS IC, 1984, GASTROENTEROLOGY, V87, P299; GARRA BS, 1990, RADIOLOGY, V174, P343, DOI 10.1148/radiology.174.2.2404312; GREINER L, 1987, DEUT MED WOCHENSCHR, V112, P1893, DOI 10.1055/s-2008-1068349; HEBERER G, 1989, ADV SURG, V23, P291; HICKMAN MS, 1986, ARCH SURG-CHICAGO, V121, P289; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KISHK SMA, 1987, AM J ROENTGENOL, V148, P875, DOI 10.2214/ajr.148.5.875; LACAINE F, 1989, J LITHOTRIPSY STONE, V1, P209; LANZINI A, 1986, J HEPATOL, V3, P241, DOI 10.1016/S0168-8278(86)80033-2; MAGNUSON TH, 1989, ARCH SURG-CHICAGO, V124, P1195; MATHIESON JR, 1989, AM J ROENTGENOL, V153, P977; MATTHEWS DE, 1988, USING UNDERSTANDING; MOSNIER H, 1989, GASTROEN CLIN BIOL, V13, P482; ODONNELL LDJ, 1988, GUT, V29, P655, DOI 10.1136/gut.29.5.655; OWENS WD, 1978, ANESTHESIOLOGY, V49, P239, DOI 10.1097/00000542-197810000-00003; PONCHON T, 1989, GASTROENTEROLOGY, V97, P457, DOI 10.1016/0016-5085(89)90083-8; RAJAGOPAL S, 1988, GUT, V29, pA1487; RAMBOW A, 1989, DEUT MED WOCHENSCHR, V114, P895, DOI 10.1055/s-2008-1066690; SACKMANN M, 1990, GASTROENTEROLOGY, V98, P392, DOI 10.1016/0016-5085(90)90830-T; SACKMANN M, 1988, NEW ENGL J MED, V318, P393, DOI 10.1056/NEJM198802183180701; SACKMANN M, 1987, ANN INTERN MED, V107, P347, DOI 10.7326/0003-4819-107-2-347; SAUERBRUCH T, 1986, NEW ENGL J MED, V314, P818, DOI 10.1056/NEJM198603273141304; SCHACHLER R, 1988, HEPATOLOGY, V8, P925, DOI 10.1002/hep.1840080437; SCHELLING G, 1989, ANESTHESIOLOGY, V70, P1022, DOI 10.1097/00000542-198906000-00027; SCHELLING G, 1989, J LITHOTR STONE DIS, V1, P218; SCHOENFIELD LJ, 1990, NEW ENGL J MED, V323, P1239, DOI 10.1056/NEJM199011013231804; SPENGLER U, 1989, GASTROENTEROLOGY, V96, P860; SYLWESTROWICZ TA, 1988, GASTROENTEROLOGY, V95, P740, DOI 10.1016/S0016-5085(88)80023-4; VANDERPOOL D, 1989, AM J SURG, V158, P194, DOI 10.1016/0002-9610(89)90251-1; VILLANOVA N, 1989, GASTROENTEROLOGY, V97, P726, DOI 10.1016/0016-5085(89)90644-6	44	151	152	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 15	1991	114	4					290	296		10.7326/0003-4819-114-4-290	http://dx.doi.org/10.7326/0003-4819-114-4-290			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EX521	1987875				2022-12-28	WOS:A1991EX52100007
J	HERMAN, PK; STACK, JH; DEMODENA, JA; EMR, SD				HERMAN, PK; STACK, JH; DEMODENA, JA; EMR, SD			A NOVEL PROTEIN-KINASE HOMOLOG ESSENTIAL FOR PROTEIN SORTING TO THE YEAST LYSOSOME-LIKE VACUOLE	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; N-MYRISTOYLTRANSFERASE; SECRETORY PATHWAY; ESCHERICHIA-COLI; MYRISTOYL-COA; ALPHA-FACTOR; SRC GENE; SEQUENCE; MUTANTS; BINDING	The VPS15 gene encodes a novel protein kinase homolog that is essential for the efficient delivery of soluble hydrolases to the yeast vacuole. Point mutations altering highly conserved residues within the Vps15p kinase domain result in the secretion of multiple vacuolar proteases. In addition, the in vivo phosphorylation of Vps15p is defective in these kinase domain mutants, suggesting that Vps15p may regulate specific protein phosphorylation reactions required for protein sorting to the yeast vacuole. Subcellular fractionation studies further demonstrate that the 1455 amino acid Vps15p is peripherally assoiciated with the cytoplasmic face of a late Golgi or vesicle compartment. This association may be mediated by myristate as Vps15p contains a consensus signal for N-terminal myristoylation. We propose that protein phosphorylation may act as a molecular "switch" within intracellular protein sorting pathways by actively diverting proteins from a default transit pathway (e.g., secretion) to an alternative pathway (e.g., to the vacuole).			HERMAN, PK (corresponding author), CALTECH, DIV BIOL, 147-75, PASADENA, CA 91125 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032703] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-32703] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; BANKAITIS VA, 1986, P NATL ACAD SCI USA, V83, P9075, DOI 10.1073/pnas.83.23.9075; BANTA LM, 1988, J CELL BIOL, V107, P1369, DOI 10.1083/jcb.107.4.1369; BOURNE HR, 1988, CELL, V53, P669, DOI 10.1016/0092-8674(88)90081-5; BRENNER S, 1987, NATURE, V329, P21, DOI 10.1038/329021a0; BRYANT DL, 1984, MOL CELL BIOL, V4, P862, DOI 10.1128/MCB.4.5.862; CARLSON M, 1982, CELL, V28, P145, DOI 10.1016/0092-8674(82)90384-1; CASADABAN MJ, 1980, J MOL BIOL, V138, P179, DOI 10.1016/0022-2836(80)90283-1; CASANOVA JE, 1990, SCIENCE, V248, P742, DOI 10.1126/science.2110383; DEVER TE, 1987, P NATL ACAD SCI USA, V84, P1814, DOI 10.1073/pnas.84.7.1814; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DEVOS AM, 1988, SCIENCE, V239, P888, DOI 10.1126/science.2448879; DIECKMANN CL, 1985, J BIOL CHEM, V260, P1513; EDELMAN AM, 1987, ANNU REV BIOCHEM, V56, P567, DOI 10.1146/annurev.biochem.56.1.567; EMR SD, 1986, J CELL BIOL, V102, P523, DOI 10.1083/jcb.102.2.523; FELDER S, 1990, CELL, V61, P623, DOI 10.1016/0092-8674(90)90474-S; FRANZUSOFF A, 1989, EMBO J, V8, P2695, DOI 10.1002/j.1460-2075.1989.tb08410.x; GALCH WE, 1989, J BIOL CHEM, V264, P16965; GOUD B, 1988, CELL, V53, P753, DOI 10.1016/0092-8674(88)90093-1; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HANKS SK, 1987, P NATL ACAD SCI USA, V84, P388, DOI 10.1073/pnas.84.2.388; HERMAN PK, 1990, MOL CELL BIOL, V10, P6742, DOI 10.1128/MCB.10.12.6742; HONEGGER AM, 1990, J CELL BIOL, V110, P1541, DOI 10.1083/jcb.110.5.1541; HUNTER T, 1987, CELL, V50, P823, DOI 10.1016/0092-8674(87)90509-5; HUNTER T, 1986, ENZYMES, V17, P191; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JOHNSON LM, 1987, CELL, V48, P875, DOI 10.1016/0092-8674(87)90084-5; JONES EW, 1977, GENETICS, V85, P23; JONES SW, 1988, P NATL ACAD SCI USA, V85, P3377, DOI 10.1073/pnas.85.10.3377; JONES TLZ, 1990, P NATL ACAD SCI USA, V87, P568, DOI 10.1073/pnas.87.2.568; JULIUS D, 1984, CELL, V36, P309, DOI 10.1016/0092-8674(84)90224-1; KAPLAN A, 1977, P NATL ACAD SCI USA, V74, P2026, DOI 10.1073/pnas.74.5.2026; KLIONSKY DJ, 1990, J BIOL CHEM, V265, P5349; KLIONSKY DJ, 1988, MOL CELL BIOL, V8, P2105, DOI 10.1128/MCB.8.5.2105; KLIONSKY DJ, 1990, MICROBIOL REV, V54, P266, DOI 10.1128/MMBR.54.3.266-292.1990; KORNFELD S, 1989, ANNU REV CELL BIOL, V5, P483, DOI 10.1146/annurev.cb.05.110189.002411; Krebs EG, 1986, ENZYMES, V17, P3, DOI 10.1016/S1874-6047(08)60426-6; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LACOUR TFM, 1985, EMBO J, V4, P2385, DOI 10.1002/j.1460-2075.1985.tb03943.x; Maniatis T., 1982, MOL CLONING; MCCORMICK F, 1985, SCIENCE, V230, P78, DOI 10.1126/science.3898366; MENDENHALL MD, 1988, P NATL ACAD SCI USA, V85, P4426, DOI 10.1073/pnas.85.12.4426; MONTELL C, 1988, CELL, V52, P757, DOI 10.1016/0092-8674(88)90413-8; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; REIMANN EM, 1984, BIOCHEMISTRY-US, V23, P4185, DOI 10.1021/bi00313a027; RENEKE JE, 1988, CELL, V55, P221, DOI 10.1016/0092-8674(88)90045-1; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; ROTHMAN JH, 1989, EMBO J, V8, P2057, DOI 10.1002/j.1460-2075.1989.tb03614.x; ROTHMAN JH, 1986, CELL, V47, P1041, DOI 10.1016/0092-8674(86)90819-6; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; RUSSELL P, 1987, CELL, V49, P559, DOI 10.1016/0092-8674(87)90458-2; SALMINEN A, 1987, CELL, V49, P527, DOI 10.1016/0092-8674(87)90455-7; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SEGEV N, 1988, CELL, V52, P915, DOI 10.1016/0092-8674(88)90433-3; Sherman F, 1979, METHODS YEAST GENETI; STEVENS T, 1982, CELL, V30, P439, DOI 10.1016/0092-8674(82)90241-0; TAKEYA T, 1983, CELL, V32, P881, DOI 10.1016/0092-8674(83)90073-9; TOWLER DA, 1987, P NATL ACAD SCI USA, V84, P2708, DOI 10.1073/pnas.84.9.2708; TOWLER DA, 1988, J BIOL CHEM, V263, P1784; TOWLER DA, 1988, ANNU REV BIOCHEM, V57, P69, DOI 10.1146/annurev.bi.57.070188.000441; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; USS JE, 1986, J VIROL, V58, P468; VALLS LA, 1987, CELL, V48, P887, DOI 10.1016/0092-8674(87)90085-7; VIDA TA, 1990, IN PRESS J CELL BIOL; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WALWORTH NC, 1989, METHOD CELL BIOL, V31, P335; WICKERHAM LJ, 1946, J BACTERIOL, V52, P293, DOI 10.1128/JB.52.3.293-301.1946	69	176	178	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 25	1991	64	2					425	437		10.1016/0092-8674(91)90650-N	http://dx.doi.org/10.1016/0092-8674(91)90650-N			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EV336	1988155				2022-12-28	WOS:A1991EV33600018
J	HUNTER, T				HUNTER, T			COOPERATION BETWEEN ONCOGENES	CELL			English	Review							PROTEIN KINASE-C; RETINOBLASTOMA GENE-PRODUCT; LARGE-T-ANTIGEN; GROWTH-FACTOR-INDEPENDENCE; MYC TRANSGENIC MICE; H-RAS ONCOGENE; CELL-CYCLE; SARCOMA-VIRUS; MITOGENIC RESPONSE; TUMOR-PROMOTER				HUNTER, T (corresponding author), SALK INST BIOL STUDIES, LA JOLLA, CA 92037 USA.							ABATE C, 1990, SCIENCE, V249, P1157, DOI 10.1126/science.2118682; ABERDAM D, 1991, MOL CELL BIOL, V11, P554, DOI 10.1128/MCB.11.1.554; ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; ADKINS B, 1984, CELL, V39, P439, DOI 10.1016/0092-8674(84)90451-3; ALEMA S, 1985, NATURE, V316, P557, DOI 10.1038/316557a0; ALEXANDER WS, 1989, ONCOGENE, V4, P575; AMBROSIO L, 1989, NATURE, V342, P288, DOI 10.1038/342288a0; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; ARMELIN HA, 1984, NATURE, V310, P655, DOI 10.1038/310655a0; AROIAN RV, 1990, IN PRESS NATURE; BAICHWAL VR, 1990, CELL, V63, P815, DOI 10.1016/0092-8674(90)90147-7; BAKER SJ, 1990, SCIENCE, V249, P912, DOI 10.1126/science.2144057; BALLARD DW, 1990, CELL, V63, P803, DOI 10.1016/0092-8674(90)90146-6; BALLESTER R, 1990, CELL, V63, P851, DOI 10.1016/0092-8674(90)90151-4; BALMAIN A, 1984, NATURE, V307, P658, DOI 10.1038/307658a0; BALMAIN A, 1988, ADV CANCER RES, V51, P147, DOI 10.1016/S0065-230X(08)60222-5; BENBROOK DM, 1990, ONCOGENE, V5, P295; BIGNAMI M, 1988, ONCOGENE, V2, P509; BISCHOFF JR, 1990, P NATL ACAD SCI USA, V87, P4766, DOI 10.1073/pnas.87.12.4766; BISHOP JM, 1991, CELL, V64, P235, DOI 10.1016/0092-8674(91)90636-D; BLACKWELL TK, 1990, SCIENCE, V250, P1149, DOI 10.1126/science.2251503; BOLEN JB, 1987, P NATL ACAD SCI USA, V84, P2251, DOI 10.1073/pnas.84.8.2251; BOS JL, 1988, MUTAT RES, V195, P255, DOI 10.1016/0165-1110(88)90004-8; BOUCHARD L, 1989, CELL, V57, P931, DOI 10.1016/0092-8674(89)90331-0; BOYLE WJ, 1991, IN PRESS CELL, V64; BUCHKOVICH K, 1989, CELL, V58, P1097, DOI 10.1016/0092-8674(89)90508-4; BUTLERGRALLA E, 1981, J CELL PHYSIOL, V107, P59, DOI 10.1002/jcp.1041070108; CAI H, 1990, MOL CELL BIOL, V10, P5314, DOI 10.1128/MCB.10.10.5314; CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G; CARTWRIGHT CA, 1990, P NATL ACAD SCI USA, V87, P558, DOI 10.1073/pnas.87.2.558; CHACKALAPARAMPIL I, 1988, CELL, V52, P801, DOI 10.1016/0092-8674(88)90422-9; CHEN PL, 1989, CELL, V58, P1193, DOI 10.1016/0092-8674(89)90517-5; CHIU R, 1989, CELL, V59, P979, DOI 10.1016/0092-8674(89)90754-X; CHOI PM, 1990, MOL CELL BIOL, V10, P4650, DOI 10.1128/MCB.10.9.4650; CLARKSON B, 1991, HEMATOLOGY, V13, P3; CLURMAN BE, 1989, MOL CELL BIOL, V9, P2657, DOI 10.1128/MCB.9.6.2657; COHEN P, 1990, TRENDS BIOCHEM SCI, V15, P98, DOI 10.1016/0968-0004(90)90192-E; COLE MD, 1986, ANNU REV GENET, V20, P361, DOI 10.1146/annurev.ge.20.120186.002045; COMPERE SJ, 1988, BIOCHIM BIOPHYS ACTA, V948, P129, DOI 10.1016/0304-419X(88)90008-X; COOPER GM, 1990, ONCOGENES; CORY S, 1988, ANNU REV IMMUNOL, V6, P25; COUGHLIN SR, 1985, CELL, V43, P243, DOI 10.1016/0092-8674(85)90029-7; CRABTREE GR, 1989, SCIENCE, V243, P355, DOI 10.1126/science.2783497; CROSS M, 1991, CELL, V64, P271, DOI 10.1016/0092-8674(91)90638-F; DAMM K, 1989, NATURE, V339, P593, DOI 10.1038/339593a0; DETHE H, 1990, NATURE, V347, P558, DOI 10.1038/347558a0; DIAMOND MI, 1990, SCIENCE, V249, P1266, DOI 10.1126/science.2119054; DILLER L, 1990, MOL CELL BIOL, V10, P5772, DOI 10.1128/MCB.10.11.5772; DOLBERG DS, 1984, NATURE, V309, P552, DOI 10.1038/309552a0; DOLBERG DS, 1985, SCIENCE, V230, P676, DOI 10.1126/science.2996144; DOTTO GP, 1988, P NATL ACAD SCI USA, V85, P6389, DOI 10.1073/pnas.85.17.6389; DOTTO GP, 1985, NATURE, V318, P472; DOWNWARD J, 1990, NATURE, V346, P719, DOI 10.1038/346719a0; DRAETTA G, 1990, TRENDS BIOCHEM SCI, V15, P378, DOI 10.1016/0968-0004(90)90235-4; DURKIN JP, 1984, J CELL PHYSIOL, V120, P135, DOI 10.1002/jcp.1041200205; DURKIN JP, 1987, MOL CELL BIOL, V7, P444, DOI 10.1128/MCB.7.1.444; DURKIN JP, 1991, IN PRESS CELL SIGNAL; DURSO G, 1990, SCIENCE, V250, P786, DOI 10.1126/science.2173140; ECKHART W, 1989, ONCOGENES MOL ORIGIN, P223; EISENMAN RN, 1989, ONCOGENES MOL ORIGIN, P175; ELLIS C, 1990, NATURE, V343, P377, DOI 10.1038/343377a0; FEARON ER, 1990, SCIENCE, V247, P49, DOI 10.1126/science.2294591; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; FIELDS S, 1990, SCIENCE, V249, P1046, DOI 10.1126/science.2144363; FINLAY CA, 1989, CELL, V57, P1083, DOI 10.1016/0092-8674(89)90045-7; FISZMAN MY, 1975, NATURE, V254, P429, DOI 10.1038/254429a0; FOKAS AS, 1991, IN PRESS CANCER RES; FORMAN B M, 1990, New Biologist, V2, P587; Frech M, 1990, SCIENCE, V249, P169, DOI 10.1126/science.2164710; FRYKBERG L, 1983, CELL, V32, P227, DOI 10.1016/0092-8674(83)90513-5; FUJII M, 1989, MOL CELL BIOL, V9, P2493, DOI 10.1128/MCB.9.6.2493; GESSLER M, 1990, NATURE, V343, P774, DOI 10.1038/343774a0; GHOSH S, 1990, CELL, V62, P1019, DOI 10.1016/0092-8674(90)90276-K; HAGAG N, 1986, NATURE, V319, P680, DOI 10.1038/319680a0; HALL A, 1990, CELL, V61, P921, DOI 10.1016/0092-8674(90)90054-I; HAN M, 1990, CELL, V63, P921, DOI 10.1016/0092-8674(90)90495-Z; HANAHAN D, 1989, SCIENCE, V246, P1265, DOI 10.1126/science.2686032; HARLOW E, 1986, MOL CELL BIOL, V6, P1579, DOI 10.1128/MCB.6.5.1579; HARRIS H, 1988, CANCER RES, V48, P3302; HARRIS H, 1990, J CELL SCI, V97, P5; HIRAKAWA T, 1988, P NATL ACAD SCI USA, V85, P1519, DOI 10.1073/pnas.85.5.1519; HOLT JT, 1986, P NATL ACAD SCI USA, V83, P4794, DOI 10.1073/pnas.83.13.4794; HOUSEY GM, 1988, CELL, V52, P343, DOI 10.1016/S0092-8674(88)80027-8; HOWE PH, 1991, IN PRESS MOL CELL BI, V11; HSIAO WLW, 1989, MOL CELL BIOL, V9, P2641, DOI 10.1128/MCB.9.6.2641; HUANG HJS, 1988, SCIENCE, V242, P1563, DOI 10.1126/science.3201247; HUNT T, 1989, NATURE, V342, P483, DOI 10.1038/342483a0; HUNTER T, 1989, CELL, V58, P1013, DOI 10.1016/0092-8674(89)90496-0; HUNTER T, 1989, ONCOGENES MOL ORIGIN, P147; IMLER JL, 1988, NATURE, V332, P275, DOI 10.1038/332275a0; IVASHKIV LB, 1990, MOL CELL BIOL, V10, P1609, DOI 10.1128/MCB.10.4.1609; JAMAL S, 1990, NATURE, V344, P463, DOI 10.1038/344463a0; JAT PS, 1989, MOL CELL BIOL, V9, P1672, DOI 10.1128/MCB.9.4.1672; JONAT C, 1990, CELL, V62, P1189, DOI 10.1016/0092-8674(90)90395-U; JONES N, 1990, CELL, V61, P9, DOI 10.1016/0092-8674(90)90207-U; KAELIN WG, 1991, IN PRESS CELL, V64; KAHN P, 1986, CELL, V45, P349, DOI 10.1016/0092-8674(86)90320-X; KAMPS MP, 1990, CELL, V60, P547, DOI 10.1016/0092-8674(90)90658-2; KAMPS MP, 1991, IN PRESS GENES DEV; KAPLAN DR, 1990, CELL, V61, P125, DOI 10.1016/0092-8674(90)90220-9; KERR LD, 1988, SCIENCE, V242, P1424, DOI 10.1126/science.2462278; KIERAN M, 1990, CELL, V62, P1007, DOI 10.1016/0092-8674(90)90275-J; KIPREOS ET, 1990, SCIENCE, V248, P217, DOI 10.1126/science.2183353; KITAYAMA H, 1989, CELL, V56, P77, DOI 10.1016/0092-8674(89)90985-9; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; KOLCH W, 1991, IN PRESS NATURE; KONGSUWAN K, 1989, NUCLEIC ACIDS RES, V17, P1881, DOI 10.1093/nar/17.5.1881; KORETZKY GA, 1990, NATURE, V346, P66, DOI 10.1038/346066a0; KOUZARIDES T, 1989, CANCER CELL-MON REV, V1, P71; KUMAR R, 1990, SCIENCE, V248, P1101, DOI 10.1126/science.2188364; LACAL JC, 1987, MOL CELL BIOL, V7, P4146, DOI 10.1128/MCB.7.11.4146; LAIHO M, 1990, CELL, V62, P175, DOI 10.1016/0092-8674(90)90251-9; LAMPH WW, 1990, P NATL ACAD SCI USA, V87, P4320, DOI 10.1073/pnas.87.11.4320; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; LANE DP, 1990, GENE DEV, V4, P1, DOI 10.1101/gad.4.1.1; LANGDON WY, 1989, ONCOGENE RES, V4, P253; LASSAR AB, 1989, CELL, V58, P659, DOI 10.1016/0092-8674(89)90101-3; LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X; LEVINE AJ, 1990, BIOCHIM BIOPHYS ACTA, V1032, P119, DOI 10.1016/0304-419X(90)90015-S; LEWIN B, 1991, CELL, V64, P303, DOI 10.1016/0092-8674(91)90640-K; LIOTTA LA, 1991, CELL, V64, P327, DOI 10.1016/0092-8674(91)90642-C; LUDLOW JW, 1989, CELL, V56, P57, DOI 10.1016/0092-8674(89)90983-5; LUDLOW JW, 1990, CELL, V60, P387, DOI 10.1016/0092-8674(90)90590-B; MACGREGOR PF, 1990, ONCOGENE, V5, P451; MARSHALL CJ, 1991, CELL, V64, P313, DOI 10.1016/0092-8674(91)90641-B; MARTIN GA, 1990, CELL, V63, P843, DOI 10.1016/0092-8674(90)90150-D; MATSUDA M, 1990, SCIENCE, V248, P1537, DOI 10.1126/science.1694307; MAYER BJ, 1988, NATURE, V332, P272, DOI 10.1038/332272a0; MAYER BJ, 1990, P NATL ACAD SCI USA, V87, P2638, DOI 10.1073/pnas.87.7.2638; MCCORMICK F, 1989, ONCOGENES MOL ORIGIN, P125; MEGIDISH T, 1989, NATURE, V342, P807, DOI 10.1038/342807a0; MERCER WE, 1982, P NATL ACAD SCI-BIOL, V79, P6309, DOI 10.1073/pnas.79.20.6309; MICHALOVITZ D, 1990, CELL, V62, P671, DOI 10.1016/0092-8674(90)90113-S; MIHARA K, 1989, SCIENCE, V246, P1300, DOI 10.1126/science.2588006; MOLLOY CJ, 1989, NATURE, V342, P711, DOI 10.1038/342711a0; MORGAN DO, 1989, CELL, V57, P775, DOI 10.1016/0092-8674(89)90792-7; MORGAN JI, 1989, TRENDS NEUROSCI, V12, P459, DOI 10.1016/0166-2236(89)90096-9; MORRISON DK, 1988, P NATL ACAD SCI USA, V85, P8855, DOI 10.1073/pnas.85.23.8855; MOSES HL, 1990, CELL, V63, P245, DOI 10.1016/0092-8674(90)90155-8; MULCAHY LS, 1985, NATURE, V313, P241, DOI 10.1038/313241a0; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; NAKABEPPU Y, 1988, CELL, V55, P907, DOI 10.1016/0092-8674(88)90146-8; NEIMAN P, 1985, P NATL ACAD SCI USA, V82, P222, DOI 10.1073/pnas.82.1.222; NESS SA, 1989, CELL, V59, P1115, DOI 10.1016/0092-8674(89)90767-8; Newbold R F, 1985, Carcinog Compr Surv, V9, P17; NEWBOLD RF, 1983, NATURE, V304, P648, DOI 10.1038/304648a0; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; NODA M, 1983, P NATL ACAD SCI-BIOL, V80, P5602, DOI 10.1073/pnas.80.18.5602; NODA M, 1985, NATURE, V318, P73, DOI 10.1038/318073a0; NORMAN C, 1988, CELL, V55, P989, DOI 10.1016/0092-8674(88)90244-9; NOURSE J, 1990, CELL, V60, P535, DOI 10.1016/0092-8674(90)90657-Z; NUNN MF, 1989, J VIROL, V63, P398, DOI 10.1128/JVI.63.1.398-402.1989; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; PALLAS DC, 1990, CELL, V60, P167, DOI 10.1016/0092-8674(90)90726-U; PALMIERI S, 1989, CURR TOP MICROBIOL, V148, P43; PARDEE AB, 1989, SCIENCE, V246, P603, DOI 10.1126/science.2683075; PERKINS A, 1990, P NATL ACAD SCI USA, V87, P8398, DOI 10.1073/pnas.87.21.8398; PERSONS DA, 1988, CELL, V52, P447, DOI 10.1016/S0092-8674(88)80037-0; PETO R, 1975, BRIT J CANCER, V32, P411, DOI 10.1038/bjc.1975.242; PIETENPOL JA, 1990, CELL, V61, P777, DOI 10.1016/0092-8674(90)90188-K; PINES J, 1990, NATURE, V346, P760, DOI 10.1038/346760a0; PLEDGER WJ, 1977, P NATL ACAD SCI USA, V74, P4481, DOI 10.1073/pnas.74.10.4481; RASSOULZADEGAN M, 1982, NATURE, V300, P713, DOI 10.1038/300713a0; RAUSCHER FJ, 1990, SCIENCE, V250, P1259, DOI 10.1126/science.2244209; RAYCROFT L, 1990, SCIENCE, V249, P1049, DOI 10.1126/science.2144364; REDDY EP, 1982, NATURE, V300, P149, DOI 10.1038/300149a0; REED JC, 1990, MOL CELL BIOL, V10, P4370, DOI 10.1128/MCB.10.8.4370; RIABOWOL KT, 1988, MOL CELL BIOL, V8, P1670, DOI 10.1128/MCB.8.4.1670; RICHARDSON HE, 1989, CELL, V59, P1127, DOI 10.1016/0092-8674(89)90768-X; RIDLEY AJ, 1988, EMBO J, V7, P1635, DOI 10.1002/j.1460-2075.1988.tb02990.x; ROBBINS PD, 1990, NATURE, V346, P668, DOI 10.1038/346668a0; ROLLINS BJ, 1989, ADV CANCER RES, V53, P1; ROTHBERG PG, 1985, BRIT J CANCER, V52, P629, DOI 10.1038/bjc.1985.237; ROY LM, 1990, CELL, V61, P825, DOI 10.1016/0092-8674(90)90192-H; RUDD CE, 1988, P NATL ACAD SCI USA, V85, P5190, DOI 10.1073/pnas.85.14.5190; RULEY HE, 1983, NATURE, V304, P602, DOI 10.1038/304602a0; RULEY HE, 1990, CANCER CELL-MON REV, V2, P258; RUPPERT JM, 1991, IN PRESS MOL CELL BI, V11; SAGATA N, 1989, NATURE, V342, P512, DOI 10.1038/342512a0; SAGATA N, 1989, SCIENCE, V245, P643, DOI 10.1126/science.2474853; SAGER R, 1989, SCIENCE, V246, P1406, DOI 10.1126/science.2574499; SATOH T, 1990, P NATL ACAD SCI USA, V87, P5993, DOI 10.1073/pnas.87.15.5993; SAWYERS CL, 1991, CELL, V64, P337, DOI 10.1016/0092-8674(91)90643-D; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; SCHER CD, 1979, BIOCHIM BIOPHYS ACTA, V560, P217, DOI 10.1016/0304-419X(79)90020-9; SCHNEIDER C, 1988, CELL, V54, P787, DOI 10.1016/S0092-8674(88)91065-3; SCHONTHAL A, 1988, COLD SPRING HARB SYM, V53, P779, DOI 10.1101/SQB.1988.053.01.088; SCHUH AC, 1990, NATURE, V346, P756, DOI 10.1038/346756a0; SCHULE R, 1990, CELL, V61, P497, DOI 10.1016/0092-8674(90)90531-I; SCHULE R, 1990, CELL, V62, P1217, DOI 10.1016/0092-8674(90)90397-W; SCHUTTE J, 1989, CELL, V59, P987, DOI 10.1016/0092-8674(89)90755-1; SHALLOWAY D, 1990, IN PRESS ADV CANCER; SHENOY S, 1989, CELL, V57, P763, DOI 10.1016/0092-8674(89)90791-5; SINN E, 1987, CELL, V49, P465, DOI 10.1016/0092-8674(87)90449-1; SMITH LJ, 1983, BLOOD, V61, P1138; SMITH MR, 1986, NATURE, V320, P540, DOI 10.1038/320540a0; SPENCER CA, 1990, IN PRESS ADV CANCER; STANBRIDGE EJ, 1981, CANCER RES, V41, P573; STANBRIDGE EJ, 1989, ONCOGENES MOL ORIGIN, P281; STEWART TA, 1984, CELL, V38, P627, DOI 10.1016/0092-8674(84)90257-5; STOKER AW, 1990, J CELL BIOL, V111, P217, DOI 10.1083/jcb.111.1.217; SUGANUMA M, 1988, P NATL ACAD SCI USA, V85, P1768, DOI 10.1073/pnas.85.6.1768; SUKUMAR S, 1990, CANCER CELL-MON REV, V2, P199; SUKUMAR S, 1989, CURR TOP MICROBIOL, V148, P93; SUKUMAR S, 1983, NATURE, V306, P658, DOI 10.1038/306658a0; TABIN CJ, 1982, NATURE, V300, P143, DOI 10.1038/300143a0; TAPAROWSKY E, 1982, NATURE, V300, P762, DOI 10.1038/300762a0; THOMPSON TC, 1989, CELL, V56, P917, DOI 10.1016/0092-8674(89)90625-9; TRAVALI S, 1991, IN PRESS MOL CELL BI, V11; VANETTEN RA, 1989, CELL, V58, P669, DOI 10.1016/0092-8674(89)90102-5; VANLOHUIZEN M, 1989, CELL, V56, P673, DOI 10.1016/0092-8674(89)90589-8; VARMUS H, 1989, ONCOGENES MOL ORIGIN, P3; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; VERBEEK S, 1991, IN PRESS MOL CELL BI, V11; VOGT M, 1986, MOL CELL BIOL, V6, P3545, DOI 10.1128/MCB.6.10.3545; VOGT M, 1987, ONCOGENE RES, V2, P49; VOGT PK, 1990, IN PRESS ADV CANCER; WALTER G, 1990, P NATL ACAD SCI USA, V87, P2521, DOI 10.1073/pnas.87.7.2521; WANG EH, 1989, CELL, V57, P379, DOI 10.1016/0092-8674(89)90913-6; WANG J, 1990, NATURE, V343, P555, DOI 10.1038/343555a0; WEINBERG RA, 1985, SCIENCE, V230, P770, DOI 10.1126/science.2997917; WEINBERG RA, 1989, CANCER RES, V49, P3713; WEINBERG RA, 1989, ONCOGENES MOL ORIGIN, P45; WEINBERG RA, 1989, ONCOGENES MOL ORIGIN, P307; WHYTE P, 1988, NATURE, V334, P124, DOI 10.1038/334124a0; WISDOM R, 1990, MOL CELL BIOL, V10, P5626, DOI 10.1128/MCB.10.11.5626; WOLF D, 1984, CELL, V38, P119, DOI 10.1016/0092-8674(84)90532-4; XU GF, 1990, CELL, V63, P835, DOI 10.1016/0092-8674(90)90149-9; YANAGIHARA K, 1990, ONCOGENE, V5, P1179; YANGYEN HF, 1990, CELL, V62, P1205, DOI 10.1016/0092-8674(90)90396-V; YU CL, 1988, CELL, V52, P63, DOI 10.1016/0092-8674(88)90531-4; YUSPA SH, 1988, ADV CANCER RES, V50, P25, DOI 10.1016/S0065-230X(08)60434-0; ZARBL H, 1985, NATURE, V315, P382, DOI 10.1038/315382a0; ZARBL H, 1987, CELL, V51, P357, DOI 10.1016/0092-8674(87)90632-5; ZENKE M, 1988, CELL, V52, P107, DOI 10.1016/0092-8674(88)90535-1; ZENKE M, 1990, CELL, V61, P1035, DOI 10.1016/0092-8674(90)90068-P; ZERIAL M, 1989, EMBO J, V8, P805, DOI 10.1002/j.1460-2075.1989.tb03441.x	241	798	850	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 25	1991	64	2					249	270		10.1016/0092-8674(91)90637-E	http://dx.doi.org/10.1016/0092-8674(91)90637-E			22	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EV336	1988147				2022-12-28	WOS:A1991EV33600005
J	DELANCEY, JOL; NYGAARD, I				DELANCEY, JOL; NYGAARD, I			EXERCISE-ASSOCIATED URINARY-INCONTINENCE	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter											DELANCEY, JOL (corresponding author), UNIV MICHIGAN,ANN ARBOR,MI 48109, USA.							NYGAARD I, 1990, OBSTET GYNECOL, V75, P848	1	6	6	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	1991	265	4					514	514		10.1001/jama.265.4.514	http://dx.doi.org/10.1001/jama.265.4.514			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ET377	1985240				2022-12-28	WOS:A1991ET37700036
J	PRENDERGAST, GC; ZIFF, EB				PRENDERGAST, GC; ZIFF, EB			METHYLATION-SENSITIVE SEQUENCE-SPECIFIC DNA-BINDING BY THE C-MYC BASIC REGION	SCIENCE			English	Article							MAJOR LATE PROMOTER; TRANSCRIPTION FACTOR; UPSTREAM ELEMENT; ONCOGENE; FOS; DIFFERENTIATION; EXPRESSION; CELLS; JUN; COMMITMENT	The function of the c-Myc oncoprotein and its role in cell growth control is unclear. A basic region of c-Myc is structurally related to the basic motifs of helix-loop-helix (HLH) and leucine zipper proteins, which provide sequence-specific DNA binding function. The c-Myc basic region was tested for its ability to bind DNA by attaching it to the HLH dimerization interface of the E12 enhancer binding factor. Dimers of the chimeric protein, termed E6, specifically bound an E box element (GGCCACGT-GACC) recognized by other HLH proteins in a manner dependent on the integrity of the c-Myc basic motif. Methylation of the core CpG in the E box recognition site specifically inhibited binding by E6, but not by two other HLH proteins. Expression of E6 (but not an E6 DNA binding mutant) suppressed the ability of c-myc to cooperate with H-ras in a rat embryo fibroblast transformation assay, suggesting that the DNA recognition specificity of E6 is related to that of c-Myc in vivo.	NYU,SCH MED,KAPLAN CANC CTR,NEW YORK,NY 10016	New York University	PRENDERGAST, GC (corresponding author), NYU,SCH MED,DEPT BIOCHEM,HOWARD HUGHES MED INST,NEW YORK,NY 10016, USA.			Ziff, Edward/0000-0001-7389-8649				BECKMANN H, 1990, GENE DEV, V4, P167, DOI 10.1101/gad.4.2.167; BESTOR TH, 1990, PHILOS T ROY SOC B, V326, P179, DOI 10.1098/rstb.1990.0002; BLACKWELL TK, COMMUNICATION; CARTHEW RW, 1985, CELL, V43, P439, DOI 10.1016/0092-8674(85)90174-6; CEDAR H, 1988, CELL, V53, P3, DOI 10.1016/0092-8674(88)90479-5; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; COPPOLA JA, 1986, NATURE, V320, P760, DOI 10.1038/320760a0; DANG C, 1989, NATURE, V339, P664; DAVIS RL, 1990, CELL, V60, P733, DOI 10.1016/0092-8674(90)90088-V; DMITROVSKY E, 1986, NATURE, V322, P748, DOI 10.1038/322748a0; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; GREGOR PD, 1990, GENE DEV, V4, P1730, DOI 10.1101/gad.4.10.1730; HANN SR, 1988, CELL, V52, P185, DOI 10.1016/0092-8674(88)90507-7; INGHIRAMI G, 1990, SCIENCE, V250, P682, DOI 10.1126/science.2237417; JONES PA, 1986, CANCER RES, V46, P461; KELEKAR A, 1986, MOL CELL BIOL, V6, P7, DOI 10.1128/MCB.6.1.7; KOUZARIDES T, 1988, NATURE, V336, P646, DOI 10.1038/336646a0; KOUZARIDES T, 1989, NATURE, V340, P568, DOI 10.1038/340568a0; LACHMAN HM, 1986, P NATL ACAD SCI USA, V83, P6480, DOI 10.1073/pnas.83.17.6480; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; MARUYAMA K, 1987, ONCOGENE, V1, P361; MIYAMOTO NG, 1985, EMBO J, V4, P3563, DOI 10.1002/j.1460-2075.1985.tb04118.x; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; NAKABEPPU Y, 1989, EMBO J, V8, P3833, DOI 10.1002/j.1460-2075.1989.tb08561.x; NEUBERG M, 1989, NATURE, V338, P589, DOI 10.1038/338589a0; PRENDERGAST GC, 1989, MOL CELL BIOL, V9, P124, DOI 10.1128/MCB.9.1.124; PRENDERGAST GC, 1989, NATURE, V341, P392, DOI 10.1038/341392a0; PRENDERGAST GC, UNPUB; RULEY HE, 1983, NATURE, V304, P602, DOI 10.1038/304602a0; SAWADOGO M, 1985, CELL, V43, P165, DOI 10.1016/0092-8674(85)90021-2; TURNER R, 1989, SCIENCE, V243, P1689, DOI 10.1126/science.2494701	31	491	504	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JAN 11	1991	251	4990					186	189		10.1126/science.1987636	http://dx.doi.org/10.1126/science.1987636			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET173	1987636				2022-12-28	WOS:A1991ET17300037
J	ORHOLM, M; MUNKHOLM, P; LANGHOLZ, E; NIELSEN, OH; SORENSEN, TIA; BINDER, V				ORHOLM, M; MUNKHOLM, P; LANGHOLZ, E; NIELSEN, OH; SORENSEN, TIA; BINDER, V			FAMILIAL OCCURRENCE OF INFLAMMATORY BOWEL-DISEASE	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							REGIONAL PATIENT GROUP; CROHNS-DISEASE; ULCERATIVE-COLITIS; PREVALENCE; COPENHAGEN; RELATIVES; COUNTY; RISK; PROGNOSIS	Background and Methods. We assessed the familial occurrence in inflammatory bowel disease in Copenhagen County, where there has been a long-term interest in the epidemiology of such disorders. In 1987 we interviewed 662 patients in whom inflammatory bowel disease had been diagnosed before 1979, asking whether their first- and second-degree relatives had this disorder. Ninety-six percent of the patients (504 with ulcerative colitis and 133 with Crohn's disease) provided adequate information. Results. As compared with the general population, the first-degree relatives of the 637 patients with ulcerative colitis or Crohn's disease had a 10-fold increase in the risk of having the same disease as the patients, after standardization for age and sex. The risk of having the other of the two diseases was also increased, but less so, and the increase in the risk of having Crohn's disease was not significant in the relatives of patients with ulcerative colitis. The risk of ulcerative colitis in first-degree relatives of patients with ulcerative colitis appeared to be virtually independent of the generation to which the first-degree relative belonged and of the sex of the patient and the relative. The risk of ulcerative colitis in first-degree relatives tended to be higher if the disease had been diagnosed in the patient before the age of 50, but the risk seemed to be independent of the current age of the relatives. The prevalence of the same disease as that of the patient (either ulcerative colitis or Crohn's disease) among second-degree relatives was increased; the prevalence of the other disease was not increased. Conclusions. The 10-fold increase in the familial risk of ulcerative colitis and Crohn's disease strongly suggests that these disorders have a genetic cause.	UNIV COPENHAGEN,HERLEV HOSP,DEPT MED GASTROENTEROL C,DK-2730 HERLEV,DENMARK	University of Copenhagen; Herlev & Gentofte Hospital			Munkholm, Pia/ABD-2432-2021; Nielsen, Ole Haagen/AAK-2482-2021	Nielsen, Ole Haagen/0000-0003-4612-8635				BINDER V, 1966, Scandinavian Journal of Gastroenterology, V1, P49; BINDER V, 1985, GUT, V26, P146, DOI 10.1136/gut.26.2.146; BINDER V, 1982, GASTROENTEROLOGY, V83, P563; BOTH H, 1983, SCAND J GASTROENTERO, V18, P987, DOI 10.3109/00365528309182127; ELSON CO, 1988, INFLAMM BOWEL DIS, P97; FARMER RG, 1980, CLIN GASTROENTEROL, V9, P271; HAMMER B, 1968, GUT, V9, P17, DOI 10.1136/gut.9.1.17; HENDRIKSEN C, 1985, GUT, V26, P158, DOI 10.1136/gut.26.2.158; KHOURY MJ, 1988, AM J EPIDEMIOL, V127, P674, DOI 10.1093/oxfordjournals.aje.a114842; KIRSNER JB, 1963, ANN INTERN MED, V59, P133, DOI 10.7326/0003-4819-59-2-133; KORELITZ BI, 1981, RECENT ADV CROHNS DI, P208; LANGHOLZ E, 1989, SCAND J GASTROENTE S, V158, P66; LARSEN PM, 1989, SCAND J GASTROENTE S, V158, P67; LASHNER BA, 1986, GASTROENTEROLOGY, V91, P1396, DOI 10.1016/0016-5085(86)90193-9; LEWKONIA RM, 1976, GUT, V17, P235, DOI 10.1136/gut.17.3.235; MAYBERRY JF, 1980, BMJ-BRIT MED J, V1, P84; MCCONNELL RB, 1986, GENETICS EPIDEMIOLOG, V11, P1; MCCONNELL RB, 1980, DEV DIGESTIVE DISEAS, P129; MONSEN U, 1987, SCAND J GASTROENTERO, V22, P214, DOI 10.3109/00365528708991882; ROTH MP, 1989, GASTROENTEROLOGY, V96, P1016, DOI 10.1016/0016-5085(89)91618-1; SHERLOCK P, 1963, GASTROENTEROLOGY, V45, P413; SINGER HC, 1971, GASTROENTEROLOGY, V61, P423; TYSK C, 1988, GUT, V29, P990, DOI 10.1136/gut.29.7.990; WEISS KM, 1982, J CHRON DIS, V35, P539, DOI 10.1016/0021-9681(82)90073-X; WETERMAN IT, 1984, GASTROENTEROLOGY, V86, P449	25	506	529	0	12	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 10	1991	324	2					84	88		10.1056/NEJM199101103240203	http://dx.doi.org/10.1056/NEJM199101103240203			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EQ977	1984188				2022-12-28	WOS:A1991EQ97700003
J	SHIODA, T; LEVY, JA; CHENGMAYER, C				SHIODA, T; LEVY, JA; CHENGMAYER, C			MACROPHAGE AND T-CELL LINE TROPISMS OF HIV-1 ARE DETERMINED BY SPECIFIC REGIONS OF THE ENVELOPE GP120 GENE	NATURE			English	Article							HUMAN IMMUNODEFICIENCY VIRUS; AIDS-ASSOCIATED RETROVIRUS; VARIANTS; TYPE-1; EXPRESSION; SEQUENCES; CAPACITY	Strains of human immunodeficiency virus type 1 (HIV-1) display a high degree of biological heterogeneity which may be linked to certain clinical manifestations of AIDS. They vary in their ability to infect different cell types 1-3, to replicate rapidly and to high titre in culture 4-6, to down-modulate the CD4 receptor 7,8, and to cause cytopathic changes in infected cells 7,9-11. Some of these in vitro properties correlate with pathogenicity of the virus in vivo 11,12. To map the viral determinants of the cellular host range of HIV-1, recombinant viruses were generated between biologically active molecular clones of HIV-1 isolates showing differences in infection of primary peripheral blood macrophages and established T-cell lines. We report here at a specific region of the envelope gp120 gene representing 159 amino-acid residues of glycoprotein gp 120 seems to determine macrophage tropism, whereas an overlapping region representing 321 amino-acid residues determines T cell-line tropism. These studies provide a basis for relating functional domains of the HIV-1 env gene to pathogenic potential.			SHIODA, T (corresponding author), UNIV CALIF SAN FRANCISCO,DEPT MED,CANC RES INST,SAN FRANCISCO,CA 94143, USA.							ASJO B, 1986, LANCET, V2, P660; BERMAN PW, 1988, J VIROL, V62, P3135, DOI 10.1128/JVI.62.9.3135-3142.1988; CASTRO BA, 1988, AIDS, V2, pS17, DOI 10.1097/00002030-198800001-00004; CHENGMAYER C, 1990, J VIROL, V64, P4390, DOI 10.1128/JVI.64.9.4390-4398.1990; CHENGMAYER C, 1988, SCIENCE, V240, P80, DOI 10.1126/science.2832945; CHENGMAYER C, 1987, P NATL ACAD SCI USA, V84, P3526, DOI 10.1073/pnas.84.10.3526; CHENGMAYER C, 1989, P NATL ACAD SCI USA, V86, P8575, DOI 10.1073/pnas.86.21.8575; EMERMAN M, 1989, CELL, V57, P1155, DOI 10.1016/0092-8674(89)90053-6; EVANS LA, 1987, J IMMUNOL, V138, P3415; EVANS LA, 1988, SCIENCE, V240, P1522, DOI 10.1126/science.2836951; FENYO EM, 1988, J VIROL, V62, P4414; FISHER AG, 1988, NATURE, V334, P444, DOI 10.1038/334444a0; GALLAHER WR, 1987, CELL, V50, P327, DOI 10.1016/0092-8674(87)90485-5; HOFFMAN AD, 1985, VIROLOGY, V147, P326, DOI 10.1016/0042-6822(85)90135-7; LASKY LA, 1987, CELL, V50, P975, DOI 10.1016/0092-8674(87)90524-1; LEVY JA, 1984, SCIENCE, V225, P840, DOI 10.1126/science.6206563; LEVY JA, 1986, ANN I PASTEUR, V138, P101; LUCIW PA, 1984, NATURE, V312, P760, DOI 10.1038/312760a0; MODROW S, 1987, J VIROL, V61, P570, DOI 10.1128/JVI.61.2.570-578.1987; ROSEN CA, 1988, P NATL ACAD SCI USA, V85, P2071, DOI 10.1073/pnas.85.7.2071; SANCHEZPESADOR R, 1986, SCIENCE, V227, P484; TATENO M, 1988, VIROLOGY, V167, P299, DOI 10.1016/0042-6822(88)90084-0; TERSMETTE M, 1988, J VIROL, V62, P2026, DOI 10.1128/JVI.62.6.2026-2032.1988; TERSMETTE M, 1989, J VIROL, V63, P2118, DOI 10.1128/JVI.63.5.2118-2125.1989; YORKHIGGINS D, 1990, J VIROL, V64, P4016, DOI 10.1128/JVI.64.8.4016-4020.1990; YOURNO J, 1989, AIDS RES HUM RETROV, V5, P565, DOI 10.1089/aid.1989.5.565	26	521	524	0	5	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JAN 10	1991	349	6305					167	169		10.1038/349167a0	http://dx.doi.org/10.1038/349167a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER418	1986308				2022-12-28	WOS:A1991ER41800062
J	GAFNI, RI				GAFNI, RI			MOTHERHOOD IN MEDICAL-SCHOOL	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article											GAFNI, RI (corresponding author), TEMPLE UNIV,HLTH SCI CTR,SCH MED,PHILADELPHIA,PA 19140, USA.								0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	1991	265	1					116	116		10.1001/jama.265.1.116	http://dx.doi.org/10.1001/jama.265.1.116			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EP555	1984109				2022-12-28	WOS:A1991EP55500042
J	GRISSO, JA; HANSEN, L; ZELLING, I; BICKEL, J; EISENBERG, JM				GRISSO, JA; HANSEN, L; ZELLING, I; BICKEL, J; EISENBERG, JM			PARENTAL LEAVE POLICIES FOR FACULTY IN UNITED-STATES MEDICAL-SCHOOLS	ANNALS OF INTERNAL MEDICINE			English	Article							WOMEN; PHYSICIANS; PREGNANCY; CAREER	Objective: To assess medical school policies for maternity and other parental leaves as well as related opportunities for part-time employment, flexibility in tenure systems, and the availability of child care centers. Design: Cross-sectional survey of all 127 U.S. medical schools based on telephone interviews and review of faculty handbooks. Measurements and Main Results: Ninety-three percent of medical schools responded. Twenty-two percent of medical schools have no written guidelines for maternity leave, 45% categorize maternity leave as a form of sick or disability leave, and only 34% have developed specific policies. Most schools (61%) require that maternity leave be taken from allotted sick days or from vacation days (or from both) for women to obtain salary support. The time available from sick and vacation leave averages 6.8 weeks. Although 72% of schools make allowances in the tenure probationary period for extended leaves of absence, few have developed specific provisions for childbearing or childrearing. Finally, 18% of medical schools have child care facilities. Conclusions: Considerable work is needed to develop adequate support for faculty members who are parents. Recommendations include developing specific parental leave policies and flexible tenure systems and providing adequate child care facilities.	ASSOC AMER MED COLL, WASHINGTON, DC 20036 USA	Association of American Medical Colleges	GRISSO, JA (corresponding author), UNIV PENN, SCH MED, DEPT MED, CLIN EPIDEMIOL UNIT, 317R NEB-6095, PHILADELPHIA, PA 19104 USA.							BICKEL J, 1988, NEW ENGL J MED, V319, P1579, DOI 10.1056/NEJM198812153192405; FRANCO K, 1983, AM J PSYCHIAT, V140, P902; LEVINSON W, 1989, NEW ENGL J MED, V321, P1511, DOI 10.1056/NEJM198911303212205; MYERS MF, 1988, DOCTORS MARRIAGES LO, P55; PARKER G, 1981, BRIT J MED PSYCHOL, V54, P143, DOI 10.1111/j.2044-8341.1981.tb01443.x; SAYRES M, 1986, NEW ENGL J MED, V314, P418, DOI 10.1056/NEJM198602133140705; SINAL S, 1988, J MED EDUC, V63, P531; WHITE LJ, 1989, ANN INTERN MED, V111, P1035; WHITING BE, 1990, ACAD MED, V65, P277, DOI 10.1097/00001888-199004000-00013; WILSON MP, 1987, YALE J BIOL MED, V60, P273; 1989, EMPLOYERS CHILD CARE	11	12	12	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 1	1991	114	1					43	45		10.7326/0003-4819-114-1-43	http://dx.doi.org/10.7326/0003-4819-114-1-43			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EQ040	1983931				2022-12-28	WOS:A1991EQ04000007
J	STEIN, JH				STEIN, JH			GRAND CRU VERSUS GENERIC - DIFFERENT APPROACHES TO ALTERING THE RATIO OF GENERAL INTERNISTS TO SUBSPECIALISTS	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							FAMILY-PRACTICE; PRIMARY CARE; MEDICINE; PHYSICIAN; MANPOWER	In the last decade internal medicine has become a less popular career choice among medical school graduates. In addition, there has been an increase in the percentage of internal medicine residents choosing subspecialty training. The factors that have led to the change in the ratio of subspecialists to general internists are discussed, and a plan is proposed that would make the practice of general internal medicine more attractive and reduce the number of subspecialty training positions in the United States.			STEIN, JH (corresponding author), UNIV TEXAS, HLTH SCI CTR, DEPT MED, 7703 FLOYD CURL DR, SAN ANTONIO, TX 78284 USA.							AIKEN LH, 1979, NEW ENGL J MED, V300, P1363, DOI 10.1056/NEJM197906143002404; ALPERT JL, PHS DHEW HRA743113 B; CHRISTIANSEN RG, 1986, JAMA-J AM MED ASSOC, V255, P2628, DOI 10.1001/jama.255.19.2628; FLEXNER A, 1910, B CARNEGIE F ADV TEA, V4; FRIEDMAN RH, 1985, ANN INTERN MED, V103, P439, DOI 10.7326/0003-4819-103-3-439; GEYMAN JP, 1986, JAMA-J AM MED ASSOC, V255, P2631, DOI 10.1001/jama.255.19.2631; GOROLL AH, 1987, PRIMARY CARE MED OFF; KLETKE PR, 1987, ANN INTERN MED, V107, P93, DOI 10.7326/0003-4819-107-1-93; PETERSDORF RG, 1975, NEW ENGL J MED, V293, P326, DOI 10.1056/NEJM197508142930704; PETERSDORF RG, 1983, NEW ENGL J MED, V309, P1053, DOI 10.1056/NEJM198310273091711; SCHROEDER SA, 1987, ANN INTERN MED, V106, P768, DOI 10.7326/0003-4819-106-5-768; SCHROEDER SA, 1984, JAMA-J AM MED ASSOC, V252, P373, DOI 10.1001/jama.252.3.373; SPIEGEL JS, 1983, NEW ENGL J MED, V308, P1208, DOI 10.1056/NEJM198305193082007; WEIL PA, 1981, ANN INTERN MED, V94, P678, DOI 10.7326/0003-4819-94-5-678; WHITE KL, 1961, NEW ENGL J MED, V265, P885, DOI 10.1056/NEJM196111022651805; WHITE WA, 1926, MEANING DISEASE, P1; Willard W, 1966, M CHALLENGE FAMILY P; 1975, ANN INTERN MED, V82, P707; 1966, GRADUATE ED PHYSICIA	19	22	22	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 1	1991	114	1					79	82		10.7326/0003-4819-114-1-79	http://dx.doi.org/10.7326/0003-4819-114-1-79			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EQ040	1983939				2022-12-28	WOS:A1991EQ04000014
J	FELDMAN, M; BURTON, ME				FELDMAN, M; BURTON, ME			DRUG-THERAPY - HISTAMINE2-RECEPTOR ANTAGONISTS - STANDARD THERAPY FOR ACID-PEPTIC DISEASES .2.	NEW ENGLAND JOURNAL OF MEDICINE			English	Review									VET AFFAIRS MED CTR, CLIN PHARMACOL SECT, DALLAS, TX 75216 USA; UNIV TEXAS, COLL PHARM, AUSTIN, TX 78712 USA; UNIV TEXAS, SW MED CTR, DEPT INTERNAL MED, DALLAS, TX 75230 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Texas System; University of Texas Austin; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	FELDMAN, M (corresponding author), VET AFFAIRS MED CTR, MED SERV, 111, 4500 S LANCASTER RD, DALLAS, TX 75216 USA.				NIDDK NIH HHS [R01 DK16816] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK016816] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALCALASANTAELLA R, 1989, DIGESTION, V42, P79, DOI 10.1159/000199829; ANDERSON W, 1988, GASTROENTEROLOGY, V95, P195, DOI 10.1016/0016-5085(88)90311-3; ASHTON MG, 1982, BRIT MED J, V284, P467, DOI 10.1136/bmj.284.6314.467; BARDHAN K D, 1979, Gut, V20, P68; BEHAR J, 1978, GASTROENTEROLOGY, V74, P441; BENNETT JR, 1983, DIGESTION, V26, P166, DOI 10.1159/000198884; BORRERO E, 1984, AM J SURG, V148, P809, DOI 10.1016/0002-9610(84)90443-4; BORRERO E, 1986, ARCH SURG-CHICAGO, V121, P810; BRAZER SR, 1989, DIGEST DIS SCI, V34, P1047, DOI 10.1007/BF01536372; BREEN KJ, 1983, MED J AUSTRALIA, V2, P555, DOI 10.5694/j.1326-5377.1983.tb122675.x; CANNON LA, 1987, ARCH INTERN MED, V147, P2101, DOI 10.1001/archinte.147.12.2101; CERULLI MA, 1987, SCAND J GASTROENTERO, V22, P79, DOI 10.3109/00365528709094490; CHERNER JA, 1988, GASTROENTEROLOGY, V95, P657, DOI 10.1016/S0016-5085(88)80012-X; CLOUD ML, 1987, SCAND J GASTROENTERO, V22, P29, DOI 10.3109/00365528709094483; COLLINS R, 1985, NEW ENGL J MED, V313, P660, DOI 10.1056/NEJM198509123131104; COOPER BT, 1987, J CLIN GASTROENTEROL, V9, P139, DOI 10.1097/00004836-198704000-00006; DELATTRE M, 1985, CURR THER RES CLIN E, V37, P677; DRIKS MR, 1987, NEW ENGL J MED, V317, P1376, DOI 10.1056/NEJM198711263172204; DUMOULIN GC, 1982, LANCET, V1, P242; EHSANULLAH RSB, 1988, BRIT MED J, V297, P1017, DOI 10.1136/bmj.297.6655.1017; FARUP PG, 1990, SCAND J GASTROENTERO, V25, P315, DOI 10.1080/00365521.1990.12067110; FIASSE R, 1980, DIGEST DIS SCI, V25, P750, DOI 10.1007/BF01345293; FRANK WO, 1989, CLIN THER, V11, P595; FRANK WO, 1989, ALIMENT PHARM THERAP, V3, P573; Gitlin N, 1987, GASTROENTEROLOGY, V92, P48, DOI 10.1016/0016-5085(87)90838-9; GOY JA, 1983, MED J AUSTRALIA, V2, P558, DOI 10.5694/j.1326-5377.1983.tb122676.x; GRAHAM DY, 1985, ANN INTERN MED, V102, P573, DOI 10.7326/0003-4819-102-5-573; GUSTAVSSON S, 1986, DIGEST DIS SCI, V31, P2, DOI 10.1007/BF01347901; HAVELUND T, 1988, BRIT MED J, V296, P89, DOI 10.1136/bmj.296.6615.89; HINE KR, 1984, DIGESTION, V29, P119, DOI 10.1159/000199020; HOGAN WJ, 1989, GASTROINTESTINAL DIS, V1, P594; HOWARD JM, 1985, GASTROENTEROLOGY, V88, P1026, DOI 10.1016/S0016-5085(85)80024-X; HOWDEN CW, 1990, ALIMENT PHARM THERAP, V4, P25; HUMPHRIES TJ, 1987, J CLIN GASTROENTEROL, V9, P28, DOI 10.1097/00004836-198702000-00007; JENSEN D M, 1990, Gastroenterology, V98, pA65; JOHNSON NJ, 1989, ALIMENT PHARM THERAP, V3, P259; Karlstadt R, 1989, AM J GASTROENTEROL, V84, P1162; KARLSTADT RG, 1990, J INTENSIVE CARE MED, V5, P26, DOI DOI 10.1177/088506669000500106; KINGSLEY AN, 1985, AM SURGEON, V51, P545; KOELZ HR, 1986, GASTROENTEROLOGY, V91, P1198, DOI 10.1016/S0016-5085(86)80017-8; LAGGNER AN, 1989, AM J MED, V86, P81, DOI 10.1016/0002-9343(89)90164-2; LANCE P, 1983, BRIT MED J, V286, P937, DOI 10.1136/bmj.286.6369.937-a; LEGERTON CW, 1984, AM J MED, V77, P2; LEPSIEN G, 1979, DEUT MED WOCHENSCHR, V104, P901, DOI 10.1055/s-0028-1104011; LIEBERMAN DA, 1986, ANN INTERN MED, V104, P21, DOI 10.7326/0003-4819-104-1-21; LUNDELL L, 1990, ALIMENT PHARM THERAP, V4, P145; MCARTHUR KE, 1987, GASTROENTEROLOGY, V93, P69, DOI 10.1016/0016-5085(87)90316-7; MCCARTHY DM, 1989, GASTROENTEROLOGY, V96, P662, DOI 10.1016/S0016-5085(89)80063-0; Miller T A, 1987, Am J Med, V83, P8, DOI 10.1016/0002-9343(87)90805-9; NACCARATTO R, 1987, SCAND J GASTROENTERO, V22, P71, DOI 10.3109/00365528709094489; OSTRO MJ, 1985, GASTROENTEROLOGY, V89, P532, DOI 10.1016/0016-5085(85)90447-0; PAGE MC, 1989, ALIMENT PHARM THERAP, V3, P425; Peura D A, 1987, Am J Med, V83, P3, DOI 10.1016/0002-9343(87)90804-7; POLESKI MH, 1986, AM J GASTROENTEROL, V81, P107; PORRO GB, 1990, GUT, V31, P397, DOI 10.1136/gut.31.4.397; POWELLJACKSON P, 1978, LANCET, V2, P1068; PRIEBE HJ, 1980, NEW ENGL J MED, V302, P426, DOI 10.1056/NEJM198002213020802; QUIK RFP, 1990, ALIMENT PHARM THERAP, V4, P201; RICHARDSON CT, 1976, NEW ENGL J MED, V294, P133, DOI 10.1056/NEJM197601152940304; RICHARDSON CT, 1985, GASTROENTEROLOGY, V89, P357, DOI 10.1016/0016-5085(85)90337-3; RICHARDSON CT, 1989, GASTROINTESTINAL DIS, V1, P879; ROBERT A, 1989, GASTROINTESTINAL DIS, V1, P772; ROBINSON MG, 1989, DIGEST DIS SCI, V34, P424, DOI 10.1007/BF01536266; ROHNER HG, 1986, AM J MED, V81, P13, DOI 10.1016/0002-9343(86)90595-4; SAMPLINER RE, 1990, DIGEST DIS SCI, V35, P93, DOI 10.1007/BF01537229; SANDMARK S, 1988, SCAND J GASTROENTERO, V23, P625, DOI 10.3109/00365528809093923; SCHAUB N, 1986, HEPATO-GASTROENTEROL, V33, P208; SCHILLER LR, 1986, GASTROENTEROLOGY, V90, P478, DOI 10.1016/0016-5085(86)90950-9; SHUMAN RB, 1987, ANN INTERN MED, V106, P562, DOI 10.7326/0003-4819-106-4-562; SIMON B, 1985, DIGESTION, V32, P32, DOI 10.1159/000199259; SIMON B, 1987, SCAND J GASTROENTERO, V22, P61, DOI 10.3109/00365528709094488; SOLL AH, 1989, GASTROINTESTINAL DIS, V1, P814; SONTAG S, 1987, ARCH INTERN MED, V147, P1485, DOI 10.1001/archinte.147.8.1485; TAKEMOTO T, 1989, GUT, V30, P1692, DOI 10.1136/gut.30.12.1692; TEXTER EC, 1986, AM J MED, V81, P25, DOI 10.1016/0002-9343(86)90597-8; THIRLBY RC, 1989, GASTROINTESTINAL DIS, V1, P952; TRYBA M, 1985, AM J MED, V79, P55, DOI 10.1016/0002-9343(85)90574-1; TRYBA M, 1987, AM J MED, V83, P117, DOI 10.1016/0002-9343(87)90840-0; VANDEVENTER GM, 1989, NEW ENGL J MED, V320, P1113, DOI 10.1056/NEJM198904273201704; WALAN A, 1989, NEW ENGL J MED, V320, P69, DOI 10.1056/NEJM198901123200201; WALT RP, 1981, GUT, V22, P319, DOI 10.1136/gut.22.4.319; WESDORP E, 1978, GASTROENTEROLOGY, V74, P821; WESDORP ICE, 1983, GUT, V24, P921, DOI 10.1136/gut.24.10.921; WILCOX CM, 1988, AM J GASTROENTEROL, V83, P1199; YOUNG MD, 1989, CLIN THER, V11, P529; ZUCKERMAN G, 1984, AM J MED, V76, P361, DOI 10.1016/0002-9343(84)90652-1; 1989, SCAND J GASTROENTE S, V168, P1	87	113	113	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 20	1990	323	25					1749	1755						7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EN375	1978926				2022-12-28	WOS:A1990EN37500007
J	VIJAYARAGHAVAN, K; RADHAIAH, G; PRAKASAM, BS; SARMA, KVR; REDDY, V				VIJAYARAGHAVAN, K; RADHAIAH, G; PRAKASAM, BS; SARMA, KVR; REDDY, V			EFFECT OF MASSIVE DOSE VITAMIN-A ON MORBIDITY AND MORTALITY IN INDIAN CHILDREN	LANCET			English	Article											VIJAYARAGHAVAN, K (corresponding author), NATL INST NUTR,HYDERABAD 500007,ANDHRA PRADESH,INDIA.							GOPALAN C, 1986, NFI B, V7, P6; MAMDANI M, 1988, EPC PUBLICATIO, V19, P36; MENON K, 1980, AM J CLIN NUTR, V33, P218, DOI 10.1093/ajcn/33.2.218; MILTON RC, 1987, AM J CLIN NUTR, V46, P827, DOI 10.1093/ajcn/46.5.827; SOMMER A, 1986, LANCET, V1, P1169; SOMMER A, 1984, AM J CLIN NUTR, V40, P1090, DOI 10.1093/ajcn/40.5.1090; SOMMER A, 1983, LANCET, V2, P585; SOMMER A, 1981, LANCET, V1, P1407; SOMMER A, 1982, NUTRITIONAL BLINDNES; TARWOTJO I, 1987, AM J CLIN NUTR, V45, P1466, DOI 10.1093/ajcn/45.6.1466; VIJAYARAGHAVAN K, 1985, Indian Pediatrics, V22, P669; WILHELM DL, 1954, J PATHOL BACTERIOL, V67, P361, DOI 10.1002/path.1700670209	12	140	143	0	3	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	DEC 1	1990	336	8727					1342	1345		10.1016/0140-6736(90)92895-O	http://dx.doi.org/10.1016/0140-6736(90)92895-O			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL365	1978164				2022-12-28	WOS:A1990EL36500004
J	TROUWBORST, A; VANWOERKENS, ECSM; VANDAELE, M; TENBRINCK, R				TROUWBORST, A; VANWOERKENS, ECSM; VANDAELE, M; TENBRINCK, R			ACUTE HYPERVOLEMIC HEMODILUTION TO AVOID BLOOD-TRANSFUSION DURING MAJOR SURGERY	LANCET			English	Article									ERASMUS UNIV,UNIV HOSP DIJKZIGT,DEPT CARDIOL,3015 GD ROTTERDAM,NETHERLANDS	Erasmus University Rotterdam; Erasmus MC	TROUWBORST, A (corresponding author), ERASMUS UNIV,UNIV HOSP DIJKZIGT,DEPT ANAESTHESIOL,DR MOLEWATERPLEIN 40,3015 GD ROTTERDAM,NETHERLANDS.							BAY J, 1968, BRIT J ANAESTH, V40, P398, DOI 10.1093/bja/40.6.398; CUTLER BS, 1984, SURGERY, V95, P717; DIXON JL, 1981, JAMA-J AM MED ASSOC, V246, P2471, DOI 10.1001/jama.246.21.2471; HEILMANN L, 1983, INFUS KLIN ERN, V10, P311; MESSMER K, 1986, EUR SURG RES, V18, P254, DOI 10.1159/000128533; NADLER SB, 1962, SURGERY, V51, P224; SINGH SK, 1987, EUR J CANCER CLIN ON, V23, P1537, DOI 10.1016/0277-5379(87)90097-6; TOY PTCY, 1987, NEW ENGL J MED, V316, P517, DOI 10.1056/NEJM198702263160906; TROUWBORST A, 1990, BRIT J ANAESTH, V64, P646, DOI 10.1093/bja/64.5.646; TROUWBORST A, 1990, ANESTH ANALG, V70, P523; WOOD JH, 1982, JAMA-J AM MED ASSOC, V248, P299; ZETTERSTROM H, 1986, ACTA ANAESTH SCAND, V30, P300, DOI 10.1111/j.1399-6576.1986.tb02418.x	12	49	68	0	3	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 24	1990	336	8726					1295	1297		10.1016/0140-6736(90)92973-L	http://dx.doi.org/10.1016/0140-6736(90)92973-L			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ943	1978123	Green Submitted			2022-12-28	WOS:A1990EJ94300012
J	RIFAT, SL; EASTWOOD, MR; MCLACHLAN, DRC; COREY, PN				RIFAT, SL; EASTWOOD, MR; MCLACHLAN, DRC; COREY, PN			EFFECT OF EXPOSURE OF MINERS TO ALUMINUM POWDER	LANCET			English	Article									UNIV TORONTO, DEPT PSYCHIAT, TORONTO M5S 1A1, ONTARIO, CANADA; UNIV TORONTO, DEPT PREVENT MED & BIOSTAT, TORONTO M5S 1A1, ONTARIO, CANADA; UNIV TORONTO, CTR RES NEURODEGENERAT DIS, TORONTO M5S 1A1, ONTARIO, CANADA	University of Toronto; University of Toronto; University of Toronto								ALFREY AC, 1976, NEW ENGL J MED, V294, P184, DOI 10.1056/NEJM197601222940402; ALFREY AC, 1989, ALUMINUM HLTH CRITIC, P101; BOEGMAN RJ, 1984, CAN J PHYSIOL PHARM, V62, P1010, DOI 10.1139/y84-170; CANDY JM, 1986, LANCET, V1, P354; CRAPPER DR, 1973, PHYSIOL BEHAV, V10, P925, DOI 10.1016/0031-9384(73)90063-2; Denny JJ, 1939, CAN MED ASSOC J, V40, P213; Dix WB., 1975, BRIEF ROYAL COMMISSI; FLATEN TP, 1986, THESIS U TRONDHEIM T; FOLSTEIN M, 1985, J AM GERIATR SOC, V33, P228, DOI 10.1111/j.1532-5415.1985.tb07109.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GANROT PO, 1986, ENVIRON HEALTH PERSP, V65, P363, DOI 10.2307/3430204; Gent M., 1980, REPORT SCI TASK FORC; LONGSTRETH WT, 1985, ARCH INTERN MED, V145, P1972, DOI 10.1001/archinte.145.11.1972; MARTYN CN, 1989, LANCET, V1, P59; MCLACHLAN DRC, 1986, NEUROBIOL AGING, V7, P525; MCLAUGHLIN AIG, 1962, BRIT J IND MED, V19, P253; MICHEL P, 1990, 2ND INT C ALZH DIS R; Muller J., 1983, STUDY MORTALITY ON 1; Muller J., 1986, STUDY MORTALITY ON 2; Newkirk TE, 1972, STANDARD PRACTICES P; NEWKIRK TE, 1956, PHYSICAL CHEM CHARAC; PERL DP, 1980, SCIENCE, V208, P297, DOI 10.1126/science.7367858; PERL DP, 1987, LANCET, V1, P1028; PFEFFER RI, 1984, AM J EPIDEMIOL, V120, P922, DOI 10.1093/oxfordjournals.aje.a113963; RAVEN JC, 1986, MANUAL RAVENS COLOUR; Smith A., 1982, SYMBOL DIGIT MODALIT; SOLOMON PR, 1988, NEUROTOXICOLOGY, V9, P443; WISNIEWSKI HM, 1989, ALUMINUM HLTH CRITIC, P125	28	192	197	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 10	1990	336	8724					1162	1165		10.1016/0140-6736(90)92775-D	http://dx.doi.org/10.1016/0140-6736(90)92775-D			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG701	1978033				2022-12-28	WOS:A1990EG70100010
J	COMFORT, A				COMFORT, A			IN MY BEGINNING IS MY END	LANCET			English	Editorial Material																		DINAN TG, 1989, ACTA PSYCHIAT SCAND, V80, P97, DOI 10.1111/j.1600-0447.1989.tb01306.x; LEWIS N, 1954, DEPRESSION; PARE CMB, 1982, LANCET, V2, P183	3	1	1	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 27	1990	336	8722					1052	1052						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF076	1977032				2022-12-28	WOS:A1990EF07600017
J	WHITTLE, HC; CAMPBELL, H; RAHMAN, S; ARMSTRONG, JRM				WHITTLE, HC; CAMPBELL, H; RAHMAN, S; ARMSTRONG, JRM			ANTIBODY PERSISTENCE IN GAMBIAN CHILDREN AFTER HIGH-DOSE EDMONSTON-ZAGREB MEASLES-VACCINE	LANCET			English	Article											WHITTLE, HC (corresponding author), MRC LABS,POB 273,BANJUL,SENEGAMBIA.		Campbell, Harry/E-2959-2010	Campbell, Harry/0000-0002-6169-6262				AABY J, 1988, LANCET, V2, P809; MARKOWITZ LE, 1990, NEW ENGL J MED, V322, P580, DOI 10.1056/NEJM199003013220903; TIDJANI O, 1989, LANCET, V2, P1357; WHITTLE H, 1988, LANCET, V2, P811; WHITTLE HC, 1988, LANCET, V1, P963; 1990, WHO WEEKLY EPIDEM RE, V2, P6	6	49	49	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 27	1990	336	8722					1046	1048		10.1016/0140-6736(90)92501-8	http://dx.doi.org/10.1016/0140-6736(90)92501-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF076	1977029				2022-12-28	WOS:A1990EF07600014
J	BLAKELEY, D; TOLLIDAY, B; COLACO, C; ROSER, B				BLAKELEY, D; TOLLIDAY, B; COLACO, C; ROSER, B			DRY INSTANT BLOOD TYPING PLATE FOR BEDSIDE USE	LANCET			English	Article									QUADRANT RES FDN,CAMBRIDGE RES LABS,181A HUNTINGDON RD,CAMBRIDGE CB3 0DJ,ENGLAND; ADDENBROOKES HOSP,DEPT HAEMATOL,TRANSFUS LAB,CAMBRIDGE CB2 2QQ,ENGLAND; UNIV CAMBRIDGE,SCH MED,DEPT CLIN BIOCHEM,CAMBRIDGE,ENGLAND	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge				Roser, Bruce/0000-0003-4773-4995				CROWE JH, 1987, BIOCHEM J, V242, P1, DOI 10.1042/bj2420001; HONIG CL, 1980, TRANSFUSION, V20, P653, DOI 10.1046/j.1537-2995.1980.20681057154.x; KOPEC AC, 1970, DISTRIBUTION BLOOD G; VOAK D, 1990, CLIN HAEMATOL, V3, P219	4	22	27	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 6	1990	336	8719					854	855		10.1016/0140-6736(90)92349-M	http://dx.doi.org/10.1016/0140-6736(90)92349-M			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB901	1976884				2022-12-28	WOS:A1990EB90100012
J	HANZLICK, R; GOWITT, GT				HANZLICK, R; GOWITT, GT			COCAINE METABOLITE DETECTION IN HOMICIDE VICTIMS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Note							COUNTY; DEATHS; EPIDEMIC; HUMANS; ABUSE	We analyzed the blood of homicide victims for the presence of cocaine's major metabolite, benzoylecgonine. During 1989 in Fulton County, Georgia, 81% of 275 homicide victims were tested for benzoylecgonine; 40% tested positive. The proportions of blacks and victims of firearm injuries who tested positive for benzoylecgonine were significantly larger than the respective proportions for whites and victims of injuries not involving firearms. The data show overall proportions of benzoylecgonine positivity much larger than those previously reported in the literature. The relationships between homicide, race, firearms, and cocaine use deserve further study.			HANZLICK, R (corresponding author), OFF MED EXAMINER FULTON CTY,50 COCA COLA PL SE,ATLANTA,GA 30303, USA.							BAILEY DN, 1989, J FORENSIC SCI, V34, P407; BASELT RC, 1982, DISPOSITION TOXIC DR, P193; CREGLER LL, 1986, NEW ENGL J MED, V315, P1495, DOI 10.1056/NEJM198612043152327; FAIRBANKS DNF, 1983, ANN PLAS SURG, V10, P452, DOI 10.1097/00000637-198306000-00003; HAMILTON HE, 1977, J FORENSIC SCI, V22, P697; HARRUFF RC, 1988, J FORENSIC SCI, V33, P1231; ISNER JM, 1986, NEW ENGL J MED, V315, P1438, DOI 10.1056/NEJM198612043152302; JEFFCOAT AR, 1989, DRUG METAB DISPOS, V17, P153; LOWRY PW, 1988, AM J EPIDEMIOL, V128, P1130; ROGERS JN, 1986, J FORENSIC SCI, V31, P1404; SANDER R, 1985, J FORENSIC SCI, V30, P478; TARDIFF K, 1989, J FORENSIC SCI, V34, P53; WETLI CV, 1985, J FORENSIC SCI, V30, P873; 1988, DATA DRUG ABUSE WARN, V7, P26	14	22	23	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 13	1991	265	6					760	761		10.1001/jama.265.6.760	http://dx.doi.org/10.1001/jama.265.6.760			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EW479	1990194				2022-12-28	WOS:A1991EW47900030
J	DOLIN, R; GRAHAM, BS; GREENBERG, SB; TACKET, CO; BELSHE, RB; MIDTHUN, K; CLEMENTS, ML; GORSE, GJ; HORGAN, BW; ATMAR, RL; KARZON, DT; BONNEZ, W; FERNIE, BF; MONTEFIORI, DC; STABLEIN, DM; SMITH, GE; KOFF, WC				DOLIN, R; GRAHAM, BS; GREENBERG, SB; TACKET, CO; BELSHE, RB; MIDTHUN, K; CLEMENTS, ML; GORSE, GJ; HORGAN, BW; ATMAR, RL; KARZON, DT; BONNEZ, W; FERNIE, BF; MONTEFIORI, DC; STABLEIN, DM; SMITH, GE; KOFF, WC			THE SAFETY AND IMMUNOGENICITY OF A HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) RECOMBINANT GP160 CANDIDATE VACCINE IN HUMANS	ANNALS OF INTERNAL MEDICINE			English	Article							INFECTION; ANTIBODIES; NEUTRALIZATION; ASSAY; CD4	Objective: To evaluate the safety and immunogenicity of a human immunodeficiency virus type 1 (HIV-1) recombinant envelope glycoprotein (rgp160) candidate vaccine in humans. Subjects: Healthy adults (72) who were seronegative for HIV-1 were randomly assigned to one of four groups. Interventions: The subjects were randomly assigned to receive 40 or 80-mu-g of rgp160, 10-mu-g of hepatitis B vaccine, or placebo in three doses (on days 0, 30, and 180), with an elective, nonblinded administration of a fourth dose on day 540. Measurements and Main Results: Neither clinical nor laboratory toxicity was encountered during a follow-up period exceeding 21 months. No effect of immunization was noted on lymphocyte counts, mitogenic responses, or delayed-type hypersensitivity. Serum antibody responses to HIV envelope proteins detected by Western blot were seen in 30 of 33 subjects (91%; 95% CI, 71% to 97%) receiving either 40- or 80-mu-g doses of rgp160 and were most commonly of weakly reactive intensity. Responses were first noted by Western blot after the second dose. They markedly increased in frequency after the third dose and declined over the next 12 to 18 months. The administration of a fourth dose resulted in homologous neutralizing activity in sera from 5 of 24 subjects (21%; CI, 7% to 37%) as well as in complement-mediated antibody-dependent enhancement in sera from 6 of 24 subjects (25%; CI, 10% to 42%). Antibody responses were detected by enzyme-linked immunosorbent assay (ELISA) less frequently than by Western blot, and these responses persisted for a shorter time. Conclusions: The administration of rgp160 was well tolerated and safe, resulted in a high rate of antibody response by Western blot after the administration of the third and fourth doses, and generated serum neutralizing activity and complement-mediated antibody-dependent enhancement in some subjects after the fourth dose.	UNIV ROCHESTER, SCH MED & DENT, ROCHESTER, NY 14642 USA; VANDERBILT UNIV, NASHVILLE, TN 37240 USA; BAYLOR UNIV, HOUSTON, TX 77030 USA; UNIV MARYLAND, BALTIMORE, MD 21201 USA; ST LOUIS UNIV, SCH MED, ST LOUIS, MO 63104 USA; JOHNS HOPKINS UNIV, SCH HYG & PUBL HLTH, BALTIMORE, MD 21218 USA; JOHNS HOPKINS UNIV, SCH MED, BALTIMORE, MD 21205 USA; GEORGETOWN UNIV, ROCKVILLE, MD USA; EMMES CORP, POTOMAC, MD USA; MILROGENESYS INC, W HAVEN, CT USA; NIAID, AIDS, ROCKVILLE, MD USA	University of Rochester; Vanderbilt University; Baylor University; University System of Maryland; University of Maryland Baltimore; Saint Louis University; Johns Hopkins University; Johns Hopkins University; Georgetown University; Emmes Corporation; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)			Atmar, Robert/AFQ-5392-2022; Graham, Barney S./AAC-5898-2019	Atmar, Robert/0000-0001-9989-6772; Graham, Barney S./0000-0001-8112-0853	NIAID NIH HHS [N01-AI-52577, N01-AI-72624, N01-AI-62528] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI052577, N01AI062528, N01AI072624] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; BARNES DM, 1988, SCIENCE, V240, P719, DOI 10.1126/science.2834823; COCHRAN MA, 1987, VACCINES 87 MODERN A, P384; DELGUERCIO P, 1987, IMMUNOL TODAY, V8, P204, DOI 10.1016/0167-5699(87)90164-2; ELLRODT A, 1987, NATURE, V325, P765, DOI 10.1038/325765a0; FAUCI AS, 1989, ANN INTERN MED, V110, P373, DOI 10.7326/0003-4819-110-5-373; JACOBSON IM, 1985, ANNU REV MED, V36, P241; KEEFER MC, 1990, IN PRESS J INFECT DI; KNIKER WT, 1979, ANN ALLERGY, V43, P73; KOFF WC, 1988, SCIENCE, V241, P426, DOI 10.1126/science.3293212; KOVACS H, 1990, 30TH INT C ANT AG CH; LOONEY DJ, 1988, SCIENCE, V241, P357, DOI 10.1126/science.3388046; MARTINEZA C, 1988, LANCET, V1, P454; MATTHEWS TJ, 1987, P NATL ACAD SCI USA, V84, P5424, DOI 10.1073/pnas.84.15.5424; MONTEFIORI DC, 1988, J CLIN MICROBIOL, V26, P231, DOI 10.1128/JCM.26.2.231-235.1988; MURPHEYCORB M, 1989, SCIENCE, V246, P1293, DOI 10.1126/science.2555923; ORENTAS RJ, 1990, SCIENCE, V248, P1234, DOI 10.1126/science.2190315; PURCELL RH, 1989, ANN INTERN MED, V110, P381; ROBINSON WE, 1988, LANCET, V1, P790; TACKET CO, 1990, AIDS RES HUM RETROV, V6, P535, DOI 10.1089/aid.1990.6.535; TAKEDA A, 1988, SCIENCE, V242, P580, DOI 10.1126/science.2972065; VISCIDI R, 1990, AIDS RES HUM RETROV, V6, P1251, DOI 10.1089/aid.1990.6.1251; VUJCIC LK, 1988, J INFECT DIS, V157, P1047, DOI 10.1093/infdis/157.5.1047; WAINHOBSON S, 1985, CELL, V40, P9, DOI 10.1016/0092-8674(85)90303-4; 1987, ABBOTT HIV EIA; 1987, HUMAN IMMUNODEFICIEN	26	185	188	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 15	1991	114	2					119	127		10.7326/0003-4819-114-2-119	http://dx.doi.org/10.7326/0003-4819-114-2-119			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ER534	1984386				2022-12-28	WOS:A1991ER53400004
J	WINGARD, JR; CURBOW, B; BAKER, F; PIANTADOSI, S				WINGARD, JR; CURBOW, B; BAKER, F; PIANTADOSI, S			HEALTH, FUNCTIONAL STATUS, AND EMPLOYMENT OF ADULT SURVIVORS OF BONE-MARROW TRANSPLANTATION	ANNALS OF INTERNAL MEDICINE			English	Article							ACUTE NONLYMPHOCYTIC LEUKEMIA; KARNOFSKY PERFORMANCE STATUS; SEVERE APLASTIC-ANEMIA; CHEMOTHERAPY; DISEASE; QUALITY; CANCER; LIFE; CYCLOPHOSPHAMIDE; RELIABILITY	Objective: To determine the health, functional ability, and employment status of adults who survive bone marrow transplantation. Design: Inception cohort study. Setting: Patients who received transplants at a single referral-based center. Patients: Adults of 18 years of age or older who had received bone marrow transplants at least 6 months previously and who were not in a life-threatening relapse were surveyed a mean of 47 months after transplant (median, 37 months; range, 6 to 149 months). Of 171 eligible patients, 157 were contacted and 135 (86%) responded. Measurements and Main Results: Patients completed a mailed survey. Medical records were also reviewed. Most patients (93%) reported they could do normal activities with minor or no physical problems (Karnofsky scores, greater-than-or-equal-to 80%). Global health was described as good to excellent by 67% of subjects. Most perceived social activities (80%) or physical functional abilities (67%) to be unimpaired or only slightly affected. Moderate or severe pain was uncommon (13%). Sixty-five percent had returned to full- or part-time employment, and one third of those who were not employed were attending school. Job discrimination and problems in obtaining insurance were reported by 23% and 39%, respectively. Among those who had been employed before illness, loss of employment was associated with lower social functioning, chronic graft-versus-host disease, greater job discrimination, and female gender using multivariate logistic regression. Conclusions: Most subjects surviving bone marrow transplant reported good to excellent health and functional ability. Three fourths were employed or enrolled in school. These outcomes are comparable to outcomes in survivors of cancer who received less intensive treatments.	JOHNS HOPKINS UNIV, SCH HYG & PUBL HLTH, DEPT ENVIRONM HLTH SCI, DIV OCCUPAT HLTH, BALTIMORE, MD 21218 USA	Johns Hopkins University	WINGARD, JR (corresponding author), JOHNS HOPKINS UNIV, SCH MED, JOHNS HOPKINS ONCOL CTR, BONE MARROW TRANSPLANTAT PROGRAM, BALTIMORE, MD 21205 USA.		Curbow, Barbara/AAB-3537-2020	Wingard, John/0000-0001-7478-5398	NATIONAL CANCER INSTITUTE [P01CA015396, P30CA006973, R01CA049218] Funding Source: NIH RePORTER; NCI NIH HHS [CA15396, CA49218, CA06973] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANDRYKOWSKI MA, 1989, BONE MARROW TRANSPL, V4, P75; ANDRYKOWSKI MA, 1989, BONE MARROW TRANSPL, V4, P505; APPELBAUM FR, 1988, BLOOD, V72, P179; APPELBAUM FR, 1984, ANN INTERN MED, V101, P581, DOI 10.7326/0003-4819-101-5-581; ARMITAGE P, 1987, STATISTICAL METHODS; BAKER F, 1990, IN PRESS SOC SCI MED; BAYEVER E, 1984, J PEDIATR-US, V105, P920, DOI 10.1016/S0022-3476(84)80078-5; BORTIN MM, 1988, NAT IMMUN CELL GROW, V7, P334; BRAINE HG, 1987, BONE MARROW TRANSPL, V2, P7; CHAMPLIN RE, 1985, ANN INTERN MED, V102, P285, DOI 10.7326/0003-4819-102-3-285; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Cox DR., 1989, ANAL BINARY DATA; CROOG SH, 1986, NEW ENGL J MED, V314, P1657, DOI 10.1056/NEJM198606263142602; ELFENBEIN GJ, 1983, TRANSPLANT P, V15, P1412; EVANS RW, 1985, NEW ENGL J MED, V312, P553, DOI 10.1056/NEJM198502283120905; FELDMAN FL, 1978, WORK CANCER HLTH HIS; FOBAIR P, 1986, J CLIN ONCOL, V4, P805, DOI 10.1200/JCO.1986.4.5.805; GELLER RB, 1989, BLOOD, V73, P2209; GRIECO A, 1984, HEALTH PSYCHOL, V3, P129, DOI 10.1037/0278-6133.3.2.129; Hollingshead August B., 1958, SOCIAL CLASS MENTAL; JENKINS CD, 1983, JAMA-J AM MED ASSOC, V250, P782, DOI 10.1001/jama.250.6.782; KARNOFSKY DA, 1948, CANCER-AM CANCER SOC, V1, P634, DOI 10.1002/1097-0142(194811)1:4<634::AID-CNCR2820010410>3.0.CO;2-L; LOESCHER LJ, 1989, ANN INTERN MED, V111, P411, DOI 10.7326/0003-4819-111-5-411; MOR V, 1984, CANCER-AM CANCER SOC, V53, P2002, DOI 10.1002/1097-0142(19840501)53:9<2002::AID-CNCR2820530933>3.0.CO;2-W; PINCUS T, 1989, ANN INTERN MED, V110, P259, DOI 10.7326/0003-4819-110-4-259; STEWART AL, 1988, MED CARE, V26, P724, DOI 10.1097/00005650-198807000-00007; STONE RW, 1975, CANCER, V36, P285, DOI 10.1002/1097-0142(197507)36:1+<285::AID-CNCR2820360709>3.0.CO;2-2; TALLMAN MS, 1989, J CLIN ONCOL, V7, P326, DOI 10.1200/JCO.1989.7.3.326; WELCHMCCAFFREY D, 1989, ANN INTERN MED, V111, P517, DOI 10.7326/0003-4819-111-6-517; WHEATLEY GM, 1974, CANCER, V33, P441, DOI 10.1002/1097-0142(197402)33:2<441::AID-CNCR2820330220>3.0.CO;2-A; WINGARD JR, 1989, BLOOD, V74, P1428; WINGARD JR, 1990, J CLIN ONCOL, V8, P820, DOI 10.1200/JCO.1990.8.5.820; WOLCOTT DL, 1986, TRANSPLANTATION, V41, P478, DOI 10.1097/00007890-198604000-00013; YATES JW, 1980, CANCER, V45, P2220, DOI 10.1002/1097-0142(19800415)45:8<2220::AID-CNCR2820450835>3.0.CO;2-Q; YEAGER AM, 1986, NEW ENGL J MED, V315, P141, DOI 10.1056/NEJM198607173150301	35	138	138	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 15	1991	114	2					113	118		10.7326/0003-4819-114-2-113	http://dx.doi.org/10.7326/0003-4819-114-2-113			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ER534	1984385				2022-12-28	WOS:A1991ER53400003
J	WONG, S; YARNOLD, PR; YANGO, C; PATTERSON, R; HARRIS, KE				WONG, S; YARNOLD, PR; YANGO, C; PATTERSON, R; HARRIS, KE			OUTCOME OF PROPHYLACTIC THERAPY FOR IDIOPATHIC ANAPHYLAXIS	ANNALS OF INTERNAL MEDICINE			English	Article								Objective: To determine the efficacy of a prophylactic regimen (prednisone, H-1 blockade, and sympathomimetic amine therapy) in patients with idiopathic anaphylaxis. Design: Clinical trial before and after treatment. Setting: Referral-based allergy clinic at a major medical center. Patients: Fifty-three patients with a history compatible with idiopathic anaphylaxis for at least 6 months before presentation to the allergy service and with subsequent management by the service for at least 6 months. Interventions: Patients with frequent life-threatening symptoms were treated with a prophylactic regimen. Patients with infrequent episodes of idiopathic anaphylaxis were only treated acutely for each episode of anaphylaxis. Measurements and Main Results: The results favored prophylactic treatment with prednisone for patients who were classified as generalized-frequent in the clinical outcome measures of frequency (per patient per year) of episodes (mean before treatment, 7.31 +/- 6.46; after treatment, 3.61 +/- 4.73; P < 0.02) and emergency room visits (mean before treatment, 1.94 +/- 3.42; after treatment, 0.21 +/- 0.44; P < 0.005) and for patients classified as angioedema-frequent in the frequency of episodes (mean before treatment, 14.93 +/- 15.89; after treatment, 2.58 +/- 2.18; P < 0.003) and emergency room visits (mean before treatment, 0.76 +/- 1.01; after treatment, 0.07 +/- 0.11; P < 0.025). No statistically significant difference was found for patients classified as generalized-infrequent in the frequency of episodes (mean before treatment, 2.01 +/- 1.30; after treatment, 1.36 +/- 1.79) or of the emergency room visits (mean before treatment, 0.56 +/- 0.71; after treatment, 0.32 +/- 0.75) or for patients classified as angioedema-infrequent in the frequency of episodes (mean before treatment, 1.94 +/- 1.55; after treatment, 2.03 +/- 2.16) or of emergency room visits (mean before treatment, 0.27 +/- 0.44; after treatment, 0.37 +/- 0.59). Conclusions: Prophylactic treatment with prednisone and H-1 antihistamines with or without sympathomimetic amines improves clinical outcome in patients who are classified as idiopathic anaphylaxis-angioedema frequent and idiopathic anaphylaxis-generalized frequent.	NORTHWESTERN UNIV, SCH MED, ALLERGY IMMUNOL SECT, 303 E CHICAGO AVE, CHICAGO, IL 60611 USA; UNIV ILLINOIS, CHICAGO, IL 60680 USA	Northwestern University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital				Yarnold, Paul/0000-0002-1648-739X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P50AI011403] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 11403] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BACAL E, 1978, CLIN ALLERGY, V8, P295, DOI 10.1111/j.1365-2222.1978.tb03227.x; BOXER M, 1987, ARCH INTERN MED, V147, P269, DOI 10.1001/archinte.147.2.269; BOXER MB, 1989, ANN ALLERGY, V62, P201; Bradley JV., 1968, DISTRIBUTION FREE ST; HENDRIX S, 1981, J ALLERGY CLIN IMMUN, V67, P8, DOI 10.1016/0091-6749(81)90038-5; KALINER M, 1984, INVEST RADIOL, V19, P116, DOI 10.1097/00004424-198403000-00007; KALINER MA, 1983, NER ALLERGY P, V5, P324; LIEBERMAN P, 1979, ARCH INTERN MED, V139, P1032, DOI 10.1001/archinte.139.9.1032; MCGRATH KG, 1984, IMMUNOL ALLERGY PRAC, V6, P41; PATTERSON R, 1974, CLIN ALLERGY, V4, P307, DOI 10.1111/j.1365-2222.1974.tb01390.x; SALE SR, 1981, JAMA-J AM MED ASSOC, V246, P2336, DOI 10.1001/jama.246.20.2336; SHEFFER AL, 1980, J ALLERGY CLIN IMMUN, V66, P106, DOI 10.1016/0091-6749(80)90056-1; SONIN L, 1983, ANN INTERN MED, V99, P634, DOI 10.7326/0003-4819-99-5-634; SONIN L, 1985, PSEUDOALLERGIC REACT, V4, P47; STRICKER WE, 1986, J ALLERGY CLIN IMMUN, V77, P516, DOI 10.1016/0091-6749(86)90188-0; WIGGINS CA, 1988, J ALLERGY CLIN IMMUN, V82, P849, DOI 10.1016/0091-6749(88)90089-9; WIGGINS CA, 1989, ANN ALLERGY, V62, P1; WONG S, 1990, ARCH INTERN MED, V150, P1323, DOI 10.1001/archinte.150.6.1323	18	34	35	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 15	1991	114	2					133	136		10.7326/0003-4819-114-2-133	http://dx.doi.org/10.7326/0003-4819-114-2-133			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ER534	1984388				2022-12-28	WOS:A1991ER53400006
J	WELLS, V; MALLUCCI, L				WELLS, V; MALLUCCI, L			IDENTIFICATION OF AN AUTOCRINE NEGATIVE GROWTH-FACTOR - MOUSE BETA-GALACTOSIDE-BINDING PROTEIN IS A CYTOSTATIC FACTOR AND CELL-GROWTH REGULATOR	CELL			English	Article							EMBRYO FIBROBLASTS; CONCANAVALIN-A; MESSENGER-RNA; INTERFERON; LECTINS; SYNTHETASE; CYCLE; PURIFICATION; LYMPHOCYTES; EXPRESSION	Murine beta-galactoside-binding protein, a protein classified as a soluble lectin, is shown to be a cell growth-regulatory molecule and a cytostatic factor. The growth-inhibitory effect is not related to lectin properties, and competition assays indicate that the protein binds to specific cell surface receptors with high affinity. It exerts control in G0 and at G2, both as a regulator of cell replication and as a cytostatic factor.			WELLS, V (corresponding author), UNITED MED & DENT SCH GUYS & ST THOMASS HOSP,SCH MED,DIV MICROBIOL,CELLULAR & MOLEC BIOL LAB,LONDON SE1 9RT,ENGLAND.							ABBOTT WM, 1989, BIOCHEM J, V259, P291, DOI 10.1042/bj2590291; BARONDES SH, 1984, SCIENCE, V223, P1259, DOI 10.1126/science.6367039; BENNETT HPJ, 1980, J LIQ CHROMATOGR, V3, P1353, DOI 10.1080/01483918008062781; BOHMER FD, 1987, J BIOL CHEM, V262, P1537; CERRA RF, 1985, J BIOL CHEM, V260, P10474; CHILDS RA, 1979, BIOCHEM J, V183, P755, DOI 10.1042/bj1830755; CIERCH LB, 1988, BIOCHEMISTRY-US, V27, P692; COURAUD PO, 1989, J BIOL CHEM, V264, P1310; CREASEY AA, 1983, MOL CELL BIOL, V3, P780, DOI 10.1128/MCB.3.5.780; DEWAARD A, 1976, J BIOL CHEM, V251, P7581; FROCKLICK CA, 1983, P NATL ACAD SCI USA, V80, P3676; GITT MA, 1986, P NATL ACAD SCI USA, V83, P7603, DOI 10.1073/pnas.83.20.7603; HUNKAPILLER M, 1985, APPLIED BIOSYSTEMS P, V14; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; LIN SL, 1986, SCIENCE, V233, P356, DOI 10.1126/science.3726533; MACKLER BF, 1972, J NATL CANCER I, V49, P935; MALLUCCI L, 1983, J INTERFERON RES, V3, P181, DOI 10.1089/jir.1983.3.181; MASSAGUE J, 1985, TRENDS BIOCHEM SCI, V10, P237, DOI 10.1016/0968-0004(85)90141-0; MCCLAIN DA, 1976, J EXP MED, V144, P1494, DOI 10.1084/jem.144.6.1494; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; OHYAMA Y, 1986, BIOCHEM BIOPH RES CO, V134, P51, DOI 10.1016/0006-291X(86)90525-5; POWELL JT, 1980, BIOCHEM J, V187, P123, DOI 10.1042/bj1870123; RALPH P, 1973, J NATL CANCER I, V51, P883, DOI 10.1093/jnci/51.3.883; RAZ A, 1988, CANCER RES, V48, P645; REVEL M, 1982, TEX REP BIOL MED, V41, P452; ROBERTS AB, 1983, BIOCHEMISTRY-US, V22, P5692, DOI 10.1021/bi00294a002; ROBERTS AB, 1985, P NATL ACAD SCI USA, V82, P119, DOI 10.1073/pnas.82.1.119; ROFF CF, 1983, BIOCHEM J, V211, P625, DOI 10.1042/bj2110625; SEED B, 1987, NATURE, V329, P840, DOI 10.1038/329840a0; TROWBRIDGE IS, 1974, NATURE, V250, P304, DOI 10.1038/250304a0; TUCKER RF, 1984, SCIENCE, V226, P705, DOI 10.1126/science.6093254; WANG LJ, 1987, CONCANAVALIN A TOOL, P194; WATERFIELD MD, 1981, BIOL BIOMEDICAL APPL, V18, P135; WATERFIELD MD, 1985, PRACTICAL PROTEIN BI, P181; WELLS V, 1985, EXP CELL RES, V159, P27, DOI 10.1016/S0014-4827(85)80034-3; WELLS V, 1983, J CELL PHYSIOL, V117, P148, DOI 10.1002/jcp.1041170203; WELLS V, 1988, J INTERFERON RES, V8, P793, DOI 10.1089/jir.1988.8.793	37	259	268	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	JAN 11	1991	64	1					91	97		10.1016/0092-8674(91)90211-G	http://dx.doi.org/10.1016/0092-8674(91)90211-G			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ET175	1986871				2022-12-28	WOS:A1991ET17500011
J	COYTE, PC; DEWEES, DN; TREBILCOCK, MJ				COYTE, PC; DEWEES, DN; TREBILCOCK, MJ			MEDICAL MALPRACTICE - THE CANADIAN EXPERIENCE	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEALTH-CARE SYSTEM		UNIV TORONTO,DEPT ECON,TORONTO M5S 1A8,ONTARIO,CANADA; UNIV TORONTO,FAC LAW,TORONTO M5S 1A8,ONTARIO,CANADA	University of Toronto; University of Toronto	COYTE, PC (corresponding author), UNIV TORONTO,FAC MED,DEPT HLTH ADM,2ND FL,MCMURRICH BLDG,TORONTO M5S 1A8,ONTARIO,CANADA.							DANZON PM, 1986, LAW CONTEMP PROBL, V49, P57, DOI 10.2307/1191415; DANZON PM, 1985, MED MALPRACTICE THEO; DEWEES DN, 1990, SCOPE TRENDS HLTH CA; Ham Christopher, 1988, MED NEGLIGENCE COMPE; HUGHES JW, 1989, INT REV LAW ECON, V9, P57; IGLEHART JK, 1986, NEW ENGL J MED, V315, P1623, DOI 10.1056/NEJM198612183152531; IGLEHART JK, 1986, NEW ENGL J MED, V315, P778, DOI 10.1056/NEJM198609183151238; IGLEHART JK, 1986, NEW ENGL J MED, V315, P202, DOI 10.1056/NEJM198607173150330; PRIEST GL, 1987, YALE LAW J, V96, P1521, DOI 10.2307/796494; REA SA, 1987, INSURANCE LAW, P1; REYNOLDS RA, 1987, JAMA-J AM MED ASSOC, V257, P2776, DOI 10.1001/jama.257.20.2776; SLOAN F, 1989, MED MALPRACTICE CRIS; TREBILCOCK, 1987, SAN DIEGO L REV, V24, P929; WEILER P, 1988, LEGAL POLICY MED INJ; WEILER PC, 1990, PATIENTS DOCTOR LAWY; 1990, TRENDS US HLTH CARE; 1988, PROFESSIONAL LIABILI; 1986, GAOHRD8721 PUBL; 1987, GAOHRD8755 PUBL; 1980, MED MALPRACTICE CLOS	20	31	31	0	0	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 10	1991	324	2					89	93		10.1056/NEJM199101103240204	http://dx.doi.org/10.1056/NEJM199101103240204			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EQ977	1984189	Bronze			2022-12-28	WOS:A1991EQ97700004
J	NIGHTINGALE, SL				NIGHTINGALE, SL			GERIATRIC USE SUBSECTION PROPOSED ON DRUG LABELING	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material											NIGHTINGALE, SL (corresponding author), US FDA,OFF HLTH AFFAIRS,PARKLAWN BLDG,5600 FISHERS LN,ROCKVILLE,MD 20857, USA.								0	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 9	1991	265	2					182	182						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EQ602	1984138				2022-12-28	WOS:A1991EQ60200008
J	VNENCAKJONES, CL; PHILLIPS, JA				VNENCAKJONES, CL; PHILLIPS, JA			HOT-SPOTS FOR GROWTH-HORMONE GENE DELETIONS IN HOMOLOGOUS REGIONS OUTSIDE OF ALU REPEATS	SCIENCE			English	Article									VANDERBILT UNIV, MED CTR, SCH MED, DEPT PEDIAT, NASHVILLE, TN 37232 USA; VANDERBILT UNIV, MED CTR, SCH MED, DEPT BIOCHEM, NASHVILLE, TN 37232 USA	Vanderbilt University; Vanderbilt University	VNENCAKJONES, CL (corresponding author), VANDERBILT UNIV, MED CTR, SCH MED, DEPT PATHOL, NASHVILLE, TN 37232 USA.				NIDDK NIH HHS [DK 35592] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK035592] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BERNSTEIN HS, 1989, J CLIN INVEST, V83, P1390, DOI 10.1172/JCI114027; BRAGA S, 1986, AM J MED GENET, V25, P443, DOI 10.1002/ajmg.1320250306; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; CHEN EY, 1989, GENOMICS, V4, P479, DOI 10.1016/0888-7543(89)90271-1; HARPER ME, 1982, AM J HUM GENET, V34, P227; HOBBS HH, 1987, NEW ENGL J MED, V317, P734, DOI 10.1056/NEJM198709173171204; HUANG LS, 1989, J BIOL CHEM, V264, P11394; KUCHERLAPATI RS, 1989, PROG NUCLEIC ACID RE, V36, P301; LARON Z, 1985, ISRAEL J MED SCI, V21, P999; LEHRMAN MA, 1986, P NATL ACAD SCI USA, V83, P3679, DOI 10.1073/pnas.83.11.3679; LEHRMAN MA, 1985, SCIENCE, V227, P140, DOI 10.1126/science.3155573; LEHRMAN MA, 1987, J BIOL CHEM, V262, P3354; LISKAY RM, 1987, GENETICS, V115, P161; MIURA O, 1989, BIOCHEMISTRY-US, V28, P4934, DOI 10.1021/bi00438a003; MYEROWITZ R, 1987, J BIOL CHEM, V262, P15396; OTTOLENGHI S, 1982, NATURE, V300, P770, DOI 10.1038/300770a0; PHILLIPS JA, 1981, P NATL ACAD SCI-BIOL, V78, P6372, DOI 10.1073/pnas.78.10.6372; ROUYER F, 1987, CELL, V51, P417, DOI 10.1016/0092-8674(87)90637-4; RUBNITZ J, 1984, MOL CELL BIOL, V4, P2253, DOI 10.1128/MCB.4.11.2253; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHEN P, 1986, GENETICS, V112, P441; SHIOKAWA S, 1988, BLOOD, V72, P1771; SMITH GR, 1981, CELL, V24, P429, DOI 10.1016/0092-8674(81)90333-0; STAHL FW, 1980, GENETICS, V94, P235; VNENCAKJONES CL, 1990, J CLIN ENDOCR METAB, V70, P1550, DOI 10.1210/jcem-70-6-1550; VNENCAKJONES CL, 1988, P NATL ACAD SCI USA, V85, P5615, DOI 10.1073/pnas.85.15.5615; VNENCAKJONES CL, UNPUB; WALDMAN AS, 1987, P NATL ACAD SCI USA, V84, P5340, DOI 10.1073/pnas.84.15.5340; WALDMAN AS, 1988, MOL CELL BIOL, V8, P5350, DOI 10.1128/MCB.8.12.5350; WATT VM, 1985, P NATL ACAD SCI USA, V82, P4768, DOI 10.1073/pnas.82.14.4768; WEINREB A, 1988, P NATL ACAD SCI USA, V85, P529, DOI 10.1073/pnas.85.2.529	31	69	69	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 21	1990	250	4988					1745	1748		10.1126/science.1980158	http://dx.doi.org/10.1126/science.1980158			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN920	1980158				2022-12-28	WOS:A1990EN92000053
J	HUDSON, CP				HUDSON, CP			HOW AIDS FORCES REAPPRAISAL OF HEPATITIS-B VIRUS CONTROL IN SUB-SAHARAN AFRICA	LANCET			English	Editorial Material											HUDSON, CP (corresponding author), UNIV LONDON LONDON SCH HYG & TROP MED,DEPT EPIDEMIOL & POPULAT SCI,KEPPEL ST,LONDON WC1E 7HT,ENGLAND.							ALTER MJ, 1986, JAMA-J AM MED ASSOC, V256, P1307, DOI 10.1001/jama.256.10.1307; Barin F, 1981, Prog Med Virol, V27, P148; BEASLEY RP, 1977, AM J EPIDEMIOL, V105, P94, DOI 10.1093/oxfordjournals.aje.a112370; BEASLEY RP, 1981, LANCET, V2, P1129; BYROM NA, 1973, J INFECT DIS, V128, P259, DOI 10.1093/infdis/128.2.259; COURSAGET P, 1987, J MED VIROL, V22, P1, DOI 10.1002/jmv.1890220102; FOSTER O, 1984, LANCET, V1, P576; HSU HY, 1986, J MED VIROL, V18, P301, DOI 10.1002/jmv.1890180402; HUDSON CP, 1988, AIDS, V2, P255, DOI 10.1097/00002030-198808000-00003; JUPP PG, 1983, S AFR MED J, V63, P77; KARIM SA, 1988, INT J EPIDEMIOL, V17, P168; KARIM SSA, 1989, AM J PUBLIC HEALTH, V79, P893, DOI 10.2105/AJPH.79.7.893; MARINIER E, 1985, J PEDIATR-US, V106, P843, DOI 10.1016/S0022-3476(85)80371-1; MCCARTHY MC, 1989, AIDS, V3, P725, DOI 10.1097/00002030-198911000-00006; MERTENS T, 1989, INFECTION, V17, P4, DOI 10.1007/BF01643488; NASIDI A, 1986, INT J EPIDEMIOL, V15, P274, DOI 10.1093/ije/15.2.274; OGSTON CW, 1981, J MED ENTOMOL, V18, P107, DOI 10.1093/jmedent/18.2.107; PARKIN DM, 1988, INT J CANCER, V41, P184, DOI 10.1002/ijc.2910410205; PRINCE AM, 1984, IARC SCI PUBL, V63, P337; RUSTGI VK, 1987, GASTROENTEROL CLIN N, V16, P545; SMITH PG, 1988, T ROY SOC TROP MED H, V82, P753, DOI 10.1016/0035-9203(88)90226-X; SOBESLAVSKY O, 1980, B WORLD HEALTH ORGAN, V58, P621; TABOR E, 1985, J MED VIROL, V15, P113, DOI 10.1002/jmv.1890150203; TERMEULEN J, 1989, EUR J EPIDEMIOL, V5, P158, DOI 10.1007/BF00156822; TSEGA E, 1986, AM J EPIDEMIOL, V123, P344, DOI 10.1093/oxfordjournals.aje.a114243; Van de Perre P, 1987, Eur J Epidemiol, V3, P14, DOI 10.1007/BF00145066; WHITTLE HC, 1983, LANCET, V1, P1203; 1987, CANCER RES, V47, P5782; 1989, LANCET, V1, P1057	29	11	11	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	DEC 1	1990	336	8727					1364	1367		10.1016/0140-6736(90)92906-X	http://dx.doi.org/10.1016/0140-6736(90)92906-X			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL365	1978174				2022-12-28	WOS:A1990EL36500014
J	TANIMURA, M; MATSUI, I; KOBAYASHI, N				TANIMURA, M; MATSUI, I; KOBAYASHI, N			CHILD-ABUSE OF ONE OF A PAIR OF TWINS IN JAPAN	LANCET			English	Article									NATL CHILDRENS HOSP,TOKYO 154,JAPAN	National Center for Child Health & Development - Japan	TANIMURA, M (corresponding author), NATL CHILDRENS MED RES CTR,DEPT CHILD ECOL,3-35-31 TAISHIRDO,SETAGAYA KU,TOKYO 154,JAPAN.							ASAKA A, 1980, JPN J HUM GENET, V25, P65, DOI 10.1007/BF01873605; BENIRSCHKE K, 1973, NEW ENGL J MED, V288, P1276, DOI 10.1056/NEJM197306142882406; FRIEDRICH WN, 1976, AM J ORTHOPSYCHIAT, V46, P580, DOI 10.1111/j.1939-0025.1976.tb00957.x; GROOTHUIS JR, 1982, PEDIATRICS, V70, P769; HERRENKOHL EC, 1979, J AM ACAD CHILD PSY, V18, P260, DOI 10.1016/S0002-7138(09)61041-4; INOUYE E, 1957, AM J HUM GENET, V9, P317; KOBAYKASHI N, 1989, J JPN PEDIATRIC SOC, V93, P2756; Nakou S, 1982, Child Abuse Negl, V6, P279, DOI 10.1016/0145-2134(82)90030-8; NELSON HB, 1985, CHILD ABUSE NEGLECT, V9, P501; 1985, JAMA-J AM MED ASSOC, V254, P796	10	28	28	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 24	1990	336	8726					1298	1299		10.1016/0140-6736(90)92975-N	http://dx.doi.org/10.1016/0140-6736(90)92975-N			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EJ943	1978124				2022-12-28	WOS:A1990EJ94300013
J	LISSIN, NM; VENYAMINOV, SY; GIRSHOVICH, AS				LISSIN, NM; VENYAMINOV, SY; GIRSHOVICH, AS			(MG-ATP)-DEPENDENT SELF-ASSEMBLY OF MOLECULAR CHAPERONE GROEL	NATURE			English	Article									ACAD SCI USSR, INST PROT RES, PUSHCHINO 142292, USSR	Russian Academy of Sciences								BOCHKAREVA ES, 1988, NATURE, V336, P254, DOI 10.1038/336254a0; CHANDRASEKHAR GN, 1986, J BIOL CHEM, V261, P2414; ELLIS J, 1987, NATURE, V328, P378, DOI 10.1038/328378a0; ELLIS RJ, 1989, TRENDS BIOCHEM SCI, V14, P339, DOI 10.1016/0968-0004(89)90168-0; FRIEDMAN DI, 1984, MICROBIOL REV, V48, P299, DOI 10.1128/MMBR.48.4.299-325.1984; GOLOUBINOFF P, 1989, NATURE, V342, P884, DOI 10.1038/342884a0; GOLOUBINOFF P, 1989, NATURE, V337, P44, DOI 10.1038/337044a0; HEMMINGSEN SM, 1988, NATURE, V333, P330, DOI 10.1038/333330a0; HENDRIX RW, 1979, J MOL BIOL, V129, P375, DOI 10.1016/0022-2836(79)90502-3; HOHN T, 1979, J MOL BIOL, V129, P359, DOI 10.1016/0022-2836(79)90501-1; ISHIHAMA A, 1976, J BIOCHEM-TOKYO, V79, P927, DOI 10.1093/oxfordjournals.jbchem.a131160; JAENICKE L, 1974, ANAL BIOCHEM, V61, P623, DOI 10.1016/0003-2697(74)90429-1; KASSENBROCK CK, 1989, EMBO J, V8, P1461, DOI 10.1002/j.1460-2075.1989.tb03529.x; LAMINET AA, 1990, EMBO J, V9, P2315, DOI 10.1002/j.1460-2075.1990.tb07403.x; LECKER S, 1989, EMBO J, V8, P2703, DOI 10.1002/j.1460-2075.1989.tb08411.x; MCLELLAN T, 1982, ANAL BIOCHEM, V126, P94, DOI 10.1016/0003-2697(82)90113-0; OROTHMAN JE, 1989, CELL, V59, P591; PELHAM HRB, 1986, CELL, V46, P959, DOI 10.1016/0092-8674(86)90693-8; PRIVALOV PL, 1988, ADV PROTEIN CHEM, V39, P191; PRIVALOV PL, 1989, ANNU REV BIOPHYS BIO, V18, P47, DOI 10.1146/annurev.biophys.18.1.47; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; VANDYK TK, 1989, NATURE, V342, P451, DOI 10.1038/342451a0	22	122	126	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 22	1990	348	6299					339	342		10.1038/348339a0	http://dx.doi.org/10.1038/348339a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EJ955	1979147				2022-12-28	WOS:A1990EJ95500062
J	ROGERS, TR; HAYNES, KA; BARNES, RA				ROGERS, TR; HAYNES, KA; BARNES, RA			VALUE OF ANTIGEN-DETECTION IN PREDICTING INVASIVE PULMONARY ASPERGILLOSIS	LANCET			English	Article											ROGERS, TR (corresponding author), CHARING CROSS & WESTMINSTER MED SCH,DEPT MED MICROBIOL,LONDON SW1P 2AR,ENGLAND.			Rogers, Thomas/0000-0003-4336-7729				AISNER J, 1977, ANN INTERN MED, V86, P539, DOI 10.7326/0003-4819-86-5-539; ANDREWS CP, 1981, AM REV RESPIR DIS, V124, P60; BARNES RA, 1988, J ANTIMICROB CHEMOTH, V22, P759, DOI 10.1093/jac/22.5.759; BENNETT JE, 1987, J INFECT DIS, V155, P1005, DOI 10.1093/infdis/155.5.1005; BURCH PA, 1987, J CLIN ONCOL, V5, P1985, DOI 10.1200/JCO.1987.5.12.1985; Cairns M R, 1986, Semin Respir Infect, V1, P166; DUPONT B, 1987, J INFECT DIS, V155, P1, DOI 10.1093/infdis/155.1.1; FISHER BD, 1981, AM J MED, V71, P571, DOI 10.1016/0002-9343(81)90208-4; FUJITA SI, 1988, J LAB CLIN MED, V112, P464; GERSON SL, 1984, ANN INTERN MED, V100, P345, DOI 10.7326/0003-4819-100-3-345; HAYNES KA, 1990, J CLIN MICROBIOL, V28, P2040, DOI 10.1128/JCM.28.9.2040-2044.1990; HERBERT PA, 1981, CHEST, V80, P220, DOI 10.1378/chest.80.2.220; JOHNSON TM, 1989, J LAB CLIN MED, V114, P700; KAHN FW, 1986, AM J CLIN PATHOL, V86, P518, DOI 10.1093/ajcp/86.4.518; PHILLIPS P, 1989, J INFECT DIS, V159, P1147, DOI 10.1093/infdis/159.6.1147; PIRSCH JD, 1986, ANN INTERN MED, V104, P619, DOI 10.7326/0003-4819-104-5-619; REISS E, 1979, INFECT IMMUN, V25, P357, DOI 10.1128/IAI.25.1.357-365.1979; SABETTA JR, 1985, J INFECT DIS, V152, P946, DOI 10.1093/infdis/152.5.946; SHERERTZ RJ, 1987, AM J MED, V83, P709, DOI 10.1016/0002-9343(87)90902-8; TALBOT GH, 1987, J INFECT DIS, V155, P12, DOI 10.1093/infdis/155.1.12; WATSON JG, 1983, J CLIN PATHOL, V36, P683, DOI 10.1136/jcp.36.6.683; WILSON EV, 1987, J MED VET MYCOL, V25, P365; WILSON EV, 1983, J MED MICROBIOL, V16, P97, DOI 10.1099/00222615-16-1-97; YOUNG RC, 1971, AM REV RESPIR DIS, V104, P710; YU B, 1990, J CLIN MICROBIOL, V28, P1575, DOI 10.1128/JCM.28.7.1575-1579.1990	25	121	124	0	2	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 17	1990	336	8725					1210	1213		10.1016/0140-6736(90)92831-2	http://dx.doi.org/10.1016/0140-6736(90)92831-2			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ064	1978070				2022-12-28	WOS:A1990EJ06400003
J	SCHWARTZ, B; FACKLAM, RR; BREIMAN, RF				SCHWARTZ, B; FACKLAM, RR; BREIMAN, RF			CHANGING EPIDEMIOLOGY OF GROUP-A STREPTOCOCCAL INFECTION IN THE USA	LANCET			English	Article									CTR DIS CONTROL,CTR INFECT DIS,DIV BACTERIAL DIS,RESP DIS BRANCH,LAB SECT,ATLANTA,GA 30333	Centers for Disease Control & Prevention - USA	SCHWARTZ, B (corresponding author), CTR DIS CONTROL,CTR INFECT DIS,DIV BACTERIAL DIS,RESP DIS BRANCH,EPIDEMIOL SECT,MAILSTOP C-09,ATLANTA,GA 30333, USA.							BARTTER T, 1988, ARCH INTERN MED, V148, P1421, DOI 10.1001/archinte.148.6.1421; BESSEN D, 1989, J EXP MED, V169, P269, DOI 10.1084/jem.169.1.269; BISNO AL, 1985, JAMA-J AM MED ASSOC, V254, P538, DOI 10.1001/jama.254.4.538; BREESE BB, 1978, BETA HEMOLYTIC STREP, P9; CONE LA, 1987, NEW ENGL J MED, V317, P146, DOI 10.1056/NEJM198707163170305; CONGENI B, 1987, J PEDIATR-US, V111, P176, DOI 10.1016/S0022-3476(87)80063-X; CRUICKSHANK JG, 1981, BRIT MED J, V282, P1944, DOI 10.1136/bmj.282.6280.1944; FISCHETTI VA, 1989, CLIN MICROBIOL REV, V2, P285, DOI 10.1128/CMR.2.3.285-314.1989; GAWORZEWSKA E, 1988, EPIDEMIOL INFECT, V100, P257, DOI 10.1017/S095026880006739X; GUIRGUIS N, 1982, AM J EPIDEMIOL, V116, P933, DOI 10.1093/oxfordjournals.aje.a113495; ISPAHANI P, 1988, J INFECTION, V16, P37, DOI 10.1016/S0163-4453(88)96073-2; KAPLAN EL, 1989, J INFECT DIS, V159, P101, DOI 10.1093/infdis/159.1.101; KAPLAN EL, 1987, J PEDIATR, V3, P244; KOHLER W, 1987, ZBL BAKT-INT J MED M, V266, P104; LANCEFIELD RC, 1959, J EXP MED, V110, P271, DOI 10.1084/jem.110.2.271; MASSELL BF, 1988, NEW ENGL J MED, V318, P280, DOI 10.1056/NEJM198802043180504; QUINN RW, 1989, REV INFECT DIS, V11, P928; QUINN RW, 1982, YALE J BIOL MED, V55, P265; SHAUNAK S, 1988, Q J MED, V69, P921; SIEGEL AC, 1961, NEW ENGL J MED, V265, P566, DOI 10.1056/NEJM196109212651202; STEVENS DL, 1989, NEW ENGL J MED, V321, P1, DOI 10.1056/NEJM198907063210101; VEASY LG, 1987, NEW ENGL J MED, V316, P421, DOI 10.1056/NEJM198702193160801; VOSTI KL, 1979, PATHOGENIC STREPTOCO, P90; WALD ER, 1987, PEDIATRICS, V80, P371; WALLACE MR, 1989, JAMA-J AM MED ASSOC, V262, P2557, DOI 10.1001/jama.262.18.2557; WANNAMAKER LW, 1963, AM J DIS CHILD, V86, P347; [No title captured]; 1990, MMWR, V39, P3	28	357	365	0	2	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 10	1990	336	8724					1167	1171		10.1016/0140-6736(90)92777-F	http://dx.doi.org/10.1016/0140-6736(90)92777-F			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG701	1978035				2022-12-28	WOS:A1990EG70100012
J	SARREL, PM; LINDSAY, DC; POOLEWILSON, PA; COLLINS, P				SARREL, PM; LINDSAY, DC; POOLEWILSON, PA; COLLINS, P			HYPOTHESIS - INHIBITION OF ENDOTHELIUM-DERIVED RELAXING FACTOR BY HEMOGLOBIN IN THE PATHOGENESIS OF PREECLAMPSIA	LANCET			English	Article									NATL HEART & LUNG INST,DEPT CARDIAC MED,LONDON SW3 6LY,ENGLAND	Imperial College London	SARREL, PM (corresponding author), YALE UNIV,SCH MED,333 CEDAR ST,NEW HAVEN,CT 06510, USA.							ALTCHEK A, 1964, CIRCULATION S2, V29, P43; BELLAR FK, 1973, THROMB DIATH HAEMO, V29, P263; CAMPBELL DM, 1983, CLIN EXP HYPERTENS B, V2, P163, DOI 10.3109/10641958309023468; CUNNINGHAM FG, 1985, AM J OBSTET GYNECOL, V153, P358, DOI 10.1016/0002-9378(85)90071-7; DEVENUTO F, 1969, BIOCHIM BIOPHYS ACTA, V193, P36, DOI 10.1016/0005-2736(69)90056-X; DUKES PP, 1961, ENDOCRINOLOGY, V69, P21, DOI 10.1210/endo-69-1-21; EDWARDS DH, 1986, CARDIOVASC RES, V20, P549, DOI 10.1093/cvr/20.8.549; GARN SM, 1988, NEW ENGL J MED, V318, P783; GRIFFITH TM, 1988, J AM COLL CARDIOL, V12, P797, DOI 10.1016/0735-1097(88)90324-5; KITZMILL.JL, 1974, AM J OBSTET GYNECOL, V118, P362, DOI 10.1016/S0002-9378(16)33794-2; KNOTTNERUS JA, 1986, LANCET, V2, P282; MAGNESS RR, 1989, AM J PHYSIOL, V256, pE536, DOI 10.1152/ajpendo.1989.256.4.E536; MATTHEWS JD, 1975, LANCET, V2, P409; MYERS PR, 1990, NATURE, V345, P161, DOI 10.1038/345161a0; PRITCHARD JA, 1954, NEW ENGL J MED, V250, P89, DOI 10.1056/NEJM195401212500301; RAFFERTY TD, 1980, AM J OBSTET GYNECOL, V138, P263, DOI 10.1016/0002-9378(80)90246-X; ROBERTS JM, 1989, AM J OBSTET GYNECOL, V161, P1200, DOI 10.1016/0002-9378(89)90665-0; SCHIFF E, 1989, NEW ENGL J MED, V321, P351, DOI 10.1056/NEJM198908103210603; SCHNEIDER CL, 1951, J OBSTET GYN BRIT EM, V58, P538; SKAJAA KR, 1929, ACTA OBSTETR ET GYNECOL SCANDINAVICA, V8, P371; TODA N, 1990, AM J PHYSIOL, V258, pH57, DOI 10.1152/ajpheart.1990.258.1.H57; VALLANCE P, 1989, LANCET, V2, P997; WEINSTEIN L, 1982, AM J OBSTET GYNECOL, V142, P159, DOI 10.1016/S0002-9378(16)32330-4	23	53	53	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 27	1990	336	8722					1030	1032		10.1016/0140-6736(90)92490-9	http://dx.doi.org/10.1016/0140-6736(90)92490-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF076	1977020				2022-12-28	WOS:A1990EF07600005
J	WALLENTIN, L				WALLENTIN, L			RISK OF MYOCARDIAL-INFARCTION AND DEATH DURING TREATMENT WITH LOW-DOSE ASPIRIN AND INTRAVENOUS HEPARIN IN MEN WITH UNSTABLE CORONARY-ARTERY DISEASE	LANCET			English	Article									LINKOPING UNIV, DEPT INTERNAL MED, S-58185 LINKOPING, SWEDEN; LINKOPING UNIV, DEPT CLIN PHYSIOL, S-58185 LINKOPING, SWEDEN	Linkoping University; Linkoping University								[Anonymous], 1988, LANCET, V2, P349; [Anonymous], 1988, BRIT MED J, V296, P320; BALSANO F, 1990, CIRCULATION, V82, P17, DOI 10.1161/01.CIR.82.1.17; BASHOUR TT, 1988, AM HEART J, V115, P850, DOI 10.1016/0002-8703(88)90889-7; BERGLUND U, IN PRESS EUR HEART J; CAIRNS JA, 1985, NEW ENGL J MED, V313, P1369, DOI 10.1056/NEJM198511283132201; EPSTEIN SE, 1984, AM J CARDIOL, V54, P1245, DOI 10.1016/S0002-9149(84)80074-0; FUSTER V, 1987, PROG CARDIOVASC DIS, V29, P325, DOI 10.1016/0033-0620(87)90001-6; FUSTER V, 1988, CIRCULATION, V77, P1213, DOI 10.1161/01.CIR.77.6.1213; HENNEKENS CH, 1989, CIRCULATION, V80, P749, DOI 10.1161/01.CIR.80.4.749; HENNEKENS CH, 1989, NEW ENGL J MED, V321, P129, DOI 10.1056/nejm198907203210301; HUBER K, 1989, THROMB RES, V55, P779, DOI 10.1016/0049-3848(89)90308-3; KLIMT CR, 1986, J AM COLL CARDIOL, V7, P251, DOI 10.1016/S0735-1097(86)80489-2; LEWIS HD, 1983, NEW ENGL J MED, V309, P396, DOI 10.1056/NEJM198308183090703; LORENZ RL, 1989, AM J CARDIOL, V64, P1185, DOI 10.1016/0002-9149(89)90875-8; PRICHARD PJ, 1989, BMJ-BRIT MED J, V298, P493, DOI 10.1136/bmj.298.6672.493; SERNERI GGN, 1990, LANCET, V335, P615; SWAHN E, 1987, AM J CARDIOL, V59, P208, DOI 10.1016/0002-9149(87)90786-7; TAVAZZI L, 1989, LANCET, V2, P182; TELFORD AM, 1981, LANCET, V1, P1225; THEROUX P, 1988, NEW ENGL J MED, V319, P1105, DOI 10.1056/NEJM198810273191701; YUSUF S, 1988, JAMA-J AM MED ASSOC, V260, P2088, DOI 10.1001/jama.260.14.2088	22	719	732	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 6	1990	336	8719					827	830						4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB901	1976875				2022-12-28	WOS:A1990EB90100001
J	BARTSCH, P; BAUMGARTNER, RW; WABER, U; MAGGIORINI, M; OELZ, O				BARTSCH, P; BAUMGARTNER, RW; WABER, U; MAGGIORINI, M; OELZ, O			COMPARISON OF CARBON-DIOXIDE-ENRICHED, OXYGEN-ENRICHED, AND NORMAL AIR IN TREATMENT OF ACUTE MOUNTAIN-SICKNESS	LANCET			English	Article									INSELSPITAL BERN, DEPT MED, CH-3010 BERN, SWITZERLAND; UNIV HOSP ZURICH, DEPT NEUROL, CH-8091 ZURICH, SWITZERLAND; UNIV HOSP ZURICH, DEPT MED, CH-8091 ZURICH, SWITZERLAND	University of Bern; University Hospital of Bern; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital				Maggiorini, Marco/0000-0001-8180-2117				Aaslid R, 1986, TRANSCRANIAL DOPPLER; BARTSCH P, 1989, J APPL PHYSIOL, V66, P2136, DOI 10.1152/jappl.1989.66.5.2136; BARTSCH P, 1990, WILDERNESS MED, V1, P162; Bartsch P., 1990, HYPOXIA ADAPTATIONS, P241; BORGSTROM L, 1975, ACTA PHYSIOL SCAND, V93, P423, DOI 10.1111/j.1748-1716.1975.tb05832.x; Childs SB, 1935, NATURE, V135, P457, DOI 10.1038/135457a0; FERRAZZINI G, 1987, BRIT MED J, V294, P1380, DOI 10.1136/bmj.294.6584.1380; HACKETT PH, 1989, LANCET, V1, P272; HACKETT PH, 1988, AVIAT SPACE ENVIR MD, V59, P950; HACKETT PH, 1990, HYPOXIA ADAPTATIONS, P295; HARVEY TC, 1988, LANCET, V2, P639; HOUSTON CS, 1975, LANCET, V2, P758; HUANG SY, 1987, J APPL PHYSIOL, V63, P395, DOI 10.1152/jappl.1987.63.1.395; JOHNSON TS, 1988, NEW ENGL J MED, V319, P841, DOI 10.1056/NEJM198809293191306; KOGURE K, 1970, AM J PHYSIOL, V219, P1393, DOI 10.1152/ajplegacy.1970.219.5.1393; LEVINE BD, 1989, NEW ENGL J MED, V321, P1707, DOI 10.1056/NEJM198912213212504; MARKWALDER TM, 1984, J CEREBR BLOOD F MET, V4, P368, DOI 10.1038/jcbfm.1984.54; MOORE LG, 1986, J APPL PHYSIOL, V60, P1407, DOI 10.1152/jappl.1986.60.4.1407; MOSSO A, 1898, LIFE MAN HIGH ALPS, P287; ROCK PB, 1987, AVIAT SPACE ENVIR MD, V58, P668; SAMPSON JB, 1983, AVIAT SPACE ENVIR MD, V54, P1063	21	40	41	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 29	1990	336	8718					772	775		10.1016/0140-6736(90)93240-P	http://dx.doi.org/10.1016/0140-6736(90)93240-P			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB077	1976147				2022-12-28	WOS:A1990EB07700005
J	COLES, C; THOMPSON, AM; ELDER, PA; COHEN, BB; MACKENZIE, IM; CRANSTON, G; CHETTY, U; MACKAY, J; MACDONALD, M; NAKAMURA, Y; HOYHEIM, B; STEEL, CM				COLES, C; THOMPSON, AM; ELDER, PA; COHEN, BB; MACKENZIE, IM; CRANSTON, G; CHETTY, U; MACKAY, J; MACDONALD, M; NAKAMURA, Y; HOYHEIM, B; STEEL, CM			EVIDENCE IMPLICATING AT LEAST 2 GENES ON CHROMOSOME-17P IN BREAST CARCINOGENESIS	LANCET			English	Article									WESTERN GEN HOSP,MRC,HUMAN GENET UNIT,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND; ROYAL INFIRM,DEPT SURG,EDINBURGH EH3 9HB,MIDLOTHIAN,SCOTLAND; INST CANC RES,DEPT BIOCHEM,TOKYO,JAPAN; UNIV UTAH,MED CTR,HOWARD HUGHES MED INST,SALT LAKE CITY,UT 84112	University of Edinburgh; Royal Infirmary of Edinburgh; Japanese Foundation for Cancer Research; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah								ALI IU, 1987, SCIENCE, V238, P185, DOI 10.1126/science.3659909; ASHTONRICKARDT PG, 1989, ONCOGENE, V4, P1169; BAKER SJ, 1989, SCIENCE, V244, P217, DOI 10.1126/science.2649981; DEVILEE P, 1990, CYTOGENET CELL GENET, V53, P52, DOI 10.1159/000132893; DEVILEE P, 1989, GENOMICS, V5, P554, DOI 10.1016/0888-7543(89)90023-2; ECCLES DM, 1990, ONCOGENE, V5, P1599; HOYHEIM B, 1989, NUCLEIC ACIDS RES, V17, P88; IGGO R, 1990, LANCET, V335, P675, DOI 10.1016/0140-6736(90)90801-B; KNUDSON AG, 1985, CANCER RES, V45, P1437; LEE JH, 1989, CANCER GENET CYTOGEN, V41, P243; LYNCH HT, 1976, CANCER GENETICS; MACKAY J, 1988, LANCET, V2, P1384; Nakamura Y, 1988, GENOMICS, V2, P302, DOI 10.1016/0888-7543(88)90018-3; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; PROSSER J, 1990, ONCOGENE, V5, P1573; TAKAHASHI T, 1989, SCIENCE, V246, P491, DOI 10.1126/science.2554494; THOMPSON AM, 1990, BRIT J CANCER, V61, P74, DOI 10.1038/bjc.1990.17; TOGUCHIDA J, 1989, CANCER RES, V49, P6247	18	225	225	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	SEP 29	1990	336	8718					761	763		10.1016/0140-6736(90)93236-I	http://dx.doi.org/10.1016/0140-6736(90)93236-I			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB077	1976143				2022-12-28	WOS:A1990EB07700001
J	FORRESTER, JM				FORRESTER, JM			USING ONESELF AS ONES ONLY EXPERIMENTAL SUBJECT	LANCET			English	Article																		ALTMAN LK, 1972, NEW ENGL J MED, V286, P346, DOI 10.1056/NEJM197202172860704; ALTMAN LK, 1987, WHO GOES FIRST STORY; [Anonymous], 1970, NATURE, V226, P869; BRINDLEY GS, 1983, BRIT J PSYCHIAT, V143, P332, DOI 10.1192/bjp.143.4.332; BRINDLEY GS, 1986, BRIT J PHARMACOL, V87, P495, DOI 10.1111/j.1476-5381.1986.tb10191.x; Brown-Sequard C. E., 1889, ARCH PHYSL, V1, P651; DEJOB C, 1970, MA MURET PROFESSEUR, P60; Forssmann W., 1974, EXPT MYSELF; Forssmann W., 1929, KLIN WOCHENSCHR, V8, P2085, DOI DOI 10.1007/BF01875120; HALDANE JBS, 1927, BEING ONES OWN RABBI, P107; HUNTER J, 1786, TREATISE VENEREAL DI, P325; Jones W.H.S., 1963, PLINY NATURAL HIST, VVIII; MELLANBY K, 1973, HUMAN GUINEA PIGS, P151; MITSCHERLICH A, 1962, DEATH DOCTORS, P354; MOLL AA, 1944, AESCULAPIUS LATIN AM, P444; SCHULTZ MG, 1968, NEW ENGL J MED, V278, P1323, DOI 10.1056/NEJM196806132782405; VEREL D, 1955, J PHYSIOL-LONDON, V130, P72, DOI 10.1113/jphysiol.1955.sp005393	17	3	3	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	SEP 29	1990	336	8718					798	799		10.1016/0140-6736(90)93254-M	http://dx.doi.org/10.1016/0140-6736(90)93254-M			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB077	1976158				2022-12-28	WOS:A1990EB07700017
J	WYNICK, D; DOLLERY, CT; BLOOM, SR; POLAK, JM; LYNN, JA				WYNICK, D; DOLLERY, CT; BLOOM, SR; POLAK, JM; LYNN, JA			HAMMERSMITH STAFF ROUNDS - GASTRINOMA SYNDROME IN MULTIPLE ENDOCRINE NEOPLASIA	BRITISH MEDICAL JOURNAL			English	Discussion											WYNICK, D (corresponding author), HAMMERSMITH HOSP,DEPT MED,LONDON W12 0HS,ENGLAND.							HAVU N, 1986, DIGESTION, V35, P42, DOI 10.1159/000199381; MAKOWKA L, 1989, SURG GYNECOL OBSTET, V168, P107; PIPELEERSMARICHAL M, 1990, NEW ENGL J MED, V322, P723, DOI 10.1056/NEJM199003153221103; SAMAAN NA, 1989, CANCER, V64, P741, DOI 10.1002/1097-0142(19890801)64:3<741::AID-CNCR2820640329>3.0.CO;2-F; THOMPSON GB, 1988, SURGERY, V104, P1011; THOMPSON NW, 1989, ANN SURG, V209, P396, DOI 10.1097/00000658-198904000-00002; VINIK AI, 1986, ANN INTERN MED, V105, P956, DOI 10.7326/0003-4819-105-6-956; WYNICK D, 1988, NEW ENGL J MED, V319, P605, DOI 10.1056/NEJM198809083191003	8	3	3	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	SEP 8	1990	301	6750					489	490		10.1136/bmj.301.6750.489	http://dx.doi.org/10.1136/bmj.301.6750.489			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DX630	1976397	Bronze, Green Published			2022-12-28	WOS:A1990DX63000024
J	RAUB, W				RAUB, W			SALIVARY-GLAND FUNCTION NOT AFFECTED BY MENOPAUSE	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material											RAUB, W (corresponding author), NIH,BETHESDA,MD 20892, USA.							1991, J GERONTOL, V46, pM11	1	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 13	1991	265	6					706	706						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EW479	1990184				2022-12-28	WOS:A1991EW47900008
J	HABER, HL; LEAVY, JA; KESSLER, PD; KUKIN, ML; GOTTLIEB, SS; PACKER, M				HABER, HL; LEAVY, JA; KESSLER, PD; KUKIN, ML; GOTTLIEB, SS; PACKER, M			THE ERYTHROCYTE SEDIMENTATION-RATE IN CONGESTIVE-HEART-FAILURE	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-ARTERY DISEASE; CLINICAL-RESPONSE; BLOOD-VISCOSITY; SURVIVAL; SYSTEM; PLASMA	Background and Methods. Physicians have long believed that the erythrocyte sedimentation rate is low in patients with congestive heart failure, but this concept is based on a misinterpretation of the results in a single report published in 1936. To reevaluate this concept in the modern era, we measured the sedimentation rate in 242 patients who were referred for treatment of chronic heart failure. Results. The sedimentation rate was low (less than 5 mm per hour) in only 24 patients (10 percent) but was increased (above 25 mm per hour) in 50 percent. Patients with low or normal sedimentation rates (less-than-or-equal-to 25 mm per hour) had more severe hemodynamic abnormalities than patients with elevated rates: lower cardiac index (mean +/- SEM, 1.7 +/- 0.1 vs. 2.0 +/- 0.1 liters per minute per square meter of body-surface area) and higher mean right atrial pressure (mean +/- SEM, 12 +/- 1 vs. 9 +/- 1 mm Hg)(both P < 0.0001). New York Heart Association functional class IV symptoms were present in 66 percent of the patients with a low or normal sedimentation rate, as compared with 42 percent of those with elevated rates (P < 0.0001). After one to three months of therapy, patients whose sedimentation rates decreased showed little hemodynamic or clinical response to treatment, whereas both cardiac performance and functional status improved in patients whose rates increased (P < 0.02 for the comparison between groups). The sedimentation rate was correlated with the plasma fibrinogen level (r = 0.64, P = 0.0025), and changes in the sedimentation rate during treatment were correlated inversely with changes in mean right atrial pressure (r = -0.57, P = 0.0002). During long-term follow-up, patients with low or normal sedimentation rates had a worse one-year survival than patients with elevated rates (41 vs. 66 percent, P = 0.01). Conclusions. These data indicate that the erythrocyte sedimentation rate is correlated with the severity of illness in patients with chronic heart failure. Because of its lack of discriminatory power, however, the test is of limited value in the clinical management of this disorder.	CUNY MT SINAI SCH MED,DIV CARDIOL,1 GUSTAVE LEVY PL,NEW YORK,NY 10029; CUNY MT SINAI SCH MED,DEPT MED,DIV CARDIOL,CTR HEART FAILURE RES,NEW YORK,NY 10029	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL025055, K04HL001229, T32HL007347] Funding Source: NIH RePORTER; NHLBI NIH HHS [K04-HL-01229, R01-HL-25055, T32-HL-07347] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BEDELL SE, 1985, AM J MED, V78, P1001, DOI 10.1016/0002-9343(85)90224-4; BOTTIGER LE, 1967, BRIT MED J, V2, P85, DOI 10.1136/bmj.2.5544.85; BRESLOW N, 1974, BIOMETRICS, V30, P89, DOI 10.2307/2529620; Coburn AF, 1936, J CLIN INVEST, V15, P715, DOI 10.1172/JCI100825; CREAGER MA, 1982, AM HEART J, V104, P1147, DOI 10.1016/0002-8703(82)90043-6; EISENBERG S, 1964, CIRCULATION, V30, P686, DOI 10.1161/01.CIR.30.5.686; ELSTER SK, 1956, AM HEART J, V51, P533, DOI 10.1016/0002-8703(56)90099-0; FABRY TL, 1987, BLOOD, V70, P1572; FLINT FJ, 1954, BRIT MED J, V2, P1018, DOI 10.1136/bmj.2.4895.1018; GAMBINO S R, 1965, Tech Bull Regist Med Technol, V35, P1; Gilligan DR, 1934, AM J MED SCI, V187, P552, DOI 10.1097/00000441-193404000-00012; GOLDSMITH RL, 1988, CIRCULATION S2, V78, P56; GRIFFITHS RA, 1984, BRIT MED J, V289, P724, DOI 10.1136/bmj.289.6447.724; Ham TH, 1938, MEDICINE, V17, P447, DOI 10.1097/00005792-193812000-00003; HAMILTON PJ, 1974, J CLIN PATHOL, V27, P326, DOI 10.1136/jcp.27.4.326; HENRY DP, 1975, LIFE SCI, V16, P375, DOI 10.1016/0024-3205(75)90258-1; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kugel MA, 1933, ARCH INTERN MED, V52, P16, DOI 10.1001/archinte.1933.00160010023002; LEE WH, 1985, J AM COLL CARDIOL, V5, P461; LEE WH, 1986, CIRCULATION, V73, P257, DOI 10.1161/01.CIR.73.2.257; LOWE GD, 1986, DIABETES RES CLIN EX, V3, P67; LOWE GDO, 1980, BRIT MED J, V280, P673, DOI 10.1136/bmj.280.6215.673; MCGINNIS AE, 1953, AM J MED SCI, V225, P599, DOI 10.1097/00000441-195306000-00002; MEADE TW, 1979, BMJ-BRIT MED J, V1, P153, DOI 10.1136/bmj.1.6157.153; PACKER M, 1985, CIRCULATION, V71, P761, DOI 10.1161/01.CIR.71.4.761; PARRY EH, 1961, ACTA MED SCAND, V169, P79; RAINER C, 1987, CIRCULATION, V76, P15, DOI 10.1161/01.CIR.76.1.15; SANGHVI L M, 1960, Postgrad Med J, V36, P620; SANGHVI LM, 1963, GERIATRICS, V18, P382; SANGHVI LM, 1962, BRIT HEART J, V24, P180; SEALEY JE, 1972, KIDNEY INT, V1, P240, DOI 10.1038/ki.1972.34; WOOD P, 1936, Q J MED, V5, P1; ZANNAD F, 1988, J HYPERTENS, V6, P293	33	54	56	0	2	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 7	1991	324	6					353	358		10.1056/NEJM199102073240601	http://dx.doi.org/10.1056/NEJM199102073240601			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EW296	1987458	Bronze			2022-12-28	WOS:A1991EW29600001
J	CAPLAN, LR; MCKEE, AC; MIKULIS, D; HEDLEYWHYTE, ET; OJEMANN, RG				CAPLAN, LR; MCKEE, AC; MIKULIS, D; HEDLEYWHYTE, ET; OJEMANN, RG			A 61-YEAR-OLD WOMAN WITH AN ABRUPT ONSET OF PARALYSIS OF THE LEGS AND IMPAIRMENT OF THE BLADDER AND BOWEL FUNCTION - SPINAL-CORD INFECTION, ACUTE, SECONDARY TO FIBROCARTILAGINOUS EMBOLI	NEW ENGLAND JOURNAL OF MEDICINE			English	Discussion							ARTERIOVENOUS-MALFORMATIONS; VASCULAR MALFORMATIONS; VENOUS INFARCTION; CLINICAL FEATURES; DIAGNOSIS; TUMORS		TUFTS UNIV, SCH MED, BOSTON, MA 02111 USA	Tufts University	CAPLAN, LR (corresponding author), NEW ENGLAND MED CTR HOSP, BOSTON, MA 02111 USA.		Hedley-Whyte, E Tessa/AAJ-9975-2021; Mikulis, David J/H-5167-2019	Hedley-Whyte, E Tessa/0000-0002-1687-8905; 				AMINOFF MJ, 1974, BRAIN, V97, P197, DOI 10.1093/brain/97.1.197; ANDERSON NE, 1987, ANN NEUROL, V21, P470, DOI 10.1002/ana.410210510; ARENDT A, 1976, HDB CLIN NEUROLOGY, V20, P323; BOTS GTAM, 1981, NEUROLOGY, V31, P1250; Caplan LR., 1990, EFFECTIVE CLIN NEURO; CAROSCIO JT, 1980, ARCH NEUROL-CHICAGO, V37, P101, DOI 10.1001/archneur.1980.00500510059011; COOK JR, 1988, VET CLIN N AM-SMALL, V18, P581, DOI 10.1016/S0195-5616(88)50056-6; COOPER PR, 1985, J NEUROSURG, V63, P492, DOI 10.3171/jns.1985.63.4.0492; DJINDJIAN M, 1977, SURG NEUROL, V8, P85; EDELSON RN, 1972, NEUROLOGY, V22, P1222, DOI 10.1212/WNL.22.12.1222; FEIGIN I, 1965, J NEUROPATH EXP NEUR, V24, P63, DOI 10.1097/00005072-196501000-00006; FOIX CH, 1926, REV NEUROL [PARIS], V2, P1; GILLILAN LA, 1970, NEUROLOGY, V20, P860, DOI 10.1212/WNL.20.9.860; GRIFFITHS IR, 1973, J COMP PATHOL, V83, P225, DOI 10.1016/0021-9975(73)90046-7; GUEGUEN B, 1987, NEUROLOGY, V37, P969, DOI 10.1212/WNL.37.6.969; Hanski W, 1977, Neuropatol Pol, V15, P479; HOUDART R, 1966, J NEUROSURG, V2, P1; HUGHES JT, 1971, NEUROLOGY, V21, P794, DOI 10.1212/WNL.21.8.794; HUGHES JT, 1966, ARCH NEUROL-CHICAGO, V15, P189, DOI 10.1001/archneur.1966.00470140079011; JURKOVIC I, 1970, ACTA NEUROPATHOL, V15, P284, DOI 10.1007/BF00686774; KEPES JJ, 1973, VIRCHOWS ARCH A, V361, P185, DOI 10.1007/BF00543983; KESTLE JRW, 1989, J NEUROSURG, V71, P938, DOI 10.3171/jns.1989.71.6.0938; KIM RC, 1984, ANN NEUROL, V15, P379, DOI 10.1002/ana.410150413; LEVITT LP, 1979, NEUROLOGY, V29, P1514, DOI 10.1212/WNL.29.11.1514; LOGUE V, 1979, J NEUROL NEUROSUR PS, V42, P1, DOI 10.1136/jnnp.42.1.1; MANCALL EL, 1964, BRAIN, V87, P639, DOI 10.1093/brain/87.4.639; NAIMAN JL, 1961, NEUROLOGY, V11, P83, DOI 10.1212/WNL.11.1.83; NASSAR SI, 1968, NEUROLOGY, V18, P87, DOI 10.1212/WNL.18.1_Part_1.87; OGATA J, 1972, J NEUROPATH EXP NEUR, V31, P519, DOI 10.1097/00005072-197207000-00009; RAO KR, 1982, J NEUROL SCI, V56, P107, DOI 10.1016/0022-510X(82)90065-X; RAWLINGS CE, 1988, SURG NEUROL, V29, P271, DOI 10.1016/0090-3019(88)90158-9; RUSSELL DS, 1963, PATHOL TUMOURS NER, P137; SATRAN R, 1988, Stroke, V19, P529; SCOTTI G, 1987, NEURORADIOLOGY, V29, P130, DOI 10.1007/BF00327537; SMITH CG, 1956, RADIOLOGY, V66, P259, DOI 10.1148/66.2.259; SRIGLEY JR, 1981, ANN NEUROL, V9, P296, DOI 10.1002/ana.410090315; SVIEN HJ, 1961, SURG GYNECOL OBSTET, V112, P729; TOBIN WD, 1976, MAYO CLIN PROC, V51, P637; VUIA O, 1969, ACTA NEUROL SCAND, V45, P216; 1970, NEW ENGL J MED, V283, P806; 1976, NEW ENGL J MED, V294, P1447	41	26	26	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 31	1991	324	5					322	332		10.1056/NEJM199101313240508	http://dx.doi.org/10.1056/NEJM199101313240508			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU922	1986291				2022-12-28	WOS:A1991EU92200008
J	MOLFINO, NA; NANNINI, LJ; MARTELLI, AN; SLUTSKY, AS				MOLFINO, NA; NANNINI, LJ; MARTELLI, AN; SLUTSKY, AS			RESPIRATORY ARREST IN NEAR-FATAL ASTHMA	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BETA-ADRENERGIC AGONISTS; ORAL THEOPHYLLINE; MORTALITY; DEATH; FENOTEROL; VENTILATION; EXPERIENCE; ZEALAND; RATES	Background and Methods. The majority of asthma-related deaths occur outside the hospital, and therefore the exact factors leading to the terminal event are difficult to ascertain. To examine the mechanisms by which patients might die during acute exacerbations of asthma, we studied 10 such patients who arrived at the hospital in respiratory arrest or in whom it developed soon (within 20 minutes) after admission. Results. The characteristics of the group were similar to those associated in the literature with a high risk of death from asthma, including a long history of the disease in young to middle-aged patients, previous life-threatening attacks or hospitalizations, delay in obtaining medical aid, and sudden onset of a rapidly progressive crisis. Extreme hypercapnia (mean [+/- SD] partial pressure of arterial carbon dioxide, 97.1 +/- 31.1 mm Hg) and acidosis (mean [+/- SD] pH, 7.01 +/- 0.11) were found before mechanical ventilation was begun, and four patients had hypokalemia on admission. Despite the severe respiratory acidosis, no patient had a serious cardiac arrhythmia during the resuscitation maneuvers or during hospitalization. We observed systemic hypertension and sinus tachycardia in eight patients, atrial fibrillation in one, and sinus bradycardia in another. In both patients with arrhythmia the heart reverted to sinus rhythm immediately after manual ventilation with 100 percent oxygen was begun. The median duration of mechanical ventilation was 12 hours, and all patients had normocapnia on discharge from the hospital. Conclusions. We conclude that at least in this group of patients, the near-fatal nature of the exacerbations was the result of severe asphyxia rather than cardiac arrhythmias. These results suggest that undertreatment rather than overtreatment may contribute to an increase in mortality from asthma.	HOSP NACL MARIA FERRER,BUENOS AIRES,ARGENTINA; UNIV TORONTO,MT SINAI HOSP,DEPT MED,DIV RESP,TORONTO M5G 1X5,ONTARIO,CANADA	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute			Slutsky, Arthur S/A-6013-2008; Slutsky, Arthur/M-3325-2019	Slutsky, Arthur S/0000-0002-6063-3876; 				[Anonymous], 1984, Thorax, V39, P505; BARGER LW, 1988, ANN ALLERGY, V60, P31; BARRIOT P, 1987, CHEST, V92, P460, DOI 10.1378/chest.92.3.460; BATEMAN JRM, 1979, THORAX, V34, P40, DOI 10.1136/thx.34.1.40; BENATAR SR, 1986, NEW ENGL J MED, V314, P423, DOI 10.1056/NEJM198602133140706; BUIST AS, 1988, CHEST, V93, P449, DOI 10.1378/chest.93.3.449; COCHRANE GM, 1975, THORAX, V30, P300, DOI 10.1136/thx.30.3.300; COLEMAN JJ, 1986, CHEST, V90, P45, DOI 10.1378/chest.90.1.45; CRANE J, 1989, LANCET, V1, P917; CROMPTON G, 1987, BRIT J DIS CHEST, V81, P321, DOI 10.1016/0007-0971(87)90179-3; DARIOLI R, 1984, AM REV RESPIR DIS, V129, P385; DRISLANE FW, 1987, AM REV RESPIR DIS, V135, P498; FLATT A, 1989, CHEST, V96, P1317, DOI 10.1378/chest.96.6.1317; HAALBOOM JRE, 1985, LANCET, V1, P1125; Huber HL, 1922, ARCH INTERN MED, V30, P689, DOI 10.1001/archinte.1922.00110120002001; JOHNSON AJ, 1984, BRIT MED J, V288, P1870, DOI 10.1136/bmj.288.6434.1870; Joseph X, 1981, Fundam Appl Toxicol, V1, P443, DOI 10.1016/S0272-0590(81)80025-5; KEMP JP, 1984, J ALLERGY CLIN IMMUN, V73, P32, DOI 10.1016/0091-6749(84)90481-0; KNOCHEL JP, 1982, AM J MED, V72, P521, DOI 10.1016/0002-9343(82)90522-8; LUKSZA AR, 1986, THORAX, V41, P459, DOI 10.1136/thx.41.6.459; MACDONALD JB, 1976, BRIT MED J, V1, P1493, DOI 10.1136/bmj.1.6024.1493; MANNING P, 1987, IRISH MED J, V80, P406; MAO Y, 1987, CAN MED ASSOC J, V137, P620; MORRIS JF, 1971, AM REV RESPIR DIS, V103, P57; MUSK AW, 1987, MED J AUSTRALIA, V147, P423, DOI 10.5694/j.1326-5377.1987.tb133582.x; NICKLAS RA, 1984, J ALLERGY CLIN IMMUN, V73, P20, DOI 10.1016/0091-6749(84)90479-2; NICKLAS RA, 1982, NEW ENGL J MED, V307, P557; REA HH, 1986, THORAX, V41, P833, DOI 10.1136/thx.41.11.833; REBUCK AS, 1971, AM J MED, V51, P788, DOI 10.1016/0002-9343(71)90307-X; ROBIN ED, 1988, CHEST, V93, P614, DOI 10.1378/chest.93.3.614; ROTHWELL RPG, 1987, NEW ZEAL MED J, V100, P199; SEARS MR, 1986, BRIT MED J, V293, P1342, DOI 10.1136/bmj.293.6558.1342; SHEFFER AL, 1987, J ALLERGY CLIN IMMUN, V80, P361, DOI 10.1016/0091-6749(87)90047-9; SIEGEL SC, 1987, J ALLERGY CLIN IMMUN, V80, P458, DOI 10.1016/0091-6749(87)90075-3; SLY RM, 1988, ANN ALLERGY, V60, P433; SWENSON E R, 1985, American Review of Respiratory Disease, V131, pA99; WESTERMAN DE, 1979, AM J MED, V66, P565, DOI 10.1016/0002-9343(79)91165-3; WILSON JD, 1981, LANCET, V1, P1235; WOOLCOCK AJ, 1986, CHEST, V90, pS40, DOI 10.1378/chest.90.5_Supplement.40S; 1987, AM REV RESPIR DIS, V136, P225; 1987, BR J DIS CHEST, V81, P30; 1982, BMJ, V285, P1251	42	173	175	0	3	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 31	1991	324	5					285	288		10.1056/NEJM199101313240502	http://dx.doi.org/10.1056/NEJM199101313240502			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU922	1986288				2022-12-28	WOS:A1991EU92200002
J	GITTES, RF				GITTES, RF			CARCINOMA OF THE PROSTATE	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							DIGITAL RECTAL EXAMINATION; RADICAL RETROPUBIC PROSTATECTOMY; POST-IRRADIATION BIOPSY; RADIATION-THERAPY; HORMONAL-THERAPY; TREATED PATIENTS; ANTI-ANDROGEN; LOCALIZED ADENOCARCINOMA; PROGNOSTIC-SIGNIFICANCE; PELVIC LYMPHADENECTOMY				GITTES, RF (corresponding author), SCRIPPS CLIN & RES FDN, 10666 N TORREY PINES RD, LA JOLLA, CA 92037 USA.							ALLHOFF EP, 1983, J UROLOGY, V129, P315, DOI 10.1016/S0022-5347(17)52074-1; ASBELL SO, 1988, INT J RADIAT ONCOL, V15, P1307, DOI 10.1016/0360-3016(88)90225-8; Bagshaw M A, 1988, NCI Monogr, P47; BAGSHAW MA, 1965, RADIOLOGY, V85, P121, DOI 10.1148/85.1.121; BASINGER GT, 1975, J UROLOGY, V114, P740, DOI 10.1016/S0022-5347(17)67132-5; BENSON MC, 1988, NATL CANCER I MONOGR, V7, P19; BIGG S W, 1989, Journal of Urology, V141, p345A; BLACKLEDGE G, 1989, Journal of Urology, V141, p347A; BLUTE ML, 1989, J UROLOGY, V142, P1262, DOI 10.1016/S0022-5347(17)39051-1; BRAWER MK, 1988, ARCH PATHOL LAB MED, V112, P1110; BRENDLER CB, 1990, J UROLOGY, V144, P1137, DOI 10.1016/S0022-5347(17)39675-1; Byar D P, 1988, NCI Monogr, P165; BYAR DP, 1972, CANCER-AM CANCER SOC, V30, P5, DOI 10.1002/1097-0142(197207)30:1<5::AID-CNCR2820300103>3.0.CO;2-S; CARLTON CE, 1976, J UROLOGY, V116, P206, DOI 10.1016/S0022-5347(17)58750-9; CARTER SS, 1989, UROL CLIN N AM, V16, P751; CHAN DW, 1987, CLIN CHEM, V33, P1916; CHODAK GW, 1984, J UROLOGY, V132, P480, DOI 10.1016/S0022-5347(17)49699-6; CHODAK GW, 1989, J UROLOGY, V141, P1136, DOI 10.1016/S0022-5347(17)41192-X; CHODAK GW, 1989, UROL CLIN N AM, V16, P657; COONER WH, 1988, J UROLOGY, V139, P758, DOI 10.1016/S0022-5347(17)42624-3; CRAWFORD ED, 1989, NEW ENGL J MED, V321, P419, DOI 10.1056/NEJM198908173210702; DALTON DL, 1989, UROLOGY, V33, P465, DOI 10.1016/0090-4295(89)90131-3; DAYAL HH, 1985, J NATL CANCER I, V74, P1001; DEVOOGT HJ, 1986, J UROLOGY, V135, P303, DOI 10.1016/S0022-5347(17)45620-5; DISILVERIO F, 1990, J UROLOGY, V143, pA308; EGAWA S, 1989, UROL CLIN N AM, V16, P741; EISENBERGER M A, 1988, NCI (National Cancer Institute) Monographs, P151; EPSTEIN JI, 1984, CANCER, V54, P1666, DOI 10.1002/1097-0142(19841015)54:8<1666::AID-CNCR2820540830>3.0.CO;2-7; FAIR WR, 1989, J UROLOGY, V142, pA282; FALLON B, 1990, UROL CLIN N AM, V17, P853; FORD TF, 1985, BRIT J UROL, V57, P50, DOI 10.1111/j.1464-410X.1985.tb08984.x; FOURCADE R O, 1990, Journal of Urology, V143, p220A; FOWLER JE, 1981, CANCER, V47, P2941, DOI 10.1002/1097-0142(19810615)47:12<2941::AID-CNCR2820471235>3.0.CO;2-F; FOWLER JE, 1981, J UROLOGY, V126, P372, DOI 10.1016/S0022-5347(17)54531-0; FREIHA FS, 1984, PROSTATE, V5, P19, DOI 10.1002/pros.2990050103; GAETA JF, 1986, UROLOGY, V27, P306, DOI 10.1016/0090-4295(86)90302-X; GAGNON JD, 1979, J UROLOGY, V121, P182, DOI 10.1016/S0022-5347(17)56713-0; GARNICK MB, 1984, NEW ENGL J MED, V311, P1281; GERVASI LA, 1989, J UROLOGY, V142, P332, DOI 10.1016/S0022-5347(17)38748-7; GIBBONS R P, 1988, NCI (National Cancer Institute) Monographs, P123; GITTES RF, 1987, NEW ENGL J MED, V317, P954, DOI 10.1056/NEJM198710083171508; Gleason DF, 1977, UROLOGIC PATHOLOGY P, P171; GLENN JF, 1990, J UROLOGY, V144, P942, DOI 10.1016/S0022-5347(17)39626-X; GOLDSTEIN I, 1984, JAMA-J AM MED ASSOC, V251, P903, DOI 10.1001/jama.251.7.903; GUILEYARDO JM, 1980, J NATL CANCER I, V65, P311; HANKS G E, 1988, NCI (National Cancer Institute) Monographs, P75; HANKS GE, 1989, UROLOGY, V33, P37, DOI 10.1016/0090-4295(89)90104-0; HERR HW, 1982, PROSTATE, V3, P339, DOI 10.1002/pros.2990030404; HILL PB, 1979, CANCER LETT, V7, P273, DOI 10.1016/S0304-3835(79)80054-3; HODGE KK, 1989, J UROLOGY, V142, P66, DOI 10.1016/S0022-5347(17)38663-9; HODGE KK, 1989, J UROLOGY, V142, P71, DOI 10.1016/S0022-5347(17)38664-0; HOLDAWAY I, 1990, Journal of Urology, V143, p220A; HOLM HH, 1983, J UROLOGY, V130, P283, DOI 10.1016/S0022-5347(17)51108-8; HORTIN GL, 1988, J UROLOGY, V139, P762, DOI 10.1016/S0022-5347(17)42627-9; HRICAK H, 1988, NCI (National Cancer Institute) Monographs, P31; HUDSON MA, 1989, J UROLOGY, V142, P1011, DOI 10.1016/S0022-5347(17)38972-3; HUGGINS C, 1945, ANN SURG, V122, P1031, DOI 10.1097/00000658-194512260-00012; Huggins C, 1941, CANCER RES, V1, P293; IVERSEN P, 1989, Journal of Urology, V141, p348A; KABALIN JN, 1989, J UROLOGY, V142, P326, DOI 10.1016/S0022-5347(17)38746-3; KABALIN JN, 1989, J UROLOGY, V141, P1091, DOI 10.1016/S0022-5347(17)41178-5; KAYE K W, 1989, Journal of Endourology, V3, P155, DOI 10.1089/end.1989.3.155; KIESLING VJ, 1980, J UROLOGY, V124, P851, DOI 10.1016/S0022-5347(17)55697-9; KLEIN LA, 1979, NEW ENGL J MED, V300, P824, DOI 10.1056/NEJM197904123001504; KRANE RJ, 1989, NEW ENGL J MED, V321, P1648, DOI 10.1056/NEJM198912143212406; KUHN JM, 1989, NEW ENGL J MED, V321, P413, DOI 10.1056/NEJM198908173210701; LABRIE F, 1982, CLIN INVEST MED, V5, P267; LABRIE F, 1983, J STEROID BIOCHEM, V19, P999, DOI 10.1016/0022-4731(83)90046-8; LANGE PH, 1989, UROLOGY, V34, P13, DOI 10.1016/0090-4295(89)90229-X; LARAMORE GE, 1985, INT J RADIAT ONCOL, V11, P1621, DOI 10.1016/0360-3016(85)90214-7; LEACH GE, 1982, J UROLOGY, V128, P505, DOI 10.1016/S0022-5347(17)53019-0; LEE F, 1989, RADIOLOGY, V170, P29, DOI 10.1148/radiology.170.1.2462262; LEE F, 1988, RADIOLOGY, V168, P389, DOI 10.1148/radiology.168.2.3293108; LEPOR H, 1988, NATL CANCER I MONOGR, V7, P117; LEVINE RL, 1979, J UROLOGY, V121, P761, DOI 10.1016/S0022-5347(17)56981-5; LOENING S A, 1989, Journal of Endourology, V3, P201, DOI 10.1089/end.1989.3.201; MANNI A, 1986, J UROLOGY, V136, P1242, DOI 10.1016/S0022-5347(17)45299-2; MCCONNELL JD, 1990, UROL CLIN N AM, V17, P661; MCCULLOUGH DL, 1972, J UROLOGY, V108, P939, DOI 10.1016/S0022-5347(17)60912-1; MCNEAL JE, 1986, LANCET, V1, P60; MCNEAL JE, 1988, AM J SURG PATHOL, V12, P897, DOI 10.1097/00000478-198812000-00001; Middleton RG, 1988, NATL CANCER I MONOGR, V7, P41; MOSTOFI FK, 1975, CANCER CHEMOTH REP 1, V59, P111; MULDOON L, 1989, UROL CLIN N AM, V16, P693; MURPHY GP, 1980, PROGR CLIN BIOL RES, V37; NACHTSHEIM DA, 1978, J UROLOGY, V120, P312, DOI 10.1016/S0022-5347(17)57150-5; NEERHUT GJ, 1988, J UROLOGY, V140, P544, DOI 10.1016/S0022-5347(17)41714-9; NESBITT JA, 1989, UROLOGY, V34, P120, DOI 10.1016/0090-4295(89)90243-4; NOBLE RL, 1977, CANCER RES, V37, P1929; ODONNELL PD, 1989, J UROLOGY, V142, P1227, DOI 10.1016/S0022-5347(17)39038-9; OESTERLING JE, 1987, J UROLOGY, V138, P92, DOI 10.1016/S0022-5347(17)43003-5; PAULSON D F, 1988, NCI (National Cancer Institute) Monographs, P127; PAULSON DF, 1980, J UROLOGY, V123, P697, DOI 10.1016/S0022-5347(17)56095-4; PAULSON DF, 1982, J UROLOGY, V127, P935, DOI 10.1016/S0022-5347(17)54136-1; PAVONEMACALUSO M, 1989, UROLOGY, V34, P27, DOI 10.1016/0090-4295(89)90232-X; PERRIN P, 1989, Journal of Endourology, V3, P109, DOI 10.1089/end.1989.3.109; PETERS CA, 1985, J UROLOGY, V134, P81, DOI 10.1016/S0022-5347(17)46991-6; PILEPICH M V, 1988, NCI (National Cancer Institute) Monographs, P61; RAGDE H, 1988, UROLOGY, V32, P503, DOI 10.1016/S0090-4295(98)90029-2; RAGDE H, 1989, Journal of Endourology, V3, P115, DOI 10.1089/end.1989.3.115; REINER WG, 1979, J UROLOGY, V121, P198, DOI 10.1016/S0022-5347(17)56718-X; ROSS R, 1986, JNCI-J NATL CANCER I, V76, P45; ROSS RK, 1988, DIAGNOSIS MANAGEMENT, P40; SAITOH H, 1984, CANCER-AM CANCER SOC, V54, P3078, DOI 10.1002/1097-0142(19841215)54:12<3078::AID-CNCR2820541245>3.0.CO;2-U; Scardino P T, 1988, NCI Monogr, P95; SCARDINO PT, 1986, J UROLOGY, V135, P510, DOI 10.1016/S0022-5347(17)45712-0; SCARDINO PT, 1989, UROL CLIN N AM, V16, P713; SCARDINO PT, 1989, UROL CLIN N AM, V16, P635; SCHALLY AV, 1971, BIOCHEM BIOPH RES CO, V43, P393, DOI 10.1016/0006-291X(71)90766-2; SCHALLY AV, 1983, PROSTATE, V4, P545, DOI 10.1002/pros.2990040602; SCHELLHAMMER PF, 1987, J UROLOGY, V137, P897, DOI 10.1016/S0022-5347(17)44289-3; SCHNALL MD, 1989, RADIOLOGY, V172, P570, DOI 10.1148/radiology.172.2.2748842; SCHROEDER FH, 1975, J UROLOGY, V114, P257, DOI 10.1016/S0022-5347(17)67002-2; SCOTT R, 1969, J UROLOGY, V101, P602, DOI 10.1016/S0022-5347(17)62388-7; SCOTT WW, 1980, CANCER-AM CANCER SOC, V45, P1929, DOI 10.1002/cncr.1980.45.s7.1929; SHEARER R J, 1973, British Journal of Urology, V45, P668, DOI 10.1111/j.1464-410X.1973.tb12238.x; SHELDON CA, 1980, J UROLOGY, V124, P626, DOI 10.1016/S0022-5347(17)55589-5; Shipley W U, 1988, NCI Monogr, P67; SILVERBERG E, 1989, CA-CANCER J CLIN, V39, P3; SMITH JA, 1990, UROL CLIN N AM, V17, P769; SNYDER P, 1989, J UROLOGY, V142, pA309; SOGANI PC, 1981, UROLOGY, V17, P39, DOI 10.1016/0090-4295(81)90009-1; STAMEY TA, 1987, NEW ENGL J MED, V317, P909, DOI 10.1056/NEJM198710083171501; STAMEY TA, 1990, J UROLOGY, V143, P1166; STAMEY TA, 1988, J UROLOGY, V139, P1235; STAMEY TA, 1989, J UROLOGY, V141, P1084, DOI 10.1016/S0022-5347(17)41176-1; STAMEY TA, 1989, J UROLOGY, V141, P1088, DOI 10.1016/S0022-5347(17)41177-3; STAMEY TA, 1989, J UROLOGY, V141, P1070; STAMEY TA, 1989, J UROLOGY, V141, P1076, DOI 10.1016/S0022-5347(17)41175-X; STAMEY TA, 1989, UROLOGY MONOGR, V10, P50; STAMEY TA, 1989, UROLOGY MONOGR, V10, P79; STEIN BS, 1985, UROLOGY, V25, P350, DOI 10.1016/0090-4295(85)90484-4; THOMPSON TC, 1989, CELL, V56, P917, DOI 10.1016/0092-8674(89)90625-9; TRACHTENBERG J, 1989, Journal of Urology, V141, p347A; VILLERS A, 1989, J UROLOGY, V142, P763, DOI 10.1016/S0022-5347(17)38881-X; VIOLA MV, 1986, NEW ENGL J MED, V314, P133, DOI 10.1056/NEJM198601163140301; WALSH P C, 1988, NCI (National Cancer Institute) Monographs, P133; Walsh P C, 1975, Urol Clin North Am, V2, P125; WALSH PC, 1970, ENDOCRINOLOGY, V87, P624, DOI 10.1210/endo-87-3-624; WALSH PC, 1987, J UROLOGY, V138, P823, DOI 10.1016/S0022-5347(17)43385-4; WALSH PC, 1982, J UROLOGY, V128, P492, DOI 10.1016/S0022-5347(17)53012-8; WANG MC, 1979, INVEST UROL, V17, P159; WHITMORE WF, 1972, J UROLOGY, V108, P918, DOI 10.1016/S0022-5347(17)60906-6; YATANI R, 1982, INT J CANCER, V29, P611, DOI 10.1002/ijc.2910290602; ZARIDZE DG, 1987, BRIT J UROL, V59, P493, DOI 10.1111/j.1464-410X.1987.tb04862.x; ZINCKE H, 1986, J UROLOGY, V135, P1199, DOI 10.1016/S0022-5347(17)46034-4; ZINCKE H, 1989, UROLOGY, V33, P27, DOI 10.1016/0090-4295(89)90103-9; 1989, J UROLOGY, V141, pA346; [No title captured]	149	402	428	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 24	1991	324	4					236	245		10.1056/NEJM199101243240406	http://dx.doi.org/10.1056/NEJM199101243240406			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU022	1985245				2022-12-28	WOS:A1991EU02200006
J	LOBEL, HO; BERNARD, KW; WILLIAMS, SL; HIGHTOWER, AW; PATCHEN, LC; CAMPBELL, CC				LOBEL, HO; BERNARD, KW; WILLIAMS, SL; HIGHTOWER, AW; PATCHEN, LC; CAMPBELL, CC			EFFECTIVENESS AND TOLERANCE OF LONG-TERM MALARIA PROPHYLAXIS WITH MEFLOQUINE - NEED FOR A BETTER DOSING REGIMEN	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PLASMODIUM-FALCIPARUM; CHLOROQUINE; TRAVELERS	To measure the effectiveness and tolerance of long-term malaria prophylaxis with mefloquine, the incidence of Plasmodium falciparum malaria and of adverse reactions was compared in Peace Corps volunteers in West Africa who took mefloquine every 2 weeks and in volunteers who took chloroquine phosphate weekly. Mefloquine was only 63% more effective than chloroquine; the monthly incidence of P falciparum infections was one case per 100 volunteers who took mefloquine and 2.7 cases per 100 volunteers who took chloroquine. Using daily proguanil (chlorguanide) hydrochloride in addition to chloroquine did not provide additional protection. All mefloquine prophylaxis failures occurred during the second week of the every-2-weeks dosing regimen in volunteers who had used mefloquine for more than 2 months. Blood concentrations of mefloquine were lower during the second week of the alternate-week regimen than during the first week, suggesting that blood levels are to low during the second week to suppress parasitemia. No serious adverse reactions were observed. The results indicate that a dosing regimen of 250 mg of mefloquine weekly should be considered for travelers to areas with chloroquine-resistant P falciparum malaria.	CTR DIS CONTROL, CTR INFECT DIS, DIV PARASIT DIS, STAT SERV, ATLANTA, GA 30333 USA; OFF INT HLTH, WASHINGTON, DC USA	Centers for Disease Control & Prevention - USA	LOBEL, HO (corresponding author), CTR DIS CONTROL, MALARIA BRANCH, ATLANTA, GA 30333 USA.							ARTHUR JD, 1990, LANCET, V335, P972, DOI 10.1016/0140-6736(90)91035-9; BERNARD KW, 1989, INT J EPIDEMIOL, V18, P220, DOI 10.1093/ije/18.1.220; BERQQUIST Y, 1988, J CHROMATOGR, V432, P253; BJORKMAN A, 1989, LANCET, V2, P865; BJORKMAN A, 1990, T ROY SOC TROP MED H, V84, P177, DOI 10.1016/0035-9203(90)90246-B; BOUDREAU EF, 1988, 37TH ANN M AM SOC TR; BRADLEY DJ, 1989, BMJ-BRIT MED J, V299, P1087, DOI 10.1136/bmj.299.6707.1087; GUESS HA, 1987, AM J EPIDEMIOL, V125, P340, DOI 10.1093/oxfordjournals.aje.a114535; LOBEL HO, 1990, B WORLD HEALTH ORGAN, V68, P209; MORAN JS, 1989, JAMA-J AM MED ASSOC, V262, P245, DOI 10.1001/jama.262.2.245; ODUOLA AMJ, 1987, LANCET, V2, P1304, DOI 10.1016/S0140-6736(87)91195-0; PEARLMAN EJ, 1980, AM J TROP MED HYG, V29, P1131, DOI 10.4269/ajtmh.1980.29.1131; PHILLIPSHOWARD PA, 1990, BMJ-BRIT MED J, V300, P499, DOI 10.1136/bmj.300.6723.499; SALAKO LA, 1987, LANCET, V1, P572; SLUTSKER L, IN PRESS B WHO; STEFFEN R, 1990, B WORLD HEALTH ORGAN, V68, P313; STEFFEN R, 1990, I PRESS T R SOC TROP; VENNING GR, 1983, BRIT MED J, V286, P458, DOI 10.1136/bmj.286.6363.458; 1990, MMWR, V39, P360; WHOMAL891054 SER PUB; 1990, MMWR, V39, P1	21	67	67	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 16	1991	265	3					361	364		10.1001/jama.265.3.361	http://dx.doi.org/10.1001/jama.265.3.361			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ER256	1984534				2022-12-28	WOS:A1991ER25600025
J	HAYWARD, RA; SHAPIRO, MF				HAYWARD, RA; SHAPIRO, MF			A NATIONAL STUDY OF AIDS AND RESIDENCY TRAINING - EXPERIENCES, CONCERNS, AND CONSEQUENCES	ANNALS OF INTERNAL MEDICINE			English	Article							ACQUIRED IMMUNODEFICIENCY SYNDROME; NEEDLESTICK INJURIES; PHYSICIAN ATTITUDES; CARE; HOMOSEXUALITY; EPIDEMIC; MEDICINE; IMPACT	Objective: To examine residents' experiences in the care of patients with the acquired immunodeficiency syndrome (AIDS), and to examine factors that my influence their attitudes about such care. Design: Cross-sectional, self-administered questionnaire survey conducted in 1989. Participants: All senior internal medicine and family medicine residents in ten geographically representative states who were identified through the 1986 National Residency Matching Program. Measurements and Main Results: Seventy-four percent of residents reported that patients with AIDS accounted for 5% or more of general medicine admissions, and 50% of residents reported that they were currently following one or more human immunodeficiency virus (HIV)-infected patients in their continuity clinics. Among residents who had provided ambulatory care to patients with AIDS, 77% felt that it was an excellent educational experience, and among those who planned to do general primary care in their future practices, 74% planned on providing primary care to patients with AIDS. However, 61% expressed concerns about the adequacy of their training in AIDS ambulatory care. A greater amount of contact with outpatients who had AIDS, but not with inpatients who had AIDS, was associated with residents' intending to provide AIDS primary care in their future practices. Among all residents, 23% reported that, if given a choice, they would not provide care to any patients with AIDS, and 23% reported that they would not work in an area with a high prevalence of AIDS because of concern about contracting the syndrome. Nine percent of residents reported that they had been exposed to a blood-contaminated needlestick from an HIV-seropositive patient. Conclusions: Although most residents have substantial contact with inpatients and outpatients with AIDS, most still find their education in AIDS ambulatory care to be deficient. A minority of residents would prefer not to care for patients with AIDS. Residency curricula should include training and experience in ambulatory AIDS care, explicitly address negative attitudes toward caring for patients with AIDS, and include programs to reduce needlestick exposures.	UNIV MICHIGAN, SCH MED, ANN ARBOR, MI 48109 USA; UNIV MICHIGAN, SCH PUBL HLTH, ANN ARBOR, MI 48109 USA; UNIV CALIF LOS ANGELES, SCH MED, LOS ANGELES, CA 90024 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA								AOUN H, 1989, NEW ENGL J MED, V321, P693, DOI 10.1056/NEJM198909073211020; COHEN PT, AIDS KNOWLEDGE BASE; COONEY TG, 1986, J GEN INTERN MED, V1, P339, DOI 10.1007/BF02596215; CROWLEY AE, 1988, 1988 1989 DIRECTORY; DONDERO TJ, 1989, 5TH INT C AIDS MONTR, P45; DOUGLAS CJ, 1985, HOSP COMMUNITY PSYCH, V36, P1309; EDMOND M, 1988, INFECT CONT HOSP EP, V9, P114, DOI 10.1086/645806; FREEMAN G, AIDS ALERT; GERBERDING JL, 1987, J INFECT DIS, V156, P861, DOI 10.1093/infdis/156.6.861; GOLDWATER PN, 1989, INFECT CONT HOSP EP, V10, P21, DOI 10.1086/645910; GOTTLIEB MS, AIDS CLIN DIGEST; HAYWARD RA, 1991, IN PRESS J GEN INTER, V6; HENDERSON DK, 1990, AIDS UPDATES, V3, P1; JAMES JS, AIDS TREATMENT NEWS; KELLY JA, 1987, J MED EDUC, V62, P549; KELLY JA, 1987, AM J PUBLIC HEALTH, V77, P789, DOI 10.2105/AJPH.77.7.789; KENNEDY DA, 1988, J HOSP INFECT, V12, P315, DOI 10.1016/0195-6701(88)90074-6; LIEU TA, 1989, ACAD MED, V64, P622, DOI 10.1097/00001888-198910000-00015; LINK RN, 1988, AM J PUBLIC HEALTH, V78, P455, DOI 10.2105/AJPH.78.4.455; LINN LS, 1989, ACAD MED, V64, P408, DOI 10.1097/00001888-198907000-00016; MATHEWS WC, 1986, WESTERN J MED, V144, P106; MCKUSICK L, 1986, W J MED, V144, P750; MELZER SM, 1989, PEDIATRICS, V84, P211; MIZES JS, 1984, PUBLIC OPIN QUART, V48, P794, DOI 10.1086/268885; MORGAN DR, 1988, J HOSP INFECT, V12, P301, DOI 10.1016/0195-6701(88)90072-2; NESS R, 1989, ACAD MED, V64, P588, DOI 10.1097/00001888-198910000-00009; NORTHFELT DW, 1988, ANN INTERN MED, V109, P773, DOI 10.7326/0003-4819-109-10-773; PRICHARD JG, 1988, J FAM PRACTICE, V27, P637; RICHARDSON JL, 1987, MED CARE, V25, P675, DOI 10.1097/00005650-198708000-00001; ROSNER F, 1989, AM J MED, V87, P601, DOI 10.1016/S0002-9343(89)80630-8; SADOVSKY R, 1989, AM FAM PHYSICIAN, V40, P121; WACHTER RM, 1986, NEW ENGL J MED, V314, P177, DOI 10.1056/NEJM198601163140310; WHITE LJ, 1988, ANN INTERN MED, V108, P460, DOI 10.7326/0003-4819-108-3-460; WORMSER GP, 1989, POSTGRAD MED, V86, P174; 1989, HIV AIDS SURVEILLANC, P1; 1990, AIDS UPDATE, V3, P3; 1987, MED WORLD NEWS, V28, P12; 1989, AIDS PRIMARY CARE PR; 1986, PUB HLTH REP, V101, P341; 1990, MMWR, V39, P1	40	67	67	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 1	1991	114	1					23	32		10.7326/0003-4819-114-1-23	http://dx.doi.org/10.7326/0003-4819-114-1-23			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EQ040	1983928				2022-12-28	WOS:A1991EQ04000004
J	WEN, L; PEAKMAN, M; LOBOYEO, A; MCFARLANE, BM; MOWAT, AP; MIELIVERGANI, G; VERGANI, D				WEN, L; PEAKMAN, M; LOBOYEO, A; MCFARLANE, BM; MOWAT, AP; MIELIVERGANI, G; VERGANI, D			T-CELL-DIRECTED HEPATOCYTE DAMAGE IN AUTOIMMUNE CHRONIC ACTIVE HEPATITIS	LANCET			English	Article							MEMBRANE LIPOPROTEIN; AUTOANTIBODIES; ANTIBODIES	To investigate the function of activated T lymphocytes in atuoimmune chronic active hepatitis, 7 or 15 T-cell clones from the peripheral blood of 8 patients were studied. These clones showed specificity for liver-membrane antigen with proliferation when stimulated by rabbit liver cell membranes. 6 of these clones reacted with liver-specific lipoprotein complex, and 1 clone (and 3 subclones) responded to the asialoglycoprotein receptor (ASGPR), both known targets of immune attack in autoimmune chronic active hepatitis. 2 of these clones stimulated autologous B lymphocytes to produce liver-membrane-specific autoantibodies and antibody to the ASGPR. These results suggest that liver-membrane-specific activated T lymphocytes in peripheral blood may be important in the autoimmune attack of chronic active hepatitis.	KINGS COLL,SCH MED & DENT,DEPT IMMUNOL,BESSEMER RD,LONDON SE5 9PJ,ENGLAND; UNIV LONDON KINGS COLL,SCH MED & DENT,DEPT CHILD HLTH,LONDON WC2R 2LS,ENGLAND; UNIV LONDON KINGS COLL,SCH MED & DENT,LIVER UNIT,LONDON WC2R 2LS,ENGLAND	University of London; King's College London; University of London; King's College London; University of London; King's College London			Vergani, Diego/H-7610-2019; Mieli-Vergani, Giorgina/G-5616-2011	Mieli-Vergani, Giorgina/0000-0002-8215-4489; Wen, Li/0000-0002-8805-2934	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ACHAORBEA H, 1988, CELL, V54, P263, DOI 10.1016/0092-8674(88)90558-2; BLUE ML, 1986, J IMMUNOL, V137, P1202; EDDLESTON ALW, 1974, LANCET, V2, P1543; Fiske CH, 1925, J BIOL CHEM, V66, P375; JENSEN DM, 1978, NEW ENGL J MED, V299, P1, DOI 10.1056/NEJM197807062990101; LOBOYEO A, 1987, CLIN EXP IMMUNOL, V67, P95; LONDEI M, 1985, SCIENCE, V228, P85, DOI 10.1126/science.3871967; MCFARLANE BM, 1986, J HEPATOL, V3, P196, DOI 10.1016/S0168-8278(86)80026-5; MCFARLANE IG, 1977, CLIN EXP IMMUNOL, V27, P381; MCFARLANE IG, 1984, LANCET, V2, P954; MIELI VERGANI G., 1979, Clinical and Experimental Immunology, V38, P16; NABHOLZ M, 1982, ISOLATION CHARACTERI, P163; Pertoft H., 1977, METHODS CELL, P25; SHERLOCK S, 1989, DISEASES LIVER BILIA, P348; SWANSON NR, 1989, CLIN IMMUNOL IMMUNOP, V52, P291, DOI 10.1016/0090-1229(89)90180-3; TASWELL C, 1981, J IMMUNOL, V126, P1614; VINCENT R, 1983, ANAL BIOCHEM, V135, P255	17	74	77	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	DEC 22	1990	336	8730					1527	1530		10.1016/0140-6736(90)93306-A	http://dx.doi.org/10.1016/0140-6736(90)93306-A			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP037	1979365				2022-12-28	WOS:A1990EP03700003
J	PRIVALSKY, ML; SHARIF, M; YAMAMOTO, KR				PRIVALSKY, ML; SHARIF, M; YAMAMOTO, KR			THE VIRAL ERBA ONCOGENE PROTEIN, A CONSTITUTIVE REPRESSOR IN ANIMAL-CELLS, IS A HORMONE-REGULATED ACTIVATOR IN YEAST	CELL			English	Article							AVIAN ERYTHROBLASTOSIS VIRUS; HEAT-SHOCK PROTEIN; THYROID-HORMONE; GLUCOCORTICOID RECEPTOR; V-ERBA; TRANS-ACTIVATION; RESPONSE ELEMENT; BINDING DOMAIN; RETINOIC-ACID; GENE	The v-erbA oncogene is a retrovirus-transduced and altered copy of a cellular gene for a thyroid hormone receptor. In animal cells, the v-erbA protein fails to respond to hormone and acts as a dominant negative allele, inhibiting gene activation normally conferred by the wild-type thyroid hormone receptor. We report here that, unexpectedly, the v-erbA protein acts as a hormone-regulated transcriptional activator in S. cerevisiae. We suggest that the ability of v-erbA protein to function as a transcriptional repressor or an activator is determined by interaction with, or modification by, other cellular factors, and that this phenomenon may be relevant to understanding ligand regulation of the normal thyroid and steroid hormone receptors.	UNIV CALIF SAN FRANCISCO,DEPT BIOCHEM & BIOPHYS,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco	PRIVALSKY, ML (corresponding author), UNIV CALIF DAVIS,DEPT MICROBIOL,DAVIS,CA 95616, USA.							AKERBLOM IE, 1988, SCIENCE, V241, P350, DOI 10.1126/science.2838908; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; BECKER DM, 1989, MOL CELL BIOL, V9, P3878, DOI 10.1128/MCB.9.9.3878; BONDE BG, 1990, J VIROL, V64, P1314, DOI 10.1128/JVI.64.3.1314-1320.1990; BOUCHER P, 1990, ONCOGENE, V5, P1303; BRESNICK EH, 1989, J BIOL CHEM, V264, P4992; DALMAN FC, 1990, J BIOL CHEM, V265, P3615; DAMM K, 1989, NATURE, V339, P593, DOI 10.1038/339593a0; DENIS M, 1989, CANCER RES, V49, pS2275; DIAMOND MI, 1990, SCIENCE, V249, P1266, DOI 10.1126/science.2119054; EILERS M, 1989, NATURE, V340, P66, DOI 10.1038/340066a0; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; GLASS CK, 1988, CELL, V54, P313, DOI 10.1016/0092-8674(88)90194-8; GLASS CK, 1987, NATURE, V329, P738, DOI 10.1038/329738a0; GOLDBERG Y, 1988, EMBO J, V7, P2425, DOI 10.1002/j.1460-2075.1988.tb03088.x; GRAF T, 1983, CELL, V34, P7, DOI 10.1016/0092-8674(83)90130-7; GRAUPNER G, 1989, NATURE, V340, P653, DOI 10.1038/340653a0; GRAVES BJ, 1986, CELL, V44, P565, DOI 10.1016/0092-8674(86)90266-7; GREEN S, 1988, TRENDS GENET, V4, P309, DOI 10.1016/0168-9525(88)90108-4; HOLLENBERG SM, 1988, CELL, V55, P899, DOI 10.1016/0092-8674(88)90145-6; INOUE A, 1983, ANAL BIOCHEM, V134, P176, DOI 10.1016/0003-2697(83)90280-4; JONAT G, 1990, CELL, V62, P1189; JONES KA, 1985, CELL, V42, P559, DOI 10.1016/0092-8674(85)90113-8; KLEINHITPASS L, 1990, CELL, V60, P247, DOI 10.1016/0092-8674(90)90740-6; KOENIG RJ, 1989, NATURE, V337, P659, DOI 10.1038/337659a0; MA J, 1987, CELL, V51, P113, DOI 10.1016/0092-8674(87)90015-8; MENDEL DB, 1990, PROG CLIN BIOL RES, V322, P97; METZGER D, 1988, NATURE, V334, P31, DOI 10.1038/334031a0; MUNOZ A, 1988, EMBO J, V7, P155, DOI 10.1002/j.1460-2075.1988.tb02795.x; NORDEEN SK, 1987, DNA-J MOLEC CELL BIO, V6, P173, DOI 10.1089/dna.1987.6.173; PICARD D, 1988, CELL, V54, P1073, DOI 10.1016/0092-8674(88)90122-5; PICARD D, 1990, IN PRESS NATURE; PRIVALSKY ML, 1988, MOL CELL BIOL, V8, P4510, DOI 10.1128/MCB.8.10.4510; PRIVALSKY ML, 1991, IN PRESS J BIOL CHEM; SAKAI DD, 1988, GENE DEV, V2, P1144, DOI 10.1101/gad.2.9.1144; SAP J, 1989, NATURE, V340, P242, DOI 10.1038/340242a0; SAP J, 1986, NATURE, V324, P635, DOI 10.1038/324635a0; SCHENA M, 1989, GENE DEV, V3, P1590, DOI 10.1101/gad.3.10.1590; SCHENA M, 1988, SCIENCE, V241, P965, DOI 10.1126/science.3043665; SCHENA M, 1990, IN PRESS METH ENZYMO; SCHULE R, 1990, CELL, V62, P1217, DOI 10.1016/0092-8674(90)90397-W; SHERIDAN PL, 1989, J BIOL CHEM, V264, P6520; SULLIVAN WP, 1988, J BIOL CHEM, V263, P14717; UMESONO K, 1988, NATURE, V336, P262, DOI 10.1038/336262a0; WEINBERGER C, 1986, NATURE, V324, P641, DOI 10.1038/324641a0; YANGYEN HF, 1990, CELL, V62, P1205, DOI 10.1016/0092-8674(90)90396-V; ZENKE M, 1988, CELL, V52, P107, DOI 10.1016/0092-8674(88)90535-1; ZENKE M, 1990, CELL, V61, P1035, DOI 10.1016/0092-8674(90)90068-P	48	86	90	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	DEC 21	1990	63	6					1277	1286		10.1016/0092-8674(90)90423-C	http://dx.doi.org/10.1016/0092-8674(90)90423-C			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN923	1979758				2022-12-28	WOS:A1990EN92300018
J	MUELDER, K; NOUROU, A				MUELDER, K; NOUROU, A			BURULI ULCER IN BENIN	LANCET			English	Article									CSD,COVE,BENIN									[Anonymous], 1970, Br Med J, V2, P390; BARTMAN K, 1988, HDB EXPT PHARM, V84, P289; BURCHARD GD, 1986, TROP MED PARASITOL, V37, P1; CHRISTIE M, 1987, MED J AUSTRALIA, V146, P600, DOI 10.5694/j.1326-5377.1987.tb120425.x; CLANCEY JK, 1964, J PATHOL BACTERIOL, V88, P174; CONNOR DH, 1966, ARCH PATHOL, V81, P183; DODGE OG, 1964, J PATHOL BACTERIOL, V88, P167, DOI 10.1002/path.1700880122; HAYMAN J, 1985, PATHOLOGY, V17, P594, DOI 10.3109/00313028509084759; Kieninger G, 1973, Infection, V1, P46, DOI 10.1007/BF01638256; KRIEG RE, 1979, AVIAT SPACE ENVIR MD, V50, P888; LUNN HF, 1965, E AFR MED J, V42, P276; MACCALLUM P, 1948, J PATHOL BACTERIOL, V60, P93, DOI 10.1002/path.1700600111; MEYERS WM, 1974, AM J TROP MED HYG, V23, P924, DOI 10.4269/ajtmh.1974.23.924; Muelder K, 1988, Trop Doct, V18, P53; OLUWASANMI JO, 1976, AM J TROP MED HYG, V25, P122, DOI 10.4269/ajtmh.1976.25.122; SONG M, 1985, DERMATOLOGICA, V171, P197, DOI 10.1159/000249419	16	33	33	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 3	1990	336	8723					1109	1111		10.1016/0140-6736(90)92581-2	http://dx.doi.org/10.1016/0140-6736(90)92581-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF992	1977990				2022-12-28	WOS:A1990EF99200014
J	DAVIES, PRF; TIGHE, SQM; GREENSLADE, GL; EVANS, GH				DAVIES, PRF; TIGHE, SQM; GREENSLADE, GL; EVANS, GH			LARYNGEAL MASK AIRWAY AND TRACHEAL TUBE INSERTION BY UNSKILLED PERSONNEL	LANCET			English	Article									ROYAL NAVAL HOSP,DEPT ANAESTHESIA,GOSPORT PO12 2AA,HANTS,ENGLAND									ALEXANDER CA, 1989, TODAYS ANAESTHETIST, V4, P200; BRAIN AIJ, 1984, ARCH EMERG MED, V1, P229; BRAIN AIJ, 1983, BRIT J ANAESTH, V55, P801, DOI 10.1093/bja/55.8.801; BRAIN AIJ, 1985, ANAESTHESIA, V40, P353; BRODRICK PM, 1989, ANAESTHESIA, V44, P283; HEATH ML, 1990, BRIT J ANAESTH, V64, pP382; JESUDIAN MCS, 1985, CRIT CARE MED, V13, P122, DOI 10.1097/00003246-198502000-00015; PEPE PE, 1985, ANN EMERG MED, V14, P1085, DOI 10.1016/S0196-0644(85)80927-6; SHEA SR, 1985, ANN EMERG MED, V14, P102, DOI 10.1016/S0196-0644(85)81069-6; WILKINSON PA, 1990, ANAESTHESIA, V45, P167, DOI 10.1111/j.1365-2044.1990.tb14296.x; WYNNE G, 1986, BRIT MED J, V293, P30, DOI 10.1136/bmj.293.6538.30; 1987, EXTENDED TRAINING AM	12	167	188	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 20	1990	336	8721					977	979		10.1016/0140-6736(90)92429-L	http://dx.doi.org/10.1016/0140-6736(90)92429-L			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ED601	1977012				2022-12-28	WOS:A1990ED60100011
J	[Anonymous]				[Anonymous]			FIBROBLAST GROWTH-FACTORS - TIME TO TAKE NOTE	LANCET			English	Editorial Material																		BAIRD A, 1989, BRIT MED BULL, V45, P438, DOI 10.1093/oxfordjournals.bmb.a072333; Baird A, 1990, HDB EXPT PHARM, P369; BUNTROCK P, 1984, EXP PATHOL-JENA, V26, P247, DOI 10.1016/S0232-1513(84)80057-2; FAKTOROVICH EG, 1990, NATURE, V347, P83, DOI 10.1038/347083a0; GOSPODAROWICZ D, 1989, SEMIN REPROD ENDOCR, V7, P21, DOI 10.1055/s-2007-1021378; KANER RJ, 1990, SCIENCE, V248, P1410, DOI 10.1126/science.2162560; LAPPI DA, 1989, BIOCHEM BIOPH RES CO, V160, P917, DOI 10.1016/0006-291X(89)92522-9; LEE PL, 1989, SCIENCE, V245, P57, DOI 10.1126/science.2544996; LOGAN A, 1990, TRENDS ENDOCRIN MET, V1, P149, DOI 10.1016/1043-2760(90)90027-Z; LOGAN A, 1990, J ENDOCRINOL, V125, P339, DOI 10.1677/joe.0.1250339; SLACK JMW, 1987, NATURE, V326, P197, DOI 10.1038/326197a0; STOPA EG, IN PRESS BIOCH BIOPH; THOMAS KA, 1985, P NATL ACAD SCI USA, V82, P6409, DOI 10.1073/pnas.82.19.6409; THOMAS KA, 1988, TRENDS BIOCHEM SCI, V13, P327, DOI 10.1016/0968-0004(88)90098-9; WHITE CW, 1989, NEW ENGL J MED, V320, P1197, DOI 10.1056/NEJM198905043201807	15	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 29	1990	336	8718					777	778						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB077	1976148				2022-12-28	WOS:A1990EB07700006
J	SALAHUDEEN, AK; WOODS, HF; PINGLE, A; SULEYMAN, MN; SHAKUNTALA, K; NANDAKUMAR, M; YAHYA, TM; DAAR, AS				SALAHUDEEN, AK; WOODS, HF; PINGLE, A; SULEYMAN, MN; SHAKUNTALA, K; NANDAKUMAR, M; YAHYA, TM; DAAR, AS			HIGH MORTALITY AMONG RECIPIENTS OF BOUGHT LIVING-UNRELATED DONOR KIDNEYS	LANCET			English	Article									SULTAN QABOOS UNIV,COLL MED,DEPT SURG,POB 32485,MUSCAT,OMAN; RENAL UNITS ABU DHABI,ABU DHABI,OMAN; RENAL UNIT DUBAI,DUBAI,OMAN; RENAL UNIT MUSCAT,MUSCAT,OMAN	Sultan Qaboos University			Kalantar-Zadeh, Kamyar/Q-4734-2018	Kalantar-Zadeh, Kamyar/0000-0002-8666-0725				ABOUNA GM, 1987, TRANSPLANT P, V19, P21; BANERJEE K, 1989, LANCET, V2, P166; BRAHAMS D, 1989, LANCET, V1, P285; DAAR AS, 1990, TRANSPLANT P, V22, P922; DAAR AS, 1988, KIDNEY TRANSPLANTATI, P709; DAAR AS, IN PRESS TRANSPL REV; GILADA IS, 1990, JUN INT AIDS C SAN F; JARAYAMAN KS, 1989, NATURE, V337, P496; KIRPLANI AL, 1987, 7TH AS C NEPHR TAIP; LEVEY AS, 1986, NEW ENGL J MED, V314, P914, DOI 10.1056/NEJM198604033141409; MARSHALL JR, 1977, AM J PSYCHIAT, V134, P575; MONACO AP, 1989, TRANSPLANT P, V21, P3403; MOORE FD, 1988, TRANSPLANT P, V20, P1061; MORRIS PJ, 1985, TRANSPLANT P, V17, P1615; MORRIS PJ, 1985, LANCET, V1, P1510; Morris PJ, 1988, KIDNEY TRANSPLANTATI, P737; PATEL CT, 1988, TRANSPLANT P, V20, P1068; QUARTO M, 1989, NEW ENGL J MED, V320, P1754; REDDY KC, 1990, TRANSPLANT P, V22, P910; SIMMONS RG, 1983, PSYCHONEPHROLOGY, V2, P275; SOLLINGER HW, 1986, ANN SURG, V204, P315, DOI 10.1097/00000658-198609000-00010; SPITAL A, 1989, TRANSPLANTATION, V49, P243; VINCENTI F, 1983, TRANSPLANTATION, V36, P626, DOI 10.1097/00007890-198336060-00006; 1985, LANCET, V2, P715; 1989, TIMES LONDON    0127	25	111	111	0	2	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	SEP 22	1990	336	8717					725	728		10.1016/0140-6736(90)92214-3	http://dx.doi.org/10.1016/0140-6736(90)92214-3			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DZ624	1975900				2022-12-28	WOS:A1990DZ62400012
J	RAUB, W				RAUB, W			NEW CONJUGATE VACCINE PROTECTS YOUNGER CHILDREN AGAINST MENINGITIS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material											RAUB, W (corresponding author), NIH,BETHESDA,MD 20892, USA.								0	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 13	1991	265	6					706	706						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EW479	1990184				2022-12-28	WOS:A1991EW47900007
J	MIRKIN, G				MIRKIN, G			EXERCISE-ASSOCIATED URTICARIA	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							INDUCED ANAPHYLAXIS; CHOLINERGIC URTICARIA				MIRKIN, G (corresponding author), GEORGETOWN UNIV,SCH MED,WASHINGTON,DC 20057, USA.							BLACK AK, 1988, ACTA DERM-VENEREOL, V68, P541; CASALE TB, 1986, JAMA-J AM MED ASSOC, V255, P2049, DOI 10.1001/jama.255.15.2049; HARRIES MG, 1979, CLIN ALLERGY, V9, P437, DOI 10.1111/j.1365-2222.1979.tb02506.x; HATTY S, 1983, POSTGRAD MED J, V59, P586, DOI 10.1136/pgmj.59.695.586; KAPLAN AP, 1981, J ALLERGY CLIN IMMUN, V68, P319, DOI 10.1016/0091-6749(81)90158-5; KIVITY S, 1988, J ALLERGY CLIN IMMUN, V81, P1155, DOI 10.1016/0091-6749(88)90884-6; KUSHIMOTO H, 1985, ARCH DERMATOL, V121, P355, DOI 10.1001/archderm.121.3.355; MCCLEAN SP, 1989, J ALLERGY CLIN IMMUN, V83, P738, DOI 10.1016/0091-6749(89)90008-0; SHEFFER AL, 1984, J ALLERGY CLIN IMMUN, V73, P699, DOI 10.1016/0091-6749(84)90309-9; SHEFFER AL, 1980, J ALLERGY CLIN IMMUN, V66, P106, DOI 10.1016/0091-6749(80)90056-1; SHEFFER AL, 1988, NEW ENGL REG ALLERGY, V9, P215	11	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	1991	265	5					650	650						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EV718	1987418				2022-12-28	WOS:A1991EV71800026
J	RIQUIMAROUX, H; GAIONI, SJ; SUGA, N				RIQUIMAROUX, H; GAIONI, SJ; SUGA, N			CORTICAL COMPUTATIONAL MAPS CONTROL AUDITORY-PERCEPTION	SCIENCE			English	Article							CF-FM BAT; FINE FREQUENCY-ANALYSIS; MUSTACHED BAT; RHINOLOPHUS-FERRUMEQUINUM; CORTEX; REPRESENTATION; VOCALIZATIONS; ECHOLOCATION; MACAQUES; COCHLEA	Mustached bats orient and find insects by emitting ultrasonic pulses and analyzing the returning echoes. Neurons in the Doppler-shifted constant-frequency (DSCF) and frequency-modulated (FM-FM) areas of the auditory cortex form maps of echo frequency (target velocity) and echo delay (target range), respectively. Bats were trained to discriminate changes in echo frequency or delay, and then these areas were selectively inactivated with muscimol. Inactivation of the DSCF area disrupted frequency but not delay discriminations; inactivation of the FM-FM area disrupted delay but not frequency discriminations. Thus, focal inactivation of specific cortical maps produces specific disruptions in the perception of biosonar signals.	WASHINGTON UNIV,DEPT BIOL,ST LOUIS,MO 63130	Washington University (WUSTL)					NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017333] Funding Source: NIH RePORTER; NINDS NIH HHS [NS17333] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALLEN WF, 1945, AM J PHYSIOL, V144, P415, DOI 10.1152/ajplegacy.1945.144.3.415; Bekhterev V, 1913, PSYCHOL OBJECTIVE; BRUNS V, 1976, J COMP PHYSIOL, V106, P77, DOI 10.1007/BF00606573; BRUNS V, 1976, J COMP PHYSIOL, V106, P87, DOI 10.1007/BF00606574; BUTLER RA, 1957, J NEUROPHYSIOL, V20, P108, DOI 10.1152/jn.1957.20.1.108; CRANFORD JL, 1976, J NEUROPHYSIOL, V39, P143, DOI 10.1152/jn.1976.39.1.143; DIAMOND IT, 1962, J NEUROPHYSIOL, V25, P223, DOI 10.1152/jn.1962.25.2.223; EVARTS EV, 1952, J NEUROPHYSIOL, V15, P443, DOI 10.1152/jn.1952.15.6.443; GAIONI SJ, 1988, ABSTR SOC NEUROSCI, V14, P1100; GAIONI SJ, IN PRESS J NEUROPHYS; GOLDBERG JM, 1961, J NEUROPHYSIOL, V24, P119, DOI 10.1152/jn.1961.24.2.119; HEFFNER HE, 1986, J NEUROPHYSIOL, V56, P683, DOI 10.1152/jn.1986.56.3.683; HEFFNER HE, 1984, SCIENCE, V226, P75, DOI 10.1126/science.6474192; HEFNER HE, 1987, 10TH MIDW M ASS RES, P87; Henson OW., 1980, ANIMAL SONAR SYSTEMS, P913, DOI [10.1007/978-1-4684-7254-7_56, DOI 10.1007/978-1-4684-7254-7_56]; HIKOSAKA O, 1985, BRAIN RES, V325, P375, DOI 10.1016/0006-8993(85)90344-0; KRNJEVIC K, 1967, EXP BRAIN RES, V3, P320, DOI 10.1007/BF00237558; KRNJEVIC K, 1963, J PHYSIOL-LONDON, V165, P274, DOI 10.1113/jphysiol.1963.sp007057; Mackintosh N. J., 1974, PSYCHOL ANIMAL LEARN; MEYER DR, 1952, J NEUROPHYSIOL, V15, P149, DOI 10.1152/jn.1952.15.2.149; ONEILL WE, 1979, SCIENCE, V203, P69, DOI 10.1126/science.758681; Schnitzler H., 1980, ANIMAL SONAR SYSTEMS, V28, P109, DOI [10.10007/978-1-4684-7254-7_6, DOI 10.1007/978-1-4684-7254-7_6]; SCHNITZLER HU, 1970, Z VERGL PHYSIOL, V68, P25, DOI 10.1007/BF00297809; SUGA N, 1987, J NEUROPHYSIOL, V58, P643, DOI 10.1152/jn.1987.58.4.643; SUGA N, 1982, J NEUROPHYSIOL, V47, P225, DOI 10.1152/jn.1982.47.2.225; SUGA N, 1985, J NEUROPHYSIOL, V53, P1109, DOI 10.1152/jn.1985.53.4.1109; SUGA N, 1986, J NEUROPHYSIOL, V55, P776, DOI 10.1152/jn.1986.55.4.776; SUGA N, 1976, SCIENCE, V194, P542, DOI 10.1126/science.973140; SUGA N, 1975, J EXP BIOL, V63, P161; Suga N, 1984, DYNAMIC ASPECTS NEOC, P315; THOMPSON RF, 1960, J NEUROPHYSIOL, V23, P321, DOI 10.1152/jn.1960.23.3.321	31	96	96	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	FEB 1	1991	251	4993					565	568		10.1126/science.1990432	http://dx.doi.org/10.1126/science.1990432			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV459	1990432				2022-12-28	WOS:A1991EV45900053
J	LEWIN, B				LEWIN, B			ONCOGENIC CONVERSION BY REGULATORY CHANGES IN TRANSCRIPTION FACTORS	CELL			English	Review							THYROID-HORMONE RECEPTOR; PROTO-ONCOGENE; C-JUN; FUNCTIONAL DOMAINS; BINDING DOMAIN; FACTOR AP-1; V-REL; FOS; GENE; INTERACTS											ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; BAICHWAL VR, 1990, CELL, V63, P815, DOI 10.1016/0092-8674(90)90147-7; BALLARD DW, 1990, CELL, V63, P803, DOI 10.1016/0092-8674(90)90146-6; BOHMANN D, 1987, SCIENCE, V238, P1386, DOI 10.1126/science.2825349; BOHMANN D, 1989, CELL, V59, P709, DOI 10.1016/0092-8674(89)90017-2; BOS TJ, 1990, GENE DEV, V4, P1677, DOI 10.1101/gad.4.10.1677; BULL P, 1990, MOL CELL BIOL, V10, P5473, DOI 10.1128/MCB.10.10.5473; CHIU R, 1989, CELL, V59, P979, DOI 10.1016/0092-8674(89)90754-X; CHIU R, 1988, CELL, V54, P541, DOI 10.1016/0092-8674(88)90076-1; DAMM K, 1989, NATURE, V339, P593, DOI 10.1038/339593a0; DIAMOND MI, 1990, SCIENCE, V249, P1266, DOI 10.1126/science.2119054; FRANZA BR, 1988, SCIENCE, V239, P1150, DOI 10.1126/science.2964084; GENTZ R, 1989, SCIENCE, V243, P1695, DOI 10.1126/science.2494702; GHOSH S, 1990, NATURE, V344, P678, DOI 10.1038/344678a0; GHOSH S, 1990, CELL, V62, P1019, DOI 10.1016/0092-8674(90)90276-K; GILMORE TD, 1988, J VIROL, V62, P703, DOI 10.1128/JVI.62.3.703-714.1988; GLINEUR C, 1990, GENE DEV, V4, P1663, DOI 10.1101/gad.4.10.1663; HALAZONETIS TD, 1988, CELL, V55, P917, DOI 10.1016/0092-8674(88)90147-X; HANNINK M, 1989, MOL CELL BIOL, V9, P4323, DOI 10.1128/MCB.9.10.4323; INTRONA M, 1990, CELL, V63, P1287, DOI 10.1016/0092-8674(90)90424-D; IP YT, 1991, CELL, V64, P439; JONAT G, 1990, CELL, V62, P1189; KAMENS J, 1990, MOL CELL BIOL, V10, P2840, DOI 10.1128/MCB.10.6.2840; KIERAN M, 1990, CELL, V62, P1007, DOI 10.1016/0092-8674(90)90275-J; LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X; LUCIBELLO FC, 1989, CELL, V59, P999, DOI 10.1016/0092-8674(89)90756-3; MUNOZ A, 1988, EMBO J, V7, P155, DOI 10.1002/j.1460-2075.1988.tb02795.x; NAKABEPPU Y, 1988, CELL, V55, P907, DOI 10.1016/0092-8674(88)90146-8; NAKABEPPU Y, 1991, IN PRESS CELL, V64; NESS SA, 1989, CELL, V59, P1115, DOI 10.1016/0092-8674(89)90767-8; PRIVALSKY ML, 1988, MOL CELL BIOL, V8, P4510, DOI 10.1128/MCB.8.10.4510; PRIVALSKY ML, 1990, CELL, V63, P1277, DOI 10.1016/0092-8674(90)90423-C; RAUSCHER FJ, 1988, CELL, V52, P471, DOI 10.1016/S0092-8674(88)80039-4; ROTH S, 1989, CELL, V59, P1189, DOI 10.1016/0092-8674(89)90774-5; RUSHLOW CA, 1989, CELL, V59, P1165, DOI 10.1016/0092-8674(89)90772-1; SAKURA H, 1989, P NATL ACAD SCI USA, V86, P5758, DOI 10.1073/pnas.86.15.5758; SAP J, 1986, NATURE, V324, P635, DOI 10.1038/324635a0; SASSONECORSI P, 1988, CELL, V54, P553, DOI 10.1016/0092-8674(88)90077-3; SCHUERMANN M, 1989, CELL, V56, P507, DOI 10.1016/0092-8674(89)90253-5; SCHULE R, 1990, CELL, V61, P497, DOI 10.1016/0092-8674(90)90531-I; SCHULE R, 1990, CELL, V62, P1217, DOI 10.1016/0092-8674(90)90397-W; SCHUTTE J, 1989, CELL, V59, P987, DOI 10.1016/0092-8674(89)90755-1; STEWARD R, 1989, CELL, V59, P1179, DOI 10.1016/0092-8674(89)90773-3; STEWARD R, 1987, SCIENCE, V238, P692, DOI 10.1126/science.3118464; TURNER R, 1989, SCIENCE, V243, P1689, DOI 10.1126/science.2494701; VANBEVEREN C, 1983, CELL, V32, P1241, DOI 10.1016/0092-8674(83)90306-9; WEINBERGER C, 1986, NATURE, V324, P641, DOI 10.1038/324641a0; WESTON K, 1989, CELL, V58, P85, DOI 10.1016/0092-8674(89)90405-4; WILHELMSEN KC, 1984, J VIROL, V52, P172, DOI 10.1128/JVI.52.1.172-182.1984; YANGYEN HF, 1990, CELL, V62, P1205, DOI 10.1016/0092-8674(90)90396-V; ZENKE M, 1988, CELL, V52, P107, DOI 10.1016/0092-8674(88)90535-1; ZENKE M, 1990, CELL, V61, P1035, DOI 10.1016/0092-8674(90)90068-P; ZERIAL M, 1989, EMBO J, V8, P805, DOI 10.1002/j.1460-2075.1989.tb03441.x	54	233	241	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	JAN 25	1991	64	2					303	312		10.1016/0092-8674(91)90640-K	http://dx.doi.org/10.1016/0092-8674(91)90640-K			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EV336	1988149				2022-12-28	WOS:A1991EV33600008
J	KLONOFF, DC; JUROW, AH				KLONOFF, DC; JUROW, AH			ACUTE WATER-INTOXICATION AS A COMPLICATION OF URINE DRUG-TESTING IN THE WORKPLACE	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Note							ULTRASOUND EXAMINATION; BRAIN EDEMA; HYPONATREMIA; EXCRETION	Urine drug testing is now mandatory in many industries. We report the first case, to our knowledge, of an adverse consequence of drug testing in the workplace: acute water intoxication. We discuss normal water metabolism and the adverse effects of water loading and impaired renal function on free water clearance. We present a literature review of seven other cases of acute voluntary water intoxication in patients without chronic psychiatric or neurologic illness. For workers undergoing urine drug testing we conclude that risk factors for acute water intoxication include (1) intake of more than 1 L of water and (2) impaired urine dilution. In a recently drug-tested worker, symptoms of cerebral dysfunction should suggest the possibility of water intoxication.	PENINSULA HOSP,DEPT MED,BURLINGAME,CA; PENINSULA HOSP,DEPT OBSTET & GYNECOL,BURLINGAME,CA		KLONOFF, DC (corresponding author), UNIV CALIF SAN FRANCISCO,DEPT MED,METAB RES UNIT,BOX 0540,ROOM HSW 1141,SAN FRANCISCO,CA 94143, USA.							ALLEN TD, 1972, SOUTHERN MED J, V65, P302, DOI 10.1097/00007611-197203000-00009; ANASTASSIADES E, 1983, BRIT MED J, V287, P1181, DOI 10.1136/bmj.287.6400.1181-a; BARTRUM RJ, 1983, REAL TIME ULTRASOUND, P129; BAYLIS PH, 1988, CLIN ENDOCRINOL, V29, P549, DOI 10.1111/j.1365-2265.1988.tb03704.x; CHRISTENSON LL, 1985, POSTGRAD MED, V77, P161, DOI 10.1080/00325481.1985.11698898; COX M, 1985, FLUIDS ELECTROLYTE A, P119; FILLY R, 1983, URORADIOLOGY INTEGRA, P311; FRIEDMAN E, 1983, J UROLOGY, V130, P566, DOI 10.1016/S0022-5347(17)51308-7; GOLDBERG M, 1981, MED CLIN N AM, V65, P251, DOI 10.1016/S0025-7125(16)31523-1; GOLDMAN MB, 1988, NEW ENGL J MED, V318, P397, DOI 10.1056/NEJM198802183180702; HANSMANN M, 1986, ULTRASOUND DIAGNOSIS, P25; KLEEMAN CR, 1970, ANNU REV MED, V21, P259, DOI 10.1146/annurev.me.21.020170.001355; KOTT E, 1985, EUR NEUROL, V24, P221, DOI 10.1159/000115798; LIPSKY MS, 1987, J FAM PRACTICE, V25, P216; MOSES AM, 1974, NEW ENGL J MED, V291, P1234, DOI 10.1056/NEJM197412052912307; PICKERING LK, 1971, J PEDIATR-US, V78, P316, DOI 10.1016/S0022-3476(71)80020-3; POLLOCK AS, 1980, AM J PHYSIOL, V239, pF195, DOI 10.1152/ajprenal.1980.239.3.F195; REES B, 1975, J AM COLL HEALTH ASS, V23, P203; ROSENSTOCK L, 1987, J GEN INTERN MED, V2, P135, DOI 10.1007/BF02596314; ROWE JW, 1979, KIDNEY INT, V16, P729, DOI 10.1038/ki.1979.189; Rowntree LG, 1923, ARCH INTERN MED, V32, P157, DOI 10.1001/archinte.1923.00110200003001; SCHRIER RW, 1975, NEW ENGL J MED, V292, P141, DOI 10.1056/NEJM197501162920306; SCHRIER RW, 1975, NEW ENGL J MED, V292, P81, DOI 10.1056/NEJM197501092920207; SHAPIRA I, 1988, J CLIN ULTRASOUND, V16, P61, DOI 10.1002/jcu.1870160114; SIMONSMEIER L M, 1988, American Pharmacy, V28, P30; ZUBENKO GS, 1987, BIOL PSYCHIAT, V22, P121, DOI 10.1016/0006-3223(87)90222-8; 1988, FED REG         1121, V53, P47002; 1989, IMPLEMENTATION GUIDE	28	27	27	1	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	1991	265	1					84	85		10.1001/jama.265.1.84	http://dx.doi.org/10.1001/jama.265.1.84			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP555	1984128				2022-12-28	WOS:A1991EP55500033
J	BROCKLEHURST, P; CARNEY, O; HELSON, K; KINGHORN, G; MERCEY, D; MINDEL, A				BROCKLEHURST, P; CARNEY, O; HELSON, K; KINGHORN, G; MERCEY, D; MINDEL, A			ACYCLOVIR, HERPES, AND PREGNANCY	LANCET			English	Letter							RECURRING GENITAL HERPES; ORAL ACYCLOVIR; SUPPRESSION; THERAPY		ROYAL HALLAMSHIRE HOSP,DEPT GENITOURINARY MED,SHEFFIELD S10 2JF,S YORKSHIRE,ENGLAND	University of Sheffield	BROCKLEHURST, P (corresponding author), MIDDLESEX HOSP,ACAD DEPT GENITOURINARY MED,LONDON W1N 8AA,ENGLAND.		Brocklehurst, Peter/B-5804-2011; Kinghorn, George/AAO-1425-2021	Kinghorn, George/0000-0001-6608-5076; Mindel, Adrian/0000-0002-8780-9982				DOUGLAS JM, 1984, NEW ENGL J MED, V310, P1551, DOI 10.1056/NEJM198406143102402; MINDEL A, 1989, GENITOURIN MED, V65, P103; MINDEL A, 1988, LANCET, V1, P926; MINDEL A, 1984, LANCET, V2, P57; SACKS SL, 1988, SEX TRANSM DIS, V15, P58, DOI 10.1097/00007435-198801000-00013; STRAUS SE, 1984, NEW ENGL J MED, V310, P1545, DOI 10.1056/NEJM198406143102401; STRAUS SE, 1988, JAMA-J AM MED ASSOC, V260, P2227, DOI 10.1001/jama.260.15.2227; STRAYPEDERSEN, 1990, LANCET, V336, P756	8	2	2	0	2	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	DEC 22	1990	336	8730					1594	1595		10.1016/0140-6736(90)93384-2	http://dx.doi.org/10.1016/0140-6736(90)93384-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP037	1979417				2022-12-28	WOS:A1990EP03700072
J	MEYTES, D; SCHOCHAT, B; LEE, H; NADEL, G; SIDI, Y; CERNEY, M; SWANSON, P; SHAKLAI, M; KILIM, Y; ELGAT, M; CHIN, E; DANON, Y; ROSENBLATT, JD				MEYTES, D; SCHOCHAT, B; LEE, H; NADEL, G; SIDI, Y; CERNEY, M; SWANSON, P; SHAKLAI, M; KILIM, Y; ELGAT, M; CHIN, E; DANON, Y; ROSENBLATT, JD			SEROLOGICAL AND MOLECULAR SURVEY FOR HTLV-I INFECTION IN A HIGH-RISK MIDDLE-EASTERN GROUP	LANCET			English	Article							CELL LEUKEMIA-VIRUS; DRUG-ABUSERS; ANTIBODIES; LYMPHOMA; INDIVIDUALS; PREVALENCE; FALASHAS; ISRAEL	To define the extent of human T-cell leukaemia virus (HTLV-1) infection among a group of Jewish immigrants to Israel with an increased frequency of adult T-cell leukaemia, various serological and molecular screening methods, including enzyme-linked immunosorbent assay (ELISA) for anti-HTLV-1, ELISA for antibody to recombinant HTLV-1 p40tax protein, and molecular detection of infection by polymerase chain reaction (PCR) amplification of HTLV-1 proviral DNA from peripheral blood mononuclear cell DNA, were used. By HTLV-1 ELISA overall rate of infection was 12% (24 of 208) among immigrants from Khurusan, northeastern Iran; no HTLV-1 carriers were detected among 111 unselected Jewish immigrants from other parts of Iran. There was unexplained clustering of HTLV-1 infection within a cohort of 32 elderly women of similar geographic origin in a home for old people - 14 were seropositive by ELISA and 19 of 29 were positive by PCR. The findings in this newly identified high-risk population suggest that in addition to ELISA, other screening techniques may be required to detect all carriers in high-risk populations.	EDITH WOLFSON MED CTR,HOLON,ISRAEL; TEL AVIV UNIV,SACKLER SCH MED,HOLON,ISRAEL; BEILINSON MED CTR,IL-49100 PETAH TIQWA,ISRAEL; MINIST HLTH,TEL AVIV,ISRAEL; ABBOTT LABS,DIV DIAGNOST,N CHICAGO,IL 60064; UNIV CALIF LOS ANGELES,SCH MED,DEPT MED,DIV HEMATOL ONCOL,LOS ANGELES,CA 90024	Tel Aviv University; Sackler Faculty of Medicine; Rabin Medical Center; Abbott Laboratories; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA				sidi, yechezkel/0000-0001-7781-6153	NCI NIH HHS [CA52410-01, CA01314] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K11CA001314, R01CA052410] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BENISHAI Z, 1985, NATURE, V315, P665, DOI 10.1038/315665a0; BIGGAR RJ, 1985, LANCET, V2, P520; BLATTNER WA, 1983, LANCET, V2, P61; BUNN PA, 1983, NEW ENGL J MED, V309, P257, DOI 10.1056/NEJM198308043090501; EHRLICH GD, 1989, BLOOD, V74, P1658; EHRLICH GD, 1989, BLOOD, V74, P1066; HINUMA Y, 1982, INT J CANCER, V29, P631, DOI 10.1002/ijc.2910290606; HINUMA Y, 1986, AIDS RES, V2, P517; KAMIHIRA S, 1989, JPN J CANCER RES, V80, P1066, DOI 10.1111/j.1349-7006.1989.tb02260.x; KARPAS A, 1986, NATURE, V319, P794, DOI 10.1038/319794a0; LEE H, 1989, SCIENCE, V244, P471, DOI 10.1126/science.2655084; LEOR J, 1988, ISRAEL J MED SCI, V24, P397; ROBERTGUROFF M, 1986, JAMA-J AM MED ASSOC, V255, P3133, DOI 10.1001/jama.255.22.3133; SIDI Y, 1990, CANCER, V65, P590, DOI 10.1002/1097-0142(19900201)65:3<590::AID-CNCR2820650334>3.0.CO;2-2; YOKATA T, 1989, INT J CANCER, V43, P970; 1972, ENCY JUDAICA, V11, P1399	16	77	78	0	3	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	DEC 22	1990	336	8730					1533	1535		10.1016/0140-6736(90)93308-C	http://dx.doi.org/10.1016/0140-6736(90)93308-C			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP037	1979367				2022-12-28	WOS:A1990EP03700005
J	AROIAN, RV; KOGA, M; MENDEL, JE; OHSHIMA, Y; STERNBERG, PW				AROIAN, RV; KOGA, M; MENDEL, JE; OHSHIMA, Y; STERNBERG, PW			THE LET-23 GENE NECESSARY FOR CAENORHABDITIS-ELEGANS VULVAR INDUCTION ENCODES A TYROSINE KINASE OF THE EGF RECEPTOR SUBFAMILY	NATURE			English	Article									KYUSHU UNIV,FAC SCI,DEPT BIOL,HIGASHI KU,FUKUOKA 812,JAPAN	Kyushu University	AROIAN, RV (corresponding author), CALTECH,ARTHUR AMOS NOYES LAB CHEM PHYS,HOWARD HUGHES MED INST,DIV BIOL,PASADENA,CA 91125, USA.			Sternberg, Paul/0000-0002-7699-0173				ANDERSON SK, 1985, MOL CELL BIOL, V5, P1122, DOI 10.1128/MCB.5.5.1122; BARSTEAD RJ, 1989, J BIOL CHEM, V264, P10177; BIETEL GJ, 1990, NATURE, V348, P503; CARPENTER G, 1979, ANNU REV BIOCHEM, V48, P193, DOI 10.1146/annurev.bi.48.070179.001205; COTTON RGH, 1988, P NATL ACAD SCI USA, V85, P4397, DOI 10.1073/pnas.85.12.4397; COULSON A, 1988, NATURE, V335, P184, DOI 10.1038/335184a0; ELLIS C, 1990, NATURE, V343, P377, DOI 10.1038/343377a0; FERGUSON EL, 1989, GENETICS, V123, P109; FERGUSON EL, 1987, NATURE, V326, P259, DOI 10.1038/326259a0; FERGUSON EL, 1985, GENETICS, V110, P17; GIBBS JB, 1988, P NATL ACAD SCI USA, V85, P5026, DOI 10.1073/pnas.85.14.5026; GREENWALD IS, 1983, CELL, V34, P435, DOI 10.1016/0092-8674(83)90377-X; HAN M, 1990, GENETICS, V126, P899; HAN M, 1990, CELL, V63, P921, DOI 10.1016/0092-8674(90)90495-Z; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HENIKOFF S, 1984, GENE, V28, P351, DOI 10.1016/0378-1119(84)90153-7; HERMAN RK, 1978, GENETICS, V88, P49; HERMAN RK, 1990, NATURE, V348, P169, DOI 10.1038/348169a0; HORVITZ HR, 1980, GENETICS, V96, P435; HUNTER T, 1986, ENZYMES, V17; KAMPS MP, 1986, MOL CELL BIOL, V6, P751, DOI 10.1128/MCB.6.3.751; KAPLAN DR, 1990, CELL, V61, P125, DOI 10.1016/0092-8674(90)90220-9; KAZLAUSKAS A, 1990, SCIENCE, V247, P1578, DOI 10.1126/science.2157284; KIM SK, 1990, GENE DEV, V4, P357, DOI 10.1101/gad.4.3.357; KIMBLE J, 1981, DEV BIOL, V87, P286, DOI 10.1016/0012-1606(81)90152-4; KRAMER JM, 1990, J MOL CELL BIOL, V10, P2081; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LIVNEH E, 1985, CELL, V40, P599, DOI 10.1016/0092-8674(85)90208-9; Maniatis T., 1982, MOL CLONING; MULCAHY LS, 1985, NATURE, V313, P241, DOI 10.1038/313241a0; NECKAMEYER WS, 1985, J VIROL, V53, P879, DOI 10.1128/JVI.53.3.879-884.1985; PARSONS JT, 1990, TRENDS GENET, V6, P169; RUVKUN G, 1989, GENETICS, V121, P501; SCHEJTER ED, 1986, CELL, V46, P1091, DOI 10.1016/0092-8674(86)90709-9; SCHLESSINGER J, 1983, CRC CR REV BIOCH MOL, V14, P93, DOI 10.3109/10409238309102791; SCHWARTZ DC, 1984, CELL, V37, P67, DOI 10.1016/0092-8674(84)90301-5; SEYDOUX G, 1989, CELL, V57, P1237, DOI 10.1016/0092-8674(89)90060-3; SHTIVELMAN E, 1986, CELL, V47, P277, DOI 10.1016/0092-8674(86)90450-2; SIGURDSON DC, 1984, GENETICS, V108, P331; STERNBERG PW, 1986, CELL, V44, P761, DOI 10.1016/0092-8674(86)90842-1; STERNBERG PW, 1989, CELL, V58, P679, DOI 10.1016/0092-8674(89)90103-7; STERNBERG PW, 1988, NATURE, V335, P551, DOI 10.1038/335551a0; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; SULSTON JE, 1981, DEV BIOL, V82, P41, DOI 10.1016/0012-1606(81)90427-9; SULSTON JE, 1980, DEV BIOL, V78, P577, DOI 10.1016/0012-1606(80)90353-X; Sulston JHJ, 1988, NEMATODE CAENORHABDI; THOMAS JH, 1990, CELL, V62, P1041, DOI 10.1016/0092-8674(90)90382-O; TRAHEY M, 1987, SCIENCE, V238, P542, DOI 10.1126/science.2821624; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; ULLRICH A, 1985, NATURE, V313, P576; WATSON MEE, 1984, NUCLEIC ACIDS RES, V12, P5145, DOI 10.1093/nar/12.13.5145; WEISSMAN BE, 1983, CELL, V32, P599, DOI 10.1016/0092-8674(83)90479-8; WITTBRODT J, 1989, NATURE, V341, P415, DOI 10.1038/341415a0; YARDEN Y, 1986, NATURE, V323, P226, DOI 10.1038/323226a0; YOCHEM J, 1988, NATURE, V335, P547, DOI 10.1038/335547a0	56	371	382	0	13	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	DEC 20	1990	348	6303					693	699		10.1038/348693a0	http://dx.doi.org/10.1038/348693a0			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EP049	1979659				2022-12-28	WOS:A1990EP04900046
J	MORGAN, MRA; FENWICK, GR				MORGAN, MRA; FENWICK, GR			NATURAL FOODBORNE TOXICANTS	LANCET			English	Article											MORGAN, MRA (corresponding author), INST FOOD RES, NORWICH LAB, COLNEY LANE, NORWICH NR4 7UA, NORFOLK, ENGLAND.							AMES BN, IN PRESS SCIENCE; CARLSSON C, 1990, LANCET, V336, P1068, DOI 10.1016/0140-6736(90)92538-S; CHEEKE R, 1989, TOXICANTS PLANT ORIG; CONCON JM, 1988, FOOD TOXICOLOGY; DENNING DW, 1987, ADVERSE DRUG REACT, V4, P175; Fenwick G. R., 1990, Trends in Food Science & Technology, V1, P23, DOI 10.1016/0924-2244(90)90007-L; FRIEDMAN M, 1984, NUTRITIONAL TOXICOLO; GEE JM, 1989, TOXICOL IN VITRO, V3, P85, DOI 10.1016/0887-2333(89)90049-0; HALL RL, 1971, FLAVOUR IND, P455; INFANTE ME, 1990, LANCET, V336, P1129, DOI 10.1016/0140-6736(90)92603-F; MCMILLAN M, 1979, Q J MED, V48, P227; MILLER K, 1987, TOXICOLOGICAL ASPECT; PERL TM, 1990, NEW ENGL J MED, V322, P1775, DOI 10.1056/NEJM199006213222504; RECHCIGL M, 1983, CRC HDB NATURALLY OC; STOLOFF L, 1987, SCIENCE, V237, P1283, DOI 10.1126/science.3629238; WODICKA VO, 1971, FOOD CHEM NEWS, V12, P11; 1987, IARC MONOGRAPHS EV S, V7, P83; 1987, BRIT MED ASS GUIDE, P24	18	15	15	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 15	1990	336	8729					1492	1495		10.1016/0140-6736(90)93189-V	http://dx.doi.org/10.1016/0140-6736(90)93189-V			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EN157	1979102				2022-12-28	WOS:A1990EN15700013
J	SEARS, MR; TAYLOR, DR; PRINT, CG; LAKE, DC; LI, QQ; FLANNERY, EM; YATES, DM; LUCAS, MK; HERBISON, GP				SEARS, MR; TAYLOR, DR; PRINT, CG; LAKE, DC; LI, QQ; FLANNERY, EM; YATES, DM; LUCAS, MK; HERBISON, GP			REGULAR INHALED BETA-AGONIST TREATMENT IN BRONCHIAL-ASTHMA	LANCET			English	Article									UNIV OTAGO,DEPT MED,DUNEDIN,NEW ZEALAND; UNIV OTAGO,DEPT PREVENT & SOCIAL MED,DUNEDIN,NEW ZEALAND	University of Otago; University of Otago				Herbison, Graham Peter/0000-0002-5684-024X; Print, Cristin/0000-0001-8345-7812				ANDERSON HR, 1989, THORAX, V44, P614, DOI 10.1136/thx.44.8.614; ARVIDSSON P, 1989, EUR RESPIR J, V2, P325; BEASLEY R, 1989, THORAX, V44, P200, DOI 10.1136/thx.44.3.200; BOSCO LA, 1987, J ALLERGY CLIN IMMUN, V80, P398, DOI 10.1016/0091-6749(87)90058-3; COCKCROFT DW, 1977, CLIN ALLERGY, V7, P235, DOI 10.1111/j.1365-2222.1977.tb01448.x; CRANE J, 1989, LANCET, V1, P917; EINSTADT WS, 1969, ANN ALLERGY, V27, P283; GALLAGHER JT, 1975, PROC R SOC SER B-BIO, V192, P49, DOI 10.1098/rspb.1975.0151; GIBSON GJ, 1978, BRIT J DIS CHEST, V72, P199, DOI 10.1016/0007-0971(78)90042-6; HARRIS R, 1981, NEW ZEAL MED J, V94, P421; HARVEY JE, 1982, THORAX, V37, P280, DOI 10.1136/thx.37.4.280; HAY IFC, 1987, LANCET, V2, P609; HORN CR, 1990, RESP MED, V84, P61, DOI 10.1016/S0954-6111(08)80096-0; JACKSON R, 1988, CHEST, V94, P914, DOI 10.1378/chest.94.5.914; KRAAN J, 1985, J ALLERGY CLIN IMMUN, V76, P628, DOI 10.1016/0091-6749(85)90786-9; LAI CKW, 1989, AM REV RESPIR DIS, V140, P917, DOI 10.1164/ajrccm/140.4.917; MORLEY J, 1990, EUR RESPIR J, V3, P228; PATAKAS D, 1988, RESPIRATION, V54, P174, DOI 10.1159/000195518; PRIOR JG, 1982, THORAX, V37, P300, DOI 10.1136/thx.37.4.300; REBUCK AS, 1987, CAN MED ASSOC J, V136, P483; REISMAN RE, 1970, J ALLERGY, V46, P162, DOI 10.1016/0021-8707(70)90095-X; SALOME CM, 1983, THORAX, V38, P854, DOI 10.1136/thx.38.11.854; SHEPHERD GL, 1981, BRIT J DIS CHEST, V75, P215, DOI 10.1016/0007-0971(81)90057-7; SHIM CS, 1986, AM REV RESPIR DIS, V133, pA176; SINCLAIR BL, 1987, THORAX, V42, P670, DOI 10.1136/thx.42.9.670; STANESCU DC, 1989, EUR RESPIR J, V2, P597; TRAUTLEIN J, 1976, CHEST, V70, P711, DOI 10.1378/chest.70.6.711; ULLMAN A, 1988, THORAX, V43, P674, DOI 10.1136/thx.43.9.674; VANMETRE TE, 1969, J ALLERGY, V43, P101, DOI 10.1016/0021-8707(69)90130-0; VANSCHAYCK CP, 1990, AM REV RESPIR DIS, V141, pA468; WILLIAMS IP, 1981, THORAX, V36, P231; WILSON JD, 1981, LANCET, V1, P1235; WOOLCOCK AJ, 1977, AM REV RESPIR DIS, V115, P191; 1975, LANCET, V1, P1073	34	953	966	1	28	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	DEC 8	1990	336	8728					1391	1396		10.1016/0140-6736(90)93098-A	http://dx.doi.org/10.1016/0140-6736(90)93098-A			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL851	1978871				2022-12-28	WOS:A1990EL85100001
J	MERIGAN, TC				MERIGAN, TC			YOU CAN TEACH AN OLD DOG NEW TRICKS - HOW AIDS TRIALS ARE PIONEERING NEW STRATEGIES	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material											MERIGAN, TC (corresponding author), STANFORD UNIV,CTR AIDS RES,STANFORD,CA 94305, USA.		Merigan, Thomas/AGQ-7464-2022					FISCHL MA, 1987, NEW ENGL J MED, V317, P185, DOI 10.1056/NEJM198707233170401; FISCHL MA, 1990, NEW ENGL J MED, V323, P1009, DOI 10.1056/NEJM199010113231501; FISCHL MA, 1990, SURROGATE ENDPOINTS, P4; LARDER BA, 1989, SCIENCE, V243, P1731, DOI 10.1126/science.2467383; LEMP GF, 1990, JAMA-J AM MED ASSOC, V263, P1497, DOI 10.1001/jama.263.11.1497; LIFSON AR, 1989, 5 INT C AIDS MONTR; MERIGAN TC, 1984, NEW ENGL J MED, V311, P1311, DOI 10.1056/NEJM198411153112009; MERIGAN TC, 1989, J INFECT DIS, V159, P390, DOI 10.1093/infdis/159.3.390; PIZZO PA, 1990, J INFECT DIS, V161, P316, DOI 10.1093/infdis/161.2.316; VOLBERDING PA, 1990, NEW ENGL J MED, V322, P941, DOI 10.1056/NEJM199004053221401	10	27	27	0	2	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 8	1990	323	19					1341	1343		10.1056/NEJM199011083231911	http://dx.doi.org/10.1056/NEJM199011083231911			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG588	1977082				2022-12-28	WOS:A1990EG58800011
J	GARRY, R				GARRY, R			SAFETY OF HYSTEROSCOPIC SURGERY	LANCET			English	Letter											GARRY, R (corresponding author), S CLEVELAND HOSP,MIDDLESBROUGH TS4 3BW,CLEVELAND,ENGLAND.							BAUMANN R, 1990, BRIT MED J, V300, P304, DOI 10.1136/bmj.300.6720.304; DAVIS JA, 1989, BRIT J OBSTET GYNAEC, V96, P928, DOI 10.1111/j.1471-0528.1989.tb03347.x; GARRY R, 1990, BR J OBSTET GYNAECOL, V301, P199; GARRY R, IN PRESS BR J OBSTET; GOLDRATH MH, 1981, AM J OBSTET GYNECOL, V140, P14, DOI 10.1016/0002-9378(81)90251-9; MAGOS AL, 1990, LANCET, V335, P44, DOI 10.1016/0140-6736(90)90165-2; MORRISON LMM, 1989, BRIT J OBSTET GYNAEC, V96, P346, DOI 10.1111/j.1471-0528.1989.tb02396.x; TOWNSEND DE, 1990, OBSTET GYNECOL, V76, P310	8	10	11	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 20	1990	336	8721					1013	1014		10.1016/0140-6736(90)92480-6	http://dx.doi.org/10.1016/0140-6736(90)92480-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ED601	1976997				2022-12-28	WOS:A1990ED60100052
J	COLLIER, AC; BOZZETTE, S; COOMBS, RW; CAUSEY, DM; SCHOENFELD, DA; SPECTOR, SA; PETTINELLI, CB; DAVIES, G; RICHMAN, DD; LEEDOM, JM; KIDD, P; COREY, L				COLLIER, AC; BOZZETTE, S; COOMBS, RW; CAUSEY, DM; SCHOENFELD, DA; SPECTOR, SA; PETTINELLI, CB; DAVIES, G; RICHMAN, DD; LEEDOM, JM; KIDD, P; COREY, L			A PILOT-STUDY OF LOW-DOSE ZIDOVUDINE IN HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									UNIV WASHINGTON,SCH MED,DEPT MED,SEATTLE,WA 98195; UNIV WASHINGTON,SCH MED,DEPT LAB MED,SEATTLE,WA 98195; UNIV CALIF SAN DIEGO,SCH MED,DEPT MED,SAN DIEGO,CA 92103; UNIV CALIF SAN DIEGO,SCH MED,DEPT PEDIAT,SAN DIEGO,CA 92103; UNIV CALIF SAN DIEGO,SCH MED,DEPT PATHOL,SAN DIEGO,CA 92103; UNIV SO CALIF,SCH MED,DEPT MED,LOS ANGELES,CA 90033; HARVARD UNIV,SCH PUBL HLTH,BOSTON,MA 02115; HARVARD UNIV,SCH MED,BOSTON,MA 02115; NIAID,DIV AIDS,BETHESDA,MD 20892; RES TRIANGLE INST,RES TRIANGLE PK,NC 27709	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Southern California; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Research Triangle Institute			Corey, Lawrence/AAE-1796-2020	Corey, Lawrence/0000-0002-2179-2436	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI027673, U01AI027664, U01AI027670] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-27673, AI-27664, AI-27670] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALLAIN JP, 1987, NEW ENGL J MED, V317, P1114, DOI 10.1056/NEJM198710293171804; CHAISSON RE, 1988, ARCH INTERN MED, V148, P2151, DOI 10.1001/archinte.148.10.2151; COOMBS RW, 1989, NEW ENGL J MED, V321, P1626, DOI 10.1056/NEJM198912143212402; CREAGHKIRK T, 1988, JAMA-J AM MED ASSOC, V260, P3009, DOI 10.1001/jama.260.20.3009; DEWOLF F, 1988, LANCET, V1, P373; DOURNON E, 1988, LANCET, V2, P1297; FAHEY JL, 1990, NEW ENGL J MED, V322, P166, DOI 10.1056/NEJM199001183220305; FIDDIAN AP, 1989, J INFECTION, V18, P79, DOI 10.1016/S0163-4453(89)80084-2; FISCHL MA, 1989, JAMA-J AM MED ASSOC, V262, P2405; FISCHL MA, 1987, NEW ENGL J MED, V317, P185, DOI 10.1056/NEJM198707233170401; FISCHL MA, 1990, NEW ENGL J MED, V323, P1009, DOI 10.1056/NEJM199010113231501; GILL PS, 1987, ANN INTERN MED, V107, P502, DOI 10.7326/0003-4819-107-4-502; GOEDERT JJ, 1987, JAMA-J AM MED ASSOC, V257, P331, DOI 10.1001/jama.257.3.331; HOLLANDER H, 1988, 4TH P INT C AIDS STO, V1, P253; JACKSON GG, 1988, ANN INTERN MED, V108, P175, DOI 10.7326/0003-4819-108-2-175; MASUR H, 1989, ANN INTERN MED, V111, P223, DOI 10.7326/0003-4819-111-3-223; MITSUYA H, 1987, NATURE, V325, P773, DOI 10.1038/325773a0; MOSS AR, 1988, BRIT MED J, V296, P745, DOI 10.1136/bmj.296.6624.745; PHAIR J, 1990, NEW ENGL J MED, V322, P161, DOI 10.1056/NEJM199001183220304; POLK BF, 1987, NEW ENGL J MED, V316, P61, DOI 10.1056/NEJM198701083160201; Reiss P, 1988, Lancet, V1, P421; RICHMAN DD, 1987, NEW ENGL J MED, V317, P192, DOI 10.1056/NEJM198707233170402; SPECTOR SA, 1989, J INFECT DIS, V159, P822, DOI 10.1093/infdis/159.5.822; STEINBERG JP, 1989, J ACQ IMMUN DEF SYND, V2, P229; STRAMER SL, 1989, AJAM, V262, P64; SURBONE A, 1988, ANN INTERN MED, V108, P534, DOI 10.7326/0003-4819-108-4-534; VOLBERDING PA, 1990, NEW ENGL J MED, V322, P941, DOI 10.1056/NEJM199004053221401; [No title captured]	28	199	199	0	1	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 11	1990	323	15					1015	1021		10.1056/NEJM199010113231502	http://dx.doi.org/10.1056/NEJM199010113231502			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB936	1977080	Bronze			2022-12-28	WOS:A1990EB93600002
J	MONUKI, ES; KUHN, R; WEINMASTER, G; TRAPP, BD; LEMKE, G				MONUKI, ES; KUHN, R; WEINMASTER, G; TRAPP, BD; LEMKE, G			EXPRESSION AND ACTIVITY OF THE POU TRANSCRIPTION FACTOR SCIP	SCIENCE			English	Article									SALK INST BIOL STUDIES, MOLEC NEUROBIOL LAB, LA JOLLA, CA 92037 USA; UNIV CALIF SAN DIEGO, DEPT NEUROSCI, LA JOLLA, CA 92093 USA; JOHNS HOPKINS UNIV, DEPT NEUROL, BALTIMORE, MD 21205 USA	Salk Institute; University of California System; University of California San Diego; Johns Hopkins University				Monuki, Edwin/0000-0001-5130-781X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023896] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 23896] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABERCROMBIE M, 1957, J CELL COMPAR PHYSL, V50, P429, DOI 10.1002/jcp.1030500308; AGUAYO AJ, 1977, NATURE, V268, P753, DOI 10.1038/268753a0; BODNER M, 1988, CELL, V55, P505, DOI 10.1016/0092-8674(88)90037-2; BRADLEY W G, 1970, Experimental Neurology, V26, P275, DOI 10.1016/0014-4886(70)90125-1; BRAY GM, 1981, ANNU REV NEUROSCI, V4, P127, DOI 10.1146/annurev.ne.04.030181.001015; BROWN MJ, 1981, EXP NEUROL, V74, P170, DOI 10.1016/0014-4886(81)90157-6; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; ELLIS L, 1986, CELL, V45, P721, DOI 10.1016/0092-8674(86)90786-5; FINNEY M, 1988, CELL, V55, P757, DOI 10.1016/0092-8674(88)90132-8; GORMAN CM, 1982, P NATL ACAD SCI-BIOL, V79, P6777, DOI 10.1073/pnas.79.22.6777; HERR W, 1988, GENE DEV, V2, P1513, DOI 10.1101/gad.2.12a.1513; HEUMANN R, 1987, J CELL BIOL, V104, P1623, DOI 10.1083/jcb.104.6.1623; INGRAHAM HA, 1988, CELL, V55, P519, DOI 10.1016/0092-8674(88)90038-4; JESSEN KR, 1990, DEVELOPMENT, V109, P91; LAMPH WW, 1990, P NATL ACAD SCI USA, V87, P4320, DOI 10.1073/pnas.87.11.4320; LEMKE G, 1988, NEURON, V1, P73, DOI 10.1016/0896-6273(88)90211-5; LEMKE G, 1988, NEURON, V1, P535, DOI 10.1016/0896-6273(88)90103-1; LEMKE G, 1988, DEVELOPMENT, V102, P499; LEMKE G, 1985, CELL, V40, P501, DOI 10.1016/0092-8674(85)90198-9; LENARDO MJ, 1989, SCIENCE, V243, P544, DOI 10.1126/science.2536195; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; MERMOD N, 1989, CELL, V58, P741, DOI 10.1016/0092-8674(89)90108-6; MONUKI ES, 1989, NEURON, V3, P783, DOI 10.1016/0896-6273(89)90247-X; MULLER MM, 1988, NATURE, V336, P544, DOI 10.1038/336544a0; OKAMOTO K, 1990, CELL, V60, P461, DOI 10.1016/0092-8674(90)90597-8; RAFF MC, 1978, CELL, V15, P813, DOI 10.1016/0092-8674(78)90266-0; ROSNER MH, 1990, NATURE, V345, P686, DOI 10.1038/345686a0; SCHEIDEREIT C, 1988, NATURE, V336, P551, DOI 10.1038/336551a0; SCHOLERHR, 1990, NATURE, V344, P435; SEHGAL A, 1988, MOL CELL BIOL, V8, P3160, DOI 10.1128/MCB.8.8.3160; STURM RA, 1988, GENE DEV, V2, P1582, DOI 10.1101/gad.2.12a.1582; TANAKA M, 1990, CELL, V60, P375, DOI 10.1016/0092-8674(90)90589-7; TRAPP BD, 1988, J NEUROSCI, V8, P3515; VERRIJZER CP, 1990, EMBO J, V9, P1883, DOI 10.1002/j.1460-2075.1990.tb08314.x; WEBSTER HD, 1984, PERIPHERAL NEUROPATH, P329; XI H, 1989, NATURE, V340, P35, DOI 10.1038/340035a0; YAN Q, 1988, J NEUROSCI, V8, P3481	37	234	237	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 14	1990	249	4974					1300	1303		10.1126/science.1975954	http://dx.doi.org/10.1126/science.1975954			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DY351	1975954				2022-12-28	WOS:A1990DY35100040
J	GELLHORN, A				GELLHORN, A			PERIODIC PHYSICIAN RECREDENTIALING	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEALTH-CARE	The quality of health care services is a major concern of consumers and commands attention in the national health policy debate. The government and business emphasize quality medical care for its immediate relevance to cost containment. Federal legislation has been introduced requiring physician recertification, 19 of 23 specialty boards are requiring periodic recertification, and it has been proposed that reimbursement for physician services be contingent on compliance with standards of medical care. In the past 3 years, planning has been in progress in New York State to implement periodic physician recredentialing for medical relicensure. The current plan emphasizes peer review of guidelines developed by specialty societies and proposes educational enhancement, not loss of license, if a need to correct deficiencies is identified.			GELLHORN, A (corresponding author), NEW YORK STATE DEPT HLTH,MED AFFAIRS,ALBANY,NY 12237, USA.							ATKINSON DI, 1989, NEW YORK STATE J MED, V89, P536; BERWICK DM, 1989, NEW ENGL J MED, V320, P53, DOI 10.1056/NEJM198901053200110; DAVIS DA, 1990, JAMA-J AM MED ASSOC, V263, P2041, DOI 10.1001/jama.263.15.2041; EADIE J, 1989, EPIDEMIOLOGY NOTES; EICHHORN JH, 1989, ANESTHESIOLOGY, V70, P572, DOI 10.1097/00000542-198904000-00002; GALUSHA BL, 1989, NEW YORK STATE J MED, V89, P219; GELLHORN A, 1989, NEW YORK STATE J MED, V89, P209; GLEICHER N, 1984, JAMA-J AM MED ASSOC, V252, P2373; KANOUSE DE, 1989, CHANGING MED PRACTIC, P238; KOSECOFF J, 1987, JAMA-J AM MED ASSOC, V258, P2708, DOI 10.1001/jama.258.19.2708; LOHR KN, 1990, NEW ENGL J MED, V322, P707, DOI 10.1056/NEJM199003083221031; LOMAS J, 1989, NEW ENGL J MED, V321, P1306, DOI 10.1056/NEJM198911093211906; MOEHEAD MA, 1989, RECREDENTIALING AMBU; REICH DR, 1989, NEW YORK STATE J MED, V89, P484; RELMAN AS, 1988, NEW ENGL J MED, V319, P1220, DOI 10.1056/NEJM198811033191810; ROPER WL, 1988, NEW ENGL J MED, V319, P1197, DOI 10.1056/NEJM198811033191805; SHAPIRO JH, 1990, AM COLL RADIOL B, V46, P11; STARK F, 1990, HR4464 HOUS WAYS MEA; WENNBERG J, 1973, SCIENCE, V182, P1102, DOI 10.1126/science.182.4117.1102; WENNBERG JE, 1977, PEDIATRICS, V59, P821; WINN JR, 1990, PHYSICIAN RECERTIFIC; ZDEB M, 1990, OCT ANN M AM PUBL HL; ZDEB MS, 1989, BIRTH-ISS PERINAT C, V16, P203, DOI 10.1111/j.1523-536X.1989.tb00899.x; 1988, MONITORING HLTH CARE; 1989, NY STATE J MED, V89, P223; 1988, RECOMMENDATIONS JOIN; 1985, NATIONAL I DRUG AB 1, V5; 1988, REPORT NEW YORK STAT; SPECIAL EXAMINATION; 1990, CITIZEN ADVOCACY NEW, V2, P1; 1989, 12 COUNC MED SPEC SO; 1987, CESAREAN CHILDBIRTH; 1989, NY STATE J MED, V89, P226; 1988, HYSTERECTOMIES NEW Y	34	19	19	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 13	1991	265	6					752	755		10.1001/jama.265.6.752	http://dx.doi.org/10.1001/jama.265.6.752			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EW479	1990192				2022-12-28	WOS:A1991EW47900028
J	BELLER, GA				BELLER, GA			PHARMACOLOGICAL STRESS IMAGING	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-ARTERY DISEASE; DIPYRIDAMOLE-INDUCED VASODILATION; ACUTE MYOCARDIAL-INFARCTION; NON-INVASIVE DETECTION; INTRAVENOUS DIPYRIDAMOLE; VASCULAR-SURGERY; CARDIAC RISK; NONINVASIVE ASSESSMENT; ORAL DIPYRIDAMOLE; EXERCISE STRESS	Pharmacologic stress imaging has increasingly been employed as an alternative to exercise imaging for detection of coronary artery disease and risk stratification particularly in patients who are unable to perform adequate exercise. Sensitivity and specificity of thallium 201 scintigraphy using intravenous dipyridamole infusion as a stress for coronary artery disease detection average 85% and 91%, respectively. Dipyridamole imaging is also useful for differentiating between ischemia and scar and identifying patients who have an increased risk for subsequent cardiac events. Dipyridamole imaging is particularly useful for preoperative risk stratification in patients undergoing surgery for peripheral vascular or aortic disease. Dipyridamole imaging is also useful for identifying residual myocardial ischemia after myocardial infarction and detecting restenosis after coronary angioplasty. Adverse side effects of dipyridamole are promptly reversed by aminophylline. Dipyridamole stress can also be employed in association with echocardiography for detection of ischemia-induced regional wall motion abnormalities.			BELLER, GA (corresponding author), UNIV VIRGINIA, HLTH SCI CTR, DEPT MED, DIV CARDIOL, BOX 158, CHARLOTTESVILLE, VA 22908 USA.							ALBRO PC, 1978, AM J CARDIOL, V42, P751, DOI 10.1016/0002-9149(78)90094-2; BECKER LC, 1978, CIRCULATION, V57, P1103, DOI 10.1161/01.CIR.57.6.1103; BELLER GA, 1983, CIRCULATION, V68, P1328, DOI 10.1161/01.CIR.68.6.1328; BELLER GA, 1985, CIRCULATION, V71, P378, DOI 10.1161/01.CIR.71.2.378; BOLOGNESE L, 1989, J AM COLL CARDIOL, V14, P357, DOI 10.1016/0735-1097(89)90186-1; BORGESNETO S, 1988, J AM COLL CARDIOL, V11, P962, DOI 10.1016/S0735-1097(98)90052-3; BOUCHER CA, 1985, NEW ENGL J MED, V312, P389, DOI 10.1056/NEJM198502143120701; BROWN KA, 1989, AM J CARDIOL, V64, P1017, DOI 10.1016/0002-9149(89)90800-X; BROWN KA, 1990, AM J CARDIOL, V65, P160, DOI 10.1016/0002-9149(90)90078-F; CASALE PN, 1988, AM J CARDIOL, V62, P799, DOI 10.1016/0002-9149(88)91225-8; CHAMBERS CE, 1988, J AM COLL CARDIOL, V12, P37, DOI 10.1016/0735-1097(88)90353-1; DEMER LL, 1989, CIRCULATION, V79, P825, DOI 10.1161/01.CIR.79.4.825; DEPUEY EG, 1990, CORONARY ARTERY DIS, V1, P75, DOI 10.1097/00019501-199001000-00011; DILSIZIAN V, 1990, NEW ENGL J MED, V323, P141, DOI 10.1056/NEJM199007193230301; EAGLE KA, 1989, ANN INTERN MED, V110, P859, DOI 10.7326/0003-4819-110-11-859; EAGLE KA, 1987, JAMA-J AM MED ASSOC, V257, P2185, DOI 10.1001/jama.257.16.2185; EICHHORN EJ, 1988, AM J CARDIOL, V62, P945, DOI 10.1016/0002-9149(88)90898-3; FLETCHER JP, 1988, J CARDIOVASC SURG, V29, P666; FRANCISCO DA, 1982, CIRCULATION, V66, P370, DOI 10.1161/01.CIR.66.2.370; FUNG AY, 1987, CIRCULATION, V76, P943, DOI 10.1161/01.CIR.76.4.943; GERSON MC, 1987, AM J CARDIOL, V60, P1399, DOI 10.1016/0002-9149(87)90629-1; GIMPLE LW, 1989, AM J CARDIOL, V64, P1243, DOI 10.1016/0002-9149(89)90561-4; GOULD KL, 1987, SEMIN NUCL MED, V17, P121, DOI 10.1016/S0001-2998(87)80017-X; GOULD KL, 1986, J AM COLL CARDIOL, V7, P775, DOI 10.1016/S0735-1097(86)80336-9; GOULD KL, 1978, AM J CARDIOL, V41, P267, DOI 10.1016/0002-9149(78)90165-0; HENDEL RC, 1990, J AM COLL CARDIOL, V15, P109, DOI 10.1016/0735-1097(90)90184-Q; HOMMA S, 1986, AM J CARDIOL, V57, P503, DOI 10.1016/0002-9149(86)90824-6; HOMMA S, 1987, AM J CARDIOL, V59, P152, DOI 10.1016/S0002-9149(87)80089-9; ISKANDRIAN AS, 1988, AM HEART J, V115, P432, DOI 10.1016/0002-8703(88)90492-9; JAIN A, 1988, J AM COLL CARDIOL, V11, P970, DOI 10.1016/S0735-1097(98)90053-5; JOSEPHSON MA, 1982, AM HEART J, V103, P1008, DOI 10.1016/0002-8703(82)90564-6; KIAT H, 1988, J AM COLL CARDIOL, V12, P1456, DOI 10.1016/S0735-1097(88)80009-3; KNABB RM, 1984, AM J PHYSIOL, V247, pH804, DOI 10.1152/ajpheart.1984.247.5.H804; LAARMAN G, 1988, INT J CARDIOL, V20, P231, DOI 10.1016/0167-5273(88)90267-7; LAM JYT, 1988, J AM COLL CARDIOL, V11, P585, DOI 10.1016/0735-1097(88)91535-5; LANE SE, 1989, AM J CARDIOL, V64, P1275, DOI 10.1016/0002-9149(89)90567-5; LEPPO J, 1982, CIRCULATION, V66, P649, DOI 10.1161/01.CIR.66.3.649; LEPPO JA, 1989, J NUCL MED, V30, P281; LEPPO JA, 1984, NEW ENGL J MED, V310, P1014, DOI 10.1056/NEJM198404193101603; LETTE J, 1989, CHEST, V95, P1345, DOI 10.1378/chest.95.6.1345; LEWEN MK, 1987, CHEST, V92, P1102, DOI 10.1378/chest.92.6.1102; MACHECOURT J, 1981, ARCH MAL COEUR VAISS, V74, P147; MARGONATO A, 1987, AM J CARDIOL, V59, P225, DOI 10.1016/0002-9149(87)90789-2; MARWICK TH, 1990, CLIN CARDIOL, V13, P14, DOI 10.1002/clc.4960130105; MAYS AE, 1984, J CLIN INVEST, V73, P1359, DOI 10.1172/JCI111339; NARITA M, 1981, JPN CIRC J, V45, P127, DOI 10.1253/jcj.45.127; OBYRNE GT, 1989, AM J CARDIOL, V64, P1022, DOI 10.1016/0002-9149(89)90801-1; OKADA RD, 1984, AM HEART J, V107, P475, DOI 10.1016/0002-8703(84)90088-7; OKADA RD, 1983, J AM COLL CARDIOL, V1, P1302, DOI 10.1016/S0735-1097(83)80144-2; OKADA RD, 1982, J CLIN INVEST, V69, P199, DOI 10.1172/JCI110431; PICANO E, 1988, AM J CARDIOL, V62, P67, DOI 10.1016/0002-9149(88)91366-5; PICANO E, 1989, CIRCULATION, V80, P450, DOI 10.1161/01.CIR.80.3.450; PIRELLI S, 1988, EUR HEART J, V9, P1324, DOI 10.1093/oxfordjournals.eurheartj.a062450; RANHOSKY A, 1990, CIRCULATION, V81, P1205, DOI 10.1161/01.CIR.81.4.1205; ROSSEN JD, 1989, CIRCULATION, V64, P871; RUDDY TD, 1987, J AM COLL CARDIOL, V10, P142, DOI 10.1016/S0735-1097(87)80172-9; RUDDY TD, 1987, J AM COLL CARDIOL, V10, P547, DOI 10.1016/S0735-1097(87)80197-3; SCHMOLINER R, 1983, CARDIOLOGY, V70, P145, DOI 10.1159/000173584; SOCHOR H, 1984, EUR HEART J, V5, P500, DOI 10.1093/oxfordjournals.eurheartj.a061697; SPARKS HV, 1986, CIRC RES, V58, P193, DOI 10.1161/01.RES.58.2.193; STRATMANN HG, 1989, AM HEART J, V117, P1344, DOI 10.1016/0002-8703(89)90417-1; SYLVEN C, 1986, BRIT MED J, V293, P227, DOI 10.1136/bmj.293.6541.227; TAILLEFER R, 1986, J AM COLL CARDIOL, V8, P76, DOI 10.1016/S0735-1097(86)80094-8; Timmis A D, 1980, Eur Heart J, V1, P275; VERANI MS, 1990, CIRCULATION, V82, P80, DOI 10.1161/01.CIR.82.1.80; VILLANUEVA FS, 1980, CIRCULATION S2, V80, P210; YOUNIS LT, 1989, J AM COLL CARDIOL, V14, P1635, DOI 10.1016/0735-1097(89)90008-9; YOUNIS LT, 1989, AM J CARDIOL, V64, P161, DOI 10.1016/0002-9149(89)90450-5	68	69	69	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	1991	265	5					633	638		10.1001/jama.265.5.633	http://dx.doi.org/10.1001/jama.265.5.633			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EV718	1987415				2022-12-28	WOS:A1991EV71800023
J	MEYER, B; HANSEN, T; NUTE, D; ALBERSHEIM, P; DARVILL, A; YORK, W; SELLERS, J				MEYER, B; HANSEN, T; NUTE, D; ALBERSHEIM, P; DARVILL, A; YORK, W; SELLERS, J			IDENTIFICATION OF THE H-1-NMR SPECTRA OF COMPLEX OLIGOSACCHARIDES WITH ARTIFICIAL NEURAL NETWORKS	SCIENCE			English	Article								Artificial neural networks can be used to identify hydrogen nuclear magnetic resonance (H-1-NMR) spectra of complex oligosaccharides. Feed-forward neural networks with back-propagation of errors can distinguish between spectra of oligosaccharides that differ by only one glycosyl residue in twenty. The artificial neural networks use features of the strongly overlapping region of the spectra (hump region) as well as features of the resolved regions of the spectra (structural reporter groups) to recognize spectra and efficiently recognized H-1-NMR spectra even when the spectra were perturbed by minor variations in their chemical shifts. Identification of spectra by neural network-based on pattern recognition techniques required less than 0.1 second. It is anticipated that artificial neural networks can be used to identify the structures of any complex carbohydrate that has been previously characterized and for which a H-1-NMR spectrum is available.	UNIV GEORGIA,DEPT BIOCHEM,ATHENS,GA 30602; UNIV GEORGIA,ARTIFICIAL INTELLIGENCE PROGRAM,ATHENS,GA 30602	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	MEYER, B (corresponding author), UNIV GEORGIA,COMPLEX CARBOHYDRATE RES CTR,ATHENS,GA 30602, USA.		Meyer, Bernd/A-8828-2008					GOUX WJ, 1989, J MAGN RESON, V85, P457, DOI 10.1016/0022-2364(89)90237-0; HISAMATSU M, UNPUB; KIEFER LL, 1990, CARBOHYD RES, V197, P139, DOI 10.1016/0008-6215(90)84137-J; McClelland J. L., 1988, EXPLORATIONS PARALLE; Rumelhart D.E., 1986, PARALLEL DISTRIBUTED, V1; SELLERS J, IN PRESS CARBOHYDR R; THOMSEN JU, 1989, J MAGN RESON, V84, P212, DOI 10.1016/0022-2364(89)90021-8; VLIEGENTHART JFG, 1983, ADV CARBOHYD CHEM BI, V41, P209, DOI 10.1016/S0065-2318(08)60059-1; YORK WS, 1990, CARBOHYD RES, V200, P9, DOI 10.1016/0008-6215(90)84179-X	9	85	92	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	FEB 1	1991	251	4993					542	544		10.1126/science.1990429	http://dx.doi.org/10.1126/science.1990429			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV459	1990429				2022-12-28	WOS:A1991EV45900044
J	CROSS, M; DEXTER, TM				CROSS, M; DEXTER, TM			GROWTH-FACTORS IN DEVELOPMENT, TRANSFORMATION, AND TUMORIGENESIS	CELL			English	Review							LEUKEMIA INHIBITORY FACTOR; GTPASE ACTIVATING PROTEIN; COLONY-STIMULATING FACTOR; PHOSPHOLIPASE-C-GAMMA; EARLY XENOPUS EMBRYO; TYROSINE PHOSPHORYLATION; FACTOR RECEPTOR; MESSENGER-RNA; TGF-BETA; MESODERM INDUCTION				CROSS, M (corresponding author), CHRISTIE HOSP & HOLT RADIUM INST, PATERSON INST CANC RES, CRC, DEPT EXPTL HAEMATOL, MANCHESTER M20 9BX, LANCS, ENGLAND.			Cross, Michael/0000-0002-8815-7621				ACLAND P, 1990, NATURE, V343, P662, DOI 10.1038/343662a0; AKHURST RJ, 1988, NATURE, V331, P363, DOI 10.1038/331363a0; AUGER KR, 1989, CELL, V57, P167, DOI 10.1016/0092-8674(89)90182-7; BARNARD JA, 1990, BIOCHIM BIOPHYS ACTA, V1032, P79, DOI 10.1016/0304-419X(90)90013-Q; BEJCEK BE, 1989, SCIENCE, V245, P1496, DOI 10.1126/science.2551043; BESMER P, 1983, J VIROL, V46, P606, DOI 10.1128/JVI.46.2.606-613.1983; BISHAYEE S, 1989, J BIOL CHEM, V264, P11699; BLOOD CH, 1990, BIOCHIM BIOPHYS ACTA, V1032, P89, DOI 10.1016/0304-419X(90)90014-R; BOGLER O, 1990, P NATL ACAD SCI USA, V87, P6368, DOI 10.1073/pnas.87.16.6368; BOUCHE G, 1987, P NATL ACAD SCI USA, V84, P6770, DOI 10.1073/pnas.84.19.6770; BURGESS WH, 1989, ANNU REV BIOCHEM, V58, P575, DOI 10.1146/annurev.bi.58.070189.003043; CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G; CHABOT B, 1988, NATURE, V335, P88, DOI 10.1038/335088a0; COFFEY RJ, 1988, CANCER RES, V48, P1596; COUGHLIN SR, 1989, SCIENCE, V243, P1191; CURRAN T, 1988, CELL, V55, P395, DOI 10.1016/0092-8674(88)90024-4; DAVIS RJ, 1985, P NATL ACAD SCI USA, V82, P4080, DOI 10.1073/pnas.82.12.4080; DEXTER TM, 1990, PHILOS T ROY SOC B, V327, P85, DOI 10.1098/rstb.1990.0045; Dickson C, 1989, Prog Growth Factor Res, V1, P123, DOI 10.1016/0955-2235(89)90006-9; DICKSON C, 1987, NATURE, V326, P833, DOI 10.1038/326833a0; DICKSON C, 1984, CELL, V37, P529, DOI 10.1016/0092-8674(84)90383-0; DOWNWARD J, 1984, NATURE, V307, P521, DOI 10.1038/307521a0; EK B, 1982, NATURE, V295, P419, DOI 10.1038/295419a0; FIBBE WE, 1988, BLOOD, V71, P430; GEISSLER EN, 1988, CELL, V55, P185, DOI 10.1016/0092-8674(88)90020-7; GILL GN, 1987, MOL CELL ENDOCRINOL, V51, P169, DOI 10.1016/0303-7207(87)90027-X; GIMBRONE MA, 1972, J EXP MED, V136, P261, DOI 10.1084/jem.136.2.261; GLINIAK BC, 1990, CELL, V63, P1073, DOI 10.1016/0092-8674(90)90510-L; GORDON MY, 1987, NATURE, V326, P403, DOI 10.1038/326403a0; GOUSTIN AS, 1986, CANCER RES, V46, P1015; GOUSTIN AS, 1985, CELL, V41, P301, DOI 10.1016/0092-8674(85)90083-2; GRAHAM GJ, 1990, NATURE, V344, P442, DOI 10.1038/344442a0; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; GRONWALD RGK, 1989, J BIOL CHEM, V264, P8120; HASELBACHER GK, 1987, P NATL ACAD SCI USA, V84, P1104, DOI 10.1073/pnas.84.4.1104; HEIKKILA R, 1987, NATURE, V328, P445, DOI 10.1038/328445a0; HELDIN CH, 1989, J BIOL CHEM, V264, P8905; HELDIN CH, 1989, EUR J BIOCHEM, V184, P487, DOI 10.1111/j.1432-1033.1989.tb15041.x; HELDIN CH, 1990, J CELL SCI, V96, P193; HERMANSSON M, 1988, P NATL ACAD SCI USA, V85, P7748, DOI 10.1073/pnas.85.20.7748; JAMAL S, 1990, NATURE, V344, P463, DOI 10.1038/344463a0; JOHNSSON A, 1984, EMBO J, V3, P921, DOI 10.1002/j.1460-2075.1984.tb01908.x; JOSEPHS SF, 1984, SCIENCE, V225, P636, DOI 10.1126/science.6740330; KAPLAN DR, 1990, CELL, V61, P125, DOI 10.1016/0092-8674(90)90220-9; KELLER JR, 1988, J EXP MED, V168, P737, DOI 10.1084/jem.168.2.737; KELLY K, 1983, CELL, V35, P603, DOI 10.1016/0092-8674(83)90092-2; KIMELMAN D, 1988, SCIENCE, V242, P1053, DOI 10.1126/science.3194757; KIMELMAN D, 1987, CELL, V51, P869, DOI 10.1016/0092-8674(87)90110-3; LINEMEYER DL, 1987, BIO-TECHNOL, V5, P960, DOI 10.1038/nbt0987-960; LIOTTA LA, 1991, CELL, V64, P327, DOI 10.1016/0092-8674(91)90642-C; LOVHAUG D, 1986, EXP HEMATOL, V14, P1037; MATSUI Y, 1990, NATURE, V347, P667, DOI 10.1038/347667a0; MCCORMICK F, 1989, CELL, V56, P5, DOI 10.1016/0092-8674(89)90976-8; MEISENHELDER J, 1989, CELL, V57, P1109, DOI 10.1016/0092-8674(89)90048-2; MERIMEE TJ, 1987, NEW ENGL J MED, V316, P906, DOI 10.1056/NEJM198704093161503; MOLLOY CJ, 1989, NATURE, V342, P711, DOI 10.1038/342711a0; MOREAU JF, 1988, NATURE, V336, P690, DOI 10.1038/336690a0; MORRISON DK, 1990, MOL CELL BIOL, V10, P2359, DOI 10.1128/MCB.10.5.2359; MORRISON DK, 1989, CELL, V58, P649, DOI 10.1016/0092-8674(89)90100-1; NISHIMURA J, 1982, P NATL ACAD SCI-BIOL, V79, P4303, DOI 10.1073/pnas.79.14.4303; OPRESKO LK, 1990, J CELL BIOL, V111, P1661, DOI 10.1083/jcb.111.4.1661; PARSONS JT, 1990, TRENDS GENET, V6, P169; PATERNO GD, 1989, DEVELOPMENT, V106, P79; RAFF MC, 1988, NATURE, V333, P562, DOI 10.1038/333562a0; RAPPOLEE DA, 1988, SCIENCE, V241, P1823, DOI 10.1126/science.3175624; RICHMOND A, 1988, EMBO J, V7, P2025, DOI 10.1002/j.1460-2075.1988.tb03042.x; ROBBINS KC, 1983, NATURE, V305, P605, DOI 10.1038/305605a0; ROBERTS AB, 1990, PHILOS T R SOC B, V327, P145, DOI 10.1098/rstb.1990.0050; ROBERTS R, 1988, NATURE, V332, P376, DOI 10.1038/332376a0; ROSA F, 1988, SCIENCE, V239, P783, DOI 10.1126/science.3422517; ROSS R, 1990, PHILOS T ROY SOC B, V327, P155, DOI 10.1098/rstb.1990.0051; ROUSSEL MF, 1987, NATURE, V325, P549, DOI 10.1038/325549a0; ROZENGURT E, 1986, SCIENCE, V234, P161, DOI 10.1126/science.3018928; SAKAMOTO H, 1986, P NATL ACAD SCI USA, V83, P3997, DOI 10.1073/pnas.83.11.3997; SAKSELA O, 1990, J CELL BIOL, V110, P767, DOI 10.1083/jcb.110.3.767; SAWYERS CL, 1991, CELL, V64, P337, DOI 10.1016/0092-8674(91)90643-D; SCHLESSINGER J, 1978, P NATL ACAD SCI USA, V75, P2659, DOI 10.1073/pnas.75.6.2659; SEIFERT RA, 1989, J BIOL CHEM, V264, P8771; SHERR CJ, 1985, CELL, V41, P665, DOI 10.1016/S0092-8674(85)80047-7; SLACK JMW, 1989, DEVELOPMENT, V105, P147; SLACK JMW, 1987, NATURE, V326, P197, DOI 10.1038/326197a0; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; SMITH CA, 1989, NATURE, V337, P181, DOI 10.1038/337181a0; Spemann H, 1924, ARCH MIKROSK ANAT EN, V100, P599, DOI 10.1007/BF02108133; SPORN MB, 1988, NATURE, V332, P217, DOI 10.1038/332217a0; Steward W P, 1989, Prog Growth Factor Res, V1, P1, DOI 10.1016/0955-2235(89)90037-9; STILES CD, 1979, P NATL ACAD SCI USA, V76, P1279, DOI 10.1073/pnas.76.3.1279; TAIRA M, 1987, P NATL ACAD SCI USA, V84, P2980, DOI 10.1073/pnas.84.9.2980; TRAHEY M, 1987, SCIENCE, V238, P542, DOI 10.1126/science.2821624; TSUTSUMI Y, 1988, ANN NY ACAD SCI, V547, P336, DOI 10.1111/j.1749-6632.1988.tb23901.x; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; VONRUDEN T, 1988, EMBO J, V7, P2749, DOI 10.1002/j.1460-2075.1988.tb03129.x; WAHL MI, 1989, MOL CELL BIOL, V9, P2934, DOI 10.1128/MCB.9.7.2934; WHETTON AD, 1989, BIOCHIM BIOPHYS ACTA, V989, P111, DOI 10.1016/0304-419X(89)90038-3; WILKINSON DG, 1989, DEVELOPMENT, V105, P131; WILKINSON DG, 1988, EMBO J, V7, P691, DOI 10.1002/j.1460-2075.1988.tb02864.x; WILLIAMS GT, 1990, NATURE, V343, P76, DOI 10.1038/343076a0; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; WRANN M, 1980, SCIENCE, V210, P1363, DOI 10.1126/science.6254158; YEH HJ, 1987, P NATL ACAD SCI USA, V84, P2317, DOI 10.1073/pnas.84.8.2317; ZAPF J, 1975, ARCH BIOCHEM BIOPHYS, V168, P638, DOI 10.1016/0003-9861(75)90296-9; ZHAN X, 1986, MOL CELL BIOL, V6, P3541, DOI 10.1128/MCB.6.10.3541; ZHAN XI, 1988, MOL CELL BIOL, V8, P3487, DOI 10.1128/MCB.8.8.3487	103	680	710	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 25	1991	64	2					271	280		10.1016/0092-8674(91)90638-F	http://dx.doi.org/10.1016/0092-8674(91)90638-F			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EV336	1988148				2022-12-28	WOS:A1991EV33600006
J	BAKER, KP; SCHATZ, G				BAKER, KP; SCHATZ, G			MITOCHONDRIAL PROTEINS ESSENTIAL FOR VIABILITY MEDIATE PROTEIN IMPORT INTO YEAST MITOCHONDRIA	NATURE			English	Review							C HEME LYASE; OUTER-MEMBRANE; CYTOCHROME-C; PRECURSOR POLYPEPTIDES; PROCESSING PROTEASE; 70-KD PROTEIN; GENE; BIOGENESIS; DEFICIENT; ENCODES	Only five mitrochondrial proteins are; known to be essential for viability of the yeast Saccharomyces cerevisiae; all of them are key components of the mitochondrial protein import system. Other components of this system are not essential for life; they include functionally redundant import receptors on the mitochondrial surface and enzymes acting upon only a few precursor proteins.			BAKER, KP (corresponding author), UNIV BASEL,BIOCTR,CH-4056 BASEL,SWITZERLAND.							ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cellbio.4.1.289; BAKER KP, 1990, NATURE, V348, P605, DOI 10.1038/348605a0; Barrett J., 1976, P67; BOEHNI P, 1980, ORG EXPRESSION MITOC, P423; BOGUSKI MS, 1990, NATURE, V346, P114, DOI 10.1038/346114a0; BOTSTEIN D, 1988, SCIENCE, V240, P1439, DOI 10.1126/science.3287619; CHENG MY, 1989, NATURE, V337, P620, DOI 10.1038/337620a0; CRAIG EA, 1989, MOL CELL BIOL, V9, P3000, DOI 10.1128/MCB.9.7.3000; CRIDDLE RS, 1969, BIOCHEMISTRY-US, V8, P322, DOI 10.1021/bi00829a045; DESHAIES RJ, 1988, NATURE, V332, P800, DOI 10.1038/332800a0; DUMONT ME, 1988, J BIOL CHEM, V263, P15928; ELLIS J, 1987, NATURE, V328, P378, DOI 10.1038/328378a0; GELI V, 1990, J BIOL CHEM, V265, P19216; HARTL FU, 1990, SCIENCE, V247, P930, DOI 10.1126/science.2406905; HASE T, 1983, EMBO J, V2, P2169, DOI 10.1002/j.1460-2075.1983.tb01718.x; HASE T, 1984, EMBO J, V3, P3157, DOI 10.1002/j.1460-2075.1984.tb02274.x; HAWLITSCHEK G, 1988, CELL, V53, P759; HINES V, 1990, EMBO J, V9, P3191, DOI 10.1002/j.1460-2075.1990.tb07517.x; JENSEN RE, 1988, EMBO J, V7, P3863, DOI 10.1002/j.1460-2075.1988.tb03272.x; KALOUSEK F, 1988, P NATL ACAD SCI USA, V85, P7536, DOI 10.1073/pnas.85.20.7536; KANG PJ, 1990, NATURE, V348, P137, DOI 10.1038/348137a0; KIEBLER M, 1990, NATURE, V348, P610, DOI 10.1038/348610a0; MCADA PC, 1982, J BIOL CHEM, V257, P3177; MCMULLIN TW, 1988, MOL CELL BIOL, V8, P371, DOI 10.1128/MCB.8.1.371; MORISHIMA N, 1990, J BIOL CHEM, V265, P15189; MURAKAMI H, 1990, NATURE, V347, P488, DOI 10.1038/347488a0; MURAKAMI H, 1988, J CELL BIOL, V107, P2051, DOI 10.1083/jcb.107.6.2051; MURAKAMI K, 1990, EMBO J, V9, P3201, DOI 10.1002/j.1460-2075.1990.tb07518.x; NICHOLSON DW, 1987, EUR J BIOCHEM, V164, P147, DOI 10.1111/j.1432-1033.1987.tb11006.x; NICHOLSON DW, 1988, J BIOL CHEM, V263, P19034; NICHOLSON DW, 1989, J BIOL CHEM, V264, P10156; OHBA M, 1987, EMBO J, V6, P2109, DOI 10.1002/j.1460-2075.1987.tb02477.x; ONO H, 1990, J BIOCHEM-TOKYO, V107, P840, DOI 10.1093/oxfordjournals.jbchem.a123135; OSTERMANN J, 1989, NATURE, V341, P125, DOI 10.1038/341125a0; OU WJ, 1989, EMBO J, V8, P2605, DOI 10.1002/j.1460-2075.1989.tb08400.x; PAIN D, 1990, NATURE, V347, P444, DOI 10.1038/347444a0; PFALLER R, 1988, J CELL BIOL, V107, P2483, DOI 10.1083/jcb.107.6.2483; POLLOCK RA, 1988, EMBO J, V7, P3493, DOI 10.1002/j.1460-2075.1988.tb03225.x; PRASAD TK, 1990, MOL CELL BIOL, V10, P3979, DOI 10.1128/MCB.10.8.3979; PRATJE E, 1986, EMBO J, V5, P1313, DOI 10.1002/j.1460-2075.1986.tb04361.x; PRATJE E, 1983, EMBO J, V2, P1049, DOI 10.1002/j.1460-2075.1983.tb01544.x; RIEZMAN H, 1983, EMBO J, V2, P1112; ROISE D, 1988, J BIOL CHEM, V263, P4509; SCHERER PE, 1990, EMBO J, V9, P4315, DOI 10.1002/j.1460-2075.1990.tb07880.x; SCHNEIDER A, IN PRESS EMBO J, V10; SCHNEIDER H, 1990, J BIOL CHEM, V265, P9681; SIKORSKI RS, 1990, CELL, V60, P307, DOI 10.1016/0092-8674(90)90745-Z; SOLLNER T, 1989, CELL, V59, P1061, DOI 10.1016/0092-8674(89)90762-9; SOLLNER T, 1990, CELL, V62, P107, DOI 10.1016/0092-8674(90)90244-9; Tzagoloff A, 1982, MITOCHONDRIA; VESTWEBER D, 1989, NATURE, V341, P205, DOI 10.1038/341205a0; WITTE C, 1988, EMBO J, V7, P1439, DOI 10.1002/j.1460-2075.1988.tb02961.x; YAFFE M, 1984, TRENDS BIOCHEM SCI, V9, P179, DOI 10.1016/0968-0004(84)90133-6; YAFFE MP, 1985, EMBO J, V4, P2069, DOI 10.1002/j.1460-2075.1985.tb03893.x; YAFFE MP, 1984, P NATL ACAD SCI-BIOL, V81, P4819, DOI 10.1073/pnas.81.15.4819; YANG M, 1988, EMBO J, V7, P3857, DOI 10.1002/j.1460-2075.1988.tb03271.x; YANG M, 1991, IN PRESS J BIOL CHEM, V266; ZWIZINSKI C, 1984, J BIOL CHEM, V259, P7850	58	254	259	0	6	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JAN 17	1991	349	6306					205	208		10.1038/349205a0	http://dx.doi.org/10.1038/349205a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET519	1987474				2022-12-28	WOS:A1991ET51900044
J	WEBSTER, MA; MOLLON, JD				WEBSTER, MA; MOLLON, JD			CHANGES IN COLOR APPEARANCE FOLLOWING POST-RECEPTORAL ADAPTATION	NATURE			English	Article							CHROMATIC MECHANISMS; LUMINANCE; VISION; GREEN; BLUE	CURRENT models of colour vision assume that colour is represented by activity in three independent post-receptoral channels: two encoding chromatic information and one encoding luminance 1. An important feature of these models is that variations in certain directions in colour space modulate the response of only one of the channels. We have tested whether such models can predict how colour appearance is altered by adaptation-induced changes in post-receptoral sensitivity. In contrast to the changes predicted by three independent channels, colour appearance is always distorted away from the direction in colour space to which the observer has adapted. This suggests that at the level at which the adaptation effects occur, there is no colour direction that invariably isolates only a single post-receptoral channel.			WEBSTER, MA (corresponding author), UNIV CAMBRIDGE,DEPT EXPTL PSYCHOL,CAMBRIDGE CB2 3EB,ENGLAND.		Mollon, John/C-3520-2009; Mollon, John/U-2631-2019	Mollon, John/0000-0001-8533-033X; Mollon, John/0000-0001-8533-033X; Webster, Michael/0000-0001-8262-7525				BARLOW HB, 1989, COMPUTING NEURON; BENZSCHAWEL T, 1982, VISION RES, V22, P69, DOI 10.1016/0042-6989(82)90168-7; BLAKEMOR.C, 1969, SCIENCE, V166, P245, DOI 10.1126/science.166.3902.245; Boynton R. M., 1979, HUMAN COLOR VISION; BOYNTON RM, 1986, PERCEPTION, V15, P755, DOI 10.1068/p150755; BOYNTON RM, 1980, COLOR RES APPL, V5, P13, DOI 10.1002/col.5080050104; DERRINGTON AM, 1984, J PHYSIOL-LONDON, V357, P241, DOI 10.1113/jphysiol.1984.sp015499; EISNER A, 1980, J OPT SOC AM, V70, P121, DOI 10.1364/JOSA.70.000121; FLANAGAN P, 1990, VISION RES, V30, P769, DOI 10.1016/0042-6989(90)90102-Q; Gibson JJ, 1937, J EXP PSYCHOL, V20, P453, DOI 10.1037/h0059826; Jameson D., 1972, HDB SENSORY PHYSL 4, V7; KRAUSKOPF J, 1986, J OPT SOC AM A, V3, P1752, DOI 10.1364/JOSAA.3.001752; KRAUSKOPF J, 1986, VISION RES, V26, P23, DOI 10.1016/0042-6989(86)90068-4; KRAUSKOPF J, 1982, VISION RES, V22, P1123, DOI 10.1016/0042-6989(82)90077-3; KRAUSKOPF J, 1990, NATURE, V348, P328, DOI 10.1038/348328a0; LE GRAND Y., 1949, REV OPTIQUE, V28, P261; MACLEOD DIA, 1979, J OPT SOC AM, V69, P1183, DOI 10.1364/JOSA.69.001183; MOLLON JD, 1989, J EXP BIOL, V146, P21; NAGY AL, 1990, J OPT SOC AM A, V7, P1209, DOI 10.1364/JOSAA.7.001209; NATHANS J, 1986, SCIENCE, V232, P193, DOI 10.1126/science.2937147; STROMEYER CF, 1988, VISION RES, V28, P931, DOI 10.1016/0042-6989(88)90102-2; SUTHERLAND NS, 1961, Q J EXP PSYCHOL, V13, P222, DOI 10.1080/17470216108416498; VONFIENDT K, 1977, PERCEPTUAL WORLD; WEBSTER MA, 1990, J OPT SOC AM A, V7, P1034, DOI 10.1364/JOSAA.7.001034	24	160	161	0	10	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JAN 17	1991	349	6306					235	238		10.1038/349235a0	http://dx.doi.org/10.1038/349235a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET519	1987475				2022-12-28	WOS:A1991ET51900054
J	FELSON, DT; SLOUTSKIS, D; ANDERSON, JJ; ANTHONY, JM; KIEL, DP				FELSON, DT; SLOUTSKIS, D; ANDERSON, JJ; ANTHONY, JM; KIEL, DP			THIAZIDE DIURETICS AND THE RISK OF HIP FRACTURE - RESULTS FROM THE FRAMINGHAM-STUDY	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POSTMENOPAUSAL WOMEN; MINERAL-CONTENT; BONE LOSS; CALCIUM	Thiazide diuretics may preserve bone mass and prevent elderly women's osteopenic fractures, but studies have not distinquished between thiazide preparations or examined former users. We performed a case-control study looking at thiazide use and subsequent hip fracture in postmenopausal female members of the Framingham Study cohort. Cases who had experienced a first hip fracture (n = 176) were compared with age-matched controls (n = 672). Results showed a modest protective effect of any recent thiazide use (not significant). However, recent pure thiazide users experienced significant protection against fracture (adjusted odds ratio, 0.31; 95% confidence interval, 0.11 to 0.88), whereas recent users of combination drugs containing thaizides experienced no protection (adjusted odds ratio, 1.16; 95% confidence interval, 0.44 to 3.05). Combination drugs generally contained only 25 mg of hydrochlorothiazide, suggesting that the small amount of thiazide was insufficient to preserve bone mass. Former thiazide users were not protected against fracture. In sum, recent pure thiazide use in women protects against hip fracture.	BOSTON CITY HOSP,DEPT MED,BOSTON,MA 02118; UNIV HOSP BOSTON,DEPT MED,BOSTON,MA 02118; BROWN UNIV,DIV GEN INTERNAL MED,PROGRAM MED,PROVIDENCE,RI 02912; RHODE ISL HOSP,PROVIDENCE,RI 02902	Boston Medical Center; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital	FELSON, DT (corresponding author), BOSTON UNIV,SCH MED,CTR ARTHRITIS,A-203,80 E CONCORD ST,BOSTON,MA 02118, USA.			Felson, David/0000-0002-2668-2447; Kiel, Douglas/0000-0001-8474-0310	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR020613] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR-20613] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ADLANDDAVENPORT P, 1985, AM J OBSTET GYNECOL, V152, P630, DOI 10.1016/S0002-9378(85)80035-1; FELSON DT, 1988, AM J EPIDEMIOL, V128, P1102; FELSON DT, 1989, J AM GERIATR SOC, V37, P495, DOI 10.1111/j.1532-5415.1989.tb05678.x; HASTINGS RP, 1986, SUGI SUPPLEMENTAL LI; HEANEY RP, 1982, AM J CLIN NUTR, V36, P986, DOI 10.1093/ajcn/36.5.986; KIEL DP, 1990, AM J EPIDEMIOL, V132, P675, DOI 10.1093/oxfordjournals.aje.a115709; KIEL DP, 1987, NEW ENGL J MED, V317, P1169, DOI 10.1056/NEJM198711053171901; LACROIX AZ, 1990, NEW ENGL J MED, V322, P286, DOI 10.1056/NEJM199002013220502; LJUNGHALL S, 1981, SCAND J UROL NEPHROL, V15, P257, DOI 10.3109/00365598109179613; RAY WA, 1989, LANCET, V1, P687; RIGGS BL, 1987, J CLIN INVEST, V80, P979, DOI 10.1172/JCI113191; TRANSBOL I, 1982, METABOLISM, V31, P383, DOI 10.1016/0026-0495(82)90115-9; WASNICH RD, 1983, NEW ENGL J MED, V309, P344, DOI 10.1056/NEJM198308113090605	13	123	130	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 16	1991	265	3					370	373		10.1001/jama.265.3.370	http://dx.doi.org/10.1001/jama.265.3.370			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ER256	1984536				2022-12-28	WOS:A1991ER25600027
J	THOMAS, BJ; ROTHSTEIN, R				THOMAS, BJ; ROTHSTEIN, R			SEX, MAPS, AND IMPRINTING	CELL			English	Review							MEIOTIC GENE CONVERSION; MITOTIC RECOMBINATION; INITIATION SITE; RIBOSOMAL DNA; S-CEREVISIAE; YEAST; TRANSCRIPTION; MICE		COLUMBIA UNIV COLL PHYS & SURG, DEPT GENET & DEV, NEW YORK, NY 10032 USA	Columbia University	THOMAS, BJ (corresponding author), UNIV CALIF LOS ANGELES, SCH MED, DEPT BIOL CHEM, LOS ANGELES, CA 90024 USA.			Rothstein, Rodney/0000-0002-4107-9654				BLACKWELL TK, 1989, ANNU REV GENET, V23, P605, DOI 10.1146/annurev.ge.23.120189.003133; CATTANACH BM, 1985, NATURE, V315, P496, DOI 10.1038/315496a0; CHRISTMAN MF, 1988, CELL, V55, P413, DOI 10.1016/0092-8674(88)90027-X; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; GOTTLIEB S, 1989, CELL, V56, P771, DOI 10.1016/0092-8674(89)90681-8; GUTZ H, 1971, GENETICS, V69, P331; Haldane JBS, 1922, J GENET, V12, P101, DOI 10.1007/BF02983075; KUNZ BA, 1981, ANNU REV GENET, V15, P57, DOI 10.1146/annurev.ge.15.120181.000421; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; MONK M, 1988, GENE DEV, V2, P921, DOI 10.1101/gad.2.8.921; NASMYTH K, 1987, SCIENCE, V237, P1162, DOI 10.1126/science.3306917; NASMYTH KA, 1982, CELL, V30, P567, DOI 10.1016/0092-8674(82)90253-7; NICOLAS A, 1989, NATURE, V338, P35, DOI 10.1038/338035a0; REIK W, 1987, NATURE, V328, P248, DOI 10.1038/328248a0; SAPIENZA C, 1987, GENE DEV, V1, P1039; SPOFFORD JB, 1959, P NATL ACAD SCI USA, V45, P1003, DOI 10.1073/pnas.45.7.1003; SUN H, 1989, NATURE, V338, P87, DOI 10.1038/338087a0; SURANI MAH, 1987, EXPT APPROACHES MAMM, P401; SWAIN JL, 1987, CELL, V50, P719, DOI 10.1016/0092-8674(87)90330-8; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; TSAO YP, 1989, CELL, V56, P111, DOI 10.1016/0092-8674(89)90989-6; VOELKELMEIMAN K, 1987, CELL, V48, P1071, DOI 10.1016/0092-8674(87)90714-8; WALLIS JW, 1989, CELL, V58, P409, DOI 10.1016/0092-8674(89)90855-6; YANCOPOULOS GD, 1986, ANNU REV IMMUNOL, V4, P339, DOI 10.1146/annurev.iy.04.040186.002011	24	51	51	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 11	1991	64	1					1	3		10.1016/0092-8674(91)90199-9	http://dx.doi.org/10.1016/0092-8674(91)90199-9			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ET175	1986861				2022-12-28	WOS:A1991ET17500001
J	DATTWYLER, RJ; VOLKMAN, DJ; CONATY, SM; PLATKIN, SP; LUFT, BJ				DATTWYLER, RJ; VOLKMAN, DJ; CONATY, SM; PLATKIN, SP; LUFT, BJ			AMOXYCILLIN PLUS PROBENECID VERSUS DOXYCYCLINE FOR TREATMENT OF ERYTHEMA MIGRANS BORRELIOSIS	LANCET			English	Article											DATTWYLER, RJ (corresponding author), SUNY STONY BROOK, HLTH SCI CTR, DEPT MED, STONY BROOK, NY 11794 USA.		Dattwyler, Raymond/ABH-2292-2021	Dattwyler, Raymond/0000-0002-1983-1301; Luft, Benjamin/0000-0001-9008-7004				ASBRINK E, 1988, ANN NY ACAD SCI, V539, P4, DOI 10.1111/j.1749-6632.1988.tb31833.x; BENACH JL, 1983, NEW ENGL J MED, V308, P740, DOI 10.1056/NEJM198303313081302; BERGER BW, 1988, ANN NY ACAD SCI, V539, P346, DOI 10.1111/j.1749-6632.1988.tb31868.x; BERGER BW, 1983, AM J DERMATOPATH, V5, P111, DOI 10.1097/00000372-198304000-00008; BIANCHI G. E., 1950, DERMATOIOGICA [BASEL], V100, P270; BURGDORFER W, 1982, SCIENCE, V216, P1317, DOI 10.1126/science.7043737; DATTWYLER RJ, 1987, ARTHRITIS RHEUM, V30, P448, DOI 10.1002/art.1780300414; EAGLE H, 1948, ANN INTERN MED, V28, P260, DOI 10.7326/0003-4819-28-2-260; Hollstrom E, 1951, ACTA DERM-VENEREOL, V31, P325; JOHNSON RC, 1987, ANTIMICROB AGENTS CH, V31, P164, DOI 10.1128/AAC.31.2.164; KUNIN CM, 1959, J CLIN INVEST, V38, P1950, DOI 10.1172/JCI103974; LUFT BJ, 1988, ANN NY ACAD SCI, V539, P352, DOI 10.1111/j.1749-6632.1988.tb31869.x; MURSIC VP, 1987, EUR J CLIN MICROBIOL, V6, P424, DOI 10.1007/BF02013102; STEERE AC, 1983, ANN INTERN MED, V99, P76, DOI 10.7326/0003-4819-99-1-76; STEERE AC, 1983, ANN INTERN MED, V99, P22, DOI 10.7326/0003-4819-99-1-22; STEERE AC, 1983, NEW ENGL J MED, V308, P733, DOI 10.1056/NEJM198303313081301; WEBER K, 1988, ANN NY ACAD SCI, V539, P324, DOI 10.1111/j.1749-6632.1988.tb31867.x	17	129	131	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 8	1990	336	8728					1404	1406		10.1016/0140-6736(90)93103-V	http://dx.doi.org/10.1016/0140-6736(90)93103-V			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL851	1978873				2022-12-28	WOS:A1990EL85100006
J	MCGINNIS, N; KUZIORA, MA; MCGINNIS, W				MCGINNIS, N; KUZIORA, MA; MCGINNIS, W			HUMAN HOX-4.2 AND DROSOPHILA DEFORMED ENCODE SIMILAR REGULATORY SPECIFICITIES IN DROSOPHILA EMBRYOS AND LARVAE	CELL			English	Article											MCGINNIS, N (corresponding author), YALE UNIV,DEPT MOLEC BIOPHYS & BIOCHEM,NEW HAVEN,CT 06511, USA.				NIGMS NIH HHS [P01 GM39813] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM039813] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AKAM M, 1989, CELL, V57, P347, DOI 10.1016/0092-8674(89)90909-4; ALTABA AR, 1989, CELL, V57, P317, DOI 10.1016/0092-8674(89)90969-0; BALLING R, 1989, CELL, V58, P337, DOI 10.1016/0092-8674(89)90848-9; BEACHY PA, 1988, CELL, V55, P1069, DOI 10.1016/0092-8674(88)90251-6; BONCINELLI E, 1988, HUM REPROD, V3, P880, DOI 10.1093/oxfordjournals.humrep.a136802; BRIDGES CB, 1923, CARNEGIE I WASH, V327, P93; CAPECCHI MR, 1989, TRENDS GENET, V5, P70, DOI 10.1016/0168-9525(89)90029-2; CARRASCO AE, 1984, CELL, V37, P409, DOI 10.1016/0092-8674(84)90371-4; CHADWICK R, 1987, EMBO J, V6, P779, DOI 10.1002/j.1460-2075.1987.tb04820.x; CHADWICK R, 1990, IN PRESS DEV BIOL; DESPLAN C, 1985, NATURE, V318, P630, DOI 10.1038/318630a0; DIEDERICH RJ, 1989, GENE DEV, V3, P399, DOI 10.1101/gad.3.3.399; DUBOULE D, 1989, EMBO J, V8, P1497, DOI 10.1002/j.1460-2075.1989.tb03534.x; DUBOULE D, 1990, IN PRESS GENOMICS; DUNCAN I, 1987, ANNU REV GENET, V21, P285, DOI 10.1146/annurev.ge.21.120187.001441; FEATHERSTONE MS, 1988, P NATL ACAD SCI USA, V85, P4760, DOI 10.1073/pnas.85.13.4760; GIBSON G, 1988, DEVELOPMENT, V102, P657; GONZALEZREYES A, 1990, CELL, V61, P515, DOI 10.1016/0092-8674(90)90533-K; GRAHAM A, 1988, GENE DEV, V2, P1424, DOI 10.1101/gad.2.11.1424; GRAHAM A, 1989, CELL, V57, P367, DOI 10.1016/0092-8674(89)90912-4; HAFEN E, 1984, NATURE, V307, P287, DOI 10.1038/307287a0; HALL MN, 1987, SCIENCE, V237, P1007, DOI 10.1126/science.2887035; HAYNIE JL, 1986, J EXP ZOOL, V237, P293, DOI 10.1002/jez.1402370302; JACK T, 1988, GENE DEV, V2, P635, DOI 10.1101/gad.2.6.635; KARCH F, 1985, CELL, V43, P81, DOI 10.1016/0092-8674(85)90014-5; KAUFMAN TC, 1990, GENETIC REGULATORY H, P309; KESSEL M, 1990, CELL, V61, P301, DOI 10.1016/0092-8674(90)90810-2; KUZIORA MA, 1988, CELL, V55, P477, DOI 10.1016/0092-8674(88)90034-7; KUZIORA MA, 1989, CELL, V59, P563, DOI 10.1016/0092-8674(89)90039-1; LEMOTTE PK, 1989, EMBO J, V8, P219, DOI 10.1002/j.1460-2075.1989.tb03367.x; LEVINE M, 1988, CELL, V55, P537, DOI 10.1016/0092-8674(88)90209-7; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; MANN RS, 1990, CELL, V60, P597, DOI 10.1016/0092-8674(90)90663-Y; MARTINEZARIAS A, 1987, DEVELOPMENT, V100, P673; MAVILIO F, 1986, NATURE, V324, P664, DOI 10.1038/324664a0; MCGINNIS W, 1984, NATURE, V308, P428, DOI 10.1038/308428a0; MCGINNIS W, 1985, COLD SPRING HARB SYM, V50, P263, DOI 10.1101/SQB.1985.050.01.033; MCGINNIS W, 1984, CELL, V37, P403, DOI 10.1016/0092-8674(84)90370-2; MERRILL VKL, 1987, DEV BIOL, V122, P379, DOI 10.1016/0012-1606(87)90303-4; MISMER D, 1987, GENETICS, V116, P565; POSTLETHWAIT JH, 1971, DEV BIOL, V25, P606, DOI 10.1016/0012-1606(71)90008-X; PTASHNE M, 1988, NATURE, V335, P683, DOI 10.1038/335683a0; REGULSKI M, 1987, EMBO J, V6, P767, DOI 10.1002/j.1460-2075.1987.tb04819.x; REGULSKI M, 1985, CELL, V43, P71, DOI 10.1016/0092-8674(85)90013-3; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; SCHNEUWLY S, 1987, NATURE, V325, P816, DOI 10.1038/325816a0; SCOTT MP, 1984, P NATL ACAD SCI-BIOL, V81, P4115, DOI 10.1073/pnas.81.13.4115; SCOTT MP, 1989, BIOCHIM BIOPHYS ACTA, V989, P25, DOI 10.1016/0304-419X(89)90033-4; STRUHL G, 1982, P NATL ACAD SCI-BIOL, V79, P7380, DOI 10.1073/pnas.79.23.7380; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; Van der Meer JM., 1977, DROS INFORM SERV, V52, P160; WHITE RAH, 1985, NATURE, V318, P567, DOI 10.1038/318567a0; WOLGEMUTH DJ, 1989, NATURE, V337, P464, DOI 10.1038/337464a0; WRIGHT CVE, 1989, CELL, V59, P81, DOI 10.1016/0092-8674(89)90871-4	54	194	200	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	NOV 30	1990	63	5					969	976		10.1016/0092-8674(90)90500-E	http://dx.doi.org/10.1016/0092-8674(90)90500-E			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EL759	1979526	hybrid			2022-12-28	WOS:A1990EL75900012
J	NAVARRO, V				NAVARRO, V			RACE OR CLASS VERSUS RACE AND CLASS - MORTALITY DIFFERENTIALS IN THE UNITED-STATES	LANCET			English	Editorial Material											NAVARRO, V (corresponding author), JOHNS HOPKINS UNIV,SCH HYG & PUBL HLTH,624 N BROADWAY,BALTIMORE,MD 21205, USA.		Navarro, Vicente/E-8174-2014	Navarro, Vicente/0000-0002-3310-3984				GREENBERG DS, 1990, LANCET, V335, P780, DOI 10.1016/0140-6736(90)90882-6; HARRISON B, 1988, GREAT UTURN CORPORAT, P128; KAPANTAIS G, 1989, ADV DATA VITAL HLTH, V172, P7; KRIEGER N, 1990, AM J EPIDEMIOL, V131, P804, DOI 10.1093/oxfordjournals.aje.a115571; LIBERATOS P, 1988, EPIDEMIOL REV, V10, P87, DOI 10.1093/oxfordjournals.epirev.a036030; MARMOT MG, 1987, ANNU REV PUBL HEALTH, V8, P111, DOI 10.1146/annurev.pu.08.050187.000551; POWELLGRINER E, 1990, CHARACTERISTICS PERS, P2; TOWNSEND P, 1990, INT J HEALTH SERV, V20, P363, DOI 10.2190/DBH3-9HYL-TQY5-Y734; VAGERO D, 1989, LANCET, V2, P35, DOI 10.1016/S0140-6736(89)90266-3; 1989, GOALS NATION YEAR 20; 1990, VITAL HLTH STATIS 10, V171, P12; 1989, HLTH CHARACTERISTICS, P11; 1990, HLTH US 1989; 1990, HLTH US 1989, P121; 1988, HLTH US 1987, P91; 1990, NY TIMES        0323, pA17; 1980, TARGETS HLTH ALL TAR, P24	17	252	252	0	11	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 17	1990	336	8725					1238	1240		10.1016/0140-6736(90)92846-A	http://dx.doi.org/10.1016/0140-6736(90)92846-A			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ064	1978083	hybrid			2022-12-28	WOS:A1990EJ06400016
J	TOOTH, D				TOOTH, D			CREATIVE EXPRESSION AND CHRONIC PAIN	LANCET			English	Editorial Material											TOOTH, D (corresponding author), BURWOOD HOSP,DEPT MUSCULOSKELETAL MED,CHRISTCHURCH,NEW ZEALAND.								0	1	1	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 17	1990	336	8725					1240	1241		10.1016/0140-6736(90)92847-B	http://dx.doi.org/10.1016/0140-6736(90)92847-B			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ064	1978084				2022-12-28	WOS:A1990EJ06400017
J	KISSINGER, CR; LIU, BS; MARTINBLANCO, E; KORNBERG, TB; PABO, CO				KISSINGER, CR; LIU, BS; MARTINBLANCO, E; KORNBERG, TB; PABO, CO			CRYSTAL-STRUCTURE OF AN ENGRAILED HOMEODOMAIN-DNA COMPLEX AT 2.8-A RESOLUTION - A FRAMEWORK FOR UNDERSTANDING HOMEODOMAIN-DNA INTERACTIONS	CELL			English	Article									JOHNS HOPKINS UNIV,SCH MED,HOWARD HUGHES MED INST,BALTIMORE,MD 21205; UNIV CALIF SAN FRANCISCO,DEPT BIOCHEM & BIOPHYS,SAN FRANCISCO,CA 94143	Howard Hughes Medical Institute; Johns Hopkins University; University of California System; University of California San Francisco	KISSINGER, CR (corresponding author), JOHNS HOPKINS UNIV,SCH MED,DEPT MOLEC BIOL & GENET,BALTIMORE,MD 21205, USA.		Martin-Blanco, Enrique/ABH-1280-2020	Martin-Blanco, Enrique/0000-0002-6926-910X	NIGMS NIH HHS [GM31471, GM24635] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031471] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AFFOLTER M, 1990, P NATL ACAD SCI USA, V87, P4093, DOI 10.1073/pnas.87.11.4093; AGGARWAL AK, 1988, SCIENCE, V242, P899, DOI 10.1126/science.3187531; BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; BRUNGER AT, 1990, XPLOR V21 MANUAL; BURLEY SK, 1985, SCIENCE, V229, P23, DOI 10.1126/science.3892686; DICKERSON RE, 1981, J MOL BIOL, V149, P761, DOI 10.1016/0022-2836(81)90357-0; HANES SD, 1989, CELL, V57, P1275, DOI 10.1016/0092-8674(89)90063-9; HERR W, 1988, GENE DEV, V2, P1513, DOI 10.1101/gad.2.12a.1513; INGRAHAM HA, 1990, CELL, V61, P1021, DOI 10.1016/0092-8674(90)90067-O; JOHNSON AD, 1980, THESIS HARVARD U CAM; JORDAN SR, 1988, SCIENCE, V242, P893, DOI 10.1126/science.3187530; JORDAN SR, 1985, SCIENCE, V230, P1383; KORNBERG T, 1981, P NATL ACAD SCI-BIOL, V78, P1095, DOI 10.1073/pnas.78.2.1095; LAUGHON A, 1984, NATURE, V310, P25, DOI 10.1038/310025a0; LIU BS, 1990, BIOCHEM BIOPH RES CO, V171, P257, DOI 10.1016/0006-291X(90)91385-6; OTWINOWSKI Z, 1988, NATURE, V335, P321, DOI 10.1038/335321a0; PABO CO, 1990, SCIENCE, V247, P1210, DOI 10.1126/science.2315694; PABO CO, 1984, ANNU REV BIOCHEM, V53, P293, DOI 10.1146/annurev.bi.53.070184.001453; POOLE SJ, 1985, CELL, V40, P37, DOI 10.1016/0092-8674(85)90306-X; QIAN YQ, 1989, CELL, V59, P573, DOI 10.1016/0092-8674(89)90040-8; ROSSMANN MG, 1980, ACTA CRYSTALLOGR B, V36, P819, DOI 10.1107/S056774088000461X; ROULD MA, 1989, SCIENCE, V246, P1135, DOI 10.1126/science.2479982; SCOTT MP, 1989, BIOCHIM BIOPHYS ACTA, V989, P25, DOI 10.1016/0304-419X(89)90033-4; SEEMAN NC, 1976, P NATL ACAD SCI USA, V73, P804, DOI 10.1073/pnas.73.3.804; SHEPHERD JCW, 1984, NATURE, V310, P70, DOI 10.1038/310070a0; SLUKA JP, 1990, BIOCHEMISTRY-US, V29, P6551, DOI 10.1021/bi00480a002; STAACKE D, 1990, EMBO J, V9, P1963, DOI 10.1002/j.1460-2075.1990.tb08324.x; TREISMAN J, 1989, CELL, V59, P553; WANG BC, 1985, METHOD ENZYMOL, V115, P90; WANG JC, 1979, P NATL ACAD SCI USA, V76, P200, DOI 10.1073/pnas.76.1.200	30	956	966	4	23	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	NOV 2	1990	63	3					579	590		10.1016/0092-8674(90)90453-L	http://dx.doi.org/10.1016/0092-8674(90)90453-L			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EG687	1977522	hybrid			2022-12-28	WOS:A1990EG68700015
J	GARSON, JA; TUKE, PW; MAKRIS, M; BRIGGS, M; MACHIN, SJ; PRESTON, FE; TEDDER, RS				GARSON, JA; TUKE, PW; MAKRIS, M; BRIGGS, M; MACHIN, SJ; PRESTON, FE; TEDDER, RS			DEMONSTRATION OF VIREMIA PATTERNS IN HEMOPHILIACS TREATED WITH HEPATITIS-C-VIRUS-CONTAMINATED FACTOR-VIII CONCENTRATES	LANCET			English	Article									UNIV COLL & MIDDLESEX SCH MED,DEPT HAEMATOL,LONDON,ENGLAND; ROYAL HALLAMSHIRE HOSP,DEPT HAEMATOL,SHEFFIELD S10 2JF,S YORKSHIRE,ENGLAND	University of London; University College London; University of Sheffield	GARSON, JA (corresponding author), UNIV COLL & MIDDLESEX SCH MED,SCH PATHOL,DEPT MED MICROBIOL,VIROL SECT,67 RIDINGHOUSE ST,LONDON W1P 7PN,ENGLAND.		Garson, Jeremy A/C-5357-2008; Makris, Mike/A-2772-2011	Makris, Mike/0000-0001-7622-7939; Tedder, Richard/0000-0002-9672-5721; Garson, Jeremy/0000-0003-0553-0126				ALTER HJ, 1989, NEW ENGL J MED, V321, P1494, DOI 10.1056/NEJM198911303212202; BRETTLER DB, 1989, BLOOD, V73, P2067; CHEINSONGPOPOV R, 1986, BRIT MED J, V293, P168, DOI 10.1136/bmj.293.6540.168; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; COLOMBO M, 1985, LANCET, V2, P1; DAVIS GL, 1989, NEW ENGL J MED, V321, P1501, DOI 10.1056/NEJM198911303212203; FLETCHER ML, 1983, BRIT MED J, V287, P1754, DOI 10.1136/bmj.287.6407.1754; GARSON JA, 1990, LANCET, V335, P1473, DOI 10.1016/0140-6736(90)91510-H; GARSON JA, 1990, LANCET, V335, P1419, DOI 10.1016/0140-6736(90)91446-H; GARSON JA, 1990, LANCET, V336, P878, DOI 10.1016/0140-6736(90)92384-T; HAY CRM, 1985, LANCET, V1, P1495; IKKALA E, 1982, BRIT J HAEMATOL, V52, P7, DOI 10.1111/j.1365-2141.1982.tb03856.x; KASPER CK, 1972, J AMER MED ASSOC, V221, P510, DOI 10.1001/jama.1972.03200180052024; KERNOFF PBA, 1987, BRIT J HAEMATOL, V67, P207, DOI 10.1111/j.1365-2141.1987.tb02328.x; KOO G, 1989, SCIENCE, V244, P362; KWOK S, 1989, NATURE, V339, P237, DOI 10.1038/339237a0; LUDLAM CA, 1989, LANCET, V2, P560; MAKRIS, 1990, LANCET, V335, P1117; PRESTON FE, 1985, LANCET, V2, P213; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; TRIGER DR, 1990, BRIT J HAEMATOL, V74, P241, DOI 10.1111/j.1365-2141.1990.tb02577.x; VANDERPOEL CL, 1990, LANCET, V335, P558, DOI 10.1016/0140-6736(90)90347-8; WAITE J, 1988, AIDS, V2, P443, DOI 10.1097/00002030-198812000-00006; WEINER AJ, 1990, LANCET, V335, P1, DOI 10.1016/0140-6736(90)90134-Q	24	214	217	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 27	1990	336	8722					1022	1025		10.1016/0140-6736(90)92487-3	http://dx.doi.org/10.1016/0140-6736(90)92487-3			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF076	1977017				2022-12-28	WOS:A1990EF07600002
J	GOUGH, AC; MILES, JS; SPURR, NK; MOSS, JE; GAEDIGK, A; EICHELBAUM, M; WOLF, CR				GOUGH, AC; MILES, JS; SPURR, NK; MOSS, JE; GAEDIGK, A; EICHELBAUM, M; WOLF, CR			IDENTIFICATION OF THE PRIMARY GENE DEFECT AT THE CYTOCHROME-P450 CYP2D LOCUS	NATURE			English	Article									UNIV EDINBURGH,DEPT BIOCHEM,IMPERIAL CANC RES FUND,MOLEC PHARMACOL GRP,HUGH ROBSON BLDG,EDINBURGH EH8 9XD,SCOTLAND; IMPERIAL CANC RES FUND,HUMAN GENET RESOURCES,CLARE HALL LABS,POTTERS BAR EN6 3LD,ENGLAND; DR MARGARETE FISCHER BOSCH INST CLIN PHARMACOL,W-7000 STUTTGART 50,GERMANY	University of Edinburgh; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital								AYESH R, 1984, NATURE, V312, P169, DOI 10.1038/312169a0; BIGGIN MD, 1983, P NATL ACAD SCI-BIOL, V80, P3963, DOI 10.1073/pnas.80.13.3963; CUPORASO N, 1989, CANCER RES, V49, P3675; CUPORASO N, 1988, P SOC CLIN ONCOL, V8; EICHELBAUM M, 1988, ISI ATLAS-PHARMACOL, V2, P243; EICHELBAUM M, 1979, EUR J CLIN PHARMACOL, V16, P183, DOI 10.1007/BF00562059; FEINBERG AP, 1983, ANAL BIOCHEM, V136, P6; FORRESTER LM, 1990, METABOLIC MOL BASIS, P3; GAEDIGK A, 1990, Naunyn-Schmiedeberg's Archives of Pharmacology, V341, pR109; GONZALEZ FJ, 1988, NATURE, V331, P442, DOI 10.1038/331442a0; GONZALEZ FJ, 1989, PHARMACOL REV, V40, P243; GUENGERICH FP, 1987, CYTOCHROME P450, V2; GUENGERICH FP, 1987, CYTOCHROME P450, V1; KAISARY A, 1987, CANCER RES, V47, P5488; KIMURA S, 1989, AM J HUM GENET, V45, P889; KRONBACH T, 1987, ANAL BIOCHEM, V162, P24, DOI 10.1016/0003-2697(87)90006-6; KWOK SCM, 1985, BIOCHEMISTRY-US, V24, P556, DOI 10.1021/bi00324a002; MAHGOUB A, 1977, LANCET, V2, P584, DOI 10.1016/S0140-6736(77)91430-1; MEYER UA, 1986, XENOBIOTICA, V16, P449, DOI 10.3109/00498258609050251; NEBERT DW, 1989, DNA-J MOLEC CELL BIO, V8, P1, DOI 10.1089/dna.1.1989.8.1; NEBERT DW, 1988, PHENOTYPIC VARIATION; ROOTS I, 1988, KLIN WOCHENSCHR, V66, P87; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1980, J MOL BIOL, V143, P161, DOI 10.1016/0022-2836(80)90196-5; SKODA RC, 1988, P NATL ACAD SCI USA, V85, P5240, DOI 10.1073/pnas.85.14.5240; SPIERS CJ, 1989, BR J CLIN PHARM, V29, P101; STADEN R, 1986, NUCLEIC ACIDS RES, V14, P217, DOI 10.1093/nar/14.1.217; TUCKER GT, 1977, LANCET, V2, P718; WOLF CR, 1986, TRENDS GENET, V2, P209, DOI 10.1016/0168-9525(86)90232-5	29	317	330	0	6	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	OCT 25	1990	347	6295					773	776		10.1038/347773a0	http://dx.doi.org/10.1038/347773a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE659	1978251				2022-12-28	WOS:A1990EE65900066
J	COOKE, EM				COOKE, EM			EPIDEMIOLOGY OF FOODBORNE ILLNESS - UK	LANCET			English	Article											COOKE, EM (corresponding author), PUBL HLTH LAB SERV,61 COLINDALE AVE,LONDON NW9 5DF,ENGLAND.							APPLETON H, 1987, CIBA F SYMP, V128, P108; Gilbert R. J., 1989, PHLS (Public Health Laboratory Service) Microbiology Digest, V6, P33; Kramer J. M., 1989, Foodborne bacterial pathogens., P21; OMAHONY M, 1990, EPIDEMIOL INFECT, V104, P389, DOI 10.1017/S0950268800047403; OMAHONY MC, 1983, LANCET, V1, P518; Skirrow M. B., 1989, PHLS (Public Health Laboratory Service) Microbiology Digest, V6, P113; SMITH HR, 1987, LANCET, V1, P1062; THRELFALL EJ, 1990, J APPL BACTERIOL, V68, P5, DOI 10.1111/j.1365-2672.1990.tb02542.x; 1989, 33 HOUS COMM PAP; 1988, WHOEHEFOS885 INF WOR; 1989, 257 SOC SERV COMM HO; 1984, LANCET, V1, P84; 1989, PHLS MICROBIOL DIG, V6, P1; 1990, REPORT COMMITTEE MIC	14	40	40	0	6	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	SEP 29	1990	336	8718					790	793		10.1016/0140-6736(90)93251-J	http://dx.doi.org/10.1016/0140-6736(90)93251-J			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB077	1976156				2022-12-28	WOS:A1990EB07700014
J	KING, M				KING, M			HEALTH IS A SUSTAINABLE STATE	LANCET			English	Editorial Material											KING, M (corresponding author), UNIV LEEDS,DEPT PUBL HLTH MED,LEEDS LS2 9LN,W YORKSHIRE,ENGLAND.							[Anonymous], 1987, OUR COMMON FUTURE; BROWN L, 1987, WORLDWATCH I STATE 1; BROWN L, 1978, 9 WORLDW PAP; DYSON T, 1985, POPUL DEV REV, V11, P399, DOI 10.2307/1973246; HILLAV, 1952, BRIT ASS ADV SCI BEL; MacIntyre A., 1987, AFTER VIRTUE; MALTHUS TR, 1798, ESSAY POPULATION; NEWCOMBE K, 1984, 16 WORLD BANK EN DEP; Notestein F., 1945, FOOD WORLD, P36; Preston S. H., 1978, EFFECTS INFANT CHILD; 1990, STATE WORLD POPULATI, P1; 1985, STATE WORLDS CHILDRE, P22; 1988, ALMA ATA YEAR 2000 R; 1987, STATE WORLDS CHILDRE, P91; 1989, SUBSAHARAN AFRICA CR, P70; 1988, STATE WORLD 1988; 1986, STATE WORLDS CHILDRE, P78	17	118	118	0	18	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	SEP 15	1990	336	8716					664	667		10.1016/0140-6736(90)92156-C	http://dx.doi.org/10.1016/0140-6736(90)92156-C			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DY737	1975859				2022-12-28	WOS:A1990DY73700010
J	GOBER, JW; CHAMPER, R; REUTER, S; SHAPIRO, L				GOBER, JW; CHAMPER, R; REUTER, S; SHAPIRO, L			EXPRESSION OF POSITIONAL INFORMATION DURING CELL-DIFFERENTIATION IN CAULOBACTER	CELL			English	Article							GRAM-NEGATIVE BACTERIA; GENE-EXPRESSION; FLAGELLAR GENE; BACILLUS-SUBTILIS; MESSENGER-RNA; TRANSCRIPTIONAL REGULATION; PROTOPLAST FUSION; ESCHERICHIA-COLI; SPATIAL CONTROL; CRESCENTUS	The asymmetric targeting of proteins to the Caulobacter predivisional cell poles yields dissimilar progeny. We show that the products of transcriptional reporter gene fusions to a flagellin gene and to the flagellar hook operon are segregated to the progeny swarmer cell. This segregation does not depend on sequences within the mRNA, but on the upstream regulatory region. The subset of developmentally regulated flagellar genes that exhibit mRNA segregation has the same upstream cis-acting elements: an activator-binding site known as the ftr sequence and an IHF-binding site. We propose that these genes are preferentially transcribed from the chromosome in the incipient swarmer cell pole of the predivisional cell.			GOBER, JW (corresponding author), STANFORD UNIV, MED CTR, SCH MED, DEPT DEV BIOL, STANFORD, CA 94305 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM032506, R01GM032506] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM32506] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BELLOFATTO V, 1984, P NATL ACAD SCI-BIOL, V81, P1035, DOI 10.1073/pnas.81.4.1035; BROYLES SS, 1986, J MOL BIOL, V187, P47, DOI 10.1016/0022-2836(86)90405-5; CHAMPER R, 1985, COLD SPRING HARB SYM, V50, P831, DOI 10.1101/SQB.1985.050.01.101; CHAMPER R, 1987, J MOL BIOL, V194, P71, DOI 10.1016/0022-2836(87)90716-9; CHEN LS, 1986, P NATL ACAD SCI USA, V83, P2860, DOI 10.1073/pnas.83.9.2860; CONTRERAS I, 1978, J BACTERIOL, V135, P1130, DOI 10.1128/JB.135.3.1130-1136.1978; COOK WR, 1986, J BACTERIOL, V168, P1430, DOI 10.1128/jb.168.3.1430-1438.1986; DINGWALL A, 1990, J BACTERIOL, V172, P6066, DOI 10.1128/jb.172.10.6066-6076.1990; DITTA G, 1980, P NATL ACAD SCI-BIOL, V77, P7347, DOI 10.1073/pnas.77.12.7347; EVINGER M, 1979, P NATL ACAD SCI USA, V76, P175, DOI 10.1073/pnas.76.1.175; EVINGER M, 1977, J BACTERIOL, V132, P294, DOI 10.1128/JB.132.1.294-301.1977; FUJITA Y, 1977, J BACTERIOL, V132, P282, DOI 10.1128/JB.132.1.282-293.1977; GOBER JW, 1990, GENE DEV, V4, P1494, DOI 10.1101/gad.4.9.1494; GOBER JW, 1990, IN PRESS J MOL BIOL; GOMES SL, 1990, J BACTERIOL, V172, P3051, DOI 10.1128/jb.172.6.3051-3059.1990; GOMES SL, 1984, J MOL BIOL, V178, P551, DOI 10.1016/0022-2836(84)90238-9; GUILLEN N, 1982, MOL GEN GENET, V185, P69, DOI 10.1007/BF00333792; HIROOKA T, 1987, J BACTERIOL, V169, P1529, DOI 10.1128/jb.169.4.1529-1536.1987; HOTCHKISS RD, 1980, P NATL ACAD SCI-BIOL, V77, P3553, DOI 10.1073/pnas.77.6.3553; KAPLAN JB, 1989, J MOL BIOL, V205, P71, DOI 10.1016/0022-2836(89)90365-3; KARMAZYNCAMPELLI C, 1989, GENE DEV, V3, P150, DOI 10.1101/gad.3.2.150; KROOS L, 1989, SCIENCE, V243, P526, DOI 10.1126/science.2492118; KUNKEL B, 1990, GENE DEV, V4, P525, DOI 10.1101/gad.4.4.525; KUNKEL B, 1988, J BACTERIOL, V170, P3513, DOI 10.1128/jb.170.8.3513-3522.1988; KUNKEL B, 1989, GENE DEV, V3, P1735, DOI 10.1101/gad.3.11.1735; LEHEGARAT E, 1978, SPORES, V7, P193; LOEWY ZG, 1987, GENE DEV, V1, P626, DOI 10.1101/gad.1.6.626; MACALISTER TJ, 1983, P NATL ACAD SCI-BIOL, V80, P1372, DOI 10.1073/pnas.80.5.1372; MACDONALD PM, 1988, NATURE, V336, P595, DOI 10.1038/336595a0; Maniatis T., 1982, MOL CLONING; MARCZYNSKI GT, 1990, J MOL BIOL, V212, P709, DOI 10.1016/0022-2836(90)90232-B; MARSH JL, 1984, GENE, V32, P481, DOI 10.1016/0378-1119(84)90022-2; MELTON DA, 1987, NATURE, V328, P80, DOI 10.1038/328080a0; MILHAUSEN M, 1983, NATURE, V302, P630, DOI 10.1038/302630a0; MINNICH SA, 1987, P NATL ACAD SCI USA, V84, P1142, DOI 10.1073/pnas.84.5.1142; MULLIN D, 1987, J MOL BIOL, V195, P939, DOI 10.1016/0022-2836(87)90497-9; MULLIN DA, 1989, J BACTERIOL, V171, P3218, DOI 10.1128/jb.171.6.3218-3227.1989; NATHAN P, 1986, J MOL BIOL, V191, P433, DOI 10.1016/0022-2836(86)90138-5; NICHOLSON WL, 1990, J BACTERIOL, V172, P7, DOI 10.1128/JB.172.1.7-14.1990; OHTA N, 1985, J MOL BIOL, V186, P107, DOI 10.1016/0022-2836(85)90261-X; POINDEXTER JS, 1964, BACTERIOL REV, V28, P231, DOI 10.1128/MMBR.28.3.231-295.1964; RATHER PN, 1988, J BACTERIOL, V170, P5086, DOI 10.1128/jb.170.11.5086-5092.1988; REUTER SH, 1987, J MOL BIOL, V194, P653, DOI 10.1016/0022-2836(87)90242-7; SHAPIRO L, 1982, J MOL BIOL, V159, P303, DOI 10.1016/0022-2836(82)90497-1; SHAPIRO L, 1989, J CELL SCI, P85; SHEFFERY M, 1981, CELL, V24, P49, DOI 10.1016/0092-8674(81)90500-6; SUN DX, 1989, GENE DEV, V3, P141, DOI 10.1101/gad.3.2.141; SWOBODA UK, 1982, J GEN MICROBIOL, V128, P291; WADA M, 1988, J MOL BIOL, V204, P581, DOI 10.1016/0022-2836(88)90357-9; XU H, 1989, P NATL ACAD SCI USA, V86, P6656, DOI 10.1073/pnas.86.17.6656	50	63	63	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 25	1991	64	2					381	391		10.1016/0092-8674(91)90646-G	http://dx.doi.org/10.1016/0092-8674(91)90646-G			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EV336	1988153				2022-12-28	WOS:A1991EV33600014
J	PHILLIPS, RE; SOLOMON, T				PHILLIPS, RE; SOLOMON, T			CEREBRAL MALARIA IN CHILDREN	LANCET			English	Review											PHILLIPS, RE (corresponding author), JOHN RADCLIFFE HOSP, INST MOLEC MED, MOLEC IMMUNOL GRP, OXFORD OX3 9DU, ENGLAND.			Solomon, Tom/0000-0001-7266-6547	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AIKAWA M, 1988, AM J TROP MED HYG, V39, P3, DOI 10.4269/ajtmh.1988.39.3; [Anonymous], 1985, LANCET, V2, P759; BARNWELL JW, 1985, J IMMUNOL, V135, P3494; BATE CAW, 1988, IMMUNOLOGY, V64, P227; BENNISH ML, 1990, NEW ENGL J MED, V322, P1357, DOI 10.1056/NEJM199005103221905; BERENDT AR, 1989, NATURE, V341, P57, DOI 10.1038/341057a0; BERENDT AR, 1990, PARASITOL TODAY, V6, P247, DOI 10.1016/0169-4758(90)90184-6; BIGGS BA, 1990, J EXP MED, V171, P1883, DOI 10.1084/jem.171.6.1883; BREWSTER DR, 1990, LANCET, V336, P1039, DOI 10.1016/0140-6736(90)92498-7; BUTCHER GA, 1990, T ROY SOC TROP MED H, V84, P658, DOI 10.1016/0035-9203(90)90134-Z; CARLSON J, IN PRESS LANCET; CARSWELL EA, 1975, P NATL ACAD SCI USA, V72, P3666, DOI 10.1073/pnas.72.9.3666; CLARK IA, 1987, AM J PATHOL, V129, P192; CLARK IA, 1989, T ROY SOC TROP MED H, V83, P436, DOI 10.1016/0035-9203(89)90240-X; DANIELS CW, 1923, LABORATORY STUDIES T, P137; Dudgeon LS, 1919, Q J MED, V11, P372; DUMAS M, 1986, 84E C PSYCH NEUR LAN, P143; EDINGTON GM, 1967, BMJ-BRIT MED J, V1, P715, DOI 10.1136/bmj.1.5542.715; EDINGTON GM, 1954, ANN TROP MED PARASIT, V48, P300, DOI 10.1080/00034983.1954.11685627; GELFAND M, 1973, TROPICAL NEUROLOGY, P247; GRAU GE, 1989, NEW ENGL J MED, V320, P1586, DOI 10.1056/NEJM198906153202404; GREENBERG AE, 1989, AM J TROP MED HYG, V40, P360, DOI 10.4269/ajtmh.1989.40.360; GREENWOOD BM, 1987, T ROY SOC TROP MED H, V81, P478, DOI 10.1016/0035-9203(87)90170-2; HENDRICKSE RG, 1971, ANN TROP MED PARASIT, V65, P1; HOFFMAN SL, 1988, J INFECT DIS, V158, P325, DOI 10.1093/infdis/158.2.325; HOWARD RJ, 1989, BLOOD, V74, P2603; JACOB CO, 1990, P NATL ACAD SCI USA, V87, P1233, DOI 10.1073/pnas.87.3.1233; Kean B. H., 1944, AMER JOUR TROP MED, V24, P317; KWIATKOWSKI D, 1990, LANCET, V336, P1201, DOI 10.1016/0140-6736(90)92827-5; LI G, 1982, Journal of Traditional Chinese Medicine, V2, P125; LOOAREESUWAN S, 1983, LANCET, V1, P434; LOOAREESUWAN S, 1990, Q J MED, V75, P471; LOOAREESUWAN S, 1983, AM J TROP MED HYG, V32, P911, DOI 10.4269/ajtmh.1983.32.911; LUSE SA, 1971, AM J TROP MED HYG, V20, P655, DOI 10.4269/ajtmh.1971.20.655; MACPHERSON GG, 1985, AM J PATHOL, V119, P385; Maegraith B, 1972, Adv Parasitol, V10, P49, DOI 10.1016/S0065-308X(08)60172-4; MAEGRAITH BG, 1984, CLIN TROPICAL DISEAS; MANSOR SM, 1990, T ROY SOC TROP MED H, V84, P482, DOI 10.1016/0035-9203(90)90007-2; MARCHIAFAVA E, 1894, SOMMER AUTUMN MALARI; MARSH K, 1988, EXP PARASITOL, V65, P202, DOI 10.1016/0014-4894(88)90123-3; MCLAUGHLIN PJ, 1990, LANCET, V336, P1014; MILLER KD, 1989, NEW ENGL J MED, V321, P65, DOI 10.1056/NEJM198907133210201; MOLYNEUX ME, 1989, Q J MED, V71, P441; MOLYNEUX ME, 1989, AM J TROP MED HYG, V40, P470, DOI 10.4269/ajtmh.1989.40.470; MURRAY CJL, 1990, T ROY SOC TROP MED H, V84, P1, DOI 10.1016/0035-9203(90)90364-K; OKITOLONDA W, 1987, BMJ-BRIT MED J, V295, P716, DOI 10.1136/bmj.295.6600.716; OQUENDO P, 1989, CELL, V58, P95, DOI 10.1016/0092-8674(89)90406-6; PAGLIARA AS, 1973, J PEDIATR-US, V82, P558, DOI 10.1016/S0022-3476(73)80581-5; PHILLIPS RE, 1989, Q J MED, V71, P477; PHILLIPS RE, 1986, Q J MED, V58, P305; PHILLIPS RE, 1985, NEW ENGL J MED, V312, P1273, DOI 10.1056/NEJM198505163122001; PHILLIPS SM, 1986, PARASITOL TODAY, V2, P296, DOI 10.1016/0169-4758(86)90123-7; Rigdon R. H., 1942, AMER JOUR TROP MED, V22, P329; ROBERTS DD, 1985, NATURE, V318, P64, DOI 10.1038/318064a0; RUDNITSKY G, 1987, J INFECT DIS, V155, P1040, DOI 10.1093/infdis/155.5.1040; SCHMUTZHARD E, 1984, T ROY SOC TROP MED H, V78, P351, DOI 10.1016/0035-9203(84)90118-4; SMISTSKAMP H, 1971, BRIT MED J, V1, P714; SPITZ S, 1946, Mil Surg, V99, P555; STACE J, 1982, PAPUA NEW GUINEA MED, V25, P230; TAYLOR TE, 1988, NEW ENGL J MED, V319, P1040, DOI 10.1056/NEJM198810203191602; UDEINYA IJ, 1981, SCIENCE, V213, P555, DOI 10.1126/science.7017935; WALLER D, 1990, T ROY SOC TROP MED H, V84, P488, DOI 10.1016/0035-9203(90)90009-4; WARRELL DA, 1989, Q J MED, V71, P369; WARRELL DA, 1988, LANCET, V2, P534; WARRELL DA, 1982, NEW ENGL J MED, V306, P313, DOI 10.1056/NEJM198202113060601; WARRELL DA, 1986, AM J TROP MED HYG, V35, P882, DOI 10.4269/ajtmh.1986.35.882; WATTANAGOON Y, 1986, BRIT MED J, V293, P11, DOI 10.1136/bmj.293.6538.11; WERY M, 1986, ANN SOC BELG MED TR, V66, P309; WHITE NJ, 1985, LANCET, V1, P776; WHITE NJ, 1988, NEW ENGL J MED, V319, P1493, DOI 10.1056/NEJM198812083192301; WHITE NJ, 1988, LANCET, V2, P64; WHITE NJ, 1983, AM J TROP MED HYG, V32, P1; WHITE NJ, 1983, NEW ENGL J MED, V309, P61, DOI 10.1056/NEJM198307143090201; WHITE NJ, 1988, EUR J CLIN PHARMACOL, V34, P1, DOI 10.1007/BF01061409; WHITE NJ, 1989, LANCET, V2, P1313, DOI 10.1016/S0140-6736(89)91918-1; WHITE NJ, 1987, LANCET, V1, P708; WOODRUFF AW, 1968, BMJ-BRIT MED J, V3, P31, DOI 10.1136/bmj.3.5609.31; 1986, T R SOC TROP MED HYG, V80, P1	78	76	77	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 1	1990	336	8727					1355	1360		10.1016/0140-6736(90)92903-U	http://dx.doi.org/10.1016/0140-6736(90)92903-U			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL365	1978171				2022-12-28	WOS:A1990EL36500011
J	FISCH, P; MALKOVSKY, M; KOVATS, S; STURM, E; BRAAKMAN, E; KLEIN, BS; VOSS, SD; MORRISSEY, LW; DEMARS, R; WELCH, WJ; BOLHUIS, RLH; SONDEL, PM				FISCH, P; MALKOVSKY, M; KOVATS, S; STURM, E; BRAAKMAN, E; KLEIN, BS; VOSS, SD; MORRISSEY, LW; DEMARS, R; WELCH, WJ; BOLHUIS, RLH; SONDEL, PM			RECOGNITION BY HUMAN V-GAMMA-9/V-DELTA-2 T-CELLS OF A GROEL HOMOLOG ON DAUDI-BURKITT LYMPHOMA-CELLS	SCIENCE			English	Article									UNIV WISCONSIN, DEPT HUMAN ONCOL, MADISON, WI 53792 USA; UNIV WISCONSIN, DEPT MED MICROBIOL & IMMUNOL, MADISON, WI 53706 USA; UNIV WISCONSIN, WISCONSIN REG PRIMATE RES CTR, MADISON, WI 53706 USA; UNIV WISCONSIN, GENET LAB, MADISON, WI 53706 USA; UNIV WISCONSIN, DEPT PEDIAT, MADISON, WI 53792 USA; UNIV WISCONSIN, DEPT MED, MADISON, WI 53792 USA; DR DANIEL DENHOED CANC CTR, 3075 EA ROTTERDAM, NETHERLANDS; UNIV CALIF SAN FRANCISCO, DEPT MED, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, DEPT PHYSIOL, SAN FRANCISCO, CA 94143 USA; UNIV WISCONSIN, DEPT GENET, MADISON, WI 53792 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Wisconsin System; University of Wisconsin Madison				Malkovsky, Miroslav/0000-0002-5056-5224; Kovats, Susan/0000-0001-5479-9952				ALLEN H, 1986, P NATL ACAD SCI USA, V83, P7447, DOI 10.1073/pnas.83.19.7447; ASARNOW DM, 1988, CELL, V55, P837, DOI 10.1016/0092-8674(88)90139-0; AUGUSTIN A, 1989, NATURE, V340, P239, DOI 10.1038/340239a0; BJORKMAN PJ, 1987, NATURE, V329, P512, DOI 10.1038/329512a0; BORN W, 1990, IMMUNOL TODAY, V11, P40; BORN W, 1990, SCIENCE, V249, P67, DOI 10.1126/science.1695022; BORST J, 1987, NATURE, V325, P683, DOI 10.1038/325683a0; BORST J, 1988, J EXP MED, V167, P1625, DOI 10.1084/jem.167.5.1625; BOTTINO C, 1988, J EXP MED, V168, P491, DOI 10.1084/jem.168.2.491; BRENNER MB, 1987, NATURE, V325, P689, DOI 10.1038/325689a0; CASORATI G, 1989, J EXP MED, V170, P1521, DOI 10.1084/jem.170.5.1521; CASTEN LA, 1988, J IMMUNOL, V140, P404; CHIEN YH, 1987, NATURE, V327, P677, DOI 10.1038/327677a0; CICCONE E, 1988, J EXP MED, V168, P1, DOI 10.1084/jem.168.1.1; DANIEL TM, 1975, AM REV RESPIR DIS, V112, P639; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; DEMARS R, 1984, HUM IMMUNOL, V11, P77, DOI 10.1016/0198-8859(84)90047-8; DEMOTZ S, 1990, SCIENCE, V249, P1028, DOI 10.1126/science.2118680; ELIAS D, 1990, P NATL ACAD SCI USA, V87, P1576, DOI 10.1073/pnas.87.4.1576; FERRINI S, 1989, EUR J IMMUNOL, V19, P57, DOI 10.1002/eji.1830190110; FISCH P, 1990, J EXP MED, V171, P1567, DOI 10.1084/jem.171.5.1567; FISCH P, UNPUB; HAPP MP, 1989, NATURE, V342, P696, DOI 10.1038/342696a0; HARDING CV, 1990, NATURE, V346, P574, DOI 10.1038/346574a0; HAREGEWOIN A, 1989, NATURE, V340, P309, DOI 10.1038/340309a0; HATA S, 1988, SCIENCE, V240, P1541, DOI 10.1126/science.3259726; HATA S, 1989, J EXP MED, V169, P41, DOI 10.1084/jem.169.1.41; HAYDAY AC, 1985, CELL, V40, P259, DOI 10.1016/0092-8674(85)90140-0; HOLOSHITZ J, 1989, NATURE, V339, P226, DOI 10.1038/339226a0; JANEWAY CA, 1988, IMMUNOL TODAY, V9, P73, DOI 10.1016/0167-5699(88)91267-4; JANIS EM, 1989, SCIENCE, V244, P713, DOI 10.1126/science.2524098; JINDAL S, 1989, MOL CELL BIOL, V9, P2279, DOI 10.1128/MCB.9.5.2279; KABELITZ D, 1990, J EXP MED, V171, P667, DOI 10.1084/jem.171.3.667; KAUFMANN SHE, 1990, IMMUNOL TODAY, V11, P129, DOI 10.1016/0167-5699(90)90050-J; KAUFMANN SHE, 1989, IMMUNOL TODAY, V59, P5; KAVATHAS P, 1980, P NATL ACAD SCI-BIOL, V77, P4251, DOI 10.1073/pnas.77.7.4251; KOGA T, 1989, SCIENCE, V245, P1112, DOI 10.1126/science.2788923; KOLLER BH, 1990, SCIENCE, V248, P1227, DOI 10.1126/science.2112266; KOVATS S, 1990, SCIENCE, V248, P220, DOI 10.1126/science.2326636; LAKEY EK, 1987, P NATL ACAD SCI USA, V84, P1659, DOI 10.1073/pnas.84.6.1659; LANIER LL, 1988, EUR J IMMUNOL, V18, P1985, DOI 10.1002/eji.1830181218; LEFRANC MP, 1986, CELL, V45, P237, DOI 10.1016/0092-8674(86)90388-0; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; LJUNGGREN HG, 1990, NATURE, V346, P476, DOI 10.1038/346476a0; MALKOVSKY M, UNPUB; MAMICHOUAIB F, 1989, EUR J IMMUNOL, V19, P1545, DOI 10.1002/eji.1830190905; MARKWELL MAK, 1978, BIOCHEMISTRY-US, V17, P4807, DOI 10.1021/bi00615a031; MARRACK P, 1990, SCIENCE, V248, P705, DOI 10.1126/science.2185544; MATIS LA, 1987, NATURE, V330, P262, DOI 10.1038/330262a0; MIOSSEC C, 1990, J EXP MED, V171, P1171, DOI 10.1084/jem.171.4.1171; MIZZEN LA, 1989, J BIOL CHEM, V264, P20664; MIZZEN LA, UNPUB; MODLIN RL, 1989, NATURE, V339, P544, DOI 10.1038/339544a0; OBRIEN RL, 1989, CELL, V57, P667, DOI 10.1016/0092-8674(89)90135-9; OTTENHOFF THM, 1988, J EXP MED, V168, P1947, DOI 10.1084/jem.168.5.1947; PARKER CM, 1990, J EXP MED, V171, P1597, DOI 10.1084/jem.171.5.1597; PORCELLI S, 1989, NATURE, V341, P447, DOI 10.1038/341447a0; QUARANTA V, 1981, IMMUNOGENETICS, V13, P285, DOI 10.1007/BF00364494; QUERTERMOUS T, 1986, SCIENCE, V231, P252, DOI 10.1126/science.3079918; QUERTERMOUS T, 1986, NATURE, V322, P184, DOI 10.1038/322184a0; RAULET DH, 1989, NATURE, V339, P342, DOI 10.1038/339342a0; RES PCM, 1988, LANCET, V2, P478, DOI 10.1016/S0140-6736(88)90123-7; ROSA F, 1983, EMBO J, V2, P239, DOI 10.1002/j.1460-2075.1983.tb01412.x; ROTHMAN JE, 1989, IMMUNOL TODAY, V59, P591; SAITO H, 1984, NATURE, V309, P757, DOI 10.1038/309757a0; SANCHEZMADRID F, 1983, J EXP MED, V158, P1785, DOI 10.1084/jem.158.6.1785; SCHNABL E, 1990, J EXP MED, V171, P1431, DOI 10.1084/jem.171.5.1431; SCHUMACHER TNM, 1990, CELL, V62, P563, DOI 10.1016/0092-8674(90)90020-F; SEONG RH, 1988, J EXP MED, V167, P288, DOI 10.1084/jem.167.2.288; SHIMIZU Y, 1989, J IMMUNOL, V142, P3320; SHINNICK TM, 1988, INFECT IMMUN, V56, P446, DOI 10.1128/IAI.56.2.446-451.1988; STROMINGER JL, 1989, CELL, V57, P895, DOI 10.1016/0092-8674(89)90326-7; STROMINGER JL, 1989, SCIENCE, V244, P943, DOI 10.1126/science.2658058; STURM E, 1989, EUR J IMMUNOL, V19, P1261, DOI 10.1002/eji.1830190717; STURM E, IN PRESS J IMMUNOL; TAKIHARA Y, 1989, J EXP MED, V169, P393, DOI 10.1084/jem.169.2.393; TRIEBEL F, 1988, J EXP MED, V167, P694, DOI 10.1084/jem.167.2.694; VANBUSKIRK A, 1989, J EXP MED, V170, P1799, DOI 10.1084/jem.170.6.1799; VANNOESEL C, 1988, NATURE, V333, P850, DOI 10.1038/333850a0; VIDOVIC D, 1989, NATURE, V340, P646, DOI 10.1038/340646a0; Welch WJ, 1990, STRESS PROTEINS BIOL, P223; WHITE J, 1989, CELL, V56, P27, DOI 10.1016/0092-8674(89)90980-X; WINFIELD JB, 1989, ARTHRITIS RHEUM, V32, P1497, DOI 10.1002/anr.1780321202; YOUNG D, 1988, P NATL ACAD SCI USA, V85, P4267, DOI 10.1073/pnas.85.12.4267; YOUNG DB, 1987, IMMUNOL TODAY, V8, P215, DOI 10.1016/0167-5699(87)90168-X; YOUNG RA, 1990, ANNU REV IMMUNOL, V8, P401, DOI 10.1146/annurev.immunol.8.1.401; ZIJLSTRA M, 1990, NATURE, V344, P742, DOI 10.1038/344742a0	87	383	386	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 30	1990	250	4985					1269	1273		10.1126/science.1978758	http://dx.doi.org/10.1126/science.1978758			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK723	1978758				2022-12-28	WOS:A1990EK72300041
J	REID, L				REID, L			FROM GRADIENTS TO AXES, FROM MORPHOGENESIS TO DIFFERENTIATION	CELL			English	Editorial Material																		AKAM M, 1989, CELL, V57, P347, DOI 10.1016/0092-8674(89)90909-4; BRICKELL PM, 1989, BIOESSAYS, V11, P145, DOI 10.1002/bies.950110508; DOLLE P, 1989, NATURE, V342, P767, DOI 10.1038/342767a0; DRIEVER W, 1989, NATURE, V340, P363, DOI 10.1038/340363a0; DRIEVER W, 1988, CELL, V54, P83, DOI 10.1016/0092-8674(88)90182-1; DRIEVER W, 1988, CELL, V54, P95, DOI 10.1016/0092-8674(88)90183-3; EDELMAN GM, 1988, BIOCHEMISTRY-US, V27, P3533, DOI 10.1021/bi00410a001; FLAUMENHAFT R, 1990, J CELL BIOL, V111, P1651, DOI 10.1083/jcb.111.4.1651; FRASER S, 1990, NATURE, V344, P431, DOI 10.1038/344431a0; GARCIABELLIDO A, 1979, SCI AM, V241, P102, DOI 10.1038/scientificamerican0779-102; GREEN JBA, 1990, NATURE, V347, P391, DOI 10.1038/347391a0; HASHIMOTO C, 1988, CELL, V52, P269, DOI 10.1016/0092-8674(88)90516-8; HAYASHI S, 1990, CELL, V63, P883, DOI 10.1016/0092-8674(90)90492-W; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; INGHAM PW, 1988, NATURE, V335, P25, DOI 10.1038/335025a0; KESSEL M, 1990, CELL, V61, P301, DOI 10.1016/0092-8674(90)90810-2; KESSEL M, 1990, SCIENCE, V249, P374, DOI 10.1126/science.1974085; KEYNES R, 1990, CELL, V62, P609, DOI 10.1016/0092-8674(90)90103-L; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; LUMSDEN A, 1989, NATURE, V337, P424, DOI 10.1038/337424a0; MALICKI J, 1990, CELL, V63, P961, DOI 10.1016/0092-8674(90)90499-5; MCGINNIS N, 1990, CELL, V63, P969, DOI 10.1016/0092-8674(90)90500-E; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; MCNEILL H, 1990, CELL, V62, P309, DOI 10.1016/0092-8674(90)90368-O; OZAWA M, 1989, EMBO J, V8, P1711, DOI 10.1002/j.1460-2075.1989.tb03563.x; POSCHEL AW, 1990, DEVELOPMENT, V108, P435; RAFF MC, 1989, SCIENCE, V243, P1450, DOI 10.1126/science.2648568; ROBERTS R, 1988, NATURE, V332, P376, DOI 10.1038/332376a0; RUOSLAHTI E, 1989, J BIOL CHEM, V264, P13369; SIMEONE A, 1990, NATURE, V346, P763, DOI 10.1038/346763a0; SMITH JC, 1989, DEVELOPMENT, V105, P665; STRUHL G, 1989, CELL, V57, P1259, DOI 10.1016/0092-8674(89)90062-7; TAKEICHI M, 1990, ANNU REV BIOCHEM, V59, P237, DOI 10.1146/annurev.biochem.59.1.237; THIERY JP, 1990, MORPHOREGULATORY MOL, P597; THOMAS KR, 1990, NATURE, V346, P847, DOI 10.1038/346847a0; THOMSEN G, 1990, CELL, V63, P485, DOI 10.1016/0092-8674(90)90445-K; WILKINSON DG, 1989, NATURE, V341, P405, DOI 10.1038/341405a0; WILKINSON DG, 1989, NATURE, V337, P461, DOI 10.1038/337461a0; WITTE ON, 1990, CELL, V63, P5, DOI 10.1016/0092-8674(90)90280-R; WOLPERT L, 1989, DEVELOPMENT, V107, P3; YAMAGUCHI Y, 1990, NATURE, V346, P281, DOI 10.1038/346281a0	41	39	39	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	NOV 30	1990	63	5					875	882		10.1016/0092-8674(90)90491-V	http://dx.doi.org/10.1016/0092-8674(90)90491-V			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EL759	1979523				2022-12-28	WOS:A1990EL75900003
J	SCARPINO, V; ARRIGO, A; BENZI, G; GARATTINI, S; LAVECCHIA, C; BERNARDI, LR; SILVESTRINI, G; TUCCIMEI, G				SCARPINO, V; ARRIGO, A; BENZI, G; GARATTINI, S; LAVECCHIA, C; BERNARDI, LR; SILVESTRINI, G; TUCCIMEI, G			EVALUATION OF PREVALENCE OF DOPING AMONG ITALIAN ATHLETES	LANCET			English	Article									INST PHARMACOL RES MARIO NEGRI, ROME, ITALY; NATL COUNCIL RES, ROME, ITALY; ITALIAN FED SPORTS MED, ROME, ITALY; UNIV PAVIA, INST CLIN NEUROL, I-27100 PAVIA, ITALY; UNIV PAVIA, FAC SCI, INST PHARMACOL, I-27100 PAVIA, ITALY	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Consiglio Nazionale delle Ricerche (CNR); University of Pavia; University of Pavia	SCARPINO, V (corresponding author), GALLUP INT RES INST, INST DOXA, VIA PANIZZA 7, I-20144 MILAN, ITALY.		Garattini, Silvio/AAA-6390-2020	Garattini, Silvio/0000-0003-0647-9297; La Vecchia, Carlo/0000-0003-1441-897X				ARMITAGE P, 1987, STATISTICAL METHODS; BUCKLEY W E, 1988, Journal of the American Medical Association, V260, P3441, DOI 10.1001/jama.260.23.3441; COLLIER J, 1988, BRIT MED J, V296, P520, DOI 10.1136/bmj.296.6621.520; Cowart V S, 1988, JAMA, V260, P1517, DOI 10.1001/jama.260.11.1513; COWART VS, 1988, JAMA-J AM MED ASSOC, V260, P3556, DOI 10.1001/jama.1988.03410240014004; COWART VS, 1988, JAMA-J AM MED ASSOC, V260, P3397, DOI 10.1001/jama.260.23.3397; DIXON B, 1988, BRIT MED J, V297, P926; FERNER RE, 1988, BRIT MED J, V877, P877; HALLAGAN JB, 1989, NEW ENGL J MED, V321, P1042, DOI 10.1056/NEJM198910123211510; MARSHALL E, 1988, SCIENCE, V242, P183, DOI 10.1126/science.3175643	10	60	63	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 27	1990	336	8722					1048	1050		10.1016/0140-6736(90)92502-9	http://dx.doi.org/10.1016/0140-6736(90)92502-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF076	1977030				2022-12-28	WOS:A1990EF07600015
J	GHIO, AJ; KENNEDY, TP; SCHAPIRA, RM; CRUMBLISS, AL; HOIDAL, JR				GHIO, AJ; KENNEDY, TP; SCHAPIRA, RM; CRUMBLISS, AL; HOIDAL, JR			HYPOTHESIS - IS LUNG-DISEASE AFTER SILICATE INHALATION CAUSED BY OXIDANT GENERATION	LANCET			English	Article									DUKE UNIV,DEPT CHEM,DURHAM,NC 27706; UNIV UTAH,DEPT INTERNAL MED,DIV RESP CRIT CARE & OCCUPAT PULM MED,SALT LAKE CITY,UT 84112	Duke University; Utah System of Higher Education; University of Utah	GHIO, AJ (corresponding author), DUKE UNIV,MED CTR,DEPT MED,DIV ALLERGY CRIT CARE & RESP MED,BOX 3177,DURHAM,NC 27710, USA.							ADDISON CC, 1962, J CHEM SOC, V1, P1468; ADLER KB, 1990, J CLIN INVEST, V85, P75, DOI 10.1172/JCI114436; BERGMAN I, 1970, Annals of Occupational Hygiene, V13, P163; BUS JS, 1984, ENVIRON HEALTH PERSP, V55, P37, DOI 10.2307/3429690; COHEN G, 1985, HDB METHODS OXYGEN R, P55; CROSS CE, 1984, LANCET, V1, P1328; Dobrilla G, 1967, Med Lav, V58, P122; DUBOIS F, 1988, AM REV RESPIR DIS, V137, P1172, DOI 10.1164/ajrccm/137.5.1172; DUGGER DL, 1964, J PHYS CHEM-US, V68, P757, DOI 10.1021/j100786a007; DUNCAN CA, 1989, CLIN CHEST MED, V10, P49; GRAF E, 1984, J BIOL CHEM, V259, P3620; Grim R.G., 1968, CLAY MINER, P185; GUEST L, 1978, ANN OCCUP HYG, V21, P151, DOI 10.1093/annhyg/21.2.151; GULUMIAN M, 1987, ENVIRON RES, V44, P254, DOI 10.1016/S0013-9351(87)80234-7; HALE WB, 1987, AM J PHYSIOL, V253, pG627, DOI 10.1152/ajpgi.1987.253.5.G627; HALLIWELL B, 1984, BIOCHEM J, V219, P1, DOI 10.1042/bj2190001; HERRERA R, 1970, SOIL SCI SOC AM PRO, V34, P740, DOI 10.2136/sssaj1970.03615995003400050021x; Iler R.K., 1979, CHEM SILICA SOLUBILI, P622; KENNEDY TP, 1989, ARCH BIOCHEM BIOPHYS, V269, P359, DOI 10.1016/0003-9861(89)90118-5; KOERTEN HK, 1986, EUR J CELL BIOL, V40, P25; KOVACS EJ, 1986, AM REV RESPIR DIS, V133, P68, DOI 10.1164/arrd.1986.133.1.68; LIBBUS BL, 1989, CANCER RES, V49, P5713; MURRAY MJ, 1978, BRIT MED J, V2, P1113, DOI 10.1136/bmj.2.6145.1113; NICULESCU T, 1981, ENVIRON RES, V25, P260, DOI 10.1016/0013-9351(81)90027-X; NOLAN RP, 1981, ENVIRON RES, V26, P503, DOI 10.1016/0013-9351(81)90226-7; REES LVC, 1982, METAL MICROSTRUCTURE, P55; RILEY DJ, 1985, LUNG, V163, P1, DOI 10.1007/BF02713801; RODHAM AW, 1969, AUST J SOIL RES, V7, P185; ROM WN, 1987, AM REV RESPIR DIS, V136, P1429, DOI 10.1164/ajrccm/136.6.1429; SCHAPIRA RM, 1990, AM REV RESPIR DIS, V141, pS414; SCHOENBERGER CI, 1984, AM REV RESPIR DIS, V129, P18; SLADE R, 1985, AM REV RESPIR DIS, V131, P742; Smith WE., 1979, DUSTS DISEASE, P335; SUZUKI Y, 1969, ENVIRON RES, V3, P107; Torii K., 1978, NATURAL ZEOLITES OCC, P441; Unger K. K., 1979, POROUS SILICA; WEISSNER JH, 1988, AM REV RESPIR DIS, V138, P445; ZSOLDOS T, 1983, EXP PATHOL-JENA, V23, P73, DOI 10.1016/S0232-1513(83)80043-7	38	38	44	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 20	1990	336	8721					967	969		10.1016/0140-6736(90)92421-D	http://dx.doi.org/10.1016/0140-6736(90)92421-D			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ED601	1977006				2022-12-28	WOS:A1990ED60100005
J	DRANGINIS, AM				DRANGINIS, AM			BINDING OF YEAST A1 AND ALPHA-2 AS A HETERODIMER TO THE OPERATOR DNA OF A HAPLOID-SPECIFIC GENE	NATURE			English	Article											DRANGINIS, AM (corresponding author), NIDDKD,CELLULAR & DEV BIOL LAB,BLDG 6,ROOM B1-10,BETHESDA,MD 20892, USA.							ASTELL CR, 1981, CELL, V27, P15, DOI 10.1016/0092-8674(81)90356-1; AUSUBEL FM, 1989, CURRENTS PROTOCOLS M; DRANGINIS AM, 1989, MOL CELL BIOL, V9, P3992, DOI 10.1128/MCB.9.9.3992; GEHRING WJ, 1986, ANNU REV GENET, V20, P147, DOI 10.1146/annurev.ge.20.120186.001051; GOUTTE C, 1988, CELL, V52, P875, DOI 10.1016/0092-8674(88)90429-1; HALL MN, 1987, SCIENCE, V237, P1007, DOI 10.1126/science.2887035; HERSKOWITZ I, 1989, NATURE, V342, P749, DOI 10.1038/342749a0; HOPE IA, 1985, CELL, V43, P177, DOI 10.1016/0092-8674(85)90022-4; HOPE IA, 1987, EMBO J, V6, P2781, DOI 10.1002/j.1460-2075.1987.tb02573.x; JARVIS EE, 1988, MOL CELL BIOL, V8, P309, DOI 10.1128/MCB.8.1.309; JOHNSON AD, 1985, CELL, V42, P237, DOI 10.1016/S0092-8674(85)80119-7; JONES N, 1990, CELL, V61, P9, DOI 10.1016/0092-8674(90)90207-U; KELEHER CA, 1988, CELL, V53, P927, DOI 10.1016/S0092-8674(88)90449-7; KELEHER CA, 1989, MOL CELL BIOL, V9, P5228, DOI 10.1128/MCB.9.11.5228; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MILLER AM, 1984, EMBO J, V3, P1061, DOI 10.1002/j.1460-2075.1984.tb01927.x; MILLER AM, 1985, NATURE, V314, P598, DOI 10.1038/314598a0; MULLER M, 1988, EMBO J, V7, P4299, DOI 10.1002/j.1460-2075.1988.tb03328.x; NER SS, 1989, MOL CELL BIOL, V9, P4613, DOI 10.1128/MCB.9.11.4613; PABO CO, 1984, ANNU REV BIOCHEM, V53, P293, DOI 10.1146/annurev.bi.53.070184.001453; PASSMORE S, 1989, GENE DEV, V3, P921, DOI 10.1101/gad.3.7.921; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Sambrook J, 1989, MOL CLONING LABORATO; SAUER RT, 1988, GENE DEV, V2, P807, DOI 10.1101/gad.2.7.807; SCHULZ B, 1990, CELL, V60, P295, DOI 10.1016/0092-8674(90)90744-Y; SHEPHERD JCW, 1984, NATURE, V310, P70, DOI 10.1038/310070a0; SILICIANO PG, 1986, P NATL ACAD SCI USA, V83, P2320, DOI 10.1073/pnas.83.8.2320; SMITH DR, 1984, CELL, V37, P645, DOI 10.1016/0092-8674(84)90396-9; STRATHERN J, 1981, J MOL BIOL, V147, P357, DOI 10.1016/0022-2836(81)90488-5; TATCHELL K, 1981, CELL, V27, P25, DOI 10.1016/0092-8674(81)90357-3; TRAVERS AA, 1989, ANNU REV BIOCHEM, V58, P427, DOI 10.1146/annurev.biochem.58.1.427	31	105	108	0	3	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	OCT 18	1990	347	6294					682	685		10.1038/347682a0	http://dx.doi.org/10.1038/347682a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED620	1977088				2022-12-28	WOS:A1990ED62000059
J	STIRRAT, GM				STIRRAT, GM			RECURRENT MISCARRIAGE .1. DEFINITION AND EPIDEMIOLOGY	LANCET			English	Review											STIRRAT, GM (corresponding author), BRISTOL MATERN HOSP,DEPT OBSTET & GYNAECOL,BRISTOL BS2 8EG,ENGLAND.							ALBERMAN E, 1987, SPONTANEOUS RECURREN, P77; Alberman E, 1988, EARLY PREGNANCY LOSS; AWAN AK, 1974, AM J OBSTET GYNECOL, V119, P525, DOI 10.1016/0002-9378(74)90214-2; EDMONDS DK, 1982, FERTIL STERIL, V38, P447; FANTEL AG, 1987, SPONTANEOUS RECURREN, P8; HARGER JH, 1983, OBSTET GYNECOL, V62, P574; HERTZPICCIOTTO I, 1988, NEW ENGL J MED, V319, P1483; LITTLE AB, 1988, NEW ENGL J MED, V319, P241, DOI 10.1056/NEJM198807283190409; MACKENZIE WE, 1988, OBSTET GYNECOL, V71, P81; MILLER JF, 1980, LANCET, V2, P554; Regan L, 1988, EARLY PREGNANCY LOSS, P23; STRAYPEDERSEN B, 1984, AM J OBSTET GYNECOL, V148, P140, DOI 10.1016/S0002-9378(84)80164-7; WARBURTON D, 1964, AM J HUM GENET, V16, P1; Warburton D, 1987, SPONTANEOUS RECURREN, P193; WHITTAKER PG, 1983, LANCET, V1, P1126; WHO (WorldHealthOrganization), 1977, ACTA OBSTET GYNECOL, V56, P247; WILCOX AJ, 1988, NEW ENGL J MED, V319, P189, DOI 10.1056/NEJM198807283190401	17	459	480	0	25	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	SEP 15	1990	336	8716					673	675		10.1016/0140-6736(90)92159-F	http://dx.doi.org/10.1016/0140-6736(90)92159-F			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DY737	1975862				2022-12-28	WOS:A1990DY73700013
J	FELSENFELD, AJ; ROBERTS, MA				FELSENFELD, AJ; ROBERTS, MA			A REPORT OF FLUOROSIS IN THE UNITED-STATES SECONDARY TO DRINKING WELL WATER	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Note							SKELETAL FLUOROSIS; FLUORIDE	A 54-year-old female resident of Wellston, Okla, was found to have osteosclerosis on a routine chest roentgenogram. Subsequent investigation disclosed the cause of her osteosclerosis to be fluorosis secondary to the ingestion of well water containing 429-mu-mol/L of fluoride (recommended levels, 11 to 58-mu-mol/L). Water samples were also obtained from the 12 wells on properties adjacent to the index case. In three other wells, all at similar depths as the well of the index case, the fluoride concentration of the water was greater than 212-mu-mol/L. Urine samples from members of the four households who obtain their drinking water from these wells contained elevated urinary fluoride levels. Thus, fluorosis may develop in certain areas of the United States as a result of the natural occurrence of fluoride in the groundwater. Consequently, in known endemic areas, it would appear reasonable to measure the fluoride concentration of the well water at the time of drilling.	OKLAHOMA DEPT HLTH,OKLAHOMA CITY,OK; VET ADM WADSWORTH MED CTR,DEPT MED,LOS ANGELES,CA 90073; UNIV CALIF LOS ANGELES,LOS ANGELES,CA 90024	University of California System; University of California Los Angeles								BELL ME, 1970, WHO MONOGRAPH, V59; BOILLAT MA, 1980, SKELETAL RADIOL, V5, P161, DOI 10.1007/BF00347257; BOWLEY NB, 1984, METABOLIC BONE STONE, P254; EVANS RA, 1984, METAB BONE DIS RELAT, V5, P111, DOI 10.1016/0221-8747(83)90011-5; FISHER RL, 1989, ARCH INTERN MED, V149, P697, DOI 10.1001/archinte.149.3.697; GRANDJEAN P, 1983, BRIT J IND MED, V40, P456; HODGE HC, 1977, J OCCUP ENVIRON MED, V19, P12, DOI 10.1097/00043764-197701000-00003; RAO TKS, 1975, KIDNEY INT, V7, P125; SIDDIQUI AH, 1955, BMJ-BRIT MED J, V2, P1408, DOI 10.1136/bmj.2.4953.1408; SINGH A, 1963, MEDICINE, V42, P229, DOI 10.1097/00005792-196305000-00003; SPAK CJ, 1985, PEDIATRICS, V75, P575; STEVENSON CA, 1957, AMER J ROENTGENOL RA, V78, P13; TEOTIA M, 1971, ARCH DIS CHILD, V46, P686, DOI 10.1136/adc.46.249.686; 1981, BMJ, V282, P253; 1980, DRINKING WATER HLTH; 1984, OCCURRENCE FLUORIDE; 1984, ENV HLTH CRITERIA FL	17	30	32	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	1991	265	4					486	488		10.1001/jama.265.4.486	http://dx.doi.org/10.1001/jama.265.4.486			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ET377	1985235				2022-12-28	WOS:A1991ET37700028
J	SIMARD, C; JOLICOEUR, P				SIMARD, C; JOLICOEUR, P			THE EFFECT OF ANTINEOPLASTIC DRUGS ON MURINE ACQUIRED-IMMUNODEFICIENCY-SYNDROME	SCIENCE			English	Article							C57BL/6 MICE; LEUKEMIA-VIRUS; RETROVIRUS; INDUCTION; LYMPHOMAS; DISEASE; MOUSE	The murine acquired immunodeficiency syndrome (MAIDS) is associated with proliferation of target cells that have been infected by a defective retrovirus. To control the growth of this primary neoplasia, virus-inoculated mice were treated with antineoplastic drugs. Paradoxically, cyclophosphamide, which is also immunosuppressive, was very effective in preventing the appearance and progression of the disease, in restoring a normal T cell function, and in depleting the number of infected target cells. This result suggests that the proliferating infected target cells were responsible for the immunodeficiency.	UNIV MONTREAL,DEPT MICROBIOL & IMMUNOL,MONTREAL H3C 3J7,QUEBEC,CANADA; CLIN RES INST MONTREAL,MOLEC BIOL LAB,MONTREAL H2W 1R7,QUEBEC,CANADA	Universite de Montreal; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal								AZIZ DC, 1989, NATURE, V338, P505, DOI 10.1038/338505a0; BULLER RML, 1987, J VIROL, V61, P383, DOI 10.1128/JVI.61.2.383-387.1987; CHATTOPADHYAY SK, 1989, P NATL ACAD SCI USA, V86, P3862, DOI 10.1073/pnas.86.10.3862; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DEWHURST S, 1990, NATURE, V345, P636, DOI 10.1038/345636a0; DUPLAN JF, 1970, B CANCER, V57, P23; FAUCI AS, 1988, SCIENCE, V239, P617, DOI 10.1126/science.3277274; FAUCI AS, 1990, J ALLERGY CLIN IMMUN, V66, P5; FREI E, 1974, CANCER RES, V34, P184; HARTLEY JW, 1989, J VIROL, V63, P1223, DOI 10.1128/JVI.63.3.1223-1231.1989; HUANG M, 1989, SCIENCE, V246, P1614, DOI 10.1126/science.2480643; KLINKEN SP, 1988, J IMMUNOL, V140, P1123; LATARJET R, 1962, INT J RADIAT BIOL RE, V5, P339, DOI 10.1080/09553006214550911; LEGRAND E, 1981, LEUKEMIA RES, V5, P223, DOI 10.1016/0145-2126(81)90107-7; Maniatis T., 1982, MOL CLONING; MARCHALORIS JJ, 1988, LYMPHOCYTE STRUCTURE; MISTRY PB, 1973, B CANCER, V60, P287; MOMPARLER RL, 1985, PHARMACOL THERAPEUT, V30, P287, DOI 10.1016/0163-7258(85)90053-1; MOSIER DE, 1985, J EXP MED, V161, P766, DOI 10.1084/jem.161.4.766; MOSIER DE, 1986, IMMUNOL INVEST, V15, P233, DOI 10.3109/08820138609026687; PATTENGALE PK, 1982, AM J PATHOL, V107, P362; SIMARD C, UNPUB; TURK JL, 1972, CLIN EXP IMMUNOL, V10, P285; WONGSTAAL F, 1985, NATURE, V317, P395, DOI 10.1038/317395a0	24	39	39	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JAN 18	1991	251	4991					305	308		10.1126/science.1987646	http://dx.doi.org/10.1126/science.1987646			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET678	1987646				2022-12-28	WOS:A1991ET67800031
J	MCDONNELL, TJ; KORSMEYER, SJ				MCDONNELL, TJ; KORSMEYER, SJ			PROGRESSION FROM LYMPHOID HYPERPLASIA TO HIGH-GRADE MALIGNANT-LYMPHOMA IN MICE TRANSGENIC FOR THE T(14, 18)	NATURE			English	Article							C-MYC ONCOGENE; CHROMOSOME TRANSLOCATIONS; NUCLEOTIDE-SEQUENCE; FOLLICULAR LYMPHOMA; BURKITT-LYMPHOMA; CELL SURVIVAL; GENE; REGION; LOCUS; ACTIVATION	FOLLICULAR lymphoma, the most common human lymphoma, characteristically has a t(14; 18) interchromosomal translocation 1,2. Its is typically an indolent disease comprised of small resting B cells, but frequently develops into a high-grade lymphoma 3. The t(14; 18) translocates the Bcl-2 gene, generating a deregulated Bcl-2-immunoglobulin fusion gene 4-8. Bcl-2 is a novel inner mitochondrial membrane protein 9 that extends the survival of certain cells by blocking programmed cell death 9-11. To determine the oncogenic potential of the t(14; 18) translocation, we produced transgenic mice bearing a Bcl-2-immunoglobulin minigene that structurally mimicked the t(14; 18) (ref. 12). An indolent follicular hyperplasia in these transgenic mice progressed to a malignant diffuse large-cell lymphoma. The long latency, progression from polyclonal to monoclonal disease, and histological conversion, are all suggestive of secondary changes. Half of the immunoblastic high-grade lymphomas had a rearranged c-myc gene. Our transgenic mice provide an animal model for tumour progression in t(14; 18) lymphoma and show that prolonged B-cell life increases tumour incidence.	WASHINGTON UNIV, SCH MED, DEPT MED, ST LOUIS, MO 63110 USA; WASHINGTON UNIV, SCH MED, DEPT MOLEC MICROBIOL, ST LOUIS, MO 63110 USA; WASHINGTON UNIV, SCH MED, DEPT PATHOL, ST LOUIS, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	MCDONNELL, TJ (corresponding author), WASHINGTON UNIV, SCH MED, HOWARD HUGHES MED INST, 660 S EUCLID, ST LOUIS, MO 63110 USA.							ADAMS JM, 1983, P NATL ACAD SCI-BIOL, V80, P1982, DOI 10.1073/pnas.80.7.1982; BAKHSHI A, 1985, CELL, V41, P899, DOI 10.1016/S0092-8674(85)80070-2; BISHOP JM, 1987, SCIENCE, V235, P305, DOI 10.1126/science.3541204; CLEARY ML, 1986, CELL, V47, P19, DOI 10.1016/0092-8674(86)90362-4; CLEARY ML, 1985, P NATL ACAD SCI USA, V82, P7439, DOI 10.1073/pnas.82.21.7439; CRISSMAN HA, 1973, J CELL BIOL, V59, P766, DOI 10.1083/jcb.59.3.766; DALLAFAVERA R, 1982, P NATL ACAD SCI-BIOL, V79, P7824, DOI 10.1073/pnas.79.24.7824; DEJONG D, 1988, NEW ENGL J MED, V318, P1373, DOI 10.1056/NEJM198805263182106; GAUWERKY CE, 1988, P NATL ACAD SCI USA, V85, P8548, DOI 10.1073/pnas.85.22.8548; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; HORNING SJ, 1984, NEW ENGL J MED, V311, P1471, DOI 10.1056/NEJM198412063112303; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; LANGDON WY, 1986, CELL, V47, P11, DOI 10.1016/0092-8674(86)90361-2; MARCU KB, 1983, P NATL ACAD SCI-BIOL, V80, P519, DOI 10.1073/pnas.80.2.519; MCDONNELL TJ, 1989, CELL, V57, P79, DOI 10.1016/0092-8674(89)90174-8; MCDONNELL TJ, 1990, CELL, V10, P1901; NUNEZ G, 1990, J IMMUNOL, V144, P3602; NUNEZ G, 1989, P NATL ACAD SCI USA, V86, P4589, DOI 10.1073/pnas.86.12.4589; PATTENGALE PK, 1983, AM J PATHOL, V113, P235; REED JC, 1990, P NATL ACAD SCI USA, V87, P3660, DOI 10.1073/pnas.87.10.3660; ROWLEY JD, 1982, SCIENCE, V216, P749, DOI 10.1126/science.7079737; SAGER R, 1989, SCIENCE, V246, P1406, DOI 10.1126/science.2574499; SETO M, 1988, EMBO J, V7, P123, DOI 10.1002/j.1460-2075.1988.tb02791.x; STANTON LW, 1982, NUCLEIC ACIDS RES, V10, P5993, DOI 10.1093/nar/10.19.5993; TAUB R, 1982, P NATL ACAD SCI-BIOL, V79, P7837, DOI 10.1073/pnas.79.24.7837; TSUJIMOTO Y, 1985, SCIENCE, V229, P1390, DOI 10.1126/science.3929382; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; YUNIS JJ, 1983, SCIENCE, V221, P227, DOI 10.1126/science.6336310	28	811	838	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 17	1991	349	6306					254	256		10.1038/349254a0	http://dx.doi.org/10.1038/349254a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET519	1987477				2022-12-28	WOS:A1991ET51900061
J	DOEZEMA, D; SKLAR, DP; ROTH, PB; RODOLICO, MP; KEY, G				DOEZEMA, D; SKLAR, DP; ROTH, PB; RODOLICO, MP; KEY, G			DEVELOPMENT OF EMERGENCY SERVICES IN COSTA-RICA - A COLLABORATIVE PROJECT IN INTERNATIONAL HEALTH	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							MORTALITY; DISEASE; CARE				DOEZEMA, D (corresponding author), UNIV NEW MEXICO,SCH MED,DIV EMERGENCY MED,620 CAMINO SALUD NE,ALBUQUERQUE,NM 87131, USA.							ALEXANDER RH, 1984, J TRAUMA, V24, P486, DOI 10.1097/00005373-198406000-00005; EVANS JR, 1981, NEW ENGL J MED, V305, P1117, DOI 10.1056/NEJM198111053051904; ISLAMI AH, 1990, JAMA-J AM MED ASSOC, V263, P3306; MUSIC SI, 1990, JAMA-J AM MED ASSOC, V263, P3309, DOI 10.1001/jama.263.24.3309; SCHAMBRA PE, 1990, JAMA-J AM MED ASSOC, V263, P3325; SKLAR DP, 1988, AM J EMERG MED, V6, P390, DOI 10.1016/0735-6757(88)90164-7; TAYLOR CE, 1979, AM J PUBLIC HEALTH, V69, P803, DOI 10.2105/AJPH.69.8.803; WALSH JA, 1979, NEW ENGL J MED, V301, P967, DOI 10.1056/NEJM197911013011804; WINTEMUTE GJ, 1985, ACCIDENT ANAL PREV, V17, P223, DOI 10.1016/0001-4575(85)90055-7; 1981, NATIONAL GEOGRPAHIC, P112; 1989, WORLD HLTH STATISTIC, P388	11	10	11	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 9	1991	265	2					188	190		10.1001/jama.265.2.188	http://dx.doi.org/10.1001/jama.265.2.188			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EQ602	1984140				2022-12-28	WOS:A1991EQ60200012
J	NIGHTINGALE, SL				NIGHTINGALE, SL			CLOTRIMAZOLE AVAILABLE WITHOUT PRESCRIPTION FOR VAGINAL YEAST INFECTIONS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material											NIGHTINGALE, SL (corresponding author), US FDA,OFF HLTH AFFAIRS,PARKLAWN BLDG,5600 FISHERS LN,ROCKVILLE,MD 20857, USA.								0	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 9	1991	265	2					182	182						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EQ602	1984138				2022-12-28	WOS:A1991EQ60200010
J	DANIELSON, PD				DANIELSON, PD			COLD FEET	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	1991	265	1					41	41						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP555	1984124				2022-12-28	WOS:A1991EP55500026
J	GOODNOUGH, LT; JOHNSTON, MFM; TOY, PTCY				GOODNOUGH, LT; JOHNSTON, MFM; TOY, PTCY			THE VARIABILITY OF TRANSFUSION PRACTICE IN CORONARY-ARTERY BYPASS-SURGERY	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ELECTIVE CARDIAC-SURGERY; NON-B HEPATITIS; AUTOLOGOUS BLOOD; CARDIOPULMONARY BYPASS; NON-A; RECIPIENTS; ANTIBODY; ENGLAND; DONORS	We audited 540 patients undergoing elective first-time coronary artery bypass grafts at 18 institutions. The purposes of the study were to describe the variability in transfusions among institutions and to determine factors that may account for variability. Mean homologous red blood cell use per patient was 2.9(+/- 0.1) U (institutional range, 0.4 to 6.3 U). One hundred seventy-seven patients (32%) received plasma (institutional range, 0% to 97%), and 119 (22%) received platelets (institutional range, 0% to 80%). After controlling for patient and surgical practice variables, transfusion practice factors still accounted for variation in red blood cell transfusions. Variation in patients receiving plasma and platelet transfusions among institutions was determined in part by prophylactic transfusions. We conclude that blood component usage for coronary artery bypass grafts differs widely among institutions. The variability in use of these components is accounted for in part by unnecessary transfusions in otherwise routine, uncomplicated coronary artery bypass graft procedures.	CASE WESTERN RESERVE UNIV,CLEVELAND,OH 44106; UNIV CALIF SAN FRANCISCO,SAN FRANCISCO,CA 94143	Case Western Reserve University; University of California System; University of California San Francisco								AYMARD JP, 1986, VOX SANG, V51, P236, DOI 10.1111/j.1423-0410.1986.tb01961.x; CHASSIN MR, 1987, JAMA-J AM MED ASSOC, V258, P2533, DOI 10.1001/jama.258.18.2533; CHASSIN MR, 1989, NEW ENGL J MED, V290, P285; COHEN ND, 1989, NEW ENGL J MED, V320, P1172, DOI 10.1056/NEJM198905043201803; COSGROVE DM, 1985, ANN THORAC SURG, V40, P380, DOI 10.1016/S0003-4975(10)60073-2; DEBANNE SM, 1983, P AM STATISTICAL ASS; FRIEDMAN BA, 1980, TRANSFUSION, V20, P179, DOI 10.1046/j.1537-2995.1980.20280169958.x; GOODNOUGH LT, 1990, AM J SURG, V159, P602, DOI 10.1016/S0002-9610(06)80079-6; GOODNOUGH LT, 1989, TRANSFUSION, V29, P821, DOI 10.1046/j.1537-2995.1989.29990070188.x; HARDING SA, 1975, J THORAC CARDIOV SUR, V70, P350; KAARIAINEN L, 1966, ANN MED EXP BIOL FEN, V44, P297; KILLIP T, 1988, NEW ENGL J MED, V319, P366, DOI 10.1056/NEJM198808113190610; KRUSKALL MS, 1986, TRANSFUSION, V26, P335, DOI 10.1046/j.1537-2995.1986.26486262740.x; LAWRENCE L, 1984, VITAL HLTH STATIS 13, V86; LOVE TR, 1987, ANN THORAC SURG, V43, P508, DOI 10.1016/S0003-4975(10)60198-1; MAGGART M, 1987, ANN THORAC SURG, V43, P231, DOI 10.1016/S0003-4975(10)60410-9; MCPHERSON K, 1982, NEW ENGL J MED, V307, P1310, DOI 10.1056/NEJM198211183072104; OWINGS DV, 1989, JAMA-J AM MED ASSOC, V262, P1963; SIMON TL, 1984, ANN THORAC SURG, V37, P359, DOI 10.1016/S0003-4975(10)60755-2; SPECTOR I, 1966, NEW ENGL J MED, V275, P1027; STEVENS CE, 1984, ANN INTERN MED, V101, P733, DOI 10.7326/0003-4819-101-6-733; THALER M, 1989, NEW ENGL J MED, V321, P25, DOI 10.1056/NEJM198907063210105; TOY PTCY, 1987, NEW ENGL J MED, V316, P517, DOI 10.1056/NEJM198702263160906; VAYDA E, 1973, NEW ENGL J MED, V289, P1224, DOI 10.1056/NEJM197312062892305; 1987, JAMA-J AM MED ASSOC, V257, P1777; 1982, PROGRAM GUIDELINES T; 1988, JAMA-J AM MED ASSOC, V260, P2700; 1985, SAS USERS GUIDE BASI, P1181; 1985, JAMA-J AM MED ASSOC, V253, P551	29	316	321	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	1991	265	1					86	90		10.1001/jama.265.1.86	http://dx.doi.org/10.1001/jama.265.1.86			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP555	1984129				2022-12-28	WOS:A1991EP55500034
J	CHEN, YMA; LEE, TH; WIKTOR, SZ; SHAW, GM; MURPHY, EL; BLATTNER, WA; ESSEX, M				CHEN, YMA; LEE, TH; WIKTOR, SZ; SHAW, GM; MURPHY, EL; BLATTNER, WA; ESSEX, M			TYPE-SPECIFIC ANTIGENS FOR SEROLOGICAL DISCRIMINATION OF HTLV-I AND HTLV-II INFECTION	LANCET			English	Article									HARVARD UNIV,SCH PUBL HLTH,DEPT CANC BIOL,665 HUNTINGTON AVE,BOSTON,MA 02115; NCI,VIRAL EPIDEMIOL SECT,BETHESDA,MD 20892; UNIV ALABAMA,DIV HEMATOL & ONCOL,BIRMINGHAM,AL 35294; UNIV CALIF SAN FRANCISCO,DEPT LAB MED,SAN FRANCISCO,CA 94143	Harvard University; Harvard T.H. Chan School of Public Health; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Alabama System; University of Alabama Birmingham; University of California System; University of California San Francisco					NATIONAL CANCER INSTITUTE [R37CA038450, R01CA038450] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL033774] Funding Source: NIH RePORTER; NCI NIH HHS [CA 38450] Funding Source: Medline; NHLBI NIH HHS [1-P50-HL-33774, HL 6456] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANDERSON DW, 1989, BLOOD, V74, P2581; ATASSI MZ, 1975, IMMUNOCHEMISTRY, V12, P423, DOI 10.1016/0019-2791(75)90010-5; BARIN F, 1985, LANCET, V2, P1387; CHEN ISY, 1983, NATURE, V305, P502, DOI 10.1038/305502a0; CHEN YMA, 1989, J VIROL, V63, P4952, DOI 10.1128/JVI.63.11.4952-4957.1989; GESSAIN A, 1985, LANCET, V2, P407; HINUMA Y, 1986, AIDS RES, V2, P517; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; JACOBSON S, 1988, NATURE, V331, P540, DOI 10.1038/331540a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE H, 1989, SCIENCE, V244, P471, DOI 10.1126/science.2655084; LEE HH, 1990, 3RD ANN RETR C HAW; LEE TH, 1984, P NATL ACAD SCI-BIOL, V81, P7579, DOI 10.1073/pnas.81.23.7579; MIYOSHI I, 1981, NATURE, V294, P770, DOI 10.1038/294770a0; OSAME M, 1986, LANCET, V1, P1031; POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415; ROSENBLATT JD, 1986, NEW ENGL J MED, V315, P372, DOI 10.1056/NEJM198608073150606; SEIKI M, 1983, P NATL ACAD SCI-BIOL, V80, P3618, DOI 10.1073/pnas.80.12.3618; WIKTOR SZ, 1990, LANCET, V335, P1533, DOI 10.1016/0140-6736(90)93078-4; YOSHIDA M, 1984, P NATL ACAD SCI-BIOL, V81, P2534, DOI 10.1073/pnas.81.8.2534	20	45	45	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 10	1990	336	8724					1153	1155		10.1016/0140-6736(90)92769-E	http://dx.doi.org/10.1016/0140-6736(90)92769-E			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG701	1978028				2022-12-28	WOS:A1990EG70100005
J	TAKAYAMA, T; MAKUUCHI, M; HIROHASHI, S; SAKAMOTO, M; OKAZAKI, N; TAKAYASU, K; KOSUGE, T; MOTOO, Y; YAMAZAKI, S; HASEGAWA, H				TAKAYAMA, T; MAKUUCHI, M; HIROHASHI, S; SAKAMOTO, M; OKAZAKI, N; TAKAYASU, K; KOSUGE, T; MOTOO, Y; YAMAZAKI, S; HASEGAWA, H			MALIGNANT TRANSFORMATION OF ADENOMATOUS HYPERPLASIA TO HEPATOCELLULAR-CARCINOMA	LANCET			English	Article									NATL CANC CTR,DEPT INTERNAL MED,TOKYO 104,JAPAN; NATL CANC CTR,DEPT DIAGNOST RADIOL,TOKYO 104,JAPAN; NATL CANC CTR,RES INST,DIV PATHOL,TOKYO 104,JAPAN; SHINSHU UNIV,SCH MED,DEPT SURG 1,MATSUMOTO,NAGANO 390,JAPAN; KANAZAWA UNIV,CANC RES INST,DEPT INTERNAL MED,KANAZAWA,ISHIKAWA 920,JAPAN	National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; Shinshu University; Kanazawa University	TAKAYAMA, T (corresponding author), NATL CANC CTR,DEPT SURG,TSUKIJI 5-1-1,CHUO KU,TOKYO 104,JAPAN.		Sakamoto, Michiie/N-2917-2015; Motoo, Yoshiharu/E-8277-2011					ARAKAWA M, 1986, GASTROENTEROLOGY, V91, P198, DOI 10.1016/0016-5085(86)90458-0; ARAKI T, 1980, AM J ROENTGENOL, V135, P1037, DOI 10.2214/ajr.135.5.1037; BANNASCH P, 1976, CANCER RES, V36, P2555; EDMONDSON HA, 1976, HEPATOCELLULAR CARCI, P309; FURUYA K, 1988, CANCER, V61, P99, DOI 10.1002/1097-0142(19880101)61:1<99::AID-CNCR2820610117>3.0.CO;2-U; KONDO F, 1989, HEPATOLOGY, V9, P751, DOI 10.1002/hep.1840090516; LIVRAGHI T, 1989, RADIOLOGY, V170, P155, DOI 10.1148/radiology.170.1.2642340; MAKUUCHI M, 1983, ULTRASOUND 82, P489; OKUDA K, 1986, J GASTROEN HEPATOL, V1, P79, DOI 10.1111/j.1440-1746.1986.tb01760.x; SAKAMOTO M, IN PRESS HUM PATHOL; SASAKI K, 1980, GANN MONOGR CANCER R, V25, P127; SCHWARTZ M, 1961, CANCER, V14, P1272, DOI 10.1002/1097-0142(196111/12)14:6<1272::AID-CNCR2820140618>3.0.CO;2-H; TAKAYASU K, 1986, AM J ROENTGENOL, V147, P525, DOI 10.2214/ajr.147.3.525; TKAAYASU K, 1990, AM J ROENTGENOL, V155, P49; TSUDA H, 1988, GASTROENTEROLOGY, V95, P1664, DOI 10.1016/S0016-5085(88)80093-3; [No title captured]	16	364	370	0	4	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 10	1990	336	8724					1150	1153		10.1016/0140-6736(90)92768-D	http://dx.doi.org/10.1016/0140-6736(90)92768-D			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG701	1978027				2022-12-28	WOS:A1990EG70100004
J	FISCHER, A; LANDAIS, P; FRIEDRICH, W; MORGAN, G; GERRITSEN, B; FASTH, A; PORTA, F; GRISCELLI, C; GOLDMAN, SF; LEVINSKY, R; VOSSEN, J				FISCHER, A; LANDAIS, P; FRIEDRICH, W; MORGAN, G; GERRITSEN, B; FASTH, A; PORTA, F; GRISCELLI, C; GOLDMAN, SF; LEVINSKY, R; VOSSEN, J			EUROPEAN EXPERIENCE OF BONE-MARROW TRANSPLANTATION FOR SEVERE COMBINED IMMUNODEFICIENCY	LANCET			English	Article									UNIV ULM CLIN,DEPT CHILD HLTH,ULM,GERMANY; UNIV BRESCIA,PAEDIAT CLIN,PAVIA,ITALY; STATE UNIV LEIDEN HOSP,DEPT PAEDIAT,2333 AA LEIDEN,NETHERLANDS; GOTHENBURG UNIV,DEPT PAEDIAT,S-41124 GOTHENBURG,SWEDEN; HOP NECKER ENFANTS MALAD,DEPT STAT & INFORMAT,F-75743 PARIS 15,FRANCE; INST CHILD HLTH,DEPT IMMUNOL,LONDON WC1N 1EH,ENGLAND	Ulm University; University of Brescia; Leiden University; Leiden University Medical Center (LUMC); University of Gothenburg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; University of London; University College London	FISCHER, A (corresponding author), HOP NECKER ENFANTS MALAD,IMMUNOL & HAEMATOL UNIT,149 RUE SEVRES,F-75743 PARIS 15,FRANCE.		Fasth, Anders/I-1109-2019					BORTIN MM, 1987, PROGR BONE MARROW TR, P243; BUCKLEY RH, 1986, J IMMUNOL, V136, P2398; BUCKLEY RH, 1989, IMMUNOLOGIC DISORDER, P774; COWAN MJ, 1985, J CLIN IMMUNOL, V5, P370, DOI 10.1007/BF00915333; EIERMANN TH, 1986, PROGR IMMUNODEFICIEN, V2, P373; FISCHER A, 1986, LANCET, V2, P1080; FISCHER A, 1986, BLOOD, V67, P444; FRIEDRICH W, 1985, EUR J PEDIATR, V144, P125, DOI 10.1007/BF00451897; GATTI RA, 1968, LANCET, V2, P1366; GLUCKSBERG H, 1974, TRANSPLANTATION, V18, P295, DOI 10.1097/00007890-197410000-00001; GOULMY E, 1976, LANCET, V2, P1206; GRISCELLI C, 1981, BONE MARROW TRANSPL, P233; JEFFREYS AJ, 1985, NATURE, V314, P67, DOI 10.1038/314067a0; KALBFEISCH JD, 1980, STATISTICAL ANAL FAI; KENNY AB, 1979, EUR J PEDIATR, V131, P155, DOI 10.1007/BF00538940; KORVER K, 1987, TRANSPLANTATION, V44, P643, DOI 10.1097/00007890-198711000-00010; MOEN RC, 1987, BLOOD, V70, P664; MORGAN G, 1986, BRIT J HAEMATOL, V62, P421, DOI 10.1111/j.1365-2141.1986.tb02953.x; MURPHY WJ, 1987, J EXP MED, V165, P1212, DOI 10.1084/jem.165.4.1212; O'Reilly R J, 1983, Birth Defects Orig Artic Ser, V19, P129; OREILLY RJ, 1984, SEMIN HEMATOL, V21, P188; OREILLY RJ, 1990, IMMUNODEF REV, V1, P273; OREILLY RJ, 1986, PRIMARY IMMUNODEFICI, P301; OREILLY RJ, 1983, RECENT ADV BONE MARR, P799; PETER HH, 1986, PROGR IMMUNODEFICIEN, V2, P287; REINHERZ EL, 1982, P NATL ACAD SCI-BIOL, V79, P6047, DOI 10.1073/pnas.79.19.6047; REISNER Y, 1983, BLOOD, V61, P341; VOSSEN JM, 1984, PROGR IMMUNODEFICIEN, P417; WIJNAENDTS L, 1989, BLOOD, V74, P2212; 1989, IMMUNODEFICIENCY REV, V1, P173	30	245	247	0	4	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 6	1990	336	8719					850	854		10.1016/0140-6736(90)92348-L	http://dx.doi.org/10.1016/0140-6736(90)92348-L			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB901	1976883				2022-12-28	WOS:A1990EB90100011
J	NICOLINI, U; NICOLAIDIS, P; FISK, NM; VAUGHAN, JI; FUSI, L; GLEESON, R; RODECK, CH				NICOLINI, U; NICOLAIDIS, P; FISK, NM; VAUGHAN, JI; FUSI, L; GLEESON, R; RODECK, CH			LIMITED ROLE OF FETAL BLOOD-SAMPLING IN PREDICTION OF OUTCOME IN INTRAUTERINE GROWTH-RETARDATION	LANCET			English	Article									HAMMERSMITH HOSP,LONDON W12 0HS,ENGLAND	Imperial College London	NICOLINI, U (corresponding author), QUEEN CHARLOTTES MATERN HOSP,ROYAL POSTGRAD MED SCH,INST OBSTET & GYNAECOL,LONDON W6 0XG,ENGLAND.		Fisk, Nicholas M/B-2126-2009	Fisk, Nicholas M/0000-0003-0031-7975				BRAR HS, 1989, AM J OBSTET GYNECOL, V160, P36, DOI 10.1016/0002-9378(89)90082-3; BURKE G, 1990, BRIT MED J, V300, P1044, DOI 10.1136/bmj.300.6731.1044; CAMPBELL S, 1977, BRIT J OBSTET GYNAEC, V84, P165, DOI 10.1111/j.1471-0528.1977.tb12550.x; CAMPBELL S, 1988, 20TH P STUD GROUP RO, P251; COX WL, 1988, AM J OBSTET GYNECOL, V159, P36, DOI 10.1016/0002-9378(88)90490-5; DAFFOS F, 1985, AM J OBSTET GYNECOL, V153, P655, DOI 10.1016/S0002-9378(85)80254-4; DIVON MY, 1989, AM J OBSTET GYNECOL, V161, P1523, DOI 10.1016/0002-9378(89)90917-4; ECONOMIDES D L, 1988, Fetal Therapy, V3, P165; ECONOMIDES DL, 1989, AM J OBSTET GYNECOL, V161, P1219, DOI 10.1016/0002-9378(89)90670-4; FEE SC, 1990, AM J OBSTET GYNECOL, V162, P802, DOI 10.1016/0002-9378(90)91014-4; HACKETT GA, 1987, BRIT MED J, V294, P13, DOI 10.1136/bmj.294.6563.13; NICOLAIDES KH, 1988, AM J OBSTET GYNECOL, V159, P1063, DOI 10.1016/0002-9378(88)90413-9; NICOLAIDES KH, 1989, AM J OBSTET GYNECOL, V161, P996, DOI 10.1016/0002-9378(89)90770-9; NICOLAIDES KH, 1988, BRIT MED J, V297, P1026, DOI 10.1136/bmj.297.6655.1026; NICOLAIDES KH, 1986, LANCET, V1, P1065; NICOLINI U, 1988, PRENATAL DIAG, V8, P665, DOI 10.1002/pd.1970080906; NICOLINI U, 1990, HORM METAB RES, V22, P426, DOI 10.1055/s-2007-1004939; NICOLINI U, 1989, AM J OBSTET GYNECOL, V161, P924, DOI 10.1016/0002-9378(89)90753-9; REUWER PJHM, 1987, LANCET, V2, P415; RUTH VJ, 1988, BRIT MED J, V297, P24, DOI 10.1136/bmj.297.6640.24; SHEPARD MJ, 1982, AM J OBSTET GYNECOL, V142, P42; SOOTHILL P W, 1986, Fetal Therapy, V1, P168; SOOTHILL PW, 1987, BRIT MED J, V294, P1051, DOI 10.1136/bmj.294.6579.1051; TYRRELL S, 1989, OBSTET GYNECOL, V74, P332; VANDENHOF MC, 1990, AM J OBSTET GYNECOL, V162, P735, DOI 10.1016/0002-9378(90)90997-L; WEINER CP, 1989, OBSTET GYNECOL, V73, P225	26	74	74	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	SEP 29	1990	336	8718					768	772		10.1016/0140-6736(90)93239-L	http://dx.doi.org/10.1016/0140-6736(90)93239-L			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB077	1976146				2022-12-28	WOS:A1990EB07700004
J	STEINBAKK, M; NAESSANDRESEN, CF; LINGAAS, E; DALE, I; BRANDTZAEG, P; FAGERHOL, MK				STEINBAKK, M; NAESSANDRESEN, CF; LINGAAS, E; DALE, I; BRANDTZAEG, P; FAGERHOL, MK			ANTIMICROBIAL ACTIONS OF CALCIUM-BINDING LEUKOCYTE L1 PROTEIN, CALPROTECTIN	LANCET			English	Article									ULLEVAL HOSP,DEPT MICROBIOL,N-0407 OSLO,NORWAY; NATL HOSP NORWAY,DEPT MICROBIOL,OSLO 1,NORWAY; NATL HOSP NORWAY,DEPT IMMUNOHISTOCHEM & IMMUNOPATHOL,OSLO 1,NORWAY; ULLEVAL HOSP,BLOOD BANK,N-0407 OSLO,NORWAY; ULLEVAL HOSP,DEPT CLIN PHYSIOL,N-0407 OSLO,NORWAY	University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; University of Oslo				Fagerhol, Magne Kristoffer/0000-0002-5103-6981				ANDERSSON KB, 1988, SCAND J IMMUNOL, V28, P241, DOI 10.1111/j.1365-3083.1988.tb02437.x; BRANDTZAEG P, 1987, AM J CLIN PATHOL, V87, P700, DOI 10.1093/ajcp/87.6.700; DALE I, 1985, AM J CLIN PATHOL, V84, P24, DOI 10.1093/ajcp/84.1.24; DALE I, 1983, EUR J BIOCHEM, V134, P1, DOI 10.1111/j.1432-1033.1983.tb07522.x; EDGEWORTH J, 1989, NATURE, V342, P189, DOI 10.1038/342189a0; EGGLETON P, 1989, J IMMUNOL METHODS, V121, P105, DOI 10.1016/0022-1759(89)90425-0; FAGERHOL MK, 1980, SCAND J HAEMATOL, V24, P393; FREEMONT P, 1989, NATURE, V339, P516, DOI 10.1038/339516b0; HOGG N, 1989, EUR J IMMUNOL, V19, P1053, DOI 10.1002/eji.1830190615; KELLY SE, 1989, J PATHOL, V159, P17, DOI 10.1002/path.1711590107; MCNAMARA MP, 1988, LANCET, V2, P1163; MUNSTERMANN U, 1990, EUR J BIOCHEM, V189, P251, DOI 10.1111/j.1432-1033.1990.tb15484.x; MURAO S, 1989, J BIOL CHEM, V264, P8356; ODINK K, 1987, NATURE, V330, P80, DOI 10.1038/330080a0; SANDER J, 1984, SCAND J CLIN LAB INV, V44, P357, DOI 10.3109/00365518409083820; SOHNLE PG, 1989, CLIN RES, V37, pA440; STOCKLEY RA, 1984, SCAND J CLIN LAB INV, V44, P629, DOI 10.3109/00365518409083622; WILKINSON MM, 1988, J CELL SCI, V91, P221	18	434	443	0	20	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	SEP 29	1990	336	8718					763	765		10.1016/0140-6736(90)93237-J	http://dx.doi.org/10.1016/0140-6736(90)93237-J			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB077	1976144				2022-12-28	WOS:A1990EB07700002
J	STRAYPEDERSEN, B				STRAYPEDERSEN, B			ACYCLOVIR IN LATE PREGNANCY TO PREVENT NEONATAL HERPES-SIMPLEX	LANCET			English	Letter											STRAYPEDERSEN, B (corresponding author), AKER UNIV HOSP,DEPT GYNAECOL & OBSTET,N-0514 OSLO 5,NORWAY.							ARVIN AM, 1986, NEW ENGL J MED, V315, P796, DOI 10.1056/NEJM198609253151303; BIKIN NJ, 1984, JAMA-J AM MED ASSOC, V251, P2816; BROWN ZA, 1989, OBSTET GYNECOL, V73, P526; CARNEY O, 1988, BRIT MED J, V296, P1643, DOI 10.1136/bmj.296.6637.1643; LISSAUER T, 1989, BRIT J OBSTET GYNAEC, V96, P1015, DOI 10.1111/j.1471-0528.1989.tb03373.x; MERTZ GJ, 1988, JAMA-J AM MED ASSOC, V260, P201, DOI 10.1001/jama.260.2.201; WHITLEY RJ, 1988, CLIN PERINATOL, V15, P903, DOI 10.1016/S0095-5108(18)30682-1; 1988, OBSTET GYNECOL, V71, P779; 1988, ACOG TECHN B     NOV; 1989, CAN MED ASSOC J, V141, P1233	10	56	57	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	SEP 22	1990	336	8717					756	756		10.1016/0140-6736(90)92255-G	http://dx.doi.org/10.1016/0140-6736(90)92255-G			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DZ624	1975931				2022-12-28	WOS:A1990DZ62400056
J	IGLEHART, JK				IGLEHART, JK			GERMANY HEALTH-CARE SYSTEM .1.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article																		BLANPAIN J, 1978, NATIONAL HLTH INSURA; BLENDON RJ, 1990, HEALTH AFFAIR, V9, P185, DOI 10.1377/hlthaff.9.2.185; GALLAGHER HG, 1990, BY TRUST BETRAYED PA; GLASER WA, 1987, PAYING HOSPITAL ORG; Kater MH, 1989, DOCTORS HITLER; Lifton R. J., 1986, NAZI DOCTORS MED KIL; Proctor Robert N., 1988, RACIAL HYGIENE MED N; RAFFEL MW, 1984, COMP HLTH SYSTEMS; RUBLEE DA, 1989, HEALTH AFFAIR, V8, P178, DOI 10.1377/hlthaff.8.3.178; SANDIER S, 1989, HLTH CARE FINANC R S, V10, P33; Schieber G J, 1990, Health Care Financ Rev, V11, P159; STONE DA, 1980, LIMITS PROFESSONAL P; WEISS SF, 1987, RACE HYGIENE NATIONA; [No title captured]; [No title captured]	15	56	56	1	4	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 14	1991	324	7					503	508		10.1056/NEJM199102143240725	http://dx.doi.org/10.1056/NEJM199102143240725			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EX363	1988843				2022-12-28	WOS:A1991EX36300028
J	WINTER, G; MILSTEIN, C				WINTER, G; MILSTEIN, C			MAN-MADE ANTIBODIES	NATURE			English	Review							POLYMERASE CHAIN-REACTION; BISPECIFIC MONOCLONAL-ANTIBODIES; IMMUNOGLOBULIN VARIABLE DOMAINS; ANTIGEN-BINDING SPECIFICITY; RESHAPING HUMAN-ANTIBODIES; ESCHERICHIA-COLI; HYBRIDOMA CELLS; IMMUNE-RESPONSE; SOMATIC HYPERMUTATION; CATALYTIC ANTIBODIES	Monoclonal antibodies can now be genetically engineered and endowed with new properties. In the future, gene technology could enable antigen-binding fragments to be made by exploiting repertoires of variable domain genes derived from immunized animals and expressed in bacteria. How readily can this approach be extended to production of 'in vitro' repertoires of variable domain genes, and obviate the immunization of animals?			WINTER, G (corresponding author), MRC,MOLEC BIOL LAB,HILLS RD,CAMBRIDGE CB2 2QH,ENGLAND.							ALLEN D, 1987, IMMUNOL REV, V96, P5, DOI 10.1111/j.1600-065X.1987.tb00506.x; BAGSHAWE KD, 1987, BRIT J CANCER, V56, P531, DOI 10.1038/bjc.1987.237; BAGSHAWE KD, 1988, BRIT J CANCER, V58, P700, DOI 10.1038/bjc.1988.293; BALDWIN E, 1989, SCIENCE, V245, P1104, DOI 10.1126/science.2672338; BEREK C, 1987, IMMUNOL REV, V96, P23, DOI 10.1111/j.1600-065X.1987.tb00507.x; BEREK C, 1988, IMMUNOL REV, V105, P5, DOI 10.1111/j.1600-065X.1988.tb00763.x; BETTER M, 1988, SCIENCE, V240, P1041, DOI 10.1126/science.3285471; BIRD RE, 1988, SCIENCE, V242, P423, DOI 10.1126/science.3140379; BOSS MA, 1984, NUCLEIC ACIDS RES, V12, P3791, DOI 10.1093/nar/12.9.3791; BOULOT G, 1990, J MOL BIOL, V213, P617, DOI 10.1016/S0022-2836(05)80248-7; BRUGGEMANN M, 1982, EMBO J, V1, P629, DOI 10.1002/j.1460-2075.1982.tb01219.x; BRUGGEMANN M, 1987, J EXP MED, V166, P1351, DOI 10.1084/jem.166.5.1351; BRUGGEMANN M, 1989, J EXP MED, V170, P2153, DOI 10.1084/jem.170.6.2153; BRUGGEMANN M, 1989, P NATL ACAD SCI USA, V86, P6709, DOI 10.1073/pnas.86.17.6709; BYRN RA, 1990, NATURE, V344, P667, DOI 10.1038/344667a0; CABILLY S, 1989, GENE, V85, P553, DOI 10.1016/0378-1119(89)90451-4; CABILLY S, 1984, P NATL ACAD SCI-BIOL, V81, P3273, DOI 10.1073/pnas.81.11.3273; CARLSON JR, 1988, MOL CELL BIOL, V8, P2638, DOI 10.1128/MCB.8.6.2638; CASALI P, 1986, SCIENCE, V234, P476, DOI 10.1126/science.3020687; CATON AJ, 1990, P NATL ACAD SCI USA, V87, P6450, DOI 10.1073/pnas.87.16.6450; CHAUDHARY VK, 1989, NATURE, V339, P394, DOI 10.1038/339394a0; CHIANG YL, 1989, BIOTECHNIQUES, V7, P360; CHOTHIA C, 1989, NATURE, V342, P877, DOI 10.1038/342877a0; CHOTHIA C, 1988, NATURE, V333, P598, DOI 10.1038/333598a0; CLARK MR, 1987, J NATL CANCER I, V79, P1393; COVALL DG, 1986, CANCER RES, V46, P3969; Croonian lecture, 1900, P R SOC LOND, V66, P424, DOI [DOI 10.1098/RSPL.1899.0121, 10.1098/rspl.1899.0121]; DELAPAZ P, 1986, EMBO J, V5, P415, DOI 10.1002/j.1460-2075.1986.tb04227.x; DUNCAN AR, 1988, NATURE, V332, P738, DOI 10.1038/332738a0; DUNCAN AR, 1988, NATURE, V332, P563, DOI 10.1038/332563a0; EKINS R, 1989, NATURE, V340, P256, DOI 10.1038/340256a0; GHERARDI E, 1990, J IMMUNOL METHODS, V126, P61, DOI 10.1016/0022-1759(90)90012-K; GLOCKSHUBER R, 1990, BIOCHEMISTRY-US, V29, P1362, DOI 10.1021/bi00458a002; GRIFFITHS GM, 1984, NATURE, V312, P271, DOI 10.1038/312271a0; HALE G, 1988, LANCET, V2, P1394; HUDSON NW, 1987, J IMMUNOL, V139, P2715; HUSE WD, 1989, SCIENCE, V246, P1275, DOI 10.1126/science.2531466; HUSTON JS, 1988, P NATL ACAD SCI USA, V85, P5879, DOI 10.1073/pnas.85.16.5879; JONES PT, 1986, NATURE, V321, P522, DOI 10.1038/321522a0; Kabat E. A., 1987, SEQUENCES PROTEINS I, DOI 10.1016/0003-2697(84)90805-4; Knapp W., 1989, LEUCOCYTE TYPING 4 W; KOCKS C, 1989, ANNU REV IMMUNOL, V7, P537, DOI 10.1146/annurev.iy.07.040189.002541; KOHLER G, 1975, NATURE, V256, P52; LANZAVECCHIA A, 1987, J IMMUN, V131; LARRICK JW, 1989, BIOCHEM BIOPH RES CO, V160, P1250, DOI 10.1016/S0006-291X(89)80138-X; LARRICK JW, 1989, BIO-TECHNOL, V7, P934, DOI 10.1038/nbt0989-934; LARRICK JW, 1990, ICSU SHORT REP, V10, P93; LESK AM, 1982, SCIENCE, V216, P539, DOI 10.1126/science.7071602; LOBUGLIO AF, 1989, P NATL ACAD SCI USA, V86, P4220, DOI 10.1073/pnas.86.11.4220; LUGER K, 1989, SCIENCE, V243, P206, DOI 10.1126/science.2643160; MARQUART M, 1980, J MOL BIOL, V141, P369, DOI 10.1016/0022-2836(80)90252-1; MCCAFFERTY J, 1990, NATURE, V348, P552, DOI 10.1038/348552a0; MCCUNE JM, 1988, SCIENCE, V241, P1632, DOI 10.1126/science.2971269; MCKEAN D, 1984, P NATL ACAD SCI-BIOL, V81, P3180, DOI 10.1073/pnas.81.10.3180; MILSTEIN C, 1990, PROC R SOC SER B-BIO, V239, P1, DOI 10.1098/rspb.1990.0006; MILSTEIN C, 1983, NATURE, V305, P537, DOI 10.1038/305537a0; MOSIER DE, 1988, NATURE, V335, P257; NEUBERGER MS, 1985, NATURE, V314, P268, DOI 10.1038/314268a0; NEUBERGER MS, 1983, EMBO J, V2, P1373, DOI 10.1002/j.1460-2075.1983.tb01594.x; NEUBERGER MS, 1984, NATURE, V312, P604, DOI 10.1038/312604a0; OI VT, 1983, P NATL ACAD SCI-BIOL, V80, P825, DOI 10.1073/pnas.80.3.825; ORLANDI R, 1989, P NATL ACAD SCI USA, V86, P3833, DOI 10.1073/pnas.86.10.3833; PERELSON AS, 1989, IMMUNOL REV, V110, P5, DOI 10.1111/j.1600-065X.1989.tb00025.x; POLLACK SJ, 1986, SCIENCE, V234, P1570, DOI 10.1126/science.3787262; QUEEN C, 1989, P NATL ACAD SCI USA, V86, P10029, DOI 10.1073/pnas.86.24.10029; RADBRUCH A, 1986, HDB EXP IMMUN, V4; Reynaud C. A., 1989, Immunoglobulin genes., P151; RIECHMANN L, 1988, NATURE, V332, P323, DOI 10.1038/332323a0; RIECHMANN L, 1988, J MOL BIOL, V203, P825, DOI 10.1016/0022-2836(88)90214-8; ROBERTS S, 1987, NATURE, V328, P731, DOI 10.1038/328731a0; RODER JC, 1986, METHOD ENZYMOL, V121, P140; RODWELL JD, 1985, BIO-TECHNOL, V3, P889, DOI 10.1038/nbt1085-889; RUDIKOFF S, 1982, P NATL ACAD SCI-BIOL, V79, P1979, DOI 10.1073/pnas.79.6.1979; SASTRY L, 1989, P NATL ACAD SCI USA, V86, P5728, DOI 10.1073/pnas.86.15.5728; SAUL FA, 1978, J BIOL CHEM, V253, P585; SCHNEE JM, 1987, P NATL ACAD SCI USA, V84, P6904, DOI 10.1073/pnas.84.19.6904; SIlverstein AM., 1989, HIST IMMUNOLOGY; SKERRA A, 1988, SCIENCE, V240, P1038, DOI 10.1126/science.3285470; SURESH MR, 1986, METHOD ENZYMOL, V121, P210; SUTHERLAND R, 1987, CANCER RES, V47, P1627; TAUB R, 1989, J BIOL CHEM, V264, P259; TRAMONTANO A, 1986, SCIENCE, V234, P1566, DOI 10.1126/science.3787261; VANDERZEE JS, 1986, CLIN EXP IMMUNOL, V64, P415; VERHOEYEN M, 1988, SCIENCE, V239, P1534, DOI 10.1126/science.2451287; VITETTA ES, 1985, ANNU REV IMMUNOL, V3, P197; WARD ES, 1989, NATURE, V341, P544, DOI 10.1038/341544a0; WARD ES, 1989, PROGR IMMUNOLOGY, V7, P1144; WENGER TL, 1985, J AM COLL CARDIOL, V5, P118; WILLIAMS WV, 1989, P NATL ACAD SCI USA, V86, P5537, DOI 10.1073/pnas.86.14.5537; ZHU DZ, 1984, J EXP MED, V160, P971, DOI 10.1084/jem.160.4.971	90	840	1413	1	111	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JAN 24	1991	349	6307					293	299		10.1038/349293a0	http://dx.doi.org/10.1038/349293a0			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU501	1987490	Bronze			2022-12-28	WOS:A1991EU50100041
J	CHAO, NJ; DUNCAN, SR; LONG, GD; HORNING, SJ; BLUME, KG				CHAO, NJ; DUNCAN, SR; LONG, GD; HORNING, SJ; BLUME, KG			CORTICOSTEROID-THERAPY FOR DIFFUSE ALVEOLAR HEMORRHAGE IN AUTOLOGOUS BONE-MARROW TRANSPLANT RECIPIENTS	ANNALS OF INTERNAL MEDICINE			English	Note											CHAO, NJ (corresponding author), STANFORD UNIV, MED CTR, BONE MARROW TRANSPLANT PROGRAM, H-1353, STANFORD, CA 94305 USA.				NATIONAL CANCER INSTITUTE [P01CA049605] Funding Source: NIH RePORTER; NCI NIH HHS [CA 49605] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		JULES-ELYSEE K, 1990, American Review of Respiratory Disease, V141, pA604; KAHN FW, 1987, AM REV RESPIR DIS, V136, P155, DOI 10.1164/ajrccm/136.1.155; LEATHERMAN JW, 1984, MEDICINE, V63, P343, DOI 10.1097/00005792-198411000-00002; ROBBINS RA, 1989, AM J MED, V87, P511	4	77	79	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 15	1991	114	2					145	146		10.7326/0003-4819-114-2-145	http://dx.doi.org/10.7326/0003-4819-114-2-145			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ER534	1984392				2022-12-28	WOS:A1991ER53400010
J	WIERSINGA, WM; TRIP, MD; VANBEEREN, MH; PLOMP, TA; OOSTING, H				WIERSINGA, WM; TRIP, MD; VANBEEREN, MH; PLOMP, TA; OOSTING, H			AN INCREASE IN PLASMA-CHOLESTEROL INDEPENDENT OF THYROID-FUNCTION DURING LONG-TERM AMIODARONE THERAPY - A DOSE-DEPENDENT RELATIONSHIP	ANNALS OF INTERNAL MEDICINE			English	Article							THYROTROPIN SECRETION; HORMONE METABOLISM; RAT MYOCARDIUM; SERUM-LIPIDS; DESETHYLAMIODARONE; THYROXINE; PITUITARY; TRIIODOTHYRONINE; DRUG; ELEVATION	Objective: To determine whether long-term amiodarone treatment is associated with a rise in plasma cholesterol, and, if so, to analyze its relation with thyroid function. Design: Consecutive entry trial, including cardiac patients who initiated amiodarone medication but excluding those with abnormal thyroid function (defined as peak thyroid-stimulating hormone [TSH] response to thyrotropin-releasing hormone [TRH] < 2.8 or > 22.0 mU/L) either before or during amiodarone treatment. Patients: Twenty-three patients who remained euthyroid were studied. Intervention: Oral administration of amiodarone (mean duration of treatment, 17 months; range, 6 to 30 months). Measurements: Fasting plasma lipids, thyroid hormones, and peak TSH to TRH values were recorded before and every 6 months during amiodarone treatment. Results: Plasma cholesterol gradually increased from 5.1 +/- 0.2 mmol/L before treatment to 6.9 +/- 0.8 mmol/L after 30 months of amiodarone medication (P < 0.001); the peak TSH response to TRH did not change. When age- and sex-specific reference values were applied, 30% of the patients had cholesterol values above the 75th percentile before treatment; this number rose to 69% after 2 years of treatment. The rise in plasma cholesterol was associated with an equal increase in apoprotein B. Plasma cholesterol was not related to the daily dose of amiodarone or to plasma concentrations of amiodarone, desethylamiodarone, thyroxine (T4), triiodothyronine (T3), or reverse triiodothyronine (rT3). Linear regression analysis indicated a positive relation between plasma cholesterol and the cumulative dose of amiodarone (r = 0.25, P < 0.05). Conclusion: Long-term amiodarone treatment is associated with a dose-dependent increase in plasma cholesterol that is independent of thyroid function.	NETHERLANDS INST DRUGS & DOPING RES, UTRECHT, NETHERLANDS		WIERSINGA, WM (corresponding author), UNIV AMSTERDAM, ACAD MED CENTRUM F5258, DEPT ENDOCRINOL, MEIBERGDREEF 9, 1105 AZ AMSTERDAM, NETHERLANDS.							ADAMS PC, 1985, CIRCULATION, V72, P1064, DOI 10.1161/01.CIR.72.5.1064; ALBERS JJ, 1989, CLIN LAB MED, V9, P137, DOI 10.1016/S0272-2712(18)30646-2; ALBERT SG, 1987, J AM COLL CARDIOL, V9, P175, DOI 10.1016/S0735-1097(87)80098-0; BURGER A, 1976, J CLIN INVEST, V58, P255, DOI 10.1172/JCI108466; CEPPI JA, 1989, J ENDOCRINOL, V121, P431, DOI 10.1677/joe.0.1210431; DEBBAS NMG, 1983, EUR J CLIN INVEST, V13, P123, DOI 10.1111/j.1365-2362.1983.tb00076.x; FALIK R, 1987, AM J MED, V82, P1102, DOI 10.1016/0002-9343(87)90211-7; FRANKLYN JA, 1989, CLIN SCI, V76, P463, DOI 10.1042/cs0760463; FRANKLYN JA, 1987, CLIN ENDOCRINOL, V27, P373, DOI 10.1111/j.1365-2265.1987.tb01164.x; FREEDBERG AS, 1970, J PHYSIOL-LONDON, V207, P357, DOI 10.1113/jphysiol.1970.sp009066; HARTONG R, 1989, NUCLEAR THYROID HORM, P51; HOLT DW, 1983, AM HEART J, V106, P840, DOI 10.1016/0002-8703(83)90006-6; KANNAN R, 1982, ATHEROSCLEROSIS, V44, P19, DOI 10.1016/0021-9150(82)90049-1; KASIM SE, 1987, ENDOCRINOLOGY, V120, P1991, DOI 10.1210/endo-120-5-1991; KATO R, 1988, AM HEART J, V115, P351, DOI 10.1016/0002-8703(88)90481-4; KRONE W, 1988, AM HEART J, V116, P1729, DOI 10.1016/0002-8703(88)90222-0; LAMBERT M, 1988, ACTA ENDOCRINOL-COP, V118, P449, DOI 10.1530/acta.0.1180449; LATHAM KR, 1987, J AM COLL CARDIOL, V9, P872, DOI 10.1016/S0735-1097(87)80244-9; LINDENMEYER M, 1984, BRIT J PHARMACOL, V82, P275, DOI 10.1111/j.1476-5381.1984.tb16468.x; MEESE R, 1985, AM J CARDIOL, V55, P849, DOI 10.1016/0002-9149(85)90173-0; MELMED S, 1981, J CLIN ENDOCR METAB, V53, P997, DOI 10.1210/jcem-53-5-997; NORMAN MF, 1989, J CLIN INVEST, V83, P306, DOI 10.1172/JCI113874; OREILLY DS, 1988, J ENDOCRINOL, V118, P349, DOI 10.1677/joe.0.1180349; PLOMP TA, 1983, J CHROMATOGR, V273, P379, DOI 10.1016/S0378-4347(00)80958-5; POLLAK PT, 1988, AM J CARDIOL, V62, P562, DOI 10.1016/0002-9149(88)90655-8; PRITCHARD DA, 1975, BRIT HEART J, V37, P856; RIFKIND BM, 1983, JAMA-J AM MED ASSOC, V250, P1869, DOI 10.1001/jama.250.14.1869; SAFRAN M, 1986, AM J MED SCI, V292, P136, DOI 10.1097/00000441-198609000-00003; SILVA JE, 1978, J CLIN INVEST, V61, P1247, DOI 10.1172/JCI109041; SINGH BN, 1989, PROG CARDIOVASC DIS, V31, P249, DOI 10.1016/0033-0620(89)90033-9; SINGH BN, 1970, BRIT J PHARMACOL, V39, P657, DOI 10.1111/j.1476-5381.1970.tb09891.x; SONNENBLICK M, 1986, CARDIOLOGY, V73, P147, DOI 10.1159/000173998; STAUBLI M, 1981, SCHWEIZ MED WSCHR, V111, P1590; WIEGAND V, 1986, BASIC RES CARDIOL, V81, P482, DOI 10.1007/BF01907754; WIERSINGA WM, 1982, METHOD ENZYMOL, V84, P272; WIERSINGA WM, 1986, POSTGRAD MED J, V62, P909, DOI 10.1136/pgmj.62.732.909; WIERSINGA WM, 1980, NETH J MED, V23, P162	37	20	21	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 15	1991	114	2					128	132		10.7326/0003-4819-114-2-128	http://dx.doi.org/10.7326/0003-4819-114-2-128			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ER534	1984387				2022-12-28	WOS:A1991ER53400005
J	KOZLOWSKI, S; TAKESHITA, T; BOEHNCKE, WH; TAKAHASHI, H; BOYD, LF; GERMAIN, RN; BERZOFSKY, JA; MARGULIES, DH				KOZLOWSKI, S; TAKESHITA, T; BOEHNCKE, WH; TAKAHASHI, H; BOYD, LF; GERMAIN, RN; BERZOFSKY, JA; MARGULIES, DH			EXCESS BETA-2 MICROGLOBULIN PROMOTING FUNCTIONAL PEPTIDE ASSOCIATION WITH PURIFIED SOLUBLE CLASS-I MHC MOLECULES	NATURE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; TOXIC LYMPHOCYTES-T; ENVELOPE PROTEIN; CELL HYBRIDOMAS; ANTIGEN; HLA; BETA-2-MICROGLOBULIN; RECOGNITION; H-2; DISSOCIATION	T LYMPHOCYTES expressing alpha-beta-receptors recognize antigenic peptide fragments bound to major histocompatibility complex class I (ref. 1) or class II (ref. 2) molecules present on the surface membranes of other cells. Peptide fragments are present in the two available HLA crystal structures3,4 and recent data indicate that peptide is required for the stable folding of the class I heavy chain and maintenance of its association with the class I light chain beta-2-microglobulin (beta-2-m), at physiological temperature5-7. To explain how the exogeneous peptide used to create targets for cytotoxic cells bearing CD8 antigen1 could associate with apparently peptide-filled extracellular class I molecules, we hypothesized that stable binding of exogenous peptide to mature class I molecules reflects either the replacement of previously bound peptide during the well documented beta-2m exchange process8 or the loading of 'empty' class I heavy chains dependent on the availability of excess beta-2m. In either case, free beta-2m should enhance peptide-class I binding. Using either isolated soluble class I molecules or living cells, we show here that free purified beta-2m markedly augments the generation of antigenic complexes capable of T-cell stimulation.	NIAID,IMMUNOL LAB,LYMPHOCYTE BIOL SECT,BETHESDA,MD 20892; NCI,METAB BRANCH,MOLEC IMMUNOGENET & VACCINE RES SECT,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	KOZLOWSKI, S (corresponding author), NIAID,IMMUNOL LAB,MOLEC BIOL SECT,BETHESDA,MD 20892, USA.		Germain, Ronald/ABE-7090-2020; Germain, Ronald N./Z-1945-2019	Margulies, David/0000-0001-8530-7375				ASHWELL JD, 1987, J EXP MED, V165, P173, DOI 10.1084/jem.165.1.173; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; CEASE KB, 1987, P NATL ACAD SCI USA, V84, P4249, DOI 10.1073/pnas.84.12.4249; GARRETT TPJ, 1989, NATURE, V342, P692, DOI 10.1038/342692a0; HOCHMAN JH, 1988, J IMMUNOL, V140, P2322; HYAFIL F, 1979, P NATL ACAD SCI USA, V76, P5834, DOI 10.1073/pnas.76.11.5834; KANE KP, 1989, NATURE, V340, P157, DOI 10.1038/340157a0; KAPPLER JW, 1981, J EXP MED, V153, P1198, DOI 10.1084/jem.153.5.1198; LJUNGGREN HG, 1990, NATURE, V346, P476, DOI 10.1038/346476a0; MARGULIES DH, 1986, P NATL ACAD SCI USA, V83, P5252, DOI 10.1073/pnas.83.14.5252; MCCLUSKEY J, 1988, J IMMUNOL, V141, P1451; PARHAM P, 1983, HUM IMMUNOL, V8, P207, DOI 10.1016/0198-8859(83)90038-1; PARKER KC, 1985, BIOCHEMISTRY-US, V24, P5543, DOI 10.1021/bi00341a039; ROCK KL, 1990, P NATL ACAD SCI USA, V87, P7517, DOI 10.1073/pnas.87.19.7517; SCHUMACHER TNM, 1990, CELL, V62, P563, DOI 10.1016/0092-8674(90)90020-F; SCHWARTZ RH, 1985, ANNU REV IMMUNOL, V3, P237, DOI 10.1146/annurev.iy.03.040185.001321; TAKAHASHI H, 1989, J EXP MED, V170, P2023, DOI 10.1084/jem.170.6.2023; TAKAHASHI H, 1988, P NATL ACAD SCI USA, V85, P3105, DOI 10.1073/pnas.85.9.3105; TOWNSEND A, 1990, CELL, V62, P285, DOI 10.1016/0092-8674(90)90366-M; TOWNSEND A, 1989, NATURE, V340, P443, DOI 10.1038/340443a0; TOWNSEND ARM, 1986, CELL, V44, P959, DOI 10.1016/0092-8674(86)90019-X; WARD PJ, 1983, IMMUNOLOGY, V48, P87; WHITE J, 1989, J IMMUNOL, V143, P1822	23	151	164	0	0	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JAN 3	1991	349	6304					74	77		10.1038/349074a0	http://dx.doi.org/10.1038/349074a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EQ601	1985269				2022-12-28	WOS:A1991EQ60100055
J	WEBER, R; LEDERGERBER, B; OPRAVIL, M; SIEGENTHALER, W; LUTHY, R				WEBER, R; LEDERGERBER, B; OPRAVIL, M; SIEGENTHALER, W; LUTHY, R			PROGRESSION OF HIV-INFECTION IN MISUSERS OF INJECTED DRUGS WHO STOP INJECTING OR FOLLOW A PROGRAM OF MAINTENANCE TREATMENT WITH METHADONE	BRITISH MEDICAL JOURNAL			English	Article							HUMAN IMMUNODEFICIENCY VIRUS; CYTOMEGALO-VIRUS; AIDS; USERS; COHORT; CELLS	Objective - To see whether misusers of injected drugs who stop injecting or switch to a programme of maintenance treatment with methadone have a reduced risk of progression of HIV infection when compared with a group of persistent misusers. Design - Observational cohort study in HIV seropositive subjects with a group of current or past history of misusing injected drugs. Setting - HIV outpatient clinic at the University Hospital of Zurich, Switzerland. Patients - 297 Current and former parenteral drug misusers (median age 27) with asymptomatic HIV infection. During the observation period 80 subjects adhered to a programme of maintenance treatment with methadone, 124 continued with parenteral drug misuse, and 93 former misusers remained free of illicit drugs. No antiretroviral treatment was given during the study. Main outcome measures - Probability of progression of HIV infection from asymptomatic to symptomatic (Centers for Disease Control stage IV) as calculated by life table analysis and compared in the three groups of patients by means of a log rank test, and predictors of disease progression as analysed with a Cox proportional hazards regression model. Results - The 297 patients were followed up for a median of 16 months. The median duration of injecting drug misuse before enrolment was 7.1 years. There were no significant differences among the three groups with respect to CD4+ counts at the beginning of the study (median 0.44 x 10(9)/1). Life table analysis showed a significantly lower probability of progression of HIV disease in both the methadone treated group and former drug misusers than in persistent injecting drug misusers. Multivariate regression analysis showed a relative risk of progression of the disease of 1.78 (95% confidence interval 1.20 to 2.67; p < 0.01) in persistent injecting drug misusers, 0.48 (0.29 to 0.77; p < 0.01) in the methadone treated group, and 0.66 (0.41 to 1.06; p = 0.085) in former drug misusers. Conclusions - Stopping the misuse of injected drugs shows the progression of HIV disease in infected subjects. Drug treatment programmes are effective in secondary prevention of HIV associated morbidity.	UNIV HOSP ZURICH,DEPT MED,DIV INFECT DIS,CH-8091 ZURICH,SWITZERLAND	University of Zurich; University Zurich Hospital			Ledergerber, Bruno/B-5656-2009; Weber, Rainer/D-5175-2012	Ledergerber, Bruno/0000-0002-6881-4401; 				BONETTI A, 1989, ANN INTERN MED, V111, P293, DOI 10.7326/0003-4819-111-4-293; BRICKNER PW, 1989, ANN INTERN MED, V110, P833, DOI 10.7326/0003-4819-110-10-833; COOPER JR, 1989, JAMA-J AM MED ASSOC, V262, P1664, DOI 10.1001/jama.262.12.1664; DAVIS MG, 1987, P NATL ACAD SCI USA, V84, P8642, DOI 10.1073/pnas.84.23.8642; DEWOLF F, 1988, J INFECT DIS, V158, P615, DOI 10.1093/infdis/158.3.615; FAUCI AS, 1988, SCIENCE, V239, P617, DOI 10.1126/science.3277274; FINNEGAN LD, 1983, RES TREATMENT NARCOT, P392; GOEDERT JJ, 1988, AIDS ETIOLOGY DIAGNO, P33; GOEDERT JJ, 1988, BMJ, V296, P745; HUBBARD RL, 1988, REV INFECT DIS, V10, P377; JARLAIS DCD, 1987, AIDS, V1, P105; JARLAIS DCD, 1989, JAMA-J AM MED ASSOC, V261, P1008; KASLOW RA, 1989, JAMA-J AM MED ASSOC, V261, P3424, DOI 10.1001/jama.261.23.3424; KLEBER HF, 1980, MED EVALUATION LONGT; Kreek M. J., 1983, RES TREATMENT NARCOT, P456; SKOLNIK PR, 1988, J INFECT DIS, V157, P508, DOI 10.1093/infdis/157.3.508; SORENSEN JL, 1989, 5 INT C IDS MONTR, P707; ZAGURY D, 1986, SCIENCE, V231, P850, DOI 10.1126/science.2418502; 1989, MMWR, V38, P369; 1987, MMWR S2S, V36, pS1	20	83	84	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	DEC 15	1990	301	6765					1362	1365		10.1136/bmj.301.6765.1362	http://dx.doi.org/10.1136/bmj.301.6765.1362			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EN919	1980219	Green Published, Bronze			2022-12-28	WOS:A1990EN91900022
J	OWENS, JE; COOK, EW; STEVENSON, I				OWENS, JE; COOK, EW; STEVENSON, I			FEATURES OF NEAR-DEATH EXPERIENCE IN RELATION TO WHETHER OR NOT PATIENTS WERE NEAR DEATH	LANCET			English	Editorial Material											OWENS, JE (corresponding author), UNIV VIRGINIA, HLTH SCI CTR, DIV PERSONAL STUDIES, BOX 152, CHARLOTTESVILLE, VA 22908 USA.							APPLEBY L, 1989, BRIT MED J, V298, P975, DOI 10.1136/bmj.298.6679.976; BLACHER RS, 1979, JAMA-J AM MED ASSOC, V242, P2291, DOI 10.1001/jama.242.21.2291; CARR D.B., 1982, J NEAR DEATH STUDIES, VII, P75; DENT JM, 1910, BEDE ECCLESIASTICAL, P132; DENT JM, 1937, PLATO REPUBLIC, V10, P318; DEQUINCEY T, 1902, CONFESSIONS ENGLISH, P252; FRIENDLY A, 1977, BEAUFORT ADMIRALTY L, P47; GABBARD GO, 1981, J NERV MENT DIS, V169, P374, DOI 10.1097/00005053-198106000-00006; Geddes Auckland, 1937, Edinb Med J, V44, P365; GREYSON B, 1980, AM J PSYCHIAT, V137, P1193; Heim A., 1892, JB SCHWEIZER ALPENCL, V27, P327; JANSEN K, 1989, BRIT MED J, V298, P1708, DOI 10.1136/bmj.298.6689.1708-b; JUDSON IR, 1983, LANCET, V2, P561; MORSE M, 1985, AM J DIS CHILD, V139, P595, DOI 10.1001/archpedi.1985.02140080065034; MORSE M, 1986, AM J DIS CHILD, V140, P1110, DOI 10.1001/archpedi.1986.02140250036031; Morse M., 1989, J NEAR DEATH STUDIES, V8, P45, DOI [10.1007/BF01076138, DOI 10.1007/BF01076138]; Myers F. W. H., 1892, P SOC PSYCHICAL RES, V8, P170; NOYES R, 1976, OMEGA-J DEATH DYING, V7, P103, DOI 10.2190/7QET-2VAU-YCDT-TJ9R; RING K, 1980, LIFE AT DEATH; ROBERTS G, 1988, BRIT J PSYCHIAT, V153, P607, DOI 10.1192/bjp.153.5.607; RODIN EA, 1980, J NERV MENT DIS, V168, P259, DOI 10.1097/00005053-198005000-00001; Sabom M. B., 1982, RECOLLECTIONS DEATH; STEVENSON I, 1989, OMEGA-J DEATH DYING, V20, P45, DOI 10.2190/D8Q9-HHKX-5JWC-FD3V; WALKER FO, 1989, JAMA-J AM MED ASSOC, V261, P3245, DOI 10.1001/jama.1989.03420220059024	24	65	67	0	18	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 10	1990	336	8724					1175	1177		10.1016/0140-6736(90)92780-L	http://dx.doi.org/10.1016/0140-6736(90)92780-L			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG701	1978037				2022-12-28	WOS:A1990EG70100014
J	HATTA, K; SCHILLING, TF; BREMILLER, RA; KIMMEL, CB				HATTA, K; SCHILLING, TF; BREMILLER, RA; KIMMEL, CB			SPECIFICATION OF JAW MUSCLE IDENTITY IN ZEBRAFISH - CORRELATION WITH ENGRAILED-HOMEOPROTEIN EXPRESSION	SCIENCE			English	Article											HATTA, K (corresponding author), UNIV OREGON,INST NEUROSCI,EUGENE,OR 97403, USA.				NICHD NIH HHS [HD22486] Funding Source: Medline; NINDS NIH HHS [NS17963] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD022486] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017963] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BRIVANLOU AH, 1989, DEVELOPMENT, V106, P611; DAVIDSON D, 1988, DEVELOPMENT, V104, P305; DAVIS CA, 1988, GENE DEV, V2, P361, DOI 10.1101/gad.2.3.361; FJOSE A, 1988, FEBS LETT, V231, P355, DOI 10.1016/0014-5793(88)80849-4; GARDNER CA, 1988, J NEUROSCI RES, V21, P426, DOI 10.1002/jnr.490210234; HANNEMAN E, 1988, DEVELOPMENT, V103, P49; HEATON MB, 1986, J COMP NEUROL, V243, P381, DOI 10.1002/cne.902430308; HOLLAND PWH, 1988, GENE DEV, V2, P773, DOI 10.1101/gad.2.7.773; INGHAM PW, 1988, NATURE, V335, P25, DOI 10.1038/335025a0; Jarvik E., 1980, BASIC STRUCTURE EVOL, V1; JOYNER AL, 1989, NATURE, V338, P153, DOI 10.1038/338153a0; KIMMEL CB, 1990, DEVELOPMENT, V108, P581; LANDMESSER LT, 1980, ANNU REV NEUROSCI, V3, P279, DOI 10.1146/annurev.ne.03.030180.001431; METCALFE WK, 1985, J COMP NEUROL, V238, P218, DOI 10.1002/cne.902380208; MOODY SA, 1989, J COMP NEUROL, V283, P38, DOI 10.1002/cne.902830105; MURPHY P, 1989, NATURE, V341, P156, DOI 10.1038/341156a0; NJOLSTAD PR, 1988, BIOCHEM BIOPH RES CO, V157, P426, DOI 10.1016/S0006-291X(88)80266-3; NODEN DM, 1983, AM J ANAT, V168, P257, DOI 10.1002/aja.1001680302; PATEL NH, 1989, CELL, V58, P955, DOI 10.1016/0092-8674(89)90947-1; STREISINGER G, 1981, NATURE, V291, P293, DOI 10.1038/291293a0; TREVARROW B, 1990, NEURON, V4, P669, DOI 10.1016/0896-6273(90)90194-K; WILKINSON DG, 1989, NATURE, V341, P405, DOI 10.1038/341405a0; WILKINSON DG, 1989, NATURE, V337, P461, DOI 10.1038/337461a0; [No title captured]	24	88	89	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 9	1990	250	4982					802	805		10.1126/science.1978412	http://dx.doi.org/10.1126/science.1978412			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG883	1978412				2022-12-28	WOS:A1990EG88300034
J	DEOLIVEIRA, MSP; MATUTES, E; FAMADAS, LC; SCHULZ, TF; CALABRO, ML; NUCCI, M; ANDRADASERPA, MJ; TEDDER, RS; WEISS, RA; CATOVSKY, D				DEOLIVEIRA, MSP; MATUTES, E; FAMADAS, LC; SCHULZ, TF; CALABRO, ML; NUCCI, M; ANDRADASERPA, MJ; TEDDER, RS; WEISS, RA; CATOVSKY, D			ADULT T-CELL LEUKEMIA LYMPHOMA IN BRAZIL AND ITS RELATION TO HTLV-1	LANCET			English	Article									ROYAL MARSDEN HOSP, INST CANC RES, ACAD DEPT HAEMATOL & CYTOGENET, FULHAM RD, LONDON SW3 6JJ, ENGLAND; INST NACL CANC, RIO DE JANEIRO, BRAZIL; HOSP UNIV FUNDAO, RIO DE JANEIRO, BRAZIL; UNIV COLL & MIDDLESEX SCH MED, VIROL MED MICROBIOL SECT, LONDON, ENGLAND	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; National Cancer Institute (Inca); University of London; University College London			Nucci, Marcio/G-4515-2012; Pombo-de-Oliveira, Maria S./I-8884-2014; Schulz, Thomas/AAA-1634-2019; Calabrò, Maria Luisa/H-6015-2016	Nucci, Marcio/0000-0003-4867-0014; Pombo-de-Oliveira, Maria S./0000-0002-1507-004X; Calabrò, Maria Luisa/0000-0001-9401-6182; Tedder, Richard/0000-0002-9672-5721; Schulz, Thomas/0000-0001-8792-5345				ANDRADASERPA MJ, 1989, INT J CANCER, V44, P389, DOI 10.1002/ijc.2910440302; BLATTNER WA, 1982, INT J CANCER, V30, P257, DOI 10.1002/ijc.2910300302; BLAYNEY DW, 1983, ANN INTERN MED, V98, P144, DOI 10.7326/0003-4819-98-2-144; BRINDLE RJ, 1988, EPIDEMIOL INFECT, V100, P153, DOI 10.1017/S095026880006564X; BUNN PA, 1983, NEW ENGL J MED, V309, P257, DOI 10.1056/NEJM198308043090501; CARTIERROVIROSA L, 1989, LANCET, V1, P556; CATOVSKY D, 1982, LANCET, V1, P639; CORTES E, 1989, NEW ENGL J MED, V320, P953, DOI 10.1056/NEJM198904133201501; DELAPORTE E, 1988, INT J CANCER, V42, P687, DOI 10.1002/ijc.2910420509; FLEMING AF, 1986, INT J CANCER, V38, P809, DOI 10.1002/ijc.2910380605; GESSAIN A, 1985, LANCET, V2, P407; KITAGAWA T, 1986, JAMA-J AM MED ASSOC, V256, P2342, DOI 10.1001/jama.1986.03380170058009; LEE H, 1989, SCIENCE, V244, P471, DOI 10.1126/science.2655084; LEE H, 1989, BLOOD, V73, P1742; MATUJTES E, 1985, RETROVIRUS HUMAN LYM, P59; MATUTES E, 1986, INT J CANCER, V38, P41, DOI 10.1002/ijc.2910380108; Montserrat E, 1989, Leuk Lymphoma, V1, P47, DOI 10.3109/10428198909042458; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SEIKI M, 1984, NATURE, V309, P640, DOI 10.1038/309640a0; SEIKI M, 1983, P NATL ACAD SCI-BIOL, V80, P3618, DOI 10.1073/pnas.80.12.3618; SHIMOYAMA M, 1986, P NATL ACAD SCI USA, V83, P4524, DOI 10.1073/pnas.83.12.4524; TAJIMAN K, 1989, CANCER MTASTAS REV, V7, P223; TANNIR N, 1985, CANCER, V55, P615, DOI 10.1002/1097-0142(19850201)55:3<615::AID-CNCR2820550323>3.0.CO;2-X; UCHIYAMA T, 1977, BLOOD, V50, P481, DOI 10.1182/blood.V50.3.481.481; VILMER E, 1985, LANCET, V2, P1301; WEBER JN, 1989, J INFECT DIS, V159, P1025, DOI 10.1093/infdis/159.6.1025; WONGSTAAL F, 1983, NATURE, V302, P626, DOI 10.1038/302626a0; YAMAGUCHI K, 1984, BLOOD, V63, P1235; ZANINOVIC V, 1990, NATURE, V344, P299, DOI 10.1038/344299b0	29	60	63	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 20	1990	336	8721					987	990		10.1016/0140-6736(90)92432-H	http://dx.doi.org/10.1016/0140-6736(90)92432-H			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ED601	1977015				2022-12-28	WOS:A1990ED60100014
J	THOMPSON, WG				THOMPSON, WG			COMPLIANCE AND CLINICAL-TRIALS IN HEART-DISEASE	LANCET			English	Letter											THOMPSON, WG (corresponding author), UNIV TENNESSEE,MED CTR,DEPT MED,KNOXVILLE,TN 37920, USA.							DiMatteo MR, 1982, ACHIEVING PATIENT CO; HORWITZ, 1990, LANCET, V336, P542; RUBERMAN W, 1984, NEW ENGL J MED, V311, P522; 1980, NEW ENGL J MED, V303, P1038; 1984, JAMA-J AM MED ASSOC, V251, P365	5	0	0	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 20	1990	336	8721					1002	1003		10.1016/0140-6736(90)92461-P	http://dx.doi.org/10.1016/0140-6736(90)92461-P			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ED601	1976979				2022-12-28	WOS:A1990ED60100028
J	GROVER, LM; TEYLER, TJ				GROVER, LM; TEYLER, TJ			2 COMPONENTS OF LONG-TERM POTENTIATION INDUCED BY DIFFERENT PATTERNS OF AFFERENT ACTIVATION	NATURE			English	Article											GROVER, LM (corresponding author), NORTHEASTERN OHIO UNIV,COLL MED,DEPT NEUROBIOL,ROOTSTOWN,OH 44272, USA.							ARTOLA A, 1987, NATURE, V330, P649, DOI 10.1038/330649a0; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P357, DOI 10.1113/jphysiol.1973.sp010274; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; CORTES R, 1983, NEUROSCI LETT, V42, P249, DOI 10.1016/0304-3940(83)90270-7; DOLPHIN AC, 1982, NATURE, V297, P496, DOI 10.1038/297496a0; GROVER LM, 1990, BRAIN RES, V506, P53, DOI 10.1016/0006-8993(90)91198-P; HARRIS EW, 1986, NEUROSCI LETT, V70, P132, DOI 10.1016/0304-3940(86)90451-9; HARRIS EW, 1984, BRAIN RES, V323, P132, DOI 10.1016/0006-8993(84)90275-0; JONES RSG, 1987, BRAIN RES, V416, P257; KUBA K, 1990, PROG NEUROBIOL, V34, P197, DOI 10.1016/0301-0082(90)90012-6; LANCASTER B, 1987, J PHYSIOL-LONDON, V389, P187, DOI 10.1113/jphysiol.1987.sp016653; LYNCH G, 1983, NATURE, V305, P7719; MADISON DV, 1984, J PHYSIOL-LONDON, V354, P319, DOI 10.1113/jphysiol.1984.sp015378; MAYER ML, 1984, J PHYSIOL-LONDON, V354, P29, DOI 10.1113/jphysiol.1984.sp015360; MIDDLEMISS DN, 1985, NATURE, V314, P94, DOI 10.1038/314094a0; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; MULKEEN D, 1987, NEUROSCI LETT, V80, P351, DOI 10.1016/0304-3940(87)90481-2; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; RAGEHR WG, 1989, NATURE, V341, P533; RANE SG, 1987, PFLUG ARCH EUR J PHY, V409, P361, DOI 10.1007/BF00583789; TAUBE JS, 1986, BRAIN RES, V379, P275, DOI 10.1016/0006-8993(86)90781-X; TELER TJ, 1984, BRAIN RES REV, V7, P15; TEYLER TJ, 1987, ANNU REV NEUROSCI, V10, P131, DOI 10.1146/annurev.ne.10.030187.001023; TEYLER TJ, 1980, BRAIN RES BULL, V5, P391, DOI 10.1016/S0361-9230(80)80009-8; TSIEN RY, 1980, BIOCHEMISTRY-US, V19, P2396, DOI 10.1021/bi00552a018	26	587	593	0	14	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	OCT 4	1990	347	6292					477	479		10.1038/347477a0	http://dx.doi.org/10.1038/347477a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB446	1977084				2022-12-28	WOS:A1990EB44600072
J	SWIFT, RG; SADLER, DB; SWIFT, M				SWIFT, RG; SADLER, DB; SWIFT, M			PSYCHIATRIC FINDINGS IN WOLFRAM SYNDROME HOMOZYGOTES	LANCET			English	Article									UNIV N CAROLINA,BIOL SCI RES CTR,CHAPEL HILL,NC 27599; UNIV N CAROLINA,DEPT PSYCHIAT,CHAPEL HILL,NC 27599; UNIV N CAROLINA,DEPT MED,CHAPEL HILL,NC 27599	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill					EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003110] Funding Source: NIH RePORTER; NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [R01AM028135] Funding Source: NIH RePORTER; NIADDK NIH HHS [AM28135] Funding Source: Medline; NICHD NIH HHS [HD 03110] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ABBOTT MH, 1987, AM J MED GENET, V26, P959, DOI 10.1002/ajmg.1320260427; BALE AE, 1985, AM J MED GENET, V20, P733, DOI 10.1002/ajmg.1320200420; BRETZ GW, 1970, AM J MED, V48, P398, DOI 10.1016/0002-9343(70)90071-9; CREMERS C W R J, 1977, Acta Paediatrica Scandinavica Supplement, P1; DAMASKE MM, 1975, J PEDIATR OPHTHALMOL, V12, P16; GOSSAIN VV, 1975, J CLIN ENDOCR METAB, V41, P1020, DOI 10.1210/jcem-41-6-1020; GREGORIOS JB, 1989, J NEUROPATH EXP NEUR, V48, P308, DOI 10.1097/00005072-198905000-00028; HOMAN MR, 1987, DIABETES CARE, V10, P664, DOI 10.2337/diacare.10.5.664; KHARDORI R, 1983, DIABETES CARE, V6, P67, DOI 10.2337/diacare.6.1.67; LESSELL S, 1977, ARCH NEUROL-CHICAGO, V34, P759, DOI 10.1001/archneur.1977.00500240047008; MARQUARDT JL, 1974, ARCH INTERN MED, V134, P32, DOI 10.1001/archinte.134.1.32; MEDELIA A, 1989, AM J PSYCHIAT, V146, P662; MORRELL D, 1986, J NATL CANCER I, V77, P89; MUDD SH, 1985, AM J HUM GENET, V37, P1; PILLEY SFJ, 1976, BRIT J OPHTHALMOL, V60, P294, DOI 10.1136/bjo.60.4.294; RAHMAN M, 1972, BR J OPHTHALMOL, V55, P338; ROSE FC, 1966, Q J MED, V35, P385; SCHIMKE RN, 1965, JAMA-J AM MED ASSOC, V193, P87; SCHOENFELD M, 1984, J NEUROL NEUROSUR PS, V47, P1283, DOI 10.1136/jnnp.47.12.1283; STANLEY CA, 1979, NEW ENGL J MED, V301, P1398; SUNDER JH, 1972, J MED GENET, V9, P408, DOI 10.1136/jmg.9.4.408; TUNBRIDGE RE, 1956, DIABETES, V5, P295, DOI 10.2337/diab.5.4.295; Wolfram D.J., 1938, MAYO CLIN PROC, V13, P715	23	137	142	2	4	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	SEP 15	1990	336	8716					667	669		10.1016/0140-6736(90)92157-D	http://dx.doi.org/10.1016/0140-6736(90)92157-D			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DY737	1975860				2022-12-28	WOS:A1990DY73700011
J	FLETCHER, JA; KOZAKEWICH, HP; HOFFER, FA; LAGE, JM; WEIDNER, N; TEPPER, R; PINKUS, GS; MORTON, CC; CORSON, JM				FLETCHER, JA; KOZAKEWICH, HP; HOFFER, FA; LAGE, JM; WEIDNER, N; TEPPER, R; PINKUS, GS; MORTON, CC; CORSON, JM			DIAGNOSTIC RELEVANCE OF CLONAL CYTOGENETIC ABERRATIONS IN MALIGNANT SOFT-TISSUE TUMORS	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHROMOSOME-ABNORMALITIES; EWINGS-SARCOMA; SOLID TUMORS; RHABDOMYOSARCOMA; TRANSLOCATION; EXPERIENCE; CHILDHOOD; LEUKEMIA	Background. Malignant soft-tissue tumors often present substantial diagnostic challenges. Chromosome aberrations that might be diagnostic have been identified in some types of soft-tissue tumors, but the overall frequency and diagnostic relevance of these aberrations have not been established. Methods. We attempted to determine the karyotypes of a series of 62 consecutive, unselected malignant spindle-cell or small round-cell soft-tissue tumors (from 46 adults and 16 children) after direct harvesting of cells or short-term culture. All tumors were examined independently by immunohistochemical staining in addition to routine light-microscopical evaluation, and all but two tumors were examined by electron microscopy. Results. Metaphases were obtained from 61 of the 62 tumors, and clonal chromosome aberrations were identified in 55 (89 percent). In the six tumors that yielded metaphases but lacked apparent clonal aberrations, the normal metaphases were found to originate from non-neoplastic stromal elements within the tumor specimens. Thus, all tumors in which karyotyping was successful contained clonal chromosome aberrations. Forty of 62 tumors (65 percent) contained clonal chromosome aberrations that either suggested or confirmed a specific diagnosis; in 15 of these tumors (24 percent of all tumors), the aberrations were important in establishing the final diagnosis. Cytogenetic analyses were particularly informative about small round-cell tumors from children: 8 of 14 round-cell tumors contained diagnostically important chromosome aberrations. Using the combined approaches of light and electron microscopy, immunohistochemistry, and cytogenetics, we established an unambiguous diagnosis for 60 of 62 tumors. Conclusions. Cytogenetic analyses reveal clonal chromosome aberrations in virtually all malignant soft-tissue tumors. These clonal chromosome aberrations, particularly in small round-cell tumors in children, often have diagnostic relevance.	CHILDRENS HOSP MED CTR,DIV HEMATOL ONCOL,BOSTON,MA 02115; CHILDRENS HOSP MED CTR,DEPT RADIOL,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DANA FARBER CANC INST,BOSTON,MA 02115; MASSACHUSETTS GEN HOSP,DIV HEMATOL ONCOL,BOSTON,MA 02114; HARVARD UNIV,SCH MED,DEPT PATHOL,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT PEDIAT,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT RADIOL,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT MED,BOSTON,MA 02115	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	FLETCHER, JA (corresponding author), BRIGHAM & WOMENS HOSP,DEPT PATHOL,75 FRANCIS ST,BOSTON,MA 02115, USA.				NATIONAL CANCER INSTITUTE [K11CA001498] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K12AG000294] Funding Source: NIH RePORTER; NCI NIH HHS [1-K11-CA-01498-01] Funding Source: Medline; NIA NIH HHS [AG-00294] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ABELL MR, 1975, CANCER, V36, P2206, DOI 10.1002/cncr.2820360938; BECHER R, 1984, J NATL CANCER I, V72, P823; CHEN TR, 1988, CANCER GENET CYTOGEN, V33, P77, DOI 10.1016/0165-4608(88)90052-0; CRIST W, 1990, BLOOD, V76, P489; DOUGLASS EC, 1990, GENE CHROMOSOME CANC, V2, P210, DOI 10.1002/gcc.2870020308; FLEJTER WL, 1989, GENE CHROMOSOME CANC, V1, P148, DOI 10.1002/gcc.2870010207; FLETCHER J A, 1990, Current Opinion in Oncology, V2, P467; FLETCHER JA, 1989, CANCER GENET CYTOGEN, V41, P224, DOI 10.1016/0165-4608(89)90263-X; FLETCHER JA, 1990, CANCER RES, V50, P4092; HAYASHI Y, 1989, CANCER, V63, P126, DOI 10.1002/1097-0142(19890101)63:1<126::AID-CNCR2820630120>3.0.CO;2-Z; HOROWITZ ME, 1986, J CLIN ONCOL, V4, P559, DOI 10.1200/JCO.1986.4.4.559; LIMON J, 1986, CANCER GENET CYTOGEN, V23, P305, DOI 10.1016/0165-4608(86)90013-0; MANDAHL N, 1989, GENE CHROMOSOME CANC, V1, P9, DOI 10.1002/gcc.2870010104; MIETTINEN M, 1988, CANCER, V62, P2060, DOI 10.1002/1097-0142(19881101)62:9<2060::AID-CNCR2820620932>3.0.CO;2-Y; MOLENAAR WM, 1989, LAB INVEST, V60, P266; MUGNERET F, 1988, CANCER GENET CYTOGEN, V32, P239, DOI 10.1016/0165-4608(88)90286-5; NILBERT M, 1988, CANCER GENET CYTOGEN, V34, P209, DOI 10.1016/0165-4608(88)90262-2; NILBERT M, 1988, CANCER GENET CYTOGEN, V36, P141; PRESANT CA, 1986, J CLIN ONCOL, V4, P1658, DOI 10.1200/JCO.1986.4.11.1658; RICCARDI VM, 1986, CANCER GENET CYTOGEN, V23, P199, DOI 10.1016/0165-4608(86)90179-2; SANDBERG AA, 1988, CANCER RES, V48, P1049; SEABRIGH.M, 1971, LANCET, V2, P971; SHENG WW, 1988, CANCER RES, V48, P983; SHIRAKI M, 1989, CANCER-AM CANCER SOC, V64, P484, DOI 10.1002/1097-0142(19890715)64:2<484::AID-CNCR2820640223>3.0.CO;2-T; TRENT J, 1985, CANCER GENET CYTOGEN, V16, P189, DOI 10.1016/0165-4608(85)90045-7; TRICHE TJ, 1989, PRINCIPLES PRACTICE, P93; TURCCAREL C, 1987, P NATL ACAD SCI USA, V84, P1981, DOI 10.1073/pnas.84.7.1981; TURCCAREL C, 1988, CANCER GENET CYTOGEN, V32, P229, DOI 10.1016/0165-4608(88)90285-3; TURCCAREL C, 1986, CANCER GENET CYTOGEN, V23, P291, DOI 10.1016/0165-4608(86)90011-7; WHANGPENG J, 1986, CANCER GENET CYTOGEN, V21, P185, DOI 10.1016/0165-4608(86)90001-4; WHANGPENG J, 1984, NEW ENGL J MED, V311, P584, DOI 10.1056/NEJM198408303110907; WILLIAMS DL, 1985, NEW ENGL J MED, V313, P640; YUNIS JJ, 1982, NEW ENGL J MED, V307, P1231, DOI 10.1056/NEJM198211113072002; YUNIS JJ, 1981, NEW ENGL J MED, V305, P135, DOI 10.1056/NEJM198107163050304	34	278	280	0	1	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 14	1991	324	7					436	442		10.1056/NEJM199102143240702	http://dx.doi.org/10.1056/NEJM199102143240702			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EX363	1988828	Bronze			2022-12-28	WOS:A1991EX36300002
J	BISHOP, JM				BISHOP, JM			MOLECULAR THEMES IN ONCOGENESIS	CELL			English	Review							PROTEIN KINASE-C; RETINOBLASTOMA GENE-PRODUCT; CELL-CYCLE; TRANSGENIC MICE; MYC ONCOGENE; P53 GENE; TYROSINE PHOSPHORYLATION; MALIGNANT TRANSFORMATION; TUMORIGENIC CONVERSION; COLORECTAL CARCINOMAS		UNIV CALIF SAN FRANCISCO, GEORGE WILLIAMS HOOPER FDN, DEPT BIOCHEM & BIOPHYS, SAN FRANCISCO, CA 94143 USA	University of California System; University of California San Francisco	BISHOP, JM (corresponding author), UNIV CALIF SAN FRANCISCO, GEORGE WILLIAMS HOOPER FDN, DEPT MICROBIOL & IMMUNOL, SAN FRANCISCO, CA 94143 USA.							AARONSON SA, 1990, CANCER CELL-MON REV, V2, P212; ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; AGHIB DF, 1990, ONCOGENE, V5, P707; ALITALO K, 1986, ADV CANCER RES, V47, P235, DOI 10.1016/S0065-230X(08)60201-8; AMBROSIO L, 1989, NATURE, V342, P288, DOI 10.1038/342288a0; AMES BN, 1990, SCIENCE, V249, P970, DOI 10.1126/science.2136249; AMES BN, 1979, SCIENCE, V204, P587, DOI 10.1126/science.373122; ARIGA H, 1989, EMBO J, V8, P4273, DOI 10.1002/j.1460-2075.1989.tb08613.x; BAKER SJ, 1990, SCIENCE, V249, P912, DOI 10.1126/science.2144057; BAKER SJ, 1989, SCIENCE, V244, P217, DOI 10.1126/science.2649981; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BERNARDS R, 1989, P NATL ACAD SCI USA, V86, P6474, DOI 10.1073/pnas.86.17.6474; Bishop J, 1982, MOL BIOL TUMOR VIRUS, P999; BISHOP JM, 1987, SCIENCE, V235, P305, DOI 10.1126/science.3541204; BISHOP JM, 1989, ONCOGENES MOL ORIGIN, P327; BODMER WF, 1987, NATURE, V328, P614, DOI 10.1038/328614a0; BOOKSTEIN R, 1990, SCIENCE, V247, P712, DOI 10.1126/science.2300823; BOUCK N, 1990, CANCER CELL-MON REV, V2, P179; BOURNE HR, 1987, NATURE, V330, P517, DOI 10.1038/330517a0; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; BOVERI T, 1929, ORIGIN MALIGNANT TUM, P26; BUCHBERG AM, 1990, NATURE, V347, P291, DOI 10.1038/347291a0; BUCHKOVICH K, 1989, CELL, V58, P1097, DOI 10.1016/0092-8674(89)90508-4; CAIRNS J, 1981, NATURE, V289, P353, DOI 10.1038/289353a0; CAIRNS J, 1991, CELL, V64; CAWTHON RM, 1990, CELL, V62, P193, DOI 10.1016/0092-8674(90)90253-B; CHACKALAPARAMPIL I, 1988, CELL, V52, P801, DOI 10.1016/0092-8674(88)90422-9; CHEN PL, 1989, CELL, V58, P1193, DOI 10.1016/0092-8674(89)90517-5; COHEN SM, 1990, SCIENCE, V249, P1007, DOI 10.1126/science.2204108; COLE MD, 1986, ANNU REV GENET, V20, P361, DOI 10.1146/annurev.ge.20.120186.002045; Cooper J.A, 1990, PEPT PROT PHOSPH, P85; COSMAN D, 1990, TRENDS BIOCHEM SCI, V15, P265, DOI 10.1016/0968-0004(90)90051-C; DAMM K, 1989, NATURE, V339, P593, DOI 10.1038/339593a0; DESCHNER EE, 1975, CANCER, V35, P413, DOI 10.1002/1097-0142(197502)35:2<413::AID-CNCR2820350217>3.0.CO;2-B; Doll R, 1981, THE CAUSES OF CANCER; DOWNWARD J, 1990, NATURE, V346, P719, DOI 10.1038/346719a0; DOWNWARD J, 1990, P NATL ACAD SCI USA, V87, P5998, DOI 10.1073/pnas.87.15.5998; DRINKWATER NR, 1990, CANCER CELL-MON REV, V2, P8; DROBETSKY E, 1983, MOL CELL BIOL, V3, P1882, DOI 10.1128/MCB.3.10.1882; DRYJA TP, 1989, NATURE, V339, P556, DOI 10.1038/339556a0; ECKHART W, 1989, ONCOGENES MOL ORIGIN, P223; EDELMAN AM, 1987, ANNU REV BIOCHEM, V56, P567, DOI 10.1146/annurev.biochem.56.1.567; ELIYAHU D, 1989, P NATL ACAD SCI USA, V86, P8763, DOI 10.1073/pnas.86.22.8763; ELLIS C, 1990, NATURE, V343, P377, DOI 10.1038/343377a0; FEARON ER, 1990, SCIENCE, V247, P49, DOI 10.1126/science.2294591; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; FIDLER IJ, 1990, J NATL CANCER I, V82, P166, DOI 10.1093/jnci/82.3.166; FIELDS S, 1990, SCIENCE, V249, P1046, DOI 10.1126/science.2144363; FONG CT, 1989, P NATL ACAD SCI USA, V86, P3753, DOI 10.1073/pnas.86.10.3753; Frech M, 1990, SCIENCE, V249, P169, DOI 10.1126/science.2164710; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; FRYKBERG L, 1987, ONCOGENE, V1, P415; FUNG YKT, 1987, SCIENCE, V236, P1657, DOI 10.1126/science.2885916; GAUWERKY CE, 1988, P NATL ACAD SCI USA, V85, P8548, DOI 10.1073/pnas.85.22.8548; GERMAN J, 1983, CHROMOSOME MUTATION; GILMORE TD, 1990, CELL, V62, P841, DOI 10.1016/0092-8674(90)90257-F; GIULOTTO E, 1987, CELL, V48, P837, DOI 10.1016/0092-8674(87)90080-8; GOULD KL, 1989, NATURE, V342, P39, DOI 10.1038/342039a0; GRAF T, 1988, LEUKEMIA, V2, P127; GUSSE M, 1989, MOL CELL BIOL, V9, P5395, DOI 10.1128/MCB.9.12.5395; HABER DA, 1990, CELL, V61, P1257, DOI 10.1016/0092-8674(90)90690-G; HALUSKA FG, 1987, ANNU REV GENET, V21, P321, DOI 10.1146/annurev.ge.21.120187.001541; HANAHAN D, 1988, ANNU REV GENET, V22, P479, DOI 10.1146/annurev.ge.22.120188.002403; HART IR, 1989, BIOCHIM BIOPHYS ACTA, V989, P65, DOI 10.1016/0304-419X(89)90035-8; HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0; HATA Y, 1990, J BIOL CHEM, V265, P7104; HAYMAN MJ, 1986, TRENDS GENET, V2, P260, DOI 10.1016/0168-9525(86)90259-3; HAYSTEAD TAJ, 1989, NATURE, V337, P78, DOI 10.1038/337078a0; HAYWARD WS, 1981, NATURE, V290, P475, DOI 10.1038/290475a0; HELM S, 1987, CANCER CYTOGENETICS; HERSKOWITZ I, 1987, NATURE, V329, P219, DOI 10.1038/329219a0; HINDS P, 1989, J VIROL, V63, P739, DOI 10.1128/JVI.63.2.739-746.1989; HOROWITZ JM, 1990, P NATL ACAD SCI USA, V87, P2775, DOI 10.1073/pnas.87.7.2775; HOUSEY GM, 1988, CELL, V52, P343, DOI 10.1016/S0092-8674(88)80027-8; HOWE JA, 1990, P NATL ACAD SCI USA, V87, P5883, DOI 10.1073/pnas.87.15.5883; HSIAO WLW, 1989, MOL CELL BIOL, V9, P2641, DOI 10.1128/MCB.9.6.2641; HUANG AL, 1981, CELL, V27, P245, DOI 10.1016/0092-8674(81)90408-6; HUANG HJS, 1988, SCIENCE, V242, P1563, DOI 10.1126/science.3201247; HUNT T, 1989, NATURE, V342, P483, DOI 10.1038/342483a0; HUNTER T, 1987, CELL, V49, P1, DOI 10.1016/0092-8674(87)90745-8; HUNTER T, 1991, CELL, V64, P249, DOI 10.1016/0092-8674(91)90637-E; HUNTER T, 1989, CELL, V58, P1013, DOI 10.1016/0092-8674(89)90496-0; HUNTER T, 1987, CELL, V50, P823, DOI 10.1016/0092-8674(87)90509-5; HUNTER T, 1989, ONCOGENES MOL ORIGIN, P147; JADAYEL D, 1990, NATURE, V343, P558, DOI 10.1038/343558a0; JAKOBOVITS EB, 1984, CELL, V38, P757, DOI 10.1016/0092-8674(84)90271-X; KAPLAN DR, 1990, CELL, V61, P125, DOI 10.1016/0092-8674(90)90220-9; KIKKAWA U, 1989, ANNU REV BIOCHEM, V58, P31, DOI 10.1146/annurev.bi.58.070189.000335; KIPREOS ET, 1990, SCIENCE, V248, P217, DOI 10.1126/science.2183353; KITAYAMA H, 1989, CELL, V56, P77, DOI 10.1016/0092-8674(89)90985-9; KNUDSON AG, 1986, ANNU REV GENET, V20, P231; KOI M, 1989, P NATL ACAD SCI USA, V86, P8773, DOI 10.1073/pnas.86.22.8773; KRENGEL U, 1990, CELL, V62, P539, DOI 10.1016/0092-8674(90)90018-A; LACOMBE ML, 1990, J BIOL CHEM, V265, P10012; LAND H, 1983, SCIENCE, V222, P771, DOI 10.1126/science.6356358; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; LANDIS CA, 1989, NATURE, V340, P692, DOI 10.1038/340692a0; LANE DP, 1990, GENE DEV, V4, P1, DOI 10.1101/gad.4.1.1; LAVIGUEUR A, 1989, MOL CELL BIOL, V9, P3982, DOI 10.1128/MCB.9.9.3982; LEE WH, 1987, SCIENCE, V235, P1394, DOI 10.1126/science.3823889; LEVINE AJ, 1990, BIOCHIM BIOPHYS ACTA, V1032, P119, DOI 10.1016/0304-419X(90)90015-S; LEVINE AJ, 1990, VIROLOGY, V177, P419, DOI 10.1016/0042-6822(90)90505-L; LEWIN B, 1991, CELL, V64, P303, DOI 10.1016/0092-8674(91)90640-K; LIOTTA LA, 1991, CELL, V64, P327, DOI 10.1016/0092-8674(91)90642-C; LIPKIN M, 1988, CANCER RES, V48, P235; LOMBARDI L, 1987, CELL, V49, P161, DOI 10.1016/0092-8674(87)90556-3; LUDLOW JW, 1990, CELL, V60, P387, DOI 10.1016/0092-8674(90)90590-B; LUGO TG, 1990, SCIENCE, V247, P1079, DOI 10.1126/science.2408149; LUSCHER B, 1990, NATURE, V344, P517, DOI 10.1038/344517a0; LUTZELSCHWAB R, 1987, EMBO J, V6, P1791, DOI 10.1002/j.1460-2075.1987.tb02432.x; LYONS J, 1990, SCIENCE, V249, P655, DOI 10.1126/science.2116665; MARSHALL CJ, 1991, CELL, V64, P313, DOI 10.1016/0092-8674(91)90641-B; MARTINSSON T, 1988, ONCOGENE, V3, P437; MCCORMICK F, 1989, NATURE, V340, P678, DOI 10.1038/340678a0; MECHLER BM, 1985, EMBO J, V4, P1551, DOI 10.1002/j.1460-2075.1985.tb03816.x; Medina D., 1975, CANCER COMPREHENSIVE, V3, P99; MEGIDISH T, 1989, NATURE, V342, P807, DOI 10.1038/342807a0; MEUTH M, 1990, BIOCHIM BIOPHYS ACTA, V1032, P1, DOI 10.1016/0304-419X(90)90009-P; MIHARA K, 1989, SCIENCE, V246, P1300, DOI 10.1126/science.2588006; MILNER J, 1990, EMBO J, V9, P2885, DOI 10.1002/j.1460-2075.1990.tb07478.x; MORGAN DO, 1989, CELL, V57, P775, DOI 10.1016/0092-8674(89)90792-7; MORRISON DK, 1989, CELL, V58, P649, DOI 10.1016/0092-8674(89)90100-1; MORRISON DK, 1988, P NATL ACAD SCI USA, V85, P8855, DOI 10.1073/pnas.85.23.8855; MULCAHY LS, 1985, NATURE, V313, P241, DOI 10.1038/313241a0; MULLIGAN LM, 1990, P NATL ACAD SCI USA, V87, P5863, DOI 10.1073/pnas.87.15.5863; MULVIHILL JJ, 1977, GENETICS HUMAN CANCE, P137; MURRAY AW, 1989, NATURE, V342, P14, DOI 10.1038/342014a0; NEWBOLD RF, 1982, NATURE, V299, P633, DOI 10.1038/299633a0; NEWMAN B, 1988, P NATL ACAD SCI USA, V85, P3044, DOI 10.1073/pnas.85.9.3044; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; NORBURY CJ, 1989, BIOCHIM BIOPHYS ACTA, V989, P85, DOI 10.1016/0304-419X(89)90036-X; NOWELL PC, 1986, CANCER RES, V46, P2203; PARDEE AB, 1989, SCIENCE, V246, P603, DOI 10.1126/science.2683075; PIETENPOL JA, 1990, CELL, V61, P777, DOI 10.1016/0092-8674(90)90188-K; PONDER B, 1989, NATURE, V340, P264, DOI 10.1038/340264a0; PONDER BAJ, 1990, TRENDS GENET, V6, P213, DOI 10.1016/0168-9525(90)90181-5; RAMSAY GM, 1990, P NATL ACAD SCI USA, V87, P2102, DOI 10.1073/pnas.87.6.2102; RAPP UR, 1988, HDB ONCOGENES, P213; RAYCROFT L, 1990, SCIENCE, V249, P1049, DOI 10.1126/science.2144364; ROBBINS PD, 1990, NATURE, V346, P668, DOI 10.1038/346668a0; ROLLINS BJ, 1989, ADV CANCER RES, V53, P1; ROSENGARD AM, 1989, NATURE, V342, P177, DOI 10.1038/342177a0; ROUS P, 1966, PRIX NOBEL 1966, P162; ROUSSEL MF, 1988, CELL, V55, P979, DOI 10.1016/0092-8674(88)90243-7; RULEY HE, 1983, NATURE, V304, P602, DOI 10.1038/304602a0; SAGATA N, 1989, NATURE, V342, P512, DOI 10.1038/342512a0; SAGATA N, 1989, SCIENCE, V245, P643, DOI 10.1126/science.2474853; SAGATA N, 1988, NATURE, V335, P519, DOI 10.1038/335519a0; SAGER R, 1989, SCIENCE, V246, P1406, DOI 10.1126/science.2574499; SAKURA H, 1989, P NATL ACAD SCI USA, V86, P5758, DOI 10.1073/pnas.86.15.5758; SAP J, 1989, NATURE, V340, P242, DOI 10.1038/340242a0; SAPIENZA C, 1990, MOL CARCINOGEN, V3, P118, DOI 10.1002/mc.2940030303; SCHNEIDER C, 1988, CELL, V54, P787, DOI 10.1016/S0092-8674(88)91065-3; SCHWAB M, 1990, GENE CHROMOSOME CANC, V1, P181, DOI 10.1002/gcc.2870010302; Scrable H J, 1990, Adv Cancer Res, V54, P25, DOI 10.1016/S0065-230X(08)60807-6; SETH A, 1988, ONCOGENE HDB, P195; SHENOY S, 1989, CELL, V57, P763, DOI 10.1016/0092-8674(89)90791-5; SMITH MR, 1986, NATURE, V320, P540, DOI 10.1038/320540a0; SPANDIDOS DA, 1984, NATURE, V310, P469, DOI 10.1038/310469a0; SPENCER CA, 1990, GENE DEV, V4, P75, DOI 10.1101/gad.4.1.75; SPRENGER F, 1989, NATURE, V338, P478, DOI 10.1038/338478a0; STARK GR, 1989, CELL, V57, P901, DOI 10.1016/0092-8674(89)90328-0; STEIN GH, 1990, SCIENCE, V249, P666, DOI 10.1126/science.2166342; STURZBECHER HW, 1990, ONCOGENE, V5, P795; SUGANUMA M, 1990, CANCER RES, V50, P3521; SUKUMAR S, 1989, CURR TOP MICROBIOL, V148, P93; SYMONDS G, 1989, ONCOGENE, V4, P285; TAKAHASHI T, 1989, SCIENCE, V246, P491, DOI 10.1126/science.2554494; THOMASSEN DG, 1985, CANCER RES, V45, P726; TLSTY TD, 1989, P NATL ACAD SCI USA, V86, P9441, DOI 10.1073/pnas.86.23.9441; TOGUCHIDA J, 1989, NATURE, V338, P156, DOI 10.1038/338156a0; TRAHEY M, 1987, SCIENCE, V238, P542, DOI 10.1126/science.2821624; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; VALLAR L, 1987, NATURE, V330, P566, DOI 10.1038/330566a0; VANETTEN RA, 1989, CELL, V58, P669, DOI 10.1016/0092-8674(89)90102-5; VARMUS H, 1989, ONCOGENES MOL ORIGIN, P3; VERSTEEG R, 1990, MOL CELL BIOL, V10, P5416, DOI 10.1128/MCB.10.10.5416; VOGELSTEIN B, 1989, SCIENCE, V244, P207, DOI 10.1126/science.2565047; WALLACE MR, 1990, SCIENCE, V249, P181, DOI 10.1126/science.2134734; WANG J, 1990, NATURE, V343, P555, DOI 10.1038/343555a0; WASYLYK C, 1990, ONCOGENE, V5, P1055; WEINBERG RA, 1990, TRENDS BIOCHEM SCI, V15, P199, DOI 10.1016/0968-0004(90)90162-5; WITTENBERG C, 1990, CELL, V62, P225, DOI 10.1016/0092-8674(90)90361-H; WOODS DF, 1989, DEV BIOL, V134, P222, DOI 10.1016/0012-1606(89)90092-4; WOOLFORD J, 1988, CELL, V55, P965, DOI 10.1016/0092-8674(88)90242-5; WRIGHT JA, 1990, P NATL ACAD SCI USA, V87, P1791, DOI 10.1073/pnas.87.5.1791; XU GF, 1990, CELL, V62, P599, DOI 10.1016/0092-8674(90)90024-9; Yunis J J, 1986, Important Adv Oncol, P93; ZINN BJ, 1988, NATURE, V332, P272	190	1548	1609	1	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 25	1991	64	2					235	248		10.1016/0092-8674(91)90636-D	http://dx.doi.org/10.1016/0092-8674(91)90636-D			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EV336	1988146				2022-12-28	WOS:A1991EV33600004
J	ESDAILE, J				ESDAILE, J			A RANDOMIZED STUDY OF THE EFFECT OF WITHDRAWING HYDROXYCHLOROQUINE SULFATE IN SYSTEMIC LUPUS-ERYTHEMATOSUS	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RHEUMATOID-ARTHRITIS; HEALTH-STATUS; CHLOROQUINE; ANTIMALARIALS; EFFICACY; CRITERIA; SAFETY	Background. The antimalarial drug hydroxychloroquine is thought to be effective in controlling some of the manifestations of systemic lupus erythematosus, but its effectiveness has not been demonstrated conclusively. Methods. We conducted a six-month, randomized, double-blind, palcebo-controlled study of the effect of discontinuing hydroxychloroquine sulfate treatment in 47 patients with clinically stable systemic lupus erythematosus. The patients were randomly assigned to continue their same dose of hydroxychloroquine (n = 25) or to receive palcebo (n = 22) for 24 weeks. Ten patients in each group were also taking prednisone. Results. The relative risk of a clinical flare-up, defined as the development of specific clinical manifestations of systemic lupus erythematosus or an increase in their severity, was 2.5 times higher (95 percent confidence interval, 1.08 to 5.58) in the patients taking placebo than in those continuing to take hydroxychloroquine (16 of 22 patients vs. 9 of 25 had flare-ups), and the time to a flare-up was shorter (P = 0.02). The relative risk of a severe exacerbation of disease that required withdrawal from the study was 6.1 times higher (95 percent confidence interval, 0.72 to 52.44) for the patients taking placebo (5 of 22 patients vs. 1 of 25 had severe exacerbations of disease). Changes in the dose of prednisone were not different in the two groups. Conclusions. Patients with quiescent systemic lupus erythematosus who are taking hydroxychloroquine are less likely to have a clinical flare-up if they are maintained on the drug.			ESDAILE, J (corresponding author), MONTREAL GEN HOSP,1650 CEDAR AVE,MONTREAL H3G 1A4,QUEBEC,CANADA.							ADAMS EM, 1983, AM J MED, V75, P321, DOI 10.1016/0002-9343(83)91211-1; BELLAMY N, 1986, J RHEUMATOL, V13, P551; BERNSTEIN HN, 1983, AM J MED, V75, P25, DOI 10.1016/0002-9343(83)91267-6; BUCHANAN R N Jr, 1959, South Med J, V52, P978; CHRISTIANSEN JV, 1956, BRIT J DERMATOL, V68, P73, DOI 10.1111/j.1365-2133.1956.tb12788.x; DUBOIS EL, 1956, ANN INTERN MED, V45, P163, DOI 10.7326/0003-4819-45-2-163; DUBOIS EL, 1978, SEMIN ARTHRITIS RHEU, V8, P33; EASTERBROOK M, 1984, OPHTHALMOLOGY, V91, P1368; ESDAILE JM, 1988, ARTHRITIS RHEUM, V31, P423, DOI 10.1002/art.1780310315; FEINSTEIN ALVAN R., 1985, CLIN EPIDEMIOLOGY AR, p[295, 298]; FERGUSON GA, 1981, STATISTICAL ANAL PSY, P316; FINBLOOM DS, 1985, J RHEUMATOL, V12, P692; Fleiss J. L., 1981, STAT METHODS RATES P, V2, P22; FRIEDMAN LM, 1985, FUNDAMENTALS CLIN TR, P44; KALBFLEISCH HD, 1981, STATISTICAL ANAL FAI, P70; KAY EA, 1987, BRIT J RHEUMATOL, V26, P375; KELSEY JL, 1986, METHODS OBSERVATIONA, P41; LEE ET, 1980, STATISTICAL METHODS, P383; LIEBERMAN JD, 1988, RHEUM DIS CLIN N AM, V14, P223; MACKENZIE AH, 1983, AM J MED, V75, P48, DOI 10.1016/0002-9343(83)90474-6; MAKSYMOWYCH W, 1987, SEMIN ARTHRITIS RHEU, V16, P206, DOI 10.1016/0049-0172(87)90023-0; MEENAN RF, 1982, ARTHRITIS RHEUM, V25, P1048, DOI 10.1002/art.1780250903; RUDNICKI RD, 1975, J RHEUMATOL, V2, P323; RUNGE LA, 1983, AM J MED, V75, P52, DOI 10.1016/0002-9343(83)91271-8; RYNES RI, 1979, ARTHRITIS RHEUM-US, V22, P832, DOI 10.1002/art.1780220805; SCHUR PH, 1983, CLIN MANAGEMENT SYST, P262; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; TETT SE, 1988, BRIT J CLIN PHARMACO, V26, P303, DOI 10.1111/j.1365-2125.1988.tb05281.x; UROWITZ MB, 1984, J RHEUMATOL, V11, P783; WALLACE DJ, 1989, 2ND P INT C SLE SING; WALLACE DJ, 1987, DUBOIS LUPUS ERYTHEM, P512; WINKELMANN R, 1961, ANN INTERN MED, V55, P772, DOI 10.7326/0003-4819-55-5-772; ZIFF M, 1958, ARTHRITIS RHEUM-US, V1, P332, DOI 10.1002/art.1780010405; 1986, ARTHRITIS RHEUM S, V29, pS93; 1982, DICT RHEUMATIC DISEA, V1	35	469	482	0	9	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 17	1991	324	3					150	154						5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ER471	1984192				2022-12-28	WOS:A1991ER47100003
J	HALL, WH				HALL, WH			TREATMENT OF EARLY-STAGE BREAST-CANCER	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material											HALL, WH (corresponding author), NIH,OFF MED APPLICAT RES,BLDG 1,ROOM 260,BETHESDA,MD 20892, USA.								0	739	745	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 16	1991	265	3					391	395						5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ER256	1984541				2022-12-28	WOS:A1991ER25600032
J	BRAUNWALD, E				BRAUNWALD, E			SUBSPECIALISTS AND INTERNAL-MEDICINE - A PERSPECTIVE	ANNALS OF INTERNAL MEDICINE			English	Editorial Material								There is a growing schism between general internal medicine and the medical subspecialties. The latter are functioning increasingly as categorical disease centers, such as cardiac or cancer centers, which involve subspecialists from several departments. These new "horizontal" organizational units are though to enhance the effectiveness of patient care as well as the generation of resources, especially for research and training. However, subspecialists operating outside of the framework of training, accreditation, and standards established by internal medicine are at risk for being less effective in dealing with the "whole" patient. Further, the critical evaluation of clinical practices of subspecialists is greatly needed and is far more likely to be accomplished effectively within departments of internal medicine than in categorical disease centers. Therefore, although some strengthening of the new horizontal organizational units now seems appropriate, this processs must not be allowed to erode the important integrating structure provided by internal medicine.			BRAUNWALD, E (corresponding author), HARVARD UNIV, BRIGHAM & WOMENS HOSP, SCH MED, 75 FRANCIS ST, BOSTON, MA 02115 USA.							BRAUNWALD E, 1982, CIRCULATION, V66, P487, DOI 10.1161/01.CIR.66.3.487; REITEMEIER RJ, 1990, ANN INTERN MED, V114, P78; THOMAS L, 1971, NEW ENGL J MED, V285, P1366, DOI 10.1056/NEJM197112092852411	3	23	23	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 1	1991	114	1					76	78		10.7326/0003-4819-114-1-76	http://dx.doi.org/10.7326/0003-4819-114-1-76			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EQ040	1983938				2022-12-28	WOS:A1991EQ04000013
J	LEWIS, CE; CLANCY, C; LEAKE, B; SCHWARTZ, JS				LEWIS, CE; CLANCY, C; LEAKE, B; SCHWARTZ, JS			THE COUNSELING PRACTICES OF INTERNISTS	ANNALS OF INTERNAL MEDICINE			English	Article							HEALTH PROMOTION; PRIMARY CARE; PHYSICIANS; SMOKING	Objectives: To determine the counseling practices of a group of internists in the areas of smoking, exercise, and alcohol and seat belt use, and to determine the associations among physicians' personal health habits and their counseling practices. Design: A random stratified sample of members and fellows of the American College of Physicians in 21 regions selected to represent all areas of the United States. Because of the relatively small proportion of women in this group, they were oversampled. Setting: Physicians' practices. Participants: One thousand three hundred and forty-nine internists (members or fellows of the College) returned questionnaires, for a response rate of 75%; 52% defined themselves as general internists. Interventions: A questionnaire was used to obtain information on internists' use of cigarettes, alcohol, and seat belts and their level of physical activity. Data were obtained on the indications used for counseling and the aggressiveness of counseling about each of these four habits. Measurements and Main Results: Bivariate and logistic regression analyses were used to compare the tendencies of internist subgroups both in using various indications for counseling and in the thoroughness of counseling. Generalists were more likely than specialists to counsel at least once all patients who were at risk and to be more aggressive in counseling. Ninety percent of respondents counseled all of their patients who smoked, but 64.5% never discussed the use of seat belts. Only 3.8% of these internists currently smoked cigarettes, 11.3% drank alcohol daily, 38.7% were extremely or quite active, and 87.3% used seat belts all or most of the time. Among men internists, for every habit except alcohol use, personal health practices were substantially associated with counseling patients; for example, nonsmoking internists were more likely to counsel smokers, and very physically active internists were more likely to counsel about exercise. Among women internists, being very physically active was associated with counseling more patients about exercise and alcohol use. Conclusions: The low level of self-reported counseling among these internists suggests that further emphasis on training in these skills is needed. The association between personal and professional practices suggests that medical schools and housestaff training programs should support health promotion activities for future internists.	UNIV CALIF LOS ANGELES, SCH PUBL HLTH, LOS ANGELES, CA 90024 USA; VIRGINIA COMMONWEALTH UNIV, MED COLL VIRGINIA, SCH MED, RICHMOND, VA 23298 USA; UNIV PENN, SCH MED, PHILADELPHIA, PA 19104 USA; UNIV PENN, LEONARD DAVID INST HLTH ECON, PHILADELPHIA, PA 19104 USA	University of California System; University of California Los Angeles; Virginia Commonwealth University; University of Pennsylvania; University of Pennsylvania	LEWIS, CE (corresponding author), UNIV CALIF LOS ANGELES, SCH MED, DEPT MED, DIV GEN INTERNAL MED, B-558 FACTOR BLDG, LOS ANGELES, CA 90024 USA.							CUMMINGS KM, 1988, HMO PRACTICE, V1, P114; DIETRICH AJ, 1984, AM J PUBLIC HEALTH, V74, P223, DOI 10.2105/AJPH.74.3.223; JENSEN EH, 1986, AM J PREV MED, V2, P226; LEWIS CE, 1986, J GEN INTERN MED, V1, P14, DOI 10.1007/BF02596319; MCALISTER A, 1985, TEX MED, V81, P55; MURPHY GP, 1983, NEW YORK STATE J MED, V83, P1353; NIE NH, 1975, SPSS STATISTICAL PAC, P532; ORLEANS CT, 1985, ANNU REV MED, V36, P51; ORLEANS CT, 1985, PREV MED, V14, P636, DOI 10.1016/0091-7435(85)90083-0; ROSEN MA, 1984, PREV MED, V13, P535, DOI 10.1016/0091-7435(84)90022-7; RUSSELL M, 1986, BEHAVIORAL COUNSELIN, P25; SCHWARTZ JS, 1991, ANN INTERN MED, V114, P46, DOI 10.7326/0003-4819-114-1-46; Stokes J 3rd, 1988, Adv Intern Med, V33, P431; WELLS KB, 1984, JAMA-J AM MED ASSOC, V252, P2846, DOI 10.1001/jama.252.20.2846; WESCHLER H, 1983, NEW ENGL J MED, V308, P97	15	199	200	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 1	1991	114	1					54	58		10.7326/0003-4819-114-1-54	http://dx.doi.org/10.7326/0003-4819-114-1-54			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EQ040	1983933				2022-12-28	WOS:A1991EQ04000009
J	SPEARING, RL; HICKTON, CM; SIZELAND, P; HANNAH, A; BAILEY, RR				SPEARING, RL; HICKTON, CM; SIZELAND, P; HANNAH, A; BAILEY, RR			QUININE-INDUCED DISSEMINATED INTRAVASCULAR COAGULATION	LANCET			English	Article							DRUG-DEPENDENT ANTIBODIES; INDUCED THROMBOCYTOPENIA; IMMUNE THROMBOCYTOPENIA; GLYCOPROTEIN-IIB; IIIA; IB; IX	Recurrent disseminated intravascular coagulation occurred in 3 women after ingestion of quinine tablets for cramp. All had circulating quinine-dependent antibodies to platelets and in 2 there was initial evidence of antibody consumption, with low titres that rose steeply over the next few days and remained high for many months.	CHRISTCHURCH HOSP,DEPT NEPHROL,CHRISTCHURCH,NEW ZEALAND	Christchurch Hospital New Zealand	SPEARING, RL (corresponding author), CHRISTCHURCH HOSP,DEPT HAEMATOL,CHRISTCHURCH,NEW ZEALAND.							ASTER RH, 1969, J CLIN INVEST, V48, P1199, DOI 10.1172/JCI106084; BARR E, 1990, BRIT MED J, V301, P323, DOI 10.1136/bmj.301.6747.323; BELKIN GA, 1967, ANN INTERN MED, V66, P583, DOI 10.7326/0003-4819-66-3-583; CHONG BH, 1989, THROMB HAEMOSTASIS, V62, P46; CHRISTIE DJ, 1985, J CLIN INVEST, V75, P310, DOI 10.1172/JCI111691; CIMO PL, 1977, AM J HEMATOL, V2, P65, DOI 10.1002/ajh.2830020109; CONNELLAN JM, 1989, THROMB HAEMOSTASIS, V62, P46; ELLIOTT HL, 1979, SCOT MED J, V24, P244, DOI 10.1177/003693307902400314; HUGHES T. A., 1925, Indian Journal of Medical Research, V13, P321; KNAPPE W, 1989, LEUCOCYTE TYPING, V4, P965; PFUELLER SL, 1988, BLOOD, V72, P1155; POWELL SE, 1988, J BONE JOINT SURG AM, V70A, P1097, DOI 10.2106/00004623-198870070-00022; Vipan W., 1865, LANCET, V2, P37; WHITE NJ, 1983, NEW ENGL J MED, V309, P61, DOI 10.1056/NEJM198307143090201; WIDMANN FK, 1985, TECHNICAL MANUAL, P461; 1986, LANCET, V1, P660	16	36	36	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	DEC 22	1990	336	8730					1535	1537		10.1016/0140-6736(90)93309-D	http://dx.doi.org/10.1016/0140-6736(90)93309-D			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP037	1979368				2022-12-28	WOS:A1990EP03700006
J	SMITH, KA; GORMAN, PA; STARK, MB; GROVES, RP; STARK, GR				SMITH, KA; GORMAN, PA; STARK, MB; GROVES, RP; STARK, GR			DISTINCTIVE CHROMOSOMAL STRUCTURES ARE FORMED VERY EARLY IN THE AMPLIFICATION OF CAD GENES IN SYRIAN-HAMSTER CELLS	CELL			English	Article							1ST 3 ENZYMES; INSITU HYBRIDIZATION; DNA AMPLIFICATION; UMP SYNTHESIS; RESISTANT; TELOMERES; (TTAGGG)N; STABILITY; SEQUENCE; MUTANTS	As visualized by in situ hybridization with fluorescence detection, newly amplified CAD genes in 10(5) cell colonies are contained in multiple copies of very large regions of DNA, each tens of megabases long. The extra DNA is usually linked to the short arm of chromosome B9, which retains CAD at its normal site. The widely spaced genes are often interspersed with new G-negative regions. Individual cells within a clone have highly variable numbers of CAD genes (range 2-15). When resistant clones are examined later, at the 10(15) cell stage, the amplified genes are usually found in much more condensed structures. We propose that, in the initial event of CAD gene amplification, much of the short arm is transferred from one B9 chromosome to another. In subsequent cell cycles this initial duplication expands rapidly through unequal but homologous sister chromatid exchanges. Relatively rare secondary events lead to more condensed structures.			SMITH, KA (corresponding author), IMPERIAL CANC RES FUND,BOX 123,LINCOLNS INN FIELDS,LONDON WC2A 3PX,ENGLAND.							EDENBERG HJ, 1975, ANNU REV GENET, V9, P245, DOI 10.1146/annurev.ge.09.120175.001333; GIULOTTO E, 1986, EMBO J, V5, P2115, DOI 10.1002/j.1460-2075.1986.tb04474.x; GRODEN J, 1990, P NATL ACAD SCI USA, V87, P4315, DOI 10.1073/pnas.87.11.4315; HASTIE ND, 1989, TRENDS GENET, V5, P326, DOI 10.1016/0168-9525(89)90137-6; KEMPE TD, 1976, CELL, V9, P541, DOI 10.1016/0092-8674(76)90036-2; LAWRENCE JB, 1988, CELL, V52, P51; MEYNE J, 1989, P NATL ACAD SCI USA, V86, P7049, DOI 10.1073/pnas.86.18.7049; MEYNE J, 1990, CHROMOSOMA, V99, P3, DOI 10.1007/BF01737283; MIELE M, 1989, MUTAT RES, V219, P171, DOI 10.1016/0921-8734(89)90012-X; MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622; PADGETT RA, 1979, J BIOL CHEM, V254, P974; PAULETTI G, 1990, P NATL ACAD SCI USA, V87, P2955, DOI 10.1073/pnas.87.8.2955; PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934; PINKEL D, 1988, P NATL ACAD SCI USA, V85, P9138, DOI 10.1073/pnas.85.23.9138; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; SAITO I, 1989, MOL CELL BIOL, V9, P2445, DOI 10.1128/MCB.9.6.2445; SCHIMKE RT, 1988, J BIOL CHEM, V263, P5989; SHIGESADA K, 1985, MOL CELL BIOL, V5, P1735, DOI 10.1128/MCB.5.7.1735; STARK GR, 1986, CANCER SURV, V5, P1; STARK GR, 1984, ANNU REV BIOCHEM, V53, P447, DOI 10.1146/annurev.bi.53.070184.002311; STARK GR, 1989, CELL, V57, P901, DOI 10.1016/0092-8674(89)90328-0; STARK GR, 1990, GENE REARRANGEMENT F, P99; Sutherland G, 1985, FRAGILE SITES HUMAN; TRASK BJ, 1989, GENE DEV, V3, P1913, DOI 10.1101/gad.3.12a.1913; WAHL GM, 1979, J BIOL CHEM, V254, P8679; WAHL GM, 1989, CANCER RES, V49, P1333; WAHL GM, 1982, MOL CELL BIOL, V2, P308, DOI 10.1128/MCB.2.3.308; ZIEG J, 1983, MOL CELL BIOL, V3, P2089, DOI 10.1128/MCB.3.11.2089	28	134	147	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	DEC 21	1990	63	6					1219	1227		10.1016/0092-8674(90)90417-D	http://dx.doi.org/10.1016/0092-8674(90)90417-D			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN923	1979757				2022-12-28	WOS:A1990EN92300012
J	MALICKI, J; SCHUGHART, K; MCGINNIS, W				MALICKI, J; SCHUGHART, K; MCGINNIS, W			MOUSE HOX-2.2 SPECIFIES THORACIC SEGMENTAL IDENTITY IN DROSOPHILA EMBRYOS AND LARVAE	CELL			English	Article									YALE UNIV,DEPT MOLEC BIOPHYS & BIOCHEM,NEW HAVEN,CT 06511; MAX PLANCK INST IMMUNBIOL,W-7800 FREIBURG,GERMANY	Yale University; Max Planck Society	MALICKI, J (corresponding author), YALE UNIV,DEPT HUMAN GENET,NEW HAVEN,CT 06511, USA.		malicki, jarema/G-8611-2014	malicki, jarema/0000-0002-5947-8805; Schughart, Klaus/0000-0002-6824-7523	NIGMS NIH HHS [P01-GM39813] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM039813] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AKAM M, 1987, DEVELOPMENT, V101, P1; AKAM M, 1989, CELL, V57, P347, DOI 10.1016/0092-8674(89)90909-4; DUBOULE D, 1989, EMBO J, V8, P1497, DOI 10.1002/j.1460-2075.1989.tb03534.x; FRISCHER LE, 1986, CELL, V47, P1017, DOI 10.1016/0092-8674(86)90816-0; GIBSON G, 1988, DEVELOPMENT, V102, P657; GONZALEZREYES A, 1990, NATURE, V334, P78; GRAHAM A, 1989, CELL, V57, P367, DOI 10.1016/0092-8674(89)90912-4; KARCH F, 1981, J MOL BIOL, V148, P219, DOI 10.1016/0022-2836(81)90536-2; KAUFMAN TC, 1990, GENETIC REGULATORY H, P309; KESSEL M, 1987, P NATL ACAD SCI USA, V84, P5306, DOI 10.1073/pnas.84.15.5306; KREITMAN M, 1983, NATURE, V304, P412, DOI 10.1038/304412a0; KUZIORA MA, 1988, CELL, V55, P477, DOI 10.1016/0092-8674(88)90034-7; KUZIORA MA, 1989, CELL, V59, P563, DOI 10.1016/0092-8674(89)90039-1; LANGERSAFER PR, 1982, P NATL ACAD SCI-BIOL, V79, P4381, DOI 10.1073/pnas.79.14.4381; LEMOTTE PK, 1989, EMBO J, V8, P219, DOI 10.1002/j.1460-2075.1989.tb03367.x; LEVINE M, 1983, EMBO J, V2, P2037, DOI 10.1002/j.1460-2075.1983.tb01697.x; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; MANN RS, 1990, CELL, V60, P597, DOI 10.1016/0092-8674(90)90663-Y; MARTINEZARIAS A, 1986, EMBO J, V5, P135, DOI 10.1002/j.1460-2075.1986.tb04187.x; MAVILIO F, 1986, NATURE, V324, P664, DOI 10.1038/324664a0; MCGINNIS N, 1990, CELL, V63, P969, DOI 10.1016/0092-8674(90)90500-E; MCGINNIS W, 1985, COLD SPRING HARB SYM, V50, P263, DOI 10.1101/SQB.1985.050.01.033; MEIJLINK F, 1987, NUCLEIC ACIDS RES, V15, P6773, DOI 10.1093/nar/15.17.6773; MULLER M, 1988, EMBO J, V7, P4299, DOI 10.1002/j.1460-2075.1988.tb03328.x; PIROTTA V, 1988, VECTORS SURVEY MOL C, P437; POSTLETHWAIT JH, 1971, DEV BIOL, V25, P606, DOI 10.1016/0012-1606(71)90008-X; REGULSKI M, 1985, CELL, V43, P71, DOI 10.1016/0092-8674(85)90013-3; ROBERTSON HM, 1988, GENETICS, V118, P461; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; SATO T, 1985, DEV BIOL, V111, P171, DOI 10.1016/0012-1606(85)90444-0; SCHNEUWLY S, 1987, EMBO J, V6, P201, DOI 10.1002/j.1460-2075.1987.tb04739.x; SCHNEUWLY S, 1986, EMBO J, V5, P733, DOI 10.1002/j.1460-2075.1986.tb04275.x; SCHNEUWLY S, 1987, NATURE, V325, P816, DOI 10.1038/325816a0; SCHUGHART K, 1988, BRIT J CANCER, V58, P9; SCHUGHART K, 1988, P NATL ACAD SCI USA, V85, P5582, DOI 10.1073/pnas.85.15.5582; SCHUGHART K, 1989, P NATL ACAD SCI USA, V86, P1; SCOTT MP, 1989, BIOCHIM BIOPHYS ACTA, V989, P25, DOI 10.1016/0304-419X(89)90033-4; STRUHL G, 1981, NATURE, V292, P635, DOI 10.1038/292635a0; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; WAKIMOTO BT, 1981, DEV BIOL, V81, P51, DOI 10.1016/0012-1606(81)90347-X; WEINZIERL R, 1987, GENE DEV, V1, P386, DOI 10.1101/gad.1.4.386; WINSLOW GM, 1989, CELL, V57, P1017, DOI 10.1016/0092-8674(89)90340-1	42	167	168	1	12	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	NOV 30	1990	63	5					961	967		10.1016/0092-8674(90)90499-5	http://dx.doi.org/10.1016/0092-8674(90)90499-5			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EL759	1979525	hybrid			2022-12-28	WOS:A1990EL75900011
J	COLLEE, JG				COLLEE, JG			BOVINE SPONGIFORM ENCEPHALOPATHY	LANCET			English	Article											COLLEE, JG (corresponding author), UNIV EDINBURGH,SCH MED,DEPT MED MICROBIOL,TEVIOT PL,EDINBURGH EH8 9AG,MIDLOTHIAN,SCOTLAND.							[Anonymous], 1988, LANCET, V2, P607; [Anonymous], 1989, REPORT WORKING PARTY; BARLOW RM, 1990, VET REC, V126, P111; BEHAN PO, 1982, BRIT MED J, V284, P1658, DOI 10.1136/bmj.284.6330.1658-a; BRUCE ME, 1987, J GEN VIROL, V68, P79, DOI 10.1099/0022-1317-68-1-79; DAWSON M, 1990, VET REC, V127, P338; DIRINGER H, 1983, NATURE, V306, P476, DOI 10.1038/306476a0; GIBBS CJ, 1980, J INFECT DIS, V142, P205, DOI 10.1093/infdis/142.2.205; GIBBS CJ, 1990, LANCET, P1275; HOLT TA, 1988, BRIT MED J, V296, P1581, DOI 10.1136/bmj.296.6636.1581; KIMBERLIN RH, 1986, NEUROPATH APPL NEURO, V12, P197, DOI 10.1111/j.1365-2990.1986.tb00050.x; KIMBERLIN RH, 1984, TRENDS NEUROSCI, V7, P312, DOI 10.1016/S0166-2236(84)80078-8; KIMBERLIN RH, 1986, NEUROPATH APPL NEURO, V12, P131, DOI 10.1111/j.1365-2990.1986.tb00046.x; KIRKWOOD JK, 1990, VET REC, V127, P418; MASTERS CL, 1979, ANN NEUROL, V5, P177, DOI 10.1002/ana.410050212; MATTHEWS WB, 1990, BRIT MED J, V300, P412, DOI 10.1136/bmj.300.6722.412; MERZ PA, 1983, NATURE, V306, P474, DOI 10.1038/306474a0; PATTISON IH, 1961, J COMP PATHOL THERAP, V71, P171, DOI 10.1016/S0368-1742(61)80021-0; PATTISON IH, 1972, VET REC, V90, P465, DOI 10.1136/vr.90.17.465; ROHWER RG, 1984, SCIENCE, V223, P600, DOI 10.1126/science.6420887; TAYLOR DM, 1989, VET REC, V125, P413, DOI 10.1136/vr.125.16.413; TAYLOR DM, 1986, NEUROPATH APPL NEURO, V12, P207, DOI 10.1111/j.1365-2990.1986.tb00051.x; WELLS GAH, 1987, VET REC, V121, P419, DOI 10.1136/vr.121.18.419; WIJERATNE WVS, 1990, VET REC, V126, P5; WILESMITH JW, 1988, VET REC, V123, P638; 1989, INTERIM REPORT CONSU; 1990, VET REC, V127, P462; 1990, LANCET, P1252	28	18	18	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 24	1990	336	8726					1300	1303		10.1016/0140-6736(90)92976-O	http://dx.doi.org/10.1016/0140-6736(90)92976-O			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ943	1978125				2022-12-28	WOS:A1990EJ94300014
J	POWER, C; POLAND, SD; BLUME, WT; GIRVIN, JP; RICE, GPA				POWER, C; POLAND, SD; BLUME, WT; GIRVIN, JP; RICE, GPA			CYTOMEGALOVIRUS AND RASMUSSEN ENCEPHALITIS	LANCET			English	Article									UNIV WESTERN ONTARIO,DEPT CLIN NEUROL SCI,LONDON N6A 3K7,ONTARIO,CANADA	Western University (University of Western Ontario)			Power, Christopher/C-7181-2013	Power, Christopher/0000-0002-5131-9711				FLETCHER CV, 1989, DICP ANN PHARMAC, V23, P5, DOI 10.1177/106002808902300101; FREEDMAN H, 1977, LANCET, V2, P666; GONCZOL E, 1984, SCIENCE, V224, P159, DOI 10.1126/science.6322309; GUPTA PC, 1984, NEUROPEDIATRICS, V15, P191, DOI 10.1055/s-2008-1052365; JOHNSON RT, 1974, PROG MED VIROL, V18, P214; LEUNG K, 1988, NATURE, V333, P776, DOI 10.1038/333776a0; LYON G, 1980, NEUROPADIATRIE, V11, P57, DOI 10.1055/s-2008-1071375; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; PARKER PJ, 1986, SCIENCE, V233, P853, DOI 10.1126/science.3755547; POLAND SD, IN PRESS J INFECT DI; POWER C, 1990, CAN J NEUROL SCI, V17, P378, DOI 10.1017/S0317167100030912; PRATT JH, 1988, EPILEPSIA, V29, P268; RASMUSSEN T, 1958, NEUROLOGY, V8, P435, DOI 10.1212/WNL.8.6.435; RASMUSSEN T, 1978, APPL NEUROPHYSIOL, V41, P1; SEISJO BB, 1986, ADV NEUROL, V44, P813; SEN R, 1986, CELL, V47, P921, DOI 10.1016/0092-8674(86)90807-X; VINTERS HV, 1989, BRAIN, V112, P127; WALTER GF, 1989, LANCET, V1, P279; WEINSHENKER BG, 1988, J IMMUNOL, V140, P1625; WOLBER RA, 1988, HUM PATHOL, V19, P736, DOI 10.1016/S0046-8177(88)80182-5	20	124	124	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 24	1990	336	8726					1282	1284		10.1016/0140-6736(90)92965-K	http://dx.doi.org/10.1016/0140-6736(90)92965-K			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ943	1978116				2022-12-28	WOS:A1990EJ94300005
J	CHEN, YMA; GOMEZLUCIA, E; OKAYAMA, A; TACHIBANA, N; LEE, TH; MUELLER, N; ESSEX, M				CHEN, YMA; GOMEZLUCIA, E; OKAYAMA, A; TACHIBANA, N; LEE, TH; MUELLER, N; ESSEX, M			ANTIBODY PROFILE OF EARLY HTLV-I INFECTION	LANCET			English	Article									HARVARD UNIV,SCH PUBL HLTH,DEPT CANC BIOL,665 HUNTINGTON AVE,BOSTON,MA 02115; MIYAZAKI MED COLL,DEPT INTERNAL MED 2,MIYAZAKI,JAPAN; HARVARD UNIV,SCH PUBL HLTH,DEPT EPIDEMIOL,BOSTON,MA 02115	Harvard University; Harvard T.H. Chan School of Public Health; University of Miyazaki; Harvard University; Harvard T.H. Chan School of Public Health			Gomez-Lucia, Esperanza/I-2058-2017	Gomez-Lucia, Esperanza/0000-0002-5261-0586	NATIONAL CANCER INSTITUTE [R01CA038450, R37CA038450] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL033774] Funding Source: NIH RePORTER; NCI NIH HHS [CA 38450] Funding Source: Medline; NHLBI NIH HHS [1-P50-HL-33774, HL 6356] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANDERSON DW, 1989, BLOOD, V74, P2581; BARIN F, 1985, LANCET, V2, P1387; BIANCO C, 1990, 3RD P ANN RETR C HAW; CHEN YMA, 1989, J VIROL, V63, P4952, DOI 10.1128/JVI.63.11.4952-4957.1989; EHRLICH GD, 1989, BLOOD, V74, P1066; GESSAIN A, 1985, LANCET, V2, P407; HINUMA Y, 1981, P NATL ACAD SCI-BIOL, V78, P6476, DOI 10.1073/pnas.78.10.6476; IKEDA M, 1984, GANN, V75, P845; INABA S, 1989, TRANSFUSION, V29, P7, DOI 10.1046/j.1537-2995.1989.29189101168.x; JACOBSON S, 1988, NATURE, V331, P540, DOI 10.1038/331540a0; KOMURO A, 1983, LANCET, V1, P240; LEE HH, 1990, 3RD P ANN RETR C HAW; LEE TH, 1984, HUMAN T CELL LEUKEMI, P111; LEVINE PH, 1988, INT J CANCER, V42, P7, DOI 10.1002/ijc.2910420103; MIYOSHI I, 1981, NATURE, V294, P770, DOI 10.1038/294770a0; MUELLER N, 1990, HUMAN RETROVIROLOGY : HTLV, P281; OKAYAMA A, 1991, J INFECT DIS, V163, P106; OSAME M, 1986, LANCET, V1, P1031; POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415; SAMUEL KP, 1984, SCIENCE, V226, P1094, DOI 10.1126/science.6208612; SEIKI M, 1983, P NATL ACAD SCI-BIOL, V80, P3618, DOI 10.1073/pnas.80.12.3618; YOSHIDA M, 1984, P NATL ACAD SCI-BIOL, V81, P2534, DOI 10.1073/pnas.81.8.2534	22	13	13	0	2	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 17	1990	336	8725					1214	1216		10.1016/0140-6736(90)92833-4	http://dx.doi.org/10.1016/0140-6736(90)92833-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ064	1978071				2022-12-28	WOS:A1990EJ06400004
J	BELL, EB; SPARSHOTT, SM				BELL, EB; SPARSHOTT, SM			INTERCONVERSION OF CD45R SUBSETS OF CD4 T-CELLS INVIVO	NATURE			English	Article											BELL, EB (corresponding author), UNIV MANCHESTER,SCH MED,DEPT CELL & STRUCT BIOL,IMMUNOL RES GRP,MANCHESTER M13 9PT,LANCS,ENGLAND.							ARTHUR RP, 1986, J EXP MED, V163, P774, DOI 10.1084/jem.163.4.774; BELL EB, 1989, IMMUNOLOGY, V68, P547; BELL EB, 1987, J IMMUNOL, V139, P1379; BIRKELAND ML, 1989, P NATL ACAD SCI USA, V86, P6734, DOI 10.1073/pnas.86.17.6734; BOTTOMLY K, 1989, EUR J IMMUNOL, V19, P617, DOI 10.1002/eji.1830190407; DRAYSON MT, 1989, J EXP MED, V170, P691, DOI 10.1084/jem.170.3.691; HUNIG T, 1989, J EXP MED, V169, P73, DOI 10.1084/jem.169.1.73; LAW DA, 1989, EUR J IMMUNOL, V19, P2289, DOI 10.1002/eji.1830191217; MERKENSCHLAGER M, 1988, EUR J IMMUNOL, V18, P1653, DOI 10.1002/eji.1830181102; MORIMOTO C, 1985, J IMMUNOL, V134, P1508; MOSMANN TR, 1987, IMMUNOL TODAY, V8, P223, DOI 10.1016/0167-5699(87)90171-X; POWRIE F, 1988, IMMUNOL TODAY, V9, P274, DOI 10.1016/0167-5699(88)91309-6; SANDERS ME, 1988, IMMUNOL TODAY, V9, P195, DOI 10.1016/0167-5699(88)91212-1; SARMIENTO M, 1982, J IMMUNOL, V128, P1676; SPICKETT GP, 1983, J EXP MED, V158, P795, DOI 10.1084/jem.158.3.795; STREULI M, 1987, J EXP MED, V166, P1548, DOI 10.1084/jem.166.5.1548; TERRY LA, 1988, IMMUNOLOGY, V64, P331; THOMAS ML, 1989, ANNU REV IMMUNOL, V7, P339, DOI 10.1146/annurev.immunol.7.1.339; WHITBY EH, 1990, IMMUNOLOGY, V69, P78; WOOLLETT GR, 1985, EUR J IMMUNOL, V15, P168, DOI 10.1002/eji.1830150211	20	360	361	0	0	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 8	1990	348	6297					163	166		10.1038/348163a0	http://dx.doi.org/10.1038/348163a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG776	1978253				2022-12-28	WOS:A1990EG77600057
J	VILJANEN, MK; PELTOLA, T; JUNNILA, SYT; OLKKONEN, L; JARVINEN, H; KUISTILA, M; HUOVINEN, P				VILJANEN, MK; PELTOLA, T; JUNNILA, SYT; OLKKONEN, L; JARVINEN, H; KUISTILA, M; HUOVINEN, P			OUTBREAK OF DIARRHEA DUE TO ESCHERICHIA-COLI 0111-B4 IN SCHOOLCHILDREN AND ADULTS - ASSOCIATION OF VI ANTIGEN-LIKE REACTIVITY	LANCET			English	Article									SALO DIST HLTH CARE CTR, SALO, FINLAND		VILJANEN, MK (corresponding author), UNIV TURKU, NATL PUBL HLTH INST, DEPT MED MICROBIOL, POB 57, SF-20521 TURKU, FINLAND.		Huovinen, Pentti/C-1917-2009					ACHARYA IL, 1987, NEW ENGL J MED, V317, P1101, DOI 10.1056/NEJM198710293171801; BRAY J, 1945, J PATHOL BACTERIOL, V57, P239, DOI 10.1002/path.1700570210; Ewing WH, 1986, EDWARDS EWINGS IDENT, V4, P181; Felix A, 1934, LANCET, V2, P186; FERGUSON WW, 1952, AM J HYG, V55, P155; GRANFORS K, 1981, J CLIN MICROBIOL, V14, P6, DOI 10.1128/JCM.14.1.6-14.1981; JOHNSON EM, 1969, J BACTERIOL, V99, P358, DOI 10.1128/JB.99.1.358-359.1969; JOHNSON EM, 1966, J BACTERIOL, V92, P1457, DOI 10.1128/JB.92.5.1457-1463.1966; JOHNSON EM, 1965, J BACTERIOL, V90, P302, DOI 10.1128/JB.90.2.302-308.1965; KAUFFMANN F, 1950, ACTA PATHOL MIC SC, V27, P552; Kauffmann F, 1966, BACTERIOLOGY ENTEROB; KESSNER DM, 1962, AM J HYG, V76, P27, DOI 10.1093/oxfordjournals.aje.a120262; KIRBY AC, 1950, LANCET, V259, P201; KNUTTON S, 1989, INFECT IMMUN, V57, P1290, DOI 10.1128/IAI.57.4.1290-1298.1989; MIAN KA, 1959, JAMA-J AM MED ASSOC, V171, P1957, DOI 10.1001/jama.1959.03010320047011; SARKKINEN HK, 1980, J VIROL METHODS, V1, P331, DOI 10.1016/0166-0934(80)90050-6; SNELLINGS NJ, 1981, J BACTERIOL, V145, P1010, DOI 10.1128/JB.145.2.1010-1017.1981; STEVENSON JS, 1950, BRIT MED J, V2, P195, DOI 10.1136/bmj.2.4672.195; SVENNERHOLM AM, 1986, J CLIN MICROBIOL, V24, P585, DOI 10.1128/JCM.24.4.585-590.1986; SVENNERHOLM AM, 1983, J CLIN MICROBIOL, V17, P596, DOI 10.1128/JCM.17.4.596-600.1983; SZU SC, 1987, J EXP MED, V166, P1510, DOI 10.1084/jem.166.5.1510	21	74	77	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 6	1990	336	8719					831	834		10.1016/0140-6736(90)92337-H	http://dx.doi.org/10.1016/0140-6736(90)92337-H			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB901	1976876				2022-12-28	WOS:A1990EB90100002
J	STIRRAT, GM				STIRRAT, GM			RECURRENT MISCARRIAGE .2. CLINICAL ASSOCIATIONS, CAUSES, AND MANAGEMENT	LANCET			English	Review											STIRRAT, GM (corresponding author), BRISTOL MATERN HOSP, DEPT OBSTET & GYNAECOL, BRISTOL BS2 8EG, ENGLAND.							BEARD RW, 1988, EARLY PREGNANCY LOSS; BENNETT MJ, 1987, SPONTANEOUS RECURREN; BRANCH DW, 1989, 4TH INT C REPR IMM; BRYANT HE, 1989, INT J EPIDEMIOL, V18, P132, DOI 10.1093/ije/18.1.132; CHRISTIANSEN OB, 1989, HUM REPROD, V4, P160, DOI 10.1093/oxfordjournals.humrep.a136863; CONLEY CL, 1952, J CLIN INVEST, V31, P621; COWCHOCK S, 1986, AM J OBSTET GYNECOL, V155, P1002, DOI 10.1016/0002-9378(86)90335-2; EDMONDS DK, 1988, EARLY PREGNANCY LOSS, P411; ELLIS SA, 1990, J IMMUNOL, V144, P731; FAULK WP, 1978, P NATL ACAD SCI USA, V75, P1947, DOI 10.1073/pnas.75.4.1947; FRITZ MA, 1988, SEMIN REPROD ENDOCR, V6, P129, DOI 10.1055/s-2007-1021349; HARGER JH, 1983, OBSTET GYNECOL, V62, P574; JOHNSON PM, 1988, BRIT J OBSTET GYNAEC, V95, P342, DOI 10.1111/j.1471-0528.1988.tb06603.x; JOHNSON PM, 1986, REPRODUCTIVE IMMUNOL, P239; KALTER H, 1987, AM J OBSTET GYNECOL, V156, P1243, DOI 10.1016/0002-9378(87)90156-6; KOVATS S, 1990, SCIENCE, V248, P220, DOI 10.1126/science.2326636; LUBBE WF, 1984, BRIT J OBSTET GYNAEC, V91, P357, DOI 10.1111/j.1471-0528.1984.tb05923.x; LUBBE WF, 1988, SEMIN REPROD ENDOCR, V6, P181, DOI 10.1055/s-2007-1021353; MCDONALD IA, 1987, SPONTANEOUS RECURREN, P168; MCDONOUGH PG, 1988, SEMIN REPROD ENDOCR, V6, P155, DOI 10.1055/s-2007-1021351; MCINTYRE JA, 1988, AM J REPROD IMMUNOL, V17, P100; MILLS JL, 1988, NEW ENGL J MED, V319, P1617, DOI 10.1056/NEJM198812223192501; MIODOVNIK M, 1985, AM J OBSTET GYNECOL, V153, P439, DOI 10.1016/0002-9378(85)90083-3; MOWBRAY JF, 1985, LANCET, V1, P941; MUELLERECKHARDT G, 1989, VOX SANG, V56, P151, DOI 10.1111/j.1423-0410.1989.tb02018.x; NAESSENS A, 1987, ACTA OBSTET GYN SCAN, V66, P513, DOI 10.3109/00016348709015726; NOVY MJ, 1988, SEMIN REPROD ENDOCR, V6, P235, DOI 10.1055/s-2007-1021357; OBER CL, 1985, FERTIL STERIL, V44, P227; OLSON SB, 1988, SEMIN REPROD ENDOCR, V6, P191, DOI 10.1055/s-2007-1021354; PATTON PE, 1988, SEMIN REPROD ENDOCR, V6, P217, DOI 10.1055/s-2007-1021356; PRENTICE RL, 1984, LANCET, V2, P464; QUINN PA, 1987, AM J OBSTET GYNECOL, V156, P291, DOI 10.1016/0002-9378(87)90270-5; SAGLE M, 1988, BMJ-BRIT MED J, V297, P1027, DOI 10.1136/bmj.297.6655.1027; SARGENT IL, 1988, LANCET, V2, P1099; SARGENT IL, 1987, J REPROD IMMUNOL, V10, P111, DOI 10.1016/0165-0378(87)90070-2; SARGENT IL, 1982, CLIN EXP IMMUNOL, V50, P601; Simpson J, 1987, SPONTANEOUS ABORTION, P51; STIRRAT GM, 1990, LANCET, V336, P673, DOI 10.1016/0140-6736(90)92159-F; Stray-Pedersen B, 1988, EARLY PREGNANCY LOSS, P433; STRAYPEDERSEN B, 1984, AM J OBSTET GYNECOL, V148, P140, DOI 10.1016/S0002-9378(84)80164-7; TAYLOR C, 1981, LANCET, V2, P68; Warburton D, 1987, SPONTANEOUS RECURREN, P193; WATTS DH, 1980, SEMIN REPROD ENDOCR, V6, P205	43	134	136	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 22	1990	336	8717					728	733		10.1016/0140-6736(90)92215-4	http://dx.doi.org/10.1016/0140-6736(90)92215-4			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DZ624	1975901				2022-12-28	WOS:A1990DZ62400013
J	[Anonymous]				[Anonymous]			FAILURE-TO-THRIVE REVISITED	LANCET			English	Editorial Material																		BATCHELOR J, 1990, FAILURE FIND FAILURE; BERWICK DM, 1982, ARCH DIS CHILD, V57, P347, DOI 10.1136/adc.57.5.347; DOWDNEY L, 1987, J CHILD PSYCHOL PSYC, V28, P529, DOI 10.1111/j.1469-7610.1987.tb00221.x; EDWARDS A, IN PRESS ARCH DIS CH; FRANK DA, 1985, NEW DIRECTIONS FAILU; GALLER JR, 1985, J AM ACAD CHILD PSY, V24, P58, DOI 10.1016/S0002-7138(09)60410-6; GLASER HH, 1980, J PEDIATR, V73, P690; HALL DMB, 1989, HLTH ALL CHILDREN; HANNAWAY PJ, 1970, CLIN PEDIATR, V9, P96, DOI 10.1177/000992287000900214; HUTTON IW, 1977, PEDIATRICS, V59, P73; IWANIEC D, 1988, EARLY PREDICTION PRE, P229; MITCHELL WG, 1980, PEDIATRICS, V65, P971; ROSENN DW, 1980, PEDIATRICS, V66, P698; WRIGHT C, 1989, DEC COMM PAED RES GR	14	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 15	1990	336	8716					662	663						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DY737	1975857				2022-12-28	WOS:A1990DY73700008
J	HADLEY, J; STEINBERG, EP; FEDER, J				HADLEY, J; STEINBERG, EP; FEDER, J			COMPARISON OF UNINSURED AND PRIVATELY INSURED HOSPITAL PATIENTS - CONDITION ON ADMISSION, RESOURCE USE, AND OUTCOME	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								To investigate the association between insurance status and condition on admission, resource use, and in-hospital mortality, we analyzed discharge abstracts for 592 598 patients hospitalized in 1987 in a national sample of hospitals. In 13 of 16 age-sex-race-specific cohorts, the uninsured had a 44% to 124% higher risk of in-hospital mortality at the time of admission than did the privately insured. After controlling for this difference, the actual in-hospital death rate was 1.2 to 3.2 times higher among uninsured patients in 11 of 16 cohorts. The uninsured also were 29% to 75% less likely to undergo each of five high-cost or high-discretion procedures and 50% less likely to have normal results on tissue pathology reports for biopsies performed during five of seven different endoscopic procedures. Our results suggest that insurance status is associated with a broad spectrum of aspects of hospital care.	JOHNS HOPKINS UNIV,JOHNS HOPKINS PROGRAM MED TECHNOL & PRACTICE ASSESSMENT,BALTIMORE,MD 21218	Johns Hopkins University	HADLEY, J (corresponding author), GEORGETOWN UNIV,SCH MED,CTR HLTH POLICY STUDIES,2233 WISCONSIN AVE NW,SUITE 525,WASHINGTON,DC 20007, USA.							ANDERSON G, 1986, HLTH CARE FINANCE RE, V8, P30; CHASSIN MR, 1986, NEW ENGL J MED, V314, P287; DAVIS K, 1983, MILBANK MEM FUND Q, V61, P160; DESHARNAIS SI, 1988, MED CARE, V26, P1129, DOI 10.1097/00005650-198812000-00004; FREEMAN H, 1987, HLTH AFF, V6, P13; GREEN J, 1990, JAMA-J AM MED ASSOC, V264, P1261, DOI 10.1001/jama.264.10.1261; GREENBERG ER, 1988, NEW ENGL J MED, V318, P612, DOI 10.1056/NEJM198803103181006; KMENTA J, 1971, ELEMENTS ECONOMETRIC, P372; ROOS NP, 1986, AM J PUBLIC HEALTH, V76, P45, DOI 10.2105/AJPH.76.1.45; SLOAN F, 1986, UNCOMPENSATED HOSPIT, P31; TODD JS, 1990, JAMA-J AM MED ASSOC, V264, P1294, DOI 10.1001/jama.264.10.1294; WEISSMAN J, 1989, JAMA-J AM MED ASSOC, V261, P3572, DOI 10.1001/jama.261.24.3572; WENNBERG J, 1984, HLTH AFF, V3, P14; WENNEKER MB, 1989, JAMA-J AM MED ASSOC, V261, P253, DOI 10.1001/jama.261.2.253; WENNEKER MB, 1990, JAMA-J AM MED ASSOC, V264, P1255, DOI 10.1001/jama.264.10.1255; 1988, MEDICAID SOURCE BOOK, P450; 1990, CALL ACTION FINAL RE, P33; 1988, EPW88537 PUBL, P229; 1985, DHHS20213 HLTH CAR B	19	266	266	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 16	1991	265	3					374	379		10.1001/jama.265.3.374	http://dx.doi.org/10.1001/jama.265.3.374			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ER256	1984537				2022-12-28	WOS:A1991ER25600028
J	KARPLUS, PA; DANIELS, MJ; HERRIOTT, JR				KARPLUS, PA; DANIELS, MJ; HERRIOTT, JR			ATOMIC-STRUCTURE OF FERREDOXIN-NADP+ REDUCTASE - PROTOTYPE FOR A STRUCTURALLY NOVEL FLAVOENZYME FAMILY	SCIENCE			English	Article							AMINO-ACID-SEQUENCE; ALPHA-HELIX DIPOLE; RELATE 2 SETS; GLUTATHIONE-REDUCTASE; NADPH-CYTOCHROME-P-450 REDUCTASE; SPINACH FERREDOXIN; ACTIVE-SITE; CHEMICAL MODIFICATION; NUCLEOTIDE-SEQUENCE; CRYSTAL-STRUCTURES	The three-dimensional structure of spinach ferredoxin-NADP+ reductase (NADP+, nicotinamide adenine dinucleotide phosphate) has been determined by x-ray diffraction at 2.6 angstroms (A) resolution and initially refined to an R factor of 0.226 at 2.2 angstrom resolution. The model includes the flavin-adenine dinucleotide (FAD) prosthetic group and the protein chain from residue 19 through the carboxyl terminus at residue 314 and is composed of two domains. The FAD binding domain (residues 19 to 161) has an antiparallel beta-barrel core and a single alpha-helix for binding the pyrophosphate of FAD. The NADP binding domain (residues 162 to 314) has a central five-strand parallel beta-sheet and six surrounding helices. Binding of the competitive inhibitor 2'-phospho-AMP (AMP, adenosine monophosphate) places the NADP binding site at the carboxyl-terminal edge of the sheet in a manner similar to the nucleotide binding of the dehydrogenase family. The structures reveal the key residues that function in cofactor binding and the catalytic center. With these key residues as a guide, conclusive evidence is presented that the ferredoxin reductase structure is a prototype for the nicotinamide dinucleotide and FAD binding domains of the enzymes NADPH-cytochrome P450 reductase, NADPH-sulfite reductase, NADH-cytochrome b5 reductase, and NADH-nitrate reductase. Thus this structure provides a structural framework for the NADH- or NADPH-dependent flavoenzyme parts of five distinct enzymes involved in photosynthesis, in the assimilation of inorganic nitrogen and sulfur, in fatty-acid oxidation, in the reduction of methemoglobin, and in the metabolism of many pesticides, drugs, and carcinogens.	UNIV WASHINGTON, DEPT BIOCHEM, SEATTLE, WA 98195 USA	University of Washington; University of Washington Seattle	KARPLUS, PA (corresponding author), CORNELL UNIV, DEPT BIOCHEM MOLEC & CELL BIOL, ITHACA, NY 14853 USA.			Karplus, Paul/0000-0001-8725-6292				APLEY EC, 1988, BIOCHIM BIOPHYS ACTA, V936, P269, DOI 10.1016/0005-2728(88)90002-3; APLEY EC, 1985, ANAL BIOCHEM, V150, P145, DOI 10.1016/0003-2697(85)90453-1; BARTON GJ, 1990, J MOL BIOL, V212, P389, DOI 10.1016/0022-2836(90)90133-7; BATIE CJ, 1984, J BIOL CHEM, V259, P1976; BATIE CJ, 1986, J BIOL CHEM, V261, P1214; Blundell T.L., 1976, PROTEIN CRYSTALLOGRA; Carrillo N, 1987, TOPICS PHOTOSYNTHESI, V8, P527; CHAN RL, 1985, ARCH BIOCHEM BIOPHYS, V240, P172, DOI 10.1016/0003-9861(85)90020-7; CIDARIA D, 1985, EUR J BIOCHEM, V146, P295, DOI 10.1111/j.1432-1033.1985.tb08652.x; CRAWFORD NM, 1988, P NATL ACAD SCI USA, V85, P5006, DOI 10.1073/pnas.85.14.5006; DAVIS DJ, 1977, ARCH BIOCHEM BIOPHYS, V184, P572, DOI 10.1016/0003-9861(77)90467-2; DICKERSON RE, 1967, ACTA CRYSTALLOGR, V23, P511, DOI 10.1107/S0365110X67003111; EGGINK G, 1990, J MOL BIOL, V212, P135, DOI 10.1016/0022-2836(90)90310-I; FAVAUDON V, 1975, BIOCHEMISTRY-US, V14, P4731, DOI 10.1021/bi00692a026; FILMAN DJ, 1982, J BIOL CHEM, V257, P13663; FUKUYAMA K, 1980, NATURE, V286, P522, DOI 10.1038/286522a0; GRAU UM, 1981, J MOL BIOL, V151, P289, DOI 10.1016/0022-2836(81)90516-7; HANIU M, 1986, BIOCHEMISTRY-US, V25, P7906, DOI 10.1021/bi00372a018; HANIU M, 1989, BIOCHEMISTRY-US, V28, P8639, DOI 10.1021/bi00447a054; HANUKOGLU I, 1989, EUR J BIOCHEM, V180, P479, DOI 10.1111/j.1432-1033.1989.tb14671.x; HEMMERICH P, 1977, ADV CHEM SER, V162, P312; HOL WGJ, 1978, NATURE, V273, P443, DOI 10.1038/273443a0; HOL WGJ, 1985, PROG BIOPHYS MOL BIO, V45, P149, DOI 10.1016/0079-6107(85)90001-X; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; KABSCH W, 1978, ACTA CRYSTALLOGR A, V34, P827, DOI 10.1107/S0567739478001680; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KARPLUS PA, 1987, J MOL BIOL, V195, P701, DOI 10.1016/0022-2836(87)90191-4; KARPLUS PA, 1989, J MOL BIOL, V210, P163, DOI 10.1016/0022-2836(89)90298-2; KARPLUS PA, 1984, BIOCHEMISTRY-US, V23, P6576, DOI 10.1021/bi00321a046; KARPLUS PA, 1982, FLAVINS FLAVOPROTEIN, P28; KIM JJP, 1988, P NATL ACAD SCI USA, V85, P6677, DOI 10.1073/pnas.85.18.6677; KOBAYASHI Y, 1990, BLOOD, V75, P1408; KRAKOW G, 1965, J BIOL CHEM, V240, P1820; LESLIE AGW, 1987, ACTA CRYSTALLOGR A, V43, P134, DOI 10.1107/S0108767387099720; LINDQVIST Y, 1989, J BIOL CHEM, V264, P3624; Massey V, 1980, BIOCHEM SOC T, V8, P246, DOI 10.1042/bst0080246; Mayhew S.G., 1975, ENZYMES, V12, P57; OSTROWSKI J, 1989, J BIOL CHEM, V264, P15796; PAI EF, 1988, BIOCHEMISTRY-US, V27, P4465, DOI 10.1021/bi00412a038; PORTER TD, 1986, BIOCHEMISTRY-US, V25, P1682, DOI 10.1021/bi00355a036; PRIESTLE JP, 1988, J APPL CRYSTALLOGR, V21, P572, DOI 10.1107/S0021889888005746; PSCHORN R, 1988, PHOTOSYNTH RES, V17, P217, DOI 10.1007/BF00035449; RICE DW, 1984, J MOL BIOL, V174, P483, DOI 10.1016/0022-2836(84)90332-2; Richardson J S, 1981, Adv Protein Chem, V34, P167, DOI 10.1016/S0065-3233(08)60520-3; Rossman M.G., 1975, ENZYMES, V11, P61, DOI 10.1016/S1874-6047(08)60210-3; ROSSMANN MG, 1974, NATURE, V250, P194, DOI 10.1038/250194a0; SABOTTKA SE, 1990, J APPL CRYSTALLOGR, V23, P199; SCHOMBURG D, 1988, J MOL GRAPHICS, V6, P161, DOI 10.1016/0263-7855(88)80069-9; SCHREUDER HA, 1988, J MOL BIOL, V199, P637, DOI 10.1016/0022-2836(88)90307-5; SCRUTTON NS, 1990, NATURE, V343, P38, DOI 10.1038/343038a0; SHERIFF S, 1981, J MOL BIOL, V145, P441, DOI 10.1016/0022-2836(81)90214-X; SHIN M, 1990, ARCH BIOCHEM BIOPHYS, V279, P97, DOI 10.1016/0003-9861(90)90467-D; SHIN M, 1965, J BIOL CHEM, V240, P1405; SHIN M, 1973, BIOCHIM BIOPHYS ACTA, V13, P292; SINGH AK, 1966, ACTA CRYSTALLOGR, V21, P279, DOI 10.1107/S0365110X66002731; SMITH WW, 1977, J MOL BIOL, V117, P195, DOI 10.1016/0022-2836(77)90031-6; STERN BK, 1960, J BIOL CHEM, V235, P209; STRITTMATTER P, 1961, J BIOL CHEM, V236, P2329; THIEME R, 1981, J MOL BIOL, V152, P763, DOI 10.1016/0022-2836(81)90126-1; TOMATSU S, 1989, GENE, V80, P353; TRONRUD DE, 1987, ACTA CRYSTALLOGR A, V43, P489, DOI 10.1107/S0108767387099124; TSUKIHARA T, 1982, BIOSYSTEMS, V15, P243, DOI 10.1016/0303-2647(82)90009-0; ULRICH GL, 1980, 9TH INT C MAGN RES B; VIEIRA BJ, 1986, BIOCHIM BIOPHYS ACTA, V851, P109, DOI 10.1016/0005-2728(86)90254-9; WANG BC, 1985, METHOD ENZYMOL, V115, P90; WIERENGA RK, 1985, BIOCHEMISTRY-US, V24, P1346, DOI 10.1021/bi00327a012; WILSON AJC, 1949, ACTA CRYSTALLOGR, V2, P318, DOI 10.1107/S0365110X49000813; XIA ZX, 1990, J MOL BIOL, V212, P837, DOI 10.1016/0022-2836(90)90240-M; YABUSAKI Y, 1988, J BIOCHEM-TOKYO, V103, P1004, DOI 10.1093/oxfordjournals.jbchem.a122370; YAO Y, 1984, J BIOCHEM-TOKYO, V95, P1513, DOI 10.1093/oxfordjournals.jbchem.a134759; YAO Y, 1985, J BIOCHEM-TOKYO, V98, P1079, DOI 10.1093/oxfordjournals.jbchem.a135355; YUBISUI T, 1984, J BIOCHEM-TOKYO, V96, P579, DOI 10.1093/oxfordjournals.jbchem.a134871; ZANETTI G, 1988, BIOCHEMISTRY-US, V27, P3753, DOI 10.1021/bi00410a035; ZANETTI G, 1983, EUR J BIOCHEM, V132, P201, DOI 10.1111/j.1432-1033.1983.tb07348.x; [No title captured]	75	489	498	3	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 4	1991	251	4989					60	66		10.1126/science.1986412	http://dx.doi.org/10.1126/science.1986412			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EQ603	1986412				2022-12-28	WOS:A1991EQ60300026
J	HOFMANN, T; KASPER, W; MEINERTZ, T; GEIBEL, A; JUST, H				HOFMANN, T; KASPER, W; MEINERTZ, T; GEIBEL, A; JUST, H			ECHOCARDIOGRAPHIC EVALUATION OF PATIENTS WITH CLINICALLY SUSPECTED ARTERIAL EMBOLI	LANCET			English	Article									UNIV FREIBURG,MED KLIN 3,W-7800 FREIBURG,GERMANY	University of Freiburg	HOFMANN, T (corresponding author), ALLGEMEINES KRANKENHAUS ST GEORG,MED KLIN 2,W-2000 HAMBURG 1,GERMANY.							ASCHENBERG W, 1986, J AM COLL CARDIOL, V7, P163, DOI 10.1016/S0735-1097(86)80275-3; BEPPU S, 1985, J AM COLL CARDIOL, V6, P744, DOI 10.1016/S0735-1097(85)80476-9; BERGERON GA, 1981, NEW ENGL J MED, V304, P489; BRAND FN, 1985, JAMA-J AM MED ASSOC, V254, P3449, DOI 10.1001/jama.254.24.3449; Close J B, 1979, J R Coll Gen Pract, V29, P547; COULSHED N, 1970, BRIT HEART J, V32, P26; EGEBLAD H, 1987, AM HEART J, V114, P648, DOI 10.1016/0002-8703(87)90765-4; ERBEL R, 1987, BRIT HEART J, V58, P45; FOGELHOLM R, 1987, BRIT MED J, V295, P305, DOI 10.1136/bmj.295.6593.305; FULKERSON PK, 1979, AM J MED, V66, P967, DOI 10.1016/0002-9343(79)90452-2; FUSTER V, 1981, AM J CARDIOL, V47, P525, DOI 10.1016/0002-9149(81)90534-8; GREENLAND P, 1981, ANN INTERN MED, V95, P51, DOI 10.7326/0003-4819-95-1-51; GUSSENHOVEN EJ, 1986, J AM COLL CARDIOL, V8, P975, DOI 10.1016/S0735-1097(86)80444-2; HOWARD RS, 1987, J NEUROL NEUROSUR PS, V50, P1142, DOI 10.1136/jnnp.50.9.1142; JESPERSEN CM, 1987, ACTA MED SCAND, V222, P37; JOHANNESSEN KA, 1988, BRIT HEART J, V60, P104; JONES HR, 1983, ANN NEUROL, V13, P314, DOI 10.1002/ana.410130315; KASPER W, 1986, Z KARDIOL, V75, P609; KOCHAR G, 1987, AM HEART J, V113, P1510, DOI 10.1016/0002-8703(87)90670-3; KOMRAD MS, 1984, NEUROLOGY, V34, P1403, DOI 10.1212/WNL.34.11.1403; LARSON EB, 1981, ANN INTERN MED, V95, P112, DOI 10.7326/0003-4819-95-1-112; LOVETT JL, 1981, ANN INTERN MED, V95, P1, DOI 10.7326/0003-4819-95-1-1; MATSUZAKI M, 1985, AM HEART J, V109, P355, DOI 10.1016/0002-8703(85)90607-6; SCHLUTER M, 1984, DEUT MED WOCHENSCHR, V109, P722, DOI 10.1055/s-2008-1069263; SCHLUTER M, 1984, AM J CARDIOL, V53, P1173, DOI 10.1016/0002-9149(84)90657-X; SHENOY MM, 1987, ARCH INTERN MED, V147, P605, DOI 10.1001/archinte.147.3.605; SHERMAN DG, 1984, ARCH NEUROL-CHICAGO, V41, P708, DOI 10.1001/archneur.1984.04050180030011; SHRESTHA NK, 1983, CIRCULATION, V67, P341, DOI 10.1161/01.CIR.67.2.341; STAFFORD WJ, 1985, BRIT HEART J, V53, P310; STERN H, 1985, Z KARDIOL, V74, P480	30	108	108	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	DEC 8	1990	336	8728					1421	1424						4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL851	1978881				2022-12-28	WOS:A1990EL85100015
J	PRELEVIC, GM; WURZBURGER, MI; BALINTPERIC, L; NESIC, JS				PRELEVIC, GM; WURZBURGER, MI; BALINTPERIC, L; NESIC, JS			INHIBITORY EFFECT OF SANDOSTATIN ON SECRETION OF LUTEINIZING-HORMONE AND OVARIAN-STEROIDS IN POLYCYSTIC-OVARY-SYNDROME	LANCET			English	Article									UNIV BELGRADE, MED CTR ZVEZDARA, SCH MED, DIV ENDOCRINOL, BELGRADE, YUGOSLAVIA	University of Belgrade								ADAMS J, 1986, BRIT MED J, V293, P355, DOI 10.1136/bmj.293.6543.355; ADASHI EY, 1981, ENDOCRINOLOGY, V108, P1441, DOI 10.1210/endo-108-4-1441; BURGHEN GA, 1980, J CLIN ENDOCR METAB, V50, P113, DOI 10.1210/jcem-50-1-113; CHANG RJ, 1983, J CLIN ENDOCR METAB, V57, P356, DOI 10.1210/jcem-57-2-356; CHIODERA P, 1986, GYNECOL OBSTET INVES, V22, P17, DOI 10.1159/000298884; CLARKE IJ, 1982, ENDOCRINOLOGY, V111, P1737, DOI 10.1210/endo-111-5-1737; DUNAIF A, 1989, J CLIN INVEST, V83, P23, DOI 10.1172/JCI113864; HOMBURG R, 1988, BRIT MED J, V297, P1024, DOI 10.1136/bmj.297.6655.1024; HOMBURG R, 1988, CLIN ENDOCRINOL, V29, P113, DOI 10.1111/j.1365-2265.1988.tb00252.x; LANZONE A, 1990, GYNECOL OBSTET INVES, V29, P149, DOI 10.1159/000293322; LIGHTMAN SL, 1986, SCAND J GASTROENTERO, V21, P84, DOI 10.3109/00365528609087435; MATTHEWS JNS, 1990, BRIT MED J, V300, P230, DOI 10.1136/bmj.300.6719.230; MILLAR RP, 1982, CLIN ENDOCRINOL, V17, P103, DOI 10.1111/j.1365-2265.1982.tb01569.x; PASQUALI R, 1982, HORM METAB RES, V14, P284, DOI 10.1055/s-2007-1018996; PRELEVIC GM, 1987, EXP CLIN ENDOCRINOL, V90, P76, DOI 10.1055/s-0029-1210675; PRELEVIC GM, 1990, GYNECOL ENDOCRINOL, V4, P1, DOI 10.3109/09513599009030686; SHOUPE D, 1983, AM J OBSTET GYNECOL, V147, P588, DOI 10.1016/0002-9378(83)90023-6; URBAN RJ, 1989, ENDOCRINOLOGY, V124, P2541, DOI 10.1210/endo-124-5-2541; VELDHUIS JD, 1986, AM J PHYSIOL, V250, pE486, DOI 10.1152/ajpendo.1986.250.4.E486; VOLPE A, 1989, GYNECOL ENDOCRINOL, V3, P125, DOI 10.3109/09513598909152459; YEN SSC, 1980, CLIN ENDOCRINOL, V12, P177, DOI 10.1111/j.1365-2265.1980.tb02132.x	21	93	94	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 13	1990	336	8720					900	903		10.1016/0140-6736(90)92270-R	http://dx.doi.org/10.1016/0140-6736(90)92270-R			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EC456	1976930				2022-12-28	WOS:A1990EC45600004
J	JOHNSTON, AM				JOHNSTON, AM			VETERINARY SOURCES OF FOODBORNE ILLNESS	LANCET			English	Article											JOHNSTON, AM (corresponding author), UNIV LONDON, ROYAL VET COLL, HAWKSHEAD LANE, HATFIELD AL9 7TA, HERTS, ENGLAND.							DAVIDSON RJ, 1989, CAN I FOOD SC TECH J, V22, P70, DOI 10.1016/S0315-5463(89)70304-7; DORN CR, 1989, EPIDEMIOL INFECT, V103, P83, DOI 10.1017/S0950268800030387; FENLON DR, 1985, J APPL BACTERIOL, V59, P537, DOI 10.1111/j.1365-2672.1985.tb03357.x; FENLON DR, 1989, J APPL BACTERIOL, V66, P191, DOI 10.1111/j.1365-2672.1989.tb02469.x; GITTER M, 1980, VET REC, V107, P390, DOI 10.1136/vr.107.17.390; JEWERS K, 1982, J ROY SOC HEALTH, V3, P114; JOHNSTON AM, 1990, OUTLOOK AGR, V19, P73, DOI 10.1177/003072709001900203; JONES F, 1985, J APPL BACTERIOL S, P275; KIRKPATRICK CE, 1989, COMP CONT EDUC PRACT, V11, P80; MCEWEN SA, 1988, J FOOD PROTECT, V51, P963, DOI 10.4315/0362-028X-51.12.963; MEANGER JD, 1989, NEW ZEAL VET J, V37, P18, DOI 10.1080/00480169.1989.35540; REILLY WJ, 1981, VET REC, V108, P553, DOI 10.1136/vr.108.26.553; SKOVGAARD N, 1988, INT J FOOD MICROBIOL, V6, P229, DOI 10.1016/S0168-1605(00)00432-3; TAY SCK, 1989, J FOOD PROTECT, V52, P202, DOI 10.4315/0362-028X-52.3.202; WOOD J, 1989, CAN VET J, V30, P833	15	10	10	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 6	1990	336	8719					856	858		10.1016/0140-6736(90)92350-Q	http://dx.doi.org/10.1016/0140-6736(90)92350-Q			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB901	1976885	Green Published			2022-12-28	WOS:A1990EB90100013
J	GUASTELLA, J; NELSON, N; NELSON, H; CZYZYK, L; KEYNAN, S; MIEDEL, MC; DAVIDSON, N; LESTER, HA; KANNER, BI				GUASTELLA, J; NELSON, N; NELSON, H; CZYZYK, L; KEYNAN, S; MIEDEL, MC; DAVIDSON, N; LESTER, HA; KANNER, BI			CLONING AND EXPRESSION OF A RAT-BRAIN GABA TRANSPORTER	SCIENCE			English	Article									HEBREW UNIV JERUSALEM,HADASSAH MED SCH,DEPT BIOCHEM,IL-91010 JERUSALEM,ISRAEL; ROCHE RES CTR,ROCHE INST MOLEC BIOL,NUTLEY,NJ 07110; CALTECH,DIV BIOL,PASADENA,CA 91125	Hebrew University of Jerusalem; Roche Holding; California Institute of Technology					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029836] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS016708, R01NS016708] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 10991, GM 29836] Funding Source: Medline; NINDS NIH HHS [NS 16708] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AUFFRAY C, 1980, EUR J BIOCHEM, V107, P303; BLAKELY RD, 1988, P NATL ACAD SCI USA, V85, P9846, DOI 10.1073/pnas.85.24.9846; BOWERY NG, 1976, NATURE, V264, P281, DOI 10.1038/264281a0; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; GRENNINGLOH G, 1987, NATURE, V328, P215, DOI 10.1038/328215a0; GUASTELLA J, UNPUB; HEDIGER MA, 1987, NATURE, V330, P379, DOI 10.1038/330379a0; HOSHINO T, 1990, MOL GEN GENET, V220, P461, DOI 10.1007/BF00391754; IVERSEN LL, 1975, BIOCHEM PHARMACOL, V24, P933, DOI 10.1016/0006-2952(75)90422-0; KANNER BI, 1978, BIOCHEMISTRY-US, V17, P1207, DOI 10.1021/bi00600a011; KANNER BI, 1989, BIOCHEMISTRY-US, V28, P3722, DOI 10.1021/bi00435a015; KOPITO RR, 1989, CELL, V59, P927, DOI 10.1016/0092-8674(89)90615-6; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LODISH HF, 1988, TRENDS BIOCHEM SCI, V13, P332, DOI 10.1016/0968-0004(88)90101-6; MANDEL M, 1988, P NATL ACAD SCI USA, V85, P5521, DOI 10.1073/pnas.85.15.5521; MARTIN D, 1976, GABA NERVOUS SYSTEM, P357; NAKAO T, 1987, MOL GEN GENET, V208, P70, DOI 10.1007/BF00330424; RADIAN R, 1986, J BIOL CHEM, V261, P5437; SARDET C, 1989, CELL, V56, P271, DOI 10.1016/0092-8674(89)90901-X; SCHOFIELD PR, 1987, NATURE, V328, P221, DOI 10.1038/328221a0; SCHON F, 1974, BRAIN RES, V66, P275, DOI 10.1016/0006-8993(74)90146-2; SCHON F, 1974, BRAIN RES, V66, P289, DOI 10.1016/0006-8993(74)90147-4; SCHOUSBOE A, 1979, J NEUROCHEM, V33, P181, DOI 10.1111/j.1471-4159.1979.tb11720.x; SCHOUSBOE A, 1986, J NEUROCHEM, V47, P758; SNUTCH TP, 1990, P NATL ACAD SCI USA, V87, P3391, DOI 10.1073/pnas.87.9.3391; VONHEIJNE G, 1983, EUR J BIOCHEM, V133, P17; WOOD JD, 1987, J NEUROCHEM, V49, P1202, DOI 10.1111/j.1471-4159.1987.tb10011.x; ZALESKA MM, 1987, P NATL ACAD SCI USA, V84, P1709, DOI 10.1073/pnas.84.6.1709	32	744	781	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	SEP 14	1990	249	4974					1303	1306		10.1126/science.1975955	http://dx.doi.org/10.1126/science.1975955			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DY351	1975955				2022-12-28	WOS:A1990DY35100041
